PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sakamoto, A; Terui, Y; Uemura, T; Igarashi, K; Kashiwagi, K				Sakamoto, Akihiko; Terui, Yusuke; Uemura, Takeshi; Igarashi, Kazuei; Kashiwagi, Keiko			Polyamines regulate gene expression by stimulating translation of histone acetyltransferase mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						polyamine; spermidine; gene expression; histone modification; histone acetyltransferase; polyamine modulon; translational regulation; histone acetyltransferase GCN5 (GCN5); histone acetyltransferase 1 (HAT1); miR-7648-5p; histone acetylase; translation regulation; miR-7648-5p	PROTEIN-SYNTHESIS; CELL-GROWTH; IN-VIVO; MODULATION; ACTIVATION; REPRESSION; COMPLEXES; PCNA	Polyamines regulate gene expression inEscherichia coliby translationally stimulating mRNAs encoding global transcription factors. In this study, we focused on histone acetylation, one of the mechanisms of epigenetic regulation of gene expression, to attempt to clarify the role of polyamines in the regulation of gene expression in eukaryotes. We found that activities of histone acetyltransferases in both the nucleus and cytoplasm decreased significantly in polyamine-reduced mouse mammary carcinoma FM3A cells. Although protein levels of histones H3 and H4 did not change in control and polyamine-reduced cells, acetylation of histones H3 and H4 was greatly decreased in the polyamine-reduced cells. Next, we used control and polyamine-reduced cells to identify histone acetyltransferases whose synthesis is stimulated by polyamines. We found that polyamines stimulate the translation of histone acetyltransferases GCN5 and HAT1. Accordingly, GCN5- and HAT1-catalyzed acetylation of specific lysine residues on histones H3 and H4 was stimulated by polyamines. Consistent with these findings, transcription of genes required for cell proliferation was enhanced by polyamines. These results indicate that polyamines regulate gene expression by enhancing the expression of the histone acetyltransferases GCN5 and HAT1 at the level of translation. Mechanistically, polyamines enhanced the interaction of microRNA-7648-5p (miR-7648-5p) with the 5?-UTR of GCN5 mRNA, resulting in stimulation of translation due to the destabilization of the double-stranded RNA (dsRNA) between the 5?-UTR and the ORF of GCN5 mRNA. Because HAT1 mRNA has a short 5?-UTR, polyamines may enhance initiation complex formation directly on this mRNA.	[Sakamoto, Akihiko; Terui, Yusuke; Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Choshi, Chiba, Japan; [Uemura, Takeshi; Igarashi, Kazuei] Amine Pharma Res Inst, Chiba, Japan; [Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan	Chiba University	Kashiwagi, K (corresponding author), Chiba Inst Sci, Fac Pharm, Choshi, Chiba, Japan.	kkashiwagi@cis.ac.jp		Sakamoto, Akihiko/0000-0002-1447-4691	Ministry of Education, Culture, Sports, Science and Technology, Japan [19K16357]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (19K16357).	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chae YB, 2014, INT J BIOL MACROMOL, V63, P56, DOI 10.1016/j.ijbiomac.2013.10.041; Di Martile M, 2016, ONCOTARGET, V7, P55789, DOI 10.18632/oncotarget.10048; Farria A, 2015, ONCOGENE, V34, P4901, DOI 10.1038/onc.2014.453; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Higashi K, 2008, BIOCHEM BIOPH RES CO, V370, P572, DOI 10.1016/j.bbrc.2008.03.137; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Igarashi K, 2019, INT J BIOCHEM CELL B, V107, P104, DOI 10.1016/j.biocel.2018.12.012; Igarashi K, 2018, J BIOL CHEM, V293, P18702, DOI 10.1074/jbc.TM118.003465; Igarashi K, 2015, IUBMB LIFE, V67, P160, DOI 10.1002/iub.1363; Imamura M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33549; Jurikova M, 2016, ACTA HISTOCHEM, V118, P544, DOI 10.1016/j.acthis.2016.05.002; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lee CY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08011-1; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Nakano S, 2004, J AM CHEM SOC, V126, P1088, DOI 10.1021/ja037314h; Narita T, 2019, NAT REV MOL CELL BIO, V20, P156, DOI 10.1038/s41580-018-0081-3; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; Nishimura K, 2009, INT J BIOCHEM CELL B, V41, P2251, DOI 10.1016/j.biocel.2009.04.021; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Parthun MR, 2007, ONCOGENE, V26, P5319, DOI 10.1038/sj.onc.1210602; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shimogori T, 1996, BIOCHEM BIOPH RES CO, V223, P544, DOI 10.1006/bbrc.1996.0931; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SU LS, 1993, GENE DEV, V7, P735, DOI 10.1101/gad.7.5.735; Terui Y, 2015, AMINO ACIDS, V47, P345, DOI 10.1007/s00726-014-1867-z; Trisciuoglio D, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8908751; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Yamaguchi K, 2018, BIOCHEM J, V475, P3797, DOI 10.1042/BCJ20180672; Yang XH, 2013, J BIOL CHEM, V288, P18271, DOI 10.1074/jbc.M113.473199	41	10	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8736	8745		10.1074/jbc.RA120.013833	http://dx.doi.org/10.1074/jbc.RA120.013833			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32376690	Green Published, hybrid			2022-12-26	WOS:000546296800010
J	Jomura, M; Kuwayama, T; Soma, Y; Yamaguchi, M; Komatsu, M; Maruyama, Y				Jomura, Mayuko; Kuwayama, Tomoko; Soma, Yuto; Yamaguchi, Muneyoshi; Komatsu, Masabumi; Maruyama, Yutaka			Mycelial biomass estimation and metabolic quotient of Lentinula edodes using species-specific qPCR	PLOS ONE			English	Article							MICROBIAL RESPIRATION; FUNGAL BIOMASS; DECOMPOSITION; NITROGEN; WOOD	Lentinula edodes, commonly known as shiitake, is an edible mushroom that is cultivated and consumed around the globe, especially in Asia. Monitoring mycelial growth inside a woody substrate is difficult, but it is essential for effective management of mushroom cultivation. Mycelial biomass also affects the rate of wood decomposition under natural conditions and must be known to determine the metabolic quotient, an important ecophysiological parameter of fungal growth. Therefore, developing a method to measure it inside a substrate would be very useful. In this study, as the first step in understanding species-specific rates of fungal decomposition of wood, we developed species-specific primers and qPCR procedures for L. edodes. We tested primer specificity using strains of L. edodes from Japan and Southeast Asia, as well as related species of fungi and plant species for cultivation of L. edodes, and generated a calibration curve for quantification of mycelial biomass in wood dust inoculated with L. edodes. The qPCR procedure we developed can specifically detect L. edodes and allowed us to quantify the increase in L. edodes biomass in wood dust substrate and calculate the metabolic quotient based on the mycelial biomass and respiration rate. Development of a species-specific method for biomass quantification will be useful for both estimation of mycelial biomass and determining the kinetics of fungal growth in decomposition processes.	[Jomura, Mayuko; Kuwayama, Tomoko; Soma, Yuto; Maruyama, Yutaka] Nihon Univ, Coll Bioresource Sci, Dept Forest Sci & Resources, Fujisawa, Kanagawa, Japan; [Yamaguchi, Muneyoshi; Komatsu, Masabumi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki, Japan	Nihon University; Forestry & Forest Products Research Institute - Japan	Jomura, M (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Forest Sci & Resources, Fujisawa, Kanagawa, Japan.	joumura.mayuko@nihon-u.ac.jp		Komatsu, Masabumi/0000-0003-4826-4219; Jomura, Mayuko/0000-0002-9858-3771	Japan Society for the Promotion of Science [17K07848]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (Grant No. 17K07848) from the Japan Society for the Promotion of Science to MJ. https://www.jsps.go.jp/english/index.html The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TH, 1993, SOIL BIOL BIOCHEM, V25, P393, DOI 10.1016/0038-0717(93)90140-7; [Anonymous], 2017, R LANG ENV STAT COMP; Ayliffe M, 2013, MOL PLANT MICROBE IN, V26, P658, DOI 10.1094/MPMI-12-12-0291-R; Baldrian P, 2016, FUNGAL ECOL, V23, P109, DOI 10.1016/j.funeco.2016.07.001; Baldrian P, 2013, FUNGAL ECOL, V6, P1, DOI 10.1016/j.funeco.2012.10.002; Brabcova V, 2018, SOIL BIOL BIOCHEM, V118, P187, DOI 10.1016/j.soilbio.2017.12.012; Bradford MA, 2014, NAT CLIM CHANGE, V4, P625, DOI [10.1038/NCLIMATE2251, 10.1038/nclimate2251]; Chiu SW, 1999, MYCOL RES, V103, P651, DOI 10.1017/S095375629900859X; Fukasawa Y, 2011, MYCOLOGIA, V103, P474, DOI 10.3852/10-246; Hibbett DS, 1998, MYCOL RES, V102, P1041, DOI 10.1017/S0953756297005996; Insam H, 1996, SOIL BIOL BIOCHEM, V28, P691, DOI 10.1016/0038-0717(95)00182-4; Kauserud H, 2012, P NATL ACAD SCI USA, V109, P14488, DOI 10.1073/pnas.1200789109; Leonhardt S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212120; Moorhead D. L., 2013, FRONT MICROBIOL, V4; Nagai Masaru, 2007, Mycoscience, V48, P125, DOI 10.1007/s10267-006-0334-4; Pegler D.N., 1983, SYDOWIA, V36, P227; Song ZW, 2015, MICROB ECOL, V69, P758, DOI 10.1007/s00248-015-0588-5; Spohn M, 2015, SOIL BIOL BIOCHEM, V81, P128, DOI 10.1016/j.soilbio.2014.11.008; Spohn M, 2015, BIOGEOSCIENCES, V12, P817, DOI 10.5194/bg-12-817-2015; Thirukkumaran CM, 2000, SOIL BIOL BIOCHEM, V32, P59, DOI 10.1016/S0038-0717(99)00129-7; Ugawa S, 2012, SOIL SCI PLANT NUTR, V58, P510, DOI 10.1080/00380768.2012.700462; Wardle DA, 1995, SOIL BIOL BIOCHEM, V27, P1601, DOI 10.1016/0038-0717(95)00093-T; Xu XF, 2017, ECOL MONOGR, V87, P429, DOI 10.1002/ecm.1258; Yamaguchi M, 2016, MYCORRHIZA, V26, P847, DOI 10.1007/s00572-016-0718-z	24	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0232049	10.1371/journal.pone.0232049	http://dx.doi.org/10.1371/journal.pone.0232049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421692	Green Published, gold			2022-12-26	WOS:000537499600007
J	Coussa-Koniski, ML; Saliba, E; Welty, FK; Deeb, M				Coussa-Koniski, Marie-Louise; Saliba, Elie; Welty, Francine K.; Deeb, Mary			Epidemiological characteristics of obstructive sleep apnea in a hospital-based historical cohort in Lebanon	PLOS ONE			English	Article							GENDER-RELATED DIFFERENCES; DAYTIME SLEEPINESS; PREVALENCE; RISK; SYMPTOMS; NOCTURIA; POPULATION; WOMEN; COMORBIDITIES; HYPERTENSION	The objective of our study was to characterize and analyze the associations between OSA (obstructive sleep apnea) and other clinical variables in adult patients referred for sleep evaluation by polysomnography at a referral center in Beirut, Lebanon, in terms of sociodemographic features, symptoms presentation and comorbidities, and evaluate the burden of comorbidities associated with this disease. All individuals with suspected Sleep Apnea referred (January 2010-September 2017) for a one-night polysomnography were included. Demographics, self-reported symptoms and comorbidities were documented. The relationship between OSA severity and the presence of symptoms and comorbidities were evaluated using multivariate logistic regression. Overall, 663 subjects were assessed. Of these, 57.3% were referred from chest physicians, and sleep test results were abnormal in 589 subjects (88.8%) of whom 526 patients (89.3%) fulfilled diagnostic criteria for OSA; 76.3% were men and women were on average older. OSA was severe in 43.2% and more severe in men. Almost all patients were symptomatic with similar to 2-4 symptoms per patient and women presented with symptoms that are more atypical. Comorbidities were significantly higher in women. In the multivariate analysis, age, male sex, obesity, symptoms of snoring, excessive daytime somnolence and witnessed apneas were associated with OSA severity. Only age and obesity were associated with self-reported diagnosis of hypertension and diabetes. This is the first study in Lebanon to explore the characteristics of patients with polysomnography-diagnosed OSA. High prevalence of severe OSA and low referral rates in the medical community support promoting awareness for an earlier diagnosis and more personalized approach in this country.	[Coussa-Koniski, Marie-Louise] Lebanese Amer Univ, Resp Div, Med Ctr, Rizk Hosp LAUMC RH, Beirut, Lebanon; [Saliba, Elie; Deeb, Mary] Lebanese Amer Univ, Gilbert & Rose Marie Chagoury Sch Med, Byblos, Lebanon; [Welty, Francine K.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Lebanese American University; Lebanese American University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Deeb, M (corresponding author), Lebanese Amer Univ, Gilbert & Rose Marie Chagoury Sch Med, Byblos, Lebanon.	mary.deeb@gmail.com	Coussa-Koniski, Marie-Louise/ABD-2413-2020	Coussa-Koniski, Marie-Louise/0000-0002-0444-0148; Saliba, Elie/0000-0001-5994-3212	Philips	Philips	The research was funded by a grant from Philips. The funding body was not involved in the design or conduct of the study, collection, management, analysis or interpretation of data, preparation or review of the manuscript.	Almendros I, 2018, RESP PHYSIOL NEUROBI, V256, P79, DOI 10.1016/j.resp.2017.08.008; Martinez-Garcia MA, 2019, AM J RESP CRIT CARE, V200, P1345, DOI 10.1164/rccm.201903-0577PP; BaHammam AS, 2008, SAUDI MED J, V29, P423; BaHammam AS, 2009, SAUDI MED J, V30, P1572; Baldwin CM, 2004, SLEEP, V27, P305, DOI 10.1093/sleep/27.2.305; Basoglu OK, 2018, SLEEP BREATH, V22, P241, DOI 10.1007/s11325-017-1482-9; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Dixon JB, 2007, OBESITY, V15, P2504, DOI 10.1038/oby.2007.297; Feldstein CA, 2013, J AM SOC HYPERTENS, V7, P75, DOI 10.1016/j.jash.2012.12.004; Feng J, 2012, SLEEP BREATH, V16, P31, DOI 10.1007/s11325-011-0481-5; Franklin KA, 2015, J THORAC DIS, V7, P1311, DOI 10.3978/j.issn.2072-1439.2015.06.11; Gozal D, 2016, SLEEP, V39, P1493, DOI 10.5665/sleep.6004; Greenberg-Dotan S, 2007, SLEEP, V30, P1173, DOI 10.1093/sleep/30.9.1173; Guo J, 2016, SLEEP BREATH, V20, P965, DOI 10.1007/s11325-016-1319-y; Hajduk IA, 2003, SLEEP, V26, P61; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Hoyos CM, 2017, RESPIROLOGY, V22, P420, DOI 10.1111/resp.12984; Iber C., 2007, AASM MANUAL SCORING; Javaheri S, 2017, J AM COLL CARDIOL, V69, P841, DOI 10.1016/j.jacc.2016.11.069; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jordan AS, 2014, LANCET, V383, P736, DOI 10.1016/S0140-6736(13)60734-5; Kapur VK, 2008, SLEEP, V31, P1127; Kaynak H, 2004, J SLEEP RES, V13, P173, DOI 10.1111/j.1365-2869.2004.00400.x; Kendzerska T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001599; Khassawneh B, 2009, SLEEP BREATH, V13, P227, DOI 10.1007/s11325-008-0240-4; Krystal A D, 1998, Sleep Med Rev, V2, P243, DOI 10.1016/S1087-0792(98)90011-9; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Lacedonia D, 2018, CLIN RESPIR J, V12, P1905, DOI 10.1111/crj.12754; Mahboub B, 2013, INT J GEN MED, V6, P109, DOI 10.2147/IJGM.S40001; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Marrone O, 2013, EUR J CLIN INVEST, V43, P27, DOI 10.1111/eci.12011; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Peppard PE, 2018, AM J RESP CRIT CARE, V197, P310, DOI 10.1164/rccm.201708-1614PP; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Ren R, 2016, HYPERTENSION, V68, P1264, DOI 10.1161/HYPERTENSIONAHA.115.06941; Ryan S, 2009, POSTGRAD MED J, V85, P693, DOI 10.1136/thx.2008.105577; Senaratna CV, 2017, SLEEP MED REV, V34, P70, DOI 10.1016/j.smrv.2016.07.002; Shepertycky MR, 2005, SLEEP, V28, P309; Sillah A, 2019, PREV MED REP, V15, DOI 10.1016/j.pmedr.2019.100886; Umlauf MG, 2004, SLEEP, V27, P139, DOI 10.1093/sleep/27.1.139; Valipour A, 2012, Pneumologie, V66, P584, DOI 10.1055/s-0032-1325664; Valipour A, 2007, SLEEP, V30, P312, DOI 10.1093/sleep/30.3.312; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van Kerrebroeck P, 2002, NEUROUROL URODYNAM, V21, P179, DOI 10.1002/nau.10053; Vats MG, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/9673054; Weaver TE, 2007, SLEEP MED REV, V11, P99, DOI 10.1016/j.smrv.2006.08.001; Yoshimura K, 2012, INT J UROL, V19, P317, DOI 10.1111/j.1442-2042.2011.02956.x; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; Young T, 1996, ARCH INTERN MED, V156, P2445, DOI 10.1001/archinte.156.21.2445; Zhang XB, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12427	52	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0231528	10.1371/journal.pone.0231528	http://dx.doi.org/10.1371/journal.pone.0231528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413035	gold, Green Published			2022-12-26	WOS:000537496000011
J	Gilley, KN; Wierenga, KA; Chauhuan, PS; Wagner, JG; Lewandowski, RP; Ross, EA; Lock, AL; Harkema, JR; Benninghoff, AD; Pestka, JJ				Gilley, Kristen N.; Wierenga, Kathryn A.; Chauhuan, Preeti S.; Wagner, James G.; Lewandowski, Ryan P.; Ross, Elizbeth A.; Lock, A. L.; Harkema, Jack R.; Benninghoff, Abby D.; Pestka, James J.			Influence of total western diet on docosahexaenoic acid suppression of silica-triggered lupus flaring in NZBWF1 mice	PLOS ONE			English	Article							FATTY-ACIDS; INTERFERON-ALPHA; DISEASE-ACTIVITY; ADIPOSE-TISSUE; ERYTHEMATOSUS; BLOOD; EXPOSURE; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; PHAGOCYTOSIS	Lupus is a debilitating multi-organ autoimmune disease clinically typified by periods of flare and remission. Exposing lupus-prone female NZBWF1 mice to crystalline silica (cSiO(2)), a known human autoimmune trigger, mimics flaring by inducing interferon-related gene (IRG) expression, inflammation, ectopic lymphoid structure (ELS) development, and autoantibody production in the lung that collectively accelerate glomerulonephritis. cSiO(2)-triggered flaring in this model can be prevented by supplementing mouse diet with the omega-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid (DHA). A limitation of previous studies was the use of purified diet that, although optimized for rodent health, does not reflect the high American intake of saturated fatty acid (SFA), omega-6 PUFAs, and total fat. To address this, we employed here a modified Total Western Diet (mTWD) emulating the 50th percentile U.S. macronutrient distribution to discern how DHA supplementation and/or SFA and omega-6 reduction influences cSiO(2)-triggered lupus flaring in female NZBWF1 mice. Six-week-old mice were fed isocaloric experimental diets for 2 wks, intranasally instilled with cSiO(2) or saline vehicle weekly for 4 wks, and tissues assessed for lupus endpoints 11 wks following cSiO(2) instillation. In mice fed basal mTWD, cSiO(2) induced robust IRG expression, proinflammatory cytokine and chemokine elevation, leukocyte infiltration, ELS neogenesis, and autoantibody production in the lung, as well as early kidney nephritis onset compared to vehicle-treated mice fed mTWD. Consumption of mTWD containing DHA at the caloric equivalent to a human dose of 5 g/day dramatically suppressed induction of all lupus-associated endpoints. While decreasing SFA and omega-6 in mTWD modestly inhibited some disease markers, DHA addition to this diet was required for maximal protection against lupus development. Taken together, DHA supplementation at a translationally relevant dose was highly effective in preventing cSiO(2)-triggered lupus flaring in NZBWF1 mice, even against the background of a typical Western diet.	[Gilley, Kristen N.; Chauhuan, Preeti S.; Ross, Elizbeth A.; Pestka, James J.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Wierenga, Kathryn A.; Chauhuan, Preeti S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Wierenga, Kathryn A.; Wagner, James G.; Harkema, Jack R.; Pestka, James J.] Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA; [Wagner, James G.; Lewandowski, Ryan P.; Harkema, Jack R.] Michigan State Univ, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA; [Lock, A. L.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Benninghoff, Abby D.] Utah State Univ, Dept Anim Dairy & Vet Sci, Sch Vet Med, Logan, UT 84322 USA; [Pestka, James J.] Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University; Utah System of Higher Education; Utah State University	Pestka, JJ (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.; Pestka, JJ (corresponding author), Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA.; Benninghoff, AD (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Sch Vet Med, Logan, UT 84322 USA.; Pestka, JJ (corresponding author), Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	Abby.Benninghoff@usu.edu; pestka@msu.edu	Benninghoff, Abby/F-7694-2011; Lock, Adam/HCH-4180-2022; Benninghoff, Abby/AAK-6775-2020; Chauhan, Preeti Singh/GWZ-4774-2022	Benninghoff, Abby/0000-0002-7993-0117; Chauhan, Preeti Singh/0000-0001-8806-9552; Pestka, James/0000-0003-4689-2756; Wierenga, Kathryn/0000-0003-1725-4616	NIH [ES027353, F31ES030593, T32ES007255]; Lupus Foundation of America; USDA National Institute of Food and Agriculture Hatch Projects [1020129, UTA01407, UTA-01456]; Dr. Robert and Carol Deibel Family Endowment	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Foundation of America; USDA National Institute of Food and Agriculture Hatch Projects; Dr. Robert and Carol Deibel Family Endowment	This research was funded by NIH ES027353 (JP), NIH F31ES030593 (KW), NIH T32ES007255 (KW), Lupus Foundation of America (JP, KW), USDA National Institute of Food and Agriculture Hatch Projects 1020129 (JP) and UTA01407 and UTA-01456 (AB), and the Dr. Robert and Carol Deibel Family Endowment (JP).	Aghdassi E, 2011, JPEN-PARENTER ENTER, V35, P198, DOI 10.1177/0148607110386378; Akbar U, 2017, JCR-J CLIN RHEUMATOL, V23, P330, DOI 10.1097/RHU.0000000000000563; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; ANSEL JC, 1985, J INVEST DERMATOL, V85, P181, DOI 10.1111/1523-1747.ep12276652; Bates MA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00632; Bates MA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02002; Bates MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160622; Bates MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125481; Lozovoy MAB, 2015, MAR DRUGS, V13, P1071, DOI 10.3390/md13021071; Bauer JW, 2009, ARTHRITIS RHEUM-US, V60, P3098, DOI 10.1002/art.24803; Benninghoff AD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02851; BEYNEN AC, 1980, AM J CLIN NUTR, V33, P81, DOI 10.1093/ajcn/33.1.81; Brandenberger C, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-26; Browning LM, 2012, AM J CLIN NUTR, V96, P748, DOI 10.3945/ajcn.112.041343; Calder PC, 2017, BIOCHEM SOC T, V45, P1105, DOI 10.1042/BST20160474; Clark KL, 2015, J AUTOIMMUN, V65, P38, DOI 10.1016/j.jaut.2015.08.005; Crow MK, 2019, ANNU REV PATHOL-MECH, V14, P369, DOI 10.1146/annurev-pathol-020117-043952; Dai C, 2014, CLIN IMMUNOL, V154, P66, DOI 10.1016/j.clim.2014.06.008; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; DUBOIS EL, 1966, J AMER MED ASSOC, V195, P285, DOI 10.1001/jama.195.4.285; Duffy EM, 2004, J RHEUMATOL, V31, P1551; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; Fenton JI, 2016, PROSTAG LEUKOTR ESS, V112, P12, DOI 10.1016/j.plefa.2016.06.004; Furie R, 2017, ARTHRITIS RHEUMATOL, V69, P376, DOI 10.1002/art.39962; Gatto M, 2019, NAT REV RHEUMATOL, V15, P30, DOI 10.1038/s41584-018-0133-2; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gonzalez-Quintial R, 2019, CLIN IMMUNOL, V205, P75, DOI 10.1016/j.clim.2019.06.003; Gurzell EA, 2014, PROSTAG LEUKOTR ESS, V91, P87, DOI 10.1016/j.plefa.2014.04.001; Hintze KJ, 2016, PROSTAG LEUKOTR ESS, V111, P37, DOI 10.1016/j.plefa.2016.03.003; Hintze KJ, 2018, ADV NUTR, V9, P263, DOI 10.1093/advances/nmy002; Hintze KJ, 2012, J AGR FOOD CHEM, V60, P6736, DOI 10.1021/jf204509a; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Innes JK, 2018, PROSTAG LEUKOTR ESS, V132, P41, DOI 10.1016/j.plefa.2018.03.004; Jacob N, 2011, J IMMUNOL, V186, P4984, DOI 10.4049/jimmunol.1000466; Joshi GN, 2017, METHODS MOL BIOL, V1519, P55, DOI 10.1007/978-1-4939-6581-6_5; Joshi GN, 2013, APOPTOSIS, V18, P271, DOI 10.1007/s10495-012-0798-y; Khamashta M, 2016, ANN RHEUM DIS, V75, P1909, DOI 10.1136/annrheumdis-2015-208562; Liu Z, 2011, ARTHRITIS RHEUM-US, V63, P219, DOI 10.1002/art.30087; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Metcalf RG, 2010, AM J CLIN NUTR, V91, P528, DOI 10.3945/ajcn.2009.28302; Metherel AH, 2019, AM J CLIN NUTR, V110, P823, DOI 10.1093/ajcn/nqz097; Morand R., 2019, ARTHR RHEUMATOL S10, V71; Navarini L, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5264195; NIAID Autoimmune Diseases Coordinating Committee, 2005, PROGR AUT DIS RES; Ostermann AI, 2017, FOOD FUNCT, V8, P2355, DOI [10.1039/c7fo00403f, 10.1039/C7FO00403F]; Parks CG, 2014, LUPUS, V23, P527, DOI 10.1177/0961203313511680; Parks CG, 2002, ARTHRITIS RHEUM-US, V46, P1840, DOI 10.1002/art.10368; Parks CG, 2017, BEST PRACT RES CL RH, V31, P306, DOI 10.1016/j.berh.2017.09.005; Parks EJ, 1999, J CLIN INVEST, V104, P1087, DOI 10.1172/JCI6572; Pestka JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100255; Pestka JJ, 2010, PROSTAG LEUKOTR ESS, V82, P251, DOI 10.1016/j.plefa.2010.02.013; Pons-Estel GJ, 2017, EXPERT REV CLIN IMMU, V13, P799, DOI 10.1080/1744666X.2017.1327352; Poppitt Sally D, 2005, Lipids Health Dis, V4, P30, DOI 10.1186/1476-511X-4-30; Ruperto N, 2011, LUPUS, V20, P453, DOI 10.1177/0961203310388445; Sang A, 2012, PROG MOL BIOL TRANSL, V105, P321, DOI 10.1016/B978-0-12-394596-9.00010-X; Schuchardt JP, 2016, PROSTAG LEUKOTR ESS, V115, P12, DOI 10.1016/j.plefa.2016.10.005; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Syrett CM, 2020, J AUTOIMMUN, V107, DOI 10.1016/j.jaut.2019.102357; Ulff-Moller CJ, 2018, ARTHRITIS RHEUMATOL, V70, P878, DOI 10.1002/art.40422; Vordenbaumen S, 2020, LUPUS, V29, P554, DOI 10.1177/0961203320912326; Vupputuri S, 2012, RENAL FAILURE, V34, P40, DOI 10.3109/0886022X.2011.623496; Walker RE, 2019, AM J CLIN NUTR, V110, P1034, DOI 10.1093/ajcn/nqz161; Wierenga KA, 2019, TOXICOL PATHOL, V47, P1004, DOI 10.1177/0192623319878398; Wolf SJ, 2019, J AUTOIMMUN, V103, DOI 10.1016/j.jaut.2019.06.002; Wright SA, 2008, ANN RHEUM DIS, V67, P841, DOI 10.1136/ard.2007.077156; Yu F, 2017, NAT REV NEPHROL, V13, P483, DOI 10.1038/nrneph.2017.85; Zock PL, 1997, AM J EPIDEMIOL, V145, P1114, DOI 10.1093/oxfordjournals.aje.a009074	68	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233183	10.1371/journal.pone.0233183	http://dx.doi.org/10.1371/journal.pone.0233183			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413078	gold, Green Published			2022-12-26	WOS:000537496000055
J	Chang, YL; Wang, JS; Yeh, HC; Ting, IW; Huang, HC; Chiang, HY; Hsiao, CT; Chu, PL; Kuo, CC				Chang, Yun-Lun; Wang, Jie-Sian; Yeh, Hung-Chieh; Ting, I-Wen; Huang, Han-Chun; Chiang, Hsiu-Yin; Hsiao, Chiung-Tzu; Chu, Pei-Lun; Kuo, Chin-Chi			Dialysis timing may be deferred toward very late initiation: An observational study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CLINICAL-PRACTICE GUIDELINE; ANTIINFLAMMATORY DRUG-USE; CARDIOVASCULAR EVENTS; EARLY START; HEMODIALYSIS; OUTCOMES; RISK; EPIDEMIOLOGY; INFECTION	The optimal timing to initiate dialysis among patients with an estimated glomerular filtration rate (eGFR) of < 5 mL/min/1.73 m2 is unknown. We hypothesized that dialysis initiation time can be deferred in this population even with high uremic burden. A case-crossover study with case (0-30 days before dialysis initiation [DI]) and control (90-120 days before DI) periods was conducted in 1,079 hemodialysis patients aged 18-90 years at China Medical University Hospital between 2006 and 2015. The uremic burden was quantified based on 7 uremic indicators that reached the predefined threshold in case period, namely hemoglobin, serum albumin, blood urea nitrogen, serum creatinine, potassium, phosphorus, and bicarbonate. Dialysis timing was classified as standard (met 0-2 uremic indicators), late (3-5 indicators), and very late (6-7 indicators). Median eGFR-DI of the 1,079 patients was 3.4 mL/min/1.73 m(2) and was 2.7 mL/min/1.73 m(2) in patients with very late initiation. The median follow-up duration was 2.42 years. Antibiotics, diuretics, antihypertensive medications, and non-steroidal anti-inflammatory drugs (NSAIDs) were more prevalently used during the case period. The fully adjusted hazards ratios of all-cause mortality for the late and very late groups were 0.97 (95% confidence interval 0.76-1.24) and 0.83 (0.61-1.15) compared with the standard group. It is safe to defer dialysis initiation among patients with chronic kidney disease (CKD) having an eGFR of < 5 mL/min/1.73 m(2) even when patients having multiple biochemical uremic burdens. Coordinated efforts in acute infection prevention, optimal fluid management, and prevention of accidental exposure to NSAIDs are crucial to prolong the dialysis-free survival.	[Chang, Yun-Lun; Wang, Jie-Sian; Yeh, Hung-Chieh; Ting, I-Wen; Kuo, Chin-Chi] China Med Univ, China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan; [Chang, Yun-Lun; Wang, Jie-Sian; Yeh, Hung-Chieh; Ting, I-Wen; Huang, Han-Chun; Chiang, Hsiu-Yin; Kuo, Chin-Chi] China Med Univ, Coll Med, Taichung, Taiwan; [Yeh, Hung-Chieh; Huang, Han-Chun; Chiang, Hsiu-Yin; Kuo, Chin-Chi] China Med Univ, Big Data Ctr, China Med Univ Hosp, Taichung, Taiwan; [Hsiao, Chiung-Tzu] China Med Univ Hosp, Dept Lab Med, Taichung, Taiwan; [Hsiao, Chiung-Tzu] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Chu, Pei-Lun] Fu Jen Catholic Univ Hosp, Div Nephrol, Dept Internal Med, New Taipei, Taiwan; [Chu, Pei-Lun] Fu Jen Catholic Univ Hosp, Sch Med, New Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Fu Jen Catholic University; Fu Jen Catholic University Hospital; Fu Jen Catholic University; Fu Jen Catholic University Hospital	Kuo, CC (corresponding author), China Med Univ, China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan.; Kuo, CC (corresponding author), China Med Univ, Coll Med, Taichung, Taiwan.; Kuo, CC (corresponding author), China Med Univ, Big Data Ctr, China Med Univ Hosp, Taichung, Taiwan.	chinchik@gmail.com	Wang, Jie-Sian/L-4452-2017	Wang, Jie-Sian/0000-0002-1943-3709	Ministry of Science and Technology of Taiwan [106-2314-B-039-041-MY3, 108-2314-B-039 -038 -MY3]; China Medical University Hospital, Taichung, Taiwan [CRS-106-018]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital, Taichung, Taiwan	This study (Chin-Chi Kuo) was supported by the Ministry of Science and Technology of Taiwan (grant number: 106-2314-B-039-041-MY3 and 108-2314-B-039 -038 -MY3) and China Medical University Hospital, Taichung, Taiwan (grant number: CRS-106-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centor RM., 1990, CLIN METHODS HIST PH; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Crews DC, 2014, AM J KIDNEY DIS, V63, P806, DOI 10.1053/j.ajkd.2013.12.010; Crews DC, 2014, J AM SOC NEPHROL, V25, P370, DOI 10.1681/ASN.2013050567; Dalrymple LS, 2008, CLIN J AM SOC NEPHRO, V3, P1487, DOI 10.2215/CJN.01290308; Dalrymple LS, 2011, CLIN J AM SOC NEPHRO, V6, P1708, DOI 10.2215/CJN.10151110; Daugirdas JT, 2015, AM J KIDNEY DIS, V66, P884, DOI 10.1053/j.ajkd.2015.07.015; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Hassan HIC, 2016, KIDNEY INT, V90, P897, DOI 10.1016/j.kint.2016.07.013; Heleniak Z, 2017, J NEPHROL, V30, P781, DOI 10.1007/s40620-016-0352-z; Hwang SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2616, DOI 10.1093/ndt/gfq308; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Khan YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159335; Kim SY, 2012, BIOMOL THER, V20, P268, DOI 10.4062/biomolther.2012.20.3.268; Kraut JA, 2018, CLIN J AM SOC NEPHRO, V13, P343, DOI 10.2215/CJN.11941017; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Liberek T, 2011, NEPHROL DIAL TRANSPL, V26, P2087, DOI 10.1093/ndt/gfr181; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; McDonald HI, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004100; Mehrotra R, 2018, NEPHROL DIAL TRANSPL, V33, P904, DOI 10.1093/ndt/gfy068; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Naughton CA, 2008, AM FAM PHYSICIAN, V78, P743; Nesrallah GE, 2014, CAN MED ASSOC J, V186, P112, DOI 10.1503/cmaj.130363; O'Hare AM, 2011, ARCH INTERN MED, V171, P1663, DOI 10.1001/archinternmed.2011.436; Pacilio M, 2016, J NEPHROL, V29, P153, DOI 10.1007/s40620-015-0243-8; Plantinga L, 2011, ANN FAM MED, V9, P423, DOI 10.1370/afm.1302; Rosansky SJ, 2014, CLIN J AM SOC NEPHRO, V9, P222, DOI 10.2215/CJN.12231213; Rosansky SJ, 2011, ARCH INTERN MED, V171, P396, DOI 10.1001/archinternmed.2010.415; Scialla JJ, 2014, KIDNEY INT, V86, P798, DOI 10.1038/ki.2014.110; Sjolander A, 2011, AM J EPIDEMIOL, V174, P1204, DOI 10.1093/aje/kwr249; States. CfDCaPCKDSSU, 2010, IND DET PREV NSAID U; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; Tattersall J, 2011, NEPHROL DIAL TRANSPL, V26, P2082, DOI 10.1093/ndt/gfr168; Teo BW, 2018, ADV CHRONIC KIDNEY D, V25, P41, DOI 10.1053/j.ackd.2017.10.005; Tsai CW, 2019, NEPHROL DIAL TRANSPL, V34, P2066, DOI 10.1093/ndt/gfy200; Tsai CW, 2018, NEPHROL DIAL TRANSPL, V33, P231, DOI 10.1093/ndt/gfx297; Viasus D, 2011, NEPHROL DIAL TRANSPL, V26, P2899, DOI 10.1093/ndt/gfq798; Wright S, 2010, CLIN J AM SOC NEPHRO, V5, P1828, DOI 10.2215/CJN.06230909; Yeh HC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54227-6; Yeh HC, 2019, CLIN CHIM ACTA, V497, P163, DOI 10.1016/j.cca.2019.07.035; Zhan M, 2017, CLIN J AM SOC NEPHRO, V12, P1778, DOI 10.2215/CJN.12311216; Zhao YY, 2018, THER APHER DIAL, V22, P600, DOI 10.1111/1744-9987.12721	44	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0233124	10.1371/journal.pone.0233124	http://dx.doi.org/10.1371/journal.pone.0233124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401817	Green Published, gold			2022-12-26	WOS:000537481000054
J	Maiello, F; Gallo, G; Coelho, C; Sucharski, F; Hardy, L; Wurtele, M				Maiello, Fernando; Gallo, Gloria; Coelho, Camila; Sucharski, Fernanda; Hardy, Leon; Wurtele, Martin			Crystal structure of Thermus thermophilus methylenetetrahydrofolate dehydrogenase and determinants of thermostability	PLOS ONE			English	Article							DYNAMICS; DEHYDROGENASE/CYCLOHYDROLASE; FLEXIBILITY; ADAPTATION; COMPLEXES; MODEL	The elucidation of mechanisms behind the thermostability of proteins is extremely important both from the theoretical and applied perspective. Here we report the crystal structure of methylenetetrahydrofolate dehydrogenase (MTHFD) from Thermus thermophilus HB8, a thermophilic model organism. Molecular dynamics trajectory analysis of this protein at different temperatures (303 K, 333 K and 363 K) was compared with homologous proteins from the less temperature resistant organism Thermoplasma acidophilum and the mesophilic organism Acinetobacter baumannii using several data reduction techniques like principal component analysis (PCA), residue interaction network (RIN) analysis and rotamer analysis. These methods enabled the determination of important residues for the thermostability of this enzyme. The description of rotamer distributions by Gini coefficients and Kullback-Leibler (KL) divergence both revealed significant correlations with temperature. The emerging view seems to indicate that a static salt bridge/charged residue network plays a fundamental role in the temperature resistance of Thermus thermophilus MTHFD by enhancing both electrostatic interactions and entropic energy dispersion. Furthermore, this analysis uncovered a relationship between residue mutations and evolutionary pressure acting on thermophilic organisms and thus could be of use for the design of future thermostable enzymes.	[Maiello, Fernando; Gallo, Gloria; Coelho, Camila; Sucharski, Fernanda; Wurtele, Martin] Univ Fed Sao Paulo, Dept Sci & Technol, Sao Jose Dos Campos, Brazil; [Hardy, Leon] Univ S Florida, Dept Phys, Tampa, FL 33620 USA	Universidade Federal de Sao Paulo (UNIFESP); State University System of Florida; University of South Florida	Wurtele, M (corresponding author), Univ Fed Sao Paulo, Dept Sci & Technol, Sao Jose Dos Campos, Brazil.	martin.wurtele@unifesp.br		Wurtele, Martin/0000-0001-8571-419X; Coelho, Camila/0000-0002-6904-8681; Maiello, Fernando/0000-0001-7721-2202; /0000-0002-6442-6604	FAPESP [11/50963-4]; CNPq [448833/2014-0]; FINEP [04.11.0043.06]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FINEP(Financiadora de Inovacao e Pesquisa (Finep))	This project obtained funding from FAPESP grant 11/50963-4 (M.W.), CNPq grant 448833/2014-0 (M.W.) and FINEP grant 04.11.0043.06 (institutional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allaire M, 1998, STRUCTURE, V6, P173, DOI 10.1016/S0969-2126(98)00019-7; Aluri S, 2016, MICROBIOL-SGM, V162, P145, DOI 10.1099/mic.0.000209; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Asai A, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e01021; Berezovsky IN, 2005, P NATL ACAD SCI USA, V102, P12742, DOI 10.1073/pnas.0503890102; Brown DK, 2017, BIOINFORMATICS, V33, P2768, DOI 10.1093/bioinformatics/btx349; DARLAND G, 1970, SCIENCE, V170, P1416, DOI 10.1126/science.170.3965.1416; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; DeLano WL, 2002, PYMOL USERS MANUAL; Dong YW, 2018, P NATL ACAD SCI USA, V115, P1274, DOI 10.1073/pnas.1718910115; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Eadsforth TC, 2012, FEBS J, V279, P4350, DOI 10.1111/febs.12025; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fu CZ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01671-5; Galindo-Murillo R, 2015, BBA-GEN SUBJECTS, V1850, P1041, DOI 10.1016/j.bbagen.2014.09.007; Gini C., 1912, STUDI EC GIURIDICI R, VIII; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; Haddad Y, 2019, BIOPHYS J, V116, P2062, DOI 10.1016/j.bpj.2019.04.017; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karshikoff A, 2015, FEBS J, V282, P3899, DOI 10.1111/febs.13343; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Ladenstein R, 2008, BIOTECHNOL BIOTEC EQ, V22, P612, DOI 10.1080/13102818.2008.10817521; Lee WH, 2011, BIOCHEM BIOPH RES CO, V406, P459, DOI 10.1016/j.bbrc.2011.02.074; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Ma BG, 2010, STRUCTURE, V18, P819, DOI 10.1016/j.str.2010.04.004; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miotto M, 2019, BIOINFORMATICS, V35, P2569, DOI 10.1093/bioinformatics/bty1011; OSHIMA T, 1971, J GEN APPL MICROBIOL, V17, P513, DOI 10.2323/jgam.17.513; OSHIMA T, 1974, INT J SYST BACTERIOL, V24, P102, DOI 10.1099/00207713-24-1-102; Papaleo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024214; Paukert J L, 1980, Methods Enzymol, V66, P616; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Ruepp A, 2000, NATURE, V407, P508, DOI 10.1038/35035069; Sadeghi M, 2006, BIOPHYS CHEM, V119, P256, DOI 10.1016/j.bpc.2005.09.018; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Saxena A, 2017, NEUROCOMPUTING, V267, P664, DOI 10.1016/j.neucom.2017.06.053; Shen BW, 1999, PROTEIN SCI, V8, P1342, DOI 10.1110/ps.8.6.1342; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sokalingam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040410; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Tedeschi PM, 2015, MOL CANCER RES, V13, P1361, DOI 10.1158/1541-7786.MCR-15-0117; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232959	10.1371/journal.pone.0232959	http://dx.doi.org/10.1371/journal.pone.0232959			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401802	Green Published, gold			2022-12-26	WOS:000537481000043
J	Wu, HY; Ng, DTW; Cheong, I; Matsudaira, P				Wu, Hongyi; Ng, Davis T. W.; Cheong, Ian; Matsudaira, Paul			The degradation-promoting roles of deubiquitinases Ubp6 and Ubp3 in cytosolic and ER protein quality control	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MISFOLDED PROTEINS; UBIQUITIN LIGASE; ENZYME; MECHANISM; PATHWAY; CHAINS; ENHANCEMENT; INHIBITOR; MEMBRANE	The quality control of intracellular proteins is achieved by degrading misfolded proteins which cannot be refolded by molecular chaperones. In eukaryotes, such degradation is handled primarily by the ubiquitin-proteasome system. However, it remained unclear whether and how protein quality control deploys various deubiquitinases. To address this question, we screened deletions or mutation of the 20 deubiquitinase genes in Saccharomyces cerevisiae and discovered that almost half of the mutations slowed the removal of misfolded proteins whereas none of the remaining mutations accelerated this process significantly. Further characterization revealed that Ubp6 maintains the level of free ubiquitin to promote the elimination of misfolded cytosolic proteins, while Ubp3 supports the degradation of misfolded cytosolic and ER luminal proteins by different mechanisms.	[Wu, Hongyi; Ng, Davis T. W.; Cheong, Ian] Natl Univ Singapore, Temasek Life Sci Lab, Singapore, Singapore; [Wu, Hongyi; Cheong, Ian; Matsudaira, Paul] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Matsudaira, Paul] Natl Univ Singapore, Mechanobiol Inst, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Wu, HY; Cheong, I (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore, Singapore.; Wu, HY; Cheong, I; Matsudaira, P (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.; Matsudaira, P (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore, Singapore.	mbiwh@nus.edu.sg; ian@tll.org.sg; dbsmpt@nus.edu.sg		Cheong, Ian/0000-0002-3062-6878; Wu, Hongyi/0000-0002-3504-0868	TLL core funding; National University of Singapore	TLL core funding; National University of Singapore(National University of Singapore)	The benchwork of this project was conducted in Temasek Lifesciences Laboratory (TLL) and generously sponsored by TLL core funding to D.T.W.N. and I.C. H.W. was a recipient of Graduate Research Scholarship from National University of Singapore and Research Assistantship from P.M.'s lab.	Amerik A, 2006, J CELL BIOL, V175, P825, DOI 10.1083/jcb.200605134; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 1997, EMBO J, V16, P4826; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Ast T, 2014, J CELL SCI, V127, P3017, DOI 10.1242/jcs.144386; Aufderheide A, 2015, P NATL ACAD SCI USA, V112, P8626, DOI 10.1073/pnas.1510449112; Baldridge RD, 2016, CELL, V166, P394, DOI 10.1016/j.cell.2016.05.048; Bashore C, 2015, NAT STRUCT MOL BIOL, V22, P712, DOI 10.1038/nsmb.3075; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Blount JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036542; Boselli M, 2017, J BIOL CHEM, V292, P19209, DOI 10.1074/jbc.M117.815126; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Choe YJ, 2016, NATURE, V531, P191, DOI 10.1038/nature16973; Cohen M, 2003, J BIOL CHEM, V278, P51989, DOI 10.1074/jbc.C300451200; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Dephoure N, 2014, ELIFE, V3, DOI 10.7554/eLife.03023; Fang NN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12907; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gowda NKC, 2013, P NATL ACAD SCI USA, V110, P5975, DOI 10.1073/pnas.1216778110; Guerriero CJ, 2016, FASEB J, V30; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hickey CM, 2016, CELL LOGIST, V6, DOI DOI 10.1080/21592799.2016.1157664; Kapadia BB, 2019, MOL CANCER THER, V18, P1475, DOI 10.1158/1535-7163.MCT-19-0307; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kawaguchi S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015532; Kim E, 2018, CELL REP, V24, P732, DOI 10.1016/j.celrep.2018.06.058; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Klabonski L, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006450; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Liu Yang, 2014, ScientificWorldJournal, V2014, P476219, DOI 10.1155/2014/476219; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Nakatsukasa K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148327; Nielsen SV, 2014, BIOMOLECULES, V4, P646, DOI 10.3390/biom4030646; Oling D, 2014, EMBO J, V33, P747, DOI 10.1002/embj.201386822; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Peterson BG, 2019, ELIFE, V8, DOI 10.7554/eLife.50903; Prasad R, 2018, J CELL BIOL, V217, P2019, DOI 10.1083/jcb.201706091; Prasad R, 2012, BIOCHEM BIOPH RES CO, V425, P689, DOI 10.1016/j.bbrc.2012.07.080; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Schmitz C, 2005, MOL BIOL CELL, V16, P1319, DOI 10.1091/mbc.E04-05-0425; Schulze JM, 2011, GENE DEV, V25, P2242, DOI 10.1101/gad.177220.111; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SIKORSKI RS, 1989, GENETICS, V122, P19; Silva GM, 2015, NAT STRUCT MOL BIOL, V22, P116, DOI 10.1038/nsmb.2955; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399; TOBIAS JW, 1991, J BIOL CHEM, V266, P12021; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Tran HJTT, 2003, BIOCHEMISTRY-US, V42, P11460, DOI 10.1021/bi035033g; Tumusiime S, 2011, J BIOL CHEM, V286, P4620, DOI 10.1074/jbc.M110.195313; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang XL, 2013, J BIOL CHEM, V288, P23295, DOI 10.1074/jbc.M113.482018; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838; Zattas D, 2016, J BIOL CHEM, V291, P12105, DOI 10.1074/jbc.M116.726877	77	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232755	10.1371/journal.pone.0232755	http://dx.doi.org/10.1371/journal.pone.0232755			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401766	Green Submitted, Green Published, gold			2022-12-26	WOS:000537481000031
J	Jiang, MM; Zhang, WW; Zhang, R; Liu, PP; Ye, YN; Yu, WW; Guo, XJ; Yu, JP				Jiang, Mengmeng; Zhang, Wenwen; Zhang, Rui; Liu, Pengpeng; Ye, Yingnan; Yu, Wenwen; Guo, Xiaojing; Yu, Jinpu			Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer	ONCOGENE			English	Article							SUPPRESSOR-CELLS; EXPRESSION; MICRORNA-9; METHYLATION; METASTASIS; ACTIVATION; INFECTION; RESPONSES; INVASION	We previously identified that the development of early-stage myeloid-derived suppressor cells (eMDSCs) in breast cancer with high IL-6 (IL-6(high)) expression was correlated with the SOCS3 deficiency-dependent hyperactivation of the JAK/STAT signaling pathway. However, the regulatory mechanisms have not yet been elucidated. In this study, we aimed to investigate how the posttranscriptional regulation mediated by cancer exosome-derived miRNAs affected the JAK/STAT signaling pathway and the development of eMDSCs. Using miRNA microarray, we screened miR-9 and miR-181a which were exclusively upregulated in eMDSCs and inversely associated with SOCS3 expression. We found both miRNAs promoted the amplification of immature eMDSCs with the strong suppression on T-cell immunity in mice and humans. Furthermore, miR-9 and miR-181a promoted 4T1 tumor growth and immune escape via enhancing eMDSCs infiltration in situ. But miR-9 and miR-181a stimulated eMDSCs development by separately inhibiting SOCS3 and PIAS3, two crucial regulators in the negative feedback loop of the JAK/STAT signaling pathway. Elevated miR-9 and miR-181a in eMDSCs was derived from tumor-derived exosomes, and blocking the exosome release could fully attenuate the miRNA-mediated regulation on eMDSCs development. In summary, our findings indicated that tumor exosome-derived miR-9 and miR-181a activated the JAK/STAT signaling pathway via targeting SOCS3 and PIAS3, respectively, and thus promoted the expansion of eMDSCs which might provide potential therapeutic target for IL-6(high) breast cancer treatment.	[Jiang, Mengmeng; Zhang, Wenwen; Zhang, Rui; Liu, Pengpeng; Ye, Yingnan; Yu, Jinpu] Tianjin Med Univ Canc Inst & Hosp, Canc Mol Diagnost Core, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc,Key Lab Canc Prevent &, Tianjin, Peoples R China; [Jiang, Mengmeng] Tianjin Third Central Hosp, Dept Oncol, Tianjin, Peoples R China; [Zhang, Wenwen; Zhang, Rui; Liu, Pengpeng; Ye, Yingnan; Yu, Wenwen; Yu, Jinpu] Tianjin Med Univ Canc Inst & Hosp, Dept Immunol, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China; [Yu, Wenwen; Yu, Jinpu] Key Lab Canc Immunol & Biotherapy, Tianjin, Peoples R China; [Guo, Xiaojing] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Breast Canc Breast Canc Prevent & Therapy, Dept Breast Pathol & Lab, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Yu, JP (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Canc Mol Diagnost Core, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc,Key Lab Canc Prevent &, Tianjin, Peoples R China.; Yu, JP (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Immunol, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China.; Yu, JP (corresponding author), Key Lab Canc Immunol & Biotherapy, Tianjin, Peoples R China.	yujinpu@tjmuch.com			National Natural Science Foundation of China [81872143, 81472473, 81772840]; National Science and Technology Support Program of China [2015BAI12B15]; Project of Science and Technology of Tianjin [13ZCZCSY20300, 18JCQNJC82700]; Key Project of Tianjin Health and Family Planning Commission [16KG126]; National Science and Technology Major Project [2018ZX09201-015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; Project of Science and Technology of Tianjin; Key Project of Tianjin Health and Family Planning Commission; National Science and Technology Major Project	This work was supported by National Natural Science Foundation of China (Grant No.81872143, 81472473, 81772840), National Science and Technology Support Program of China (Grant No.2015BAI12B15), National Science and Technology Major Project (Grant No.2018ZX09201-015), Project of Science and Technology of Tianjin (Grant No.13ZCZCSY20300, 18JCQNJC82700) and Key Project of Tianjin Health and Family Planning Commission (Grant No.16KG126). We appreciate the efforts of Dr Juntian Liu and Dr Shixia Li of Department of Preventive Health Screening Center in sample collection. We thank Dr Xiubao Ren of Department of Biotherapy for support of Flow cytometry. We also thank Prof Weijia Zhang of Department of Medicine of Icahn School of Medicine at Mount Sinai for constructive comments to our manuscript.	Al-Mahmood S, 2018, DRUG DELIV TRANSL RE, V8, P1483, DOI 10.1007/s13346-018-0551-3; Arora T, 2003, J BIOL CHEM, V278, P21327, DOI 10.1074/jbc.C300119200; Baroni S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.224; Bhatia A, 2014, EXPERT REV CLIN IMMU, V10, P41, DOI 10.1586/1744666X.2014.865519; Bjornetro T, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1567219; Boosani CS, 2015, MOL BIOL REP, V42, P853, DOI 10.1007/s11033-015-3860-3; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Cao Q, 2013, PHYSIOL GENOMICS, V45, P1206, DOI 10.1152/physiolgenomics.00122.2013; Dudda JC, 2013, IMMUNITY, V38, P742, DOI 10.1016/j.immuni.2012.12.006; Guo XF, 2018, ONCOGENE, V37, P4239, DOI 10.1038/s41388-018-0261-9; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Isomoto H, 2009, DIGESTION, V79, P2, DOI 10.1159/000167859; Jang MH, 2017, HUM PATHOL, V68, P69, DOI 10.1016/j.humpath.2017.08.026; Jiang MM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01840; Jiang MM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00070; Khatibi S, 2017, GROWTH FACTORS, V35, P100, DOI 10.1080/08977194.2017.1363746; Lao MX, 2016, J IMMUNOL, V196, P596, DOI 10.4049/jimmunol.1403254; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; McClure C, 2017, IMMUNOL CELL BIOL, V95, P42, DOI 10.1038/icb.2016.63; Niu J, 2016, ONCOGENE, V35, P1302, DOI 10.1038/onc.2015.189; Orangi E, 2019, GENE, V687, P272, DOI 10.1016/j.gene.2018.11.036; Pu SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23115; Pyzer AR, 2016, INT J CANCER, V139, P1915, DOI 10.1002/ijc.30232; Ru Peng, 2011, Genes Cancer, V2, P720, DOI 10.1177/1947601911425832; Sade-Feldman M, 2016, CLIN CANCER RES, V22, P5661, DOI 10.1158/1078-0432.CCR-15-3104; Seif F, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0177-y; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Sporn JC, 2019, J SURG RES, V233, P426, DOI 10.1016/j.jss.2018.08.020; Tian J, 2015, J IMMUNOL, V195, P1301, DOI 10.4049/jimmunol.1500209; Tischoff I, 2007, GUT, V56, P1047, DOI 10.1136/gut.2006.111633; Tussie-Luna MI, 2002, P NATL ACAD SCI USA, V99, P12807, DOI 10.1073/pnas.192464499; Xu Z, 2017, FEBS J, V284, P2410, DOI 10.1111/febs.14133; Yang L, 2018, J NEUROIMMUNE PHARM, V13, P330, DOI 10.1007/s11481-018-9779-4; Yu JP, 2014, J IMMUNOL, V193, P2574, DOI 10.4049/jimmunol.1400833; Yu JP, 2013, J IMMUNOL, V190, P3783, DOI 10.4049/jimmunol.1201449; Zhang WW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01699; Zhang X, 2014, J VIRAL HEPATITIS, V21, P264, DOI 10.1111/jvh.12137; Zhao Y, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1004983; Zhen J, 2019, BIOMED PHARMACOTHER, V116, DOI 10.1016/j.biopha.2019.109016; Zheng HB, 2015, INT J CLIN EXP MED, V8, P20263; Zhou ZP, 2010, STEM CELLS, V28, P620, DOI 10.1002/stem.301; Zhu KP, 2019, MOL THER, V27, P518, DOI 10.1016/j.ymthe.2019.01.001	43	46	46	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	24					4681	4694		10.1038/s41388-020-1322-4	http://dx.doi.org/10.1038/s41388-020-1322-4		MAY 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LY0HO	32398867				2022-12-26	WOS:000532103100002
J	Boykin, KL; Carter, RT; Butler-Perez, K; Buck, CQ; Peters, JW; Rockwell, KE; Mitchell, MA				Boykin, Kimberly L.; Carter, Renee T.; Butler-Perez, Karina; Buck, Cameron Q.; Peters, Jordan W.; Rockwell, Kelly E.; Mitchell, Mark A.			Digestibility of black soldier fly larvae (Hermetia illucens) fed to leopard geckos (Eublepharis macularius)	PLOS ONE			English	Article							VITAMIN-A; NUTRIENT COMPOSITION; SEDATION; HEALTH; LIVER; SERUM; FOOD	Black soldier fly (BSF) larvae have been marketed as an excellent choice for providing calcium to reptiles without the need of dusting or gut loading. However, previous studies have indicated that they have limited calcium digestibility and are deficient in fat soluble vitamins (A, D-3, and E). In this feeding and digestibility trial, 24 adult male leopard geckos were fed one of three diets for 4 months: 1) whole, vitamin A gut loaded larvae; 2) needle pierced, vitamin A gut loaded larvae; or 3) whole, non-gut loaded larvae. Fecal output from the geckos was collected daily and apparent digestibility was calculated for dry matter, protein, fat, and minerals. There were no differences in digestibility coefficients among groups. Most nutrients were well digested by the leopard geckos when compared to previous studies, with the exception of calcium (digestibility co-efficient 43%), as the calcium-rich exoskeleton usually remained intact after passage through the GI tract. Biochemistry profiles revealed possible deficits occurring over time for calcium, sodium, and total protein. In regards to vitamin A digestibility, plasma and liver vitamin A concentrations were significantly higher in the supplemented groups (plasma-gut loaded groups: 33.38 +/- 7.11 ng/ml, control group: 25.8 +/- 6.72 ng/ml, t = 1.906, p = 0.04; liver-gut loaded groups: 28.67 +/- 18.90 mu g/g, control group: 14.13 +/- 7.41 mu g/g, t = 1.951, p = 0.03). While leopard geckos are able to digest most of the nutrients provided by BSF larvae, including those that have been gut loaded, more research needs to be performed to assess whether or not they provide adequate calcium in their non-supplemented form.	[Boykin, Kimberly L.; Carter, Renee T.; Butler-Perez, Karina; Peters, Jordan W.; Mitchell, Mark A.] Louisiana State Univ, Sch Vet Med, Dept Vet Clin Sci, Baton Rouge, LA 70803 USA; [Buck, Cameron Q.] Tuskegee Univ, Coll Vet Med, Tuskegee, AL 36088 USA; [Rockwell, Kelly E.] Berkeley Dog & Cat Hosp, Berkeley, CA USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Tuskegee University	Boykin, KL (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Vet Clin Sci, Baton Rouge, LA 70803 USA.	kboykin@lsu.edu		Boykin, Kimberly/0000-0002-0316-3118; Carter, Renee/0000-0002-7963-9063	Louisiana State University VCS Corp grant [8262]; Fluker Farms, Inc.; Abaxis, Inc.	Louisiana State University VCS Corp grant; Fluker Farms, Inc.; Abaxis, Inc.	Primary funding for this study was provided to KB and MM by the Louisiana State University VCS Corp grant (#8262). Additional support was provided by Fluker Farms, Inc. (flukerfarms.com) and Abaxis, Inc. (abaxis.com). The funder (Abaxis, Inc.) provided support in the form of research materials and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Fluker Farms, Inc.) provided support in the form of materials, funding, and salary to author [KB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the `author contributions' section.	Abate A. L., 2003, Journal of Herpetological Medicine and Surgery, V13, P23; Alberton S, 2018, P ARAV, P933; Allen ME., 1989, THESIS; Ariel E, 1997, AUST VET J, V75, P247, DOI 10.1111/j.1751-0813.1997.tb10089.x; Berkvens CN, 2014, ZOO BIOL, V33, P536, DOI 10.1002/zoo.21169; Boyer TH., 2019, MADERS REPTILE AMPHI, P1316; Boykin KL, 2018, P ARAV, P981; Boykin KL, 2018, P ARAV, P975; CALLE PP, 1994, J ZOO WILDLIFE MED, V25, P53; Cojean O, 2018, J ANIM PHYSIOL AN N, V102, P1411, DOI 10.1111/jpn.12924; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Dierenfeld Ellen S., 2008, Journal of Herpetological Medicine and Surgery, V18, P100; Doss GA, 2017, VET ANAESTH ANALG, V44, P1175, DOI 10.1016/j.vaa.2017.03.007; Dutton C, 2014, ZOO BIOL, V33, P553, DOI 10.1002/zoo.21167; Ferguson GW, 1996, ZOO BIOL, V15, P279; Fink DM, 2018, JAVMA-J AM VET MED A, V253, P1146, DOI 10.2460/javma.253.9.1146; Finke MD, 2013, ZOO BIOL, V32, P27, DOI 10.1002/zoo.21012; Finke MD, 2003, ZOO BIOL, V22, P147, DOI 10.1002/zoo.10082; Finke MD, 2002, ZOO BIOL, V21, P269, DOI 10.1002/zoo.10031; Hume EM, 1949, MEDICAL RES COUNCIL, V264; Johannsen O. A., 1922, Journal of the New York Entomological Society, V30, P141; Klaphake Eric, 2010, Veterinary Clinics of North America Exotic Animal Practice, V13, P375, DOI 10.1016/j.cvex.2010.05.007; Knafo SE, 2016, J ZOO WILDLIFE MED, V47, P1000, DOI 10.1638/2015-0127.1; Kroenlein KR, 2008, J WILDLIFE DIS, V44, P664, DOI 10.7589/0090-3558-44.3.664; Mans Christoph, 2014, Vet Clin North Am Exot Anim Pract, V17, P369, DOI 10.1016/j.cvex.2014.05.002; MCCARTHY PT, 1952, J NUTR, V46, P361, DOI 10.1093/jn/46.3.361; National Research Council (NRC), 1995, NUTR REQ LAB AN, DOI [10.17226/4758, DOI 10.17226/4758]; Oonincx DGAB, 2018, NATURE SCI REPORTS, V8, P1; PENNINO M, 1991, International Zoo Yearbook, V30, P143; Ploog C, 2015, P 11 C ZOO WILDL NUT; Raila J, 2002, COMP BIOCHEM PHYS A, V132, P513, DOI 10.1016/S1095-6433(02)00098-3; SCHWEIGERT FJ, 1991, J VET MED A, V38, P35, DOI 10.1111/j.1439-0442.1991.tb00981.x; Spranghers T, 2017, J SCI FOOD AGR, V97, P2594, DOI 10.1002/jsfa.8081; Stahl S.J., 2019, MADERS REPTILE AMPHI, P201; Sullivan KE, 2014, J ZOO WILDLIFE MED, V45, P892, DOI 10.1638/2013-0289.1; Tschirner M, 2015, J INSECTS FOOD FEED, V1, P249, DOI 10.3920/JIFF2014.0008; van der Loo B, 2004, J CARDIOVASC PHARM, V43, P26, DOI 10.1097/00005344-200401000-00005; Wiggans KT, 2018, JAVMA-J AM VET MED A, V252, P316, DOI 10.2460/javma.252.3.316	38	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232496	10.1371/journal.pone.0232496	http://dx.doi.org/10.1371/journal.pone.0232496			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392254	gold, Green Published			2022-12-26	WOS:000537470300008
J	Cifkova, R; Bruthans, J; Wohlfahrt, P; Krajcoviechova, A; Sulc, P; Jozifova, M; Eremiasova, L; Pudil, J; Linhart, A; Widimsky, J; Filipovsky, J; Mayer, O; Skodova, Z; Poledne, R; Stavek, P; Lanska, V				Cifkova, Renata; Bruthans, Jan; Wohlfahrt, Peter; Krajcoviechova, Alena; Sulc, Pavel; Jozifova, Marie; Eremiasova, Lenka; Pudil, Jan; Linhart, Ales; Widimsky, Jiri, Jr.; Filipovsky, Jan; Mayer, Otto, Jr.; Skodova, Zdenka; Poledne, Rudolf; Stavek, Petr; Lanska, Vera			30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985-2016/17	PLOS ONE			English	Article							HEART-DISEASE MORTALITY; SYSTEMATIC ANALYSIS; EUROPEAN-SOCIETY; TIME TRENDS; PREVALENCE; HYPERTENSION; STATISTICS; CARDIOLOGY; BURDEN	Background Compared with Western Europe, the decline in cardiovascular (CV) mortality has been delayed in former communist countries in Europe, including the Czech Republic. We have assessed longitudinal trends in major CV risk factors in the Czech Republic from 1985 to 2016/17, covering the transition from the totalitarian regime to democracy. Methods There were 7 independent cross-sectional surveys for major CV risk factors conducted in the Czech Republic in the same 6 country districts within the WHO MONICA Project (1985, 1988, 1992) and the Czech post-MONICA study (1997/98, 2000/01, 2007/08 and 2016/2017), including a total of 7,606 males and 8,050 females. The population samples were randomly selected (1%, aged 25-64 years). Results Over the period of 31/32 years, there was a significant decrease in the prevalence of smoking in males (from 45.0% to 23.9%; p < 0.001) and no change in females. BMI increased only in males. Systolic and diastolic blood pressure decreased significantly in both genders, while the prevalence of hypertension declined only in females. Awareness of hypertension, the proportion of individuals treated by antihypertensive drugs and consequently hypertension control improved in both genders. A substantial decrease in total cholesterol was seen in both sexes (males: from 6.21 +/- 1.29 to 5.30 +/- 1.05 mmol/L; p < 0.001; females: from 6.18 +/- 1.26 to 5.31 +/- 1.00 mmol/L; p < 0.001). Conclusions The significant improvement in most CV risk factors between 1985 and 2016/17 substantially contributed to the remarkable decrease in CV mortality in the Czech Republic.	[Cifkova, Renata; Bruthans, Jan; Wohlfahrt, Peter; Krajcoviechova, Alena; Sulc, Pavel; Jozifova, Marie] Charles Univ Prague, Fac Med 1, Ctr Cardiovasc Prevent, Prague, Czech Republic; [Cifkova, Renata; Bruthans, Jan; Wohlfahrt, Peter; Krajcoviechova, Alena; Sulc, Pavel; Jozifova, Marie] Charles Univ Prague, Thomayer Hosp, Prague, Czech Republic; [Cifkova, Renata; Eremiasova, Lenka; Pudil, Jan; Linhart, Ales] Charles Univ Prague, Fac Med 1, Dept Med 2, Prague, Czech Republic; [Widimsky, Jiri, Jr.] Charles Univ Prague, Fac Med 1, Dept Med 3, Prague, Czech Republic; [Filipovsky, Jan; Mayer, Otto, Jr.] Charles Univ Prague, Fac Med, Dept Med 2, Plzen, Czech Republic; [Skodova, Zdenka] Inst Clin & Expt Med, Dept Prevent Cardiol, Prague, Czech Republic; [Poledne, Rudolf; Stavek, Petr] Inst Clin & Expt Med, Atherosclerosis Res Lab, Prague, Czech Republic; [Lanska, Vera] Inst Clin & Expt Med, Med Stat Unit, Prague, Czech Republic	Charles University Prague; Charles University Prague; Thomayer Hospital; Charles University Prague; Charles University Prague; Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM)	Cifkova, R (corresponding author), Charles Univ Prague, Fac Med 1, Ctr Cardiovasc Prevent, Prague, Czech Republic.; Cifkova, R (corresponding author), Charles Univ Prague, Thomayer Hosp, Prague, Czech Republic.; Cifkova, R (corresponding author), Charles Univ Prague, Fac Med 1, Dept Med 2, Prague, Czech Republic.	renata.cifkova@ftn.cz	Sulc, Pavel/L-9149-2018	Sulc, Pavel/0000-0003-4485-6647	Ministry of Health of the Czech Republic [15-27109A]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	The study was supported by grant No. 15-27109A provided by the Ministry of Health of the Czech Republic.	[Anonymous], 2018, CZECH HLTH STAT YB 2; Ascherio A, 1996, HYPERTENSION, V27, P1065, DOI 10.1161/01.HYP.27.5.1065; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bentham J, 2016, ELIFE, V5, DOI 10.7554/eLife.13410.001; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Borodulin K, 2015, EUR J PUBLIC HEALTH, V25, P539, DOI 10.1093/eurpub/cku174; Bruthans J, 2014, EUR J PREV CARDIOL, V21, P829, DOI 10.1177/2047487312469476; Cifkova R, 2010, ATHEROSCLEROSIS, V211, P676, DOI 10.1016/j.atherosclerosis.2010.04.007; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Dofkova M, 2001, PUBLIC HEALTH NUTR, V4, P999, DOI 10.1079/PHN2001169; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Hartley A, 2016, CIRCULATION, V133, P1916, DOI 10.1161/CIRCULATIONAHA.115.018931; Helis E, 2011, EUR J CARDIOV PREV R, V18, P347, DOI 10.1177/1741826710389361; Leenen FHH, 2008, CAN MED ASSOC J, V178, P1441, DOI 10.1503/cmaj.071340; Mensah GA, 2017, JAMA-J AM MED ASSOC, V317, P1955, DOI 10.1001/jama.2017.4168; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Muller-Nordhorn J, 2004, J EPIDEMIOL COMMUN H, V58, P481, DOI 10.1136/jech.2003.013367; OECD, 2017, OB UPD 2017; Poirier P, 2009, CIRCULATION, V120, P86, DOI 10.1161/CIRCULATIONAHA.109.192575; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Sans S, 1997, EUR HEART J, V18, P1231; Taddei C, 2020, INT J EPIDEMIOL, V49, P173, DOI 10.1093/ije/dyz099; Tamosiunas A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3387-0; Timmis A, 2020, EUR HEART J, V41, P12, DOI 10.1093/eurheartj/ehz859; Tolonen H, 2006, EUR J CARDIOV PREV R, V13, P104; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Vollenweider P, 2013, BMC P, V7, P6; Wilkins E., 2017, EUROPEAN CARDIOVASCU; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Zhong Y, 2017, EUR J PREV CARDIOL, V24, P612, DOI 10.1177/2047487316676905; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	32	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232845	10.1371/journal.pone.0232845	http://dx.doi.org/10.1371/journal.pone.0232845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392239	Green Published, gold			2022-12-26	WOS:000537470300027
J	Chileshe, J; Talsma, EF; Schoustra, SE; Borgonjen-van den Berg, KJ; Handema, R; Zwaan, BJ; Brouwer, ID				Chileshe, Justin; Talsma, Elise F.; Schoustra, Sijmen E.; Borgonjen-van den Berg, Karin J.; Handema, Ray; Zwaan, Bas J.; Brouwer, Inge D.			Potential contribution of cereal and milk based fermented foods to dietary nutrient intake of 1-5 years old children in Central province in Zambia	PLOS ONE			English	Article							COMPLEMENTARY FEEDING RECOMMENDATIONS; LACTIC-ACID BACTERIA; PROCESSING METHODS; MAIZE; IRON; YOGURT; BIOAVAILABILITY; MICRONUTRIENT; FORTIFICATION; PROBIOTICS	Zambia is still facing undernutrition and micronutrient deficiencies despite fortification and supplementation programmes stressing the need for additional solutions. Fermented foods have the potential to improve nutrient intake and, therefore, could have an important role in food based recommendations (FBRs) to ensure adequate intake of nutrients for optimal health of populations. Secondary dietary intake data was used in Optifood, a linear programming software to develop FBRs, for children aged 1-3 and 4-5 years in Mkushi district of Zambia. Three scenarios per age group were modeled to determine FBRs based on: (1) FBRs based on local available foods (2) FBR and Mabisi, a fermented milk beverage, and (3) FBR with Munkoyo, a cereal fermented beverage. The scenarios were compared to assess whether addition of Mabisi or Munkoyo achieved a better nutrient intake. FBRs based on only locally available non-fermented foods did not meet >= 70% of recommended nutrient intake (RNI) for calcium, fat, iron and zinc, so-called problem nutrients. The addition of Munkoyo to the FBRs did not reduce the number of problem nutrients, but after adding Mabisi to the FBR's only iron (67% of RNI) in the 1-3 year age group and only zinc (67% of RNI) in the 4-5 year age group remained problem nutrients. Mabisi, a fermented milk product in combination with the local food pattern is a good additional source of nutrients for these age groups. However, additional nutrition sensitive and cost-effective measures would still be needed to improve nutrient intake, especially that of iron and zinc.	[Chileshe, Justin; Schoustra, Sijmen E.; Zwaan, Bas J.] Wageningen Univ & Res, Plant Sci Grp, Lab Genet, Wageningen, Netherlands; [Chileshe, Justin; Talsma, Elise F.; Borgonjen-van den Berg, Karin J.; Brouwer, Inge D.] Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands; [Chileshe, Justin; Handema, Ray] Trop Dis Res Ctr, Ndola, Zambia; [Schoustra, Sijmen E.] Univ Zambia, Sch Agr Sci, Dept Food Sci & Nutr, Lusaka, Zambia	Wageningen University & Research; Wageningen University & Research; University of Zambia	Chileshe, J (corresponding author), Wageningen Univ & Res, Plant Sci Grp, Lab Genet, Wageningen, Netherlands.; Chileshe, J (corresponding author), Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands.; Chileshe, J (corresponding author), Trop Dis Res Ctr, Ndola, Zambia.	chileshej@tdrc.org.zm	Schoustra, Sijmen E/H-3882-2012; Zwaan, Bas/D-8721-2015	Talsma, Elise/0000-0002-6034-4708; Zwaan, Bas/0000-0002-8221-4998; Chileshe, Justin/0000-0003-4134-2851	Nutricia Reserarch Foundation of the Netherlands [2015-51]; Dutch Research Council (NWO-WOTRO Science for Global Development) [W08.250.2013.108]; HarvestPlus, Washington, DC	Nutricia Reserarch Foundation of the Netherlands(Danone Nutricia); Dutch Research Council (NWO-WOTRO Science for Global Development); HarvestPlus, Washington, DC	1. SES received funds from Nutricia Reserarch Foundation of the Netherlands (Grant 2015-51), https://www.nutriciaresearchfoundation.org/research-grants-awards/2.SES received funds from The Dutch Research Council (NWO-WOTRO Science for Global Development), Grant W08.250.2013.108, https://www.nwo.nl/en/about-nwo/organisation/nwo-domains/wotro The initial study was funded by HarvestPlus, Washington, DC. No. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesta S, 2008, ENFERM INFEC MICR CL, V26, P552, DOI 10.1157/13128271; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Burchi F, 2011, INT J ENV RES PUB HE, V8, P358, DOI 10.3390/ijerph8020358; Buyuktuncer Z, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-91; Caswell BL, 2015, FOOD NUTR BULL, V36, P467, DOI 10.1177/0379572115612631; Central Statistical Office/Zambia Ministry of Health/Zambia University of Zambia Teaching Hospital Virology Laboratory University of Zambia Department of Population Studies Tropical Diseases Research Centre/Zambia ICF International, 2015, ZAMB DEM HLTH SURV 2; Chilton SN, 2015, NUTRIENTS, V7, P390, DOI 10.3390/nu7010390; Daelmans B, 2013, MATERN CHILD NUTR, V9, P116, DOI 10.1111/mcn.12083; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027; Das J. K, 2019, COCHRANE DATABASE SY; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Vrese M, 2001, AM J CLIN NUTR, V73, p421S, DOI 10.1093/ajcn/73.2.421s; Egounlety M, 2002, INT J FOOD SCI NUTR, V53, P15; Ferguson EL, 2004, J NUTR, V134, P951, DOI 10.1093/jn/134.4.951; Ferguson E, 2015, MATERN CHILD NUTR, V11, P6, DOI 10.1111/mcn.12243; Ferguson EL, 2006, J NUTR, V136, P2399, DOI 10.1093/jn/136.9.2399; Food N Nutrition Commission of Zambia UoZ MOST: the USAID Micronutrient Program United States Center for Disease Control, 2004, MOST USAID MICR PROG; Food Organization A, 2009, NUTR COUNTR PROF REP; Gibson RS, 2006, P NUTR SOC, V65, P160, DOI 10.1079/PNS2006489; Goldbohm RA, 2011, AM J CLIN NUTR, V93, P615, DOI 10.3945/ajcn.110.000430; Gupta RK, 2015, J FOOD SCI TECH MYS, V52, P676, DOI 10.1007/s13197-013-0978-y; Harris J., 2014, TURNING RAPID GROWTH; Haug A., 2010, AFRICAN J FOOD AGR N, V10; Heaney RP, 2002, J AM DIET ASSOC, V102, P1672, DOI 10.1016/S0002-8223(02)90356-1; Hotz C, 2001, J AGR FOOD CHEM, V49, P692, DOI 10.1021/jf000462w; Hotz C, 2009, NUTR SURVEY CENTRAL; Hotz C, 2007, J NUTR, V137, P1097, DOI 10.1093/jn/137.4.1097; Hotz C, 2012, PUBLIC HEALTH NUTR, V15, P1688, DOI 10.1017/S1368980012000924; Hurrell RF, 2003, AM J CLIN NUTR, V77, P1213, DOI 10.1093/ajcn/77.5.1213; Joint FWU, 2001, HUM EN REQ; Kort R, 2012, TRENDS BIOTECHNOL, V30, P613, DOI 10.1016/j.tibtech.2012.09.002; Kujinga P, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12515; Lazarte CE, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.27796; LeBlanc JG, 2011, J APPL MICROBIOL, V111, P1297, DOI 10.1111/j.1365-2672.2011.05157.x; Levesque S, 2015, PUBLIC HEALTH NUTR, V18, P622, DOI 10.1017/S1368980014000706; Maillot M, 2007, AM J CLIN NUTR, V86, P690; Mildon A, 2015, FOOD NUTR BULL, V36, P3, DOI 10.1177/156482651503600101; Moonga HB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213541; Nguz K., 2004, Journal of Science and Technology, P9; Nyirenda DB., 2007, COMMON ZAMBIAN FOODS; O'Connor LM, 2014, DIABETOLOGIA, V57, P909, DOI 10.1007/s00125-014-3176-1; Oikeh SO, 2003, J AGR FOOD CHEM, V51, P3688, DOI 10.1021/jf0261708; Olivares M, 2006, J DAIRY RES, V73, P492, DOI 10.1017/S0022029906002068; Owino V. O., 2008, African Journal of Food, Agriculture, Nutrition and Development, V8, P28; Pashapour N, 2006, TURKISH J PEDIATR, V48, P115; Phuka JC, 2012, MATERN CHILD NUTR, V8, P239, DOI 10.1111/j.1740-8709.2011.00294.x; Reinhardt Kristina, 2014, Front Nutr, V1, P13, DOI 10.3389/fnut.2014.00013; Santika O, 2009, J NUTR, V139, P135, DOI 10.3945/jn.108.092270; Sazawal S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-514; Schoustra SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063948; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Skau JK, 2014, AM J CLIN NUTR; Staff WHO Organization WH UNICEF, 2003, GLOB STRAT INF YOUNG; Suri DJ, 2016, COMPR REV FOOD SCI F, V15, P912, DOI 10.1111/1541-4337.12216; Talsma EF, 2018, PUBLIC HEALTH NUTR, V21, P365, DOI 10.1017/S1368980017002506; Vossenaar M, 2017, PUBLIC HEALTH NUTR, V20, P971, DOI [10.1017/S1368980016003116, 10.1017/s1368980016003116]; Walker SP, 2007, J NUTR, V137, P2464, DOI 10.1093/jn/137.11.2464; Wouters JTM, 2002, INT DAIRY J, V12, P91, DOI 10.1016/S0958-6946(01)00151-0; Zambia MoH, 2015, ZAMB NAT MAL IND SUR; Zhang ZY, 2016, FOOD NUTR BULL, V37, P303, DOI 10.1177/0379572116647823; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564; Zironi E, 2014, ITALIAN J FOOD SAFET, V3	63	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232824	10.1371/journal.pone.0232824	http://dx.doi.org/10.1371/journal.pone.0232824			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384114	Green Published, gold			2022-12-26	WOS:000537468300031
J	Emerenziani, GP; Vaccaro, MG; Izzo, G; Greco, F; Rotundo, L; Lacava, R; La Vignera, S; Calogero, AE; Lenzi, A; Averse, A				Emerenziani, Gian Pietro; Vaccaro, Maria Grazia; Izzo, Giulia; Greco, Francesca; Rotundo, Luca; Lacava, Roberto; La Vignera, Sandro; Calogero, Aldo Eugenio; Lenzi, Andrea; Averse, Antonio			Prediction equation for estimating cognitive function using physical fitness parameters in older adults	PLOS ONE			English	Article							PARKINSONS-DISEASE; EXERCISE CAPACITY; GRIP STRENGTH; MORTALITY; PERFORMANCE; REDUCTION; BENEFITS; DECLINE; BRAIN; GAIT	Ageing is associated with declines in cognitive functions and physical fitness (PF). Physical exercise training and physical activity (PA) have been shown to have positive effects on cognitive functions and brain plasticity. This study aims to establish a practical equation for evaluating cognitive functions using PF parameters in healthy older adults. One-hundred and two older subjects were physically and clinically evaluated. Participants performed the Short Physical Performance Battery (SPPB) and handgrip test (HG); general cognitive functions were examined using the Mini Mental State Examination (MMSE). For all of them, a multiple regression analysis was used to predict MMSE from age, SPPB and HG variables. The new equation was cross validated to determine its prediction accuracy. Considering that SPPB and MMSE reference score are not different between genders, only one equation was developed for females and males. Age, SPPB and HG correlated significantly (p<0.01) with the MMSE score. The developed equation was MMSE = 19.479 + (1.548 x SPPB)-(0.130 x age) (R-2 = 0.72 and root mean square errors of 3.6). The results of PF are useful for exercise specialists to achieve the best physical exercise training and PA in older adults. In conclusion, this study showed for the first time that our new equation can be used to predict subjects' cognitive functions based on SPPB results and subject age. We suggest its use when patients' cognitive functions or more appropriate clinical tests cannot be pursued.	[Emerenziani, Gian Pietro; Izzo, Giulia; Greco, Francesca; Rotundo, Luca; Averse, Antonio] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy; [Vaccaro, Maria Grazia] Magna Graecia Univ Catanzaro, Neurosci Ctr, Catanzaro, Italy; [Lacava, Roberto] DSS CZ Ambulatorio Geriatria Disturbi Cognit & De, PST Umberto Primo, Catanzaro, Italy; [La Vignera, Sandro; Calogero, Aldo Eugenio] Univ Catania, Dept Clin & Expt Med, Catania, Italy; [Lenzi, Andrea] Sapienza Univ Rome, Policlin Umberto 1, Dept Expt Med, Rome, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; University of Catania; Sapienza University Rome; University Hospital Sapienza Rome	Emerenziani, GP (corresponding author), Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy.	emerenziani@unicz.it	Calogero, Aldo E./AAA-9538-2021; Emerenziani, Gian Pietro/ABF-1876-2020; VACCARO, Maria Grazia/ABD-9308-2020; Greco, Francesca/GLS-1643-2022	Calogero, Aldo E./0000-0001-6950-335X; Emerenziani, Gian Pietro/0000-0002-5426-5317; VACCARO, Maria Grazia/0000-0001-8666-0461; Greco, Francesca/0000-0002-6539-7796	MIUR [2015XCR88M_008, 2017FJSM9S]	MIUR(Ministry of Education, Universities and Research (MIUR))	This research was partially funded by MIUR Grant no 2015XCR88M_008 to Prof. Antonio Aversa and no 2017FJSM9S to G.P. Emerenziani. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DLJ, 2015, J CHEM INF MODEL, V55, P1316, DOI 10.1021/acs.jcim.5b00206; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Beier M, 2014, ARCH PHYS MED REHAB, V95, P1328, DOI [10.1016/j.apmr.2013.04.008, 10.1016/j.apmr.2014.02.017]; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Borges SD, 2018, AGING NEUROPSYCHOL C, V25, P23, DOI 10.1080/13825585.2016.1258035; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Chang YK, 2012, J AGING PHYS ACTIV, V20, P497, DOI 10.1123/japa.20.4.497; Chen YL, 2018, NEUROPSYCH DIS TREAT, V14, P1381, DOI 10.2147/NDT.S159174; Demnitz N, 2016, GAIT POSTURE, V50, P164, DOI 10.1016/j.gaitpost.2016.08.028; Duca Y, 2019, ANDROLOGIA, V51, DOI 10.1111/and.13264; Falbo S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5812092; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hooghiemstra AM, 2017, J GERONTOL A-BIOL, V72, P846, DOI 10.1093/gerona/glx003; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Korpelainen R, 2016, ANN MED, V48, P359, DOI 10.1080/07853890.2016.1178856; Kujala UM, 2010, SCAND J MED SCI SPOR, V20, P367, DOI 10.1111/j.1600-0838.2010.01137.x; Liu PZ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00052; Macera CA, 2003, ARTHRIT RHEUM-ARTHR, V49, P122, DOI 10.1002/art.10907; Mattson MP, 2014, J PARKINSON DIS, V4, P1, DOI 10.3233/JPD-130335; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Mura G, 2014, CNS SPECTRUMS, V19, P496, DOI 10.1017/S1092852913000953; Myers J, 2004, AM J MED, V117, P912, DOI 10.1016/j.amjmed.2004.06.047; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Norouzi E, 2019, PHYSICIAN SPORTSMED, V47, P471, DOI 10.1080/00913847.2019.1623996; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Ruegsegger GN, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029694; Salehi A, 2003, TRENDS NEUROSCI, V26, P73, DOI 10.1016/S0166-2236(02)00038-3; Schoenfeld TJ, 2013, J NEUROSCI, V33, P7770, DOI 10.1523/JNEUROSCI.5352-12.2013; SCHWARZ L, 1992, SPORTS MED, V13, P25, DOI 10.2165/00007256-199213010-00003; Sessa Francesco, 2020, Aging Male, V23, P14, DOI 10.1080/13685538.2018.1482866; Sherrington C, 2017, BRIT J SPORT MED, V51, P1749, DOI 10.1136/bjsports-2016-096547; Vaccaro MG, 2019, INT J ENDOCRINOL, V2019, DOI 10.1155/2019/2048391; Veronese N, 2016, EXP GERONTOL, V81, P110, DOI 10.1016/j.exger.2016.05.008; Vina J, 2012, BRIT J PHARMACOL, V167, P1, DOI 10.1111/j.1476-5381.2012.01970.x; Voelcker-Rehage C, 2013, NEUROSCI BIOBEHAV R, V37, P2268, DOI 10.1016/j.neubiorev.2013.01.028; Wang CY, 2010, ARCH PHYS MED REHAB, V91, P1747, DOI 10.1016/j.apmr.2010.07.225; Wollesen B, 2014, EUR REV AGING PHYS A, V11, P5, DOI 10.1007/s11556-013-0122-z; World Health Organization, 2015, 1 WORLD REP AG HLTH; Yogev-Seligmann G, 2012, ARCH PHYS MED REHAB, V93, P176, DOI 10.1016/j.apmr.2011.06.005; Young J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005381.pub4	44	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232894	10.1371/journal.pone.0232894	http://dx.doi.org/10.1371/journal.pone.0232894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZX	32379838	Green Published, gold			2022-12-26	WOS:000537285700077
J	Strahl, J; Abele, D				Strahl, Julia; Abele, Doris			Nitric oxide mediates metabolic functions in the bivalve Arctica islandica under hypoxia	PLOS ONE			English	Article							NITROGEN-EXCRETION; NITRATE REDUCTASE; SYNTHASE ACTIVITY; REACTIVE OXYGEN; PEROXYNITRITE; INHIBITION; SUBSTRATE; ASSAY	The free radical nitric oxide (NO) is a powerful metabolic regulator in vertebrates and invertebrates. At cellular concentrations in the nanomolar range, and simultaneously reduced internal oxygen partial pressures (pO(2)), NO completely inhibits cytochrome-c-oxidase (CytOx) activity and hence mitochondrial- and whole-tissue respiration. The infaunal clam Arctica islandica regulates pO(2) of hemolymph and mantle cavity water to mean values of <5 kPa, even in a completely oxygen-saturated environment of 21 kPa. These low internal pO(2) values support a longer NO lifespan and NO accumulation in the body fluids and can thus trigger a depression of metabolic rate in the clams. Measurable amounts of NO formation were detected in hemocyte cells (similar to 110 pmol NO 100(-1) hemocytes h(-1) at 6 kPa), which was not prevented in the presence of the NO synthase inhibitor L-NAME, and in the gill filaments of A. islandica. Adding a NO donor to intact gills and tissue homogenate significantly inhibited gill respiration and CytOx activity below 10 kPa. Meanwhile, the addition of the NO-oxidation product nitrite did not affect metabolic rates. The high nitrite levels found in the hemolymph of experimental mussels under anoxia do not indicate cellular NO production, but could be an indication of nitrate reduction by facultative anaerobic bacteria associated with tissue and/or hemolymph biofilms. Our results suggest that NO plays an important role in the initiation of metabolic depression during self-induced burrowing and shell closure of A. islandica. Furthermore, NO appears to reduce mitochondrial oxygen radical formation during surfacing and cellular reoxygenation after prolonged periods of hypoxia and anoxia.	[Strahl, Julia; Abele, Doris] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Strahl, Julia] Carl von Ossietzky Univ Oldenburg, Helmholtz Inst Funct Marine Biodivers, Oldenburg, Germany; [Strahl, Julia] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, Oldenburg, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Strahl, J (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany.; Strahl, J (corresponding author), Carl von Ossietzky Univ Oldenburg, Helmholtz Inst Funct Marine Biodivers, Oldenburg, Germany.; Strahl, J (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, Oldenburg, Germany.	julia.strahl@hifmb.de		Abele, Doris/0000-0002-5766-5017; Strahl, Julia/0000-0001-9496-4019	German Science foundation (DFG) [AB124/10-1, DR262/10-1]; Ministry for Science and Culture of Lower Saxony; Volkswagen Foundation through the "Niedersachsisches Vorab" grant program [ZN3285]	German Science foundation (DFG)(German Research Foundation (DFG)); Ministry for Science and Culture of Lower Saxony; Volkswagen Foundation through the "Niedersachsisches Vorab" grant program	The cooperative project between the Alfred Wegener Institute and the University of Bremen was financed by the German Science foundation (DFG), grant numbers AB124/10-1 and DR262/10-1 (https://www.dfg.de/en/).HIFMB is a collaboration between the Alfred Wegener Institute Helmholtz-Center for Polar and Marine Research, and the Carl-von-Ossietzky University Oldenburg, initially funded by the Ministry for Science and Culture of Lower Saxony and the Volkswagen Foundation through the "Niedersachsisches Vorab" grant program (grant number ZN3285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2010, CAN J FISH AQUAT SCI, V67, P977, DOI 10.1139/F10-035; Bayne B.L., 1976, MARINE MUSSELS THEIR; BAYNE BL, 1971, COMP BIOCHEM PHYSIOL, V40, P1065, DOI 10.1016/0300-9629(71)90295-7; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Boveris A, 2000, FREE RADICALS CHEM B; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; CHEN JC, 1994, MAR ECOL PROG SER, V110, P85, DOI 10.3354/meps110085; COCKCROFT AC, 1990, MAR ECOL PROG SER, V60, P57, DOI 10.3354/meps060057; COLE JA, 1990, FEMS SYMP, P57; CONTE A, 1995, FEBS LETT, V365, P120, DOI 10.1016/0014-5793(95)00439-G; Cooper CE, 2002, TRENDS BIOCHEM SCI, V27, P33, DOI 10.1016/S0968-0004(01)02035-7; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dailianis S, 2009, FISH SHELLFISH IMMUN, V27, P446, DOI 10.1016/j.fsi.2009.06.016; Gladwin MT, 2005, NATURE CHEM BIOL; Gonzalez PM, 2008, AQUAT TOXICOL, V89, P122, DOI 10.1016/j.aquatox.2008.06.008; Hardewig I, 1999, AM J PHYSIOL-REG I, V277, pR508, DOI 10.1152/ajpregu.1999.277.2.R508; Heisterkamp IM, 2010, MAR ECOL PROG SER, V415, P1, DOI 10.3354/meps08727; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; Horn MA, 2003, APPL ENVIRON MICROB, V69, P1662, DOI 10.1128/AEM.69.3.1662-1669.2003; Jacklet Jon W., 1997, Invertebrate Neuroscience, V3, P1, DOI 10.1007/BF02481710; Jansson EA, 2008, NAT CHEM BIOL, V4, P411, DOI 10.1038/nchembio.92; Jensen FB, 2007, J EXP BIOL, V210, P3387, DOI 10.1242/jeb.008748; Kelley EE, 2006, FREE RADICAL BIO MED, V40, P952, DOI 10.1016/j.freeradbiomed.2005.11.008; KUCERA I, 1983, BIOCHEM BIOPH RES CO, V117, P252; Lambert C, 2007, AQUACULTURE, V270, P413, DOI 10.1016/j.aquaculture.2007.04.074; Gonzalez PM, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01709; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Moroz LL, 1996, J NEUROCHEM, V66, P873; Moroz LL, 1995, ACTA BIOL HUNG, V46, P169; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Novas A, 2007, FISH SHELLFISH IMMUN, V23, P886, DOI 10.1016/j.fsi.2007.04.007; Okada S, 1996, PHYSIOL CHEM PHYS ME, V28, P69; Palumbo A, 2005, COMP BIOCHEM PHYS A, V142, P241, DOI 10.1016/j.cbpb.2005.05.043; Poderoso JJ, 1999, J BIOL CHEM, V274, P37709, DOI 10.1074/jbc.274.53.37709; POGREBNAYA VL, 1975, J APPL CHEM-USSR+, V48, P1004; Pujalte M J, 1999, Int Microbiol, V2, P259; Ramos-Vasconcelos GR, 2003, J EXP BIOL, V206, P675, DOI 10.1242/jeb.00124; Rivera-Ingraham GA, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0137-1; Rubiolo JA, 2019, INSIGHTS MUSSEL MICR, P95; Samouilov A, 1998, ARCH BIOCHEM BIOPHYS, V357, P1, DOI 10.1006/abbi.1998.0785; Schreiber F., 2009, DETECTING UNDERSTAND; Smith KL, 2000, SCI TOTAL ENVIRON, V262, P185, DOI 10.1016/S0048-9697(00)00599-4; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Stefano GB, 2002, BRAIN RES, V924, P82, DOI 10.1016/S0006-8993(01)03227-9; Stief P, 2013, BIOGEOSCIENCES, V10, P7829, DOI 10.5194/bg-10-7829-2013; Strahl J., 2011, LIFE STRATEGIES LONG; Strahl J, 2011, J EXP BIOL, V214, P4223, DOI 10.1242/jeb.055178; Strahl J, 2011, COMP BIOCHEM PHYS A, V158, P513, DOI 10.1016/j.cbpa.2010.12.015; Tafalla C, 2003, DEV COMP IMMUNOL, V27, P197, DOI 10.1016/S0145-305X(02)00098-8; TAYLOR AC, 1976, J MAR BIOL ASSOC UK, V56, P95, DOI 10.1017/S0025315400020464; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; Weigelt-Krenz S, 2010, MEERESUMWELT AKTUELL; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3	57	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232360	10.1371/journal.pone.0232360	http://dx.doi.org/10.1371/journal.pone.0232360			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379772	gold, Green Published			2022-12-26	WOS:000537285700031
J	Alemu, A; Yesuf, A; Gebrehanna, E; Zerihun, B; Getu, M; Worku, T; Bitew, ZW				Alemu, Ayinalem; Yesuf, Aman; Gebrehanna, Ewenat; Zerihun, Betselot; Getu, Melak; Worku, Teshager; Bitew, Zebenay Workneh			Incidence and predictors of extrapulmonary tuberculosis among people living with Human Immunodeficiency Virus in Addis Ababa, Ethiopia: A retrospective cohort study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; POSITIVE PATIENTS; PREVALENCE	Background Extrapulmonary tuberculosis is an emerging public health problem among HIV positives compared to the general population. This study aimed to assess the incidence and predictors of extrapulmonary tuberculosis among people living with HIV in selected health facilities in Addis Ababa, Ethiopia, from 01 January 2013 up to 31 December 2018. Methods A retrospective cohort study design was employed based on data collected from 566 HIV positive individuals. Data were entered using EpiInfo version 7.1 and analyzed by SPSS version 20. The incidence rate was determined per 100 person-years. Kaplan-Meier estimates used to estimate survivor and the hazard function, whereas log-rank tests used to compare survival curves and hazard across different categories. Cox proportional hazard model was used to identify the predictors and 95%CI of the hazard ratio were computed. P-value< 0.05 in the multivariable analysis was considered statistically significant. Results Five hundred sixty-six HIV positive individuals were followed for 2140.08 person-years. Among them, 72 developed extrapulmonary tuberculosis that gives an incidence rate of 3.36/100 person-years (95%CI = 2.68-4.22). The most frequent forms of extrapulmonary tuberculosis were; lymph node tuberculosis (56%, 41) followed equally by pleural tuberculosis (15%, 11) and disseminated tuberculosis (15%, 11). The majority (70.83%) of the cases occurred within the first year of follow-up. In multivariable Cox regression analysis, baseline WHO stage III/IV (AHR = 2.720, 95%CI = 1.575-4.697), baseline CD4 count< 50cells/mu l (AHR = 4.073, 95%CI = 2.064-8.040), baseline CD4 count 50-200 cells/mu l (AHR = 2.360, 95%CI = 1.314-4.239) and baseline Hgb< 10 mg/dl (AHR = 1.979, 95%CI = 1.091-3.591) were the independent risk factors. While isoniazid prophylaxis (AHR = 0.232, 95%CI = 0.095-0.565) and taking antiretroviral drugs (AHR = 0.134, 95%CI = 0.075-0.238) had a protective benefit. Conclusion Extrapulmonary tuberculosis co-infection was common among HIV positive individuals, and mostly occurred in those with advanced immune suppression. The risk decreases in those taking antiretroviral therapy and took isoniazid preventive treatment. Screening of HIV positives for extrapulmonary tuberculosis throughout their follow-up would be important.	[Alemu, Ayinalem; Zerihun, Betselot; Getu, Melak] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Yesuf, Aman; Gebrehanna, Ewenat; Bitew, Zebenay Workneh] St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia; [Worku, Teshager] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia	Haramaya University	Alemu, A (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.	ayinalemal@gmail.com	Endries, Aman Yesuf/AAN-6871-2021	Alemu Shitie, Ayinalem/0000-0001-5307-8774; /0000-0002-4565-5364; Zerihun, Betselot/0000-0003-4277-2247; Gebrehanna, Ewenat/0000-0002-7396-9491				Abate E, 2012, PLOS ONE, V7; Abossie A, 2017, THER CLIN RISK MANAG, V13, P361, DOI 10.2147/TCRM.S127765; Ahmed A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016961; Al-Ghafli H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213846; Alemu YM, 2016, BMJ OPEN, V6; Alene KA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-292; [Anonymous], 2018, GLOBAL TUBERCULOSIS; Assebe LF, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1719-0; Auld AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054665; Ayalaw Sualiha Gebeyaw, 2015, Int Sch Res Notices, V2015, P307810, DOI 10.1155/2015/307810; Ayele HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142290; Bonnet MMB, 2006, AIDS, V20, P1275, DOI 10.1097/01.aids.0000232235.26630.ee; Dalbo M., 2016, ADV INFECT DIS, V06, P70, DOI 10.4236/aid.2016.62010; del Amo J, 2012, CLIN INFECT DIS, V54, P1364, DOI 10.1093/cid/cis203; Endalamaw Aklilu, 2018, BMC Res Notes, V11, P745, DOI 10.1186/s13104-018-3846-z; Fanosie A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150646; Fekadu S, 2015, J INFECT DEV COUNTR, V9, P898, DOI 10.3855/jidc.5667; Gonzalez OY, 2003, INT J TUBERC LUNG D, V7, P1178; Iliyasu Z, 2009, J EPIDEMIOL, V19, P81, DOI 10.2188/jea.JE20080026; Jerene D, 2017, INT J TUBERC LUNG D, V21, P32, DOI 10.5588/ijtld.16.0105; Kassa A, 2012, T ROY SOC TROP MED H, V106, P363, DOI 10.1016/j.trstmh.2012.03.002; Kibret KT., 2013, PLOS ONE, V8; Korma W, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1177-4; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Mohammed H, 2018, HIV AIDS-RES PALLIAT, V10, P225, DOI 10.2147/HIV.S176587; Negussie Abel, 2018, BMC Res Notes, V11, P417, DOI 10.1186/s13104-018-3530-3; Pathmanathan I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173309; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Qian X, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0106-1; Ravikumar P, 2017, INT J ADV MED, V4, P209, DOI [10.18203/2349-3933. ijam20170113, DOI 10.18203/2349-3933.IJAM20170113]; Semu M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2109-7; Singh G, 2014, INDONESIAN J CHEST, V1; Taha M, 2011, ETHIOPIAN J HLTH SCI, V21; Tiruneh Gemechu, 2019, Interdiscip Perspect Infect Dis, V2019, P1413427, DOI 10.1155/2019/1413427; Wondimeneh Yitayih, 2012, BMC Res Notes, V5, P331, DOI 10.1186/1756-0500-5-331; Yirdaw KD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211688; Yirdaw KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104557	37	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232426	10.1371/journal.pone.0232426	http://dx.doi.org/10.1371/journal.pone.0232426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374773	gold, Green Published			2022-12-26	WOS:000537283500034
J	Lunge, A; Gupta, R; Choudhary, E; Agarwal, N				Lunge, Ajitesh; Gupta, Radhika; Choudhary, Eira; Agarwal, Nisheeth			The unfoldase ClpC1 ofMycobacterium tuberculosisregulates the expression of a distinct subset of proteins having intrinsically disordered termini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; caseinolytic protease; ClpC1 unfoldase; ATPase; intrinsically disordered region; Hsp20; proteolysis; protein degradation; tuberculosis; heat shock protein (HSP)	CHAPERONE; PROTEASE; DEGRADATION; BINDING	The human pathogenMycobacterium tuberculosis(Mtb) harbors a well-orchestrated Clp (caseinolytic protease) proteolytic machinery consisting of two oligomeric segments, a barrel-shaped heterotetradecameric protease core comprising the ClpP1 and ClpP2 subunits, and hexameric ring-like ATP-dependent unfoldases composed of ClpX or ClpC1. The roles of the ClpP1P2 protease subunits are well-established in Mtb, but the potential roles of the associated unfoldases, such as ClpC1, remain elusive. Using a CRISPR interference?mediated gene silencing approach, here we demonstrate thatclpC1is indispensable for the extracellular growth of Mtb and for its survival in macrophages. The results from isobaric tags for relative and absolute quantitation?based quantitative proteomic experiments withclpC1- andclpP2-depleted Mtb cells suggested that the ClpC1P1P2 complex critically maintains the homeostasis of various growth-essential proteins in Mtb, several of which contain intrinsically disordered regions at their termini. We show that the Clp machinery regulates dosage-sensitive proteins such as the small heat shock protein Hsp20, which exists in a dodecameric conformation. Further, we observed that Hsp20 is poorly expressed in WT Mtb and that its expression is greatly induced upon depletion ofclpC1orclpP2. Remarkably, high Hsp20 protein levels were detected in theclpC1(?)orclpP2(?)knockdown strains but not in the parental bacteria, despite significant induction ofhsp20transcripts. In summary, the cellular levels of oligomeric proteins such as Hsp20 are maintained post-translationally through their recognition, disassembly, and degradation by ClpC1, which requires disordered ends in its protein substrates.	[Lunge, Ajitesh; Choudhary, Eira; Agarwal, Nisheeth] Natl Capital Reg Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, Faridabad, India; [Lunge, Ajitesh] Jawaharlal Nehru Univ, New Delhi, India; [Gupta, Radhika] Univ Delhi, Daulat Ram Coll, Delhi, India; [Gupta, Radhika] Inst Genom & Integrat Biol, New Delhi, India; [Choudhary, Eira] Symbiosis Int Deemed Univ, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Jawaharlal Nehru University, New Delhi; University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Symbiosis International University	Agarwal, N (corresponding author), Natl Capital Reg Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, Faridabad, India.	nisheeth@thsti.res.in		Agarwal, Nisheeth/0000-0001-9203-3026; Gupta, Radhika/0000-0002-0445-0194	Department of Biotechnology, Government of India [BT/PR19140/MED/29/1104/2016, BT/PR25690/GET/119/142/2017]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Grants BT/PR19140/MED/29/1104/2016 (to A. L. and N. A.) and BT/PR25690/GET/119/142/2017 (to N. A.) from the Department of Biotechnology, Government of India.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ahmad J, 2020, FEBS OPEN BIO, V10, P70, DOI 10.1002/2211-5463.12749; Alhuwaider AAH, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00049; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bhandari S, 2019, PROTEINS, V87, P365, DOI 10.1002/prot.25657; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Danelishvili L, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00430-17; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Faizullin D A, 2013, Bioorg Khim, V39, P411; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Ghazaei C, 2018, J MED MICROBIOL, V67, P1203, DOI 10.1099/jmm.0.000811; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hoskins JR, 2006, P NATL ACAD SCI USA, V103, P909, DOI 10.1073/pnas.0509154103; Hoskins JR, 1998, P NATL ACAD SCI USA, V95, P12135, DOI 10.1073/pnas.95.21.12135; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Leodolter J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125345; Lupoli TJ, 2018, ACS INFECT DIS, V4, P478, DOI 10.1021/acsinfecdis.7b00231; Lupoli TJ, 2016, P NATL ACAD SCI USA, V113, pE7947, DOI 10.1073/pnas.1617644113; Marsee JD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113651; Pang XH, 2007, J BACTERIOL, V189, P6213, DOI 10.1128/JB.00492-07; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Raju RM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003994; Rizo AN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10150-y; Santra M, 2017, P NATL ACAD SCI USA, V114, pE2654, DOI 10.1073/pnas.1620646114; Schmitz KR, 2014, MOL MICROBIOL, V93, P617, DOI 10.1111/mmi.12694; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Thakur P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35475-4; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky Vladimir N, 2013, Intrinsically Disord Proteins, V1, pe24684, DOI 10.4161/idp.24684; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029	42	9	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9455	9473		10.1074/jbc.RA120.013456	http://dx.doi.org/10.1074/jbc.RA120.013456			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409584	Green Published, hybrid			2022-12-26	WOS:000552758600016
J	Kitajima, M; Miyata, C; Tamura, K; Kinoshita, A; Arai, H				Kitajima, Masaki; Miyata, Chiharu; Tamura, Keiko; Kinoshita, Ayae; Arai, Hidenori			Factors associated with the job satisfaction of certified nurses and nurse specialists in cancer care in Japan: Analysis based on the Basic Plan to Promote Cancer Control Programs	PLOS ONE			English	Article							ORGANIZATIONAL COMMITMENT; WORK ENGAGEMENT; CASE-MANAGEMENT	Background As the Japanese population ages, the number of cancer patients will likely increase. Therefore, qualified cancer health care providers should be recruited and retained. Nurse job satisfaction is influenced by numerous factors and may affect staff turnover and patient outcomes. Objectives To evaluate the job satisfaction of certified nurses and nurse specialists in Japanese cancer care and elucidate factors associated with job satisfaction. Methods Participants in this cross-sectional study comprised 200 certified nurse specialists and 1,472 certified nurses working in Japanese cancer care. A chi-square test and logistic regression analysis were conducted to identify job satisfaction factors. Results Job satisfaction was present in 38.45% and 49.00% of certified nurses and nurse specialists, respectively. Certified nurses associated job satisfaction with cross-departmental activities (OR 2.24, p< 0.001), positive evaluation from senior stuff (OR 4.58, p< 0.001), appropriate staff allocation (OR 1.75, p< 0.001), more than five years certified nurse experience (OR 1.91, p< 0.001), and positive evaluation of the development of certified nurses (OR 2.13, p< 0.01) and nurse specialists (OR 1.37, p< 0.05). Low job satisfaction was associated with working on a ward (OR 0.51, p< 0.001) and a capacity of more than 200 beds (OR 0.33, p = 0.00). Certified nurse specialists associated job satisfaction with palliative care team participation (OR 2.64, p<0.05), cross-sectional activities (OR 7.06, p<0.01), positive evaluation from senior stuff (OR 13.15, p< 0.001), presence of certified nurses in radiation therapy (OR 2.91, p<0.05), positive certified nurse specialist development evaluation (OR 7.35, p<0.001), medical service fees (OR 3.78, p<0.01), and independent activities (OR 11.34, p< 0.01). Conclusions We identified factors related to activities, facilities, and the cancer care team associated with job satisfaction of certified nurses and nurse specialists in Japanese cancer care. Suggestions are provided to enhance job satisfaction through Japan's Basic Plan to Promote Cancer Control, which may help hospital administrators retain nursing staff.	[Kitajima, Masaki; Tamura, Keiko; Kinoshita, Ayae] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Miyata, Chiharu] Mie Univ, Grad Sch Med, Nursing, Tsu, Mie, Japan; [Arai, Hidenori] Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan	Kyoto University; Mie University; National Center for Geriatrics & Gerontology	Arai, H (corresponding author), Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan.	harai@ncgg.go.jp	Arai, Hidenori/P-9816-2017	Arai, Hidenori/0000-0002-9000-6849	Japan Geriatrics Society; JSPS KAKENHI [JP17K18202]; Yasuda Memorial Medical Foundation	Japan Geriatrics Society; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yasuda Memorial Medical Foundation	This study was supported by research grants from The Japan Geriatrics Society (H.A.), JSPS KAKENHI (JP17K18202) (M.K.) and Yasuda Memorial Medical Foundation (M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijo R, 2017, J WELLNESS HLTH CARE, V41, P113; Asai N, 2017, KAWASAKI MED WELFARE, V26, P192; Baba K, 2013, J JAPAN SOC NURS RES, V36, P95; Baba R, 2014, PALLIAT CARE RES, V5, P127; Blanchfield K C, 1996, Nurs Adm Q, V20, P42; BROOKS JL, 1991, J VOCAT BEHAV, V38, P53, DOI 10.1016/0001-8791(91)90017-G; CARLSEN RH, 1981, RES NURS HEALTH, V4, P251, DOI 10.1002/nur.4770040207; Cho Julia, 2006, Nurs Leadersh (Tor Ont), V19, P43; COHEN EL, 1991, J NURS ADMIN, V21, P20; DEMPSTER JS, 1994, NURS PRACT FORUM, V5, P227; Fumatsu I, 2013, NURS J OSAKA U, V19, P25; GOODE CJ, 1995, NURS ECON, V13, P337; Hakanen JJ, 2006, J SCHOOL PSYCHOL, V43, P495, DOI 10.1016/j.jsp.2005.11.001; Halcomb E, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0819-1; Halfer D, 2006, NURS ECON, V24, P150; Hamaguchi K, 2010, J JAPAN SOC CANC NUR, V24, P52; Hasegawa H, 2009, CANC NURS 2, V14, P787; Hasegawa M, 2012, JAPAN J BREAST CANC, V27, P102; Hiraoka K, 2017, B NAT HOSP ORG HIMEJ, V15, P14; Japanese Association of Certified Nurse Specialists, 2015, JAP ASS CERT NURS SP; Japanese Nursing Association, 2016, CERT NURS; Koyano Y., 2000, B ST LUKES COLL NURS, V26, P50; Koyashiki C, 2018, CAREER NURS RES, V8, P54; Kozu M, 2010, J JAPAN SOC CANC NUR, V24, P45; Kramer M, 1987, Nurs Manage, V18, P38; Kramer M, 1987, Nurs Manage, V18, P33; Kuroda M, 2011, IBARAKI PREFECTURAL, V41, P29; Lawrence LA, 2011, NURS FORUM, V46, P256, DOI 10.1111/j.1744-6198.2011.00237.x; Longest B B Jr, 1974, J Nurs Adm, V4, P46, DOI 10.1097/00005110-197405000-00019; McNeese-Smith DK, 2001, J HEALTHC MANAG, V46, P173, DOI 10.1097/00115514-200105000-00008; MEYER JP, 1993, J APPL PSYCHOL, V78, P538, DOI 10.1037/0021-9010.78.4.538; Ministry of Health Labour and Welfare, 2013, CANC MEAS PROM BAS P; Miyakubi Y, 2012, J NURS STUD, V11, P12; Monden Morito, 2013, Gan To Kagaku Ryoho, V40, P559; Morita T, 2006, J PAIN SYMPTOM MANAG, V31, P306, DOI 10.1016/j.jpainsymman.2005.09.004; Nakajima M, 2015, J JAPAN NURS ASS, V45, P193; Nakamura K, 2019, J NIIGATA SEIRYO ACA, V12, P13; Noto Y, 2013, J RADIOL NURS SOC JA, V1, P22; Oncology Nursing Society, 1997, STATEMENT SCOPE STAN; Robbins SP, 1997, MANAGEMENT ORG BEHAV; Satoh M, 2017, JPN J NURS SCI, V14, P49, DOI 10.1111/jjns.12135; Seki Y, 2012, MIE NURS J, V14, P41; Shirouzu M., 2009, ST MARYS COLL B, V23, P155; Simpson K, 1985, Nurs Adm Q, V9, P64; SLAVITT DB, 1978, NURS RES, V27, P114; STAMPS PL, 1978, MED CARE, V16, P337, DOI 10.1097/00005650-197804000-00006; Tei-Tominaga Maki, 2009, Nihon Koshu Eisei Zasshi, V56, P301; Toku M, 2008, KANAGAWA PREFECTURAL, V14, P29; Ugwuegbu D C, 1977, J Adv Nurs, V2, P29, DOI 10.1111/j.1365-2648.1977.tb03310.x; Umeda K, 2009, CANC NURS 1, V14, P595; United Nations., 2013, REP INT NARC CONTR B, P1, DOI [10.18356/4dd21afa-en, DOI 10.18356/4DD21AFA-EN]; Vandenberghe C, 2004, J VOCAT BEHAV, V64, P47, DOI 10.1016/S0001-8791(03)00029-0; Wu L, 2006, NURS EDUC TODAY, V26, P304, DOI 10.1016/j.nedt.2005.10.011; Yarbo CH, 1996, CANC NURSING COMPREH, P12; Yoshida H, 2013, JAPAN J APPL PSYCHOL, V39, P13	55	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0232336	10.1371/journal.pone.0232336	http://dx.doi.org/10.1371/journal.pone.0232336			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1CK	32421704	gold, Green Submitted, Green Published			2022-12-26	WOS:000537499600008
J	Uttley, J; Fotios, S; Lovelace, R				Uttley, Jim; Fotios, Steve; Lovelace, Robin			Road lighting density and brightness linked with increased cycling rates after-dark	PLOS ONE			English	Article							IMPACT; POLLUTION; NETWORK; HEALTH	Cycling has a range of benefits as is recognised by national and international policies aiming to increase cycling rates. Darkness acts as a barrier to people cycling, with fewer people cycling after-dark when seasonal and time-of-day factors are accounted for. This paper explores whether road lighting can reduce the negative impact of darkness on cycling rates. Changes in cycling rates between daylight and after-dark were quantified for 48 locations in Birmingham, United Kingdom, by calculating an odds ratio. These odds ratios were compared against two measures of road lighting at each location: 1) Density of road lighting lanterns; 2) Relative brightness as estimated from night-time aerial images. Locations with no road lighting showed a significantly greater reduction in cycling after-dark compared with locations that had some lighting. A nonlinear relationship was found between relative brightness at a location at night and the reduction in cyclists after-dark. Small initial increases in brightness resulted in large reductions in the difference between cyclist numbers in daylight and after-dark, but this effect reached a plateau as brightness increased. These results suggest only a minimal amount of lighting can promote cycling after-dark, making it an attractive mode of transport year-round.	[Uttley, Jim; Fotios, Steve] Univ Sheffield, Sch Architecture, Arts Tower, Sheffield, S Yorkshire, England; [Lovelace, Robin] Univ Leeds, Inst Transport Studies, Leeds, W Yorkshire, England	University of Sheffield; University of Leeds	Uttley, J (corresponding author), Univ Sheffield, Sch Architecture, Arts Tower, Sheffield, S Yorkshire, England.	j.uttley@sheffield.ac.uk	Uttley, Jim/H-3952-2014	Uttley, Jim/0000-0002-8080-3473; Lovelace, Robin/0000-0001-5679-6536	White Rose Collaboration Fund [156259-1]; Engineering and Physical Sciences Research Council [EP/M02900X/1]; EPSRC [EP/M02900X/1] Funding Source: UKRI	White Rose Collaboration Fund; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	JU, SF and RL were supported by funding from the White Rose Collaboration Fund (grant number 156259-1) -https://whiterose.ac.uk/collaboration-fund/JU and SF were supported by funding from the MERLIN-2 project, funded by the Engineering and Physical Sciences Research Council (grant number EP/M02900X/1) -https://gow.epsrc.ukri.org/NGBOViewGrant.aspx? GrantRef=EP/M02900X/1 These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aultman-Hall L, 2009, TRANSPORT RES REC, P35, DOI 10.3141/2140-0; British Standards Institution, 2016, 1320132015 BS EN BSI; Bullough JD, 2014, LEUKOS, V10, P3, DOI 10.1080/15502724.2013.827516; Celis-Morales CA, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1456; Chen P, 2016, ACCIDENT ANAL PREV, V86, P239, DOI 10.1016/j.aap.2015.11.002; Commission Internationale de l'Eclairage, 2017, 1152010 CIE; De Vos J, 2016, TRANSPORTATION, V43, P771, DOI 10.1007/s11116-015-9619-9; Department for Business Energy & Industrial Strategy, 2019, GREENH GAS REP CONV; Department for Transport, 2017, CYCL WALK INV STRAT; European Committee for Standardization, 2016, 1320122015 EN EUR CO; European Cyclists' Federation, CYCL MOR OFT 2 COOL; Fotios S., 2005, Lighting Research & Technology, V37, P271, DOI 10.1191/1365782805li139oa; Fotios S, 2019, LIGHTING RES TECHNOL, V51, P557, DOI 10.1177/1477153518775464; Fotios S, 2019, LIGHTING RES TECHNOL, V51, P55, DOI 10.1177/1477153517738306; Fotios S, 2017, LIGHTING RES TECHNOL, V49, P586, DOI 10.1177/1477153515625103; Fotios SA, 2011, LIGHTING RES TECHNOL, V43, P143, DOI 10.1177/1477153510393932; Hale JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061460; Johansson C, 2017, SCI TOTAL ENVIRON, V584, P55, DOI 10.1016/j.scitotenv.2017.01.145; Johansson O, 2009, ACCIDENT ANAL PREV, V41, P809, DOI 10.1016/j.aap.2009.04.003; Kreitzman L., 1999, THE 24 HOUR SOC; Kuechly HU, 2012, REMOTE SENS ENVIRON, V126, P39, DOI 10.1016/j.rse.2012.08.008; Lovelace R, 2011, ENERG POLICY, V39, P2075, DOI 10.1016/j.enpol.2011.01.051; Mantuano A, 2017, CASE STUD TRANSP POL, V5, P408, DOI 10.1016/j.cstp.2016.06.001; Maxwell Gill, 2007, Employee Relations, V29, P138, DOI 10.1108/01425450710719987; Mueller N, 2018, PREV MED, V109, P62, DOI 10.1016/j.ypmed.2017.12.011; Newman O, 1972, DEFENSIBLE SPACE; Ogilvie D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000694; Ordnance Survey, 2017, US GUID TECHN SPEC; PAUL SR, 1989, STAT MED, V8, P1455, DOI 10.1002/sim.4780081205; Public Health England, 2016, HLTH MATT GETT EV AD; QGIS Development Team, 2018, GEOGRAPHIC INFORM SY; Quinet KD, 1998, EVALUATION REV, V22, P751, DOI 10.1177/0193841X9802200603; Raynham P, 2020, LIGHTING RES TECHNOL, V52, P485, DOI 10.1177/1477153519870857; Richbell S, 2007, INT J RETAIL DISTRIB, V35, P54, DOI 10.1108/09590550710722341; Schepers P, 2011, ERGONOMICS, V54, P315, DOI 10.1080/00140139.2011.558633; Song Y, 2017, TRANSPORT RES A-POL, V95, P320, DOI 10.1016/j.tra.2016.11.017; Sullivan JM, 2007, ACCIDENT ANAL PREV, V39, P638, DOI 10.1016/j.aap.2006.10.010; Sustrans, 2018, ALL CITIES PUBLICATI; Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227; Transport for London, 2016, LOND CYCL DES STAND; Treinen JJ, 2006, IBM SYST J, V45, P773, DOI 10.1147/sj.454.0773; Uttley J, 2017, J ENVIRON PSYCHOL, V53, P1, DOI 10.1016/j.jenvp.2017.06.003; Uttley J, 2017, ACCIDENT ANAL PREV, V108, P189, DOI 10.1016/j.aap.2017.09.005; Walton D, 2007, ROAD TRANSP RES, V16, P60; Wanvik PO, 2009, ACCIDENT ANAL PREV, V41, P123, DOI 10.1016/j.aap.2008.10.003; Winters M, 2011, TRANSPORTATION, V38, P153, DOI 10.1007/s11116-010-9284-y	47	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233105	10.1371/journal.pone.0233105	http://dx.doi.org/10.1371/journal.pone.0233105			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1BA	32413065	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000537496000048
J	Nyambe, S; Agestika, L; Yamauchi, T				Nyambe, Sikopo; Agestika, Lina; Yamauchi, Taro			The improved and the unimproved: Factors influencing sanitation and diarrhoea in a peri-urban settlement of Lusaka, Zambia	PLOS ONE			English	Article							SHARED SANITATION; INTERVENTION; QUALITY	Accounting for peri-urban sanitation poses a unique challenge due to its high density, unplanned stature, with limited space and funding for conventional sanitation instalment. To better understand users, needs and inform peri-urban sanitation policy, our study used multivariate stepwise logistic regression to assess the factors associated with use of improved (toilet) and unimproved (chamber) sanitation facilities among peri-urban residents. We analysed data from 205 household heads in 1 peri-urban settlement of Lusaka, Zambia on socio-demographics (economic status, education level, marital status, etc.), household sanitation characteristics (toilet facility, ownership and management) and household diarrhoea prevalence. Household water, sanitation and hygiene (WASH) facilities were assessed based on WHO-UNICEF criteria. Of particular interest was the simultaneous use of toilet facilities and chambers, an alternative form of unimproved sanitation with focus towards all-in-one suitable alternatives. Findings revealed that having a regular income, private toilet facility, improved drinking water and handwashing facility were all positively correlated to having an improved toilet facility. Interestingly, both improved toilets and chambers indicated increased odds for diarrhoea prevalence. Odds of chamber usage were also higher for females and users of unimproved toilet facilities. Moreover, when toilets were owned by residents, and hygiene was managed externally, use of chambers was more likely. Findings finally revealed higher diarrhoea prevalence for toilets with more users. Results highlight the need for a holistic, simultaneous approach to WASH for overall success in sanitation. To better access and increase peri-urban sanitation, this study recommends a separate sanitation ladder for high density areas which considers improved private and shared facilities, toilet management and all-inclusive usage (cancelling unimproved alternatives). It further calls for financial plans supporting urban poor access to basic sanitation and increased education on toilet facility models, hygiene, management and risk to help with choice and proper facility use to maximize toilet use benefit.	[Nyambe, Sikopo; Agestika, Lina] Hokkaido Univ, Grad Sch Hlth Sci, Lab Human Ecol, Sapporo, Hokkaido, Japan; [Yamauchi, Taro] Hokkaido Univ, Lab Human Ecol, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Yamauchi, Taro] Res Inst Human & Nat, Kyoto, Japan	Hokkaido University; Hokkaido University; Research Institute for Humanity & Nature (RIHN)	Yamauchi, T (corresponding author), Hokkaido Univ, Lab Human Ecol, Fac Hlth Sci, Sapporo, Hokkaido, Japan.; Yamauchi, T (corresponding author), Res Inst Human & Nat, Kyoto, Japan.	taroy@med.hokudai.ac.jp	Agestika, Lina/AAH-5032-2021; Agestika, Lina/GQY-4644-2022	Nyambe, Sikopo/0000-0001-7073-7073	Research Institute for Humanity and Nature (RIHN) [14200107]; Japan Society for the Promotion of Science KAKENHI	Research Institute for Humanity and Nature (RIHN); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Our research activities were supported by: (i) "The Sanitation Value Chain: Designing Sanitation Systems as Eco-Community Value System" Project, Research Institute for Humanity and Nature (RIHN, Project No.14200107). URL: http://www.chikyu.ac.jp/rihn_e/; and (ii) Japan Society for the Promotion of Science KAKENHI to TY. URL: https://www.jsps.go.jp/index.html SN, LA and TY are all members of the RIHN Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari P, 2019, INT J ENV RES PUB HE, V16, P1; Bhatt N, 2019, PLOS ONE, V14, P1; Central Statistical Office, 2016, 2015 LIV COND MON SU; Central Statistical Office (CSO), 2014, ZAMB DEM HLTH SURV 2, P518; Cherunya PC, 2020, RES POLICY, V49, DOI 10.1016/j.respol.2019.103841; Chipungu J, 2019, J WATER SANIT HYG DE, V9, P102, DOI 10.2166/washdev.2018.102; Freeman MC, 2017, INT J HYG ENVIR HEAL, V220, P928, DOI 10.1016/j.ijheh.2017.05.007; Gross E, 2014, WATER RESOUR RES, V50, P8314, DOI 10.1002/2014WR015899; Kapata N, 2018, J INFECT DIS, V218, pS181, DOI 10.1093/infdis/jiy490; Kumar S, 2013, HEALTH ECON, V22, P410, DOI 10.1002/hec.2809; Kwiringira J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-624; Mara D, 2016, T ROY SOC TROP MED H, V110, P265, DOI 10.1093/trstmh/trw029; Martin NA, 2018, TROP MED INT HEALTH, V23, P122, DOI 10.1111/tmi.13011; Mo Ibrahim Foundation, 2015, FACTS FIG AFR URB DY; Munshifwa EK, 2016, LAND USE POLICY, V57, P479, DOI 10.1016/j.landusepol.2016.06.012; Nyambe S., 2018, SANIT VALUE CHAIN, V2, P39; Pickering AJ, 2015, LANCET GLOB HEALTH, V3, pE701, DOI 10.1016/S2214-109X(15)00144-8; Republic of Zambia, 2006, 5 NAT DEV PLAN; Satterthwaite D, 2015, ENVIRON URBAN, V27, P3, DOI 10.1177/0956247815576286; Scott P, 2013, HABITAT INT, V40, P58, DOI 10.1016/j.habitatint.2013.02.004; Sigler R, 2015, HEALTH PROMOT INT, V30, P16, DOI 10.1093/heapro/dau073; Sinyange N, 2018, MMWR-MORBID MORTAL W, V67, P556, DOI 10.15585/mmwr.mm6719a5; The World Bank, 2015, PROJ APPR DOC PROP C; Tidwell JB, 2019, LANCET PLANET HEALTH, V3, pE187, DOI 10.1016/S2542-5196(19)30036-1; UN Water, 2013, ZAMB UN WAT COUNTR B; UNICEF and WHO, 2018, COR QUEST WAT SAN HY; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; WHO Global Task Force on Cholera Control, 2011, CHOL COUNTR PROF ZAM; World Health Organization, 2018, TREATMENT PREVENTION, DOI DOI 10.1126/SCIENCE.1223389; WORLD HEALTH ORGANIZATION (WHO); UNITED NATIONS CHILDREN'S FUND (UNICEF), 2017, PROGR DRINK WAT SAN, DOI DOI 10.1111/TMI.12329; Yogananth N, 2018, T ROY SOC TROP MED H, V112, P349, DOI 10.1093/trstmh/try064	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232763	10.1371/journal.pone.0232763	http://dx.doi.org/10.1371/journal.pone.0232763			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0VG	32401762	gold, Green Published			2022-12-26	WOS:000537481000032
J	Wang, M; Zhang, C				Wang, Mei; Zhang, Chi			Low LEF1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; MYELOID NEOPLASMS; CLASS DISCOVERY; CLASSIFICATION; REVISION; MODELS; TCF-1	Early T-cell precursor (ETP) is the only subtype of acute T-cell lymphoblastic leukemia (T-ALL) listed in the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia. Patients with ETP tend to have worse disease outcomes. ETP is defined by a series of immune markers. The diagnosis of ETP status can be vague due to the limitation of the current measurement. In this study, we performed unsupervised clustering and supervised prediction to investigate whether a molecular biomarker can be used to identify the ETP status in order to stratify risk groups. We found that the ETP status can be predicted by the expression level of Lymphoid enhancer binding factor 1 (LEF1) with high accuracy (AUC of ROC = 0.957 and 0.933 in two T-ALL cohorts). The patients with ETP subtype have a lower level of LEF1 comparing to the those without ETP. We suggest that incorporating the biomarker LEF1 with traditional immune-phenotyping will improve the diagnosis of ETP.	[Wang, Mei] Peking Univ, Sch Life Sci, Beijing, Peoples R China; [Zhang, Chi] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Wang, M (corresponding author), Peking Univ, Sch Life Sci, Beijing, Peoples R China.	mei_wang@outlook.com			National Natural Science Foundation of China [81900155]; 100 Young Talents Program of Chinese Academy of Sciences; Strategic Priority Research Program of Chinese Academy of Sciences [XDB26000000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 100 Young Talents Program of Chinese Academy of Sciences; Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	This research is supported by National Natural Science Foundation of China (81900155) to M.W., the 100 Young Talents Program of Chinese Academy of Sciences and the Strategic Priority Research Program of Chinese Academy of Sciences (XDB26000000) to C.Z.	Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Bond J, 2017, J CLIN ONCOL, V35, P2683, DOI 10.1200/JCO.2016.71.8585; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; COX DR, 1972, J R STAT SOC B, V34, P187; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fu Y, 2014, LEUKEMIA LYMPHOMA, V55, P371, DOI 10.3109/10428194.2013.805759; Giambra V, 2016, BLOOD, V128; Gutierrez A, 2011, BLOOD, V118, P4169, DOI 10.1182/blood-2010-11-318873; Jain N, 2016, BLOOD, V127, P1863, DOI 10.1182/blood-2015-08-661702; Jia M, 2015, INT J LAB HEMATOL, V37, P631, DOI 10.1111/ijlh.12375; Khogeer H, 2019, BRIT J HAEMATOL, V186, P538, DOI 10.1111/bjh.15960; Liu Y, 2017, NAT GENET, V49, P1211, DOI 10.1038/ng.3909; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma Meilin, 2012, Front Med, V6, P416, DOI 10.1007/s11684-012-0224-4; Mary Goldman B. C., 2019, BIORXIV, DOI [DOI 10.1101/326470, 10.1101/326470]; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Santiago L, 2017, AM J CANCER RES, V7, P1389; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van Vlierberghe P, 2013, BLOOD, V122, P74, DOI 10.1182/blood-2013-03-491092; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Yu SY, 2016, J BIOL CHEM, V291, P11148, DOI 10.1074/jbc.M116.717801; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009	30	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232520	10.1371/journal.pone.0232520	http://dx.doi.org/10.1371/journal.pone.0232520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401815	gold, Green Published			2022-12-26	WOS:000537481000019
J	Jung, TH; Chung, EB; Kim, HW; Choi, SW; Park, SJ; Mukhtar, AS; Chung, HM; Kim, E; Huh, KM; Kim, DS; Kang, SW; Moon, SH				Jung, Taek-Hee; Chung, Eun-Bin; Kim, Hyung Woo; Choi, Seong Woo; Park, Soon-Jung; Mukhtar, Anthony Safaa; Chung, Hyung-Min; Kim, Eunmi; Huh, Kang Moo; Kim, Dong Sung; Kang, Sun-Woong; Moon, Sung-Hwan			Application of co-culture technology of epithelial type cells and mesenchymal type cells using nanopatterned structures	PLOS ONE			English	Article							STEM-CELLS; MITOMYCIN-C; DIFFERENTIATION; GROWTH; DEATH; PERSPECTIVE; APOPTOSIS; ASSAY; FATE	Various nanopatterning techniques have been developed to improve cell proliferation and differentiation efficiency. As we previously reported, nanopillars and pores are able to sustain human pluripotent stem cells and differentiate pancreatic cells. From this, the nanoscale patterns would be effective environment for the co-culturing of epithelial and mesenchymal cell types. Interestingly, the nanopatterning selectively reduced the proliferative rate of mesenchymal cells while increasing the expression of adhesion protein in epithelial type cells. Additionally, co-cultured cells on the nanopatterning were not negatively affected in terms of cell function metabolic ability or cell survival. This is in contrast to conventional co-culturing methods such as ultraviolet or chemical treatments. The nanopatterning appears to be an effective environment for mesenchymal co-cultures with typically low proliferative rates cells such as astrocytes, neurons, melanocytes, and fibroblasts without using potentially damaging treatments.	[Jung, Taek-Hee; Park, Soon-Jung; Mukhtar, Anthony Safaa; Moon, Sung-Hwan] T&R Biofab Co Ltd, Res Inst, Shihung, South Korea; [Chung, Eun-Bin; Chung, Hyung-Min] Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul, South Korea; [Kim, Hyung Woo; Kim, Dong Sung] Pohang Univ Sci & Technol, Dept Mech Engn, POSTECH Pohang, Pohang, South Korea; [Choi, Seong Woo] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul, South Korea; [Kim, Eunmi] Amorepacific Corp, R&D Unit, Yongin, Gyeonggi Do, South Korea; [Huh, Kang Moo] Chungnam Natl Univ, Dept Polymer Sci & Engn, Daejeon, South Korea; [Kang, Sun-Woong] Korea Inst Toxicol, Res Grp Biomimet Adv Technol, Daejeon, South Korea; [Kang, Sun-Woong] Univ Sci & Technol, Dept Human & Environm Toxicol, Daejeon, South Korea; [Moon, Sung-Hwan] Konkuk Univ, Sch Med, Dept Med Sci, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Chungnam National University; Korea Institute of Toxicology; University of Science & Technology (UST); Konkuk University; Konkuk University Medical Center	Moon, SH (corresponding author), T&R Biofab Co Ltd, Res Inst, Shihung, South Korea.; Kim, DS (corresponding author), Pohang Univ Sci & Technol, Dept Mech Engn, POSTECH Pohang, Pohang, South Korea.; Kang, SW (corresponding author), Korea Inst Toxicol, Res Grp Biomimet Adv Technol, Daejeon, South Korea.; Kang, SW (corresponding author), Univ Sci & Technol, Dept Human & Environm Toxicol, Daejeon, South Korea.; Moon, SH (corresponding author), Konkuk Univ, Sch Med, Dept Med Sci, Seoul, South Korea.	smkds@postech.ac.kr; swkang@kitox.re.kr; sunghwanmoon@kku.ac.kr	Kang, Sun-Woong/AAU-8744-2020; Moon, Sung-Hwan/ABI-4375-2020	Choi, Seongwoo/0000-0002-7906-495X; Kim, Hyung Woo/0000-0002-0593-6284; Moon, Sunghwan/0000-0003-1858-0261	Bio & Medical Technology Development Program of the National Research Foundation - MSIP [NRF-2016M3A9B4919616, NRF-2019M3A9H1103331]; Ministry of Trade, Industry and Energy (MOTIE) [20000325]; National Research Foundation grant (MSIT) - Republic of Korea government [2017R1A2A1A05001090]	Bio & Medical Technology Development Program of the National Research Foundation - MSIP; Ministry of Trade, Industry and Energy (MOTIE); National Research Foundation grant (MSIT) - Republic of Korea government	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation funded by the MSIP (NRF-2016M3A9B4919616, NRF-2019M3A9H1103331) and by a grant (20000325) from the Technology Innovation Program funded from the Ministry of Trade, Industry and Energy (MOTIE), and National Research Foundation grant (MSIT) (No. 2017R1A2A1A05001090) funded by the Republic of Korea government. T&R Biofab Co. Ltd and Amorepacific Corporation did not provide financial support, and did not have any roles in this study. The authors belonging to T&R Biofab and Amorepacific companies recently moved to the companies, and no funds have been contributed by the companies.	Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012; Bae D, 2014, BIOMATERIALS, V35, P916, DOI 10.1016/j.biomaterials.2013.10.031; BUFFEY JA, 1994, BRIT J DERMATOL, V131, P836, DOI 10.1111/j.1365-2133.1994.tb08586.x; Cha KJ, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/5/055002; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; Goers L, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0065; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Guillouf C, 1999, EXP CELL RES, V246, P384, DOI 10.1006/excr.1998.4316; Hershko A, 1999, PHILOS T R SOC B, V354, P1571, DOI 10.1098/rstb.1999.0500; Jung T, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7859184; Kang SG, 2001, CURR EYE RES, V22, P174, DOI 10.1076/ceyr.22.3.174.5513; Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042; Kim JH, 2016, ACS NANO, V10, P3342, DOI 10.1021/acsnano.5b06985; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Lyssiotis CA, 2011, ANGEW CHEM INT EDIT, V50, P200, DOI 10.1002/anie.201004284; Mikheev AM, 2007, BIOCHEM BIOPH RES CO, V352, P675, DOI 10.1016/j.bbrc.2006.11.079; Moller MB, 2000, LEUKEMIA LYMPHOMA, V39, P19, DOI 10.3109/10428190009053535; Moon SH, 2013, BIOMATERIALS, V34, P4013, DOI 10.1016/j.biomaterials.2013.02.022; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Odawara A, 2014, BIOCHEM BIOPH RES CO, V443, P1176, DOI 10.1016/j.bbrc.2013.12.142; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Park KS, 2012, MACROMOL BIOSCI, V12, P1480, DOI 10.1002/mabi.201200225; Park SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11091-2; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Seltana A, 2010, WOUND REPAIR REGEN, V18, P114, DOI 10.1111/j.1524-475X.2009.00554.x; Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007; Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Titushkin Igor A., 2010, Critical Reviews in Biomedical Engineering, V38, P393, DOI 10.1615/CritRevBiomedEng.v38.i5.10; Wang RL, 2015, J BIOMOL SCREEN, V20, P422, DOI 10.1177/1087057114557621; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037; Yun YJ, 2019, MAT SCI ENG C-MATER, V103, DOI 10.1016/j.msec.2019.05.014; Zorlutuna P, 2009, ACTA BIOMATER, V5, P2451, DOI 10.1016/j.actbio.2009.03.027	38	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232899	10.1371/journal.pone.0232899	http://dx.doi.org/10.1371/journal.pone.0232899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392240	gold, Green Published			2022-12-26	WOS:000537470300030
J	Latuszek, A; Liu, YS; Olsen, O; Foster, R; Cao, M; Lovric, I; Yuan, M; Liu, NN; Chen, H; Zhang, Q; Xiao, H; Springer, C; Ehrlich, G; Kamat, V; Rafique, A; Hu, Y; Krueger, P; Huang, T; Poueymirou, W; Babb, R; Rosconi, MP; Retter, MW; Chen, G; Morton, L; Zambrowicz, B; Cao, JT; Romano, C; Olson, WC				Latuszek, Adrianna; Liu, Yashu; Olsen, Olav; Foster, Randi; Cao, Marc; Lovric, Irena; Yuan, Ming; Liu, Nina; Chen, Henry; Zhang, Qian; Xiao, Hui; Springer, Carola; Ehrlich, George; Kamat, Vishal; Rafique, Ashique; Hu, Ying; Krueger, Pamela; Huang, Tammy; Poueymirou, William; Babb, Robert; Rosconi, Michael P.; Retter, Marc W.; Chen, Gang; Morton, Lori; Zambrowicz, Brian; Cao, Jingtai; Romano, Carmelo; Olson, William C.			Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5	PLOS ONE			English	Article							DEPENDENT ANTIGEN-BINDING; MEMBRANE ATTACK; MONOCLONAL-ANTIBODIES; ECULIZUMAB; IMMUNOLOGY; THERAPY; TARGET	Complement is a key component of the innate immune system. Inappropriate complement activation underlies the pathophysiology of a variety of diseases. Complement component 5 (C5) is a validated therapeutic target for complement-mediated diseases, but the development of new therapeutics has been limited by a paucity of preclinical models to evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) properties of candidate therapies. The present report describes a novel humanized C5 mouse and its utility in evaluating a panel of fully human anti-C5 antibodies. Surprisingly, humanized C5 mice revealed marked differences in clearance rates amongst a panel of anti-C5 antibodies. One antibody, pozelimab (REGN3918), bound C5 and C5 variants with high affinity and potently blocked complement-mediated hemolysis in vitro. In studies conducted in both humanized C5 mice and cynomolgus monkeys, pozelimab demonstrated prolonged PK and durable suppression of hemolytic activity ex vivo. In humanized C5 mice, a switch in dosing from in-house eculizumab to pozelimab was associated with normalization of serum C5 concentrations, sustained suppression of hemolytic activity ex vivo, and no overt toxicity. Our findings demonstrate the value of humanized C5 mice in identifying new therapeutic candidates and treatment options for complement-mediated diseases.	[Latuszek, Adrianna; Liu, Yashu; Olsen, Olav; Foster, Randi; Cao, Marc; Lovric, Irena; Yuan, Ming; Liu, Nina; Chen, Henry; Zhang, Qian; Xiao, Hui; Springer, Carola; Ehrlich, George; Kamat, Vishal; Rafique, Ashique; Hu, Ying; Krueger, Pamela; Huang, Tammy; Poueymirou, William; Babb, Robert; Rosconi, Michael P.; Retter, Marc W.; Chen, Gang; Morton, Lori; Zambrowicz, Brian; Cao, Jingtai; Romano, Carmelo; Olson, William C.] Regeneron Pharmaceut Inc, New York, NY USA	Regeneron	Olsen, O (corresponding author), Regeneron Pharmaceut Inc, New York, NY USA.	olav.olsen@regeneron.com		Olsen, Olav/0000-0002-6583-209X; Kamat, Vishal/0000-0002-6299-7024; Morton, Lori/0000-0002-5214-5784	Regeneron Pharmaceuticals, Inc.	Regeneron Pharmaceuticals, Inc.(Regeneron)	All authors have a commercial affiliation with Regeneron Pharmaceuticals, Inc., which fully supported all studies reported in this manuscript. As such, Regeneron employees played active roles in all aspects of the research including study design, data collection and analysis, and the preparation and publication of this manuscript.	Glovsky MM, 2004, ANN ALLERG ASTHMA IM, V93, P513, DOI 10.1016/S1081-1206(10)61257-4; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; Hillmen P, N ENGL J MED, V355, P1233; Hironiwa N, 2016, MABS-AUSTIN, V8, P65, DOI 10.1080/19420862.2015.1110660; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Jore MM, 2016, NAT STRUCT MOL BIOL, V23, P378, DOI 10.1038/nsmb.3196; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; Marzari R, 2002, EUR J IMMUNOL, V32, P2773, DOI 10.1002/1521-4141(2002010)32:10<2773::AID-IMMU2773>3.0.CO;2-G; Milton M, 2014, INVEST OPHTH VIS SCI, V55; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Morgan BP, 1999, CRIT REV IMMUNOL, V19, P173; Murphy AJ, 2014, P NATL ACAD SCI USA, V111, P5153, DOI 10.1073/pnas.1324022111; Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112; PODACK ER, 1984, J BIOL CHEM, V259, P8641; PODACK ER, 1984, MOL IMMUNOL, V21, P589, DOI 10.1016/0161-5890(84)90044-0; Pyzik M, 2015, J IMMUNOL, V194, P4595, DOI 10.4049/jimmunol.1403014; Risitano AM, 2018, AM J HEMATOL, V93, P564, DOI 10.1002/ajh.25016; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Sheridan D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195909; Thomas TC, 1996, MOL IMMUNOL, V33, P1389, DOI 10.1016/S0161-5890(96)00078-8; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weyne J, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-112262; Wong EKS, 2015, TRANSL RES, V165, P306, DOI 10.1016/j.trsl.2014.10.010; Yang XY, 2014, CURR OPIN BIOTECH, V30, P225, DOI 10.1016/j.copbio.2014.09.001	26	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0231892	10.1371/journal.pone.0231892	http://dx.doi.org/10.1371/journal.pone.0231892			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384086	Green Published, gold			2022-12-26	WOS:000537468300006
J	Dagnew, GW; Asresie, MB; Fekadu, GA				Dagnew, Gizachew Worku; Asresie, Melash Belachew; Fekadu, Gedefaw Abeje			Factors associated with sexually transmitted infections among sexually active men in Ethiopia. Further analysis of 2016 Ethiopian demographic and health survey data	PLOS ONE			English	Article							PREVALENCE; DISEASES; HIV	Background Sexually-transmitted infections are a public health problem in developing countries including Ethiopia. However, there is limited evidence on factors associated with sexually-transmitted infections among men in Ethiopia. Therefore, this analysis was done to fill this gap. Methods This analysis was done based on the 2016 Ethiopian demographic health survey data. The survey was a community-based cross-sectional study conducted from January 18 to June 27, 2016. The survey used two stage-stratified cluster sampling technique. A total of 8849 sexually active men were included in this analysis. Descriptive and analytical analyses were performed. A p-value of less than 0.05 was used to declare statistical significance. Results Muslim men (AOR = 1.68; 95%CI: 1.02-2.76), men who were not exposed to media (AOR = 1.75; 95%CI: 1.01-3.03) and men who had multiple sexual partners (AOR = 2.29; 95%CI: 1.05-5.01) had higher odds of having a sexually transmitted infection. In addition, men living in Amhara (AOR = 3.31; 95%CI: 1.33-8.22), Oromia (AOR = 4.62; 95%CI: 1.85-11.55), Gambella (AOR = 3.64; 95%CI: 1.27-10.42), and Harari regions (AOR = 4.57; 95%CI: 1.49-14.02) had higher odds of developing sexually transmitted infection. On the other hand, men who believe women are asked to use a condom if she knows he has STIs (AOR = 0.53; 95%CI: 0.33-0.85) had low odds of developing a sexually transmitted infection. Conclusions Men not exposed to mass media, Muslims and men with multi-sexual partners had higher odds of having sexually transmitted infections. Encouraging monogamous relationships and exposing men to mass media may help to reduce the burden of STIs in Ethiopia.	[Dagnew, Gizachew Worku; Asresie, Melash Belachew; Fekadu, Gedefaw Abeje] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia	Bahir Dar University	Dagnew, GW (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia.	giz.work12@gmail.com	Dagnew, Gizachew Worku/ABE-7194-2021	Dagnew, Gizachew Worku/0000-0003-2043-3041; Asresie, Melash Belachew/0000-0002-4173-0646				[Anonymous], 2012, GLOB INC PREV SEL CU; Anteneh ZA, 2017, HIV AIDS-RES PALLIAT, V9, P43, DOI 10.2147/HIV.S127319; Aral SO, 2001, INT J STD AIDS, V12, P211, DOI 10.1258/0956462011922814; Bereket Yohannes T.G., 2013, INT J SCI TECHNOLOGY, V2; Central statistical agency (CSA) [Ethiopia] and ICF, 2016, ETH DEM HLTH SURV 20; Central Statistical Agency [Ethiopia] and ORC Macro, 2006, ETH DEM HLTH SURV 20; Cook CT, 2007, J BLACK STUD, V38, P232, DOI 10.1177/0021934705285695; Coyle K., 2016, PUBLIC HLTH REPORTS; CSA-Ethiopia & ICF-International, 2012, ETH DEM HLTH SURV 20; Drain PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-172; Ethiopian Public Health Institute (EPHI), 2018, ETH POP BAS HIV IMP; Ezra M, 2003, J COMP FAM STUD, V34, P509, DOI 10.3138/jcfs.34.4.509; Fenton KA, 2005, J INFECT DIS, V191, pS127, DOI 10.1086/425286; Hailu A., 2008, ORIENTAL ANTHR, V8, P169, DOI 10.1177/0976343020080111; Infections ST, 2012, SEX TRANSM INF STIS; Kibret GD, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0594-9; Leddy A, 2016, AIDS CARE, V28, P228, DOI 10.1080/09540121.2015.1080792; Low N, 2006, LANCET, V368, P2001, DOI 10.1016/S0140-6736(06)69482-8; Mengistu TS, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-38; MOH Ethiopia, 2015, NAT GUID MAN SEX TRA; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Rowley J, 2019, B WORLD HEALTH ORGAN, V97, P548, DOI 10.2471/BLT.18.228486; Suzanna C., 2018, PLOSMED, V15; Unemo M, 2017, LANCET INFECT DIS, V17, pE235, DOI [10.1016/s1473-3099(17)30310-9, 10.1016/S1473-3099(17)30310-9]; WHO, 2006, GLOB STRAT PREV CONT; WINGOOD GM, 1995, AM J PUBLIC HEALTH, V85, P592, DOI 10.2105/AJPH.85.4.592; Winston SE, 2015, SEX TRANSM INFECT, V91, P353, DOI 10.1136/sextrans-2014-051797; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, 2018, REP GLOB SEX TRANSM; World Health Organization, 2007, GLOB STRAT PREV CONT	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232793	10.1371/journal.pone.0232793	http://dx.doi.org/10.1371/journal.pone.0232793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZX	32380513	gold, Green Published			2022-12-26	WOS:000537285700068
J	Hajizadeh, M; Michaud, B; Desmyttere, G; Carmona, JP; Begon, M				Hajizadeh, Maryam; Michaud, Benjamin; Desmyttere, Gauthier; Carmona, Jean-Philippe; Begon, Mickael			Predicting foot orthosis deformation based on its contour kinematics during walking	PLOS ONE			English	Article							PLANTAR PRESSURE; PRONATED FOOT; KINETICS; INSOLES; DESIGN; MOTION; SHAPE; KNEE; GAIT; ARCH	Background Customized foot orthoses (FOs) are designed based on foot posture and function, while the interaction between these metrics and FO deformation remains unknown due to technical problems. Our aim was to predict FO deformation under dynamic loading using an artificial intelligence (AI) approach, and to report the deformation of two FOs of different stiffness during walking. Methods Each FO was fixed on a plate, and six triad reflective markers were fitted on its contour, and 55 markers on its plantar surface. Manual loadings with known magnitude and application point were applied to deform "sport" and "regular" (stiffer) FOs in all regions (training session). Then, 13 healthy male subjects walked with the same FOs inside shoes, where the triad markers were visible by means of shoe holes (walking session). The marker trajectories were recorded using optoelectronic system. A neural network was trained to find the dependency between the orientation of triads on FO contour and the position of markers on its plantar surface. After tuning hyperparameters and evaluating the performance of the model, marker positions on FOs surfaces were predicted during walking for each subject. Statistical parametric mapping was used to compare the pattern of deformation between two FOs. Results Overall, the model showed an average error of < 0.6 mm for predicting the marker positions on both FOs. The training setup was appropriate to simulate the range of triads' displacement and the peak loading on FOs during walking. Sport FO showed different pattern and significantly higher range of deformation during walking compared to regular FO. Conclusion Our technique enables an indirect and accurate estimation of FO surface deformation during walking. The AI model was capable to make a distinction between two FOs with different stiffness and between subjects. This innovative approach can help to optimally customize the FO design.	[Hajizadeh, Maryam; Begon, Mickael] Univ Montreal, Fac Med, Inst Biomed Engn, Lab Simulat & Movement Modelling, Montreal, PQ, Canada; [Michaud, Benjamin; Desmyttere, Gauthier; Begon, Mickael] Univ Montreal, Fac Med, Sch Kinesiol & Phys Act Sci, Lab Simulat & Movement Modelling, Montreal, PQ, Canada; [Carmona, Jean-Philippe] Caboma, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Hajizadeh, M (corresponding author), Univ Montreal, Fac Med, Inst Biomed Engn, Lab Simulat & Movement Modelling, Montreal, PQ, Canada.	maryam.hajizadeh@umontreal.ca		Hajizadeh, Maryam/0000-0003-1424-499X	NSERC (Natural Sciences and Engineering Research Council) RD Coop; Medicus; Caboma; MEDTEQ [RDCPJ 506194-16]; FRQNT (The Fonds de recherche du Que'bec -Nature et technologies) [208405]	NSERC (Natural Sciences and Engineering Research Council) RD Coop; Medicus; Caboma; MEDTEQ; FRQNT (The Fonds de recherche du Que'bec -Nature et technologies)	This manuscript is a part of research project which is financially supported by NSERC (Natural Sciences and Engineering Research Council) R&D Coop with industrial partners Medicus and Caboma, and MEDTEQ under grant number RDCPJ 506194-16, principal researcher: Mickael Begon (MB), original project title: "FOOT (Functional Optimized Orthotic Trabecular Insole): Une orthese plantaire personnalise ' e selon la dynamique du pied pour l'impresson 3D" ("customized foot orthosis to meet the demands of foot dynamics for 3D printing"), and URL funder: https://www.nserc-crsng.gc.ca/index_eng.asp.In addition, FRQNT (The Fonds de recherche du Que ' bec -Nature et technologies) provided financial support in the form of doctoral research scholarships program for foreign students (DE), File No. 208405, awarded to Maryam Hajizadeh (MH), and URL funder: http://www.frqnt.gouv.qc.ca/en/accueil The funders, either NSERC, MEDTEQ or FRQNT, as well as our industrial partner Medicus did not have any role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript. However, JeanPhilippe Carmona (JPC), a mechanical engineer in Caboma, was involved during our regular meetings and brought technical ideas to improve the algorithms and interpretation of results. JPC also contributed to reviewing and editing the paper.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Barton G., 2018, GAIT POSTURE, V65, P299, DOI [10.1016/j.gaitpost.2018.06.194, DOI 10.1016/J.GAITPOST.2018.06.194]; Blezkiewicz MI, 2018, ACTA BIOENGINEERING, V20; Cheung JTM, 2008, MED ENG PHYS, V30, P269, DOI 10.1016/j.medengphy.2007.05.002; Cheung JTM, 2006, CLIN BIOMECH, V21, P194, DOI 10.1016/j.clinbiomech.2005.09.016; Dars S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193060; Desmyttere G, 2018, CLIN BIOMECH, V59, P117, DOI 10.1016/j.clinbiomech.2018.09.018; Farahpour N, 2016, J BIOMECH, V49, P1705, DOI 10.1016/j.jbiomech.2016.03.056; Fukuchi CA, 2016, J AM PODIAT MED ASSN, V106, P411, DOI 10.7547/15-077; Gross KD, 2011, ARTHRIT CARE RES, V63, P937, DOI 10.1002/acr.20431; Hansen ST, 2010, DRENNANS CHILDS FOOT, V2, P526; Hatfield GL, 2016, J ORTHOP RES, V34, P1597, DOI 10.1002/jor.23174; Joo SB, 2016, J BIOMECH, V49, P3153, DOI 10.1016/j.jbiomech.2016.07.029; Keijsers NLW, 2013, CLIN BIOMECH, V28, P350, DOI 10.1016/j.clinbiomech.2013.01.012; Kelly LA, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0174; Kelly LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1076; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Khashei M, 2010, EXPERT SYST APPL, V37, P479, DOI 10.1016/j.eswa.2009.05.044; Lee Michael S, 2005, J Foot Ankle Surg, V44, P78, DOI 10.1053/j.jfas.2004.12.001; Li L, 2018, INT J ENVIRON SCI TE, V3, P1; Mills K, 2010, BRIT J SPORT MED, V44, P1035, DOI 10.1136/bjsm.2009.066977; Monnet T, 2012, MED ENG PHYS, V34, P1200, DOI 10.1016/j.medengphy.2012.05.006; Muller M, 2005, ACM T GRAPHIC, V24, P471, DOI 10.1145/1073204.1073216; Mun K.-R., 2018, SCI REP, V8, P1; Oh K, 2017, J BIOMECH, V53, P127, DOI 10.1016/j.jbiomech.2017.01.014; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Perhamre S, 2012, SCAND J MED SCI SPOR, V22, P516, DOI 10.1111/j.1600-0838.2010.01266.x; Razeghi M, 2000, SPORTS MED, V29, P425, DOI 10.2165/00007256-200029060-00005; Stacoff A, 2000, CLIN BIOMECH, V15, P54, DOI 10.1016/S0268-0033(99)00028-5; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Telfer S, 2017, J BIOMECH, V60, P157, DOI 10.1016/j.jbiomech.2017.06.028; Telfer S, 2013, J BIOMECH, V46, P1489, DOI 10.1016/j.jbiomech.2013.03.036; Vlutters M, 2018, J BIOMECH, V68, P93, DOI 10.1016/j.jbiomech.2017.12.021; Wahmkow G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172334; WANG CL, 1994, CLIN BIOMECH, V9, P297, DOI 10.1016/0268-0033(94)90042-6; Wang QN, 2010, INT J HUM ROBOT, V7, P295, DOI 10.1142/S021984361000209X; White, 1992, ARTIFICIAL NEURAL NE; Zhang XY, 2014, GAIT POSTURE, V39, P1012, DOI 10.1016/j.gaitpost.2013.12.025	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232677	10.1371/journal.pone.0232677	http://dx.doi.org/10.1371/journal.pone.0232677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379801	Green Published, gold			2022-12-26	WOS:000537285700054
J	Davis, MC; Messina, MA; Nicolosi, G; Petralia, S; Baker, MD IV; Mayne, CKS; Dinon, CM; Moss, CJ; Onac, BP; Garey, JR				Davis, Madison C.; Messina, Maria A.; Nicolosi, Giuseppe; Petralia, Salvatore; Baker, Melvin D.; Mayne, Christiana K. S.; Dinon, Chelsea M.; Moss, Christina J.; Onac, Bogdan P.; Garey, James R.			Surface runoff alters cave microbial community structure and function	PLOS ONE			English	Article							FERROMANGANESE DEPOSITS; WALL BIOFILMS; SP NOV.; KARST; SYSTEM; SULFIDE; GEOMICROBIOLOGY; PRECIPITATION; GEOCHEMISTRY; POPULATIONS	Caves formed by sulfuric acid dissolution have been identified worldwide. These caves can host diverse microbial communities that are responsible for speleogenesis and speleothem formation. It is not well understood how microbial communities change in response to surface water entering caves. Illumina 16S rRNA sequencing and bioinformatic tools were used to determine the impact of surface water on the microbial community diversity and function within a spring pool found deep in the Monte Conca Cave system in Sicily, Italy. Sulfur oxidizers comprised more than 90% of the microbial community during the dry season and were replaced by potential anthropogenic contaminants such as Escherichia and Lysinibacillus species after heavy rains. One sampling date appeared to show a transition between the wet and dry seasons when potential anthropogenic contaminants (67.3%), sulfur-oxidizing bacteria (13.6%), and nitrogen-fixing bacteria (6.5%) were all present within the spring pool.	[Davis, Madison C.; Baker, Melvin D.; Mayne, Christiana K. S.; Dinon, Chelsea M.; Moss, Christina J.; Garey, James R.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Messina, Maria A.; Nicolosi, Giuseppe; Petralia, Salvatore] Ctr Speleol Etneo, Catania, Italy; [Nicolosi, Giuseppe] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Petralia, Salvatore] Appl Chem Works, Paterno, Ct, Italy; [Onac, Bogdan P.] Univ S Florida, Sch Geosci, Karst Res Grp, Tampa, FL 33620 USA	State University System of Florida; University of South Florida; University of Turin; State University System of Florida; University of South Florida	Garey, JR (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	garey@usf.edu	Nicolosi, Giuseppe/AAJ-9815-2021; Petralia, Salvatore/AFQ-5651-2022	Petralia, Salvatore/0000-0001-5692-1130; Nicolosi, Giuseppe/0000-0002-6360-7171; messina, marianna/0000-0002-8652-4248				Banks ED, 2010, GEOMICROBIOL J, V27, P444, DOI 10.1080/01490450903485136; Barton HA, 2007, INT J SPELEOL, V36, P93, DOI 10.5038/1827-806X.36.2.5; Bastian F, 2009, RES MICROBIOL, V160, P38, DOI 10.1016/j.resmic.2008.10.001; Cardoso RB, 2006, BIOTECHNOL BIOENG, V95, P1148, DOI 10.1002/bit.21084; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Carmichael SK, 2013, J CAVE KARST STUD, V75, P189, DOI 10.4311/2012MB0267; Chen Y, 2009, ISME J, V3, P1093, DOI 10.1038/ismej.2009.57; Cheng MG, 2015, ANTON LEEUW INT J G, V107, P157, DOI 10.1007/s10482-014-0313-2; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; D'Angeli IM, 2017, SCI TOTAL ENVIRON, V598, P538, DOI 10.1016/j.scitotenv.2017.03.270; Davis MC, 2018, WATER-SUI, V10, DOI 10.3390/w10080972; DuChene HR, 2017, CAVE KARST SYSTEMS, P511, DOI 10.1007/978-3-319-53348-3_31; Egemeier SJ, 1973, THESIS; Engel AS, 2004, GEOLOGY, V32, P369, DOI 10.1130/G20288.1; Engel AS, 2003, APPL ENVIRON MICROB, V69, P5503, DOI 10.1128/AEM.69.9.5503-5511.2003; Engel AS, 2001, GEOMICROBIOL J, V18, P259, DOI 10.1080/01490450152467787; Fernandez-Cortes A, 2011, ENVIRON SCI POLLUT R, V18, P1037, DOI 10.1007/s11356-011-0513-5; GALDENZI S, 1995, ENVIRON GEOL, V26, P39, DOI 10.1007/BF00776030; Galdenzi S, 2017, CAVE KARST SYSTEMS, P143, DOI 10.1007/978-3-319-53348-3_8; GREEN W D, 1990, Transactions of the Kentucky Academy of Science, V51, P177; Hill C.A., 1987, N M BUR MINES BULL, V117; Hose LD, 2000, CHEM GEOL, V169, P399, DOI 10.1016/S0009-2541(00)00217-5; Hose LD, 2017, CAVE KARST SYSTEMS, P803, DOI 10.1007/978-3-319-53348-3_54; Jones DS, 2008, J CAVE KARST STUD, V70, P78; Klimchouk A, 2017, CAVE KARST SYSTEMS, P1, DOI 10.1007/978-3-319-53348-3; Kong DL, 2014, INT J SYST EVOL MICR, V64, P2593, DOI 10.1099/ijs.0.061465-0; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lavoie KH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169339; Macalady JL, 2008, ISME J, V2, P590, DOI 10.1038/ismej.2008.25; Macalady JL, 2007, ENVIRON MICROBIOL, V9, P1402, DOI 10.1111/j.1462-2920.2007.01256.x; Macalady JL, 2006, APPL ENVIRON MICROB, V72, P5596, DOI 10.1128/AEM.00715-06; Maciejewska M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01181; Madonia G, 2011, ACTA CARSOLOGICA, V40, P53; MCFETERS GA, 1974, APPL MICROBIOL, V27, P823, DOI 10.1128/AEM.27.5.823-829.1974; Melim LA, 2001, GEOMICROBIOL J, V18, P311, DOI 10.1080/01490450152467813; Menning DM, 2018, ESTUAR COAST, V41, P430, DOI 10.1007/s12237-017-0281-7; Messina M, 2015, INT J SPELEOL, V44, P125, DOI 10.5038/1827-806X.44.2.3; MODRA H, 2017, VET MED, V62; Moss CJ, 2017, GEOLOGICAL SOC AM AB, V49, P32, DOI [10.1130/abs/2017AM-300284, DOI 10.1130/ABS/2017AM-300284]; Mulec J, 2012, INT J SPELEOL, V41, P1, DOI 10.5038/1827-806X.41.1.1; Northup DE, 2003, ENVIRON MICROBIOL, V5, P1071, DOI 10.1046/j.1462-2920.2003.00500.x; Northup Diana E., 2000, Journal of Cave and Karst Studies, V62, P80; PASQUARELL GC, 1995, J ENVIRON QUAL, V24, P959, DOI 10.2134/jeq1995.00472425002400050026x; Principi P., 1931, GROTTE ITALIA, V5, P1; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Sarbu SM, 1996, SCIENCE, V272, P1953, DOI 10.1126/science.272.5270.1953; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seman M, 2015, FOLIA MICROBIOL, V60, P269, DOI 10.1007/s12223-014-0362-y; SORENSEN J, 1980, APPL ENVIRON MICROB, V39, P105; Spilde MN, 2005, GEOMICROBIOL J, V22, P99, DOI 10.1080/01490450590945889; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Vattano M., 2008, THESIS; Vlasceanu L, 2000, GEOMICROBIOL J, V17, P125, DOI 10.1080/01490450050023809; Westcott SL, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00073-17	54	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232742	10.1371/journal.pone.0232742	http://dx.doi.org/10.1371/journal.pone.0232742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374788	Green Published, gold			2022-12-26	WOS:000537283500056
J	Singh, AS; Takhellambam, MC; Cappelletti, P; Feligioni, M				Singh, Asem Surindro; Takhellambam, Machathoibi Chanu; Cappelletti, Pamela; Feligioni, Marco			Immediate early gene kakusei potentially plays a role in the daily foraging of honey bees	PLOS ONE			English	Article							MUSHROOM BODIES; NEURAL ACTIVITY; EXPRESSION; IDENTIFICATION; VARIANTS; BRAINS	kakusei is a non-coding RNA that is overexpressed in foraging bee brain. This study describes a possible role of the IEG kakusei during the daily foraging of honey bees. kakusei was found to be transiently upregulated within two hours during rewarded foraging. Interestingly, during unrewarded foraging the gene was also found to be up-regulated, but immediately lowered when food was not rewarded. Moreover, the kakusei overexpression was diminished within a very short time when the time schedule of feeding was changed. This indicates the potential role of kakusei on the motivation of learned reward foraging. These results provide evidence for a dynamic role of kakusei during for aging of bees, and eventually its possible involvement in learning and memory. Thus the kakusei gene could be used as search tool in finding distinct molecular pathways that mediate diverse behavioral components of foraging.	[Singh, Asem Surindro] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Singh, Asem Surindro] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Takhellambam, Machathoibi Chanu] Manipur Univ, Dept Biotechnol, Imphal, Manipur, India; [Cappelletti, Pamela; Feligioni, Marco] Casa Cura Policlin, Dept Neurorehabil Sci, Lab Neurobiol Translat Med, Milan, Italy	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Mississippi; University of Mississippi Medical Center; Manipur University	Singh, AS (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.; Singh, AS (corresponding author), Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA.	asemsuren@gmail.com		Singh, Asem Surindro/0000-0003-1999-2321; Cappelletti, Pamela/0000-0002-2062-4852	Council of Scientific and Industrial Research, Govt. of India [09/860(0167)/2015-EMR-1]; Bridging Postdoctoral Fellowship by National Centre for Biological Sciences, TIFR, India	Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Bridging Postdoctoral Fellowship by National Centre for Biological Sciences, TIFR, India	This work was completed with the help of Research Associate Fellowship provided by Council of Scientific and Industrial Research, Govt. of India, Award no. 09/860(0167)/2015-EMR-1 and Bridging Postdoctoral Fellowship by National Centre for Biological Sciences, TIFR, India, to Dr. Asem Surindro Singh.	Abbott KR, 2009, ANIM BEHAV, V78, P633, DOI 10.1016/j.anbehav.2009.05.029; Alaux C, 2007, J CHEM ECOL, V33, P1346, DOI 10.1007/s10886-007-9301-6; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Clayton DF, 2013, ANNU REV GENOM HUM G, V14, P45, DOI 10.1146/annurev-genom-090711-163809; Fujita N, 2013, CURR BIOL, V23, P2063, DOI 10.1016/j.cub.2013.08.051; HUGHES P, 1995, PHARMACOL REV, V47, P133; Ishimoto H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003843; Khamis AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11136; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Kiya T, 2008, INSECT MOL BIOL, V17, P531, DOI 10.1111/j.1365-2583.2008.00821.x; Kiya T, 2012, INT J MOL SCI, V13, P15496, DOI 10.3390/ijms131215496; Kiya T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019301; Lagisz M, 2016, BEHAV GENET, V46, P242, DOI 10.1007/s10519-015-9749-z; Loebrich S, 2009, PHYSIOL REV, V89, P1079, DOI 10.1152/physrev.00013.2009; Lutz CC, 2013, J EXP BIOL, V216, P2031, DOI 10.1242/jeb.084905; Michelsen A, 2003, J COMP PHYSIOL A, V189, P165, DOI 10.1007/s00359-003-0398-y; Motulsky H., 1999, ANAL DATA GRAPHPAD P; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; Perez-Cadahia B, 2011, BIOCHEM CELL BIOL, V89, P61, DOI 10.1139/O10-138; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Seeley T., 1995, WISDOM HIVE SOCIAL P; Seeley TD, 2006, AM SCI, V94, P220, DOI 10.1511/2006.59.220; Shah A, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00865; Singh AS, 2018, INSECT MOL BIOL, V27, P90, DOI 10.1111/imb.12350; Singh AS, 2014, OA AUTISM, V08, P8; Singh AS, 2019, ADV MED BIOL, V153; Sommerlandt FMJ, 2019, CELL MOL LIFE SCI, V76, P637, DOI 10.1007/s00018-018-2948-z; Stephanie AM, 2011, LEARN MEMORY, V18, P24; Thorpe WilliamHoman., 1983, BIOGRAPHICAL MEMOIRS, V29, P196, DOI DOI 10.1098/RSBM.1983.0008; Ugajin A, 2013, FEBS LETT, V587, P3224, DOI 10.1016/j.febslet.2013.08.014; von Frisch K, 1969, DANCE LANGUAGE ORIEN; Watanabe Takayuki, 2018, eNeuro, V5, DOI 10.1523/ENEURO.0061-18.2018; Yamazaki Y, 2006, FEBS LETT, V580, P2667, DOI 10.1016/j.febslet.2006.04.016	34	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0222256	10.1371/journal.pone.0222256	http://dx.doi.org/10.1371/journal.pone.0222256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374761	Green Submitted, Green Published, gold			2022-12-26	WOS:000537283500001
J	Travis, SM; DAmico, K; Yu, IM; McMahon, C; Hamid, S; Ramirez-Arellano, G; Jeffrey, PD; Hughson, FM				Travis, Sophie M.; DAmico, Kevin; Yu, I-Mei; McMahon, Conor; Hamid, Safraz; Ramirez-Arellano, Gabriel; Jeffrey, Philip D.; Hughson, Frederick M.			Structural basis for the binding of SNAREs to the multisubunit tethering complex Dsl1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane trafficking; SNARE protein; X-ray crystallography; COPI; vesicle; yeast; multisubunit tethering complex; Dsl1 complex; CATCHR complex	N-TERMINAL DOMAIN; ENDOPLASMIC-RETICULUM; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; PROTEIN; MEMBRANE; YEAST; INTERACTS; FUSION; CONSERVATION	Multisubunit-tethering complexes (MTCs) are large (250 to >750 kDa), conserved macromolecular machines that are essential for solubleN-ethylmaleimide?sensitive factor attachment protein receptor (SNARE)?mediated membrane fusion in all eukaryotes. MTCs are thought to organize membrane trafficking by mediating the initial long-range interaction between a vesicle and its target membrane and promoting the formation of membrane-bridging SNARE complexes. Previously, we reported the structure of the yeast Dsl1 complex, the simplest known MTC, which is essential for coat protein I (COPI) mediated transport from the Golgi to the endoplasmic reticulum (ER). This structure suggests how the Dsl1 complex might tether a vesicle to its target membrane by binding at one end to the COPI coat and at the other to ER-associated SNAREs. Here, we used X-ray crystallography to investigate these Dsl1?SNARE interactions in greater detail. The Dsl1 complex comprises three subunits that together form a two-legged structure with a central hinge. We found that distal regions of each leg bind N-terminal Habc domains of the ER SNAREs Sec20 (a Qb-SNARE) and Use1 (a Qc-SNARE). The observed binding modes appear to anchor the Dsl1 complex to the ER target membrane while simultaneously ensuring that both SNAREs are in open conformations, with their SNARE motifs available for assembly. The proximity of the two SNARE motifs, and therefore their ability to enter the same SNARE complex, will depend on the relative orientation of the two Dsl1 legs. These results underscore the critical roles of SNARE N-terminal domains in mediating interactions with other elements of the vesicle docking and fusion machinery.	[Travis, Sophie M.; DAmico, Kevin; Yu, I-Mei; McMahon, Conor; Hamid, Safraz; Ramirez-Arellano, Gabriel; Jeffrey, Philip D.; Hughson, Frederick M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Yu, I-Mei] Stevenage Biosci Catalyst, Freeline Therapeut, Stevenage, Herts, England; [McMahon, Conor] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Princeton University; Harvard University; Harvard Medical School	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu		DAmico, Kevin/0000-0002-8888-0713; Travis, Sophie/0000-0002-1728-1705; McMahon, Conor/0000-0001-9971-7869; Hamid, Safraz/0000-0001-8342-7760; Jeffrey, Philip/0000-0002-4351-5341	National Institutes of Health [T32GM007388, F31GM12676, R01GM071574]; U.S. Department of Energy Office of Science User Facility [DE-SC0012704]; NIGMS, National Institutes of Health through Biomedical Technology Research Resource P41 Grant [P41GM111244]; U.S. Department of Energy Office of Biological and Environmental Research Grant [KP1605010]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NIGMS, National Institutes of Health through Biomedical Technology Research Resource P41 Grant; U.S. Department of Energy Office of Biological and Environmental Research Grant(United States Department of Energy (DOE))	This work was supported by National Institutes of Health Grants T32GM007388 (to S. M. T. and K. D.), F31GM12676 (to S. M. T.), and R01GM071574 (to F. M. H.). This research used the AMX and FMX Beamlines of the National Synchrotron Light Source II, a U.S. Department of Energy Office of Science User Facility operated by Brookhaven National Laboratory under Contract DE-SC0012704. The Life Science Biomedical Technology Research resource, which supports AMX and FMX, is primarily supported by the NIGMS, National Institutes of Health through Biomedical Technology Research Resource P41 Grant P41GM111244, and by U.S. Department of Energy Office of Biological and Environmental Research Grant KP1605010. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abascal-Palacios G, 2013, STRUCTURE, V21, P1698, DOI 10.1016/j.str.2013.06.025; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov A, 2004, MOL CELL PROTEOMICS, V3, P934, DOI 10.1074/mcp.T400008-MCP200; Andag U, 2003, J BIOL CHEM, V278, P51722, DOI 10.1074/jbc.M308740200; Antonin W, 2002, J BIOL CHEM, V277, P36449, DOI 10.1074/jbc.M204369200; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baker RW, 2016, NAT REV MOL CELL BIO, V17, P465, DOI 10.1038/nrm.2016.65; Baker RW, 2015, SCIENCE, V349, P1111, DOI 10.1126/science.aac7906; Cheung PYP, 2015, ELIFE, V4, DOI 10.7554/eLife.12790; Chou HT, 2016, NAT STRUCT MOL BIOL, V23, P761, DOI 10.1038/nsmb.3264; Chowdhury SR, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201902114; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; D'Agostino M, 2017, NATURE, V551, P634, DOI 10.1038/nature24469; Daste F, 2015, J CELL SCI, V128, P4263, DOI 10.1242/jcs.178574; Demircioglu FE, 2014, P NATL ACAD SCI USA, V111, P13828, DOI 10.1073/pnas.1408254111; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dubuke ML, 2015, J BIOL CHEM, V290, P28245, DOI 10.1074/jbc.M115.673806; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fridmann-Sirkis Y, 2006, TRAFFIC, V7, P182, DOI 10.1111/j.1600-0854.2005.00374.x; Gao GB, 2020, TRAFFIC, V21, P274, DOI 10.1111/tra.12720; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gillingham AK, 2019, CURR OPIN CELL BIOL, V59, P140, DOI 10.1016/j.ceb.2019.04.010; Gillingham AK, 2016, TRENDS CELL BIOL, V26, P399, DOI 10.1016/j.tcb.2016.02.005; Ha JY, 2016, NAT STRUCT MOL BIOL, V23, P758, DOI 10.1038/nsmb.3263; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; Hsia KC, 2010, P NATL ACAD SCI USA, V107, P11271, DOI 10.1073/pnas.1006297107; Jiao JY, 2018, ELIFE, V7, DOI 10.7554/eLife.41771; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Kraynack BA, 2005, MOL BIOL CELL, V16, P3963, DOI 10.1091/mbc.E05-01-0056; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meiringer CTA, 2011, J BIOL CHEM, V286, P25039, DOI 10.1074/jbc.M110.215327; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Murray DH, 2016, NATURE, V537, P107, DOI 10.1038/nature19326; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Pei JM, 2009, J MOL BIOL, V391, P509, DOI 10.1016/j.jmb.2009.06.054; Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song H, 2020, ELIFE, V9, DOI 10.7554/eLife.53559; Suckling RJ, 2015, P NATL ACAD SCI USA, V112, P14242, DOI 10.1073/pnas.1506186112; SWEET DJ, 1993, EMBO J, V12, P2831, DOI 10.1002/j.1460-2075.1993.tb05944.x; Travis SM, 2019, P NATL ACAD SCI USA, V116, P24031, DOI 10.1073/pnas.1909697116; Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548; Ungermann C, 2019, TRAFFIC, V20, P479, DOI 10.1111/tra.12655; Wang J, 2011, P NATL ACAD SCI USA, V108, P12277, DOI 10.1073/pnas.1013101108; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whyte JRC, 2002, J CELL SCI, V115, P2627; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Yue P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14236; Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012	62	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10125	10135		10.1074/jbc.RA120.013654	http://dx.doi.org/10.1074/jbc.RA120.013654			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32409579	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000556713400003
J	Ajayi, AI; Somefun, OD				Ajayi, Anthony Idowu; Somefun, Oluwaseyi Dolapo			Recreational drug use among Nigerian university students: Prevalence, correlates and frequency of use	PLOS ONE			English	Article							FAMILY-STRUCTURE; SUBSTANCE USE; ADOLESCENTS; ALCOHOL; CANNABIS; SUPPORT; GENDER; DEPENDENCE; INITIATION; COMMUNITY	Background Given the paucity of data on recreational drug use and the recent media attention on the abuse of drugs such as codeine cough syrups and tramadol, in Nigeria, our study examined the prevalence and frequency of recreational drug use among young adults from two Nigerian universities. We drew from the Socio-ecological Model to examine the influence of factors at the individual and family level on recreational drug use among adolescents and young adults. Methods This cross-sectional study was conducted between February and March 2018 among a final sample of 784 male and female university students selected using stratified random sampling. Binary logistic regression was used to identify significant predictors of ever use and current use of drugs. Results Our analyses showed that 24.5% of students had ever used drugs for recreational purposes, and 17.5% are current users. The median drug use frequency over the past month was six days among current users (n = 137). In the multivariable analyses, living in the same household as one's mother (AOR 0.28 95% CI 0.16-0.49), adequate family support (AOR 0.48 95% CI 0.26-0.89) and frequent attendance of religious fellowships (AOR 0.13 95% CI 0.07-0.25) were significantly associated with a lower likelihood of recreational drug use. However, male sex (AOR 1.52 95% CI 1.05-2.21) was associated with higher odds of recreational drug use. Conclusion The family should be considered as an important unit to sensitize young people on the harmful effects of drug use. It is also vital that religious leaders speak against drug use in their various fellowships. There is a need to address recreational drug use on Nigerian campuses by educating students about its adverse impacts.	[Ajayi, Anthony Idowu] African Populat & Hlth Res Ctr, Populat Dynam & Sexual & Reprod Hlth & Rights Uni, Nairobi, Kenya; [Somefun, Oluwaseyi Dolapo] Univ Witwatersrand, Demog & Populat Studies DPS, Johannesburg, South Africa	African Population & Health Research Centre; University of Witwatersrand	Ajayi, AI (corresponding author), African Populat & Hlth Res Ctr, Populat Dynam & Sexual & Reprod Hlth & Rights Uni, Nairobi, Kenya.	ajayianthony@gmail.com	Ajayi, Anthony Idowu/N-4272-2016	Ajayi, Anthony Idowu/0000-0002-6004-3972				Abdeta T, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1284-4; Abio Anne, 2020, J Inj Violence Res, V12, P21, DOI 10.5249/jivr.v12i1.1195; ADELEKAN ML, 1992, DRUG ALCOHOL DEPEN, V29, P255, DOI 10.1016/0376-8716(92)90100-Q; Ajayi AI, 2019, TRANSACTIONAL SEX NI, V14; Ajayi AI, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7310-3; Ajayi AI, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012226; AMOATENG AY, 1986, SOCIOL PERSPECT, V29, P53, DOI 10.2307/1388942; [Anonymous], [No title captured]; BARNES GM, 1992, J MARRIAGE FAM, V54, P763, DOI 10.2307/353159; Blanco C, 2016, JAMA PSYCHIAT, V73, P388, DOI 10.1001/jamapsychiatry.2015.3229; Broman CL, 2008, J FAM ISSUES, V29, P1625, DOI 10.1177/0192513X08322776; Bronfenbrenner U., 1994, INT ENCY ED, V3, P37; Browning CR, 2005, AM SOCIOL REV, V70, P758, DOI 10.1177/000312240507000502; Buck JM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00151; Cotto JH, 2010, GENDER MED, V7, P402, DOI 10.1016/j.genm.2010.09.004; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Di Forti M, 2014, SCHIZOPHRENIA BULL, V40, P1509, DOI 10.1093/schbul/sbt181; Doku D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-571; Ford JA, 2009, YOUTH SOC, V40, P336, DOI 10.1177/0044118X08316345; Grant CN, 2017, PAED CHILD HEALT-CAN, V22, P98, DOI 10.1093/pch/pxx017; Hall WD, 2016, LANCET PSYCHIAT, V3, P265, DOI 10.1016/S2215-0366(16)00013-4; Hemovich V, 2011, PSYCHOL HEALTH MED, V16, P249, DOI 10.1080/13548506.2010.532560; Hemovich V, 2009, SUBST USE MISUSE, V44, P2099, DOI 10.3109/10826080902858375; HOFFMANN JP, 1993, J DRUG ISSUES, V23, P535, DOI 10.1177/002204269302300312; Humensky JL, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-19; Leatherdale ST, 2012, ADDICT BEHAV, V37, P318, DOI 10.1016/j.addbeh.2011.10.007; Ledoux S, 2002, ALCOHOL ALCOHOLISM, V37, P52, DOI 10.1093/alcalc/37.1.52; Marshall BDL, 2010, ADDICTION, V105, P991, DOI 10.1111/j.1360-0443.2010.02932.x; Mehanovic E, 2020, DRUG ALCOHOL DEPEN, V206, DOI 10.1016/j.drugalcdep.2019.04.028; Molla M, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S6; Mosley WH, 2000, CONSEQUENCES MATERNA; Mowen TJ, 2015, JUSTICE Q, V32, P337, DOI 10.1080/07418825.2013.771207; Newcomb ME, 2014, AM J PUBLIC HEALTH, V104, P304, DOI 10.2105/AJPH.2013.301702; Paula CS, 2012, REV BRAS PSIQUIATR, V34, P334, DOI 10.1016/j.rbp.2012.04.001; Pierce M, 2017, DRUG ALCOHOL DEPEN, V179, P309, DOI 10.1016/j.drugalcdep.2017.07.024; Qureshi Adnan I, 2014, J Vasc Interv Neurol, V7, P76; Ritchwood TD, 2015, CHILD YOUTH SERV REV, V52, P74, DOI 10.1016/j.childyouth.2015.03.005; Scott S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172286; STERN M, 1984, ADOLESCENCE, V19, P301; Sullivan TN, 2004, J CLIN CHILD ADOLESC, V33, P488, DOI 10.1207/s15374424jccp3303_6; UNODC, 2018, WORLD DRUG REP 2018; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Watt MH, 2014, INT J DRUG POLICY, V25, P219, DOI 10.1016/j.drugpo.2013.10.007; WHO, 2018, AD HLTH RISKS SOL; Zhou H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157122	45	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0232964	10.1371/journal.pone.0232964	http://dx.doi.org/10.1371/journal.pone.0232964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1CK	32421722	gold, Green Published			2022-12-26	WOS:000537499600021
J	Elhag, MS; Jin, Y; Amin, MA; Ismail, HAHA; Hong, ST; Jang, HI; Doh, Y; Cha, S				Elhag, Mousab Siddig; Jin, Yan; Amin, Mutamad Ahmad; Ismail, Hassan Ahmed Hassan Ahmed; Hong, Sung-Tae; Jang, Hae In; Doh, Youngah; Cha, Seungman			Cost and logistics implications of a nationwide survey of schistosomiasis and other intestinal helminthiases in Sudan: Key activities and cost components	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; SOIL-TRANSMITTED HELMINTHIASIS; INFECTION; PREVALENCE; TRACHOMA; PROGRESS; HEALTH	It is vital to share details of concrete experiences of conducting a nationwide disease survey. By doing so, the global health community could adapt previous experiences to expand geographic mapping programs, eventually contributing to the development of disease control and elimination strategies. A nationwide survey of schistosomiasis and intestinal helminthiases was conducted from December 2016 to March 2017 in Sudan. We aimed to describe details of the key activities and cost components required for the nationwide survey. We investigated which activities were necessary to prepare and conduct a nationwide survey of schistosomiasis and intestinal helminthiases, and the types and amounts of transportation, personnel, survey equipment, and consumables that were required. In addition, we estimated financial and economic costs from the perspectives of the donor and the Ministry of Health. Cash expenditures incurred to implement the survey were defined as financial costs. For economic costs, we considered the true value for society as a whole, and this category therefore accounted for the costs of all goods and services used for the project, including those that were not sold in the market and therefore had no market price (e.g., time spent by head teachers and teachers). We organized costs into capital and recurrent items. We ran one-way sensitivity and probabilistic analyses using Monte-Carlo methods with 10,000 draws to examine the robustness of the primary analysis results. A total of USD 1,465,902 and USD 1,516,238 was incurred for the financial and economic costs, respectively. The key cost drivers of the nationwide survey were personnel and transportation, for both financial and economic costs. Personnel and transportation accounted for around 64% and 18% of financial costs, respectively. If a government finds a way to mobilize existing government officials with no additional payments using the health system already in place, the cost of a nationwide survey could be remarkably reduced.	[Elhag, Mousab Siddig; Ismail, Hassan Ahmed Hassan Ahmed] Fed Minist Hlth, Communicable & Noncommunicable Dis Control Direct, Khartoum, Sudan; [Jin, Yan] Dongguk Univ, Coll Med, Dept Microbiol, Gyeongju, South Korea; [Amin, Mutamad Ahmad] Ahfad Univ Women, Res & Grants Unit, Khartoum, Sudan; [Hong, Sung-Tae] Seoul Natl Univ, Coll Med, Dept Trop Med & Parasitol, Seoul, South Korea; [Jang, Hae In; Doh, Youngah] Korea Int Cooperat Agcy, East Africa Dept, Sungnam, South Korea; [Cha, Seungman] Handong Global Univ, Dept Global Dev & Entrepreneurship, Grad Sch Global Dev & Entrepreneurship, Pohang, South Korea; [Cha, Seungman] London Sch Hyg & Trop Med, Dept Dis Control, London, England	Dongguk University; Seoul National University (SNU); Handong Global University; University of London; London School of Hygiene & Tropical Medicine	Cha, S (corresponding author), Handong Global Univ, Dept Global Dev & Entrepreneurship, Grad Sch Global Dev & Entrepreneurship, Pohang, South Korea.; Cha, S (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London, England.	seungman.cha@handong.edu		Ismail, Hassan Ahmed Hassan Ahmed/0000-0001-6554-9596; JIN, YAN/0000-0002-6118-2069; Cha, Seungman/0000-0003-1264-3313	Korea International Cooperation Agency (KOICA) [P-201500145]	Korea International Cooperation Agency (KOICA)	This project was funded by the Korea International Cooperation Agency (KOICA, P-201500145). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton RA, 2011, TROP MED INT HEALTH, V16, P1099, DOI 10.1111/j.1365-3156.2011.02815.x; Assoum M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2505-x; Baker MC, 2010, LANCET, V375, P231, DOI 10.1016/S0140-6736(09)61458-6; Boko PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162798; Brady MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005097; Brooker S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000779; Cha S, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3689-z; Cha S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4719-4; Chen CQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000979; Corstjens PLAM, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0368-1; Croce D, 2010, ACTA TROP, V113, P279, DOI 10.1016/j.actatropica.2009.11.011; Drummond MF, 2015, METHODS EC EVALUATIO; FMOH, 2015, MAST PLAN NEGL TROP; FMOH, 2011, NAT PLAN EL SCHIST S; Gass KM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005944; Kastner RJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005934; Kittur N, 2016, AM J TROP MED HYG, V94, P605, DOI 10.4269/ajtmh.15-0725; Knowles SCL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005599; Kolaczinski JH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000745; Levy PS, 2008, SAMPLING POPULATIONS, V4th; Liese BH, 2014, INT HEALTH, V6, P162, DOI 10.1093/inthealth/ihu052; Lo NC, 2018, P NATL ACAD SCI USA, V115, pE584, DOI 10.1073/pnas.1708729114; Lo NC, 2017, LANCET INFECT DIS, V17, pE64, DOI 10.1016/S1473-3099(16)30535-7; Lo NC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004894; Midzi N, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003014; Molyneux DH, 2017, LANCET, V389, P312, DOI 10.1016/S0140-6736(16)30171-4; Nascimento GL, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760180347; NTD-SC, 2019, COAL OP RES NEGL TRO; NTD-SC, 2016, OP RES EL NTDS UPD N; Pelletreau S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001380; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Solomon AW, 2015, OPHTHAL EPIDEMIOL, V22, P214, DOI 10.3109/09286586.2015.1037401; Sousa-Figueiredo JC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003831; Stanton MC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0946-4; Sturrock HJW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000537; Trotignon G, 2017, PLOS NEGLECT TROP D, V11, DOI [10.1371/journal.pntd.0006023, 10.1371/journal.pntd.000602]; Turner HC, 2017, TRENDS PARASITOL, V33, P435, DOI 10.1016/j.pt.2017.01.007; WHO, 2006, PREV CHEM HUM HELM; WHO, 2019, COMM DIS CLUST ANN R; WHO, 1987, GLOB SCHIST ATL; WHO. World Health Organization, 1991, BAS LAB METH HUM PAR; World Health Organization, 2018, EXP SPEC PROJ EL NEG; Worrell CM, 2015, AM J TROP MED HYG, V92, P1233, DOI 10.4269/ajtmh.14-0644	44	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0226586	10.1371/journal.pone.0226586	http://dx.doi.org/10.1371/journal.pone.0226586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421720	Green Published, gold			2022-12-26	WOS:000537499600001
J	Pena-Ahumada, B; Saldarriaga-Cordoba, M; Kardailsky, O; Moncada, X; Moraga, M; Matisoo-Smith, E; Seelenfreund, D; Seelenfreund, A				Pena-Ahumada, Barbara; Saldarriaga-Cordoba, Monica; Kardailsky, Olga; Moncada, Ximena; Moraga, Mauricio; Matisoo-Smith, Elizabeth; Seelenfreund, Daniela; Seelenfreund, Andrea			A tale of textiles: Genetic characterization of historical paper mulberry barkcloth from Oceania	PLOS ONE			English	Article							PAPYRIFERA L. VENT.; ANCIENT DNA; PACIFIC; PHYLOGEOGRAPHY; ARCHIPELAGO; SEQUENCES	Humans introduced paper mulberry (Broussonetia papyrifera) from Taiwan into the Pacific over 5000 years ago as a fiber source to make barkcloth textiles that were, and still are, important cultural artifacts throughout the Pacific. We have used B. papyrifera, a species closely associated to humans, as a proxy to understand the human settlement of the Pacific Islands. We report the first genetic analysis of paper mulberry textiles from historical and archaeological contexts (200 to 50 years before present) and compare our results with genetic data obtained from contemporary and herbarium paper mulberry samples. Following stringent ancient DNA protocols, we extracted DNA from 13 barkcloth textiles. We confirmed that the fiber source is paper mulberry in nine of the 13 textiles studied using the nuclear ITS-1 marker and by statistical estimates. We detected high genetic diversity in historical Pacific paper mulberry barkcloth with a set of ten microsatellites, showing new alleles and specific genetic patterns. These genetic signatures allow tracing connections to plants from the Asian homeland, Near and Remote Oceania, establishing links not observed previously (using the same genetic tools) in extant plants or herbaria samples. These results show that historic barkcloth textiles are cultural materials amenable to genetic analysis to reveal human history and that these artifacts may harbor evidence of greater genetic diversity in Pacific B. papyrifera in the past.	[Pena-Ahumada, Barbara; Saldarriaga-Cordoba, Monica; Seelenfreund, Daniela] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago, Chile; [Saldarriaga-Cordoba, Monica; Kardailsky, Olga] Univ Bernardo OHiggins, Ctr Invest Recursos Nat & Sustentabilidad, Santiago, Chile; [Kardailsky, Olga; Matisoo-Smith, Elizabeth] Univ Otago, Dept Anat, Dunedin, New Zealand; [Moncada, Ximena] CEAZA, La Serena, Chile; [Moraga, Mauricio] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Genet Humana, Santiago, Chile; [Moraga, Mauricio] Univ Chile, Fac Ciencias Sociales, Dept Antropol, Santiago, Chile; [Seelenfreund, Andrea] Univ Acad Humanismo Cristiano, Fac Ciencias Sociales, Escuela Antropol, Santiago, Chile	Universidad de Chile; Universidad  Bernardo O'Higgins; University of Otago; Universidad de Chile; Universidad de Chile; Universidad Academia de Humanismo Cristiano	Seelenfreund, D (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago, Chile.; Seelenfreund, A (corresponding author), Univ Acad Humanismo Cristiano, Fac Ciencias Sociales, Escuela Antropol, Santiago, Chile.	dseelen@ciq.uchile.cl; aseelenfreund@academia.cl		Matisoo-Smith, Elizabeth/0000-0002-3500-8307	CONICYT (Chile) [FONDECYT 1120175, FONDECYT 1180052]; University of Chile; Programa PME (BP-A); Programa Enlace Facultad de Ciencias Quimicas y Farmaceuticas, PEEI 2017	CONICYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); University of Chile; Programa PME (BP-A); Programa Enlace Facultad de Ciencias Quimicas y Farmaceuticas, PEEI 2017	This work received funding from CONICYT (Chile), https://www.conicyt.cl/, grants FONDECYT 1120175 (AS) and FONDECYT 1180052 (AS); University of Chile, http://www.uchile.cl/, Programa PME (BP-A) and Programa Enlace Facultad de Ciencias Quimicas y Farmaceuticas, PEEI 2017 (DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Bastian F, 2018, J ARCHAEOL SCI-REP, V19, P323, DOI 10.1016/j.jasrep.2018.03.002; Chang CS, 2015, P NATL ACAD SCI USA, V112, P13537, DOI 10.1073/pnas.1503205112; Charleux M., 2017, TAPA ECORCE ETOFFE A; Cooper A, 2000, SCIENCE, V289, P1139; Dabney J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012567; Daniels V., 2005, CONSERVATOR, V29, P95, DOI DOI 10.1080/01410096.2005.9995216; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gonzalez-Lorca J, 2015, NEW ZEAL J BOT, V53, P75, DOI 10.1080/0028825X.2015.1010546; Green EJ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8070180; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartnup K, 2011, MOL BIOL EVOL, V28, P2741, DOI 10.1093/molbev/msr107; Kayser M, 2010, CURR BIOL, V20, pR194, DOI 10.1016/j.cub.2009.12.004; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Kooijman S., 1972, BISHOP MUSEUM B, V234; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lee T, 2007, P ROY SOC B-BIOL SCI, V274, P2907, DOI 10.1098/rspb.2007.1009; Lipson M, 2018, CURR BIOL, V28, P1157, DOI 10.1016/j.cub.2018.02.051; Marota I, 2002, AM J PHYS ANTHROPOL, V117, P310, DOI 10.1002/ajpa.10045; Matisoo-Smith E, 2002, HUM BIOL, V74, P489, DOI 10.1353/hub.2002.0032; Matisoo-Smith E, 2009, J ISL COAST ARCHAEOL, V4, P151, DOI [DOI 10.1080/15564890903155273, 10.1080/15564890903155273]; Mesenholler P, 2013, MADE OCEANIA; Moncada X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056549; Neich R, 2004, PACIFIC TAPA; Olivares G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217107; Payacan C, 2017, ANN BOT-LONDON, V120, P387, DOI 10.1093/aob/mcx062; Pearson William R, 2013, Curr Protoc Bioinformatics, VChapter 3, DOI 10.1002/0471250953.bi0301s42; Penailillo J, 2017, APPL PLANT SCI, V5, DOI 10.3732/apps.1700044; Penailillo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161148; Renfrew C, 2009, SCIENCE, V323, P467, DOI 10.1126/science.1168953; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Seelenfreund A, 2016, J ARCHAEOL SCI, V76, P56, DOI 10.1016/j.jas.2016.10.008; Seelenfreund D, 2011, NEW ZEAL J BOT, V49, P413, DOI 10.1080/0028825X.2011.579135; Seelenfreund D, 2010, NEW ZEAL J BOT, V48, P231, DOI 10.1080/0028825X.2010.520323; Speirs AK, 2009, TERRA AUSTRALIS, V30, P175; Storey AA, 2013, J ISL COAST ARCHAEOL, V8, P37, DOI 10.1080/15564894.2012.761299; Teasdale MD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0379; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; White JP, 2001, PACIFIC 2000: PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON EASTER ISLAND AND THE PACIFIC, P37	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233113	10.1371/journal.pone.0233113	http://dx.doi.org/10.1371/journal.pone.0233113			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421727	Green Published, gold			2022-12-26	WOS:000537499600027
J	Bianchetto-Aguilera, F; Tamassia, N; Gasperini, S; Calzetti, F; Finotti, G; Gardiman, E; Montioli, R; Bresciani, D; Vermi, W; Cassatella, MA				Bianchetto-Aguilera, Francisco; Tamassia, Nicola; Gasperini, Sara; Calzetti, Federica; Finotti, Giulia; Gardiman, Elisa; Montioli, Riccardo; Bresciani, Debora; Vermi, William; Cassatella, Marco Antonio			Deciphering the fate of slan(+)-monocytes in human tonsils by gene expression profiling	FASEB JOURNAL			English	Article						blood; CD1c(+)DC; cDC2; classical; non-classical monocytes; gene expression; slan(+)-monocytes; tonsil	HUMAN DENDRITIC CELLS; 6-SULFO LACNAC; MONOCYTES REVEALS; HUMAN MACROPHAGES; APOPTOTIC CELLS; TRANSCRIPTION; CLEARANCE; RECEPTORS; SUBSET	Monocytic cells perform crucial homeostatic and defensive functions. However, their fate and characterization at the transcriptomic level in human tissues are partially understood, often as a consequence of the lack of specific markers allowing their unequivocal identification. The 6-sulfo LacNAc (slan) antigen identifies a subset of non-classical (NC) monocytes in the bloodstream, namely the slan(+)-monocytes. In recent studies, we and other groups have reported that, in tonsils, slan marks dendritic cell (DC)-like cells, as defined by morphological, phenotypical, and functional criteria. However, subsequent investigations in lymphomas have uncovered a significant heterogeneity of tumor-infiltrating slan(+)-cells, including a macrophage-like state. Based on their emerging role in tissue inflammation and cancer, herein we investigated slan(+)-cell fate in tonsils by using a molecular-based approach. Hence, RNA from tonsil slan(+)-cells, conventional CD1c(+)DCs (cDC2) and CD11b(+)CD14(+)-macrophages was subjected to gene expression analysis. For comparison, transcriptomes were also obtained from blood cDC2, classical (CL), intermediate (INT), NC, and slan(+)-monocytes. Data demonstrate that the main trajectory of human slan(+)-monocytes infiltrating the tonsil tissue is toward a macrophage-like population, displaying molecular features distinct from those of tonsil CD11b(+)CD14(+)-macrophages and cDC2. These findings provide a novel view on the terminal differentiation path of slan(+)-monocytes, which is relevant for inflammatory diseases and lymphomas.	[Bianchetto-Aguilera, Francisco; Tamassia, Nicola; Gasperini, Sara; Calzetti, Federica; Finotti, Giulia; Gardiman, Elisa; Cassatella, Marco Antonio] Univ Verona, Dept Med, Sect Gen Pathol, Str Le Grazie 8, Verona, Italy; [Montioli, Riccardo] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Bresciani, Debora; Vermi, William] Univ Brescia, Dept Mol & Translat Med, Sect Pathol, Brescia, Italy; [Vermi, William] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	University of Verona; University of Verona; University of Brescia; Washington University (WUSTL)	Tamassia, N; Cassatella, MA (corresponding author), Univ Verona, Dept Med, Sect Gen Pathol, Str Le Grazie 8, Verona, Italy.	nicola.tamassia@univr.it; marco.cassatella@univr.it	Tamassia, Nicola/J-8621-2016; Bianchetto Aguilera, Francisco Miguel Angel/GNW-3583-2022; Gardiman, Elisa/ABD-6131-2021; Cassatella, M A/B-8037-2013	Tamassia, Nicola/0000-0003-2990-3003; Bianchetto Aguilera, Francisco Miguel Angel/0000-0003-3910-4715; Cassatella, M A/0000-0001-7824-1806; Gardiman, Elisa/0000-0002-5431-9610	Associazione Italiana per la Ricerca sul Cancro [IG-20339]; Ministero dell'Istruzione, dell'Universita e della Ricerca [2015YYKPNN_002, 20177J4E75_004]; University of Verona	Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Istruzione, dell'Universita e della Ricerca; University of Verona	Associazione Italiana per la Ricerca sul Cancro, Grant/Award Number: IG-20339; Ministero dell'Istruzione, dell'Universita e della Ricerca, Grant/Award Number: 2015YYKPNN_002 and 20177J4E75_004;University of Verona, Grant/Award Number: Ricerca di Base 2015	A-Gonzalez N, 2011, BBA-MOL BASIS DIS, V1812, P982, DOI 10.1016/j.bbadis.2010.12.015; Ahmad F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00948; Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Brocheriou I, 2011, ATHEROSCLEROSIS, V214, P316, DOI 10.1016/j.atherosclerosis.2010.11.023; Calzetti F, 2018, J ALLERGY CLIN IMMUN, V141, P2276, DOI 10.1016/j.jaci.2017.12.988; CONSTANTIN G, 1994, FEBS LETT, V350, P66, DOI 10.1016/0014-5793(94)00735-7; Costantini C, 2011, BLOOD, V117, P1677, DOI 10.1182/blood-2010-06-287243; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; de Baey A, 2003, J IMMUNOL, V170, P5089, DOI 10.4049/jimmunol.170.10.5089; de Baey A, 2001, EUR J IMMUNOL, V31, P1646, DOI 10.1002/1521-4141(200106)31:6<1646::AID-IMMU1646>3.0.CO;2-X; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Endreffy I, 2017, IMMUNOL RES, V65, P1025, DOI 10.1007/s12026-017-8943-x; Frankenberger M, 2012, EUR J IMMUNOL, V42, P957, DOI 10.1002/eji.201141907; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Goudot C, 2017, IMMUNITY, V47, P582, DOI 10.1016/j.immuni.2017.08.016; Gren ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144351; Hansel A, 2013, J AUTOIMMUN, V40, P1, DOI 10.1016/j.jaut.2012.07.005; Hansel A, 2011, J ALLERGY CLIN IMMUN, V127, P787, DOI 10.1016/j.jaci.2010.12.009; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hamers AAJ, 2019, ARTERIOSCL THROM VAS, V39, P25, DOI 10.1161/ATVBAHA.118.311022; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hofer TP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02052; Hofer TP, 2015, BLOOD, V126, P2601, DOI 10.1182/blood-2015-06-651331; HOLNESS CL, 1993, BLOOD, V81, P1607; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Italiani P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087680; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Tran MTN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01711-0; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Micheletti A, 2016, ONCOTARGET, V7, P161, DOI 10.18632/oncotarget.6660; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Olingy CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00477-1; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; PrabhuDas MR, 2017, J IMMUNOL, V198, P3775, DOI 10.4049/jimmunol.1700373; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188; Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Thielens NM, 2017, MOL IMMUNOL, V89, P73, DOI 10.1016/j.molimm.2017.05.025; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; van Leeuwen-Kerkhoff N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01619; van Leeuwen-Kerkhoff N, 2017, J LEUKOCYTE BIOL, V102, P1055, DOI 10.1189/jlb.3MA0117-037R; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vermi W, 2018, CANCER RES, V78, P3544, DOI 10.1158/0008-5472.CAN-17-2344; Vermi W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4029; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	58	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9269	9284		10.1096/fj.202000181R	http://dx.doi.org/10.1096/fj.202000181R		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32413173				2022-12-26	WOS:000533182000001
J	Dececchi, TA; Mloszewska, AM; Holtz, TR; Habib, MB; Larsson, HCE				Dececchi, T. Alexander; Mloszewska, Aleksandra M.; Holtz, Thomas R., Jr.; Habib, Michael B.; Larsson, Hans C. E.			The fast and the frugal: Divergent locomotory strategies drive limb lengthening in theropod dinosaurs	PLOS ONE			English	Article							MAXIMUM RUNNING SPEEDS; BODY-MASS; BIPEDAL LOCOMOTION; MAMMALS; BIOMECHANICS; BIRDS; TYRANNOSAURUS; PROPORTIONS; ENERGETICS; EVOLUTION	Limb length, cursoriality and speed have long been areas of significant interest in theropod paleobiology, since locomotory capacity, especially running ability, is critical in the pursuit of prey and to avoid becoming prey. The impact of allometry on running ability, and the limiting effect of large body size, are aspects that are traditionally overlooked. Since several different non-avian theropod lineages have each independently evolved body sizes greater than any known terrestrial carnivorous mammal, similar to 1000kg or more, the effect that such large mass has on movement ability and energetics is an area with significant implications for Mesozoic paleoecology. Here, using expansive datasets that incorporate several different metrics to estimate body size, limb length and running speed, we calculate the effects of allometry on running ability. We test traditional metrics used to evaluate cursoriality in nonavian theropods such as distal limb length, relative hindlimb length, and compare the energetic cost savings of relative hindlimb elongation between members of the Tyrannosauridae and more basal megacarnivores such as Allosauroidea or Ceratosauridae. We find that once the limiting effects of body size increase is incorporated there is no significant correlation to top speed between any of the commonly used metrics, including the newly suggested distal limb index (Tibia + Metatarsus/ Femur length). The data also shows a significant split between large and small bodied theropods in terms of maximizing running potential suggesting two distinct strategies for promoting limb elongation based on the organisms' size. For small and medium sized theropods increased leg length seems to correlate with a desire to increase top speed while amongst larger taxa it corresponds more closely to energetic efficiency and reducing foraging costs. We also find, using 3D volumetric mass estimates, that the Tyrannosauridae show significant cost of transport savings compared to more basal clades, indicating reduced energy expenditures during foraging and likely reduced need for hunting forays. This suggests that amongst theropods, hindlimb evolution was not dictated by one particular strategy. Amongst smaller bodied taxa the competing pressures of being both a predator and a prey item dominant while larger ones, freed from predation pressure, seek to maximize foraging ability. We also discuss the implications both for interactions amongst specific clades and Mesozoic paleobiology and paleoecological reconstructions as a whole.	[Dececchi, T. Alexander] Mt Marty Coll, Dept Biol, Div Nat Sci, Yankton, SD 57078 USA; [Holtz, Thomas R., Jr.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Holtz, Thomas R., Jr.] Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Habib, Michael B.] Univ Southern Calif, Keck Sch Med USC, Integrat Anat Sci, Los Angeles, CA 90007 USA; [Larsson, Hans C. E.] McGill Univ, Redpath Museum, Montreal, PQ, Canada	University System of Maryland; University of Maryland College Park; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Southern California; McGill University	Dececchi, TA (corresponding author), Mt Marty Coll, Dept Biol, Div Nat Sci, Yankton, SD 57078 USA.	alex.dececchi@mtmc.edu		Dececchi, Thomas Alexander/0000-0001-7972-3866; Holtz, Thomas/0000-0002-2906-4900				ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; Allen V, 2013, NATURE, V497, P104, DOI 10.1038/nature12059; Barrick RE, 1999, PALAEONTOLOGIA ELECT; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benson RBJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1780; Benton MJ, 2014, CURR BIOL, V24, pR87, DOI 10.1016/j.cub.2013.11.063; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; BIEWENER AA, 1989, BIOSCIENCE, V39, P776, DOI 10.2307/1311183; Birn-Jeffery AV, 2014, J EXP BIOL, V217, P3786, DOI 10.1242/jeb.102640; Bishop PJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192172; Campione NE, 2014, METHODS ECOL EVOL, V5, P913, DOI 10.1111/2041-210X.12226; Carbone C, 2005, AM NAT, V165, P290, DOI 10.1086/426790; Carbone C, 2011, P R SOC B; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Carrano Matthew T., 2006, P225; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Cau A, 2017, NATURE, V552, P395, DOI 10.1038/nature24679; Christiansen P, 2002, ZOOL J LINN SOC-LOND, V136, P685, DOI 10.1046/j.1096-3642.2002.00041.x; Christiansen P, 2002, J ORNITHOL, V143, P356; Coria RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157973; COTTAM CLARENCE, 1942, WILSON BULL, V54, P121; Currie PJ, 2018, PALAEOGEOGR PALAEOCL, V494, P5, DOI 10.1016/j.palaeo.2017.10.035; Currie PJ, 2010, CAN J EARTH SCI, V47, P1277, DOI 10.1139/E10-072; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; D'Emic MD, 2010, PALAEOGEOGR PALAEOCL, V297, P486, DOI 10.1016/j.palaeo.2010.08.032; Day JJ, 2002, NATURE, V415, P494, DOI 10.1038/415494a; Dececchi TA, 2013, EVOLUTION, V67, P2741, DOI 10.1111/evo.12150; ELLIOTT JP, 1977, CAN J ZOOL, V55, P1811, DOI 10.1139/z77-235; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Farlow JO, 2010, HIST BIOL, V22, P403, DOI 10.1080/08912961003787598; Farlow James O., 1994, Historical Biology, V7, P159; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Foth C, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1076-y; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028964; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021376; Fuentes MA, 2016, J THEOR BIOL, V390, P127, DOI 10.1016/j.jtbi.2015.10.039; Funston GF, 2018, PALAEOGEOGR PALAEOCL, V494, P101, DOI 10.1016/j.palaeo.2017.10.023; GARLAND T, 1983, J ZOOL, V199, P157, DOI 10.1111/j.1469-7998.1983.tb02087.x; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; Gatesy SM, 2009, J VERTEBR PALEONTOL, V29, P535, DOI 10.1671/039.029.0213; Gorman EJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051925, DOI 10.1371/JOURNAL.PONE.0051925]; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; Henderson DM, 2003, P ROY SOC LOND B BIO, V271, P57; Hirt MR, 2017, NAT ECOL EVOL, V1, P1116, DOI 10.1038/s41559-017-0241-4; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Hone DWE, 2015, PEERJ, V3, DOI 10.7717/peerj.885; Hone DWE, 2010, LETHAIA, V43, P232, DOI 10.1111/j.1502-3931.2009.00187.x; Hubel TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11034; Huh M, 2006, CRETACEOUS RES, V27, P123, DOI 10.1016/j.cretres.2005.10.003; Hutchinson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026037; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Hutchinson JR, 2005, PALEOBIOLOGY, V31, P676; Hutchinson JR, 2003, NATURE, V422, P493, DOI 10.1038/422493a; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Hutchinson JR, 2006, J EXPT BIOL, V209; Jacobsen Aase Roland, 1998, Historical Biology, V13, P17; Janosov M, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa69e7; Kane A, 2016, AM NATURALIST, V187; Kilbourne BM, 2010, J ANAT, V217, P135, DOI 10.1111/j.1469-7580.2010.01253.x; Kim BS, 2010, PALAEOGEOGR PALAEOCL, V293, P1, DOI 10.1016/j.palaeo.2010.04.020; Kim JY, 2012, ICHNOS, V19, P50, DOI 10.1080/10420940.2011.625779; Kim S. Y., 2018, SCI REPORTS, V8; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Lehman Thomas M., 2001, P310; Lockley MG, 2015, PALAEOGEOGR PALAEOCL, V423, P62, DOI 10.1016/j.palaeo.2015.01.028; Makovicky PJ, DINOSAURS LIVING, V201, P9; McCrea RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103613; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; Nesbitt SJ, 2019, NAT ECOL EVOL, V3, P892, DOI 10.1038/s41559-019-0888-0; Persons WS, 2020, ANAT REC, V303, P656, DOI 10.1002/ar.24118; Persons WS, 2016, SCI REP-UK, V6, DOI 10.1038/srep19828; Pontzer H, 2009, PLOS ONE, V4, pA127, DOI 10.1371/journal.pone.0007783; Ruiz J, 2018, CRETACEOUS RES, V82, P81, DOI 10.1016/j.cretres.2017.05.033; Ruiz J, 2013, ICHNOS, V20, P31, DOI 10.1080/10420940.2012.759115; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Smith SD, 2016, CRETACEOUS RES, V61, P1, DOI 10.1016/j.cretres.2015.12.020; Snively E, 2019, PEERJ, V7, DOI 10.7717/peerj.6432; Talori YS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35966-4; Vaughan CL, 2005, GAIT POSTURE, V21, P350, DOI 10.1016/j.gaitpost.2004.01.011; Weems Robert E., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P379; Zanno LE, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0308-7; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827	87	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0223698	10.1371/journal.pone.0223698	http://dx.doi.org/10.1371/journal.pone.0223698			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401793	Green Published, gold, Green Submitted			2022-12-26	WOS:000537481000001
J	Allen, S; Allen, D; Moss, K; Le Roux, G; Phoenix, VR; Sonke, JE				Allen, Steve; Allen, Deonie; Moss, Kerry; Le Roux, Gael; Phoenix, Vernon R.; Sonke, Jeroen E.			Examination of the ocean as a source for atmospheric microplastics	PLOS ONE			English	Article							DEPOSITION; CHEMISTRY; TRANSPORT; BACTERIA; PLASTICS; FALLOUT; FIBERS; DUST; FOG	Global plastic litter pollution has been increasing alongside demand since plastic products gained commercial popularity in the 1930's. Current plastic pollutant research has generally assumed that once plastics enter the ocean they are there to stay, retained permanently within the ocean currents, biota or sediment until eventual deposition on the sea floor or become washed up onto the beach. In contrast to this, we suggest it appears that some plastic particles could be leaving the sea and entering the atmosphere along with sea salt, bacteria, virus' and algae. This occurs via the process of bubble burst ejection and wave action, for example from strong wind or sea state turbulence. In this manuscript we review evidence from the existing literature which is relevant to this theory and follow this with a pilot study which analyses microplastics (MP) in sea spray. Here we show first evidence of MP particles, analysed by mu Raman, in marine boundary layer air samples on the French Atlantic coast during both onshore (average of 2.9MP/m(3)) and offshore (average of 9.6MP/m(3)) winds. Notably, during sampling, the convergence of sea breeze meant our samples were dominated by sea spray, increasing our capacity to sample MPs if they were released from the sea. Our results indicate a potential for MPs to be released from the marine environment into the atmosphere by sea-spray giving a globally extrapolated figure of 136000 ton/yr blowing on shore.	[Allen, Steve; Allen, Deonie; Phoenix, Vernon R.] Univ Strathclyde, Ctr Water Environm Sustainabil & Publ Hlth, Dept Civil & Environm Engn, Glasgow, Lanark, Scotland; [Allen, Steve; Allen, Deonie; Le Roux, Gael] ENSAT, UMR CNRS 5245, EcoLab Lab Ecol Fonct & Environm, Toulouse, France; [Moss, Kerry] Nelson Mandela Univ, Ocean Sci, Port Elizabeth, South Africa; [Sonke, Jeroen E.] Univ Toulouse, Geosci Environm Toulouse, CNRS, OMP, Toulouse, France	University of Strathclyde; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Nelson Mandela University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Allen, S (corresponding author), Univ Strathclyde, Ctr Water Environm Sustainabil & Publ Hlth, Dept Civil & Environm Engn, Glasgow, Lanark, Scotland.; Allen, S (corresponding author), ENSAT, UMR CNRS 5245, EcoLab Lab Ecol Fonct & Environm, Toulouse, France.	steve.allen@strath.ac.uk	Le Roux, Gael/K-1154-2012; Phoenix, Vernon/J-8871-2014	Le Roux, Gael/0000-0002-1579-0178; Phoenix, Vernon/0000-0002-8682-5200; Allen, Steve/0000-0002-2333-6514; allen, deonie/0000-0002-4038-9394	GET; WESP (University of Strathclyde); People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant through the PRESTIGE programme [PCOFUND-GA-2013-609102]; CNRS TRAM Project [ANR-15-CE01-0008]; Observatoire Homme-Milieu Pyrenees Haut Vicdessos -LABEX DRIIHM [ANR-11-LABX-0010]; H2020 ERA-PLANET iGOSP programme [689443]; Leverhulme Trust Early Careers Fellowship Grant 'Looking back for the future through archives of Airborne Microplastic Pollution' [ECF-2019-306]	GET; WESP (University of Strathclyde); People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant through the PRESTIGE programme(General Electric); CNRS TRAM Project; Observatoire Homme-Milieu Pyrenees Haut Vicdessos -LABEX DRIIHM; H2020 ERA-PLANET iGOSP programme; Leverhulme Trust Early Careers Fellowship Grant 'Looking back for the future through archives of Airborne Microplastic Pollution'	The data has been funded by GET and WESP (University of Strathclyde) research department support. The research leading to these results has also received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement n. PCOFUND-GA-2013-609102, through the PRESTIGE programme coordinated by Campus France. The research has been supported by the CNRS TRAM Project, ANR-15-CE01-0008, Observatoire Homme-Milieu Pyrenees Haut Vicdessos -LABEX DRIIHM ANR-11-LABX-0010, and by and the H2020 ERA-PLANET (689443) iGOSP programme. This research was also supported by the Leverhulme Trust Early Careers Fellowship Grant 'Looking back for the future through archives of Airborne Microplastic Pollution', grant number ECF-2019-306.	Akdogan Z, 2019, ENVIRON POLLUT, V254, DOI 10.1016/j.envpol.2019.113011; Allen S, 2019, NAT GEOSCI, V12, P339, DOI 10.1038/s41561-019-0335-5; Andreae MO, 2008, EARTH-SCI REV, V89, P13, DOI 10.1016/j.earscirev.2008.03.001; Archer CL, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005462; Athanasopoulou E, 2008, ATMOS CHEM PHYS, V8, P5755, DOI 10.5194/acp-8-5755-2008; Bergmann M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax1157; Cai LQ, 2017, ENVIRON SCI POLLUT R, V24, P24928, DOI 10.1007/s11356-017-0116-x; Choy CA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44117-2; Corcoran PL, 2009, MAR POLLUT BULL, V58, P80, DOI 10.1016/j.marpolbul.2008.08.022; Dawson AL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03465-9; Demoz B.B, 1995, ATMOS RES, V41, P46672; Dris R, 2017, ENVIRON POLLUT, V221, P453, DOI 10.1016/j.envpol.2016.12.013; Dris R, 2016, MAR POLLUT BULL, V104, P290, DOI 10.1016/j.marpolbul.2016.01.006; Enyoh CE, 2019, ENVIRON MONIT ASSESS, V191, DOI 10.1007/s10661-019-7842-0; Erinin MA, 2019, GEOPHYS RES LETT, V46, P8244, DOI 10.1029/2019GL082831; Fanourgakis GS, 2019, ATMOS CHEM PHYS DISC, P1, DOI [10.5194/acp-2018-1340, DOI 10.5194/ACP-2018-1340]; Ganguly M, 2019, ACS EARTH SPACE CHEM, V3, P1729, DOI 10.1021/acsearthspacechem.9b00132; Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782; Herckes P, 2002, ATMOS RES, V64, P99, DOI 10.1016/S0169-8095(02)00083-2; Hong Kong Observatory, 2018, WEATH DEC 2016 WARN, P1; Hoppel WA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD002014; Jahnke A, 2017, ENVIRON SCI TECH LET, V4, P85, DOI 10.1021/acs.estlett.7b00008; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Julienne F, 2019, CHEMOSPHERE, V236, DOI 10.1016/j.chemosphere.2019.124409; KENYON KW, 1969, AUK, V86, P339, DOI 10.2307/4083505; Klein M, 2019, SCI TOTAL ENVIRON, V685, P96, DOI 10.1016/j.scitotenv.2019.05.405; Koelmans AA, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa9500; Koracin D, 2014, ATMOS RES, V143, P142, DOI 10.1016/j.atmosres.2013.12.012; Kukulka T, 2017, J PHYS OCEANOGR, V47, P1637, DOI 10.1175/JPO-D-16-0244.1; Lambert S, 2016, CHEMOSPHERE, V145, P265, DOI 10.1016/j.chemosphere.2015.11.078; Lewis E. R., 2004, SEA SALT AEROSOL PRO; Liu KF, 2019, ERGONOMICS, V62, P1289, DOI 10.1080/00140139.2019.1629637; Marticorena B, 1997, J GEOPHYS RES-ATMOS, V102, P4387, DOI 10.1029/96JD02964; Mattsson K, 2015, ENVIRON SCI-PROC IMP, V17, P1712, DOI 10.1039/c5em00227c; Maximenko N, 2012, MAR POLLUT BULL, V65, P51, DOI 10.1016/j.marpolbul.2011.04.016; McWilliams JC, 1997, J FLUID MECH, V334, P1, DOI 10.1017/S0022112096004375; MeteoFrance, 2018, MET CLIM MIM; MOSER ML, 1992, COLON WATERBIRD, V15, P83, DOI 10.2307/1521357; O'Dowd CD, 2007, PHILOS T R SOC A, V365, P1753, DOI 10.1098/rsta.2007.2043; Plastics Europe, 2019, PLAST FACTS 2019; Posfai M, 2003, ATMOS RES, V66, P231, DOI 10.1016/S0169-8095(03)00039-5; QUINN JA, 1975, CHEM ENG SCI, V30, P1177, DOI 10.1016/0009-2509(75)87021-7; Reche I, 2018, ISME J, V12, P1154, DOI 10.1038/s41396-017-0042-4; Richter DH, 2016, PHYS TODAY, V69, P34, DOI 10.1063/PT.3.3363; Roman P, 2013, CRIT REV ENV SCI TEC, V43, P1517, DOI 10.1080/10643389.2011.647794; Sharma N, 2011, ENCY ENV HLTH, DOI [10.1016/b978-0-444-52272-6.00332-9, DOI 10.1016/B978-0-444-52272-6.00332-9]; Shim WJ, 2015, ARCH ENVIRON CON TOX, V69, P265, DOI 10.1007/s00244-015-0216-x; Slonosky VC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014302; Sofiev M, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014713; Song YK, 2017, ENVIRON SCI TECHNOL, V51, P4368, DOI 10.1021/acs.est.6b06155; van der Does M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau2768; van der Does M, 2018, AEOLIAN RES, V33, P106, DOI 10.1016/j.aeolia.2018.06.001; van Sebille E, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124006; Wichmann D, 2019, J GEOPHYS RES-OCEANS, V124, P6086, DOI 10.1029/2019JC015328; Wright SL, 2019, ENV INT; Wrzesinsky T, 2000, ATMOS ENVIRON, V34, P1487, DOI 10.1016/S1352-2310(99)00348-9; Yan JP, 2016, CHEMOSPHERE, V159, P244, DOI 10.1016/j.chemosphere.2016.06.006; Zender CS, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002775; ZENG QL, 2019, J HAZARD MATER, V380, DOI DOI 10.1016/J.JHAZMAT.2019.121846; Zhang K, 2016, ENVIRON POLLUT, V219, P450, DOI 10.1016/j.envpol.2016.05.048; Zhang Y, 2020, EARTH SCI REV; Zhang YL, 2019, ENVIRON POLLUT, V254, DOI 10.1016/j.envpol.2019.07.121; Zhao SY, 2017, ANAL METHODS-UK, V9, P1470, DOI 10.1039/c6ay02302a	63	82	83	12	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232746	10.1371/journal.pone.0232746	http://dx.doi.org/10.1371/journal.pone.0232746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396561	Green Accepted, Green Published, gold			2022-12-26	WOS:000537475000019
J	Harjo, M; Jarvekulg, M; Tamm, T; Otero, TF; Kiefer, R				Harjo, Madis; Jarvekulg, Martin; Tamm, Tarmo; Otero, Toribio F.; Kiefer, Rudolf			Concept of an artificial muscle design on polypyrrole nanofiber scaffolds	PLOS ONE			English	Article							CONDUCTING POLYMERS; ELASTIC-MODULUS; ACTUATORS; ENERGY; SOLVENT; ELECTROCHEMISTRY; ELECTROLYTE; DEPENDENCE; STRAIN; DRIVEN	Here we present the synthesis and characterization of two new conducting materials having a high electro-chemo-mechanical activity for possible applications as artificial muscles or soft smart actuators in biomimetic structures. Glucose-gelatin nanofiber scaffolds (CFS) were coated with polypyrrole (PPy) first by chemical polymerization followed by electrochemical polymerization doped with dodecylbenzensulfonate (DBS-) forming CFS-PPy/DBS films, or with trifluoromethanesulfonate (CF3SO3-, TF) giving CFS-PPy/TF films. The composition, electronic and ionic conductivity of the materials were determined using different techniques. The electro-chemo-mechanical characterization of the films was carried out by cyclic voltammetry and square wave potential steps in bis(trifluoromethane)sulfonimide lithium solutions of propylene carbonate (LiTFSI-PC). Linear actuation of the CFS-PPy/DBS material exhibited 20% of strain variation with a stress of 0.14 MPa, rather similar to skeletal muscles. After 1000 cycles, the creeping effect was as low as 0,2% having a good long-term stability showing a strain variation per cycle of -1.8% (after 1000 cycles). Those material properties are excellent for future technological applications as artificial muscles, batteries, smart membranes, and so on.	[Harjo, Madis; Tamm, Tarmo] Univ Tartu, Fac Sci & Technol, Intelligent Mat & Syst Lab, Tartu, Estonia; [Jarvekulg, Martin] Univ Tartu, Fac Sci & Technol, Inst Phys, Tartu, Estonia; [Otero, Toribio F.] Univ Politecn Cartagena, Ctr Electrochem & Intelligent Mat CEMI, Murcia, Spain; [Kiefer, Rudolf] Ton Duc Thang Univ, Conducting Polymers Composites & Applicat Res Grp, Fac Appl Sci, Ho Chi Minh City, Vietnam	University of Tartu; University of Tartu; University of Tartu Institute of Physics; Ton Duc Thang University	Kiefer, R (corresponding author), Ton Duc Thang Univ, Conducting Polymers Composites & Applicat Res Grp, Fac Appl Sci, Ho Chi Minh City, Vietnam.	rudolf.kiefer@tdtu.edu.vn	OTERO, TORIBIO/C-8348-2009; Kiefer, Rudolf/E-9834-2014; Tamm, Tarmo/J-2847-2013; Jarvekulg, Martin/B-4638-2017	OTERO, TORIBIO/0000-0002-8517-1428; Kiefer, Rudolf/0000-0001-7692-6705; Tamm, Tarmo/0000-0003-0466-2514; Jarvekulg, Martin/0000-0002-9181-3124	Estonian Research Council [PRG772]	Estonian Research Council(Estonian Research Council)	The work was supported by Estonian Research Council Grant PRG772 The fund refer to Martin Jarvekulg The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir N, 2015, SENSOR ACTUAT B-CHEM, V216, P24, DOI 10.1016/j.snb.2015.03.098; Aziz S, 2020, MATER HORIZ, V7, P667, DOI 10.1039/c9mh01441a; Baughman RH, 1996, SYNTHETIC MET, V78, P339, DOI 10.1016/0379-6779(96)80158-5; Bay L, 2001, J PHYS CHEM B, V105, P8492, DOI 10.1021/jp003872w; Bonastre J, 2014, SYNTHETIC MET, V187, P37, DOI 10.1016/j.synthmet.2013.10.020; Chen XW, 1996, J PHYS CHEM-US, V100, P15202, DOI 10.1021/jp9601779; Fahlgren A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134023; Fannir A, 2019, ADV MATER TECHNOL-US, V4, DOI 10.1002/admt.201800519; Otero TF, 2017, INT J SMART NANO MAT, V8, P125, DOI 10.1080/19475411.2018.1434256; Gomez-Romero P, 2005, J MATER SCI, V40, P1423, DOI 10.1007/s10853-005-0578-y; Hara S, 2005, CHEM LETT, V34, P784, DOI 10.1246/cl.2005.784; Hara S, 2004, J MATER CHEM, V14, P1516, DOI 10.1039/b404232h; Harjo M, 2019, POLYMERS-BASEL, V1043, P1; Harjo M, 2019, POLYMERS, V1054, P1; Harjo M, 2020, J APPL POLYM SCI, V137, DOI 10.1002/app.48533; Harjo M, 2017, SYNTHETIC MET, V232, P25, DOI 10.1016/j.synthmet.2017.07.014; Heinze J, 2010, CHEM REV, V110, P4724, DOI 10.1021/cr900226k; Hsu CF, 2008, SYNTHETIC MET, V158, P946, DOI 10.1016/j.synthmet.2008.06.017; JAAKSON P, 2016, SPIE, V9798, DOI DOI 10.1117/12.2219053; Khadka R, 2017, SYNTHETIC MET, V232, P1, DOI 10.1016/j.synthmet.2017.07.011; Kiefer R, 2007, ELECTROCHIM ACTA, V52, P2386, DOI 10.1016/j.electacta.2006.08.058; Kiefer R, 2016, SENSOR ACTUAT B-CHEM, V233, P328, DOI 10.1016/j.snb.2016.04.090; Kiefer R, 2013, SYNTHETIC MET, V171, P69, DOI 10.1016/j.synthmet.2013.03.017; Kivilo A, 2016, RSC ADV, V6, P96484, DOI 10.1039/c6ra20766a; Lim HK, 2005, J APPL POLYM SCI, V97, P1170, DOI 10.1002/app.21824; Lundin V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018624; Madden JD, 1999, SYNTHETIC MET, V105, P61, DOI 10.1016/S0379-6779(99)00034-X; Madden JD, 2002, MATER RES SOC SYMP P, V698, P137; Madden JD, 2007, SENSOR ACTUAT A-PHYS, V133, P210, DOI 10.1016/j.sna.2006.03.016; Marcilla R, 2006, SYNTHETIC MET, V156, P1133, DOI 10.1016/j.synthmet.2006.08.001; Martinez JG, 2018, SMART MATER STRUCT, V27, DOI 10.1088/1361-665X/aabab5; Maziz A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600327; Maziz A, 2015, PROC SPIE, V9430, DOI 10.1117/12.2081821; Melling D, 2019, ADV MATER, V31, DOI 10.1002/adma.201808210; Naficy S, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/7/075005; Omastova M, 2003, SYNTHETIC MET, V138, P447, DOI 10.1016/S0379-6779(02)00498-8; Otero TF, 2003, ADV MATER, V15, P279, DOI 10.1002/adma.200390066; Otero TF, 2003, SENSOR ACTUAT B-CHEM, V96, P152, DOI 10.1016/S0925-4005(03)00518-5; Otero TF, 2003, J PHYS CHEM B, V107, P6730, DOI 10.1021/jp027748j; Otero TF., 2016, CONDUCTING POLYM BIO, DOI [10.1039/9781782623748-FP001, DOI 10.1039/9781782623748-FP001]; Otero TF, 2018, CHEMELECTROCHEM, V5, P3335, DOI 10.1002/celc.201800905; Otero TF, 2015, PROG POLYM SCI, V44, P62, DOI 10.1016/j.progpolymsci.2014.09.002; Otero TF, 2013, POLYM REV, V53, P311, DOI 10.1080/15583724.2013.805772; Otero TF, 2013, J MATER CHEM B, V1, P26, DOI 10.1039/c2tb00176d; Otero TF, 2012, CHEM MATER, V24, P4093, DOI 10.1021/cm302847r; Otero TF, 2011, J SOLID STATE ELECTR, V15, P1169, DOI 10.1007/s10008-010-1170-1; Ouyang J, 1997, POLYMER, V38, P1971, DOI 10.1016/S0032-3861(96)00749-5; Plesse C, 2009, ADV SCI TECH, V61, P53; Pytel RZ, 2008, POLYMER, V49, P2008, DOI 10.1016/j.polymer.2008.01.053; Qi BH, 2004, J PHYS CHEM B, V108, P6222, DOI 10.1021/jp031092s; Shoa T, 2011, IEEE-ASME T MECH, V16, P42, DOI 10.1109/TMECH.2010.2090166; Shoa T, 2010, SYNTHETIC MET, V160, P1280, DOI 10.1016/j.synthmet.2010.04.001; Smela E, 2001, J PHYS CHEM B, V105, P9395, DOI 10.1021/jp004126u; Thi-Hiep Nguyen, 2010, Journal of Biomedical Science & Engineering, V3, P1117, DOI 10.4236/jbise.2010.312145; Valero L, 2015, J SOLID STATE ELECTR, V19, P2683, DOI 10.1007/s10008-015-2775-1; Vidanapathirana KP, 2002, SOLID STATE IONICS, V154, P331, DOI 10.1016/S0167-2738(02)00530-1; Wolf MT, 2015, ADV DRUG DELIVER REV, V84, P208, DOI 10.1016/j.addr.2014.08.011; Zondaka Z, 2016, RSC ADV, V6, P26380, DOI 10.1039/c6ra01511e	58	10	10	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232851	10.1371/journal.pone.0232851	http://dx.doi.org/10.1371/journal.pone.0232851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392238	Green Published, gold			2022-12-26	WOS:000537470300028
J	Rahman, AE; Herrera, S; Rubayet, S; Banik, G; Hasan, R; Ahsan, Z; Siraj, W; Ahmed, A; Siddique, AB; Sadeq-ur Rahman, Q; Vaz, LME; Islam, MJ; Hossain, MA; Shahidullah, M; Osmani, MM; Arifeen, SEL; Wall, SN				Rahman, Ahmed Ehsanur; Herrera, Samantha; Rubayet, Sayed; Banik, Goutom; Hasan, Rezaul; Ahsan, Ziaul; Siraj, Wahida; Ahmed, Anisuddin; Siddique, Abu Bakkar; Sadeq-ur Rahman, Qazi; Vaz, Lara M. E.; Islam, M. Jahurul; Hossain, M. Altaf; Shahidullah, M.; Osmani, M. Mohiuddin; Arifeen, Shams E. L.; Wall, Stephen N.			Managing possible serious bacterial infection of young infants where referral is not possible: Lessons from the early implementation experience in Kushtia District learning laboratory, Bangladesh	PLOS ONE			English	Article							BENZYLPENICILLIN PLUS GENTAMICIN; SIMPLIFIED ANTIBIOTIC REGIMENS; OPEN-LABEL; SOUTH-ASIA; CARE; FACILITIES; COUNTRIES; MORTALITY; QUALITY	Background Serious infections account for 25% of global newborn deaths annually, most in low-resource settings where hospital-based treatment is not accessible or feasible. In Bangladesh, one-third of neonatal deaths are attributable to serious infection; in 2014, the government adopted new policy for outpatient management of danger signs indicating possible serious bacterial infections (PSBI) when referral was not possible. We conducted implementation research to understand what it takes for a district health team to implement quality outpatient PSBI management per national guidelines. Methods PSBI management was introduced as part of the Comprehensive Newborn Care Package in 2015. The study piloted this package through government health systems with limited partner support to inform scale-up efforts. Data collection included facility register reviews for cases seen at primary level facilities; facility readiness and provider knowledge and skills assessments; household surveys capturing caregiver knowledge of newborn danger signs and care-seeking for newborn illness; and follow-up case tracking, capturing treatment adherence and outcomes. Analysis consisted of descriptive statistics. Results Over the 15-month implementation period, 1432 young infants received care, of which 649 (45%) were classified as PSBI. Estimated coverage of care-seeking increased from 22% to 42% during the implementation period. Although facility readiness and providers' skills increased, providers' adherence to guidelines was not optimal. Among locally managed PSBI cases, 75% completed the oral antibiotic course and 15% received the fourth day follow-up. Care-seeking remained high among private providers (95%), predominantly village health doctors (over 80%). Conclusions Facility readiness, including health care provider knowledge and skills were strengthened; future efforts should focus on improving provider adherence to guidelines. Social and behavior change strategies targeting families and communities should explore shifting care-seeking from private, possibly less-qualified providers. Strategies to improve private sector management of PSBI cases and improved linkages between private and public sector providers could be explored.	[Rahman, Ahmed Ehsanur; Banik, Goutom; Hasan, Rezaul; Siraj, Wahida; Ahmed, Anisuddin; Siddique, Abu Bakkar; Sadeq-ur Rahman, Qazi; Arifeen, Shams E. L.] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Dhaka, Bangladesh; [Herrera, Samantha; Wall, Stephen N.] Saving Newborn Lives, Save Children, Washington, DC USA; [Rubayet, Sayed; Ahsan, Ziaul] Ipas, Dhaka, Bangladesh; [Siraj, Wahida] Save Children Int, Dhaka, Bangladesh; [Vaz, Lara M. E.] Populat Reference Bur, Washington, DC USA; [Islam, M. Jahurul] MoHFW, DGHS, Natl Newborn Hlth Program & Integrated Management, Dhaka, Bangladesh; [Hossain, M. Altaf; Osmani, M. Mohiuddin] Minist Hlth & Family Welf MoHFW, Dhaka, Bangladesh; [Shahidullah, M.] Bangabandhu Sheikh Mujib Med Univ BSMMU, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Save the Children; Save the Children; Bangabandhu Sheikh Mujib Medical University (BSMMU)	Herrera, S (corresponding author), Saving Newborn Lives, Save Children, Washington, DC USA.	sherrera@savechildren.org	Rahman, Ahmed Ehsanur/ABC-5318-2021	Hasan, Rezaul/0000-0002-3844-8113; Siddique, Md. Abu Bakkar/0000-0002-1484-0823	Bill AMP; Melinda Gates Foundation	Bill AMP; Melinda Gates Foundation(CGIAR)	This work was supported through a grant made by the Bill & Melinda Gates Foundation to Save the Children US for the Saving Newborn Lives project. Foundation staff had no role in design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, J TROP PEDIATRICS, V47, P98, DOI 10.1093/tropej/47.2.98; Anwar I, 2009, J HEALTH POPUL NUTR, V27, P139, DOI 10.3329/jhpn.v27i2.3327; Applegate JA, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001643; Arifeen SE, 2005, B WORLD HEALTH ORGAN, V83, P260; Bahl R, 2018, MANAGEMENT POSSIBLE; Baqui AH, 2015, LANCET GLOB HEALTH, V3, pE279, DOI 10.1016/S2214-109X(14)70347-X; Chowdhury Sameena, 2009, Bangladesh Med Res Counc Bull, V35, P53; Chowdhury SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204902; Civil Registration and Vital Statistics (CRVS) Secretariat: Cabinet Division, 2015, BANGL SAMPL REG VIT; Darmstadt GL, 2006, J HEALTH POPUL NUTR, V24, P380; Fleischmann C., 2015, CRIT CARE, V19, pP21, DOI [10.1186/cc14101, DOI 10.1186/CC14101]; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Hoque DME, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-197; Islam A, 2013, BANGLADESH HLTH NEWB; Kissoon N, 2015, J INFECTION, V71, pS21, DOI 10.1016/j.jinf.2015.04.016; Kissoon N, 2011, PEDIATR CRIT CARE ME, V12, P494, DOI 10.1097/PCC.0b013e318207096c; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Mahmood SS, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-18; Ministry of Health and Family Welfare of Government of Bangladesh, 2015, MAN INF 0 59 DAYS IN; Mir F, 2017, LANCET GLOB HEALTH, V5, pE177, DOI [10.1016/s2214-109x(16)30335-7, 10.1016/S2214-109X(16)30335-7]; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ICF International and ICBBRB, 2012, BANGL MAT MORT HLTH; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; Rahman MH, 2015, INT HEALTH, V7, P266, DOI 10.1093/inthealth/ihu077; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Saha SK, 2018, LANCET, V392, P145, DOI 10.1016/S0140-6736(18)31127-9; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Shah R, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-417; Thaver D, 2009, PEDIATR INFECT DIS J, V28, pS3, DOI 10.1097/INF.0b013e3181958755; Tshefu A, 2015, LANCET, V385, P1767, DOI 10.1016/S0140-6736(14)62284-4; Tshefu A, 2015, LANCET, V385, P1758, DOI 10.1016/S0140-6736(14)62285-6; UNICEF, 2015, COMMITTING CHILD SUR; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; World Bank, 2003, 27005BD WORLD BANK; World Health Organization, 2015, GUID MAN POSS SER BA; World Health Organization, 2011, POCK BOOK HOSP CAR C; Zaidi AKM, 2012, PEDIATR INFECT DIS J, V31, P667, DOI 10.1097/INF.0b013e318256f86c	39	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232675	10.1371/journal.pone.0232675	http://dx.doi.org/10.1371/journal.pone.0232675			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392209	Green Published, gold			2022-12-26	WOS:000537470300017
J	Shi, W; Jiang, HC; Mao, X; Xu, HY				Shi, Wei; Jiang, Hanchao; Mao, Xue; Xu, Hongyan			Pollen record of climate change during the last deglaciation from the eastern Tibetan Plateau	PLOS ONE			English	Article							LACUSTRINE SEDIMENTS; SOUTHWESTERN CHINA; LATE PLEISTOCENE; MONSOON CLIMATE; LAKE; HOLOCENE; LOESS; RECONSTRUCTION; PROVENANCE; VEGETATION	The eastern Tibetan Plateau (TP) is a climatically sensitive area affected by the Indian Summer Monsoon (ISM). A new pollen record from a lacustrine sediment in Mao County shows that the study area was covered mainly by shrubs and herbs during the last deglaciation, indicating open and sparse forest grasslands. Hydrophilous herbs were mainly dominated by Cyperaceae, Poaceae, Myriophyllum, Polygonum and Typha, and they gradually increased from 18.7 to 16.8 ka, suggesting a transition to a more humid climate. This corresponds to climate cooling over the same period. From 16.8 to 14.6 ka, hydrophilous herbs continued to increase, coincident with a general ameliorating trend indicated by delta O-18 records from East Asia. Between 14.6 and 14.0 ka, the mean content of hydrophilous herbs reached peak in the sequence, corresponding to relatively high delta O-18 values during this period. From similar to 14.0 to 12.9 ka, the abundance of hydrophilous herbs decreased significantly. Over the same period, the Greenland ice core shows a decrease in delta O-18 and low-latitude cave stalagmites in China record an increase in delta O-18. This implies that longitudinal temperature gradients increased and drove the southward retreat of the ISM, which in turn drove a continuous decrease in the abundance of hydrophilous herbs in the study area. From 12.9 to 11.6 ka, the mean content of hydrophilous herbs decreased to the lowest (8.3%) in the whole sequence, indicating a cold and dry climate in the study area. A positive shift in delta O-18 records during 11.6-10.6 ka was matched by a significant increase in the abundance of hydrophilous herbs in the study area, indicating a warm and humid climate trending. Hence, the ISM has had a significant impact on the climate of the eastern TP since the onset of deglaciation around similar to 16.8 ka.	[Shi, Wei; Jiang, Hanchao; Mao, Xue; Xu, Hongyan] China Earthquake Adm, State Key Lab Earthquake Dynam, Inst Geol, Beijing, Peoples R China; [Shi, Wei] Univ Chinese Acad Sci, Coll Earth Sci, Beijing, Peoples R China	China Earthquake Administration; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, HC (corresponding author), China Earthquake Adm, State Key Lab Earthquake Dynam, Inst Geol, Beijing, Peoples R China.	hcjiang@ies.ac.cn	Jiang, Hanchao/ABG-2653-2020	Jiang, Hanchao/0000-0003-3391-4477	National Key Research and Development Program of China [2017YFC1501000]; National Natural Science Foundation of China [41572346]; National Nonprofit Fundamental Research Grant of China, Institute of Geology, China Earthquake Administration [IGCEA1713, IGCEA1906]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nonprofit Fundamental Research Grant of China, Institute of Geology, China Earthquake Administration	This work was funded by the National Key Research and Development Program of China (2017YFC1501000), the National Natural Science Foundation of China (41572346) and the National Nonprofit Fundamental Research Grant of China, Institute of Geology, China Earthquake Administration (Grant No. IGCEA1713, IGCEA1906).	Bird BW, 2014, EARTH PLANET SC LETT, V399, P92, DOI 10.1016/j.epsl.2014.05.017; Chen FH, 2019, NATURE, V569, P409, DOI 10.1038/s41586-019-1139-x; Chen FH, 1997, PALAEOGEOGR PALAEOCL, V130, P323, DOI 10.1016/S0031-0182(96)00149-6; Cheng Y, 2014, THESIS, P1; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; DANSGAARD W, 1993, ENDEAVOUR, V17, P12, DOI 10.1016/0160-9327(93)90005-N; GUIOT J, 1989, NATURE, V338, P309, DOI 10.1038/338309a0; Han WX, 2010, QUATERN INT, V218, P94, DOI 10.1016/j.quaint.2010.01.002; Hodell DA, 1999, QUATERNARY RES, V52, P369, DOI 10.1006/qres.1999.2072; JARVIS DI, 1992, REV PALAEOBOT PALYNO, V75, P239, DOI 10.1016/0034-6667(92)90018-C; Ji JF, 2005, EARTH PLANET SC LETT, V233, P61, DOI 10.1016/j.epsl.2005.02.025; Jiang HC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16027-8; Jiang HC, 2014, GEOMORPHOLOGY, V204, P518, DOI 10.1016/j.geomorph.2013.08.032; Jiang HC, 2013, J QUATERNARY SCI, V28, P720, DOI 10.1002/jqs.2661; Jiang HC, 2011, QUATERNARY SCI REV, V30, P769, DOI 10.1016/j.quascirev.2010.12.024; Li JF, 2020, EARTH-SCI REV, V202, DOI 10.1016/j.earscirev.2020.103114; [李艳豪 Li Yanhao], 2015, [地震地质, Seismology and Geology], V37, P1147; Liang LJ, 2017, QUATERN INT, V430, P41, DOI 10.1016/j.quaint.2015.07.037; LIU KB, 1992, QUATERNARY RES, V38, P32, DOI 10.1016/0033-5894(92)90028-H; Mitchell GF, 1958, NEW PHYTOL, V57, P256; Nishimura M, 2014, PALAEOGEOGR PALAEOCL, V396, P75, DOI 10.1016/j.palaeo.2013.12.015; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Schlutz F, 2009, QUATERNARY SCI REV, V28, P1449, DOI 10.1016/j.quascirev.2009.01.009; SUN HL, 1996, FORMATION EVOLUTION, P101; Sun XJ, 2003, MAR GEOL, V201, P97, DOI 10.1016/S0025-3227(03)00211-1; Umer M, 2007, QUATERNARY SCI REV, V26, P2229, DOI 10.1016/j.quascirev.2007.05.004; Wang H, 2010, PALAEOGEOGR PALAEOCL, V286, P171, DOI 10.1016/j.palaeo.2009.12.015; Wang Xiao-qun, 2013, Earth Science - Journal of China University of Geosciences, V38, P975, DOI 10.3799/dqkx.2013.095; Wang Y, 2014, CLIM PAST, V10, P21, DOI 10.5194/cp-10-21-2014; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Xu H, 2014, QUATERNARY SCI REV, V89, P85, DOI 10.1016/j.quascirev.2014.02.011; Xu HY, 2013, QUATERN INT, V286, P45, DOI 10.1016/j.quaint.2012.04.014; Zhang HB, 2018, SCIENCE, V362, P580, DOI 10.1126/science.aat9393; Zhang YQ, 2009, ACTA GEOL SIN-ENGL, V83, P694, DOI 10.1111/j.1755-6724.2009.00093.x; Zhou R., 2015, ACTA GEOL SINENGL, V81, P593	35	5	7	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232803	10.1371/journal.pone.0232803	http://dx.doi.org/10.1371/journal.pone.0232803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374789	gold, Green Published			2022-12-26	WOS:000537283500061
J	Wu, JB; Yuan, J; Price, NE; Wang, YS				Wu, Jiabin; Yuan, Jun; Price, Nathan E.; Wang, Yinsheng			Ada protein? and sequence context?dependent mutagenesis of alkyl phosphotriester lesions inEscherichia colicells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA alkylation; DNA replication; DNA repair; translesion synthesis; mutagenesis; replication bypass; Ada; sequence context; alkyl phosphotriester; diastereomer; mutagenesis mechanism; DNA polymerase; DNA damage	ESCHERICHIA-COLI; DNA-REPAIR; ETHYL-PHOSPHOTRIESTER; BYPASS; ALKYLPHOSPHOTRIESTERS; POLYMERASE; SITE	Alkyl phosphotriester (alkyl-PTE) lesions are frequently induced in DNA and are resistant to repair. Here, we synthesized and characterized methyl (Me)- andn-butyl (nBu)-PTEs in two diastereomeric configurations (S(p)andR(p)) at six different flanking dinucleotide sites,i.e. XT and TX(X= A, C, or G), and assessed how these lesions impact DNA replication inEscherichia colicells. When single-stranded vectors contained anS(p)-Me-PTE in the sequence contexts of 5?-AT-3?, 5?-CT-3?, or 5?-GT-3?, DNA replication was highly efficient and the replication products for all three sequence contexts contained 85?90% AT and 5?10% TG. Thus, the replication outcome was largely independent of the identity of the 5? nucleotide adjacent to anS(p)-Me-PTE. Furthermore, replication across these lesions was not dependent on the activities of DNA polymerases II, IV, or V; Ada, a protein involved in adaptive response and repair ofS(p)-Me-PTE inE. coli, however, was essential for the generation of the mutagenic products. Additionally, theR(p)diastereomer of Me-PTEs atXT sites and both diastereomers of Me-PTEs at TXsites exhibited error-free replication bypass. Moreover,S-p-nBu-PTEs atXT sites did not strongly impede DNA replication, and othernBu-PTEs displayed moderate blockage effects, with none of them being mutagenic. Taken together, these findings provide in-depth understanding of how alkyl-PTE lesions are recognized by the DNA replication machinery in prokaryotic cells and reveal that Ada contributes to mutagenesis ofS(p)-Me-PTEs inE. coli.	[Wu, Jiabin; Yuan, Jun; Wang, Yinsheng] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Price, Nathan E.; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA.; Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wu, Jiabin/AID-4204-2022; Wang, Yin/HCI-9352-2022	Wu, Jiabin/0000-0002-7380-7038; 	National Institutes of Health [R01 CA236204]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01 CA236204 (to Y. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; DEMPLE B, 1985, P NATL ACAD SCI USA, V82, P2688, DOI 10.1073/pnas.82.9.2688; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Guichard Y, 2000, CANCER RES, V60, P1276; Harper M, 2012, MUTAT RES-FUND MOL M, V731, P64, DOI 10.1016/j.mrfmmm.2011.10.011; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; Hong HZ, 2007, NUCLEIC ACIDS RES, V35, P7118, DOI 10.1093/nar/gkm851; Jones GDD, 2010, MUTAGENESIS, V25, P3, DOI 10.1093/mutage/gep038; Le Pla RC, 2004, CHEM RES TOXICOL, V17, P1491, DOI 10.1021/tx049798g; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Ma B, 2018, CHEM RES TOXICOL, V31, P48, DOI 10.1021/acs.chemrestox.7b00281; MCCARTHY TV, 1985, NUCLEIC ACIDS RES, V13, P2683, DOI 10.1093/nar/13.8.2683; MYERS LC, 1993, SCIENCE, V261, P1164, DOI 10.1126/science.8395079; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; NAKAMURA T, 1988, J MOL BIOL, V202, P483, DOI 10.1016/0022-2836(88)90280-X; Neeley WL, 2007, J BIOL CHEM, V282, P12741, DOI 10.1074/jbc.M700575200; Rye PT, 2008, DNA REPAIR, V7, P170, DOI 10.1016/j.dnarep.2007.09.003; SAMSON L, 1977, NATURE, V267, P281, DOI 10.1038/267281a0; SEDGWICK B, 1988, J BIOL CHEM, V263, P4430; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; Thomason L. C., 2007, CURRENT PROTOCOLS MO, V79, P1, DOI [DOI 10.1002/0471142727.mb0117s79, 10.1002/0471142727.mb0117s79, DOI 10.1002/0471142727.MB0117S79]; Tsujikawa L, 2003, NUCLEIC ACIDS RES, V31, P4965, DOI 10.1093/nar/gkg722; Wang PC, 2019, J BIOL CHEM, V294, P3899, DOI 10.1074/jbc.RA118.007358; Wang PC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv941; Wu JB, 2018, NUCLEIC ACIDS RES, V46, P4013, DOI 10.1093/nar/gky140; Zhai QQ, 2014, NUCLEIC ACIDS RES, V42, P10529, DOI 10.1093/nar/gku748	26	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8775	8783		10.1074/jbc.RA120.013657	http://dx.doi.org/10.1074/jbc.RA120.013657			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32381504	Green Published, hybrid			2022-12-26	WOS:000546296800013
J	Shashar, S; Kloog, I; Erez, O; Shtein, A; Yitshak-Sade, M; Sarov, B; Novack, L				Shashar, Sagi; Kloog, Itai; Erez, Offer; Shtein, Alexandra; Yitshak-Sade, Maayan; Sarov, Batia; Novack, Lena			Temperature and preeclampsia: Epidemiological evidence that perturbation in maternal heat homeostasis affects pregnancy outcome	PLOS ONE			English	Article							ANTI-ANGIOGENIC FACTORS; ADVERSE BIRTH OUTCOMES; AMBIENT-TEMPERATURE; SEASONAL-VARIATION; AIR-POLLUTION; MORTALITY; HEALTH; ASSOCIATION; RISK; EXPOSURE	Introduction This study aims to determine the association between temperature and preeclampsia and whether it is affected by seasonality and rural/urban lifestyle. Methods This cohort study included women who delivered at our medical center from 2004 to 2013 (31,101 women, 64,566 deliveries). Temperature values were obtained from a spatiotemporally resolved estimation model performing predictions at a 1x1km spatial resolution. In "Warm" pregnancies > 50% of gestation occurred during the spring-summer period. In cold pregnancies > 50% of gestation occurred during the fall and winter. Generalized estimating equation multivariable models were used to estimate the association between temperature and incidence of preeclampsia. Results 1) The incidence of preeclampsia in at least one pregnancy was 7% (2173/64,566); 2) during "warm" pregnancies, an elevation of one IQR of the average temperature in the 1st or the 3rd trimesters was associated with an increased risk to develop preeclampsia [patients with Jewish ethnicity: 1st trimester: relative risk (RR) of 2.38(95%CI 1.50; 3.80), 3rd trimester 1.94(95%CI 1.34;2.81); Bedouins: 1st trimester: RR = 2.91(95%CI 1.98;4.28), 3rd trimester: RR = 2.37(95%CI 1.75;3.20)]; 3) In "cold" pregnancies, an elevation of one IQR of average temperature was associated with a lower risk to develop preeclampsia among patients with Bedouin-Arab ethnicity RR = 0.68 (95% CI 0.49-0.94) for 1st trimester and RR = 0.62 (95% CI 0.44-0.87) for 3rd trimester. Conclusions 1) Elevated averaged temperature during the 1st or 3rd trimesters in "warm" pregnancies confer an increased risk for the development of preeclampsia, especially in nomadic patients; 2) Of interest, during cold pregnancies, elevated averaged temperature was associated with a lower risk to develop preeclampsia for nomadic patients. 3) These findings suggest temperature might be associated with perturbations in maternal heat homeostasis resulting in reallocation of energy resources and their availability to the fetus that may increase the risk for preeclampsia. This observation is especially relevant in the context of global warming and its effects on maternal/fetal reproductive health.	[Shashar, Sagi; Novack, Lena] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Clin Res Ctr, Beer Sheva, Israel; [Kloog, Itai; Shtein, Alexandra] Ben Gurion Univ Negev, Fac Humanities & Social Sci, Dept Geog & Environm Dev, Beer Sheva, Israel; [Erez, Offer] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Matern Dept D, Div Obstet & Gynecol, Beer Sheva, Israel; [Yitshak-Sade, Maayan] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, Boston, MA USA; [Sarov, Batia] Ben Gurion Univ Negev, Fac Heath Sci, Dept Publ Hlth, Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Ben Gurion University	Shashar, S (corresponding author), Ben Gurion Univ Negev, Soroka Univ Med Ctr, Clin Res Ctr, Beer Sheva, Israel.	sagishas@post.bgu.ac.il		Yitshak-Sade, Maayan/0000-0003-4453-0401	EHF (Environment and Health Fund) [RPGA 1401]	EHF (Environment and Health Fund)	The study was funded by EHF (Environment and Health Fund), Project Number: RPGA 1401. IK and OE received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.ehf.org.il/en".	Abraham E, 2018, ENVIRON INT, V118, P334, DOI 10.1016/j.envint.2018.05.007; Algert CS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.020; Alpert P, 2004, INT J CLIMATOL, V24, P1013, DOI 10.1002/joc.1037; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Auger N, 2017, PAEDIATR PERINAT EP, V31, P267, DOI 10.1111/ppe.12362; Barton JR, 2019, AM J OBSTET GYNECOL; Basu R, 2017, PAEDIATR PERINAT EP, V31, P272, DOI 10.1111/ppe.12365; Beltran AJ, 2014, INT J ENV RES PUB HE, V11, P91, DOI 10.3390/ijerph110100091; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Brosens I, 2019, AM J OBSTET GYNECOL, P30320; Cai H, 2020, J OBSTET GYNAECOL, V40, P137, DOI 10.1080/01443615.2019.1588238; Chaiworapongsa T, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.10.001; Cleveland WS, 2012, ROB LOC WEIGHT REGR; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Erez O, 2008, J MATERN-FETAL NEO M, V21, P279, DOI 10.1080/14767050802034545; Espinoza J, 2006, J MATERN-FETAL NEO M, V19, P607, DOI 10.1080/14767050600922677; Harris LK, 2019, AM J OBSTET GYNECOL; Higazi AAR, 1996, PLACENTA, V17, P683, DOI 10.1016/S0143-4004(96)80019-1; Ibrahimou B, 2014, J OCCUP ENVIRON MED, V56, P1228, DOI 10.1097/JOM.0000000000000317; Israel CBS, 2008, CHAR CLASS GEOGR UN; Kim H, 2015, SCI TOTAL ENVIRON, V512, P74, DOI 10.1016/j.scitotenv.2015.01.012; Kloog I, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0420-z; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Lavigne E, 2016, ENVIRON RES, V148, P457, DOI 10.1016/j.envres.2016.04.026; Li R, 2017, AM J OBSTET GYNECOL, V217, P235, DOI 10.1016/j.ajog.2017.06.011; Li XL, 2016, PREGNANCY HYPERTENS, V6, P47, DOI 10.1016/j.preghy.2015.12.003; Mayo RP, 2016, PLACENTA, V43, P54, DOI 10.1016/j.placenta.2016.05.001; Nobles CJ, 2019, HYPERTENSION, V74, P384, DOI 10.1161/HYPERTENSIONAHA.119.12731; O'Neill MS, 2007, EPIDEMIOLOGY, V18, P664, DOI 10.1097/EDE.0b013e3181570ab9; O'Neill MS, 2005, J URBAN HEALTH, V82, P191, DOI 10.1093/jurban/jti043; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Phillips JK, 2004, OBSTET GYNECOL, V104, P1015, DOI 10.1097/01.AOG.0000143306.88438.cf; Poursafa P, 2015, J RES MED SCI, V20, P397; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Romero R, 2017, AM J OBSTET GYNECOL, V217, P282, DOI 10.1016/j.ajog.2017.06.003; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1384, DOI 10.3109/14767051003681121; Rosenfeld A, 2017, ENVIRON RES, V159, P297, DOI 10.1016/j.envres.2017.08.017; Rudra CB, 2005, J MATERN-FETAL NEO M, V18, P319, DOI 10.1080/14767050500275838; Rylander C, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.19538; Sarov Batia, 2010, PERINATAL MORTALITY; Shi LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30161; Stevens W, 2017, AM J OBSTET GYNECOL, V217, P237, DOI 10.1016/j.ajog.2017.04.032; Tam WH, 2008, GYNECOL OBSTET INVES, V66, P22, DOI 10.1159/000114252; Than NG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01661; Toft JH, 2009, WHOLE GENOME MICROAR; Vicedo-Cabrera AM, 2018, CLIMATIC CHANGE, V150, P391, DOI 10.1007/s10584-018-2274-3; Wang Q, 2018, ENVIRON POLLUT, V237, P18, DOI 10.1016/j.envpol.2018.02.010; Wu Jun, 2016, Res Rep Health Eff Inst, V2016, P1; Yitshak-Sade M, 2016, CHEMOSPHERE, V160, P314, DOI 10.1016/j.chemosphere.2016.06.104; Zanobetti A, 2018, CURR EPIDEMIOL REP, V5, P125, DOI 10.1007/s40471-018-0150-3; Zhao MP, 2019, ENVIRON HEALTH-GLOB, V18, DOI 10.1186/s12940-019-0538-7	51	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0232877	10.1371/journal.pone.0232877	http://dx.doi.org/10.1371/journal.pone.0232877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421729	gold, Green Published			2022-12-26	WOS:000537499600020
J	Gittenberger-de Groot, AC; Peterson, JC; Wisse, LJ; Roest, AAW; Poelmann, RE; Bokenkamp, R; Elzenga, NJ; Hazekamp, M; Bartelings, MM; Jongbloed, MRM; DeRuiter, MC				Gittenberger-de Groot, Adriana C.; Peterson, Joshua C.; Wisse, Lambertus J.; Roest, Arno A. W.; Poelmann, Robert E.; Bokenkamp, Regina; Elzenga, Nynke J.; Hazekamp, Mark; Bartelings, Margot M.; Jongbloed, Monique R. M.; DeRuiter, Marco C.			Pulmonary ductal coarctation and left pulmonary artery interruption; pathology and role of neural crest and second heart field during development	PLOS ONE			English	Article							AORTIC-ARCH ANOMALIES; OUTFLOW TRACT; CARDIAC ANOMALIES; MOUSE EMBRYOS; SYSTEM; ARTERIOSUS; TETRALOGY; MORPHOGENESIS; ROTATION; FALLOT	Objectives In congenital heart malformations with pulmonary stenosis to atresia an abnormal lateral ductus arteriosus to left pulmonary artery connection can lead to a localised narrowing (pulmonary ductal coarctation) or even interruption We investigated embryonic remodelling and pathogenesis of this area. Material and methods Normal development was studied in WntCre reporter mice (E10.0-12.5) for neural crest cells and Nkx2.5 immunostaining for second heart field cells. Data were compared to stage matched human embryos and a VEGF120/120 mutant mouse strain developing pulmonary atresia. Results Normal mouse and human embryos showed that the mid-pharyngeal endothelial plexus, connected side-ways to the 6th pharyngeal arch artery. The ventral segment formed the proximal pulmonary artery. The dorsal segment (future DA) was solely surrounded by neural crest cells. The ventral segment had a dual outer lining with neural crest and second heart field cells, while the distal pulmonary artery was covered by none of these cells. The asymmetric contribution of second heart field to the future pulmonary trunk on the left side of the aortic sac (so-called pulmonary push) was evident. The ventral segment became incorporated into the pulmonary trunk leading to a separate connection of the left and right pulmonary arteries. The VEGF120/120 embryos showed a stunted pulmonary push and a variety of vascular anomalies. Summary Side-way connection of the DA to the left pulmonary artery is a congenital anomaly. The primary problem is a stunted development of the pulmonary push leading to pulmonary stenosis/atresia and a subsequent lack of proper incorporation of the ventral segment into the aortic sac. Clinically, the aberrant smooth muscle tissue of the ductus arteriosus should be addressed to prohibit development of severe pulmonary ductal coarctation or even interruption of the left pulmonary artery.	[Gittenberger-de Groot, Adriana C.; Poelmann, Robert E.; Jongbloed, Monique R. M.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Gittenberger-de Groot, Adriana C.; Peterson, Joshua C.; Wisse, Lambertus J.; Roest, Arno A. W.; Elzenga, Nynke J.; Bartelings, Margot M.; Jongbloed, Monique R. M.; DeRuiter, Marco C.] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Roest, Arno A. W.; Bokenkamp, Regina] Leiden Univ, Med Ctr, Dept Pediat Cardiol, Leiden, Netherlands; [Poelmann, Robert E.] Leiden Univ, Dept Anim Sci & Hlth, Leiden, Netherlands; [Elzenga, Nynke J.] Univ Hosp Groningen, Dept Pediat Cardiol, Groningen, Netherlands; [Hazekamp, Mark] Leiden Univ, Med Ctr, Dept Cardiothorac Surg, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Gittenberger-de Groot, AC (corresponding author), Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands.; Gittenberger-de Groot, AC (corresponding author), Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands.	acgitten@lumc.nl	Roest, Arno AW/AAC-5588-2020; Jongbloed, Monique/AAA-4239-2022	Roest, Arno AW/0000-0002-0153-5934; Jongbloed, Monique/0000-0002-9132-0418; hazekamp, mark/0000-0002-3150-5007	Netherlands Heart Foundation [31190BAV]	Netherlands Heart Foundation(Netherlands Heart Foundation)	Funding and salary support of JP was provided by a grant of The Netherlands Heart Foundation (Projectcode: 31190BAV). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NHF:www.hartstichting.nl.	Akaike T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214139; Bajolle F, 2006, CIRC RES, V98, P421, DOI 10.1161/01.RES.0000202800.85341.6e; Bergwerff M, 1999, ANAT EMBRYOL, V200, P559, DOI 10.1007/s004290050304; Bergwerff M, 1998, CIRC RES, V82, P221; Blom, 2005, CIRCULATION, V112, pE71, DOI 10.1161/CIRCULATIONAHA.105.167946; Blom NA, 1999, CIRCULATION, V99, P800, DOI 10.1161/01.CIR.99.6.800; Bokenkamp R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086892; Bokenkamp R, 2010, NEONATOLOGY, V98, P6, DOI 10.1159/000262481; Brink J, 2015, ANN THORAC SURG, V99, P641, DOI 10.1016/j.athoracsur.2014.09.034; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Congdon ED, 1922, CONTRIB EMBRYOL, V14, P49; DERUITER MC, 1993, CIRCULATION, V87, P1306, DOI 10.1161/01.CIR.87.4.1306; DERUITER MC, 1989, ANAT EMBRYOL, V179, P319; ELZENGA NJ, 1990, J THORAC CARDIOV SUR, V100, P416; ELZENGA NJ, 1986, INT J CARDIOL, V11, P195, DOI 10.1016/0167-5273(86)90179-8; ELZENGA NJ, 1983, BRIT HEART J, V49, P317; ELZENGA NJ, 1986, INT J CARDIOL, V13, P289, DOI 10.1016/0167-5273(86)90116-6; Hammer S, 2008, J CELL BIOCHEM, V104, P1022, DOI 10.1002/jcb.21686; Harmon AW, 2013, GENESIS, V51, P862, DOI 10.1002/dvg.22721; Ivey KN, 2008, CIRC RES, V103, P388, DOI 10.1161/CIRCRESAHA.108.180661; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kelly RG, 2002, TRENDS GENET, V18, P210, DOI 10.1016/S0168-9525(02)02642-2; Lazzarini R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209930; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; LUHMER I, 1993, J THORAC CARDIOV SUR, V106, P889; Marino B, 1996, AM J CARDIOL, V77, P505, DOI 10.1016/S0002-9149(97)89345-9; Mastromoro G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211170; Molin DGM, 2004, BIRTH DEFECTS RES A, V70, P927, DOI 10.1002/bdra.20101; Momma K, 1996, AM J CARDIOL, V78, P591, DOI 10.1016/S0002-9149(96)00374-8; MOMMA K, 1995, AM J CARDIOL, V76, P618, DOI 10.1016/S0002-9149(99)80170-2; MOMMA K, 1986, BRIT HEART J, V55, P39; Peterson JC, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.034637; PRESBITERO P, 1984, BRIT HEART J, V52, P178; Rammeloo LAJ, 2015, PEDIATR CARDIOL, V36, P89, DOI 10.1007/s00246-014-0969-4; Rana MS, 2014, AM J MED GENET A, V164, P1372, DOI 10.1002/ajmg.a.35881; SANTOS MA, 1980, CIRCULATION, V62, P818, DOI 10.1161/01.CIR.62.4.818; Scherptong RWC, 2012, DEV DYNAM, V241, P1413, DOI 10.1002/dvdy.23833; Sizarov A, 2012, J ANAT, V220, P336, DOI 10.1111/j.1469-7580.2012.01474.x; Sizarov A, 2010, CIRCULATION, V122, P798, DOI 10.1161/CIRCULATIONAHA.110.953844; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; van den Akker NMS, 2007, CIRC RES, V100, P842, DOI 10.1161/01.RES.0000261656.04773.39; Van der Sterren S, 2014, J PHYSIOL PHARMACOL, V65, P283; Waldman JD, 1996, ANN THORAC SURG, V62, P161, DOI 10.1016/0003-4975(96)00229-9; Waldo K, 1999, J CLIN INVEST, V103, P1499, DOI 10.1172/JCI6501; Yokoyama U, 2017, J PHYSIOL SCI, V67, P259, DOI 10.1007/s12576-016-0512-x	45	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0228478	10.1371/journal.pone.0228478	http://dx.doi.org/10.1371/journal.pone.0228478			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413023	Green Published, Green Submitted, gold			2022-12-26	WOS:000537496000003
J	Andrea, M; Francesco, EF; Sergio, I; Alessandra, G; Maria, AM; Cinzia, C; Lorenzo, B; Arianna, M; Cecilia, C; Patrizia, R; Laura, T; Giuseppe, LR; Sergio, L; Laura, B				Andrea, Moglia; Francesco, Elia Florio; Sergio, Iacopino; Alessandra, Guerrieri; Maria, Anna Milani; Cinzia, Comino; Lorenzo, Barchi; Arianna, Marengo; Cecilia, Cagliero; Patrizia, Rubiolo; Laura, Toppino; Giuseppe, Leonardo Rotino; Sergio, Lanteri; Laura, Bassolino			Identification of a new R3 MYB type repressor and functional characterization of the members of the MBW transcriptional complex involved in anthocyanin biosynthesis in eggplant (S. melongena L.)	PLOS ONE			English	Article							MOLECULAR ANALYSIS; PETUNIA ENCODES; PIGMENTATION; PROTEIN; EVOLUTION; GENE; ACCUMULATION; VECTORS; LOCUS	Here we focus on the highly conserved MYB-bHLH-WD repeat (MBW) transcriptional complex model in eggplant, which is pivotal in the transcriptional regulation of the anthocyanin biosynthetic pathway. Through a genome-wide approach performed on the recently released Eggplant Genome (cv. 67/3) previously identified, and reconfirmed by us, members belonging to the MBW complex (SmelANT1, SmelAN2, SmelJAF13, SmelAN1) were functionally characterized. Furthermore, a regulatory R3 MYB type repressor (Smel-MYBL1), never reported before, was identified and characterized as well. Through a qPCR approach, we revealed specific transcriptional patterns of candidate genes in different plant tissue/organs at two stages of fruit development. Two strategies were adopted for investigating the interactions of bHLH partners (SmelAN1, SmelJAF13) with MYB counterparts (SmelANT1, SmelAN2 and SmelMYBL1): Yeast Two Hybrid (Y2H) and Bimolecular Fluorescent Complementation (BiFC) in A. thaliana mesophylls protoplast. Agro-infiltration experiments highlighted that N. benthamiana leaves transiently expressing SmelANT1 and SmelAN2 showed an anthocyanin-pigmented phenotype, while their co-expression with SmelMYBL1 prevented anthocyanin accumulation. Our results suggest that SmelMYBL1 may inhibits the MBW complex via the competition with MYB activators for bHLH binding site, although this hypothesis requires further elucidation.	[Andrea, Moglia; Maria, Anna Milani; Cinzia, Comino; Lorenzo, Barchi; Sergio, Lanteri] Univ Torino, Dept Agr Forest & Food Sci Plant Genet & Breeding, Grugliasco, TO, Italy; [Francesco, Elia Florio; Laura, Toppino; Giuseppe, Leonardo Rotino; Laura, Bassolino] CREA, Res Ctr Genom & Bioinformat, Montanaso Lombardo, LO, Italy; [Sergio, Iacopino] Scuola Super Sant Anna, Inst Life Sci, PlantLab, Ghezzano, PI, Italy; [Sergio, Iacopino] Univ Pisa, Dept Biol, Pisa, PI, Italy; [Alessandra, Guerrieri] Univ Amsterdam, Plant Hormone Biol Grp, SILS, Amsterdam, Netherlands; [Arianna, Marengo; Cecilia, Cagliero; Patrizia, Rubiolo] Univ Torino, Dept Drug Sci & Technol, Turin, TO, Italy; [Laura, Bassolino] CREA, Res Ctr Cereal & Ind Crops, Bologna, Italy	University of Turin; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Scuola Superiore Sant'Anna; University of Pisa; University of Amsterdam; Vrije Universiteit Amsterdam; University of Turin; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Laura, B (corresponding author), CREA, Res Ctr Genom & Bioinformat, Montanaso Lombardo, LO, Italy.; Laura, B (corresponding author), CREA, Res Ctr Cereal & Ind Crops, Bologna, Italy.	laura.bassolino@crea.gov.it	Bassolino, Laura/AHA-4771-2022; Bassolino, Laura/AGM-7099-2022; Bassolino, Laura/AGM-7097-2022; BARCHI, Lorenzo/ABC-4206-2020	Bassolino, Laura/0000-0002-7242-0499; BARCHI, Lorenzo/0000-0001-6414-4239; MOGLIA, Andrea/0000-0001-7431-844X; Toppino, Laura/0000-0002-8664-1233; Cagliero, Cecilia/0000-0003-3512-6124; RUBIOLO, Patrizia/0000-0002-6819-2614				Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; Allan AC, 2018, TRENDS PLANT SCI, V23, P693, DOI 10.1016/j.tplants.2018.06.001; Barbierato V, 2017, PROTOPLASMA, V254, P2215, DOI 10.1007/s00709-017-1111-2; Barchi L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47985-w; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Cao X, 2017, J EXP BOT, V68, P5745, DOI 10.1093/jxb/erx382; Cavallini E, 2015, PLANT PHYSIOL, V167, P1448, DOI 10.1104/pp.114.256172; Chen LH, 2019, PLANT PHYSIOL BIOCH, V136, P178, DOI 10.1016/j.plaphy.2019.01.024; Colanero S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00830; D'Amelia V, 2018, PHYTOCHEM REV, V17, P611, DOI 10.1007/s11101-018-9568-y; D'Amelia V, 2018, PLANT CELL ENVIRON, V41, P1038, DOI 10.1111/pce.12966; D'Amelia V, 2014, PLANT J, V80, P527, DOI 10.1111/tpj.12653; Davies KM, 2012, FUNCT PLANT BIOL, V39, P619, DOI 10.1071/FP12195; deVetten N, 1997, GENE DEV, V11, P1422, DOI 10.1101/gad.11.11.1422; Docimo T, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01233; Gates DJ, 2018, NEW PHYTOL, V217, P1346, DOI 10.1111/nph.14830; Gisbert C, 2016, HORTSCIENCE; Iacopino S, 2019, PLANT PHYSIOL, V179, P986, DOI 10.1104/pp.18.01003; Jiang MM, 2016, PLANT SCI, V249, P46, DOI 10.1016/j.plantsci.2016.04.001; Jun JH, 2015, PLANT CELL, V27, P2860, DOI 10.1105/tpc.15.00476; Kiferle C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136365; Kovinich Nik, 2015, Plant Signal Behav, V10, pe1027850, DOI 10.1080/15592324.2015.1027850; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Li J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4587-z; Li J, 2017, PLANT CELL ENVIRON, V40, P3069, DOI 10.1111/pce.13074; Li ST, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27522; Li ZJ, 2016, PLANT CELL PHYSIOL, V57, P1657, DOI 10.1093/pcp/pcw091; Liu JY, 2015, MOL PLANT, V8, P689, DOI 10.1016/j.molp.2015.03.012; Liu Y, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00052; Ma DW, 2019, TRENDS PLANT SCI, V24, P275, DOI 10.1016/j.tplants.2018.12.003; Mennella G, 2012, J AGR FOOD CHEM, V60, P11821, DOI 10.1021/jf3037424; Moglia A, 2019, 61 SIGA ANN C; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Putta S, 2017, CURR PHARM DESIGN, V23, P6321, DOI 10.2174/1381612823666170519151801; Quattrocchio F, 1998, PLANT J, V13, P475, DOI 10.1046/j.1365-313X.1998.00046.x; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Shukla V, 2019, MOL PLANT, V12, P538, DOI 10.1016/j.molp.2019.01.007; Spelt C, 2000, PLANT CELL, V12, P1619, DOI 10.1105/tpc.12.9.1619; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Sun H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1209-2; Sun WJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194847; Toppino L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00256; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang RQ, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010054; Yoshida K, 2015, PLANT PHYSIOL, V167, P693, DOI 10.1104/pp.114.253674; Zhang YJ, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0454-2; Zhang YJ, 2014, J AGR FOOD CHEM, V62, P2906, DOI 10.1021/jf404574c; Zhong SL, 2008, TRANSGENIC RES, V17, P985, DOI 10.1007/s11248-008-9199-y	50	15	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232986	10.1371/journal.pone.0232986	http://dx.doi.org/10.1371/journal.pone.0232986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407419	Green Published, gold			2022-12-26	WOS:000537490700053
J	Mandala, S; Di, TC; Sunar, MS; Adiwijaya				Mandala, Satria; Di, Tham Cai; Sunar, Mohd Shahrizal; Adiwijaya			ECG-based prediction algorithm for imminent malignant ventricular arrhythmias using decision tree	PLOS ONE			English	Article								Spontaneous prediction of malignant ventricular arrhythmia (MVA) is useful to avoid delay in rescue operations. Recently, researchers have developed several algorithms to predict MVA using various features derived from electrocardiogram (ECG). However, there are several unresolved issues regarding MVA prediction such as the effect of number of ECG features on a prediction remaining unclear, possibility that an alert for occurring MVA may arrive very late and uncertainty in the performance of the algorithm predicting MVA minutes before onset. To overcome the aforementioned problems, this research conducts an in-depth study on the number and types of ECG features that are implemented in a decision tree classifier. In addition, this research also investigates an algorithm's execution time before the occurrence of MVA to minimize delays in warnings for MVA. Lastly, this research aims to study both the sensitivity and specificity of an algorithm to reveal the performance of MVA prediction algorithms from time to time. To strengthen the results of analysis, several classifiers such as support vector machine and naive Bayes are also examined for the purpose of comparison study. There are three phases required to achieve the objectives. The first phase is literature review on existing relevant studies. The second phase deals with design and development of four modules for predicting MVA. Rigorous experiments are performed in the feature selection and classification modules. The results show that eight ECG features with decision tree classifier achieved good prediction performance in terms of execution time and sensitivity. In addition, the results show that the highest percentage for sensitivity and specificity is 95% and 90% respectively, in the fourth 5-minute interval (15.1 minutes-20 minutes) that preceded the onset of an arrhythmia event. Such results imply that the fourth 5-minute interval would be the best time to perform prediction.	[Mandala, Satria; Adiwijaya] Telkom Univ, Human Centr HUMIC Engn, Bandung, Indonesia; [Mandala, Satria; Adiwijaya] Telkom Univ, Sch Comp, Bandung, Indonesia; [Di, Tham Cai; Sunar, Mohd Shahrizal] Univ Teknol Malaysia, Inst Human Cent Engn, Media & Game Innovat Ctr Excellence, Johor Baharu, Johor, Malaysia; [Di, Tham Cai; Sunar, Mohd Shahrizal] Univ Teknol Malaysia, Fac Engn, Sch Comp, Johor Baharu, Johor, Malaysia	Universitas Telkom; Universitas Telkom; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia	Mandala, S (corresponding author), Telkom Univ, Human Centr HUMIC Engn, Bandung, Indonesia.; Mandala, S (corresponding author), Telkom Univ, Sch Comp, Bandung, Indonesia.	satriamandala@telkomuniversity.ac.id	, Adiwijaya/AAE-2481-2021; Mandala, Satria/AAV-5378-2020; Sunar, Mohd Shahrizal/AFQ-7366-2022	, Adiwijaya/0000-0002-3518-7587; Mandala, Satria/0000-0001-6997-5875; Sunar, Mohd Shahrizal/0000-0002-0244-1622	Kemenristek/BRIN (Ministry of Research and Technology, Republic of Indonesia) [25/GI/PPK/E/E4/2019]	Kemenristek/BRIN (Ministry of Research and Technology, Republic of Indonesia)(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	The authors deeply thank and acknowledge Kemenristek/BRIN (Ministry of Research and Technology, Republic of Indonesia) in supporting this research through PPTI program, under contract no.25/GI/PPK/E/E4/2019.	Aleman-Fernandez AA, 2014, CORSALUD, V6, P63; [Anonymous], 2016, INT J BIOSCI BIOTECH, DOI DOI 10.14257/IJBSBT.2016.8.2.22; Bayasi N, 2016, IEEE T VLSI SYST, V24, P1962, DOI 10.1109/TVLSI.2015.2475119; Camm AJ, 1996, CIRCULATION, V93, P1043; Colunas MFM, 2011, INT WIREL COMMUN, P2157, DOI 10.1109/IWCMC.2011.5982868; Ebrahimzadeh E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081896; Fairooz T, 2016, BIOMED PHYS ENG EXPR, V2, DOI 10.1088/2057-1976/2/2/025006; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; James G., 2013, INTRO STAT LEARNING, DOI [10.1007/978-1-4614-7138-7, DOI 10.1007/978-1-4614-7138-7]; Jen KK, 2008, J MED BIOL ENG, V28, P31; Joo SG, 2010, EUROPEAN HEART J, V1, P585; Karimuribo Esron Daniel, 2017, JMIR Public Health Surveill, V3, pe94, DOI 10.2196/publichealth.7373; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lee HS, 2016, AER ADV ENG RES, V93, P1; Lee S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30005; Mandala S, 2017, J MED BIOL ENG, V37, P441, DOI 10.1007/s40846-017-0281-x; Martin-Yebra A, 2013, COMPUT CARDIOL CONF, V40, P133; Mudry A, 2011, ADV OTO-RHINO-LARYNG, V71, P1, DOI 10.1159/000323569; Murugappan R., 2013, STAR; Pan J, 2015, CHINESE MED J-PEKING, V128, P550, DOI 10.4103/0366-6999.151115; Raeiatibanadkooki Mahsa, 2014, Acta Inform Med, V22, P389, DOI 10.5455/aim.2014.22.389-392; Ragupathi Loheetha, 2014, Indian Heart J, V66 Suppl 1, pS71, DOI 10.1016/j.ihj.2013.12.035; Refaeilzadeh P, 2007, AAAI WORKSH, V3; Riasi A, 2015, 2015 INTERNATIONAL SYMPOSIUM ON ARTIFICIAL INTELLIGENCE AND SIGNAL PROCESSING (AISP), P170, DOI 10.1109/AISP.2015.7123515; Rizal A, 2020, INT J INNOVATIVE TEC, V9, P346; Rozen G, 2013, PACE, V36, P1342, DOI 10.1111/pace.12180; Sachdev M, 2010, J ELECTROCARDIOL, V43, P400, DOI 10.1016/j.jelectrocard.2010.02.005; Sedghamiz H., 2014, MATLAB IMPLEMENTATIO; Siroky DS, 2009, STAT SURV, V3, P147, DOI 10.1214/07-SS033; Sohn K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50487-4; Tereshchenko LG, 2009, CIRC-ARRHYTHMIA ELEC, V2, P276, DOI 10.1161/CIRCEP.108.829440; The MathWorks Inc., 2015, MATLAB R2015A DOC; Watanabe H., 2012, 2012 IEEE 14th International Conference on e-Health Networking, Applications and Services (Healthcom 2012), P292, DOI 10.1109/HealthCom.2012.6379423; Wollmann CG, 2015, PHYSIOL MEAS, V36, P1047, DOI 10.1088/0967-3334/36/5/1047; Yan HM, 2006, EXPERT SYST APPL, V30, P272, DOI 10.1016/j.eswa.2005.07.022; Zhao QB, 2005, PROCEEDINGS OF THE 2005 INTERNATIONAL CONFERENCE ON NEURAL NETWORKS AND BRAIN, VOLS 1-3, P1089; Zipes DP, 2006, MANAGEMENT PATIENTS, P54	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0231635	10.1371/journal.pone.0231635	http://dx.doi.org/10.1371/journal.pone.0231635			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407335	Green Published, gold			2022-12-26	WOS:000537490700008
J	Silverman, JG; Fonseka, RW; Dehingia, N; Boyce, SC; Chandurkar, D; Singh, K; Hay, K; Atmavilas, Y; Raj, A				Silverman, Jay G.; Fonseka, Ruvani W.; Dehingia, Nabamallika; Boyce, Sabrina C.; Chandurkar, Dharmendra; Singh, Kultar; Hay, Katherine; Atmavilas, Yamini; Raj, Anita			Associations between recent intimate partner violence and receipt and quality of perinatal health services in Uttar Pradesh	PLOS ONE			English	Article							DOMESTIC VIOLENCE; PREGNANCY; CARE; MORTALITY; IMPACT; ABUSE; WOMEN; CHILD	Background India suffers some of the highest maternal and neonatal mortality rates in the world. Intimate partner violence (IPV) can be a barrier to utilization of perinatal care, and has been associated with poor maternal and neonatal health outcomes. However, studies that assess the relationship between IPV and perinatal health care often focus solely on receipt of services, and not the quality of the services received. Methods and findings Data were collected in 2016-2017 from a representative sample of women (15-49yrs) in Uttar Pradesh, India who had given birth within the previous 12 months (N = 5020), including use of perinatal health services and past 12 months experiences of physical and sexual IPV. Multivariate logistic regression models assessed whether physical or sexual IPV were associated with perinatal health service utilization and quality. Reports of IPV were not associated with odds of receiving antenatal care or a health worker home visit during the third trimester, but physical IPV was associated with fewer diagnostic tests during antenatal visits (beta = -0.30), and fewer health topics covered during home visits (beta = -0.44). Recent physical and recent sexual IPV were both associated with decreased odds of institutional delivery (physical IPV AOR 0.65; sexual IPV AOR 0.61), and recent sexual IPV was associated with leaving a delivery facility earlier than recommended (AOR = 1.87). Neither form of IPV was associated with receipt of a postnatal home visit, but recent physical IPV was associated with fewer health topics discussed during such visits (beta = -0.26). Conclusions In this study, reduced quantity and quality of perinatal health care were associated with recent IPV experiences. In cases where IPV was not related to care receipt, IPV remained associated with diminished care quality. Additional study to understand the mechanisms underlying associations between IPV and care qualities is required to inform health services.	[Silverman, Jay G.; Fonseka, Ruvani W.; Dehingia, Nabamallika; Boyce, Sabrina C.; Raj, Anita] Univ Calif San Diego, Ctr Gender Equ & Hlth GEH, La Jolla, CA 92093 USA; [Chandurkar, Dharmendra; Singh, Kultar] Sambodhi Res & Commun Pvt Ltd, Noida, Uttar Pradesh, India; [Hay, Katherine] Bill & Melinda Gates Fdn Seattle Off, Seattle, WA USA; [Atmavilas, Yamini] Bill & Melinda Gates Fdn India Country Off, Delhi, Uttar Pradesh, India	University of California System; University of California San Diego	Silverman, JG (corresponding author), Univ Calif San Diego, Ctr Gender Equ & Hlth GEH, La Jolla, CA 92093 USA.	jgsilverman@ucsd.edu	Hay, Katherine/ABB-7795-2021; Dehingia, Nabamallika/AAY-5588-2021; Dehingia, Nabamallika/AAF-1639-2021	Dehingia, Nabamallika/0000-0003-1787-9050; Fonseka, Ruvani W./0000-0002-2809-3574	Bill and Melinda Gates Foundation (BMGF); BMGF via Sambodhi Research and Communications Private Limited; BMGF [OPP1083531]; Sambodhi Research and Communications Private Limited	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); BMGF via Sambodhi Research and Communications Private Limited; BMGF; Sambodhi Research and Communications Private Limited	This manuscript and the survey used for data collection were supported by the Bill and Melinda Gates Foundation (BMGF www.gatesfoundation.org). JGS, RWF, ND, SCB and AR received funding from BMGF via Sambodhi Research and Communications Private Limited, where DC and KS are staff and received BMGF funding directly [all funded through #OPP1083531]. DC and KS received support in the form of a salary from Sambodhi Research and Communications Private Limited. KH and YA are BMGF staff who participated in the development of this study and the generation of this manuscript, and are recognized as coauthors. In their roles with BMGF, they were involved with the design and conduct of the TSU survey from which data for this study were obtained. They provided some oversight of data collection and management, and gave input into analyses included in this manuscript. They assisted with the interpretation of this paper and reviewed and approved this final manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acharya A, 2015, AM J PUBLIC HEALTH, V105, P144, DOI 10.2105/AJPH.2014.302092; Ackerson LK, 2009, PEDIATRICS, V124, pE878, DOI 10.1542/peds.2009-0524; Afulani PA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0925-9; Ahmed S, 2006, AM J PUBLIC HEALTH, V96, P1423, DOI 10.2105/AJPH.2005.066316; Alhusen JL, 2014, J WOMENS HEALTH, V23, P920, DOI 10.1089/jwh.2014.4862; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Beydoun HA, 2011, SOC SCI MED, V72, P867, DOI 10.1016/j.socscimed.2011.01.006; Boyce SC, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1577-0; Campbell J, 2004, VIOLENCE AGAINST WOM, V10, P770, DOI 10.1177/1077801204265551; Chalmers B, 2001, BIRTH-ISS PERINAT C, V28, P202, DOI 10.1046/j.1523-536x.2001.00202.x; Chatterjee A, 2011, BJOG-INT J OBSTET GY, V118, P47, DOI 10.1111/j.1471-0528.2011.03112.x; Desa U, 2016, TRANSF OUR WORLD 203; Dhar D, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0551-2; Gilmore B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-847; International Institute for Population Sciences, 2005, NAT FAM HLTH SURV NF; Kuhlmann AKS, 2017, REV PANAM SALUD PUBL, V41; Leserman J, 1996, PSYCHOSOM MED, V58, P4, DOI 10.1097/00006842-199601000-00002; Mahapatro M, 2011, J INTERPERS VIOLENCE, V26, P2973, DOI 10.1177/0886260510390948; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Office of the Registrar General & Census Commissioner India, 2012, ANN HLTH SURV B VIT; Ononokpono DN, 2014, HEALTH CARE WOMEN IN, V35, P973, DOI 10.1080/07399332.2014.924939; Rahman M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-913; Raj A, 2010, ARCH DIS CHILD, V95, P931, DOI 10.1136/adc.2009.178707; Raj A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4258; Sankar MJ, 2016, J PERINATOL, V36, pS3, DOI 10.1038/jp.2016.183; Seth A, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0538-6; Silverman JG, 2006, AM J OBSTET GYNECOL, V195, P140, DOI 10.1016/j.ajog.2005.12.052; Silverman JG, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0223-z; Silverman JG, 2016, MATERN CHILD HLTH J, V20, P149, DOI 10.1007/s10995-015-1814-y; StataCorp, 2009, STAT STAT SOFTW REL; Sudha S, 2011, WOMEN HEALTH ISS, V21, P214, DOI 10.1016/j.whi.2011.01.004; Tuncalp O, 2015, BJOG-INT J OBSTET GY, V122, P1045, DOI 10.1111/1471-0528.13451; Wardlaw T, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-82; WHO, 2022, WHO RECOMMENDATIONS; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232079	10.1371/journal.pone.0232079	http://dx.doi.org/10.1371/journal.pone.0232079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407320	Green Published, gold			2022-12-26	WOS:000537490700011
J	Westerlaken-van Ginkel, CD; Vonk, JM; Flokstra-de Blok, BMJ; Sprikkelman, AB; Koppelman, GH; Dubois, AEJ				Westerlaken-van Ginkel, Cornelia Doriene; Vonk, Judith M.; Flokstra-de Blok, Bertine M. J.; Sprikkelman, Aline B.; Koppelman, Gerard H.; Dubois, Anthony E. J.			Likely questionnaire-diagnosed food allergy in 78, 890 adults from the northern Netherlands	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH SURVEY; DOUBLE-BLIND; ADOLESCENTS; PREVALENCE; MANAGEMENT; POPULATION; CHALLENGES; GUIDELINES; CHILDHOOD	Background It is challenging to define likely food allergy (FA) in large populations which limited the number of large studies regarding risk factors for FA. Objective We studied the prevalence and characteristics of self-reported FA (s-rFA) in the large, population-based Dutch Lifelines cohort and identified associated risk factors. Methods Likely food allergic cases (LikelyFA) were classified based on questionnaire reported characteristics consistent with FA. Subjects with atypical characteristics were classified as Indeterminate. We investigated 13 potential risk factors for LikelyFA such as birth mode and living on a farm and addressed health-related quality of life (H-RQOL). Results Of the 78, 890 subjects, 12.1% had s-rFA of which 4.0% and 8.1% were classified as LikelyFA and Indeterminate, respectively. Younger age, female sex, asthma, eczema and nasal allergy increased the risk of LikelyFA (p-value range <1.00*10(-250)-1.29*10(-7)). Living in a small city/large village or suburb during childhood was associated with a higher risk of LikelyFA than living on a farm (p-value = 7.81*10(-4) and p = 4.84*10(-4), respectively). Subjects classified as Indeterminate more often reported depression and burn-out compared to those without FA (p-value = 1.46*10(-4) and p = 8.39*10(-13), respectively). No association was found with ethnicity, (duration of) breastfeeding, birth mode and reported eating disorder. Mental and physical component scores measuring H-RQOL were lower in both those classified as LikelyFA and Indeterminate compared to those without FA. Conclusion The prevalence of s-rFA among adults is considerable and one-third reports characteristics consistent with LikelyFA. Living on a farm decreased the risk of LikelyFA. The association of poorer H-RQOL as well as depression and burn-out with questionable self-perceived FA is striking and a priority for future study.	[Westerlaken-van Ginkel, Cornelia Doriene; Flokstra-de Blok, Bertine M. J.; Sprikkelman, Aline B.; Koppelman, Gerard H.; Dubois, Anthony E. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Paediat Pulmonol & Paediat Allergy, Groningen, Netherlands; [Westerlaken-van Ginkel, Cornelia Doriene; Vonk, Judith M.; Flokstra-de Blok, Bertine M. J.; Sprikkelman, Aline B.; Koppelman, Gerard H.; Dubois, Anthony E. J.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Flokstra-de Blok, Bertine M. J.] Gen Practitioners Res Inst, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Westerlaken-van Ginkel, CD (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Paediat Pulmonol & Paediat Allergy, Groningen, Netherlands.; Westerlaken-van Ginkel, CD (corresponding author), Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands.	c.d.van.ginkel@umcg.nl		Koppelman, Gerard/0000-0001-8567-3252	Netherlands Organization of Scientific Research (NWO) [175.010.2007.006]; Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); 'Ruimtelijk Economisch Programma' (REP); Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); 'Ruimtelijk Economisch Programma' (REP); Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation	The Lifelines Cohort Study is supported by The Netherlands Organization of Scientific Research (NWO; Grant 175.010.2007.006); the Economic Structure Enhancing Fund (FES) of the Dutch government; the Ministry of Economic Affairs; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the Northern Netherlands Collaboration of Provinces (SNN); the 'Ruimtelijk Economisch Programma' (REP); the Province of Groningen; University Medical Center Groningen; the University of Groningen; the Dutch Kidney Foundation; and the Dutch Diabetes Research Foundation.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Acker WW, 2017, J ALLERGY CLIN IMMUN, V140, P1587, DOI 10.1016/j.jaci.2017.04.006; Afify SM, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-017-0174-z; Beyer K, 2005, CURR OPIN ALLERGY CL, V5, P261, DOI 10.1097/01.all.0000168792.27948.f9; Boyce JA, 2011, NUTR RES, V31, P61, DOI 10.1016/j.nutres.2011.01.001; Brew BK, 2018, CLIN EXP ALLERGY, V48, P703, DOI 10.1111/cea.13127; Burney PGJ, 2014, ALLERGY, V69, P365, DOI 10.1111/all.12341; Carballo I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149330; Ferro MA, 2016, ALLERGY, V71, P532, DOI 10.1111/all.12829; Fish EN, 2008, X FILES IMMUNITY SEX, V8; Flokstra-de Blok BMJ, 2010, ALLERGY, V65, P238, DOI 10.1111/j.1398-9995.2009.02121.x; Flokstra-de Blok BMJ, 2017, J ASTHMA ALLERGY, V10, P57, DOI 10.2147/JAA.S123260; Flokstra-de Blok Bertine M J, 2011, Pediatr Allergy Immunol, V22, P374, DOI 10.1111/j.1399-3038.2011.01171.x; Fox M, 2013, EUR J PUBLIC HEALTH, V23, P757, DOI 10.1093/eurpub/ckt010; Gupta RS, 2012, CLIN PEDIATR, V51, P856, DOI 10.1177/0009922812448526; JANSEN JJN, 1994, J ALLERGY CLIN IMMUN, V93, P446; Kirchner B, 2016, J ALLERGY CLIN IMMUN, V137, P1893, DOI 10.1016/j.jaci.2015.10.028; Klijs B, 2015, ONE PLOS, V10; Le TM, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0051-1; Lluis A, 2014, J ALLERGY CLIN IMMUN, V133; Loss G, 2011, J ALLERGY CLIN IMMUN, V128, P766, DOI 10.1016/j.jaci.2011.07.048; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Michel S, 2013, ALLERGY, V68, P355, DOI 10.1111/all.12097; Muraro A, 2014, ALLERGY, V69, P1008, DOI 10.1111/all.12429; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; Polloni L, 2015, ANN ALLERG ASTHMA IM, V115, P158, DOI 10.1016/j.anai.2015.05.023; Quigley J, 2017, CURR PSYCHIAT REP, V19, P17; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Silva LA, 2016, INT ARCH ALLERGY IMM, V171, P261, DOI 10.1159/000453036; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; van der Velde JL, 2012, J ALLERGY CLIN IMMUN, V130, P1136, DOI 10.1016/j.jaci.2012.05.037; van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2; van Ginkel CD, 2018, ALLERGY, V73, P1337, DOI 10.1111/all.13432; van Ginkel CDD, 2018, EUR J CLIN NUTR; Wamboldt MZ, 2000, AM J MED GENET, V96, P146, DOI 10.1002/(SICI)1096-8628(20000403)96:2<146::AID-AJMG4>3.0.CO;2-J; Waserman S, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0284-3; Werfel T, 2015, ALLERGY, V70, P1079, DOI 10.1111/all.12666	41	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0231818	10.1371/journal.pone.0231818	http://dx.doi.org/10.1371/journal.pone.0231818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401757	Green Published, gold			2022-12-26	WOS:000537481000005
J	Bae, TW				Bae, Tae Wuk			Image-quality metric system for color filter array evaluation	PLOS ONE			English	Article							SIMILARITY INDEX; DESIGN	A modern color filter array (CFA) output is rendered into the final output image using a demosaicing algorithm. During this process, the rendered image is affected by optical and carrier cross talk of the CFA pattern and demosaicing algorithm. Although many CFA patterns have been proposed thus far, an image-quality (IQ) evaluation system capable of comprehensively evaluating the IQ of each CFA pattern has yet to be developed, although IQ evaluation items using local characteristics or specific domain have been created. Hence, we present an IQ metric system to evaluate the IQ performance of CFA patterns. The proposed CFA evaluation system includes proposed metrics such as the moire robustness using the experimentally determined moire starting point (MSP) and achromatic reproduction (AR) error, as well as existing metrics such as color accuracy using CIELAB, a color reproduction error using spatial CIELAB, structural information using the structure similarity, the image contrast based on MTF50, structural and color distortion using the mean deviation similarity index (MDSI), and perceptual similarity using Haar wavelet-based perceptual similarity index (HaarPSI). Through our experiment, we confirmed that the proposed CFA evaluation system can assess the IQ for an existing CFA. Moreover, the proposed system can be used to design or evaluate new CFAs by automatically checking the individual performance for the metrics used.	[Bae, Tae Wuk] Elect & Telecommun Res Inst, Daegu Gyeongbuk Res Ctr, Daegu, South Korea	Electronics & Telecommunications Research Institute - Korea (ETRI)	Bae, TW (corresponding author), Elect & Telecommun Res Inst, Daegu Gyeongbuk Res Ctr, Daegu, South Korea.	nanninggo@gmail.com						Adams J, 1998, IEEE MICRO, V18, P20, DOI 10.1109/40.743681; Bayer B. E., 1975, US patent 3971065: color imaging array, Patent No. 3971065; Bovik AC, 2009, ESSENTIAL GUIDE TO IMAGE PROCESSING, 2ND EDITION, P43, DOI 10.1016/B978-0-12-374457-9.00003-2; Chen JQ, 2009, IEEE T ELECTRON DEV, V56, P2496, DOI 10.1109/TED.2009.2030995; Chung KH, 2010, J ELECTRON IMAGING, V19, DOI 10.1117/1.3432484; Eckert MP, 1998, SIGNAL PROCESS, V70, P177, DOI 10.1016/S0165-1684(98)00124-8; Eskicioglu AM, 1995, IEEE T COMMUN, V43, P2959, DOI 10.1109/26.477498; Farrell JE, 2004, P SOC PHOTO-OPT INS, V5294, P124; Farrell J, 2008, PROC SPIE, V6817, DOI 10.1117/12.767901; Farrell JE, 2012, APPL OPTICS, V51, pA80, DOI 10.1364/AO.51.000A80; FillFactory, TECHN IM SENS COL FI; Gasparini F, 2012, EURASIP J ADV SIG PR, P1, DOI 10.1186/1687-6180-2012-123; Gindele E., 2002, U.S. Patent, Patent No. [6 476 865 B1, 6476865, 6,476,865]; Girod Bernd, 1993, P207; Gunturk BK, 2002, IEEE T IMAGE PROCESS, V11, P997, DOI 10.1109/TIP.2002.801121; Hamilton JF, 2001, US Patent, Patent No. [6,330,029B1, 6330029]; Hamilton John, 1997, U.S. Patent, Patent No. [5,629,734, 5629734]; Hirakawa K, 2008, IEEE T IMAGE PROCESS, V17, P1876, DOI 10.1109/TIP.2008.2002164; HUNTER RS, 1948, J OPT SOC AM, V38, P1094; ImagEval Consulting LLC, ISET CALC SYST MTF U; Kijima T, 2007, US Patent, Patent No. [20,070,177,236, 20070177236]; Kumar M, 2009, IEEE IMAGE PROC, P2681, DOI 10.1109/ICIP.2009.5414126; Lansel SP., 2011, THESIS; Lukac R, 2005, IEEE T CONSUM ELECTR, V51, P1260, DOI 10.1109/TCE.2005.1561853; Lukac R, 2006, 2006 23RD BIENNIAL SYMPOSIUM ON COMMUNICATIONS, P352, DOI 10.1109/BSC.2006.1644640; Mokrzycki W. S., 2011, Machine Graphics & Vision, V20, P383; Nafchi HZ, 2016, IEEE ACCESS, V4, P5579, DOI 10.1109/ACCESS.2016.2604042; OSTER G, 1964, J OPT SOC AM, V54, P169, DOI 10.1364/JOSA.54.000169; Parmar Manu, 2009, Proceedings of the SPIE - The International Society for Optical Engineering, V7250, DOI 10.1117/12.806367; POIRSON AB, 1993, J OPT SOC AM A, V10, P2458, DOI 10.1364/JOSAA.10.002458; Poirson AB, 1996, VISION RES, V36, P515, DOI 10.1016/0042-6989(96)89251-0; Reisenhofer R, 2018, SIGNAL PROCESS-IMAGE, V61, P33, DOI 10.1016/j.image.2017.11.001; Sajadi B, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964960; Sato I, 1983, US Patent, Patent No. [4,390,895, 4390895]; Sugiyama T, 2010, US Patent, Patent No. [7,746,394, 7746394]; Susanu G, 2008, US Patent, Patent No. [8,264,576, 8264576]; TEO PC, 1994, P SOC PHOTO-OPT INS, V2179, P127, DOI 10.1117/12.172664; University of London, COL FILT ARR DES MET; Vrhel M, 2005, IEEE SIGNAL PROC MAG, V22, P23, DOI 10.1109/MSP.2005.1407712; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; Williams D, 1998, IMAGE PROCESSING IMAGE QUALITY IMAGE CAPTURE SYSTEMS CONFERENCE, P133; Williams D., 2003, Proceedings of the SPIE - The International Society for Optical Engineering, V5294, P93, DOI 10.1117/12.532405; Winkler S, 1999, PROC SPIE, V3644, P175, DOI 10.1117/12.348438; Yamagami T., 1994, U.S. Patent, Patent No. [5,323,233, 5323233]; Yamanaka S., 1977, U.S. Patent, Patent No. [4 054 906, 4054906, 4,054,906]; Zhang X., 1997, Journal of the Society for Information Display, V5, P61, DOI 10.1889/1.1985127; Zhang XM, 1997, P SOC PHOTO-OPT INS, V3025, P154, DOI 10.1117/12.270048; Zhang XM, 1997, COMPCON IEEE, P44, DOI 10.1109/CMPCON.1997.584669; Zhang XM, 1998, SIGNAL PROCESS, V70, P201, DOI 10.1016/S0165-1684(98)00125-X; Zheng MC, 2015, AER ADV ENG RES, V13, P1	51	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232583	10.1371/journal.pone.0232583	http://dx.doi.org/10.1371/journal.pone.0232583			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392215	gold, Green Published			2022-12-26	WOS:000537470300013
J	Gavhi, F; Kuonza, L; Musekiwa, A; Motaze, NV				Gavhi, Fhatuwani; Kuonza, Lazarus; Musekiwa, Alfred; Motaze, Nkengafac Villyen			Factors associated with mortality in children under five years old hospitalized for Severe Acute Malnutrition in Limpopo province, South Africa, 2014-2018: A cross-sectional analytic study	PLOS ONE			English	Article							MALNOURISHED CHILDREN; SURVIVAL	Background In South Africa, 30.9% of children under five years with Severe Acute Malnutrition (SAM) died in 2018. We aimed to identify factors associated with mortality among children under five years hospitalized with SAM in Limpopo province, South Africa. Methods We conducted a cross-sectional study including children under five years admitted with SAM from 2014 to 2018 in public hospitals of Limpopo province. We extracted socio-demographic and clinical data from hospital records. We used logistic regression to identify factors associated with mortality. Findings We included 956 children, 50.2% (480/956) male and 49.8% (476/956) female. The median age was 13 months (inter quartile range: 9-19 months). The overall SAM mortality over the study period was 25.9% (248/956). The most common complications were diarrhea, 63.8% (610/956), and lower respiratory tract infections (LRTIs), 42.4% (405/956). Factors associated with mortality included herbal medication use (adjusted Odds Ratio (aOR): 2.2, 95% Confidence Interval (CI): 1.4-3.5, p = 0.001), poor appetite (aOR: 2.7, 95% CI: 1.4-5.2, p = 0.003), Mid-upper circumference (MUAC) < 11.5 cm (aOR: 3.0, 95% CI: 1.9-4.7, p< 0.001), lower respiratory tract infections (LRTIs) (aOR: 1.6, 95% CI: 1.2-2.0, p< 0.001), anemia (aOR: 2.5, 95% CI: 1.1-5.3, p = 0.021), hypoglycemia (aOR: 12.4, 95% CI: 7.1-21.8, p<0.001) and human immunodeficiency virus (HIV) infection (aOR: 2.3, 95% CI: 1.6-3.3, p< 0.001). Interpretation Herbal medication use, poor appetite, LRTIs, anemia, hypoglycemia, and HIV infection were associated with mortality among children with SAM. These factors should guide management of children with SAM.	[Gavhi, Fhatuwani; Kuonza, Lazarus; Motaze, Nkengafac Villyen] Natl Inst Communicable Dis, Div Natl Hlth Lab Serv, Johannesburg, South Africa; [Gavhi, Fhatuwani; Kuonza, Lazarus; Musekiwa, Alfred] Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa; [Kuonza, Lazarus] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Motaze, Nkengafac Villyen] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Global Hlth, Cape Town, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Pretoria; University of Witwatersrand; Stellenbosch University	Gavhi, F (corresponding author), Natl Inst Communicable Dis, Div Natl Hlth Lab Serv, Johannesburg, South Africa.; Gavhi, F (corresponding author), Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa.	fhatuwanigavhi@yahoo.com		Musekiwa, Alfred/0000-0001-5880-3680; Kuonza, Lazarus/0000-0001-5338-320X				Acevedo P, 2017, ENDOCRINOL DIAB NUTR, V64, P204, DOI 10.1016/j.endinu.2017.01.008; Anthony A., 2013, ASSESSMENT CLIN PRAC; Attia S, 2016, AM J CLIN NUTR, V104, P1441, DOI 10.3945/ajcn.116.130518; Bamford L, 2018, SAMJ S AFR MED J, V108, pS33, DOI 10.7196/SAMJ.2018.v108i3.12772; Benyera O, 2013, S AFR J CHILD HEALTH, V7, P135, DOI 10.7196/SAJCH.626; Bhutta ZA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.67; Bwakura-Dangarembizi M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023077; Chola L, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.27265; Dambisya YM., 2003, S AFRICA E AFR MED J, V80, P402, DOI DOI 10.4314/eamj.v80i8.8730; Desta K., 2015, J NUTR DISORD THER, V5, P160, DOI DOI 10.4172/2161-0509.1000160; Girum T, 2017, THER CLIN RISK MANAG, V13, P101, DOI 10.2147/TCRM.S119826; Hossain M, 2017, J PAEDIATR CHILD H, V53, P474, DOI 10.1111/jpc.13443; Limpopo Department of Health, 2016, ANN REPORT; Mambulu-Chikankheni FN, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0255-z; Massyn N., 2019, DISTRICT HEATH BAROM; Meera Shekar, 2016, Field Exchange - Emergency Nutrition Network ENN, P40; Munthali Tendai, 2017, BMC Res Notes, V10, P206, DOI 10.1186/s13104-017-2529-5; Munthali T, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0072-1; Muzigaba M, 2017, S AFR J CHILD HEALTH, V11, P46, DOI [10.7196/SAJCH.2017.v11i1.1202, 10.7196/sajch.2017v11i1.1202]; Muzigaba M, 2018, AFR J PRIM HEALTH CA, V10, DOI 10.4102/phcfm.v10i1.1547; Mwambete K D, 2010, Tanzan J Health Res, V12, P47; Nilsson M, 2016, NATURE, V534, P320, DOI 10.1038/534320a; Nxumalo N., 2014, WARD BASED COMMUNITY; Oumer A, 2016, E AFR J HLTH BIOMED, V1, P13; Posadzki P, 2013, CLIN MED, V13, P7, DOI 10.7861/clinmedicine.13-1-7; Rasmussen J, 2012, EUR J CLIN NUTR, V66, P998, DOI 10.1038/ejcn.2012.95; Statistic South Africa, 2018, S AFR MID POP EST 20; Stephen C., 2016, SAVING CHILDREN 2012; Taneja S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197832; Tette EMA, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0682-y; UNICEF, 2021, UNICEF DAT MON SIT C; UNICEF WHO, 2019, UNICEF WHO WORLD BAN; Wagnew F, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0309-x; World Health Organization, 2013, GUID UPD MAN SEV AC; Yohannes Tadele, 2017, BMC Nutr, V3, P18, DOI 10.1186/s40795-017-0135-5	35	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232838	10.1371/journal.pone.0232838	http://dx.doi.org/10.1371/journal.pone.0232838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384106	gold, Green Published			2022-12-26	WOS:000537468300033
J	Navarrete, E; DiAz-Villasenor, A; Diaz, G; Salazar, AM; Montufar-Chaveznava, R; Ostrosky-Wegman, P; Caldelas, I				Navarrete, Erika; Diaz-Villasenor, Andrea; Diaz, Georgina; Maria Salazar, Ana; Montufar-Chaveznava, Rodrigo; Ostrosky-Wegman, Patricia; Caldelas, Ivette			Misadjustment of diurnal expression of core temperature and locomotor activity in lactating rabbits associated with maternal over-nutrition before and during pregnancy	PLOS ONE			English	Article							HIGH-FAT DIET; CIRCADIAN-RHYTHMS; BODY-TEMPERATURE; GENE-EXPRESSION; INSULIN-RESISTANCE; METABOLIC SYNDROME; IN-UTERO; OBESITY; CLOCK; MODEL	Metabolic parameters ranging from circulating nutrient levels and substrate utilization to energy expenditure and thermogenesis are temporally modulated by the circadian timing system. During critical embryonic developmental periods, maternal over-nutrition could alter key elements in different tissues associated with the generation of circadian rhythmicity, compromising normal rhythmicity development. To address this issue, we determine whether maternal over-nutrition leads to alterations in the development of circadian rhythmicity at physiological and behavioral levels in the offspring. For this, female rabbits were fed a standard diet (SD) or high-fat and carbohydrate diet (HFCD) before mating and during gestation. Core body temperature and gross locomotor activity were continuously recorded in newborn rabbits, daily measurements of body weight and the amount of milk ingested was carried out. At the end of lactation, tissue samples, including brown adipose tissue (BAT) and white adipose tissue (WAT), were obtained for determining the expression of uncoupling protein-1 (UCP1) and cell death-inducing DNA fragmentation factor-like effector A (CIDEA) genes. HFCD pups exhibited conspicuous differences in the development of the daily rhythm of temperature and locomotor activity compared to the SD pups, including a significant increase in the daily mean core temperature, changes in the time when temperature or activity remains above the average, shifts in the acrophase, decrease in the duration and intensity of the anticipatory rise previous to nursing, and changes in frequency of the rhythms. HFCD pups exhibited a significant increase in BAT thermogenesis markers, and a decrease of these markers in WAT, indicating more heat generation by brown adipocytes and alterations in the browning process. These results indicate that maternal over-nutrition alters offspring homeostatic and chronostatic regulation at the physiological and behavioral levels. Further studies are needed to determine whether these alterations are associated with the changes in the organization of the circadian system of the progeny.	[Navarrete, Erika; Diaz-Villasenor, Andrea; Diaz, Georgina; Maria Salazar, Ana; Ostrosky-Wegman, Patricia; Caldelas, Ivette] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City, DF, Mexico; [Montufar-Chaveznava, Rodrigo] Univ Nacl Autonoma Mexico, Fac Ingn, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Caldelas, I (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City, DF, Mexico.	caldelas@biomedicas.unam.mx			CONACyT Fronteras de la Ciencia grant [398]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica grant [PAPIIT IN212516, PAPIIT IN211219]; Programa Institucional de Estrategias de Prevencion en Obesidad y Diabetes del Instituto de Investigaciones Biomedicas-UNAM	CONACyT Fronteras de la Ciencia grant; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica grant; Programa Institucional de Estrategias de Prevencion en Obesidad y Diabetes del Instituto de Investigaciones Biomedicas-UNAM	IC received the CONACyT Fronteras de la Ciencia grant (398), Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica grant (PAPIIT IN212516 and PAPIIT IN211219). IC, PO, AD and AMS received financial support of the Programa Institucional de Estrategias de Prevencion en Obesidad y Diabetes del Instituto de Investigaciones Biomedicas-UNAM.	Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205; Borengasser SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084209; Carroll JF, 1996, AM J PHYSIOL-HEART C, V271, pH373, DOI 10.1152/ajpheart.1996.271.1.H373; Castillo MR, 2005, PHYSIOL BEHAV, V86, P538, DOI 10.1016/j.physbeh.2005.08.018; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Coifman R. R., 1995, TRANSLATION INVARIAN, P125, DOI [10.1007/978-1-4612-2544-7, DOI 10.1007/978-1-4612-2544-7_9, 10.1007/978-1-4612-2544-7_9]; Corbalan-Tutau MD, 2011, CHRONOBIOL INT, V28, P425, DOI 10.3109/07420528.2011.574766; Cripps RL, 2009, CLIN SCI, V117, P85, DOI 10.1042/CS20080393; DAWKINS MJR, 1964, J PHYSIOL-LONDON, V172, P216, DOI 10.1113/jphysiol.1964.sp007414; Delezie J, 2011, ANN NY ACAD SCI, V1243, P30, DOI 10.1111/j.1749-6632.2011.06246.x; Desai M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.025; Deutsch J. A., 1957, British Journal of Animal Behaviour, V5, P53, DOI 10.1016/S0950-5601(57)80026-4; Di Cintio E, 2001, EUR J OBSTET GYN R B, V95, P132, DOI 10.1016/S0301-2115(00)00363-8; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425; Drummond H, 2000, ETHOLOGY, V106, P511, DOI 10.1046/j.1439-0310.2000.00554.x; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Fan J, 2000, J Atheroscler Thromb, V7, P26; Fannin D. R., 1998, SIGNALS SYSTEMS CONT; Favaron PO, 2019, PLACENTA, V81, P32, DOI 10.1016/j.placenta.2019.04.002; Flouris AD, 2017, HORM MOL BIOL CLIN I, V31, DOI 10.1515/hmbci-2016-0048; Fromme T, 2011, AM J PHYSIOL-REG I, V300, pR1, DOI 10.1152/ajpregu.00411.2010; FUKAGAWA K, 1992, AM J PHYSIOL, V263, pR1169, DOI 10.1152/ajpregu.1992.263.6.R1169; Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI 10.1293/tox.2013-0060; Garcia RA, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0081-2; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gupta A, 2009, J ENDOCRINOL, V200, P293, DOI 10.1677/JOE-08-0429; HAHN P, 1984, J NUTR, V114, P1231, DOI 10.1093/jn/114.7.1231; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hernandez-Higareda S, 2017, CIR CIR, V85, P292, DOI 10.1016/j.circir.2016.10.004; Hoffmann ME, 2012, OBESITY, V20, P1585, DOI 10.1038/oby.2011.380; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; HULL D, 1965, J PHYSIOL-LONDON, V177, P192, DOI 10.1113/jphysiol.1965.sp007585; Hynd PI, 2014, INT J OBESITY, V38, P231, DOI 10.1038/ijo.2013.110; Jilge B, 2001, CHRONOBIOL INT, V18, P1, DOI 10.1081/CBI-100001275; Arias-Mutis OJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178315; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Liang XW, 2016, J PHYSIOL-LONDON, V594, P4453, DOI 10.1113/JP272123; Bonet ML, 2017, BIOCHIMIE, V134, P99, DOI 10.1016/j.biochi.2016.12.014; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Martino TA, 2007, HYPERTENSION, V49, P1104, DOI 10.1161/HYPERTENSIONAHA.106.083568; Maskrey M, 2001, AM J PHYSIOL-REG I, V281, pR1675, DOI 10.1152/ajpregu.2001.281.5.R1675; Mendonca JEF, 2004, NUTR NEUROSCI, V7, P223, DOI 10.1080/10284150400010038; Montufar-Chaveznava R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074048; Murabayashi N, 2013, EUR J OBSTET GYN R B, V169, P39, DOI 10.1016/j.ejogrb.2013.02.003; MURAKAMI DM, 1995, AM J PHYSIOL-REG I, V269, pR1038, DOI 10.1152/ajpregu.1995.269.5.R1038; Nathanlelsz PW, 2007, CLIN PERINATOL, V34, P515, DOI 10.1016/j.clp.2007.09.005; Navarrete E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156539; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; OSBORNE AR, 1995, NEUROREPORT, V6, P2187, DOI 10.1097/00001756-199511000-00021; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccione G, 2011, INT J OBESITY, V35, P1011, DOI 10.1038/ijo.2010.253; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Savastano DM, 2009, AM J CLIN NUTR, V90, P1124, DOI 10.3945/ajcn.2009.27567; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Srivastava S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00038; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stunkard AJ, 2003, INT J OBESITY, V27, P1, DOI 10.1038/sj.ijo.0802186; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Sutton GM, 2010, ENDOCRINOLOGY, V151, P1570, DOI 10.1210/en.2009-1133; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Trejo-Munoz L, 2012, PHYSIOL BEHAV, V106, P587, DOI 10.1016/j.physbeh.2012.04.005; TUCKER GS, 1982, EXP BRAIN RES, V48, P263; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Viveros N., 2016, THESIS; Walker B E, 1999, Nutr Neurosci, V2, P19, DOI 10.1080/1028415X.1999.11747258; Wang DF, 2015, CHRONOBIOL INT, V32, P615, DOI 10.3109/07420528.2015.1025958; Waqar AB, 2010, ATHEROSCLEROSIS, V213, P148, DOI 10.1016/j.atherosclerosis.2010.07.051; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; ZARROW MX, 1965, SCIENCE, V150, P1835, DOI 10.1126/science.150.3705.1835; Zhang F, 2018, CELL METAB, V27, P252, DOI 10.1016/j.cmet.2017.12.004; Zhang XJ, 2008, J NUTR, V138, P515, DOI 10.1093/jn/138.3.515	83	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232400	10.1371/journal.pone.0232400	http://dx.doi.org/10.1371/journal.pone.0232400			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384084	Green Published, gold			2022-12-26	WOS:000537468300012
J	Li, SN; Peng, LB; Tan, CQ; Zeng, XH; Wan, XM; Luo, X; Yi, LD; Li, JH				Li, Sini; Peng, Liubao; Tan, Chongqing; Zeng, Xiaohui; Wan, Xiaomin; Luo, Xia; Yi, Lidan; Li, Jianhe			Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China	PLOS ONE			English	Article							ECONOMIC-EVALUATION; DOUBLE-BLIND; CHEMOTHERAPY; BEVACIZUMAB; COMBINATION; PERSPECTIVE; RAINBOW; PHASE	Aim That clinical trial (RAINBOW) showed that a 7.4 months overall survival benefit with the combination therapy with ramucirumab (RAM) and paclitaxel (PAC) as second-line therapy for patients with recurrent or metastatic gastric or gastro-oesophageal junction adenocarcinoma, compared with placebo (PLA) plus paclitaxel. We performed an analysis to assess the cost-effectiveness of RAM from a Chinese perspective and recognized the range of drug costs. Methods By building a Markov model to estimate quality-adjusted life-years (QALYs), life-years (LYs) and lifetime costs. Transition probabilities, costs and utilities were estimated for the published literature, Chinese health care system and local price setting. We performed threshold analyses and probabilistic sensitivity analyses to evaluate the uncertainty of the model. Results Compared with PLA strategy, RAM strategy provided an incremental survival benefit of 1.22 LYs and 0.64 QALYs. The probabilistic sensitivity analysis showed that when RAM costs less than $151 or $753 per 4 weeks, the incremental cost-effectiveness ratio (ICER) approximated the willingness-to-pay threshold (WTP), suggesting that there was 50% likelihood that the ICER for RAM + PAC would be less than $44528.4 per QALY or $48121 per QALY, respectively. Conclusions For patients with advanced gastric or gastro-oesophageal junction adenocarcinoma who fail first-line chemotherapy, our results are conducive to the multilateral drug price guidance negotiations of RAM in China.	[Li, Sini] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Peng, Liubao; Tan, Chongqing; Wan, Xiaomin; Luo, Xia; Yi, Lidan; Li, Jianhe] Cent South Univ, Xiangya Hosp 2, Dept Pharm, Changsha, Hunan, Peoples R China; [Zeng, Xiaohui] Cent South Univ, Xiangya Hosp 2, PET CT Ctr, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Li, JH (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Pharm, Changsha, Hunan, Peoples R China.	lijianhexy@126.com	Wan, Xiaomin/GPX-4388-2022	Li, Sini/0000-0002-1347-4024; /0000-0001-5315-8141				Boku N, 2014, GASTRIC CANCER, V17, P1, DOI 10.1007/s10120-013-0252-z; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buyukkaramikli NC, 2017, PHARMACOECONOMICS, V35, P1211, DOI 10.1007/s40273-017-0528-y; Choi YY, 2015, YONSEI MED J, V56, P1177, DOI 10.3349/ymj.2015.56.5.1177; Durkee BY, 2016, J CLIN ONCOL, V34, P902, DOI 10.1200/JCO.2015.62.9105; Goldstein DA, 2015, J CLIN ONCOL, V33, P3727, DOI 10.1200/JCO.2015.61.9569; Goldstein DA, 2015, J CLIN ONCOL, V33, P1112, DOI 10.1200/JCO.2014.58.4904; Greig SL, 2015, BIODRUGS, V29, P341, DOI 10.1007/s40259-015-0138-1; Gridelli C, 2014, J CANCER RES CLIN, V140, P1783, DOI 10.1007/s00432-014-1715-2; Juttner S, 2006, J CLIN ONCOL, V24, P228, DOI 10.1200/JCO.2004.00.3467; Lam SW, 2017, PHARMACOTHERAPY, V37, P94, DOI 10.1002/phar.1870; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Peng JY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199553; Peng LB, 2009, PHARMACOECONOMICS, V27, P873, DOI 10.2165/11314750-000000000-00000; Shitara K, 2016, GASTRIC CANCER, V19, P927, DOI 10.1007/s10120-015-0559-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Suzuki S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-659; Tan CQ, 2014, PHARMACOECONOMICS, V32, P235, DOI 10.1007/s40273-013-0065-2; Tan CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083396; Tao C, 2017, INT J CARDIOL, V240, P403, DOI 10.1016/j.ijcard.2017.05.003; The People's Bank of China, EXCH RAT; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Wan XM, 2017, CANCER-AM CANCER SOC, V123, P2634, DOI 10.1002/cncr.30666; Wan XM, 2019, BREAST, V43, P1, DOI 10.1016/j.breast.2018.10.004; WHO, GLOB 2012 EST STOM C; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Wu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032530; Wu B, 2012, CLIN THER, V34, P468, DOI 10.1016/j.clinthera.2012.01.012; Zeng XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088881	31	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232240	10.1371/journal.pone.0232240	http://dx.doi.org/10.1371/journal.pone.0232240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379763	Green Published, gold			2022-12-26	WOS:000537285700028
J	Garcia, LN; Leimgruber, C; Nicola, JP; Quintar, AA; Maldonado, CA				Noemi Garcia, Luciana; Leimgruber, Carolina; Pablo Nicola, Juan; Alfredo Quintar, Amado; Alicia Maldonado, Cristina			Neonatal endotoxin stimulation is associated with a long-term bronchiolar epithelial expression of innate immune and anti-allergic markers that attenuates the allergic response	PLOS ONE			English	Article							SURFACTANT PROTEIN-D; THYMIC STROMAL LYMPHOPOIETIN; CORD BLOOD-CELLS; CLARA CELLS; AIRWAY INFLAMMATION; MURINE MODEL; ALVEOLAR MACROPHAGES; EXPOSURE; ASTHMA; SENSITIZATION	Allergic asthma is the most common phenotype of the pathology, having an early-onset in childhood and producing a Th2-driven airways remodeling process that leads to symptoms and pathophysiological changes. The avoidance of aeroallergen exposure in early life has been shown to prevent asthma, but without repeated success and with the underlying preventive mechanisms at the beginning of asthma far to be fully recognized. In the present study, we aimed to evaluate if neonatal LPS-induced boost in epithelial host defenses contribute to prevent OVA-induced asthma in adult mice. To this, we focused on the response of bronchiolar club cells (CC), which are highly specialized in maintaining the epithelial homeostasis in the lung. In these cells, neonatal LPS administration increased the expression of TLR4 and TNF alpha, as well as the immunodulatory/antiallergic proteins: club cell secretory protein (CCSP) and surfactant protein D (SP-D). LPS also prevented mucous metaplasia of club cells and reduced the epidermal growth factor receptor (EGFR)-dependent mucin overproduction, with mice displaying normal breathing patterns after OVA challenge. Furthermore, the overexpression of the epithelial Th2-related molecule TSLP was blunted, and normal TSLP and IL-4 levels were found in the bronchoalveolar lavage. A lower eosinophilia was detected in LPS-pretreated mice, along with an increase in phagocytes and regulatory cells (CD4+CD25+FOXP3+ and CD4+IL-10+), together with higher levels of IL-12 and TNF alpha. In conclusion, our study demonstrates stable asthma-preventive epithelial effects promoted by neonatal LPS stimulation, leading to the presence of regulatory cells in the lung. These anti-allergic dynamic mechanisms would be overlaid in the epithelium, favored by an adequate epidemiological environment, during the development of asthma.	[Noemi Garcia, Luciana; Alfredo Quintar, Amado; Alicia Maldonado, Cristina] Univ Nacl Cordoba, Fac Ciencias Med, Ctr Microscopia Elect, Cordoba, Argentina; [Noemi Garcia, Luciana; Leimgruber, Carolina; Alfredo Quintar, Amado; Alicia Maldonado, Cristina] Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Ciencias Salud INICSA, Cordoba, Argentina; [Pablo Nicola, Juan] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Cordoba, Argentina; [Pablo Nicola, Juan] Consejo Nacl Invest Cient & Tecn CONICET, Ctr Invest Bioquim Clin & Inmunol CIBICI, Cordoba, Argentina	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Garcia, LN (corresponding author), Univ Nacl Cordoba, Fac Ciencias Med, Ctr Microscopia Elect, Cordoba, Argentina.; Garcia, LN (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Ciencias Salud INICSA, Cordoba, Argentina.	binlugarcia@gmail.com	Quintar, Amado/ABE-2764-2021	Garcia, Luciana/0000-0001-9837-2934	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET PIP 2014-2016) [112 201301 00108]; Secretaria de Ciencia y Tecnologia Universidad Nacional de Cordoba (SECyT-UNC); Agencia Nacional de Promocion Cientifica y Tecnologica-Ministerio de Ciencia y Tecnologia [PICT 2012-654]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET PIP 2014-2016); Secretaria de Ciencia y Tecnologia Universidad Nacional de Cordoba (SECyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Agencia Nacional de Promocion Cientifica y Tecnologica-Ministerio de Ciencia y Tecnologia(ANPCyTMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET PIP 2014-2016 No. 112 201301 00108 to CM), Secretaria de Ciencia y Tecnologia Universidad Nacional de Cordoba (SECyT-UNC, 2014-2015, 2015-2017 to CM and AQ), and Agencia Nacional de Promocion Cientifica y Tecnologica-Ministerio de Ciencia y Tecnologia (PICT 2012-654 to AQ and CM).	Basso B, 2004, VACCINE, V22, P1868, DOI 10.1016/j.vaccine.2003.11.013; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Blumer N, 2005, CLIN EXP ALLERGY, V35, P397, DOI 10.1111/j.1365-2222.2005.02184.x; Braun-Fahrlander C, 2003, CURR OPIN ALLERGY CL, V3, P325, DOI 10.1097/01.all.0000092600.10871.e0; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Ege MJ, 2008, J ALLERGY CLIN IMMUN, V122, P407, DOI 10.1016/j.jaci.2008.06.011; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Elizur A, 2007, AM J PHYSIOL-LUNG C, V293, pL383, DOI 10.1152/ajplung.00024.2007; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Frei R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091097; Freishtat RJ, 2011, AM J RESP CELL MOL, V44, P863, DOI 10.1165/rcmb.2010-0029OC; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Garcia LN, 2015, EXP BIOL MED, V240, P904, DOI 10.1177/1535370214562338; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gerhold K, 2002, PATHOBIOLOGY, V70, P255, DOI 10.1159/000070738; Gerhold K, 2003, J ALLERGY CLIN IMMUN, V112, P389, DOI 10.1067/mai.2003.1646; Gerhold K, 2008, INT ARCH ALLERGY IMM, V147, P25, DOI 10.1159/000128583; Gerhold K, 2006, J ALLERGY CLIN IMMUN, V118, P666, DOI 10.1016/j.jaci.2006.05.022; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Hartl D, 2006, EUR J CLIN INVEST, V36, P423, DOI 10.1111/j.1365-2362.2006.01648.x; Hawrylowicz C, 2010, NAT MED, V16, P274, DOI 10.1038/nm0310-274; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Holgate ST, 2010, CLIN SCI, V118, P439, DOI 10.1042/CS20090474; Holt PG, 2009, J EXP MED, V206, P2861, DOI 10.1084/jem.20092469; Holt PG, 1996, J EXP MED, V183, P1297, DOI 10.1084/jem.183.4.1297; Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x; Hrdy J, 2010, FOLIA MICROBIOL, V55, P515, DOI 10.1007/s12223-010-0085-7; Hung CH, 2004, J ALLERGY CLIN IMMUN, V114, P664, DOI 10.1016/j.jaci.2004.05.042; Jackson Daniel J, 2014, Ann Am Thorac Soc, V11 Suppl 3, pS139, DOI 10.1513/AnnalsATS.201312-448LD; Johansson S, 2007, J ALLERGY CLIN IMMUN, V120, P308, DOI 10.1016/j.jaci.2007.03.021; Johansson S, 2009, INFLAMMATION, V32, P65, DOI 10.1007/s10753-008-9103-1; Kuperman DA, 2005, J IMMUNOL, V175, P3746, DOI 10.4049/jimmunol.175.6.3746; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lin TH, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00440; Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4; Maldonado CA, 2011, HISTOL HISTOPATHOL, V26, P747, DOI 10.14670/HH-26.747; Martinez FD, 2011, J ALLERGY CLIN IMMUN, V128, P939, DOI 10.1016/j.jaci.2011.09.020; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nguyen Khoa D, 2010, Allergy Asthma Clin Immunol, V6, P4, DOI 10.1186/1710-1492-6-4; Nigo YI, 2006, P NATL ACAD SCI USA, V103, P2286, DOI 10.1073/pnas.0510685103; Pfefferle PI, 2008, J ALLERGY CLIN IMMUN, V122, P711, DOI 10.1016/j.jaci.2008.06.035; Polte T, 2008, J ALLERGY CLIN IMMUN, V122, P1022, DOI 10.1016/j.jaci.2008.09.014; Ray MK, 1996, J HISTOCHEM CYTOCHEM, V44, P919, DOI 10.1177/44.8.8756763; Ray R, 2006, FEBS LETT, V580, P6022, DOI 10.1016/j.febslet.2006.09.059; Reece P, 2011, J ALLERGY CLIN IMMUN, V127, P447, DOI 10.1016/j.jaci.2010.11.006; Renz H, 2002, J ALLERGY CLIN IMMUN, V109, P338, DOI 10.1067/mai.2002.121459; Reynolds SD, 2010, INT J BIOCHEM CELL B, V42, P1, DOI 10.1016/j.biocel.2009.09.002; Robinson M, 2012, IMMUNOL CELL BIOL, V90, P917, DOI 10.1038/icb.2012.47; Rohmann K, 2011, CELL TISSUE RES, V343, P167, DOI 10.1007/s00441-010-1048-7; Roth FD, 2007, HISTOCHEM CELL BIOL, V127, P55, DOI 10.1007/s00418-006-0220-3; Schaub B, 2004, CLIN EXP ALLERGY, V34, P1819, DOI 10.1111/j.1365-2222.2004.02068.x; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Shijubo N, 1999, LUNG, V177, P45, DOI 10.1007/PL00007626; Simpson A, 2010, CLIN EXP ALLERGY, V40, P209, DOI 10.1111/j.1365-2222.2009.03391.x; Snyder JC, 2010, AM J RESP CELL MOL, V42, P161, DOI 10.1165/rcmb.2008-0353OC; Sonar SS, 2012, EUR RESPIR J, V39, P429, DOI 10.1183/09031936.00197810; Strachan DP, 1996, ARCH DIS CHILD, V74, P422, DOI 10.1136/adc.74.5.422; Thaweerujirot C, 2019, ASIAN PAC J ALLERGY, V37, P123, DOI 10.12932/AP-060118-0232; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230; VOORHOUT WF, 1992, J HISTOCHEM CYTOCHEM, V40, P1589, DOI 10.1177/40.10.1527377; Wang JY, 2001, CLIN EXP ALLERGY, V31, P652, DOI 10.1046/j.1365-2222.2001.01031.x; Wang YF, 2006, J ALLERGY CLIN IMMUN, V118, P143, DOI 10.1016/j.jaci.2006.03.020; West Erin E, 2012, Drug Discov Today Dis Mech, V9, DOI 10.1016/j.ddmec.2012.09.003; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Wong CJ, 1996, PEDIATR RES, V39, P930, DOI 10.1203/00006450-199606000-00002; Yang R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00913; Zhou BH, 2008, J IMMUNOL, V181, P6557, DOI 10.4049/jimmunol.181.9.6557	70	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0226233	10.1371/journal.pone.0226233	http://dx.doi.org/10.1371/journal.pone.0226233			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379832	Green Published, gold			2022-12-26	WOS:000537285700004
J	Kang, N; Matsui, TS; Liu, SY; Fujiwara, S; Deguchi, S				Kang, Na; Matsui, Tsubasa S.; Liu, Shiyou; Fujiwara, Sachiko; Deguchi, Shinji			Comprehensive analysis on the whole Rho-GAP family reveals that ARHGAP4 suppresses EMT in epithelial cells under negative regulation by Septin9	FASEB JOURNAL			English	Article						ARHGAP4; epithelial-mesenchymal transition; FAK; Src pathway; Rho-GAP; Septin9	PROTEINS; MECHANISMS; MIGRATION; NETWORKS; DYNAMICS; GTPASES	Epithelial to mesenchymal transition (EMT) is a fundamental biological process that occurs during development and tumorigenesis. The Rho family of GTPases (Rho-family) is a well-characterized regulator of actin cytoskeleton that gives rise to EMT-associated cell activities. Meanwhile, there are in total at least 66 different Rho-GTPase-activating proteins (Rho-GAPs), which, as an upstream regulator, inactivate specific members of the Rho-family in a cell context-dependent manner. However, molecular roles of individual Rho-GAPs are poorly understood, particularly regarding their involvements in EMT. Here, based on comprehensive screening on the whole Rho-GAP family, we identified specific Rho-GAPs that are responsible for the maintenance of epithelial cell phenotypes, suppressing EMT in human mammary epithelial cells. Specifically, we revealed that at least two Rho-GAPs, that is, ARHGAP4 and SH3BP1, critically regulate the cell morphology. Among them, we focused on ARHGAP4 and demonstrated with multidisciplinary approaches that this specific Rho-GAP regulates epithelial/mesenchymal-selective marker expression, cell proliferation, migration, 3D morphogenesis, and focal adhesion/stress fiber-driven physical force generation in a manner reminiscent of the EMT process. Furthermore, we identified Septin9 with proteomic analyses as a negative regulator of ARHGAP4, which promotes the occurrence of EMT by activation of the FAK/Src signaling pathway. These findings shed light on the novel Rho-GAP-associated pathway in the EMT process under development and tumorigenesis.	[Kang, Na; Matsui, Tsubasa S.; Liu, Shiyou; Fujiwara, Sachiko; Deguchi, Shinji] Osaka Univ, Grad Sch Engn Sci, Div Bioengn, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan; [Fujiwara, Sachiko] Univ Leipzig, Inst Biol, Leipzig, Germany	Osaka University; Leipzig University	Deguchi, S (corresponding author), Osaka Univ, Grad Sch Engn Sci, Div Bioengn, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	deguchi@me.es.osaka-u.ac.jp		Fujiwara, Sachiko/0000-0002-5620-637X; Deguchi, Shinji/0000-0002-0556-4599	Chinese Scholarship Council; JSPS [15H03004, 18H03518]	Chinese Scholarship Council(China Scholarship Council); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Chinese Scholarship Council; JSPS, Grant/Award Number: 15H03004 and 18H03518	Amin E, 2016, J BIOL CHEM, V291, P20353, DOI 10.1074/jbc.M116.736967; Bahler M, 2011, BIOCHEM SOC T, V39, P1166, DOI 10.1042/BST0391166; Bai X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3910; Barrett T, 1997, NATURE, V385, P458, DOI 10.1038/385458a0; Basu Sayon, 2018, F1000Res, V7, DOI 10.12688/f1000research.15782.1; Berndt S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215140; Blangy A, 2017, BIOL CELL, V109, P115, DOI 10.1111/boc.201600053; Braun AC, 2015, J CELL SCI, V128, P1386, DOI 10.1242/jcs.163857; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; CICCHETTI P, 1995, EMBO J, V14, P3127, DOI 10.1002/j.1460-2075.1995.tb07315.x; Elbediwy A, 2012, J CELL BIOL, V198, P677, DOI 10.1083/jcb.201202094; Fuchtbauer A, 2011, BIOL CHEM, V392, P769, DOI 10.1515/BC.2011.088; Fujiwara S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195124; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; Han Y, 2019, AM J CANCER RES, V9, P800; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Harding MA, 2010, EUR J CANCER, V46, P1252, DOI 10.1016/j.ejca.2010.02.025; Hatzoglou A, 2007, MOL BIOL CELL, V18, P1242, DOI 10.1091/mbc.E06-06-0510; Huang GH, 2017, MOL CELL NEUROSCI, V80, P18, DOI 10.1016/j.mcn.2017.01.007; Hunter GL, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0625-9; Ichikawa T, 2017, J CELL SCI, V130, P3517, DOI 10.1242/jcs.200691; Insinna C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08192-9; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lazarini M, 2013, BBA-MOL BASIS DIS, V1832, P365, DOI 10.1016/j.bbadis.2012.11.010; Leggett SE, 2016, INTEGR BIOL-UK, V8, P1133, DOI 10.1039/c6ib00139d; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Matte BF, 2019, J CELL SCI, V132, DOI 10.1242/jcs.224360; Mead TJ, 2018, CELL REP, V23, P485, DOI 10.1016/j.celrep.2018.03.034; Nasrollahi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18831; Regev M, 2017, CELL ADHES MIGR, V11, P367, DOI 10.1080/19336918.2016.1227910; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rosa LRO, 2018, J CELL PHYSIOL, V233, P8477, DOI 10.1002/jcp.26829; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saenz-Narciso B, 2016, BIOESSAYS, V38, P1246, DOI 10.1002/bies.201600165; Shen L, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.48; Tajadura-Ortega V, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0489-4; Tang JY, 2019, EXP CELL RES, V374, P46, DOI 10.1016/j.yexcr.2018.11.007; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Ungefroren H, 2018, DEV DYNAM, V247, P11; Wang J, 2017, BMC BIOL, V15, DOI 10.1186/s12915-016-0335-5; Wang Z.B., 2011, INT J VIDEO IMAGE PR, V11, P13; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xu DC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0547-4; Xu Y, 2014, J IMMUNOL, V192, P3559, DOI 10.4049/jimmunol.1300695; Zhang Y, 2019, FASEB J, V33, P7822, DOI 10.1096/fj.201801936RRR; Zhao GX, 2019, ONCOGENE, V38, P4574, DOI 10.1038/s41388-019-0740-7	47	13	13	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8326	8340		10.1096/fj.201902750RR	http://dx.doi.org/10.1096/fj.201902750RR		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32378260	Bronze			2022-12-26	WOS:000530924700001
J	Widner, DL; Harris, KA; Corey, L; Breaker, RR				Widner, Danielle L.; Harris, Kimberly A.; Corey, Lukas; Breaker, Ronald R.			Bacillus haloduransOapB forms a high-affinity complex with the P13 region of the noncoding RNA OLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribonuclear protein (RNP); ribozyme; RNA-binding protein; RNA-protein interaction; Bacillus; Gram-positive bacteria; OapA; OLE RNA; OLE-associated protein; YbzG	SELF-SPLICING RNA; RULES	Noncoding RNAs (ncRNAs) longer than 200 nucleotides are rare in bacteria, likely because bacterial genomes are under strong evolutionary pressures to maintain a small genome size. Of the long ncRNAs unique to bacteria, the OLE (ornate, large, extremophilic) RNA class is among the largest and most structurally complex. OLE RNAs form a ribonucleoprotein (RNP) complex by partnering with at least two proteins, OapA and OapB, that directly bind OLE RNA. The biochemical functions of the OLE RNP complex remain unknown, but are required for proper adaptation to certain environmental stresses, such as cold temperatures, short chain alcohols, and high magnesium concentrations. In the current study, we used electrophoretic mobility shift assays to examine the binding of OLE RNA fragments by OapB and found that OapB recognizes a small subregion of OLE RNA, including stem P13, with a dissociation constant (K-D) of ?700 pm. Analyses with mutated RNA constructs, and the application ofin vitroselection, revealed that strong binding of OLE RNA by OapB requires a stem containing a precisely located single-nucleotide bulge and a GNRA tetraloop. Although the vast majority of bacteria with theolegene also have theoapBgene, there are many whose genomes containoapBbut lackole, suggesting that OapB has other RNA partners in some species that might exhibit similar structural features.	[Widner, Danielle L.; Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Harris, Kimberly A.; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; [Harris, Kimberly A.; Corey, Lukas; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Breaker, RR (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA.; Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	ronald.breaker@yale.edu			National Institutes of Health [GM022778, F32GM116426]; Foundation for the National Institutes of Health [T32GM007223]; Howard Hughes Medical Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by National Institutes of Health Grant F32GM116426 (to K. A. H.), National Institutes of Health Grant GM022778 (to D. L. W., K. A. H., L. C., and R. R. B.), Foundation for the National Institutes of Health Grant T32GM007223 (to D. L. W.), and the Howard Hughes Medical Institute (to D. L. W., K. A. H., L. C., and R. R. B). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; Block KF, 2011, MOL MICROBIOL, V79, P21, DOI 10.1111/j.1365-2958.2010.07439.x; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Correll CC, 2003, RNA, V9, P355, DOI 10.1261/rna.2147803; Costa M, 1997, EMBO J, V16, P3289, DOI 10.1093/emboj/16.11.3289; Fiore JL, 2013, Q REV BIOPHYS, V46, P223, DOI 10.1017/S0033583513000048; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Harris KA, 2019, MOL MICROBIOL, V112, P1552, DOI 10.1111/mmi.14379; Harris KA, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.RWR-0005-2017; Harris KA, 2018, P NATL ACAD SCI USA, V115, pE6319, DOI 10.1073/pnas.1803191115; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koo BM, 2017, CELL SYST, V4, P291, DOI 10.1016/j.cels.2016.12.013; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Kyrpides NC, 1996, TRENDS BIOCHEM SCI, V21, P425, DOI 10.1016/S0968-0004(96)30036-4; MOLINARO M, 1995, NUCLEIC ACIDS RES, V23, P3056, DOI 10.1093/nar/23.15.3056; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Puerta-Fernandez E, 2006, P NATL ACAD SCI USA, V103, P19490, DOI 10.1073/pnas.0607493103; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Takami H, 1999, BIOSCI BIOTECH BIOCH, V63, P943, DOI 10.1271/bbb.63.943; Wallace JG, 2011, LETT APPL MICROBIOL, V52, P430, DOI 10.1111/j.1472-765X.2011.03017.x; Wallace JG, 2012, NUCLEIC ACIDS RES, V40, P6898, DOI 10.1093/nar/gks352; Weinberg Z, 2017, NUCLEIC ACIDS RES, V45, P10811, DOI 10.1093/nar/gkx699; Weinberg Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-3; Weinberg Z, 2009, NATURE, V462, P656, DOI 10.1038/nature08586	26	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9326	9334		10.1074/jbc.RA120.012676	http://dx.doi.org/10.1074/jbc.RA120.012676			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32376692	hybrid, Green Published			2022-12-26	WOS:000552758600006
J	Chen, LF; Lyons, MR; Liu, F; Green, MV; Hedrick, NG; Williams, AB; Narayanan, A; Yasuda, R; West, AE				Chen, Liang-Fu; Lyons, Michelle R.; Liu, Fang; Green, Matthew V.; Hedrick, Nathan G.; Williams, Ashley B.; Narayanan, Arthy; Yasuda, Ryohei; West, Anne E.			The NMDA receptor subunit GluN3A regulates synaptic activity-induced and myocyte enhancer factor 2C (MEF2C)-dependent transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N?methyl?d?aspartate receptor (NMDA receptor; NMDAR); p38 MAPK; excitation-transcription coupling; neurodevelopment; brain-derived neurotrophic factor (BDNF); gene regulation; synaptic activity; mitogen-activated protein kinase (MAPK) signaling; glutamate receptor ionotropic NMDA (GluN); ionotropic glutamate receptor; MEF2 transcription factors	ACTIVATED PROTEIN-KINASE; NR3A-CONTAINING NMDARS; NUCLEAR TRANSLOCATION; BDNF TRANSCRIPTION; MAP KINASE; EXPRESSION; P38; MATURATION; PLASTICITY; MEF2	N-Methyl-d-aspartate type glutamate receptors (NMDARs) are key mediators of synaptic activity-regulated gene transcription in neurons, both during development and in the adult brain. Developmental differences in the glutamate receptor ionotropic NMDA 2 (GluN2) subunit composition of NMDARs determines whether they activate the transcription factor cAMP-responsive element-binding protein 1 (CREB). However, whether the developmentally regulated GluN3A subunit also modulates NMDAR-induced transcription is unknown. Here, using an array of techniques, including quantitative real-time PCR, immunostaining, reporter gene assays, RNA-Seq, and two-photon glutamate uncaging with calcium imaging, we show that knocking down GluN3A in rat hippocampal neurons promotes the inducible transcription of a subset of NMDAR-sensitive genes. We found that this enhancement is mediated by the accumulation of phosphorylated p38 mitogen-activated protein kinase in the nucleus, which drives the activation of the transcription factor myocyte enhancer factor 2C (MEF2C) and promotes the transcription of a subset of synaptic activity-induced genes, includingbrain-derived neurotrophic factor(Bdnf) andactivity-regulated cytoskeleton-associated protein(Arc). Our evidence that GluN3A regulates MEF2C-dependent transcription reveals a novel mechanism by which NMDAR subunit composition confers specificity to the program of synaptic activity-regulated gene transcription in developing neurons.	[Chen, Liang-Fu; Lyons, Michelle R.; Liu, Fang; Green, Matthew V.; Hedrick, Nathan G.; Williams, Ashley B.; Narayanan, Arthy; West, Anne E.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Yasuda, Ryohei] Max Planck Florida Inst Neurosci, Jupiter, FL USA	Duke University; Max Planck Society	West, AE (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	west@neuro.duke.edu			Ruth K. and Shepherd Broad Foundation; NIH [R01NS098804, DP1NS096787, R01MH080047]	Ruth K. and Shepherd Broad Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Ruth K. and Shepherd Broad Foundation and NIH grants R01NS098804 (to L. -F. C., F. L., M. V. G., A. B. W., A. N., and A. E. W.), DP1NS096787 (to N. G. H. and R. Y.) and R01MH080047 (to N. G. H. and R. Y.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Hallaq RA, 2002, MOL PHARMACOL, V62, P1119, DOI 10.1124/mol.62.5.1119; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Chan SF, 2001, J NEUROSCI, V21, P7985, DOI 10.1523/JNEUROSCI.21-20-07985.2001; Chen LF, 2019, CELL REP, V26, P1174, DOI 10.1016/j.celrep.2019.01.032; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Fiuza M, 2013, P NATL ACAD SCI USA, V110, P20807, DOI 10.1073/pnas.1312211110; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gang L, 2006, J BIOL CHEM, V281, P6087, DOI 10.1074/jbc.M507610200; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gong XW, 2010, J CELL BIOCHEM, V110, P1420, DOI 10.1002/jcb.22675; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Henson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042327; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Joo JY, 2016, NAT NEUROSCI, V19, P75, DOI 10.1038/nn.4170; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lyons MR, 2016, J NEUROCHEM, V137, P164, DOI 10.1111/jnc.13556; Lyons MR, 2012, J NEUROSCI, V32, P12780, DOI 10.1523/JNEUROSCI.0534-12.2012; Lyons MR, 2011, PROG NEUROBIOL, V94, P259, DOI 10.1016/j.pneurobio.2011.05.003; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; McDowell KA, 2010, J NEUROSCI, V30, P7453, DOI 10.1523/JNEUROSCI.3997-09.2010; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Pilli J, 2012, NEUROSCIENCE, V222, P75, DOI 10.1016/j.neuroscience.2012.07.020; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; West A E, 2014, Handb Exp Pharmacol, V220, P67, DOI 10.1007/978-3-642-45106-5_4; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wild AR, 2019, CELL REP, V26, P3537, DOI 10.1016/j.celrep.2019.03.005; Wyllie DJA, 2013, NEUROPHARMACOLOGY, V74, P4, DOI 10.1016/j.neuropharm.2013.01.016; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Zehorai E, 2014, MOL CELL BIOL, V34, P259, DOI 10.1128/MCB.00799-13; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	55	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8613	8627		10.1074/jbc.RA119.010266	http://dx.doi.org/10.1074/jbc.RA119.010266			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32393578	hybrid, Green Published			2022-12-26	WOS:000546986500025
J	Pandey, S; Ramsakha, N; Sharma, R; Gulia, R; Ojha, P; Lu, W; Bhattacharyya, S				Pandey, Saurabh; Ramsakha, Namrata; Sharma, Rohan; Gulia, Ravinder; Ojha, Prachi; Lu, Wei; Bhattacharyya, Samarjit			The post-synaptic scaffolding protein tamalin regulates ligand-mediated trafficking of metabotropic glutamate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; trafficking; internalization; G-protein coupled receptor; metabotropic glutamate receptors; neurotransmitter receptors; tamalin; S-SCAM; synaptic plasticity; endocytosis	LONG-TERM DEPRESSION; FRAGILE-X; SYNAPTIC PLASTICITY; PDZ DOMAIN; DESENSITIZATION; ENDOCYTOSIS; PHOSPHORYLATION; INTERNALIZATION; UBIQUITINATION; PHARMACOLOGY	Group I metabotropic glutamate receptors (mGluRs) play important roles in various neuronal functions and have also been implicated in multiple neuropsychiatric disorders like fragile X syndrome, autism, and others. mGluR trafficking not only plays important roles in controlling the spatiotemporal localization of these receptors in the cell but also regulates the activity of these receptors. Despite this obvious significance, the cellular machineries that control the trafficking of group I metabotropic glutamate receptors in the central nervous system have not been studied in detail. The post-synaptic scaffolding protein tamalin has been shown to interact with group I mGluRs and also with many other proteins involved in protein trafficking in neurons. Using a molecular replacement approach in mouse hippocampal neurons, we show here that tamalin plays a critical role in the ligand-dependent internalization of mGluR1 and mGluR5, members of the group I mGluR family. Specifically, knockdown of endogenous tamalin inhibited the ligand-dependent internalization of these two receptors. Both N-terminal and C-terminal regions of tamalin played critical roles in mGluR1 endocytosis. Furthermore, we found that tamalin regulates mGluR1 internalization by interacting with S-SCAM, a protein that has been implicated in vesicular trafficking. Finally, we demonstrate that tamalin plays a critical role in mGluR-mediated internalization of ?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, a process believed to be the cellular correlate for mGluR-dependent synaptic plasticity. Taken together, these findings reveal a mechanistic role of tamalin in the trafficking of group I mGluRs and suggest its physiological implications in the brain.	[Pandey, Saurabh; Ramsakha, Namrata; Sharma, Rohan; Gulia, Ravinder; Ojha, Prachi; Bhattacharyya, Samarjit] Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sas Nagar, Punjab, India; [Pandey, Saurabh; Lu, Wei] NINDS, Synapse & Neural Circuit Res Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Indian Institute of Science Education & Research (IISER) - Mohali; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Bhattacharyya, S (corresponding author), Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sas Nagar, Punjab, India.	samarjit@iisermohali.ac.in	Pandey, Saurabh/AHH-0237-2022; Gulia, Ravinder/AAD-3983-2021; Lu, Wei/S-5617-2018	Pandey, Saurabh/0000-0003-2340-4975; Bhattacharyya, Samarjit/0000-0002-7055-7555; Lu, Wei/0000-0001-6668-8432	Indian Institute of Science Education and Research Mohali; Department of Science and Technology, India [EMR/2016/005249]; CSIR fellowship; UGC fellowships; National Institutes of Health, NINDS intramural research program	Indian Institute of Science Education and Research Mohali; Department of Science and Technology, India(Department of Science & Technology (India)); CSIR fellowship(Council of Scientific & Industrial Research (CSIR) - India); UGC fellowships; National Institutes of Health, NINDS intramural research program	This work was supported by Indian Institute of Science Education and Research Mohali and a grant from Department of Science and Technology, India (Grant EMR/2016/005249). S.P. acknowledges receipt of a CSIR fellowship. N.R, R.S., and R.G. acknowledge receipt of UGC fellowships. P.O. acknowledges receipt of a fellowship from the Indian Institute of Science Education and Research Mohali. W.L. is supported by National Institutes of Health, NINDS intramural research program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anwyl R, 2006, PROG NEUROBIOL, V78, P17, DOI 10.1016/j.pneurobio.2005.12.001; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bhattacharyya S, 2016, INT J BIOCHEM CELL B, V77, P205, DOI 10.1016/j.biocel.2016.03.003; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Biou V, 2008, P NATL ACAD SCI USA, V105, P1038, DOI 10.1073/pnas.0711412105; Choi KY, 2011, J NEUROSCI, V31, P5921, DOI 10.1523/JNEUROSCI.6253-10.2011; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Citri A, 2009, EUR J NEUROSCI, V30, P1443, DOI 10.1111/j.1460-9568.2009.06950.x; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dale LB, 2002, NEUROCHEM INT, V41, P319, DOI 10.1016/S0197-0186(02)00073-6; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Francesconi A, 2000, P NATL ACAD SCI USA, V97, P6185, DOI 10.1073/pnas.97.11.6185; Gladding CM, 2009, PHARMACOL REV, V61, P395, DOI 10.1124/pr.109.001735; Gulia R, 2017, J BIOL CHEM, V292, P1426, DOI 10.1074/jbc.M116.752105; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Kim CH, 2008, J NEUROSCI RES, V86, P1, DOI 10.1002/jnr.21437; Kitano J, 2003, J BIOL CHEM, V278, P14762, DOI 10.1074/jbc.M300184200; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Mahato PK, 2015, NEUROSCIENCE, V306, P138, DOI 10.1016/j.neuroscience.2015.08.031; Mahato PK, 2018, ADV EXP MED BIOL, V1112, P163, DOI 10.1007/978-981-13-3065-0_12; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Mundell SJ, 2004, BIOCHEMISTRY-US, V43, P7541, DOI 10.1021/bi0359022; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pandey S, 2014, J NEUROCHEM, V131, P602, DOI 10.1111/jnc.12930; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Sallese M, 2000, FASEB J, V14, P2569, DOI 10.1096/fj.00-0072com; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma R, 2019, METHOD CELL BIOL, V149, P107, DOI 10.1016/bs.mcb.2018.08.008; Sharma R, 2018, J NEUROSCI, V38, P8605, DOI 10.1523/JNEUROSCI.0454-18.2018; Sugi T, 2007, EMBO J, V26, P2192, DOI 10.1038/sj.emboj.7601651; Trivedi RR, 2012, BIOCHEM BIOPH RES CO, V427, P185, DOI 10.1016/j.bbrc.2012.09.040; Wang H, 2009, SCIENCE, V326, P1554, DOI 10.1126/science.1178496	35	9	9	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8575	8588		10.1074/jbc.RA119.011979	http://dx.doi.org/10.1074/jbc.RA119.011979			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32376687	hybrid, Green Published			2022-12-26	WOS:000546986500021
J	Debaker, C; Djemai, B; Ciobanu, L; Tsurugizawa, T; Le Bihan, D				Debaker, Clement; Djemai, Boucif; Ciobanu, Luisa; Tsurugizawa, Tomokazu; Le Bihan, Denis			Diffusion MRI reveals in vivo and non-invasively changes in astrocyte function induced by an aquaporin-4 inhibitor	PLOS ONE			English	Article							INTRAVOXEL INCOHERENT MOTION; CEREBROSPINAL-FLUID; CSF FLOW; GADOLINIUM; CLEARANCE; TRANSPORT; SPACE; AQP4	The Glymphatic System (GS) has been proposed as a mechanism to clear brain tissue from waste. Its dysfunction might lead to several brain pathologies, including the Alzheimer's disease. A key component of the GS and brain tissue water circulation is the astrocyte which is regulated by acquaporin-4 (AQP4), a membrane-bound water channel on the astrocytic end-feet. Here we investigated the potential of diffusion MRI to monitor astrocyte activity in a mouse brain model through the inhibition of AQP4 channels with TGN-020. Upon TGN-020 injection, we observed a significant decrease in the Sindex, a diffusion marker of tissue microstructure, and a significant increase of the water diffusion coefficient (sADC) in cerebral cortex and hippocampus compared to saline injection. These results indicate the suitability of diffusion MRI to monitor astrocytic activity in vivo and non-invasively.	[Debaker, Clement; Djemai, Boucif; Ciobanu, Luisa; Tsurugizawa, Tomokazu; Le Bihan, Denis] NeuroSpin, Gif Sur Yvette, France		Tsurugizawa, T; Le Bihan, D (corresponding author), NeuroSpin, Gif Sur Yvette, France.	tsurugizawa@gmail.com; denis.lebihan@gmail.com	Tsurugizawa, Tomokazu/AAQ-4810-2020; Ciobanu, Luisa/E-7331-2014	Le Bihan, Denis/0000-0002-4454-729X; Ciobanu, Luisa/0000-0001-6932-6859	French National Research Agency project "MrGLY" [ANR-17-CE37-0010]	French National Research Agency project "MrGLY"(French National Research Agency (ANR))	This research was supported by a public grant of the French National Research Agency project "MrGLY", reference: ANR-17-CE37-0010, DLB=PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Badaut J, 2011, J CEREBR BLOOD F MET, V31, P819, DOI 10.1038/jcbfm.2010.163; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Boespflug EL, 2018, BIOL PSYCHIAT, V83, P328, DOI 10.1016/j.biopsych.2017.11.031; Demiral SB, 2019, NEUROIMAGE, V185, P263, DOI 10.1016/j.neuroimage.2018.10.043; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Fultz NE, 2019, SCIENCE, V366, P628, DOI 10.1126/science.aax5440; Gaberel T, 2014, STROKE, V45, P3092, DOI 10.1161/STROKEAHA.114.006617; Gakuba C, 2018, THERANOSTICS, V8, P710, DOI 10.7150/thno.19154; Hablitz LM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5447; Harrison IF, 2018, ELIFE, V7, DOI 10.7554/eLife.34028; Hsu MS, 2011, NEUROSCIENCE, V178, P21, DOI 10.1016/j.neuroscience.2011.01.020; Hubbard JA, 2015, ASN NEURO, V7, DOI 10.1177/1759091415605486; Igarashi H, 2013, NEUROREPORT, V24, P324, DOI 10.1097/WNR.0b013e32835fc827; Igarashi H, 2011, NEUROL SCI, V32, P113, DOI 10.1007/s10072-010-0431-1; Iima M, 2020, EUR RADIOL, V30, P2561, DOI 10.1007/s00330-019-06648-0; Iima M, 2016, RADIOLOGY, V278, P13, DOI 10.1148/radiol.2015150244; Iima M, 2015, INVEST RADIOL, V50, P205, DOI 10.1097/RLI.0000000000000094; Ikeshima-Kataoka H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081306; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; JOLESZ FA, 1987, INVEST RADIOL, V22, P761, DOI 10.1097/00004424-198710000-00001; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Keller D, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00083; Le Bihan D, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002203, 10.1371/journal.pbio.1002246]; Lilius TO, 2019, J CONTROL RELEASE, V304, P29, DOI 10.1016/j.jconrel.2019.05.005; Lizarbe Blanca, 2013, Front Neuroenergetics, V5, P6, DOI 10.3389/fnene.2013.00006; Mestre H, 2018, ELIFE, V7, DOI 10.7554/eLife.40070; Mukherjee A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13891; Nakada T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081798; Nedergaard M, 2016, SCI AM, V314, P44, DOI 10.1038/scientificamerican0316-44; Nicchia GP, 2003, FASEB J, V17, P1508, DOI 10.1096/fj.02-1183fje; Nishiyama S, 2016, Biochem Biophys Rep, V7, P45, DOI 10.1016/j.bbrep.2016.05.012; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Ohene Y, 2019, NEUROIMAGE, V188, P515, DOI 10.1016/j.neuroimage.2018.12.026; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Papadopoulos MC, 2008, PROG BRAIN RES, V170, P589, DOI 10.1016/S0079-6123(08)00446-9; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; Peres EA, 2018, INT J RADIAT ONCOL, V102, P1244, DOI 10.1016/j.ijrobp.2018.01.070; Ringstad G, 2017, BRAIN, V140, P2691, DOI 10.1093/brain/awx191; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Sepehrband F, 2019, NEUROIMAGE, V197, P243, DOI 10.1016/j.neuroimage.2019.04.070; Shen MD, 2013, BRAIN, V136, P2825, DOI 10.1093/brain/awt166; Shokri-Kojori E, 2018, P NATL ACAD SCI USA, V115, P4483, DOI 10.1073/pnas.1721694115; Simon MJ, 2016, BBA-MOL BASIS DIS, V1862, P442, DOI 10.1016/j.bbadis.2015.10.014; Taoka T, 2020, J MAGN RESON IMAGING, V51, P11, DOI 10.1002/jmri.26892; Taoka T, 2018, INVEST RADIOL, V53, P529, DOI 10.1097/RLI.0000000000000473; Taoka T, 2018, MAGN RESON MED SCI, V17, P111, DOI 10.2463/mrms.rev.2017-0116; Taoka T, 2017, JPN J RADIOL, V35, P172, DOI 10.1007/s11604-017-0617-z; Teng Z, 2018, AGING DIS, V9, P808, DOI 10.14336/AD.2017.1115; Thomas C, 2018, NEUROIMAGE, V173, P25, DOI 10.1016/j.neuroimage.2018.02.026; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xiong BY, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00128; Yamada S, 2008, RADIOLOGY, V249, P644, DOI 10.1148/radiol.2492071985	56	17	17	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0229702	10.1371/journal.pone.0229702	http://dx.doi.org/10.1371/journal.pone.0229702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413082	Green Submitted, Green Published, gold			2022-12-26	WOS:000537496000007
J	Fernandez-Ballesteros, R; Olmos, R; Perez-Ortiz, L; Sanchez-Izquierdo, M				Fernandez-Ballesteros, Rocio; Olmos, Ricardo; Perez-Ortiz, Lourdes; Sanchez-Izquierdo, Macarena			Cultural aging stereotypes in European Countries: Are they a risk to Active Aging?	PLOS ONE			English	Article							UNIVERSAL DIMENSIONS; SELF-PERCEPTIONS; CONTENT MODEL; OLDER-ADULTS; AGE; COMPETENCE; WARMTH; THREAT; ATTITUDES	A growing body of literature acknowledges the association between negative stereotypes and individual components of active aging, but very few studies have tested this association, at both individual and population levels. The Stereotypes Content Model (SCM) states that the cultural aging stereotyping of higher warmth than competence (called paternalistic or ambivalent prejudice) is universal. Our aims in this study are to test the extent to which the universality of this stereotype is confirmed in European Countries as well as how far "positive", "negative" or "ambivalent" views towards older people, and other negative attitudes such as prejudice and behaviours such as discrimination, predict active aging assessed both at individual and population levels. We have analyzed data from the European Social Survey-2008 (ESS-2008), containing SCM stereotypical and other appraisal items (such as direct prejudice and perceived discrimination) about adults aged over-70 from 29 European countries. First, SCM cultural stereotypes about older adults ("friendly", "competent", and "ambivalent") were calculated; secondly, after developing a typology of countries based on their "negative", "ambivalent" and "positive" views about older adults, the universality of cultural stereotypes was tested; thirdly, taking into consideration ESS data of those older persons (over 70s) who self-reported indicators of active aging (health, happiness, satisfaction and social participation), multilevel analyses were performed, taking our inter-individual measure of active aging as dependent variable and our stereotypical classification (positive/negative/ambivalent), direct prejudice and perceived discrimination as predictors; finally, relationships between stereotypical and appraisal items on older adults were examined at population level with country data from Active Aging Indexes. Our results show cultural stereotypes about older people (more friendly than competent) are widespread in most European countries, and negative cultural views of older adults are negatively associated with active aging both at individual and population level, supporting that negative cultural views of older adults could be considered as a threat to active aging.	[Fernandez-Ballesteros, Rocio] Autonomous Univ Madrid, Dept Psychobiol & Hlth, Madrid, Spain; [Olmos, Ricardo] Autonomous Univ Madrid, Dept Methodol, Madrid, Spain; [Perez-Ortiz, Lourdes] Autonomous Univ Madrid, Dept Sociol, Madrid, Spain; [Sanchez-Izquierdo, Macarena] Univ Pontificia Comillas, Dept Psychol, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Autonomous University of Madrid; Comillas Pontifical University	Sanchez-Izquierdo, M (corresponding author), Univ Pontificia Comillas, Dept Psychol, Madrid, Spain.	msizquierdo@comillas.edu	Izquierdo, Macarena Sánchez/X-1107-2018; Fernandez-Ballesteros, Rocio/C-6503-2011	Izquierdo, Macarena Sánchez/0000-0002-6444-0545; Fernandez-Ballesteros, Rocio/0000-0001-7357-9082; Olmos Albacete, Ricardo/0000-0002-1298-6861				Abdou CM, 2016, AM J PREV MED, V50, P191, DOI 10.1016/j.amepre.2015.07.034; Abrams D., 2011, PREDICTORS ATTITUDES; Abrams D., 2011, TECHNICAL REPORT; Ashmore Richard D., 1981, COGNITIVE PROCESSES; Brothers A, 2017, J AGING PHYS ACTIV, V25, P402, DOI 10.1123/japa.2016-0039; Burgess DJ, 2010, J GEN INTERN MED, V25, pS169, DOI 10.1007/s11606-009-1221-4; Bustillos A, 2012, REV MEX SALUD PUBLIC, V2, P104; Bustillos A, 2013, GEROPSYCH, V26, P211, DOI 10.1024/1662-9647/a000089; BUTLER RN, 1969, GERONTOLOGIST, V9, P243, DOI 10.1093/geront/9.4_Part_1.243; Caprara MG, 2018, CAMBRIDGE HDB SUCCES; Cook T.D., 1985, SOCIAL SCI SOCIAL PO, P21; Coudin G, 2010, AGING MENT HEALTH, V14, P516, DOI 10.1080/13607861003713182; COUSINS SO, 2000, J GERONTOL B-PSYCHOL, V55, pP28; Cuddy A.J.C., 2002, AGEISM STEREOTYPING, DOI 10.1017/CBO9781107415324.004; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Cuddy AJC, 2009, BRIT J SOC PSYCHOL, V48, P1, DOI 10.1348/014466608X314935; Durante F, 2013, BRIT J SOC PSYCHOL, V52, P726, DOI 10.1111/bjso.12005; Fernandez-Ballesteros R, 2019, CAMBRIDGE HDB SUCCES; Fernandez-Ballesteros R, 2018, CLIN INTERV AGING, V13, P1613, DOI 10.2147/CIA.S169487; Fernandez-Ballesteros R, 2017, ARCH GERONTOL GERIAT, V71, P14, DOI 10.1016/j.archger.2017.02.004; Fernandez-Ballesteros R, 2016, CLIN INTERV AGING, V11, DOI 10.2147/CIA.S96235; Fernandez-Ballesteros R, 2015, EXP AGING RES, V41, P410, DOI 10.1080/0361073X.2015.1053757; Fernandez-Ballesteros R, 2013, EDUC GERONTOL, V39, P119, DOI 10.1080/03601277.2012.699817; Fiske S. T, 1998, HDB SOCIAL PSYCHOL, P357, DOI DOI 10.1002/9780470561119; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Fiske ST, 1999, J SOC ISSUES, V55, P473, DOI 10.1111/0022-4537.00128; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Glick P, 1996, J PERS SOC PSYCHOL, V70, P491, DOI 10.1037/0022-3514.70.3.491; Hess TM, 2003, J GERONTOL B-PSYCHOL, V58, pP3, DOI 10.1093/geronb/58.1.P3; Hoffman L, 2015, MULTIVAR APPL SER, P1; Hummert M.L., 2011, HDB PSYCHOL AGING, P249, DOI [10.1016/B978-0-12-380882-0.00016-4, DOI 10.1016/B978-0-12-380882-0.00016-4]; Levy B, 1999, OMEGA-J DEATH DYING, V40, P409, DOI 10.2190/Y2GE-BVYQ-NF0E-83VR; Levy B, 2009, CURR DIR PSYCHOL SCI, V18, P332, DOI 10.1111/j.1467-8721.2009.01662.x; Levy BR, 2017, GERONTOLOGIST, V57, pS118, DOI 10.1093/geront/gnx059; Levy BR, 2016, PSYCHOL AGING, V31, P82, DOI 10.1037/pag0000062; Levy BR, 2015, J GERONTOL B-PSYCHOL, V70, P886, DOI 10.1093/geronb/gbu082; Levy BR, 2009, PSYCHOL AGING, V24, P230, DOI 10.1037/a0014563; Levy BR, 2009, PSYCHOL SCI, V20, P296, DOI 10.1111/j.1467-9280.2009.02298.x; Levy BR, 2002, J PERS SOC PSYCHOL, V83, P261, DOI 10.1037//0022-3514.83.2.261; Levy BR, 2005, PSYCHOL HEALTH, V20, P553, DOI 10.1080/14768320500066381; Levy BR, 2003, J GERONTOL B-PSYCHOL, V58, pP203, DOI 10.1093/geronb/58.4.P203; Nelson TD, 2002, STEREOTYPING PAD PRE; Nelson TD, 2016, J SOC ISSUES, V72, P191, DOI 10.1111/josi.12162; North MS, 2015, PSYCHOL BULL, V141, P993, DOI 10.1037/a0039469; North MS, 2012, PSYCHOL BULL, V138, P982, DOI 10.1037/a0027843; Palmore E., 1999, AGEISM NEGATIVE POSI; Sarkisian CA, 2005, J GEN INTERN MED, V20, P911, DOI 10.1111/j.1525-1497.2005.0204.x; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Swift HJ, 2017, SOC ISS POLICY REV, V11, P195, DOI 10.1111/sipr.12031; UN, 2002, 2 AS MUND ENV MADR E; Vauclair CM, 2016, PSYCHOL AGING, V31, P699, DOI 10.1037/pag0000125; Vauclair CM, 2015, J GERONTOL B-PSYCHOL, V70, P650, DOI 10.1093/geronb/gbu074; World Health Organization, 2002, ACT AG POL FRAM; Zaidi A., 2013, ACTIVE AGEING INDEX	54	5	5	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232340	10.1371/journal.pone.0232340	http://dx.doi.org/10.1371/journal.pone.0232340			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1BA	32413041	gold, Green Published			2022-12-26	WOS:000537496000014
J	Sanhoun, AR; Traore, SG; Gboko, KDT; Kirioua, J; Kurt, F; Otaru, N; Iten, P; Kaindi, DWM; Kreikemeyer, B; Renault, P; Dao, D; Hattendorf, J; Meile, L; Koussemon, M; Jans, C; Bonfoh, B				Sanhoun, Aime R.; Traore, Sylvain G.; Gboko, Kossia D. T.; Kirioua, Jerome; Kurt, Fabienne; Otaru, Nize; Iten, Patriz; Kaindi, Dasel W. M.; Kreikemeyer, Bernd; Renault, Pierre; Dao, Daouda; Hattendorf, Jan; Meile, Leo; Koussemon, Marina; Jans, Christoph; Bonfoh, Bassirou			Traditional milk transformation schemes in Cote d'Ivoire and their impact on the prevalence of Streptococcus bovis complex bacteria in dairy products	PLOS ONE			English	Article							BOVIS/STREPTOCOCCUS EQUINUS COMPLEX; INFANTARIUS SUBSP INFANTARIUS; MICROBIOLOGICAL QUALITY; FOOD SAFETY; RAW; IDENTIFICATION; COMMUNITIES; VARIANTS; EAST	The Streptococcus bovis/Streptococcus equinus complex (SBSEC) and possibly Streptococcus infantarius subsp. infantarius (Sii) are associated with human and animal diseases. Sii predominate in spontaneously fermented milk products with unknown public health effects. Sii/SBSEC prevalence data from West Africa in correlation with milk transformation practices are limited. Northern Cote d'Ivoire served as study area due to its importance in milk production and consumption and to link a wider Sudano-Sahelian pastoral zone of cross-border trade. We aimed to describe the cow milk value chain and determine Sii/ SBSEC prevalence with a cross-sectional study. Dairy production practices were described as non-compliant with basic hygiene standards. The system is influenced by secular sociocultural practices and environmental conditions affecting product properties. Phenotypic and molecular analyses identified SBSEC in 27/43 (62.8%) fermented and 26/67 (38.8%) unfermented milk samples. Stratified by collection stage, fermented milk at producer and vendor levels featured highest SBSEC prevalence of 71.4% and 63.6%, respectively. Sii with 62.8% and 38.8% as well as Streptococcus gallolyticus subsp. macedonicus with 7.0% and 7.5% were the predominant SBSEC species identified among fermented and unfermented milk samples, respectively. The population structure of Sii/SBSEC isolates seems to reflect evolving novel dairy-adapted, non-adapted and potentially pathogenic lineages. Northern Cote d'Ivoire was confirmed as area with high Sii presence in dairy products. The observed production practices and the high diversity of Sii/SBSEC supports in-depth investigations on Sii ecology niche, product safety and related technology in the dairy value chain potentially affecting large population groups across sub-Saharan Africa.	[Sanhoun, Aime R.; Koussemon, Marina] Univ Nangui Abrogoua, UFR Sci & Technol Aliments STA, Abidjan, Cote Ivoire; [Sanhoun, Aime R.; Traore, Sylvain G.; Gboko, Kossia D. T.; Dao, Daouda; Bonfoh, Bassirou] Ctr Suisse Rech Sci Code Ivre CSRS, Abidjan, Cote Ivoire; [Traore, Sylvain G.; Kirioua, Jerome] Univ Peleforo Gon Coulibaly, Dept Biochim Genet, Korhogo, Cote Ivoire; [Gboko, Kossia D. T.] Ecole Interetats Sci & Med Vet Dakar, Dakar, Senegal; [Kurt, Fabienne; Otaru, Nize; Iten, Patriz; Meile, Leo; Jans, Christoph] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Kaindi, Dasel W. M.] Univ Nairobi, Dept Food Sci Nutr & Technol, Nairobi, Kenya; [Kreikemeyer, Bernd] Rostock Univ, Med Ctr Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Renault, Pierre] INRA, UMR MICALIS 1319, Jouy En Josas, France; [Dao, Daouda] Univ Felix Houphouet Boigny, UFR Sci Econ & Gest SEG, Abidjan, Cote Ivoire; [Hattendorf, Jan; Bonfoh, Bassirou] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Hattendorf, Jan; Bonfoh, Bassirou] Univ Basel, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Nairobi; University of Rostock; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Jans, C (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland.	christoph.jans@hest.ethz.ch	Hattendorf, Jan/F-5371-2010	Hattendorf, Jan/0000-0002-1176-401X; Kurt, Fabienne/0000-0001-7950-2721; SANHOUN, Aime Roland/0000-0002-7443-3808; Jans, Christoph/0000-0003-0387-606X	ERAfrica program theme "New Ideas" project - Swiss National Science Foundation [ERAfrica_NI_021, IZEAZ0_154308]; DELTAS Africa Initiative [Afrique] [One-ASPIRE/DEL-15-008]; African Academy of Sciences (AAS); Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Wellcome Trust [107753/A/15/Z]; UK government	ERAfrica program theme "New Ideas" project - Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); DELTAS Africa Initiative [Afrique]; African Academy of Sciences (AAS); Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Wellcome Trust(Wellcome TrustEuropean Commission); UK government	This study was funded by the ERAfrica program theme "New Ideas" project No ERAfrica_NI_021 (all authors, Swiss Partners FK, NO, PI, JH, LM, CJ funded by the Swiss National Science Foundation Project No IZEAZ0_154308). This paper is partially based on work supported by the DELTAS Africa Initiative [Afrique One-ASPIRE/DEL-15-008]. Afrique One-ASPIRE is funded by a consortium of donors including the African Academy of Sciences (AAS), Alliance for Accelerating Excellence in Science in Africa (AESA), the New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency, the Wellcome Trust [107753/A/15/Z] and the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgadir W, 2008, INT J FOOD MICROBIOL, V127, P215, DOI 10.1016/j.ijfoodmicro.2008.07.008; Affessi AS, 2015, AGRON AFR, V27, P315; Ancey V., 1997, MODELE IVOIRIEN QUES, P669; Ben-Chetrit E, 2017, EUR J CLIN MICROBIOL, V36, P387, DOI 10.1007/s10096-016-2814-6; Bonfoh B, 2006, FOOD CONTROL, V17, P153, DOI 10.1016/j.foodcont.2004.09.015; Bonfoh B, 2003, FOOD CONTROL, V14, P495, DOI 10.1016/S0956-7135(02)00109-3; Cheng R, 2017, J FOOD PROTECT, V80, P57, DOI [10.4315/0362-028x.jfp-15-561, 10.4315/0362-028X.JFP-15-561]; Chimuti S., 2016, African Journal of Microbiology Research, V10, P1257; Claeys WL, 2014, FOOD CONTROL, V42, P188, DOI 10.1016/j.foodcont.2014.01.045; Elhadi YA, 2015, PASTORALISM, V5, DOI 10.1186/s13570-015-0028-7; FAO, 1995, APPR VILL AFR LAIT P; Fokou G., 2011, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V64, P81; Fokou G., 2010, AFR ST PROD ANIM, V8, P75; Franz CMAP, 2014, INT J FOOD MICROBIOL, V190, P84, DOI 10.1016/j.ijfoodmicro.2014.08.033; Gboko KDT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225452; Gevers D, 2001, FEMS MICROBIOL LETT, V205, P31, DOI 10.1016/S0378-1097(01)00439-6; GOLDENBERGER D, 1995, PCR METH APPL, V4, P368; ILRI CIAT ICARDA WorldFish Centre, 2011, CGIAR RES PROGR 3 7; ISO, 2010, 688752010 ISO; Jans C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00603; Jans C, 2017, FOOD MICROBIOL, V65, P64, DOI 10.1016/j.fm.2017.01.017; Jans C, 2017, INT J FOOD MICROBIOL, V250, P27, DOI 10.1016/j.ijfoodmicro.2017.03.012; Jans C, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0735-2; Jans C, 2013, INT J FOOD MICROBIOL, V167, P186, DOI 10.1016/j.ijfoodmicro.2013.09.008; Jans C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-200; Jans C, 2012, LWT-FOOD SCI TECHNOL, V47, P371, DOI 10.1016/j.lwt.2012.01.034; Jans C, 2012, FOOD MICROBIOL, V31, P33, DOI 10.1016/j.fm.2012.02.001; Jans C, 2012, FEMS MICROBIOL LETT, V326, P144, DOI 10.1111/j.1574-6968.2011.02443.x; Kaindi DWM, 2018, ACTA TROP, V178, P10, DOI 10.1016/j.actatropica.2017.10.018; Kaindi DWM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27383-4; Kalupahana R, 2016, FOOD CONTROL, V63, P128, DOI 10.1016/j.foodcont.2015.11.012; Kanoute YB, 2017, ACTA TROP, V165, P66, DOI 10.1016/j.actatropica.2016.02.012; Kouame-Sina SM, 2010, REV AFRICAINE SANTE, V5, P35; Kouame-Sina SM, 2012, FOOD NUTR BULL, V33, P223, DOI 10.1177/156482651203300402; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Musabyemariya B., 2011, THESIS; Njage PMK, 2012, AFR J MICROBIOL RES, V6, P6031, DOI 10.5897/AJMR11.1547; Njage PMK, 2012, AFR J MICROBIOL RES, V6, P1446, DOI 10.5897/AJMR11.1293; Odueke OB, 2016, FOOD BIOPROCESS TECH, V9, P751, DOI 10.1007/s11947-016-1709-y; Papadimitriou K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-272; PNIA, 2010, PRES PROGR RAPP EXP; Reta M.A., 2016, INT J FLOW CONTROL, V3, P2, DOI DOI 10.1186/S40550-016-0027-5; Secretariat Technique Permanent du Comite, 2014, RGPH 2014 REC GEN PO; Tankoano A., 2016, African Journal of Microbiology Research, V10, P535; Wafula W. N., 2016, International Journal of Food Contamination, V3, DOI 10.1186/s40550-016-0032-8; Wullschleger S, 2013, INT DAIRY J, V29, P28, DOI 10.1016/j.idairyj.2012.08.001; Yapo RI, INT J BIOL CHEM SCI, V10, P1433	47	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233132	10.1371/journal.pone.0233132	http://dx.doi.org/10.1371/journal.pone.0233132			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413097	gold, Green Published, Green Accepted			2022-12-26	WOS:000537496000050
J	Ahmadi, H; Nayeri, Z; Minuchehr, Z; Sabouni, F; Mohammadi, M				Ahmadi, Hosein; Nayeri, Zahra; Minuchehr, Zarrin; Sabouni, Farzaneh; Mohammadi, Mehdi			Betanin purification from red beetroots and evaluation of its anti-oxidant and anti-inflammatory activity on LPS-activated microglial cells	PLOS ONE			English	Article							LYSOSOMAL MEMBRANE PERMEABILIZATION; NITRIC-OXIDE; APOPTOSIS; NEUROINFLAMMATION; BETALAINS; PATHWAY; DEATH; TNF	Microglial activation can release free radicals and various pro-inflammatory cytokines, which implicates the progress of a neurodegenerative disease. Therefore suppression of microglial activation can be an appropriate strategy for combating neurodegenerative diseases. Betanin is a red food dye that acts as free radical scavenger and can be a promising candidate for this purpose. In this study, purification of betanin from red beetroots was carried out by normal phase colum chromatography, yielding 500 mg of betanin from 100 g of red beetroot. The purified betanin was evaluated by TLC, UV-visible, HPLC, ESI-MASS, FT-IR spectroscopy. Investigation on the inhibitory effect of betanin on activated microglia was performed using primary microglial culture. The results showed that betanin significantly inhibited lipopolysaccharide induced microglial function including the production of nitric oxide free radicals, reactive oxygen species, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and interleukin-1 beta (IL-1 beta). Moreover, betanin modulated mitochondrial membrane potential, lysosomal membrane permeabilization and adenosine triphosphate. We further investigated the interaction of betanin with TNF-alpha, IL-6 and Nitric oxide synthase (iNOS or NOS2) using in silico molecular docking analysis. The docking results demonstrated that betanin have significant negative binding energy against active sites of TNF-alpha, IL-6 and iNOS.	[Ahmadi, Hosein; Nayeri, Zahra; Sabouni, Farzaneh] Natl Inst Genet Engn & Biotechnol NIGEB, Inst Med Biotechnol, Dept Mol Med, Tehran, Iran; [Ahmadi, Hosein; Nayeri, Zahra; Minuchehr, Zarrin] Natl Inst Genet Engn & Biotechnol NIGEB, Inst Ind & Environm Biotechnol, Syst Biotechnol Dept, Tehran, Iran; [Ahmadi, Hosein; Mohammadi, Mehdi] Natl Inst Genet Engn & Biotechnol NIGEB, Bioproc Engn Dept, Inst Ind & Environm Biotechnol, Tehran, Iran		Sabouni, F (corresponding author), Natl Inst Genet Engn & Biotechnol NIGEB, Inst Med Biotechnol, Dept Mol Med, Tehran, Iran.; Mohammadi, M (corresponding author), Natl Inst Genet Engn & Biotechnol NIGEB, Bioproc Engn Dept, Inst Ind & Environm Biotechnol, Tehran, Iran.	sabouni@nigeb.ac.ir; m.mohammadi@nigeb.ac.ir		Nayeri, Zahra/0000-0003-3453-3190; Minuchehr, Zarrin/0000-0002-3734-745X	National Institute of Genetic Engineering and Biotechnology [595]	National Institute of Genetic Engineering and Biotechnology	This work was financially supported by the National Institute of Genetic Engineering and Biotechnology (grant number: 595) to FS.	Arulselvan P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5276130; Azeredo HMC, 2009, INT J FOOD SCI TECH, V44, P2365, DOI 10.1111/j.1365-2621.2007.01668.x; Blaser H, 2016, TRENDS CELL BIOL, V26, P249, DOI 10.1016/j.tcb.2015.12.002; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; Cai XY, 2018, REDOX BIOL, V18, P65, DOI 10.1016/j.redox.2018.06.010; Chang HR, 2014, J MED FOOD, V17, P1306, DOI 10.1089/jmf.2013.3037; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chun JM, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-234; Delgado-Vargas F, 2000, CRIT REV FOOD SCI, V40, P173, DOI 10.1080/10408690091189257; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Esatbeyoglu T, 2015, MOL NUTR FOOD RES, V59, P36, DOI 10.1002/mnfr.201400484; Feuerstein G, 1994, CYTOKINES INFLAMMATI; Fiebich BL, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00329; Gasztonyi MN, 2001, J SCI FOOD AGR, V81, P932, DOI 10.1002/jsfa.899; Ghosh M, 2011, FEBS LETT, V585, P623, DOI 10.1016/j.febslet.2010.12.043; Goncalves L, 2012, COMP STUDY PURIFICAT; Habibi Z, 2010, NAT PROD RES, V24, P1013, DOI 10.1080/14786410902885138; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Kallberg M, TEMPLATE BASED PROTE; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; McDonald DD, 2019, J AM ASSOC NURSE PRA, V31, P206, DOI 10.1097/JXX.0000000000000130; Nimse SB, 2015, RSC ADV, V5, P27986, DOI 10.1039/c4ra13315c; Nowacki L, 2015, PHYTOTHER RES, V29, P1964, DOI 10.1002/ptr.5491; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Owens T, 2009, CURR TOP MICROBIOL, V336, P105, DOI 10.1007/978-3-642-00549-7_6; Patel NK, 2014, NAT PROD COMMUN, V9, P661; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Phaniendra A, 2015, INDIAN J CLIN BIOCHE, V30, P11, DOI 10.1007/s12291-014-0446-0; Przyjemska M, 2012, PHYTOTHER RES, V26, P845, DOI [10.1002/ptr.3649, DOI 10.1002/PTR.3649]; Ransohoff RM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020560; Reddy Muntha K., 2005, RELATIVE INHIBITION; Saeed D., 2016, J NEUROL NEUROSURG S, V1; Schwede T, 2003, SWISS MODEL AUTOMATE; Sethi G, 2008, MOL CANCER THER, V7, P1604, DOI 10.1158/1535-7163.MCT-07-2424; Shalapour S, 2019, IMMUNITY, V51, P15, DOI 10.1016/j.immuni.2019.06.021; Shin EM, 2014, J CLIN INVEST, V124, P3807, DOI 10.1172/JCI73451; Shin SS, 2015, BIOL PHARM BULL, V38, P1081, DOI 10.1248/bpb.b15-00186; Sreekanth D, 2007, PHYTOMEDICINE, V14, P739, DOI 10.1016/j.phymed.2007.03.017; Tan DH, 2015, FOOD CHEM TOXICOL, V78, P141, DOI 10.1016/j.fct.2015.01.018; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Todoric J, 2019, CANCER CELL, V35, P714, DOI 10.1016/j.ccell.2019.04.001; Van den Bossche J, 2016, CELL REP, V17, P684, DOI 10.1016/j.celrep.2016.09.008; van Zutphen T, 2016, J HEPATOL, V65, P1198, DOI 10.1016/j.jhep.2016.05.046; Waisman A, 2015, TRENDS IMMUNOL, V36, P625, DOI 10.1016/j.it.2015.08.005; Yi YS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/270302; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou JY, 2019, BIOMED PHARMACOTHER, V111, P315, DOI 10.1016/j.biopha.2018.10.201	51	21	22	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0233088	10.1371/journal.pone.0233088	http://dx.doi.org/10.1371/journal.pone.0233088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401824	gold, Green Published			2022-12-26	WOS:000537481000053
J	Carlsen, EM; Renault, KM; Moller, BK; Norgaard, K; Jensen, JEB; Lauenborg, J; Cortes, D; Pryds, O				Carlsen, Emma Malchau; Renault, Kristina Martha; Moller, Bertha Kanijo; Norgaard, Kirsten; Jensen, Jens-Erik Beck; Lauenborg, Jeannet; Cortes, Dina; Pryds, Ole			Newborn body composition after maternal bariatric surgery	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; BIRTH-WEIGHT; PERINATAL OUTCOMES; PREGNANCY; OBESITY; OVERWEIGHT; ADIPOSITY; CHILDHOOD; GROWTH; WOMEN	Introduction In pregnancy after Roux-en-Y gastric bypass (RYGB), there is increased risk of low birthweight in the offspring. The present study examined how offspring body composition was affected by RYGB. Material and methods Mother-newborn dyads, where the mothers had undergone RYGB were included. Main outcome measure was neonatal body composition. Neonatal body composition was assessed by dual-energy X-ray absorptiometry scanning (DXA) within 48 hours after birth. In a statistical model offspring born after RYGB were compared with a reference material of offspring and analyses were made to estimate the effect of maternal pre-pregnancy body mass index (BMI), gestational weight gain, parity, gestational age at birth and newborn sex on newborn body composition. Analyses were made to estimate the impact of maternal weight loss before pregnancy and of other effects of bariatric surgery respectively. The study was performed at a university hospital between October 2012 and December 2013. Results We included 25 mother-newborn dyads where the mothers had undergone RYGB and compared them to a reference material of 311 mother-newborn dyads with comparable pre-pregnancy BMI. Offspring born by mothers after RYGB had lower birthweight ( 335g, p< 0.001), fat-free mass (268g, p< 0.001) and fat% (2.8%, p< 0.001) compared with reference material. Only 2% of the average reduction in newborn fat free mass could be attributed to maternal pre-pregnancy weight loss whereas other effects of RYGB accounted for 98%. Regarding reduction in fat mass 52% was attributed to weight loss and 47% to other effects of surgery. Conclusion Offspring born after maternal bariatric surgery, had lower birthweight, fat-free mass and fat percentage when compared with a reference material. RYGB itself and not the pre-pregnancy weight loss seems to have had the greatest impact on fetal growth.	[Carlsen, Emma Malchau; Moller, Bertha Kanijo; Cortes, Dina; Pryds, Ole] Univ Copenhagen, Hvidovre Hosp, Dept Pediat, Hvidovre, Denmark; [Renault, Kristina Martha] Univ Copenhagen, Hvidovre Hosp, Dept Obstet & Gynaecol, Hvidovre, Denmark; [Renault, Kristina Martha] Copenhagen Univ Hosp, Rigshosp, Obstet Clin, Copenhagen, Denmark; [Norgaard, Kirsten] Steno Diabet Ctr Copenhagen, Gentofte, Denmark; [Jensen, Jens-Erik Beck] Univ Copenhagen, Hvidovre Hosp, Dept Endocrinol, Hvidovre, Denmark; [Lauenborg, Jeannet] Univ Copenhagen, Herlev Hosp, Dept Obstet & Gynaecol, Herlev, Denmark; [Cortes, Dina] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Pryds, Ole] Randers Univ Hosp, Dept Pediat, Randers, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Carlsen, EM (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Pediat, Hvidovre, Denmark.	emc@dadlnet.dk		Jensen, Jens-Erik Beck/0000-0003-4290-0480; Carlsen, Emma Malchau/0000-0002-5563-1964; Cortes, Dina/0000-0002-6852-6530; Renault, Kristina Martha/0000-0002-6387-9652; Lauenborg, Jeannet/0000-0002-8485-3793	Hvidovre University Hospital	Hvidovre University Hospital	The study was funded by the Hvidovre University Hospital and the funding had no role in study design, data analysis, decision to publish or preparation of the manuscript.	Berglind D, 2014, PEDIATR OBES, V9, P427, DOI 10.1111/j.2047-6310.2013.00205.x; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Carlsen EM, 2014, ACTA PAEDIATR, V103, P939, DOI 10.1111/apa.12713; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; Charkamyani F, 2021, J MATERN-FETAL NEO M, V34, P1855, DOI 10.1080/14767058.2019.1651267; Cooke RJ, 2010, PEDIATR RES, V67, P660, DOI 10.1203/PDR.0b013e3181da8d01; Crozier SR, 2010, AM J CLIN NUTR, V91, P1745, DOI 10.3945/ajcn.2009.29128; de Knegt VE, 2015, J CLIN DENSITOM, V18, P117, DOI 10.1016/j.jocd.2014.08.004; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Dell'Agnolo CM, 2015, OBES SURG, V25, P2030, DOI 10.1007/s11695-015-1668-9; Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3; Gob CS, 2017, DIABETOLOGIA, V60, P2504, DOI 10.1007/s00125-017-4437-6; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hull HR, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.004; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2079, DOI 10.1210/jc.2007-2850; Jensen DM, 2003, AM J OBSTET GYNECOL, V189, P239, DOI 10.1067/mob.2003.441; Johansson K, 2015, NEW ENGL J MED, V372, P814, DOI 10.1056/NEJMoa1405789; Kjaer MM, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.046; Kjaer MM, 2013, ACTA OBSTET GYN SCAN, V92, P264, DOI 10.1111/aogs.12035; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Marsal K, 1992, ACTA PAEDIAT OSLO NO, V85, P843; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Mingrone G, 2015, LANCET, V386, P964, DOI 10.1016/S0140-6736(15)00075-6; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Rasmussen EL, 2005, DIABETES CARE, V28, P151, DOI 10.2337/diacare.28.1.151; Renault KM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.029; Roos N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6460; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Sewell MF, 2006, AM J OBSTET GYNECOL, V195, P1100, DOI 10.1016/j.ajog.2006.06.014; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Stentebjerg LL, 2017, J MATERN-FETAL NEO M, V30, P1182, DOI 10.1080/14767058.2016.1208746; Stephansson O, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002656; Stephansson O, 2016, NEW ENGL J MED, V375, P805, DOI 10.1056/NEJMc1516566	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0231579	10.1371/journal.pone.0231579	http://dx.doi.org/10.1371/journal.pone.0231579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401753	gold, Green Published			2022-12-26	WOS:000537481000004
J	Smith, RL; Sawbridge, T; Mann, R; Kaur, J; May, TW; Edwards, J				Smith, Reannon L.; Sawbridge, Tim; Mann, Ross; Kaur, Jatinder; May, Tom W.; Edwards, Jacqueline			Rediscovering an old foe: Optimised molecular methods for DNA extraction and sequencing applications for fungarium specimens of powdery mildew (Erysiphales)	PLOS ONE			English	Article							HERBARIUM SPECIMENS; AMPLIFICATION; IDENTIFICATION; EVOLUTION	The purpose of this study was to identify a reliable DNA extraction protocol to use on 25-year-old powdery mildew specimens from the reference collection VPRI in order to produce high quality sequences suitable to address taxonomic phylogenetic questions. We tested 13 extraction protocols and two library preparation kits and found the combination of the E.Z.N. A.(R) Forensic DNA kit for DNA extraction and the NuGen Ovation (R) Ultralow System library preparation kit was the most suitable for this purpose.	[Smith, Reannon L.; Sawbridge, Tim; Mann, Ross; Kaur, Jatinder; Edwards, Jacqueline] Dept Jobs Agr Victoria Res Reg & Precincts, Bundoora, Vic, Australia; [Smith, Reannon L.; Sawbridge, Tim; Edwards, Jacqueline] La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia; [May, Tom W.] Royal Bot Gardens Victoria, Melbourne, Vic, Australia	La Trobe University	Smith, RL (corresponding author), Dept Jobs Agr Victoria Res Reg & Precincts, Bundoora, Vic, Australia.; Smith, RL (corresponding author), La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia.	reannon.smith@agriculture.vic.gov.au	May, Tom/C-2460-2014	May, Tom/0000-0003-2214-4972; Edwards, Jacqueline/0000-0003-0310-7236; Smith, Reannon/0000-0002-3794-5900				Bebber DP, 2010, P NATL ACAD SCI USA, V107, P22169, DOI 10.1073/pnas.1011841108; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Braun U., 2012, TAXONOMIC MANUAL ERY; BRUNS TD, 1990, MYCOLOGIA, V82, P175, DOI 10.2307/3759846; Burrell AS, 2015, J HUM EVOL, V79, P35, DOI 10.1016/j.jhevol.2014.10.015; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Choi J, 2015, PEERJ, V3, DOI 10.7717/peerj.1087; Cunnington JH, 2004, AUSTRALAS PLANT PATH, V33, P281, DOI 10.1071/AP04017; Cunnington JH, 2003, AUSTRALAS PLANT PATH, V32, P421, DOI 10.1071/AP03045; Drabkova L, 2002, PLANT MOL BIOL REP, V20, P161, DOI 10.1007/BF02799431; Edgar R. C., 2004, NUCL ACIDS RES, V32; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Ellingham O, 2019, MYCOLOGIA, V111, P798, DOI 10.1080/00275514.2019.1643644; Feau N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018803; FISH S, 1970, ANNU REV PHYTOPATHOL, V8, P13, DOI 10.1146/annurev.py.08.090170.000305; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Glawe DA, 2008, ANNU REV PHYTOPATHOL, V46, P27, DOI 10.1146/annurev.phyto.46.081407.104740; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutaker RM, 2017, CURR OPIN PLANT BIOL, V36, P38, DOI 10.1016/j.pbi.2017.01.002; Hart ML, 2016, TAXON, V65, P1081, DOI 10.12705/655.9; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Hirata Tetsuya, 1996, Mycoscience, V37, P283, DOI 10.1007/BF02461299; Hyde KD, 2010, PERSOONIA, V25, P50, DOI 10.3767/003158510X548668; Kemp BM, 2006, J ARCHAEOL SCI, V33, P1680, DOI 10.1016/j.jas.2006.02.015; Li WB, 2006, J MICROBIOL METH, V65, P237, DOI 10.1016/j.mimet.2005.07.014; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lister DL, 2008, TAXON, V57, P254, DOI 10.2307/25065966; Matlock B., 2015, 52646 THERM SCI INC; Nascimento FS, 2016, J MICROBIOL METH, V130, P23, DOI 10.1016/j.mimet.2016.08.020; O'Rourke DH, 2000, ANNU REV ANTHROPOL, V29, P217, DOI 10.1146/annurev.anthro.29.1.217; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pintye A, 2012, PHYTOPATHOLOGY, V102, P707, DOI 10.1094/PHYTO-10-11-0270; Richards SM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209499; Ridout CJ, 2009, COMPR TREAT, V2, P51; Ristaino JB, 1998, PHYTOPATHOLOGY, V88, P1120, DOI 10.1094/PHYTO.1998.88.11.1120; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Shivas RG, 2006, AUSTRALAS PLANT PATH, V35, P195, DOI 10.1071/AP06003; Sproul JS, 2017, MOL ECOL RESOUR, V17, P1183, DOI 10.1111/1755-0998.12660; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Takamatsu S, 2000, MYCOL RES, V104, P1304, DOI 10.1017/S0953756200003014; Takamatsu S, 2010, PERSOONIA, V24, P38, DOI 10.3767/003158510X494596; Takamatsu Susumu, 2004, Mycoscience, V45, P147, DOI 10.1007/s10267-003-0159-3; Takamatsu S, 2013, J GEN PLANT PATHOL, V79, P218, DOI 10.1007/s10327-013-0447-5; Takamatsu Susumu, 2001, Mycoscience, V42, P135, DOI 10.1007/BF02463987; Takamatu S, 2008, MYCOL RES, V112, P299, DOI 10.1016/j.mycres.2007.11.014; Taylor JW, 1994, ANCIENT DNA RECOVERY, P165; Telle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003584; Thiers B., 2016, INDEX HERBARIUM; Urbanietz A, 2005, PLANT PATHOL, V54, P125, DOI 10.1111/j.1365-3059.2005.01156.x; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; Wiess CL, 2016, ROYAL SOC OPEN SCI, V3; Yoshida K, 2013, PLOS ELIFE, V2; Zeng CX, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0300-0	54	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232535	10.1371/journal.pone.0232535	http://dx.doi.org/10.1371/journal.pone.0232535			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0VG	32401807	Green Published, gold			2022-12-26	WOS:000537481000022
J	Talukdar, D; Seenivasan, S; Cameron, AJ; Sacks, G				Talukdar, Debabrata; Seenivasan, Satheesh; Cameron, Adrian J.; Sacks, Gary			The association between national income and adult obesity prevalence: Empirical insights into temporal patterns and moderators of the association using 40 years of data across 147 countries	PLOS ONE			English	Article							ECONOMIC-GROWTH; GLOBALIZATION; URBANIZATION; OVERWEIGHT; SMOKING	Background At a country level, population obesity prevalence is often associated with economic affluence, reflecting a potential adverse outcome concomitant with economic growth. We estimated the pattern and strength of the empirically observed relationship between national income and adult obesity prevalence, and the moderating role of countries' macro-environments on this relationship. Methods We assembled data on national obesity prevalence, income and a range of variables that characterize macro-environments related to 147 countries from multiple international organizations and databases. We used a Bayesian hierarchical model to estimate the relationship (elasticities) between national income (using Gross Domestic Product Per Capita, GDPPC) and adult obesity prevalence, and the moderating effects of five different dimensions (globalization orientation, demographic characteristics, economic environment, labor market characteristics, and strength of health policies) of countries' macro-environments on the income elasticities. Using the latest (2019-2024) available national income growth projections from the International Monetary Fund, we forecast future global trends in obesity prevalence. Findings Over the 40-years 1975-2014, adult obesity prevalence increased at a declining rate with GDPPC across the 147 countries. The mean income elasticity estimates were 1.23 (95% credible interval 1.04-1.42) for males and 1.01 (0.82-1.18) for females. The elasticities were positively associated with the extent of political globalization and negatively associated with urbanization and share of agriculture in the national GDP. Income based projections indicate that obesity prevalence would continue to grow at an average annual rate of 2.47% across the studied countries during 2019-2024. Conclusions Population obesity prevalence exhibits a positive relationship with national income and there is no evidence that the relationship, while weakening, actually turns negative at higher income levels ("obesity Kuznets curve"). Based on current trends, global obesity prevalence will continue to increase during 2019-2024, with the rate of growth higher in low- and middle-income countries. As most people currently live in low- and middle-income countries with rising incomes, our findings underscore the urgent societal imperatives for effective policy initiatives, especially those that target the concomitant "nutrition transition" process with economic affluence, to break or at least further weaken the positive relationship of population obesity prevalence with national income.	[Talukdar, Debabrata] SUNY Buffalo, Community Global Hlth Equ, Buffalo, NY 14260 USA; [Talukdar, Debabrata] SUNY Buffalo, Sch Management, Buffalo, NY 14260 USA; [Seenivasan, Satheesh] Monash Univ, Monash Business Sch, Dept Mkt, Melbourne, Vic, Australia; [Cameron, Adrian J.; Sacks, Gary] Deakin Univ, Global Obes Ctr, Geelong, Vic, Australia	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Monash University; Deakin University	Talukdar, D (corresponding author), SUNY Buffalo, Community Global Hlth Equ, Buffalo, NY 14260 USA.; Talukdar, D (corresponding author), SUNY Buffalo, Sch Management, Buffalo, NY 14260 USA.	dtalukda@buffalo.edu		Talukdar, Debabrata/0000-0001-6616-7581; Seenivasan, Satheesh/0000-0001-5489-1038	Australian Research Council [DE160100307, DE160100141]; NHMRC Centre of Research Excellence in Food Retail Environments for Health (Australia) [APP1152968]; Heart Foundation Future Leader Fellowship from the National Heart Foundation of Australia; NHMRC Centre for Research Excellence entitled Reducing Salt Intake Using Food Policy Interventions (Australia) [APP1117300]	Australian Research Council(Australian Research Council); NHMRC Centre of Research Excellence in Food Retail Environments for Health (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation Future Leader Fellowship from the National Heart Foundation of Australia; NHMRC Centre for Research Excellence entitled Reducing Salt Intake Using Food Policy Interventions (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	GS and AJC are recipients of Australian Research Council Discovery Early Career Researcher Awards (project numbers DE160100307 and DE160100141, respectively), and they are researchers within a NHMRC Centre of Research Excellence in Food Retail Environments for Health (APP1152968) (Australia). GS is also the recipient of a Heart Foundation Future Leader Fellowship from the National Heart Foundation of Australia, and he is a researcher within a NHMRC Centre for Research Excellence entitled Reducing Salt Intake Using Food Policy Interventions (APP1117300) (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Atkinson Kaitlin, 2016, Prev Med Rep, V3, P40, DOI 10.1016/j.pmedr.2015.11.009; Bagnall AM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6274-z; Befort CA, 2012, J RURAL HEALTH, V28, P392, DOI 10.1111/j.1748-0361.2012.00411.x; Bellisari A, 2008, OBES REV, V9, P165, DOI 10.1111/j.1467-789X.2007.00392.x; Bixby H, 2019, NATURE, V569, P260, DOI 10.1038/s41586-019-1171-x; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Canella DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092752; Courtemanche C, 2018, J HEALTH ECON, V57, P31, DOI 10.1016/j.jhealeco.2017.10.006; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; Dare S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123579; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Dobbs R., 2014, OVERCOMING OBESITY I; Dornelles A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219365; Dreher A, 2006, APPL ECON, V38, P1091, DOI 10.1080/00036840500392078; Egger G, 2012, ECON HUM BIOL, V10, P147, DOI 10.1016/j.ehb.2012.01.002; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Giles-Corti B, 2016, LANCET, V388, P2912, DOI 10.1016/S0140-6736(16)30066-6; Goryakin Y, 2015, SOC SCI MED, V133, P67, DOI 10.1016/j.socscimed.2015.03.030; Grecu AM, 2015, APPL ECON LETT, V22, P539, DOI 10.1080/13504851.2014.955251; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Institute for Health Metrics and Evaluation (IHME), 2018, FIND GLOB BURD DIS S; International Energy Agency and and the World Bank, 2019, SUST EN ALL SE4ALL D; International Labour Organization, 2019, ILO KEY IND LAB MARK; International Monetary Fund, 2019, WORLD EC OUTLOOK; International Telecommunications Union, 2018, WORLD TEL ICT DEV RE; Jaacks LM, 2019, LANCET DIABETES ENDO, V7, P231, DOI 10.1016/S2213-8587(19)30026-9; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Loureiro ML, 2005, AM J AGR ECON, V87, P1147, DOI 10.1111/j.1467-8276.2005.00800.x; Masood M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178928; Neuman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099327; Pampel FC, 2012, SOC SCI MED, V74, P1073, DOI 10.1016/j.socscimed.2011.12.028; Pickett KE, 2005, J EPIDEMIOL COMMUN H, V59, P670, DOI 10.1136/jech.2004.028795; Popkin BM, 2017, NUTR REV, V75, P73, DOI 10.1093/nutrit/nuw064; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Ralston J, 2018, LANCET, V392, P1384, DOI 10.1016/S0140-6736(18)32537-6; Rossi P. E., 2012, BAYESIAN STAT MARKET; Rybnikova NA, 2016, INT J OBESITY, V40, P815, DOI 10.1038/ijo.2015.255; South A, 2011, R J, V3, P3; Su DJ, 2012, J BIOSOC SCI, V44, P417, DOI 10.1017/S002193201100071X; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Talukdar D, 2002, MARKET SCI, V21, P97, DOI 10.1287/mksc.21.1.97.161; Templin T, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002968; UNESCO Institute for Statistics, 2019, DAT SUST DEV GOALS; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; Wells JCK, 2012, SOC SCI MED, V75, P482, DOI 10.1016/j.socscimed.2012.03.029; Windarti N, 2019, PUBLIC HEALTH, V169, P26, DOI 10.1016/j.puhe.2019.01.004; World Bank, WORLD DEV IND; World Health Organization, GLOB HLTH OBS DAT; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2015, INT REP COMM END CHI	54	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232236	10.1371/journal.pone.0232236	http://dx.doi.org/10.1371/journal.pone.0232236			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0VG	32401794	Green Published, gold			2022-12-26	WOS:000537481000011
J	Al-Zahrani, KN; Abou-Hamad, J; Cook, DP; Prycel, BR; Hodgins, JJ; Labreche, C; Robineau-Charette, P; de Souza, CT; Bell, JC; Auer, RC; Ardolino, M; Vanderhyden, BC; Sabourin, LA				Al-Zahrani, Khalid N.; Abou-Hamad, John; Cook, David P.; Prycel, Benjamin R.; Hodgins, Jonathan J.; Labreche, Cedrik; Robineau-Charette, Pascale; de Souza, Christiano T.; Bell, John C.; Auer, Rebecca C.; Ardolino, Michele; Vanderhyden, Barbara C.; Sabourin, Luc A.			Loss of the Ste20-like kinase induces a basal/stem-like phenotype in HER2-positive breast cancers	ONCOGENE			English	Article							MOUSE MODELS; SLK; ACTIVATION; CELLS; EXPRESSION; SOX10	HER2 is overexpressed in 20-30% of all breast cancers and is associated with an invasive disease and poor clinical outcome. The Ste20-like kinase (SLK) is activated downstream of HER2/Neu and is required for efficient epithelial-to-mesenchymal transition, cell cycle progression, and migration in the mammary epithelium. Here we show that loss of SLK in a murine model of HER2/Neu-positive breast cancers significantly accelerates tumor onset and decreases overall survival. Transcriptional profiling of SLK knockout HER2/Neu-derived tumor cells revealed a strong induction in the triple-negative breast cancer marker, Sox10, accompanied by an increase in mammary stem/progenitor activity. Similarly, we demonstrate that SLK and Sox10 expression are inversely correlated in patient samples, with the loss of SLK and acquisition of Sox10 marking the triple-negative subtype. Furthermore, pharmacological inhibition of AKT reduces SLK-null tumor growth in vivo and is rescued by ectopic Sox10 expression, suggesting that Sox10 is a critical regulator of tumor growth downstream of SLK/AKT. These findings highlight a role for SLK in negatively regulating HER2-induced mammary tumorigenesis and provide mechanistic insight into the regulation of Sox10 expression in breast cancer.	[Al-Zahrani, Khalid N.; Abou-Hamad, John; Cook, David P.; Prycel, Benjamin R.; Hodgins, Jonathan J.; Labreche, Cedrik; Robineau-Charette, Pascale; de Souza, Christiano T.; Bell, John C.; Auer, Rebecca C.; Ardolino, Michele; Vanderhyden, Barbara C.; Sabourin, Luc A.] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON K1H 8L6, Canada; [Al-Zahrani, Khalid N.; Abou-Hamad, John; Cook, David P.; Prycel, Benjamin R.; Labreche, Cedrik; Robineau-Charette, Pascale; Vanderhyden, Barbara C.; Sabourin, Luc A.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Hodgins, Jonathan J.; Bell, John C.; Auer, Rebecca C.; Ardolino, Michele] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Auer, Rebecca C.] Univ Ottawa, Dept Surg, Ottawa, ON K1H 8M5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Sabourin, LA (corresponding author), Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON K1H 8L6, Canada.; Sabourin, LA (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.	lsabourin@ohri.ca		Al-Zahrani, Khalid/0000-0001-5771-7537; Ardolino, Michele/0000-0003-4114-0985; Cook, David/0000-0001-7639-6724; Abou-Hamad, John/0000-0003-0138-1821	Canadian Breast Cancer Foundation; Canadian Institutes of Health Research; Ontario Graduate Scholarship; Cancer Research Society; Canadian Cancer Society Research Institute	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Cancer Research Society; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	KNA-Z and BRP are funded by the Canadian Breast Cancer Foundation. JA-H, JJH, and DPC are funded by scholarships from the Canadian Institutes of Health Research. PR-C is funded by an Ontario Graduate Scholarship. This study was supported by grants from the Canadian Breast Cancer Foundation, the Cancer Research Society, the Canadian Institutes of Health Research and the Canadian Cancer Society Research Institute. This work was also supported in part by a generous donation from Mr Eugene Tasse.	Al-Zahrani Khalid N, 2018, Oncotarget, V9, P33348, DOI 10.18632/oncotarget.26072; Al-Zahrani KN, 2013, CELL ADHES MIGR, V7, P1, DOI 10.4161/cam.22495; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Burnett JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15821; Chan CT, 2005, BREAST CANCER RES TR, V91, P187, DOI 10.1007/s10549-004-7715-1; Chen ZY, 2014, DEVELOPMENT, V141, P2691, DOI 10.1242/dev.108944; Cimino-Mathews A, 2013, HUM PATHOL, V44, P959, DOI 10.1016/j.humpath.2012.09.005; Conway J, 2017, ONCOTARGET, V8, P98745, DOI 10.18632/oncotarget.21928; Cossu-Rocca P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141763; Costa RLB, 2018, BREAST CANCER RES TR, V169, P397, DOI 10.1007/s10549-018-4697-y; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Dravis C, 2018, CANCER CELL, V34, P466, DOI 10.1016/j.ccell.2018.08.001; Dravis C, 2015, CELL REP, V12, P2035, DOI 10.1016/j.celrep.2015.08.040; Guilluy C, 2008, CIRC RES, V102, P1265, DOI 10.1161/CIRCRESAHA.107.164764; Gullick WJ, 1998, BREAST CANCER RES TR, V52, P43, DOI 10.1023/A:1006107016969; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hutchinson JN, 2004, CANCER RES, V64, P3171, DOI 10.1158/0008-5472.CAN-03-3465; Kim SB, 2017, LANCET ONCOL, V18, P1360, DOI 10.1016/S1470-2045(17)30450-3; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Liu H, 2018, CANCER DISCOV, V8, P354, DOI 10.1158/2159-8290.CD-17-0679; MANSOUR EG, 1994, CANCER, V74, P381, DOI 10.1002/cncr.2820741326; Menard S, 2000, J CELL PHYSIOL, V182, P150, DOI 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E; Neuzil J, 2007, BIOCHEM BIOPH RES CO, V355, P855, DOI 10.1016/j.bbrc.2007.01.159; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pryce BR, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-016-0119-1; Roovers K, 2009, ONCOGENE, V28, P2839, DOI 10.1038/onc.2009.146; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Wang K, 2018, NEOPLASMA, V65, P185, DOI 10.4149/neo_2018_170318N193; Wisinski KB, 2016, CLIN CANCER RES, V22, P2659, DOI 10.1158/1078-0432.CCR-15-2365; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Zuo Y, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-0966-2	35	5	5	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	23					4592	4602		10.1038/s41388-020-1315-3	http://dx.doi.org/10.1038/s41388-020-1315-3		MAY 2020	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LU5ZF	32393835				2022-12-26	WOS:000531771800001
J	Alamneh, AA; Endris, BS; Gebreyesus, SH				Alamneh, Alehegn Aderaw; Endris, Bilal Shikur; Gebreyesus, Seifu Hagos			Caffeine, alcohol, khat, and tobacco use during pregnancy in Butajira, South Central Ethiopia	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; MATERNAL SMOKING; RISK-FACTORS; COFFEE CONSUMPTION; BIRTH-WEIGHT; PREVALENCE; FETAL; CIGARETTE; TEA; ASSOCIATION	Background The use of excessive caffeine and consumption of alcohol, cigarette, and khat during pregnancy can result in adverse health effects on the fetus. The World Health Organization (WHO) recommends a daily caffeine intake not exceeding 300 mg. Likewise, pregnant women are recommended to avoid alcohol, khat and tobacco use. However, the prevalence's of the use of substances among pregnant women were not well studied in developing countries such as Ethiopia. Therefore, the study aimed to estimate the prevalence of caffeine and alcohol consumption, khat chewing, and tobacco use during pregnancy and identify key factors associated with excess caffeine consumption. Methods We conducted a community based cross-sectional study and used a random sampling technique to recruit 352 pregnant women. We adapted a questionnaire from Caffeine Consumption Questionnaire-Revised (CCQ-R), Alcohol Use Disorder Identification Test (AUDIT), Global Adult Tobacco Survey (GATS), and Ethiopian Demographic Health Survey 2016 for caffeine, alcohol consumption, tobacco use, and khat chewing assessment, respectively. We conducted non-consecutive two days 24-hour recall to determine the habitual intake of caffeine from caffeinated beverages and foods. Prevalence with 95% confidence interval was estimated for excess caffeine intake per day, alcohol consumption, khat chewing, and passive tobacco smoking. We ran a multivariable binary logistic regression model to identify factors associated with excess caffeine intake. Results Almost all pregnant women (98.2%) consumed caffeine as estimated using the 2 days 24-hour average. The median daily caffeine intake was 170.5 mg and ranged from 0.00 mg to 549.8 mg per day. In addition, 17.6% (95% CI: 13.9%, 22.0%) of them had a daily caffeine consumption of 300 mg and above exceeding the WHO recommended daily caffeine intake during pregnancy. The prevalence of alcohol consumption and Khat chewing were 10.0% (95% CI: 7.2%, 13.7%) and 35.8% (95% CI: 30.8, 41.0%) respectively. None of the pregnant women were active tobacco smokers. However, 23.2% (95% CI: 19.0, 28.0%) were passive tobacco smokers. We found that pregnant women in the richest wealth quintile (AOR = 3.66; 95% CI: 1.13, 11.88), and the first trimester of pregnancy (AOR = 4.04; 95% CI: 1.26, 13.05) had higher odds of consuming excessive caffeine. Conclusions The study showed a considerable magnitude of substance use among pregnant women in the study area. Given this findings, we recommend, programs and services focusing on pregnant women to consider addressing substance use.	[Alamneh, Alehegn Aderaw] Debre Markos Univ, Dept Human Nutr & Food Sci, Coll Hlth Sci, Debre Markos, Ethiopia; [Endris, Bilal Shikur; Gebreyesus, Seifu Hagos] Addis Ababa Univ, Dept Nutr & Dietet, Sch Publ Hlth, Addis Ababa, Ethiopia	Addis Ababa University	Alamneh, AA (corresponding author), Debre Markos Univ, Dept Human Nutr & Food Sci, Coll Hlth Sci, Debre Markos, Ethiopia.	alehegn12aderaw@gmail.com		Alamneh, Alehegn/0000-0002-1689-7356				ABEL EL, 1995, NEUROTOXICOL TERATOL, V17, P445, DOI 10.1016/0892-0362(95)98055-6; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P84, DOI 10.1111/j.1600-0447.1999.tb10699.x; American Pregnancy Association, CAFF INT PREGN; Anteab K, 2014, ASSESSMENT PREVALENC, V2014; Balwicki L, 2016, INT J PUBLIC HEALTH, V61, P111, DOI 10.1007/s00038-015-0735-2; Boggs DA, 2010, AM J CLIN NUTR, V92, P960, DOI 10.3945/ajcn.2010.29598; Chen LW, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0174-6; CSA Ethiopia and ICF, 2016, ETH DEM HLTH SURV 20; Cui Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084640; Demelash H, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0677-y; Dendir E, 2017, ETHIOP J HEALTH DEV, V31, P27; Dependence WECoD World Health Organization, 2006, 9241209429 WHO; Dupraz J, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13795; Ergin I, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-325; Gessesse D, 2013, FAVOURING DEMONISED; Global Adult Tobacco Survey Collaborative Group, 2011, TOB QUEST SURV SUBS; Goh GBB, 2014, HEPATOLOGY, V60, P661, DOI 10.1002/hep.27054; Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941; Grosso LM, 2008, ANN EPIDEMIOL, V18, P172, DOI 10.1016/j.annepidem.2007.11.005; Haile D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130460; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hanson M, 2011, AM J CLIN NUTR, V94, p1754S, DOI 10.3945/ajcn.110.001206; INFANTERIVARD C, 1993, JAMA-J AM MED ASSOC, V270, P2940, DOI 10.1001/jama.270.24.2940; International Food Information Council Foundation, 2008, CAFF HLTH CLAR CONTR; Irons Jessica G., 2016, Journal of Caffeine Research, V6, P20, DOI 10.1089/jcr.2015.0012; ISLAM MW, 1994, DRUG CHEM TOXICOL, V17, P51, DOI 10.3109/01480549409064046; JANSSON T, 1988, J ETHNOPHARMACOL, V23, P19, DOI 10.1016/0378-8741(88)90111-0; Jaruvongvanich V, 2017, CLIN RES HEPATOL GAS, V41, P46, DOI 10.1016/j.clinre.2016.05.012; Kawasaki Y, 2017, TOB INDUC DIS, V15, DOI 10.1186/s12971-017-0139-6; Kedir H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078601; Khawaja M, 2008, MATERN CHILD HLTH J, V12, P308, DOI 10.1007/s10995-007-0231-2; Lakew Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1820-4; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S6; Latino-Martel P, 2010, CANCER EPIDEM BIOMAR, V19, P1238, DOI 10.1158/1055-9965.EPI-09-1110; Lawson CC, 2004, REPROD TOXICOL, V18, P625, DOI 10.1016/j.reprotox.2004.03.004; Li T, 2016, INT J CLIN EXP MED, V9, P12109; LITTLE RE, 1993, AM J EPIDEMIOL, V137, P1177, DOI 10.1093/oxfordjournals.aje.a116620; Lyons Kerry, 2016, Nurs Stand, V31, P18; Manari AP, 2003, ADDICT BIOL, V8, P201, DOI 10.1080/1355621031000117437; Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012; Masho SW, 2013, MATERN CHILD HLTH J, V17, P1167, DOI 10.1007/s10995-012-1103-y; Matijasevich Alicia, 2005, Cad. Saúde Pública, V21, P1676, DOI 10.1590/S0102-311X2005000600014; MCDONALD AD, 1992, AM J PUBLIC HEALTH, V82, P87, DOI 10.2105/AJPH.82.1.87; Meghea CI, 2014, CENT EUR J PUBL HEAL, V22, P153, DOI 10.21101/cejph.a3947; Miller MW, 1996, BRAIN RES, V734, P286; Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279; Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840; Onwuka CI, 2016, J CLIN DIAGN RES, V10, pQC10, DOI 10.7860/JCDR/2016/21036.8449; Paradis AD, 2017, J EPIDEMIOL COMMUN H, V71, P889, DOI 10.1136/jech-2016-208511; Patra J, 2011, BJOG-INT J OBSTET GY, V118, P1411, DOI 10.1111/j.1471-0528.2011.03050.x; Popova S, 2017, BIOCH CELL BIOL; Popova S, 2017, COUNTING COSTS DRINK, V95, P320; Popova S, 2016, TROP MED INT HEALTH, V21, P1209, DOI 10.1111/tmi.12755; Veloso LUP, 2013, REV LAT-AM ENFERM, V21, P433, DOI 10.1590/S0104-11692013000100020; Rasch V, 2003, ACTA OBSTET GYN SCAN, V82, P182, DOI 10.1034/j.1600-0412.2003.00078.x; Rhee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132334; Santos C, 2010, J ALZHEIMERS DIS, V20, pS187, DOI 10.3233/JAD-2010-091387; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sbrana M, 2016, SAO PAULO MED J, V134, P146, DOI 10.1590/1516-3180.2015.02040211; Sebastiani G, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081008; Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42; Shen HF, 2016, THER ADV GASTROENTER, V9, P113, DOI 10.1177/1756283X15593700; Smith L, 2014, MIDWIFERY, V30, P1173, DOI 10.1016/j.midw.2014.04.002; Tanaka K, 2017, TOB INDUC DIS, V15, DOI 10.1186/s12971-017-0138-7; Torp-Pedersen T, 2010, AM J EPIDEMIOL, V171, P868, DOI 10.1093/aje/kwq010; Walton HB, 2013, SCOT MED J, V58, P217, DOI 10.1177/0036933013507869; Werler MM, 2015, PAEDIATR PERINAT EP, V29, P3, DOI 10.1111/ppe.12163; WEST JR, 1994, METAB BRAIN DIS, V9, P291, DOI 10.1007/BF02098878; WHO, 2022, WHO RECOMMENDATIONS; Wisborg K, 2003, BRIT MED J, V326, P420, DOI 10.1136/bmj.326.7386.420; Wondimkun Z.T., 2016, AM J APPL CHEM, V4, P59, DOI [DOI 10.11648/J.AJAC.20160402.14, 10.11648/j.ajac.20160402.14]; World Health Organization, RESTR CAFF INT PREGN; World Health Organization, 2013, WHO GUID APPR GUID R; Yoseph M.E., 2013, CULTURE COFFEE TRANS; Zdravkovic T, 2005, PLACENTA, V26, pS81, DOI 10.1016/j.placenta.2005.02.003	75	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232712	10.1371/journal.pone.0232712	http://dx.doi.org/10.1371/journal.pone.0232712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0QJ	32384102	gold, Green Published			2022-12-26	WOS:000537468300027
J	Ahmed, J; Alam, A; Khokhar, S; Khowaja, S; Kumar, R; Greenow, CR				Ahmed, Jamil; Alam, Ashraful; Khokhar, Saadat; Khowaja, Sadiq; Kumar, Ramesh; Greenow, Camille Raynes			Exploring women's experience of healthcare use during pregnancy and childbirth to understand factors contributing to perinatal deaths in Pakistan: A qualitative study	PLOS ONE			English	Article							PREVENTABLE DEATHS; NEONATAL-MORTALITY; CESAREAN-SECTION; STILLBIRTHS; RATES	Understanding key healthcare system challenges experienced by women during pregnancy and birth is crucial to scale up available interventions and reduce perinatal mortality. A community perspective about preferences and experience of care during this period can be used to improve community-based programs to reduce perinatal mortality. Using a qualitative exploratory approach, we examined women's experience of perinatal loss, aiming to understand the main factors, as perceived and experienced by women, leading to perinatal loss. Qualitative in-depth Interviews were conducted with 25 mothers with a recent perinatal loss, three family members, six healthcare officials, and two focus group discussions with 17 lady health workers. Data were analysed using inductive and deductive coding, by thematic analysis. Our findings revealed three distinct but interrelated themes, which include: 1) poor access to care during pregnancy and birth, 2) unavailability of appropriate healthcare services, and 3) poor quality of care during pregnancy and birth. Women frequently delayed seeking formal care around birth because of delays by themselves, their family members, or the local traditional birth attendants who frequently induced births at women's homes without recognising the dangers to the mothers or their babies. Preference for private care was common, however they often could not bear the cost of care when they needed caesarean section or in-patient care for their sick newborns because these services were absent in public health facilities of the district. Referral to the regional tertiary care hospital was often not officially arranged leading to risky births in small and crowded private clinics. Women's views about negative staff attitudes and the lack of attention given to them in public health facilities highlighted a lack of quality and respectful antenatal care. Improvement in women's access to essential care during pregnancy and around birth, availability of emergency obstetric and newborn care, improving the quality of maternal and newborn care in both public and private health facilities at the district level might reduce perinatal mortality in Pakistan.	[Ahmed, Jamil] Arabian Gulf Univ, Coll Med & Med Sci, Dept Family & Community Med, Manama, Bahrain; [Ahmed, Jamil; Alam, Ashraful; Greenow, Camille Raynes] Univ Sydney, Sydney Sch Publ Hlth, Camperdown, NSW, Australia; [Khokhar, Saadat] JHPIEGO Pakistan, Lahore, Pakistan; [Khowaja, Sadiq] Dist Hlth Off Tando Muhammad Khan, Sindh, Pakistan; [Kumar, Ramesh] Hlth Serv Acad, Islamabad, Pakistan	Arabian Gulf University; University of Sydney; Jhpiego; Health Services Academy	Ahmed, J (corresponding author), Arabian Gulf Univ, Coll Med & Med Sci, Dept Family & Community Med, Manama, Bahrain.; Ahmed, J (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Camperdown, NSW, Australia.	jahm3675@sydney.edu.au	Kumar, Ramesh/O-1479-2019; ahm, Ja/GLS-0443-2022	Kumar, Ramesh/0000-0002-9701-3179; ahm, Ja/0000-0002-3635-7912; Alam, Neeloy Ashraful/0000-0001-7034-1095	Postgraduate Research Support Scheme of the University of Sydney, Australia; Research Student Grant Scheme of the University of Sydney, Australia; NHMRC CDF [1086062]; Robinson Fellowship, University of Sydney	Postgraduate Research Support Scheme of the University of Sydney, Australia; Research Student Grant Scheme of the University of Sydney, Australia; NHMRC CDF(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Robinson Fellowship, University of Sydney	This work was supported by Postgraduate Research Support Scheme and Research Student Grant Scheme of the University of Sydney, Australia. CRG was funded by an NHMRC CDF #1086062, and a Robinson Fellowship, University of Sydney.	Agha S, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0201-5; Agrawal P, 2014, LANCET GLOB HEALTH, V2, pE133, DOI 10.1016/S2214-109X(14)70006-3; Ahmed J., 2018, J GLOBAL HLTH REPORT, V2, DOI [10.29392/joghr.2.e2018030, DOI 10.29392/JOGHR.2.E2018030]; Alliance for M, 2018, LANCET GLOB HLTH; Ansari MS, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0042-7; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Christou A, 2019, COMMUNITY HEALTHCARE; de Bernis L, 2016, LANCET, V387, P703, DOI 10.1016/S0140-6736(15)00954-X; Dickson KE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S1; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Hameed W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194601; Janjua NZ, 2005, INT J QUAL HEALTH C, V17, P401, DOI 10.1093/intqhc/mzi048; Jehan I, 2009, B WORLD HEALTH ORGAN, V87, P130, DOI 10.2471/BLT.08.050963; Kayode GA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1061-2; Khan AA, 2012, J PAK MED ASSOC, V62, P1149; Khan MS, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7326-8; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Mannava P, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0117-9; Mathai M, 2016, BJOG-INT J OBSTET GY, V123, P569, DOI 10.1111/1471-0528.13344; National institute of population studies, 2018, PAK DEM HLTH SURV PD; Okawa S, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001078; Ologunde R, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.022; Patel AB, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2302-4; Paudel M, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-018-0148-y; Smith GCS, 2017, BEST PRACT RES CL OB, V38, P71, DOI 10.1016/j.bpobgyn.2016.08.002; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P993, DOI 10.1111/tmi.12121; ten Hoope-Bender P, 2016, LANCET, V387, pE14, DOI 10.1016/S0140-6736(15)01277-5; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thorsen VC, 2011, BMC NURS, V10, DOI 10.1186/1472-6955-10-9; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Treacy L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188280; Upadhyay RP, 2013, J TROP PEDIATRICS, V59, P100, DOI 10.1093/tropej/fms060; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S7; Ye J, 2016, BJOG-INT J OBSTET GY, V123, P745, DOI 10.1111/1471-0528.13592; Yoshida S, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010508; Zafar S, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0039-2	38	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232823	10.1371/journal.pone.0232823	http://dx.doi.org/10.1371/journal.pone.0232823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZX	32379843	gold, Green Published			2022-12-26	WOS:000537285700070
J	Ipa, M; Widawati, M; Laksono, AD; Kusrini, I; Dhewantara, PW				Ipa, Mara; Widawati, Mutiara; Laksono, Agung Dwi; Kusrini, Ina; Dhewantara, Pandji Wibawa			Variation of preventive practices and its association with malaria infection in eastern Indonesia: Findings from community-based survey	PLOS ONE			English	Article							RISK; TRANSMISSION; NETS	Background Geographical variation may likely influence the effectiveness of prevention efforts for malaria across Indonesia, in addition to factors at the individual level, household level, and contextual factors. This study aimed to describe preventive practices at individual and a household levels applied by rural communities in five provinces in eastern Indonesia and its association with the incidence of malaria among adult (>= 15 years) populations. Methods This study analyzed a subset of data of nationally representative community-based survey 2018 Riset Kesehatan Dasar (Riskesdas). Data for socio-demographic (age, gender, education and occupation) and preventive behaviors (use of mosquito bed nets while slept, insecticide-treated mosquito nets (ITNs), mosquito repellent, mosquito electric rackets, mosquito coil/electric anti-mosquito mats, and mosquito window screen) were collected. Data were analyzed using bivariate and multivariable logistic regression model. Results Total of 56,159 respondents (n = 23,070 households) living in rural areas in Maluku (n = 8044), North Maluku (n = 7356), East Nusa Tenggara (n = 23,254), West Papua (n = 5759) and Papua (n = 11,746) were included in the study. In the multivariable models, using a bed net while slept likely reduced the odds of self-reported malaria among Maluku participants. Reduced odds ratios of self-reported malaria were identified in those participants who used ITNs (North Maluku, ENT, Papua), repellent (Maluku, West Papua, Papua), anti-mosquito racket (ENT), coil (Maluku, North Maluku, Papua) and window screen (West Papua, Papua). Conclusion Our study concluded that the protective effects of preventive practices were varied among localities, suggesting the need for specific intervention programs.	[Ipa, Mara; Widawati, Mutiara; Dhewantara, Pandji Wibawa] Natl Minist Hlth Indonesia, Natl Inst Hlth Res & Dev, Pangandaran Unit Hlth Res & Dev, Pangandaran, West Java, Indonesia; [Laksono, Agung Dwi] Natl Minist Hlth Indonesia, Natl Inst Hlth Res & Dev, Ctr Res & Dev Humanities & Hlth Management, Jakarta, Indonesia; [Kusrini, Ina] Natl Minist Hlth Indonesia, Natl Inst Hlth Res & Dev, Magelang Unit Hlth Res & Dev, Magelang, Central Java, Indonesia	National Institute of Health Research & Development - Indonesia; National Institute of Health Research & Development - Indonesia; National Institute of Health Research & Development - Indonesia	Ipa, M (corresponding author), Natl Minist Hlth Indonesia, Natl Inst Hlth Res & Dev, Pangandaran Unit Hlth Res & Dev, Pangandaran, West Java, Indonesia.	tiarmara@gmail.com	Dhewantara, Pandji Wibawa/O-7852-2015; Laksono, Agung Dwi/N-5161-2018; Wulandari, Ratna/AAN-9410-2020; kusrini, ina/O-2160-2018; Ipa, Mara/AAQ-7992-2020; Widawati, Mutiara/L-8576-2013	Dhewantara, Pandji Wibawa/0000-0002-9461-0648; Laksono, Agung Dwi/0000-0002-9056-0399; Wulandari, Ratna/0000-0003-4365-5747; kusrini, ina/0000-0001-6997-4821; Ipa, Mara/0000-0002-4831-6536; Widawati, Mutiara/0000-0002-1649-4688				Afify A, 2019, CURR BIOL, V29, P3669, DOI 10.1016/j.cub.2019.09.007; [Anonymous], 2018, COCHRANE DB SYST REV, V2018, DOI [10.1002/14651858.CD011595.pub2/full%0A, DOI 10.1002/14651858.CD011595.PUB2/FULL%0A]; [Anonymous], 2019, GUID LAB FIELD TEST; Ansari M. A., 2003, Journal of Vector Borne Diseases, V40, P33; Asante F.A., 2003, EC BURDEN MALARIA GH, P1; Asingizwe D, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2904-x; Barbara K.A., 2011, S E ASIAN J TROP MED, V42; Bayoh MN, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-380; Bernier UR, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007188; Byrne Neville, 2007, Travel Med Infect Dis, V5, P135, DOI 10.1016/j.tmaid.2006.04.003; Debo Gidie Woju, 2016, Trop Dis Travel Med Vaccines, V2, P16, DOI 10.1186/s40794-016-0033-x; Dhewantara PW, 2019, MALARIA J, V18, P1, DOI [10.1186/s12936-018-2635-4, DOI 10.1186/S12936-018-2635-4]; Gryseels C, 2015, FACTORS INFLUENCING, P1; Guerini M., 2018, MALARIA J, P1, DOI [DOI 10.1186/S12936-017-2149-5, 10.1186/s12936-017-2149-5]; Hasyim H, 2019, MALARIA J, P1, DOI [10.1186/s12936-018-2635-4, DOI 10.1186/S12936-018-2635-4]; Hasyim H, 2018, MALARIA J, V17, P1, DOI DOI 10.1186/S12936-017-2149-5; Hay SI, 2005, NATURE REV MICROBIOL; Hogarh JN, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2412-4; Huho B, 2013, INT J EPIDEMIOL, V42, P235, DOI 10.1093/ije/dys214; Iliyasu Z, 2013, ACTA TROP, V128, P630, DOI 10.1016/j.actatropica.2013.09.011; Jusoh N, 2007, MED J INDONES, V16, P267; Kepha S, MALAR J; Killeen GF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1280-z; Kirby MJ, 2009, LANCET; Kroeger A, 1997, AM J TROP MED HYG, V56, P580, DOI 10.4269/ajtmh.1997.56.580; Larson A, 2000, AUST NZ J PUBL HEAL, V24, P374, DOI 10.1111/j.1467-842X.2000.tb01596.x; Mathanga DP, 2015, MALARIA J, V14, P1; Messina JP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-161; Ministry of Health Indonesia, 2018, IND HLTH PROF; Ministry of Health of the Republic of Indonesia, 2019, IND HLTH PROF 2019; Ministry of Youth and Sports-General Directorate of Sports, 2015, SPOR GENEL MUDURLUGU; Monasch R, 2004, AM J TROP MED HYG, V71, P232, DOI 10.4269/ajtmh.2004.71.232; Morakinyo OM, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2463-6; Mujiyono, 2018, BALABA J LITBANG PEN, V14, P1; National Institute of Health Research and Development of The Indonesia Ministry of Health, 2019, 2018 IND BAS HLTH SU; Olowookere SA, 2013, ASIA PAC FAM MED, V12, P1, DOI [10.1186/1447-056X-12-1, DOI 10.1186/1447-056X-12-1]; Omumbo JA, 2005, ACTA TROP, V93, P11, DOI 10.1016/j.actatropica.2004.08.010; Peterson I, 2009, AM J TROP MED HYG, V80, P103, DOI 10.4269/ajtmh.2009.80.103; Pinchoff J, 2015, AM J TROP MED HYG, V93, P954, DOI 10.4269/ajtmh.15-0093; Provincal Bureau of Statistics of East Nusa Tenggara, 2019, E NUS TENGG PROV FIG; Provincal Bureau of Statistics of Maluku, 2018, MAL PROV FIG; Provincal Bureau of Statistics of North Maluku, 2019, N MAL FIG; Provincal Bureau of Statistics of Papua, 2018, PAP PROV FIG; Provincal Bureau of Statistics of West Papua, 2018, W PAP PROV FIG; Rowland M, 2004, TROP MED INT HEALTH, V9, P335, DOI 10.1111/j.1365-3156.2004.01198.x; Sangoro O, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-347; Santrock J.W., 2002, LIFE SPAN DEV PERKEM; Satitvipawee P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1115; Sitohang V, 2018, LANCET GLOB HEALTH, V6, pE604, DOI 10.1016/S2214-109X(18)30198-0; Tadesse F, PREVALENCE ASS RISK; Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P10, DOI 10.1016/0035-9203(87)90472-X; Trung H.D., TROP MED INT HEAL, V10; van Eijk AM, 2016, PARASITE VECTOR, P1, DOI [10.1186/s13071-015-1291-6, DOI 10.1186/S13071-015-1291-6]; Wanzirah H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117396; WHO, 2018, WORLD MAL REP 2018; Wilson ML, 2015, AM J TROP MED HYG, V93, P110, DOI 10.4269/ajtmh.14-0834; World Health Organization Global Malaria Programme, 2015, GLOB MAL PROGR GLOB; World Health Organization Malaria Team, 2019, WORLD MAL REP 2019; Yimer F, MALAR J	60	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232909	10.1371/journal.pone.0232909	http://dx.doi.org/10.1371/journal.pone.0232909			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379812	Green Published, gold			2022-12-26	WOS:000537285700079
J	Tsuruda, M; Yoshino, H; Okamura, S; Kuroshima, K; Osako, Y; Sakaguchi, T; Sugita, S; Tatarano, S; Nakagawa, M; Enokida, H				Tsuruda, Masafumi; Yoshino, Hirofumi; Okamura, Shunsuke; Kuroshima, Kazuki; Osako, Yoichi; Sakaguchi, Takashi; Sugita, Satoshi; Tatarano, Shuichi; Nakagawa, Masayuki; Enokida, Hideki			Oncogenic effects of RAB27B through exosome independent function in renal cell carcinoma including sunitinib-resistant	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; ENRICHMENT ANALYSIS; MEMBRANE-VESICLES; CANCER CELLS; EXPRESSION; SECRETION; THERAPY; MANAGEMENT; MICRORNAS; GROWTH	Exosomes are 40-100 nm nano-sized extracellular vesicles. They are released from many cell types and move into the extracellular space, thereby transferring their components to recipient cells. Exosomes are receiving increasing attention as novel structures participating in intracellular communication. RAB27B is one of the leading proteins involved in exosome secretion, and oncogenic effects have been reported in several cancers. In recent years, molecularly targeted agents typified by sunitinib are widely used for the treatment of metastatic or recurrent renal cell carcinoma (RCC). However, intrinsic or acquired resistance to sunitinib has become a major issue. The present study aimed to elucidate the role of RAB27B in RCC including sunitinib-resistant and its role in exosomes. Bioinformatic analyses revealed that high expression of RAB27B correlates with progression of RCC. The expression of RAB27B protein in RCC cell lines was significantly enhanced compared with that in normal kidney cell lines. Furthermore, RAB27B protein expression was enhanced in all of the tested sunitinib-resistant RCC cell lines compared to parental cells. Although no specific effect of RAB27B on exosomes was identified in RCC cells, loss-of-function studies demonstrated that knockdown of RAB27B suppressed cell proliferation, migration and invasive activities. Moreover, anti-tumor effects of RAB27B downregulation were also observed in sunitinib-resistant RCC cells. RNA sequence and pathway analysis suggested that the oncogenic effects of RAB27B might be associated with MAPK and VEGF signaling pathways. These results showed that RAB27B is a prognostic marker and a novel therapeutic target in sunitinib-sensitive and -resistant RCCs. Further analyses should improve our understanding of sunitinib resistance in RCC.	[Tsuruda, Masafumi; Yoshino, Hirofumi; Okamura, Shunsuke; Kuroshima, Kazuki; Osako, Yoichi; Sakaguchi, Takashi; Sugita, Satoshi; Tatarano, Shuichi; Nakagawa, Masayuki; Enokida, Hideki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima, Japan	Kagoshima University	Enokida, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima, Japan.	enokida@m.kufm.kgoshima-u.ac.jp	Tatarano, Shuichi/GSO-1421-2022	Tatarano, Shuichi/0000-0003-4224-5084	KAKENHI (KIBAN-B) [16H05464, 17H04332]; KAKENHI (KIBAN-C) [16K11015]; KAKENHI (WAKATE-B) [17K16799]; Shinnihon Foundation of Advanced Medical Treatment Research; Takeda Science Foundation; Foundation for Promotion of Cancer Research in Japan	KAKENHI (KIBAN-B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI (KIBAN-C)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI (WAKATE-B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Shinnihon Foundation of Advanced Medical Treatment Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation for Promotion of Cancer Research in Japan	This study was supported by the KAKENHI (KIBAN-B) 16H05464 and 17H04332, KAKENHI (KIBAN-C) 16K11015, KAKENHI (WAKATE-B) 17K16799, The Shinnihon Foundation of Advanced Medical Treatment Research, Takeda Science Foundation, and Foundation for Promotion of Cancer Research in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abak A, 2018, PEERJ, V6, DOI 10.7717/peerj.4763; Anaya J., 2016, ONCOLNC LINKING TCGA, DOI [10.7287/PEERJ.PREPRINTS.1780, DOI 10.7287/PEERJ.PREPRINTS.1780]; Antonelli A, 2007, BJU INT, V99, P296, DOI 10.1111/j.1464-410X.2006.06616.x; Bao J, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/913106; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bhuin T, 2014, EXP CELL RES, V328, P1, DOI 10.1016/j.yexcr.2014.07.027; Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Butz H, 2016, EUR UROL FOCUS, V2, P210, DOI 10.1016/j.euf.2015.11.006; CAI S, 2019, GASTROENTEROLOGY, V19, DOI DOI 10.1053/J.GASTRO.2018.10.026; Cao ZG, 2019, BIOCHEM BIOPH RES CO, V515, P345, DOI 10.1016/j.bbrc.2019.05.120; Capitanio U, 2016, LANCET, V387, P894, DOI 10.1016/S0140-6736(15)00046-X; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Cesi G, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0886-x; Challagundla KB, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv135; Chen G.M., 2018, EVID-BASED COMPL ALT, V2018, P1, DOI [10.1146/annurev-pharmtox-010611-134717, DOI 10.1146/ANNUREV-PHARMTOX-010611-134717]; Chen JJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7027380; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Corcoran C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050999; Dong WW, 2012, WORLD J GASTROENTERO, V18, P1806, DOI 10.3748/wjg.v18.i15.1806; Fernandes DS, 2015, FUTURE ONCOL, V11, P121, DOI 10.2217/fon.14.133; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gao YQ, 2016, ONCOTARGET, V7, P63374, DOI 10.18632/oncotarget.11463; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hendrix A, 2013, EXOSOMES MICROVESICL, V3, P1, DOI [10.5772/56521, DOI 10.5772/56521]; Hendrix A, 2010, JNCI-J NATL CANCER I, V102, P866, DOI 10.1093/jnci/djq153; Hidaka H, 2012, ONCOTARGET, V3, P44; Hong Y, 2017, J NEUROSCI, V37, P9550, DOI 10.1523/JNEUROSCI.1418-17.2017; Horie K, 2017, BIOCHEM BIOPH RES CO, V492, P356, DOI 10.1016/j.bbrc.2017.08.107; Huang D, 2008, CANCER RES, V68, P81, DOI 10.1158/0008-5472.CAN-07-5311; Huang M, 2019, ANAL CHEM, V91, P12307, DOI 10.1021/acs.analchem.9b02485; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Ishibashi K, 2017, ONCOTARGET, V8, P55230, DOI 10.18632/oncotarget.19420; Jae N, 2015, FEBS LETT, V589, P3182, DOI 10.1016/j.febslet.2015.08.040; Janzen NK, 2003, UROL CLIN N AM, V30, P843, DOI 10.1016/S0094-0143(03)00056-9; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Li Guangpu, 2015, Methods Mol Biol, V1298, P1, DOI 10.1007/978-1-4939-2569-8_1; Li JY, 2017, PANCREAS, V46, P1173, DOI 10.1097/MPA.0000000000000910; Li J, 2016, INT J ONCOL, V49, P838, DOI 10.3892/ijo.2016.3560; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Mc Namee N, 2018, BBA-REV CANCER, V1870, P123, DOI 10.1016/j.bbcan.2018.07.003; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; NAGATA K, 1989, J BIOL CHEM, V264, P17000; Nathan P, 2006, BRIT J CANCER, V94, P1217, DOI 10.1038/sj.bjc.6603025; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; O'Neill CP, 2019, CANCERS, V11, DOI 10.3390/cancers11020136; Osako Y, 2019, INT J ONCOL, V54, P1759, DOI 10.3892/ijo.2019.4736; Ostenfeld MS, 2014, CANCER RES, V74, P5758, DOI 10.1158/0008-5472.CAN-13-3512; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pfeffer SR, 2010, NAT CELL BIOL, V12, P3, DOI 10.1038/ncb0110-3; Pu YG, 2016, CLIN EXP METASTAS, V33, P359, DOI 10.1007/s10585-016-9783-0; Qu L, 2016, CANCER CELL, V29, P653, DOI 10.1016/j.ccell.2016.03.004; Raimondo F, 2013, MOL BIOSYST, V9, P1220, DOI 10.1039/c3mb25582d; Rajendran L, 2014, J NEUROSCI, V34, P15482, DOI 10.1523/JNEUROSCI.3258-14.2014; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ren P, 2016, ONCOL LETT, V12, P1539, DOI 10.3892/ol.2016.4801; Rini BI, 2007, CLIN CANCER RES, V13, P1098, DOI 10.1158/1078-0432.CCR-06-1989; Sakaguchi T, 2018, BRIT J CANCER, V118, DOI 10.1038/bjc.2017.439; Sarfaty M, 2018, EUR UROL, V73, P628, DOI 10.1016/j.eururo.2017.07.041; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tanaka C, 2012, BIOCHEM BIOPH RES CO, V419, P368, DOI 10.1016/j.bbrc.2012.02.030; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang HJ, 2015, ONCOL REP, V34, P1503, DOI 10.3892/or.2015.4125; Wong MCS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15922-4; Wu GL, 2019, GENE, V709, P48, DOI 10.1016/j.gene.2019.04.005; Wu XQ, 2017, NEUROSCI BULL, V33, P331, DOI 10.1007/s12264-016-0092-z; Yamada Y, 2013, CANCER SCI, V104, P304, DOI 10.1111/cas.12072; Yang L, 2013, UROL INT, V91, P363, DOI 10.1159/000348747; Yeung CLA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11150; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Yoshino H, 2017, CANCER RES, V77, P6321, DOI 10.1158/0008-5472.CAN-17-1589; Zhang JX, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-242; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zhang W, 2018, EUR UROL FOCUS, V4, P412, DOI 10.1016/j.euf.2016.09.007; Zhang Y, 2017, DNA CELL BIOL, V36, P202, DOI 10.1089/dna.2016.3496	85	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232545	10.1371/journal.pone.0232545	http://dx.doi.org/10.1371/journal.pone.0232545			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379831	Green Published, gold			2022-12-26	WOS:000537285700039
J	Morimoto, K; Suzuki, N; Tanida, I; Kakuta, S; Furuta, Y; Uchiyama, Y; Hanada, K; Suzuki, Y; Yamaji, T				Morimoto, Kanta; Suzuki, Noriko; Tanida, Isei; Kakuta, Soichiro; Furuta, Yoko; Uchiyama, Yasuo; Hanada, Kentaro; Suzuki, Yusuke; Yamaji, Toshiyuki			Blood group P1 antigen?bearing glycoproteins are functional but less efficient receptors of Shiga toxin than conventional glycolipid-based receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein; glycolipid; Shiga toxin; receptor; glycomics; retrograde transport; CRISPR; Cas; glycan remodeling; blood group P1 antigen; globotriaosylceramide (Gb3)	PIGEON EGG-WHITE; DIARRHEAGENIC ESCHERICHIA-COLI; N-GLYCAN STRUCTURES; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; SHIGELLA-DYSENTERIAE; MAJOR GLYCOPROTEINS; CRYSTAL-STRUCTURE; URBAN PIGEONS; HELA-CELLS	Shiga toxin (STx) is a virulence factor produced by enterohemorrhagicEscherichia coli.STx is taken up by mammalian host cells by binding to the glycosphingolipid (GSL) globotriaosylceramide (Gb3; Gal?1-4Gal?1-4Glc-ceramide) and causes cell death after its retrograde membrane transport. However, the contribution of the hydrophobic portion of Gb3 (ceramide) to STx transport remains unclear. In pigeons, blood group P1 glycan antigens (Gal?1-4Gal?1-4GlcNAc-) are expressed on glycoproteins that are synthesized by ?1,4-galactosyltransferase 2 (pA4GalT2). To examine whether these glycoproteins can also function as STx receptors, here we constructed glycan-remodeled HeLa cell variants lacking Gb3 expression but instead expressing pA4GalT2-synthesized P1 glycan antigens on glycoproteins. We compared STx binding and sensitivity of these variants with those of the parental, Gb3-expressing HeLa cells. The glycan-remodeled cells bound STx1 viaN-glycans of glycoproteins and were sensitive to STx1 even without Gb3 expression, indicating that P1-containing glycoproteins also function as STx receptors. However, these variants were significantly less sensitive to STx than the parent cells. Fluorescence microscopy and correlative light EM revealed that the STx1 B subunit accumulates to lower levels in the Golgi apparatus after glycoprotein-mediated than after Gb3-mediated uptake but instead accumulates in vacuole-like structures probably derived from early endosomes. Furthermore, coexpression of Gal?1-4Gal on both glycoproteins and GSLs reduced the sensitivity of cells to STx1 compared with those expressing Gal?1-4Gal only on GSLs, probably because of competition for STx binding or internalization. We conclude that lipid-based receptors are much more effective in STx retrograde transport and mediate greater STx cytotoxicity than protein-based receptors.	[Morimoto, Kanta; Hanada, Kentaro; Yamaji, Toshiyuki] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Morimoto, Kanta; Suzuki, Yusuke] Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Tokyo, Japan; [Tanida, Isei; Kakuta, Soichiro; Furuta, Yoko; Uchiyama, Yasuo] Juntendo Univ, Dept Cellular & Mol Neuropathol, Grad Sch Med, Tokyo, Japan; [Kakuta, Soichiro] Juntendo Univ, Lab Morphol & Image Anal, Grad Sch Med, Biomed Res Ctr, Tokyo, Japan; [Suzuki, Noriko] Niigata Univ, Grad Sch Sci & Technol, Niigata, Japan	National Institute of Infectious Diseases (NIID); Nihon University; Juntendo University; Juntendo University; Niigata University	Yamaji, T (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan.; Suzuki, N (corresponding author), Niigata Univ, Grad Sch Sci & Technol, Niigata, Japan.	nrsuzuki@gs.niigata-u.ac.jp; tyamaji@nih.go.jp		Hanada, Kentaro/0000-0003-1383-2781	JSPS KAKENHI [JP17K07357]; Uchida Energy Science Promotion Foundation; MEXT KAKENHI [JP17H06417]; AMED [JP19fm0208005j0103, JP19ae0101068j0104, JP19gm0910005j0005]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uchida Energy Science Promotion Foundation(Uchida Energy Science Promotion Foundation); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED	This work was supported by the JSPS KAKENHI (No. JP17K07357 to T. Y.), the Uchida Energy Science Promotion Foundation (to N. S.), MEXT KAKENHI (No. JP17H06417 to K. H.), AMED (No. JP19fm0208005j0103 and JP19ae0101068j0104 to T. Y. and JP19gm0910005j0005 to K. H.).	Arab S, 1998, J CELL PHYSIOL, V177, P646, DOI 10.1002/(SICI)1097-4652(199812)177:4<646::AID-JCP15>3.0.CO;2-B; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borges CA, 2017, J MICROBIOL, V55, P344, DOI 10.1007/s12275-017-6523-3; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; Cherian RM, 2014, GLYCOBIOLOGY, V24, P26, DOI 10.1093/glycob/cwt086; DONOHUEROLFE A, 1989, INFECT IMMUN, V57, P3888, DOI 10.1128/IAI.57.12.3888-3893.1989; El-Sayed A, 2013, MOL THER, V21, P1118, DOI 10.1038/mt.2013.54; Elkin SR, 2016, WIEN MED WOCHENSCHR, V166, P196, DOI 10.1007/s10354-016-0432-7; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Ferreira APA, 2018, TRENDS CELL BIOL, V28, P188, DOI 10.1016/j.tcb.2017.11.004; Foster G., 2009, APPL ENVIRON MICROB, V72, P2265, DOI [10.1007/s00284-009-9434-7, DOI 10.1007/S00284-009-9434-7]; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; HOLM S, 1979, SCAND J STAT, V6, P65; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; KIARASH A, 1994, J BIOL CHEM, V269, P11138; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; KURAYA N, 1992, J BIOCHEM, V112, P122, DOI 10.1093/oxfordjournals.jbchem.a123850; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Miyake M, 2000, ANAL BIOCHEM, V281, P202, DOI 10.1006/abio.2000.4559; Morabito S, 2001, VET MICROBIOL, V82, P275, DOI 10.1016/S0378-1135(01)00393-5; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mukhopadhyay S, 2013, MOL BIOL CELL, V24, P2311, DOI 10.1091/mbc.E13-01-0057; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; SANDVIG K, 1989, J CELL BIOL, V108, P1331, DOI 10.1083/jcb.108.4.1331; Selyunin AS, 2015, TRAFFIC, V16, P1270, DOI 10.1111/tra.12338; Shapiro MD, 2013, SCIENCE, V339, P1063, DOI 10.1126/science.1230422; Shimizu H, 1998, BIOCHEMISTRY-US, V37, P11078, DOI 10.1021/bi980946+; Silva VL, 2009, CURR MICROBIOL, V59, P302, DOI 10.1007/s00284-009-9434-7; Smith DC, 2006, MOL BIOL CELL, V17, P1375, DOI 10.1091/mbc.e05-11-1035; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; Stenfelt L, 2019, TRANSFUSION, V59, P1108, DOI 10.1111/trf.15115; Suzuki N, 2004, P NATL ACAD SCI USA, V101, P9023, DOI 10.1073/pnas.0402822101; Suzuki N, 2003, J BIOL CHEM, V278, P46293, DOI 10.1074/jbc.M307132200; Suzuki N, 2001, J BIOL CHEM, V276, P23221, DOI 10.1074/jbc.M101379200; Suzuki N, 2020, TRENDS GLYCOSCI GLYC, V32, pE7, DOI 10.4052/tigg.1843.1E; Suzuki N, 2019, GLYCOBIOLOGY, V29, P625, DOI 10.1093/glycob/cwz038; Suzuki N, 2019, ANAL BIOCHEM, V567, P117, DOI 10.1016/j.ab.2018.11.014; Suzuki N, 2011, GLYCOBIOLOGY, V21, P283, DOI 10.1093/glycob/cwq163; Suzuki N, 2010, J BIOL CHEM, V285, P5178, DOI 10.1074/jbc.M109.018663; Suzuki N, 2009, GLYCOBIOLOGY, V19, P693, DOI 10.1093/glycob/cwp025; Takahashi N, 2001, J BIOL CHEM, V276, P23230, DOI 10.1074/jbc.M101380200; Tomoda H, 2002, ANAL BIOCHEM, V311, P50, DOI 10.1016/S0003-2697(02)00380-9; Utskarpen A, 2007, BIOCHEM BIOPH RES CO, V358, P566, DOI 10.1016/j.bbrc.2007.04.159; Watanabe M, 2004, J INFECT DIS, V189, P360, DOI 10.1086/381124; Yahiro K, 2010, MICROB PATHOGENESIS, V49, P153, DOI 10.1016/j.micpath.2010.05.007; Yamaji T, 2005, GLYCOBIOLOGY, V15, P667, DOI 10.1093/glycob/cwi048; Yamaji T, 2019, ISCIENCE, V15, P407, DOI 10.1016/j.isci.2019.05.005; Yamaji T, 2019, ISCIENCE, V11, P409, DOI 10.1016/j.isci.2018.12.039; Yamaji T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101761; Yamaji T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088124; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005	65	7	7	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9490	9501		10.1074/jbc.RA120.013926	http://dx.doi.org/10.1074/jbc.RA120.013926			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409578	hybrid, Green Published			2022-12-26	WOS:000552758600018
J	Soysa, HSM; Aunkham, A; Schulte, A; Suginta, W				Soysa, Hannadige Sasimali Madusanka; Aunkham, Anuwat; Schulte, Albert; Suginta, Wipa			Single-channel properties, sugar specificity, and role of chitoporin in adaptive survival ofVibrio choleraetype strain O1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						black lipid membrane; chitin uptake; liposome swelling assay; outer membrane proteins; sugar transport; protein-ligand interactions; Vibrio cholerae; VcChiP; chitoporin; chitooligosaccharide; chitin; single-molecule biophysics; membrane reconstitution	BACTERIUM VIBRIO-FURNISSII; ESCHERICHIA-COLI; CRYSTAL-STRUCTURES; MOLECULAR-CLONING; CHITIN CATABOLISM; IN-VIVO; PORIN; MALTOPORIN; SURFACE; IDENTIFICATION	Vibrio choleraeis a Gram-negative, facultative anaerobic bacterial species that causes serious disease and can grow on various carbon sources, including chitin polysaccharides. In saltwater, its attachment to chitin surfaces not only serves as the initial step of nutrient recruitment but is also a crucial mechanism underlying cholera epidemics. In this study, we report the first characterization of a chitooligosaccharide-specific chitoporin,VcChiP, from the cell envelope of theV. choleraetype strain O1. We modeled the structure ofVcChiP, revealing a trimeric cylinder that forms single channels in phospholipid bilayers. The membrane-reconstitutedVcChiP channel was highly dynamic and voltage induced. Substate openings O-1?, O-2?, and O-3?, between the fully open states O-1, O-2, and O-3, were polarity selective, with nonohmic conductance profiles. Results of liposome-swelling assays suggested thatVcChiP can transport monosaccharides, as well as chitooligosaccharides, but not other oligosaccharides. Of note, an outer-membrane porin (omp)-deficient strain ofEscherichia coliexpressing heterologousVcChiP could grow on M9 minimal medium supplemented with small chitooligosaccharides. These results support a crucial role of chitoporin in the adaptive survival of bacteria on chitinous nutrients. Our findings also suggest a promising means of vaccine development based on surface-exposed outer-membrane proteins and the design of novel anticholera agents based on chitooligosaccharide-mimicking analogs.	[Soysa, Hannadige Sasimali Madusanka] Suranaree Univ Technol, Sch Chem, Inst Sci, Nakhon Ratchasima, Thailand; [Aunkham, Anuwat; Schulte, Albert; Suginta, Wipa] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn BSE, Payupnai, Rayong, Thailand; [Soysa, Hannadige Sasimali Madusanka] Sabaragamuwa Univ Sri Lanka, Fac Appl Sci, Dept Phys Sci & Technol, Belihuloya, Sri Lanka	Suranaree University of Technology; Vidyasirimedhi Institute of Science & Technology; Sabaragamuwa University of Sri Lanka	Suginta, W (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn BSE, Payupnai, Rayong, Thailand.	sasimalisoysa@gmail.com; wipa.s@vistec.ac.th		M. Soysa, H. Sasimali/0000-0003-3244-8670; Suginta, Wipa/0000-0001-5927-7192	Suranaree University of Technology [SUT1-102-5936-05]; Vidyasirimedhi Institute of Science and Technology (VISTEC) [300/111100/1711111000030]; Thailand Research Fund (TRF) through The Basic Research Grant [BRG610008]; Thailand Science Research and Innovation (TSRI) under the Global Partnership Grant	Suranaree University of Technology; Vidyasirimedhi Institute of Science and Technology (VISTEC); Thailand Research Fund (TRF) through The Basic Research Grant(Thailand Research Fund (TRF)); Thailand Science Research and Innovation (TSRI) under the Global Partnership Grant	This research was supported by Suranaree University of Technology (grant no. SUT1-102-5936-05). W. S. also received funding from Vidyasirimedhi Institute of Science and Technology (VISTEC) (grant no. 300/111100/1711111000030) and the Thailand Research Fund (TRF) through The Basic Research Grant (grant no. BRG610008). W. S. also received financial support from Thailand Science Research and Innovation (TSRI) under the Global Partnership Grant.	Almagro-Moreno S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004787; Andersen C, 2002, J BIOL CHEM, V277, P41318, DOI 10.1074/jbc.M206804200; Andersen C, 1999, MOL MICROBIOL, V32, P851, DOI 10.1046/j.1365-2958.1999.01406.x; Aunkham A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02523-y; Bartlett DH, 2005, SCIENCE, V310, P1775, DOI 10.1126/science.1122396; Blokesch M, 2012, ENVIRON MICROBIOL, V14, P1898, DOI 10.1111/j.1462-2920.2011.02689.x; Chakrabarti Sr, 1996, J BACTERIOL, V178, P524, DOI 10.1128/jb.178.2.524-530.1996; Chatterjee S, 2007, J MED MICROBIOL, V56, P824, DOI 10.1099/jmm.0.46982-0; Chen M, 2008, CHEMBIOCHEM, V9, P3029, DOI 10.1002/cbic.200800444; Chumjan W, 2015, J BIOL CHEM, V290, P19184, DOI 10.1074/jbc.M115.660530; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Conner Jenna G, 2016, Microbiol Spectr, V4, DOI 10.1128/microbiolspec.VMBF-0015-2015; Danelon C, 2003, J BIOL CHEM, V278, P35542, DOI 10.1074/jbc.M305434200; Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0; Eppens EF, 1997, FEBS LETT, V415, P317, DOI 10.1016/S0014-5793(97)01150-2; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Goulart CL, 2015, BBA-BIOMEMBRANES, V1848, P680, DOI 10.1016/j.bbamem.2014.11.009; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Li XB, 2007, GLYCOBIOLOGY, V17, P1377, DOI 10.1093/glycob/cwm096; Liu JM, 2012, BBA-BIOMEMBRANES, V1818, P2908, DOI 10.1016/j.bbamem.2012.07.009; Lutz C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00375; Meekrathok P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149228; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Moraes TF, 2007, NAT STRUCT MOL BIOL, V14, P85, DOI 10.1038/nsmb1189; Nahar S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00260; NALIN DR, 1979, INFECT IMMUN, V25, P768, DOI 10.1128/IAI.25.2.768-770.1979; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Paliy O, 2007, APPL MICROBIOL BIOT, V73, P1169, DOI 10.1007/s00253-006-0554-8; Park JK, 2000, J BIOL CHEM, V275, P33077, DOI 10.1074/jbc.M001042200; Pathania M, 2018, STRUCTURE, V26, P708, DOI 10.1016/j.str.2018.03.010; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Sikora AE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003126; Simonet VC, 2003, J BIOL CHEM, V278, P17539, DOI 10.1074/jbc.M301202200; Soysa HSM, 2016, J BIOL CHEM, V291, P13622, DOI 10.1074/jbc.M116.728881; Stauder M, 2010, ENV MICROBIOL REP, V2, P140, DOI 10.1111/j.1758-2229.2009.00121.x; Suginta W, 2000, J APPL MICROBIOL, V89, P76, DOI 10.1046/j.1365-2672.2000.01076.x; Suginta W, 2016, INT J BIOL MACROMOL, V93, P1111, DOI 10.1016/j.ijbiomac.2016.09.066; Suginta W, 2016, BBA-BIOMEMBRANES, V1858, P3032, DOI 10.1016/j.bbamem.2016.09.007; Suginta W, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.238102; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Suginta W, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-40; Sun SY, 2015, ISME J, V9, P1812, DOI 10.1038/ismej.2014.265; Sun Y, 2013, MOL MICROBIOL, V89, P583, DOI 10.1111/mmi.12307; Tanabe M, 2010, P NATL ACAD SCI USA, V107, P6811, DOI 10.1073/pnas.0912115107; Tarsi R, 1999, APPL ENVIRON MICROB, V65, P1348; Vezzulli L, 2008, LETT APPL MICROBIOL, V46, P119, DOI 10.1111/j.1472-765X.2007.02269.x; Williams TC, 2014, APPL ENVIRON MICROB, V80, P1580, DOI 10.1128/AEM.03811-13; Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137	56	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9421	9432		10.1074/jbc.RA120.012921	http://dx.doi.org/10.1074/jbc.RA120.012921			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409576	Green Published, hybrid			2022-12-26	WOS:000552758600013
J	Chotipanich, A; Kongpit, N				Chotipanich, Adit; Kongpit, Nampheng			Precision and reliability of tape measurements in the assessment of head and neck lymphedema	PLOS ONE			English	Article								Objectives Tape measurement is a commonly used method in the clinical assessment of lymphedema. However, few studies have assessed the precision and reliability of tape measurement in assessing head and neck lymphedema. This study aimed to evaluate the reliability and precision of using tape measurement, performed by different evaluators, for the assessment of head and neck lymphedema. Methods This study was conducted at a tertiary care cancer hospital. Between January and December 2019, 50 patients with head and neck cancers and 50 normal subjects were enrolled. Each subject was examined using tape measurements for 7 point-to-point distances of facial landmarks, 3 circumferences of the neck (upper, middle, and lower), and 2 circumferences of the face (vertical and oblique) by 3 random examiners. Test precision and reliability were assessed with the within-subject standard deviation (S-w) and intra-class correlation coefficient (ICC), respectively. Results Overall, the standard deviation of the tape measurements varied in the range of 4.6 mm to 18.3 mm. The measurement of distance between the tragus and mouth angle (S-w: 4.6 mm) yielded the highest precision, but the reliability (ICC: 0.66) was moderate. The reliabilities of neck circumference measurements (ICC: 0.90-0.95) were good to excellent, but the precisions (S-w: 8.3-12.3 mm) were lower than those of point-to-point facial measurements (S-w: 4.6-8.8 mm). Conclusions The different methods of tape measurements varied in precision and reliability. Thus, clinicians should not rely on a single measurement when evaluating head and neck lymphedema.	[Chotipanich, Adit] Chonburi Canc Hosp, Minist Publ Hlth, Head & Neck Unit, Dept Med Serv, Chon Buri, Thailand; [Kongpit, Nampheng] Chonburi Canc Hosp, Minist Publ Hlth, Nursing Unit, Dept Med Serv, Chon Buri, Thailand	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand	Chotipanich, A (corresponding author), Chonburi Canc Hosp, Minist Publ Hlth, Head & Neck Unit, Dept Med Serv, Chon Buri, Thailand.	adit_c@ccc.in.th	chotipanich, adit/AAO-9121-2021	chotipanich, adit/0000-0002-3180-930X				Aulino JM, 2018, LYMPHAT RES BIOL, V16, P69, DOI 10.1089/lrb.2017.0024; Deng J, 2015, ORAL ONCOL, V51, P431, DOI 10.1016/j.oraloncology.2015.01.005; Deng J, 2012, J PAIN SYMPTOM MANAG, V43, P244, DOI 10.1016/j.jpainsymman.2011.03.019; Nixon Jodie, 2014, Br J Community Nurs, VSuppl, pS8; Pleil JD, 2018, J TOXICOL ENV HEAL B, V21, P161, DOI 10.1080/10937404.2018.1490128; Purcell A, 2016, HEAD NECK-J SCI SPEC, V38, P79, DOI 10.1002/hed.23853; Smith BG, 2010, CURR OPIN OTOLARYNGO, V18, P153, DOI [10.1097/MOO.0b013e32833aac21, 10.1097/MOO.0b013e3283393799]; Villafuerte-Nunez AE., 2013, DISCRETE DYN NAT SOC, V2013, P1; Warren AG, 2007, ANN PLAS SURG, V58, P541, DOI 10.1097/01.sap.0000244977.84130.cf	9	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233395	10.1371/journal.pone.0233395	http://dx.doi.org/10.1371/journal.pone.0233395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421740	Green Published, gold			2022-12-26	WOS:000537499600049
J	Macagno, A; Athanasiou, A; Wittig, A; Huber, R; Weber, S; Keller, T; Rhiel, M; Golding, B; Schiess, R				Macagno, Annalisa; Athanasiou, Alcibiade; Wittig, Anja; Huber, Ramy; Weber, Stephan; Keller, Thomas; Rhiel, Martin; Golding, Bruno; Schiess, Ralph			Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANGIOGENESIS; EXPRESSION; BENIGN; HYPERPLASIA; PROGRESSION; PROGNOSIS; LUNG	The Prostate Specific Antigen (PSA) test suffers from low specificity for the diagnosis of Prostate Cancer (PCa). We originally discovered two cancer-related proteins thrombospondin-1 (THBS1) and cathepsin D (CTSD) using a mass-spectrometry-based proteomics approach. The two serum proteins were shown to improve the diagnosis of high-grade PCa. Thus, we developed quantitative ELISAs for the determination of their concentration in human serum. Here we report their analytical performance in terms of limit of detection, specificity, precision, linearity and interferences, which were determined based on CLSI guidelines. Further, we investigated the influence of pre-analytical factors on concentration measurements. For this, blood from 4-6 donors was collected in different tubes and stored at room temperature for different times prior to centrifugation at different centrifugal forces and temperatures. Stability of THBS1 and CTSD under different storage temperatures was also evaluated. Our results show that the assays are specific, linear and sensitive enough to allow measurement of clinical samples. Precision in terms of repeatability and total within-laboratory coefficient of variation (CV) are 5.5% and 8.1% for THBS1 and 4.3% and 7.2% for CTSD, respectively. Relative laboratory-to-laboratory differences were -6.3% for THBS1 and -3% for CTSD. Both THBS1 and CTSD were stable in serum samples, with 80-120% recoveries of concentrations across donors, sample preparation and storage. In conclusion, the ELISAs as part of the novel commercial in vitro diagnostic test Proclarix are suitable for the use in clinical practice. THBS1 and CTSD can be accurately measured for their intended use independent of the lot and laboratory when conditions consistent with routine practice for PSA sampling and storage are used.	[Macagno, Annalisa; Athanasiou, Alcibiade; Wittig, Anja; Huber, Ramy; Rhiel, Martin; Golding, Bruno; Schiess, Ralph] Proteomedix, Schlieren, Switzerland; [Weber, Stephan; Keller, Thomas] ACOMED Stat, Leipzig, Germany		Schiess, R (corresponding author), Proteomedix, Schlieren, Switzerland.	schiess@proteomedix.com	Keller, Thomas/ABA-7285-2021	Keller, Thomas/0000-0001-8160-3046	Proteomedix	Proteomedix	Funding for this work was provided by Proteomedix: https://www.proteomedix.com.Authors AM, AA, AW, RH, MR, BG, RS are employed by Proteomedix and hold stock options, while RS holds founder shares of Proteomedix. TK and SW are providing paid statistical consultancy to Proteomedix, and are employed by ACOMED Statistik (https://www.acomed-statistik.de/statistics/statistical-services.html).The funders provided support in the form of salaries for authors AM, AA, AW, RH, MR, BG, RS, consulting fees to TK and SW and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Barclay JL, 2016, ANN CLIN BIOCHEM, V53, P606, DOI 10.1177/0004563216628891; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Bowen RAR, 2014, BIOCHEM MEDICA, V24, P31, DOI 10.11613/BM.2014.006; CHARRIE A, 1995, CLIN CHEM, V41, P480; Cima I, 2011, P NATL ACAD SCI USA, V108, P3342, DOI 10.1073/pnas.1013699108; CLSI, 2018, GUID EP37 SUPPL TABL; CLSI, 2018, GUID EP09 MEAS PROC; CLSI, 2014, GUID EP05 EV PREC QU; CLSI, 2012, GUID EP17 EV DET CAP; Dittadi R, 2019, CLIN CHEM LAB MED, V57, P521, DOI 10.1515/cclm-2018-0596; Doll JA, 2001, PROSTATE, V49, P293, DOI 10.1002/pros.10025; El Melegy NT, 2010, BRIT J BIOMED SCI, V67, P109; Endt K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181557; FERNANDO SA, 1992, J IMMUNOL METHODS, V151, P47; Gonzalez FJ, 2004, INT J BIOL MARKER, V19, P221, DOI 10.1177/172460080401900307; Hoffman RM, 2011, NEW ENGL J MED, V365, P2013, DOI 10.1056/NEJMcp1103642; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Klocker H, 2018, EUROPEAN UROLOGY S, V17, pe544; Klocker Helmut, 2020, BJUI Compass, V1, P15, DOI 10.1002/bco2.8; Kricka LJ, 1999, CLIN CHEM, V45, P942; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Leto G, 2004, CLIN EXP METASTAS, V21, P91, DOI 10.1023/B:CLIN.0000024740.44602.b7; Miyata Y, 2013, INT J MOL SCI, V14, P12249, DOI 10.3390/ijms140612249; Pankaj K., 2017, MEASURING AGREEMENT; Ren B, 2006, BBA-REV CANCER, V1765, P178, DOI 10.1016/j.bbcan.2005.11.002; Roberts DD, 1996, FASEB J, V10, P1183, DOI 10.1096/fasebj.10.10.8751720; Russo G, 2012, BJU INT, V110, pE794, DOI 10.1111/j.1464-410X.2012.11444.x; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Selby C, 1999, ANN CLIN BIOCHEM, V36, P704, DOI 10.1177/000456329903600603; Shafer MW, 2007, PROSTATE, V67, P255, DOI 10.1002/pros.20514; Starlinger P, 2011, DIS MARKERS, V31, P55, DOI [10.1155/2011/535109, 10.3233/DMA-2011-0798]; Steuber T, 2019, BJU INT, V123, P826, DOI 10.1111/bju.14540; Suedmeyer WK, 1998, EXOT PET PRACT, V3, P27; Vallbo C, 2004, BJU INT, V93, P1339, DOI 10.1111/j.1464-410X.2004.04818.x; Vetvicka V., 2012, J CANC THER RES, V1, P22, DOI DOI 10.7243/2049-7962-1-22; Wang TN, 1996, J SURG RES, V63, P39, DOI 10.1006/jsre.1996.0219; Yamaguchi M, 2002, LUNG CANCER-J IASLC, V36, P143, DOI 10.1016/S0169-5002(01)00470-6; ZABRENETZKY V, 1994, INT J CANCER, V59, P191, DOI 10.1002/ijc.2910590209; Zhao XY, 2012, J IMMUNOL METHODS, V378, P72, DOI 10.1016/j.jim.2012.02.007	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233442	10.1371/journal.pone.0233442	http://dx.doi.org/10.1371/journal.pone.0233442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421745	Green Published, gold			2022-12-26	WOS:000537499600052
J	Bosco, A; Jones, KA; Di Lorito, C; Stephan, BCM; Orrell, M; Oliveira, D				Bosco, Alessandro; Jones, Katy A.; Di Lorito, Claudio; Stephan, Blossom C. M.; Orrell, Martin; Oliveira, Deborah			Changing lifestyle for dementia risk reduction: Inductive content analysis of a national UK survey	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HEALTH; PREVENTION; KNOWLEDGE	Objective To explore what motivates individuals to change their behaviour to reduce their risk of dementia. Methods We conducted secondary qualitative analysis of a UK-based online survey on motivation to change lifestyle and health behaviour for dementia risk reduction. Participants were recruited through social media, the Join Dementia Research network and the National Institute for Health Research Portfolio. Free-text comments from people aged.50 years were analysed by two researchers independently using inductive content analysis. Inter-rater agreement was measured through Cohen's Kappa coefficient. Results Of the 3,948 participants completing the survey, 653 provided free text comments that were included in the analysis (Mean age = 64.1; SD = 8.3 years). The majority of the sample were women (n = 459; 70.3%), Caucasian (n = 625; 95.7%) and married/in partnership (n = 459; 70.3%). Three overarching themes were identified: (1) motivators to changing lifestyle; (2) barriers for lifestyle change; and, (3) quality of the information received. The inter-rater reliability of the coding was high (k = 0.7). Having a family history of dementia or feeling like they had a healthy lifestyle already were motivating factors for behaviour change. Having competing health priorities other than dementia and caring for someone acted as de-motivators as they reduced the time available to dedicate to one's own health. Evidence-based information around dementia prevention was a motivator, but commonly the information was not trusted. Discussion Aligned with the World Health Organisation (WHO) mandate on dementia prevention, community health campaigns targeting population awareness around behaviour change and dementia risk factor reduction are urgently needed. To be successful, such campaigns will need to be accompanied by individual approaches that can overcome age-related barriers and individual differences in motivation levels, personal barriers and trust in the information received.	[Bosco, Alessandro; Jones, Katy A.; Stephan, Blossom C. M.; Orrell, Martin] Univ Nottingham, Div Psychiat & Appl Psychol, Nottingham, England; [Di Lorito, Claudio] Univ Nottingham, Div Rehabil Ageing & Wellbeing, Nottingham, England; [Oliveira, Deborah] Univ Fed Sao Paulo UNIFESP, Dept Psychiat, Sao Paulo, SP, Brazil	University of Nottingham; University of Nottingham; Universidade Federal de Sao Paulo (UNIFESP)	Bosco, A (corresponding author), Univ Nottingham, Div Psychiat & Appl Psychol, Nottingham, England.	alessandro.bosco@nottingham.ac.uk		Di Lorito, Claudio/0000-0002-8953-0117; Oliveira, Deborah/0000-0002-6616-533X; Orrell, Martin/0000-0002-1169-3530	Alzheimer's Research UK	Alzheimer's Research UK(Alzheimer's Research UK (ARUK))	This is a secondary data analysis based on a dataset of a large scale survey funded by the Alzheimer's Research UK (Midland).	Alzheimer's Research UK, 2018, DEM ATT MON; Arai Y, 2008, INT J GERIATR PSYCH, V23, P433, DOI 10.1002/gps.1977; Bailey P, 2019, ASIA-PAC J-JPN FOCU, V17; Brookes G, 2018, SOC SEMIOT, V28, P371, DOI 10.1080/10350330.2017.1345111; Carlyle R., 2010, TIMES; Cations M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196085; Chaudhuri S, 2013, CIN-COMPUT INFORM NU, V31, P547, DOI 10.1097/01.NCN.0000432131.92020.42; Dijkstra SC, 2014, APPETITE, V82, P166, DOI 10.1016/j.appet.2014.07.021; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Hochbaum G, 1952, US PUBLIC HLTH SERVI; Janevic MR, 2012, MED CARE, V50, P441, DOI 10.1097/MLR.0b013e3182422a52; Kane RL, INTERVENTIONS PREVEN; Kessler EM, 2012, EUR J AGEING, V9, P275, DOI 10.1007/s10433-012-0242-8; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Li X, 2011, PSYCHOGERIATRICS, V11, P83, DOI 10.1111/j.1479-8301.2010.00349.x; Liljas AEM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6911-1; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lockenhoff CE, 2004, J PERS, V72, P1395, DOI 10.1111/j.1467-6494.2004.00301.x; McParland P, 2012, INT PSYCHOGERIATR, V24, P1600, DOI 10.1017/S1041610212000658; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; NVivo, 2012, QUAL DAT AN SOFTW; Office for National Statistics (ONS), 2015, DEATHS REG ENGL WAL; Peel E, 2014, SOCIOL HEALTH ILL, V36, P885, DOI 10.1111/1467-9566.12122; Powell-Wiley TM, 2014, PUBLIC HEALTH NUTR, V17, P2641, DOI 10.1017/S1368980014000196; Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8; Rakesh G, 2017, THER ADV CHRONIC DIS, V8, P121, DOI 10.1177/2040622317712442; Smith BJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-661; Tang WZ, 2017, ARCH GERONTOL GERIAT, V71, P43, DOI 10.1016/j.archger.2017.02.013; World Health Organization, 2017, GLOBAL ACTION PLAN P	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233039	10.1371/journal.pone.0233039	http://dx.doi.org/10.1371/journal.pone.0233039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1BA	32413085	Green Published, gold			2022-12-26	WOS:000537496000042
J	Liebl, K; Zacharias, M				Liebl, Korbinian; Zacharias, Martin			How global DNA unwinding causes non-uniform stress distribution and melting of DNA	PLOS ONE			English	Article							DUPLEX DESTABILIZATION; TORSIONAL STRESS; NUCLEIC-ACIDS; DYNAMICS; MECHANISM; RNA; DENATURATION; TWIST	DNA unwinding is an important process that controls binding of proteins, gene expression and melting of double-stranded DNA. In a series of all-atom MD simulations on two DNA molecules containing a transcription start TATA-box sequence we demonstrate that application of a global restraint on the DNA twisting dramatically changes the coupling between helical parameters and the distribution of deformation energy along the sequence. Whereas only short range nearest-neighbor coupling is observed in the relaxed case, long-range coupling is induced in the globally restrained case. With increased overall unwinding the elastic deformation energy is strongly non-uniformly distributed resulting ultimately in a local melting transition of only the TATA box segment during the simulations. The deformation energy tends to be stored more in cytidine/guanine rich regions associated with a change in conformational substate distribution. Upon TATA box melting the deformation energy is largely absorbed by the melting bubble with the rest of the sequences relaxing back to near B-form. The simulations allow us to characterize the structural changes and the propagation of the elastic energy but also to calculate the associated free energy change upon DNA unwinding up to DNA melting. Finally, we design an Ising model for predicting the local melting transition based on empirical parameters. The direct comparison with the atomistic MD simulations indicates a remarkably good agreement for the predicted necessary torsional stress to induce a melting transition, for the position and length of the melted region and for the calculated associated free energy change between both approaches.	[Liebl, Korbinian; Zacharias, Martin] Tech Univ Munich, Phys Dept T38, Garching, Germany	Technical University of Munich	Zacharias, M (corresponding author), Tech Univ Munich, Phys Dept T38, Garching, Germany.	zacharias@tum.de		Liebl, Korbinian/0000-0002-2407-4763	Leibniz super computer center	Leibniz super computer center	We thank P. Marlow for helpful discussions and acknowledge support by the Leibniz super computer center.	Alexandrov BS, 2010, NUCLEIC ACIDS RES, V38, P1790, DOI 10.1093/nar/gkp1084; Balaceanu A, 2017, J PHYS CHEM LETT, V8, P21, DOI 10.1021/acs.jpclett.6b02451; BENHAM CJ, 1979, P NATL ACAD SCI USA, V76, P3870, DOI 10.1073/pnas.76.8.3870; BENHAM CJ, 1992, J MOL BIOL, V225, P835, DOI 10.1016/0022-2836(92)90404-8; Benham CJ, 1996, J MOL BIOL, V255, P425, DOI 10.1006/jmbi.1996.0035; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Case D. A., 2019, AMBER 19; Colizzi F, 2019, P NATL ACAD SCI USA, V116, P22471, DOI 10.1073/pnas.1901086116; Daniel Jost, 2008, J PHYS CONDENS MATT, V21; Dans PD, 2014, NUCLEIC ACIDS RES, V42, P11304, DOI 10.1093/nar/gku809; DICAPUA E, 1983, EMBO J, V2, P1531, DOI 10.1002/j.1460-2075.1983.tb01619.x; Dittmore A, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.147801; Djuranovic D, 2004, BIOPOLYMERS, V73, P356, DOI 10.1002/bip.10528; Gonzalez O, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4789411; Hase F, 2016, NUCLEIC ACIDS RES, V44, P7100, DOI 10.1093/nar/gkw607; HAYS JB, 1978, P NATL ACAD SCI USA, V75, P4125, DOI 10.1073/pnas.75.9.4125; Irobalieva RN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9440; Ivani I, 2016, NAT METHODS, V13, P55, DOI [10.1038/NMETH.3658, 10.1038/nmeth.3658]; Izanloo C, 2011, J COMPUT CHEM, V32, P3354, DOI 10.1002/jcc.21908; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jost D, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031912; Kannan S, 2006, BIOPHYS J, V91, P2956, DOI 10.1529/biophysj.106.087163; Kim SH, 2018, ELIFE, V7, DOI 10.7554/eLife.36557; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; KOWALSKI D, 1988, P NATL ACAD SCI USA, V85, P9464, DOI 10.1073/pnas.85.24.9464; Kriegel F, 2017, J STRUCT BIOL, V197, P26, DOI 10.1016/j.jsb.2016.06.022; Krueger A, 2006, BIOPHYS J, V90, P3091, DOI 10.1529/biophysj.105.078774; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lankas F, 2009, PHYS CHEM CHEM PHYS, V11, P10565, DOI 10.1039/b919565n; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Liebl K, 2019, NUCLEIC ACIDS RES, V47, P1132, DOI 10.1093/nar/gky1237; Liebl K, 2017, J PHYS CHEM B, V121, P11019, DOI 10.1021/acs.jpcb.7b07701; Liebl K, 2015, NUCLEIC ACIDS RES, V43, P10143, DOI 10.1093/nar/gkv1028; Lipfert J, 2014, P NATL ACAD SCI USA, V111, P15408, DOI 10.1073/pnas.1407197111; Matek C, 2015, SCI REP-UK, V5, DOI 10.1038/srep07655; Mitchell JS, 2011, NUCLEIC ACIDS RES, V39, P3928, DOI 10.1093/nar/gkq1312; Oberstrass FC, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178103; Protozanova E, 2004, J MOL BIOL, V342, P775, DOI 10.1016/j.jmb.2004.07.075; Randall GL, 2009, NUCLEIC ACIDS RES, V37, P5568, DOI 10.1093/nar/gkp556; Reymer A, 2018, NUCLEIC ACIDS RES, V46, P1684, DOI 10.1093/nar/gkx1270; Salerno D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.118303; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; Sutthibutpong T, 2016, NUCLEIC ACIDS RES, V44, P9121, DOI 10.1093/nar/gkw815; Tan D, 2018, P NATL ACAD SCI USA, V115, pE1346, DOI 10.1073/pnas.1713027115; Tomas Drsata, 2013, J CHEM THEORY COMPUT, V9, P707, DOI [10.1021/ct300671y, DOI 10.1021/CT300671Y]; Vlijm R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141576; Wang HQ, 2004, GENOME RES, V14, P1575, DOI 10.1101/gr.2080004; Xu X, 2016, P NATL ACAD SCI USA, V113, P116, DOI 10.1073/pnas.1517511113; Yoo J, 2018, PHYS CHEM CHEM PHYS, V20, P8432, DOI [10.1039/C7CP08185E, 10.1039/c7cp08185e]; Zgarbova M, 2017, J CHEM INF MODEL, V57, P275, DOI 10.1021/acs.jcim.6b00621; Zhu FQ, 2012, J COMPUT CHEM, V33, P453, DOI 10.1002/jcc.21989	52	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232976	10.1371/journal.pone.0232976	http://dx.doi.org/10.1371/journal.pone.0232976			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413048	Green Published, gold			2022-12-26	WOS:000537496000032
J	Ekpo, P; Inthasin, N; Matamnan, S; Wongprompitak, P; Wattanapanitch, M; Boonwong, C; Chirapapaisan, C; Ngowyutagon, P; Uiprasertkul, M; Prabhasawat, P; Tantibhedhyangkul, W				Ekpo, Pattama; Inthasin, Naharuthai; Matamnan, Sutthicha; Wongprompitak, Patimaporn; Wattanapanitch, Methichit; Boonwong, Chawikan; Chirapapaisan, Chareenun; Ngowyutagon, Panotsom; Uiprasertkul, Mongkol; Prabhasawat, Pinnita; Tantibhedhyangkul, Wiwit			Characterization of limbal explant sites: Optimization of stem cell outgrowth in in vitro culture	PLOS ONE			English	Article							EPITHELIAL TRANSPLANTATION; ISOFORMS	Simple limbal epithelial transplantation (SLET) and cultivated limbal epithelial transplantation (CLET) are proven techniques for treating limbal stem cell deficiency (LSCD). However, the precise regions that are most suitable for preparing explants for transplantation have not been identified conclusively. Accordingly, this in vitro study aimed at determining ideal sites to be selected for tissue harvest for limbal stem cell culture and transplantation. We evaluated cell outgrowth potential and the expression of stem cell markers in cultures from 48 limbal explants from five cadaveric donors. The limbal explants were generated from the three specific sites: Lcor (located innermost and adjacent to the cornea), Lm (middle limbus), and Lconj (located outermost adjacent to the conjunctiva). We found that explants from the Lconj and Lm sites exhibited higher growth potential than those from the Lcor site. Transcript encoding the stem cell marker and p63 isoform,.Np63, was detected in cells from Lm and Lconj explants; expression levels were slightly, though significantly (p-value < 0.05), higher in Lm than in Lconj, although expression of.Np63a protein was similar in cells from all explants. Differential expression of ATP-Binding Cassette Subfamily G Member 2 (ABCG2) did not reach statistical significance. Immunohistochemistry by indirect immunofluorescence analysis of limbus tissue revealed that the basal layer in explant tissue from Lconj and Lm contained markedly more stem cells than found in Lcor explant tissue; these findings correlate with a higher capacity for growth. Collectively, our findings suggest that explants from the Lconj and Lm sites should be selected for limbal cell expansion for both CLET and SLET procedures. These new insights may guide surgeons toward specific limbal sites that are most suitable for stem cell culture and transplantation and may ultimately improve treatment outcomes in the patients with LSCD.	[Ekpo, Pattama; Inthasin, Naharuthai; Wongprompitak, Patimaporn; Tantibhedhyangkul, Wiwit] Mahidol Univ, Siriraj Hosp, Dept Immunol, Fac Med, Bangkok, Thailand; [Ekpo, Pattama; Matamnan, Sutthicha; Boonwong, Chawikan] Mahidol Univ, Siriraj Hosp, Fac Med, Res Dept, Bangkok, Thailand; [Wattanapanitch, Methichit] Mahidol Univ, Siriraj Ctr Regenerat Med SiCRM, Fac Med, Res Dept,Siriraj Hosp, Bangkok, Thailand; [Chirapapaisan, Chareenun; Ngowyutagon, Panotsom; Prabhasawat, Pinnita] Mahidol Univ, Fac Med, Dept Ophthalmol, Siriraj Hosp, Bangkok, Thailand; [Uiprasertkul, Mongkol] Mahidol Univ, Fac Med, Dept Pathol, Siriraj Hosp, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Ekpo, P; Tantibhedhyangkul, W (corresponding author), Mahidol Univ, Siriraj Hosp, Dept Immunol, Fac Med, Bangkok, Thailand.; Ekpo, P (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Res Dept, Bangkok, Thailand.	pattama.ekp@mahidol.ac.th; wiwit.tan@mahidol.ac.th	Wattanapanitch, Methichit/X-5942-2019; Wongprompitak, Patimaporn/GWQ-9050-2022; Wongprompitak, Patimaporn/ABF-4039-2020	Wattanapanitch, Methichit/0000-0003-2508-5760; Wongprompitak, Patimaporn/0000-0003-3740-8643	National Science and Technology Development Agency (NSTDA), Pathum Thani, Thailand [P-16-50679]; Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University	National Science and Technology Development Agency (NSTDA), Pathum Thani, Thailand; Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University	This work was supported by a grant from the National Science and Technology Development Agency (NSTDA), Pathum Thani, Thailand (grant no. P-16-50679). PP, WT, PW, MW, CC, PN and MU are supported by Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; Borroni D, 2018, SURV OPHTHALMOL, V63, P869, DOI 10.1016/j.survophthal.2018.05.003; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Ewel J, 2013, J OCULAR BIOL, V1; Ghoubay-Benallaoua D, 2011, MOL VIS, V17, P341; Gonzalez S, 2017, TISSUE ENG PART C-ME, V23, P219, DOI 10.1089/ten.tec.2016.0388; Grieve K, 2015, EXP EYE RES, V140, P75, DOI 10.1016/j.exer.2015.08.003; Haagdorens M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9798374; Hogerheyde TA, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8310127; Jackson CJ, 2020, STEM CELL TRANSL MED, V9, P316, DOI 10.1002/sctm.19-0203; Kethiri AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185623; KINOSHITA S, 1982, INVEST OPHTH VIS SCI, V23, P73; Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Prabhasawat P, 2016, CELL TISSUE BANK, V17, P491, DOI 10.1007/s10561-016-9575-4; Prabhasawat P, 2012, CLIN OPHTHALMOL, V6, P1483, DOI 10.2147/OPTH.S33951; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Sacchetti M, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8086269; Sangwan VS, 2017, CURR OPIN OPHTHALMOL, V28, P382, DOI 10.1097/ICU.0000000000000377; Sangwan VS, 2012, BRIT J OPHTHALMOL, V96, P931, DOI 10.1136/bjophthalmol-2011-301164; Singh V, 2015, INT REV CEL MOL BIO, V319, P45, DOI 10.1016/bs.ircmb.2015.07.001; Sun CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144571; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; Tong CM, 2013, 2013 CROSS STRAIT QUAD-REGIONAL RADIO SCIENCE AND WIRELESS TECHNOLOGY CONFERENCE (CSQRWC), P79, DOI 10.1109/CSQRWC.2013.6657356; Utheim OA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212524; Utheim TP, 2016, J FUNCT BIOMATER, V7, DOI 10.3390/jfb7010005; Utheim Tor Paaske, 2013, Methods Mol Biol, V1014, P3, DOI 10.1007/978-1-62703-432-6_1; Vemuganti Geeta K., 2004, Indian Journal of Ophthalmology, V52, P113; Wongprompitak P, 2020, ASIAN PAC J ALLERGY, V38, P129, DOI 10.12932/AP-110518-0311; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007	32	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233075	10.1371/journal.pone.0233075	http://dx.doi.org/10.1371/journal.pone.0233075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407348	Green Published, gold			2022-12-26	WOS:000537490700063
J	Santaca, M; Agrillo, C				Santaca, Maria; Agrillo, Christian			Two halves are less than the whole: Evidence of a length bisection bias in fish (Poecilia reticulata)	PLOS ONE			English	Article							ILLUSION; SPACE	The horizontal-vertical (HV) illusion is characterized by a tendency to overestimate the length of vertically-arranged objects. Comparative research is primarily confined to primates, a range of species that, although arboreal, often explore their environment moving along the horizontal axis. Such behaviour may have led to the development of asymmetrical perceptual mechanisms to make relative size judgments of objects placed vertically and horizontally. We observed the susceptibility to the HV illusion in fish, whose ability to swim along the horizontal and vertical plane permits them to scan objects' size equally on both axes. Guppies (Poecilia reticulata) were trained to select the longer orange line to receive a food reward. In the test phase, two arrays, containing two same-sized lines were presented, one horizontally and the other vertically. Black lines were also included in each pattern to generate the perception of an inverted T-shape (where a horizontal line is bisected by a vertical one) or an L-shape (no bisection). No bias was observed in the L-shape, which supports the idea of differential perceptual mechanisms for primates and fish. In the inverted T-shape, guppies estimated the bisected line as shorter, providing the first evidence of a length bisection bias in a fish species.	[Santaca, Maria; Agrillo, Christian] Univ Padua, Dept Gen Psychol, Padua, Italy; [Agrillo, Christian] Univ Padua, Padua Neurosci Ctr, Padua, Italy	University of Padua; University of Padua	Santaca, M (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	santacamaria@gmail.com	Santacà, Maria/F-9779-2019	Santacà, Maria/0000-0001-6590-3831	research program 'Dipartimenti di Eccellenza' [commi 314-337, legge 232/2016]; PRIN 2015 from MIUR [2015FFATB7]; 'STARS@unipd' (ANIM_ILLUS) grant from the University of Padova	research program 'Dipartimenti di Eccellenza'; PRIN 2015 from MIUR(Ministry of Education, Universities and Research (MIUR)); 'STARS@unipd' (ANIM_ILLUS) grant from the University of Padova	The present work was carried out within the scope of the research program 'Dipartimenti di Eccellenza' (art.1, commi 314-337, legge 232/2016). This work was supported by PRIN 2015 (grant number: 2015FFATB7) from MIUR and by 'STARS@unipd' (ANIM_ILLUS) grant from the University of Padova to C.A.	Agrillo C, 2020, ANIM COGN, P1, DOI [10.1007/s10071-019-01310-0, DOI 10.1007/S10071-019-01310-0]; Agrillo C, 2016, J COMP PSYCHOL, V130, P55, DOI 10.1037/com0000020; [Anonymous], THESIS; AVERY GC, 1969, J EXP PSYCHOL, V81, P376, DOI 10.1037/h0027737; DOMINGUEZ KE, 1954, J GENET PSYCHOL, V85, P105, DOI 10.1080/00221325.1954.10532865; Feng LC, 2017, PSYCHON B REV, V24, P262, DOI 10.3758/s13423-016-1133-3; FINGER FW, 1947, J EXP PSYCHOL, V37, P243, DOI 10.1037/h0055605; GIRGUS JS, 1975, CAN J PSYCHOL, V29, P59, DOI 10.1037/h0082021; Gori S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06443; GREGORY RL, 1963, NATURE, V199, P678, DOI 10.1038/199678a0; Gregory RL, 1997, PHILOS T ROY SOC B, V352, P1121, DOI 10.1098/rstb.1997.0095; Harrington D., 1971, OPTOMETRY VISION SCI, V48, P850; Kotrschal A, 2013, ANIM BEHAV, V86, pE4, DOI 10.1016/j.anbehav.2013.07.011; KUNNAPAS TM, 1955, J EXP PSYCHOL, V49, P134; KUNNAPAS TM, 1957, J EXP PSYCHOL, V53, P405; Lachenbruch P.A., 1989, J AM STAT ASSOC, V84, P1096, DOI DOI 10.2307/2290095; Lucon-Xiccato T, 2019, ANIM COGN, V22, P291, DOI 10.1007/s10071-019-01237-6; Lucon-Xiccato T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13447-4; Lucon-Xiccato T, 2015, ANIM BEHAV, V107, P183, DOI 10.1016/j.anbehav.2015.06.019; Lucon-Xiccato T, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0206; Mamassian P, 2010, VISION RES, V50, P956, DOI 10.1016/j.visres.2010.03.005; Pecunioso A, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12010006; Pecunioso A, 2020, ACTA PSYCHOL, V205, DOI 10.1016/j.actpsy.2020.103053; Petrazzini MEM, 2018, J COMP PSYCHOL, V132, P48, DOI 10.1037/com0000092; Petrazzini MEM, 2012, BEHAV BRAIN RES, V233, P443, DOI 10.1016/j.bbr.2012.05.044; Revesz G, 1924, B J PSYCHOL-GEN SECT, V14, P387, DOI 10.1111/j.2044-8295.1924.tb00151.x; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Santaca M, 2020, CURR ZOOL, V66, P205, DOI 10.1093/cz/zoz041; The World Conservation Union, 2014, IUCN RED LIST THREAD; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233157	10.1371/journal.pone.0233157	http://dx.doi.org/10.1371/journal.pone.0233157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407367	Green Published, gold			2022-12-26	WOS:000537490700077
J	Chen, C; Kuo, YH; Lin, CC; Chao, CY; Pai, MH; Chiang, EPI; Tang, FY				Chen, Ching; Kuo, Yueh-Hsiung; Lin, Cheng-Chieh; Chao, Che-Yi; Pai, Man-Hui; Chiang, En-Pei Isabel; Tang, Feng-Yao			Decyl caffeic acid inhibits the proliferation of colorectal cancer cells in an autophagy-dependent manner in vitro and in vivo	PLOS ONE			English	Article							TUMOR; COLON; GROWTH; MTOR; SUPPRESSES; PROPOLIS; BECLIN-1; ARREST; CAPE; AKT	The treatment of human colorectal cancer (CRC) cells through suppressing the abnormal survival signaling pathways has recently become a significant area of focus. In this study, our results demonstrated that decyl caffeic acid (DC), one of the novel caffeic acid derivatives, remarkedly suppressed the growth of CRC cells both in vitro and in vivo. The inhibitory effects of DC on CRC cells were investigated in an in vitro cell model and in vivo using a xenograft mouse model. CRC cells were treated with DC at various dosages (0, 10, 20 and 40 mu M), and cell survival, the apoptotic index and the autophagy level were measured using an MTT assay and flow cytometry analysis, respectively. The signaling cascades in CRC were examined by Western blot assay. The anti-cancer effects of DC on tumor growth were examined by using CRC HCT-116 cells implanted in an animal model. Our results indicated that DC differentially suppressed the growth of CRC HT-29 and HCT-116 cells through an enhancement of cell-cycle arrest at the S phase. DC inhibited the expression of cell-cycle regulators, which include cyclin E and cyclin A proteins. The molecular mechanisms of action were correlated to the blockade of the STAT3 and Akt signaling cascades. Strikingly, a high dosage of DC prompted a self-protection action through inducing cell-dependent autophagy in HCT-116 cells. Suppression of autophagy induced cell death in the treatment of DC in HCT-116 cells. DC seemed to inhibit cell proliferation of CRC differentially, and the therapeutic advantage appeared to be autophagy dependent. Moreover, consumption of DC blocked the tumor growth of colorectal adenocarcinoma in an experimental animal model. In conclusion, our results suggested that DC could act as a therapeutic agent through the significant suppression of tumor growth of human CRC cells.	[Chen, Ching; Tang, Feng-Yao] China Med Univ, Dept Nutr, Biomed Sci Lab, Taichung, Taiwan; [Kuo, Yueh-Hsiung] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Kuo, Yueh-Hsiung] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Lin, Cheng-Chieh] Asia Univ, Dept Healthcare Adm, Coll Hlth Sci, Taichung, Taiwan; [Chao, Che-Yi] Asia Univ, Dept Food Nutr & Hlth Biotechnol, Taichung, Taiwan; [Chao, Che-Yi] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Pai, Man-Hui] Taipei Med Univ, Sch Med, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan; [Chiang, En-Pei Isabel] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung, Taiwan; [Chiang, En-Pei Isabel] Natl Chung Hsing Univ, Innovat & Dev Ctr Sustainable Agr IDCSA, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; National Chung Hsing University; National Chung Hsing University	Tang, FY (corresponding author), China Med Univ, Dept Nutr, Biomed Sci Lab, Taichung, Taiwan.	vincenttang@mail.cmu.edu.tw	Chiang, EnPei/K-1694-2013	Chiang, EnPei/0000-0002-0158-0962	Ministry of Science and Technology (MOST), Taiwan, R.O.C. [MOST-104-2320-B-039-041-MY3, 107-2320-B039-008-MY3, MOST 107-2320-B-005 -003 MY3, 107-2621-M-005-008 -MY3, MOST1072321-B-005-009, 108-2321-B-005-004]; China Medical University (CMU) [CMU102-ASIA-23, CMU103-ASIA-20, CMU103-S46, CMU104-S-32]; Ministry of Education (MOE) Taiwan under the Higher Education Sprout Project at NCHU-IDCSA	Ministry of Science and Technology (MOST), Taiwan, R.O.C.; China Medical University (CMU)(China Medical University); Ministry of Education (MOE) Taiwan under the Higher Education Sprout Project at NCHU-IDCSA	This research project is supported by the grant of Ministry of Science and Technology (MOST), Taiwan, R.O.C. under the agreements MOST-104-2320-B-039-041-MY3, 107-2320-B039-008-MY3, MOST 107-2320-B-005 -003 MY3, 107-2621-M-005-008 -MY3, MOST1072321-B-005-009, 108-2321-B-005-004, China Medical University (CMU) grant under agreements CMU102-ASIA-23, CMU103-ASIA-20, CMU103-S46, CMU104-S-32, and as well as in part by the Ministry of Education (MOE) Taiwan under the Higher Education Sprout Project at NCHU-IDCSA. Any results, conclusions, or implication described in this publication are from the author(s) of this manuscript and do not necessarily reflect the view of the MOST, MOE, Asia University and CMU.	Bao YH, 2016, ONCOTARGET, V7, P26780, DOI 10.18632/oncotarget.8511; Bondi J, 2005, J CLIN PATHOL, V58, P509, DOI 10.1136/jcp.2004.020347; Chen C, 2017, ONCOL REP, V38, P2901, DOI 10.3892/or.2017.5943; Chiang EPI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099631; Danielsen SA, 2015, BBA-REV CANCER, V1855, P104, DOI 10.1016/j.bbcan.2014.09.008; Demestre M, 2009, PHYTOTHER RES, V23, P226, DOI 10.1002/ptr.2594; Doherty J, 2018, NAT CELL BIOL, V20, P1110, DOI 10.1038/s41556-018-0201-5; Fu LL, 2013, INT J BIOCHEM CELL B, V45, P921, DOI 10.1016/j.biocel.2013.02.007; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gonzalez-Sarrias A, 2013, FOOD CHEM, V136, P636, DOI 10.1016/j.foodchem.2012.08.023; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Huang YH, 2017, ONCOTARGET, V8, P52783, DOI 10.18632/oncotarget.17189; Koustas E, 2017, CANCER LETT, V396, P94, DOI 10.1016/j.canlet.2017.03.023; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee YS, 2013, J NAT PROD, V76, P2195, DOI 10.1021/np4005135; Liu JT, 2015, CLIN LUNG CANCER, V16, pE55, DOI 10.1016/j.cllc.2015.03.006; Mao MT, 2017, BIOCHEM BIOPH RES CO, V490, P1244, DOI 10.1016/j.bbrc.2017.07.002; Nazarko VY, 2013, NAT CELL BIOL, V15, P727, DOI 10.1038/ncb2797; Park JH, 2017, CLIN CANCER RES, V23, P1698, DOI 10.1158/1078-0432.CCR-16-1416; Pearce A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184360; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Strimpakos AS, 2009, CANCER TREAT REV, V35, P148, DOI 10.1016/j.ctrv.2008.09.006; Thome MP, 2016, J CELL SCI, V129, P4622, DOI 10.1242/jcs.195057; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Wu J, 2011, CANCER LETT, V308, P43, DOI 10.1016/j.canlet.2011.04.012	25	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232832	10.1371/journal.pone.0232832	http://dx.doi.org/10.1371/journal.pone.0232832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401800	Green Published, gold			2022-12-26	WOS:000537481000033
J	Trindade-da-Silva, CA; Clemente-Napimoga, JT; Abdalla, HB; Rosa, SM; Ueira-Vieira, C; Morisseau, C; Verri, WA; Montalli, VAM; Hammock, BD; Napimoga, MH				Trindade-da-Silva, Carlos A.; Clemente-Napimoga, Juliana T.; Abdalla, Henrique B.; Rosa, Sergio Marcolino; Ueira-Vieira, Carlos; Morisseau, Christophe; Verri Jr, Waldiceu A.; Martins Montalli, Victor Angelo; Hammock, Bruce D.; Napimoga, Marcelo H.			Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model	FASEB JOURNAL			English	Article						rheumatoid arthritis; soluble epoxide hydrolase; TPPU; Th1; Th17; Treg	MODIFYING ANTIRHEUMATIC DRUGS; ENDOPLASMIC-RETICULUM STRESS; RHEUMATOID-ARTHRITIS; THERAPEUTIC TARGET; FATTY-ACID; TH17 CELLS; PAIN; INFLAMMATION; PREVALENCE; EXPRESSION	Epoxyeicosatrienoic acids (EET) and related epoxy fatty acids (EpFA) are endogenous anti-inflammatory compounds, which are converted by the soluble epoxide hydrolase (sEH) to dihydroxylethersatrienoic acids (DHETs) with lessened biological effects. Inhibition of sEH is used as a strategy to increase EET levels leading to lower inflammation. Rheumatoid arthritis is a chronic autoimmune disease that leads to destruction of joint tissues. This pathogenesis involves a complex interplay between the immune system, and environmental factors. Here, we investigate the effects of inhibiting sEH with 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) on a collagen-induced arthritis model. The treatment with TPPU ameliorates hyperalgesia, edema, and decreases the expression of important pro-inflammatory cytokines of Th1 and Th17 profiles, while increasing Treg cells. Considering the challenges to control RA, this study provides robust data supporting that inhibition of the sEH is a promising target to treat arthritis.	[Trindade-da-Silva, Carlos A.; Clemente-Napimoga, Juliana T.; Abdalla, Henrique B.; Rosa, Sergio Marcolino; Martins Montalli, Victor Angelo; Napimoga, Marcelo H.] Inst Sao Leopoldo Mandic, Fac Sao Leopoldo Mandic, Lab Neuroimmune Interface Pain Res, R Jose Rocha Junqueira 13, BR-13045755 Campinas, SP, Brazil; [Ueira-Vieira, Carlos] Univ Fed Uberlandia, Inst Biotechnol, Lab Genet, Uberlandia, MG, Brazil; [Morisseau, Christophe; Hammock, Bruce D.] Univ Calif Davis, UC Davis Comprehens Canc Ctr, Dept Entomol & Hematol, Davis, CA 95616 USA; [Verri Jr, Waldiceu A.] State Univ Londrina UEL, Biol Sci Ctr, Dept Pathol Sci, Londrina, Parana, Brazil; [Hammock, Bruce D.] EicOsis LLC, Davis, CA USA	Faculdade Sao Leopoldo Mandic; Universidade Federal de Uberlandia; University of California System; University of California Davis; Universidade Estadual de Londrina	Napimoga, MH (corresponding author), Inst Sao Leopoldo Mandic, Fac Sao Leopoldo Mandic, Lab Neuroimmune Interface Pain Res, R Jose Rocha Junqueira 13, BR-13045755 Campinas, SP, Brazil.	marcelo.napimoga@gmail.com	Clemente-Napimoga, Juliana T/E-5163-2013; da Silva, Carlos Antonio Trindade/AAN-6561-2020; Abdalla, Henrique Ballassini/M-2565-2014; Napimoga, Marcelo/S-2434-2019; Montalli, Victor/E-7246-2013; WA, Verri/I-1330-2013; da Silva, Carlos Antonio Trindade/I-4250-2013	Clemente-Napimoga, Juliana T/0000-0003-1068-3039; da Silva, Carlos Antonio Trindade/0000-0002-5669-4190; Abdalla, Henrique Ballassini/0000-0002-7517-2830; Napimoga, Marcelo/0000-0003-4472-365X; Montalli, Victor/0000-0002-1927-7718; WA, Verri/0000-0003-2756-9283; da Silva, Carlos Antonio Trindade/0000-0002-5669-4190; Morisseau, Christophe/0000-0002-5672-6631	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2017/22334-9]; MCTI \ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302527/2019-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; HHS \ NIH \ National Institute of Environmental Health Sciences (NIEHS) [R35 ES030443, P42ES04699]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MCTI \ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); HHS \ NIH \ National Institute of Environmental Health Sciences (NIEHS)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Grant/Award Number: 2017/22334-9; MCTI vertical bar Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Grant/Award Number: 302527/2019-2; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Grant/Award Number: 001; HHS vertical bar NIH vertical bar National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: R35 ES030443 and P42ES04699	Attias M, 2019, CLIN EXP IMMUNOL, V197, P36, DOI 10.1111/cei.13290; Bettaieb A, 2015, MOL PHARMACOL, V88, P281, DOI 10.1124/mol.114.097501; Borghi SM, 2018, J NUTR BIOCHEM, V53, P81, DOI 10.1016/j.jnutbio.2017.10.010; Carregaro V, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9626427; Carregaro V, 2011, J IMMUNOL, V187, P4347, DOI 10.4049/jimmunol.1003404; Chatzidionysiou K, 2017, ANN RHEUM DIS, V76, P1102, DOI 10.1136/annrheumdis-2016-210711; Chen ZH, 2020, SHOCK, V53, P761, DOI 10.1097/SHK.0000000000001408; Dinarello CA, 2003, VACCINE, V21, pS24, DOI 10.1016/S0264-410X(03)00196-8; Dong RL, 2017, ONCOTARGET, V8, P50958, DOI 10.18632/oncotarget.17331; Faulkner J, 2015, J DIABETES METAB, V6, DOI 10.4172/2155-6156.1000555; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Harris TR, 2013, GENE, V526, P61, DOI 10.1016/j.gene.2013.05.008; Huh JR, 2012, EUR J IMMUNOL, V42, P2232, DOI 10.1002/eji.201242740; Inceoglu B, 2015, P NATL ACAD SCI USA, V112, P9082, DOI 10.1073/pnas.1510137112; Inceoglu B, 2012, P NATL ACAD SCI USA, V109, P11390, DOI 10.1073/pnas.1208708109; Kamali AN, 2019, MOL IMMUNOL, V105, P107, DOI 10.1016/j.molimm.2018.11.015; Kobayashi H, 2006, ARTHRITIS RHEUM-US, V54, P1132, DOI 10.1002/art.21754; Kodani SD, 2019, BIOCHIMIE, V159, P59, DOI 10.1016/j.biochi.2019.01.020; Kohler BM, 2019, J CLIN MED, V8, DOI 10.3390/jcm8070938; Kuo SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176052; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; McReynolds CB, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00533; Napimoga MH, 2018, J PERIODONTAL RES, V53, P743, DOI 10.1111/jre.12559; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Oestreich KJ, 2012, TRENDS IMMUNOL, V33, P78, DOI 10.1016/j.it.2011.10.005; Oh JS, 2013, RHEUMATOL INT, V33, P381, DOI 10.1007/s00296-012-2365-9; Osterman C, 2015, AM J SPORT MED, V43, P1474, DOI 10.1177/0363546515570463; Otter SJ, 2010, CLIN RHEUMATOL, V29, P255, DOI 10.1007/s10067-009-1312-y; Park J, 2019, INT J FINANC STUD, V7, DOI 10.3390/ijfs7010010; Park J, 2018, AM J PUBLIC HEALTH, V108, P256, DOI [10.2105/AJPH.2017.304179, 10.2105/ajph.2017.304179]; Peres RS, 2015, P NATL ACAD SCI USA, V112, P2509, DOI 10.1073/pnas.1424792112; Rose TE, 2010, J MED CHEM, V53, P7067, DOI 10.1021/jm100691c; Ruiz-Miyazawa KW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32334-0; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Staurengo-Ferrari L, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01536; Su ZL, 2013, MOL MED REP, V8, P113, DOI 10.3892/mmr.2013.1476; Sultana S, 2018, IMMUNOL LETT, V196, P33, DOI 10.1016/j.imlet.2018.01.005; Trindade-da-Silva CA, 2017, J PHARMACOL EXP THER, V361, P408, DOI 10.1124/jpet.116.238113; Tsai HJ, 2010, EUR J PHARM SCI, V40, P222, DOI 10.1016/j.ejps.2010.03.018; Tu RR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23504-1; Valdes AM, 2018, J LIPID RES, V59, P1763, DOI 10.1194/jlr.P085118; Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655; Wagner KM, 2017, PHARMACOL THERAPEUT, V180, P62, DOI 10.1016/j.pharmthera.2017.06.006; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Xu DM, 2010, J IMMUNOL, V184, P2620, DOI 10.4049/jimmunol.0902685; Yao L, 2019, AM J PHYSIOL-GASTR L, V316, pG527, DOI 10.1152/ajpgi.00148.2018; Yin H, 2011, INT IMMUNOPHARMACOL, V11, P2112, DOI 10.1016/j.intimp.2011.09.004; Yu Q, 2014, CENT EUR J IMMUNOL, V39, P100, DOI 10.5114/ceji.2014.42133; Zarpelon AC, 2013, BRIT J PHARMACOL, V169, P90, DOI 10.1111/bph.12110; Zarpelon AC, 2016, FASEB J, V30, P54, DOI 10.1096/fj.14-267146	50	7	7	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9074	9086		10.1096/fj.202000415R	http://dx.doi.org/10.1096/fj.202000415R		MAY 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32400048	Green Published, hybrid			2022-12-26	WOS:000532213200001
J	Apgar, JR; Tam, ASP; Sorm, R; Moesta, S; King, AC; Yang, H; Kelleher, K; Murphy, D; D'Antona, AM; Yan, GY; Zhong, XT; Rodriguez, L; Ma, WJ; Ferguson, DE; Carven, GJ; Bennett, EM; Lin, L				Apgar, James R.; Tam, Amy S. P.; Sorm, Rhady; Moesta, Sybille; King, Amy C.; Yang, Han; Kelleher, Kerry; Murphy, Denise; D'Antona, Aaron M.; Yan, Guoying; Zhong, Xiaotian; Rodriguez, Linette; Ma, Weijun; Ferguson, Darren E.; Carven, Gregory J.; Bennett, Eric M.; Lin, Laura			Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design	PLOS ONE			English	Article							CONCENTRATION-DEPENDENT VISCOSITY; REVERSIBLE SELF-ASSOCIATION; IGG1 MONOCLONAL-ANTIBODY; IMGT; CHARGE; BEHAVIOR; PDGF	For an antibody to be a successful therapeutic many competing factors require optimization, including binding affinity, biophysical characteristics, and immunogenicity risk. Additional constraints may arise from the need to formulate antibodies at high concentrations (> 150 mg/ml) to enable subcutaneous dosing with reasonable volume (ideally < 1.0 mL). Unfortunately, antibodies at high concentrations may exhibit high viscosities that place impractical constraints (such as multiple injections or large needle diameters) on delivery and impede efficient manufacturing. Here we describe the optimization of an anti-PDGF-BB antibody to reduce viscosity, enabling an increase in the formulated concentration from 80 mg/ml to greater than 160 mg/ml, while maintaining the binding affinity. We performed two rounds of structure guided rational design to optimize the surface electrostatic properties. Analysis of this set demonstrated that a net-positive charge change, and disruption of negative charge patches were associated with decreased viscosity, but the effect was greatly dependent on the local surface environment. Our work here provides a comprehensive study exploring a wide sampling of charge-changes in the Fv and CDR regions along with targeting multiple negative charge patches. In total, we generated viscosity measurements for 40 unique antibody variants with full sequence information which provides a significantly larger and more complete dataset than has previously been reported.	[Apgar, James R.; Tam, Amy S. P.; Sorm, Rhady; Moesta, Sybille; King, Amy C.; Yang, Han; Kelleher, Kerry; Murphy, Denise; D'Antona, Aaron M.; Yan, Guoying; Zhong, Xiaotian; Rodriguez, Linette; Ma, Weijun; Ferguson, Darren E.; Carven, Gregory J.; Bennett, Eric M.; Lin, Laura] Pfizer Inc, BioMed Design, Cambridge, MA 02139 USA; [Moesta, Sybille] St Georges Univ, Sch Med, True Blue, Grenada; [Carven, Gregory J.] Scholar Rock, Cambridge, MA USA	Pfizer	Apgar, JR (corresponding author), Pfizer Inc, BioMed Design, Cambridge, MA 02139 USA.	james.r.apgar@pfizer.com		Bennett, Eric/0000-0001-5784-0797; Apgar, James/0000-0002-4669-0188				Agrawal NJ, 2016, MABS-AUSTIN, V8, P43, DOI 10.1080/19420862.2015.1099773; [Anonymous], PYMOL MOL GRAPH SYST; [Anonymous], 2016, MOL OP ENR 2016 08; Avery LB, 2018, MABS-AUSTIN, V10, P244, DOI 10.1080/19420862.2017.1417718; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Berteau C, 2015, MED DEVICES-EVID RES, V8, P473, DOI 10.2147/MDER.S91019; Borrebaeck CA., 1995, ANTIBODY ENG; Boswell CA, 2010, BIOCONJUGATE CHEM, V21, P2153, DOI 10.1021/bc100261d; Bumbaca D, 2012, AAPS J, V14, P554, DOI 10.1208/s12248-012-9369-y; Chaudhri A, 2013, J PHYS CHEM B, V117, P1269, DOI 10.1021/jp3108396; Chow CK, 2016, MOL PHARMACEUT, V13, P915, DOI 10.1021/acs.molpharmaceut.5b00817; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Esfandiary R, 2015, J PHARM SCI-US, V104, P577, DOI 10.1002/jps.24237; Ezan E, 2013, ADV DRUG DELIVER REV, V65, P1065, DOI 10.1016/j.addr.2013.03.007; Geoghegan JC, 2016, MABS-AUSTIN, V8, P941, DOI 10.1080/19420862.2016.1171444; Guo Z, 2012, PHARM RES-DORDR, V29, P3102, DOI 10.1007/s11095-012-0802-9; He F, 2011, PHARM RES-DORDR, V28, P1552, DOI 10.1007/s11095-011-0388-7; Inoue N, 2014, J BIOSCI BIOENG, V117, P539, DOI 10.1016/j.jbiosc.2013.10.016; Kaplon H, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1703531; Klinkhammer BM, 2018, MOL ASPECTS MED, V62, P44, DOI 10.1016/j.mam.2017.11.008; Kuai J, 2015, BIOCHEMISTRY-US, V54, P1918, DOI 10.1021/bi5015425; Lefranc Marie-Paule, 2004, In Silico Biology, V4, P17; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Lefranc MP, 2003, NUCLEIC ACIDS RES, V31, P307, DOI 10.1093/nar/gkg085; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li L, 2014, PHARM RES-DORDR, V31, P3161, DOI 10.1007/s11095-014-1409-0; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; MATLAB, 2019, MATLAB VERS 9 10 0 1; McDonald TA, 2010, CURR OPIN MOL THER, V12, P461; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nichols P, 2015, MABS-AUSTIN, V7, P212, DOI 10.4161/19420862.2014.985504; Rabia LA, 2018, PROTEIN ENG DES SEL, V31, P409, DOI 10.1093/protein/gzz002; Richter WF, 2012, AAPS J, V14, P559, DOI 10.1208/s12248-012-9367-0; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; ROSS PD, 1977, BIOCHEM BIOPH RES CO, V76, P971, DOI 10.1016/0006-291X(77)90950-0; Ruiz M, 2000, NUCLEIC ACIDS RES, V28, P219, DOI 10.1093/nar/28.1.219; Scherer TM, 2013, J PHYS CHEM B, V117, P2254, DOI 10.1021/jp3091717; Sharma VK, 2014, P NATL ACAD SCI USA, V111, P18601, DOI 10.1073/pnas.1421779112; Shire SJ, 2004, J PHARM SCI-US, V93, P1390, DOI 10.1002/jps.20079; Tiller KE, 2017, J BIOL CHEM, V292, P16638, DOI 10.1074/jbc.M117.783837; Tomar DS, 2017, MABS-AUSTIN, V9, P476, DOI 10.1080/19420862.2017.1285479; Tomar DS, 2016, MABS-AUSTIN, V8, P216, DOI 10.1080/19420862.2015.1128606; Yadav S, 2012, MOL PHARMACEUT, V9, P791, DOI 10.1021/mp200566k; Yadav S, 2010, J PHARM SCI-US, V99, P4812, DOI 10.1002/jps.22190; Yadav S, 2010, J PHARM SCI-US, V99, P1152, DOI 10.1002/jps.21898	49	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232713	10.1371/journal.pone.0232713	http://dx.doi.org/10.1371/journal.pone.0232713			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379792	Green Published, gold			2022-12-26	WOS:000537285700059
J	Nadipuram, SM; Thind, AC; Rayatpisheh, S; Wohlschlegel, JA; Bradley, PJ				Nadipuram, Santhosh Mukund; Thind, Amara Cervantes; Rayatpisheh, Shima; Wohlschlegel, James Akira; Bradley, Peter John			Proximity biotinylation reveals novel secreted dense granule proteins of Toxoplasma gondii bradyzoites	PLOS ONE			English	Article							ALPHA-GALACTOSIDASE ACTIVITY; HOST-PARASITE INTERACTIONS; SACCHAROMYCES-CARLSBERGENSIS; PARASITOPHOROUS VACUOLE; PROTOZOAN PARASITE; IN-VIVO; PURIFICATION; ORGANELLES; LOCALIZATION; TACHYZOITE	Toxoplasma gondii is an obligate intracellular parasite which is capable of establishing lifelong chronic infection in any mammalian host. During the intracellular life cycle, the parasite secretes an array of proteins into the parasitophorous vacuole (PV) where it resides. Specialized organelles called the dense granules secrete GRA proteins that are known to participate in nutrient acquisition, immune evasion, and host cell-cycle manipulation. Although many GRAs have been discovered which are expressed during the acute infection mediated by tachyzoites, little is known about those that participate in the chronic infection mediated by the bradyzoite form of the parasite. In this study, we sought to uncover novel bradyzoite-upregulated GRA proteins using proximity biotinylation, which we previously used to examine the secreted proteome of the tachyzoites. Using a fusion of the bradyzoite upregulated protein MAG1 to BirA* as bait and a strain with improved switch efficiency, we identified a number of novel GRA proteins which are expressed in bradyzoites. After using the CRISPR/Cas9 system to characterize these proteins by gene knockout, we focused on one of these GRAs (GRA55) and found it was important for the establishment or maintenance of cysts in the mouse brain. These findings highlight new components of the GRA proteome of the tissue-cyst life stage of T. gondii and identify potential targets that are important for maintenance of parasite persistence in vivo.	[Nadipuram, Santhosh Mukund; Thind, Amara Cervantes; Bradley, Peter John] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Nadipuram, Santhosh Mukund] Cedar Sinai Med Ctr, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA USA; [Thind, Amara Cervantes; Wohlschlegel, James Akira; Bradley, Peter John] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Rayatpisheh, Shima; Wohlschlegel, James Akira] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Rayatpisheh, Shima; Wohlschlegel, James Akira] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA USA	University of California System; University of California Los Angeles; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bradley, PJ (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Bradley, PJ (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.	pbradley@ucla.edu			NIH [AI064616, AI125106, GM089778]; Ruth L. Kirschstein National Research Service Award (T32) [AI007323]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award (T32)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants AI064616 and AI125106 to P.J.B., and no. GM089778 to J.A.W., the Ruth L. Kirschstein National Research Service Award (T32) AI007323 to S.M.N and A.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED MU, 1964, CAN J BIOCHEM PHYS, V42, P605, DOI 10.1139/o64-073; BAILEY RW, 1962, NATURE, V195, P79, DOI 10.1038/195079b0; Beck JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004025; Beraki T, 2019, P NATL ACAD SCI USA, V116, P6361, DOI 10.1073/pnas.1816161116; Bittame A, 2015, BIOCHEM BIOPH RES CO, V459, P107, DOI 10.1016/j.bbrc.2015.02.078; Bougdour A, 2013, CELL HOST MICROBE, V13, P489, DOI 10.1016/j.chom.2013.03.002; Bradley PJ, 2020, METHODS MOL BIOL, V2071, P323, DOI 10.1007/978-1-4939-9857-9_18; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Braun L, 2019, NAT MICROBIOL, V4, P1208, DOI 10.1038/s41564-019-0431-8; Braun L, 2013, J EXP MED, V210, P2071, DOI 10.1084/jem.20130103; Buchholz KR, 2013, EUKARYOT CELL, V12, P399, DOI 10.1128/EC.00343-12; Buchholz KR, 2011, EUKARYOT CELL, V10, P1637, DOI 10.1128/EC.05182-11; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers VB, 1999, ARMED DANGEROUS TOXO, P10; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Chen AL, 2015, MBIO, V6, DOI 10.1128/mBio.02357-14; COLEMAN RL, 1968, BIOCHIM BIOPHYS ACTA, V159, P192, DOI 10.1016/0005-2744(68)90261-1; Di Cristina M, 2004, MICROBES INFECT, V6, P164, DOI 10.1016/j.micinf.2003.11.009; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Ferguson DJP, 1999, PARASITOLOGY, V119, P259, DOI 10.1017/S0031182099004692; Ferguson DJP, 2002, TRENDS PARASITOL, V18, P482, DOI 10.1016/S1471-4922(02)02349-8; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; FRIIS J., 1959, COMP REND TRAV LAB CARLSBERG SER CHIM, V31, P272; Gold DA, 2015, CELL HOST MICROBE, V17, P642, DOI 10.1016/j.chom.2015.04.003; Guevara RB, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00487-19; HARPAZ N, 1974, BIOCHIM BIOPHYS ACTA, V341, P213, DOI 10.1016/0005-2744(74)90082-5; HERRERO P, 1980, CELL MOL BIOL, V26, P485; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Hsiao CHC, 2013, TRAFFIC, V14, P519, DOI 10.1111/tra.12049; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Innes EA, 1997, COMP IMMUNOL MICROB, V20, P131, DOI 10.1016/S0147-9571(96)00038-0; Labruyere, 1999, DIFFERENTIAL MEMBRAN; Lamarque MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5098; LAZO PS, 1977, EUR J BIOCHEM, V77, P375, DOI 10.1111/j.1432-1033.1977.tb11677.x; LAZO PS, 1978, ARCH BIOCHEM BIOPHYS, V191, P316, DOI 10.1016/0003-9861(78)90094-2; Lemgruber L, 2011, CELL MICROBIOL, V13, P1920, DOI 10.1111/j.1462-5822.2011.01681.x; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MALHOTRA OP, 1967, BIOCHEM J, V103, P508, DOI 10.1042/bj1030508; Mayoral J, 2020, METHODS MOL BIOL, V2071, P269, DOI 10.1007/978-1-4939-9857-9_15; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; Mercier C, 2002, MOL BIOL CELL, V13, P2397, DOI 10.1091/mbc.E02-01-0021; Mercier C, 2015, TRENDS PARASITOL, V31, P60, DOI 10.1016/j.pt.2014.12.002; Milligan-Myhre K, 2016, MOL MICROBIOL, V102, P1086, DOI 10.1111/mmi.13538; MITAL BK, 1973, APPL MICROBIOL, V26, P783, DOI 10.1128/AEM.26.5.783-788.1973; Nadipuram SM, 2016, MBIO, V7, DOI 10.1128/mBio.00808-16; Nam HW, 2009, KOREAN J PARASITOL, V47, pS29, DOI 10.3347/kjp.2009.47.S.S29; Naor A, 2018, MBIO, V9, DOI [10.1128/mbio.02401-17, 10.1128/mBio.02401-17]; Opitz C, 2002, MOL MICROBIOL, V45, P597, DOI 10.1046/j.1365-2958.2002.03056.x; Panas MW, 2019, HCE, V10, P18; Paredes-Santos T, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00321; PARMLEY SF, 1994, MOL BIOCHEM PARASIT, V66, P283, DOI 10.1016/0166-6851(94)90155-4; Pittman KJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-806; Radke JB, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007035; RAO KS, 1970, J NEUROCHEM, V17, P483, DOI 10.1111/j.1471-4159.1970.tb00525.x; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Rome ME, 2008, INFECT IMMUN, V76, P4865, DOI 10.1128/IAI.00782-08; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; SCHMITT R, 1966, BIOCHEM BIOPH RES CO, V22, P473, DOI 10.1016/0006-291X(66)90297-X; Shastri AJ, 2014, INFECT IMMUN, V82, P2595, DOI 10.1128/IAI.01339-13; Shen B, 2017, METHODS MOL BIOL, V1498, P79, DOI 10.1007/978-1-4939-6472-7_6; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Sibley LD, REGULATED SECRETION, P9; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; Soldati D, 2004, TRENDS PARASITOL, V20, P567, DOI 10.1016/j.pt.2004.09.009; Tomita T, 2013, PLOS PATHOG, V9, DOI [10.1371/journal.ppat.1003823, DOI 10.1371/journal.ppat.1003823]; Tomita T, 2017, MBIO, V8, DOI [10.1128/mBio.02048-16, 10.1128/mbio.02048-16]; TORPIER G, 1993, EXP PARASITOL, V77, P13, DOI 10.1006/expr.1993.1056; Tu V, 2019, MBIO, V10, DOI [10.1128/mBio.00469-19, 10.1128/mbio.00469-19]; Waldman B.S., 2019, BIORXIV, DOI [10.1101/660753, DOI 10.2139/SSRN.3404261]; Wang QL, 2020, METHODS MOL BIOL, V2071, P99, DOI 10.1007/978-1-4939-9857-9_5; Watts E, 2015, MBIO, V6, DOI 10.1128/mBio.01155-15; Zhang YW, 2001, INFECT IMMUN, V69, P501, DOI 10.1128/IAI.69.1.501-507.2001	77	13	13	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232552	10.1371/journal.pone.0232552	http://dx.doi.org/10.1371/journal.pone.0232552			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374791	gold, Green Published			2022-12-26	WOS:000537283500041
J	Gawlinski, D; Gawlinska, K; Frankowska, M; Filip, M				Gawlinski, Dawid; Gawlinska, Kinga; Frankowska, Malgorzata; Filip, Malgorzata			Maternal high-sugar diet changes offspring vulnerability to reinstatement of cocaine-seeking behavior: Role of melanocortin-4 receptors	FASEB JOURNAL			English	Article						cocaine self-administration; high-sugar diet; maternal diet; MC-4R; rat offspring	DORSOMEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; DORSAL HIPPOCAMPUS; NUCLEUS-ACCUMBENS; LOCOMOTOR SENSITIZATION; PERINATAL EXPOSURE; ETHANOL INTAKE; MENTAL-HEALTH; SUBSTANCE USE; NOSE-POKING	Maternal diet significantly influences the proper development of offspring in utero. Modifications of diet composition may lead to metabolic and mental disorders that may predispose offspring to a substance use disorder. We assessed the impact of a maternal high-sugar diet (HSD, rich in sucrose) consumed during pregnancy and lactation on the offspring phenotype in the context of the rewarding and motivational effects of cocaine and changes within the central melanocortin (MC) system. Using an intravenous cocaine self-administration model, we showed that maternal HSD leads to increased relapse of cocaine-seeking behavior in male offspring. In addition, we demonstrated that cocaine induces changes in the level of MC-4 receptors in the offspring brain, and these changes depend on maternal diet. These studies also reveal that an MC-4 receptor antagonist reduces the reinstatement of cocaine-seeking behavior, and offspring exposed to maternal HSD are more sensitive to its effects than offspring exposed to the maternal control diet. Taken together, the results suggest that a maternal HSD and MC-4 receptors play an important role in cocaine relapse.	[Gawlinski, Dawid; Gawlinska, Kinga; Frankowska, Malgorzata; Filip, Malgorzata] Polish Acad Sci, Maj Inst Pharmacol, Dept Drug Addict Pharmacol, Smetna St 12, PL-31343 Krakow, Poland	Polish Academy of Sciences; Maj Institute of Pharmacology of the Polish Academy of Sciences	Filip, M (corresponding author), Polish Acad Sci, Maj Inst Pharmacol, Dept Drug Addict Pharmacol, Smetna St 12, PL-31343 Krakow, Poland.	mal.fil@if-pan.krakow.pl	Gawliński, Dawid/ABB-3000-2020; Gawlińska, Kinga/AAJ-3232-2021	Gawliński, Dawid/0000-0002-9376-0564; Gawlińska, Kinga/0000-0001-7015-154X; Frankowska, Malgorzata/0000-0002-6646-6140	Narodowe Centrum Nauki (NCN) [UMO-2016/21/B/NZ4/00203]	Narodowe Centrum Nauki (NCN)(National Science Centre, Poland)	Narodowe Centrum Nauki (NCN), Grant/Award Number: UMO-2016/21/B/NZ4/00203	Adan RAH, 1997, PEPTIDES, V18, P1279, DOI 10.1016/S0196-9781(97)00078-8; Ahmed S, 2014, NEUROCHEM RES, V39, P815, DOI 10.1007/s11064-014-1274-6; Martinez JA, 2012, P NUTR SOC, V71, P276, DOI 10.1017/S0029665112000055; Alserda E, 2013, EUR J PHARMACOL, V719, P187, DOI 10.1016/j.ejphar.2013.04.052; Alvaro JD, 1996, MOL PHARMACOL, V50, P583; Alvaro JD, 2003, J PHARMACOL EXP THER, V304, P391, DOI 10.1124/jpet.102.040311; Avena NM, 2005, PHYSIOL BEHAV, V84, P359, DOI 10.1016/j.physbeh.2004.12.016; Baskin R, 2015, APPETITE, V91, P41, DOI 10.1016/j.appet.2015.03.017; Bassareo V, 2015, BEHAV BRAIN RES, V294, P215, DOI 10.1016/j.bbr.2015.08.006; Bassareo V, 2015, BEHAV BRAIN RES, V287, P200, DOI 10.1016/j.bbr.2015.03.056; Bello NT, 2002, NEUROREPORT, V13, P1575, DOI 10.1097/00001756-200208270-00017; Bocarsly ME, 2012, PHYSIOL BEHAV, V107, P568, DOI 10.1016/j.physbeh.2012.04.024; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Cui H, 2013, GENES BRAIN BEHAV, V12, P658, DOI 10.1111/gbb.12057; Delaney-Black V, 2011, NEUROTOXICOL TERATOL, V33, P110, DOI 10.1016/j.ntt.2010.06.011; DESAI M, 2014, AM J OBSTET GYNECOL, V237, pE1, DOI DOI 10.1016/J.AJ0G.2014.03.025; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; Farrell MR, 2018, PROG NEURO-PSYCHOPH, V87, P33, DOI 10.1016/j.pnpbp.2018.01.002; Frank DA, 2011, NEUROTOXICOL TERATOL, V33, P100, DOI 10.1016/j.ntt.2010.06.002; Fuchs RA, 2005, NEUROPSYCHOPHARMACOL, V30, P296, DOI 10.1038/sj.npp.1300579; Fuchs RA, 2007, EUR J NEUROSCI, V26, P487, DOI 10.1111/j.1460-9568.2007.05674.x; Girardet C, 2018, OBESITY, V26, P1849, DOI 10.1002/oby.22306; Gosnell BA, 2005, BRAIN RES, V1031, P194, DOI 10.1016/j.brainres.2004.10.037; Grimm JW, 2005, PHYSIOL BEHAV, V84, P73, DOI 10.1016/j.physbeh.2004.10.011; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Hecht GS, 1998, BEHAV NEUROSCI, V112, P410, DOI 10.1037/0735-7044.112.2.410; Heindel JJ, 2015, CURR OPIN PEDIATR, V27, P248, DOI 10.1097/MOP.0000000000000191; Hsu R, 2005, EUR J NEUROSCI, V21, P2233, DOI 10.1111/j.1460-9568.2005.04038.x; Jacka FN, 2013, J AM ACAD CHILD PSY, V52, P1038, DOI 10.1016/j.jaac.2013.07.002; Jastrzebska J, 2015, BEHAV BRAIN RES, V293, P62, DOI 10.1016/j.bbr.2015.06.040; Johnson WG, 1999, AM J MED GENET, V88, P311, DOI 10.1002/(SICI)1096-8628(19990820)88:4<311::AID-AJMG6>3.3.CO;2-M; Jones KT, 2017, J NEUROCHEM, V140, P728, DOI 10.1111/jnc.13930; Kamat PK, 2014, METHODSX, V1, P102, DOI 10.1016/j.mex.2014.08.002; Karatayev O, 2015, ALCOHOL, V49, P479, DOI 10.1016/j.alcohol.2015.03.002; Keller RW, 1996, NEUROSCI LETT, V205, P153, DOI 10.1016/0304-3940(96)12409-5; Khoo SYS, 2017, GENES BRAIN BEHAV, V16, P185, DOI 10.1111/gbb.12328; Kokare DM, 2008, BRAIN RES, V1216, P53, DOI 10.1016/j.brainres.2008.03.064; Lee BR, 2013, NAT NEUROSCI, V16, P1644, DOI 10.1038/nn.3533; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Li Yan-Qing, 2016, Shengli Xuebao, V68, P233, DOI 10.13294/j.aps.2016.0045; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lindblom J, 2002, PHARMACOL BIOCHEM BE, V72, P491, DOI 10.1016/S0091-3057(02)00719-0; Lindblom J, 2002, PHARMACOL RES, V45, P119, DOI 10.1006/phrs.2001.0913; Lindblom J, 2001, NEUROREPORT, V12, P2155, DOI 10.1097/00001756-200107200-00022; Menting MD, 2019, NEUROSCI BIOBEHAV R, V98, P107, DOI 10.1016/j.neubiorev.2018.12.023; Minnes S, 2014, DRUG ALCOHOL DEPEN, V134, P201, DOI 10.1016/j.drugalcdep.2013.09.031; Morganstern I, 2013, PSYCHOPHARMACOLOGY, V230, P509, DOI 10.1007/s00213-013-3178-6; Navarro M, 2005, ALCOHOL CLIN EXP RES, V29, P949, DOI 10.1097/01.ALC.0000167740.19702.8C; Navarro M, 2003, NEUROPEPTIDES, V37, P338, DOI 10.1016/j.npep.2003.10.003; Nicholson JR, 2006, J PHARMACOL EXP THER, V317, P771, DOI 10.1124/jpet.105.097725; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Pandit R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121768; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ploj K, 2002, BRAIN RES BULL, V59, P97, DOI 10.1016/S0361-9230(02)00844-4; Qi XL, 2015, ADDICT BIOL, V20, P324, DOI 10.1111/adb.12129; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Richardson GA, 2019, DRUG ALCOHOL DEPEN, V195, P121, DOI 10.1016/j.drugalcdep.2018.10.033; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Rocha BA, 2002, PSYCHOPHARMACOLOGY, V163, P221, DOI 10.1007/s00213-002-1140-0; Sanchez MS, 2001, CELL MOL NEUROBIOL, V21, P523, DOI 10.1023/A:1013871407464; Shelkar GP, 2015, ADDICT BIOL, V20, P302, DOI 10.1111/adb.12126; Spangler R, 2004, MOL BRAIN RES, V124, P134, DOI 10.1016/j.molbrainres.2004.02.013; Stefanik MT, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00213; Stewart J, 2008, PHILOS T R SOC B, V363, P3147, DOI 10.1098/rstb.2008.0084; Sullivan EL, 2015, HORM BEHAV, V76, P153, DOI 10.1016/j.yhbeh.2015.04.008; Vos TJ, 2004, J MED CHEM, V47, P1602, DOI 10.1021/jm034244g; Wells AM, 2011, LEARN MEMORY, V18, P693, DOI 10.1101/lm.2273111; Wirth MM, 2001, BRAIN RES, V897, P169, DOI 10.1016/S0006-8993(01)02087-X; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003	70	10	10	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9192	9206		10.1096/fj.202000163R	http://dx.doi.org/10.1096/fj.202000163R		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32421249	Bronze			2022-12-26	WOS:000533521600001
J	Su, LH; Chen, IL; Tang, YF; Lee, JS; Liu, JW				Su, Li-Hsiang; Chen, I-Ling; Tang, Ya-Fen; Lee, Jen-Sin; Liu, Jien-Wei			Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: A propensity-matched case-control study	PLOS ONE			English	Article							STEWARDSHIP PROGRAM; DISEASES SOCIETY; EPIDEMIOLOGY; OUTCOMES; SUSCEPTIBILITY; SURVEILLANCE; PREVALENCE; GUIDELINES; TAIWAN; UPDATE	Background and objectives Incidence rates of healthcare-associated infections (HAIs) depend upon infection control policy and practices, and the effectiveness of the implementation of antibiotic stewardship. Amongst intensive care unit (ICU) patients with HAIs, a substantial number of pathogens were reported to be multidrug-resistant bacteria (MDRB). However, impacts of ICU HAIs due to MDRB (MDRB-HAIs) remain understudied. Our study aimed to evaluate the negative impacts of MRDB-HAIs versus HAIs due to non-MDRB (non-MRDB-HAIs). Methods Among 60,317 adult patients admitted at ICUs of a 2680-bed medical centre in Taiwan between January 2010 and December 2017, 279 pairs of propensity-score matched MRDB-HAI and non-MRDB-HAI were analyzed. Principal findings Between the MDRB-HAI group and the non-MDRB-HAI group, significant differences were found in overall hospital costs, costs of medical and nursing services, medication, and rooms/beds, and in ICU length-of-stay (LOS). As compared with the non-MDRB-HAI group, the mean of the overall hospital costs of patients in the MDRB-HAI group was increased by 26%; for categorized expenditures, the mean of costs of medical and nursing services of patients in the MDRB-HAI group was increased by 8%, of medication by 26.9%, of rooms/beds by 10.3%. The mean ICU LOS in the MDRB-HAI group was increased by 13%. Mortality rates in both groups did not significantly differ. Conclusions These data clearly demonstrate more negative impacts of MDRB-HAIs in ICUs. The quantified financial burdens will be helpful for hospital/government policymakers in allocating resources to mitigate MDRB-HAIs in ICUs; in case of need for clarification/verification of the medico-economic burdens of MDRB-HAIs in different healthcare systems, this study provides a model to facilitate the evaluations.	[Su, Li-Hsiang; Tang, Ya-Fen; Liu, Jien-Wei] Kaohsiung Chang Gung Mem Hosp, Infect Control Team, Kaohsiung, Taiwan; [Chen, I-Ling] Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan; [Chen, I-Ling] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan; [Lee, Jen-Sin] I Shou Univ, Fac Finance, Kaohsiung, Taiwan; [Liu, Jien-Wei] Kaohsiung Chang Gung Mem Hosp, Div Infect Dis, Dept Internal Med, Kaohsiung, Taiwan; [Liu, Jien-Wei] Chang Gung Univ, Med Coll, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical University; I Shou University; Chang Gung Memorial Hospital; Chang Gung University	Liu, JW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Infect Control Team, Kaohsiung, Taiwan.; Lee, JS (corresponding author), I Shou Univ, Fac Finance, Kaohsiung, Taiwan.; Liu, JW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Infect Dis, Dept Internal Med, Kaohsiung, Taiwan.; Liu, JW (corresponding author), Chang Gung Univ, Med Coll, Taoyuan, Taiwan.	jensinlee01@gmail.com; 88b0@adm.cgmh.org.tw			Kaohsiung Chang Gung Memorial Hospital, Taiwan [CMRPG8H0591, CMRPG8D0841]	Kaohsiung Chang Gung Memorial Hospital, Taiwan	This work was supported by Grant CMRPG8H0591 (L-HS) and partially supported by Grant CMRPG8D0841 (J-WL) from Kaohsiung Chang Gung Memorial Hospital, Taiwan; the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alvarez-Lerma F, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01825-17; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118; Ben-Ami R, 2012, ANTIMICROB AGENTS CH, V56, P2518, DOI 10.1128/AAC.05947-11; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Centers for Disease Control R.O.C (Taiwan), NOS INF SURV SYST; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chemaly RF, 2014, THER ADV INFECT DIS, V2, P79, DOI 10.1177/2049936114543287; Chen IL, 2018, J MICROBIOL IMMUNOL, V51, P55, DOI 10.1016/j.jmii.2016.06.007; Chen IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065621; Chiang CH, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0422-1; Dick AW, 2015, AM J INFECT CONTROL, V43, P4, DOI 10.1016/j.ajic.2014.07.014; Founou RC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189621; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Haque M, 2018, INFECT DRUG RESIST, V11, P2321, DOI 10.2147/IDR.S177247; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lai CC, 2011, J ANTIMICROB CHEMOTH, V66, P1374, DOI 10.1093/jac/dkr103; Liu JW, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00023-19; Liu JW, 2012, ANTIMICROB AGENTS CH, V56, P1414, DOI 10.1128/AAC.05879-11; Ma XD, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2051-8; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mitchell BG, 2018, JT COMM J QUAL PATIE, V44, P613, DOI 10.1016/j.jcjq.2018.02.002; Muraki Y, 2013, INFECTION, V41, P415, DOI 10.1007/s15010-013-0440-0; Naylor NR, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0336-y; Pfaller MA, 2013, J CLIN MICROBIOL, V51, P2571, DOI 10.1128/JCM.00308-13; Pogorzelska-Maziarz M, 2018, AM J INFECT CONTROL, V46, P852, DOI 10.1016/j.ajic.2018.04.202; Rahmqvist M, 2016, AM J INFECT CONTROL, V44, P500, DOI 10.1016/j.ajic.2016.01.035; Sader HS, 2014, INT J ANTIMICROB AG, V43, P328, DOI 10.1016/j.ijantimicag.2014.01.007; Scales DC, 2011, JAMA-J AM MED ASSOC, V305, P363, DOI 10.1001/jama.2010.2000; Stibich M, 2011, INFECT CONT HOSP EP, V32, P286, DOI 10.1086/658329; Ternavasio-de la Vega HG, 2014, ANTIMICROB AGENTS CH, V58, P7025, DOI 10.1128/AAC.03796-14; Ting SW, 2018, J MICROBIOL IMMUNOL, V51, P621, DOI 10.1016/j.jmii.2016.08.022; Tosi M., 2018, J EMERG CRIT CARE ME, V2, P103, DOI [10.21037/jeccm.2018.11.08, DOI 10.21037/JECCM.2018.11.08]; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; World Health Organization, HLTH CAR ASS INF FAC; Wu TY, 2010, LONDON J PRIM CARE, V3, P115, DOI 10.1080/17571472.2010.11493315; Zilahi G, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0199-4	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233265	10.1371/journal.pone.0233265	http://dx.doi.org/10.1371/journal.pone.0233265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421700	gold, Green Published			2022-12-26	WOS:000537499600038
J	Shaat, N; Katsarou, A; Shahida, B; Prasad, RB; Kristensen, K; Planck, T				Shaat, Nael; Katsarou, Anastasia; Shahida, Bushra; Prasad, Rashmi B.; Kristensen, Karl; Planck, Tereza			Association between the rs1544410 polymorphism in the vitamin D receptor (VDR) gene and insulin secretion after gestational diabetes mellitus	PLOS ONE			English	Article							D-BINDING PROTEIN; BETA-CELL FUNCTION; ORAL GLUCOSE-TOLERANCE; D METABOLISM; RESISTANCE; HOMEOSTASIS; ETHNICITY; GENOTYPE; HEALTH; RS7041	Background and aims Genetic variants involved in vitamin D metabolism have been associated with diabetes and related syndromes/diseases. We wanted to investigate possible associations of polymorphisms in genes involved in vitamin D metabolism with indices of insulin resistance and insulin secretion, and also with development of diabetes after gestational diabetes mellitus (GDM). Materials and methods We have studied 376 women with previous GDM. Eight single nucleotide polymorphisms (SNPs) in the genes for vitamin D receptor (VDR) [rs731236, rs7975232, rs10735810, and rs1544410], vitamin D binding protein (DBP) [rs7041 and rs4588], and cytochrome P450 family 27 subfamily B member 1 (CYP27B1) [rs10877012 and rs4646536] were genotyped by TaqMan Allelic Discrimination Assay using the Quantstudio 7 Flex system. A 75-g oral glucose tolerance test (OGTT) was performed 1-2 years postpartum. The homeostasis model assessment of insulin resistance (HOMA-IR) and the disposition index [(insulinogenic index: I30/G30)/HOMA-IR] were used to calculate insulin resistance and insulin secretion, respectively. Serum samples for determination of 25(OH)D3 were collected at the time of the OGTT. Manifestation of diabetes was followed up to five years postpartum. Results After adjustment for BMI, age, and ethnicity, the A-allele of the VDR rs1544410 polymorphism was found to be associated with increased disposition index (difference per allele = 3.56, 95% CI: 0.4567-6.674; p = 0.03). The A-allele of the DBP rs7041 polymorphism was found to be associated with 25(OH)D3 levels (difference [in nmol/L] per allele = - 5.478, 95% CI: -8.315 to - 2.641; p = 0.0002), as was the T-allele of the DBP rs4588 polymorphism (OR = -6.319, 95% CI: -9.466 to -3.171; p = 0.0001). None of the SNPs were significantly associated with HOMA-IR or postpartum diabetes. Conclusions This study provides evidence that the rs1544410 polymorphism of the VDR gene may be associated with increased insulin secretion in women after pregnancy complicated by GDM. Further studies in other populations are needed to confirm the results.	[Shaat, Nael; Katsarou, Anastasia; Shahida, Bushra; Prasad, Rashmi B.; Kristensen, Karl; Planck, Tereza] Lund Univ, Dept Clin Sci Genom Diabet & Endocrinol, Malmo, Sweden; [Shaat, Nael; Katsarou, Anastasia; Planck, Tereza] Skane Univ Hosp, Dept Endocrinol, Malmo, Sweden; [Kristensen, Karl] Skane Univ Hosp, Dept Obstet & Gynaecol, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Shaat, N (corresponding author), Lund Univ, Dept Clin Sci Genom Diabet & Endocrinol, Malmo, Sweden.; Shaat, N (corresponding author), Skane Univ Hosp, Dept Endocrinol, Malmo, Sweden.	nael.shaat@med.lu.se	Prasad, Rashmi/Y-4276-2019; Prasad, Rashmi B/GRJ-5491-2022	Prasad, Rashmi B/0000-0002-4400-6741; Kristensen, Karl/0000-0003-3209-2459; Shahida, Bushra/0000-0002-2226-5902	Research Funds of Skane University Hospital; Skane County Council Research and Development Foundation; ALF Region Skane	Research Funds of Skane University Hospital; Skane County Council Research and Development Foundation; ALF Region Skane	The study was supported by grants from the Research Funds of Skane University Hospital, the Skane County Council Research and Development Foundation and ALF Region Skane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg E, 2011, ACTA OBSTET GYN SCAN, V90, P1252, DOI 10.1111/j.1600-0412.2011.01214.x; ARNAUD J, 1993, HUM GENET, V92, P183; Bailey R, 2007, DIABETES, V56, P2616, DOI 10.2337/db07-0652; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Cheng Q, 2011, DIABETOLOGIA, V54, P2077, DOI 10.1007/s00125-011-2100-1; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Fadl HE, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000221; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Ganz AB, 2018, FASEB J, V32, P2012, DOI 10.1096/fj.201700992R; Han FF, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0477-7; Hitman GA, 1998, DIABETES, V47, P688, DOI 10.2337/diabetes.47.4.688; Ignell C, 2013, ACTA DIABETOL, V50, P927, DOI 10.1007/s00592-013-0484-8; Jensen CC, 2002, DIABETES, V51, P2170, DOI 10.2337/diabetes.51.7.2170; Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad; Lafi ZM, 2015, GENET TEST MOL BIOMA, V19, P629, DOI 10.1089/gtmb.2015.0058; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Malik R, 2018, CAN J DIABETES, V42, P251, DOI 10.1016/j.jcjd.2017.06.003; Marquina C, 2019, OBES REV, V20, P262, DOI 10.1111/obr.12793; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metzger BE, 1998, DIABETES CARE, V21, pB161; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Ogunkolade BW, 2002, DIABETES, V51, P2294, DOI 10.2337/diabetes.51.7.2294; Oh JY, 2002, METABOLISM, V51, P356, DOI 10.1053/meta.2002.29969; Ortlepp JR, 2003, DIABETIC MED, V20, P451, DOI 10.1046/j.1464-5491.2003.00971.x; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Rahman MM, 2017, GENE, V636, P42, DOI 10.1016/j.gene.2017.09.008; Santos BR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173695; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Shaat N, 2017, ACTA OBSTET GYN SCAN, V96, P821, DOI 10.1111/aogs.13124; Surveillance WHODoND, 1999, DEF DIAGN CLASS DIAB; Wang HM, 2017, AGING DIS, V8, P346, DOI 10.14336/AD.2016.1021; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	35	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232297	10.1371/journal.pone.0232297	http://dx.doi.org/10.1371/journal.pone.0232297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407388	gold, Green Published			2022-12-26	WOS:000537490700018
J	Sacristan, HJ; Mufari, JR; Lorenzo, RA; Boy, CC; Lovrich, GA				Javier Sacristan, Hernan; Romina Mufari, Jesica; Antonio Lorenzo, Rodrigo; Clementina Boy, Claudia; Alejandro Lovrich, Gustavo			Ontogenetic changes in energetic reserves, digestive enzymes, amino acid and energy content of Lithodes santolla (Anomura: Lithodidae): Baseline for culture	PLOS ONE			English	Article							SOUTHERN KING CRAB; LECITHOTROPHIC LARVAL DEVELOPMENT; CHASMAGNATHUS-GRANULATA DANA; PERFORMANCE LIQUID-CHROMATOGRAPHY; PENAEUS-VANNAMEI BOONE; BIOCHEMICAL-COMPOSITION; LITOPENAEUS-VANNAMEI; NEPHROPS-NORVEGICUS; HIGH-PROTEIN; BLUE-CRAB	The southern king crab (SKC) Lithodes santolla is an important commercial species in southern South America. Fishing pressure has caused the deterioration of its stocks. Currently, culture techniques are being developed for producing SKC juveniles to enhance the natural population and to recover the fishing stock. Therefore, it is necessary to know about physiology, energetic and nutritional requirements for SKC maintenance in hatchery. Thus, this study aims to evaluate the biochemical and physiological changes in the midgut gland, muscle and hemolymph of juveniles, pre-adults and adults of wild SKC. The energetic reserves, digestive enzymes activity, amino acid profile and energy were quantified in twelve juveniles, ten pre-adult, and ten adult crabs. Juveniles showed high glycogen and low lipids in the midgut gland, and low proteins and low lactate in muscle. In the hemolymph, juveniles had high lipids. Pre-adults had high glycogen and lipids in the midgut gland, and both high protein and lactate in muscle. In the hemolymph, pre-adults had high lipids. Adults had low glycogen and high lipids in midgut gland, and both high proteins and high lactate in muscle. In hemolymph, adults had high glucose and lactate. Juveniles and pre-adults had high proteinase activity, whereas adults had high lipase activity. Major essential amino acids of SKC were arginine, methionine, and tryptophan, and the non-essential amino acids were glycine, aspartic acid and glutamic acid. On another hand, SKC had similar energy in the midgut gland and muscle, regardless of the ontogenetic stage. Moreover, we demonstrated that the biochemical energy calculation underestimates the actual measured values by a calorimeter. Thus, our results help to understand the physiological changes, energetic and nutritional requirements of L. santolla, and this study is a baseline for research on diet formulation for maintaining this species under culture conditions.	[Javier Sacristan, Hernan; Antonio Lorenzo, Rodrigo; Clementina Boy, Claudia; Alejandro Lovrich, Gustavo] Consejo Nacl Invest Cient & Tecn, Ctr Austral Invest Cient CADIC, Ushuaia, Argentina; [Romina Mufari, Jesica] Consejo Nacl Invest Cient & Tecn, Inst Invest Biol & Tecnol IIByT, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Sacristan, HJ (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Austral Invest Cient CADIC, Ushuaia, Argentina.	hernansacristan@cadic-conicet.gob.ar		Lorenzo, Rodrigo/0000-0001-9212-311X	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 12-0554, PICT 16-0142, 2015-2968]; CONICET-Proyectos para Unidades Ejecutoras [P-UE 2016. Res 3334/16]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET-Proyectos para Unidades Ejecutoras	Funds for this research were provided by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICTs 12-0554 and 16-0142 to GAL and 2015-2968 to HJS) and CONICET-Proyectos para Unidades Ejecutoras (P-UE 2016. Res 3334/16).	ALAIZ M, 1992, J CHROMATOGR, V591, P181, DOI 10.1016/0021-9673(92)80236-N; Alam MS, 2002, COMP BIOCHEM PHYS B, V133, P289, DOI 10.1016/S1096-4959(02)00165-3; Anger K, 2004, J EXP MAR BIOL ECOL, V306, P217, DOI 10.1016/j.jembe.2004.01.010; Anger K, 1996, MAR BIOL, V126, P283, DOI 10.1007/BF00347453; Anger K., 2001, BIOL DECAPOD CRUSTAC; [Anonymous], [No title captured]; AOAC, 1999, OFF METH AN ASS OFF; Arcos-Ortega GF, 2019, LAT AM J AQUAT RES, V47, P480, DOI 10.3856/vol47-issue3-fulltext-10; Barrento S, 2010, J FOOD COMPOS ANAL, V23, P716, DOI 10.1016/j.jfca.2010.03.019; Belgrad BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145481; BENITEZ L.V., 1989, FISH NUTR RES ASIA, V4, P23; Boy CC, 2009, POLAR BIOL, V32, P9, DOI 10.1007/s00300-008-0495-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodersen CC, 1989, DIET INFLUENCES CANN, P377; CASTILLE FL, 1993, AQUACULTURE, V113, P65, DOI 10.1016/0044-8486(93)90341-U; Chang E.S., 1983, P263; Coloso R.M., 1980, B PHILLIPPINE BIOCH, V3, P12; Comoglio L., 1996, BIOL PESQ, V25, P51; Cunningham DT, 1969, STUDY FOOD FEEDING R; Cuzon G, 2004, AQUACULTURE, V235, P513, DOI 10.1016/j.aquaculture.2003.12.022; Das N. N., 1996, Aquaculture Research, V27, P543, DOI 10.1111/j.1365-2109.1996.tb01285.x; Daza E, 2019, 1232 EMT I FORM PESQ, P1; Di Rienzo J.A., 2011, INFOSTAT VERSION 201; Di Salvatore P., 2019, EFECTOS PRACTICAS PE, P190; Facanha FN, 2016, AQUACULTURE, V463, P16, DOI 10.1016/j.aquaculture.2016.05.024; FAO, 2017, GLOB PROD STAT; Feder HM, 1981, E BERING SEA SHELF O, V2, P1229; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRINGS CS, 1970, AM J CLIN PATHOL, V53, P89; Fuertes JB, 2013, AQUACULTURE, V388, P159, DOI 10.1016/j.aquaculture.2013.01.028; Garcia F, 2002, LIPIDS, V37, P581, DOI 10.1007/s11745-002-0936-9; GARCIACARRENO FL, 1992, COMP BIOCHEM PHYS B, V103, P575, DOI 10.1016/0305-0491(92)90373-Y; Gonz?lez-Orteg?n E., 2018, SCI REP-UK, V8, P1, DOI DOI 10.1038/S41598-017-17765-5; Gowland-Sainz M., 2018, BIOL REPRODUCCION CE; Gunasekera RM, 1999, AQUAT LIVING RESOUR, V12, P255, DOI 10.1016/S0990-7440(00)86636-X; HARRISON K E, 1990, Journal of Shellfish Research, V9, P1; HENRY RP, 1994, J EXP BIOL, V186, P215; Herreid C.F. II, 1988, P333, DOI 10.1017/CBO9780511753428.011; HIRD FJR, 1986, COMP BIOCHEM PHYS B, V85, P285, DOI 10.1016/0305-0491(86)90001-5; Hirota S, 2008, J BIOL CHEM, V283, P31941, DOI 10.1074/jbc.M803433200; Hoglund E, 2005, AQUACULTURE, V249, P525, DOI 10.1016/j.aquaculture.2005.04.028; Hseu JR, 2003, AQUACULTURE, V218, P251, DOI 10.1016/S0044-8486(02)00503-3; Icely J.D., 1992, P147; Sacristan HJ, 2019, FISH RES, V218, P83, DOI 10.1016/j.fishres.2019.05.006; Sacristan HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184060; Sacristan HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150854; JEWETT SC, 1982, MAR BIOL, V66, P243, DOI 10.1007/BF00397029; Johnston D, 2005, BIOL BULL-US, V208, P36, DOI 10.2307/3593099; Johnston DJ, 2003, MAR BIOL, V143, P1071, DOI 10.1007/s00227-003-1154-0; JOHNSTON MA, 1972, COMP BIOCHEM PHYSIOL, V41, P433, DOI 10.1016/0305-0491(72)90046-6; Kattner G, 2003, J EXP MAR BIOL ECOL, V292, P61, DOI 10.1016/S0022-0981(03)00143-6; KOMATSU M, 1992, COMP BIOCHEM PHYS B, V103, P363, DOI 10.1016/0305-0491(92)90305-B; KUCHARSKI LCR, 1991, COMP BIOCHEM PHYS A, V100, P599, DOI 10.1016/0300-9629(91)90376-N; KUCHARSKI LCR, 1991, COMP BIOCHEM PHYS A, V99, P215, DOI 10.1016/0300-9629(91)90261-A; LALLIER FH, 1991, B MAR SCI, V48, P665; LEE PG, 1984, AQUACULTURE, V42, P225, DOI 10.1016/0044-8486(84)90103-0; Lemos D, 2001, MAR BIOL, V138, P985, DOI 10.1007/s002270000516; Leopoldo J, 2010, AQUACULTURE, V310, P84, DOI 10.1016/j.aquaculture.2010.09.038; Litaay M, 2001, AQUAT LIVING RESOUR, V14, P335, DOI 10.1016/S0990-7440(01)01133-0; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Lopez-Lopez S, 2005, AQUACULT NUTR, V11, P79, DOI 10.1111/j.1365-2095.2004.00305.x; Lovrich G. A, 2002, PROGR REP, V2, P147; Lovrich GA, 2003, J EXP MAR BIOL ECOL, V288, P65, DOI 10.1016/S0022-0981(02)00596-8; Lovrich GA, ESTADO POBLACIONAL C, P82; Lovrich GA, 2014, KING CRABS OF THE WORLD: BIOLOGY AND FISHERIES MANAGEMENT, P449; Lucas A., 1996, PHYS CONCEPTS BIOENE; Mangum C.P., 1983, P373; Marsden GE, 1997, AQUACULTURE, V149, P145, DOI 10.1016/S0044-8486(96)01430-5; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Mente E, 2002, J EXP BIOL, V205, P3107; Mente E., 2003, NUTR PHYSL METABOLIS; Mente E, 2010, INTEGR ZOOL, V5, P256, DOI 10.1111/j.1749-4877.2010.00211.x; MILLAMENA O M, 1990, Journal of the World Aquaculture Society, V21, P116, DOI 10.1111/j.1749-7345.1990.tb00531.x; Millamena OM, 1998, AQUACULTURE, V164, P95, DOI 10.1016/S0044-8486(98)00179-3; Moller H, 2008, J EXP MAR BIOL ECOL, V361, P75, DOI 10.1016/j.jembe.2008.04.013; Morris S, 2010, J EXP BIOL, V213, P3062, DOI 10.1242/jeb.045153; MURIANA FJG, 1993, J BIOCHEM, V114, P223, DOI 10.1093/oxfordjournals.jbchem.a124158; OCONNOR JD, 1968, AM ZOOL, V8, P529; Oliveira GT, 1997, COMP BIOCHEM PHYS A, V118, P1429, DOI 10.1016/S0300-9629(97)00241-7; Oliveira GT, 2004, COMP BIOCHEM PHYS A, V137, P383, DOI 10.1016/j.cbpb.2003.10.017; Oliveira GT, 2001, MAR BIOL, V139, P335, DOI 10.1007/s002270100569; Ong BL, 2006, J SHELLFISH RES, V25, P113, DOI 10.2983/0730-8000(2006)25[113:IOFOHS]2.0.CO;2; PASCUAL FP, 1986, MEM KAGOSHIMA U RES, V7, P65; Paula SM, 2018, AQUACULTURE, V495, P575, DOI 10.1016/j.aquaculture.2018.06.030; PENAFLORIDA VD, 1989, AQUACULTURE, V83, P319, DOI 10.1016/0044-8486(89)90043-4; Pinheiro J., 2006, MIXED EFFECTS MODELS; Ridgway ID, 2006, J EXP MAR BIOL ECOL, V328, P251, DOI 10.1016/j.jembe.2005.07.015; RODRIGUEZ A, 1994, MAR BIOL, V118, P45, DOI 10.1007/BF00699218; Romano N, 2017, REV FISH SCI AQUAC, V25, P42, DOI 10.1080/23308249.2016.1221379; Rosa R, 2005, HYDROBIOLOGIA, V537, P207, DOI 10.1007/s10750-004-2841-7; Rosa R, 2005, COMP BIOCHEM PHYS B, V140, P241, DOI 10.1016/j.cbpc.2004.10.009; Rosa R, 2004, J SCI FOOD AGR, V84, P89, DOI 10.1002/jsfa.1619; Rosa R, 2003, DEEP-SEA RES PT I, V50, P119, DOI 10.1016/S0967-0637(02)00147-4; Saborowski R, 2006, MAR BIOL, V149, P865, DOI 10.1007/s00227-005-0240-x; Sanchez-Paz A, 2006, INSECT BIOCHEM MOLEC, V36, P241, DOI 10.1016/j.ibmb.2006.01.002; STEVENS BG, 1982, MAR BIOL, V72, P135, DOI 10.1007/BF00396914; SUAREZ RK, 1987, CAN J ZOOL, V65, P1869, DOI 10.1139/z87-287; Sui LY, 2011, AQUACULTURE, V315, P16, DOI 10.1016/j.aquaculture.2010.06.021; Tarverdieva M.I., 1985, INT KING CRAB S, P319; TARVERDIEVA MI, 1979, BIOL MORYA-VLAD+, P53; THABREW MI, 1971, COMP BIOCHEM PHYSIOL, V40, P531, DOI 10.1016/0305-0491(71)90238-0; Urbina MA, 2013, COMP BIOCHEM PHYS A, V166, P538, DOI 10.1016/j.cbpa.2013.08.006; Verri T, 2001, COMP BIOCHEM PHYS A, V130, P585, DOI 10.1016/S1095-6433(01)00434-2; VERSAW WK, 1989, J FOOD SCI, V54, P1557, DOI 10.1111/j.1365-2621.1989.tb05159.x; Vinagre AS, 2002, CAN J ZOOL, V80, P1413, DOI 10.1139/Z02-122; Vinuesa J., 1984, ESTUDIO BIOL PESQUER, P441; Vinuesa JH, 2013, FEEDING STRATEGY EAR; Wells RMG, 2001, COMP BIOCHEM PHYS B, V130, P339, DOI 10.1016/S1096-4959(01)00439-0; Winberg GG., 1971, METHODS ESTIMATION P; WINBERG S, 1993, COMP BIOCHEM PHYS C, V106, P597, DOI 10.1016/0742-8413(93)90216-8; Winberg S, 2001, J EXP BIOL, V204, P3867; Yust MM, 2004, FOOD CHEM, V85, P317, DOI 10.1016/j.foodchem.2003.07.026; Zmora O, 2005, AQUACULTURE, V244, P129, DOI 10.1016/j.aquaculture.2004.11.012; Zuur Alain F., 2009, P1	114	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232880	10.1371/journal.pone.0232880	http://dx.doi.org/10.1371/journal.pone.0232880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401761	gold, Green Published			2022-12-26	WOS:000537481000037
J	Tsai, HY; Cericola, F; Edriss, V; Andersen, JR; Orabiid, J; Jensen, JD; Jahoor, A; Janss, L; Jensen, J				Tsai, Hsin-Yuan; Cericola, Fabio; Edriss, Vahid; Andersen, Jeppe Reitan; Orabiid, Jihad; Jensen, Jens Due; Jahoor, Ahmed; Janss, Luc; Jensen, Just			Use of multiple traits genomic prediction, genotype by environment interactions and spatial effect to improve prediction accuracy in yield data	PLOS ONE			English	Article							SELECTION; MARKERS	Genomic selection has been extensively implemented in plant breeding schemes. Genomic selection incorporates dense genome-wide markers to predict the breeding values for important traits based on information from genotype and phenotype records on traits of interest in a reference population. To date, most relevant investigations have been performed using single trait genomic prediction models (STGP). However, records for several traits at once are usually documented for breeding lines in commercial breeding programs. By incorporating benefits from genetic characterizations of correlated phenotypes, multiple trait genomic prediction (MTGP) may be a useful tool for improving prediction accuracy in genetic evaluations. The objective of this study was to test whether the use of MTGP and including proper modeling of spatial effects can improve the prediction accuracy of breeding values in commercial barley and wheat breeding lines. We genotyped 1,317 spring barley and 1,325 winter wheat lines from a commercial breeding program with the Illumina 9K barley and 15K wheat SNP-chip (respectively) and phenotyped them across multiple years and locations. Results showed that the MTGP approach increased correlations between future performance and estimated breeding value of yields by 7% in barley and by 57% in wheat relative to using the STGP approach for each trait individually. Analyses combining genomic data, pedigree information, and proper modeling of spatial effects further increased the prediction accuracy by 4% in barley and 3% in wheat relative to the model using genomic relationships only. The prediction accuracy for yield in wheat and barley yield trait breeding, were improved by combining MTGP and spatial effects in the model.	[Tsai, Hsin-Yuan; Jensen, Just] Aarhus Univ, Ctr Quantitat Genet & Genom, Tjele, Denmark; [Tsai, Hsin-Yuan] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Cericola, Fabio] Rijk Zwaan, De Lier, Netherlands; [Edriss, Vahid; Andersen, Jeppe Reitan; Orabiid, Jihad; Jensen, Jens Due; Jahoor, Ahmed] Nord Seed, Galten, Denmark; [Jahoor, Ahmed] Swedish Univ Agr Sci, Dept Plant Breeding, Alnarp, Sweden	Aarhus University; National Sun Yat Sen University; Swedish University of Agricultural Sciences	Tsai, HY (corresponding author), Aarhus Univ, Ctr Quantitat Genet & Genom, Tjele, Denmark.; Tsai, HY (corresponding author), Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan.	hsinyuandna01@gmail.com	Orabi, Jihad/ABB-1020-2020	Andersen, Jeppe Reitan/0000-0003-4666-3400; Orabi, Jihad/0000-0001-9641-6657; Edriss, Vahid/0000-0003-4361-091X	Danish Green Development and Demonstration Program from the Danish Ministry of Food and Agriculture [34009-12-0511]; Nordic Seed A/S; Aarhus University	Danish Green Development and Demonstration Program from the Danish Ministry of Food and Agriculture; Nordic Seed A/S; Aarhus University	This study was funded by Danish Green Development and Demonstration Program (Grant No. 34009-12-0511) from the Danish Ministry of Food and Agriculture, and Nordic Seed A/S. In this study, the funding was used by the university partner -Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, J INDIAN SOC AGR STA; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Bao Y, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0324-3; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Calus MPL, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-26; Cericola F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169606; Conner JK, 2002, NATURE, V420, P407, DOI 10.1038/nature01105; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; EMIK LO, 1949, J HERED, V40, P51, DOI 10.1093/oxfordjournals.jhered.a105986; Falconer D. S., 1996, Introduction to quantitative genetics.; Guo G, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-30; Guo ZG, 2016, THEOR APPL GENET, V129, P2413, DOI 10.1007/s00122-016-2780-5; Haile JK, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-018-0818-x; Hayes BJ, 2017, THEOR APPL GENET, V130, P2505, DOI 10.1007/s00122-017-2972-7; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1976, BIOMETRICS, V32, P69, DOI 10.2307/2529339; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Hickey JM, 2017, NAT GENET, V49, P1297, DOI 10.1038/ng.3920; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Madsen P., 2013, DMU USERS GUIDE PACK; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen T, 2013, ANNU REV ANIM BIOSCI, V1, P221, DOI 10.1146/annurev-animal-031412-103705; Montesinos-Lopez OA, 2016, G3-GENES GENOM GENET, V6, P2725, DOI 10.1534/g3.116.032359; Nielsen NH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164494; Okeke UG, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0361-y; Petersen R. G., 1994, AGR FIELD EXPT DESIG; R Core Team, 2021, R LANGUAGE ENV STAT; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Rutkoski J, 2012, PLANT GENOME-US, V5, P51, DOI 10.3835/plantgenome2012.02.0001; Schulthess AW, 2016, THEOR APPL GENET, V129, P273, DOI 10.1007/s00122-015-2626-6; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Sreenivasulu Nese, 2008, Int J Plant Genomics, V2008, P486258, DOI 10.1155/2008/486258; Sukumaran S, 2017, G3-GENES GENOM GENET, V7, P481, DOI 10.1534/g3.116.036251; Tsuruta S, 2011, J DAIRY SCI, V94, P4198, DOI 10.3168/jds.2011-4256; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Ward J, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0169-0; Xu CW, 2009, GENET RES, V91, P23, DOI 10.1017/S0016672308009956; Xu SZ, 2016, PLANT J, V88, P219, DOI 10.1111/tpj.13242; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143	44	13	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232665	10.1371/journal.pone.0232665	http://dx.doi.org/10.1371/journal.pone.0232665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401769	Green Published, gold			2022-12-26	WOS:000537481000029
J	Zeng, YY; Chen, MX; Ganesh, S; Hu, SZ; Chen, HL				Zeng, Yuyang; Chen, Mengxi; Ganesh, Sridha; Hu, Shunze; Chen, Honglei			Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer	PLOS ONE			English	Article							AUTOPHAGY; ACTIVATION; BIOMARKER; CELLS	Objective Altered expression of caveolin-1 (CAV1) and autophagy marker ATG4C is observed in various types of human cancers. However, the clinical significance of CAV1 and ATG4C expression in epithelial ovarian cancer (EOC) remains largely unknown. The present study aims to explore the clinicopathological value and prognostic significance of CAV1 and ATG4C expression in EOC. Methods The expression pattern and prognostic value of CAV1 and ATG4C mRNA in EOC were analyzed using data from the Cancer Genome Atlas (TCGA) database (N = 373). In addition, immunohistochemistry analysis was performed to detect and assay the expression of CAV1 and ATG4C proteins in tissue microarray of EOC. Results Based on TCGA data, Kaplan-Meier analysis indicated that patients with low CAV1 mRNA (p = 0.021) and high ATG4C mRNA (p = 0.018) expression had a significantly shorter overall survival (OS). Cox regression analysis demonstrated that the expression levels of CAV1 (p = 0.023) and ATG4C mRNA (p = 0.040) were independent prognostic factors for OS in EOC. In addition, the Concordance Index of the nomogram for OS prediction was 0.660. Immunohistochemical analysis showed the expression levels of stromal CAV1 and cancerous ATG4C proteins, and high expression of both CAV1 and ATG4C protein in the stroma were found to significantly correlate with the histologic subtypes of EOC, especially with serous subtype. Conclusions Decreased expression of CAV1 mRNA and increased expression of ATG4C mRNA in EOC can predict poor overall survival. The expression levels of CAV1 protein in stromal cells and ATG4C protein in cancer cells are significantly associated with histologic subtypes of EOC. These findings suggest that CAV1 and ATG4C serve as useful prognostic biomarkers and candidate therapeutic targets in EOC.	[Zeng, Yuyang; Chen, Mengxi; Ganesh, Sridha; Chen, Honglei] Wuhan Univ, Sch Basic Med Sci, Dept Pathol, Wuhan, Hubei, Peoples R China; [Hu, Shunze] Maternal & Child Hlth Hosp Hubei, Dept Pathol, Wuhan, Hubei, Peoples R China; [Chen, Honglei] Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan, Hubei, Peoples R China; [Zeng, Yuyang] Wuhan Univ, Renmin Hosp, Dept Ophthalmol, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Chen, HL (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Pathol, Wuhan, Hubei, Peoples R China.; Hu, SZ (corresponding author), Maternal & Child Hlth Hosp Hubei, Dept Pathol, Wuhan, Hubei, Peoples R China.; Chen, HL (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan, Hubei, Peoples R China.	hushunze925@icloud.com; hl-chen@whu.edu.cn	Chen, Honglei/ABG-8632-2021	Chen, Hong-Lei/0000-0001-9832-1336	Joint Grant of Health Commission of Hubei Province [WJ2018H0151]; Innovation Project of Wuhan University Medical School [MS2016001]	Joint Grant of Health Commission of Hubei Province; Innovation Project of Wuhan University Medical School	This work was supported by the Joint Grant of Health Commission of Hubei Province (WJ2018H0151) for Dr.Hu and the Innovation Project of Wuhan University Medical School (No. MS2016001) for DR. Zeng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cheng JPX, 2016, TRENDS CELL BIOL, V26, P177, DOI 10.1016/j.tcb.2015.10.010; Chiu WT, 2011, CANCER RES, V71, P4932, DOI 10.1158/0008-5472.CAN-10-4249; Codenotti S, 2019, CANCER LETT, V449, P135, DOI 10.1016/j.canlet.2019.02.013; Colombo PE, 2014, CRIT REV ONCOL HEMAT, V89, P207, DOI 10.1016/j.critrevonc.2013.08.017; Curtis M, 2019, CELL METAB, V29, P141, DOI 10.1016/j.cmet.2018.08.007; Dai ZH, 2019, REPROD FERT DEVELOP, V31, P1057, DOI 10.1071/RD18296; Davidson B, 2001, GYNECOL ONCOL, V81, P166, DOI 10.1006/gyno.2001.6156; Eliyatkin N, 2018, PATHOL ONCOL RES, V24, P59, DOI 10.1007/s12253-017-0212-8; Fernandez AF, 2015, J CLIN INVEST, V125, P33, DOI 10.1172/JCI73940; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Fridolfsson HN, 2014, FASEB J, V28, P3823, DOI 10.1096/fj.14-252320; Fu P, 2017, ONCOTARGETS THER, V10, P819, DOI 10.2147/OTT.S123912; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Ghosh A, 2015, J BIOL CHEM, V290, P10309, DOI 10.1074/jbc.M114.610659; Gong Yan, 2019, Asian Pac J Cancer Prev, V20, P3259, DOI 10.31557/APJCP.2019.20.11.3259; Kanlikilicer P, 2018, EBIOMEDICINE, V38, P100, DOI 10.1016/j.ebiom.2018.11.004; Ketteler J, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030348; Kim YJ, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0892-0; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Li MH, 2010, TUMORI, V96, P734, DOI 10.1177/030089161009600516; Limpert AS, 2018, TRENDS PHARMACOL SCI, V39, P1021, DOI 10.1016/j.tips.2018.10.004; Lisanti MP, 2013, CELL CYCLE, V12, P2723, DOI 10.4161/cc.25695; Lu Zhaohui, 2014, Zhonghua Bing Li Xue Za Zhi, V43, P649; Miyamoto M, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e33; Mowers EE, 2018, FEBS J, V285, P1751, DOI 10.1111/febs.14388; Onorati AV, 2018, CANCER-AM CANCER SOC, V124, P3307, DOI 10.1002/cncr.31335; Prat J, 2015, J GYNECOL ONCOL, V26, P87, DOI 10.3802/jgo.2015.26.2.87; Qian XL, 2019, ONCOTARGETS THER, V12, P1539, DOI 10.2147/OTT.S191317; Rasmussen MS, 2017, AUTOPHAGY, V13, P834, DOI 10.1080/15548627.2017.1287651; Sanchez-Wandelmer J, 2017, ONCOTARGET, V8, P108290, DOI 10.18632/oncotarget.22714; Sayhan S, 2015, GINEKOL POL, V86, P424; Schoenherr C, 2017, ELIFE, V6, DOI 10.7554/eLife.23172; Sharifi MN, 2016, CELL REP, V15, P1660, DOI 10.1016/j.celrep.2016.04.065; Shen XJ, 2015, INT J BIOL SCI, V11, P370, DOI 10.7150/ijbs.10666; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soslow RA, 2008, INT J GYNECOL PATHOL, V27, P161, DOI 10.1097/PGP.0b013e31815ea812; Thuwajit C, 2018, MED RES REV, V38, P1235, DOI 10.1002/med.21473; Wang SQ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7454031; Wentzensen N, 2016, J CLIN ONCOL, V34, P2888, DOI 10.1200/JCO.2016.66.8178; Zhan L, 2016, ONCOTARGET, V7, P83476, DOI 10.18632/oncotarget.13080; Zhang L, 2016, CANCER LETT, V373, P19, DOI 10.1016/j.canlet.2016.01.022; Zhao XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059102	45	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232235	10.1371/journal.pone.0232235	http://dx.doi.org/10.1371/journal.pone.0232235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401768	gold, Green Published			2022-12-26	WOS:000537481000010
J	Mashanov, V; Akiona, J; Khoury, M; Ferrier, J; Reid, R; Machado, DJ; Zueva, O; Janies, D				Mashanov, Vladimir; Akiona, Jennifer; Khoury, Maleana; Ferrier, Jacob; Reid, Robert; Machado, Denis Jacob; Zueva, Olga; Janies, Daniel			Active Notch signaling is required for arm regeneration in a brittle star	PLOS ONE			English	Article							EXPRESSION; INVOLVEMENT; ALIGNMENT; ECTODERM; IMMUNITY; PLATFORM	Cell signaling pathways play key roles in coordinating cellular events in development. The Notch signaling pathway is highly conserved across all multicellular animals and is known to coordinate a multitude of diverse cellular events, including proliferation, differentiation, fate specification, and cell death. Specific functions of the pathway are, however, highly context-dependent and are not well characterized in post-traumatic regeneration. Here, we use a small-molecule inhibitor of the pathway (DAPT) to demonstrate that Notch signaling is required for proper arm regeneration in the brittle star Ophioderma brevispina, a highly regenerative member of the phylum Echinodermata. We also employ a transcriptome-wide gene expression analysis (RNA-seq) to characterize the downstream genes controlled by the Notch pathway in the brittle star regeneration. We demonstrate that arm regeneration involves an extensive cross-talk between the Notch pathway and other cell signaling pathways. In the regrowing arm, Notch regulates the composition of the extracellular matrix, cell migration, proliferation, and apoptosis, as well as components of the innate immune response. We also show for the first time that Notch signaling regulates the activity of several transposable elements. Our data also suggests that one of the possible mechanisms through which Notch sustains its activity in the regenerating tissues is via suppression of Neuralized1.	[Mashanov, Vladimir; Akiona, Jennifer; Khoury, Maleana; Zueva, Olga] Univ North Florida, Dept Biol, Jacksonville, FL 32224 USA; [Mashanov, Vladimir] Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA; [Ferrier, Jacob; Reid, Robert; Machado, Denis Jacob; Janies, Daniel] Univ N Carolina, Charlotte, NC USA	State University System of Florida; University of North Florida; Wake Forest University; University of North Carolina; University of North Carolina Charlotte	Mashanov, V (corresponding author), Univ North Florida, Dept Biol, Jacksonville, FL 32224 USA.; Mashanov, V (corresponding author), Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA.	vmashano@wakehealth.edu	Machado, Denis Jacob/I-1452-2015	Machado, Denis Jacob/0000-0001-9858-4515; Reid, Robert/0000-0001-7125-7151; Ferrier, Jacob/0000-0002-4173-1040; Mashanov, Vladimir/0000-0001-6875-7518	National Institute of General Medical Sciences of the National Institutes of Health [R15GM128066]; University of North Florida; University of North Carolina at Charlotte (College of Computing and Informatics); University of North Carolina at Charlotte (University Honors Program); University of North Carolina at Charlotte (University Professional Internship Program); University of North Carolina at Charlotte (Department of Bioinformatics and Genomics); University of North Carolina at Charlotte (University Research Computing division)	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of North Florida; University of North Carolina at Charlotte (College of Computing and Informatics); University of North Carolina at Charlotte (University Honors Program); University of North Carolina at Charlotte (University Professional Internship Program); University of North Carolina at Charlotte (Department of Bioinformatics and Genomics); University of North Carolina at Charlotte (University Research Computing division)	Research reported in this publication was supported by The National Institute of General Medical Sciences of the National Institutes of Health under award number R15GM128066. University of North Florida and The University of North Carolina at Charlotte (College of Computing and Informatics, The University Honors Program, The University Professional Internship Program, The Department of Bioinformatics and Genomics, and the University Research Computing division) 25% ($101,313.54) of the project was funded with Federal money. There was no funding from nongovernmental sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2019, R LANG ENV STAT COMP; Favarolo MB, 2018, MECH DEVELOP, V154, P122, DOI 10.1016/j.mod.2018.06.005; Ben Khadra Y, 2018, RESULTS PROBL CELL D, V65, P285, DOI 10.1007/978-3-319-92486-1_14; Byrne M., 1994, OPHIUROIDEA, V14, P247; Czarkwiani A, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0149-x; Czarkwiani A, 2013, GENE EXPR PATTERNS, V13, P464, DOI 10.1016/j.gep.2013.09.002; Davidson NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0410-6; Dupont S, 2006, J EXP BIOL, V209, P3873, DOI 10.1242/jeb.02445; Erkenbrack EM, 2018, DEV GENES EVOL, V228, P1, DOI 10.1007/s00427-017-0599-y; Foster S, 2019, MOL REPROD DEV, V86, P931, DOI 10.1002/mrd.23181; Fresno C, 2013, BIOINFORMATICS, V29, P2810, DOI 10.1093/bioinformatics/btt487; Gao LL, 2017, DEV COMP IMMUNOL, V67, P413, DOI 10.1016/j.dci.2016.08.010; Garcia-Arraras JE, 2018, RESULTS PROBL CELL D, V65, P255, DOI 10.1007/978-3-319-92486-1_13; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Herrmann A, 2018, MOBILE DNA-UK, V9, DOI 10.1186/s13100-018-0116-5; Hinman VF, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.316; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ignatiadis N, 2016, NAT METHODS, V13, P577, DOI [10.1038/nmeth.3885, 10.1038/NMETH.3885]; Lamash NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058433; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Layden MJ, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-30; Lloyd-Lewis B, 2019, CURR OPIN CELL BIOL, V61, P16, DOI 10.1016/j.ceb.2019.06.003; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacGrogan D, 2018, NAT REV CARDIOL, V15, P685, DOI 10.1038/s41569-018-0100-2; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marlow H, 2012, DEV BIOL, V362, P295, DOI 10.1016/j.ydbio.2011.11.012; Mashanov Vladimir S, 2012, Mob Genet Elements, V2, P244; Mashanov VS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-357; Mashanov VS, 2012, DEV DYNAM, V241, P1625, DOI 10.1002/dvdy.23844; Mellott DO, 2017, DEVELOPMENT, V144, P3602, DOI 10.1242/dev.151720; Mescher AL, 2017, DEV COMP IMMUNOL, V66, P98, DOI 10.1016/j.dci.2016.02.015; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Munder S, 2013, DEV BIOL, V383, P146, DOI 10.1016/j.ydbio.2013.08.022; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nakamura K, 2007, BRAIN RES, V1136, P28, DOI 10.1016/j.brainres.2006.12.032; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Reinardy HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133860; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Suarez NA, 2018, DEV NEUROBIOL, V78, P434, DOI 10.1002/dneu.22567; Suntsova M, 2015, CELL MOL LIFE SCI, V72, P3653, DOI 10.1007/s00018-015-1947-6; Teider N, 2010, NEURO-ONCOLOGY, V12, P1244, DOI 10.1093/neuonc/noq091; Vazquez-Velez GE, 2016, J HISTOCHEM CYTOCHEM, V64, P381, DOI 10.1369/0022155416645781; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Walton KD, 2006, DEV BIOL, V300, P153, DOI 10.1016/j.ydbio.2006.08.064; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112; Zhang RR, 2018, CELL TISSUE RES, V371, P73, DOI 10.1007/s00441-017-2641-9; Zhao L, 2014, P NATL ACAD SCI USA, V111, P1403, DOI 10.1073/pnas.1311705111; Zueva O, 2018, FRONT ZOOL, V15, DOI 10.1186/s12983-017-0247-4	55	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232981	10.1371/journal.pone.0232981	http://dx.doi.org/10.1371/journal.pone.0232981			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396580	Green Submitted, Green Published, gold			2022-12-26	WOS:000537475000032
J	Cao, YB; Wei, YN; Fan, W; Peng, M; Bao, LL				Cao, Yanbo; Wei, Ya-ni; Fan, Wen; Peng, Min; Bao, Liangliang			Experimental study of land subsidence in response to groundwater withdrawal and recharge in Changping District of Beijing	PLOS ONE			English	Article							VERTICAL DEFORMATION; NUMERICAL-SIMULATION; SAR INTERFEROMETRY; PLAIN; DELTA; PREDICTION; CITY	Over exploitation of groundwater in Changping District of Beijing city has caused serious land subsidence in the past decades. In recent years, the operation of the South-to-North Water Transfer Project has reduced the land subsidence rate. In this paper, Experimental tests are performed using the GDS Consolidation Testing System to characterize the compression and rebound of soils at depths of less than 100 m caused by groundwater withdrawal and recharge in Changping District. The results indicate that the compressible layers are the main contributors to land subsidence. The first compressible layer experiences greater deformation and more considerable hysteresis than the other compressible layers with the same decrease in the pore water pressure. Therefore, the exploitation of the adjacent aquifer should be controlled in the future. The deformation in the second and third compressible layers is a gradual and long-term process with little rebound; therefore, the subsidence should be seriously addressed when the groundwater in the two compressible layers is exploited on a large scale. In the same compressible layer, silty clay is more compressible and hysteretic than silt. For the same soil sample, the deformation rate decreases gradually as the pore water pressure decreases, whereas the creep deformation shows an overall increasing trend. A parameter named the subsidence index C-w is proposed in this paper to describe the soil compressibility during groundwater withdrawal. All the soil samples are characterized by elastic-plastic deformation, and the shallow soil samples with less pore water pressure decrease are more likely to rebound.	[Cao, Yanbo; Wei, Ya-ni; Fan, Wen] Changan Univ, Sch Geol Engn & Geomat, Xian, Shaanxi, Peoples R China; [Fan, Wen; Peng, Min] China Elect Res Inst Engn Invest & Design, Xian, Shaanxi, Peoples R China; [Bao, Liangliang] Yulin Univ, Sch Civil Engn, Yulin, Shaanxi, Peoples R China	Chang'an University; Yulin University	Wei, YN (corresponding author), Changan Univ, Sch Geol Engn & Geomat, Xian, Shaanxi, Peoples R China.	weiyani2006@126.com		Cao, Yanbo/0000-0002-9713-4341	Department of Science and Technology of Shaanxi Province [2019SF-233, 2017JM5144]; Science and Technology Bureau of Yulin city [2014cxy-04]	Department of Science and Technology of Shaanxi Province; Science and Technology Bureau of Yulin city	This study was supported by the Department of Science and Technology of Shaanxi Province (Grant No. 2019SF-233, and 2017JM5144) to Min Peng and Liangliang Bao. This study was supported by Science and Technology Bureau of Yulin city (Grant No. 2014cxy-04) to Yanbo Cao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boni R, 2015, ENG GEOL, V198, P40, DOI 10.1016/j.enggeo.2015.08.014; Budhu M, 2011, INT J GEOMECH, V11, P1, DOI 10.1061/(ASCE)GM.1943-5622.0000060; Cao Y., 2011, THESIS; Chai JC, 2004, GEOTECHNIQUE, V54, P143, DOI 10.1680/geot.54.2.143.36332; Chen BB, 2019, INT J APPL EARTH OBS, V75, P54, DOI 10.1016/j.jag.2018.09.003; Chen R, 1994, CHINESE ECONOMY IN TRANSITION, P95; Conway BD, 2016, HYDROGEOL J, V24, P649, DOI 10.1007/s10040-015-1329-z; Eriksen HO, 2017, REMOTE SENS ENVIRON, V191, P297, DOI 10.1016/j.rse.2016.12.024; Galloway DL, 2016, HYDROGEOL J, V24, P547, DOI 10.1007/s10040-016-1386-y; Galloway DL, 2011, HYDROGEOL J, V19, P1459, DOI 10.1007/s10040-011-0775-5; He P, 2018, ROCK SOIL MECH, V39, P3773, DOI 10.16285/j.rsm.2018.0231; Karila K, 2013, ISPRS INT J GEO-INF, V2, P797, DOI 10.3390/ijgi2030797; Khorrami M, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11040377; Kihm JH, 2007, J HYDROL, V335, P1, DOI 10.1016/j.jhydrol.2006.09.031; KONG LZ, 2019, WATER-SUI, V11, DOI DOI 10.3390/W11091873; Li J, 2019, J MAR SCI ENG, V7, DOI 10.3390/jmse7030058; Li YY, 2017, WATER-SUI, V9, DOI 10.3390/w9010064; Li YQ, 2014, ENG GEOL, V183, P247, DOI 10.1016/j.enggeo.2014.08.020; LIU Er-min, 2014, BEIJING WATER, V4, P24; Liu J, 2019, ENVIRON EARTH SCI, V78, DOI 10.1007/s12665-019-8409-7; Mahmoudpour M, 2016, ENG GEOL, V201, P6, DOI 10.1016/j.enggeo.2015.12.004; Mohammady M, 2019, ENVIRON EARTH SCI, V78, DOI 10.1007/s12665-019-8518-3; Moteahd FS, 2019, ENVIRON EARTH SCI, V78, DOI 10.1007/s12665-019-8413-y; Rahmati O, 2019, SCI TOTAL ENVIRON, V672, P239, DOI 10.1016/j.scitotenv.2019.03.496; Rahmati O, 2019, J ENVIRON MANAGE, V236, P466, DOI 10.1016/j.jenvman.2019.02.020; Rateb A, 2019, WATER-SUI, V11, DOI 10.3390/w11081658; Riel B, 2018, WATER RESOUR RES, V54, P3557, DOI 10.1029/2017WR021978; Shen SL, 2011, CAN GEOTECH J, V48, P1378, DOI [10.1139/t11-049, 10.1139/T11-049]; Shi XQ, 2008, HYDROGEOL J, V16, P593, DOI 10.1007/s10040-007-0237-2; Tangdamrongsub N, 2019, REMOTE SENS ENVIRON, V233, DOI 10.1016/j.rse.2019.111385; Wang J, 2014, SOC SCI CHINA, V35, P44, DOI 10.1080/02529203.2014.900885; Wang YQ, 2019, B ENG GEOL ENVIRON, V78, P2851, DOI 10.1007/s10064-018-1278-6; Wei YN, 2017, HYDROGEOL J, V25, P297, DOI 10.1007/s10040-016-1498-4; Wright TJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018827; Xu YS, 2008, NAT HAZARDS, V45, P123, DOI 10.1007/s11069-007-9168-4; Xu YS, 2012, HYDROGEOL J, V20, P1623, DOI 10.1007/s10040-012-0892-9; Yang F., 2018, YELLOW RIVER, V40, P82; Yang JL, 2019, ENVIRON MONIT ASSESS, V191, DOI 10.1007/s10661-019-7296-4; Yang Y, 2015, ENVIRON EARTH SCI, V73, P4191, DOI 10.1007/s12665-014-3705-8; Ye SJ, 2016, HYDROGEOL J, V24, P685, DOI 10.1007/s10040-015-1356-9; Zhang H, 2019, WATER-SUI, V11, DOI 10.3390/w11091775; Zhang JZ, 2015, NAT HAZARDS, V75, P2385, DOI 10.1007/s11069-014-1434-7; [张雯 Zhang Wen], 2015, [地球信息科学学报, Journal of Geo-Information Science], V17, P909; Zhang YQ, 2017, J HYDROL, V548, P342, DOI 10.1016/j.jhydrol.2017.03.018; Zhang YQ, 2014, HYDROGEOL J, V22, P397, DOI 10.1007/s10040-013-1069-x; Zhu BY, 2019, NAT HAZARDS, V97, P379, DOI 10.1007/s11069-019-03650-z; Zhu L, 2015, ENG GEOL, V193, P243, DOI 10.1016/j.enggeo.2015.04.020; [No title captured]	48	5	5	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232828	10.1371/journal.pone.0232828	http://dx.doi.org/10.1371/journal.pone.0232828			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7ZI	32384123	Green Published, gold			2022-12-26	WOS:000532467400001
J	Choi, JH; Woo, HM; Lee, TY; Lee, SY; Shim, SM; Park, WJ; Yang, JS; Kim, JA; Yun, MR; Kim, DW; Kim, SS; Zhang, Y; Shi, W; Wang, LS; Graham, BS; Mascola, JR; Wang, NS; McLellan, JS; Lee, JY; Lee, H				Choi, Jang-Hoon; Woo, Hye-Min; Lee, Tae-young; Lee, So-young; Shim, Sang-Mu; Park, Woo-Jung; Yang, Jeong-Sun; Kim, Joo Ae; Yun, Mi-Ran; Kim, Dae-Won; Kim, Sung Soon; Zhang, Yi; Shi, Wei; Wang, Lingshu; Graham, Barney S.; Mascola, John R.; Wang, Nanshuang; McLellan, Jason S.; Lee, Joo-Yeon; Lee, Hansaem			Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus	PLOS ONE			English	Article							MERS-COV; MOUSE MODEL; POSTEXPOSURE EFFICACY; IDENTIFICATION; NEUTRALIZATION; DESIGN	Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory infection and continues to infect humans, thereby contributing to a high mortality rate (34.3% in 2019). In the absence of an available licensed vaccine and antiviral agent, therapeutic human antibodies have been suggested as candidates for treatment. In this study, human monoclonal antibodies were isolated by sorting B cells from patient's PBMC cells with prefusion stabilized spike (S) probes and a direct immunoglobulin cloning strategy. We identified six receptor-binding domain (RBD)-specific and five S1 (non-RBD)-specific antibodies, among which, only the RBD-specific antibodies showed high neutralizing potency (IC50 0.006-1.787 mu g/ml) as well as high affinity to RBD. Notably, passive immunization using a highly potent antibody (KNIH90-F1) at a relatively low dose (2 mg/kg) completely protected transgenic mice expressing human DPP4 against MERS-CoV lethal challenge. These results suggested that human monoclonal antibodies isolated by using the rationally designed prefusion MERS-CoV S probe could be considered potential candidates for the development of therapeutic and/or prophylactic antiviral agents for MERS-CoV human infection.	[Choi, Jang-Hoon] Korea Ctr Dis Control & Prevent, Korea Natl Inst Hlth, Ctr Infect Dis Res, Div Viral Dis Res, Cheongju, South Korea; [Woo, Hye-Min; Lee, Tae-young; Lee, So-young; Shim, Sang-Mu; Park, Woo-Jung; Yang, Jeong-Sun; Lee, Joo-Yeon; Lee, Hansaem] Korea Ctr Dis Control & Prevent, Div Emerging Infect Dis & Vector Res, Ctr Infect Dis Res, Korea Natl Inst Hlth, Cheongju, South Korea; [Kim, Joo Ae; Yun, Mi-Ran; Kim, Dae-Won] Korea Ctr Dis Control & Prevent, Div Vaccine Res, Ctr Infect Dis Res, Korea Natl Inst Hlth, Cheongju, South Korea; [Kim, Sung Soon] Korea Ctr Dis Control & Prevent, Div Bacterial Dis Res, Ctr Infect Dis Res, Korea Natl Inst Hlth, Cheongju, South Korea; [Zhang, Yi; Shi, Wei; Wang, Lingshu; Graham, Barney S.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Wang, Nanshuang; McLellan, Jason S.] Univ Texas Austin, Coll Nat Sci, Dept Mol Biosci, Austin, TX 78712 USA	Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Austin	Lee, H (corresponding author), Korea Ctr Dis Control & Prevent, Div Emerging Infect Dis & Vector Res, Ctr Infect Dis Res, Korea Natl Inst Hlth, Cheongju, South Korea.	saem777@korea.kr	Mascola, John/AAI-7193-2021	Lee, Hansaem/0000-0002-9430-8123; Wang, Lingshu/0000-0002-8404-4910	Korea National Institute of Health fund [2016-NG47001-00, 4845-300-210-13]; National Institute of Allergy and Infectious Diseases, NIH, USA	Korea National Institute of Health fund; National Institute of Allergy and Infectious Diseases, NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a Korea National Institute of Health fund (2016-NG47001-00, 4845-300-210-13) and intramural funding from the National Institute of Allergy and Infectious Diseases, NIH, USA. J. C., S. S. K., B. S. G., J. R. M., L.W. and H. L. designed the experiments. J.C., L.W., H.M.W, and H.L. expressed and purified antibodies. J. C. and H. L. prepared this manuscript. H. M. W., J. A. K. and W. J. P. carried out the neutralizing assay with live MERS-CoV. Y. Z. and W. S. expressed and purified RBD, S1, and S2 proteins. N. W. and J. M. designed and produced the S-2P probe. T. L., S. L., S. M. S. and J. S. Y. performed the animal experiments. M. R. Y. and D. W. K. analyzed the computational structure modeling of RBD and mAb interation. J.C. and H.L. wrote the paper with contributions from S.S.K, L. W. and B. S. G.	Agrawal AS, 2015, J VIROL, V89, P3659, DOI 10.1128/JVI.03427-14; Al-Tawfiq JA, 2014, INT J INFECT DIS, V20, P42, DOI 10.1016/j.ijid.2013.12.003; Beigel JH, 2018, LANCET INFECT DIS, V18, P410, DOI 10.1016/S1473-3099(18)30002-1; Channappanavar R, 2019, J CLIN INVEST, P1558; Chen YZ, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.50; Chen Z, 2017, J INFECT DIS, V215, P1807, DOI 10.1093/infdis/jix209; Chong YP, 2015, INFECT CHEMOTHER, V47, P212, DOI 10.3947/ic.2015.47.3.212; Chuang GY, 2017, J VIROL, V91, DOI 10.1128/JVI.02268-16; Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112; David D, 2018, ONE HEALTH-AMSTERDAM, V5, P65, DOI 10.1016/j.onehlt.2018.05.002; Dyall Julie, 2017, Drugs, V77, P1935, DOI 10.1007/s40265-017-0830-1; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Huh HJ, 2017, ANN LAB MED, V37, P494, DOI 10.3343/alm.2017.37.6.494; Jiang LW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008140; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim J, 2020, J KOREAN MED SCI, V35, pe3; KIM Y, 2019, ANTIBODIES, V8, DOI DOI 10.1002/PSP4.12369; Lai ST, 2005, EUR J CLIN MICROBIOL, V24, P583, DOI 10.1007/s10096-005-0004-z; Li WT, 2017, P NATL ACAD SCI USA, V114, pE8508, DOI 10.1073/pnas.1712592114; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Niu PH, 2018, J INFECT DIS, V218, P1249, DOI 10.1093/infdis/jiy311; Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Raj VS, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas9667; Ramakrishnan Muthannan Andavar, 2016, World J Virol, V5, P85, DOI 10.5501/wjv.v5.i2.85; Salazar G, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0019-3; Sheikh V, 2018, NEW ENGL J MED, V379, P605, DOI 10.1056/NEJMp1808729; Sircar A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000644; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Song YJ, 2018, EPIDEMIOL HEALTH, V40, DOI 10.4178/epih.e2018014; Tan HX, 2019, J CLIN INVEST, V129, P850, DOI 10.1172/JCI123366; Tang XC, 2014, P NATL ACAD SCI USA, V111, pE2018, DOI 10.1073/pnas.1402074111; Wang LS, 2018, J VIROL, V92, DOI 10.1128/JVI.02002-17; Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712; Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92; Wec AZ, 2019, CELL HOST MICROBE, V25, P39, DOI 10.1016/j.chom.2018.12.004; WHO, 2019, WHO; Widjaja I, 2019, EMERG MICROBES INFEC, V8, P516, DOI 10.1080/22221751.2019.1597644; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Ying TL, 2014, J VIROL, V88, P7796, DOI 10.1128/JVI.00912-14; Yu XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13133; Zhao GY, 2018, J VIROL, V92, DOI 10.1128/JVI.00837-18; Zhou YS, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010060	48	5	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232757	10.1371/journal.pone.0232757	http://dx.doi.org/10.1371/journal.pone.0232757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384116	Green Published, gold			2022-12-26	WOS:000537468300029
J	Morrison, PK; Newbold, CJ; Jones, E; Worgan, HJ; Grove-White, DH; Dugdale, AH; Barfoot, C; Harris, PA; Argo, CM				Morrison, Philippa K.; Newbold, Charles J.; Jones, Eleanor; Worgan, Hilary J.; Grove-White, Dai H.; Dugdale, Alexandra H.; Barfoot, Clare; Harris, Patricia A.; Argo, Caroline McG.			Effect of age and the individual on the gastrointestinal bacteriome of ponies fed a high-starch diet	PLOS ONE			English	Article							MICROBIAL DISORDERS; EQUINE HINDGUT; HORSES; MANAGEMENT; FERMENTATION; RESISTANCE; DIGESTION; PROFILE; BARLEY; IMPACT	Bacteria residing in the gastrointestinal tract of mammals are crucial for the digestion of dietary nutrients. Bacterial community composition is modified by age and diet in other species. Although horses are adapted to consuming fibre-based diets, high-energy, often high-starch containing feeds are increasingly used. The current study assessed the impact of age on the faecal bacteriome of ponies transitioning from a hay-based diet to a high-starch diet. Over two years, 23 Welsh Section A pony mares were evaluated (Controls, 5-15 years, n = 6/year, 12 in total; Aged, >= 19 years, n = 6 Year 1; n = 5 Year 2, 11 in total). Across the same 30-week (May to November) period in each year, animals were randomly assigned to a 5-week period of study and were individually fed the same hay to maintenance (2% body mass as daily dry matter intake) for 4-weeks. During the final week, 2g starch per kg body mass (micronized steam-flaked barley) was incorporated into the diet (3-day transition and 5 days at maximum). Faecal samples were collected for 11 days (final 3 days hay and 8 days hay + barley feeding). Bacterial communities were determined using Ion Torrent Sequencing of amplified V1-V2 hypervariable regions of 16S rRNA. Age had a minimal effect on the bacteriome response to diet. The dietary transition increased Candidatus Saccharibacteria and Firmicutes phyla abundance and reduced Fibrobactres abundance. At the genera level, Streptococcus abundance was increased but not consistently across individual animals. Bacterial diversity was reduced during dietary transition in Streptococcus 'responders'. Faecal pH and VFA concentrations were modified by diet but considerable inter-individual variation was present. The current study describes compositional changes in the faecal bacteriome associated with the transition from a fibre-based to a high-starch diet in ponies and emphasises the individual nature of dietary responses, which may reflect functional differences in the bacterial populations present in the hindgut.	[Morrison, Philippa K.; Argo, Caroline McG.] Scotlands Rural Coll, Aberdeen, Scotland; [Newbold, Charles J.] Scotlands Rural Coll, Edinburgh, Midlothian, Scotland; [Jones, Eleanor; Worgan, Hilary J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Grove-White, Dai H.] Univ Liverpool, Fac Hlth & Life Sci, Wirral, Merseyside, England; [Dugdale, Alexandra H.] ChesterGates Vet Specialists CVS UK Ltd, Chester, Cheshire, England; [Barfoot, Clare] MARS Horsecare UK Ltd, Milton Keynes, Bucks, England; [Harris, Patricia A.] WALTHAM Petcare Sci Inst, Melton Mowbray, Leics, England	Scotland's Rural College; Scotland's Rural College; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Liverpool; Mars; Mars; WALTHAM Petcare Science Institute	Morrison, PK (corresponding author), Scotlands Rural Coll, Aberdeen, Scotland.	philippa.morrison@sruc.ac.uk		Morrison, Philippa/0000-0003-4187-0371	WALTHAM Petcare Science Institute	WALTHAM Petcare Science Institute	The study was funded by WALTHAM Petcare Science Institute (https://www.waltham.com/). Co-authors PH and CB are employed by the funding organization. Co-author AD is employed by ChesterGates Veterinary Specialists CVS Ltd. The funder provided support in the form of salaries for author PM and with exception of PH and CB, did not have any additional role in the conceptualization, methodology, investigation, data curation, formal analysis, decision to publish, or preparation of the manuscript. PH was involved in conceptualization, formal analysis, methodology, and writing - review & editing. CB was involved in conceptualization.	Argo CM, 2012, VET J, V194, P179, DOI 10.1016/j.tvjl.2012.09.020; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Costa MC, 2018, VET CLIN N AM-EQUINE, V34, P1, DOI 10.1016/j.cveq.2017.11.005; Daly K, 2012, BRIT J NUTR, V107, P989, DOI 10.1017/S0007114511003825; de Fombelle A, 2001, J EQUINE VET SCI, V21, P439, DOI 10.1016/S0737-0806(01)70018-4; de la Fuente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101435; Destrez A, 2019, PHYSIOL BEHAV, V202, P94, DOI 10.1016/j.physbeh.2019.02.003; Dougal K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01502; Dougal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087424; Dougal K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077660; Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x; Dugdale AHA, 2011, EQUINE VET J, V43, P562, DOI 10.1111/j.2042-3306.2010.00327.x; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Frank N, 2010, J VET INTERN MED, V24, P467, DOI 10.1111/j.1939-1676.2010.0503.x; Geor RJ, 2009, VET CLIN N AM-EQUINE, V25, P51, DOI 10.1016/j.cveq.2009.02.001; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Grimm P, 2017, ANIMAL, V11, P1136, DOI 10.1017/S1751731116002779; Harlow BE, 2015, J APPL MICROBIOL, V119, P1234, DOI 10.1111/jam.12927; Heiman ML, 2016, MOL METAB, V5, P317, DOI 10.1016/j.molmet.2016.02.005; Huws SA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02161; Ireland JL, 2011, EQUINE VET J, V43, P30, DOI 10.1111/j.2042-3306.2010.00145.x; Jaccard P, B SOC VAUD SCI NAT, V44, P223; JANIS C, 1976, EVOLUTION, V30, P757, DOI 10.1111/j.1558-5646.1976.tb00957.x; Julliand V, 2006, LIVEST SCI, V100, P44, DOI 10.1016/j.livprodsci.2005.11.001; Julliand V, 2001, J EQUINE VET SCI, V21, P543, DOI 10.1016/S0737-0806(01)70159-1; Julliand V, 2017, J EQUINE VET SCI, V52, P23, DOI 10.1016/j.jevs.2017.03.002; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Kohnke J, 1992, FEEDING NUTR MAKING; Kristoffersen C, 2016, MICROBES ENVIRON, V31, P378, DOI 10.1264/jsme2.ME16061; Kunz IGZ, 2019, J EQUINE VET SCI, V77, P98, DOI 10.1016/j.jevs.2019.01.018; Li FY, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00061-17; Maffei VJ, 2017, J GERONTOL A-BIOL, V72, P1474, DOI 10.1093/gerona/glx042; McGowan TW, 2013, EQUINE VET J, V45, P66, DOI 10.1111/j.2042-3306.2012.00575.x; MEYER H, 1995, J VET MED A, V42, P371, DOI 10.1111/j.1439-0442.1995.tb00389.x; Mihlbachler MC, 2011, SCIENCE, V331, P1178, DOI 10.1126/science.1196166; Milinovich GJ, 2008, ISME J, V2, P1089, DOI 10.1038/ismej.2008.67; Mitnitski Arnold B, 2002, BMC Geriatr, V2, P1; Morrison PK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03017; Murray JAMD, 2014, LIVEST SCI, V159, P67, DOI 10.1016/j.livsci.2013.10.017; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Philippeau C, 2015, ANIMAL, V9, P1943, DOI 10.1017/S1751731115001524; Philippeau C, 2014, J ANIM SCI, V92, P2087, DOI 10.2527/jas.2013-6850; Salem SE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26930-3; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; STEWART CS, 1985, J GEN MICROBIOL, V131, P427; Vital M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/892568; Walshe N, 2019, INT J PARASITOL, V49, P489, DOI 10.1016/j.ijpara.2019.02.003; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warzecha CM, 2017, J ANIM SCI, V95, P5077, DOI 10.2527/jas2017.1754; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	51	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232689	10.1371/journal.pone.0232689	http://dx.doi.org/10.1371/journal.pone.0232689			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384105	Green Published, gold			2022-12-26	WOS:000537468300023
J	Cass, JA; Williams, CD; Theriot, J				Cass, Julie A.; Williams, C. David; Theriot, Julie			A Bayesian framework for the detection of diffusive heterogeneity	PLOS ONE			English	Article								Cells are crowded and spatially heterogeneous, complicating the transport of organelles, proteins and other substrates. One aspect of this complex physical environment, the mobility of passively transported substrates, can be quantitatively characterized by the diffusion coefficient: a descriptor of how rapidly substrates will diffuse in the cell, dependent on their size and effective local viscosity. The spatial dependence of diffusivity is challenging to quantitatively characterize, because temporally and spatially finite observations offer limited information about a spatially varying stochastic process. We present a Bayesian framework that estimates diffusion coefficients from single particle trajectories, and predicts our ability to distinguish differences in diffusion coefficient estimates, conditional on how much they differ and the amount of data collected. This framework is packaged into a public software repository, including a tutorial Jupyter notebook demonstrating implementation of our method for diffusivity estimation, analysis of sources of uncertainty estimation, and visualization of all results. This estimation and uncertainty analysis allows our framework to be used as a guide in experimental design of diffusivity assays.	[Cass, Julie A.; Williams, C. David; Theriot, Julie] Allen Inst Cell Sci, Seattle, WA 98109 USA; [Theriot, Julie] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Cass, JA (corresponding author), Allen Inst Cell Sci, Seattle, WA 98109 USA.	juliec@alleninstitute.org	Theriot, Julie/HHN-2034-2022	Theriot, Julie/0000-0002-2334-2535	Allen Institute for Cell Science	Allen Institute for Cell Science	This work has been completed and funded by the Allen Institute for Cell Science.	Frost NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036751; Gelman A., 2004, BAYESIAN DATA ANAL; Harwardt MLIE, 2018, BIOPHYS J, V114, P2432, DOI 10.1016/j.bpj.2018.03.013; Karslake JD, 2019, BIORXIV, DOI [10.1101/578567, DOI 10.1101/578567]; Lampo TJ, 2017, BIOPHYS J, V112, P532, DOI 10.1016/j.bpj.2016.11.3208; LEE GM, 1991, P NATL ACAD SCI USA, V88, P6274, DOI 10.1073/pnas.88.14.6274; Llera A, 2016, ARXIV160501019STATME; Machan R, 2010, INT J MOL SCI, V11, P427, DOI 10.3390/ijms11020427; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914; Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Valentine MT, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061506; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; Wu PH, 2012, NAT PROTOC, V7, P155, DOI 10.1038/nprot.2011.436	15	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0221841	10.1371/journal.pone.0221841	http://dx.doi.org/10.1371/journal.pone.0221841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379846	Green Published, Green Submitted, gold			2022-12-26	WOS:000537285700001
J	Gutierrez-Albanchez, E; Gradillas, A; Garcia, A; Garcia-Villaraco, A; Gutierrez-Manero, J; Ramos-Solano, B				Gutierrez-Albanchez, Enrique; Gradillas, Ana; Garcia, Antonia; Garcia-Villaraco, Ana; Gutierrez-Manero, Javier; Ramos-Solano, Beatriz			Elicitation with Bacillus QV15 reveals a pivotal role of F3H on flavonoid metabolism improving adaptation to biotic stress in blackberry	PLOS ONE			English	Article							SECONDARY METABOLISM; ARABIDOPSIS-THALIANA; SYSTEMIC RESISTANCE; PLANT; GROWTH; ANTIOXIDANTS; RHIZOSPHERE; PROTECTION; REGULATORS; DEFENSE	The aim of this study is to determine the involvement of the flavonol-anthocyanin pathway on plant adaptation to biotic stress using the B.amyloliquefaciens QV15 to trigger blackberry metabolism and identify target genes to improve plant fitness and fruit quality. To achieve this goal, field-grown blackberries were root-inoculated with QV15 along its growth cycle. At fruiting, a transcriptomic analysis by RNA-Seq was performed on leaves and fruits of treated and non-treated field-grown blackberries after a sustained mildew outbreak; expression of the regulating and core genes of the Flavonol-Anthocyanin pathway were analysed by qPCR and metabolomic profiles by UHPLC/ESI-qTOF-MS; plant protection was found to be up to 88%. Overexpression of step-controlling genes in leaves and fruits, associated to lower concentration of flavonols and anthocyanins in QV15-treated plants, together with a higher protection suggest a phytoanticipin role for flavonols in blackberry; kempferol-3-O-rutinoside concentration was strikingly high. Overexpression of RuF3H (Flavonol-3-hidroxylase) suggests a pivotal role in the coordination of committing steps in this pathway, controlling carbon flux towards the different sinks. Furthermore, this C demand is supported by an activation of the photosynthetic machinery, and boosted by a coordinated control of ROS into a sub-lethal range, and associated to enhanced protection to biotic stress.	[Gutierrez-Albanchez, Enrique; Garcia-Villaraco, Ana; Gutierrez-Manero, Javier; Ramos-Solano, Beatriz] Univ San Pablo CEU Univ, Fac Farm, Dept Pharmaceut & Hlth Sci, Madrid, Spain; [Gradillas, Ana; Garcia, Antonia] Univ San Pablo CEU Univ, Fac Farm, Dept Chem & Biochem, Madrid, Spain	San Pablo CEU University; San Pablo CEU University	Gutierrez-Albanchez, E; Ramos-Solano, B (corresponding author), Univ San Pablo CEU Univ, Fac Farm, Dept Pharmaceut & Hlth Sci, Madrid, Spain.	enriquegutierrez2013@gmail.com; bramsol@ces.es	Garcia, Antonia/C-4296-2008; Ramos-Solano, Beatriz/I-6545-2015; NICOLAS, ANA GRADILLAS/F-1575-2017; Gutierrez-Manero, Francisco Javier/C-1110-2016	Garcia, Antonia/0000-0002-1521-8489; Ramos-Solano, Beatriz/0000-0003-0280-5198; NICOLAS, ANA GRADILLAS/0000-0001-7290-5210; Gutierrez-Manero, Francisco Javier/0000-0001-5230-6798; GARCIA-VILLARAC VELASCO, ANA/0000-0002-4081-5226	Spanish Ministerio de Economia y Competitividad [AGL2013-45189, CTQ2014-55279-R, BES-2014-0769990]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad for projects AGL2013-45189 (BRS, JGM), CTQ2014-55279-R (AG) and grant reference BES-2014-0769990 to EGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2013, PLANT PHYSIOL BIOCH, V72, P35, DOI 10.1016/j.plaphy.2013.03.014; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Algar E, 2014, PLANT PHYSIOL BIOCH, V82, P9, DOI 10.1016/j.plaphy.2014.05.001; Algar E, 2012, J AGR FOOD CHEM, V60, P11080, DOI 10.1021/jf303334q; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bano A, 2017, PLANT BIOLOGY, V19, P406, DOI 10.1111/plb.12535; Barriuso J, 2008, J APPL MICROBIOL, V105, P1298, DOI 10.1111/j.1365-2672.2008.03862.x; Barriuso J, 2008, PHYTOPATHOLOGY, V98, P666, DOI 10.1094/PHYTO-98-6-0666; Barriuso J, 2005, MICROB ECOL, V50, P82, DOI 10.1007/s00248-004-0112-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biala W, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01610; Bidart-Bouzat MG, 2008, J CHEM ECOL, V34, P1026, DOI 10.1007/s10886-008-9498-z; Bohm G, 2016, J AGR ECOL RES INT, V5, P1, DOI [10.9734/JAERI/2016/22186, DOI 10.9734/JAERI/2016/22186]; Boue SM, 2009, J AGR FOOD CHEM, V57, P2614, DOI 10.1021/jf8040403; Brunetti C, 2013, INT J MOL SCI, V14, P3540, DOI 10.3390/ijms14023540; Cassidy A, 2018, MOL ASPECTS MED, V61, P76, DOI 10.1016/j.mam.2017.05.002; Cesco S, 2012, BIOL FERT SOILS, V48, P123, DOI 10.1007/s00374-011-0653-2; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Desta K., 2016, FRONT NAT PRO CHEM, V2, P393; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Garcia-Seco D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142639; Garcia-Seco D, 2013, AGRON SUSTAIN DEV, V33, P385, DOI 10.1007/s13593-012-0103-z; Giusti M, CUR PROTOCOLS FOOD A; Gradillas A, 2019, J PHARMACEUT BIOMED, V164, P47, DOI 10.1016/j.jpba.2018.10.014; Gupta S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1293-y; Albanchez EG, 2018, J PLANT INTERACT, V13, P398, DOI 10.1080/17429145.2018.1484187; Gutierrez E., 2017, FLAVONOIDS FROM BIOS, VInTech, P129; Gutierrez E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00472; Gutierrez-Albanchez E, 2019, J SCI FOOD AGR, V99, P2939, DOI 10.1002/jsfa.9507; Gutierrez-Manero FJ., 2012, INT J CURR MICROBIOL, V4, P224; Hasegawa M, 2014, MOLECULES, V19, P11404, DOI 10.3390/molecules190811404; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jiang N, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5020027; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JS, 2015, GENES GENOM, V37, P387, DOI 10.1007/s13258-015-0267-4; Koskimaki JJ, 2009, EUR J PLANT PATHOL, V125, P629, DOI 10.1007/s10658-009-9511-6; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XD, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00559; Liu JY, 2015, MOL PLANT, V8, P689, DOI 10.1016/j.molp.2015.03.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makoi JHJR, 2010, FIELD CROP RES, V118, P21, DOI 10.1016/j.fcr.2010.03.012; Mierziak J, 2014, MOLECULES, V19, P16240, DOI 10.3390/molecules191016240; Mouradov A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00620; Ning YS, 2017, TRENDS PLANT SCI, V22, P1069, DOI 10.1016/j.tplants.2017.09.010; Nutzmann HW, 2016, NEW PHYTOL, V211, P771, DOI 10.1111/nph.13981; Oh MM, 2009, J PLANT PHYSIOL, V166, P180, DOI 10.1016/j.jplph.2008.04.015; Parvez MM, 2004, BIOCHEM SYST ECOL, V32, P631, DOI 10.1016/j.bse.2003.12.002; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Ramos-Solano B, 2014, PLANT PHYSIOL BIOCH, V74, P1, DOI 10.1016/j.plaphy.2013.10.029; Seema T, 2018, J PHARMACOG PHYTOCHE, V2; Selvaraj T, 2008, MAEJO INT J SCI TECH, V2, P516; Shakya P., 2017, J PHARM PHARM; Shibu Prasanth SCR., 2017, INT J CHEM TECH RES, V10, P359; Song GC, 2013, MOLECULES, V18, P12877, DOI 10.3390/molecules181012877; Thabti I, 2014, INT J FOOD PROP, V17, P842, DOI 10.1080/10942912.2012.660722; Weidenborner M., 1994, Acta Horticulturae, P702; Weston LA, 2013, J CHEM ECOL, V39, P283, DOI 10.1007/s10886-013-0248-5; Wink M, 2008, NAT PROD COMMUN, V3, P1205; Xi HF, 2015, NEW ZEAL J CROP HORT, V43, P163, DOI 10.1080/01140671.2014.989862; Xu BJ, 2007, J FOOD SCI, V72, pS159, DOI 10.1111/j.1750-3841.2006.00260.x; Samaniego-Gamez BY, 2016, CHIL J AGR RES, V76, DOI 10.4067/S0718-58392016000400003	64	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232626	10.1371/journal.pone.0232626	http://dx.doi.org/10.1371/journal.pone.0232626			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374762	Green Published, gold			2022-12-26	WOS:000537283500047
J	Gordon, DM; Neifer, KL; Hamoud, ARA; Hawk, CF; Nestor-Kalinoski, AL; Miruzzi, SA; Morran, MP; Adeosun, SO; Sarver, JG; Erhardt, PW; McCullumsmith, RE; Stec, DE; Hinds, TD				Gordon, Darren M.; Neifer, Kari L.; Hamoud, Abdul-Rizaq Ali; Hawk, Charles F.; Nestor-Kalinoski, Andrea L.; Miruzzi, Scott A.; Morran, Michael P.; Adeosun, Samuel O.; Sarver, Jeffrey G.; Erhardt, Paul W.; McCullumsmith, Robert E.; Stec, David E.; Hinds, Terry D., Jr.			Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator?activated receptor ?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hormone; PPAR?; PPAR?; PPAR?; peroxisome proliferator?activated receptor (PPAR); nuclear receptor; biliverdin; beige fat; browning; obesity; peroxisome proliferator-activated receptor (PPAR); hormone; fatty acid oxidation	INCREASES INSULIN SENSITIVITY; BILIVERDIN REDUCTASE; PPAR-GAMMA; FATTY LIVER; SERUM BILIRUBIN; METABOLIC SYNDROME; UGT1A1-ASTERISK-28 ALLELE; GLUCOCORTICOID-RECEPTOR; CARDIOVASCULAR-DISEASE; UNCOUPLING PROTEIN-1	Activation of lipid-burning pathways in the fat-storing white adipose tissue (WAT) is a promising strategy to improve metabolic health and reduce obesity, insulin resistance, and type II diabetes. For unknown reasons, bilirubin levels are negatively associated with obesity and diabetes. Here, using mice and an array of approaches, including MRI to assess body composition, biochemical assays to measure bilirubin and fatty acids, MitoTracker-based mitochondrial analysis, immunofluorescence, and high-throughput coregulator analysis, we show that bilirubin functions as a molecular switch for the nuclear receptor transcription factor peroxisome proliferator?activated receptor ? (PPAR?). Bilirubin exerted its effects by recruiting and dissociating specific coregulators in WAT, driving the expression of PPAR? target genes such as uncoupling protein 1 (Ucp1) and adrenoreceptor ? 3 (Adrb3). We also found that bilirubin is a selective ligand for PPAR? and does not affect the activities of the related proteins PPAR? and PPAR?. We further found that diet-induced obese mice with mild hyperbilirubinemia have reduced WAT size and an increased number of mitochondria, associated with a restructuring of PPAR?-binding coregulators. We conclude that bilirubin strongly affects organismal body weight by reshaping the PPAR? coregulator profile, remodeling WAT to improve metabolic function, and reducing fat accumulation.	[Gordon, Darren M.; Neifer, Kari L.; Hamoud, Abdul-Rizaq Ali; Hawk, Charles F.; Miruzzi, Scott A.; McCullumsmith, Robert E.; Hinds, Terry D., Jr.] Univ Toledo, Coll Med & Life Sci, Dept Neurosci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Gordon, Darren M.; Hinds, Terry D., Jr.] Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res CeDER, 2801 W Bancroft St, Toledo, OH 43606 USA; [Nestor-Kalinoski, Andrea L.; Morran, Michael P.] Univ Toledo, Coll Med & Life Sci, Adv Microscopy & Imaging Ctr, Dept Surg, 2801 W Bancroft St, Toledo, OH 43606 USA; [Adeosun, Samuel O.; Stec, David E.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Cardiorenal & Metab Dis Res Ctr, Jackson, MS 39216 USA; [Sarver, Jeffrey G.] Univ Toledo, Coll Pharm & Pharmaceut Sci, Ctr Drug Design & Dev CD3, Dept Pharmacol & Expt Therapeut, 2801 W Bancroft St, Toledo, OH 43606 USA; [Erhardt, Paul W.] Univ Toledo, Coll Pharm & Pharmaceut Sci, Ctr Drug Design & Dev CD3, Dept Med & Biol Chem, 2801 W Bancroft St, Toledo, OH 43606 USA; [McCullumsmith, Robert E.] ProMedica, Toledo, OH USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Mississippi; University of Mississippi Medical Center; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Hinds, TD (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Neurosci, 2801 W Bancroft St, Toledo, OH 43606 USA.; Hinds, TD (corresponding author), Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res CeDER, 2801 W Bancroft St, Toledo, OH 43606 USA.	Terry.Hinds@utoledo.edu	Hamoud, Ahmed A./L-4118-2019; McCullumsmith, Robert/GYR-1547-2022; Gordon, Darren/AAE-6400-2021; HAMOUD, AHMED A./J-5568-2016; Hinds, Terry/B-8495-2015	Hamoud, Ahmed A./0000-0002-8877-7337; Gordon, Darren/0000-0002-4848-1419; HAMOUD, AHMED A./0000-0002-8877-7337; Adeosun, Samuel/0000-0002-2331-7911; Hinds, Terry/0000-0002-7599-1529; Kalinoski, Andrea/0000-0002-1475-3578; Erhardt, Paul/0000-0002-7330-0384	National Institutes of Health (NIH) [1R01DK12179701A1, 1R01DK126884-01]; NHLBI, NIH [K01HL-125445, P01 HL05197-11]; NIGMS, National Institutes of Health [P20GM104357-02]; NIGMS (NIH) as one of its Centers of Biomedical Research Excellence (COBRE) [P30GM122733]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS (NIH) as one of its Centers of Biomedical Research Excellence (COBRE)	This work was supported by the National Institutes of Health (NIH) Grants 1R01DK12179701A1 (to D. E. S.) and 1R01DK126884-01 (to D. E. S. and T. D. H.); NHLBI, NIH, Grants K01HL-125445 (to T. D. H.) and P01 HL05197-11 (to D. E. S.); and NIGMS, National Institutes of Health, Grant P20GM104357-02 (to D. E. S.). This project was supported in part by Grant P30GM122733 (Chemistry and DMPK Core Faculty) funded by NIGMS (NIH) as one of its Centers of Biomedical Research Excellence (COBRE). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8052; Adeosun SO, 2018, AM J PHYSIOL-RENAL, V315, pF323, DOI 10.1152/ajprenal.00495.2017; Adeosun Samuel O, 2018, React Oxyg Species (Apex), V5, P35, DOI 10.20455/ros.2018.809; Andersson C, 2009, METABOLISM, V58, P1109, DOI 10.1016/j.metabol.2009.04.003; AWRUCH J, 1984, BIOCHIM BIOPHYS ACTA, V787, P146, DOI 10.1016/0167-4838(84)90073-6; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; BELL JE, 1988, ARCH BIOCHEM BIOPHYS, V263, P1, DOI 10.1016/0003-9861(88)90607-8; Belo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098467; Bosma PJ, 2003, J HEPATOL, V38, P107, DOI 10.1016/S0168-8278(02)00359-8; Bougarne N, 2018, ENDOCR REV, V39, P760, DOI 10.1210/er.2018-00064; Broekema MF, 2018, ENDOCRINOLOGY, V159, P2397, DOI 10.1210/en.2018-00149; Brunmeir R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061738; Chen WC, 2014, MED SCI SPORT EXER, V46, P1517, DOI 10.1249/MSS.0000000000000272; Cheriyath Pramil, 2010, J Clin Med Res, V2, P201, DOI 10.4021/jocmr425w; Choi SH, 2013, NUTR METAB CARDIOVAS, V23, P31, DOI 10.1016/j.numecd.2011.03.001; Christian M, 2015, ADIPOCYTE, V4, P50, DOI 10.4161/adip.29853; Croce AC, 2014, J BIOPHOTONICS, V7, P810, DOI 10.1002/jbio.201300039; Debevec D, 2007, MOL ENDOCRINOL, V21, P1581, DOI 10.1210/me.2007-0103; Defour M, 2018, MOL METAB, V10, P39, DOI 10.1016/j.molmet.2018.01.023; Gonzalez MD, 2012, PPAR RES, V2012, DOI 10.1155/2012/483536; Dong HS, 2014, ENDOCRINOLOGY, V155, P818, DOI 10.1210/en.2013-1667; Dunn FL, 2011, J DIABETES COMPLICAT, V25, P151, DOI 10.1016/j.jdiacomp.2010.06.006; Ebke LA, 2014, OBESITY, V22, P1246, DOI 10.1002/oby.20634; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Feldman PL, 2008, CURR TOP MED CHEM, V8, P728, DOI 10.2174/156802608784535084; Festuccia WT, 2008, ENDOCRINOLOGY, V149, P2121, DOI 10.1210/en.2007-1553; Festuccia WT, 2009, AM J PHYSIOL-REG I, V296, pR1327, DOI 10.1152/ajpregu.91012.2008; Forbes-Hernandez TY, 2020, FOOD FUNCT, V11, P297, DOI [10.1039/c9fo02285f, 10.1039/C9FO02285F]; Fritah A, 2010, CARDIOVASC RES, V86, P443, DOI 10.1093/cvr/cvp418; Fruchart JC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-82; FRYDMAN RB, 1987, BIOCHIM BIOPHYS ACTA, V916, P500, DOI 10.1016/0167-4838(87)90197-X; FRYDMAN RB, 1982, BIOCHEM BIOPH RES CO, V105, P752, DOI 10.1016/0006-291X(82)91498-X; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; Giudici M, 2016, HANDB EXP PHARMACOL, V233, P95, DOI 10.1007/164_2015_5; Gordon DM, 2019, PHYSIOL GENOMICS, V51, P234, DOI 10.1152/physiolgenomics.00028.2019; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; GREENE BI, 1981, P NATL ACAD SCI USA, V78, P2008, DOI 10.1073/pnas.78.4.2008; Guzek Marek, 2012, Przegl Epidemiol, V66, P495; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; Haluzik M, 2004, ENDOCRINOLOGY, V145, P1662, DOI 10.1210/en.2003-1015; Hamoud AR, 2018, TRENDS ENDOCRIN MET, V29, P140, DOI 10.1016/j.tem.2018.01.002; Han SS, 2010, TOHOKU J EXP MED, V221, P133, DOI 10.1620/tjem.221.133; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Harano Y, 2006, LIVER INT, V26, P613, DOI 10.1111/j.1478-3231.2006.01265.x; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Higgins LS, 2010, AM J CLIN NUTR, V91, p267S, DOI 10.3945/ajcn.2009.28449E; Hinds TD, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0994-z; Hinds TD, 2018, HYPERTENSION, V72, P788, DOI 10.1161/HYPERTENSIONAHA.118.11130; Hinds TD, 2017, AM J PHYSIOL-ENDOC M, V312, pE291, DOI 10.1152/ajpendo.00396.2016; Hinds TD, 2016, J BIOL CHEM, V291, P25179, DOI 10.1074/jbc.M116.731703; Hinds TD, 2016, PPAR RES, V2016, DOI 10.1155/2016/6218637; Hinds TD, 2014, OBESITY, V22, P705, DOI 10.1002/oby.20559; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Hughes MLR, 2015, J BIOL CHEM, V290, P13895, DOI 10.1074/jbc.M114.605998; Jang BK, 2012, CLIN MOL HEPATOL, V18, P357, DOI 10.3350/cmh.2012.18.4.357; Jo J, 2011, ENDOCRINE, V39, P182, DOI 10.1007/s12020-010-9417-2; John K, 2016, AM J PHYSIOL-ENDOC M, V310, pE249, DOI 10.1152/ajpendo.00478.2015; Jorgensen ME, 2014, NUTR METAB CARDIOVAS, V24, P656, DOI 10.1016/j.numecd.2013.12.009; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kim MJ, 2017, BIOMATERIALS, V133, P242, DOI 10.1016/j.biomaterials.2017.04.029; Kim SH, 2016, DIABETES METAB J, V40, P12, DOI 10.4093/dmj.2016.40.1.12; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Kwak MS, 2012, CLIN MOL HEPATOL, V18, P383, DOI 10.3350/cmh.2012.18.4.383; Kwon KM, 2011, J WOMENS HEALTH, V20, P963, DOI 10.1089/jwh.2010.2453; Lamola AA, 2014, PHOTOCHEM PHOTOBIOL, V90, P294, DOI 10.1111/php.12167; Larter CZ, 2012, J GASTROEN HEPATOL, V27, P341, DOI 10.1111/j.1440-1746.2011.06939.x; Lasar D, 2018, CELL REP, V22, P760, DOI 10.1016/j.celrep.2017.12.067; Lee Y, 2016, ANGEW CHEM INT EDIT, V55, P7460, DOI 10.1002/anie.201602525; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; LEVI AJ, 1969, J CLIN INVEST, V48, P2156, DOI 10.1172/JCI106182; LIGHTNER DA, 1979, P NATL ACAD SCI USA, V76, P29, DOI 10.1073/pnas.76.1.29; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Liu JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09886; Martinez-Jimenez CP, 2010, MOL CELL BIOL, V30, P565, DOI 10.1128/MCB.00927-09; Matsumoto K, 2007, J BIOL CHEM, V282, P17053, DOI 10.1074/jbc.M701956200; MCDONAGH AF, 1982, J AM CHEM SOC, V104, P6867, DOI 10.1021/ja00388a104; Meixiong J, 2019, ELIFE, V8, DOI 10.7554/eLife.44116; Miyata KS, 1998, MOL CELL ENDOCRINOL, V146, P69; Molzer C, 2016, SCI REP-UK, V6, DOI 10.1038/srep30051; MUSTAFA MG, 1969, J BIOL CHEM, V244, P6403; O'Brien L, 2015, TRENDS ENDOCRIN MET, V26, P212, DOI 10.1016/j.tem.2015.02.001; Pan YY, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00671; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Petersen CE, 2000, J BIOL CHEM, V275, P20985, DOI 10.1074/jbc.M001038200; Plavskii V. Yu, 2007, Journal of Applied Spectroscopy, V74, P120, DOI 10.1007/s10812-007-0019-6; Preidis GA, 2017, J CLIN INVEST, V127, P1193, DOI [10.1172/jci88893, 10.1172/JCI88893]; Rachid TL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191365; Rachid TL, 2015, CELL BIOCHEM FUNCT, V33, P249, DOI 10.1002/cbf.3111; Rachid TL, 2015, MOL CELL ENDOCRINOL, V402, P86, DOI 10.1016/j.mce.2014.12.027; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Ren HZ, 2010, PPAR RES, V2010, DOI 10.1155/2010/727194; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Rosell M, 2011, BBA-MOL BASIS DIS, V1812, P919, DOI 10.1016/j.bbadis.2010.12.016; Sakamoto T, 2016, AM J PHYSIOL-ENDOC M, V310, pE676, DOI 10.1152/ajpendo.00028.2015; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Schwertner HA, 2008, ATHEROSCLEROSIS, V198, P1, DOI 10.1016/j.atherosclerosis.2008.01.001; Seale P, 2015, DIABETES, V64, P2369, DOI 10.2337/db15-0203; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; Shen YC, 2020, CELL REP, V30, P3079, DOI 10.1016/j.celrep.2020.02.032; Stec DE, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030387; Stec DE, 2019, AM J PHYSIOL-REG I, V317, pR733, DOI 10.1152/ajpregu.00153.2019; Stec DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153427; Stechschulte LA, 2016, ENDOCRINOLOGY, V157, P3888, DOI 10.1210/en.2015-1996; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1254, DOI 10.1210/me.2014-1023; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1265, DOI 10.1210/me.2014-1022; STUMPF DA, 1985, BIOCHEM MED METAB B, V34, P226, DOI 10.1016/0006-2944(85)90115-2; Sun ZL, 2017, BIOCHEM BIOPH RES CO, V492, P295, DOI 10.1016/j.bbrc.2017.08.129; Sundararaghavan VL, 2018, TRANSPLANT REV-ORLAN, V32, P234, DOI 10.1016/j.trre.2018.06.003; Takahashi A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215274; Takei R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223302; Thyagarajan B, 2017, HORM MOL BIOL CLIN I, V31, DOI 10.1515/hmbci-2017-0016; Torgerson JS, 1997, OBES RES, V5, P105, DOI 10.1002/j.1550-8528.1997.tb00650.x; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Vitek L, 2020, MED RES REV, V40, P1335, DOI 10.1002/med.21660; Vitek L, 2019, ARCH BIOCHEM BIOPHYS, V672, DOI 10.1016/j.abb.2019.108062; Wang L, 2013, DIABETES, V62, P4122, DOI 10.2337/db13-0518; Wang S, 2019, THERANOSTICS, V9, P5122, DOI 10.7150/thno.35773; Weaver L, 2018, AM J PHYSIOL-GASTR L, V314, pG668, DOI 10.1152/ajpgi.00026.2018; Weikum ER, 2018, PROTEIN SCI, V27, P1876, DOI 10.1002/pro.3496; Wu YH, 2011, J DIABETES, V3, P217, DOI 10.1111/j.1753-0407.2011.00138.x	123	35	35	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					9804	9822		10.1074/jbc.RA120.013700	http://dx.doi.org/10.1074/jbc.RA120.013700			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32404366	Green Published, hybrid			2022-12-26	WOS:000553333300004
J	Pedersen, H; Jensen, RK; Hansen, AG; Gadeberg, TAF; Thiel, S; Laursen, NS; Andersen, GR				Pedersen, Henrik; Jensen, Rasmus K.; Hansen, Annette G.; Gadeberg, Trine A. F.; Thiel, Steffen; Laursen, Nick S.; Andersen, Gregers R.			A C3-specific nanobody that blocks all three activation pathways in the human and murine complement system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						single-domain antibody; complement system; inhibitor; innate immunity; antibody; structural biology; nanobody; C3 convertase; single-domain antibody (sdAb nanobody)	ALTERNATIVE PATHWAY; STRUCTURAL INSIGHT; MOLECULAR-BASIS; C3; RECOGNITION; COMPSTATIN; REVEALS; CRIG	The complement system is a tightly controlled proteolytic cascade in the innate immune system, which tags intruding pathogens and dying host cells for clearance. An essential protein in this process is complement component C3. Uncontrolled complement activation has been implicated in several human diseases and disorders and has spurred the development of therapeutic approaches that modulate the complement system. Here, using purified proteins and several biochemical assays and surface plasmon resonance, we report that our nanobody, hC3Nb2, inhibits C3 deposition by all complement pathways. We observe that the hC3Nb2 nanobody binds human native C3 and its degradation products with low nanomolar affinity and does not interfere with the endogenous regulation of C3b deposition mediated by Factors H and I. Using negative stain EM analysis and functional assays, we demonstrate that hC3Nb2 inhibits the substrate?convertase interaction by binding to the MG3 and MG4 domains of C3 and C3b. Furthermore, we notice that hC3Nb2 is cross-reactive and inhibits the lectin and alternative pathway in murine serum. We conclude that hC3Nb2 is a potent, general, and versatile inhibitor of the human and murine complement cascades. Its cross-reactivity suggests that this nanobody may be valuable for analysis of complement activation within animal models of both acute and chronic diseases.	[Pedersen, Henrik; Jensen, Rasmus K.; Gadeberg, Trine A. F.; Laursen, Nick S.; Andersen, Gregers R.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Hansen, Annette G.; Thiel, Steffen] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University; Aarhus University	Andersen, GR (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	gra@mbg.au.dk		Jensen, Rasmus Kjeldsen/0000-0001-5472-4862; Andersen, Gregers Rom/0000-0001-6292-3319; Pedersen, Henrik/0000-0003-4911-5119; Thiel, Steffen/0000-0002-4817-155X	Lundbeck Foundation (BRAINSTRUC) [R155-2015-2666]; Aarhus University Science and Technology	Lundbeck Foundation (BRAINSTRUC); Aarhus University Science and Technology	This work was supported by the Lundbeck Foundation (BRAINSTRUC, R155-2015-2666) and the Aarhus University Science and Technology Ph.D. School GSST.	Andersen KR, 2013, PROTEINS, V81, P1857, DOI 10.1002/prot.24364; Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Bajic G, 2013, P NATL ACAD SCI USA, V110, P16426, DOI 10.1073/pnas.1311261110; Bexborn F, 2008, MOL IMMUNOL, V45, P2370, DOI 10.1016/j.molimm.2007.11.003; Broadley SP, 2016, CELL HOST MICROBE, V20, P36, DOI 10.1016/j.chom.2016.05.023; Campagne MV, 2016, IMMUNOBIOLOGY, V221, P733, DOI 10.1016/j.imbio.2015.11.007; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Chen X, 2012, P NATL ACAD SCI USA, V109, P4586, DOI 10.1073/pnas.1202051109; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Elverdi T, 2019, DRUG DES DEV THER, V13, P1251, DOI 10.2147/DDDT.S134470; Engstrom G, 2007, J HUM HYPERTENS, V21, P276, DOI 10.1038/sj.jhh.1002129; Forneris F, 2016, EMBO J, V35, P1133, DOI 10.15252/embj.201593673; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Grant T, 2018, ELIFE, V7, DOI 10.7554/eLife.35383; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; Harboe M, 2009, MOL IMMUNOL, V47, P373, DOI 10.1016/j.molimm.2009.09.005; Heesterbeek DAC, 2018, J INNATE IMMUN, V10, P455, DOI 10.1159/000491439; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Hill A, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.28; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jensen RK, 2018, J BIOL CHEM, V293, P6269, DOI 10.1074/jbc.RA117.001179; Kjaer TR, 2013, MOL IMMUNOL, V56, P222, DOI 10.1016/j.molimm.2013.05.220; Kojouharova M, 2010, MOL IMMUNOL, V47, P2154, DOI 10.1016/j.molimm.2010.05.011; Kotimaa J, 2016, MOL IMMUNOL, V76, P13, DOI 10.1016/j.molimm.2016.06.004; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341; Laursen NS, 2010, P NATL ACAD SCI USA, V107, P3681, DOI 10.1073/pnas.0910565107; Liszewski MK, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0029-z; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lukacsi S, 2017, IMMUNOL LETT, V189, P64, DOI 10.1016/j.imlet.2017.05.014; Mastellos DC, 2019, NAT REV DRUG DISCOV, V18, P707, DOI 10.1038/s41573-019-0031-6; Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Pedersen DV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02007; Pedersen DV, 2017, EMBO J, V36, P1084, DOI 10.15252/embj.201696173; Risitano AM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01157; de Cordoba SR, 2014, SEMIN THROMB HEMOST, V40, P422, DOI 10.1055/s-0034-1375296; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Roumenina LT, 2009, BLOOD, V114, P2837, DOI 10.1182/blood-2009-01-197640; Schatz-Jakobsen JA, 2016, IMMUNOL REV, V274, P59, DOI 10.1111/imr.12465; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Smith RJH, 2019, NAT REV NEPHROL, V15, P129, DOI 10.1038/s41581-018-0107-2; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; van den Elsen JMH, 2011, SCIENCE, V332, P608, DOI 10.1126/science.1201954; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Xue XG, 2017, NAT STRUCT MOL BIOL, V24, P643, DOI 10.1038/nsmb.3427; Yatime L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02822; Zelek WM, 2019, MOL IMMUNOL, V114, P341, DOI 10.1016/j.molimm.2019.07.030	56	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8746	8758		10.1074/jbc.RA119.012339	http://dx.doi.org/10.1074/jbc.RA119.012339			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32376685	Green Published, hybrid			2022-12-26	WOS:000546296800011
J	Lenzo, V; Bordino, V; Bonanno, GA; Quattropani, MC				Lenzo, Vittorio; Bordino, Valentina; Bonanno, George A.; Quattropani, Maria C.			Understanding the role of regulatory flexibility and context sensitivity in preventing burnout in a palliative home care team	PLOS ONE			English	Article							SUPPRESS EMOTIONAL EXPRESSION; PSYCHOLOGICAL MORBIDITY; PERSONALITY-FACTORS; RESILIENCE; NURSES; CLINICIAN; HOSPICE; PREVALENCE; PROFESSIONALS; PREDICTORS	Although burnout syndrome has been investigated in depth, studies specifically focused on palliative home care are still limited. Moreover, there is still a lack of evidence regarding the interplay between emotional flexibility and sensitivity to context in preventing burnout in home care settings. For these reasons, the aims of this study were to examine burnout symptoms among practitioners specializing in palliative home care and to investigate the role of regulatory flexibility and sensitivity to context in understanding burnout. An exploratory cross-sectional design was adopted. A convenience sample (n = 65) of Italian specialist palliative care practitioners participated in this study. Participants were recruited between February and April 2019 from two palliative home care services that predominantly cared for end-of-life cancer patients. The Italian version of the Maslach Burnout Inventory (MBI), the Flexible Regulation of Emotional Expression (FREE) scale (a measure of emotional flexibility), and the Context Sensitivity Index (CSI) (a measure of sensitivity to context) were administered. Analyses of variance were conducted using the three MBI factors as dependent variables and profession as an independent variable. Subsequently, three identical analyses of covariance were conducted with age, work experience, flexibility and sensitivity to context as covariates. The results showed a low burnout risk for all three of the MBI factors, and there were no gender differences. An ANOVA revealed a significant effect of profession type and age on the emotional exhaustion factor of the MBI, and an ANCOVA indicated that these effects persisted after covariates were accounted for. The results also showed a significant effect of the FREE score on emotional exhaustion. These findings can help explain the differential contributions of profession type and age to the burnout symptoms investigated. In addition, the emotional flexibility component, as an aspect of resilience, represents a significant and specific factor of emotional exhaustion. Interventions to prevent burnout must consider these relationships.	[Lenzo, Vittorio; Quattropani, Maria C.] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Bordino, Valentina] Sisifo Consortium Social Cooperat, Palliat Home Care Serv, Catania, Italy; [Bonanno, George A.] Columbia Univ, Teachers Coll, New York, NY 10027 USA	University of Messina; Columbia University; Columbia University Teachers College	Lenzo, V (corresponding author), Univ Messina, Dept Clin & Expt Med, Messina, Italy.	vittorio.lenzo@unime.it	Quattropani, Maria C./G-3504-2015; Lenzo, Vittorio/C-9425-2017	Quattropani, Maria C./0000-0003-0711-6412; Lenzo, Vittorio/0000-0001-8391-5123				Ablett JR, 2007, PSYCHO-ONCOL, V16, P733, DOI 10.1002/pon.1130; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ang SY, 2018, APPL NURS RES, V43, P105, DOI 10.1016/j.apnr.2018.07.007; Armon G, 2014, PERS INDIV DIFFER, V58, P112, DOI 10.1016/j.paid.2013.10.020; Armon G, 2012, J PERS, V80, P403, DOI 10.1111/j.1467-6494.2011.00731.x; Back AL, 2016, J PAIN SYMPTOM MANAG, V52, P284, DOI 10.1016/j.jpainsymman.2016.02.002; Birk JL, 2016, EMOTION, V16, P657, DOI 10.1037/emo0000157; Bonanno GA, 2004, PSYCHOL SCI, V15, P482, DOI 10.1111/j.0956-7976.2004.00705.x; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2014, REGULATORY FLEXIBILI, DOI [10.1037/e530972014-001, DOI 10.1037/E530972014-001]; Bonanno GA, CONTEXT SENSITIVITY; Bonanno GA, 2020, ASSESSMENT, V27, P261, DOI 10.1177/1073191118820131; Bonanno GA, 2013, PERSPECT PSYCHOL SCI, V8, P591, DOI 10.1177/1745691613504116; Brewer E., 2004, HUMAN RESOURCE DEV R, V3, P102, DOI [10.1177/1534484304263335, DOI 10.1177/1534484304263335]; Bujang M.A., 2017, EPIDEMIOL BIOSTAT PU, V14, DOI 10.2427/12267; Burns KEA, 2019, CAN J ANESTH, V66, P503, DOI 10.1007/s12630-019-01321-y; Burton CL, 2016, PSYCHOL ASSESSMENT, V28, P929, DOI 10.1037/pas0000231; Cherny N., 2015, OXFORD TXB PALLIATIV, Vfifth, DOI [10.1093/med/9780199656097.001.0001, DOI 10.1093/MED/9780199656097.001.0001]; Cohen J.E., 1988, STAT POWER ANAL BEHA; De la Fuente-Solana EI, 2017, EUR J ONCOL NURS, V30, P91, DOI 10.1016/j.ejon.2017.08.004; Dreano-Hartz S, 2016, PALLIAT SUPPORT CARE, V14, P402, DOI 10.1017/S1478951515000991; Dunwoodie DA, 2007, INTERN MED J, V37, P693, DOI 10.1111/j.1445-5994.2007.01384.x; Dyrbye LN, 2010, MED EDUC, V44, P1016, DOI 10.1111/j.1365-2923.2010.03754.x; Faul F., 1992, GPOWER PRIORI POSTHO; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gama G, 2014, EUR J ONCOL NURS, V18, P527, DOI 10.1016/j.ejon.2014.04.005; Gerhart J, 2016, J CONTEXT BEHAV SCI, V5, P89, DOI 10.1016/j.jcbs.2016.04.003; Gupta S, 2011, J ABNORM PSYCHOL, V120, P635, DOI 10.1037/a0023541; Harrison KL, 2017, J PAIN SYMPTOM MANAG, V53, P1091, DOI 10.1016/j.jpainsymman.2017.01.007; Kamal AH, 2016, J PAIN SYMPTOM MANAG, V51, P690, DOI 10.1016/j.jpainsymman.2015.10.020; Kavalieratos D, 2016, J PAIN SYMPTOM MANAG, V51, P404, DOI 10.1016/j.jpainsymman.2015.12.299; Kelly EP, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.12981; Koh MYH, 2015, PALLIATIVE MED, V29, P633, DOI 10.1177/0269216315575850; Lapa TA, 2017, EUR J ANAESTH, V34, P41, DOI 10.1097/EJA.0000000000000500; Lenzo V, 2020, MINERVA PSICH, V61, P10, DOI 10.23736/S0391-1772.19.02033-8; Lenzo V, 2016, EUR PROC SOC BEHAV, V9, P1, DOI 10.15405/epsbs.2016.05.02.1; Levy-Gigi E, 2016, STRESS, V19, P1, DOI 10.3109/10253890.2015.1113523; Garcia GM, 2012, INT NURS REV, V59, P101, DOI 10.1111/j.1466-7657.2011.00927.x; Marchalik D, 2019, ANN PALLIAT MED, V8, P428, DOI 10.21037/apm.2019.05.02; Masel EK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158830; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C., 1981, MASLACH BURNOUT INVE; McGreevy CA, 2015, PERS INDIV DIFFER, V85, P93, DOI 10.1016/j.paid.2015.04.033; O'Connor K, 2018, EUR PSYCHIAT, V53, P74, DOI 10.1016/j.eurpsy.2018.06.003; Ostacoli L, 2010, PALLIAT SUPPORT CARE, V8, P427, DOI 10.1017/S1478951510000295; Parola Vitor, 2016, JBI Database System Rev Implement Rep, V14, P45, DOI 10.11124/JBISRIR-2016-2633; Picione RD, 2017, J CONSTR PSYCHOL, V30, P339, DOI 10.1080/10720537.2016.1227738; Purvanova RK, 2010, J VOCAT BEHAV, V77, P168, DOI 10.1016/j.jvb.2010.04.006; Quattropani MC, 2017, PSICOLOGIA SALUTE, P121, DOI [10.3280/pds2017-002006, DOI 10.3280/PDS2017-002006]; Rizo-Baeza M, 2018, J NURS MANAGE, V26, P19, DOI 10.1111/jonm.12506; Rotenstein LS, 2018, JAMA-J AM MED ASSOC, V320, P1131, DOI 10.1001/jama.2018.12777; Rugnone L, 2017, WORLD FUTURES, V73, P353, DOI DOI 10.1080/02604027.2017.1333872; Rushton CH, 2015, AM J CRIT CARE, V24, P412, DOI 10.4037/ajcc2015291; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; Sirigatti S., 1993, ADAPTATION ADJUSTMEN; Southwick SM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25338; Steven B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210325; Swider BW, 2010, J VOCAT BEHAV, V76, P487, DOI 10.1016/j.jvb.2010.01.003; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X; World Health Organization, 2004, PALL CAR SOL FACTS	64	12	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233173	10.1371/journal.pone.0233173	http://dx.doi.org/10.1371/journal.pone.0233173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1CK	32421730	Green Published, gold			2022-12-26	WOS:000537499600032
J	Chaurasiya, S; Widmann, S; Botero, C; Lin, CY; Gustafsson, JA; Strom, AM				Chaurasiya, Surendra; Widmann, Scott; Botero, Cindy; Lin, Chin-Yo; Gustafsson, Jan-Ake; Strom, Anders M.			Estrogen receptor beta exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity	PLOS ONE			English	Article							GENOME-WIDE; BREAST; PROLIFERATION; GENES; DIFFERENTIATION	Estrogen receptor beta (ER beta) was first identified in the rodent prostate and is abundantly expressed in human and rodent prostate epithelium, stroma, immune cells and endothelium of the blood vessels. In the prostates of mice with inactivated ER beta, mutant phenotypes include epithelial hyperplasia and increased expression of androgen receptor (AR)-regulated genes, most of which are also upregulated in prostate cancer (PCa). ER beta is expressed in both basal and luminal cells in the prostate while AR is expressed in luminal but not in the basal cell layer which harbors the prostate stem cells. To investigate the mechanisms of action of ER beta and its potential cross-talk with AR, we used RNA-seq to study the effects of estradiol or the synthetic ligand, LY3201, in AR-positive LNCaP PCa cells which had been engineered to express ER beta. Transcriptomic analysis indicated relatively few changes in gene expression with ER beta overexpression, but robust responses following ligand treatments. There is significant overlap of responsive genes between the two ligands, estradiol and LY3201 as well as ligand-specific alterations. Gene set analysis of down-regulated genes identified an enrichment of androgen-responsive genes, such as FKBP5, CAMKK2, and TBC1D4. Consistently, AR transcript, protein levels, and transcriptional activity were down-regulated following ER beta activation. In agreement with this, we find that the phosphorylation of the CAMKK2 target, AMPK, was repressed by ligand-activated ER beta. These findings suggest that ER beta-mediated signaling pathways are involved in the negative regulation of AR expression and activity, thus supporting a tumor suppressive role for ER beta in PCa.	[Chaurasiya, Surendra; Widmann, Scott; Botero, Cindy; Lin, Chin-Yo; Gustafsson, Jan-Ake; Strom, Anders M.] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Sci & Engn Res Ctr, Houston, TX 77004 USA; [Gustafsson, Jan-Ake] Karolinska Inst, Dept BioSci & Nutr, Huddinge, Sweden	University of Houston System; University of Houston; Karolinska Institutet	Strom, AM (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Sci & Engn Res Ctr, Houston, TX 77004 USA.	amstrom@uh.edu	Chaurasiya, Surendra/ABC-9119-2021		Brockman Foundation [000176005]; Robert A. Welch Foundation [E-0004]	Brockman Foundation; Robert A. Welch Foundation(The Welch Foundation)	JAG, The Brockman Foundation 000176005, Robert A. Welch Foundation (E-0004) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Crawford ED, 2018, J UROLOGY, V200, P956, DOI 10.1016/j.juro.2018.04.083; Dadwal UC, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00335; Dago DN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1541-1; Dey P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128239; Dey P, 2012, MOL ENDOCRINOL, V26, P1991, DOI 10.1210/me.2012.1227; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Faria Michelle, 2018, Oncotarget, V9, P36273, DOI 10.18632/oncotarget.26345; Gonzalez-Bengtsson A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164241; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; He YF, 2019, ONCOGENE, V38, P2337, DOI 10.1038/s41388-018-0583-7; Imamov O, 2004, P NATL ACAD SCI USA, V101, P9375, DOI 10.1073/pnas.0403041101; Kabir NN, 2014, MOL BIOL REP, V41, P7729, DOI 10.1007/s11033-014-3684-6; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Liao GQ, 2003, J BIOL CHEM, V278, P5052, DOI 10.1074/jbc.M206374200; Liu JY, 2017, ONCOTARGET, V8, P50002, DOI 10.18632/oncotarget.18442; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mak P, 2013, P NATL ACAD SCI USA, V110, P4708, DOI 10.1073/pnas.1221654110; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Omoto Y, 2015, CANCER SCI, V106, P337, DOI 10.1111/cas.12613; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Sharma M, 2018, WORLD J GASTRO ENDOS, V10, P10, DOI 10.4253/wjge.v10.i1.10; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Weihua Zhang, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P6330, DOI 10.1073/pnas.111150898; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Wu WF, 2017, P NATL ACAD SCI USA, V114, pE3816, DOI 10.1073/pnas.1702211114; Zhou M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42313-8	31	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0226057	10.1371/journal.pone.0226057	http://dx.doi.org/10.1371/journal.pone.0226057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413024	Green Published, Green Submitted, gold			2022-12-26	WOS:000537496000001
J	Huang, CJ; Tseng, CL; Chen, HS; Hwu, CM; Tang, KT; Won, JGS; Shih, CW; Yeh, CC; Yang, CC; Wang, FF				Huang, Chun-Jui; Tseng, Chi-Lung; Chen, Harn-Shen; Hwu, Chii-Min; Tang, Kam-Tsun; Won, Justin Ging-Shing; Shih, Chiao-Wei; Yeh, Chang-Ching; Yang, Chen-Chang; Wang, Fan-Fen			Iodine nutritional status of pregnant women in an urban area of northern Taiwan in 2018	PLOS ONE			English	Article							AMERICAN THYROID ASSOCIATION; SIMPLE MICROPLATE METHOD; URINARY IODINE; DEFICIENCY; CHILDREN; OUTCOMES; CONSEQUENCES	Pregnant women are considered as one of the most vulnerable groups for iodine deficiency. The Nutrition and Health Survey in Taiwan 2013 revealed that the median urinary iodine concentration (UIC) of non-pregnant women of child-bearing age of 15-44 years was 124 mu g/L, which was adequate in general, but insufficient according to pregnancy criteria. The aim of this study was to determine the iodine nutritional status of pregnant women in an urban area of Northern Taiwan. A hospital-based cross-sectional survey was conducted in Taipei Veterans General Hospital. Random spot urine samples were collected from January to October, 2018 and UIC was determined by inductively coupled plasma mass-spectrometry. A food frequency questionnaire was also delivered to the participants. The overall median UIC was 225.3 mu g/L (IQR: 109.1-514.2 mu g/L) for 257 pregnant women ranging from 21-47 years-old. The distribution of UIC was as follows: 35.4% with UIC < 150 mu g/L, 17.1% with UIC within 150-249 mu g/L, 21.8% with UIC within 250-499 mu g/L, and 25.7% with UIC >= 500 mu g/L. The use of prenatal multivitamin was very common among the participants: 79.4% (n = 204) took multivitamin either every day or less frequently, with 52.5% (n = 135) taking one pill every day, and only 20.6% (n = 53) never took multivitamin during their pregnancy. Other commonly consumed iodine-containing foods were dairy products and fish. Our results indicate that the iodine status in the studied women is adequate. However, efforts are still needed to avoid iodine deficiency as well as iodine excess.	[Huang, Chun-Jui; Chen, Harn-Shen; Hwu, Chii-Min; Tang, Kam-Tsun; Won, Justin Ging-Shing; Shih, Chiao-Wei; Wang, Fan-Fen] Taipei Vet Gen Hosp, Dept Med, Div Endocrinol & Metab, Taipei, Taiwan; [Huang, Chun-Jui; Tseng, Chi-Lung; Chen, Harn-Shen; Hwu, Chii-Min; Tang, Kam-Tsun; Won, Justin Ging-Shing; Yang, Chen-Chang] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Huang, Chun-Jui; Yang, Chen-Chang] Natl Yang Ming Univ, Inst Publ Hlth, Sch Med, Taipei, Taiwan; [Tseng, Chi-Lung] Taoyuan Gen Hosp, Minist Hlth & Welf, Div Gastroenterol, Dept Internal Med, Taoyuan, Taiwan; [Tseng, Chi-Lung; Yeh, Chang-Ching] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Yeh, Chang-Ching] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Yeh, Chang-Ching] Natl Yang Ming Univ, Sch Med, Dept Obstet & Gynecol, Fac Med, Taipei, Taiwan; [Yang, Chen-Chang] Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei, Taiwan; [Yang, Chen-Chang] Taipei Vet Gen Hosp, Dept Med, Div Clin Toxicol & Occupat Med, Taipei, Taiwan; [Wang, Fan-Fen] Taipei City Hosp, Yangming Branch, Dept Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei City Hospital	Wang, FF (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Endocrinol & Metab, Taipei, Taiwan.; Wang, FF (corresponding author), Taipei City Hosp, Yangming Branch, Dept Med, Taipei, Taiwan.	doc1298d@yahoo.com.tw	Hwu, Chii-Min/AAZ-7384-2021	Huang, Chun-Jui/0000-0001-7353-3578; YEH, CHANG-CHING/0000-0003-0690-7503	Ministry of Science and Technology, Taiwan [MOST 107-2314-B-075-070, MOST 108-2314-B-075-010]; Taipei Veterans General Hospital [V108B-024, V109B-035]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This research was partially supported by research grants from the Ministry of Science and Technology, Taiwan, MOST 107-2314-B-075-070, MOST 108-2314-B-075-010 and from Taipei Veterans General Hospital, V108B-024, V109B-035 to CJH.	Aakre I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187241; Ainy E, 2007, CLIN ENDOCRINOL, V67, P577, DOI 10.1111/j.1365-2265.2007.02928.x; Alexander EK, 2017, THYROID, V27, P315, DOI 10.1089/thy.2016.0457; [Anonymous], 2007, ASS IOD DEF DIS MON; Bath SC, 2013, LANCET, V382, P331, DOI 10.1016/S0140-6736(13)60436-5; Bougma K, 2013, NUTRIENTS, V5, P1384, DOI 10.3390/nu5041384; Brander L, 2003, J ENDOCRINOL INVEST, V26, P389, DOI 10.1007/BF03345192; Caldwell KL, 2013, THYROID, V23, P927, DOI 10.1089/thy.2013.0012; Caldwell KL, 2003, CLIN CHEM, V49, P1019, DOI 10.1373/49.6.1019; Chen K P, 1976, Taiwan Yi Xue Hui Za Zhi, V75, P471; Chen W, 2018, AM J CLIN NUTR, V107, P780, DOI 10.1093/ajcn/nqy011; Chen W, 2015, CLIN ENDOCRINOL, V83, P399, DOI 10.1111/cen.12625; Chiou S.T., 2016, HLTH INEQUALITIES TA, P50; Department of Household Registration Affairs Ministry of the Interior Taiwan, TAIW POP DAT SHEET; FISHER DA, 1981, NEW ENGL J MED, V304, P702, DOI 10.1056/NEJM198103193041205; Fuse Y, 2011, J CLIN ENDOCR METAB, V96, P3846, DOI 10.1210/jc.2011-2180; Glinoer D, 2000, THYROID, V10, P871, DOI 10.1089/thy.2000.10.871; Gordon RC, 2009, AM J CLIN NUTR, V90, P1264, DOI 10.3945/ajcn.2009.28145; Huang CJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090520; Hynes KL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010172; Hynes KL, 2013, J CLIN ENDOCR METAB, V98, P1954, DOI 10.1210/jc.2012-4249; Iodine global network, 2015, TAIWAN RAISE IODINE; Katagiri R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173722; Kawaishi K HY, 1944, J FORMOS MED ASSOC, V43, P481; Leung AM, 2014, NAT REV ENDOCRINOL, V10, P136, DOI 10.1038/nrendo.2013.251; Ohashi T, 2000, CLIN CHEM, V46, P529; Patey-Pirra S, 2014, REV EPIDEMIOL SANTE, V62, P65, DOI 10.1016/j.respe.2013.08.004; Pearce EN, 2017, THYROID, V27, P137, DOI 10.1089/thy.2016.0678; Pearce EN, 2016, AM J CLIN NUTR, V104, p918S, DOI 10.3945/ajcn.115.110429; Pinheiro RL, 2019, ACTA MEDICA PORT, V32, P219, DOI 10.20344/amp.11057; Pino S, 1996, CLIN CHEM, V42, P239; Qian M, 2005, ASIA PAC J CLIN NUTR, V14, P32; Sang ZN, 2012, J CLIN ENDOCR METAB, V97, pE1363, DOI 10.1210/jc.2011-3438; Shaw NS, MYTH IODINE NUTR TAI; Shaw NS, 2012, DOH101FDA31410 MIN H; Shi XG, 2015, J CLIN ENDOCR METAB, V100, P1630, DOI 10.1210/jc.2014-3704; Stilwell G, 2008, J CLIN ENDOCR METAB, V93, P1737, DOI 10.1210/jc.2007-1715; Tang KT, 2016, J FORMOS MED ASSOC, V115, P645, DOI 10.1016/j.jfma.2015.06.014; Tang KT, 2015, THYROID, V25, P1173, DOI 10.1089/thy.2015.0184; Tang KT, 2014, ASIA PAC J CLIN NUTR, V23, P481, DOI 10.6133/apjcn.2014.23.3.20; THEODOROPOULOS T, 1979, SCIENCE, V205, P502, DOI 10.1126/science.451615; Trumpff C, 2013, J TRACE ELEM MED BIO, V27, P174, DOI 10.1016/j.jtemb.2013.01.002; Wang FF, 2018, FOOD NUTR BULL, V39, P75, DOI 10.1177/0379572117738883; WOLFF J, 1948, J BIOL CHEM, V174, P555; Won JGS, 2013, URINARY IODINE ANAL; Zimmermann MB, 2015, LANCET DIABETES ENDO, V3, P286, DOI 10.1016/S2213-8587(14)70225-6; Zimmermann MB, 2012, PAEDIATR PERINAT EP, V26, P108, DOI 10.1111/j.1365-3016.2012.01275.x	47	3	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233162	10.1371/journal.pone.0233162	http://dx.doi.org/10.1371/journal.pone.0233162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413050	Green Published, gold			2022-12-26	WOS:000537496000051
J	Jaouen, K; Trost, M; Bourgon, N; Colleter, R; Le Cabec, A; Tutken, T; Oliveira, RE; Pons, ML; Mejean, P; Steinbrenner, S; Chmeleff, J; Strauss, A				Jaouen, Klervia; Trost, Manuel; Bourgon, Nicolas; Colleter, Rozenn; Le Cabec, Adeline; Tutken, Thomas; Oliveira, Rodrigo Elias; Pons, Marie Laure; Mejean, Pauline; Steinbrenner, Sven; Chmeleff, Jerome; Strauss, Andre			Zinc isotope variations in archeological human teeth (Lapa do Santo, Brazil) reveal dietary transitions in childhood and no contamination from gloves	PLOS ONE			English	Article							TRACE-ELEMENT; ORAL-HEALTH; PREGNANCY; COPPER; ABSORPTION; LACTATION; PRODUCTS; RATIOS; IRON	Zinc (Zn) isotope ratios of dental enamel are a promising tracer for dietary reconstruction in archeology, but its use is still in its infancy. A recent study demonstrated a high risk of Zn contamination from nitrile, and latex gloves used during chemical sample preparation. Here we assess the potential impact of the use of such gloves during enamel sampling on the Zn isotope composition of teeth from a population of early Holocene hunter gatherers from Lapa do Santo, Lagoa Santa, Minas Gerais, Brazil. We first examined the amount of Zn and its isotopic composition released from the gloves used in this study by soaking them in weak nitric acid and water. We compared Zn isotope ratios obtained from teeth that were sampled wearing nitrile, latex or no gloves. Finally, we performed a linear mixed model (LMM) to investigate post hoc the relationship between the gloves used for sampling and the Zn isotope variability in dental enamel. We found that the gloves used in this study released a similar amount of Zn compared to previous work, but only in acidic solution. Zn isotope ratios of teeth and the LMM identified no sign of significant Zn coming from the gloves when teeth were handled for enamel sampling. We hypothesize that Zn in gloves is mostly released by contact with acids. We found that the main source of Zn isotope variability in the Lapa do Santo population was related to the developmental stage of the tooth tissues sampled. We report identical results for two individuals coming from a different archeological context. Tooth enamel formed in utero and/or during the two first years of life showed higher Zn isotope ratios than enamel formed after weaning. More work is required to systematically investigate if Zn isotopes can be used as a breastfeeding tracer.	[Jaouen, Klervia; Mejean, Pauline; Chmeleff, Jerome] CNRS, Geosci Environm Toulouse, Observ Midi Pyrenees, UMR 5563, Toulouse, France; [Jaouen, Klervia; Trost, Manuel; Bourgon, Nicolas; Le Cabec, Adeline; Steinbrenner, Sven] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Bourgon, Nicolas; Tutken, Thomas] Johannes Gutenberg Univ Mainz, AG Angew & Analyt Palaontol, Mainz, Germany; [Colleter, Rozenn] Natl Inst Prevent Archeol Res, Inrap, Cesson Sevigne, France; [Colleter, Rozenn] Univ Toulouse, CNRS, AMIS, UMR 5288, Toulouse, France; [Le Cabec, Adeline] Univ Bordeaux, UMR 5199, CNRS, PACEA, Pessac, France; [Oliveira, Rodrigo Elias] Univ Sao Paulo, Inst Biociencias, Lab Arqueol & Antropol Ambiental & Evolut, Sao Paulo, Brazil; [Pons, Marie Laure] Aix Marseille Univ, CEREGE, CNRS, IRD,INRAE,Coll France, Aix En Provence, France; [Strauss, Andre] Univ Sao Paulo, Museu Arqueol & Etnol, Sao Paulo, Brazil	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); Max Planck Society; Johannes Gutenberg University of Mainz; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Universidade de Sao Paulo	Jaouen, K (corresponding author), CNRS, Geosci Environm Toulouse, Observ Midi Pyrenees, UMR 5563, Toulouse, France.; Jaouen, K (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	Klervia.jaouen@get.omp.eu	Colleter, Rozenn/AAZ-6899-2021; Tütken, Thomas/E-4988-2010; LE CABEC, Adeline/I-1661-2019; Strauss, Andre/K-4089-2015	LE CABEC, Adeline/0000-0001-6948-4726; Mejean, Pauline/0000-0002-9114-9454; Colleter, Rozenn/0000-0003-2711-115X; Pons, Marie-Laure/0000-0001-5183-0424; Strauss, Andre/0000-0002-2336-1381; Tutken, Thomas/0000-0002-2590-8600	Max Planck Society; FAPESP [04/01321-6, 08/51747-0, 17/16451-2]; CNPQ [435980/2018-1]; DFG ("PALAODIET" project) [378496604]; MSCA [753059]; ERC ARCHEIS [803676]	Max Planck Society(Max Planck SocietyFoundation CELLEX); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DFG ("PALAODIET" project)(German Research Foundation (DFG)); MSCA; ERC ARCHEIS	Max Planck Society funded the cost of isotope analyses, and FAPESP (04/01321-6, 08/51747-0, 17/16451-2) and CNPQ (435980/2018-1) supported investigation at Lapa do Santo to AS. Salary support was provided to NB and MT by the DFG ("PALAODIET" project (378496604), to MLP by the MSCA (753059, SPECADIS), and to KJ and PM by the ERC ARCHEIS (Grant number: 803676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarede F, 2011, METALLOMICS, V3, P926, DOI 10.1039/c1mt00025j; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; Baayen RH, ANAL LINGUISTIC DATA, P200; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D., 2014, ARXIV14065823STAT; Bourgon N, 2020, P NATL ACAD SCI USA, V117, P4675, DOI 10.1073/pnas.1911744117; Bueno Lucas, 2017, ARCHAEOLOGICAL PALEO, P345, DOI [DOI 10.1007/978-3-319-57466-0, 10.1007/978-3-319-57466-0_16, DOI 10.1007/978-3-319-57466-0_16]; Colleter R, 2019, ARCHAEOL ANTHROP SCI, V11, P823, DOI 10.1007/s12520-017-0547-9; Costas-Rodriguez M, 2014, METALLOMICS, V6, P139, DOI 10.1039/c3mt00244f; Da-Gloria P, 2014, AM J PHYS ANTHROPOL, V154, P11, DOI 10.1002/ajpa.22467; Dolphin AE, 2005, AM J PHYS ANTHROPOL, V128, P878, DOI 10.1002/ajpa.20213; Dolphin AE, 2009, AM J PHYS ANTHROPOL, V140, P399, DOI 10.1002/ajpa.21068; Donangelo CM, 2005, AM J CLIN NUTR, V82, P118, DOI 10.1093/ajcn/82.1.118; Fatima T, 2016, J PAK MED ASSOC, V66, P1019; Feitosa SF, 2010, CAD SAUDE PUBLICA, V26, P853, DOI 10.1590/S0102-311X2010000500002; Field A, 2005, EXPLORATORY FACTOR A, P619; Fung EB, 1997, AM J CLIN NUTR, V66, P80, DOI 10.1093/ajcn/66.1.80; Garcon M, 2017, GEOSTAND GEOANAL RES, V41, P367, DOI 10.1111/ggr.12161; Hambidge KM, 2006, AM J CLIN NUTR, V84, P1102, DOI 10.1093/ajcn/84.5.1102; Hermenegildo T., 2009, THESIS; Horta BL, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-23; Jaouen K, 2019, METALLOMICS, V11, P1049, DOI 10.1039/c8mt00286j; Jaouen K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23249-x; Jaouen K, 2017, AM J PHYS ANTHROPOL, V162, P491, DOI 10.1002/ajpa.23132; Jaouen K, 2016, SCI REP-UK, V6, DOI 10.1038/srep26281; Jaouen K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152299; Jaouen K, 2013, EARTH PLANET SC LETT, V374, P164, DOI 10.1016/j.epsl.2013.05.037; Kalicanin B, 2016, BIOL TRACE ELEM RES, V170, P476, DOI 10.1007/s12011-015-0477-2; LeBlanc A, 1999, SCI TOTAL ENVIRON, V229, P121, DOI 10.1016/S0048-9697(99)00059-5; Lonnerdal B, 2000, J NUTR, V130, p1378S, DOI 10.1093/jn/130.5.1378S; LOUGH SA, 1963, P SOC EXP BIOL MED, V112, P631, DOI 10.3181/00379727-112-28124; Lu PJ, 2015, J FOOD DRUG ANAL, V23, P587, DOI 10.1016/j.jfda.2015.02.009; Marechal CN, 1999, CHEM GEOL, V156, P251, DOI 10.1016/S0009-2541(98)00191-0; Donangelo CM, 2012, NUTRIENTS, V4, P782, DOI 10.3390/nu4070782; McCullagh P, 1989, GEN LINEAR MODELS; Moynier F, 2006, GEOCHIM COSMOCHIM AC, V70, P6103, DOI 10.1016/j.gca.2006.02.030; Moynier F, 2017, REV MINERAL GEOCHEM, V82, P543, DOI 10.2138/rmg.2017.82.13; Neves WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032228; Ortega D., 2019, BOT MICROREMAINS LIT; Posth C, 2018, CELL, V175, P1185, DOI 10.1016/j.cell.2018.10.027; R Core Team, 2018, R LANG ENV STAT COMP, P14; SANDSTROM B, 1983, AM J DIS CHILD, V137, P726, DOI 10.1001/archpedi.1983.02140340010002; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Strauss A., 2017, ARCHAEOLOGICAL PALEO, P275; Strauss A, 2016, ANTIQUITY, V90, P1454, DOI 10.15184/aqy.2016.220; Strauss A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137456; Stuart-Macadam P., 2017, BREASTFEEDING BICULT; Tacail T, 2017, P NATL ACAD SCI USA, V114, P6268, DOI 10.1073/pnas.1704412114; Veile A, 2015, J HUM LACT, V31, P145, DOI 10.1177/0890334414557177; Villagran XS, 2017, J ARCHAEOL SCI, V77, P10, DOI 10.1016/j.jas.2016.07.008; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568	51	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232379	10.1371/journal.pone.0232379	http://dx.doi.org/10.1371/journal.pone.0232379			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0YZ	32407324	Green Published, gold			2022-12-26	WOS:000537490700020
J	Vender, M; Krivochen, DG; Compostella, A; Phillips, B; Delfitto, D; Saddy, D				Vender, Maria; Krivochen, Diego Gabriel; Compostella, Arianna; Phillips, Beth; Delfitto, Denis; Saddy, Douglas			Disentangling sequential from hierarchical learning in Artificial Grammar Learning: Evidence from a modified Simon Task	PLOS ONE			English	Article							LANGUAGE; COMBINATORICS; RECURSION	In this paper we probe the interaction between sequential and hierarchical learning by investigating implicit learning in a group of school-aged children. We administered a serial reaction time task, in the form of a modified Simon Task in which the stimuli were organised following the rules of two distinct artificial grammars, specifically Lindenmayer systems: the Fibonacci grammar (Fib) and the Skip grammar (a modification of the former). The choice of grammars is determined by the goal of this study, which is to investigate how sensitivity to structure emerges in the course of exposure to an input whose surface transitional properties (by hypothesis) bootstrap structure. The studies conducted to date have been mainly designed to investigate low-level superficial regularities, learnable in purely statistical terms, whereas hierarchical learning has not been effectively investigated yet. The possibility to directly pinpoint the interplay between sequential and hierarchical learning is instead at the core of our study: we presented children with two grammars, Fib and Skip, which share the same transitional regularities, thus providing identical opportunities for sequential learning, while crucially differing in their hierarchical structure. More particularly, there are specific points in the sequence (k-points), which, despite giving rise to the same transitional regularities in the two grammars, support hierarchical reconstruction in Fib but not in Skip. In our protocol, children were simply asked to perform a traditional Simon Task, and they were completely unaware of the real purposes of the task. Results indicate that sequential learning occurred in both grammars, as shown by the decrease in reaction times throughout the task, while differences were found in the sensitivity to k-points: these, we contend, play a role in hierarchical reconstruction in Fib, whereas they are devoid of structural significance in Skip. More particularly, we found that children were faster in correspondence to k-points in sequences produced by Fib, thus providing an entirely new kind of evidence for the hypothesis that implicit learning involves an early activation of strategies of hierarchical reconstruction, based on a straightforward interplay with the statistically-based computation of transitional regularities on the sequences of symbols.	[Vender, Maria; Krivochen, Diego Gabriel; Compostella, Arianna; Delfitto, Denis] Univ Verona, Dept Cultures & Civilizat, Verona, Italy; [Phillips, Beth; Saddy, Douglas] Univ Reading, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England	University of Verona; University of Reading	Vender, M (corresponding author), Univ Verona, Dept Cultures & Civilizat, Verona, Italy.	maria.vender@univr.it		Saddy, Doug/0000-0001-8501-6076	European Union's Seventh Framework Programme for research, technological development, and demonstration [613465]	European Union's Seventh Framework Programme for research, technological development, and demonstration	research leading to these results has received funding from the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 613465.	Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Belacchi C., 2008, STANDARDIZZAZIONE IT; Chomsky N., 1957, SYNTACTIC STRUCTURES; Chomsky Noam, 1959, INFORM CONTR, V2, DOI [10.1016/S0019-9958(59)90362-6, DOI 10.1016/S0019-9958(59)90362-6]; Christiansen MH, 2012, LANG COGNITIVE PROC, V27, P231, DOI 10.1080/01690965.2011.606666; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Corballis MC, 2007, COGNITIVE SCI, V31, P697, DOI 10.1080/15326900701399947; Daland R, 2011, COGNITIVE SCI, V35, P119, DOI 10.1111/j.1551-6709.2010.01160.x; de Vries MH, 2008, COGNITION, V107, P763, DOI 10.1016/j.cognition.2007.09.002; DIENES Z, 1995, J EXP PSYCHOL LEARN, V21, P1322, DOI 10.1037/0278-7393.21.5.1322; Embick D, 2015, LANG COGN NEUROSCI, V30, P357, DOI 10.1080/23273798.2014.980750; Fitch WT, 2012, PHILOS T R SOC B, V367, P1933, DOI 10.1098/rstb.2012.0103; Fossum V, 2012, P 3 WORKSHOP COGNITI, P61; Frank SL, 2011, PSYCHOL SCI, V22, P829, DOI 10.1177/0956797611409589; GAZDAR G, 1981, LINGUIST INQ, V12, P155; Goldberg N., 2014, THESIS; GREIBACH SA, 1965, J ACM, V12, P42, DOI 10.1145/321250.321254; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hopcroft J.E., 1969, FORMAL LANGUAGES THE; Idsardi WJ, 2009, BIOLINGUISTICS, V3, P404; Idsardi WJ, 2008, BIOLINGUISTICS, V2, P233; KLEIN D, 2001, P 5 C NAT LANG LEARN, P113; Krivochen D., 2019, COMMUNICATION, DOI [10.13140/RG.2.2.29942.96320, DOI 10.13140/RG.2.2.29942.96320]; Krivochen DG, 2018, MODEL LINDENMAYER RE; Krivochen DG, 2018, CLASSIFICATION LINDE; Krivochen DG, 2018, CLASSIFYING POINTS L, DOI [10.13140/RG.2.2.25719.88484, DOI 10.13140/RG.2.2.25719.88484]; LANGENDOEN DT, 1975, LINGUIST INQ, V6, P533; Lasnik H., 2011, BIOLINGUISTIC ENTERP, P354; LINDENMAYER A, 1968, J THEOR BIOL, V18, P280, DOI 10.1016/0022-5193(68)90079-9; Lobina DJ, 2011, LANG COGNITIVE PROC, V26, P1563, DOI 10.1080/01690965.2011.560006; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; Martins MD, 2012, PHILOS T R SOC B, V367, P2055, DOI 10.1098/rstb.2012.0097; McCawley J., 1978, CLS, V4, P71; Medeiros DP, 2018, LANGUAGE, SYNTAX, AND THE NATURAL SCIENCES, P333; Medeiros DP, 2008, BIOLINGUISTICS, V2, P152; Misyak JB, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00031; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Oseki Y., 2019, P WORKSH COGN MOD CO, P43, DOI [10.18653/v1/W19-2905, DOI 10.18653/V1/W19-2905]; Piattelli-Palmarini M, 2008, PHYS LIFE REV, V5, P207, DOI 10.1016/j.plrev.2008.07.002; Post EL, 1943, AM J MATH, V65, P197, DOI 10.2307/2371809; Pothos EM, 2007, PSYCHOL BULL, V133, P227, DOI 10.1037/0033-2909.133.2.227; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; Rohrmeier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045885; Rozenberg G., 1980, MATH THEORY L SYSTEM; Saddy D., 2019, STRUCTURE CONSTITUEN; Saddy D., 2010, COMMUNICATION; Saddy D., 2009, REC STRUCT COMPL LAN; Saddy D, 2018, LANGUAGE, SYNTAX, AND THE NATURAL SCIENCES, P316; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Schiel F., 2011, NEW TOOLS METH VER L; SHIEBER SM, 1985, LINGUIST PHILOS, V8, P333, DOI 10.1007/BF00630917; Shirley EJ, 2014, THESIS; Solan Z, 2005, P NATL ACAD SCI USA, V102, P11629, DOI 10.1073/pnas.0409746102; Uriagereka J., 2012, SPELL OUT MINIMALIST; Uriagereka Juan, 1998, RHYME REASON INTRO M; Vender M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01647; Virpioja S, 2018, COGNITIVE SCI, V42, P939, DOI 10.1111/cogs.12576; Vitanyi PMB, 1978, LINDENMAYER SYSTEMS	59	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232687	10.1371/journal.pone.0232687	http://dx.doi.org/10.1371/journal.pone.0232687			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407332	Green Published, Green Accepted, gold			2022-12-26	WOS:000537490700031
J	Ali, OG; Ghanem, AN; Ustun, B				Ali, Ozden Gur; Ghanem, Angi Nazih; Ustun, Bedirhan			Estimating the potential impact of behavioral public health interventions nationally while maintaining agreement with global patterns on relative risks	PLOS ONE			English	Article							LIFE-YEARS DALYS; SYSTEMATIC ANALYSIS; VEGETABLE CONSUMPTION; DIABETES-MELLITUS; PHYSICAL-ACTIVITY; DISEASE; BURDEN; FRUIT; WORLDWIDE; INJURIES	Objective This paper introduces a novel method to evaluate the local impact of behavioral scenarios on disease prevalence and burden with representative individual level data while ensuring that the model is in agreement with the qualitative patterns of global relative risk (RR) estimates. The method is used to estimate the impact of behavioral scenarios on the burden of disease due to ischemic heart disease (IHD) and diabetes in the Turkish adult population. Methods Disease specific Hierarchical Bayes (HB) models estimate the individual disease probability as a function of behaviors, demographics, socio-economics and other controls, where constraints are specified based on the global RR estimates. The simulator combines the counterfactual disease probability estimates with disability adjusted life year (DALY)-perprevalent-case estimates and rolls up to the targeted population level, thus reflecting the local joint distribution of exposures. The Global Burden of Disease (GBD) 2016 study meta-analysis results guide the analysis of the Turkish National Health Surveys (2008 to 2016) that contain more than 90 thousand observations. Findings The proposed Qualitative Informative HB models do not sacrifice predictive accuracy versus benchmarks (logistic regression and HB models with non-informative and numerical informative priors) while agreeing with the global patterns. In the Turkish adult population, Increasing Physical Activity reduces the DALYs substantially for both IHD by 8.6% (6.4% 11.2%), and Diabetes by 8.1% (5.8% 10.6%), (90% uncertainty intervals). Eliminating Smoking and Second-hand Smoke predominantly decreases the IHD burden 13.1% (10.4% 15.8%) versus Diabetes 2.8% (1.1% 4.6%). Increasing Fruit and Vegetable Consumption, on the other hand, reduces IHD DALYs by 4.1% (2.8% 5.4%) while not improving the Diabetes burden 0.1% (0% 0.1%). Conclusion While the national RR estimates are in qualitative agreement with the global patterns, the scenario impact estimates are markedly different than the attributable risk estimates from the GBD analysis and allow evaluation of practical scenarios with multiple behaviors.	[Ali, Ozden Gur] Koc Univ, Coll Adm Sci & Econ, Istanbul, Turkey; [Ghanem, Angi Nazih] Koc Univ, Coll Engn, Istanbul, Turkey; [Ustun, Bedirhan] Koc Univ, Sch Med, Istanbul, Turkey	Koc University; Koc University; Koc University	Ali, OG (corresponding author), Koc Univ, Coll Adm Sci & Econ, Istanbul, Turkey.	oal@ku.edu.tr	Ali, Ozden F Gur/B-3364-2013	Ali, Ozden F Gur/0000-0002-9409-4532				[Anonymous], 2013, TEXTS STAT SCI SERIE; [Anonymous], 2008, DAT US GUID BRFSS PH; Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.85; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ford ES, 2001, PREV MED, V32, P33, DOI 10.1006/pmed.2000.0772; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gorski MT, 2015, J HEALTHC LEADERSH, V7, P81, DOI 10.2147/JHL.S69188; Hackshaw A, 2018, BMJ-BRIT MED J, V360, DOI [10.1136/bmj.j5855, 10.1136/bmj.k1611]; Harding AH, 2008, ARCH INTERN MED, V168, P1493, DOI 10.1001/archinte.168.14.1493; Hastie T., 2009, UNSUPERVISED LEARNIN; Hill LD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186834; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Klijs B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-378; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Melaku YA, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0447-x; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Otto MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151503; Plummer M, 2013, RJAGS BAYESIAN GRAPH, V3; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Satman I, 2013, EUR J EPIDEMIOL, V28, P169, DOI 10.1007/s10654-013-9771-5; Schroders J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179186; Soares-Miranda L, 2016, CIRCULATION, V133, P147, DOI 10.1161/CIRCULATIONAHA.115.018323; Villegas R, 2008, J NUTR, V138, P574, DOI 10.1093/jn/138.3.574; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; Wang YC, 2012, HEALTH AFFAIR, V31, P199, DOI 10.1377/hlthaff.2011.0410; WHO, 2018, LEG BAC LIM COUNTR; World Health Organization, 2018, GLOB BURD DIS 2004 U; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zimmerman E.B., 2015, POPULATION HLTH BEHA, P347	38	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232951	10.1371/journal.pone.0232951	http://dx.doi.org/10.1371/journal.pone.0232951			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401782	gold, Green Published			2022-12-26	WOS:000537481000042
J	Ng, SSM; Liu, TW; Kwong, PWH; Choy, HM; Fong, TYK; Lee, JYC; Tan, YL; Tong, GYH; Wong, CCY; Lai, CYY; Tse, MMY				Ng, Shamay S. M.; Liu, Tai-Wa; Kwong, Patrick W. H.; Choy, Ho-Man; Fong, Terence Y. K.; Lee, Justine Y. C.; Tan, Yi-Li; Tong, Gary Y. H.; Wong, Crystal C. Y.; Lai, Cynthia Y. Y.; Tse, Mimi M. Y.			Psychometric testing of the Fall Risks for Older People in the Community screening tool (FROP-Com screen) for community-dwelling people with stroke	PLOS ONE			English	Article							BALANCE; RELIABILITY; FEAR	Objective The Falls Risk for Older People in the Community assessment (FROP-Com) was originally developed using 13 risk factors to identify the fall risks of community-dwelling older people. To suit the practical use in busy clinical settings, a brief version adopting 3 most fall predictive risk factors from the original FROP-Com, including the number of falls in the past 12 months, assistance required to perform domestic activities of daily living and observation of balance, was developed for screening purpose (FROP-Com screen). The objectives of this study were to investigate the inter-rater and test-retest reliability, concurrent and convergent validity, and minimum detectable change of the FROP-Com screen in community-dwelling people with stroke. Participants Community-dwelling people with stroke (n = 48) were recruited from a local self-help group, and community-dwelling older people (n = 40) were recruited as control subjects. Results The FROP-Com screen exhibited moderate inter-rater (Intraclass correlation coefficient [ICC](2,1) = 0.79, 95% confidence interval [CI]: 0.65-0.87) and test-retest reliability (ICC3,1 = 0.70, 95% CI: 0.46-0.83) and weak associations with two balance measures, the Berg Balance Scale (BBS) (rho = -0.38, p = 0.008) and the Timed "Up & Go" (TUG) test (rho = 0.35, p = 0.016). The screen also exhibited a moderate association with the Chinese version of the Activities-specific Balance Confidence Scale (ABC-C) (ABC-C; rho = -0.65, p < 0.001), a measure of subjective balance confidence. Conclusions The FROP-Com screen is a reliable clinical tool with convergent validity paralleled with subjective balance confidence measure that can be used in fall risk screening of communitydwelling people with stroke. However, one individual item, the observation of balance, will require additional refinement to improve the potential measurement error.	[Ng, Shamay S. M.; Liu, Tai-Wa; Choy, Ho-Man; Fong, Terence Y. K.; Lee, Justine Y. C.; Tan, Yi-Li; Tong, Gary Y. H.; Wong, Crystal C. Y.; Lai, Cynthia Y. Y.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Hong Kong, Peoples R China; [Liu, Tai-Wa] Open Univ Hong Kong, Sch Nursing & Hlth Studies, Ho Man Tin, Hong Kong, Peoples R China; [Kwong, Patrick W. H.] Nanyang Technol Univ, Rehabil Res Inst Singapore, Singapore, Singapore; [Tse, Mimi M. Y.] Hong Kong Polytech Univ, Sch Nursing, Hung Hom, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Metropolitan University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Hong Kong Polytechnic University	Ng, SSM (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Hong Kong, Peoples R China.	Shamay.Ng@polyu.edu.hk	Kwong, Wai Hang/AAZ-5331-2020; Kwong, Patrick W.H./AAY-2084-2020	Kwong, Wai Hang/0000-0002-1834-5715; Kwong, Patrick W.H./0000-0002-1834-5715; Liu, Tai Wa/0000-0002-7860-8089	Research Grants Council, Hong Kong [15101217]	Research Grants Council, Hong Kong(Hong Kong Research Grants Council)	This study was supported by the General Research Fund (Ref: 15101217) from the Research Grants Council, Hong Kong, to Prof. Shamay Ng and her team.	Au-Yeung SSY, 2009, NEUROREHAB NEURAL RE, V23, P515, DOI 10.1177/1545968308326425; BERG K, 1989, Physiotherapy Canada, V41, P304; Chu L. W., 1995, Hong Kong Medical Journal, V1, P207; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Fix A, 1988, PROFESSIONAL MANUAL; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Flansbjer UB, 2012, PM&R, V4, P165, DOI 10.1016/j.pmrj.2011.11.004; FORSTER A, 1995, BRIT MED J, V311, P83, DOI 10.1136/bmj.311.6997.83; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hill KD, 1996, ARCH PHYS MED REHAB, V77, P1025, DOI 10.1016/S0003-9993(96)90063-5; Hyndman D, 2002, ARCH PHYS MED REHAB, V83, P165, DOI 10.1053/apmr.2002.28030; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Liu TW, 2015, ARCH PHYS MED REHAB, V96, P1684, DOI 10.1016/j.apmr.2015.05.005; Mak MK, 2007, ARCH PHYS MED REHAB, V88, P496, DOI 10.1016/j.apmr.2007.01.018; Mao HF, 2002, STROKE, V33, P1022, DOI 10.1161/01.STR.0000012516.63191.C5; NYBERG L, 1995, STROKE, V26, P838, DOI 10.1161/01.STR.26.5.838; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Russell MA, 2008, AGE AGEING, V37, P634, DOI 10.1093/ageing/afn129; Russell MA, 2009, AGE AGEING, V38, P40, DOI 10.1093/ageing/afn196; Stevenson TJ, 2001, AUST J PHYSIOTHER, V47, P29, DOI 10.1016/S0004-9514(14)60296-8; Sze KH, 2001, ARCH PHYS MED REHAB, V82, P1219, DOI 10.1053/apmr.2001.25094; Viera AJ, 2005, FAM MED, V37, P360; World Health Organization, 2008, WHO GLOB REP FALL PR	23	1	1	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0233045	10.1371/journal.pone.0233045	http://dx.doi.org/10.1371/journal.pone.0233045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401819	Green Published, gold			2022-12-26	WOS:000537481000051
J	Walker, CL; Ehinger, N; Mason, B; Oler, E; Little, MTE; Ohuma, EO; Papageorghiou, AT; Nayeri, U; Curry, C; Waldorf, KMA				Walker, Christie L.; Ehinger, Noah; Mason, Brittney; Oler, Elizabeth; Little, Marie-Terese E.; Ohuma, Eric O.; Papageorghiou, Aris T.; Nayeri, Unzila; Curry, Christine; Waldorf, Kristina M. Adams			Ultrasound prediction of Zika virus-associated congenital injury using the profile of fetal growth	PLOS ONE			English	Article							INFECTION; INFANTS; OUTCOMES; PREGNANCY; BIRTH; WOMEN; BORN	Zika virus (ZIKV) is a mosquito-transmitted flavivirus, recently linked to microcephaly and central nervous system anomalies following infection in pregnancy. Striking findings of disproportionate growth with a smaller than expected head relative to body length have been observed more commonly among fetuses with exposure to ZIKV in utero compared to pregnancies without ZIKV infection regardless of other signs of congenital infection including microcephaly. This study's objective was to determine the diagnostic accuracy of femursparing profile of intrauterine growth restriction for the identification of ZIKV-associated congenital injuries on postnatal testing. A retrospective cohort study of pregnant women with possible or confirmed ZIKV infection between January 1, 2016 and December 31, 2017 were included. Subjects were excluded if no prenatal ultrasound was available. A femursparing profile of growth restriction determined using INTERGROWTH-21st sonographic standard for head circumference to femur length (HC: FL). Congenital injuries were determined postnatally by imaging, comprehensive eye exam and standard newborn hearing screen. A total of 111 pregnant women diagnosed with ZIKV infection underwent fetal ultrasound and 95 neonates had complete postnatal evaluation. Prenatal microcephaly was detected in 5% of fetuses (6/111). Postnatal testing detected ZIKV-associated congenital injuries in 25% of neonates (24/95). A HC: FL Z-score <=-1.3 had a 52% specificity (95% CI 41-63%), 82% negative predictive value (NPV, 95% CI 73-88%) for the detection of ZIKV-associated congenital injuries in the neonatal period. A more stringent threshold with a Z-score <=-2 was associated with a 90% specificity (95% CI 81-95%), 81% NPV (95% CI 77-85%). Excluding cases of fetal microcephaly, HC: FL (Z-score <=-2) demonstrated a similar specificity (89%, 95% CI 81-95%) with superior NPV (87%, 95% CI 84-90%). The sono-graphic recognition of a normally proportioned fetus may be useful prenatally to exclude a wider spectrum of ZIKV-associated congenital injuries detected postnatally.	[Walker, Christie L.; Oler, Elizabeth] Univ Washington, Dept Obstet & Gynecol, Div Maternal Fetal Med, Seattle, WA 98195 USA; [Ehinger, Noah; Mason, Brittney; Curry, Christine] Univ Miami Hlth Syst, Dept Obstet & Gynecol, Miami, FL USA; [Little, Marie-Terese E.] 4th Dimens Biomed Res Commun, Victoria, BC, Canada; [Ohuma, Eric O.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Ohuma, Eric O.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Papageorghiou, Aris T.] Univ Oxford, Green Templeton Coll, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Papageorghiou, Aris T.] Univ Oxford, Green Templeton Coll, Oxford Maternal & Perinatal Hlth Inst, Oxford, England; [Nayeri, Unzila] Univ Miami Hlth Syst, Dept Obstet & Gynecol, Div Maternal Fetal Med, Miami, FL USA; [Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Waldorf, Kristina M. Adams] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Waldorf, Kristina M. Adams] Gothenburg Univ, Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden	University of Washington; University of Washington Seattle; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Gothenburg	Curry, C (corresponding author), Univ Miami Hlth Syst, Dept Obstet & Gynecol, Miami, FL USA.; Nayeri, U (corresponding author), Univ Miami Hlth Syst, Dept Obstet & Gynecol, Div Maternal Fetal Med, Miami, FL USA.; Waldorf, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Waldorf, KMA (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Waldorf, KMA (corresponding author), Gothenburg Univ, Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.	unzilanayeri@gmail.com; clcurry@gmail.com; adamsk@uw.edu	Adams Waldorf, Kristina/F-2608-2013	Adams Waldorf, Kristina/0000-0002-6939-7224; Papageorghiou, Aris T./0000-0001-8143-2232	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; National Center for Research Resources of the National Institutes of Health [AI143265, AI144938]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Allergy and Infectious Diseases and the National Center for Research Resources of the National Institutes of Health [grant numbers AI143265 (K.A. W) and AI144938 (K.A.W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Waldorf KM, 2018, TRENDS MICROBIOL; Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1; [Anonymous], 2017, INTERGROWTH 21 APPL; Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cauchemez S, 2016, LANCET; Centers for Disease Control and Prevention, 2017, GUID LAB TEST ZIK VI; Chibueze EC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01991-y; Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720; de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584; Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450; Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Louis GMB, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.032; da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956; Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012; Mulkey SB, 2018, JAMA PEDIAT; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Pereira JP, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6529; Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1; Sanz Cortes M, 2018, AM J OBSTET GYNECOLO; Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2; Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1; Shiu C, 2018, EMERG INFECT DIS, V24, P1, DOI 10.3201/eid2401.170979; Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043; van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2; Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901; Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047; 2002, INT J GYNECOL OBSTET, V76, P95	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0233023	10.1371/journal.pone.0233023	http://dx.doi.org/10.1371/journal.pone.0233023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401826	Green Published, Green Accepted, gold			2022-12-26	WOS:000537481000048
J	Sharma, N; Lavania, M; Kukreti, V; Lal, B				Sharma, Neha; Lavania, Meeta; Kukreti, Vipin; Lal, Banwari			Instigation of indigenous thermophilic bacterial consortia for enhanced oil recovery from high temperature oil reservoirs	PLOS ONE			English	Article							BIOSURFACTANT PRODUCTION	The purpose of the study involves the development of an anaerobic, thermophilic microbial consortium TERIK from the high temperature reservoir of Gujarat for enhance oil recovery. To isolate indigenous microbial consortia, anaerobic baltch media were prepared and inoculated with the formation water; incubated at 65 degrees C for 10 days. Further, the microbial metabolites were analyzed by gas chromatography, FTIR and surface tension. The efficiency of isolated consortia towards enhancing oil recovery was analyzed through core flood assay. The novelty of studied consortia was that, it produces biomass (600 mg/l), bio-surfactant (325 mg/l), and volatile fatty acids (250 mg/l) at 65 degrees C in the span of 10 days, that are adequate to alter the surface tension (70 to 34 mNm(-1) ) and sweep efficiency of zones facilitating the displacement of oil. TERIK was identified as Clostridium sp. The FTIR spectra of biosurfactant indicate the presence of N-H stretch, amides and polysaccharide. A core flooding assay was designed to explore the potential of TERIK towards enhancing oil recovery. The results showed an effective reduction in permeability at residual oil saturation from 2.14 +/- 0.1 to 1.39 +/- 0.05 mD and 19% incremental oil recovery.	[Sharma, Neha; Lavania, Meeta; Lal, Banwari] Energy & Resources Inst, Microbial Biotechnol Div, New Delhi, India; [Kukreti, Vipin] Inst Reservoir Studies Oil & Nat Gas Corp Ltd, Ahmadabad, Gujarat, India	TERI University; Oil & Natural Gas Corporation	Lavania, M (corresponding author), Energy & Resources Inst, Microbial Biotechnol Div, New Delhi, India.	meetal@teri.res.in		LAVANIA, MEETA/0000-0002-2313-6408	The Institute of Reservoir Studies Oil and Natural Gas Corporation Limited (IRS-ONGC)	The Institute of Reservoir Studies Oil and Natural Gas Corporation Limited (IRS-ONGC)	The Institute of Reservoir Studies Oil and Natural Gas Corporation Limited (IRS-ONGC) provided support in the form of a salary for VK. The present study was conducted under a collaborating Research project where samples were collected jointly by Institute of Reservoir Studies Oil and Natural Gas Corporation Limited (IRS-ONGC) & The Energy and Resources Institute (TERI) from the Gujarat oil reservoir. IRS-ONGC also provided support in data collection and/or in core flood data analysis in the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Adelzadeh MR, 2010, SCI IRAN TRANS C, V17, P46; Al-Sulaimani H., 2011, BIOTECHNOL BIOINFORM, V1, P147; Balogun FO, 2015, S AFR J BOT, V98, P170, DOI 10.1016/j.sajb.2015.03.014; Basera P, 2019, RSC ADV, V9, P17040, DOI 10.1039/c9ra01959f; Braun F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125552; Brown LR, 2010, CURR OPIN MICROBIOL, V13, P316, DOI 10.1016/j.mib.2010.01.011; Coty VF, 1983, P INT C MICR ENH OIL; De S, 2015, RSC ADV, V5, P65757, DOI 10.1039/c5ra11101c; Donio MBS, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-149; Gao CH, 2018, J PETROL SCI ENG, V166, P55, DOI 10.1016/j.petrol.2018.03.037; Ghojavand H, 2008, APPL MICROBIOL BIOT, V80, P1073, DOI 10.1007/s00253-008-1570-7; Gonzalez-Gil G, 2003, BIOTECHNOL BIOENG, V82, P134, DOI 10.1002/bit.10551; Gray MR, 2008, ANN TECHN C; Gudina EJ, 2013, J HAZARD MATER, V261, P106, DOI 10.1016/j.jhazmat.2013.06.071; Guyton A.C., 2006, TXB MED PHYSL; Hosseininoosheri P, 2016, FUEL, V183, P501, DOI 10.1016/j.fuel.2016.06.035; Jimoh IA, 2012, GSTF INT J BIOSCIENC, V1; Ketuly KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059296; Ku YH, 2011, J PETROL SCI ENG, V78, P233, DOI 10.1016/j.petrol.2011.06.005; Lavania M, 2015, FUEL, V144, P349, DOI 10.1016/j.fuel.2014.12.003; Lazar I, 2007, PETROL SCI TECHNOL, V25, P1353, DOI 10.1080/10916460701287714; Lenchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066588; Liu JF, 2005, J PETROL SCI ENG, V48, P265, DOI 10.1016/j.petrol.2005.06.008; Maneerat S., 2007, SONGKLANAKARIN J SCI, V29, P781; McInerney MJ, 2005, PETROLEUM MICROBIOLOGY, P215; Nagalakshmi T, 2014, INDIAN J SCI TECHN S, V7, P68; Olorunnisola O. S., 2012, African Journal of Biotechnology, V11, P14934; Patowary K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00279; Phetcharat T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198050; Plaire D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177112; Pornsunthorntawee O, 2008, BIORESOURCE TECHNOL, V99, P1589, DOI 10.1016/j.biortech.2007.04.020; Pu SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190236; Putra AD, 2019, J GYNECOL SURG, V35, P272, DOI 10.1089/gyn.2019.0011; Rathi R, 2015, RSC ADV, V5, P88115, DOI 10.1039/c5ra10489k; Sharma N., 2017, ANN PHARM PHARM, V2, P1058; Sharma N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02357; She YH, 2011, APPL BIOCHEM BIOTECH, V163, P223, DOI 10.1007/s12010-010-9032-y; Shibulal B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171432; Shibulal B, 2014, SCI WORLD J, DOI 10.1155/2014/309159; Stephens JO, 2000, UTILIZATION MICROFLO; Suthar H, 2008, J MICROBIOL METH, V75, P225, DOI 10.1016/j.mimet.2008.06.007; Suthar H, 2009, J MICROBIOL BIOTECHN, V19, P1230, DOI 10.4014/jmb.0904.04043; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033535; Vanavil B, 2013, J MICROBIOL BIOTECHN, V23, P1229, DOI 10.4014/jmb.1212.12031; Varjani S.J., 2014, INT J INNOV RES SCI, V3, P9205; Varjani SJ, 2014, THESIS; Vasconcellos SP, 2011, WORLD J MICROB BIOT, V27, P1513, DOI 10.1007/s11274-010-0581-6; [王登庆 WANG Deng-qing], 2009, [中国石油大学学报. 自然科学版, Journal of China University of Petroleum. Edition of Natrual Science], V33, P114; Yakubu M. T., 2007, Pharmacognosy Magazine, V3, P34; Yakubu MT, 2003, NIG J PURE APPL SCI, V13, P1395; Yan P, 2012, BIORESOURCE TECHNOL, V116, P24, DOI 10.1016/j.biortech.2012.04.024; Youssef N, 2007, APPL ENVIRON MICROB, V73, P1239, DOI 10.1128/AEM.02264-06	53	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0229889	10.1371/journal.pone.0229889	http://dx.doi.org/10.1371/journal.pone.0229889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396555	Green Published, gold			2022-12-26	WOS:000537475000005
J	Talwar, N; Churchill, NW; Hird, MA; Tam, F; Graham, SJ; Schweizer, TA				Talwar, Natasha; Churchill, Nathan W.; Hird, Megan A.; Tam, Fred; Graham, Simon J.; Schweizer, Tom A.			Functional magnetic resonance imaging of the trail-making test in older adults	PLOS ONE			English	Article							TEMPORAL-LOBE ATROPHY; BLOOD-FLOW ACTIVATION; AGE-RELATED-CHANGES; COGNITIVE IMPAIRMENT; NORMATIVE DATA; ALZHEIMERS-DISEASE; NEURAL EFFICIENCY; ELDERLY ADULTS; VISUAL-SEARCH; BRAIN CHANGES	The trail-making test (TMT) is a popular neuropsychological test, which is used extensively to measure cognitive impairment associated with neurodegenerative disorders in older adults. Behavioural performance on the TMT has been investigated in older populations, but there is limited research on task-related brain activity in older adults. The current study administered a naturalistic version of the TMT to a healthy older-aged population in an MRI environment using a novel, MRI-compatible tablet. Functional MRI was conducted during task completion, allowing characterization of the brain activity associated with the TMT. Performance on the TMT was evaluated using number of errors and seconds per completion of each link. Results are reported for 36 cognitively healthy older adults between the ages of 52 and 85. Task-related activation was observed in extensive regions of the bilateral frontal, parietal, temporal and occipital lobes as well as key motor areas. Increased age was associated with reduced brain activity and worse task performance. Specifically, older age was correlated with decreased task-related activity in the bilateral occipital, temporal and parietal lobes. These results suggest that healthy older aging significantly affects brain function during the TMT, which consequently may result in performance decrements. The current study reveals the brain activation patterns underlying TMT performance in a healthy older aging population, which functions as an important, clinically-relevant control to compare to pathological aging in future investigations.	[Talwar, Natasha; Churchill, Nathan W.; Hird, Megan A.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Tam, Fred; Graham, Simon J.] Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Fac Med, Toronto, ON, Canada; [Schweizer, Tom A.] St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Schweizer, TA (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.; Schweizer, TA (corresponding author), St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada.	Tom.Schweizer@unityhealth.to		Graham, Simon/0000-0002-9647-6569	Ministry of Transportation Ontario through the Road Safety Community Partnership Program; Alzheimer's Association Research Grant [AARG-16-442685]	Ministry of Transportation Ontario through the Road Safety Community Partnership Program; Alzheimer's Association Research Grant	The work completed in the current study was supported by funding provided to T.A.S. from the Ministry of Transportation Ontario through the Road Safety Community Partnership Program (https://www.ontario.ca/page/ministrytransportation) and an Alzheimer's Association Research Grant (AARG-16-442685) (https://www.alz.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2011, BEHAV NEUROL, V24, P159, DOI [10.3233/BEN-2011-0278, 10.1155/2011/476893]; Amieva H, 1998, J CLIN EXP NEUROPSYC, V20, P280, DOI 10.1076/jcen.20.2.280.1161; Ashendorf L, 2008, ARCH CLIN NEUROPSYCH, V23, P129, DOI 10.1016/j.acn.2007.11.005; Bastos-Leite AJ, 2007, STROKE, V38, P3182, DOI 10.1161/STROKEAHA.107.490102; Beckham JC, 1998, J TRAUMA STRESS, V11, P811, DOI 10.1023/A:1024409903617; Bellebaum C, 2007, CEREBELLUM, V6, P184, DOI 10.1080/14734220601169707; Bolcekova E, 2017, BIOMED CENTRAL, V4, P13; Bossers WJR, 2012, DEMENT GER COGN D EX, V2, P589, DOI 10.1159/000345038; Burton EJ, 2009, BRAIN, V132, P195, DOI 10.1093/brain/awn298; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Campbell KL, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00073; Chan D, 2001, ANN NEUROL, V49, P433, DOI 10.1002/ana.92.abs; CHARLOT V, 1992, NEUROPSYCHOLOGIA, V30, P565, DOI 10.1016/0028-3932(92)90059-U; Churchill NW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131520; Churchill NW, 2013, NEUROIMAGE, V82, P306, DOI 10.1016/j.neuroimage.2013.05.102; Churchill NW, 2017, OPTIMIZING FMRI PREP, DOI [10.1016/j.neuroimage.2017.02.028, DOI 10.1016/J.NEUROIMAGE.2017.02.028]; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; Deng ID, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00097; Dennis NA, HDB AGING COGN; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; Elias MF, 2011, EXP AGING RES, V37, P142, DOI 10.1080/0361073X.2011.554511; Ernst LH, 2012, J NEAR INFRARED SPEC, V20, P93, DOI 10.1255/jnirs.970; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gottwald B, 2004, J NEUROL NEUROSUR PS, V75, P1524, DOI 10.1136/jnnp.2003.018093; Grabner RH, 2006, BRAIN RES BULL, V69, P422, DOI 10.1016/j.brainresbull.2006.02.009; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; GREENLIEF CL, 1985, PERCEPT MOTOR SKILL, V61, P1283, DOI 10.2466/pms.1985.61.3f.1283; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagen K, ACTIVATION TRAIL MAK, DOI [10.1016/j.neuroimage.2013.09.014, DOI 10.1016/J.NEUROIMAGE.2013.09.014]; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Jacobson SC, 2011, BRAIN COGNITION, V77, P60, DOI 10.1016/j.bandc.2011.06.001; Karimpoor M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00496; Karimpoor M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00150; Kennedy KJ, 1981, PERCEPTUAL MOTOR SKI, V52; Korf ESC, 2004, NEUROLOGY, V63, P94, DOI 10.1212/01.WNL.0000133114.92694.93; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Lenehan ME, 2015, PSYCHOGERIATRICS, V15, P154, DOI 10.1111/psyg.12083; Leonards U, 2000, J COGNITIVE NEUROSCI, V12, P61, DOI 10.1162/089892900564073; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lindquist MA, 2009, NEUROIMAGE, V45, pS187, DOI 10.1016/j.neuroimage.2008.10.065; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Miller IN, 2015, EXP AGING RES, V41, P386, DOI 10.1080/0361073X.2015.1053755; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Moritz S, 2002, ARCH CLIN NEUROPSYCH, V17, P477, DOI 10.1016/S0887-6177(01)00130-5; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Muller LD, 2014, NEUROPSYCHOLOGIA, V56, P271, DOI 10.1016/j.neuropsychologia.2014.01.019; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nobre AC, 2003, NEUROIMAGE, V18, P91, DOI 10.1006/nimg.2002.1329; O'Rourke JJF, 2011, J CLIN EXP NEUROPSYC, V33, P567, DOI 10.1080/13803395.2010.541228; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oosterman JM, 2008, BRAIN COGNITION, V68, P128, DOI 10.1016/j.bandc.2008.03.006; Oosterman JM, 2010, CLIN NEUROPSYCHOL, V24, P203, DOI 10.1080/13854040903482848; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rypma B, 2005, CORTEX, V41, P582, DOI 10.1016/S0010-9452(08)70198-9; Salthouse TA, 2000, NEUROPSYCHOLOGY, V14, P102, DOI 10.1037/0894-4105.14.1.102; Salthouse TA, 2011, INTELLIGENCE, V39, P222, DOI 10.1016/j.intell.2011.03.001; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Shibuya-Tayoshi S, 2007, PSYCHIAT CLIN NEUROS, V61, P616, DOI 10.1111/j.1440-1819.2007.01727.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Strothert SC, 2002, NEUROIMAGE, V15, P747, DOI 10.1006/nimg.2001.1034; Talwar NA, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00025; Tam CWC, 2005, NEUROLOGY, V64, P861, DOI 10.1212/01.WNL.0000153070.82309.D4; Tam F, 2012, HUM BRAIN MAPP, V33, P1750, DOI 10.1002/hbm.21375; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Visser PJ, 1999, J NEUROL, V246, P477, DOI 10.1007/s004150050387; Weintraub D, 2005, DEMENT GERIATR COGN, V20, P140, DOI 10.1159/000087043; Wilson RS, 2009, NEUROLOGY, V72, P460, DOI 10.1212/01.wnl.0000341782.71418.6c; Wright ME, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00371; Yochim B, 2007, ARTIC J INT NEUROPSY; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	81	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232469	10.1371/journal.pone.0232469	http://dx.doi.org/10.1371/journal.pone.0232469			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396540	Green Published, gold			2022-12-26	WOS:000537475000010
J	Huttin, O; Mandry, D; Popovic, B; Rossignol, P; Odille, F; Micard, E; Lamiral, Z; Zannad, F; Girerd, N; Marie, PY				Huttin, Olivier; Mandry, Damien; Popovic, Batric; Rossignol, Patrick; Odille, Freddy; Micard, Emilien; Lamiral, Zohra; Zannad, Faiez; Girerd, Nicolas; Marie, Pierre-Yves			Plasma Galectin-3 predicts deleterious vascular dysfunction affecting post-myocardial infarction patients: An explanatory study	PLOS ONE			English	Article							HEART-FAILURE; CARDIOVASCULAR-DISEASE; HYPERTENSION; ASSOCIATION	Objectives In a previous analysis of a post-myocardial infarction (MI) cohort, abnormally high systemic vascular resistances (SVR) were shown to be frequently revealed by MRI during the healing period, independently of MI severity, giving evidence of vascular dysfunction and limiting further recovery of cardiac function. The present ancillary and exploratory analysis of the same cohort was aimed at characterizing those patients suffering from high SVR remotely from MI with a large a panel of cardiovascular MRI parameters and blood biomarkers. Methods MRI and blood sampling were performed 2-4 days after a reperfused MI and 6 months thereafter in 121 patients. SVR were monitored with a phase-contrast MRI sequence and patients with abnormally high SVR at 6-months were characterized through MRI parameters and blood biomarkers, including Galectin-3, an indicator of cardiovascular inflammation and fibrosis after MI. SVR were normal at 6-months in 90 patients (SVR-) and abnormally high in 31 among whom 21 already had high SVR at the acute phase (SVR++) while 10 did not (SVR+). Results When compared with SVR-, both SVR+ and SVR++ exhibited lower recovery in cardiac function from baseline to 6-months, while baseline levels of Galectin-3 were significantly different in both SVR+ (median: 14.4 (interquartile range: 12.3-16.7) ng.mL(-1)) and SVR++ (13.0 (11.7-19.4) ng.mL(-1)) compared to SVR-(11.7 (9.8-13.5) ng.mL(-1), both p < 0.05). Plasma Galectin-3 was an independent baseline predictor of high SVR at 6-months (p = 0.002), together with the baseline levels of SVR and left ventricular end-diastolic volume, whereas indices of MI severity and left ventricular function were not. In conclusion, plasma Galectin-3 predicts a deleterious vascular dysfunction affecting post-MI patients, an observation that could lead to consider new therapeutic targets if confirmed through dedicated prospective studies.	[Huttin, Olivier; Popovic, Batric; Rossignol, Patrick; Zannad, Faiez; Girerd, Nicolas; Marie, Pierre-Yves] Univ Lorraine, INSERM, UMR 1116, Nancy, France; [Huttin, Olivier; Popovic, Batric; Zannad, Faiez; Girerd, Nicolas] Univ Lorraine, CHRU Nancy, Dept Cardiol, Nancy, France; [Mandry, Damien; Odille, Freddy; Micard, Emilien] Univ Lorraine, INSERM, UMR 1254, Nancy, France; [Mandry, Damien] Univ Lorraine, CHRU Nancy, Dept Radiol, Nancy, France; [Rossignol, Patrick; Odille, Freddy; Micard, Emilien; Lamiral, Zohra; Zannad, Faiez; Girerd, Nicolas] Univ Lorraine, CHRU Nancy, INSERM, CIC 1433, Nancy, France; [Rossignol, Patrick] FCRIN INI CRCT, Nancy, France; [Marie, Pierre-Yves] Univ Lorraine, CHRU Nancy, Nucl Med & Nancyclotep Imaging Platform, Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Universite de Lorraine; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Universite de Lorraine	Marie, PY (corresponding author), Univ Lorraine, INSERM, UMR 1116, Nancy, France.; Marie, PY (corresponding author), Univ Lorraine, CHRU Nancy, Nucl Med & Nancyclotep Imaging Platform, Nancy, France.	py.marie@chru-nancy.fr	Odille, Freddy/H-7650-2019; GIRERD, Nicolas/D-5493-2011; HUttin, Olivier/AAW-8052-2020; Marie, pierre-yves/AAY-6971-2020	Odille, Freddy/0000-0001-5260-8905; Girerd, Nicolas/0000-0002-3278-2057	French "Programme Hospitalier de Recherche Clinique" (2010); RHU FIGHT-HF program [ANR-15-RHU-0004]	French "Programme Hospitalier de Recherche Clinique" (2010); RHU FIGHT-HF program	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Academic fundings were obtained through the French "Programme Hospitalier de Recherche Clinique" (2010) and the RHU FIGHT-HF program (ANR-15-RHU-0004)	Anyfanti P, 2019, CLIN CARDIOL, V42, P62, DOI 10.1002/clc.23105; Bagnall AJ, 2010, CIRC-CARDIOVASC QUAL, V3, P530, DOI 10.1161/CIRCOUTCOMES.109.919415; Bezin J, 2014, EUR J CLIN PHARMACOL, V70, P429, DOI 10.1007/s00228-013-1614-5; Calvier L, 2013, ARTERIOSCL THROM VAS, V33, P67, DOI 10.1161/ATVBAHA.112.300569; Cole RT, 2012, EXPERT REV CARDIOVAS, V10, P1141, DOI [10.1586/erc.12.108, 10.1586/ERC.12.108]; D'Elia N, 2015, JACC-CARDIOVASC IMAG, V8, P1430, DOI 10.1016/j.jcmg.2015.10.005; Davila DF, 2008, INT J CARDIOL, V124, P134, DOI 10.1016/j.ijcard.2007.01.089; Gislason GH, 2006, EUR HEART J, V27, P1153, DOI 10.1093/eurheartj/ehi705; Hanif K, 2010, HYPERTENS RES, V33, P11, DOI 10.1038/hr.2009.184; Hogas S, 2017, ARCH MED SCI, V13, P897, DOI 10.5114/aoms.2016.58664; Huttin O, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-016-0314-6; Jagodzinski A, 2015, INT J CARDIOL, V192, P33, DOI 10.1016/j.ijcard.2015.05.040; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li MX, 2020, AM J CARDIOVASC DRUG, V20, P333, DOI 10.1007/s40256-019-00387-9; Libhaber E, 2015, HYPERTENSION, V65, P1356, DOI 10.1161/HYPERTENSIONAHA.115.05159; Madrigal-Matute J., 2014, J AM HEART ASSOC, V3, P1; Maeder MT, 2010, J AM COLL CARDIOL, V56, P855, DOI 10.1016/j.jacc.2010.04.040; Mandry D, 2012, J HYPERTENS, V30, P567, DOI 10.1097/HJH.0b013e32834f6f3f; Marie PY, 2016, J HYPERTENS, V34, P967, DOI 10.1097/HJH.0000000000000889; Menini S, 2013, CARDIOVASC RES, V100, P472, DOI 10.1093/cvr/cvt206; Meyer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119432; Parrott CW, 2005, AM J HYPERTENS, V18, p82S, DOI 10.1016/j.amjhyper.2004.11.024; Rizzoni D, 2019, HIGH BLOOD PRESS CAR, V26, P183, DOI 10.1007/s40292-019-00320-w; Suthahar N, 2018, THERANOSTICS, V8, P593, DOI 10.7150/thno.22196; Tarjus A, 2015, HYPERTENSION, V66, P158, DOI 10.1161/HYPERTENSIONAHA.115.05431; te Riet L, 2015, CIRC RES, V116, P960, DOI 10.1161/CIRCRESAHA.116.303587; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	27	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232572	10.1371/journal.pone.0232572	http://dx.doi.org/10.1371/journal.pone.0232572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392260	Green Published, gold			2022-12-26	WOS:000537470300010
J	Tachkov, K; Mitov, K; Koleva, Y; Mitkova, Z; Kamusheva, M; Dimitrova, M; Petkova, V; Savova, A; Doneva, M; Tcarukciev, D; Valov, V; Angelova, G; Manova, M; Petrova, G				Tachkov, Konstantin; Mitov, Konstantin; Koleva, Yordanka; Mitkova, Zornitsa; Kamusheva, Maria; Dimitrova, Maria; Petkova, Valentina; Savova, Alexandra; Doneva, Miglena; Tcarukciev, Dimitar; Valov, Vasil; Angelova, Galia; Manova, Manoela; Petrova, Guenka			Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria	PLOS ONE			English	Article							FOLLOW-UP; MORTALITY; COHORT; MELLITUS; QUALITY; ADULTS; IMPACT; RISK	Aims To evaluate the expected life expectancy in patients with diabetes in Bulgaria and to compare it to the expected life expectancy of the non-diabetic population in the country. Methods It is a retrospective observational population study on individuals diagnosed with diabetes, compared to the non-diabetic population in Bulgaria for the period 2012-2015. Data from the national diabetes register and national statistical institute were used to construct lifetables with probability of survival with t-test and Chi Square test. Confounder analysis was done by age, sex, and type of diabetes. All-cause mortality and deaths in diabetic patients were analyzed. Kaplan-Meier survival curves were constructed for each age group and a log-rank analysis was conducted. Results Average life expectancy in the non-diabetic population, patients with Type 1 DM and with Type 2 DM is 74.8; 70.96 and 75.19 years, respectively. For 2012-2015 the mortality in the non-diabetic population remained constant and lower (average-1.48%) compared to type-1 DM (5.25%) and Type-2 (4.27%). Relative risk of death in diabetics was higher overall (12%), after the age of 70 before which the relative risk was higher for the non-diabetic population. This was observed as a trend in all analyzed years. Conclusion Patients with type 2 DM have a longer life-expectancy than patients with type-1 DM and overall Diabetics life expectancy equals that of the non-diabetic population, which could suggest improved disease control and its associated complications in Bulgaria. Male diabetics show slightly longer life expectancy than their counterparts in the non-diabetic population, by a marginal gain of 0.6 years for the entire observed period. Life expectancy in diabetic women increased by 1.3 years, which was not observed in the non-diabetic population. Prevalence of diabetes was higher for women. Improved diabetes control may explain this gain in life; however other studies are needed to confirm this.	[Tachkov, Konstantin; Mitov, Konstantin; Mitkova, Zornitsa; Kamusheva, Maria; Dimitrova, Maria; Petkova, Valentina; Savova, Alexandra; Doneva, Miglena; Manova, Manoela; Petrova, Guenka] Med Univ Sofia, Fac Pharm, Sofia, Bulgaria; [Koleva, Yordanka] Tulane Univ, New Orleans, LA 70118 USA; [Tcarukciev, Dimitar] Med Univ Sofia Ivan Penchev, Univ Endocrinol Hosp, Sofia, Bulgaria; [Valov, Vasil] NovoNordisk Pharma, Sofia, Bulgaria; [Angelova, Galia] Bulgarian Acad Sci, Inst Informat & Informat Technol, Sofia, Bulgaria	Medical University Sofia; Tulane University; Bulgarian Academy of Sciences	Petrova, G (corresponding author), Med Univ Sofia, Fac Pharm, Sofia, Bulgaria.	gpetrova@pharmfac.mu-sofia.bg	Petkova, Valentina/X-5479-2018; Kamusheva, Maria/AAI-1960-2021; Dimitrova, Maria/AAE-4435-2021; Doneva, Miglena/AAQ-3522-2021; Petrova, Guenka/I-6863-2019	Petkova, Valentina/0000-0002-6938-1054; Doneva, Miglena/0000-0002-8187-8952; Manova, Manoela/0000-0002-8749-7974				Anwer Z, 2011, EUR REV MED PHARMACO, V15, P1256; Bardenheier BH, 2016, DIABETES CARE, V39, P1222, DOI 10.2337/dc15-1095; Borissova A -MI, 2012, ENDOCRINOLOGY, V17, P182; Borissova AM, 2015, CLIN MED INSIGHTS-EN, V8, P41, DOI 10.4137/CMED.S24742; Dale AC, 2007, EUR HEART J, V28, P2924, DOI 10.1093/eurheartj/ehm447; Dyakova M, 2008, CROAT MED J, V49, P783, DOI 10.3325/cmj.2008.49.783; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huo LL, 2016, DIABETOLOGIA, V59, P1437, DOI 10.1007/s00125-016-3948-x; Ioacara S, 2018, ACTA DIABETOL, V55, P821, DOI 10.1007/s00592-018-1156-5; KROLEWSKI AS, 1985, AM J MED, V78, P785, DOI 10.1016/0002-9343(85)90284-0; Leal J, 2009, EUR HEART J, V30, P834, DOI 10.1093/eurheartj/ehn567; Livingstone SJ, 2015, JAMA-J AM MED ASSOC, V313, P37, DOI 10.1001/jama.2014.16425; Loukine L, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-7; Lutgers HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006817; Moyo S, 2019, ADV AFR ECON SOC POL, P3, DOI 10.1007/978-981-10-5840-0_1; Muschik D, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0124-6; Ostrowska J, 2017, VALUE HEALTH, V20, pA476, DOI 10.1016/j.jval.2017.08.442; Rehm J, 2013, ALCOHOL RES-CURR REV, V35, P174; Roper NA, 2001, BRIT MED J, V322, P1389, DOI 10.1136/bmj.322.7299.1389; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Sikdar KC, 2010, QUAL LIFE RES, V19, P781, DOI 10.1007/s11136-010-9641-5; Tachkov K, 2019, BIOTECHNOL BIOTEC EQ, V33, P814, DOI 10.1080/13102818.2019.1604160; US Bureau of Labor Statistics, 2016, NAT CENS FAT OCC INJ, P1; World Health Organization, 2016, WHO GLOBAL REPORT DI, P1; World Health Organization, 2018, WORLD HLTH STAT 2019	26	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232815	10.1371/journal.pone.0232815	http://dx.doi.org/10.1371/journal.pone.0232815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392235	gold, Green Published			2022-12-26	WOS:000537470300025
J	Widatalla, N; Kasahara, Y; Kimura, Y; Khandoker, A				Widatalla, Namareq; Kasahara, Yoshiyuki; Kimura, Yoshitaka; Khandoker, Ahsan			Model based estimation of QT intervals in non-invasive fetal ECG signals	PLOS ONE			English	Article							HEART-RATE CORRECTION; DEVELOPMENTAL-CHANGES; K+ CURRENTS; ELECTROCARDIOGRAM; REPOLARIZATION; HODGKIN; AXON	The end timing of T waves in fetal electrocardiogram (fECG) is important for the evaluation of ST and QT intervals which are vital markers to assess cardiac repolarization patterns. Monitoring malignant fetal arrhythmias in utero is fundamental to care in congenital heart anomalies preventing perinatal death. Currently, reliable detection of end of T waves is possible only by using fetal scalp ECG (fsECG) and fetal magnetocardiography (fMCG). fMCG is expensive and less accessible and fsECG is an invasive technique available only during intrapartum period. Another safer and affordable alternative is the non-invasive fECG (nfECG) which can provide similar assessment provided by fsECG and fMECG but with less accuracy (not beat by beat). Detection of T waves using nfECG is challenging because of their low amplitudes and high noise. In this study, a novel model-based method that estimates the end of T waves in nfECG signals is proposed. The repolarization phase has been modeled as the discharging phase of a capacitor. To test the model, fECG signals were collected from 58 pregnant women (age: (34 +/- 6) years old) bearing normal and abnormal fetuses with gestational age (GA) 20-41 weeks. QT and QTc intervals have been calculated to test the level of agreement between the model-based and reference values (fsECG and Doppler Ultrasound (DUS) signals) in normal subjects. The results of the test showed high agreement between modelbased and reference values (difference < 5%), which implies that the proposed model could be an alternative method to detect the end of T waves in nfECG signals.	[Widatalla, Namareq; Kasahara, Yoshiyuki; Kimura, Yoshitaka] Tohoku Univ, Grad Sch Biomed Engn, Next Generat Biol Informat Technol, Sendai, Miyagi, Japan; [Kasahara, Yoshiyuki; Kimura, Yoshitaka] Tohoku Univ, Grad Sch Med, Adv Interdisciplinary Biomed Engn, Sendai, Miyagi, Japan; [Khandoker, Ahsan] Khalifa Univ, Healthcare Engn Innovat Ctr HEIC, Dept Biomed Engn, Abu Dhabi, U Arab Emirates	Tohoku University; Tohoku University; Khalifa University of Science & Technology	Widatalla, N (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Next Generat Biol Informat Technol, Sendai, Miyagi, Japan.	namareq.widatalla@gmail.com	Khandoker, Ahsan Habib/B-3754-2013	Khandoker, Ahsan Habib/0000-0002-0636-1646; Kasahara, Yoshiyuki/0000-0002-9508-2218; Widatalla, Namareq/0000-0001-9848-8531	RIKEN Healthcare and Medical Data Platform Project; Shiguredo Inc.; Khalifa University Abu Dhabi [2019-023]; Japan Agency for Medical Research and development, AMED	RIKEN Healthcare and Medical Data Platform Project; Shiguredo Inc.; Khalifa University Abu Dhabi; Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	The work in this paper has been supported by RIKEN Healthcare and Medical Data Platform Project to YKa and YKi, the funding for basic medical research by Shiguredo Inc. to YKa and collaborative CIRA grant (2019-023) awarded to AK by Khalifa University Abu Dhabi. Also, the research is partially supported by the Project for Baby and Infant in Research of Health and Development to Adolescent and Young adult from Japan Agency for Medical Research and development, AMED to YKa and YKi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOUD S, 1990, COMPUT BIOL MED, V20, P147, DOI 10.1016/0010-4825(90)90001-6; Alexander CKA., 2006, FUNDAMENTALS ELECT C; Alnuaimi S, 2018, IDENTIFICATION FETAL; Alnuaimi SA, 2017, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00082; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Behar J, 2016, PHYSIOL MEAS, V37, P1392, DOI 10.1088/0967-3334/37/9/1392; Benatar A, 2001, HEART, V86, P199, DOI 10.1136/heart.86.2.199; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Clifford GD, 2014, PHYSIOL MEAS, V35, P1521, DOI 10.1088/0967-3334/35/8/1521; COUCH JR, 1969, CIRC RES, V24, P19, DOI 10.1161/01.RES.24.1.19; di Bernanrdo D, 2002, PHYSIOL MEAS, V23, P355, DOI 10.1088/0967-3334/23/2/311; Donofrio MT, 2014, CIRCULATION, V129, P2183, DOI 10.1161/01.cir.0000437597.44550.5d; Draghici AE, 2016, J PHYSIOL ANTHROPOL, V35, DOI 10.1186/s40101-016-0113-7; Edwards AG, 2017, CLIN MED INSIGHTS-CA, V11, DOI 10.1177/1179546816686061; Elgendi M, 2015, SENSORS-BASEL, V15, P17693, DOI 10.3390/s150717693; Fridericia L, 1920, ACTA MED SCAND, V57, P469, DOI DOI 10.1111/J.0954-6820.1920.TB18266.X; FUNCKBRENTANO C, 1993, AM J CARDIOL, V72, pB17, DOI 10.1016/0002-9149(93)90035-B; Furutani K, 2019, J GEN PHYSIOL, V151, P214, DOI 10.1085/jgp.201812192; Gima K, 2002, CIRC RES, V90, P889, DOI 10.1161/01.RES.0000016960.61087.86; Grunnet M, 2010, ACTA PHYSIOL, V198, P1, DOI 10.1111/j.1748-1716.2009.02072.x; Hamaguchi S, 2013, J PHARMACOL SCI, V123, P167, DOI 10.1254/jphs.13099FP; HODGES M, 1983, J AM COLL CARDIOL, V1, P694; HUYNH TV, 1992, CIRC RES, V70, P508, DOI 10.1161/01.RES.70.3.508; J Adam, 2012, Rev Obstet Gynecol, V5, pe132; Khandoker A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31898-1; Khandoker AH, 2009, MED BIOL ENG COMPUT, V47, P1075, DOI 10.1007/s11517-009-0528-y; KONARZEWSKA H, 1995, CIRCULATION, V92, P1179, DOI 10.1161/01.CIR.92.5.1179; Kwon Ji Young, 2016, Obstet Gynecol Sci, V59, P79, DOI 10.5468/ogs.2016.59.2.79; Malik M, 2001, J CARDIOVASC ELECTR, V12, P411, DOI 10.1046/j.1540-8167.2001.00411.x; Marzbanrad F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00313; Marzbanrad F, 2014, IEEE J BIOMED HEALTH, V18, P1169, DOI 10.1109/JBHI.2013.2286155; Mozos I, 2011, J ELECTROCARDIOL, V44, P105, DOI 10.1016/j.jelectrocard.2010.10.034; Noble D, 2007, J PHYSIOL-LONDON, V580, P15, DOI 10.1113/jphysiol.2006.119370; Oudijk MA, 2004, BJOG-INT J OBSTET GY, V111, P656, DOI 10.1111/j.1471-0528.2004.00178.x; Parodi M, 1997, INT J CIRC THEOR APP, V25, P115, DOI 10.1002/(SICI)1097-007X(199703/04)25:2<115::AID-CTA957>3.0.CO;2-#; Phan DQ, 2015, J PEDIATR-US, V166, P960, DOI 10.1016/j.jpeds.2014.12.037; Qiu H, 2007, EVALUATION QT INTERV; SAGIE A, 1992, AM J CARDIOL, V70, P797, DOI 10.1016/0002-9149(92)90562-D; Sameni Reza, 2010, Open Pacing Electrophysiol Ther J, V3, P4; Sato M, 2007, IEEE T BIO-MED ENG, V54, P49, DOI 10.1109/TBME.2006.883791; Sato N, 2011, TOHOKU J EXP MED, V225, P89, DOI 10.1620/tjem.225.89; Stinstra J, 2002, BJOG-INT J OBSTET GY, V109, P1235; Strand S, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013436; Strand SA, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab0a2c; Strasburger JF, 2008, HEART RHYTHM, V5, P1073, DOI 10.1016/j.hrthm.2008.02.035; Su L., 2017, FRONT APPL MATH STAT, V3; Vahedi F, 2011, ANN NONINVAS ELECTRO, V16, P287, DOI 10.1111/j.1542-474X.2011.00444.x; Vandenberk B, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003264; Velayo CL, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00437; Wernicke JF, 2005, J CARDIOVASC ELECTR, V16, P76, DOI 10.1046/j.1540-8167.2005.03520.x; Wilders R, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00106	52	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232769	10.1371/journal.pone.0232769	http://dx.doi.org/10.1371/journal.pone.0232769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392232	gold, Green Published			2022-12-26	WOS:000537470300023
J	Currey-Randall, LM; Cappo, M; Simpfendorfer, CA; Farabaugh, NF; Heupel, MR				Currey-Randall, Leanne M.; Cappo, Mike; Simpfendorfer, Colin A.; Farabaugh, Naomi F.; Heupel, Michelle R.			Optimal soak times for Baited Remote Underwater Video Station surveys of reef-associated elasmobranchs	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SHARK POPULATIONS; RESIDENCY PATTERNS; FISH; ABUNDANCE; BRUVS; BIODIVERSITY; DIVERSITY; MOVEMENTS; NEED	Effective sampling of marine communities is essential to provide robust estimates of species richness and abundance. Baited Remote Underwater Video Stations (BRUVS) are a useful tool in assessment of fish assemblages, but research on the optimal sampling period required to record common and rare elasmobranch species is limited. An appropriate 'soak time' (time elapsed between settlement of the BRUVS on the seabed and when it is hauled off the seabed) requires consideration, since longer soak times may be required to record species rare in occurrence, or sightings in areas of generally low elasmobranch abundance. We analysed 5352 BRUVS deployments with a range of soak times across 21 countries in the Coral Triangle and Pacific Ocean, to determine the optimal soak time required for sampling reef-associated elasmobranchs, considering species rarity, and community abundance at each site. Species were categorised into 4 'rarity' groups (very rare to common), by their relative occurrence in the dataset, defined simply by the proportion of BRUVS on which they occurred. Individual BRUVS were categorised into 3 'abundance' groups (low to high) by overall relative elasmobranch abundance, defined as total number of all elasmobranchs sighted per unit of sampling effort. The effects of BRUVS soak times, and levels of rarity and abundance groupings, on the time to first sighting (TFS) and time to maximum number of elasmobranchs observed (t(MaxN)) were examined. We found that TFS occurred earlier for species groups with high occurrence, and on BRUVS with high elasmobranch abundance, yet longer soak times were not essential to observe rarer species. Our models indicated an optimum of 95% of both sighting event types (TFS, t(MaxN)) was recorded within 63-77 minutes, and a soak time of 60 minutes recorded 78-94% of the elasmobranch sighting events recorded (78-94% of TFS events and 82-90% of t(MaxN) events), when species rarity and abundance on BRUVS was accounted for. Our study shows that deployments of similar to 77 minutes are optimal for recording all species we observed, although 60 minutes soak time effectively samples the majority of elasmobranch species in shallow coral reef habitats using BRUVS.	[Currey-Randall, Leanne M.; Cappo, Mike; Heupel, Michelle R.] Australian Inst Marine Sci, Townsville, Qld, Australia; [Simpfendorfer, Colin A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia; [Simpfendorfer, Colin A.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Farabaugh, Naomi F.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Heupel, Michelle R.] Univ Tasmania, Integrated Marine Observing Syst IMOS, Hobart, Tas, Australia	Australian Institute of Marine Science; James Cook University; James Cook University; State University System of Florida; Florida International University; University of Tasmania	Currey-Randall, LM (corresponding author), Australian Inst Marine Sci, Townsville, Qld, Australia.	currey@aims.gov.au	Currey-Randall, Leanne/AAS-8975-2020	Currey-Randall, Leanne/0000-0002-3772-1288; Farabaugh, naomi/0000-0002-7839-7453	Paul G Allen Philanthropies [11861]; Pew Foundation; Florida International University's Tropical Conservation Institute	Paul G Allen Philanthropies; Pew Foundation; Florida International University's Tropical Conservation Institute	This work is a contribution of the Global FinPrint Project, supported by Paul G Allen Philanthropies under grant number 11861, Pew Foundation, and Florida International University's Tropical Conservation Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Marrero D, 2018, MAR ECOL PROG SER, V593, P73, DOI 10.3354/meps12505; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Asher J, 2017, THESIS; Asher J, 2017, SCI REP, V7, P18, DOI [10.1038/s41598-017-00050-w, DOI 10.1038/S41598-017-00050-W]; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Bicknell AWJ, 2019, MAR ENVIRON RES, V147, P126, DOI 10.1016/j.marenvres.2019.04.007; Blaber SJM, 2009, REV FISH BIOL FISHER, V19, P367, DOI 10.1007/s11160-009-9110-9; BLAYLOCK RA, 1989, COPEIA, P744; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Brooks Edward J., 2011, Endangered Species Research, V13, P231, DOI 10.3354/esr00331; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M., 2007, AUSTR SOC FISH BIOL; Chin A, 2013, J FISH BIOL, V82, P1192, DOI 10.1111/jfb.12057; Cochran WG, 1957, EXPT DESIGNS; De Vos L, 2015, AFR J MAR SCI, V37, P209, DOI 10.2989/1814232X.2015.1036119; De Vos L, 2014, AFR J MAR SCI, V36, P1, DOI 10.2989/1814232X.2013.873739; De'ath G, 2017, MODIFIED VERSION GRE; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Devine BM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19115-x; Dulvy NK, 2017, CURR BIOL, V27, pR565, DOI 10.1016/j.cub.2017.04.038; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Espinoza M, 2015, MAR BIOL, V162, P343, DOI 10.1007/s00227-014-2572-x; Espinoza M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106885; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gladstone W, 2012, J EXP MAR BIOL ECOL, V429, P28, DOI 10.1016/j.jembe.2012.06.013; Goetze JS, 2013, CORAL REEFS, V32, P121, DOI 10.1007/s00338-012-0970-4; Goetze JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200960; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Harasti D, 2017, MAR FRESHWATER RES, V68, P1391, DOI 10.1071/MF16184; Harasti D, 2015, J EXP MAR BIOL ECOL, V463, P173, DOI 10.1016/j.jembe.2014.12.003; Harvey ES, 2019, SHARK RES EMERGING T; Haywood M., 2013, USE BRUVS TOOL ASSES; Heupel MR, 2009, FISH RES, V95, P350, DOI 10.1016/j.fishres.2008.10.005; Heupel MR, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00012; Heupel MR, 2018, MAR ECOL PROG SER, V589, P179, DOI 10.3354/meps12423; Jabado RW, 2018, FISH FISH, V19, P1043, DOI 10.1111/faf.12311; Kilfoil JP, 2017, MAR ECOL PROG SER, V585, P113, DOI 10.3354/meps12395; Langlois T., 2018, FIELD MANUALS MARINE, P82, DOI [DOI 10.11636/9781925297669, DOI 10.1177/0894318405277523]; Litvinov Feodor, 2007, Fish and Aquatic Resources Series, V12, P202; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; McCauley DJ, 2012, ECOL APPL, V22, P385, DOI 10.1890/11-1059.1; Meekan M. M., 2006, SURVEYS SHARK FIN FI; Misa WFXE, 2016, J EXP MAR BIOL ECOL, V479, P20, DOI 10.1016/j.jembe.2016.03.001; Mitchell JD, 2018, REV FISH BIOL FISHER, V28, P715, DOI 10.1007/s11160-018-9528-z; Murray R, 2019, J ASIA-PAC BIODIVERS, V12, P49, DOI 10.1016/j.japb.2018.09.009; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Papastamatiou YP, 2010, MAR FRESHWATER RES, V61, P1366, DOI 10.1071/MF10056; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Rizzari JR, 2014, MAR BIOL, V161, P2847, DOI 10.1007/s00227-014-2550-3; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Santana-Garcon J, 2014, J EXP MAR BIOL ECOL, V460, P153, DOI 10.1016/j.jembe.2014.07.003; Schonlau M, 2005, STATA J, V5, P330, DOI 10.1177/1536867X0500500304; Schramm KD, 2020, J EXP MAR BIOL ECOL, V524, DOI 10.1016/j.jembe.2019.151273; Sherman CS, 2018, J EXP MAR BIOL ECOL, V503, P80, DOI 10.1016/j.jembe.2018.03.002; Spaet JLY, 2016, BIOL CONSERV, V201, P20, DOI 10.1016/j.biocon.2016.06.018; Speed CW, 2018, BIOL CONSERV, V220, P308, DOI 10.1016/j.biocon.2018.01.010; Unsworth RKF, 2014, ESTUAR COAST SHELF S, V150, P281, DOI 10.1016/j.ecss.2014.03.020; Vianna GMS, 2016, CORAL REEFS, V35, P973, DOI 10.1007/s00338-016-1437-9; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; White J, 2013, J EXP MAR BIOL ECOL, V448, P281, DOI 10.1016/j.jembe.2013.08.004; Whitmarsh SK, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171993; Whitmarsh SK, 2017, REV FISH BIOL FISHER, V27, P53, DOI 10.1007/s11160-016-9450-1	64	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0231688	10.1371/journal.pone.0231688	http://dx.doi.org/10.1371/journal.pone.0231688			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384087	Green Published, Green Accepted, gold			2022-12-26	WOS:000537468300004
J	Montoto-Martinez, T; Hernandez-Brito, JJ; Gelado-Caballero, MD				Montoto-Martinez, Tania; Joaquin Hernandez-Brito, Jose; Dolores Gelado-Caballero, Ma			Pump-underway ship intake: An unexploited opportunity for Marine Strategy Framework Directive (MSFD) microplastic monitoring needs on coastal and oceanic waters	PLOS ONE			English	Article							PLASTIC DEBRIS; ATLANTIC-OCEAN; SEA-SURFACE; POLLUTION; INGESTION; ISLANDS; FISH; ABUNDANCE; ACCUMULATION; ENVIRONMENT	Broad scale sampling methods for microplastic monitoring in the open ocean waters remain a challenge in oceanography. A large number of samples is required to understand the distribution, abundance and fate of microplastic particles in the environment. Despite more than a decade of widespread study, there is currently no established time series of microplastic measurements and the research community is yet to establish a standardised set of methods that will allow data to be collected in a quick, affordable and interoperable way. We present a sampling technique involving the connection of a custom-built microplastic sampling device to the pump-underway ship intake system of a research vessel (RV) as an unexploited opportunity for oceanic monitoring needs concerning microplastic abundance and distribution. The method is cost effective, highly versatile and accurate, and is able to sample particles down to 50 mu m from opportunity platforms, thus contributing to an emerging area of study, and in particular helping to increase the monitoring reporting of data, and thereby serving as a valuable aid for the implementation of the Marine Strategy Framework Directive (MSFD). Sampling was performed during three consecutive oceanographic cruises in the subtropical NE Atlantic over a year, sampling subsurface waters (4 m depth) during navigation and while on coastal and oceanic stations. Microplastic particles were found in all stations and transects sampled. Fibres (64.42%) were predominant over fragments (35.58%), with the concentration values falling within the ranges of data reported for other areas of the Atlantic.	[Montoto-Martinez, Tania; Joaquin Hernandez-Brito, Jose; Dolores Gelado-Caballero, Ma] Univ Las Palmas Gran Canaria, Environm Technol Management & Biogeochem Res Grp, Las Palmas Gran Canaria, Canary Islands, Spain; [Joaquin Hernandez-Brito, Jose] Atlantic Int Res Ctr, Azores, Portugal; [Joaquin Hernandez-Brito, Jose] Ocean Platform Canary Isl, Gran Canaria, Canary Islands, Spain; [Montoto-Martinez, Tania] Univ Las Palmas Gran Canaria, Chem Dept, Marine Sci Fac, Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Montoto-Martinez, T (corresponding author), Univ Las Palmas Gran Canaria, Environm Technol Management & Biogeochem Res Grp, Las Palmas Gran Canaria, Canary Islands, Spain.; Montoto-Martinez, T (corresponding author), Univ Las Palmas Gran Canaria, Chem Dept, Marine Sci Fac, Gran Canaria, Spain.	tania.montoto@ulpgc.es	Hernandez-Brito, Jose Joaquin/B-8288-2015; Montoto-Martinez, Tania/B-6187-2018	Hernandez-Brito, Jose Joaquin/0000-0002-5305-1667; Gelado-Caballero, M.D./0000-0003-4001-9673; Montoto-Martinez, Tania/0000-0002-1770-3189	University of Las Palmas de Gran Canaria; European Regional Development Fund through the Madeira-Acores-Canarias Territorial Cooperation Operational Program (POMAC) 2014-2020 through the MARCET Project [MAC/1.1b/149]	University of Las Palmas de Gran Canaria; European Regional Development Fund through the Madeira-Acores-Canarias Territorial Cooperation Operational Program (POMAC) 2014-2020 through the MARCET Project	This work has been supported by a postgraduate research scholarship from the University of Las Palmas de Gran Canaria and carried out with funding from the European Regional Development Fund through the Madeira-Acores-Canarias Territorial Cooperation Operational Program (POMAC) 2014-2020 through the MARCET Project (MAC/1.1b/149).	Amelineau F, 2016, ENVIRON POLLUT, V219, P1131, DOI 10.1016/j.envpol.2016.09.017; [Anonymous], 2019, R LANG ENV STAT COMP; Avio CG, 2017, ENVIRON POLLUT, V227, P207, DOI 10.1016/j.envpol.2017.04.066; Bakir A, 2016, ENVIRON POLLUT, V219, P56, DOI 10.1016/j.envpol.2016.09.046; Barboza LGA, 2019, WORLD SEAS: AN ENVIRONMENTAL EVALUATION, VOL III: ECOLOGICAL ISSUES AND ENVIRONMENTAL IMPACTS, 2ND EDITION, P329, DOI 10.1016/B978-0-12-805052-1.00020-6; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Barrows A., 2017, NATL MICROPLASTICS F, DOI [10.13140/RG.2.2.19421.41446., DOI 10.13140/RG.2.2.19421.41446]; Baztan J, 2014, MAR POLLUT BULL, V80, P302, DOI 10.1016/j.marpolbul.2013.12.052; Bellas J, 2016, MAR POLLUT BULL, V109, P55, DOI 10.1016/j.marpolbul.2016.06.026; Bergmann M., 2017, P75; Browne MA, 2010, ENVIRON SCI TECHNOL, V44, P3404, DOI 10.1021/es903784e; Chubarenko I., 2017, P15; Cincinelli A, 2017, CHEMOSPHERE, V175, P391, DOI 10.1016/j.chemosphere.2017.02.024; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; Covernton GA, 2019, SCI TOTAL ENVIRON, V667, P124, DOI 10.1016/j.scitotenv.2019.02.346; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Desforges JPW, 2014, MAR POLLUT BULL, V79, P94, DOI 10.1016/j.marpolbul.2013.12.035; Dris R, 2017, ENVIRON POLLUT, V221, P453, DOI 10.1016/j.envpol.2016.12.013; Duis K, 2016, ENVIRON SCI EUR, V28, DOI 10.1186/s12302-015-0069-y; Enders K, 2015, MAR POLLUT BULL, V100, P70, DOI 10.1016/j.marpolbul.2015.09.027; Fossi MC, 2012, MAR POLLUT BULL, V64, P2374, DOI 10.1016/j.marpolbul.2012.08.013; Free CM, 2014, MAR POLLUT BULL, V85, P156, DOI 10.1016/j.marpolbul.2014.06.001; Frias J., 2019, STANDARDISED PROTOCO, DOI [10.13140/RG.2.2.14181.45282, DOI 10.13140/RG.2.2.14181.45282]; Gago J, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00219; Galgani F., 2013, GUIDANCE MONITORING; Hernandez-Gonzalez A, 2018, MAR POLLUT BULL, V137, P526, DOI 10.1016/j.marpolbul.2018.10.026; Herrera A, 2019, MAR POLLUT BULL, V139, P127, DOI 10.1016/j.marpolbul.2018.12.022; Herrera A, 2018, MAR POLLUT BULL, V129, P494, DOI 10.1016/j.marpolbul.2017.10.020; Jamieson AJ, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.180667; Kanhai LK, 2017, MAR POLLUT BULL, V115, P307, DOI 10.1016/j.marpolbul.2016.12.025; Katsanevakis S., 2008, MARINE POLLUTION NEW, P53; Kukulka T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051116; Lenz R, 2018, WATER-SUI, V10, DOI 10.3390/w10081055; Lenz R, 2015, MAR POLLUT BULL, V100, P82, DOI 10.1016/j.marpolbul.2015.09.026; Loder MGJ, 2015, MARINE ANTHROPOGENIC LITTER, P201, DOI 10.1007/978-3-319-16510-3_8; Lusher A, 2015, MARINE ANTHROPOGENIC LITTER, P245, DOI 10.1007/978-3-319-16510-3_10; Lusher AL, 2014, MAR POLLUT BULL, V88, P325, DOI 10.1016/j.marpolbul.2014.08.023; Mai L, 2018, ENVIRON SCI POLLUT R, V25, P11319, DOI 10.1007/s11356-018-1692-0; Miller ME, 2017, MAR POLLUT BULL, V123, P6, DOI 10.1016/j.marpolbul.2017.08.058; Monteiro RCP, 2018, ENVIRON POLLUT, V238, P103, DOI 10.1016/j.envpol.2018.01.096; Murphy F., 2017, P78; Neves D, 2015, MAR POLLUT BULL, V101, P119, DOI 10.1016/j.marpolbul.2015.11.008; Noren F, 2010, SURVEY MICROSCOPIC A, P12; Ocean Conservancy International Coastal Cleanup, 2019, BEACH 2019 REP, P32; OSPAR Commission, 2017, OSPAR INT ASS 2017; Pahl S, 2019, SCI PERSPECTIVE MICR; Piha Henna E., 2011, MARINE LITTER TECHNI, DOI [10.2788/92438, DOI 10.2788/92438]; QGIS Development Team, 2015, QGIS GEOGR INF SYST; Rocha-Santos T, 2015, TRAC-TREND ANAL CHEM, V65, P47, DOI 10.1016/j.trac.2014.10.011; ROTHSTEIN SI, 1973, CONDOR, V75, P344, DOI 10.2307/1366176; Ryan PG, 2015, MARINE ANTHROPOGENIC LITTER, P1, DOI 10.1007/978-3-319-16510-3_1; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Setala O., 2017, P154; Setala O, 2016, MAR POLLUT BULL, V110, P177, DOI 10.1016/j.marpolbul.2016.06.065; Song YK, 2014, ENVIRON SCI TECHNOL, V48, P9014, DOI 10.1021/es501757s; Steer M, 2017, ENVIRON POLLUT, V226, P250, DOI 10.1016/j.envpol.2017.03.062; Stock F, 2019, TRAC-TREND ANAL CHEM, V113, P84, DOI 10.1016/j.trac.2019.01.014; Sui Y, 2018, MODELING, SOLVING AND APPLICATION FOR TOPOLOGY OPTIMIZATION OF CONTINUUM STRUCTURES: ICM METHOD BASED ON STEP FUNCTION, P1; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Thompson RC., 2006, MAR NAT CONSERV EUR, V193, P107; UNEP, 2016, MAR PLAST DEBR MICR; UNEP & NOAA, 2018, 6 INT MAR DEBR C P S; van Wijnen J, 2019, SCI TOTAL ENVIRON, V673, P392, DOI 10.1016/j.scitotenv.2019.04.078; Vendel AL, 2017, MAR POLLUT BULL, V117, P448, DOI 10.1016/j.marpolbul.2017.01.081; Werner Stefanie, 2016, HARM CAUSED MARINE L, DOI DOI 10.2788/690366; WILSON TRS, 1975, DEEP-SEA RES, V22, P571, DOI 10.1016/0011-7471(75)90039-X; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; Zobkov MB, 2019, MAR POLLUT BULL, V138, P193, DOI 10.1016/j.marpolbul.2018.11.047	69	7	7	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232744	10.1371/journal.pone.0232744	http://dx.doi.org/10.1371/journal.pone.0232744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384129	Green Published, gold			2022-12-26	WOS:000537468300028
J	Hallmark, HT; Cerny, M; Brzobohaty, B; Rashotte, AM				Hallmark, H. Tucker; Cerny, Martin; Brzobohaty, Bretislav; Rashotte, Aaron M.			trans-Zeatin-N-glucosides have biological activity in Arabidopsis thaliana	PLOS ONE			English	Article							EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; CYTOKININ RESPONSE; HISTIDINE KINASE; EXPRESSION ANALYSIS; BETA-GLUCOSIDASE; LEAF SENESCENCE; CELL-DIVISION; PROTEOME; PATHWAY; FAMILY	Cytokinin is an indispensable phytohormone responsible for physiological processes ranging from root development to leaf senescence. The term "cytokinin" refers to several dozen adenine-derived compounds occurring naturally in plants. Cytokinins (CKs) can be divided into various classes and forms; base forms are generally considered to be active while highly abundant cytokinin-N-glucosides (CKNGs), composed of a CK base irreversibly conjugated to a glucose molecule, are considered inactive. However, results from early CK studies suggest CKNGs do not always lack activity despite the perpetuation over several decades in the literature that they are inactive. Here we show that exogenous application of trans-Zeatin-N-glucosides (tZNGs, a specific class of CKNGs) to Arabidopsis results in CK response comparable to the application of an active CK base. These results are most apparent in senescence assays where both a CK base (tZ) and tZNGs (tZ7G, tZ9G) delay senescence in cotyledons. Further experiments involving root growth and shoot regeneration revealed tZNGs do not always have the same effects as tZ, and have largely distinct effects on the transcriptome and proteome. These data are in contrast to previous reports of CKNGs being inactive and raise questions about the function of these compounds as well as their mechanism of action.	[Hallmark, H. Tucker; Rashotte, Aaron M.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Cerny, Martin; Brzobohaty, Bretislav; Rashotte, Aaron M.] Mendel Univ Brno, Fac AgriSci, Dept Mol Biol & Radiobiol, Brno, Czech Republic	Auburn University System; Auburn University; Mendel University in Brno	Rashotte, AM (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.; Rashotte, AM (corresponding author), Mendel Univ Brno, Fac AgriSci, Dept Mol Biol & Radiobiol, Brno, Czech Republic.	rashotte@auburn.edu	Cerny, Martin/D-7226-2012; Brzobohaty, Bretislav/D-7212-2012	Cerny, Martin/0000-0002-0651-4219; Brzobohaty, Bretislav/0000-0002-1552-1314; Hallmark, H. Tucker/0000-0002-2412-1806; Rashotte, Aaron/0000-0001-5034-4395	Auburn University IGP grant [190561]; Mendel University/EU International Development grant [CZ.02.2.69/0.0/0.0/16_027/0007953]; Ministry of Education, Youth and Sports of CR project from European Regional Development Fund "Centre for Experimental Plant Biology" [CZ.02.1.01/0.0/0.0/16_019/0000738]	Auburn University IGP grant; Mendel University/EU International Development grant; Ministry of Education, Youth and Sports of CR project from European Regional Development Fund "Centre for Experimental Plant Biology"	Funding support for this work comes from an Auburn University IGP grant 190561 to A. M.R. and H.T.H., a Mendel University/EU International Development grant CZ.02.2.69/0.0/0.0/16_027/0007953 to A.M.R., and the Ministry of Education, Youth and Sports of CR project from European Regional Development Fund "Centre for Experimental Plant Biology" No. CZ.02.1.01/0.0/0.0/16_019/0000738 to M.C. and B.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Auer CA, 1997, PLANT GROWTH REGUL, P23, DOI [10.1023/a:1005853128971, DOI 10.1023/A:1005853128971]; Bairu MW, 2011, PLANT GROWTH REGUL, V63, P147, DOI 10.1007/s10725-010-9554-x; Bhargava A, 2013, PLANT PHYSIOL; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRZOBOHATY B, 1993, SCIENCE, V262, P1051, DOI 10.1126/science.8235622; Burkle L, 2003, PLANT J, V34, P13, DOI 10.1046/j.1365-313X.2003.01700.x; Cerna H, 2017, J PROTEOMICS, V153, P78, DOI 10.1016/j.jprot.2016.05.018; Cerny M, 2014, PLANT CELL ENVIRON, V37, P1641, DOI 10.1111/pce.12270; Cerny M, 2013, J EXP BOT, V64, P4193, DOI 10.1093/jxb/ert227; Cerny M, 2011, J EXP BOT, V62, P921, DOI 10.1093/jxb/erq322; DELEUZE GG, 1972, BIOCHEM BIOPH RES CO, V48, P1426, DOI 10.1016/0006-291X(72)90872-8; Deng Y, 2010, PLANT CELL, V22, P1232, DOI 10.1105/tpc.108.065128; ENTSCH B, 1979, PLANT SCI LETT, V14, P205, DOI 10.1016/0304-4211(79)90061-0; FALK A, 1995, PLANT PHYSIOL, V108, P1369, DOI 10.1104/pp.108.4.1369; FLETCHER RA, 1971, PLANTA, V101, P88, DOI 10.1007/BF00387693; FOX JE, 1973, PLANT PHYSIOL, V52, P627, DOI 10.1104/pp.52.6.627; Gajdosova S., 2011, BIOL EFFECTS METABOL; Galuszka P, 2007, J PLANT GROWTH REGUL, V26, P255, DOI 10.1007/s00344-007-9008-5; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; Graf A, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160333; Hirose N, 2005, PLANT PHYSIOL, V138, P196, DOI 10.1104/pp.105.060137; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hooper CM, 2017, NUCLEIC ACIDS RES, V45, pD1064, DOI 10.1093/nar/gkw1041; Hosek P, 2020, NEW PHYTOL, V225, P2423, DOI 10.1111/nph.16310; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; Jiskrova E, 2016, NEW BIOTECHNOL, V33, P735, DOI 10.1016/j.nbt.2015.12.010; Jones RJ, 1997, PLANT GROWTH REGUL, V23, P123, DOI 10.1023/A:1005913311266; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; Kiba T, 2019, SCI REP, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Kiba T, 2013, DEV CELL, V27, P452, DOI 10.1016/j.devcel.2013.10.004; Kieber Joseph J, 2014, Arabidopsis Book, V12, pe0168, DOI 10.1199/tab.0168; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; Ko D, 2014, P NATL ACAD SCI USA, V111, P7150, DOI 10.1073/pnas.1321519111; Kubo M, 2000, PLANT J, V23, P385, DOI 10.1046/j.1365-313x.2000.00796.x; Letham D. S., 1983, Journal of Plant Growth Regulation, V2, P103, DOI 10.1007/BF02042238; LETHAM DS, 1971, PHYSIOL PLANTARUM, V25, P391, DOI 10.1111/j.1399-3054.1971.tb01462.x; LETHAM DS, 1967, ANN REV PLANT PHYSIO, V18, P349, DOI 10.1146/annurev.pp.18.060167.002025; LETHAM DS, 1983, ANNU REV PLANT PHYS, V34, P163, DOI 10.1146/annurev.pp.34.060183.001115; Li YJ, 2015, PLANT SCI, V236, P157, DOI 10.1016/j.plantsci.2015.04.002; Lochmanova G, 2008, J EXP BOT, V59, P3705, DOI 10.1093/jxb/ern220; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McGaw BA, 1983, PHYTOCHEMISTRY, P22; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; PALNI LMS, 1984, PLANTA, V160, P242, DOI 10.1007/BF00402861; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Rashotte AM, 2003, PLANT PHYSIOL, V132, P1998, DOI 10.1104/pp.103.021436; REITER RS, 1994, PLANT CELL, V6, P1253, DOI 10.1105/tpc.6.9.1253; Romanov GA, 2006, J EXP BOT, V57, P4051, DOI 10.1093/jxb/erl179; Sakakibara H, 2005, P NATL ACAD SCI USA, V102, P9972, DOI 10.1073/pnas.0500793102; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; SCHMITZ RY, 1972, PHYTOCHEMISTRY, V11, P1603, DOI 10.1016/0031-9422(72)85006-4; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Spichal L, 2004, PLANT CELL PHYSIOL, V45, P1299, DOI 10.1093/pcp/pch132; Spichal L, 2012, FUNCT PLANT BIOL, V39, P267, DOI 10.1071/FP11276; SPIESS LD, 1975, PLANT PHYSIOL, V55, P583, DOI 10.1104/pp.55.3.583; STENLID G, 1982, PHYSIOL PLANTARUM, V56, P500, DOI 10.1111/j.1399-3054.1982.tb04546.x; Sumanta N, 2014, RES J CHEM SCI, V9; Sun JP, 2005, J INTEGR PLANT BIOL, V47, P588, DOI 10.1111/j.1744-7909.2005.00104.x; Suzuki T, 2002, PLANT CELL PHYSIOL, V43, P123, DOI 10.1093/pcp/pcf007; Tian T, 2017, NUCLEIC ACIDS RES, V45, pW122, DOI 10.1093/nar/gkx382; Tokunaga H, 2012, PLANT J, V69, P355, DOI 10.1111/j.1365-313X.2011.04795.x; Wang J, 2011, PLANT CELL PHYSIOL, V52, P2200, DOI 10.1093/pcp/pcr152; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; YOSHIDA R, 1972, PLANT CELL PHYSIOL, V13, P337, DOI 10.1093/oxfordjournals.pcp.a074744; Zaveska Drabkova L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125411; Zd'arska M, 2013, PLANT PHYSIOL, V161, P918, DOI 10.1104/pp.112.202853; Zhang M, 2014, J CHIN HUM RESOUR MA, V5, P14, DOI 10.1108/JCHRM-12-2013-0034; Zhang YX, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S8; Zizkova E, 2017, ANN BOT-LONDON, V119, P151, DOI 10.1093/aob/mcw194; Zwack PJ, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24737; Zwack PJ, 2013, PLANT CELL PHYSIOL, V54, P971, DOI 10.1093/pcp/pct049	75	20	20	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232762	10.1371/journal.pone.0232762	http://dx.doi.org/10.1371/journal.pone.0232762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379789	Green Published, gold			2022-12-26	WOS:000537285700064
J	Jhun, EH; Sadhu, N; He, Y; Yao, YW; Wilkie, DJ; Molokie, RE; Wang, ZJ				Jhun, Ellie H.; Sadhu, Nilanjana; He, Ying; Yao, Yingwei; Wilkie, Diana J.; Molokie, Robert E.; Wang, Zaijie Jim			S100B single nucleotide polymorphisms exhibit sex-specific associations with chronic pain in sickle cell disease in a largely African-American cohort	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINE EXPRESSION; CARE UTILIZATION; SERUM CONCENTRATIONS; ASTROCYTIC REACTION; GENE POLYMORPHISMS; SENSITIVITY; PROTEIN; ADULTS; OUTPATIENTS; MANAGEMENT	Background Pain in sickle cell disease (SCD) is severe and multifaceted resulting in significant differences in its frequency and intensity among individuals. In this study, we examined the influence of S100B gene single nucleotide polymorphisms (SNP) on acute and chronic pain variability in SCD. Methods Composite pain index (CPI) scores captured chronic pain. Painful crisis related emergency care utilization recorded acute pain incidence. Genotyping was performed using MassARRAY iPLEX platform. Results Regression analysis revealed associations of increased CPI with rs9722 A allele in additive (p = 0.005) and dominant (p = 0.005) models. Rs1051169 G allele on the other hand was associated with decreased CPI in additive (p = 0.001), and dominant (p = 0.005) models. Sex-specific analysis found that these associations were significant in females but not males in this cohort. Linkage analysis identified two haploblocks. Block 1 (rs9983698rs9722) haplotype T-A was associated with increased CPI (p = 0.002) while block 2 (rs1051169-rs11911834) haplotype G-G was associated with decreased CPI (p = 0.001). Both haplotypic associations were only significant in females. No association of S100B SNPs with utilization reached statistical significance. Conclusions S100B SNPs and haplotypes are associated with chronic pain in female, but not male, patients with SCD, implicating a potential role of S100B polymorphism in SCD pain heterogeneity in a sex-dependent manner.	[Jhun, Ellie H.; Sadhu, Nilanjana; He, Ying; Molokie, Robert E.; Wang, Zaijie Jim] Univ Illinois, Coll Pharm, Dept Pharmaceut Sci, Chicago, IL 60607 USA; [He, Ying; Molokie, Robert E.; Wang, Zaijie Jim] Univ Illinois, Comprehens Sickle Cell Ctr, Chicago, IL 60607 USA; [Yao, Yingwei; Wilkie, Diana J.] Univ Florida, Coll Nursing, Dept Biobehav Nursing Sci, Gainesville, FL 32611 USA; [Molokie, Robert E.] Jesse Brown Vet Adm Med Ctr, Chicago, IL USA; [Molokie, Robert E.] Univ Illinois, Coll Med, Div Hematol Oncol, Chicago, IL USA; [Wang, Zaijie Jim] Univ Illinois, Coll Med, Dept Neurol & Rehabil, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, ZJ (corresponding author), Univ Illinois, Coll Pharm, Dept Pharmaceut Sci, Chicago, IL 60607 USA.; Wang, ZJ (corresponding author), Univ Illinois, Comprehens Sickle Cell Ctr, Chicago, IL 60607 USA.; Wang, ZJ (corresponding author), Univ Illinois, Coll Med, Dept Neurol & Rehabil, Chicago, IL 60607 USA.	zjwang@uic.edu	Wilkie, Diana J./ABG-5417-2021	Wilkie, Diana J./0000-0002-3954-8933; Molokie, Robert/0000-0003-3623-7395	National Heart, Lung, and Blood Institute [R01HL124945, R35HL140031, T32DE018381]; National Institute of Dental and Craniofacial Research;  [R01HL078536]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); 	DJW -R01HL078536; National Heart, Lung, and Blood Institute REM -R01HL124945; National Heart, Lung, and Blood Institute ZJW R35HL140031; National Heart, Lung, and Blood Institute EHJ -T32DE018381; National Institute of Dental and Craniofacial Research.	Aisiku IP, 2009, ANN EMERG MED, V53, P587, DOI 10.1016/j.annemergmed.2008.07.050; Ballas SK, 2012, BLOOD, V120, P3647, DOI 10.1182/blood-2012-04-383430; Ballas SK, 2005, HEMATOL ONCOL CLIN N, V19, P785, DOI 10.1016/j.hoc.2005.07.008; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Belfer I, 2014, AM J HEMATOL, V89, P187, DOI 10.1002/ajh.23613; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blinder MA, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.1379.1379; Brousseau DC, 2010, JAMA-J AM MED ASSOC, V303, P1288, DOI 10.1001/jama.2010.378; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Canzobre MC, 2010, NEUROSCI LETT, V470, P71, DOI 10.1016/j.neulet.2009.12.060; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Edwards RR, 2016, J PAIN, V17, pT70, DOI 10.1016/j.jpain.2016.01.001; Edwards RR, 2016, PAIN, V157, P1851, DOI 10.1097/j.pain.0000000000000602; Ezenwa MO, 2014, J PAIN SYMPTOM MANAG, V48, P65, DOI 10.1016/j.jpainsymman.2013.08.020; Fillingim RB, 2005, J PAIN, V6, P159, DOI 10.1016/j.jpain.2004.11.008; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Heizmann CW, 1999, NEUROCHEM RES, V24, P1097, DOI 10.1023/A:1020700117665; Hohoff C, 2010, AM J MED GENET B, V153B, P291, DOI 10.1002/ajmg.b.30950; Hu XY, 2016, PHARMACOGENOMICS, V17, P1999, DOI 10.2217/pgs-2016-0085; Ishiguro H, 2019, SPINE J, V19, P1434, DOI 10.1016/j.spinee.2019.04.006; Jhun E, 2014, ANESTH ANALG, V119, P1201, DOI 10.1213/ANE.0000000000000382; Jhun EH, 2018, PHARMACOGENOMICS, V19, P401, DOI 10.2217/pgs-2017-0198; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Liao HY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42531; Liu JX, 2005, BIOCHEM BIOPH RES CO, V328, P335, DOI 10.1016/j.bbrc.2004.12.175; Lu Y, 2011, BRAIN RES BULL, V84, P178, DOI 10.1016/j.brainresbull.2010.12.007; Lu YL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19156-w; Meloto CB, 2016, PAIN, V157, P858, DOI 10.1097/j.pain.0000000000000449; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Mogil JS, 2010, PROG BRAIN RES, V186, P141, DOI 10.1016/B978-0-444-53630-3.00009-9; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Ngamkham S, 2011, CANCER NURS, V34, P228, DOI 10.1097/NCC.0b013e3181faab63; Nygaard O, 1997, CLIN CHEM, V43, P541; Olsen MB, 2012, J NEUROSCI, V32, P9831, DOI 10.1523/JNEUROSCI.1742-12.2012; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Sdhu N, 2018, EXP HEMATOL, V66, P42, DOI 10.1016/j.exphem.2018.07.004; Shankar SM, 2005, AM J HEMATOL, V80, P262, DOI 10.1002/ajh.20485; Shi YQ, 2012, J NEUROSCI, V32, P10833, DOI 10.1523/JNEUROSCI.5628-11.2012; Smith WR, 2008, ANN INTERN MED, V148, P94, DOI 10.7326/0003-4819-148-2-200801150-00004; Tanga FY, 2006, NEUROSCIENCE, V140, P1003, DOI 10.1016/j.neuroscience.2006.02.070; Teepker M, 2009, HEADACHE, V49, P245, DOI 10.1111/j.1526-4610.2008.01228.x; Vandenbergh DJ, 2003, AM J HUM BIOL, V15, P637, DOI 10.1002/ajhb.10177; Wang ZJJ, 2010, HEMATOL-AM SOC HEMAT, P403, DOI 10.1182/asheducation-2010.1.403; Wilkie DJ, 2015, PAIN MED, V16, P1341, DOI 10.1111/pme.12703; Wilkie DJ, 2010, J NATL MED ASSOC, V102, P18, DOI 10.1016/S0027-9684(15)30471-5; Wilkie DJ, 2003, J PAIN SYMPTOM MANAG, V25, P213, DOI 10.1016/S0885-3924(02)00638-3; Yang K, 2009, CAN J PSYCHIAT, V54, P312, DOI 10.1177/070674370905400505; Young EE, 2012, J MED GENET, V49, P1, DOI 10.1136/jmedgenet-2011-100386; Zanette SA, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-46; Zhai JG, 2012, SCHIZOPHR RES, V134, P89, DOI 10.1016/j.schres.2011.09.029; Zhai JG, 2011, BEHAV BRAIN RES, V217, P363, DOI 10.1016/j.bbr.2010.11.004; ZHANG X, 2018, BLOOD S, V132, DOI DOI 10.1182/BLOOD-2018-99-115395; Zhang X, 2020, AM J HEMATOL, V95, pE62, DOI 10.1002/ajh.25691	59	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232721	10.1371/journal.pone.0232721	http://dx.doi.org/10.1371/journal.pone.0232721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZX	32379790	Green Published, gold			2022-12-26	WOS:000537285700060
J	Sauini, T; da Fonseca-Kruel, VS; Yazbek, PB; Matta, P; Cassas, F; da Cruz, C; Barretto, EHP; dos Santos, MA; Gomes, MAS; Garcia, RJF; Honda, S; Passero, LFD; Conde, BE; Rodrigues, E				Sauini, Thamara; da Fonseca-Kruel, Viviane Stern; Yazbek, Priscila Baptistela; Matta, Priscila; Cassas, Fernando; da Cruz, Crenilda; Pereira Barretto, Eduardo Hortal; dos Santos, Maria Alice; Silva Gomes, Maria Angelica; Francischetti Garcia, Ricardo Jose; Honda, Sumiko; Domingues Passero, Luiz Felipe; Conde, Bruno Esteves; Rodrigues, Eliana			Participatory methods on the recording of traditional knowledge about medicinal plants in Atlantic forest, Ubatuba, Sao Paulo, Brazil	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; COMMUNITY; CONSERVATION; ETHNOBIOLOGY; ETHNOBOTANY; REGION; RIVER	Introduction Ethnobotanical studies that include participatory methods aim to engage residents in different steps to promote the strengthening and perpetuation of local culture, and empowerment in making decisions about the use of available environmental resources. Thus, the aim of this project was to perform an ethnobotanical survey based on traditional knowledge of medicinal plants with the active participation of residents living in Bairro do Cambury, Ubatuba, Sao Paulo State, Brazil. Materials and methods During meetings held between the researchers and community members, locally used plants were regarded as an important means for preserving local knowledge for future generations. Some residents showed interest in participating as local partners, and training courses for collecting ethnobotanical data were offered. Local partners and researchers from Sao Paulo Federal University (Universidade Federal de Sao Paulo) utilized ethnobotanical methods to select and interview the specialists in medicinal plants for 80 days between 2016 and 2018. Data on plant use were recorded, and plants were collected and deposited in two herbaria. Furthermore, participant observation and fieldwork diaries were used by the researchers, aiding the data analysis. Results Three local partners participated in objective definitions, data collection, analysis and publication. Nine local specialists were interviewed by the local partners and indicated the use of 82 plant species in 90 recipes for 55 therapeutic uses. These uses were grouped into 12 categories. In addition, a video and booklet were created. Conclusions Data obtained during participatory research show that training local communities in the registration of their own knowledge is feasible and necessary since they register knowledge based on local perceptions, as well as valuing knowledge and approaching the current discussion about intellectual property is a global concern.	[Sauini, Thamara; Yazbek, Priscila Baptistela; Cassas, Fernando; Conde, Bruno Esteves; Rodrigues, Eliana] Univ Fed Sao Paulo, UNIFESP, Ctr Ethnobot & Ethnopharmacol Studies CEE, Dept Environm Sci, Sao Paulo, Brazil; [da Fonseca-Kruel, Viviane Stern] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil; [Matta, Priscila] Univ Sao Paulo CEstA USP, Amerindian Studies Ctr, Sao Paulo, Brazil; [da Cruz, Crenilda; dos Santos, Maria Alice; Silva Gomes, Maria Angelica] Assoc Remanescentes Quilombo Cambury, Ubatuba, SP, Brazil; [Pereira Barretto, Eduardo Hortal; Francischetti Garcia, Ricardo Jose; Honda, Sumiko] Secretaria Municipal Verde Meio Ambiente Prefeitu, Herbario Municipal PMSP, Sao Paulo, Brazil; [Domingues Passero, Luiz Felipe] Sao Paulo State Univ, UNESP, Inst Biosci, Sao Vicente, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Jardim Botanico do Rio de Janeiro; Universidade Estadual Paulista	Sauini, T (corresponding author), Univ Fed Sao Paulo, UNIFESP, Ctr Ethnobot & Ethnopharmacol Studies CEE, Dept Environm Sci, Sao Paulo, Brazil.	tha.sauini@gamil.com	Cassas, Fernando/AAM-5743-2020; Rodrigues, Eliana/B-5839-2013; Passero, Luiz Felipe D/B-9549-2012	Cassas, Fernando/0000-0002-5923-9919; Rodrigues, Eliana/0000-0001-8847-6676; Passero, Luiz Felipe D/0000-0002-5986-6381; Reis, AlessanRSS/0000-0001-8486-7469	FAPESP BIOTA PROGRAM [2015/120460]; CNPq -Universal 2016 [400802/2016-3]	FAPESP BIOTA PROGRAM(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq -Universal 2016	The research was funded by FAPESP BIOTA PROGRAM (process number 2015/120460) and CNPq -Universal 2016 (process number 400802/2016-3) to ER.	Alexiades MN., 1996, SELECTED GUIDELINES; AMOROZO M C D M, 1988, Boletim do Museu Paraense Emilio Goeldi Serie Botanica, V4, P47; Barroso RM, 2010, ACTA BOT BRAS, V24, P518, DOI 10.1590/S0102-33062010000200022; Begossi A, 2002, HUM ECOL, V30, P281, DOI 10.1023/A:1016564217719; Beltreschi L, 2019, ENVIRON DEV SUSTAIN, V21, P1185, DOI 10.1007/s10668-017-0079-6; Bernard H.R., 1988, RES METHODS CULTURAL; CFCBR Almeida, 2002, INTERCIENCIA, V27, P276; Cunninghan AB, 2001, CONSERVATION MANUAL; Albuquerque UP, 2009, BIODIVERS CONSERV, V18, P127, DOI 10.1007/s10531-008-9463-8; de Santana BF, 2016, J ETHNOPHARMACOL, V181, P37, DOI 10.1016/j.jep.2016.01.014; Ericson JA, 2006, LANDSCAPE URBAN PLAN, V74, P242, DOI 10.1016/j.landurbplan.2004.09.006; Etkin NL, 2005, INTEGRATING ETHNOGRA, P1; Garcia D, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-29; GARLET T. M. B., 2001, REV BRAS PLANTAS MED, V4, P9; Gilmore MP, 2012, J ETHNOBIOL, V32, P6, DOI 10.2993/0278-0771-32.1.6; Goebel A, 1998, DEV CHANGE, V29, P277, DOI 10.1111/1467-7660.00079; Gomes TB, 2012, ACTA BOT BRAS, V26, P796, DOI 10.1590/S0102-33062012000400009; Grasser S, 2016, J ETHNOBIOL ETHNOMED, V12, DOI 10.1186/s13002-016-0119-6; Hitziger M, 2016, J ETHNOPHARMACOL, V186, P61, DOI 10.1016/j.jep.2016.03.040; Hunn Eugene, 2007, Journal of Ethnobiology, V27, P1, DOI 10.2993/0278-0771(2007)27[1:EIFP]2.0.CO;2; INPE, 2018, ATL REM FLOR MAT ATL; Johnson N, 2004, NAT RESOUR FORUM, V28, P189, DOI 10.1111/j.1477-8947.2004.00088.x; Jovchelevich P, 2008, REV BRAS AGROECOL, V3, P1; Kalibo HW, 2007, LANDSCAPE URBAN PLAN, V82, P145, DOI 10.1016/j.landurbplan.2007.02.005; Kawa NC, 2016, CULT AGRIC FOOD ENVI, V38, P84, DOI 10.1111/cuag.12073; Santos JDL, 2012, J ETHNOPHARMACOL, V142, P503, DOI 10.1016/j.jep.2012.05.027; Malinowski B, 1990, DESVENDANDO MASCARAS, P39; Martinelli G, 2013, LIVRO VERMELHO FLORA; Medley KE, 2005, FIELD METHOD, V17, P302, DOI [10.1177/1525822X05277462, DOI 10.1177/1525822X05277462]; Merzouki A, 2000, FITOTERAPIA, V71, P278, DOI 10.1016/S0367-326X(00)00139-8; Moreira FR, 2017, REV BRAS CIENC, V5, P5; Mosse D., 2001, Participation: the new tyranny?, P16; Neto F.R.G, 2014, Rev. bras. plantas med., V16, P856, DOI 10.1590/1983-084X/11_207; O PAULO, 2002, REL TECN CIENT REM C; Oliveira L.R., 2015, REV VERDE AGROECOLOG, V10, P25, DOI [10.18378/rvads.v10i3.3408, DOI 10.18378/RVADS.V10I3.3408]; Paniagua-Zambrana NY, 2018, J ETHNOBIOL ETHNOMED, V9, P14; Pinto Erika de Paula Pedro, 2006, Acta Bot. Bras., V20, P751, DOI 10.1590/S0102-33062006000400001; Rego C.A.R.M., 2016, ACTA AGRON, V65, P284, DOI [10.15446/acag.v65n3.50240, DOI 10.15446/ACAG.V65N3.50240]; Rodrigues E, 2005, PHYTOTHER RES, V19, P129, DOI 10.1002/ptr.1636; Rodrigues E, 2004, PHYTOTHER RES, V18, P748, DOI 10.1002/ptr.1535; Rodrigues E, 2006, PHYTOTHER RES, V20, P378, DOI 10.1002/ptr.1866; Gazzaneo LRS, 2005, J ETHNOBIOL ETHNOMED, V1, DOI 10.1186/1746-4269-1-9; Schultes R.E, 2008, ETHNOBOTANY EVOLUTIO; Crepaldi MOS, 2010, BIODIVERS CONSERV, V19, P37, DOI 10.1007/s10531-009-9700-9; Silva N.C.B., 2012, B LATINOAM CARIBE PL, V11, P435; Stepp J.R., 2005, FIELD METHOD, V17, P211, DOI [10.1177/1525822X05277459, DOI 10.1177/1525822X05277459]; Tribess B, 2015, J ETHNOPHARMACOL, V164, P136, DOI 10.1016/j.jep.2015.02.005; Tuler AC, 2011, LEVANTAMENTO ETNOBOT; Voeks RA, 1996, ECON BOT, V50, P381, DOI 10.1007/BF02866520; Wolverton S, 2013, ETHNOBIOL LETT, V4, P21; Yazbek PB, 2019, J ETHNOPHARMACOL, V244, DOI 10.1016/j.jep.2019.112123; Zank S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174731	52	3	3	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232288	10.1371/journal.pone.0232288	http://dx.doi.org/10.1371/journal.pone.0232288			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZX	32379779	Green Published, gold			2022-12-26	WOS:000537285700029
J	Souza, MR; Ibelli, AMG; Savoldi, IR; Cantao, ME; Peixoto, JD; Mores, MAZ; Lopes, JS; Coutinho, LL; Ledur, MC				Souza, Mayla Regina; Guaratini Ibelli, Adriana Mercia; Savoldi, Igor Ricardo; Cantao, Mauricio Egidio; Peixoto, Jane de Oliveira; Zanella Mores, Marcos Antonio; Lopes, Jader Silva; Coutinho, Luiz Lehmann; Ledur, Monica Correa			Transcriptome analysis identifies genes involved with the development of umbilical hernias in pigs	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COLLAGEN VI ALPHA-5; EXTRACELLULAR-MATRIX; CELL-ADHESION; ACTIN POLYMERIZATION; HENNEKAM SYNDROME; C-FOS; EXPRESSION; MUTATIONS; APOPTOSIS	Umbilical hernia (UH) is one of the most frequent defects affecting pig production, however, it also affects humans and other mammals. UH is characterized as an abnormal protrusion of the abdominal contents to the umbilical region, causing pain, discomfort and reduced performance in pigs. Some genomic regions associated to UH have already been identified, however, no study involving RNA sequencing was performed when umbilical tissue is considered. Therefore, here, we have sequenced the umbilical ring transcriptome of five normal and five UH-affected pigs to uncover genes and pathways involved with UH development. A total of 13,216 transcripts were expressed in the umbilical ring tissue. From those, 230 genes were differentially expressed (DE) between normal and UH-affected pigs (FDR < 0.05), being 145 downregulated and 85 upregulated in the affected compared to the normal pigs. A total of 68 significant biological processes were identified and the most relevant were extracellular matrix, immune system, anatomical development, cell adhesion, membrane components, receptor activation, calcium binding and immune synapse. The results pointed out ACAN, MMPs, COLs, EPYC, VIT, CCBE1 and LGALS3 as strong candidates to trigger umbilical hernias in pigs since they act in the extracellular matrix remodeling and in the production, integrity and resistance of the collagen. We have generated the first transcriptome of the pig umbilical ring tissue, which allowed the identification of genes that had not yet been related to umbilical hernias in pigs. Nevertheless, further studies are needed to identify the causal mutations, SNPs and CNVs in these genes to improve our understanding of the mechanisms of gene regulation.	[Souza, Mayla Regina; Savoldi, Igor Ricardo; Ledur, Monica Correa] Univ Estado Santa Catarina, Ctr Educ Super Oeste, UDESC, Programa Posgrad Zootecnia, Chapeco, SC, Brazil; [Guaratini Ibelli, Adriana Mercia; Cantao, Mauricio Egidio; Peixoto, Jane de Oliveira; Zanella Mores, Marcos Antonio; Ledur, Monica Correa] Embrapa Suinos & Aves, Concordia, SC, Brazil; [Lopes, Jader Silva] BRF SA, Faxinal Dos Guedes, SC, Brazil; [Coutinho, Luiz Lehmann] Univ Sao Paulo, Lab Biotecnol Anim, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil	Universidade do Estado de Santa Catarina; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo	Ledur, MC (corresponding author), Univ Estado Santa Catarina, Ctr Educ Super Oeste, UDESC, Programa Posgrad Zootecnia, Chapeco, SC, Brazil.; Ledur, MC (corresponding author), Embrapa Suinos & Aves, Concordia, SC, Brazil.	monica.ledur@embrapa.br	Souza, Mayla/AAD-9252-2021; Coutinho, Luiz L/C-8455-2012; Ibelli, Adriana/B-4510-2010; Ledur, Monica/A-5667-2013	Souza, Mayla/0000-0002-2452-9633; Coutinho, Luiz L/0000-0002-7266-8881; Ibelli, Adriana/0000-0003-0626-8879; Savoldi, Igor Ricardo/0000-0001-6821-1523; Ledur, Monica/0000-0002-2645-4735	National Council of Scientific and Technological Development (CNPq) from the Brazilian Government [476146/2013-5]; CAPES/FAPESC scholarship; PROMOP/UDESC scholarship; Coordenacao de Aperfeioamento de Pessoal de Ni'vel Superior-Brasil (CAPES) [001]	National Council of Scientific and Technological Development (CNPq) from the Brazilian Government(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/FAPESC scholarship; PROMOP/UDESC scholarship; Coordenacao de Aperfeioamento de Pessoal de Ni'vel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by project #476146/2013-5 from the National Council of Scientific and Technological Development (CNPq) from the Brazilian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MRS was sponsored by a CAPES/FAPESC scholarship. IRS receives a PROMOP/UDESC scholarship. The authors are grateful to Alexandre L. Tessmann for technical assistance. MCL and LLC are CNPq fellows. We thank the Coordenacao de Aperfeioamento de Pessoal de Ni ' vel Superior-Brasil (CAPES-Finance Code 001) for the free access to the journals used in the literature review.	Abdulhaleem MFA, 2015, DEV NEUROBIOL, V75, P494, DOI 10.1002/dneu.22238; Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Alexandratos N., 2012, WORLD AGR 2030 2050, DOI DOI 10.22004/AG.ECON.288998; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Antoniou SA, 2009, EUR J CLIN INVEST, V39, P953, DOI 10.1111/j.1365-2362.2009.02199.x; Appierto V, 2004, CELL DEATH DIFFER, V11, P270, DOI 10.1038/sj.cdd.4401349; Atkinson M, 2017, CVJ; Bae SH, 2014, HUM MUTAT, V35, P1506, DOI 10.1002/humu.22701; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson M, 2009, ALLERGY, V64, P1286, DOI 10.1111/j.1398-9995.2009.01991.x; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Byers PH, 2012, J INVEST DERMATOL, V132, pE6, DOI 10.1038/skinbio.2012.3; COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9; Connell F, 2010, HUM GENET, V127, P231, DOI 10.1007/s00439-009-0766-y; Csikos M, 2004, EXP DERMATOL, V13, P185, DOI 10.1111/j.0906-6705.2004.0120.x; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; De Paepe A, 2012, CLIN GENET, V82, P1, DOI 10.1111/j.1399-0004.2012.01858.x; Deere M, 1999, GENOME RES, V9, P449; Diaz R, 2011, AM J PATHOL, V178, P2641, DOI 10.1016/j.ajpath.2011.02.044; Ding NS, 2009, J ANIM SCI, V87, P2469, DOI 10.2527/jas.2008-1601; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doege H, 2000, BIOCHEM J, V350, P771, DOI 10.1042/0264-6021:3500771; Dragos A, 2017, TRENDS MICROBIOL, V25, P257, DOI 10.1016/j.tim.2016.12.010; Eming SA, 2007, CLIN DERMATOL, V25, P79, DOI 10.1016/j.clindermatol.2006.09.011; Eser B, 2010, GENET TEST MOL BIOMA, V14, P313, DOI 10.1089/gtmb.2009.0202; Fernandes LT, P WORLD C GEN APPL L; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Franz MG, 2008, SURG CLIN N AM, V88, P1, DOI 10.1016/j.suc.2007.10.007; Gee HY, 2015, J CLIN INVEST, V125, P2375, DOI 10.1172/JCI79504; Gerber PJ, 2010, MEAT SCI, V84, P244, DOI 10.1016/j.meatsci.2009.10.016; Glorieux FH, 2008, BEST PRACT RES CL RH, V22, P85, DOI 10.1016/j.berh.2007.12.012; Grindflek E, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4812-9; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Harrison B, 2016, PRS-GLOB OPEN, V4, DOI 10.1097/GOX.0000000000001036; HARTWIG NG, 1989, HUM PATHOL, V20, P1071, DOI 10.1016/0046-8177(89)90225-6; HAYES HM, 1974, AM J VET RES, V35, P839; HEINEGARD D, 1989, FASEB J, V3, P2042, DOI 10.1096/fasebj.3.9.2663581; Helmersson J, 2009, PROSTAG LEUKOTR ESS, V80, P51, DOI 10.1016/j.plefa.2008.11.001; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Hu ZL, 2019, NUCLEIC ACIDS RES, V47, pD701, DOI 10.1093/nar/gky1084; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Ivanovski I, 2018, AM J MED GENET A, V176, P1166, DOI 10.1002/ajmg.a.38652; Jackson CC, 2016, J CLIN IMMUNOL, V36, P19, DOI 10.1007/s10875-015-0225-6; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Jimenez-Heffernan JA, 2004, VIRCHOWS ARCH, V444, P247, DOI 10.1007/s00428-003-0963-3; Johnson JL, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015297; Khalili AA, 2015, INT J MOL SCI, V16, P18149, DOI 10.3390/ijms160818149; Kohn KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099269; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Kremmidiotis G, 1998, GENOMICS, V49, P467, DOI 10.1006/geno.1998.5281; Kurita K, 1996, BIOCHEM J, V318, P909, DOI 10.1042/bj3180909; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Li X, 2019, ANIM GENET, V50, P162, DOI 10.1111/age.12760; Liao X J, 2015, Genetika, V51, P1163, DOI 10.7868/S0016675815100100; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Long Y, 2016, ANIM GENET, V47, P298, DOI 10.1111/age.12402; Lorenzetti WR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204348; Lugassy J, 2006, AM J HUM GENET, V79, P724, DOI 10.1086/507792; Mahner S, 2008, BRIT J CANCER, V99, P1269, DOI 10.1038/sj.bjc.6604650; Martin-Alguacil N, 2020, J COMP PATHOL, V175, P69, DOI 10.1016/j.jcpa.2019.12.003; Mayer JE, 2013, SPINE J, V13, P299, DOI 10.1016/j.spinee.2013.01.041; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Muller FB, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9437; Neice AE, 2016, J CLIN ANESTH, V33, P26, DOI 10.1016/j.jclinane.2016.01.005; OKUDA S, 1990, J CLIN INVEST, V86, P453, DOI 10.1172/JCI114731; Perera RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181580; Petersen HH, 2008, VET REC, V162, P377, DOI 10.1136/vr.162.12.377; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; Polosa R, 2000, J ALLERGY CLIN IMMUN, V106, P1124; Purcell JW, 2018, CANCER RES, V78, P4059, DOI 10.1158/0008-5472.CAN-18-0327; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Radu P, 2015, CHIRURGIA-BUCHAREST, V110, P224; RCoreTeam R, 2008, R LANG ENV STAT COMP; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romano GD, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020117; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Rutten-Ramos SC, 2006, J SWINE HEAL PROD; Sabatelli P, 2012, MATRIX BIOL, V31, P187, DOI 10.1016/j.matbio.2011.12.003; Sabatelli P, 2011, J INVEST DERMATOL, V131, P99, DOI 10.1038/jid.2010.284; Sato T, 2006, ARTHRITIS RHEUM-US, V54, P808, DOI 10.1002/art.21638; Satoh K, 2002, BIOCHEM BIOPH RES CO, V290, P756, DOI 10.1006/bbrc.2001.6272; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; Scheuerle AE, 2018, AM J MED GENET A, V176, P2858, DOI 10.1002/ajmg.a.40633; Schuilenga-Hut PHL, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9124; Schumpelick V, 2007, RECURRENT HERNIA PRE, P359; Searcy-Bernal R, 1994, J AM VET MED ASS; Sevillano CA, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0096-6; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Spycher M, 2018, ANIM GENET, V49, P641, DOI 10.1111/age.12727; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Tagliavini F, 2014, BBA-MOL BASIS DIS, V1842, P1604, DOI 10.1016/j.bbadis.2014.05.033; Tajima M, 1999, J VET INTERN MED, V13, P202, DOI 10.1892/0891-6640(1999)013&lt;0202:GDODSP&gt;2.3.CO;2; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thaller G, 1996, J ANIM BREED GENET, V113, P77, DOI 10.1111/j.1439-0388.1996.tb00593.x; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanegas OC, 2001, P NATL ACAD SCI USA, V98, P7516; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Vlahakis A, 2017, J MOL BIOL, V429, P515, DOI 10.1016/j.jmb.2016.11.027; Walters R., 2016, PIGPROGRESS GENETIC; Wang PF, 2009, MOL VIS, V15, P2045; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu RJ, 2016, ONCOTARGET, V7, P18440, DOI 10.18632/oncotarget.7825; Yamaguchi F, 2016, TOHOKU J EXP MED, V240, P67, DOI 10.1620/tjem.240.67; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; ZEMPO N, 1994, J VASC SURG, V20, P209, DOI 10.1016/0741-5214(94)90008-6; Zhang JP, 2013, J BIOL CHEM, V288, P8053, DOI 10.1074/jbc.M112.433995; Zhang RZ, 2002, J BIOL CHEM, V277, P43557, DOI 10.1074/jbc.M207696200; Zhao X, 2009, ASS HOXA10 ZFPM2 MMP, V65, P1368; Zhbannikov IY, 2017, ACM-BCB' 2017: PROCEEDINGS OF THE 8TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY,AND HEALTH INFORMATICS, P407, DOI 10.1145/3107411.3107446; Zheng H, 2002, WORLD J SURG, V26, P401, DOI 10.1007/s00268-001-0239-5	118	4	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232542	10.1371/journal.pone.0232542	http://dx.doi.org/10.1371/journal.pone.0232542			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379844	gold, Green Published			2022-12-26	WOS:000537285700038
J	Moon, SW; Lee, EH; Choi, JS; Leem, AY; Lee, SH; Lee, SH; Kim, SY; Chung, KS; Jung, JY; Park, MS; Kim, YS; Kang, YA				Moon, Sung Woo; Lee, Eun Hye; Choi, Ji Soo; Leem, Ah Young; Lee, Su Hwan; Lee, Sang Hoon; Kim, Song Yee; Chung, Kyung Soo; Jung, Ji Ye; Park, Moo Suk; Kim, Young Sam; Kang, Young Ae			Impact of prognostic nutritional index on outcomes in patients with Mycobacterium avium complex pulmonary disease	PLOS ONE			English	Article							GASTRIC-CANCER PATIENTS; LUNG-DISEASE; LYMPHOCYTE; COMPLICATIONS; INFLAMMATION; RECURRENCE; ALBUMIN; SCORE	Onodera's prognostic nutritional index (PNI) is useful in predicting prognosis of various diseases. But the usefulness of PNI in non-surgical patients has not been sufficiently proven yet. In patients with mycobacterium avium complex pulmonary disease (MAC-PD), malnutrition is an important factor that affects the quality of life and morbidity. Here, we aimed to evaluate whether PNI is related with clinical outcomes in MAC-PD patients. We examined 663 patients diagnosed with MAC-PD between May 2005 and November 2017. PNI score was calculated at the time of diagnosis and treatment initiation, and patients were divided into malnutrition and non-malnutrition groups according to a cut-off PNI score of 45. As the recommended duration of treatment for MAC-PD is 12 months following sputum conversion, treatment duration less than 12 months was defined as treatment intolerance. Survivals were compared with the log-rank test. Multivariate logistic regression and multivariate Cox proportional hazards models were used to estimate the odds ratio (OR) and hazards ratio (HR) for treatment intolerance and mortality, respectively. Of the 306 patients that received treatment, 193 received treatment longer than 12 months. In the multivariable logistic regression model, malnutrition at the time of treatment initiation was related with treatment intolerance (OR: 2.559, 95% confidence interval [CI]: 1.414-4.634, P = 0.002). Patients in the malnutrition group at the time of diagnosis exhibited lower survival (P < 0.001) and malnutrition at the time of diagnosis was a significant risk for all-cause mortality (HR: 2.755, 95% CI: 1.610-4.475, P<0.001). Malnutrition, as defined by PNI, is an independent predictor for treatment intolerance and all-cause mortality in patients with MAC-PD.	[Moon, Sung Woo; Lee, Eun Hye; Choi, Ji Soo; Leem, Ah Young; Lee, Su Hwan; Lee, Sang Hoon; Kim, Song Yee; Chung, Kyung Soo; Jung, Ji Ye; Park, Moo Suk; Kim, Young Sam; Kang, Young Ae] Yonsei Univ, Severance Hosp, Dept Internal Med, Coll Med,Div Pulmonol, Seoul, South Korea; [Kang, Young Ae] Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kang, YA (corresponding author), Yonsei Univ, Severance Hosp, Dept Internal Med, Coll Med,Div Pulmonol, Seoul, South Korea.; Kang, YA (corresponding author), Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul, South Korea.	mdkang@yuhs.ac	Jung, Ji Ye/AAB-4993-2021	Leem, Ah Young/0000-0001-5165-3704; Kim, Song Yee/0000-0001-8627-486X; Jung, Ji Ye/0000-0003-1589-4142; Choi, Ji Soo/0000-0003-2716-6775; Lee, Eun Hye/0000-0003-2570-3442; Chung, Kyung Soo/0000-0003-1604-8730; Lee, Sang Hoon/0000-0002-7706-5318; Lee, Su Hwan/0000-0002-3487-2574; Kang, Young Ae/0000-0002-7783-5271; Moon, Sung Woo/0000-0001-9917-9802; Kim, Young Sam/0000-0001-9656-8482; Park, Moo Suk/0000-0003-0820-7615				Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; ARORA NS, 1982, AM REV RESPIR DIS, V126, P5; BALAKRISHNAN K, 1995, IMMUNOL INVEST, V24, P233, DOI 10.3109/08820139509062775; Bossi P, 2018, ESMO OPEN, V3, DOI 10.1136/esmoopen-2018-000449; CHANDRA RK, 1982, NUTR RES, V2, P223, DOI 10.1016/S0271-5317(82)80003-1; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Field SK, 2003, CHEST, V124, P1482, DOI 10.1378/chest.124.4.1482; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Henkle E, 2015, ANN AM THORAC SOC, V12, P642, DOI 10.1513/AnnalsATS.201412-559OC; Huppert FA, 1998, EXP GERONTOL, V33, P593, DOI 10.1016/S0531-5565(98)00033-3; Hwang JA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00537-2016; Kanda M, 2011, BRIT J SURG, V98, P268, DOI 10.1002/bjs.7305; Kartalija M, 2013, AM J RESP CRIT CARE, V187, P197, DOI 10.1164/rccm.201206-1035OC; Kim CY, 2018, CLIN NUTR EDINBURGH, DOI [10.5588/ijtld.14.0139, DOI 10.5588/IJTLD.14.0139]; Kim RD, 2008, AM J RESP CRIT CARE, V178, P1066, DOI 10.1164/rccm.200805-686OC; Kim SJ, 2014, INT J TUBERC LUNG D, V18, P730, DOI 10.5588/ijtld.13.0792; Kim SJ, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-016-0349-3; Kim SY, 2017, DIAGN MICR INFEC DIS, V88, P125, DOI 10.1016/j.diagmicrobio.2017.02.017; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Kuroda D, 2018, GASTRIC CANCER, V21, P204, DOI 10.1007/s10120-017-0744-3; Kwon YS, 2019, TUBERC RESPIR DIS, V82, P15, DOI 10.4046/trd.2018.0060; Leon JB, 2001, J RENAL NUTR, V11, P9, DOI 10.1016/S1051-2276(01)79890-1; Marras TK, 2013, EMERG INFECT DIS, V19, P1889, DOI 10.3201/eid1911.130737; Mehta M, 2011, RESP MED, V105, P1718, DOI 10.1016/j.rmed.2011.08.004; Migita K, 2013, ANN SURG ONCOL, V20, P2647, DOI 10.1245/s10434-013-2926-5; Min J, 2015, INT J TUBERC LUNG D, V19, P1239, DOI 10.5588/ijtld.14.0139; Nozoe T, 2002, EUR J SURG ONCOL, V28, P396, DOI 10.1053/ejso.2002.1257; Nozoe T, 2012, SURG TODAY, V42, P532, DOI 10.1007/s00595-011-0061-0; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Pan QX, 2017, MOL CLIN ONCOL, V6, P566, DOI 10.3892/mco.2017.1166; Pinato DJ, 2012, BRIT J CANCER, V106, P1439, DOI 10.1038/bjc.2012.92; Sakurai K, 2016, ANN SURG ONCOL, V23, P525, DOI 10.1245/s10434-015-4814-7; Schols AM, 2014, EUR RESPIR J, V44, P1504, DOI 10.1183/09031936.00070914; Siedner MJ, 2018, J INFECT DIS, V217, P347, DOI 10.1093/infdis/jix463; Tokunaga R, 2015, DIS COLON RECTUM, V58, P1048, DOI 10.1097/DCR.0000000000000458; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; Toth S, 2004, WIEN KLIN WOCHENSCHR, V116, P617, DOI 10.1007/s00508-004-0226-6; van Ingen J, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00170-2018; Yang YC, 2016, ONCOTARGET, V7, P58543, DOI 10.18632/oncotarget.10148	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232714	10.1371/journal.pone.0232714	http://dx.doi.org/10.1371/journal.pone.0232714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374770	Green Published, gold			2022-12-26	WOS:000537283500053
J	Han, ZY; Ruthel, G; Dash, S; Berry, CT; Freedman, BD; Harty, RN; Shtanko, O				Han, Ziying; Ruthel, Gordon; Dash, Shantoshini; Berry, Corbett T.; Freedman, Bruce D.; Harty, Ronald N.; Shtanko, Olena			Angiomotin regulates budding and spread of Ebola virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ebola virus; angiomotin (Amot); filovirus; budding; virus-like particle (VLP); PPxY motif; L-domain; Hippo pathway; WW-domain protein; Yes-associated protein (YAP); virology; virus; actin; angiomotin; budding; filovirus; virus-like particle (VLP)	CELL-PROLIFERATION; FAMILY-MEMBERS; HOST PROTEINS; VP40 PROTEIN; INTERACTS; DOMAINS; TSG101	The Ebola virus (EBOV) VP40 matrix protein (eVP40) orchestrates assembly and budding of virions in part by hijacking select WW-domain?bearing host proteins via its PPxY late (L)-domain motif. Angiomotin (Amot) is a multifunctional PPxY-containing adaptor protein that regulates angiogenesis, actin dynamics, and cell migration/motility. Amot also regulates the Hippo signaling pathway via interactions with the WW-domain?containing Hippo effector protein Yes-associated protein (YAP). In this report, we demonstrate that endogenous Amot is crucial for positively regulating egress of eVP40 virus-like particles (VLPs) and for egress and spread of authentic EBOV. Mechanistically, we show that ectopic YAP expression inhibits eVP40 VLP egress and that Amot co-expression rescues budding of eVP40 VLPs in a dose-dependent and PPxY-dependent manner. Moreover, results obtained with confocal and total internal reflection fluorescence microscopy suggested that Amot's role in actin organization and dynamics also contributes to promoting eVP40-mediated egress. In summary, these findings reveal a functional and competitive interplay between virus and host proteins involving the multifunctional PPxY-containing adaptor Amot, which regulates both the Hippo pathway and actin dynamics. We propose that our results have wide-ranging implications for understanding the biology and pathology of EBOV infections.	[Han, Ziying; Ruthel, Gordon; Dash, Shantoshini; Berry, Corbett T.; Freedman, Bruce D.; Harty, Ronald N.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA USA; [Shtanko, Olena] Texas Biomed Res Inst, Host Pathogen Interact, San Antonio, TX 78227 USA	University of Pennsylvania; Texas Biomedical Research Institute	Harty, RN (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA USA.; Shtanko, O (corresponding author), Texas Biomed Res Inst, Host Pathogen Interact, San Antonio, TX 78227 USA.	rharty@vet.upenn.edu; oshtanko@txbiomed.org	Ruthel, Gordon/GYU-9133-2022	Ruthel, Gordon/0000-0001-9193-5589; Shtanko, Olena/0000-0002-9848-8870	University Research Foundation Award (Penn); National Institutes of Health [AI138052, AI139392]; Texas Biomedical Research Institute	University Research Foundation Award (Penn); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Biomedical Research Institute	Funding was provided in part by a University Research Foundation Award (Penn) and National Institutes of Health Grants AI138052 and AI139392 (to R. N. H.). Biosafety level-4 live virus studies were supported by the Texas Biomedical Research Institute (to O. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Chan SW, 2013, J BIOL CHEM, V288, P37296, DOI 10.1074/jbc.M113.527598; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Han ZY, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008231; Hartlieb B, 2006, VIROLOGY, V344, P64, DOI 10.1016/j.virol.2005.09.018; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Hong WJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004573; Jasenosky LD, 2004, VIRUS RES, V106, P181, DOI 10.1016/j.virusres.2004.08.014; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Liu YJ, 2011, IEEE SYS MAN CYBERN, P2011, DOI 10.1109/ICSMC.2011.6083967; Lv M, 2017, INT J BIOL SCI, V13, P772, DOI 10.7150/ijbs.19603; Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701; Mercenne G, 2015, ELIFE, V4, DOI 10.7554/eLife.03778; Moleirinho S, 2017, ELIFE, V6, DOI 10.7554/eLife.23966; Moleirinho S, 2014, FEBS LETT, V588, P2693, DOI 10.1016/j.febslet.2014.02.006; Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099; Pei ZF, 2010, VIROLOGY, V397, P155, DOI 10.1016/j.virol.2009.11.002; Proszynski TJ, 2013, J CELL SCI, V126, P2225, DOI 10.1242/jcs.121327; Ray G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020128; Shtanko O, 2018, ANTIVIR RES, V149, P154, DOI 10.1016/j.antiviral.2017.11.016; Spadaro D, 2012, ESSAYS BIOCHEM, V53, P83, DOI [10.1042/BSE0530083, 10.1042/bse0530083]; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; van den Dries K, 2019, J CELL SCI, V132, DOI 10.1242/jcs.236828; Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003; Zeng XK, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.113; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	27	7	7	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8596	8601		10.1074/jbc.AC120.013171	http://dx.doi.org/10.1074/jbc.AC120.013171			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32381509	hybrid, Green Published			2022-12-26	WOS:000546986500023
J	Reig-Valiente, JL; Borreda, C; Talon, M; Domingo, C				Luis Reig-Valiente, Juan; Borreda, Carles; Talon, Manuel; Domingo, Concha			The G123 rice mutant, carrying a mutation in SE13, presents alterations in the expression patterns of photosynthetic and major flowering regulatory genes	PLOS ONE			English	Article							PHOTOPERIODIC CONTROL; NATURAL VARIATION; HEADING DATE; RED LIGHT; PHYTOCHROME; CONSTANS; TIME; CULTIVATION; ADAPTATION; REPRESSOR	Day length is a determinant of flowering time in rice. Phytochromes participate in flowering regulation by measuring the number of daylight hours to which the plant is exposed. Here we describe G123, a rice mutant generated by irradiation, which displays insensitivity to the photoperiod and early flowering under both long day and short day conditions. To detect the mutation responsible for the early flowering phenotype exhibited by G123, we generated an F2 population, derived from crossing with the wild-type, and used a pipeline to detect genomic structural variation, initially developed for human genomes. We detected a deletion in the G123 genome that affects the PHOTOPERIOD SENSITIVITY13 (SE13) gene, which encodes a phytochromobilin synthase, an enzyme implicated in phytochrome chromophore biosynthesis. The transcriptomic analysis, performed by RNA-seq, in the G123 plants indicated an alteration in photosynthesis and other processes related to response to light. The expression patterns of the main flowering regulatory genes, such as Ghd7, Ghd8 and PRR37, were altered in the plants grown under both long day and short day conditions. These findings indicate that phytochromes are also involved in the regulation of these genes under short day conditions, and extend the role of phytochromes in flowering regulation in rice.	[Luis Reig-Valiente, Juan; Borreda, Carles; Talon, Manuel; Domingo, Concha] Inst Valenciano Invest Agr, Ctr Genom, Moncada, Spain; [Luis Reig-Valiente, Juan] Swedish Univ Agr Sci, Dept Plant Biol, Uppsala, Sweden; [Luis Reig-Valiente, Juan] Swedish Univ Agr Sci, Linnean Ctr Plant Biol, Uppsala, Sweden	Instituto Valenciano de Investigaciones Agrarias (IVIA); Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Domingo, C (corresponding author), Inst Valenciano Invest Agr, Ctr Genom, Moncada, Spain.	domingo_concar@gva.es	Domingo, Concha/D-3372-2012; Talon, Manuel/C-8540-2014; Borreda, Carles/R-6914-2018	Domingo, Concha/0000-0002-7204-7591; Talon, Manuel/0000-0003-4291-9333; Reig Valiente, Juan Luis/0000-0001-9894-0196; Borreda, Carles/0000-0001-9624-7152	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [RTA2014-00058-C03-01]; European Social Fund [01/14-FSE-0]; Generalitat Valenciana [ACIF/2016/117]	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); European Social Fund(European Social Fund (ESF)); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA, http://www.inia.es) (grant RTA2014-00058-C03-01). JLRV was funded by the European Social Fund (https://ec.europa.eu/social/).(fellowship number 01/14-FSE-0) and CB by Generalitat Valenciana (https://www.gva.es/) (ACIF/2016/117) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Andres F, 2009, PLANT PHYSIOL, V151, P681, DOI 10.1104/pp.109.139097; Brambilla V, 2017, PLANT CELL, V29, P2801, DOI 10.1105/tpc.17.00645; Chiang C, 2015, NAT METHODS, V12, P966, DOI [10.1038/nmeth.3505, 10.1038/NMETH.3505]; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Endo-Higashi N, 2011, PLANT CELL PHYSIOL, V52, P1083, DOI 10.1093/pcp/pcr059; Gomez-Ariza J, 2015, J EXP BOT, V66, P2027, DOI 10.1093/jxb/erv004; Goretti D, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006530; Gross BL, 2014, P NATL ACAD SCI USA, V111, P6190, DOI 10.1073/pnas.1308942110; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Itoh H, 2019, PLANT CELL PHYSIOL, V60, P549, DOI 10.1093/pcp/pcy225; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Izawa T, 2007, J EXP BOT, V58, P3091, DOI 10.1093/jxb/erm159; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Koo BH, 2013, MOL PLANT, V6, P1877, DOI 10.1093/mp/sst088; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Lazaro A, 2015, PLANT CELL, V27, P2437, DOI 10.1105/tpc.15.00529; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naranjo L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-101; Nemoto Y, 2016, PLANT J, V86, P221, DOI 10.1111/tpj.13168; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; Osugi A, 2011, PLANT PHYSIOL, V157, P1128, DOI 10.1104/pp.111.181792; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saito H, 2011, THEOR APPL GENET, V122, P109, DOI 10.1007/s00122-010-1426-2; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Takano M, 2009, P NATL ACAD SCI USA, V106, P14705, DOI 10.1073/pnas.0907378106; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Wu WX, 2013, P NATL ACAD SCI USA, V110, P2775, DOI 10.1073/pnas.1213962110; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Yang Y, 2013, MOL PLANT, V6, P202, DOI 10.1093/mp/sss062; Yoshitake Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep07709; Yu JW, 2008, MOL CELL, V32, P617, DOI 10.1016/j.molcel.2008.09.026; Zhao JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043705; Zheng TH, 2019, NEW PHYTOL, V224, P306, DOI 10.1111/nph.16010	42	3	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233120	10.1371/journal.pone.0233120	http://dx.doi.org/10.1371/journal.pone.0233120			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421736	Green Published, gold			2022-12-26	WOS:000537499600029
J	Diallo, MA; Badiane, AS; Diongue, K; Sakande, L; Ndiaye, M; Seck, MC; Ndiaye, D				Diallo, Mamadou Alpha; Badiane, Aida Sadikh; Diongue, Khadim; Sakande, Linda; Ndiaye, Mouhamadou; Seck, Mame Cheikh; Ndiaye, Daouda			A twenty-eight-year laboratory-based retrospective trend analysis of malaria in Dakar, Senegal	PLOS ONE			English	Article							MORTALITY	Introduction Health facility-based records offer a rich source of information to understand trends and changes in malaria cases over time. This study is aimed at determining the changes in malaria occurrence over the last 28 years, from 1989 to 2016 in Dakar, Senegal. Methods Laboratory suspected and confirmed malaria records from 1989 to 2016 were reviewed from the laboratory registers of the Laboratory of Parasitology and Mycology of Aristide Le Dantec Hospital. Interrupted time series (ITS) analysis was used to estimate the changes by comparing malaria cases post-intervention (2006-2016) with that of the pre-intervention (1989-2005) period. Results A total of 5,876 laboratory confirmed malaria cases were reported out of 29,852 tested cases, with total slide positivity rate (SPR) of 19.7%. Malaria case counts exhibited a fluctuating trend with major peaks occurring in the years 1995 and 2003 with SPR of 42.3% and 42.5%, respectively. Overall, a remarkable decline in the total number of laboratory confirmed malaria cases was observed over the last 28 years. P. falciparum was almost the only reported species, accounting for 99.98% of cases. The highest SPR was observed in the age group of under five years during the pre-intervention period while this shifted to the age group of 6-15 years old for the subsequent years. Two major malaria peak seasons were observed: one in September during the pre-intervention period and the other in November for the post-intervention period. The ITS analysis showed a dramatic decline of 83.6% in SPR following the scale-up of interventions in 2006. Conclusion A remarkable decline in laboratory confirmed malaria cases in Dakar over 28 years was observed. The period of rapid decline in malaria SPR coincided with the scale-up in interventions beginning in 2006 with the introduction of ACTs, followed by the widespread introduction in 2008 of bed nets treated with insecticides. Robust surveillance data should be maintained in the context of malaria elimination efforts.	[Diallo, Mamadou Alpha; Badiane, Aida Sadikh; Diongue, Khadim; Sakande, Linda; Ndiaye, Mouhamadou; Seck, Mame Cheikh; Ndiaye, Daouda] Univ Cheikh Anta Diop, Dept Parasitol, Dakar, Senegal	University Cheikh Anta Diop Dakar	Diallo, MA (corresponding author), Univ Cheikh Anta Diop, Dept Parasitol, Dakar, Senegal.	mamadoualpha.diallo@ucad.edu.sn	SECK, Mame Cheikh/HDN-6078-2022; Diallo, Mamadou Alpha/AAV-3911-2020; DIONGUE, Khadim/P-1016-2019; DIALLO, Mamadou Alpha/U-4838-2017	SECK, Mame Cheikh/0000-0002-8326-5359; DIONGUE, Khadim/0000-0002-7033-1169; DIALLO, Mamadou Alpha/0000-0001-6478-7875				Borderon M, 2013, ONZIEMES RENCONTRES, P20; Bouyou-akotet MK, 2008, GABON 2000 2008, P7, DOI [10.1186/1475-2875-8-300, DOI 10.1186/1475-2875-8-300]; Brasseur P, 2015, Bull Soc Pathol Exot, V108, P10, DOI 10.1007/s13149-014-0404-3; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Daniels RF, 2015, P NATL ACAD SCI USA, V112, P7067, DOI 10.1073/pnas.1505691112; Diouf I, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101119; Duthe G, 2008, POPULATION, V63, P505, DOI 10.3917/popu.803.0505; Feleke DG, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2474-3; Giardina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032625; Gilbert M., 2000, VALIDITE PRIDES DONN; Keita Y, 2017, ARCH PEDIATRIE, V24, P415, DOI 10.1016/j.arcped.2017.01.002; Legesse Deresse, 2015, Malar Res Treat, V2015, P123682, DOI 10.1155/2015/123682; Machault V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-138; Malaria Control and Elimination Partnership in Africa (MACEPA), 2018, SEN CHART PATH MAL E; Ndiaye O, 2001, Sante, V11, P25; Nuwaha F, 2001, HEALTH POLICY PLANN, V16, P1, DOI 10.1093/heapol/16.1.1; Okello G, 2019, MALARIA J, P1, DOI [10.1186/s12936-018-2635-4, DOI 10.1186/S12936-018-2635-4]; Pison G, 2018, INT J EPIDEMIOL, V47, P1025, DOI 10.1093/ije/dyy075; PNLP, 2013, LUTT PAL SEN HIST PA; PNLP, 2015, PLAN STRAT NAT LUTT; Programme National de Lutte contre le Paludisme (PNLP), 2014, CADR STRAT NAT LUTT; Programme National de Lutte contre le Paludisme (PNLP), 2018, B EP ANN PAUL DISM S; SHAFFER JG, 2018, INFECT DIS POVERTY, V7, DOI DOI 10.1186/S40249-017-0384-1; Sougoufara S, 2018, AM J TROP MED HYG, V98, P1343, DOI 10.4269/ajtmh.17-0009; Texier G, 2008, MALARIA J, V7, P1, DOI [10.1186/1475-2875-7-1, DOI 10.1186/1475-2875-7-1]; Thwing J, 2017, AM J TROP MED HYG, V97, P89, DOI 10.4269/ajtmh.16-0953; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1; USAID, 2015, EV IMP SCAL UP MAL C; WHO, 2018, WORLD MAL REP 2018	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0231587	10.1371/journal.pone.0231587	http://dx.doi.org/10.1371/journal.pone.0231587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413069	gold, Green Published			2022-12-26	WOS:000537496000012
J	Zhu, X; Lyu, C; Ji, DH; Liao, H; Li, F				Zhu, Xun; Lyu, Chen; Ji, Donghong; Liao, Han; Li, Fei			Deep neural model with self-training for scientific keyphrase extraction	PLOS ONE			English	Article								Scientific information extraction is a crucial step for understanding scientific publications. In this paper, we focus on scientific keyphrase extraction, which aims to identify keyphrases from scientific articles and classify them into predefined categories. We present a neural network based approach for this task, which employs the bidirectional long short-memory (LSTM) to represent the sentences in the article. On top of the bidirectional LSTM layer in our neural model, conditional random field (CRF) is used to predict the label sequence for the whole sentence. Considering the expensive annotated data for supervised learning methods, we introduce self-training method into our neural model to leverage the unlabeled articles. Experimental results on the ScienceIE corpus and ACL keyphrase corpus show that our neural model achieves promising performance without any hand-designed features and external knowledge resources. Furthermore, it efficiently incorporates the unlabeled data and achieve competitive performance compared with previous state-of-the-art systems.	[Zhu, Xun; Ji, Donghong; Li, Fei] Wuhan Univ, Sch Cyber Sci & Engn, Minist Educ, Key Lab Aerosp Informat Secur & Trusted Comp, Wuhan, Hubei, Peoples R China; [Zhu, Xun; Liao, Han] Jianghan Univ, Sch Math & Comp Sci, Wuhan, Hubei, Peoples R China; [Lyu, Chen] Guangdong Univ Foreign Studies, Lab Language & Artificial Intelligence, Guangzhou, Guangdong, Peoples R China; [Lyu, Chen] Guangdong Univ Foreign Studies, Collaborat Innovat Ctr Language Res & Serv, Guangzhou, Guangdong, Peoples R China	Wuhan University; Jianghan University; Guangdong University of Foreign Studies; Guangdong University of Foreign Studies	Ji, DH (corresponding author), Wuhan Univ, Sch Cyber Sci & Engn, Minist Educ, Key Lab Aerosp Informat Secur & Trusted Comp, Wuhan, Hubei, Peoples R China.; Lyu, C (corresponding author), Guangdong Univ Foreign Studies, Lab Language & Artificial Intelligence, Guangzhou, Guangdong, Peoples R China.; Lyu, C (corresponding author), Guangdong Univ Foreign Studies, Collaborat Innovat Ctr Language Res & Serv, Guangzhou, Guangdong, Peoples R China.	lvchen1989@whu.edu.cn; dhji@whu.edu.cn	Lyu, Chen/GSD-2121-2022	Zhu, Xun/0000-0002-5143-6774	National Natural Science Foundation of China [61772378]; Social Science Foundation of Ministry of Education of China [18JZD015, 19YJCZH114]; Natural Science Foundation of Hubei Province [2012FFA088]; Special Innovation Project of Guangdong Education Department [2018KTSCX059]; National Key Research and Development Program of China [2017YFC1200500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Science Foundation of Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Special Innovation Project of Guangdong Education Department; National Key Research and Development Program of China	This work was supported in part by the National Natural Science Foundation of China (No. 61772378), the Social Science Foundation of Ministry of Education of China (No. 18JZD015, 19YJCZH114), the Natural Science Foundation of Hubei Province (No. 2012FFA088), the Special Innovation Project of Guangdong Education Department (No. 2018KTSCX059), and the National Key Research and Development Program of China (No. 2017YFC1200500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zaidy RA, 2019, WEB CONFERENCE 2019: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2019), P2551, DOI 10.1145/3308558.3313642; Ammar W., 2017, P 11 INT WORKSHOP SE, P592, DOI [10.18653/v1/S17-2097, DOI 10.18653/V1/S17-2097, DOI 10.18653/V1/S17-2097HTTP://WWW.ACLWEB.ORG/ANTHOLOGY/S17-2097]; [Anonymous], P 11 INT WORKSH SEM; Augenstein I., P 11 INT WORKSH SEM, P546, DOI [10.18653/v1/s17-2091, DOI 10.18653/V1/S17-2091]; Berend G, 2016, NAT LANG ENG, V22, P73, DOI 10.1017/S1351324914000126; Bird S, 2008, SIXTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, LREC 2008, P1755; Boudin F., 2018, NAACL HLT, V2, P667, DOI DOI 10.18653/V1/N18-2105; Bougouin Adrien, 2013, INT JOINT C NAT LANG, P543; Campos R, 2018, LECT NOTES COMPUT SC, V10772, P684, DOI 10.1007/978-3-319-76941-7_63; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Devlin J., 2019, BERT PRETRAINING DEE, V1, P4171, DOI [10.18653/v1/N19-1423, DOI 10.18653/V1/N19-1423]; Dong XS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216046; Duchi J, 2011, J MACH LEARN RES, V12, P2121; El-Beltagy S.R., 2010, PROC 5 INT WORKSHOP, P190; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Grineva Maria, 2009, P 18 INT C WORLD WID, P661, DOI DOI 10.1145/1526709.1526798; Guo JL, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P628, DOI 10.1145/1571941.1572049; Gupta Sonal, 2011, P 5 INT JOINT C NAT, P1, DOI DOI 10.1145/2064942.2064944; Hasan KS, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P1262; Hasan Kazi Saidul, 2010, P 23 INT C COMP LING, P365; Huang Zhiheng, 2015, CORR; Hulth A, 2003, PROCEEDINGS OF THE 2003 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P216; Kim SN, 2013, LANG RESOUR EVAL, V47, P723, DOI 10.1007/s10579-012-9210-3; Kim Su Nam, 2010, P 5 INT WORKSH SEM E, P21, DOI DOI 10.1007/S10579-012-9210-3; Lafferty John D., 2001, ICML 01, P282, DOI DOI 10.5555/645530.655813; Lample Guillaume, 2016, P NAACL HLT, P260, DOI [DOI 10.18653/V1/N16-1030, 10.18653/v1/N16-1030]; Lyu C, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1868-5; Ma XZ, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P1064; Mahata D., 2018, P NAACL 18, V2, P634; Manning CD, 2014, PROCEEDINGS OF 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: SYSTEM DEMONSTRATIONS, P55, DOI 10.3115/v1/p14-5010; Medelyan O., 2009, P C EMP METH NAT LAN, V3, P1318, DOI DOI 10.3115/1699648.1699678; Mihalcea R., 2004, P EMNLP, P404, DOI DOI 10.3115/1219044.1219064; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Nguyen TD, 2007, LECT NOTES COMPUT SC, V4822, P317; Pennington J., 2014, P 2014 C EMPIRICAL M, P1532, DOI DOI 10.3115/V1/D14-1162; Peters M., 2018, PROC NAACL, P2227, DOI DOI 10.18653/V1/N18-1202; Ren YF, 2016, AAAI CONF ARTIF INTE, P215; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; Shi W, 2017, DATA SCI ENG, V2, P275, DOI 10.1007/s41019-017-0055-z; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Tsai CT, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P1733, DOI 10.1145/2505515.2505613; Turney P. D., 2000, Information Retrieval, V2, P303, DOI 10.1023/A:1009976227802; Wan XJ, 2010, ACM T INFORM SYST, V28, DOI 10.1145/1740592.1740596; Wang R, 2015, LECT NOTES COMPUT SC, V9093, P257, DOI 10.1007/978-3-319-19548-3_21; Witten IH., 2005, DESIGN USABILITY DIG, P129, DOI DOI 10.4018/978-1-59140-441-5.CH008; Wu Z., 2013, P C N AM CHAPT ASS C, P259; Yang ZW, 2021, ANIM BIOTECHNOL, V32, P67, DOI 10.1080/10495398.2019.1653901; Yih Wen-tau, 2006, P 15 INT C WORLD WID, P213, DOI DOI 10.1145/1135777.1135813; Yu Y, 2018, PROCEEDINGS OF THE ELEVENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION (LREC 2018), P3723; Zhang MS, 2016, LREC 2016 - TENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P225; Zhang Qi, 2016, P 2016 C EMP METH NA, P836, DOI DOI 10.18653/V1/D16-1080; Zhang Y., 2007, J DIGITAL INFORM MAN, V5, P323; Zhang Y, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P1554	55	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232547	10.1371/journal.pone.0232547	http://dx.doi.org/10.1371/journal.pone.0232547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413094	gold, Green Published			2022-12-26	WOS:000537496000018
J	Gehrke, SA; Aramburu, J; Perez-Diaz, L; do Prado, TD; Dedavid, BA; Mazon, P; De Aza, PN				Alexandre Gehrke, Sergio; Aramburu, Jaime Junior; Perez-Diaz, Leticia; do Prado, Tales Dias; Dedavid, Berenice Anina; Mazon, Patricia; De Aza, Piedad N.			Can changes in implant macrogeometry accelerate the osseointegration process?: An in vivo experimental biomechanical and histological evaluations	PLOS ONE			English	Article							BONE; STABILITY; TORQUE; STRENGTH; DENSITY	Objectives The propose was to compare this new implant macrogeometry with a control implant with a conventional macrogeometry. Materials and methods Eighty-six conical implants were divided in two groups (n = 43 per group): group control (group CON) that were used conical implants with a conventional macrogeometry and, group test (group TEST) that were used implants with the new macrogeometry. The new implant macrogeometry show several circular healing cambers between the threads, distributed in the implant body. Three implants of each group were used to scanning electronic microscopy (SEM) analysis and, other eighty samples (n = 40 per group) were inserted the tibia of ten rabbit (n = 2 per tibia), determined by randomization. The animals were sacrificed (n = 5 per time) at 3-weeks (Time 1) and at 4-weeks after the implantations (Time 2). The biomechanical evaluation proposed was the measurement of the implant stability quotient (ISQ) and the removal torque values (RTv). The microscopical analysis was a histomorphometric measurement of the bone to implant contact (%BIC) and the SEM evaluation of the bone adhered on the removed implants. Results The results showed that the implants of the group TEST produced a significant enhancement in the osseointegration in comparison with the group CON. The ISQ and RTv tests showed superior values for the group TEST in the both measured times (3- and 4-weeks), with significant differences (p < 0.05). More residual bone in quantity and quality was observed in the samples of the group TEST on the surface of the removed implants. Moreover, the %BIC demonstrated an important increasing for the group TEST in both times, with statistical differences (in Time 1 p = 0.0103 and in Time 2 p < 0.0003). Conclusions Then, we can conclude that the alterations in the implant macrogeometry promote several benefits on the osseointegration process.	[Alexandre Gehrke, Sergio; Aramburu, Jaime Junior] Biotecnos, Dept Res, Montevideo, Uruguay; [Alexandre Gehrke, Sergio] Univ Catolica Murcia UCAM, Dept Biotechnol, Murcia, Spain; [Perez-Diaz, Leticia] Univ Republica, Fac Ciencias, Lab Interacc Mol, Montevideo, Uruguay; [do Prado, Tales Dias] Univ Rio Verde, Dept Surg, Fac Med Vet, Rio Verde, Go, Brazil; [Dedavid, Berenice Anina] Pontificial Catholic Univ Rio Grande do Sul, Dept Mat Engn, Porto Alegre, RS, Brazil; [Mazon, Patricia] Univ Miguel Hernandez, Dept Mat Opt & Tecnol Elect, Elche, Alicante, Spain; [De Aza, Piedad N.] Univ Miguel Hernandez, Inst Bioingn, Elche, Alicante, Spain	Universidad Catolica de Murcia; Universidad de la Republica, Uruguay; Universidade de Rio Verde Universidade Fesurv; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche	Gehrke, SA (corresponding author), Biotecnos, Dept Res, Montevideo, Uruguay.; Gehrke, SA (corresponding author), Univ Catolica Murcia UCAM, Dept Biotechnol, Murcia, Spain.	sergio.gehrke@hotmail.com	Gehrke, Sergio Alexandre/ABB-6500-2021; De Aza, Piedad/A-7621-2015	Gehrke, Sergio Alexandre/0000-0002-5863-9101; De Aza, Piedad/0000-0001-9316-4407; Dedavid, Berenice Anina/0000-0002-3995-4747	Biotecnos Research Center	Biotecnos Research Center	Biotecnos Research Center provided support in the form of salary for author SAG, who is the director and a researcher at the laboratory. The specific role of this author is articulated in the `author contributions' section. Biotecnos Research Center is a company dedicated to conducting material analysis, and its facilities were used to perform histological sections and images.The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldahlawi S, 2018, CLIN COSMET INVESTIG, V10, P203, DOI 10.2147/CCIDE.S174895; Gehrke SA, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060777; Gehrke SA, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4265474; Alghamdi HS, 2018, J FUNCT BIOMATER, V9, DOI 10.3390/jfb9010007; Salatti DB, 2019, INT J ORAL MAX IMPL, V34, P886, DOI 10.11607/jomi.7361; Barros RRM, 2009, J PERIODONTOL, V80, P499, DOI [10.1902/jop.2009.080484, 10.1902/jop.2009.080484 ]; Bashutski JD, 2009, J PERIODONTOL, V80, P700, DOI 10.1902/jop.2009.080581; Bidgoli Mohsen, 2015, J Long Term Eff Med Implants, V25, P209; Campos FE, 2012, J ORAL MAXIL SURG, V70, pE43, DOI 10.1016/j.joms.2011.08.006; CAVALCANTI JHD, 2019, MAT BASEL, V12, DOI DOI 10.3390/MA12050840; Cha JY, 2015, J DENT RES, V94, P482, DOI 10.1177/0022034514566029; Chuang SK, 2002, J DENT RES, V81, P572, DOI 10.1177/154405910208100814; Coelho PG, 2015, DENT MATER, V31, P37, DOI 10.1016/j.dental.2014.10.007; Coelho PG, 2011, J MECH BEHAV BIOMED, V4, P1974, DOI 10.1016/j.jmbbm.2011.06.016; Donati M, 2018, CLIN ORAL IMPLAN RES, V29, P480, DOI 10.1111/clr.13145; dos Santos MV, 2011, CLIN IMPLANT DENT R, V13, P215, DOI 10.1111/j.1708-8208.2009.00202.x; Elias CN, 2015, DENT MATER, V31, pE1, DOI 10.1016/j.dental.2014.10.002; Gehrke SA, 2019, MAT BASEL, V19; Gehrke SA, 2019, MAT BASEL, V14; Gehrke SA, 2018, CLIN ORAL IMPLAN RES, V29, P785, DOI 10.1111/clr.12909; Gehrke SA, 2015, J CRANIOFAC SURG, V26, P1482, DOI 10.1097/SCS.0000000000001788; Carvalho ACGD, 2011, INT J ORAL MAX IMPL, V26, P1193; Halldin A, 2014, CLIN IMPLANT DENT R, V16, P383, DOI 10.1111/cid.12000; Hanawa T, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00170; Hartung Thomas, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS81, DOI 10.1016/j.parkreldis.2008.04.003; Howe MS, 2019, J DENT, V84, P9, DOI 10.1016/j.jdent.2019.03.008; Jimbo R, 2014, INT J ORAL MAX SURG, V43, P1269, DOI 10.1016/j.ijom.2014.03.017; Kang HG, 2018, INT J ORAL MAX IMPL, V33, P780, DOI 10.11607/jomi.5871; Leonard G, 2009, CLIN ORAL IMPLAN RES, V20, P232, DOI 10.1111/j.1600-0501.2008.01640.x; Lukaszewska-Kuska M, 2018, MICRON, V105, P55, DOI 10.1016/j.micron.2017.11.010; Marin C, 2010, CLIN ORAL IMPLAN RES, V21, P577, DOI 10.1111/j.1600-0501.2009.01853.x; Negri B, 2013, CLIN IMPLANT DENT R, V15, P799, DOI 10.1111/j.1708-8208.2011.00431.x; Niimi A, 1997, CLIN ORAL IMPLAN RES, V8, P286, DOI 10.1034/j.1600-0501.1997.080406.x; O'Sullivan D, 2000, Clin Implant Dent Relat Res, V2, P85, DOI 10.1111/j.1708-8208.2000.tb00110.x; Ogle Orrett E, 2015, Dent Clin North Am, V59, P505, DOI 10.1016/j.cden.2014.12.003; Pellegrini G, 2018, J INVESTIG CLIN DENT, V9, DOI 10.1111/jicd.12349; Salles MB, 2018, MATERIALS, V11, DOI 10.3390/ma11122532; Sartoretto Suelen Cristina, 2017, Braz. Dent. J., V28, P559, DOI 10.1590/0103-6440201601559; Smeets R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6285620; Tabassum A, 2014, CLIN ORAL IMPLAN RES, V25, P487, DOI 10.1111/clr.12180; Tabassum A, 2009, CLIN ORAL IMPLAN RES, V20, P327, DOI 10.1111/j.1600-0501.2008.01692.x; Testori T, 2003, INT J ORAL MAX IMPL, V18, P544; Testori Tiziano, 2003, Pract Proced Aesthet Dent, V15, P787; Trisi P, 2011, INT J ORAL MAX IMPL, V26, P837	44	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233304	10.1371/journal.pone.0233304	http://dx.doi.org/10.1371/journal.pone.0233304			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407416	Green Published, gold			2022-12-26	WOS:000537490700089
J	Ede, T; von Keyserlingk, MAG; Weary, DM				Ede, Thomas; von Keyserlingk, Marina A. G.; Weary, Daniel M.			Social approach and place aversion in relation to conspecific pain in dairy calves	PLOS ONE			English	Article							BEHAVIOR; EMPATHY; CONSOLATION; STRESS	Despite scientific interest in animal empathy, and growing public concern for farm animal welfare, the empathic abilities of farm animals remain under researched. In this study, we investigated empathic responses of young Holstein dairy calves to conspecifics recovering from hot-iron disbudding, a painful procedure common on dairy farms. A combination of social approach and place conditioning was used. First, 'observer' calves witnessed two 'demonstrator' calves recover from either a painful procedure (hot-iron disbudding and sedation) or a sham procedure (sedation alone) in distinct pens. Observer calves spent more time in proximity and paid more attention to calves recovering from the painful procedure compared to sham calves (proximity: 59.6 +/- 4.3%; attention: 54.3 +/- 1.5%). Observers were then tested for conditioned place aversion (in the absence of demonstrators) at 48h, 72h and 96h after the second demonstration; observers tended to avoid the pen associated with conspecific pain during the second of the three tests, spending 34.8 +/- 9.6% of their time in this pen. No strong evidence of pain empathy was found, but our tentative results encourage further research on empathy in animals.	[Ede, Thomas; von Keyserlingk, Marina A. G.; Weary, Daniel M.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada	University of British Columbia	Weary, DM (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada.	dan.weary@ubc.ca	; Weary, Daniel/A-8868-2010	Ede, Thomas/0000-0002-2187-6293; Weary, Daniel/0000-0002-0917-3982	Canada's Natural Science and Engineering Research Council [RGPIN-2016-04620]	Canada's Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by a Discovery grant (RGPIN-2016-04620) from Canada's Natural Science and Engineering Research Council to D.M. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Bruchey AK, 2010, BEHAV BRAIN RES, V214, P80, DOI 10.1016/j.bbr.2010.04.047; Clay Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055206; de Waal FBM, 2017, NAT REV NEUROSCI, V18, P498, DOI 10.1038/nrn.2017.72; Decety J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0077; Ede T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41798-7; Edgar JL, 2012, APPL ANIM BEHAV SCI, V138, P182, DOI 10.1016/j.applanim.2012.02.006; Edgar JL, 2011, P ROY SOC B-BIOL SCI, V278, P3129, DOI 10.1098/rspb.2010.2701; Edgar JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031542; Flower FC, 2001, APPL ANIM BEHAV SCI, V70, P275, DOI 10.1016/S0168-1591(00)00164-7; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Herskin MS, 2018, FRONT VET SCI, P5, DOI [10.3389/FVETS.2018.00005, DOI 10.3389/FVETS.2018.00005]; Hild S, 2011, APPL ANIM BEHAV SCI, V132, P114, DOI 10.1016/j.applanim.2011.04.003; Holm L, 2002, APPL ANIM BEHAV SCI, V79, P175, DOI 10.1016/S0168-1591(02)00137-5; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Langford DJ, 2010, SOC NEUROSCI-UK, V5, P163, DOI 10.1080/17470910903216609; McMillan FD, 2016, PHYSIOL BEHAV, V167, P154, DOI 10.1016/j.physbeh.2016.09.013; Panksepp J, 2013, TRENDS NEUROSCI, V36, P489, DOI 10.1016/j.tins.2013.04.009; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rault JL, 2012, APPL ANIM BEHAV SCI, V136, P1, DOI 10.1016/j.applanim.2011.10.002; RICE GE, 1962, J COMP PHYSIOL PSYCH, V55, P123, DOI 10.1037/h0042276; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Sato N, 2015, ANIM COGN, V18, P1039, DOI 10.1007/s10071-015-0872-2; Sivaselvachandran S, 2018, NEUROSCI BIOBEHAV R, V91, P130, DOI 10.1016/j.neubiorev.2016.06.007; Smith ML, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600855; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Vasconcelos M, 2012, BIOL LETTERS, V8, P910, DOI 10.1098/rsbl.2012.0554; Watanabe S, 2012, BEHAV PROCESS, V90, P167, DOI 10.1016/j.beproc.2012.01.001; WECHKIN S, 1964, PSYCHON SCI, V1, P47, DOI 10.3758/BF03342783; Winder CB, 2018, J DAIRY SCI, V101, P5411, DOI 10.3168/jds.2017-14092	30	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232897	10.1371/journal.pone.0232897	http://dx.doi.org/10.1371/journal.pone.0232897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407340	gold, Green Published			2022-12-26	WOS:000537490700044
J	van der Straaten, R; Wesseling, M; Jonkers, I; Vanwanseele, B; Bruijnes, AKBD; Malcorps, J; Bellemans, J; Truijen, J; De Baets, L; Timmermans, A				van der Straaten, R.; Wesseling, M.; Jonkers, I.; Vanwanseele, B.; Bruijnes, A. K. B. D.; Malcorps, J.; Bellemans, J.; Truijen, J.; De Baets, L.; Timmermans, A.			Discriminant validity of 3D joint kinematics and centre of mass displacement measured by inertial sensor technology during the unipodal stance task	PLOS ONE			English	Article							REPORTED KNEE INSTABILITY; MEASUREMENT UNITS; RISK-FACTORS; PART 1; OSTEOARTHRITIS; MOTION; PREVALENCE; SYSTEM; LIMITATIONS; VALIDATION	Background The unipodal stance task is a clinical task that quantifies postural stability and alignment of the lower limb joints, while weight bearing on one leg. As persons with knee osteoarthritis (KOA) have poor postural and knee joint stability, objective assessment of this task might be useful. Objective To investigate the discriminant validity of three-dimensional joint kinematics and centre of mass displacement (COM) between healthy controls and persons with knee KOA, during unipodal stance using inertial sensors. Additionally, the reliability, agreement and construct validity are assessed to determine the reproducibility and accuracy of the discriminating parameters. Methods Twenty healthy controls and 19 persons with unilateral severe KOA were included. Five repetitions of the unipodal stance task were simultaneously recorded by an inertial sensor system and a camera-based system (gold standard). Statistical significant differences in kinematic waveforms between healthy controls and persons with severe knee KOA were determined using one-dimensional statistical parametric mapping (SPM1D). Results Persons with severe knee KOA had more lateral trunk lean towards the contralateral leg, more hip flexion throughout the performance of the unipodal stance task, more pelvic obliquity and COM displacement towards the contralateral side. However, for the latter two parameters the minimum detectable change was greater than the difference between healthy controls and persons with severe knee KOA. The construct validity was good (coefficient of multiple correlation 0.75, 0.83 respectively) and the root mean squared error (RMSE) was low (RMSE <1.5 degrees) for the discriminant parameters. Conclusion Inertial sensor based movement analysis can discriminate between healthy controls and persons with severe knee KOA for lateral trunk lean and hip flexion, but unfortunately not for the knee angles. Further research is required to improve the reproducibility and accuracy of the inertial sensor measurements before they can be used to assess differences in tasks with a small range of motion.	[van der Straaten, R.; De Baets, L.; Timmermans, A.] Hasselt Univ, REVAL Rehabil Res Ctr, Diepenbeek, Belgium; [Wesseling, M.; Jonkers, I.; Vanwanseele, B.] Katholieke Univ Leuven, Human Movement Biomech, Dept Movement Sci, Leuven, Belgium; [Bruijnes, A. K. B. D.; Bellemans, J.; Truijen, J.] Ziekenhuis Oost Limburg, Dept Orthopaed, Genk, Belgium; [Malcorps, J.] Jessa Hosp, Dept Orthopaed Surg, Hasselt, Belgium	Hasselt University; KU Leuven; East Limburg Hospital	van der Straaten, R (corresponding author), Hasselt Univ, REVAL Rehabil Res Ctr, Diepenbeek, Belgium.	rob.vanderstraaten@uhasselt.be	Vanwanseele, Benedicte/AAQ-1706-2021	Vanwanseele, Benedicte/0000-0002-6158-9483; Wesseling, Mariska/0000-0002-3347-2130; Timmermans, Annick/0000-0002-5461-947X	foundation Limburg Sterk Merk; province of Limburg; Flemish government; Hasselt University; Jessa Hospital; Ziekenhuis Oost-Limburg	foundation Limburg Sterk Merk; province of Limburg; Flemish government(European Commission); Hasselt University; Jessa Hospital; Ziekenhuis Oost-Limburg	This research is part of the Limburg Clinical Research Center (LCRC) UHasselt-ZOLJessa, supported by the foundation Limburg Sterk Merk, province of Limburg, Flemish government, Hasselt University, Jessa Hospital and Ziekenhuis Oost-Limburg. The organizations did not have a contribution to the creation of this manuscript.	Al-Amri M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18030719; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Felson DT, 2007, ANN INTERN MED, V147, P534, DOI 10.7326/0003-4819-147-8-200710160-00005; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Ferrari A, 2010, GAIT POSTURE, V31, P540, DOI 10.1016/j.gaitpost.2010.02.009; Fitzgerald GK, 2004, ARTHRIT RHEUM-ARTHR, V51, P941, DOI 10.1002/art.20825; Fleeton G, 2016, ARTHRIT CARE RES, V68, P463, DOI 10.1002/acr.22692; Fregly BJ, 2012, J ORTHOP RES, V30, P503, DOI 10.1002/jor.22023; Heidari B, 2011, CASP J INTERN MED, V2, P205; Holla JFM, 2011, OSTEOARTHR CARTILAGE, V19, P411, DOI 10.1016/j.joca.2011.01.013; Komnik I, 2015, GAIT POSTURE, V41, P370, DOI 10.1016/j.gaitpost.2015.01.019; Laidig D, 2017, INT C REHAB ROBOT, P971, DOI 10.1109/ICORR.2017.8009375; Lenhart RL, 2015, ANN BIOMED ENG, V43, P2675, DOI 10.1007/s10439-015-1326-3; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Mundt M, 2019, J BIOMECH, V84, P81, DOI 10.1016/j.jbiomech.2018.12.023; Northon S, 2018, KNEE, V25, P1040, DOI 10.1016/j.knee.2018.08.011; Nuesch C, 2017, J BIOMECH, V57, P32, DOI 10.1016/j.jbiomech.2017.03.015; Picerno P, 2017, GAIT POSTURE, V51, P239, DOI 10.1016/j.gaitpost.2016.11.008; Robert-Lachaine X, 2017, MED BIOL ENG COMPUT, V55, P609, DOI 10.1007/s11517-016-1537-2; Robert-Lachaine X, 2017, GAIT POSTURE, V54, P80, DOI 10.1016/j.gaitpost.2017.02.029; Roetenberg D, 2007, IEEE T BIO-MED ENG, V54, P883, DOI 10.1109/TBME.2006.889184; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Schepers HM, 2009, IEEE T BIO-MED ENG, V56, P1189, DOI 10.1109/TBME.2008.2011059; Schepers M., 2018, XSENS TECHNOL, V8; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Smith CR, 2018, COMP M BIO BIO E-IV, V6, P491, DOI 10.1080/21681163.2016.1172346; Steultjens MPM, 2000, RHEUMATOLOGY, V39, P955, DOI 10.1093/rheumatology/39.9.955; Takacs J, 2012, J BIOMECH, V45, P2791, DOI 10.1016/j.jbiomech.2012.08.041; Teufl W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213064; Turcot K, 2011, OSTEOARTHR CARTILAGE, V19, P281, DOI 10.1016/j.joca.2010.12.007; van der Esch M, 2008, OSTEOARTHR CARTILAGE, V16, P522, DOI 10.1016/j.joca.2007.08.008; van der Esch M, 2012, CLIN RHEUMATOL, V31, P1505, DOI 10.1007/s10067-012-2025-1; van der Straaten R, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19010141; van der Straaten R, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082638; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	37	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232513	10.1371/journal.pone.0232513	http://dx.doi.org/10.1371/journal.pone.0232513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407415	Green Published, gold			2022-12-26	WOS:000537490700022
J	van Dijk, B; Allen, KJH; Helal, M; Vogely, HC; Lam, MGEH; de Klerk, JMH; Weinans, H; van der Wal, BCH; Dadachova, E				van Dijk, B.; Allen, K. J. H.; Helal, M.; Vogely, H. C.; Lam, M. G. E. H.; de Klerk, J. M. H.; Weinans, H.; van der Wal, B. C. H.; Dadachova, E.			Radioimmunotherapy of methicillin-resistant Staphylococcus aureus in planktonic state and biofilms	PLOS ONE			English	Article							INFECTION	Background Implant associated infections such as periprosthetic joint infections are difficult to treat as the bacteria form a biofilm on the prosthetic material. This biofilm complicates surgical and antibiotic treatment. With rising antibiotic resistance, alternative treatment options are needed to treat these infections in the future. The aim of this article is to provide proof-of-principle data required for further development of radioimmunotherapy for non-invasive treatment of implant associated infections. Methods Planktonic cells and biofilms of Methicillin-resistant staphylococcus aureus are grown and treated with radioimmunotherapy. The monoclonal antibodies used, target wall teichoic acids that are cell and biofilm specific. Three different radionuclides in different doses were used. Viability and metabolic activity of the bacterial cells and biofilms were measured by CFU dilution and XTT reduction. Results Alpha-RIT with Bismuth-213 showed significant and dose dependent killing in both planktonic MRSA and biofilm. When planktonic bacteria were treated with 370 kBq of Bi-213-RIT 99% of the bacteria were killed. Complete killing of the bacteria in the biofilm was seen at 185 kBq. Beta-RIT with Lutetium-177 and Actinium-225 showed little to no significant killing. Conclusion Our results demonstrate the ability of specific antibodies loaded with an alpha-emitter Bismuth-213 to selectively kill staphylococcus aureus cells in vitro in both planktonic and biofilm state. RIT could therefore be a potentially alternative treatment modality against planktonic and biofilm-related microbial infections.	[van Dijk, B.; Vogely, H. C.; Weinans, H.; van der Wal, B. C. H.] Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands; [Allen, K. J. H.; Helal, M.; Dadachova, E.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada; [Lam, M. G. E. H.] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands; [de Klerk, J. M. H.] Meander Med Ctr Amersfoort, Dept Nucl Med, Amersfoort, Netherlands; [Weinans, H.] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands	Utrecht University; Utrecht University Medical Center; University of Saskatchewan; Utrecht University; Utrecht University Medical Center; Meander Medisch Centrum; Delft University of Technology	Dadachova, E (corresponding author), Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada.	ekaterina.dadachova@usask.ca			Health Holland; Netherlands Organization for Scientific Research (NWO) [LSHM17026]	Health Holland; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was funded by Health Holland, which is non for profit organization, financed by the Netherlands Organization for Scientific Research (NWO), Grant number LSHM17026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJH, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10040262; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Bryan RA, 2013, FUTURE MICROBIOL, V8, P1081, DOI 10.2217/fmb.13.79; Bryan RA, 2010, J INFECT DIS, V202, P633, DOI 10.1086/654813; Dadachova E, 2004, ANTIMICROB AGENTS CH, V48, P1624, DOI 10.1128/AAC.48.5.1624-1629.2004; Dadachova E, 2004, ANTIMICROB AGENTS CH, V48, P1004, DOI 10.1128/AAC.48.3.1004-1006.2004; Dadachova E, 2003, P NATL ACAD SCI USA, V100, P10942, DOI 10.1073/pnas.1731272100; Helal M, 2018, RADIOIMMUNOTHERAPY N, V33, P1; Larson SM, 2015, NAT REV CANCER, V15, P347, DOI 10.1038/nrc3925; Parvizi J, 2011, CLIN ORTHOP RELAT R, V469, P3022, DOI 10.1007/s11999-011-1971-2; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Quirk EK, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu016; Sadovskaya I, 2006, FEMS IMMUNOL MED MIC, V47, P75, DOI 10.1111/j.1574-695X.2006.00068.x; Stepanovic S, 2007, APMIS; Zimmerli W, 2012, FEMS IMMUNOL MED MIC, V65, P158, DOI 10.1111/j.1574-695X.2012.00938.x	15	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233086	10.1371/journal.pone.0233086	http://dx.doi.org/10.1371/journal.pone.0233086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407350	Green Published, gold			2022-12-26	WOS:000537490700068
J	Ahn, S; Chung, YR; Seo, AN; Kim, M; Woo, JW; Park, SY				Ahn, Soomin; Chung, Yul Ri; Seo, An Na; Kim, Milim; Woo, Ji Won; Park, So Yeon			Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer	PLOS ONE			English	Article							PATHOLOGICAL COMPLETE RESPONSE; T-CELL SUBSETS; NEOADJUVANT CHEMOTHERAPY; RESIDUAL DISEASE; IMMUNITY; SURVIVAL; BURDEN; TRIAL	Tumor-infiltrating lymphocyte (TIL) levels have prognostic and predictive values in treatment-naive breast cancers. However, there have been controversies regarding TIL subset changes and their clinical implications in post-treatment breast cancers. This study aimed to explore change and prognostic significance of TIL subset infiltration after primary systemic therapy (PST) in breast cancer. One-hundred-fifty-five patients who had residual disease after anthracycline- or anthracycline plus taxane-based PST were included. The quantities of intratumoral and stromal TIL subsets (CD8+, CD4+, and FOXP3+ TILs) in pre- and post-PST breast cancer samples, as well as changes between them, were analyzed along with their correlations with clinicopathologic features and outcome of patients. As a whole, intratumoral CD8+ and CD4+ TILs increased after PST while stromal TILs decreased. Both intratumoral and stromal FOXP3+ TILs decreased after PST. The chemo-sensitive group [residual cancer burden (RCB) class I and II] showed the same pattern of change in intratumoral CD8+ TILs as the whole group, whereas the chemo-resistant group (RCB class III) showed no significant change in intratumoral CD8+ TIL infiltration after PST. Survival analyses for each TIL subset as well as their ratios revealed that high levels of intratumoral, stromal, and total CD8+ TIL infiltration after PST were independent predictors of longer patient survival. In subgroup analyses, CD8+ TIL infiltration after PST revealed prognostic significance in the chemo-resistant group but not in the chemo-sensitive group. In conclusion, infiltration of CD8+, CD4+, and FOXP3+ TIL changed after PST in the intratumoral and stromal compartments. Especially, increase of intratumoral CD8+ TILs was associated with chemo-responsiveness. Moreover, CD8+ TIL status in residual tumors after PST may be used as a potential prognostic marker in breast cancer patients who receive PST and provide additional prognostic information to chemo-resistant group.	[Ahn, Soomin; Chung, Yul Ri; Kim, Milim; Woo, Ji Won; Park, So Yeon] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, Gyeonggi, South Korea; [Chung, Yul Ri; Kim, Milim; Woo, Ji Won; Park, So Yeon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Seo, An Na] Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Pathol, Daegu, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University	Park, SY (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, Gyeonggi, South Korea.; Park, SY (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea.	sypmd@snu.ac.kr		Park, So Yeon/0000-0002-0299-7268; Woo, Ji Won/0000-0003-1659-7123	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2018R1A2B6005559]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This study was supported by grants from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (Grant No. NRF-2018R1A2B6005559) to Park SY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali HR, 2014, ANN ONCOL, V25, P1536, DOI 10.1093/annonc/mdu191; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Carson WE, 2004, CLIN CANCER RES, V10, P3401, DOI 10.1158/1078-0432.CCR-1016-03; Chung YR, 2017, BREAST CANCER RES TR, V161, P409, DOI 10.1007/s10549-016-4072-9; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Dieci MV, 2014, ANN ONCOL, V25, P611, DOI 10.1093/annonc/mdt556; Dieci MV, 2018, SEMIN CANCER BIOL, V52, P16, DOI 10.1016/j.semcancer.2017.10.003; Garcia-Martinez E, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0488-5; Gnant M, 2011, BREAST CARE, V6, P136, DOI 10.1159/000328054; Hamy AS, 2019, CLIN CANCER RES, V25, P6731, DOI 10.1158/1078-0432.CCR-18-3017; Ibrahim EM, 2014, BREAST CANCER RES TR, V148, P467, DOI 10.1007/s10549-014-3185-2; Kim HJ, 2014, CANCER IMMUNOL RES, V2, P91, DOI 10.1158/2326-6066.CIR-13-0216; Ladoire S, 2008, CLIN CANCER RES, V14, P2413, DOI 10.1158/1078-0432.CCR-07-4491; Ladoire S, 2011, J PATHOL, V224, P389, DOI 10.1002/path.2866; Lee HJ, 2013, J BREAST CANCER, V16, P32, DOI 10.4048/jbc.2013.16.1.32; Liu FF, 2012, BREAST CANCER RES TR, V135, P459, DOI 10.1007/s10549-012-2132-3; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Luen SJ, 2019, ANN ONCOL, V30, P236, DOI 10.1093/annonc/mdy547; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mahmoud SMA, 2011, BREAST CANCER RES TR, V127, P99, DOI 10.1007/s10549-010-0987-8; Mao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115103; Mattarollo SR, 2011, CANCER RES, V71, P4809, DOI 10.1158/0008-5472.CAN-11-0753; Melichar B, 2014, ANTICANCER RES, V34, P1115; Miyashita M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0632-x; Pelekanou V, 2018, MOL CANCER THER, V17, P1324, DOI 10.1158/1535-7163.MCT-17-1005; Pelekanou V, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0884-8; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Schmidt M, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-0942-x; Seo AN, 2013, BRIT J CANCER, V109, P2705, DOI 10.1038/bjc.2013.634; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Thompson AM, 2012, ANN ONCOL, V23, P231, DOI 10.1093/annonc/mds324; Zitvogel L, 2008, J CLIN INVEST, V118, P1991, DOI 10.1172/JCI35180	33	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0233037	10.1371/journal.pone.0233037	http://dx.doi.org/10.1371/journal.pone.0233037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401825	Green Published, gold			2022-12-26	WOS:000537481000049
J	Anomal, RF; Brandao, DS; Porto, SB; de Oliveira, SS; de Souza, RFL; Fiel, JD; Gomes, BD; Pires, IAH; Pereira, A				Anomal, Renata Figueiredo; Brandao, Daniel Soares; Porto, Silvia Beltrame; de Oliveira, Sostenes Silva; Lacerda de Souza, Rafaela Faustino; Fiel, Jose de Santana; Gomes, Bruno Duarte; Hazin Pires, Izabel Augusta; Pereira, Antonio, Jr.			The role of frontal and parietal cortex in the performance of gifted and average adolescents in a mental rotation task	PLOS ONE			English	Article							SEX-DIFFERENCES; SPATIAL ABILITY; INTELLIGENCE; ACTIVATION; SCIENCE; MATHEMATICS; ATTENTION; NETWORK; MEMORY; METAANALYSES	Visual-spatial abilities are usually neglected in academic settings, even though several studies have shown that their predictive power in science, technology, engineering, and mathematics domains exceeds that of math and verbal ability. This neglect means that many spatially talented youths are not identified and nurtured, at a great cost to society. In the present work, we aim to identify behavioral and electrophysiological markers associated with visual spatial-ability in intellectually gifted adolescents (N = 15) compared to age-matched controls (N = 15). The participants performed a classic three-dimensional mental rotation task developed by Shepard and Metzler (1971) [33] while event-related potentials were measured in both frontal and parietal regions of interest. While response time was similar in the two groups, gifted subjects performed the test with greater accuracy. There was no indication of interhemispheric asymmetry of ERPs over parietal regions in both groups, although interhemispheric differences were observed in the frontal lobes. Moreover, intelligence quotient and working memory measures predicted variance in ERP's amplitude in the right parietal and frontal hemispheres. We conclude that while gifted adolescents do not display a different pattern of electroencephalographic activity over the parietal cortex while performing the mental rotation task, their performance is correlated with the amplitude of ERPs in the frontal cortex during the execution of this task.	[Anomal, Renata Figueiredo; Brandao, Daniel Soares; Lacerda de Souza, Rafaela Faustino] Univ Fed Rio Grande do Norte, Inst Brain, Natal, RN, Brazil; [Porto, Silvia Beltrame; Hazin Pires, Izabel Augusta] Univ Fed Rio Grande do Norte, Dept Psychol, Natal, RN, Brazil; [de Oliveira, Sostenes Silva] Mauricio Nassau Coll, Natal, RN, Brazil; [Fiel, Jose de Santana; Pereira, Antonio, Jr.] Fed Univ Para, Dept Elect & Biomed Engn, Inst Technol, Belem, PA, Brazil; [Gomes, Bruno Duarte] Fed Univ Para, Inst Biol, Belem, PA, Brazil; [Anomal, Renata Figueiredo] Univ Fed Rio Grande do Norte, Dept Morphol, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Rio Grande do Norte	Pereira, A (corresponding author), Fed Univ Para, Dept Elect & Biomed Engn, Inst Technol, Belem, PA, Brazil.	apereira@ufpa.br	Pereira, Antonio/AAY-4372-2020	Pereira, Antonio/0000-0002-0808-1058; Oliveira, Sostenes/0000-0002-7116-581X; Anomal, Renata/0000-0003-3528-0535	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The author(s) received support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for this work.r We would like to thank the students and families of both the Juvenal Lamartine School and the Talent Metropolis Project for volunteering for this work. The authors received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES.	Alencar E.M.L.S., 2009, INT HDB GIFTEDNESS, P1491, DOI [10.1007/978-1-4020-6162-2_77, DOI 10.1007/978-1-4020-6162-2_77]; Amalric M, 2016, P NATL ACAD SCI USA, V113, P4909, DOI 10.1073/pnas.1603205113; Andersen L, 2014, ROEPER REV, V36, P114, DOI 10.1080/02783193.2014.884198; Arsalidou M, 2011, NEUROIMAGE, V54, P2382, DOI 10.1016/j.neuroimage.2010.10.009; Borst G, 2011, J COGN PSYCHOL, V23, P60, DOI 10.1080/20445911.2011.454498; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; CASEY MB, 1995, DEV PSYCHOL, V31, P697, DOI 10.1037/0012-1649.31.4.697; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Cole MW, 2010, J NEUROSCI, V30, P14245, DOI 10.1523/JNEUROSCI.1662-10.2010; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Coull JT, 1998, NEUROIMAGE, V8, P176, DOI 10.1006/nimg.1998.0354; Desco M, 2011, NEUROIMAGE, V57, P281, DOI 10.1016/j.neuroimage.2011.03.063; DITUNNO PL, 1990, CORTEX, V26, P177, DOI 10.1016/S0010-9452(13)80349-8; FERGUSON ES, 1977, SCIENCE, V197, P827, DOI 10.1126/science.197.4306.827; Formisano E, 2002, NEURON, V35, P185, DOI 10.1016/S0896-6273(02)00747-X; Ganis G., 2015, J OPEN PSYCHOL DATA, V3, pe3, DOI [10.5334/jopd.ai, DOI 10.5334/JOPD.AI]; Gottfredson LS, 1997, INTELLIGENCE, V24, P13, DOI 10.1016/S0160-2896(97)90011-8; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; Gustafsson JE., 2001, INT EDUC J, V2, P166; Hamm JP, 2004, NEUROPSYCHOLOGIA, V42, P810, DOI 10.1016/j.neuropsychologia.2003.11.009; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Hegarty M, 2004, INTELLIGENCE, V32, P175, DOI 10.1016/j.intell.2003.12.001; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P535, DOI 10.1017/S0048577202020449; Hilger K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15795-7; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; Jordan K, 2001, NEUROIMAGE, V13, P143, DOI 10.1006/nimg.2000.0677; Jung RE, 1999, P ROY SOC B-BIOL SCI, V266, P1375, DOI 10.1098/rspb.1999.0790; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Just MA, 2001, J EXP PSYCHOL GEN, V130, P493, DOI 10.1037/0096-3445.130.3.493; Kaufmann L, 2011, DEV NEUROPSYCHOL, V36, P763, DOI 10.1080/87565641.2010.549884; Keating D. P., 2009, DEV GIFTEDNESS TALEN, P189; Kim M, 2016, GIFTED CHILD QUART, V60, P102, DOI 10.1177/0016986216630607; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Kung E, 2010, MEM COGNITION, V38, P206, DOI 10.3758/MC.38.2.206; Lohman D.F., 1994, ENCY INTELLIGENCE, P1000; Lubinski D, 2006, PERSPECT PSYCHOL SCI, V1, P316, DOI 10.1111/j.1745-6916.2006.00019.x; Makel MC, 2016, PSYCHOL SCI, V27, P1004, DOI 10.1177/0956797616644735; Mathewson JH, 1999, SCI EDUC, V83, P33, DOI 10.1002/(SICI)1098-237X(199901)83:1<33::AID-SCE2>3.3.CO;2-Q; McGrew KS, 2009, INTELLIGENCE, V37, P1, DOI 10.1016/j.intell.2008.08.004; MEHTA Z, 1991, CORTEX, V27, P153, DOI 10.1016/S0010-9452(13)80121-9; Milivojevic B, 2009, NEUROREPORT, V20, P1507, DOI 10.1097/WNR.0b013e32832ea6fd; Neubauer AC, 2010, INTELLIGENCE, V38, P529, DOI 10.1016/j.intell.2010.06.001; Newcombe NS., 2013, AM ED, V37, P26; O'Boyle MW, 2005, COGNITIVE BRAIN RES, V25, P583, DOI 10.1016/j.cogbrainres.2005.08.004; OBoyle MW, 1995, DEV NEUROPSYCHOL, V11, P415, DOI 10.1080/87565649509540630; Pfeiffer SI, 2012, J PSYCHOEDUC ASSESS, V30, P3, DOI 10.1177/0734282911428192; Pfleiderer B, 2004, NEUROSCIENCE, V123, P1053, DOI 10.1016/j.neuroscience.2003.11.008; Preusse F, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00022; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Quan C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184963; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Roid GH., 2003, STANFORD BINET INTEL, V5th; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; RUGG MD, 1995, OX PSYCH S, P27; Sack AT, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00214; Schendan HE, 2009, BRAIN RES, V1294, P91, DOI 10.1016/j.brainres.2009.07.036; Sekowski AE, 2015, GIFTED ED INT, V31, P73; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Skagerlund K, 2019, J COGNITIVE NEUROSCI, V31, P560, DOI 10.1162/jocn_a_01367; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Spelke ES, 2005, AM PSYCHOL, V60, P950, DOI 10.1037/0003-066X.60.9.950; Subotnik R. F., 2003, ROEPER REV, V26, P14, DOI DOI 10.1080/02783190309554233; Vaivre-Douret L, 2011, INT J PEDIAT, V2011, DOI 10.1155/2011/420297; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Varriale V, 2018, INTELLIGENCE, V69, P146, DOI 10.1016/j.intell.2018.05.007; Wai J, 2009, J EDUC PSYCHOL, V101, P817, DOI 10.1037/a0016127; Wechsler D., 2008, WECHSLER ADULT INTEL; Wechsler D., 2003, TECHNICAL INTERPRETI; Wendelken C, 2017, J NEUROSCI, V37, P8549, DOI 10.1523/JNEUROSCI.3726-16.2017; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P452, DOI 10.1111/j.1469-8986.1989.tb01951.x; Yu QB, 2009, NEUROREPORT, V20, P43, DOI 10.1097/WNR.0b013e32831c50f4; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013; Ziegler A, 2012, HIGH ABIL STUD, V23, P3, DOI 10.1080/13598139.2012.679085	75	3	3	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232660	10.1371/journal.pone.0232660	http://dx.doi.org/10.1371/journal.pone.0232660			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0VG	32401804	Green Published, gold			2022-12-26	WOS:000537481000027
J	Abrahamsen, R; Gundersen, GF; Svendsen, MV; Klepaker, G; Kongerud, J; Fell, AKM				Abrahamsen, Regine; Gundersen, Golin Finckenhagen; Svendsen, Martin Veel; Klepaker, Geir; Kongerud, Johny; Fell, Anne Kristin Moller			Possible risk factors for poor asthma control assessed in a cross-sectional population-based study from Telemark, Norway	PLOS ONE			English	Article							QUESTIONNAIRE; SYMPTOMS; VALIDITY; RELIABILITY; SPIROMETRY; EXPOSURE	This cross-sectional study of the general population of Telemark County, Norway, aimed to identify risk factors associated with poor asthma control as defined by the Asthma Control Test (ACT), and to determine the proportions of patients with poorly controlled asthma who had undergone spirometry, used asthma medication, or been examined by a pulmonary physician. In 2014-2015, the study recruited 326 subjects aged 16-50 years who had self-reported physician-diagnosed asthma and presence of respiratory symptoms during the previous 12 months. The clinical outcome measures were body mass index (BMI), forced vital capacity (FVC) and forced expiratory volume in one second (FEV1), fractional exhaled nitric oxide (FeNO), immunoglobulin E (IgE) in serum and serum C-reactive protein (CRP). An ACT score <= 19 was defined as poorly controlled asthma. Overall, 113 subjects (35%) reported poor asthma control. The odds ratios (ORs) and 95% confidence intervals (CIs) for factors associated with poorly controlled asthma were: self-reported occupational exposure to vapor, gas, dust, or fumes during the previous 12 months (OR 2.0; 95% CI 1.1-3.6), body mass index >= 30 kg/m(2) (OR 2.2; 95% CI 1.2-4.1), female sex (OR 2.6; 95% CI 1.5-4.7), current smoking (OR 2.8; 95% CI 1.5-5.3), and past smoking (OR 2.3; 95% CI 1.3-4.0). Poor asthma control was also associated with reduced FEV1 after bronchodilation (beta-3.6; 95% CI -7.0 to -0.2). Moreover, 13% of the participants with poor asthma control reported no use of asthma medication, 51% had not been assessed by a pulmonary physician, and 20% had never undergone spirometry. Because these data are cross-sectional, further studies assessing possible risk factors in general and objectively measured occupational exposure in particular are needed. However, our results suggest that there is room for improvement with regards to use of spirometry and pulmonary physician referrals when a patient's asthma is inadequately controlled.	[Abrahamsen, Regine; Gundersen, Golin Finckenhagen; Svendsen, Martin Veel; Klepaker, Geir; Fell, Anne Kristin Moller] Telemark Hosp, Dept Occupat & Environm Med, Skien, Norway; [Klepaker, Geir; Kongerud, Johny] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Kongerud, Johny] Oslo Univ Hosp, Dept Resp Med, Oslo, Norway	Telemark Hospital Trust; University of Oslo; University of Oslo	Fell, AKM (corresponding author), Telemark Hosp, Dept Occupat & Environm Med, Skien, Norway.	annfel@sthf.no			Department of Research and Development at Telemark Hospital, Skien, Norway [18.72]	Department of Research and Development at Telemark Hospital, Skien, Norway	The funder of this study was the Department of Research and Development at Telemark Hospital, Skien, Norway; grant number 18.72, grant receiver Ms. Golin Finckenhagen Gundersen. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Abrahamsen R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009912; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Backman H, 2017, EUR CLIN RESPIR J, V4, DOI 10.1080/20018525.2017.1334508; Blanc PD, 2005, AM J IND MED, V48, P110, DOI 10.1002/ajim.20187; Boulet LP, 2008, CAN RESPIR J, V15, P275, DOI 10.1155/2008/725074; Braido F, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0374-z; BURNEY PGJ, 1989, EUR RESPIR J, V2, P940; Capelo AV, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0076-y; DEMARCO R, 1994, EUR RESPIR J, V7, P2139, DOI 10.1183/09031936.94.07122139; Denlinger LC, 2017, AM J RESP CRIT CARE, V195, P302, DOI 10.1164/rccm.201602-0419OC; Global Initiative for Asthma (GINA), 2019, GLOB STRAT ASTHM MAN; Haugan Tommy, 2008, Tidsskr Nor Laegeforen, V128, P2431; Huang S, 2015, EUR RESPIR J, V45, P338, DOI 10.1183/09031936.00108514; Joensen Lisa, 2010, Tidsskr Nor Laegeforen, V130, P33, DOI 10.4045/tidsskr.08.0671; Kim JL, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0306-1; Klepaker G, 2019, RESPIRATION, V28, P1; KONGERUD J, 1989, SCAND J WORK ENV HEA, V15, P364, DOI 10.5271/sjweh.1838; Lisspers K, 2013, J ASTHMA, V50, P1090, DOI 10.3109/02770903.2013.834502; Louis R, 2019, ALLERGY ASTHMA CL IM, V15, DOI 10.1186/s13223-019-0331-8; Lv Nan, 2014, Ann Am Thorac Soc, V11, P1218, DOI 10.1513/AnnalsATS.201405-214OC; Maalej Sonia, 2012, Tanaffos, V11, P38; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Ministry of Health and Care Services, NAT STRAT COPD 2006; Moscato G, 2011, ALLERGY, V66, P1164, DOI 10.1111/j.1398-9995.2011.02615.x; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Norwegian Prescription Database TNIoPHN, 2019, DRUGS OBSTR AIRW DIS; Oei SM, 2011, RESPIROLOGY, V16, P803, DOI 10.1111/j.1440-1843.2011.01969.x; Porsbjerg C, 2018, EUR CLIN RESPIR J, V5, DOI 10.1080/20018525.2018.1440868; Price D, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.9; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Quinlan PJ, 2009, OCCUP ENVIRON MED, V66, P154, DOI 10.1136/oem.2008.040022; Quirce S, 2017, EXPERT REV CLIN IMMU, V13, P271, DOI 10.1080/1744666X.2017.1239529; Reddel HK, 2015, EUR RESPIR J, V46, P622, DOI 10.1183/13993003.00853-2015; Ronmark E, 1999, EUR J EPIDEMIOL, V15, P293, DOI 10.1023/A:1007582518922; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Tanaka A, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0144-8; Tarlo SM, 2014, NEW ENGL J MED, V370, P640, DOI 10.1056/NEJMra1301758; Torchyan AA, 2017, ALLERGY ASTHMA PROC, V38, pE47, DOI 10.2500/aap.2017.38.4035; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; World Health Organisation, 2018, WHO FACT SHEET OB OV; Zeiger RS, 2016, J ALLER CL IMM-PRACT, V4, P120, DOI 10.1016/j.jaip.2015.08.003	42	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232621	10.1371/journal.pone.0232621	http://dx.doi.org/10.1371/journal.pone.0232621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396562	gold, Green Published			2022-12-26	WOS:000537475000014
J	Machiela, E; Liontis, T; Dues, DJ; Rudich, PD; Traa, A; Wyman, L; Kaufman, C; Cooper, JF; Lew, L; Nadarajan, S; Senchuk, MM; Van Raamsdonk, JM				Machiela, Emily; Liontis, Thomas; Dues, Dylan J.; Rudich, Paige D.; Traa, Annika; Wyman, Leslie; Kaufman, Corah; Cooper, Jason F.; Lew, Leira; Nadarajan, Saravanapriah; Senchuk, Megan M.; Van Raamsdonk, Jeremy M.			Disruption of mitochondrial dynamics increases stress resistance through activation of multiple stress response pathways	FASEB JOURNAL			English	Article						C; elegans; genetics; mitochondria; mitochondrial dynamics; stress resistance	CAENORHABDITIS-ELEGANS; LIFE-SPAN; C. ELEGANS; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; HEAT-SHOCK; PROTEIN; FISSION; MORPHOLOGY; FUSION	Mitochondria are dynamic organelles that can change shape and size depending on the needs of the cell through the processes of mitochondrial fission and fusion. In this work, we investigated the role of mitochondrial dynamics in organismal stress response. By using C. elegans as a genetic model, we could visualize mitochondrial morphology in a live organism with well-established stress assays and well-characterized stress response pathways. We found that disrupting mitochondrial fission (DRP1/drp-1) or fusion (OPA1/eat-3, MFN/fzo-1) genes caused alterations in mitochondrial morphology that impacted both mitochondrial function and physiologic rates. While both mitochondrial fission and mitochondrial fusion mutants showed increased sensitivity to osmotic stress and anoxia, surprisingly we found that the mitochondrial fusion mutants eat-3 and fzo-1 are more resistant to both heat stress and oxidative stress. In exploring the mechanism of increased stress resistance, we found that disruption of mitochondrial fusion genes resulted in the upregulation of multiple stress response pathways. Overall, this work demonstrates that disrupting mitochondrial dynamics can have opposite effects on resistance to different types of stress. Our results suggest that disruption of mitochondrial fusion activates multiple stress response pathways that enhance resistance to specific stresses.	[Machiela, Emily; Dues, Dylan J.; Wyman, Leslie; Kaufman, Corah; Cooper, Jason F.; Lew, Leira; Senchuk, Megan M.; Van Raamsdonk, Jeremy M.] Van Andel Res Inst, Ctr Neurodegenerat Sci, Lab Aging & Neurodegenerat Dis, Grand Rapids, MI USA; [Liontis, Thomas; Rudich, Paige D.; Traa, Annika; Van Raamsdonk, Jeremy M.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Liontis, Thomas; Rudich, Paige D.; Traa, Annika; Van Raamsdonk, Jeremy M.] McGill Univ, Res Inst, Hlth Ctr, Metab Disorders & Complicat Program, 1001 Decarie Blvd, Montreal, PQ, Canada; [Liontis, Thomas; Rudich, Paige D.; Traa, Annika; Van Raamsdonk, Jeremy M.] McGill Univ, Res Inst, Hlth Ctr, Brain Repair & Integrat Neurosci Program, 1001 Decarie Blvd, Montreal, PQ, Canada; [Nadarajan, Saravanapriah; Van Raamsdonk, Jeremy M.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Van Raamsdonk, Jeremy M.] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada	Van Andel Institute; McGill University; McGill University; McGill University; Harvard University; Harvard Medical School; McGill University	Van Raamsdonk, JM (corresponding author), McGill Univ, Res Inst, Hlth Ctr, Metab Disorders & Complicat Program, 1001 Decarie Blvd, Montreal, PQ, Canada.; Van Raamsdonk, JM (corresponding author), McGill Univ, Res Inst, Hlth Ctr, Brain Repair & Integrat Neurosci Program, 1001 Decarie Blvd, Montreal, PQ, Canada.	jeremy.vanraamsdonk@mcgill.ca	Machiela, Emily/AAB-2426-2021	Traa, Annika/0000-0002-9311-5696; Liontis, Thomas/0000-0003-3376-1511	National Institute of General Medical Sciences [R01 GM121756]; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	National Institute of General Medical Sciences, Grant/Award Number: R01 GM121756; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Breckenridge DG, 2009, CURR BIOL, V19, P768, DOI 10.1016/j.cub.2009.03.022; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Byrne JJ, 2019, CELL MOL LIFE SCI, V76, P1967, DOI 10.1007/s00018-019-03024-5; Cooper JF, 2018, EXP NEUROL, V310, P58, DOI 10.1016/j.expneurol.2018.09.001; Cooper JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16637-2; De Castro E, 2004, FREE RADICAL BIO MED, V37, P139, DOI 10.1016/j.freeradbiomed.2004.04.021; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Detienne Giel, 2016, Worm, V5, pe1230585, DOI 10.1080/21624054.2016.1230585; Dues DJ, 2019, J GERONTOL A-BIOL, V74, P1206, DOI 10.1093/gerona/gly213; Dues DJ, 2017, FREE RADICAL BIO MED, V108, P362, DOI 10.1016/j.freeradbiomed.2017.04.004; Dues DJ, 2016, AGING-US, V8, P777, DOI 10.18632/aging.100939; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frazier HN, 2009, CURR BIOL, V19, P859, DOI 10.1016/j.cub.2009.03.066; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hwang AB, 2011, AGING-US, V3, P304, DOI 10.18632/aging.100292; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Johnson D, 2010, MOL BIOL CELL, V21, P2191, DOI 10.1091/mbc.E09-10-0874; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kaufman DM, 2015, CURR BIOL, V25, P2171, DOI 10.1016/j.cub.2015.06.062; Labbadia J, 2017, CELL REP, V21, P1481, DOI 10.1016/j.celrep.2017.10.038; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lamitina ST, 2004, AM J PHYSIOL-CELL PH, V286, pC785, DOI 10.1152/ajpcell.00381.2003; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Link CD, 2002, METHOD ENZYMOL, V353, P497; Lu BW, 2009, CURR NEUROL NEUROSCI, V9, P212, DOI 10.1007/s11910-009-0032-7; Luz AL, 2017, TOXICOLOGY, V387, P81, DOI 10.1016/j.tox.2017.05.018; Luz AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130940; Machiela E, 2016, NEUROBIOL DIS, V96, P1, DOI 10.1016/j.nbd.2016.08.008; Maycotte P, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317698391; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Park HEH, 2017, MOL CELLS, V40, P90, DOI 10.14348/molcells.2017.0017; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Redpath CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069165; Regmi SG, 2014, AGING-US, V6, P118, DOI 10.18632/aging.100639; Rolland SG, 2013, P NATL ACAD SCI USA, V110, pE2967, DOI 10.1073/pnas.1303872110; Rolland SG, 2009, J CELL BIOL, V186, P525, DOI 10.1083/jcb.200905070; Schakel C, 2015, 8TH ACM INTERNATIONAL CONFERENCE ON PERVASIVE TECHNOLOGIES RELATED TO ASSISTIVE ENVIRONMENTS (PETRA 2015), DOI 10.1145/2769493.2769499; Senchuk MM, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2086; Senchuk MM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007268; Tan FJ, 2008, J CELL SCI, V121, P3373, DOI 10.1242/jcs.032904; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Tullet JMA, 2017, AGING CELL, V16, P1191, DOI 10.1111/acel.12627; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; van Horssen J, 2017, NEUROSCI LETT; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2010, GENETICS, V185, P559, DOI 10.1534/genetics.110.115378; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wu ZY, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0615-3; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038701; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zevian SC, 2014, METHODS, V68, P450, DOI 10.1016/j.ymeth.2014.04.015; Zhang PC, 2013, CELL METAB, V17, P85, DOI 10.1016/j.cmet.2012.12.013; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348; Zorzano A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00101; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	67	11	13	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8475	8492		10.1096/fj.201903235R	http://dx.doi.org/10.1096/fj.201903235R		MAY 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32385951	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000532119900001
J	Hamdi, F; Tuting, C; Semchonok, DA; Visscher, KM; Kyrilis, FL; Meister, A; Skalidis, I; Schmidt, L; Parthier, C; Stubbs, MT; Kastritis, PL				Hamdi, Farzad; Tueting, Christian; Semchonok, Dmitry A.; Visscher, Koen M.; Kyrilis, Fotis L.; Meister, Annette; Skalidis, Ioannis; Schmidt, Lisa; Parthier, Christoph; Stubbs, Milton T.; Kastritis, Panagiotis L.			2.7 angstrom cryo-EM structure of vitrified M. musculus H-chain apoferritin from a compact 200 keV cryo-microscope	PLOS ONE			English	Article							INDUCED MOTION CORRECTION; SCATTERING FACTORS; ATOMIC-STRUCTURE; ELECTRON; RESOLUTION; REFINEMENT; MODEL; BACTERIORHODOPSIN	Here we present the structure of mouse H-chain apoferritin at 2.7 A (FSC = 0.143) solved by single particle cryogenic electron microscopy (cryo-EM) using a 200 kV device, the Thermo Fisher Glacios (R). This is a compact, two-lens illumination system with a constant power objective lens, without any energy filters or aberration correctors, often thought of as a "screening cryo-microscope". Coulomb potential maps reveal clear densities for main chain carbonyl oxygens, residue side chains (including alternative conformations) and bound solvent molecules. We used a quasi-crystallographic reciprocal space approach to fit model coordinates to the experimental cryo-EM map. We argue that the advantages offered by (a) the high electronic and mechanical stability of the microscope, (b) the high emission stability and low beam energy spread of the high brightness Field Emission Gun (X-FEG), (c) direct electron detection technology and (d) particle-based Contrast Transfer Function (CTF) refinement have contributed to achieving high resolution. Overall, we show that basic electron optical settings for automated cryo-electron microscopy imaging can be used to determine structures approaching atomic resolution.	[Hamdi, Farzad; Tueting, Christian; Semchonok, Dmitry A.; Kyrilis, Fotis L.; Meister, Annette; Skalidis, Ioannis; Schmidt, Lisa; Stubbs, Milton T.; Kastritis, Panagiotis L.] Martin Luther Univ Halle Wittenberg, Charles Tanford Prot Zentrum, ZIK HALOmem, Halle, Germany; [Visscher, Koen M.] Vrije Univ Amsterdam, Fac Sci, AIMMS Div Mol Toxicol, Amsterdam, Netherlands; [Meister, Annette; Parthier, Christoph; Stubbs, Milton T.; Kastritis, Panagiotis L.] Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Charles Tanford Prot Zentrum, Halle, Germany; [Kastritis, Panagiotis L.] Martin Luther Univ Halle Wittenberg, Biozentrum, ZIK HALOmem, Halle, Germany	Martin Luther University Halle Wittenberg; Vrije Universiteit Amsterdam; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Stubbs, MT; Kastritis, PL (corresponding author), Martin Luther Univ Halle Wittenberg, Charles Tanford Prot Zentrum, ZIK HALOmem, Halle, Germany.; Stubbs, MT; Kastritis, PL (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Charles Tanford Prot Zentrum, Halle, Germany.; Kastritis, PL (corresponding author), Martin Luther Univ Halle Wittenberg, Biozentrum, ZIK HALOmem, Halle, Germany.	stubbs@biochemtech.uni-halle.de; panagiotis.kastritis@bct.uni-halle.de	Kastritis, Panagiotis L/F-2498-2010; Kastritis, Panagiotis/AAL-7029-2021; Stubbs, Milton/ABC-7585-2020	Kastritis, Panagiotis L/0000-0002-1463-8422; Kastritis, Panagiotis/0000-0002-1463-8422; Stubbs, Milton/0000-0003-1278-9013; Tueting, Christian/0000-0001-6209-4012; Hamdi, Farzad/0000-0002-2155-5000; Schmidt, Lisa/0000-0002-1445-8149; KYRILIS, FOTIS/0000-0002-4040-6289; Skalidis, Ioannis/0000-0002-3077-9014; Parthier, Christoph/0000-0001-7740-8117; Semchonok, Dmitry A./0000-0003-1622-9443	Federal Ministry for Education and Research (BMBF, ZIK program) [02Z22HN23]; European Regional Development Funds [EFRE: ZS/2016/04/78115]; Martin Luther University Halle-Wittenberg	Federal Ministry for Education and Research (BMBF, ZIK program)(Federal Ministry of Education & Research (BMBF)); European Regional Development Funds(European Commission); Martin Luther University Halle-Wittenberg	This work was supported by the Federal Ministry for Education and Research (BMBF, ZIK program) [grant number 02Z22HN23 to P.L.K.]; the European Regional Development Funds for Saxony-Anhalt [grant number EFRE: ZS/2016/04/78115 to P.L.K. and M.T.S.] and the Martin Luther University Halle-Wittenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Bou-Abdallah F, 2010, BBA-GEN SUBJECTS, V1800, P719, DOI 10.1016/j.bbagen.2010.03.021; Burnley T, 2017, ACTA CRYSTALLOGR D, V73, P469, DOI 10.1107/S2059798317007859; Cao L, 2018, P NATL ACAD SCI USA, V115, P13087, DOI 10.1073/pnas.1814309115; Chen CY, 2019, J AM CHEM SOC, V141, P6136, DOI 10.1021/jacs.9b01354; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Crichton RR, 2010, BBA-GEN SUBJECTS, V1800, P706, DOI 10.1016/j.bbagen.2010.03.019; Danev R, 2019, TRENDS BIOCHEM SCI, V44, P837, DOI 10.1016/j.tibs.2019.04.008; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; Egerton RF, 2019, MICRON, V119, P72, DOI 10.1016/j.micron.2019.01.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Hamaguchi T, 2019, J STRUCT BIOL, V207, P40, DOI 10.1016/j.jsb.2019.04.011; Hattne J, 2018, STRUCTURE, V26, P759, DOI 10.1016/j.str.2018.03.021; Herzik MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08991-8; Herzik MA, 2017, NAT METHODS, V14, P1075, DOI [10.1038/NMETH.4461, 10.1038/nmeth.4461]; Jiang JS, 2015, NATURE, V521, P545, DOI 10.1038/nature14247; Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Li KP, 2019, J STRUCT BIOL, V206, P225, DOI 10.1016/j.jsb.2019.03.007; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lyumkis D, 2019, J BIOL CHEM, V294, P5181, DOI 10.1074/jbc.REV118.005602; Majorovits E, 2016, BIOPHYS J, V110, P776, DOI 10.1016/j.bpj.2016.01.023; Marques MA, 2019, CURR OPIN STRUC BIOL, V58, P214, DOI 10.1016/j.sbi.2019.04.006; Meng X, 2017, ULTRAMICROSCOPY, V173, P14, DOI 10.1016/j.ultramic.2016.11.009; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; Moriya T, 2017, JOVE-J VIS EXP, DOI 10.3791/55448; Muller DA, 2006, ULTRAMICROSCOPY, V106, P1033, DOI 10.1016/j.ultramic.2006.04.017; Naydenova K, 2019, P NATL ACAD SCI USA, V116, P11718, DOI 10.1073/pnas.1904766116; Naydenova K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00782-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Radoul M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26550; Scouras AD, 2011, PROTEIN SCI, V20, P341, DOI 10.1002/pro.565; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Tegunov D, 2019, NAT METHODS, V16, P1146, DOI 10.1038/s41592-019-0580-y; Wu M, 2020, J STRUCT BIOL X, V4; Yonekura K, 2018, IUCRJ, V5, P348, DOI 10.1107/S2052252518005237; Yonekura K, 2016, J APPL CRYSTALLOGR, V49, P1517, DOI 10.1107/S1600576716011274; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang R, 2019, NAT MICROBIOL, V4, P675, DOI 10.1038/s41564-018-0356-7; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	48	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232540	10.1371/journal.pone.0232540	http://dx.doi.org/10.1371/journal.pone.0232540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374767	Green Published, Green Submitted, gold			2022-12-26	WOS:000537283500040
J	Artz, JH; Tokmina-Lukaszewska, M; Mulder, DW; Lubner, CE; Gutekunst, K; Appel, J; Bothner, B; Boehm, M; King, PW				Artz, Jacob H.; Tokmina-Lukaszewska, Monika; Mulder, David W.; Lubner, Carolyn E.; Gutekunst, Kirstin; Appel, Jens; Bothner, Brian; Boehm, Marko; King, Paul W.			The structure and reactivity of the HoxEFU complex from the cyanobacterium Synechocystis sp. PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Synechocystis; HoxEFU; diaphorase; photosynthesis; kinetics; protein cross-linking; electron paramagnetic resonance (EPR); bidirectional hydrogenase; protein-protein interaction; nickel-iron enzyme; cooperativity; hydrogenase; nickel	BIDIRECTIONAL HYDROGENASE; NEGATIVE COOPERATIVITY; KINETIC COOPERATIVITY; CATALYTIC-PROPERTIES; NADPH FLUORESCENCE; NIFE-HYDROGENASE; WILD-TYPE; PROTEIN; FERREDOXIN; BINDING	Cyanobacterial Hox is a [NiFe] hydrogenase that consists of the hydrogen (H-2)-activating subunits HoxYH, which form a complex with the HoxEFU assembly to mediate reactions with soluble electron carriers like NAD(P)H and ferredoxin (Fdx), thereby coupling photosynthetic electron transfer to energy-transforming catalytic reactions. Researchers studying the HoxEFUYH complex have observed that HoxEFU can be isolated independently of HoxYH, leading to the hypothesis that HoxEFU is a distinct functional subcomplex rather than an artifact of Hox complex isolation. Moreover, outstanding questions about the reactivity of Hox with natural substrates and the site(s) of substrate interactions and coupling of H-2, NAD(P)H, and Fdx remain to be resolved. To address these questions, here we analyzed recombinantly produced HoxEFU by electron paramagnetic resonance spectroscopy and kinetic assays with natural substrates. The purified HoxEFU subcomplex catalyzed electron transfer reactions among NAD(P)H, flavodoxin, and several ferredoxins, thus functioningin vitroas a shuttle among different cyanobacterial pools of reducing equivalents. Both Fdx1-dependent reductions of NAD(+)and NADP(+)were cooperative. HoxEFU also catalyzed the flavodoxin-dependent reduction of NAD(P)(+), Fdx2-dependent oxidation of NADH and Fdx4- and Fdx11-dependent reduction of NAD(+). MS-based mapping identified an Fdx1-binding site at the junction of HoxE and HoxF, adjacent to iron-sulfur (FeS) clusters in both subunits. Overall, the reactivity of HoxEFU observed here suggests that it functions in managing peripheral electron flow from photosynthetic electron transfer, findings that reveal detailed insights into how ubiquitous cellular components may be used to allocate energy flow into specific bioenergetic products.	[Artz, Jacob H.; Mulder, David W.; Lubner, Carolyn E.; King, Paul W.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Tokmina-Lukaszewska, Monika; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Gutekunst, Kirstin; Appel, Jens; Boehm, Marko] Univ Kiel, Bot Inst, Kiel, Germany	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Montana State University System; Montana State University Bozeman; University of Kiel	King, PW (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA.	paul.king@nrel.gov	Mulder, David/AHC-0138-2022	Mulder, David/0000-0003-0559-0145; King, Paul/0000-0001-5039-654X; Appel, Jens/0000-0002-0658-7899; Gutekunst, Kirstin/0000-0003-4366-423X	U.S. Department of Energy Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, Photosynthetic Systems Program	U.S. Department of Energy Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, Photosynthetic Systems Program(United States Department of Energy (DOE))	Funding was provided by the U.S. Department of Energy Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, Photosynthetic Systems Program.	Angeleri M, 2018, FEBS LETT, V592, P411, DOI 10.1002/1873-3468.12970; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Aubert-Jousset E, 2011, FEBS J, V278, P4035, DOI 10.1111/j.1742-4658.2011.08308.x; Boehm M, 2016, PHOTOSYNTH RES, V128, P45, DOI 10.1007/s11120-015-0198-6; BOTTIN H, 1992, BIOCHIM BIOPHYS ACTA, V1101, P48, DOI 10.1016/0167-4838(92)90465-P; Buckel W, 2018, CHEM REV, V118, P3862, DOI 10.1021/acs.chemrev.7b00707; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; Burroughs NJ, 2014, ENERG ENVIRON SCI, V7, P3791, DOI 10.1039/c4ee02502d; Carrieri D, 2011, BIORESOURCE TECHNOL, V102, P8368, DOI 10.1016/j.biortech.2011.03.103; Cassier-Chauvat Corinne, 2014, Life-Basel, V4, P666, DOI 10.3390/life4040666; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cornish-Bowden A, 2004, FRONT DIABETES, V16, P125; CORNISHBOWDEN A, 1987, J THEOR BIOL, V124, P1, DOI 10.1016/S0022-5193(87)80248-5; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Eckert C, 2012, J BIOL CHEM, V287, P43502, DOI 10.1074/jbc.M112.392407; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Foyer CH, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0374; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; Gutekunst K, 2014, J BIOL CHEM, V289, P1930, DOI 10.1074/jbc.M113.526376; HAMMES GG, 1974, ANNU REV BIOPHYS BIO, V3, P1, DOI 10.1146/annurev.bb.03.060174.000245; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Ison J, 2016, NUCLEIC ACIDS RES, V44, pD38, DOI 10.1093/nar/gkv1116; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kauny J, 2014, BBA-BIOENERGETICS, V1837, P792, DOI 10.1016/j.bbabio.2014.01.009; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khanna N, 2015, INT J MOL SCI, V16, P10537, DOI 10.3390/ijms160510537; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Lauterbach L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025939; Lauterbach L, 2011, EUR J INORG CHEM, P1067, DOI 10.1002/ejic.201001053; Ledbetter RN, 2017, BIOCHEMISTRY-US, V56, P4177, DOI 10.1021/acs.biochem.7b00389; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; Lima DB, 2015, J PROTEOMICS, V129, P51, DOI 10.1016/j.jprot.2015.01.013; Lu L, 2018, J PROTEOME RES, V17, P2370, DOI 10.1021/acs.jproteome.8b00141; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; McIntosh CL, 2011, J AM CHEM SOC, V133, P11308, DOI 10.1021/ja203376y; Mi HL, 2000, PLANT CELL PHYSIOL, V41, P1129, DOI 10.1093/pcp/pcd038; Michoux F, 2010, BIOCHEMISTRY-US, V49, P7411, DOI 10.1021/bi1011145; Motomura T, 2019, BBA-BIOENERGETICS, V1860, DOI 10.1016/j.bbabio.2019.148084; Osanai T, 2014, ENVIRON MICROBIOL, V16, P512, DOI 10.1111/1462-2920.12170; Palagyi-Meszaros LS, 2009, FEBS J, V276, P164, DOI 10.1111/j.1742-4658.2008.06770.x; Peden EA, 2013, J BIOL CHEM, V288, P35192, DOI 10.1074/jbc.M113.483727; Peters JW, 2018, CURR OPIN CHEM BIOL, V47, P32, DOI 10.1016/j.cbpa.2018.07.026; Peters JW, 2015, BBA-MOL CELL RES, V1853, P1350, DOI 10.1016/j.bbamcr.2014.11.021; Poudel S, 2016, BBA-GEN SUBJECTS, V1860, P1910, DOI 10.1016/j.bbagen.2016.05.034; Rakhely G, 2004, APPL ENVIRON MICROB, V70, P722, DOI 10.1128/AEM.70.2.722-728.2004; Roessler MM, 2018, CHEM SOC REV, V47, P2534, DOI 10.1039/c6cs00565a; Sanchez JE, 2015, BIOCHEMISTRY-US, V54, P3360, DOI 10.1021/acs.biochem.5b00174; Sanker S, 2001, J BIOL CHEM, V276, P37922; Schmitz O, 2002, BBA-BIOENERGETICS, V1554, P66, DOI 10.1016/S0005-2728(02)00214-1; Schmitz O, 1996, FEMS MICROBIOL LETT, V135, P97; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schorsch M, 2018, P NATL ACAD SCI USA, V115, pE12111, DOI 10.1073/pnas.1810379115; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Schuller JM, 2019, SCIENCE, V363, P257, DOI 10.1126/science.aau3613; Schut GJ, 2019, J BIOL CHEM, V294, P3271, DOI 10.1074/jbc.RA118.005653; Serebryakova LT, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1370, DOI 10.1134/S0006297906120133; Shomura Y, 2017, SCIENCE, V357, P928, DOI 10.1126/science.aan4497; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Takahashi H, 2008, J EXP BOT, V59, P3009, DOI 10.1093/jxb/ern157; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; TANFORD C, 1985, P NATL ACAD SCI USA, V82, P4688, DOI 10.1073/pnas.82.14.4688; van den Heuvel RHH, 2003, J MOL BIOL, V330, P113, DOI 10.1016/S0022-2836(03)00522-9; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; WEBER J, 1993, J BIOL CHEM, V268, P20126; Yacoby I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035886; Yang ZY, 2016, BIOCHEMISTRY-US, V55, P3625, DOI 10.1021/acs.biochem.6b00421; Zhao JD, 1998, ANAL BIOCHEM, V264, P263, DOI 10.1006/abio.1998.2845	72	8	8	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9445	9454		10.1074/jbc.RA120.013136	http://dx.doi.org/10.1074/jbc.RA120.013136			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409585	hybrid, Green Published			2022-12-26	WOS:000552758600015
J	Abrego-Peredo, A; Romero-Ramirez, H; Espinosa, E; Lopez-Herrera, G; Garcia-Garcia, F; Flores-Munoz, M; Sandoval-Montes, C; Rodriguez-Alba, JC				Abrego-Peredo, Amayrani; Romero-Ramirez, Hector; Espinosa, Enrique; Lopez-Herrera, Gabriela; Garcia-Garcia, Fabio; Flores-Munoz, Monica; Sandoval-Montes, Claudia; Carlos Rodriguez-Alba, Juan			Naringenin mitigates autoimmune features in lupus-prone mice by modulation of T-cell subsets and cytokines profile	PLOS ONE			English	Article							SYSTEMIC AUTOIMMUNITY; ERYTHEMATOSUS; ACTIVATION; DISEASE; ANTIBODIES; GAMMA	Naringenin is flavonoid mainly found in citrus fruits which has shown several biological properties. In this work, we evaluated the therapeutic potential of the flavonoid Naringenin. Five-month-old B6.MRL-Fas(lpr)/J lupus-prone mice were administered daily orally with Naringenin for seven months. We showed that Naringenin treatment at 50 or 100 mg/kg inhibited the splenomegaly and decreased the levels of anti-nuclear and anti-dsDNA autoantibodies. Furthermore, a reduction in serum concentration of TNF-alpha, IFN-gamma and IL-6 was observed in the mice provided with Naringenin. Interestingly, serum levels of IL-10 increased. Naringenin decreased the frequency and absolute numbers of splenic effector memory T cells. Additionally, in order to be able to evaluate whether Naringenin prevented kidney damage, twelve-week-old MRL/MpJ-Fas(lpr)/J mice, an accelerated lupus model, were orally administered with Naringenin at 100 mg/kg for six weeks. Surprisingly, Naringenin treatment prevented kidney damage and reduced the development of fibrosis similar to cyclophosphamide group. Moreover, Naringenin treatment increased the percentage of regulatory T cells in this aggressive model of lupus. Together, these results suggest a potential ability of Naringenin to reduce the autoimmunity in lupus-prone mice by modulation of T-cell subsets and cytokines profile that mitigate the development of important lupus clinical manifestations.	[Abrego-Peredo, Amayrani; Garcia-Garcia, Fabio; Flores-Munoz, Monica; Carlos Rodriguez-Alba, Juan] Univ Veracruzana, Inst Ciencias Salud, Programa Doctorado Ciencias Salud, Xalapa, Veracruz, Mexico; [Abrego-Peredo, Amayrani; Carlos Rodriguez-Alba, Juan] Univ Veracruzana, Inst Ciencias Salud, Unidad Citometria Flujo, Xalapa, Veracruz, Mexico; [Romero-Ramirez, Hector] Ctr Invest & Estudios Avanzados IPN, Dept Biomed Mol, Mexico City, DF, Mexico; [Espinosa, Enrique] Inst Nacl Enfermedades Resp, Invest Inmunol Integrat, Mexico City, DF, Mexico; [Lopez-Herrera, Gabriela] Inst Nacl Pediat, Unidad Invest Inmunodeficiencias, Mexico City, DF, Mexico; [Garcia-Garcia, Fabio] Univ Veracruzana, Inst Ciencias Salud, Lab Biol Sueno, Xalapa, Veracruz, Mexico; [Flores-Munoz, Monica] Univ Veracruzana, Inst Ciencias Salud, Lab Invest Med Traslac, Xalapa, Veracruz, Mexico; [Sandoval-Montes, Claudia] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Inmunol, Mexico City, DF, Mexico	Universidad Veracruzana; Universidad Veracruzana; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Veracruzana; Universidad Veracruzana; Instituto Politecnico Nacional - Mexico	Rodriguez-Alba, JC (corresponding author), Univ Veracruzana, Inst Ciencias Salud, Programa Doctorado Ciencias Salud, Xalapa, Veracruz, Mexico.; Rodriguez-Alba, JC (corresponding author), Univ Veracruzana, Inst Ciencias Salud, Unidad Citometria Flujo, Xalapa, Veracruz, Mexico.	carlorodriguez@uv.mx	Lopez-Herrera, Gabriela/HHN-1429-2022; HERRERA, GABRIELA/AAL-1781-2021; Espinosa, Enrique/F-1882-2019	Lopez-Herrera, Gabriela/0000-0002-5498-6739; Espinosa, Enrique/0000-0002-3231-1626; ROMERO, HECTOR/0000-0001-5082-847X; Abrego-Peredo, Amayrani/0000-0002-1455-8465	Consejo Nacional de Ciencia y Tecnologia (CONACyT)	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Consejo Nacional de Ciencia y Tecnologia (CONACyT) provided the funding for the development of this research, but CONACyT had no participation in the study design, data collection and analysis, nor in the decision to publish or prepare the manuscript.	Adachi M, 1996, P NATL ACAD SCI USA, V93, P2131, DOI 10.1073/pnas.93.5.2131; Amissah-Arthur MB, 2010, THER ADV CHRONIC DIS, V1, P163, DOI 10.1177/2040622310380100; Azuma T, 2013, J NUTR, V143, P827, DOI 10.3945/jn.113.174508; Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Chan O, 1998, J IMMUNOL, V160, P51; Cozzani E, 2014, AUTOIMMUNE DIS, P1; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; Devarajan P, 2013, IMMUNOL RES, V57, P12, DOI 10.1007/s12026-013-8448-1; Dorner T, 2019, LANCET, V393, P2344, DOI 10.1016/S0140-6736(19)30546-X; Dou W, 2013, BR J NUTR, P1; Fritsch RD, 2006, ARTHRITIS RHEUM, V54, P2184, DOI 10.1002/art.21943; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Guo A, 2015, SCI REP, P1; Guo L., 2015, 2015 Asia-Pacific Microwave Conference (APMC). Proceedings, P1, DOI 10.1109/APMC.2015.7413131; Haas C, 1997, J IMMUNOL, V158, P5484; Hong YH, 2008, LUPUS, V17, P814, DOI 10.1177/0961203308091287; Hosseinzade A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00051; Jiang CC, 2007, J IMMUNOL, V178, P7422, DOI 10.4049/jimmunol.178.11.7422; Jin L, 2017, J IMMUNOL, P1; Jordan N, 2016, IMMUNOTARGETS THER, V5, P9, DOI 10.2147/ITT.S40675; Khan MK, 2014, J FOOD COMPOS ANAL, V33, P85, DOI 10.1016/j.jfca.2013.11.004; Koenig KF, 2012, CYTOKINE, V60, P410, DOI 10.1016/j.cyto.2012.07.004; Lemay S, 1996, KIDNEY INT, V50, P85, DOI 10.1038/ki.1996.290; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Liao JY, 2016, CLIN IMMUNOL, V162, P74, DOI 10.1016/j.clim.2015.11.006; Lin F, 2015, INT IMMUNOPHARMACOL, V28, P859, DOI 10.1016/j.intimp.2015.03.044; Liu J, 2006, GENES IMMUN, V7, P156, DOI 10.1038/sj.gene.6364286; Lui M, 2003, SCAND J IMMUNOL, V59, P198; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Medina-Inojosa J, 2016, OBES OPEN ACCESS, V2, P1; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mok CC, 2014, EXPERT OPIN EMERG DR, V19, P303, DOI 10.1517/14728214.2014.894018; Monk CR, 2005, ARTHRITIS RHEUM, V52, P1180, DOI 10.1002/art.20976; Niu XL, 2018, J NUTR BIOCHEM, V58, P71, DOI 10.1016/j.jnutbio.2018.04.008; Ohl K, 2015, EUR J IMMUNOL, V45, P344, DOI 10.1002/eji.201344280; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Patel K, 2018, CHIN J INTEGR MED, V24, P551, DOI 10.1007/s11655-014-1960-x; Pathak S, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3465; Peng H, 2013, CLIN RHEUMATOL, V32, P1255, DOI 10.1007/s10067-013-2294-3; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Ponticelli C, 2010, PHARMACEUTICALS, V3, P300, DOI 10.3390/ph3010300; Rekvig OP, 2015, CLIN EXP IMMUNOL, V179, P5, DOI 10.1111/cei.12296; Rengasamy KRR, 2019, PHARMACOL THERAPEUT, V194, P107, DOI 10.1016/j.pharmthera.2018.09.009; Reyes-Thomas J, 2011, CLIN REV ALLERG IMMU, V40, P138, DOI 10.1007/s12016-010-8197-z; Sawla P, 2012, AUTOIMMUN REV, V11, P611, DOI 10.1016/j.autrev.2011.09.008; Scheinecker C, 2010, J AUTOIMMUN, V35, P269, DOI 10.1016/j.jaut.2010.06.018; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; Tackey E, 2004, LUPUS, V13, P339, DOI 10.1191/0961203304lu1023oa; Touma Z, 2017, LUPUS SCI MED, V4, DOI 10.1136/lupus-2017-000239; Umare V, 2014, MEDIATORS OF INFLAMM, P1; Wang J, 2018, FOOD BIOPROCESS TECH, P1, DOI [10.3389/fimmu.2018.00001, DOI 10.3389/FIMMU.2018.00001]; Wang JP, 2018, J NUTR BIOCHEM, V54, P130, DOI 10.1016/j.jnutbio.2017.12.004; Wang Z, 2014, PLOS ONE; Weber GF, 2004, AUTOIMMUNITY, V37, P1, DOI 10.1080/08916930310001630316; Xu SP, 2018, INT J MOL MED, V42, P3220, DOI 10.3892/ijmm.2018.3903; Yan XJ, 2009, CLIN IMMUNOL, V131, P481, DOI 10.1016/j.clim.2009.01.013; YANG J, 2019, IEEE T CIRCUITS-I, V10, P1; Yang Y, 2018, INT IMMUNOPHARMACOL, V54, P153, DOI 10.1016/j.intimp.2017.11.013; Yildirim-Toruner C, 2011, J ALLERGY CLIN IMMUN, V127, P303, DOI 10.1016/j.jaci.2010.12.1087; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835; Yin ZN, 2002, J IMMUNOL, V169, P2148, DOI 10.4049/jimmunol.169.4.2148; Yung S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00475; Zeng WF, 2018, PHARMACOL RES, V135, P122, DOI 10.1016/j.phrs.2018.08.002; Zhang F, BREAST CANCER RES, V18, P1; Zhu L, 2010, J BIOMED BIOTECHNOL, P1	66	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233138	10.1371/journal.pone.0233138	http://dx.doi.org/10.1371/journal.pone.0233138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421738	gold, Green Published			2022-12-26	WOS:000537499600031
J	Ceyhan, Y; Zhang, MQ; Guo, JT; Sandoval, CG; Vacher, J; Kaftanovskaya, EM; Agoulnik, AI; Agoulnik, IU				Ceyhan, Yasemin; Zhang, Manqi; Guo, Jingtao; Sandoval, Carlos G.; Vacher, Jean; Kaftanovskaya, Elena M.; Agoulnik, Alexander I.; Agoulnik, Irina U.			Deletion of inositol polyphosphate 4-phosphatase type-II B affects spermatogenesis in mice	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; TUMOR-SUPPRESSOR; ANDROGEN RECEPTOR; PROTEIN; MOUSE; PI3K; INPP4B; TISSUE; MAINTENANCE; DEFICIENT	Inositol polyphosphate-4-phosphatase type II (INPP4B) is a dual-specificity phosphatase that acts as a tumor suppressor in multiple cancers. INPP4B dephosphorylates phospholipids at the 4th position of the inositol ring and inhibits AKT and PKC signaling by hydrolyzing of PI(3,4)P2 and PI(4,5)P2, respectively. INPP4B protein phosphatase targets include phospho-tyrosines on Akt and phospho-serine and phospho-threonine on PTEN. INPP4B is highly expressed in testes, suggesting its role in testes development and physiology. The objective of this study was to determine whether Inpp4b deletion impacts testicular function in mice. In testis, Inpp4b expression was the highest in postmeiotic germ cells in both mice and men. The testes of Inpp4b knockout male mice were significantly smaller compared to the testes of wild-type (WT) males. Inpp4b(-/-) males produced fewer mature sperm cells compared to WT, and this difference increased with age and high fat diet (HFD). Reduction in early steroidogenic enzymes and luteinizing hormone (LH) receptor gene expression was detected, although androgen receptor (AR) protein level was similar in WT and Inpp4b(-/-) testes. Germ cell apoptosis was significantly increased in the knockout mice, while expression of meiotic marker gamma H2A.X was decreased. Our data demonstrate that INPP4B plays a role in maintenance of male germ cell differentiation and protects testis functions against deleterious effects of aging and high fat diet.	[Ceyhan, Yasemin; Sandoval, Carlos G.; Kaftanovskaya, Elena M.; Agoulnik, Alexander I.; Agoulnik, Irina U.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA; [Zhang, Manqi] Duke Univ, Dept Med, Div Med Oncol, Durham, NC USA; [Guo, Jingtao] Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Oncol Sci, Salt Lake City, UT USA; [Guo, Jingtao] Univ Utah, Sch Med, Howard Hughes Med Inst, Huntsman Canc Inst, Salt Lake City, UT USA; [Guo, Jingtao] Univ Utah, Hlth Sci Ctr, Ctr Reconstruct Urol & Mens Hlth, Dept Surg Androl Urol, Salt Lake City, UT USA; [Vacher, Jean] Univ Montreal, Inst Rech Clin Montreal, Dept Med, Montreal, PQ, Canada; [Agoulnik, Alexander I.; Agoulnik, Irina U.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA	State University System of Florida; Florida International University; Duke University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; State University System of Florida; Florida International University	Agoulnik, IU (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA.; Agoulnik, IU (corresponding author), Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA.	iagoulni@fiu.edu		Agoulnik, Irina/0000-0003-4889-0324; Guo, Jingtao/0000-0002-0159-5021	NCI [R15 CA179287-01A1]; NIDDK [1R01DK110167]; Herbert Wertheim College of Medicine Graduate Program, FIU; Eunice Kennedy Shriver NICHD/NIH (NCTRI) [P50-HD28934]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Herbert Wertheim College of Medicine Graduate Program, FIU; Eunice Kennedy Shriver NICHD/NIH (NCTRI)	This work was supported by NCI grant R15 CA179287-01A1 (IUA, MZ), NIDDK 1R01DK110167 (AIA, IUA, EYK), YC was supported by the Herbert Wertheim College of Medicine Graduate Program, FIU. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by the Eunice Kennedy Shriver NICHD/NIH (NCTRI) Grant P50-HD28934.	Agoulnik IU, 2011, ONCOTARGET, V2, P321; Baksi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29369-8; Barratt CLR, 2017, HUM REPROD UPDATE, V23, P660, DOI 10.1093/humupd/dmx021; Bellani MA, 2005, J CELL SCI, V118, P3233, DOI 10.1242/jcs.02466; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Benesh EC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03466; Brill JA, 2000, DEVELOPMENT, V127, P3855; Brill JA, 2016, SEMIN CELL DEV BIOL, V59, P2, DOI 10.1016/j.semcdb.2016.06.010; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Chalmel F, 2012, HUM REPROD, V27, P3233, DOI 10.1093/humrep/des301; Clavijo RI, 2018, TRANSL ANDROL UROL, V7, pS367, DOI 10.21037/tau.2018.03.25; Crean AJ, 2019, OBES REV, V20, P921, DOI 10.1111/obr.12827; Darbandi M, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0406-2; De Gendt K, 2012, MOL CELL ENDOCRINOL, V352, P13, DOI 10.1016/j.mce.2011.08.008; Duale N, 2014, ANDROLOGY-US, V2, P234, DOI 10.1111/j.2047-2927.2013.00178.x; Endo T, 2017, P NATL ACAD SCI USA, V114, pE10132, DOI 10.1073/pnas.1710837114; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Ferguson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077351; Ferron M, 2011, CELL METAB, V14, P466, DOI 10.1016/j.cmet.2011.08.013; Gatt MK, 2006, J CELL SCI, V119, P2225, DOI 10.1242/jcs.02933; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Giansanti MG, 2006, CURR BIOL, V16, P195, DOI 10.1016/j.cub.2005.12.011; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Guo JT, 2018, CELL RES, V28, P1141, DOI 10.1038/s41422-018-0099-2; Gupta S, 2017, J BIOSCIENCES, V42, P285, DOI 10.1007/s12038-017-9678-5; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Hedger MP, 2003, J REPROD IMMUNOL, V58, P1, DOI 10.1016/S0165-0378(02)00060-8; Hellsten E, 2002, BIOL REPROD, V66, P1522, DOI 10.1095/biolreprod66.5.1522; Hellsten E, 2001, DEV BIOL, V240, P641, DOI 10.1006/dbio.2001.0476; Hodgson MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060455; Hodgson MC, 2011, CANCER RES, V71, P572, DOI 10.1158/0008-5472.CAN-10-2314; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang ZH, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103382; Katz DJ, 2017, AUST FAM PHYSICIAN, V46, P641; Kim DH, 2013, INT J OBESITY, V37, P853, DOI 10.1038/ijo.2012.141; Krishnamurthy H, 2000, BIOL REPROD, V62, P1146, DOI 10.1095/biolreprod62.5.1146; Lai MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090243; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Leduc F, 2008, BIOL REPROD, V78, P324, DOI 10.1095/biolreprod.107.064162; Lopez SM, 2013, BIOCHEM BIOPH RES CO, V440, P277, DOI 10.1016/j.bbrc.2013.09.077; Loveland KL, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00307; Mengual L, 2009, J UROLOGY, V182, P741, DOI 10.1016/j.juro.2009.03.084; Mu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43475; O'Shaughnessy PJ, 2014, SEMIN CELL DEV BIOL, V29, P55, DOI 10.1016/j.semcdb.2014.02.010; Palmer Nicole O, 2012, Spermatogenesis, V2, P253; Sato T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01911; Sharma RP, 2017, ENVIRON INT, V99, P1, DOI 10.1016/j.envint.2016.09.016; Song SH, 2016, ASIAN J ANDROL, V18, P350, DOI 10.4103/1008-682X.178857; SURESH R, 1992, J BIOSCIENCE, V17, P413, DOI 10.1007/BF02720096; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tsai MY, 2006, P NATL ACAD SCI USA, V103, P18975, DOI 10.1073/pnas.0608565103; Zhang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00505-0; Zhang MQ, 2019, ONCOGENE, V38, P1121, DOI 10.1038/s41388-018-0498-3; Zhou W, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0034-x	56	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233163	10.1371/journal.pone.0233163	http://dx.doi.org/10.1371/journal.pone.0233163			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413098	gold, Green Published			2022-12-26	WOS:000537496000052
J	Pawlicka, A; Pawlicki, M; Tomaszewska, R; Choras, M; Gerlach, R				Pawlicka, Aleksandra; Pawlicki, Marek; Tomaszewska, Renata; Choras, Michal; Gerlach, Ryszard			Innovative machine learning approach and evaluation campaign for predicting the subjective feeling of work-life balance among employees	PLOS ONE			English	Article							QUALITY	At present, many researchers see hope that artificial intelligence, machine learning in particular, will improve several aspects of the everyday life for individuals, cities and whole nations alike. For example, it has been speculated that the so-called machine learning could soon relieve employees of part of the duties, which may improve processes or help to find the most effective ways of performing tasks. Consequently, in the long run, it would help to enhance employees' work-life balance. Thus, workers' overall quality of life would improve, too. However, what would happen if machine learning as such were employed to try and find the ways of achieving work-life balance? This is why the authors of the paper decided to utilize a machine learning tool to search for the factors that influence the subjective feeling of one's work-life balance. The possible results could help to predict and prevent the occurrence of work-life imbalance in the future. In order to do so, the data provided by an exceptionally sizeable group of 800 employees was utilised; it was one of the largest sample groups in similar studies in Poland so far. Additionally, this was one of the first studies where so many employees had been analysed using an artificial neural network. In order to enable replicability of the study, the specific setup of the study and the description of the dataset are provided. Having analysed the data and having conducted several experiments, the correlations between some factors and work-life balance have indeed been identified: it has been found that the most significant was the relation between the feeling of balance and the actual working hours; shifting it resulted in the tool predicting the switch from balance to imbalance, and vice versa. Other factors that proved significant for the predicted WLB are the amount of free time a week the employee has for themselves, working at weekends only, being self-employed and the subjective assessment of one's financial status. In the study the dataset gets balanced, the most important features are selected with the selectKbest algorithm, an artificial neural network of 2 hidden layers with 50 and 25 neurons, ReLU and ADAM is constructed and trained on 90% of the dataset. In tests, it predicts WLB based on the prepared dataset and selected features with 81% accuracy.	[Pawlicka, Aleksandra] ITTI, Bydgoszcz, Poland; [Pawlicki, Marek] UTP Univ Sci & Technol, Bydgoszcz, Poland; [Tomaszewska, Renata] Kazimierz Wielki Univ Bydgoszcz, Bydgoszcz, Poland; [Choras, Michal] UTP Univ Sci & Technol, Bydgoszcz, Poland; [Gerlach, Ryszard] Kazimierz Wielki Univ Bydgoszcz, Bydgoszcz, Poland	Bydgoszcz University of Science & Technology; Kazimierz Wielki University; Bydgoszcz University of Science & Technology; Kazimierz Wielki University	Pawlicka, A (corresponding author), ITTI, Bydgoszcz, Poland.	oliko.aleksandra@gmail.com	Pawlicki, Marek/ABC-3938-2021; Pawlicka, Aleksandra/GLV-2607-2022	Pawlicki, Marek/0000-0001-5881-6406; Pawlicka, Aleksandra/0000-0003-4380-014X; Tomaszewska, Renata/0000-0001-9605-1483				Anand V, 2016, INDIAN J SCI TECHNOL; Clark SC, 2000, HUM RELAT, V53, P747, DOI 10.1177/0018726700536001; Clutterbuck D., 2003, MANAGING WORK LIFE B; Devadoss AV, 2014, INT J SCI ENG RES, V5; Eby LT, 2005, J VOCAT BEHAV, V66, P124, DOI 10.1016/j.jvb.2003.11.003; Fleetwood S, 2007, INT J HUM RESOUR MAN, V18, P387, DOI 10.1080/09585190601167441; Greenhaus G.H., 2010, HDB OCCUPATIONAL HLT, P165, DOI DOI 10.2307/J.CTV1CHS29W.14; Greenhaus JH, 2003, J VOCAT BEHAV, V63, P510, DOI 10.1016/S0001-8791(02)00042-8; Gurney K., 2018, INTRO NEURAL NETWORK; Kalliath T, 2008, J MANAGE ORGAN, V14, P323, DOI 10.5172/jmo.837.14.3.323; Kirchmeyer C, 2000, TR ORG BEHAV, V7, P79; Kofodimos J., 1993, BALANCING ACT; Kukreja H., 2016, INT J ADV RES INNOVA, V1, P27; Lewis S., 2018, CAMBRIDGE HDB GLOBAL, P720; Marks SR, 1996, J MARRIAGE FAM; Meenakshi S.P., 2013, IOSR J BUSINESS MANA, V14, P31, DOI [10.9790/487X-1433135, DOI 10.9790/487X-1433135]; Pawlicki M., 2019, PROGR COMPUTER RECOG, P130; Preetha A, 2015, INT J EMERGING TECHN, V18; Ramos HR, 2015, INT J HAPPINESS DEV, V2; Ruzevicius J, 2017, QUAL-ACCESS SUCCESS, V18, P77; Tomaszewska R, 2019, J ED SOC POLICY, V6, P42; Tomaszewska-Lipiec R., 2018, PRACA ZAWODOWAZYCIE; White A., 2019, TECHNOLOGY SIGNALS; Wilkins J., 2018, IMPO; Work-Life Balance, 2015, CHARTERED MANAGEMENT	25	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232771	10.1371/journal.pone.0232771	http://dx.doi.org/10.1371/journal.pone.0232771			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1BA	32413040	Green Published, gold			2022-12-26	WOS:000537496000019
J	Zhang, JW; Cordshagen, A; Medina, I; Nothwang, HG; Wisniewski, JR; Winklhofer, M; Hartmann, AM				Zhang, Jinwei; Cordshagen, Antje; Medina, Igor; Nothwang, Hans Gerd; Wisniewski, Jacek R.; Winklhofer, Michael; Hartmann, Anna-Maria			Staurosporine and NEM mainly impair WNK-SPAK/OSR1 mediated phosphorylation of KCC2 and NKCC1	PLOS ONE			English	Article							K-CL COTRANSPORTER; PROTEIN-KINASE-C; CATION-CHLORIDE COTRANSPORTERS; GRAMICIDIN PERFORATED-PATCH; CRYO-EM STRUCTURES; NA-K-2CL COTRANSPORT; SPAK/OSR1 KINASES; REGULATE NKCC1; ACTIVATION; RAT	The pivotal role of KCC2 and NKCC1 in development and maintenance of fast inhibitory neurotransmission and their implication in severe human diseases arouse interest in post-transcriptional regulatory mechanisms such as (de)phosphorylation. Staurosporine (broad kinase inhibitor) and N-ethylmalemide (NEM) that modulate kinase and phosphatase activities enhance KCC2 and decrease NKCC1 activity. Here, we investigated the regulatory mechanism for this reciprocal regulation by mass spectrometry and immunoblot analyses using phospho-specific antibodies. Our analyses revealed that application of staurosporine or NEM dephosphorylates Thr(1007) of KCC2, and Thr(203), Thr(207) and Thr(212) of NKCC1. Dephosphorylation of Thr(1007) of KCC2, and Thr(207) and Thr(212) of NKCC1 were previously demonstrated to activate KCC2 and to inactivate NKCC1. In addition, application of the two agents resulted in dephosphorylation of the T-loop and S-loop phosphorylation sites Thr(233) and Ser(373) of SPAK, a critical kinase in the WNK-SPAK/OSR1 signaling module mediating phosphorylation of KCC2 and NKCC1. Taken together, these results suggest that reciprocal regulation of KCC2 and NKCC1 via staurosporine and NEM is based on WNK-SPAK/OSR1 signaling. The key regulatory phospho-site Ser(940) of KCC2 is not critically involved in the enhanced activation of KCC2 upon staurosporine and NEM treatment, as both agents have opposite effects on its phosphorylation status. Finally, NEM acts in a tissue-specific manner on Ser(940), as shown by comparative analysis in HEK293 cells and immature cultured hippocampal neurons. In summary, our analyses identified phospho-sites that are responsive to staurosporine or NEM application. This provides important information towards a better understanding of the cooperative interactions of different phospho-sites.	[Zhang, Jinwei] Univ Exeter, Inst Biomed & Clin Sci, Coll Med & Hlth, Hatherly Labs,Med Sch, Exeter, Devon, England; [Zhang, Jinwei] Xiamen Univ, Xiamen Cardiovasc Hosp, Sch Med, Xiamen, Peoples R China; [Cordshagen, Antje; Nothwang, Hans Gerd; Hartmann, Anna-Maria] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Div Neurogenet, Oldenburg, Germany; [Medina, Igor] Aix Marseille Univ, INSERM, Unite 1249, INMED Inst Neurobiol Mediterranee,UMR 1249, Marseille, France; [Nothwang, Hans Gerd; Winklhofer, Michael; Hartmann, Anna-Maria] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Ctr Excellence Hearing4all, Oldenburg, Germany; [Wisniewski, Jacek R.] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Biochem Prote Grp, Martinsried, Germany; [Winklhofer, Michael] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci IBU, Oldenburg, Germany	University of Exeter; Xiamen University; Carl von Ossietzky Universitat Oldenburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Max Planck Society; Carl von Ossietzky Universitat Oldenburg	Hartmann, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Div Neurogenet, Oldenburg, Germany.; Hartmann, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany.	anna.maria.hartmann@uol.de	Winklhofer, Michael/B-7349-2009; Zhang, Jinwei/Q-7959-2019; Medina, Igor/O-5532-2016	Winklhofer, Michael/0000-0003-1352-9723; Zhang, Jinwei/0000-0001-8683-509X; Medina, Igor/0000-0001-6839-5414; Nothwang, Hans Gerd/0000-0001-7695-6437	Deutsche Forschungsgemeinschaft [NO428/14-1, HA 6338/2-1]; Max-Planck Society for the Advancement of Science by the German Research Foundation (DFG/Gottfried Wilhelm Leibniz Prize); National Natural Science Foundation of China [81970238]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Society for the Advancement of Science by the German Research Foundation (DFG/Gottfried Wilhelm Leibniz Prize); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Deutsche Forschungsgemeinschaft (grants NO428/14-1 to H.G.N; and HA 6338/2-1 to A.-M. H). The work was further funded by Max-Planck Society for the Advancement of Science by the German Research Foundation (DFG/Gottfried Wilhelm Leibniz Prize to J.R.W.) and the National Natural Science Foundation of China (No. 81970238 to J.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilles K, 2007, J NEUROSCI, V27, P8616, DOI 10.1523/JNEUROSCI.5041-06.2007; Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Alessi DR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005365; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Ben-Ari Y, 2017, TRENDS NEUROSCI, V40, P536, DOI 10.1016/j.tins.2017.07.001; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Bize I, 2000, J MEMBRANE BIOL, V177, P159, DOI 10.1007/s002320001109; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Cheng N, 2007, J IMMUNOL, V179, P7720, DOI 10.4049/jimmunol.179.11.7720; Chew TA, 2019, NATURE, V572, P488, DOI 10.1038/s41586-019-1438-2; Conway LC, 2017, J BIOL CHEM, V292, P21253, DOI 10.1074/jbc.M117.817841; Cordshagen A, 2018, J BIOL CHEM, V293, P16984, DOI 10.1074/jbc.RA118.004349; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Culliford SJ, 2003, CELL PHYSIOL BIOCHEM, V13, P181, DOI 10.1159/000072420; Daigle ND, 2009, J CELL PHYSIOL, V220, P680, DOI 10.1002/jcp.21814; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; De los Heros P, 2005, PNAS, V103, P1976; de los Heros P, 2014, BIOCHEM J, V458, P559, DOI 10.1042/BJ20131478; Del Castillo IC, 2005, AM J PHYSIOL-CELL PH, V289, pC1332, DOI 10.1152/ajpcell.00580.2004; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Delpire E, 2020, AM J PHYSIOL-CELL PH, V318, pC225, DOI 10.1152/ajpcell.00465.2019; Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106; Di Fulvio M, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P169; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Flatman PW, 2002, BBA-BIOMEMBRANES, V1566, P140, DOI 10.1016/S0005-2736(02)00586-2; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Friedel P, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0354; Gagnon E, 2005, AM J PHYSIOL-CELL PH, V290, P134; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KB, 2013, AM J PHYSIOL-CELL PH, V304, pC693, DOI 10.1152/ajpcell.00350.2012; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Garon L, 2000, J BIOL CHEM, V275, P32027, DOI 10.1074/jbc.M000108200; Geng Y, 2009, J BIOL CHEM, V284, P14020, DOI 10.1074/jbc.M900142200; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Hartmann A-M, 2014, MOL BIOL EVOL; Hartmann A-M, 2014, FRONTIERS CELLULAR N, V8; Hartmann AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179968; Hartmann AM, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00470; Hartmann AM, 2010, J BIOL CHEM, V285, P23994, DOI 10.1074/jbc.M110.144063; Hartmann AM, 2009, J NEUROCHEM, V111, P321, DOI 10.1111/j.1471-4159.2009.06343.x; Heubl M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01749-0; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Inoue K, 2012, J BIOL CHEM, V287, P20839, DOI 10.1074/jbc.M111.319418; JENNINGS ML, 1991, J GEN PHYSIOL, V97, P799, DOI 10.1085/jgp.97.4.799; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2016, J NEUROPHYSIOL, V115, P8, DOI 10.1152/jn.00865.2015; Kahle KT, 2014, EMBO REP, V15, P766, DOI 10.15252/embr.201438840; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Kahle KT, 2010, BBA-MOL BASIS DIS, V1802, P1150, DOI 10.1016/j.bbadis.2010.07.009; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; Lee HHC, 2007, KCC, V2; Liu S, 2019, SCIENCE, V366, P505, DOI 10.1126/science.aay3129; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Lytle C, 1998, AM J PHYSIOL-CELL PH, V274, pC299, DOI 10.1152/ajpcell.1998.274.2.C299; Lytle C, 2002, AM J PHYSIOL-CELL PH, V283, pC1422, DOI 10.1152/ajpcell.00130.2002; Markkanen M, 2017, BRAIN RES, V1675, P87, DOI 10.1016/j.brainres.2017.08.034; Medina I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00027; MERNER ND, 2015, FRONTIERS CELLULAR N, V9, P13159, DOI DOI 10.3389/FNCEL.2015.00009; Moore YE, 2018, P NATL ACAD SCI USA, V115, P10166, DOI 10.1073/pnas.1810134115; Moore YE, 2017, TRENDS NEUROSCI, V40, P555, DOI 10.1016/j.tins.2017.06.008; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Muzyamba MC, 1999, J PHYSIOL-LONDON, V517, P421, DOI 10.1111/j.1469-7793.1999.0421t.x; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Owens DF, 1996, J NEUROSCI, V16, P6414; Arroyo JP, 2013, MOL ASPECTS MED, V34, P288, DOI 10.1016/j.mam.2012.05.002; PALFREY HC, 1993, AM J PHYSIOL, V264, pC1270, DOI 10.1152/ajpcell.1993.264.5.C1270; PALMER RH, 1994, FEBS LETT, V356, P5, DOI 10.1016/0014-5793(94)01202-4; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Pisella LI, 2019, IMPAIRED REGULATION, V12; Price GD, 2006, J NEUROSCI, V26, P11432, DOI 10.1523/JNEUROSCI.1660-06.2006; Puskarjov M, 2014, NEUROPHARMACOLOGY; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Salzer E, 2016, J CLIN IMMUNOL, V36, P631, DOI 10.1007/s10875-016-0323-0; Shekarabi M, 2017, CELL METAB, V25, P285, DOI 10.1016/j.cmet.2017.01.007; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Silayeva L, 2015, P NATL ACAD SCI USA, V112, P3523, DOI 10.1073/pnas.1415126112; Sipila ST, 2009, J NEUROSCI, V29, P6982, DOI 10.1523/JNEUROSCI.0443-09.2009; Smith L, 2008, J BIOL CHEM, V283, P22147, DOI 10.1074/jbc.M801752200; Stempka L, 1997, J BIOL CHEM, V272, P6805, DOI 10.1074/jbc.272.10.6805; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; Titz S, 2015, NEUROPHARMACOLOGY; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Uchida S, 2014, BIOL CELL, V106, P45, DOI 10.1111/boc.201300069; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Vardi N, 2000, J NEUROSCI, V20, P7657; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Webb BLJ, 2000, BRIT J PHARMACOL, V130, P1433, DOI 10.1038/sj.bjp.0703452; Weber M, 2014, J BIOL CHEM; Wenz M, 2009, BIOCHEM BIOPH RES CO, V381, P388, DOI 10.1016/j.bbrc.2009.02.057; Wisniewski JR, 2016, ANAL CHEM, V88, P5438, DOI 10.1021/acs.analchem.6b00859; Wisniewski JR, 2015, ANAL CHEM, V87, P4110, DOI 10.1021/ac504689z; Wisniewski JR, 2012, ANAL CHEM, V84, P2631, DOI 10.1021/ac300006b; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Yang X., 2020, STEM CELL RES THER, V11, P1, DOI [10.1186/scrt42, DOI 10.1186/SCRT42]; Yassin L, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00065; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093; Zhu L, 2008, EPILEPSY RES, V79, P201, DOI 10.1016/j.eplepsyres.2008.02.005	119	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232967	10.1371/journal.pone.0232967	http://dx.doi.org/10.1371/journal.pone.0232967			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413057	Green Published, gold			2022-12-26	WOS:000537496000031
J	McClean, CM; Tobin, DM				McClean, Colleen M.; Tobin, David M.			Early cell-autonomous accumulation of neutral lipids during infection promotes mycobacterial growth	PLOS ONE			English	Article							STATIN ADJUNCTIVE THERAPY; GRANULOMA-FORMATION; FOAMY MACROPHAGES; NILE RED; TUBERCULOSIS; CHOLESTEROL; ZEBRAFISH; METABOLISM; HOMEOSTASIS; AUTOPHAGY	Lipids represent an important source of nutrition for infecting mycobacteria, accumulating within the necrotic core of granulomas and present in foamy macrophages associated with mycobacterial infection. In order to better understand the timing, process and importance of lipid accumulation, we developed methods for direct in vivo visualization and quantification of this process using the zebrafish-M. marinum larval model of infection. We find that neutral lipids accumulate cell-autonomously in mycobacterium-infected macrophages in vivo during early infection, with detectable levels of accumulation by two days post-infection. Treatment with ezetimibe, an FDA-approved drug, resulted in decreased levels of free cholesterol and neutral lipids, and a reduction of bacterial growth in vivo. The effect of ezetimibe in reducing bacterial growth was dependent on the mce4 operon, a key bacterial determinant of lipid utilization. Thus, in vivo, lipid accumulation can occur cell-autonomously at early timepoints of mycobacterial infection, and limitation of this process results in decreased bacterial burden.	[McClean, Colleen M.; Tobin, David M.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [McClean, Colleen M.; Tobin, David M.] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27708 USA; [McClean, Colleen M.] Duke Univ, Sch Med, Med Scientist Training Program, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Tobin, DM (corresponding author), Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.; Tobin, DM (corresponding author), Duke Univ, Sch Med, Dept Immunol, Durham, NC 27708 USA.	david.tobin@duke.edu		McClean, Colleen/0000-0002-1698-1136; Tobin, David/0000-0003-3465-5518	NIH [F30 AI126693]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	C.M.M. was funded by an NIH Fellowship F30 AI126693. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Alffenaar JWC, 2016, ANTIMICROB AGENTS CH, V60, P7004, DOI 10.1128/AAC.01836-16; Alvarez MI, 2017, P NATL ACAD SCI USA, V114, pE7746, DOI 10.1073/pnas.1706070114; Anderson JL, 2016, METHOD CELL BIOL, V133, P165, DOI 10.1016/bs.mcb.2016.04.011; Anderson JL, 2011, METHOD CELL BIOL, V101, P111, DOI 10.1016/B978-0-12-387036-0.00005-0; Baek JS, 2012, CHOLESTEROL, DOI 10.1155/2012/564705; Berney M, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TBTB2-0030-2016; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Christensen H, 1999, MOL MICROBIOL, V31, P1561, DOI 10.1046/j.1365-2958.1999.01304.x; Clifton JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012386; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cosma Christine L, 2006, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/0471729256.mc10b02s3; Cronan MR, 2016, IMMUNITY, V45, P861, DOI 10.1016/j.immuni.2016.09.014; Cronan MR, 2014, DIS MODEL MECH, V7, P777, DOI 10.1242/dmm.016089; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Dkhar HK, 2014, J IMMUNOL, V193, P295, DOI 10.4049/jimmunol.1400092; Dutta NK, 2016, J ANTIMICROB CHEMOTH, V71, P1570, DOI 10.1093/jac/dkw014; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Genicot G, 2005, THERIOGENOLOGY, V63, P1181, DOI 10.1016/j.theriogenology.2004.06.006; Genoula M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00459; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Guerrini Valentina, 2018, PLoS Pathog, V14, pe1007223, DOI 10.1371/journal.ppat.1007223; Hosseini R, 2014, AUTOPHAGY, V10, P1844, DOI 10.4161/auto.29992; Jaisinghani N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01490; Johansen MD, 2018, DEV COMP IMMUNOL, V88, P169, DOI 10.1016/j.dci.2018.07.022; Joshi SM, 2006, P NATL ACAD SCI USA, V103, P11760, DOI 10.1073/pnas.0603179103; Kauffman KD, 2018, MUCOSAL IMMUNOL, V11, P462, DOI 10.1038/mi.2017.60; Knight M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006874; KOREN E, 1990, ATHEROSCLEROSIS, V85, P175, DOI 10.1016/0021-9150(90)90109-V; Kosoglou T, 2005, CLIN PHARMACOKINET, V44, P467, DOI 10.2165/00003088-200544050-00002; Libbing CL, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040354; Lovewell RR, 2016, CURR OPIN MICROBIOL, V29, P30, DOI 10.1016/j.mib.2015.10.002; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Maurya RK, 2019, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00450; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; Maxfield FR, 2012, METHOD CELL BIOL, V108, P367, DOI 10.1016/B978-0-12-386487-1.00017-1; McCann JR, 2011, J BACTERIOL, V193, P854, DOI 10.1128/JB.01271-10; McClean CM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw068; Minchin JEN, 2017, METHOD CELL BIOL, V138, P3, DOI 10.1016/bs.mcb.2016.11.010; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; MULLER CP, 1984, CYTOMETRY, V5, P42, DOI 10.1002/cyto.990050108; Nazarova EV, 2017, ELIFE, V6, DOI 10.7554/eLife.26969; Oehlers SH, 2015, NATURE, V517, P612, DOI 10.1038/nature13967; Ouimet M, 2012, ARTERIOSCL THROM VAS, V32, P575, DOI 10.1161/ATVBAHA.111.240705; Pagan AJ, 2018, ANNU REV IMMUNOL, V36, P639, DOI 10.1146/annurev-immunol-032712-100022; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parihar SP, 2019, NAT REV IMMUNOL, V19, P104, DOI 10.1038/s41577-018-0094-3; Parihar SP, 2014, J INFECT DIS, V209, P754, DOI 10.1093/infdis/jit550; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Senaratne RH, 2008, J MED MICROBIOL, V57, P164, DOI 10.1099/jmm.0.47454-0; Singh V, 2012, CELL HOST MICROBE, V12, P669, DOI 10.1016/j.chom.2012.09.012; Talayero Beatriz G, 2011, Curr Cardiol Rep, V13, P544, DOI 10.1007/s11886-011-0220-3; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Vermeulen I, 2017, J LIPID RES, V58, P709, DOI 10.1194/jlr.M073171; Walton EM, 2018, CELL HOST MICROBE, V24, P514, DOI 10.1016/j.chom.2018.09.004; Wilburn KM, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty021	63	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232251	10.1371/journal.pone.0232251	http://dx.doi.org/10.1371/journal.pone.0232251			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407412	Green Published, gold			2022-12-26	WOS:000537490700017
J	Secor, DH; O'Brien, MHP; Gahagan, BI; Watterson, JC; Fox, DA				Secor, David H.; O'Brien, Michael H. P.; Gahagan, Benjamin I.; Watterson, J. Carter; Fox, Dewayne A.			Differential migration in Chesapeake Bay striped bass	PLOS ONE			English	Article							MORONE-SAXATILIS; HUDSON RIVER; ATLANTIC COAST; POPULATION-STRUCTURE; BLUEFIN TUNA; PATTERNS; ADULT; STOCK; AGE; TEMPERATURE	Differential migration-increased migration propensity with increasing individual size-is common in migratory species. Like other forms of partial migration, it provides spatial buffering against regional differences in habitat quality and sources of mortality. We investigated differential migration and its consequences to survival and reproductive patterns in striped bass, a species with well-known plasticity in migration behaviors. A size-stratified sample of Potomac River (Chesapeake Bay) Morone saxatilis striped bass was implanted with acoustic transmitters and their subsequent coastal shelf migrations recorded over a 4-yr period by telemetry receivers throughout the Mid-Atlantic Bight and Southern New England. A generalized linear mixed model predicted that >= 50% of both males and females depart the Chesapeake Bay at large sizes >80 cm total length. Egressing striped bass exited through both the Chesapeake Bay mouth and Delaware Bay (via the Chesapeake and Delaware Canal), favoring the former. All large fish migrated to Massachusetts shelf waters and in subsequent years repeatedly returned to regions within Massachusetts and Cape Cod Bays. Within this dominant behavior, minority behaviors included straying, skipped spawning, and residency by large individuals (those expected to migrate). Analysis of the last day of transmission indicated that small resident striped bass experienced nearly 2-fold higher loss rates (70% yr(-1)) than coastal shelf emigrants (37% yr(-1)). The study confirmed expectations for a threshold size at emigration and different mortality levels between Chesapeake Bay (resident) and ocean (migratory) population contingents; and supported the central premise of the current assessment and management framework of a two-contingent population: smaller Chesapeake Bay residents and a larger ocean contingent. An improved understanding of differential migration thus affords an opportunity to specify stock assessments according to different population sub-components, and tailor reference points and control rules between regions and fishing stakeholder groups.	[Secor, David H.; O'Brien, Michael H. P.] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [Gahagan, Benjamin I.] Massachusetts Div Marine Fisheries, Gloucester, MA USA; [Watterson, J. Carter] US Navy, Naval Facil Engn Command Atlantic, Norfolk, VA USA; [Fox, Dewayne A.] Delaware State Univ, Coll Agr Sci & Technol, Dover, DE USA	University System of Maryland; University of Maryland Center for Environmental Science; Massachusetts Division of Marine Fisheries; Delaware State University	Secor, DH (corresponding author), Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA.	secor@umces.edu	O'Brien, Michael HP/ABF-9080-2021; Secor, David H./D-4367-2012	O'Brien, Michael HP/0000-0003-1420-6395; Secor, David H./0000-0001-6007-4827	Atlantic States Marine Fisheries Commission; National Oceanic and Atmospheric Administration Chesapeake Bay Office [16-0401]	Atlantic States Marine Fisheries Commission; National Oceanic and Atmospheric Administration Chesapeake Bay Office(National Oceanic Atmospheric Admin (NOAA) - USA)	DHS received support for this research by the Atlantic States Marine Fisheries Commission and the the National Oceanic and Atmospheric Administration Chesapeake Bay Office: Grant No. 16-0401.	Able KW, 2007, FISH B-NOAA, V105, P426; Ahrenholz DW., 1991, MAR FISH REV, V53, P3, DOI DOI 10.1111/BJD.14714; Babaluk JA, 2000, ARCTIC, V53, P161; Baker R. R., 1978, EVOLUTIONARY ECOLOGY; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BERLINSKY DL, 1995, T AM FISH SOC, V124, P207, DOI 10.1577/1548-8659(1995)124&lt;0207:AAMEFA&gt;2.3.CO;2; Brown KM, 2005, HEREDITY, V94, P606, DOI 10.1038/sj.hdy.6800668; Callihan JL, 2008, FISH OCEANOGR, V17, P191, DOI 10.1111/j.1365-2419.2008.00468.x; Center NNFS, 2019, 66 NE REG STOCK ASS, P1170; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; CHAPOTON ROBERT B., 1961, TRANS AMER FISH SOC, V90, P13, DOI 10.1577/1548-8659(1961)90[13:ACMOLS]2.0.CO;2; CLARK J, 1968, T AM FISH SOC, V97, P320, DOI 10.1577/1548-8659(1968)97[320:SMOSBC]2.0.CO;2; [Commission AASMF Committee LE], 2014, MEMORANDUM ENVORCEME, P2; Conrath CL, 2008, ENVIRON BIOL FISH, V82, P123, DOI 10.1007/s10641-007-9263-0; DiBenedetto D., 2004, RUN ANGLERS JOURNEY; DORAZIO RM, 1994, T AM FISH SOC, V123, P950, DOI 10.1577/1548-8659(1994)123<0950:TREOMO>2.3.CO;2; Gahagan BI, 2015, MAR ECOL PROG SER, V525, P185, DOI 10.3354/meps11152; Gauthier DT, 2008, ECOL APPL, V18, P1718, DOI 10.1890/07-2083.1; Gauthier DT, 2013, J HERED, V104, P510, DOI 10.1093/jhered/est031; Greenberg R., 2005, BIRDS 2 WORLDS ECOLO; Grothues TM, CHALLENGES DIADROMOU; Haeseker SL, 1996, T AM FISH SOC, V125, P690, DOI 10.1577/1548-8659(1996)125<0690:SDACOS>2.3.CO;2; Harden Jones F.R., 1968, FISH MIGRATION; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Hollema HM, 2017, FISH RES, V187, P168, DOI 10.1016/j.fishres.2016.11.006; Huse G, 2010, MAR ECOL PROG SER, V409, P189, DOI 10.3354/meps08620; Itoh T, 2003, FISH B-NOAA, V101, P514; Jones CM, 1998, FISH B-NOAA, V96, P451; Kerr LA, 2010, ECOL APPL, V20, P497, DOI 10.1890/08-1382.1; Kneebone J, 2014, T AM FISH SOC, V143, P1115, DOI 10.1080/00028487.2014.889752; KOHLENSTEIN LC, 1981, T AM FISH SOC, V110, P168, DOI 10.1577/1548-8659(1981)110<168:OTPOTC>2.0.CO;2; Kraus RT, 2005, MAR ECOL PROG SER, V291, P301, DOI 10.3354/meps291301; Latour RJ, 2019, SUMMARY REPORT 66 NE; Liao HS, 2013, T AM FISH SOC, V142, P193, DOI 10.1080/00028487.2012.705255; MANSUETI ROMEO J., 1961, CHESAPEAKE SCI, V2, P9, DOI 10.2307/1350717; MASSMANN WILLIAM H., 1961, CHESAPEAKE SCI, V2, P37, DOI 10.2307/1350718; Mather ME, 2010, J FISH BIOL, V77, P2326, DOI 10.1111/j.1095-8649.2010.02811.x; Mather ME, 2009, FISH B-NOAA, V107, P329; McFarlane GA, 2003, FISH B-NOAA, V101, P358; McQuinn IH, 1997, REV FISH BIOL FISHER, V7, P297, DOI 10.1023/A:1018491828875; Merriman D., 1941, STUDIES STRIPED BASS, P1; Ng CL, 2007, T AM FISH SOC, V136, P1344, DOI 10.1577/T06-250.1; Overton AS, 2008, FISH B-NOAA, V106, P174; Overton AS, 2009, T AM FISH SOC, V138, P915, DOI 10.1577/T07-261.1; Peer AC, 2014, N AM J FISH MANAGE, V34, P94, DOI 10.1080/02755947.2013.847877; R Core Team, 2021, R LANGUAGE ENV STAT; Rideout RM, 2005, FISH FISH, V6, P50, DOI 10.1111/j.1467-2679.2005.00174.x; ROFF DA, 1988, ENVIRON BIOL FISH, V22, P133, DOI 10.1007/BF00001543; Rothermel E., 2019, SEASONAL MIGRATIONS; RUTHERFORD ES, 1995, FISH B-NOAA, V93, P315; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Secor DH, 2015, CONSERV BIOL, V29, P400, DOI 10.1111/cobi.12392; Secor DH, 2008, T AM FISH SOC, V137, P782, DOI 10.1577/T07-105.1; Secor DH, 2007, FISH B-NOAA, V105, P62; SECOR DH, 1995, FISH B-NOAA, V93, P186; Secor DH, 2000, ICES J MAR SCI, V57, P403, DOI 10.1006/jmsc.1999.0520; Secor DH, 2015, MIGRATION ECOLOGY OF MARINE FISHES, P1; Secor DH, 1999, FISH RES, V43, P13, DOI 10.1016/S0165-7836(99)00064-8; Secor DH, 1996, ESTUARIES, V19, P778, DOI 10.2307/1352297; Striper Cole J., 1978, STORY FISH MAN; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; Wagner GN, 2011, REV FISH BIOL FISHER, V21, P71, DOI 10.1007/s11160-010-9191-5; Waldman J, 2012, J APPL ICHTHYOL, V28, P1, DOI 10.1111/j.1439-0426.2011.01888.x; WALDMAN JR, 1990, T AM FISH SOC, V119, P910, DOI 10.1577/1548-8659(1990)119<0910:RDOHRS>2.3.CO;2; Wallace EJ, 2018, J MAR RES, V76, P163, DOI 10.1357/002224018826473281; Walter JF, 2003, FISHERIES MANAG ECOL, V10, P349, DOI 10.1046/j.1365-2400.2003.00373.x; WEBB PW, 1984, J EXP BIOL, V109, P77; Welsh SA, 2007, T AM FISH SOC, V136, P34, DOI 10.1577/T05-319.1; Wingate RL, 2007, T AM FISH SOC, V136, P95, DOI 10.1577/T06-056.1; Wingate RL, 2011, T AM FISH SOC, V140, P1441, DOI 10.1080/00028487.2011.630279; WIRGIN I, 1993, T AM FISH SOC, V122, P669, DOI 10.1577/1548-8659(1993)122<0669:UOMDPT>2.3.CO;2; Zlokovitz ER, 2003, FISH RES, V63, P245, DOI 10.1016/S0165-7836(03)00069-9	72	9	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233103	10.1371/journal.pone.0233103	http://dx.doi.org/10.1371/journal.pone.0233103			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407398	Green Published, gold			2022-12-26	WOS:000537490700070
J	Tebrun, W; Motola, G; Hafez, MH; Bachmeier, J; Schmidt, V; Renfert, K; Reichelt, C; Bruggemann-Schwarze, S; Pees, M				Tebrun, Wiebke; Motola, Gerzon; Hafez, Mohamed Hafez; Bachmeier, Josef; Schmidt, Volker; Renfert, Kevin; Reichelt, Christian; Brueggemann-Schwarze, Sarah; Pees, Michael			Preliminary study: Health and performance assessment in broiler chicks following application of six different hatching egg disinfection protocols	PLOS ONE			English	Article							ESCHERICHIA-COLI; EXTENDED-SPECTRUM; HYDROGEN-PEROXIDE; FORMALDEHYDE FUMIGATION; YOLK-SAC; ANTIMICROBIAL RESISTANCE; SALMONELLA-ENTERITIDIS; BEAM IRRADIATION; HIGH PREVALENCE; KUPFFER CELLS	As part of a Germany-wide project that evaluates strategies for the reduction of multi-resistant bacteria along the poultry production chain, the impact of different hatching egg disinfectants on hatchability and health of the broiler chicks was evaluated. Animal trials were conducted with extended-spectrum beta-lactamase- (ESBL) producing Escherichia (E.) coli contaminated hatching eggs and six disinfection protocols that used formaldehyde, hydrogen peroxide, low-energy electron irradiation, peracetic acid and an essential oil preparation. Each protocol was tested on a group of 50 chicks. Equally sized positive and negative control groups were carried along for each trial. Hatchability, mortality and body weight were recorded as performance parameters. During necropsy of half of the animals in each group on day 7 and 14 respectively, macroscopic abnormalities, body weight, weights of liver and gut convolute were recorded and a range of tissue samples for histological examination were collected as part of the health assessment. A decrease in hatchability was recorded for spray application of essential oils. Body weight development was overall comparable, in several groups even superior, to the Ross308 performance objectives, but a reduced performance was seen in the hydrogen peroxide group. Histologically, lymphoid follicles were regularly seen in all sampled organs and no consistent differences were observed between contaminated and non-contaminated groups. Significances were infrequently and inconsistently seen. In conclusion, remarkable findings were a decrease in hatchability caused by the essential oils spray application and a reduced body weight development in the hydrogen peroxide group. Therefore, the essential oils preparation as spray application was deemed inappropriate in practice, while the application of hydrogen peroxide was considered in need of further research. The other trial results indicate that the tested hatching egg disinfectants present a possible alternative to formaldehyde.	[Tebrun, Wiebke; Schmidt, Volker; Renfert, Kevin; Reichelt, Christian; Pees, Michael] Univ Leipzig, Univ Teaching Hosp, Dept Birds & Reptiles, Tierkliniken, Leipzig, Germany; [Motola, Gerzon; Hafez, Mohamed Hafez; Brueggemann-Schwarze, Sarah] Free Univ Berlin, Inst Poultry Dis, Berlin, Germany; [Bachmeier, Josef] Bruterei Sud, Regenstauf, Germany; [Tebrun, Wiebke] Ludwig Maximilians Univ Munchen, Clin Birds Small Mammals Reptiles & Ornamental Fi, Oberschleissheim, Germany; [Renfert, Kevin] Tierarztliche Klin Schwerin, Schwerin, Germany	Leipzig University; Free University of Berlin; University of Munich	Pees, M (corresponding author), Univ Leipzig, Univ Teaching Hosp, Dept Birds & Reptiles, Tierkliniken, Leipzig, Germany.	pees@vogelklinik.uni-leipzig.de	Schmidt, Volker/I-7708-2019	Schmidt, Volker/0000-0002-6001-9542	Federal Office for Agriculture and Food [2817701714]; Bruterei Sud	Federal Office for Agriculture and Food; Bruterei Sud	MP and MHH have been funded by the Federal Office for Agriculture and Food (www.ble.de).Grant number awarded for MP and MHH: 2817701714. One coauthor was employed by the commercial company Bruterei Sud. Bruterei Sud provided support in the form of salary for one author [JB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	Anna CK, 2015, OPEN CHEM, V13, P1269, DOI 10.1515/chem-2015-0140; [Anonymous], 2003, DIS POULT; Batkowska J, 2017, EUR POULTRY SCI, V81, DOI 10.1399/eps.2017.211; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Bortolaia V, 2011, APPL ENVIRON MICROB, V77, P5830, DOI 10.1128/AEM.02890-10; Bourassa DV, 2002, J APPL POULTRY RES, V11, P397, DOI 10.1093/japr/11.4.397; Brower CH, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP292, 10.1289/ehp292]; Cadirci S, 2009, ARCH GEFLUGELKD, V73, P116; Casella T, 2017, INT J FOOD MICROBIOL, V257, P271, DOI 10.1016/j.ijfoodmicro.2017.07.005; Castaneda SMP, 1996, ACTA ALIMENT HUNG, V25, P305; Cristofari-Marquand E, 2007, J OCCUP HEALTH, V49, P155, DOI 10.1539/joh.49.155; Dame-Korevaar A, 2019, PREV VET MED, V162, P136, DOI 10.1016/j.prevetmed.2018.12.002; De Cesare A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176309; Duong A, 2011, MUTAT RES-REV MUTAT, V728, P118, DOI 10.1016/j.mrrev.2011.07.003; Dzoma BM, 2001, J AVIAN MED SURG, V15, P81, DOI 10.1647/1082-6742(2001)015[0081:YSRITO]2.0.CO;2; Echols MS, CLIN AVIAN MED; Entenman C, 1940, J BIOL CHEM, V133, P231; ESTEBAN S, 1991, J COMP PHYSIOL B, V160, P645, DOI 10.1007/BF00571262; Fan XT, 2017, RADIAT PHYS CHEM, V130, P306, DOI 10.1016/j.radphyschem.2016.09.015; Ferreira JC, 2016, DIAGN MICR INFEC DIS, V85, P444, DOI 10.1016/j.diagmicrobio.2016.05.011; Fletcher O.J., 2008, AVIAN HISTOPATHOLOGY; ] Fries R, 2001, PRAXIS GEFLUGELFLEIS; GERRITS AR, 1992, ARCH GEFLUGELKD, V56, P179; Gottselig SM, 2016, POULTRY SCI, V95, P1356, DOI 10.3382/ps/pev450; HAFEZ HM, 1993, TIERARZTL UMSCHAU, V48, P517; HAFEZ HM, 1995, ARCH GEFLUGELKD, V59, P69; Hayretdag S, 2008, TURK J VET ANIM SCI, V32, P263; Hering J, 2016, PREV VET MED, V125, P154, DOI 10.1016/j.prevetmed.2016.01.003; Himathongkham S, 1999, INT J FOOD MICROBIOL, V49, P161, DOI 10.1016/S0168-1605(99)00092-6; Hrnar C., 2012, SCI PAP ANIM SCI BIO, V45, P411; Johns JL, 2012, VET PATHOL, V49, P508, DOI 10.1177/0300985811432344; Kalidari GA, 2009, J POULT SCI, V46, P59, DOI 10.2141/jpsa.46.59; Keita A, 2016, POULTRY SCI, V95, P1609, DOI 10.3382/ps/pew058; Khan K. A., 2004, Pakistan Veterinary Journal, V24, P46; Kim CH, 2010, J BLOOD MED, V1, P13, DOI 10.2147/JBM.S7224; Krizman M, 2017, J FOOD PROTECT, V80, P113, DOI [10.4315/0362-028X.JFP-16-214, 10.4315/0362-028x.jfp-16-214]; Kundu D, 2014, MEAT SCI, V96, P413, DOI 10.1016/j.meatsci.2013.07.034; Lee MD, 2008, AM ASS AVIAN PATHOLO, P10; Liu WJ, 2017, J MED MICROBIOL, V66, P13, DOI 10.1099/jmm.0.000403; Lucht L, 1997, J FOOD SAFETY, V17, P261, DOI 10.1111/j.1745-4565.1997.tb00193.x; Maamar E, 2016, INT J FOOD MICROBIOL, V231, P69, DOI 10.1016/j.ijfoodmicro.2016.05.001; Melo EF, 2019, POULTRY SCI, V98, P2466, DOI 10.3382/ps/pez022; Mezhoud H, 2016, AVIAN PATHOL, V45, P493, DOI 10.1080/03079457.2016.1167837; Musgrove MT, 2010, J APPL POULTRY RES, V19, P387, DOI 10.3382/japr.2009-00105; NAKAMURA K, 1986, VET PATHOL, V23, P712, DOI 10.1177/030098588602300610; Nongtaodum S, 2013, J FOOD SCI, V78, pS329, DOI 10.1111/1750-3841.12035; Ny S, 2017, J ANTIMICROB CHEMOTH, V72, P582, DOI 10.1093/jac/dkw419; Olsen R, 2017, POULTRY SCI, V96, P3901, DOI 10.3382/ps/pex182; Olsen RH, 2014, AVIAN PATHOL, V43, P199, DOI 10.1080/03079457.2014.907866; PADRON M, 1995, AVIAN DIS, V39, P627, DOI 10.2307/1591818; Porter RE, 1998, POULTRY SCI, V77, P1159, DOI 10.1093/ps/77.8.1159; Projahn M, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02364-16; Reese S, 2006, VET RES, V37, P311, DOI 10.1051/vetres:2006003; Rehkopf AC, 2017, POULTRY SCI, V96, P3709, DOI 10.3382/ps/pex166; RIDGWAY HF, 1982, APPL ENVIRON MICROB, V44, P972, DOI 10.1128/AEM.44.4.972-987.1982; Rupp N., 2008, THESIS; Russell SM, 2003, POULTRY SCI, V82, P158, DOI 10.1093/ps/82.1.158; Sander JE, 1999, AVIAN DIS, V43, P227, DOI 10.2307/1592612; SHELDON BW, 1991, POULTRY SCI, V70, P1092, DOI 10.3382/ps.0701092; Tesfai AT, 2011, INT J RADIAT BIOL, V87, P571, DOI 10.3109/09553002.2011.565400; Todoriki S, 2000, RADIAT PHYS CHEM, V57, P253, DOI 10.1016/S0969-806X(99)00389-8; Tschudin-Sutter S, 2014, INFECT CONT HOSP EP, V35, P581, DOI 10.1086/675831; Vandyousefi S, 2017, J FOOD PROCESS PRES, V41, DOI 10.1111/jfpp.12859; Vervelde L, 1997, AVIAN PATHOL, V26, P803, DOI 10.1080/03079459708419254; WARDLE EN, 1987, LIVER, V7, P63; Wells JB, 2010, POULTRY SCI, V89, P2499, DOI 10.3382/ps.2009-00604; WHISTLER PE, 1989, POULTRY SCI, V68, P1074, DOI 10.3382/ps.0681074; Wray C., 1996, Poultry diseases,, P9; Yildirim I, 2003, REV MED VET-TOULOUSE, V154, P367; Yong HI, 2015, RADIAT PHYS CHEM, V115, P153, DOI 10.1016/j.radphyschem.2015.06.023; ZAKARIA AH, 1991, BRIT POULTRY SCI, V32, P103, DOI 10.1080/00071669108417331; Zulkifli I, 1999, VET RES COMMUN, V23, P91, DOI 10.1023/A:1006202418092	72	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232825	10.1371/journal.pone.0232825	http://dx.doi.org/10.1371/journal.pone.0232825			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407391	Green Published, gold			2022-12-26	WOS:000537490700039
J	Li, W; Wang, QX; Qi, XY; Guo, YY; Lu, HM; Chen, YH; Lu, ZM; Yan, Q; Zhu, XF; Jung, JU; Tosato, OAN; Gao, SJ; Lu, C				Li, Wan; Wang, Qingxia; Qi, Xiaoyu; Guo, Yuanyuan; Lu, Hongmei; Chen, Yuheng; Lu, Zhongmou; Yan, Qin; Zhu, Xiaofei; Jung, Jae U.; Tosato, Giovanna; Gao, Shou-Jiang; Lu, Chun			Viral interleukin-6 encoded by an oncogenic virus promotes angiogenesis and cellular transformation by enhancing STAT3-mediated epigenetic silencing of caveolin 1	ONCOGENE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; HIV-1 NEF; STAT3; GENE; ACTIVATION; TRANSCRIPTION; PROTEIN; VIL-6; IL-6	Kaposi's sarcoma (KS) caused by oncogenic Kaposi's sarcoma-associated herpesvirus (KSHV) is a highly angiogenic and invasive vascular tumor and the most common AIDS-associated cancer. KSHV-encoded viral interleukin-6 (vIL-6) is implicated in the development of KSHV-induced malignancies; however, the mechanisms underlying vIL-6-induced angiogenesis and tumorigenesis remain undefined. Here, we show that vIL-6 promotes angiogenesis, cell proliferation, and invasion by downregulating caveolin 1 (CAV1) that plays a pivotal and versatile role in multiple cancer-associated processes. Mechanistically, vIL-6 signaling led to the phosphorylation and acetylation of STAT3 that targeted DNA methyltransferase 1 (DNMT1) in a sequential manner. Specifically, the vIL-6-induced phosphorylated form of STAT3 transcriptionally activated DNMT1 expression. Furthermore, vIL-6-induced acetylated form of STAT3 interacted with DNMT1 to form a transcription factor complex that bound to and methylated the CAV1 promoter, leading to CAV1 expression silencing. In fact, downregulation of CAV1 expression resulted in the activation of AKT signaling, promoting cell invasion, and growth transformation induced by KSHV. Finally, genetic deletion of vIL-6 from the KSHV genome abolished KSHV-induced cellular transformation and impaired angiogenesis. Our results reveal that vIL-6 epigenetically silences CAV1 expression to promote angiogenesis and tumorigenesis by regulating the formation of STAT3-DNMT1 complex. These novel findings define a mechanism by which KSHV inhibits the CAV1 pathway and establish the scientific basis for targeting this pathway to treat KSHV-associated cancers.	[Li, Wan; Wang, Qingxia; Qi, Xiaoyu; Chen, Yuheng; Lu, Zhongmou; Yan, Qin; Lu, Chun] Nanjing Med Univ, Dept Microbiol, Nanjing 211166, Peoples R China; [Li, Wan; Lu, Chun] Nanjing Med Univ, Womens Hosp, Nanjing Matern & Child Hlth Hosp, Dept Gynecol, Nanjing 210029, Peoples R China; [Li, Wan; Lu, Chun] Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Nanjing 211166, Peoples R China; [Guo, Yuanyuan] Nanjing Univ Chinese Med, Coll Med & Life Sci, Nanjing 210023, Peoples R China; [Lu, Hongmei] Nanjing Med Univ, Dept Obstet, Affiliated Hosp 1, Nanjing 210036, Peoples R China; [Zhu, Xiaofei] Nanjing Univ Chinese Med, Dept Lab Med, Affiliated Hosp, Nanjing 210029, Peoples R China; [Jung, Jae U.] Univ Southern Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Tosato, Giovanna] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Gao, Shou-Jiang] Univ Pittsburgh, UPMC Hillman Canc Ctr, Dept Microbiol & Mol Genet, Pittsburgh, PA 15232 USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing University of Chinese Medicine; Nanjing Medical University; Nanjing University of Chinese Medicine; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lu, C (corresponding author), Nanjing Med Univ, Dept Microbiol, Nanjing 211166, Peoples R China.; Lu, C (corresponding author), Nanjing Med Univ, Womens Hosp, Nanjing Matern & Child Hlth Hosp, Dept Gynecol, Nanjing 210029, Peoples R China.; Lu, C (corresponding author), Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Nanjing 211166, Peoples R China.; Zhu, XF (corresponding author), Nanjing Univ Chinese Med, Dept Lab Med, Affiliated Hosp, Nanjing 210029, Peoples R China.	zxfyxjy@163.com; clu@njmu.edu.cn		Tosato, Giovanna/0000-0003-1663-3227; Lu, Chun/0000-0002-6078-9352; Gao, Shou-Jiang/0000-0001-6194-1742	National Natural Science Foundation of China [81730062, 81761128003, 31800148, 81503368]; Natural Science Foundation of Jiangsu Province [BK20180681]; Nanjing Medical University [KY101RC1710]; NIH [R01CA213275, CA200422, AI073099, AI116585, AI129496, AI140718, AI140705, DE023926, DE027888, DE028521]; Fletcher Jones Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Nanjing Medical University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fletcher Jones Foundation	This work was supported by grants from National Natural Science Foundation of China (81730062, 81761128003, 31800148, and 81503368), Natural Science Foundation of Jiangsu Province (BK20180681), Nanjing Medical University (KY101RC1710), a grant from NIH (R01CA213275), and grants (CA200422, AI073099, AI116585, AI129496, AI140718, AI140705, DE023926, DE027888, DE028521 and Fletcher Jones Foundation).	Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Aoki Y, 2001, BLOOD, V97, P2173, DOI 10.1182/blood.V97.7.2173; Belo Y, 2019, BBA-GEN SUBJECTS, V1863, P1343, DOI 10.1016/j.bbagen.2019.05.019; Bhatt AP, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00401; Boshoff C, 2001, ANNU REV MED, V52, P453, DOI 10.1146/annurev.med.52.1.453; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Chandriani S, 2010, J VIROL, V84, P5565, DOI 10.1128/JVI.02723-09; Cousins E, 2013, J VIROL, V87, P10816, DOI 10.1128/JVI.02047-13; Cui J, 2001, PROSTATE, V46, P249, DOI 10.1002/1097-0045(20010215)46:3<249::AID-PROS1030>3.0.CO;2-#; Ding XY, 2019, CELL DEATH DIFFER, V26, P1970, DOI 10.1038/s41418-018-0268-3; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fullwood RA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204947; Giffin L, 2015, MBIO, V6, DOI 10.1128/mBio.01499-15; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Gruffaz M, 2017, CANCER RES, V77, P7094, DOI 10.1158/0008-5472.CAN-17-2321; Gu XW, 2017, PROG RETIN EYE RES, V56, P84, DOI 10.1016/j.preteyeres.2016.09.005; Hu F, 2006, J VIROL, V80, P10874, DOI 10.1128/JVI.00767-06; Hu MM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005171; Jones T, 2014, CELL CYCLE, V13, P845, DOI 10.4161/cc.27758; Jones T, 2012, J CLIN INVEST, V122, P1076, DOI 10.1172/JCI58530; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Lamaze C, 2017, CURR OPIN CELL BIOL, V47, P117, DOI 10.1016/j.ceb.2017.02.014; Lee H, 2012, P NATL ACAD SCI USA, V109, P7765, DOI 10.1073/pnas.1205132109; Lee MS, 2016, MBIO, V7, DOI 10.1128/mBio.02109-15; Lee MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004412; Li TT, 2019, J VIROL, V93, DOI 10.1128/JVI.01599-18; Li W, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007578; Li W, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005605; Magnaudeix A, 2016, ACTA BIOMATER, V38, P179, DOI 10.1016/j.actbio.2016.04.039; Mergia A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060129; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Moody R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003857; Morris VA, 2008, J VIROL, V82, P8771, DOI 10.1128/JVI.00766-08; Morris VA, 2012, VIROLOGY, V428, P112, DOI 10.1016/j.virol.2012.03.013; Nwosu ZC, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0558-7; Punjabi AS, 2007, J VIROL, V81, P2449, DOI 10.1128/JVI.01769-06; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Senetta R, 2013, J CELL MOL MED, V17, P325, DOI 10.1111/jcmm.12030; Stary CM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00393; Suthaus J, 2012, BLOOD, V119, P5173, DOI 10.1182/blood-2011-09-377705; Syeed N, 2012, ASIAN PAC J CANCER P, V13, P371, DOI 10.7314/APJCP.2012.13.1.371; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Uldrick TS, 2010, CLIN INFECT DIS, V51, P350, DOI 10.1086/654798; Wake MS, 2015, FEBS J, V282, P2600, DOI 10.1111/febs.13285; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Wen KW, 2010, CANCER LETT, V289, P140, DOI 10.1016/j.canlet.2009.07.004; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093478; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; Xu HP, 2017, ONCOTARGET, V8, P76165, DOI 10.18632/oncotarget.19191; Xue M, 2014, NUCLEIC ACIDS RES, V42, P9862, DOI 10.1093/nar/gku583; Yao SH, 2015, NUCLEIC ACIDS RES, V43, P9362, DOI 10.1093/nar/gkv988; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang Q, 2006, BLOOD, V108, P1058, DOI 10.1182/blood-2005-08-007377; Zhou F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053145; Zhu X, 2014, ONCOGENE, V33, P1986, DOI 10.1038/onc.2013.136; Zhu Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005648	59	8	9	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	23					4603	4618		10.1038/s41388-020-1317-1	http://dx.doi.org/10.1038/s41388-020-1317-1		MAY 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LU5ZF	32393833	Green Accepted			2022-12-26	WOS:000531771800002
J	Sjollin, I; Back, M; Nilsson, L; Schiopu, A; Leosdottir, M				Sjollin, Ingela; Back, Maria; Nilsson, Lennart; Schiopu, Alexandru; Leosdottir, Margret			Association between attending exercise-based cardiac rehabilitation and cardiovascular risk factors at one-year post myocardial infarction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; METAANALYSIS; SEX; PREVENTION; ENROLLMENT; PROGRAMS; EFFICACY; THERAPY; WOMEN; MEN	Background Randomized trials confirm the benefits of exercise-based cardiac rehabilitation on cardiovascular risk factors. Whether exercise-based cardiac rehabilitation provides the same favourable effects in real-life cardiac rehabilitation settings, in the modern era of myocardial infarction treatment, is less well known. We examined the association between attending exercise-based cardiac rehabilitation and improvements in cardiovascular risk factors at one-year post myocardial infarction in patients included in the Swedish heart disease registry, SWEDEHEART. Methods In this retrospective registry-based cohort study, we included 19 136 patients post myocardial infarction (75% men, 62.8 +/- 8.7 years) who were registered in SWEDEHEART between 2011 and 2013. The association between attending exercise-based cardiac rehabilitation (43% participation rate) and changes in cardiovascular risk profile between baseline and one-year follow-up was assessed using multivariable regression analysis adjusting for age, comorbidities and medication. Results Attenders more often reported to have stopped smoking (men 64% vs 50%; women 64% vs 53%, p< 0.001 for both, only smokers at baseline considered), be more physically active (men 3.9 +/- 2.5 vs 3.4 +/- 2.7 days/week; women 3.8 +/- 2.6 vs 3.0 +/- 2.8 days/week, p< 0.001 for both) and achieved a slightly larger reduction in triglycerides (men -0.2 +/- 0.8 vs -0.1 +/- 0.9 mmol/L, p = 0.001; women -0.1 +/- 0.6 vs 0.0 +/- 0.8 mmol/L, p = 0.01) at one-year compared to non-attenders. Male attenders gained less weight (+0.0 +/- 5.7 vs +0.3 +/- 5.7 kg, p = 0.01) while female attenders achieved better lipid control (total cholesterol -1.2 +/- 1.4 vs -0.9 +/- 1.4 mmol/L, p< 0.001; low-density lipoprotein -1.2 +/- 1.2 vs -0.9 +/- 1.2 mmol/L, p< 0.001) compared to nonattenders. Conclusions In an unselected registry cohort of patients post myocardial infarction, compared to nonattenders those attending exercise-based cardiac rehabilitation achieved significantly larger improvements in cardiovascular risk factors at one-year after the acute event.	[Sjollin, Ingela; Schiopu, Alexandru; Leosdottir, Margret] Lund Univ, Fac Med, Dept Clin Sci Malmo, Malmo, Sweden; [Sjollin, Ingela; Schiopu, Alexandru; Leosdottir, Margret] Skane Univ Hosp, Dept Cardiol, Malmo, Sweden; [Back, Maria] Linkoping Univ, Div Physiotherapy, Dept Med & Hlth Sci, Linkoping, Sweden; [Back, Maria] Sahlgrens Univ Hosp, Dept Occupat Therapy & Physiotherapy, Gothenburg, Sweden; [Nilsson, Lennart] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden	Lund University; Lund University; Skane University Hospital; Linkoping University; Sahlgrenska University Hospital; Linkoping University	Leosdottir, M (corresponding author), Lund Univ, Fac Med, Dept Clin Sci Malmo, Malmo, Sweden.; Leosdottir, M (corresponding author), Skane Univ Hosp, Dept Cardiol, Malmo, Sweden.	margret.leosdottir@med.lu.se	Schiopu, Alexandru/AAY-7229-2021	Leosdottir, Margret/0000-0003-1677-1566; Back, Maria/0000-0002-6031-7478; Schiopu, Alexandru/0000-0002-7587-5050				Anderson L, 2016, COCHRANE DB SYST REV, DOI [10.1016/j.jacc.2015.10.044, 10.1002/14651858.CD001800.pub3]; Back M, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0512-7; Back M, 2008, EUR J CARDIOVASC NUR, V7, P307, DOI 10.1016/j.ejcnurse.2008.02.001; Balady GJ, 2011, CIRCULATION, V124, P2951, DOI 10.1161/CIR.0b013e31823b21e2; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Borg S, 2019, BMC SPORTS SCI MED R, V11, DOI 10.1186/s13102-019-0125-9; Canto JG, 2012, JAMA-J AM MED ASSOC, V307, P813, DOI 10.1001/jama.2012.199; Caru M, 2018, WORLD J CARDIOL, V10, P26, DOI 10.4330/wjc.v10.i4.26; Colella TJF, 2015, EUR J PREV CARDIOL, V22, P423, DOI 10.1177/2047487314520783; Cooper AF, 2007, HEART, V93, P53, DOI 10.1136/hrt.2005.081299; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Dowd KP, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-017-0636-2; Ekblom O, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010108; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Gerber Y, 2011, EUR J EPIDEMIOL, V26, P109, DOI 10.1007/s10654-010-9523-8; Giallauria Francesco, 2005, Monaldi Arch Chest Dis, V64, P110; Gibbons Larry W., 2001, Cardiology Clinics, V19, P347, DOI 10.1016/S0733-8651(05)70221-6; Goldfarb AH, 1997, SPORTS MED, V24, P8, DOI 10.2165/00007256-199724010-00002; Gorczyca AM, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005354; Harrison AS, 2018, EUR J PREV CARDIOL, V25, P1925, DOI 10.1177/2047487318798923; Jernberg T, 2012, SWEDEHEART ANN REPOR; Jernberg T, 2014, SWEDEHEART ANN REPOR; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED; Kotseva K, 2018, EUR J PREV CARDIOL, V25, P1242, DOI 10.1177/2047487318781359; Lawler PR, 2011, AM HEART J, V162, P571, DOI 10.1016/j.ahj.2011.07.017; Lemes IR, 2018, J AM SOC HYPERTENS, V12, P580, DOI 10.1016/j.jash.2018.06.007; Mandsager K, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3605; McKee G, 2014, EUR J CARDIOVASC NUR, V13, P329, DOI 10.1177/1474515113496686; Mikkelsen Tatsiana, 2014, Dan Med J, V61, pA4919; Neubeck L, 2012, EUR J PREV CARDIOL, V19, P494, DOI 10.1177/1741826711409326; Ostman C, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0590-y; Pan B, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0703-3; Pattyn N, 2013, SPORTS MED, V43, P121, DOI 10.1007/s40279-012-0003-z; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Piepoli MF, 2014, EUR J PREV CARDIOL, V21, P664, DOI 10.1177/2047487312449597; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rauch B, 2016, EUR J PREV CARDIOL, V23, P1914, DOI 10.1177/2047487316671181; Resurreccion DM, 2017, J WOMENS HEALTH, V26, P849, DOI 10.1089/jwh.2016.6249; Samayoa L, 2014, CAN J CARDIOL, V30, P793, DOI 10.1016/j.cjca.2013.11.007; Sandercock GRH, 2007, J SPORT SCI MED, V6, P471; Sumner J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177658; Taylor RS, 2006, EUR J CARDIOV PREV R, V13, P369, DOI 10.1097/00149831-200606000-00012; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Wallert J, 2020, EUR J PREV CARDIOL, V27, P145, DOI 10.1177/2047487319871714; Well RP, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019656; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; Witvrouwen I, 2021, EUR J PREV CARDIOL, V28, P779, DOI 10.1177/2047487319838221; Wyke S, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002736	50	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232772	10.1371/journal.pone.0232772	http://dx.doi.org/10.1371/journal.pone.0232772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392231	Green Published, gold			2022-12-26	WOS:000537470300024
J	Prevey, JS; Parker, LE; Harrington, CA				Prevey, Janet S.; Parker, Lauren E.; Harrington, Constance A.			Projected impacts of climate change on the range and phenology of three culturally-important shrub species	PLOS ONE			English	Article							MAXIMUM-ENTROPY; PLANT PHENOLOGY; NICHE; SENSITIVITY; MODELS; FOREST; DISTRIBUTIONS; TEMPERATURE; MANAGEMENT; RESPONSES	Climate change is shifting both the habitat suitability and the timing of critical biological events, such as flowering and fruiting, for plant species across the globe. Here, we ask how both the distribution and phenology of three food-producing shrubs native to northwestern North America might shift as the climate changes. To address this question, we compared gridded climate data with species location data to identify climate variables that best predicted the current bioclimatic niches of beaked hazelnut (Corylus cornuta), Oregon grape (Mahonia aquifolium), and salal (Gaultheria shallon). We also developed thermal-sum models for the timing of flowering and fruit ripening for these species. We then used multi-model ensemble future climate projections to estimate how species range and phenology may change under future conditions. Modelling efforts showed extreme minimum temperature, climate moisture deficit, and mean summer precipitation were predictive of climatic suitability across all three species. Future bioclimatic niche models project substantial reductions in habitat suitability across the lower elevation and southern portions of the species' current ranges by the end of the 21st century. Thermal-sum phenology models for these species indicate that flowering and the ripening of fruits and nuts will advance an average of 25 days by the mid-21st century, and 36 days by the late-21st century under a high emissions scenario (RCP 8.5). Future changes in the climatic niche and phenology of these important food-producing species may alter trophic relationships, with cascading impacts on regional ecosystems.	[Prevey, Janet S.] US Geol Survey, Ft Collins, CO 80526 USA; [Prevey, Janet S.; Harrington, Constance A.] US Forest Serv, Pacific Northwest Res Stn, USDA, Olympia, WA 98502 USA; [Parker, Lauren E.] Univ Calif Davis, USDA Calif Climate Hub, John Muir Inst Environm, Davis, CA 95616 USA	United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Davis	Prevey, JS (corresponding author), US Geol Survey, Ft Collins, CO 80526 USA.; Prevey, JS (corresponding author), US Forest Serv, Pacific Northwest Res Stn, USDA, Olympia, WA 98502 USA.	jprevey@usgs.gov	; Prevey, Janet/O-1537-2014	/0000-0003-0731-4371; Prevey, Janet/0000-0003-2879-6453; Parker, Lauren/0000-0002-3292-1774	U.S. Geological Survey, Northwest Climate Science Center [USGS G17PG00111]; USGS [17-IA-11261993099]; Yakama Nation [17-CO-11261993-100]	U.S. Geological Survey, Northwest Climate Science Center; USGS(United States Geological Survey); Yakama Nation	JSP and CAH received a grant through the U.S. Geological Survey, Northwest Climate Science Center, grant number: USGS G17PG00111, USFS Agreement 17-IA-11261993099 website: https://www.usgs.gov/landresources/climate-adaptation-science-centers/northwest-casc.CAH received a grant through the Yakama Nation, grant number: USFS Agreement 17-CO-11261993-100, website: http://www.yakamanation-nsn.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SJ, 2001, US FOR SERV T R NC, V217, P18; [Anonymous], [No title captured]; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], CURR PROJ CLIM DAT N; [Anonymous], [No title captured]; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Basler D, 2016, AGR FOREST METEOROL, V217, P10, DOI 10.1016/j.agrformet.2015.11.007; Beaubien E, 2011, BIOSCIENCE, V61, P514, DOI 10.1525/bio.2011.61.7.6; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Caffarra A, 2011, CLIM RES, V46, P147, DOI 10.3354/cr00980; Carey AB, 2003, FORESTRY, V76, P127, DOI 10.1093/forestry/76.2.127; Morellato LPC, 2016, BIOL CONSERV, V195, P60, DOI 10.1016/j.biocon.2015.12.033; Chuine I, 2016, GLOBAL CHANGE BIOL, V22, P3444, DOI 10.1111/gcb.13383; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Deacy WW, 2017, P NATL ACAD SCI USA, V114, P10432, DOI 10.1073/pnas.1705248114; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Flynn DFB, 2018, NEW PHYTOL, V219, P1353, DOI 10.1111/nph.15232; HALPERN CB, 1995, ECOL APPL, V5, P913, DOI 10.2307/2269343; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Hamann A, 2013, B AM METEOROL SOC, V94, P1307, DOI 10.1175/BAMS-D-12-00145.1; Hanberry BB, 2015, BASIC APPL ECOL, V16, P231, DOI 10.1016/j.baae.2015.02.002; Hannah L, 2002, GLOBAL ECOL BIOGEOGR, V11, P485, DOI 10.1046/j.1466-822X.2002.00306.x; Hanninen H, 2019, TRENDS PLANT SCI, V24, P199, DOI 10.1016/j.tplants.2018.11.006; Holden ZA, 2012, WILDLIFE SOC B, V36, P226, DOI 10.1002/wsb.128; Hufkens K, 2018, METHODS ECOL EVOL, V9, P1276, DOI 10.1111/2041-210X.12970; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Laskin DN, 2019, NAT CLIM CHANGE, V9, P419, DOI 10.1038/s41558-019-0454-4; Lindh BC, 2018, INT J BIOMETEOROL, V62, P1675, DOI 10.1007/s00484-018-1567-6; Maurer GE, 2014, WATER RESOUR RES, V50, P5216, DOI 10.1002/2013WR014452; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Morin X, 2007, ECOLOGY, V88, P2280, DOI 10.1890/06-1591.1; Parker LE, 2018, CLIMATIC CHANGE, V147, P211, DOI 10.1007/s10584-017-2118-6; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pei SJ, 2009, FOREST ECOL MANAG, V257, P2017, DOI 10.1016/j.foreco.2009.01.003; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Plant Phenology Data, PLANT PHEN DAT DAT T; Prevey J, 2017, GLOBAL CHANGE BIOL, V23, P2660, DOI 10.1111/gcb.13619; Prevey JS, 2020, AGR FOREST METEOROL, V280, DOI 10.1016/j.agrformet.2019.107803; Rangwala I, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024040; Roberts AMI, 2015, GLOBAL CHANGE BIOL, V21, P2603, DOI 10.1111/gcb.12896; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Smithers BV, 2018, GLOBAL CHANGE BIOL, V24, pE442, DOI 10.1111/gcb.13881; Sofaer HR, 2019, BIOSCIENCE, V69, P544, DOI 10.1093/biosci/biz045; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Tappeiner JC, 1993, CANADIAN J FOREST RE; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Thornton P.E., 2018, DAYMET DAILY SURFACE, DOI 10.3334/ORNLDAAC/1328; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Tirmenstein D., 1990, GAULTHERIA SHALLON F; van Gils H, 2014, J NAT CONSERV, V22, P23, DOI 10.1016/j.jnc.2013.08.001; VanDerWal J, 2013, NAT CLIM CHANGE, V3, P239, DOI [10.1038/nclimate1688, 10.1038/NCLIMATE1688]; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156720; White SN, 2012, HORTSCIENCE, V47, P1014, DOI 10.21273/HORTSCI.47.8.1014; Wilbur L., BLUHM PLANT PHENOLOG; Willis CG, 2017, TRENDS ECOL EVOL, V32, P531, DOI 10.1016/j.tree.2017.03.015; Woodward FI, 2004, PHILOS T ROY SOC B, V359, P1465, DOI 10.1098/rstb.2004.1525; Yost AC, 2008, ECOL INFORM, V3, P375, DOI 10.1016/j.ecoinf.2008.08.004	63	9	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232537	10.1371/journal.pone.0232537	http://dx.doi.org/10.1371/journal.pone.0232537			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384124	Green Published, gold			2022-12-26	WOS:000537468300017
J	Abdul-Rahman, A; Morgan, W; Yu, DY				Abdul-Rahman, Anmar; Morgan, William; Yu, Dao-Yi			Measurement of normal retinal vascular pulse wave attenuation using modified photoplethysmography	PLOS ONE			English	Article							ARTERIAL-PRESSURE; VENOUS PULSATION; INTRAOCULAR-PRESSURE; AORTIC PRESSURE; VEIN PULSATION; FLOW; VELOCITY; PROPAGATION; VESSELS; FREQUENCY	Pulse wave attenuation characteristics reflect compliance and resistance properties of the vessel wall as well as initial pulse generation factors. Recently, it has become possible to measure and map the retinal vessel wall pulse wave amplitudes. Predictable pulse wave amplitude distribution may allow inferences to be made concerning vascular compliance and resistance. Twenty-eight eyes from sixteen subjects (8 male and 8 female) were examined using modified retinal photoplethysmography with simultaneous ophthalmodynamometry. This allowed the assessment of vessel wall pulsation amplitudes under a dynamic range of intraocular pressures. Pulse amplitudes were calculated using harmonic regression analysis. The pulse wave attenuation was measured under different ranges of ophthalmodynamometric force (ODF) as a function of distance along the vessel (V-Dist), which in turn was calculated in disc diameters (DD) from the center of the optic disc. A linear mixed-effects model with randomized slopes and intercepts was used to estimate the correlations between the logarithmically transformed harmonic regression wave amplitude (HRWa) and the Fourier trigonometric coefficients with the predictors (V-Dist and ODF). The retinal venous harmonic regression wave attenuation (coefficient value +/- standard error) -0.40 +/- 0.065/DD, (p-value < 0.00001, 95% confidence interval (CI) -0.53 to -0.27), which was approximately twice that of the arterial -0.17 +/- 0.048/DD, (p-value < 0.0004, 95% CI = -0.27 to -0.08). There was a positive correlation between attenuation of the harmonic regression wave and ophthalmodynamometric force in both vascular systems. The attenuation of all but the sine coefficient of the second Fourier harmonic (b(n2)) achieved statistical significance in the correlation with V-Dist. The cosine coefficient of the first Fourier harmonic a(n1) was the only coefficient to achieve statistical significance in the correlation with the predictors V-Dist and ODF in both vascular systems. The a(n1) coefficient value in the correlation with V-Dist was -3.79 +/- 0.78 and -1.269 +/- 0.37 (p < 0.0006), while this coefficient value in the correlation with ODF was 0.026 +/- 0.0099 and 0.009 +/- 0.04 (p < 0.01) in both the retinal veins and arteries respectively. The predictable attenuation characteristics in normal subjects suggest that this technique may allow the non-invasive quantification of retinal vascular compliance and other hemodynamic parameters.	[Abdul-Rahman, Anmar] Counties Manukau DHB, Dept Ophthalmol, Auckland, New Zealand; [Morgan, William; Yu, Dao-Yi] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA, Australia; [Morgan, William; Yu, Dao-Yi] Univ WA, Lions Eye Inst, Perth, WA, Australia	University of Western Australia; Lions Eye Institute; University of Western Australia	Abdul-Rahman, A (corresponding author), Counties Manukau DHB, Dept Ophthalmol, Auckland, New Zealand.	anmar_rahman@hotmail.com	Abdul-Rahman, Anmar/ABA-5090-2021	Abdul-Rahman, Anmar/0000-0002-0812-8944; Yu, Dao-Yi/0000-0002-9490-534X				Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; ANLIKER M, 1968, CIRC RES, V23, P539, DOI 10.1161/01.RES.23.4.539; Balaratnasingam C, 2007, BRIT J OPHTHALMOL, V91, P441, DOI 10.1136/bjo.2006.105338; Bateman GA, 2000, AM J NEURORADIOL, V21, P1574; BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P445, DOI 10.1113/jphysiol.1961.sp006686; BERTRAM CD, 1980, J BIOMECH, V13, P1061, DOI 10.1016/0021-9290(80)90050-0; Betz-Stablein B, 2018, STAT METHODS MED RES, V27, P1575, DOI 10.1177/0962280216665504; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brockwell PJ, 2016, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-3-319-29854-2_1; Burton AC, 1972, PHYSL BIOPHYSICS CIR, P51; Caro CG., 2011, MECH CIRCULATION, DOI [10.1017/CBO9781139013406, DOI 10.1017/CBO9781139013406]; CHEN HC, 1994, EYE, V8, P97, DOI 10.1038/eye.1994.19; Cheung N, 2007, ANN NEUROL, V62, P618, DOI 10.1002/ana.21236; CONRAD WA, 1969, IEEE T BIO-MED ENG, VBM16, P284, DOI 10.1109/TBME.1969.4502660; Conway ML, 2010, J CATARACT REFR SURG, V36, P268, DOI 10.1016/j.jcrs.2009.09.013; Do H, 2008, INVEST OPHTH VIS SCI, V49, P5438; FARROW RL, 1961, CIRC RES, V9, P395, DOI 10.1161/01.RES.9.2.395; Feher JJ, 2012, QUANTITATIVE HUMAN P, P498; Findl O, 1997, CURR EYE RES, V16, P1024, DOI 10.1076/ceyr.16.10.1024.9024; Fung YC., 1997, BIOMECHANICS CIRCULA, DOI [10.1007/978-1-4757-2696-1, DOI 10.1007/978-1-4757-2696-1]; Garhofer G, 2010, ACTA OPHTHALMOL, V88, P717, DOI 10.1111/j.1755-3768.2009.01587.x; Glasser SP, 1997, AM J HYPERTENS, V10, P1175; Golzan SM, 2014, MICROVASC RES, V92, P56, DOI 10.1016/j.mvr.2013.12.006; Guidoboni G, 2014, INVEST OPHTH VIS SCI, V55, P4105, DOI 10.1167/iovs.13-13611; HAINSWORTH R, 1990, NEWS PHYSIOL SCI, V5, P250; HAMER J, 1977, J NEUROSURG, V46, P36, DOI 10.3171/jns.1977.46.1.0036; Harms MPM, 1999, CLIN SCI, V97, P291, DOI 10.1042/CS19990061; Harris A, 1996, BRIT J OPHTHALMOL, V80, P1055, DOI 10.1136/bjo.80.12.1055; HEDGES TR, 1994, OPHTHALMOLOGY, V101, P542; Heil M, 1997, J FLUID MECH, V353, P285, DOI 10.1017/S0022112097007490; HOGAN MJ, 1963, J ULTRA MOL STRUCT R, V9, P10, DOI 10.1016/S0022-5320(63)80033-7; Imholz BPM, 1998, CARDIOVASC RES, V38, P605, DOI 10.1016/S0008-6363(98)00067-4; Jacks AS, 2003, J NEUROL NEUROSUR PS, V74, P7, DOI 10.1136/jnnp.74.1.7; Jonas JB, 2004, ACTA OPHTHALMOL SCAN, V82, P239, DOI 10.1111/j.1600-0420.2004.00150a.x; Jonas JB, 2003, GRAEF ARCH CLIN EXP, V241, P367, DOI 10.1007/s00417-003-0643-7; Jonas JB, 2003, BRIT J OPHTHALMOL, V87, P577, DOI 10.1136/bjo.87.5.577; Jonas JB, 2007, AM J OPHTHALMOL, V143, P112, DOI 10.1016/j.ajo.2006.09.019; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096273; Kawasaki R, 2009, J HYPERTENS, V27, P2386, DOI 10.1097/HJH.0b013e3283310f7e; Keener J. P., 2008, MATH PHYSL, DOI [10.1007/978-0-387-79388-7, DOI 10.1007/978-0-387-79388-7]; Kotliar K, 2013, MICROCIRCULATION, V20, P405, DOI 10.1111/micc.12036; Kotliar KE, 2011, BRIT J OPHTHALMOL, V95, P675, DOI 10.1136/bjo.2010.181263; Kumar Dinesh Kant, 2013, ISRN Ophthalmol, V2013, P865834, DOI 10.1155/2013/865834; Lam J, 2016, EXP EYE RES, V145, P341, DOI 10.1016/j.exer.2016.02.003; Legler U, 2009, J GLAUCOMA, V18, P210, DOI 10.1097/IJG.0b013e318182edd2; Levine DN, 1998, MICROVASC RES, V56, P154, DOI 10.1006/mvre.1998.2098; Li JK, 2004, DYNAMICS VASCULAR SY, V1, P76, DOI [10.1142/9789812562661_0003, DOI 10.1142/9789812562661_0003]; LI JKJ, 1980, J BIOMECH, V13, P1023, DOI 10.1016/0021-9290(80)90046-9; LI JKJ, 1981, CIRC RES, V49, P442, DOI 10.1161/01.RES.49.2.442; Lim LS, 2017, INVEST OPHTH VIS SCI, V58, P200, DOI 10.1167/iovs.17-21699; Maschal Jr RA, 2010, REV BAYER PATTERN CO, P1, DOI [10.21236/ada513752, DOI 10.21236/ADA513752]; McAllister IL, 2014, OPHTHALMOLOGY, V121, P2228, DOI 10.1016/j.ophtha.2014.05.031; McDonald D., 1965, P 4 INT C RHEOL NEW, P205; McDonald D. A., 1968, HEMORHEOLOGY, P113; MCDONALD DA, 1968, J APPL PHYSIOL, V24, P73, DOI 10.1152/jappl.1968.24.1.73; MILNOR WR, 1978, CIRC RES, V43, P870, DOI 10.1161/01.RES.43.6.870; MILNOR WR, 1975, CIRC RES, V36, P631, DOI 10.1161/01.RES.36.5.631; MOOK GA, 1979, CARDIOVASC RES, V13, P233, DOI 10.1093/cvr/13.4.233; MORENO A H, 1970, Circulation Research, V27, P1069; Moret F, 2011, INVEST OPHTH VIS SCI, V52, P5457, DOI 10.1167/iovs.10-6806; Morgan WH, 2004, OPHTHALMOLOGY, V111, P1489, DOI 10.1016/j.ophtha.2003.12.053; Morgan WH, 1998, BRIT J OPHTHALMOL, V82, P821, DOI 10.1136/bjo.82.7.821; Morgan WH, 2016, PROG RETIN EYE RES, V55, P82, DOI 10.1016/j.preteyeres.2016.06.003; Morgan WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116475; Morgan WH, 2014, INVEST OPHTH VIS SCI, V55, P5998, DOI 10.1167/iovs.14-15104; Morgan WH, 2012, INVEST OPHTH VIS SCI, V53, P4676, DOI 10.1167/iovs.12-9837; Morgan WH, 2010, GRAEF ARCH CLIN EXP, V248, P401, DOI 10.1007/s00417-009-1288-y; Moxham D.I., 2003, SOUTH-SCHOLARLY J, V9, P40, DOI [DOI 10.1080/22201173.2003.10872991, 10.1080/22201173.2003.10872991]; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Naschitz Jochanan E, 2004, J Clin Monit Comput, V18, P333, DOI 10.1007/s10877-005-4300-z; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; Nichols W W, 2001, J Cardiovasc Pharmacol Ther, V6, P5, DOI 10.1177/107424840100600102; Nitzan M, 1998, LASER MED SCI, V13, P189, DOI 10.1007/s101030050073; Nitzan M, 2001, MED BIOL ENG COMPUT, V39, P579, DOI 10.1007/BF02345149; OLIVA I, 1976, Vasa, V5, P95; Payne RA, 2006, J APPL PHYSIOL, V100, P136, DOI 10.1152/japplphysiol.00657.2005; Pholuang J, 2012, INT J PURE APPL MATH, V78, P721; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Portney LG, 2009, FDN CLIN RES APPL PR, V892, P587; PORTNOY HD, 1981, NEUROSURGERY, V9, P14, DOI 10.1227/00006123-198107000-00004; R Core Team, 2019, R LANGUAGE ENV STAT; Radke RJ, 2005, IEEE T IMAGE PROCESS, V14, P294, DOI 10.1109/TIP.2004.838698; Robertson MB, 2001, MAGN RESON IMAGING, V19, P685, DOI 10.1016/S0730-725X(01)00376-9; Romano SM, 2002, CRIT CARE MED, V30, P1834, DOI 10.1097/00003246-200208000-00027; Salvi P, 2012, PULSE WAVES, P17, DOI [DOI 10.1007/978-88-470-2439-7_4, 10.1007/978-88-470-2439-7_4]; Seifertl B U, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 2, P678, DOI 10.1515/bmte.2002.47.s1b.678; SHEREBRIN MH, 1990, IEEE T BIO-MED ENG, V37, P313, DOI 10.1109/10.52332; SIMONSON E, 1956, Geriatrics, V11, P425; Spahr H, 2015, OPT LETT, V40, P4771, DOI 10.1364/OL.40.004771; Tozzi P, 2000, AM J PHYSIOL-HEART C, V278, pH1407, DOI 10.1152/ajpheart.2000.278.4.H1407; Westlake WH, 2001, CLIN EXP OPHTHALMOL, V29, P167, DOI 10.1046/j.1442-9071.2001.00399.x; Whitlock MC, 2009, ANAL BIOL DATA, P326; Wieben O., 1997, DESIGN PULSE OXIMETE, P40; Winer Nathaniel, 2003, Curr Diab Rep, V3, P230, DOI 10.1007/s11892-003-0069-y; WOMERSLEY JR, 1957, PHYS MED BIOL, V2, P178, DOI 10.1088/0031-9155/2/2/305; Zamir M, 2000, BIOL PHYS SERIES, P113, DOI [10.1007/978-1-4612-1282-9_5, DOI 10.1007/978-1-4612-1282-9_5]; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633	97	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232523	10.1371/journal.pone.0232523	http://dx.doi.org/10.1371/journal.pone.0232523			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379837	Green Published, gold			2022-12-26	WOS:000537285700037
J	Jedlinska-Pijanowska, D; Kasztelewicz, B; Czech-Kowalska, J; Jaworski, M; Charusta-Sienkiewicz, K; Dobrzanska, A				Jedlinska-Pijanowska, Dominika; Kasztelewicz, Beata; Czech-Kowalska, Justyna; Jaworski, Maciej; Charusta-Sienkiewicz, Klaudia; Dobrzanska, Anna			Association between single nucleotide polymorphisms (SNPs) of IL1, IL12, IL28 and TLR4 and symptoms of congenital cytomegalovirus infection	PLOS ONE			English	Article							CMV INFECTION; GENES; DISEASE; RISK; REACTIVATION; PROSPECTS; RS3212227; IMMUNITY; CELLS	Congenital cytomegalovirus (cCMV) infection is the most common intrauterine infection. A non-specific immune response is the first line of host defense mechanism against human cytomegalovirus (HCMV). There is limited data on associations between Single Nucleotide Polymorphisms (SNPs) in genes involving innate immunity and the risk and clinical manifestation of cCMV infection. The aim of the study was to investigate association between selected SNPs in genes encoding cytokines and cytokine receptors, and predisposition to cCMV infection including symptomatic course of disease and symptoms. A panel of eight SNPs: IL1B rs16944, IL12B rs3212227, IL28B rs12979860, CCL2 rs1024611, DC-SIGN rs735240, TLR2 rs5743708, TLR4 rs4986791, TLR9 rs352140 was analyzed in 233 infants (92 cCMV-infected and 141 healthy controls). Associations between genotyped SNPs and predisposition to cCMV infection and symptoms were analyzed. The association analysis was performed using SNPStats software. No statistically significant association was found between any genotyped SNPs and predisposition to cCMV infection and symptomatic course of disease. In relation to particular symptoms, polymorphism of IL12B rs3212227 was linked to decreased risk of prematurity (OR = 0.37;95%CI,0.14-0.98;p = 0.025), while polymorphism of IL1B rs16944 was linked to reduced risk of splenomegaly (OR = 0.36;95% CI,0.14-0.98; p = 0.034) in infants with cCMV infection. An increased risk of thrombocytopenia was associated with IL28B rs12979860 polymorphism (OR = 2.55;95%CI,1.03-6.32;p = 0.042), while hepatitis was associated with SNP of TLR4rs4986791 (OR = 7.80;95% CI,1.49-40,81; p = 0.024). This is the first study to demonstrate four new associations between SNPs in selected genes (IL1B, IL12B, IL28B, TLR4) and particular symptoms in cCMV disease. Further studies on the role of SNPs in the pathogenesis of cCMV infection and incorporation of selected SNPs in the clinical practice might be considered in the future.	[Jedlinska-Pijanowska, Dominika; Czech-Kowalska, Justyna; Charusta-Sienkiewicz, Klaudia; Dobrzanska, Anna] Childrens Mem Hlth Inst, Neonatal Intens Care Unit, Warsaw, Poland; [Kasztelewicz, Beata] Childrens Mem Hlth Inst, Dept Clin Microbiol & Immunol, Warsaw, Poland; [Jaworski, Maciej] Childrens Mem Hlth Inst, Dept Biochem Radioimmunol & Expt Med, Warsaw, Poland	Children's Memorial Health Institute; Children's Memorial Health Institute; Children's Memorial Health Institute	Czech-Kowalska, J (corresponding author), Childrens Mem Hlth Inst, Neonatal Intens Care Unit, Warsaw, Poland.	j.kowalska@ipczd.pl	Kasztelewicz, Beata/L-8250-2019; Czech-Kowalska, Justyna/B-4306-2014	Kasztelewicz, Beata/0000-0003-1504-5589; Czech-Kowalska, Justyna/0000-0001-7563-3951; Jaworski, Maciej/0000-0002-6758-371X	Children's Memorial Health Institute [S158/17]	Children's Memorial Health Institute	Work was supported by internal research grant of the Children's Memorial Health Institute no S158/17.	Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bochud PY, 2009, EUR J CLIN MICROBIOL, V28, P1055, DOI 10.1007/s10096-009-0746-0; Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629; Bravo D, 2014, J MED VIROL, V86, P838, DOI 10.1002/jmv.23865; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Cheneau C, 2018, J INFECT DIS, V218, P490, DOI 10.1093/infdis/jiy194; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Egli A, 2014, J INFECT DIS, V210, P717, DOI 10.1093/infdis/jiu144; El-Sayed MF, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-142; Fernandez-Ruiz M, 2015, AM J TRANSPLANT, V15, P1323, DOI 10.1111/ajt.13107; Hamilton ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052899; Hoffmann TW, 2008, TRANSPLANTATION, V85, P1406, DOI 10.1097/TP.0b013e31816c7dc7; Inagaki K, 2019, J PEDIATR-US, V204, P142, DOI 10.1016/j.jpeds.2018.08.038; Kasztelewicz B, 2017, EUR J CLIN MICROBIOL, V36, P1811, DOI 10.1007/s10096-017-2996-6; Kijpittayarit S, 2007, CLIN INFECT DIS, V44, P1315, DOI 10.1086/514339; Kim M, 2016, CANCER RES TREAT, V48, P1330, DOI 10.4143/crt.2015.463; Li J, 2016, MOD RHEUMATOL, V26, P749, DOI 10.3109/14397595.2016.1157282; Loeffler J, 2006, J CLIN MICROBIOL, V44, P1847, DOI 10.1128/JCM.44.5.1847-1850.2006; Lorenzoni F, 2014, J MATERN-FETAL NEO M, V27, P1589, DOI 10.3109/14767058.2013.871253; Lupianez CB, 2016, INFECT IMMUN, V84, P643, DOI 10.1128/IAI.01359-15; Melit LE, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152692; Ohashi J, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-38; Paradowska E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154100; Pare A, 2018, P NATL ACAD SCI USA, V115, pE1194, DOI 10.1073/pnas.1714948115; Perez-Flores I, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz325; Pitlick M M, 2015, J Neonatal Perinatal Med, V8, P427, DOI 10.3233/NPM-15990002; Plosa EJ, 2012, PEDIATR REV, V33, P156, DOI 10.1542/pir.33-4-156; Racicot K, 2017, J CLIN INVEST, V127, P1591, DOI 10.1172/JCI87490; Schleiss Mark R, 2018, Contemp Pediatr, V35, P16; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Spanou E, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00065; Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008; Taniguchi R, 2013, INT J INFECT DIS, V17, pE1092, DOI 10.1016/j.ijid.2013.06.004; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Turner KM, 2014, PEDIATRICS, V133, pE609, DOI 10.1542/peds.2013-2217; Wujcicka W, 2017, MICROB PATHOGENESIS, V105, P106, DOI 10.1016/j.micpath.2017.02.017; Wujcicka W, 2017, VIROL J, V14, DOI 10.1186/s12985-016-0679-z; Wujcicka W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122831; Yew KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044500; Zhu KJ, 2013, RHEUMATOL INT, V33, P1785, DOI 10.1007/s00296-012-2637-4; Zi-long Yao Q-rL, 2019, BIOMED RES INT, V2019, P9	42	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233096	10.1371/journal.pone.0233096	http://dx.doi.org/10.1371/journal.pone.0233096			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421725	Green Published, gold			2022-12-26	WOS:000537499600026
J	Leszko, M; Keenan-Devlin, L; Adam, EK; Buss, C; Grobman, W; Simhan, H; Wadhwa, P; Mroczek, DK; Borders, A				Leszko, Magdalena; Keenan-Devlin, Lauren; Adam, Emma K.; Buss, Claudia; Grobman, William; Simhan, Hyagriv; Wadhwa, Pathik; Mroczek, Daniel K.; Borders, Ann			Are personality traits associated with smoking and alcohol use prior to and during pregnancy?	PLOS ONE			English	Article							LEADING BEHAVIORAL CONTRIBUTORS; 5-FACTOR MODEL; MATERNAL SMOKING; UNITED-STATES; NEGATIVE AFFECT; BINGE DRINKING; HIGH-RISK; CESSATION; WOMEN; POPULATION	Cigarette smoking and alcohol consumption during pregnancy can have detrimental effects on the developing fetus, including fetal alcohol syndrome and low birth weight. Surprisingly little is known about the association of personality traits with smoking and alcohol consumption in the specific subpopulation of pregnant women. This study analyzed data from a geographically diverse sample of 603 pregnant women, aged 18 years and older, who provided information regarding their smoking and drinking habits before and during pregnancy. We compared women who consumed alcohol or smoked cigarettes before pregnancy with women who quit or continued smoking or drinking during pregnancy. Associations between personality and maladaptive behaviors prior to and during pregnancy were modeled using logistic regression. The study revealed that women who scored high on openness to experience were significantly more likely to continue alcohol consumption during pregnancy (OR = 1.07, 95% CI 1.01, 1.14, p = .02). This association was maintained after adjusting for potential confounds. This study demonstrated a significant relationship between personality traits and women's likelihood of continued alcohol consumption prior to and during pregnancy. Understanding personality-based determinants of health-detrimental behavior is important in order to design interventions that aim at decreasing rates of maladaptive health behaviors among pregnant women.	[Leszko, Magdalena] Univ Szczecin, Dept Psychol, Szczecin, Poland; [Keenan-Devlin, Lauren; Borders, Ann] Univ Chicago, NorthShore Univ Hlth Syst, Pritzker Sch Med, Div Maternal Fetal Med,Dept Obstet & Gynecol, Evanston, IL USA; [Adam, Emma K.] Inst Policy Res, Evanston, IL USA; [Adam, Emma K.] Northwestern Univ, Sch Educ & Social Policy, Evanston, IL USA; [Buss, Claudia; Wadhwa, Pathik] Univ Calif Irvine, Hlth & Dis Res Program, Irvine, CA USA; [Buss, Claudia] Univ Med Berlin, Charite, Berlin, Germany; [Grobman, William] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Div Maternal Fetal Med, Evanston, IL USA; [Grobman, William; Borders, Ann] Inst Publ Hlth & Med, Ctr Healthcare Studies, Chicago, IL USA; [Simhan, Hyagriv] Univ Pittsburgh, Sch Med, Div Maternal Fetal Med, Pittsburgh, PA USA; [Simhan, Hyagriv] Magee Womens Hosp, Div Obstet Serv, Pittsburgh, PA USA; [Mroczek, Daniel K.] Northwestern Univ, Dept Psychol, Weinberg Coll Arts & Sci, Evanston, IL USA	University of Szczecin; NorthShore University Health System; University of Chicago; Northwestern University; University of California System; University of California Irvine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University	Leszko, M (corresponding author), Univ Szczecin, Dept Psychol, Szczecin, Poland.	magdalena.leszko@usz.edu.pl	Buss, Claudia/ABC-3687-2020	Buss, Claudia/0000-0002-8738-3133	National Children's Study: Vanguard Study-Task Order 5: Stress and Cortisol Measurement for the National Children's Study [HHSN275201200007-HHSN27500005]	National Children's Study: Vanguard Study-Task Order 5: Stress and Cortisol Measurement for the National Children's Study	This study was supported by: HHSN275201200007-HHSN27500005. National Children's Study: Vanguard Study-Task Order 5: Stress and Cortisol Measurement for the National Children's Study. Dr. Ann Borders was the recipient of the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMADA SJ, 1991, PSYCHOSOM MED, V53, P165, DOI 10.1097/00006842-199103000-00006; American College of Obstetrics and Gynecology, 2010, OBSTET GYNECOL, V116, P1241, DOI [10.1097/AOG.0b013e3182004fcd, DOI 10.1097/A0G.06013E3182004FAL], 10.1097/AOG]; Andres R L, 2000, Semin Neonatol, V5, P231, DOI 10.1053/siny.2000.0025; Arai Y, 1997, ADDICTION, V92, P1023, DOI 10.1111/j.1360-0443.1997.tb02982.x; Asendorpf JB, 1998, J PERS SOC PSYCHOL, V74, P1531, DOI 10.1037/0022-3514.74.6.1531; Beijers C, 2014, ADDICT BEHAV, V39, P980, DOI 10.1016/j.addbeh.2014.01.022; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Caligiuri PM, 2000, PERS PSYCHOL, V53, P67, DOI 10.1111/j.1744-6570.2000.tb00194.x; Casetta B, 2017, NICOTINE TOB RES, V19, P1401, DOI 10.1093/ntr/ntw266; Centers for Disease Control and Prevention (US), ALC FREE PREGN IS BE; Cerda M, 2011, SOC SCI MED, V73, P1178, DOI 10.1016/j.socscimed.2011.07.025; Chamberlain Catherine, 2013, Cochrane Database Syst Rev, pCD001055, DOI 10.1002/14651858.CD001055.pub4; Chapman S, 2008, TOB CONTROL, V17, P25, DOI 10.1136/tc.2007.021386; Chassin L, 2007, J APPL DEV PSYCHOL, V28, P264, DOI 10.1016/j.appdev.2007.02.005; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cook M, 1998, PERS INDIV DIFFER, V24, P641, DOI 10.1016/S0191-8869(97)00214-6; Costa PT, 2007, REVISED NEO PERSONAL; Curry SJ, 2001, PSYCHOL ADDICT BEHAV, V15, P126, DOI 10.1037/0893-164X.15.2.126; Curtin Sally C, 2016, Natl Vital Stat Rep, V65, P1; DiClemente CC, 2000, TOB CONTROL, V9, P16; Dunkel-Schetter C., 2011, HDB STRESS SCI BIOL, P321; Ebrahim SH, 1998, OBSTET GYNECOL, V92, P187, DOI 10.1016/S0029-7844(98)00205-1; Ernst M, 2001, J AM ACAD CHILD PSY, V40, P630, DOI 10.1097/00004583-200106000-00007; Fairbairn CE, 2015, J ABNORM PSYCHOL, V124, P660, DOI 10.1037/abn0000024; Gilbert DG, 1997, PROG R RES, V28, P132; Grekin ER, 2006, PSYCHOL ADDICT BEHAV, V20, P415, DOI 10.1037/0893-164X.20.4.415; Gupta PC, 2004, BMJ-BRIT MED J, V328, P1538, DOI 10.1136/bmj.38113.687882.EB; Hakulinen C, 2019, PSYCHOL MED, V49, P224, DOI 10.1017/S0033291718000636; Hakulinen C, 2015, ADDICTION, V110, P1844, DOI 10.1111/add.13079; Hakulinen C, 2015, DRUG ALCOHOL DEPEN, V151, P110, DOI 10.1016/j.drugalcdep.2015.03.008; Hannover W, 2009, ADDICT BEHAV, V34, P1, DOI 10.1016/j.addbeh.2008.07.021; Henderson J, 2007, BJOG-INT J OBSTET GY, V114, P243, DOI 10.1111/j.1471-0528.2006.01163.x; Hill SY, 2000, BIOL PSYCHIAT, V48, P265, DOI 10.1016/S0006-3223(00)00841-6; Hill SY, 1999, J STUD ALCOHOL, V60, P7, DOI 10.15288/jsa.1999.60.7; Huckle T, 2010, ADDICTION, V105, P1192, DOI 10.1111/j.1360-0443.2010.02931.x; Jacobson JL, 2002, ALCOHOL RES HEALTH, V26, P282; Kassel JD, 2003, PSYCHOL BULL, V129, P270, DOI 10.1037/0033-2909.129.2.270; Kazdin Alan F., 2000, ENCY PSYCHOL, V5; Kesmodel U, 2002, AM J EPIDEMIOL, V155, P305, DOI 10.1093/aje/155.4.305; Kubicka L, 2001, ADDICTION, V96, P1615, DOI 10.1046/j.1360-0443.2001.961116158.x; Larkins JM, 2006, PSYCHOL ADDICT BEHAV, V20, P471, DOI 10.1037/0893-164X.20.4.471; Lerman C, 2000, MOL PSYCHIATR, V5, P189, DOI 10.1038/sj.mp.4000672; Leung DYP, 2013, ASIAN PAC J CANCER P, V14, P5351, DOI 10.7314/APJCP.2013.14.9.5351; Little TD, 2014, J PEDIATR PSYCHOL, V39, P151, DOI 10.1093/jpepsy/jst048; Magnusson A, 2007, DRUG ALCOHOL DEPEN, V89, P275, DOI 10.1016/j.drugalcdep.2007.01.015; Malouff JM, 2007, J DRUG EDUC, V37, P277, DOI 10.2190/DE.37.3.d; Malouff JM, 2006, J DRUG EDUC, V36, P47, DOI 10.2190/9EP8-17P8-EKG7-66AD; Martin JL, 2015, EAT BEHAV, V17, P149, DOI 10.1016/j.eatbeh.2015.02.002; Massey SH, 2011, AM J ADDICTION, V20, P143, DOI 10.1111/j.1521-0391.2010.00110.x; Maxson PJ, 2012, ADDICT BEHAV, V37, P153, DOI 10.1016/j.addbeh.2011.08.011; McCrae RR, 2005, J PERS SOC PSYCHOL, V88, P547, DOI 10.1037/0022-3514.88.3.547; Miller GE, 2017, BRAIN BEHAV IMMUN, V65, P11, DOI 10.1016/j.bbi.2017.04.018; Miller GE, 2017, BRAIN BEHAV IMMUN, V64, P276, DOI 10.1016/j.bbi.2017.04.014; Mroczek DK, 2009, J RES PERS, V43, P653, DOI 10.1016/j.jrp.2009.03.016; Munafo MR, 2007, NICOTINE TOB RES, V9, P405, DOI 10.1080/14622200701188851; Orleans CT, 2001, WESTERN J MED, V174, P276, DOI 10.1136/ewjm.174.4.276; Pickett KE, 2008, J EPIDEMIOL COMMUN H, V62, P318, DOI 10.1136/jech.2006.058768; Pollack HA, 2001, AM J PUBLIC HEALTH, V91, P432, DOI 10.2105/AJPH.91.3.432; RAUSCH JL, 1990, BRIT J ADDICT, V85, P929; Raynor DA, 2009, J AM COLL HEALTH, V58, P73, DOI 10.3200/JACH.58.1.73-82; Read JP, 2006, J STUD ALCOHOL, V67, P204, DOI 10.15288/jsa.2006.67.204; Roberts BW, 2005, J RES PERS, V39, P166, DOI 10.1016/j.jrp.2004.08.002; Rush CC, 2009, PSYCHOL ADDICT BEHAV, V23, P140, DOI 10.1037/a0013167; Russell DW, 1997, J PERS, V65, P649, DOI 10.1111/j.1467-6494.1997.tb00330.x; SAMPSON RJ, 1990, AM SOCIOL REV, V55, P609, DOI 10.2307/2095859; Sayal K, 2007, PEDIATRICS, V119, pE426, DOI 10.1542/peds.2006-1840; Scaife JC, 2009, PHARMACOL BIOCHEM BE, V93, P354, DOI 10.1016/j.pbb.2009.05.015; Schneider S, 2010, DRUG ALCOHOL REV, V29, P81, DOI 10.1111/j.1465-3362.2009.00098.x; Severson HH, 1997, PREV MED, V26, P120, DOI 10.1006/pmed.1996.9983; Skagerstrom J, 2011, J WOMENS HEALTH, V20, P901, DOI 10.1089/jwh.2010.2216; Smedberg J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-213; Sokol RJ, 2003, JAMA-J AM MED ASSOC, V290, P2996, DOI 10.1001/jama.290.22.2996; Stubera J, 2008, SOC SCI MED, V67, P420, DOI 10.1016/j.socscimed.2008.03.010; Tan CH, 2015, MMWR-MORBID MORTAL W, V64, P1042, DOI 10.15585/mmwr.mm6437a3; TATE JC, 1994, ADDICTION, V89, P321, DOI 10.1111/j.1360-0443.1994.tb00899.x; Terracciano A, 2004, ADDICTION, V99, P472, DOI 10.1111/j.1360-0443.2004.00687.x; Tong VT, 2013, PUBLIC HEALTH REP, V128, P179, DOI 10.1177/003335491312800308; Tong Van T., 2009, Morbidity and Mortality Weekly Report, V58, P1; Turiano NA, 2015, HEALTH PSYCHOL, V34, P51, DOI 10.1037/hea0000038; Turiano NA, 2012, J RES PERS, V46, P719, DOI 10.1016/j.jrp.2012.08.009; Vollrath M, 1999, EUR J PERSONALITY, V13, P39, DOI 10.1002/(SICI)1099-0984(199901/02)13:1<39::AID-PER328>3.0.CO;2-J; Wickstrom R, 2007, CURR NEUROPHARMACOL, V5, P213, DOI 10.2174/157015907781695955; Wilkinson D, 2004, BRIT J HEALTH PSYCH, V9, P315, DOI 10.1348/1359107041557075; Wisborg K, 2000, ARCH DIS CHILD, V83, P203, DOI 10.1136/adc.83.3.203; Wong M, 2001, CAN J PUBLIC HEALTH, V92, P109, DOI 10.1007/BF03404942; World Health Organization, 2013, WHO REC PREV MAN TOB; Yali AM, 1999, J PSYCHOSOM OBST GYN, V20, P39, DOI 10.3109/01674829909075575; Zvolensky MJ, 2015, J PSYCHIATR RES, V63, P91, DOI 10.1016/j.jpsychires.2015.02.008	88	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0232668	10.1371/journal.pone.0232668	http://dx.doi.org/10.1371/journal.pone.0232668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1CK	32421742	Green Published, gold			2022-12-26	WOS:000537499600014
J	Imai, E; Usui, J; Kaneko, S; Kawamura, T; Suka, M; Yamagata, K				Imai, Eri; Usui, Joichi; Kaneko, Shuzo; Kawamura, Tetsuya; Suka, Machi; Yamagata, Kunihiro			The precise long-term outcomes of adult IgA nephropathy by mail questionnaires: Better renal survival compared to earlier cohort studies	PLOS ONE			English	Article							OXFORD CLASSIFICATION; SCORING SYSTEM; RISK-FACTORS; PROGNOSIS; VALIDATION	The estimated 20-year renal survival rate of immunoglobulin A (IgA) nephropathy is approx. 60%, but it is difficult to determine the 'big picture' for IgA nephropathy because a biopsy is essential for its diagnosis. Here we attempted to determine the longer and more precise renal prognosis of IgA nephropathy. We examined 310 patients with primary IgA nephropathy. Using the patients' clinical records and histological reports from our hospital and other clinics, we surveyed their renal prognoses and treatments within 1 year post-biopsy, and we sent questionnaires to the patients who had stopped visiting any hospital. We set renal death as the primary endpoint and analyzed factors related to renal death. The total patient cohort was 267: 159 males, 108 females; average age at biopsy, 37.7 years; average estimated glomerular filtration rate (eGFR), 69.7 mL/min/1.73m(2); urinary protein, 1.3 g/day. The mean follow-up duration was prolonged to 13.8 +/- 8.9 years (vs. 9.2 +/- 8.5 years using only medical records). The 10- and 20-year follow-up rates were 61.7% and 27.3%. The 10-, 20-year renal survival rates were 83.6% and 72.5%. Lower eGFR, hypertension, and smoking were revealed as factors independently related to renal death. To study survival of relatively benign diseases such as IgA nephropathy, longer survival rate was affected by many censoring cases. The results regarding the long-term renal prognoses of IgA nephropathy patients (including those with a mild phenotype) obtained by our analysis of a questionnaire sent to the patients provided more precise and longer-term prognoses compared to earlier studies.	[Imai, Eri] Univ Tsukuba, Grad Sch Comprehens Human Sci Major Med Sci, Tsukuba, Ibaraki, Japan; [Usui, Joichi; Kaneko, Shuzo; Kawamura, Tetsuya; Yamagata, Kunihiro] Univ Tsukuba, Dept Nephrol, Fac Med, Tsukuba, Ibaraki, Japan; [Suka, Machi] Jikei Univ, Sch Med, Dept Publ Hlth & Environm Med, Tokyo, Japan	University of Tsukuba; University of Tsukuba; Jikei University	Usui, J (corresponding author), Univ Tsukuba, Dept Nephrol, Fac Med, Tsukuba, Ibaraki, Japan.	j-usui@md.tsukuba.ac.jp			Research Committee of Intractable Renal Diseases, of the Ministry of Health, Labor, and Welfare of Japan [H29-017]	Research Committee of Intractable Renal Diseases, of the Ministry of Health, Labor, and Welfare of Japan	This work was supported by grants from the Research Committee of Intractable Renal Diseases, of the Ministry of Health, Labor, and Welfare of Japan (H29-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No author was United States Government Employee.	Alamartine E, 2011, CLIN J AM SOC NEPHRO, V6, P2384, DOI 10.2215/CJN.01170211; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Chacko B, 2005, NEPHROLOGY, V10, P496, DOI 10.1111/j.1440-1797.2005.00445.x; Cheng J, 2009, INT J CLIN PRACT, V63, P880, DOI 10.1111/j.1742-1241.2009.02038.x; D'Amico G, 1984, Contrib Nephrol, V40, P208; Endo Masayuki, 2008, Nihon Jinzo Gakkai Shi, V50, P442; Geddes CC, 2003, NEPHROL DIAL TRANSPL, V18, P1541, DOI 10.1093/ndt/gfg207; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273; Herzenberg AM, 2011, KIDNEY INT, V80, P310, DOI 10.1038/ki.2011.126; Kang SH, 2012, NEPHROL DIAL TRANSPL, V27, P252, DOI 10.1093/ndt/gfr295; Katafuchi R, 2003, AM J KIDNEY DIS, V41, P972, DOI 10.1016/S0272-6386(03)00194-X; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051225; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Moriyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091756; Orth SR, 1998, KIDNEY INT, V54, P926, DOI 10.1046/j.1523-1755.1998.00067.x; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Sharma P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007751.pub2; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; Trimarchi H, 2017, KIDNEY INT, V91, P1014, DOI 10.1016/j.kint.2017.02.003; Usui J, 2001, INTERNAL MED, V40, P697, DOI 10.2169/internalmedicine.40.697; Wakai K, 2006, NEPHROL DIAL TRANSPL, V21, P2800, DOI 10.1093/ndt/gfl342; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Yamamoto R, 2010, AM J KIDNEY DIS, V56, P313, DOI 10.1053/j.ajkd.2010.02.351; Yasunaga Hideo, 2006, Nihon Koshu Eisei Zasshi, V53, P40	27	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233186	10.1371/journal.pone.0233186	http://dx.doi.org/10.1371/journal.pone.0233186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413080	Green Published, gold			2022-12-26	WOS:000537496000057
J	Gao, W; Sanna, M; Tsai, MK; Wen, CP				Gao, Wayne; Sanna, Mattia; Tsai, Min Kuang; Wen, Chi Pang			Geo-temporal distribution of 1,688 Chinese healthcare workers infected with COVID-19 in severe conditions-A secondary data analysis	PLOS ONE			English	Article								Introduction The COVID-19 outbreak is posing an unprecedented challenge to healthcare workers. This study analyzes the geo-temporal effects on disease severity for the 1,688 Chinese healthcare workers infected with COVID-19. Methods Using the descriptive results recently reported by the Chinese CDC, we compare the percentage of infected healthcare workers in severe conditions over time and across three areas in China, and the fatality rate of infected healthcare workers with all the infected individuals in China aged 22-59 years. Results Among the infected Chinese healthcare workers whose symptoms onset appeared during the same ten-day period, the percentage of those in severe conditions decreased significantly from 19.7% (Jan 11-20) to 14.4% (Jan 21-31) to 8.7% (Feb 1-11). Across the country, there was also a significant difference in the disease severity, with Wuhan being the most severe (17.3%), followed by Hubei Province (10.2%), and the rest of China (6.6%). The case fatality rate for the 1,688 infected Chinese healthcare workers was significantly lower than that for the 29,798 infected patients aged 20-59 years-0.3% (5/1,688) vs. 0.65% (193/29,798), respectively. Conclusion The disease severity among infected healthcare workers improved considerably over a short period of time in China. The more severe conditions in Wuhan compared to the rest of the country may be attributable to the draconian lockdown. The clinical outcomes of infected Chinese healthcare workers may represent a more accurate estimation of the severity of COVID-19 for those who have access to quality healthcare.	[Gao, Wayne; Sanna, Mattia] Taipei Med Univ, Masters Program Global Hlth & Dev, Taipei, Taiwan; [Tsai, Min Kuang; Wen, Chi Pang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Wen, Chi Pang] China Med Univ Hosp, Taichung, Taiwan	Taipei Medical University; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Gao, W (corresponding author), Taipei Med Univ, Masters Program Global Hlth & Dev, Taipei, Taiwan.	waynegao@tmu.edu.tw	Sanna, Mattia/L-2405-2015	Sanna, Mattia/0000-0001-7262-0856; Gao, Wayne/0000-0002-6083-5849				Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Ji Y, LANCET GLOBAL HLTH; National Health Commission of the People's Republic of China, 2020, TRANSCR PRESS C INF; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; WHO, 2020, RESP COMM SPREAD COV, P1, DOI DOI 10.1017/DMP.2020.166; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]; Zeng Y, LANCET GLOBAL HLTH	11	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233255	10.1371/journal.pone.0233255	http://dx.doi.org/10.1371/journal.pone.0233255			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407411	Green Submitted, Green Published, gold			2022-12-26	WOS:000537490700087
J	Ko, YC; Wey, SY; Chen, WT; Chang, YF; Chen, MJ; Chiou, SH; Liu, CJL; Lee, CY				Ko, Yu-Chieh; Wey, Shih-Yu; Chen, Wei-Ta; Chang, Yu-Fan; Chen, Mei-Ju; Chiou, Shih-Hwa; Liu, Catherine Jui-Ling; Lee, Chen-Yi			Deep learning assisted detection of glaucomatous optic neuropathy and potential designs for a generalizable model	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; PREVALENCE; BLINDNESS	Purpose To evaluate ways to improve the generalizability of a deep learning algorithm for identifying glaucomatous optic neuropathy (GON) using a limited number of fundus photographs, as well as the key features being used for classification. Methods A total of 944 fundus images from Taipei Veterans General Hospital (TVGH) were retrospectively collected. Clinical and demographic characteristics, including structural and functional measurements of the images with GON, were recorded. Transfer learning based on VGGNet was used to construct a convolutional neural network (CNN) to identify GON. To avoid missing cases with advanced GON, an ensemble model was adopted in which a support vector machine classifier would make final classification based on cup-to-disc ratio if the CNN classifier had low-confidence score. The CNN classifier was first established using TVGH dataset, and then fine-tuned by combining the training images of TVGH and DrishtiGS datasets. Class activation map (CAM) was used to identify key features used for CNN classification. Performance of each classifier was determined through area under receiver operating characteristic curve (AUC) and compared with the ensemble model by diagnostic accuracy. Results In 187 TVGH test images, the accuracy, sensitivity, and specificity of the CNN classifier were 95.0%, 95.7%, and 94.2%, respectively, and the AUC was 0.992 compared to the 92.8% accuracy rate of the ensemble model. For the Drishti-GS test images, the accuracy of the CNN, the fine-tuned CNN and ensemble model was 33.3%, 80.3%, and 80.3%, respectively. The CNN classifier did not misclassify images with moderate to severe diseases. Class-discriminative regions revealed by CAM co-localized with known characteristics of GON. Conclusions The ensemble model or a fine-tuned CNN classifier may be potential designs to build a generalizable deep learning model for glaucoma detection when large image databases are not available.	[Ko, Yu-Chieh; Chang, Yu-Fan; Chen, Mei-Ju; Liu, Catherine Jui-Ling] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Ko, Yu-Chieh; Chen, Mei-Ju; Liu, Catherine Jui-Ling] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Ko, Yu-Chieh; Chang, Yu-Fan; Chiou, Shih-Hwa] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei, Taiwan; [Wey, Shih-Yu; Lee, Chen-Yi] Natl Chiao Tung Univ, Dept Elect Engn, Hsinchu, Taiwan; [Chen, Wei-Ta] Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan; [Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Liu, CJL (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Liu, CJL (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.; Lee, CY (corresponding author), Natl Chiao Tung Univ, Dept Elect Engn, Hsinchu, Taiwan.	jlliu@vghtpe.gov.tw; cylee@si2lab.org		Ko, Yu-Chieh/0000-0002-0818-4962	Ministry of Science and Technology, TAIWAN [MOST 106-2634-F-075-001, MOST 107-2634F-075-001, MOST 1062314-B-075-037-, MOST 105-2314-B-075-047]; Taipei Veterans General Hospital [V107C-114]	Ministry of Science and Technology, TAIWAN(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	CJL and YCK received funds from the Ministry of Science and Technology, TAIWAN (MOST 106-2634-F-075-001 and MOST 107-2634F-075-001 to CJL; MOST 1062314-B-075-037-; MOST 105-2314-B-075-047 to YCK); YCK received funds from Taipei Veterans General Hospital (V107C-114). The funding source had no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data, or decision to submit results.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Ayub J, 2016, P 2016 INT C COMP EL; Badala F, 2007, AM J OPHTHALMOL, V144, P724, DOI 10.1016/j.ajo.2007.07.010; Burr J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11410; Chen PP, 2003, OPHTHALMOLOGY, V110, P726, DOI 10.1016/S0161-6420(02)01974-7; Christopher M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35044-9; Diaz-Pinto A, 2019, BIOMED ENG ONLINE, V18, DOI 10.1186/s12938-019-0649-y; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Ernest PJ, 2013, OPHTHALMOLOGY, V120, P512, DOI 10.1016/j.ophtha.2012.09.005; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P1118, DOI 10.1136/bjo.82.10.1118; Gu J, 2017, ARXIV151207108V6; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Haleem MS, 2013, COMPUT MED IMAG GRAP, V37, P581, DOI 10.1016/j.compmedimag.2013.09.005; Hertzog LH, 1996, OPHTHALMOLOGY, V103, P1009, DOI 10.1016/S0161-6420(96)30573-3; Orlando JI, 2017, PROC SPIE, V10160, DOI 10.1117/12.2255740; Jonas JB, 2017, LANCET, V390, P2183, DOI 10.1016/S0140-6736(17)31469-1; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Krause J, 2018, OPHTHALMOLOGY, V125, P1264, DOI 10.1016/j.ophtha.2018.01.034; Li ZX, 2018, OPHTHALMOLOGY, V125, P1199, DOI 10.1016/j.ophtha.2018.01.023; Lin M, 2014, PUBLIC HEALTH NUTR, V17, P2029, DOI [10.1017/S1368980013002176, 10.1109/PLASMA.2013.6634954]; Liu HR, 2019, JAMA OPHTHALMOL, V137, P1353, DOI 10.1001/jamaophthalmol.2019.3501; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Myers JS, 2018, CLIN EXP OPHTHALMOL, V46, P169, DOI 10.1111/ceo.13138; O'Neill EC, 2014, JAMA OPHTHALMOL, V132, P560, DOI 10.1001/jamaophthalmol.2014.96; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Phene S, 2018, ARXIV181208911V1; Sivaswamy J., 2015, JSM BIOMED IMAGING D, V2, DOI 10.1109/ISBI.2014.6867807; Springenberg JT, 2014, ARXIV; Thomas SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113779; Yosinski J, 2014, ARXIV14111792V1; Zhou B, 2015, ARXIV151204150	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233079	10.1371/journal.pone.0233079	http://dx.doi.org/10.1371/journal.pone.0233079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407355	gold, Green Published			2022-12-26	WOS:000537490700065
J	Lu, ZB; Dong, S; Li, C; Li, LL; Yu, Y; Yin, SY; Men, XY				Lu, Zengbin; Dong, Song; Li, Chao; Li, Lili; Yu, Yi; Yin, Shuyan; Men, Xingyuan			Sublethal and transgenerational effects of sulfoxaflor on the demography and feeding behaviour of the mirid bug Apolygus lucorum	PLOS ONE			English	Article							NITROMETHYLENE NEONICOTINOID INSECTICIDE; LIFE TABLE PARAMETERS; RHOPALOSIPHUM-PADI; BROWN PLANTHOPPER; SULFOXIMINE INSECTICIDE; APHIS-GOSSYPII; LETHAL; COTTON; REPRODUCTION; RESISTANCE	Sulfoxaflor, the first commercially available sulfoximine insecticide, has been used for the control of sap-feeding insect pests such as plant bugs and aphids on a variety of crops. However, its sublethal effects on the mirid bug Apolygus lucorum, one of the key insect pests of Bt cotton and fruit trees in China, have not been fully examined. Here, we evaluated the demography and feeding behaviour of A. lucorum exposed to sulfoxaflor. The leaf-dipping bioassay showed that the LC10 and LC30 of sulfoxaflor against 3rd-instar nymphs of this insect were 1.23 and 8.37 mg L-1, respectively. The LC10 significantly extended the nymphal duration and decreased the oviposition period by 5.29 days and female fecundity by 56.99% in the parent generation (F0). The longer duration of egg, 5th-instar nymphs, preadult, and male adult longevity were observed in the F1 generation (F1) at LC10. At the LC30, the duration of egg and 1st-instar nymph, female adult longevity, and oviposition period of the F1 were significantly shorter, while the nymphal duration in the F0 and duration of 5th-instar nymphs, preadult survival rate, and male adult longevity in the F1 significantly increased. The net reproductive rate (R-0), intrinsic rate of increase (r), and finite rate of increase (lambda) in the F1 were not significantly affected by these two concentrations, whereas the mean generation time (T) was lower at the LC30. Additionally, the probe counts and cells mixture feeding time were markedly lengthened by the LC10 and LC30, respectively, when A. lucorum nymphs exposed to sulfoxaflor fed on Bt cotton plants without insecticides. These results clearly indicate that sulfoxaflor causes sublethal effects on A. lucorum and the transgenerational effects depend on the tested concentrations.	[Lu, Zengbin] Minist Agr & Rural Affairs, Shandong Acad Agr Sci, Key Lab Biol & Genet Improvement Maize Northern Y, Natl Engn Lab Wheat & Maize,Maize Res Inst, Jinan, Peoples R China; [Dong, Song; Li, Chao; Li, Lili; Yu, Yi; Men, Xingyuan] Shandong Acad Agr Sci, Inst Plant Protect, Jinan, Peoples R China; [Yin, Shuyan] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China	Ministry of Agriculture & Rural Affairs; Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences; Shandong Agricultural University	Men, XY (corresponding author), Shandong Acad Agr Sci, Inst Plant Protect, Jinan, Peoples R China.	menxy2000@hotmail.com		Lu, Zengbin/0000-0002-2446-0699	National Key R&D Program of China [2017YFD0201900]; Key R&D Program of Shandong Province [2017CXGC0214, 2018GNC111019]; Agricultural Science and Technology Innovation Project of Shandong Academy of Agricultural Sciences [CXGC2016A09, CXGC2016B11]	National Key R&D Program of China; Key R&D Program of Shandong Province; Agricultural Science and Technology Innovation Project of Shandong Academy of Agricultural Sciences	This work was supported by the National Key R&D Program of China (2017YFD0201900), the Key R&D Program of Shandong Province (2017CXGC0214, 2018GNC111019), and the Agricultural Science and Technology Innovation Project of Shandong Academy of Agricultural Sciences (CXGC2016A09 and CXGC2016B11).	Babcock JM, 2011, PEST MANAG SCI, V67, P328, DOI 10.1002/ps.2069; Bao HB, 2009, PEST MANAG SCI, V65, P170, DOI 10.1002/ps.1664; Boina DR, 2009, PEST MANAG SCI, V65, P870, DOI 10.1002/ps.1767; Brandstatter E., 1999, METHODS PSYCHOL RES, V4, P33; Brar GS, 2017, INT J PEST MANAGE, V63, P299, DOI 10.1080/09670874.2016.1258501; Chen XW, 2016, ECOTOXICOLOGY, V25, P1841, DOI 10.1007/s10646-016-1732-9; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Chi H., 2021, 2 SEX MSCHART COMPUT; Cira TM, 2017, J PEST SCI, V90, P1257, DOI 10.1007/s10340-017-0871-y; Cui L, 2012, PEST MANAG SCI, V68, P1484, DOI 10.1002/ps.3333; Cui L, 2010, PEST MANAG SCI, V66, P779, DOI 10.1002/ps.1942; Daniels M, 2009, J INSECT PHYSIOL, V55, P758, DOI 10.1016/j.jinsphys.2009.03.002; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Efron B., 1994, INTRO BOOTSTRAP; Fang Y, 2018, J INSECT SCI, V18, DOI 10.1093/jisesa/iey025; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Huang Y.B., 2012, J AGR, V61, P37, DOI DOI 10.1016/B978-0-12-803265-7.00011-7; Jeong Seok-Won, 2017, Journal of Plant Biotechnology, V44, P115, DOI 10.5010/JPB.2017.44.2.115; Koo HN, 2015, ENTOMOL EXP APPL, V154, P110, DOI 10.1111/eea.12260; Lashkari MR, 2007, INSECT SCI, V14, P207, DOI 10.1111/j.1744-7917.2007.00145.x; Li Guo-Ping, 2017, Acta Entomologica Sinica, V60, P650, DOI 10.16380/j.kcxb.2017.06.005; Li WQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204097; Liao X, 2019, CROP PROT, V118, P6, DOI 10.1016/j.cropro.2018.12.005; Longhurst C, 2013, PEST MANAG SCI, V69, P809, DOI 10.1002/ps.3439; Lu Y., 2008, BIOL CONTROL COTTON; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Ma YJ, 2013, CHINA COTTON, V40, P31; Pan HS, 2014, J PEST SCI, V87, P731, DOI 10.1007/s10340-014-0610-6; Passos LC, 2018, ENTOMOL GEN, V38, P127, DOI 10.1127/entomologia/2018/0744; Qu YY, 2017, ECOTOXICOLOGY, V26, P1002, DOI 10.1007/s10646-017-1828-x; Qu YY, 2015, ECOTOXICOLOGY, V24, P479, DOI 10.1007/s10646-014-1396-2; Santos MF, 2016, J PEST SCI, V89, P231, DOI 10.1007/s10340-015-0666-y; Sparks TC, 2013, PESTIC BIOCHEM PHYS, V107, P1, DOI 10.1016/j.pestbp.2013.05.014; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Tan Yao, 2012, Chinese Journal of Applied Entomology, V49, P348; Tang QL, 2015, J ECON ENTOMOL, V108, P2720, DOI 10.1093/jee/tov221; Wang SY, 2017, J PEST SCI, V90, P389, DOI 10.1007/s10340-016-0770-7; Watson GB, 2011, INSECT BIOCHEM MOLEC, V41, P432, DOI 10.1016/j.ibmb.2011.01.009; Whalon ME, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P5, DOI 10.1079/9781845933531.0005; Xiang X, 2019, CROP PROT, V120, P97, DOI 10.1016/j.cropro.2019.02.016; Xin JJ, 2019, J INTEGR AGR, V18, P1613, DOI [10.1016/S2095-3119(18)62094-5, 10.1016/s2095-3119(18)62094-5]; Xu L, 2016, J ASIA-PAC ENTOMOL, V19, P683, DOI 10.1016/j.aspen.2016.06.013; Yuan HB, 2017, INSECT SCI, V24, P743, DOI 10.1111/1744-7917.12357; Zeng XY, 2016, J ECON ENTOMOL, V109, P1595, DOI 10.1093/jee/tow104; Zhang J, 2010, APPL ENTOMOL ZOOL; Zhao Qiu-jian, 2011, Scientia Agricultura Sinica, V44, P2260; Zhen CG, 2018, PESTIC BIOCHEM PHYS, V144, P57, DOI 10.1016/j.pestbp.2017.11.008; Zhu YM, 2011, J AGR FOOD CHEM, V59, P2950, DOI 10.1021/jf102765x	50	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232812	10.1371/journal.pone.0232812	http://dx.doi.org/10.1371/journal.pone.0232812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407334	Green Published, gold			2022-12-26	WOS:000537490700037
J	Meyer-Schaller, N; Tiede, S; Ivanek, R; Diepenbruck, M; Christofori, G				Meyer-Schaller, Nathalie; Tiede, Stefanie; Ivanek, Robert; Diepenbruck, Maren; Christofori, Gerhard			A dual role of Irf1 in maintaining epithelial identity but also enabling EMT and metastasis formation of breast cancer cells	ONCOGENE			English	Article							REGULATORY FACTOR-I; INTERFERON; INDUCTION; PATHWAY; FAMILY; TARGET	An epithelial to mesenchymal transition (EMT) is an embryonic dedifferentiation program which is aberrantly activated in cancer cells to acquire cellular plasticity. This plasticity increases the ability of breast cancer cells to invade into surrounding tissue, to seed metastasis at distant sites and to resist to chemotherapy. In this study, we have observed a higher expression of interferon-related factors in basal-like and claudin-low subtypes of breast cancer in patients, known to be associated with EMT. Notably, Irf1 exerts essential functions during the EMT process, yet it is also required for the maintenance of an epithelial differentiation status of mammary gland epithelial cells: RNAi-mediated ablation of Irf1 in mammary epithelial cells results in the expression of mesenchymal factors and Smad transcriptional activity. Conversely, ablation of Irf1 during TGF beta-induced EMT prevents a mesenchymal transition and stabilizes the expression of E-cadherin. In the basal-like murine breast cancer cell line 4T1, RNAi-mediated ablation of Irf1 reduces colony formation and cell migration in vitro and shedding of circulating tumor cells and metastasis formation in vivo. This context-dependent dual role of Irf1 in the regulation of epithelial-mesenchymal plasticity provides important new insights into the functional contribution and therapeutic potential of interferon-regulated factors in breast cancer.	[Meyer-Schaller, Nathalie; Tiede, Stefanie; Ivanek, Robert; Diepenbruck, Maren; Christofori, Gerhard] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Ivanek, Robert] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland	University of Basel; Swiss Institute of Bioinformatics	Meyer-Schaller, N; Christofori, G (corresponding author), Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.	nathalie.meyer-schaller@unibas.ch; gerhard.christofori@unibas.ch			Swiss National Science Foundation [310030B_163471]; SystemsX.ch RTD Cellplasticity; Swiss Cancer League [KFS-3479-08-2014]; Krebsliga Beider Basel [03-2013]; Marie-Heim Vogtlin grant from the Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch RTD Cellplasticity; Swiss Cancer League; Krebsliga Beider Basel; Marie-Heim Vogtlin grant from the Swiss National Science Foundation	We thank Petra Schmidt for technical assistance with immunoblotting and quantitative RT-PCR, Helena Antoniadis for help with mouse work, Christian Beisel and the D-BSSE sequencing facility for RNA-sequencing, Pascal Lorenz and the DBM Mattenstrasse microscopy facility for microscopy and image quantification support. This work was supported by the Swiss National Science Foundation (310030B_163471), the SystemsX.ch RTD Cellplasticity, the Swiss Cancer League (KFS-3479-08-2014), the Krebsliga Beider Basel (03-2013) (all GC) and by a Marie-Heim Vogtlin grant from the Swiss National Science Foundation (NM-S).	Alsamman K, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171672; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bouker KB, 2005, CARCINOGENESIS, V26, P1527, DOI 10.1093/carcin/bgi113; Bouker KB, 2004, CANCER RES, V64, P4030, DOI 10.1158/0008-5472.CAN-03-3602; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dror N, 2007, MOL IMMUNOL, V44, P338, DOI 10.1016/j.molimm.2006.02.026; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Guerrero Michael S, 2012, Genes Cancer, V3, P371, DOI 10.1177/1947601912458585; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Irudayam JI, 2015, STEM CELL RES, V15, P354, DOI 10.1016/j.scr.2015.08.003; Jiang L, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1186-z; Jiang YY, 2020, CANCER LETT, V468, P72, DOI 10.1016/j.canlet.2019.10.013; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Lotz-Jenne C, 2016, ONCOTARGET, V7, P25983, DOI 10.18632/oncotarget.8418; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Meyer-Schaller N, 2019, DEV CELL, V48, P539, DOI 10.1016/j.devcel.2018.12.023; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Pavan S, 2018, ONCOGENE, V37, P4197, DOI 10.1038/s41388-018-0270-8; Pavan S, 2013, EUR J CANCER, V49, P964, DOI 10.1016/j.ejca.2012.09.024; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Stemmler MP, 2019, NAT CELL BIOL, V21, P102, DOI 10.1038/s41556-018-0196-y; Waldmeier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048651; Yanai H, 2012, ONCOIMMUNOLOGY, V1, P1376, DOI 10.4161/onci.22475; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; You FP, 2013, NAT IMMUNOL, V14, P1237, DOI 10.1038/ni.2756; Yu M, 2017, INT J ONCOL, V50, P975, DOI 10.3892/ijo.2017.3852	34	3	3	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	24					4728	4740		10.1038/s41388-020-1326-0	http://dx.doi.org/10.1038/s41388-020-1326-0		MAY 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LY0HO	32404986				2022-12-26	WOS:000532807900001
J	Monteiro-Neto, V; de Souza, CD; Gonzaga, LF; da Silveira, BC; Sousa, NCF; Pontes, JP; Santos, DM; Martins, WC; Pessoa, JFV; Carvalho, AR; Almeida, VSS; de Oliveira, NMT; de Araujo, TS; Maria-Ferreira, D; Mendes, SJF; Ferro, TAF; Fernandes, ES				Monteiro-Neto, Valerio; de Souza, Claudio D.; Gonzaga, Laoane F.; da Silveira, Bruna C.; Sousa, Nagila C. F.; Pontes, Jaqueline P.; Santos, Deivid M.; Martins, Wanessa C.; Pessoa, Jorge F. V.; Carvalho Junior, Alexsander R.; Almeida, Viviane S. S.; de Oliveira, Natalia M. T.; de Araujo, Thayla S.; Maria-Ferreira, Daniele; Mendes, Saulo J. F.; Ferro, Thiago A. F.; Fernandes, Elizabeth S.			Cuminaldehyde potentiates the antimicrobial actions of ciprofloxacin against Staphylococcus aureus and Escherichia coli	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; ESSENTIAL OILS; BIOFILM FORMATION; ANTIBACTERIAL; SEPSIS; PREDICTION; SPICES; SKIN	Escherichia coli and Staphylococcus aureus are important agents of urinary tract infections that can often evolve to severe infections. The rise of antibiotic-resistant strains has driven the search for novel therapies to replace the use or act as adjuvants of antibiotics. In this context, plant-derived compounds have been widely investigated. Cuminaldehyde is suggested as the major antimicrobial compound of the cumin seed essential oil. However, this effect is not fully understood. Herein, we investigated the in silico and in vitro activities of cuminaldehyde, as well as its ability to potentiate ciprofloxacin effects against S. aureus and E. coli. In silico analyses were performed by using different computational tools. The PASS online and SwissADME programmes were used for the prediction of biological activities and oral bioavailability of cuminaldehyde. For analysis of the possible toxic effects and the theoretical pharmacokinetic parameters of the compound, the Osiris, SwissADME and PROTOX programmes were used. Estimations of cuminaldehyde gastrointestinal absorption, blood brain barrier permeability and skin permeation by using SwissADME; and drug likeness and score by using Osiris, were also evaluated The in vitro antimicrobial effects of cuminaldehyde were determined by using microdilution, biofilm formation and time-kill assays. In silico analysis indicated that cuminaldehyde may act as an antimicrobial and as a membrane permeability enhancer. It was suggested to be highly absorbable by the gastrointestinal tract and likely to cross the blood brain barrier. Also, irritative and harmful effects were predicted for cuminaldehyde if swallowed at its LD50. Good oral bioavailability and drug score were also found for this compound. Cuminaldehyde presented antimicrobial and anti-biofilm effects against S. aureus and E. coli.. When co-incubated with ciprofloxacin, it enhanced the antibiotic antimicrobial and anti-biofilm actions. We suggest that cuminaldehyde may be useful as an adjuvant therapy to ciprofloxacin in S. aureus and E. coli-induced infections.	[Monteiro-Neto, Valerio; de Souza, Claudio D.; Gonzaga, Laoane F.; Sousa, Nagila C. F.; Pontes, Jaqueline P.; Santos, Deivid M.; Martins, Wanessa C.; Pessoa, Jorge F. V.; de Araujo, Thayla S.; Mendes, Saulo J. F.; Ferro, Thiago A. F.; Fernandes, Elizabeth S.] Univ Ceuma, Programa Posgrad, Sao Luis, MA, Brazil; [Monteiro-Neto, Valerio; Almeida, Viviane S. S.] Univ Fed Maranhao, Sao Luis, MA, Brazil; [da Silveira, Bruna C.; de Oliveira, Natalia M. T.; Maria-Ferreira, Daniele; Fernandes, Elizabeth S.] Inst Pesquisa Pele Pequeno Principe, Curitiba, PR, Brazil; [da Silveira, Bruna C.; de Oliveira, Natalia M. T.; Maria-Ferreira, Daniele; Fernandes, Elizabeth S.] Fac Pequeno Principe, Curitiba, PR, Brazil; [Carvalho Junior, Alexsander R.] Univ Sao Paulo, Dept Parasitol, Sao Paulo, SP, Brazil	Universidade Ceuma; Universidade Federal do Maranhao; Hospital Pequeno Principe; Hospital Pequeno Principe; Universidade de Sao Paulo	Ferro, TAF; Fernandes, ES (corresponding author), Univ Ceuma, Programa Posgrad, Sao Luis, MA, Brazil.; Fernandes, ES (corresponding author), Inst Pesquisa Pele Pequeno Principe, Curitiba, PR, Brazil.; Fernandes, ES (corresponding author), Fac Pequeno Principe, Curitiba, PR, Brazil.	thafeitosaf@hotmail.com; elizabeth.fernandes@pelepequenoprincipe.org.br	Fernandes, Elizabeth S./Q-7276-2019; Fernandes, Elizabeth S/J-9397-2012; CarvalhoJunior, Alexsander Rodrigues/N-5501-2019; Maria-Ferreira, Daniele/AAQ-2015-2020; Maria-Ferreira, Daniele/AAE-9373-2020; Monteiro-Neto, Valério/J-6049-2012	Fernandes, Elizabeth S./0000-0002-0567-2514; CarvalhoJunior, Alexsander Rodrigues/0000-0002-5535-3036; Maria-Ferreira, Daniele/0000-0001-7992-510X; Monteiro-Neto, Valério/0000-0003-2868-1314; Santos, Deivid/0000-0003-3632-1167; Mulinari Turin de Oliveira, Natalia/0000-0003-2174-5282	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [3325/2013, 001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [309046/2016-5, 305676/20199]; Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (FAPEMA) [03207/18]; INCT-INOVAMED [465430/2014-7]; FAPEMA; CNPq; Santander Universidades programme; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); CAPES; Instituto de Pesquisa Pele Pequeno Principe	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (FAPEMA)(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA)); INCT-INOVAMED; FAPEMA(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Santander Universidades programme; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto de Pesquisa Pele Pequeno Principe	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; grant number 3325/2013; finance code 001), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant numbers 309046/2016-5 and 305676/20199), Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (FAPEMA; grant number 03207/18) and INCT-INOVAMED (grant number 465430/2014-7). J.P.P. and N.C.F.S. are students receiving grants from FAPEMA. L.F.G. is an undergraduate student receiving a grant from CNPq. D.M.S. is an undergraduate student receiving a grant from the Santander Universidades programme. A.R.C.Jr. and N.M.T.O. are PhD students receiving grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and CAPES, respectively. B.C.d.S. is a MSc student receiving a studentship from Instituto de Pesquisa Pele Pequeno Principe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Mageed MA, 2012, J ESSENT OIL BEAR PL, V15, P614, DOI 10.1080/0972060X.2012.10644096; Allahghadri T, 2010, J FOOD SCI, V75, pH54, DOI 10.1111/j.1750-3841.2009.01467.x; Bag A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131321; Baraboutis IG, 2010, EUR J CLIN MICROBIOL, V29, P1095, DOI 10.1007/s10096-010-0967-2; Bergin SP, 2017, CURR TOP MICROBIOL, V409, P263, DOI 10.1007/82_2015_5001; Borges A, 2016, MOLECULES, V21, DOI 10.3390/molecules21070877; Cardona AF, 2015, CLIN INFECT DIS, V61, pS69, DOI 10.1093/cid/civ528; Chen M, 2013, INT J MOL SCI, V14, P18488, DOI 10.3390/ijms140918488; Chiang CY, 2018, MBIO, V9, DOI [10.1128/mBio.01932-17, 10.1128/mbio.01932-17]; Chin JN, 2008, J ANTIMICROB CHEMOTH, V61, P365, DOI 10.1093/jac/dkm457; Chung PY, 2014, PATHOG DIS, V70, P231, DOI 10.1111/2049-632X.12141; CLSI, 2019, M100 CLSI; Cordoba G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2785-y; Cui HY, 2019, ULTRASON SONOCHEM, V56, P84, DOI 10.1016/j.ultsonch.2019.04.001; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Derakhshan S, 2010, PHARMACOGN MAG, V6, P57, DOI 10.4103/0973-1296.59967; Drwal MN, 2014, NUCLEIC ACIDS RES, V42, pW53, DOI 10.1093/nar/gku401; Eduardo LD, 2018, CURR TOP MED CHEM, V18, P917, DOI [10.2174/1568026618666180712093914, 10.2174/1568026619666181130141818]; Fasugba O, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1282-4; Ferro TAF, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02052; Gomes IB, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw014; Hernandez-Ochoa L, 2014, J FOOD SCI TECH MYS, V51, P957, DOI 10.1007/s13197-011-0598-3; Jokinen E, 2018, INFECT DIS-NOR, V50, P52, DOI 10.1080/23744235.2017.1405276; Kakarla P, 2017, ARCH MICROBIOL, V199, P465, DOI 10.1007/s00203-016-1314-5; Karakonstantis S, 2018, INFECTION, V46, P293, DOI 10.1007/s15010-017-1100-6; Khalil N, 2018, FUTUR J PHARM SCI, V4, P88, DOI 10.1016/j.fjps.2017.10.004; Khurana N, 2011, EUR J PHARMACOL, V662, P22, DOI 10.1016/j.ejphar.2011.04.048; Kirmusaoglu S, 2017, UROL J, V14, P3028; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Lishman H, 2018, INT J ANTIMICROB AG, V52, P790, DOI 10.1016/j.ijantimicag.2018.08.013; Mnif S, 2015, CHEM BIODIVERS, V12, P733, DOI 10.1002/cbdv.201400305; Naveed R, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-265; Gobatto ALN, 2017, SHOCK, V47, P6, DOI 10.1097/SHK.0000000000000703; Owen L, 2018, MOL CELL PROBE, V38, P25, DOI 10.1016/j.mcp.2017.12.004; Ozcan M, 2001, EUR FOOD RES TECHNOL, V212, P658, DOI 10.1007/s002170100310; Rath S, 2014, INTEGR MED RES, V3, P133, DOI 10.1016/j.imr.2014.04.002; Ray GT, 2013, DIAGN MICR INFEC DIS, V76, P24, DOI 10.1016/j.diagmicrobio.2013.02.020; Sabir N, 2017, AM J INFECT CONTROL, V45, P1101, DOI 10.1016/j.ajic.2017.05.009; Schaeffer AJ, 2002, AM J MED, V113, p45S; Shayegh S, 2008, NAT PROD RES, V22, P429; Singh R. P., 2017, Pharmacognosy Journal, V9, P292, DOI 10.5530/pj.2017.3.51; Vale J, 2019, LETT APPL MICROBIOL, V68, P313, DOI 10.1111/lam.13137; Vollaro A, 2019, NEW MICROBIOL, V42, P21; Walker JN, 2017, P NATL ACAD SCI USA, V114, pE8721, DOI 10.1073/pnas.1707572114; Yousefi M, 2016, IRAN J PUBLIC HEALTH, V45, P485; Yusef D, 2018, PEDIATR NEONATOL, V59, P35, DOI 10.1016/j.pedneo.2017.06.001; Zacchino SA, 2017, PHYTOMEDICINE, V37, P27, DOI 10.1016/j.phymed.2017.10.018; Zolfaghari MR., 2015, J ESSENT OIL BEAR PL, V18, P582	48	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232987	10.1371/journal.pone.0232987	http://dx.doi.org/10.1371/journal.pone.0232987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407399	gold, Green Published			2022-12-26	WOS:000537490700054
J	Nordstrom, B; James, MC; Worm, B				Nordstrom, Bethany; James, Michael C.; Worm, Boris			Jellyfish distribution in space and time predicts leatherback sea turtle hot spots in the Northwest Atlantic	PLOS ONE			English	Article							NIANTIC RIVER ESTUARY; SPECIES-RANGE SHIFTS; GELATINOUS ZOOPLANKTON; DERMOCHELYS-CORIACEA; CYANEA-CAPILLATA; CANADIAN WATERS; AURELIA-AURITA; CNIDARIA; HABITAT; OCEAN	Leatherback sea turtles (Dermochelys coriacea) migrate to temperate Canadian Atlantic waters to feed on gelatinous zooplankton ('jellyfish') every summer. However, the spatiotemporal connection between predator foraging and prey-field dynamics has not been studied at the large scales over which these migratory animals occur. We use 8903 tows of groundfish survey jellyfish bycatch data between 2006-2017 to reveal spatial jellyfish hot spots, and matched these data to satellite-telemetry leatherback data over time and space. We found highly significant overlap of jellyfish and leatherback distribution on the Scotian Shelf (r = 0.89), moderately strong correlations of jellyfish and leatherback spatial hot spots in the Gulf of St. Lawrence (r = 0.59), and strong correlations in the Bay of Fundy (r = 0.74), which supports much lower jellyfish density. Over time, jellyfish bycatch data revealed a slight northward range shift in the Gulf of St. Lawrence, consistent with gradual warming of these waters. Two-stage generalized linear modelling corroborated that sea surface temperature, year, and region were significant predictors of jellyfish biomass, suggesting a climate signal on jellyfish distribution, which may shift leatherback critical feeding habitat over time. These findings are useful in predicting dynamic habitat use for endangered leatherback turtles, and can help to anticipate large-scale changes in their distribution in response to climate-related changes in prey availability.	[Nordstrom, Bethany; Worm, Boris] Dalhousie Univ, Biol Dept, Halifax, NS, Canada; [Nordstrom, Bethany] Univ Western Australia, Sch Biol Sci, Perth, WA, Australia; [James, Michael C.] Fisheries & Oceans Canada, Populat Ecol Div, Dartmouth, NS, Canada	Dalhousie University; University of Western Australia; Fisheries & Oceans Canada	Nordstrom, B (corresponding author), Dalhousie Univ, Biol Dept, Halifax, NS, Canada.; Nordstrom, B (corresponding author), Univ Western Australia, Sch Biol Sci, Perth, WA, Australia.	bethany.nordstrom@dal.ca		Worm, Boris/0000-0002-5742-8716	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada First Research Excellent Fund; Canadian Wildlife Federation; Environment Canada; Conservation International; Nature Seekers (Trinidad); Fisheries and Oceans Canada; Ocean Frontier Institute (Module G)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada First Research Excellent Fund; Canadian Wildlife Federation; Environment Canada(CGIAR); Conservation International; Nature Seekers (Trinidad); Fisheries and Oceans Canada; Ocean Frontier Institute (Module G)	This work was funded in part by Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada First Research Excellent Fund (https://www.cfref-apogee.gc.ca/ home-accueil-eng.aspx). BN and BW received funding from these funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank E. Bond, K. Martin, and the Canadian Sea Turtle Network for assistance with leatherback turtle data compilation; D. Clark, J. Emberley, D. Ricard, S. Plourde for contributing jellyfish data from DFO trawl surveys; and C. Caverhill from the Remote Sensing Group, Bedford Institute of Oceanography, for contributing sea surface temperature data. We gratefully acknowledge Canadian Wildlife Federation, Conservation International, Environment Canada, Nature Seekers (Trinidad) and Fisheries and Oceans Canada for support of related leatherback turtle scientific sampling activities. This study is in part based on a M.Sc. thesis by B.N. at Dalhousie University, Canada, funded in part by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Ocean Frontier Institute (Module G).	Aleksa KT, 2018, MAR ECOL PROG SER, V591, P71, DOI 10.3354/meps12327; [Anonymous], 2019, R LANG ENV STAT COMP; Arai MN, 1997, FUNCTIONAL BIOL SCYP; Archibald DW, 2016, MAR ECOL PROG SER, V547, P233, DOI 10.3354/meps11648; Aubert A, 2018, MAR POLICY, V89, P100, DOI 10.1016/j.marpol.2017.12.010; Bailey H, 2012, ECOL APPL, V22, P735, DOI 10.1890/11-0633; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Bastian T, 2011, ICES J MAR SCI, V68, P436, DOI 10.1093/icesjms/fsq178; Benson SR, 2007, FISH B-NOAA, V105, P337; BREWER RH, 1991, J EXP MAR BIOL ECOL, V152, P49, DOI 10.1016/0022-0981(91)90134-I; BREWER RH, 1989, BIOL BULL, V176, P272, DOI 10.2307/1541985; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Brown MW, 1999, F524580064 BEDF I OC; Brown MW, 2000, F524590035 BEDF I OC; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Carrothers PJG, 1988, CAN TECH REP FISH AQ; Chadwick E.M.P., 2007, AZMP B, V6, P25; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2012, COSEWIC ASS STAT REP; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Davies KTA, 2019, MAR POLICY, V104, P157, DOI 10.1016/j.marpol.2019.02.019; de Lafontaine Y., 1991, Canadian Special Publication of Fisheries and Aquatic Sciences, V113, P99; Decker MB, 2018, MAR ECOL PROG SER, V591, P57, DOI 10.3354/meps12273; Devine L., 2017, CHEM BIOL OCEANOGRAP; Doyle TK, 2007, HYDROBIOLOGIA, V579, P29, DOI 10.1007/s10750-006-0362-2; Dufour R., 2007, CAN TECH REP FISH AQ; Fisheries and Oceans Canada, 2014, SPEC RISK ACT REC ST, P68; Fisheries and Oceans Canada, 2016, 2016011 DFO CAN SCI; Fisheries and Oceans Canada, 2016, 2016016 DFO CAN SCI; Fuchs B, 2014, CURR BIOL, V24, P263, DOI 10.1016/j.cub.2013.12.003; Galbraith P.S., 2016, DFO CAN SCI ADVIS SE; Gambill M, 2014, J EXP MAR BIOL ECOL, V459, P17, DOI 10.1016/j.jembe.2014.05.005; Gawinski C, 2019, DATA BRIEF, V25, DOI 10.1016/j.dib.2019.104186; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gilbert M., 2008, ICES CM, P18; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Graham WM, 2003, MAR ECOL PROG SER, V254, P129, DOI 10.3354/meps254129; Gregr EJ, 2015, 2015079 DFO CAN SCI; GRONDAHL F, 1988, MAR BIOL, V97, P541, DOI 10.1007/BF00391050; Hamelin KM, 2017, AQUAT CONSERV, V27, P631, DOI 10.1002/aqc.2733; Hamelin KM, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00158.1; Hansson LJ, 1997, MAR ECOL PROG SER, V161, P145, DOI 10.3354/meps161145; Harrison AL, 2018, NAT ECOL EVOL, V2, P1571, DOI 10.1038/s41559-018-0646-8; HAY SJ, 1990, NETH J SEA RES, V25, P113, DOI 10.1016/0077-7579(90)90013-7; Hays GC, 2006, ECOLOGY, V87, P2647, DOI 10.1890/0012-9658(2006)87[2647:FFMOLT]2.0.CO;2; Heaslip SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033259; Hebert D., 2018, CAN SCI ADVIS SEC RE; Hebert D., 2015, DFO CAN SCI ADVIS SE, V83, P49; Holst S, 2012, HYDROBIOLOGIA, V690, P127, DOI 10.1007/s10750-012-1043-y; Holstein TW, 2014, CURR BIOL, V24, pR159, DOI 10.1016/j.cub.2014.01.003; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Houghton JDR, 2007, HYDROBIOLOGIA, V589, P1, DOI 10.1007/s10750-007-0572-2; Hurley I, 2019, CONSERVATION SCI PRA, V1; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; James Michael C., 2001, Chelonian Conservation and Biology, V4, P202; James MC, 2006, BIOL CONSERV, V133, P347, DOI 10.1016/j.biocon.2006.06.012; Johnson C, 2016, 2016003 DFO CAN SCI, V2016, P51; Lascelles B, 2014, AQUAT CONSERV, V24, P111, DOI 10.1002/aqc.2512; Lee SK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048856; Li WKW, 2008, LIMNOL OCEANOGR, V53, P1734, DOI 10.4319/lo.2008.53.5.1734; Locke A., 2002, CAN MANUSCR REP FISH; Lucas CH, 2012, ADV MAR BIOL, V63, P133, DOI 10.1016/B978-0-12-394282-1.00003-X; Maxwell SM, 2015, MAR POLICY, V58, P42, DOI 10.1016/j.marpol.2015.03.014; Meyer-Gutbrod EL, 2018, OCEANOGRAPHY, V31, P19, DOI 10.5670/oceanog.2018.209; Meyer-Gutbrod EL, 2018, GLOBAL CHANGE BIOL, V24, P455, DOI 10.1111/gcb.13929; Mosnier A, 2019, CAN J ZOOL, V97, P464, DOI 10.1139/cjz-2018-0167; Nordstrom B, 2019, MAR ECOL PROG SER, V620, P15, DOI 10.3354/meps12978; Northwest Atlantic Leatherback Working Group, 2019, IUCN RED LIST THREAT, P16, DOI [10.2305/IUCN.UK.2019-2.RLTS.T46967827A83327767.en, DOI 10.2305/IUCN.UK.2019-2.RLTS.T46967827A83327767.EN]; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pitt Kylie A., 2014, P79; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Record N, 2019, OCEANOGRAPHY, V32; Saba VS, 2016, J GEOPHYS RES-OCEANS, V121, P118, DOI 10.1002/2015JC011346; Sherrill-Mix SA, 2008, BEHAV ECOL, V19, P231, DOI 10.1093/beheco/arm104; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; SIPOS JC, 1968, J FISH RES BOARD CAN, V25, P1561, DOI 10.1139/f68-141; Stephens DW, 1987, FORAGING THEORY; Stevenson DE, 2019, POLAR BIOL, V42, P407, DOI 10.1007/s00300-018-2431-1; Suchman CL, 2008, MAR ECOL PROG SER, V358, P161, DOI 10.3354/meps07313; Tiwari M., 2013, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2013-2.RLTS.T46967827A46967830.en, DOI 10.2305/IUCN.UK.2013-2.RLTS.T46967827A46967830.EN]; Visser F, 2011, MAR ECOL PROG SER, V440, P267, DOI 10.3354/meps09349; Wallace B. P., 2015, FEVO, V3, P1; Wallace BP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29106-1	84	2	3	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232628	10.1371/journal.pone.0232628	http://dx.doi.org/10.1371/journal.pone.0232628			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407338	gold, Green Published			2022-12-26	WOS:000537490700027
J	Okorie-Kanu, OJ; Anyanwu, MU; Ezenduka, EV; Mgbeahuruike, AC; Thapaliya, D; Gerbig, G; Ugwuijem, EE; Okorie-Kanu, CO; Agbowo, P; Olorunleke, S; Nwanta, JA; Chah, KF; Smith, TC				Okorie-Kanu, Onyinye J.; Anyanwu, Madubuike U.; Ezenduka, Ekene V.; Mgbeahuruike, Anthony C.; Thapaliya, Dipendra; Gerbig, Gracen; Ugwuijem, Ejike E.; Okorie-Kanu, Christian O.; Agbowo, Philip; Olorunleke, Solomon; Nwanta, John A.; Chah, Kennedy F.; Smith, Tara C.			Molecular epidemiology, genetic diversity and antimicrobial resistance of Staphylococcus aureus isolated from chicken and pig carcasses, and carcass handlers	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; LIVESTOCK-ASSOCIATED MRSA; METHICILLIN-RESISTANT; NASAL CARRIAGE; UNITED-STATES; PREVALENCE; SPREAD; MEAT; SUSCEPTIBILITY; POPULATION	The epidemiology of Staphylococcus aureus in food animals, associated products, and their zoonotic potential in Nigeria are poorly understood. This study aimed to provide data on the prevalence, genetic characteristics and antimicrobial resistance of S. aureus isolated from chicken and pig carcasses, and persons in contact with the carcasses at slaughterhouses in Nigeria. Surface swabs were collected randomly from 600 chicken and 600 pig carcasses. Nasal swabs were collected from 45 workers in chicken slaughterhouses and 45 pig slaughterhouse workers. S. aureus isolates were analyzed by spa typing. They were also examined for presence of the Panton-Valentine Leucocidin (PVL) and mecA genes, as well as for antimicrobial resistance phenotype. Overall, 53 S. aureus isolates were recovered (28 from chicken carcasses, 17 from pig carcasses, 5 from chicken carcass handlers and 3 from pig carcass handlers). Among the isolates, 19 (35.8%) were PVL-positive and 12 (22.6%) carried the mecA gene. The 53 isolates belonged to 19 spa types. The Based Upon Repeat Pattern (BURP) algorithm separated the isolates into 2 spa-clonal complexes (spa-CC) and 9 singletons including 2 novel spa types (t18345 and t18346). The clonal complexes (CC) detected were CC1, CC5, CC8, CC15, CC88 and CC152. CC15-related isolates represented by spa type t084 (32.1%) and CC5 represented by spa type t311 (35.3%) predominated among isolates from chicken carcasses/handlers, and pig carcasses/handlers, respectively. Multidrug resistance exhibited by all the CC except CC8, was observed among isolates from chicken carcasses (64.3%), pig carcasses (41.2%), handlers of chicken meat (40.0%) and handlers of pork (33.3%). All the CC showed varying degrees of resistance to tetracycline while CC15 and CC5 exhibited the highest resistance to sulphamethoxazole/trimethoprim and erythromycin, respectively. The predominant antimicrobial resistance pattern observed was penicillin-tetracycline-sulphamethoxazole/trimethoprim (PEN-TETSXT). In conclusion, food animals processed in Enugu State in Southeast Nigeria are potential vehicles for transmission of PVL-positive multiple-drug resistant S. aureus and methicillin-resistant S. aureus from farm to slaughterhouse and potentially to the human population. Public health intervention programs at pre- and post-slaughter stages should be considered in Nigerian slaughterhouses.	[Okorie-Kanu, Onyinye J.; Ezenduka, Ekene V.; Agbowo, Philip; Olorunleke, Solomon; Nwanta, John A.] Univ Nigeria, Dept Vet Publ Hlth & Prevent Med, Nsukka, Enugu State, Nigeria; [Anyanwu, Madubuike U.; Mgbeahuruike, Anthony C.; Chah, Kennedy F.] Univ Nigeria, Dept Vet Microbiol & Pathol, Microbiol Unit, Nsukka, Enugu State, Nigeria; [Thapaliya, Dipendra; Gerbig, Gracen; Smith, Tara C.] Kent State Univ, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44242 USA; [Ugwuijem, Ejike E.] Univ Nigeria, Dept Microbiol, Nsukka, Enugu State, Nigeria; [Okorie-Kanu, Christian O.] Michael Okpara Univ Agr, Dept Vet Pathol, Umudike, Abia State, Nigeria	University of Nigeria; University of Nigeria; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of Nigeria	Okorie-Kanu, OJ (corresponding author), Univ Nigeria, Dept Vet Publ Hlth & Prevent Med, Nsukka, Enugu State, Nigeria.	onyinye.okoro@unn.edu.ng	Josephine, OKORIE-KANU/AAX-1025-2020; OLORUNLEKE, SOLOMON O/AAJ-9438-2021; Olorunleke, Solomon Olabiyi/AHE-8170-2022; Anyanwu, Madubuike/P-2818-2018	OLORUNLEKE, SOLOMON O/0000-0002-8512-5253; Olorunleke, Solomon Olabiyi/0000-0002-8512-5253; Okorie-Kanu, Onyinye/0000-0002-8836-9966; Anyanwu, Madubuike/0000-0002-2754-103X	University of Nigeria, Nsukka; Smith Emerging Infections Laboratory	University of Nigeria, Nsukka; Smith Emerging Infections Laboratory	This study was sponsored by the authors and partly supported by a grant received by OJO from the University of Nigeria, Nsukka through the "Needs Assessment Intervention fund" for Academic Staff Training and Development. We are also grateful to Smith Emerging Infections Laboratory for releasing materials for the work when the authors' funds and grant could no longer sustain the work.	Abdulgader SM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00348; Abdulrahman HI, 2018, ASIAN J RES ANIM VET, V1, P1; Abubakar U, 2018, J INFECT PUBLIC HEAL, V11, P763, DOI 10.1016/j.jiph.2018.05.013; Adesokan HK, 2015, ONDERSTEPOORT J VET, V82, DOI [10.4102/ojvr.v82i1.816, 10.4102/OJVR.V82I1.816]; Aires de Sousa M, 2006, J CLIN MICROBIOL, V44, P3790, DOI 10.1128/JCM.01192-06; Aires-De-Sousa M, 2017, CLIN MICROBIOL INFEC, V23, P373, DOI 10.1016/j.cmi.2016.11.002; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; AYENI FA, 2018, PEERJ, V6, DOI DOI 10.7717/PEERJ; Ayepola OO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137531; Ben Slama K, 2011, EUR J CLIN MICROBIOL, V30, P499, DOI 10.1007/s10096-010-1109-6; Bhatta DR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1531-1; Bosgelmez-Tinaz G, 2006, EUR J CLIN MICROBIOL, V25, P410, DOI 10.1007/s10096-006-0153-8; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P160, DOI 10.1111/j.1469-0691.2010.03219.x; Camargo CH, 2013, DIAGN MICR INFEC DIS, V76, P372, DOI 10.1016/j.diagmicrobio.2013.03.013; CLSI, 2022, CLIN LAB STAND I PER; CLSI, 2018, M07 CLSI, DOI DOI 10.1016/J.DIAGMICROBIO.2013.01.001; Cuny C, 2015, ANTIBIOTICS-BASEL, V4, P521, DOI 10.3390/antibiotics4040521; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; ECDC, 2020, ANN REPORT EUROPEAN; Egyir B, 2015, J GLOB ANTIMICROB RE, V3, P26, DOI 10.1016/j.jgar.2014.11.006; Egyir B, 2013, J GLOB ANTIMICROB RE, V1, P189, DOI 10.1016/j.jgar.2013.05.006; Egyir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089716; Ezenduka EV, 2011, TROP ANIM HEALTH PRO, V43, P557, DOI 10.1007/s11250-010-9730-z; Fall C, 2012, FOODBORNE PATHOG DIS, V9, P962, DOI 10.1089/fpd.2012.1197; Fang H, 2008, CLIN MICROBIOL INFEC, V14, P370, DOI 10.1111/j.1469-0691.2007.01941.x; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Gulani I. A., 2016, Journal of Advanced Veterinary and Animal Research, V3, P152, DOI 10.5455/javar.2016.c145; Hadyeh E, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00130; Ilczyszyn WM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151937; Islam TAB, 2015, TZU CHI MED J, V27, P10, DOI 10.1016/j.tcmj.2014.12.001; Jackson CR, 2013, J CLIN MICROBIOL, V51, P1199, DOI 10.1128/JCM.03166-12; Journals I., 2013, IOSR J, V5, P53, DOI [10.9790/2380-0535355, DOI 10.9790/2380-0535355]; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kong HS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00838; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Kwon NH, 2006, VET MICROBIOL, V117, P304, DOI 10.1016/j.vetmic.2006.05.006; Liao F, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1239-z; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lozano C, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4010012; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Makama SD, 2007, POPUL DEV REV, V33, P206; Masiuk H, 2010, J CLIN MICROBIOL, V48, P1527, DOI 10.1128/JCM.02094-09; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; McGuinness WA, 2017, YALE J BIOL MED, V90, P269; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Mkize N, 2017, J S AFR VET ASSOC, V88, DOI 10.4102/jsava.v88i0.1416; Momoh AH, 2018, TROP ANIM HEALTH PRO, V50, P1565, DOI 10.1007/s11250-018-1596-5; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168433; Monecke S, 2013, VET MICROBIOL, V162, P806, DOI 10.1016/j.vetmic.2012.10.018; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Mulders MN, 2010, EPIDEMIOL INFECT, V138, P743, DOI 10.1017/S0950268810000075; Nimmo GR, 2012, CLIN MICROBIOL INFEC, V18, P725, DOI 10.1111/j.1469-0691.2012.03822.x; NNACHI AU, 2014, EJPM, V2, P9, DOI DOI 10.11648/J.EJPM.20140201.12; Nulens E, 2008, J CLIN MICROBIOL, V46, P2438, DOI 10.1128/JCM.00808-08; Nworie A., 2013, MICROBIOL RES INT, V1, P48; Nworie A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2936461; O'Brien AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030092; O'Hara FP, 2016, MICROB DRUG RESIST, V22, P88, DOI 10.1089/mdr.2014.0238; Odetokun IA, 2018, VET MICROBIOL, V216, P52, DOI 10.1016/j.vetmic.2018.01.022; Okon KO, 2009, J CLIN MICROBIOL, V47, P3000, DOI 10.1128/JCM.01119-09; OKUNLOLA IO, 2015, EUR J EXP BIOL, V5, P50; Oloso NO, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061284; Otalu OJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03098; Raji A, 2013, DIAGN MICR INFEC DIS, V77, P367, DOI 10.1016/j.diagmicrobio.2013.08.030; Rolo J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006674; Ruffing U, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00214-8; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Seidl K, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0075-3; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Smith TC, 2018, MICROBES INFECT, V20, P323, DOI 10.1016/j.micinf.2018.05.004; Stewart-Johnson A, 2019, TROP ANIM HEALTH PRO, V51, P369, DOI 10.1007/s11250-018-1699-z; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Stryjewski ME, 2014, CLIN INFECT DIS, V58, pS10, DOI 10.1093/cid/cit613; Thapaliya D, 2017, FOOD MICROBIOL, V65, P122, DOI 10.1016/j.fm.2017.01.015; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; WHO, 2019, MOD LISTS ESS MED; Wu DD, 2018, INT J INFECT DIS, V71, P107, DOI 10.1016/j.ijid.2018.04.798; You JHS, 2017, ASIA-PAC J PUBLIC HE, V29, P451, DOI 10.1177/1010539517717365	84	12	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232913	10.1371/journal.pone.0232913	http://dx.doi.org/10.1371/journal.pone.0232913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407414	gold, Green Published			2022-12-26	WOS:000537490700047
J	Zhang, XL; Li, YP; Xing, QJ; Yue, LQ; Qi, HY				Zhang, Xiaolan; Li, Yuepeng; Xing, Qiaojuan; Yue, Lingqi; Qi, Hongyan			Genome-wide identification of mitogen-activated protein kinase (MAPK) cascade and expression profiling of CmMAPKs in melon (Cucumis melo L.)	PLOS ONE			English	Article							PHYTOALEXIN BIOSYNTHESIS; PLANT-GROWTH; ARABIDOPSIS; STRESS; PHOSPHORYLATION; RESPONSES; ABA; UPSTREAM; ETHYLENE; NETWORK	Mitogen-activated protein kinase (MAPK) is a form of serine/threonine protein kinase that activated by extracellular stimulation acting through the MAPK cascade (MAPKKK-MAPKK-MAPK). The MAPK cascade gene family, an important family of protein kinases, plays a vital role in responding to various stresses and hormone signal transduction processes in plants. In this study, we identified 14 CmMAPKs, 6 CmMAPKKs and 64 CmMAPKKKs in melon genome. Based on structural characteristics and a comparison of phylogenetic relationships of MAPK gene families from Arabidopsis, cucumber and watermelon, CmMAPKs and CmMAPKKs were categorized into 4 groups, and CmMAPKKKs were categorized into 3 groups. Furthermore, chromosome location revealed an unevenly distribution on chromosomes of MAPK cascade genes in melon, respectively. Eventually, qRT-PCR analysis showed that all 14 CmMAPKs had different expression patterns under drought, salt, salicylic acid (SA), methyl jasmonate (MeJA), red light (RL), and Podosphaera xanthii (P. xanthii) treatments. Overall, the expression levels of CmMAPK3 and CmMAPK7 under different treatments were higher than those in control. Our study provides an important basis for future functional verification of MAPK genes in regulating responses to stress and signal substance in melon.	[Zhang, Xiaolan; Li, Yuepeng; Xing, Qiaojuan; Yue, Lingqi; Qi, Hongyan] Shenyang Agr Univ, Coll Hort, Shenyang, Liaoning, Peoples R China; [Zhang, Xiaolan; Li, Yuepeng; Xing, Qiaojuan; Yue, Lingqi; Qi, Hongyan] Educ Minist & Liaoning prov, Key Lab Protected Hort, Shenyang, Liaoning, Peoples R China; [Zhang, Xiaolan; Li, Yuepeng; Xing, Qiaojuan; Yue, Lingqi; Qi, Hongyan] Northern Natl & Local Joint Engn Res Ctr Hort Fac, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Qi, HY (corresponding author), Shenyang Agr Univ, Coll Hort, Shenyang, Liaoning, Peoples R China.; Qi, HY (corresponding author), Educ Minist & Liaoning prov, Key Lab Protected Hort, Shenyang, Liaoning, Peoples R China.; Qi, HY (corresponding author), Northern Natl & Local Joint Engn Res Ctr Hort Fac, Shenyang, Liaoning, Peoples R China.	qihongyan@syau.edu.cn			National Natural Science Funding [31872131]; Agriculture Research System of China [CARS-25]	National Natural Science Funding(National Natural Science Foundation of China (NSFC)); Agriculture Research System of China	This research was supported by the National Natural Science Funding (31872131) and the Agriculture Research System of China (CARS-25).	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bi GZ, 2018, PLANT CELL, V30, P1543, DOI 10.1105/tpc.17.00981; Cakir B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00556; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226055; Chen T, 2012, PLANT CELL, V24, P823, DOI 10.1105/tpc.112.095984; Chung SW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220015; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Danquah A, 2015, PLANT J, V82, P232, DOI 10.1111/tpj.12808; de Zelicourt A, 2016, TRENDS PLANT SCI, V21, P677, DOI 10.1016/j.tplants.2016.04.004; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Doczi R, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00202; Furuya T, 2014, FEBS LETT, V588, P2025, DOI 10.1016/j.febslet.2014.04.032; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Genot B, 2017, PLANT PHYSIOL, V174, P1238, DOI 10.1104/pp.17.00378; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jiang M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1452-1; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Li FJ, 2017, NEW PHYTOL, V215, P1462, DOI 10.1111/nph.14680; Li H, 2017, DEV CELL, V43, P630, DOI 10.1016/j.devcel.2017.09.025; Liu S., 2001, MODERN PRACTICAL SOI; Ljaz B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.02139860213986; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Matsuoka D, 2018, PLANT BIOTECHNOL-NAR, V35, P171, DOI 10.5511/plantbiotechnology.18.0412a; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Nakagami H, 2006, J BIOL CHEM, V281, P38697, DOI 10.1074/jbc.M605293200; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Shi J, 2010, PLANT MOL BIOL, V74, P1, DOI 10.1007/s11103-010-9661-0; Singh R, 2014, PROTEOMICS, V14, P105, DOI 10.1002/pmic.201300125; Song QM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0681-4; Su JB, 2017, PLANT CELL, V29, P526, DOI 10.1105/tpc.16.00577; Sun MH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13627-2; Sun TJ, 2018, EMBO REP, V19, DOI 10.15252/embr.201745324; Takahashi Y, 2010, PLANT CELL PHYSIOL, V51, P1766, DOI 10.1093/pcp/pcq135; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thulasi DK, 2018, CELL MOL LIFE SCI, V75, P2981, DOI [10.1007/s00018-018-2839, DOI 10.1007/S00018-018-2839]; Virk N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133975; Wang C, 2018, MOL PLANT PATHOL, V19, P1624, DOI 10.1111/mpp.12635; Wang JY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1249-2; Xu J, 2008, J BIOL CHEM, V283, P26996, DOI 10.1074/jbc.M801392200; Xu J, 2016, PLANT CELL, V28, P1144, DOI 10.1105/tpc.15.00871; Yao Jian, 2015, Genomics and Applied Biology, V34, P2779; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang MM, 2018, CURR OPIN PLANT BIOL, V45, P1, DOI 10.1016/j.pbi.2018.04.012; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zhang T, 2006, PLANT PHYSIOL BIOCH, V44, P274, DOI 10.1016/j.plaphy.2006.06.004; Zhao FY, 2013, ENVIRON SCI POLLUT R, V20, P5449, DOI 10.1007/s11356-013-1559-3; Zhao YY, 2014, J EXP BOT, V65, P4907, DOI 10.1093/jxb/eru247; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029; Zong XJ, 2009, PLANTA, V229, P485, DOI 10.1007/s00425-008-0848-4	55	5	5	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232756	10.1371/journal.pone.0232756	http://dx.doi.org/10.1371/journal.pone.0232756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407323	gold, Green Published			2022-12-26	WOS:000537490700033
J	De la Garza-Salazar, F; Romero-Ibarguengoitia, ME; Rodriguez-Diaz, EA; Azpiri-Lopez, JR; Gonzalez-Cantu, A				De la Garza-Salazar, Fernando; Elena Romero-Ibarguengoitia, Maria; Abraham Rodriguez-Diaz, Elias; Ramon Azpiri-Lopez, Jose; Gonzalez-Cantu, Arnulfo			Improvement of electrocardiographic diagnostic accuracy of left ventricular hypertrophy using a Machine Learning approach	PLOS ONE			English	Article							ASSOCIATION; ABNORMALITIES; ECG; RECOMMENDATIONS; VALIDATION; STATEMENT; DISEASE; SYSTEM; RISK	The electrocardiogram (ECG) is the most common tool used to predict left ventricular hypertrophy (LVH). However, it is limited by its low accuracy (<60%) and sensitivity (30%). We set forth the hypothesis that the Machine Learning (ML) C5.0 algorithm could optimize the ECG in the prediction of LVH by echocardiography (Echo) while also establishing ECG-LVH phenotypes. We used Echo as the standard diagnostic tool to detect LVH and measured the ECG abnormalities found in Echo-LVH. We included 432 patients (power = 99%). Of these, 202 patients (46.7%) had Echo-LVH and 240 (55.6%) were males. We included a wide range of ventricular masses and Echo-LVH severities which were classified as mild (n = 77, 38.1%), moderate (n = 50, 24.7%) and severe (n = 75, 37.1%). Data was divided into a training/testing set (80%/20%) and we applied logistic regression analysis on the ECG measurements. The logistic regression model with the best ability to identify Echo-LVH was introduced into the C5.0 ML algorithm. We created multiple decision trees and selected the tree with the highest performance. The resultant five-level binary decision tree used only six predictive variables and had an accuracy of 71.4% (95%CI, 65.5-80.2), a sensitivity of 79.6%, specificity of 53%, positive predictive value of 66.6% and a negative predictive value of 69.3%. Internal validation reached a mean accuracy of 71.4% (64.4-78.5). Our results were reproduced in a second validation group and a similar diagnostic accuracy was obtained, 73.3% (95%CI, 65.5-80.2), sensitivity (81.6%), specificity (69.3%), positive predictive value (56.3%) and negative predictive value (88.6%). We calculated the Romhilt-Estes multilevel score and compared it to our model. The accuracy of the Romhilt-Estes system had an accuracy of 61.3% (CI95%, 56.5-65.9), a sensitivity of 23.2% and a specificity of 94.8% with similar results in the external validation group. In conclusion, the C5.0 ML algorithm surpassed the accuracy of current ECG criteria in the detection of Echo-LVH. Our new criteria hinge on ECG abnormalities that identify high-risk patients and provide some insight on electrogenesis in Echo-LVH.	[De la Garza-Salazar, Fernando; Elena Romero-Ibarguengoitia, Maria; Gonzalez-Cantu, Arnulfo] Univ Monterrey, Escuela Med, Especialidades Med, Monterrey, Nuevo Leon, Mexico; [De la Garza-Salazar, Fernando] Hosp Christus Muguerza Alta Especialidad, Dept Med Interna, Monterrey, Nuevo Leon, Mexico; [Elena Romero-Ibarguengoitia, Maria; Gonzalez-Cantu, Arnulfo] Hosp Christus Muguerza, Alta Especialdiad, Direcc Ensenanza & Invest Salud, Monterrey, Nuevo Leon, Mexico; [Abraham Rodriguez-Diaz, Elias; Ramon Azpiri-Lopez, Jose] Hosp Christus Muguerza, Alta Especialdiad, Dept Cardiol, Monterrey, Nuevo Leon, Mexico	Tecnologico de Monterrey; Universidad de Monterrey	Gonzalez-Cantu, A (corresponding author), Univ Monterrey, Escuela Med, Especialidades Med, Monterrey, Nuevo Leon, Mexico.; Gonzalez-Cantu, A (corresponding author), Hosp Christus Muguerza, Alta Especialdiad, Direcc Ensenanza & Invest Salud, Monterrey, Nuevo Leon, Mexico.	drgzzcantu@gmail.com	Gonzalez, Arnulfo/AAD-9873-2019	Romero-Ibarguengoitia, Maria Elena/0000-0002-2572-4043; De la Garza Salazar, Fernando/0000-0003-0080-487X; Gonzalez-Cantu, Arnulfo/0000-0003-0103-0079; Rodriguez Diaz, Elias Abraham/0000-0003-2551-1758				Auer R, 2012, JAMA-J AM MED ASSOC, V307, P1497, DOI 10.1001/jama.2012.434; Bacharova L, 2014, CURR CARDIOL REV, V10, P257, DOI 10.2174/1573403X10666140514103220; Bacharova L, 2011, J ELECTROCARDIOL, V44, P568, DOI 10.1016/j.jelectrocard.2011.06.005; Bacharova L, 2010, J ELECTROCARDIOL, V43, P197, DOI 10.1016/j.jelectrocard.2010.03.003; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Braunstein ED, 2019, WORLD J CARDIOL, V11, P94, DOI 10.4330/wjc.v11.i3.94; Brijain M., 2014, SURVEY DECISION TREE; CASALE PN, 1987, CIRCULATION, V75, P565, DOI 10.1161/01.CIR.75.3.565; CASALE PN, 1985, J AM COLL CARDIOL, V6, P572, DOI 10.1016/S0735-1097(85)80115-7; Cutler MJ, 2011, TRENDS PHARMACOL SCI, V32, P174, DOI 10.1016/j.tips.2010.12.001; Denes P, 2013, AM J CARDIOL, V112, P1667, DOI 10.1016/j.amjcard.2013.08.004; Estes EH, 2015, AM HEART J, V170, P1220, DOI 10.1016/j.ahj.2015.09.016; Hancock EW, 2009, CIRCULATION, V119, pE251, DOI 10.1161/CIRCULATIONAHA.108.191097; HUWEZ FU, 1992, BRIT HEART J, V67, P304; Kaiser W, 1996, J ELECTROCARDIOL, V29, P17, DOI 10.1016/S0022-0736(96)80004-5; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lewis T., 1909, HEART; Lu N, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0637-8; Luo W, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5870; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Ogah OS, 2008, CARDIOVASC J AFR, V19, P39; Okin PM, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007564; Pewsner D, 2007, BMJ-BRIT MED J, V335, P711, DOI 10.1136/bmj.39276.636354.AE; Rodrigues JCL, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0246-1; ROMHILT DW, 1968, AM HEART J, V75, P752, DOI 10.1016/0002-8703(68)90035-5; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Sundstrom J, 2001, CIRCULATION, V103, P2346; Zago Gabriel Tozatto, 2015, Res. Biomed. Eng., V31, P125, DOI 10.1590/2446-4740.0691	29	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232657	10.1371/journal.pone.0232657	http://dx.doi.org/10.1371/journal.pone.0232657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401764	Green Published, gold			2022-12-26	WOS:000537481000026
J	Giraldes, BW; Goodwin, C; Al-Fardi, NAA; Engmann, A; Leitao, A; Ahmed, AA; Ahmed, KO; Abdulkader, HA; Al-Korbi, HA; Al Easaid, HSS; Eltai, NOA; Hanifi-Moghaddam, P				Giraldes, Bruno Welter; Goodwin, Claire; Al-Fardi, Noora A. A.; Engmann, Amanda; Leitao, Alexandra; Ahmed, Asma A.; Ahmed, Kamelia O.; Abdulkader, Hadil A.; Al-Korbi, Halah A.; Al Easaid, Hala Sultan Saif; Eltai, Nahla O. Ahmed; Hanifi-Moghaddam, Pejman			Two new sponge species (Demospongiae: Chalinidae and Suberitidae) isolated from hyperarid mangroves of Qatar with notes on their potential antibacterial bioactivity	PLOS ONE			English	Article							MARINE SPONGES; PERSIAN-GULF; DRUGS; SEA; DECAPODA; BACTERIA; FAUNA	This study presents the taxonomic description of two new sponge species that are intimately associated with the hyperarid mangrove ecosystem of Qatar. The study includes a preliminary evaluation of the sponges' potential bioactivity against pathogens. Chalinula qatari sp. nov. is a fragile thinly encrusting sponge with a vivid maroon colour in life, often with oscular chimneys and commonly recorded on pneumatophores in the intertidal and shallow subtidal zone. Suberites luna sp. nov. is a massive globular-lobate sponge with a greenish-black colour externally and a yellowish orange colour internally, recorded on pneumatophores in the shallow subtidal zone, with large specimens near the seagrass ecosystem that surrounds the mangrove. For both species, a drug extraction protocol and an antibacterial experiment was performed. The extract of Suberites luna sp. nov. was found to be bioactive against recognized pathogens such as Staphylococcus epidermidis, Staphylococcus aureus and Enterococcus faecalis, but no bioactive activity was recorded for Chalinula qatari sp. nov. This study highlights the importance of increasing bioprospecting effort in hyperarid conditions and the importance of combining bioprospecting with taxonomic studies for the identification of novel marine drugs.	[Giraldes, Bruno Welter; Al-Fardi, Noora A. A.; Engmann, Amanda; Leitao, Alexandra] Qatar Univ, Ctr Environm Sci, Doha, Qatar; [Goodwin, Claire] Huntsman Marine Sci Ctr, St Andrews, NB, Canada; [Goodwin, Claire] Univ New Brunswick, St John, NB, Canada; [Ahmed, Asma A.; Ahmed, Kamelia O.; Abdulkader, Hadil A.; Al-Korbi, Halah A.; Hanifi-Moghaddam, Pejman] Qatar Univ, Coll Hlth Sci, Dept Biomed Sci, Doha, Qatar; [Al Easaid, Hala Sultan Saif] Qatar Univ, Coll Arts & Sci, Dept Chem & Earth Sci, Doha, Qatar; [Eltai, Nahla O. Ahmed] Qatar Univ QA, Biomed Res Ctr, Doha, Qatar	Qatar University; University of New Brunswick; Qatar University; Qatar University; Qatar University	Giraldes, BW (corresponding author), Qatar Univ, Ctr Environm Sci, Doha, Qatar.; Hanifi-Moghaddam, P (corresponding author), Qatar Univ, Coll Hlth Sci, Dept Biomed Sci, Doha, Qatar.	bweltergiraldes@qu.edu.qa; phanifi@gmail.com		Al Easa, Hala/0000-0002-1231-8126; Welter Giraldes, Bruno/0000-0002-6845-3183	Qatar National Library; Qatar National Research Fund (Qatar Foundation) [UREP21-141-3-032]	Qatar National Library(Qatar National Research Fund (QNRF)); Qatar National Research Fund (Qatar Foundation)(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	BWG -"The publication of this article was funded by the Qatar National Library. This publication was made possible by the UREP award [UREP21-141-3-032 "The potential antibacterial effect of the Marine Sponges of the Qatar Marine Zone"] from the Qatar National Research Fund (a member of Qatar Foundation). https://www.qnrf.org/en-us/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdillah S., 2013, J PHARM RES, V6, P685, DOI [10.1016/j.jopr.2013.07.001, DOI 10.1016/J.JOPR.2013.07.001, DOI 10.1016/J.J0PR.2013.07.001]; Al-Ansari EMAS, 2015, ESTUAR COAST SHELF S, V159, P60, DOI 10.1016/j.ecss.2015.03.022; Al-khayat J, 2020, REG STUD MAR SCI, DOI [10.1016/j.rsma.2020.101257, DOI 10.1016/J.RSMA.2020.101257]; Al-Maslamani I., 2015, INT J RES STUDIES BI, V3, P62; Ashrafi H, 2020, ZOOTAXA, V4747, P521, DOI 10.11646/zootaxa.4747.3.6; Becking L. E., 2009, Zoologische Mededelingen (Leiden), V83, P853; Becking LE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075996, 10.1371/journal.pone.0079276]; Beesoo R, 2017, COMP BIOCHEM PHYS C, V196, P81, DOI 10.1016/j.cbpc.2017.04.001; Bosch DT, 1995, SEASHELLS E ARABIA; Boury-Esnault N., 1997, SMITHSON CONTRIB ZOO, V596, P55, DOI DOI 10.5479/SI.00810282.596; Camp EF, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00433; Cutignano A, 2015, MAR DRUGS, V13, P5736, DOI 10.3390/md13095736; De Grave S, 2006, ZOOTAXA, P37, DOI 10.11646/zootaxa.1187.1.2; de Weerdt WH, 1867, SYSTEMA PORIFERA GUI; Dendy, 1922, T LINN SOC LOND, V7, P1, DOI 10.1111/j.1096-3642.1922.tb00547.x; Dewi AS, 2012, SQUALEN, V7, P97, DOI [10.15578/squalen.v7i3.6, DOI 10.15578/SQUALEN.V7I3.6]; Dodd RS, 1999, AQUAT BOT, V63, P291, DOI 10.1016/S0304-3770(98)00124-7; Dyshlovoy SA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/469309; Erpenbeck D, 2016, MAR POLLUT BULL, V105, P507, DOI 10.1016/j.marpolbul.2015.12.004; Gaonkar CA, 2010, INDIAN J MAR SCI, V39, P74; Giraldes Bruno Welter, 2016, Egyptian Journal of Aquatic Research, V42, P111; Giraldes BW, 2017, ZOOTAXA, V4250, P389, DOI 10.11646/zootaxa.4250.4.9; Giray B, 2020, J OBSTET GYNAECOL, V40, P406, DOI 10.1080/01443615.2019.1633517; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; Harvey A, 2000, DRUG DISCOV TODAY, V5, P294, DOI 10.1016/S1359-6446(00)01511-7; Hooper JN, 2002, GUIDE CLASSIFICATION; HOPKINS SEWELL H., 1956, BULL MARINE SCI GULF AND CARIBBEAN, V6, P44; Kijjoa A., 2004, MAR DRUGS, V2, P73, DOI [DOI 10.3390/MD202073, https://doi.org/10.3390/md202073, 10.3390/md202073]; Larghi EL, 2009, TETRAHEDRON, V65, P4257, DOI 10.1016/j.tet.2009.03.027; Leal MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030580; Marinho PR, 2010, REV BRAS FARMACOGN, V20, P267, DOI 10.1590/S0102-695X2010000200022; MULLER WEG, 1995, NATURWISSENSCHAFTEN, V82, P321; Naderloo R., 2017, ATLAS CRABS PERSIAN; Najafi A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01500; Nazemi M, 2014, J MYCOL MED, V24, P220, DOI 10.1016/j.mycmed.2014.03.005; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Penesyan A, 2010, MAR DRUGS, V8, P438, DOI 10.3390/md8030438; Picton BE, 2007, SPONGES BRITAIN IREL, DOI [10.3390/md13095736, DOI 10.3390/MD13095736]; PRICE ARG, 1982, J NAT HIST, V16, P519, DOI 10.1080/00222938200770421; PROKSCH P, 1994, TOXICON, V32, P639, DOI 10.1016/0041-0101(94)90334-4; Proksch P., 2003, MAR DRUGS, V1, P5, DOI [DOI 10.3390/MD101005, 10.3390/md101005]; Pulitzer-Finali G., 1993, ANN MUSEO CIVICO STO, V89, P247; Richmond Matthew, 1997, GUIDE SEASHORES E AF; Ridley SO, 1884, REPORT ZOOLOGICAL CO; Riegl B.M., 2012, CORAL REEFS GULF, V3, DOI [10.1007/978-94-007-3008-3_1, DOI 10.1007/978-94-007-3008-3_1]; Samaai T, NEW SPECIES HABITAT; Seradj H., 2012, IRANIAN J PHARM SCI, V8, P249; Shaari K, 2009, MAR DRUGS, V7, P1, DOI 10.3390/md7010001; Sheppard Charles, 2012, P349; Sipkema D, 2005, BIOTECHNOL BIOENG, V90, P201, DOI 10.1002/bit.20404; Soest R. W. M. van, 2002, SYSTEMA PORIFERA GUI, P227, DOI DOI 10.1007/978-1-4615-0747-5_; Teraminami T, 2014, LANDSC ECOL ENG, V10, P285, DOI 10.1007/s11355-013-0224-9; Teta R, 2012, MAR DRUGS, V10, P1383, DOI 10.3390/md10061383; Thomas P.A., 1986, Journal of the Marine Biological Association of India, V22, P8; Thomas P.A., 1973, Annales Mus r Afr cent (Ser 8 Sci zool), VNo. 203, P1; Vacelet J, 2001, J MAR BIOL ASSOC UK, V81, P943, DOI 10.1017/S0025315401004878; van Soest R.W.M., 2008, Zoologische Mededelingen (Leiden), V82, P749; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; VANSOEST RWM, 1989, NETH J SEA RES, V23, P223, DOI 10.1016/0077-7579(89)90016-1; VOGEL S, 1977, P NATL ACAD SCI USA, V74, P2069, DOI 10.1073/pnas.74.5.2069; von Salm JL, 2016, ORG LETT, V18, P2596, DOI 10.1021/acs.orglett.6b00979; Walton MEM, 2014, MAR ECOL PROG SER, V507, P125, DOI 10.3354/meps10827; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42	63	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232205	10.1371/journal.pone.0232205	http://dx.doi.org/10.1371/journal.pone.0232205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401792	Green Published, gold			2022-12-26	WOS:000537481000009
J	Audibert, S; Tanguy-le-Gac, N; Rech, J; Turlan, C; Bouet, JY; Bystricky, K; Lane, D				Audibert, Sylvain; Tanguy-le-Gac, Nicolas; Rech, Jrme; Turlan, Catherine; Bouet, Jean-Yves; Bystricky, Kerstin; Lane, David			Addressing the role of centromere sites in activation of ParB proteins for partition complex assembly	PLOS ONE			English	Article							PLASMID PARTITION; ESCHERICHIA-COLI; P1 PLASMID; EFFECTOR NUCLEASES; DNA-BINDING; IN-VITRO; SEGREGATION; GENE; CHROMOSOME; SEQUENCE	The ParB-parS partition complexes that bacterial replicons use to ensure their faithful inheritance also find employment in visualization of DNA loci, as less intrusive alternatives to fluorescent repressor-operator systems. The ability of ParB molecules to interact via their Nterminal domains and to bind to non-specific DNA enables expansion of the initial complex to a size both functional in partition and, via fusion to fluorescent peptides, visible by light microscopy. We have investigated whether it is possible to dispense with the need to insert parS in the genomic locus of interest, by determining whether ParB fused to proteins that bind specifically to natural DNA sequences can still assemble visible complexes. In yeast cells, coproduction of fusions of ParB to a fluorescent peptide and to a TALE protein targeting an endogenous sequence did not yield visible foci; nor did any of several variants of these components. In E.coli, coproduction of fusions of SopB (F plasmid ParB) to fluorescent peptide, and to dCas9 together with specific guide RNAs, likewise yielded no foci. The result of coproducing analogous fusions of SopB proteins with distinct binding specificities was also negative. Our observations imply that in order to assemble higher order partition complexes, ParB proteins need specific activation through binding to their cognate parS sites.	[Audibert, Sylvain; Tanguy-le-Gac, Nicolas; Bystricky, Kerstin] Univ Toulouse UPS, CNRS, Ctr Biol Integrat CBI, Lab Biol Mol Eucaryote LBME, Toulouse, France; [Rech, Jrme; Turlan, Catherine; Bouet, Jean-Yves; Lane, David] UPS, Lab Microbiol & Genet Mol LMGM, CBI, CNRS, Toulouse, France; [Bystricky, Kerstin] Inst Univ France IUF, Paris, France; [Audibert, Sylvain] Genome Damage & Stabil, Brighton, E Sussex, England	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut Universitaire de France	Lane, D (corresponding author), UPS, Lab Microbiol & Genet Mol LMGM, CBI, CNRS, Toulouse, France.	dave@ibcg.biotoul.fr	Bouet, Jean-Yves/H-8469-2019; Bystricky, Kerstin/B-8670-2009	Bouet, Jean-Yves/0000-0003-1488-5455; Lane, David/0000-0002-8656-4725; Audibert, Sylvain/0000-0002-4414-1345; Bystricky, Kerstin/0000-0001-6717-3721	IBM; Agence Nationale de la Recherche; SPAREDAM, ANDY	IBM(International Business Machines (IBM)); Agence Nationale de la Recherche(French National Research Agency (ANR)); SPAREDAM, ANDY	JYB; IBM; Agence Nationale de la Recherche KB; SPAREDAM, ANDY; Agence Nationale de la Recherche https://anr.fr/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Seng Y, 2009, J BIOL CHEM, V284, P30067, DOI 10.1074/jbc.M109.044800; Bartosik AA, 2004, J BACTERIOL, V186, P6983, DOI 10.1128/JB.186.20.6983-6998.2004; Bingle LEH, 2005, J MOL BIOL, V349, P302, DOI 10.1016/j.jmb.2005.03.062; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; Bouet JY, 2009, J BIOL CHEM, V284, P165, DOI 10.1074/jbc.M802752200; Bouet JY, 2005, MOL MICROBIOL, V55, P511, DOI 10.1111/j.1365-2958.2004.04396.x; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Broedersz CP, 2014, P NATL ACAD SCI USA, V111, P8809, DOI 10.1073/pnas.1402529111; CARO L, 1969, J MOL BIOL, V45, P325, DOI 10.1016/0022-2836(69)90108-9; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Debaugny RE, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188516; Diaz R, 2015, PLASMID, V80, P54, DOI 10.1016/j.plasmid.2015.03.007; Erdmann N, 1999, P NATL ACAD SCI USA, V96, P14905, DOI 10.1073/pnas.96.26.14905; Fisher GL, 2017, ELIFE, P6; Funnell BE, 2005, PLASMID, V53, P119, DOI 10.1016/j.plasmid.2004.12.009; Germier T, 2017, BIOPHYS J, V113, P1383, DOI 10.1016/j.bpj.2017.08.014; Gordon GS, 1997, CELL, V90, P1113, DOI 10.1016/S0092-8674(00)80377-3; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Hanai R, 1996, J BIOL CHEM, V271, P17469, DOI 10.1074/jbc.271.29.17469; Hao JJ, 2002, J BACTERIOL, V184, P4857, DOI 10.1128/JB.184.17.4857-4867.2002; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hyde EI, 2017, BIOCHEM J, V474, P3121, DOI 10.1042/BCJ20170281; Khare D, 2004, NAT STRUCT MOL BIOL, V11, P656, DOI 10.1038/nsmb773; Kusiak M, 2011, J BACTERIOL, V193, P3342, DOI 10.1128/JB.00328-11; LANE D, 1994, J MOL BIOL, V242, P339, DOI 10.1006/jmbi.1994.1585; Lassadi I, 2015, PLOS COMPUTATIONAL B; Lemonnier M, 1998, MICROBIOL-SGM, V144, P751, DOI 10.1099/00221287-144-3-751; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li YF, 2002, MOL MICROBIOL, V46, P63, DOI 10.1046/j.1365-2958.2002.03156.x; Lobocka M, 1996, J MOL BIOL, V259, P366, DOI 10.1006/jmbi.1996.0326; Lukaszewicz M, 2002, NUCLEIC ACIDS RES, V30, P1046, DOI 10.1093/nar/30.4.1046; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mariame B, 2018, J VIROL, V92, P22; Olins DE, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180058; Osorio-Valeriano M, 2019, CELL, V179, P1512, DOI 10.1016/j.cell.2019.11.015; Pillet F, 2011, NUCLEIC ACIDS RES, V39, P7477, DOI 10.1093/nar/gkr457; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Radnedge L, 1998, EMBO J, V17, P6076, DOI 10.1093/emboj/17.20.6076; Ravin N, 1999, J BACTERIOL, V181, P6898, DOI 10.1128/JB.181.22.6898-6906.1999; Ravin NV, 2003, J MOL BIOL, V329, P875, DOI 10.1016/S0022-2836(03)00525-4; Ravin V, 2000, J MOL BIOL, V299, P53, DOI 10.1006/jmbi.2000.3731; Rodionov O, 2004, MOL MICROBIOL, V52, P1215, DOI 10.1111/j.1365-2958.2004.04055.x; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Saad H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004187; Sanchez A, 2015, CELL SYST, V1, P163, DOI 10.1016/j.cels.2015.07.013; Sanchez A, 2013, NUCLEIC ACIDS RES, V41, P3094, DOI 10.1093/nar/gkt018; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2010, NUCLEIC ACIDS RES, V38, P4514, DOI 10.1093/nar/gkq161; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Soh YM, 2019, SCIENCE, V366, P1129, DOI 10.1126/science.aay3965; Song D, 2017, NUCLEIC ACIDS RES, V45, P7106, DOI 10.1093/nar/gkx271; Surtees JA, 1999, J BACTERIOL, V181, P5898, DOI 10.1128/JB.181.19.5898-5908.1999; van Raaphorst R, 2017, P NATL ACAD SCI USA, V114, pE5959, DOI 10.1073/pnas.1620608114; XIA GX, 1993, J BACTERIOL, V175, P4165, DOI 10.1128/JB.175.13.4165-4175.1993; Yates P, 1999, J MOL BIOL, V290, P627, DOI 10.1006/jmbi.1999.2909; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	60	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0226472	10.1371/journal.pone.0226472	http://dx.doi.org/10.1371/journal.pone.0226472			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379828	Green Published, gold			2022-12-26	WOS:000537285700006
J	Kang, SH; Lee, WH; Lee, CM; Sim, JS; Won, SY; Han, SR; Kwon, SJ; Kim, JS; Kim, CK; Oh, TJ				Kang, Sang-Ho; Lee, Woo-Haeng; Lee, Chang-Muk; Sim, Joon-Soo; Won, So Youn; Han, So-Ra; Kwon, Soo-Jin; Kim, Jung Sun; Kim, Chang-Kug; Oh, Tae-Jin			De novo transcriptome sequence of Senna tora provides insights into anthraquinone biosynthesis	PLOS ONE			English	Article							CASSIA-TORA; GENE-EXPRESSION; SEEDS; GENERATION; ALIGNMENT; PROTEIN; ENZYME; CELLS; RHEIN; TOOL	Senna tora is an annual herb with rich source of anthraquinones that have tremendous pharmacological properties. However, there is little mention of genetic information for this species, especially regarding the biosynthetic pathways of anthraquinones. To understand the key genes and regulatory mechanism of anthraquinone biosynthesis pathways, we performed spatial and temporal transcriptome sequencing of S. tora using short RNA sequencing (RNA-Seq) and long-read isoform sequencing (Iso-Seq) technologies, and generated two unigene sets composed of 118,635 and 39,364, respectively. A comprehensive functional annotation and classification with multiple public databases identified array of genes involved in major secondary metabolite biosynthesis pathways and important transcription factor (TF) families (MYB, MYB-related, AP2/ERF, C2C2-YABBY, and bHLH). Differential expression analysis indicated that the expression level of genes involved in anthraquinone biosynthetic pathway regulates differently depending on the degree of tissues and seeds development. Furthermore, we identified that the amount of anthraquinone compounds were greater in late seeds than early ones. In conclusion, these results provide a rich resource for understanding the anthraquinone metabolism in S. tora.	[Kang, Sang-Ho; Won, So Youn; Kwon, Soo-Jin; Kim, Jung Sun; Kim, Chang-Kug] RDA, Natl Inst Agr Sci, Genom Div, Jeonju, South Korea; [Lee, Woo-Haeng; Han, So-Ra; Oh, Tae-Jin] SunMoon Univ, Dept Life Sci & Biochem Engn, Asan, South Korea; [Lee, Chang-Muk; Sim, Joon-Soo] RDA, Natl Inst Agr Sci, Metab Engn Div, Jeonju, South Korea; [Oh, Tae-Jin] Genome Based BioIT Convergence Inst, Asan, South Korea; [Oh, Tae-Jin] SunMoon Univ, Dept Pharmaceut Engn & Biotechnol, Asan, South Korea	National Institute of Agricultural Sciences; Rural Development Administration (RDA); Sun Moon University; National Institute of Agricultural Sciences; Rural Development Administration (RDA); Sun Moon University	Kang, SH; Kim, CK (corresponding author), RDA, Natl Inst Agr Sci, Genom Div, Jeonju, South Korea.; Oh, TJ (corresponding author), SunMoon Univ, Dept Life Sci & Biochem Engn, Asan, South Korea.; Oh, TJ (corresponding author), Genome Based BioIT Convergence Inst, Asan, South Korea.; Oh, TJ (corresponding author), SunMoon Univ, Dept Pharmaceut Engn & Biotechnol, Asan, South Korea.	hosang93@korea.kr; chang@korea.kr; tjoh3782@sunmoon.ac.kr	Kim, Jung Sun/AAB-6974-2020	Kang, Sang-Ho/0000-0002-3795-2780	National Institute of Agricultural Sciences [PJ013818, PJ010457]; Cooperative Research Program for Agriculture Science and Technology Development [PJ013818, PJ010457]; Cooperative Research Program for Agriculture Science and Technology Development [Project title: National Agricultural Genome Program], Rural Development Administration, Republic of Korea [PJ010457]	National Institute of Agricultural Sciences; Cooperative Research Program for Agriculture Science and Technology Development(Rural Development Administration (RDA), Republic of Korea); Cooperative Research Program for Agriculture Science and Technology Development [Project title: National Agricultural Genome Program], Rural Development Administration, Republic of Korea	SHK received the award, Grant numbers: PJ013818 and PJ010457, Full name of each funder: National Institute of Agricultural Sciences and Cooperative Research Program for Agriculture Science and Technology Development, URL: www.naas.go.kr and www.rda.go.kr, No: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was carried out with the support of National Institute of Agricultural Sciences [Project no. PJ013818] and Cooperative Research Program for Agriculture Science and Technology Development [Project title: National Agricultural Genome Program, Project no. PJ010457], Rural Development Administration, Republic of Korea.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Au KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046679; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Azelmat J, 2015, ARCH ORAL BIOL, V60, P342, DOI 10.1016/j.archoralbio.2014.11.006; Baba SA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1894-5; Chien SC, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/357357; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; D'Agostino N, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-53; Deng Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092476; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Gonzalez-Garay ML, 2016, TRANSCRIPTOMICS GENE; Gordon SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132628; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Hyun SK, 2009, PHYTOTHER RES, V23, P178, DOI 10.1002/ptr.2579; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; Jain R, 2010, ASIAN J CHEM, V22, P7585; Jang DS, 2007, BIOL PHARM BULL, V30, P2207, DOI 10.1248/bpb.30.2207; Jo IH, 2017, GENES-BASEL, V8, DOI 10.3390/genes8090228; Kang SH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208344; Kim M, 2015, J AGR FOOD CHEM, V63, P9037, DOI 10.1021/acs.jafc.5b03836; Kim YM, 2004, J AGR FOOD CHEM, V52, P6096, DOI 10.1021/jf049379p; Kufner Isabell, 2008, BMC Res Notes, V1, P43, DOI 10.1186/1756-0500-1-43; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.31; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Link M, 2004, FEBS LETT, V573, P105, DOI 10.1016/j.febslet.2004.07.062; Liu J, 2012, J EXP BOT, V63, P3727, DOI 10.1093/jxb/ers066; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Omidbakhshfard MA, 2015, MOL PLANT, V8, P998, DOI 10.1016/j.molp.2015.01.013; Pandith SA, 2016, PLANT PHYSIOL, V171, P2599, DOI 10.1104/pp.16.00003; Panigrahi GK, 2016, TOXICOL LETT, V245, P15, DOI 10.1016/j.toxlet.2016.01.006; Panigrahi GK, 2015, CHEM RES TOXICOL, V28, P1120, DOI 10.1021/acs.chemrestox.5b00056; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Patil UK, 2004, J ETHNOPHARMACOL, V90, P249, DOI 10.1016/j.jep.2003.10.007; Pawar HA, 2011, INT J PHARM SCI RES, V2, P2286, DOI 10.13040/IJPSR.0975-8232.2(9).2286-91; Pouladi N, 2016, Yearb Med Inform, P194; Reddy NRR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129422; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Schmieder R, 2012, BIOINFORMATICS, V28, P433, DOI 10.1093/bioinformatics/btr669; Shukla S. K., 2013, Online Journal of Biological Sciences, V13, P13; Smita Jain, 2010, Indian Journal of Natural Products and Resources, V1, P430; WONG SM, 1989, PLANTA MED, P276, DOI 10.1055/s-2006-962003; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Yen GC, 1999, J AGR FOOD CHEM, V47, P1326, DOI 10.1021/jf9810618; Zhang DF, 2008, PLANT SCI, V175, P809, DOI 10.1016/j.plantsci.2008.08.002; Zhao X, 2013, ONCOL LETT, V5, P1036, DOI 10.3892/ol.2012.1097	50	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0225564	10.1371/journal.pone.0225564	http://dx.doi.org/10.1371/journal.pone.0225564			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32380515	Green Published, Green Submitted, gold			2022-12-26	WOS:000537285700003
J	Hsia, Y; Ho, TC; Yang, CH; Hsieh, YT; Lai, TT; Yang, CM				Hsia, Yun; Ho, Tzyy-Chang; Yang, Chang-Hao; Hsieh, Yi-Ting; Lai, Tso-Ting; Yang, Chung-May			Clinical characteristics and long-term evolution of lamellar macular hole in high myopia	PLOS ONE			English	Article							RETINAL-DETACHMENT; NATURAL COURSE; FOLLOW-UP; TRACTION; VITRECTOMY; RETINOSCHISIS; FOVEOSCHISIS; EYES	Purpose To evaluate the clinical characteristics and evolution of lamellar macular hole (LMH) in high myopia and the parameters associated with structural worsening, defined as the development of foveal detachment or full-thickness macular hole. Methods Patients with high myopia and LMH were retrospectively recruited. The clinical characteristics and various parameters of optical coherence tomography were identified at baseline and during follow-up visits. Cox regression analysis was used to evaluate the hazard ratios for foveal detachment and full-thickness macular hole. Results Among 112 eyes (98 patients), 64.3% were female; the mean axial length of all eyes was 29.6 +/- 1.9 mm. The `LMH without retinoschisis' group accounted for 39.3% of the eyes. Forty-two percent developed structural worsening within a median follow-up of 67 months. Multivariable regression on all cases showed elevated tissue inside the LMH (P = 0.003) protected against structural worsening while V-shaped LMH (P = 0.006) predicted it. In the "LMH with retinoschisis group", ellipsoid zone disruption (P = 0.035), and V-shaped LMH (P = 0.014) predicted structural worsening, while elevated tissue inside the LMH (P = 0.028) protected against it. In the "LMH without retinoschisis group", no associated factor was identified. Conclusions LMHs in high myopia are unstable, especially those with V-shaped LMH. Elevated tissue inside LMHs have a protective effect against further structural worsening.	[Hsia, Yun; Ho, Tzyy-Chang; Yang, Chang-Hao; Hsieh, Yi-Ting; Lai, Tso-Ting; Yang, Chung-May] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Yang, Chang-Hao; Yang, Chung-May] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Lai, Tso-Ting] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Yang, CM (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.; Yang, CM (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	chungmay@ntu.edu.tw	Yang, Chung-May/AAV-3737-2020; Yang, Chang-Hao/AAR-3759-2021	YANG, CHANG-HAO/0000-0002-4328-8716; Lai, Tso-Ting/0000-0002-8247-7018; YANG, CHUNG-MAY/0000-0003-4082-420X; Hsia, Yun/0000-0001-6972-7732				Chen QY, 2019, AM J OPHTHALMOL, V208, P356, DOI 10.1016/j.ajo.2019.07.010; Chen SN, 2016, AM J OPHTHALMOL, V162, P99, DOI 10.1016/j.ajo.2015.11.013; Cheng C, 2016, RETINA-J RET VIT DIS, V36, P717, DOI 10.1097/IAE.0000000000000757; dell'Omo R, 2018, GRAEF ARCH CLIN EXP, V256, P1281, DOI 10.1007/s00417-018-3995-8; Duker JS, 2013, OPHTHALMOLOGY, V120, P2611, DOI 10.1016/j.ophtha.2013.07.042; Gaucher D, 2007, AM J OPHTHALMOL, V143, P455, DOI 10.1016/j.ajo.2006.10.053; Gohil R, 2015, EYE, V29, P593, DOI 10.1038/eye.2014.311; Govetto A, 2016, AM J OPHTHALMOL, V164, P99, DOI 10.1016/j.ajo.2016.02.008; Hattori K, 2018, RETINA-J RET VIT DIS, V38, pS23, DOI 10.1097/IAE.0000000000001927; Ho TC, 2018, ACTA OPHTHALMOL, V96, pE46, DOI 10.1111/aos.13514; Ho TC, 2014, RETINA-J RET VIT DIS, V34, P1833, DOI 10.1097/IAE.0000000000000149; Ikuno Y, 2017, RETINA-J RET VIT DIS, V37, P2347, DOI 10.1097/IAE.0000000000001489; Lai TT, 2018, RETINA-J RET VIT DIS, V38, P1316, DOI 10.1097/IAE.0000000000001708; Lin CW, 2015, EYE, V29, P388, DOI 10.1038/eye.2014.312; Pang CE, 2014, RETINA-J RET VIT DIS, V34, P1513, DOI 10.1097/IAE.0000000000000163; Panozzo G, 2004, ARCH OPHTHALMOL-CHIC, V122, P1455, DOI 10.1001/archopht.122.10.1455; Panozzo G, 2007, ARCH OPHTHALMOL-CHIC, V125, P767, DOI 10.1001/archopht.125.6.767; Purtskhvanidze K, 2018, GRAEF ARCH CLIN EXP, V256, P1067, DOI 10.1007/s00417-018-3972-2; Rino F, 2016, GRAEF ARCH CLIN EXP, V254, P2141, DOI 10.1007/s00417-016-3371-5; Shimada N, 2013, AM J OPHTHALMOL, V156, P948, DOI 10.1016/j.ajo.2013.06.031; Sun CB, 2010, EYE, V24, P1787, DOI 10.1038/eye.2010.123; Tanaka Y, 2011, AM J OPHTHALMOL, V152, P96, DOI 10.1016/j.ajo.2011.01.021; Wang SW, 2019, EYE, V33, P1305, DOI 10.1038/s41433-019-0424-0	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232852	10.1371/journal.pone.0232852	http://dx.doi.org/10.1371/journal.pone.0232852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374792	Green Published, gold			2022-12-26	WOS:000537283500064
J	Raveendran, RN; Tsang, K; Tiwana, D; Chow, A; Thompson, B				Raveendran, Rajkumar Nallour; Tsang, Katelyn; Tiwana, Dilraj; Chow, Amy; Thompson, Benjamin			Anodal transcranial direct current stimulation reduces collinear lateral inhibition in normal peripheral vision	PLOS ONE			English	Article							VISUAL-CORTEX; MOTOR CORTEX; TDCS; SUPPRESSION; AMBLYOPIA; FACILITATION; MODULATION; MECHANISMS; ATTENTION	Collinear flanking stimuli can reduce the detectability of a Gabor target presented in peripheral vision. This phenomenon is called collinear lateral inhibition and it may contribute to crowding in peripheral vision. Perceptual learning can reduce collinear lateral inhibition in peripheral vision, however intensive training is required. Our aim was to assess whether modulation of collinear lateral inhibition can be achieved within a short time-frame using a single 20-minute session of primary visual cortex anodal transcranial direct current stimulation (a-tDCS). Thirteen observers with normal vision performed a 2AFC contrast detection task with collinear flankers positioned at a distance of 2. from the target (lateral inhibition) or 6. (control condition). The stimuli were presented 6 degrees to the left of a central cross and fixation was monitored with an infra-red eye tracker. Participants each completed two randomly sequenced, single-masked stimulation sessions; real anodal tDCS and sham tDCS. For the 2. separation condition, a-tDCS induced a significant reduction in detection threshold (reduced lateral inhibition). Sham stimulation had no effect. No effects of a-tDCS were observed for the 6. separation condition. This result lays the foundation for future work investigating whether a-tDCS may be useful as a visual rehabilitation tool for individuals with central vision loss who are reliant on peripheral vision.	[Raveendran, Rajkumar Nallour] Envision Res Inst, Wichita, KS 67203 USA; [Raveendran, Rajkumar Nallour; Tsang, Katelyn; Tiwana, Dilraj; Chow, Amy; Thompson, Benjamin] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada	University of Waterloo	Raveendran, RN (corresponding author), Envision Res Inst, Wichita, KS 67203 USA.; Raveendran, RN (corresponding author), Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada.	sachinrajopto@gmail.com		Tsang, Katelyn/0000-0001-9260-8483; Nallour Raveendran, Rajkumar/0000-0003-1536-6358	Envision Postdoctoral research fellowship by LC Industries; NSERC grants [RPIN-05394, RGPAS-477166]	Envision Postdoctoral research fellowship by LC Industries; NSERC grants	RNR - Envision Postdoctoral research fellowship by LC Industries. BT: NSERC grants RPIN-05394 and RGPAS-477166. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonenko D, 2017, J NEUROSCI, V37, P4065, DOI 10.1523/JNEUROSCI.0079-17.2017; Behrens JR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00238; Bonder T, 2018, FRONT PSYCHOL, V9, DOI [10.3389/fpsyg.2078.00159, 10.3389/fpsyg.2018.00159]; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Chen J, 2014, J NEUROSCI, V34, P10465, DOI 10.1523/JNEUROSCI.1140-14.2014; Cheung SH, 2005, VISUAL NEUROSCI, V22, P187, DOI 10.1017/S0952523805222071; Chung STL, 2007, J VISION, V7, DOI 10.1167/7.2.10; Chung STL, 2007, VISION RES, V47, P3150, DOI 10.1016/j.visres.2007.08.017; Contemori G, 2019, NEUROPSYCHOLOGIA, V125, P129, DOI 10.1016/j.neuropsychologia.2019.02.001; Ding ZF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19280; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; Fletcher DC, 1997, OPHTHALMOLOGY, V104, P632, DOI 10.1016/S0161-6420(97)30260-7; Freeman E, 2001, NAT NEUROSCI, V4, P1032, DOI 10.1038/nn728; Kim S, 2014, NEUROIMAGE, V99, P237, DOI 10.1016/j.neuroimage.2014.05.070; Kiorpes L, 2006, STRABISMUS, V14, P3, DOI 10.1080/09273970500536193; Lev M, 2015, J VISION, V15, DOI 10.1167/15.13.10; Lev M, 2011, VISION RES, V51, P2488, DOI 10.1016/j.visres.2011.10.008; Levi DM, 2006, STRABISMUS, V14, P11, DOI 10.1080/09273970500536243; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Levi DM, 2011, CURR BIOL, V21, pR678, DOI 10.1016/j.cub.2011.07.025; Levi DM, 2009, VISION RES, V49, P2535, DOI 10.1016/j.visres.2009.02.010; Lu ZL, 2009, PERCEPTION, V38, P11; Maniglia M, 2019, BRAIN STRUCT FUNCT, V224, P3399, DOI 10.1007/s00429-019-01964-z; Maniglia M, 2018, CURR OPIN BEHAV SCI, V20, P47, DOI 10.1016/j.cobeha.2017.10.004; Maniglia M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18261-6; Maniglia M, 2016, RESTOR NEUROL NEUROS, V34, P697, DOI 10.3233/RNN-150575; Maniglia M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15530; Maniglia M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025568; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; PEIRCE JW, 2009, FRONTIERS, V2, DOI DOI 10.3389/NEURO.11.010.2008; Pelli DG, 2008, CURR OPIN NEUROBIOL, V18, P445, DOI 10.1016/j.conb.2008.09.008; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Pirulli C, 2013, BRAIN STIMUL, V6, P683, DOI 10.1016/j.brs.2012.12.005; Polat U, 1996, VISION RES, V36, P2099, DOI 10.1016/0042-6989(95)00281-2; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Reinhart RMG, 2017, ATTEN PERCEPT PSYCHO, V79, P3, DOI 10.3758/s13414-016-1224-2; Reinhart RMG, 2016, CURR BIOL, V26, P1867, DOI 10.1016/j.cub.2016.05.019; Rushmore RJ, 2013, EUR J NEUROSCI, V38, P3799, DOI 10.1111/ejn.12373; Schwarzkopf DS, 2011, J NEUROSCI, V31, P3143, DOI 10.1523/JNEUROSCI.4863-10.2011; Shani R, 2005, VISION RES, V45, P2009, DOI 10.1016/j.visres.2005.01.024; Spiegel DP, 2013, NEUROTHERAPEUTICS, V10, P831, DOI 10.1007/s13311-013-0200-y; Spiegel DP, 2013, NEUROREHAB NEURAL RE, V27, P760, DOI 10.1177/1545968313491006; Spiegel DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036220; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Timberlake GT, 2005, OPTOMETRY VISION SCI, V82, P177, DOI 10.1097/01.OPX.0000156311.49058.C8; Wallace JM, 2017, J VISION, V17, DOI 10.1167/17.1.33; Woods AJ, 2016, CLIN NEUROPHYSIOL, V127, P1031, DOI 10.1016/j.clinph.2015.11.012	50	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232276	10.1371/journal.pone.0232276	http://dx.doi.org/10.1371/journal.pone.0232276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374787	Green Published, gold, Green Submitted			2022-12-26	WOS:000537283500029
J	Matos, I; Fernandes, A; Maso, I; Oliveira, J; de Jesus, PA; Fraga-Maia, H; Pinto, EB				Matos, Isabela; Fernandes, Adriana; Maso, Iara; Oliveira-Filho, Jamary; de Jesus, Pedro Antonio; Fraga-Maia, Helena; Pinto, Elen Beatriz			Investigating predictors of community integration in individuals after stroke in a residential setting: A longitutinal study	PLOS ONE			English	Article							PARTICIPATION; SURVIVORS; SMOKING; DISABILITY; APHASIA; HEALTH; WORK; LIFE	Aim To identify potential predictors of community integration in individuals after stroke using a residential setting-based strategy. Method A prospective cohort of post-stroke individuals was recruited from the Stroke Unit of the Roberto Santos General Hospital (UAVC-HGRS). All included individuals were aged over 18 years, received a diagnosis of ischemic stroke confirmed by neuroimaging and resided in the city of Salvador (Bahia, Brazil). Following discharge from the stroke unit, the individuals themselves, or their responsible parties, were contacted by telephone to schedule a home visit no less than three months after discharge. All subjects were examined in their homes, at which time the Community Integration Questionnaire (CIQ) was also applied. A robust linear regression model was used to assess community reintegration using CIQ score as the outcome variable. Results A total of 124 individuals effectively fulfilled the eligibility criteria: 51.6% were females, the median (IQR) age was 63(53-69) years, 82.3% were non-white, 53.2% were married, the median (IQR) of years of schooling was 6 (4-12) and family income averaged two minimum monthly wages. Investigated individuals presented a median (IQR) NIH Stroke Scale (NIHSS) score of 7 (4-12). Multivariate linear regression identified the following independent predictors of community integration: age (beta = -0.095; 95% CI = -0.165 to -0.025; p = 0.008), diabetes mellitus (beta = -2.348; 95% CI = -4.125 to -0.571; p = 0.010), smoking habit (beta = -2.951; 95% CI = -5.081 to -0.821; p = 0.007), functional capacity upon hospital discharge (beta = 0.168; 95% CI = 0.093 to 0.242; p = < 0.001) and stroke severity (beta = -0.163; CI = -0.318 to -0.009); p = 0.038). Conclusions Regardless of length of time since stroke, individuals present restrictions that compromise their reintegration into their respective communities. The demographic, clinical and functional factors identified herein as potential predictors should be considered when conducting regular follow-up, as well as in the rehabilitation of individuals after stroke with the purpose to identify the interventions necessary to optimize their reintegration into the community.	[Matos, Isabela; Fernandes, Adriana; Maso, Iara; Pinto, Elen Beatriz] Bahiana Sch Med & Publ Hlth, Motor Behav & Neurorehabil Res Grp, Salvador, BA, Brazil; [Maso, Iara; de Jesus, Pedro Antonio] Roberto Santos Gen Hosp, Salvador, BA, Brazil; [Oliveira-Filho, Jamary; de Jesus, Pedro Antonio] Univ Fed Bahia, Salvador, BA, Brazil; [Fraga-Maia, Helena] Bahia State Univ, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade do Estado Bahia	Pinto, EB (corresponding author), Bahiana Sch Med & Publ Hlth, Motor Behav & Neurorehabil Res Grp, Salvador, BA, Brazil.	elen.neuro@gmail.com		Jesus, Pedro Antonio/0000-0003-1211-2272; Pinto, Elen/0000-0003-3753-923X	Coordination Program for Personal Improvement in Higher Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES)	Coordination Program for Personal Improvement in Higher Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES)	With regard to funding, Adriana Fernandes and Isabela Matos received scholarship grants during the study period from the Coordination Program for Personal Improvement in Higher Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES). None of the other authors received any specific funding for this work The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa Marcelia Barezzi, 2018, Rev. bras. geriatr. gerontol., V21, P123, DOI 10.1590/1981-22562018021.170185; Bettger JP, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-281; Blomgren C, 2018, SCAND J OCCUP THER, V25, P119, DOI 10.1080/11038128.2017.1329343; Chau JPC, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-49; Cincura C, 2009, CEREBROVASC DIS, V27, P119, DOI 10.1159/000177918; Dalemans RJ, 2010, ARCH PHYS MED REHAB, V91, P395, DOI 10.1016/j.apmr.2009.10.021; Dalemans RJP, 2010, DISABIL REHABIL, V32, P1678, DOI 10.3109/09638281003649938; de Graaf JA, 2018, DISABIL REHABIL, V40, P637, DOI 10.1080/09638288.2016.1271466; Elloker T, 2019, DISABIL REHABIL, V41, P2640, DOI 10.1080/09638288.2018.1473509; Engel-Yeger B, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/5472018; Fama ME, 2014, SEMIN NEUROL, V34, P504, DOI 10.1055/s-0034-1396004; Foley EL, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/2606039; Hoyle M, 2012, BRAIN IMPAIR, V13, P4, DOI 10.1017/BrImp.2012.9; Hu LZ, 2007, J OCCUP HEALTH, V49, P443, DOI 10.1539/joh.49.443; Jellema S, 2017, CLIN REHABIL, V31, P936, DOI 10.1177/0269215516671013; Jette AM, 2006, PHYS THER, V86, P726, DOI 10.1093/ptj/86.5.726; Jia Q, 2011, STROKE, V42, P2758, DOI 10.1161/STROKEAHA.111.621649; Joseph C, 2013, AFR HEALTH SCI, V13, P646, DOI 10.4314/ahs.v13i3.18; Kumagai N, 2013, J NEUROL SCI, V335, P164, DOI 10.1016/j.jns.2013.09.023; Lee H, 2015, YONSEI MED J, V56, P1694, DOI 10.3349/ymj.2015.56.6.1694; Lopez-Espuela F, 2016, AM J CRIT CARE, V25, P144, DOI 10.4037/ajcc2016215; Maso I, 2019, NEUROREHAB NEURAL RE, V33, P614, DOI 10.1177/1545968319856894; Mayo NE, 2014, QUAL LIFE RES, V23, P39, DOI 10.1007/s11136-013-0441-6; Nayak AR, 2016, ANN NEUROSCI, V23, P199, DOI 10.1159/000449480; Obembe A, 2013, HONG KONG PHYSIOTHER, V31, P69, DOI 10.1016/j.hkpj.2013.04.001; Ovbiagele B, 2006, CEREBROVASC DIS, V21, P260, DOI 10.1159/000091224; Pinto EB, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-65; Rejno A, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1300; Fraga-Maia HMS, 2015, CIENC SAUDE COLETIVA, V20, P1340, DOI 10.1590/1413-81232015205.08312014; Singam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144344; Song T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181196; Spek V, 2018, PSYCHOL HEALTH, V33, P1456, DOI 10.1080/08870446.2018.1508684; Stead LG, 2009, NEUROCRIT CARE, V10, P181, DOI 10.1007/s12028-008-9080-0; Tanaka H, 2014, INT ARCH OCC ENV HEA, V87, P445, DOI 10.1007/s00420-013-0883-8; Tornbom K, 2017, ACTA NEUROL SCAND, V135, P649, DOI 10.1111/ane.12661; Tse T, 2017, J REHABIL MED, V49, P120, DOI 10.2340/16501977-2184; Verberne DPJ, 2018, NEUROREHAB NEURAL RE, V32, P821, DOI 10.1177/1545968318796341	37	2	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233015	10.1371/journal.pone.0233015	http://dx.doi.org/10.1371/journal.pone.0233015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1CK	32421731	gold, Green Published			2022-12-26	WOS:000537499600023
J	Hao, S; Kassahun, A; Bouzembrak, Y; Marvin, H				Hao, Shuai; Kassahun, Ayalew; Bouzembrak, Yamine; Marvin, Hans			Identification of potential vulnerable points and paths of contamination in the Dutch broiler meat trade network	PLOS ONE			English	Article							CAMPYLOBACTER SPP.; SUPPLY CHAIN; QUALITY; SAFETY	The poultry meat supply chain is complex and therefore vulnerable to many potential contaminations that may occur. To ensure a safe product for the consumer, an efficient traceability system is required that enables a quick and efficient identification of the potential sources of contamination and proper implementation of mitigation actions. In this study, we explored the use of graph theory to construct a food supply chain network for the broiler meat supply chain in the Netherlands and tested it as a traceability system. To build the graph, we first identified the main actors in the supply chain such as broiler breeder farms, broiler farms, slaughterhouses, processors, and retailers. The capacity data of each supply chain actor, represented by its production or trade volumes, were gathered from various sources. The trade relationships between the supply chain actors were collected and the missing relationships were estimated using the gravity model. Once the network was modeled, we computed degree centrality and betweenness centrality to identify critical nodes in the network. In addition, we computed trade density to get insight into the complexity of subnetworks. We identified the critical nodes at each stage of the Dutch broiler meat supply chain and verified our results with a domain expert of the Dutch poultry industry and literature. The results showed that processors with own slaughtering facility were the most critical points in the broiler meat supply chain.	[Hao, Shuai] Wageningen Univ, Food Qual & Design, Wageningen, Netherlands; [Kassahun, Ayalew] Wageningen Univ, Informat Technol, Wageningen, Netherlands; [Bouzembrak, Yamine; Marvin, Hans] Wageningen Food Safety Res, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Kassahun, A (corresponding author), Wageningen Univ, Informat Technol, Wageningen, Netherlands.	ayalew.kassahun@wur.nl	Kassahun, ir. Ayalew/AAA-1724-2021	Kassahun, ir. Ayalew/0000-0003-1066-7127				Agrimatie, 2018, HOLD AN FARM SIZ LAY; Aho P. W., 2002, Commercial chicken meat and egg production, P3; Aung MM, 2014, FOOD CONTROL, V39, P172, DOI 10.1016/j.foodcont.2013.11.007; Banach J, 2017, CHEM PHYS HAZARDS DU; Bell D. D., 2002, Commercial chicken meat and egg production, P19; CBS, 2018, POPULATION; CBS Statline, 2018, AGR CROPS LIV LAND U; Chades I, 2011, P NATL ACAD SCI USA, V108, P8323, DOI 10.1073/pnas.1016846108; Hagedoorn J, 2002, ORGAN STUD, V23, P525, DOI 10.1177/0170840602234002; Hoovers DB, 2018, CO SEARCH; Hue O, 2010, FOOD MICROBIOL, V27, P992, DOI 10.1016/j.fm.2010.06.004; John C., 2016, TOPOLOGY GEOMETRY 2; Jozwiak A, 2006, J VET MED B, V53, P291, DOI 10.1111/j.1439-0450.2006.00958.x; Kepaptsoglou K., 2010, OPEN EC J, V03; Kompass, 2018, GLOB B2B ONL DIR; Krichene H., 2018, FIRMS CHOOSE THEIR P; Lebl K, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00048; Minar N, 2002, EMERGING TECHNOLOGY; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Patsias A, 2006, FOOD MICROBIOL, V23, P423, DOI 10.1016/j.fm.2005.08.004; Pinior B., 2012, Journal on Chain and Network Science, V12, P25, DOI 10.3920/JCNS2012.x001; PPE, 2013, PPE STAT JAARR PLUIM; QGIS, 2020, QGIS FREE OP SOURC G; Retail Insiders, 2018, POEL; Sampers I, 2010, INT J FOOD MICROBIOL, V137, P147, DOI 10.1016/j.ijfoodmicro.2009.11.013; Spencer JL, 2004, METH MOL B, V268, P503; Statista, 2018, NUMB ENT PROC PRES P; Statista, 2018, CAP CON POULTR NETH; The Poultry Site, 2018, POULTR MEAT NETH; Tsola E, 2008, FOOD CONTROL, V19, P423, DOI 10.1016/j.foodcont.2007.05.003; USDA, 2017, SUMM REC CAS CAL YEA; van Asselt ED, 2008, J APPL MICROBIOL, V105, P1392, DOI 10.1111/j.1365-2672.2008.03875.x; van Bergeijk P.A.G., 2010, GRAVITY MODEL INT TR, P1; van Plaggenhoef W., 2007, INTEGRATION SELF REG; vlam.be, 2019, NED GEV KON 2019; Windhorst H. W., 2011, Lohmann Information, V46, P28; Zbrun MV, 2013, NEW ZEAL VET J, V61, P337, DOI 10.1080/00480169.2013.817294	37	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233376	10.1371/journal.pone.0233376	http://dx.doi.org/10.1371/journal.pone.0233376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413072	gold, Green Published			2022-12-26	WOS:000537496000064
J	Hayward, JJ; Kelly-Smith, M; Boyko, AR; Burmeister, L; De Risio, L; Mellersh, C; Freeman, J; Strain, GM				Hayward, Jessica J.; Kelly-Smith, Maria; Boyko, Adam R.; Burmeister, Louise; De Risio, Luisa; Mellersh, Cathryn; Freeman, Julia; Strain, George M.			A genome-wide association study of deafness in three canine breeds	PLOS ONE			English	Article							CONGENITAL SENSORINEURAL DEAFNESS; NON-SYNDROMIC DEAFNESS; TRANSCRIPTION-FACTOR; TRANSPORT-SYSTEM; PIGMENTATION; MITF; ELIMINATION; MELANOCYTES; CANDIDATE; HEARING	Congenital deafness in the domestic dog is usually related to the presence of white pigmentation, which is controlled primarily by the piebald locus on chromosome 20 and also by merle on chromosome 10. Pigment-associated deafness is also seen in other species, including cats, mice, sheep, alpacas, horses, cows, pigs, and humans, but the genetic factors determining why some piebald or merle dogs develop deafness while others do not have yet to be determined. Here we perform a genome-wide association study (GWAS) to identify regions of the canine genome significantly associated with deafness in three dog breeds carrying piebald: Dalmatian, Australian cattle dog, and English setter. We include bilaterally deaf, unilaterally deaf, and matched control dogs from the same litter, phenotyped using the brainstem auditory evoked response (BAER) hearing test. Principal component analysis showed that we have different distributions of cases and controls in genetically distinct Dalmatian populations, therefore GWAS was performed separately for North American and UK samples. We identified one genome-wide significant association and 14 suggestive (chromosome-wide) associations using the GWAS design of bilaterally deaf vs. control Australian cattle dogs. However, these associations were not located on the same chromosome as the piebald locus, indicating the complexity of the genetics underlying this disease in the domestic dog. Because of this apparent complex genetic architecture, larger sample sizes may be needed to detect the genetic loci modulating risk in piebald dogs.	[Hayward, Jessica J.; Boyko, Adam R.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Kelly-Smith, Maria; Strain, George M.] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Burmeister, Louise; De Risio, Luisa; Mellersh, Cathryn; Freeman, Julia] Anim Hlth Trust, Newmarket, Suffolk, England	Cornell University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Animal Health Trust	Strain, GM (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	strain@lsu.edu	De Risio, Luisa/ABB-3561-2020; Strain, George/AGZ-7275-2022; Hayward, Jessica/AGW-0493-2022	De Risio, Luisa/0000-0001-9005-4165; Strain, George/0000-0002-6084-4438; Burmeister, Louise/0000-0002-6551-055X; Kelly-Smith, Maria/0000-0003-3375-6587	American Kennel Club Canine Health Foundation [CHF 2172, CHF 2387]; Australian Cattle Dog Club of America; Dalmatian Club of America; English Setter Association of America	American Kennel Club Canine Health Foundation; Australian Cattle Dog Club of America; Dalmatian Club of America; English Setter Association of America	Financial support from the American Kennel Club Canine Health Foundation (http://www.akcchf.org/) through grants CHF 2172 (GMS and ARB) and CHF 2387 (GMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Canine Health Foundation funds were provided by Australian Cattle Dog Club of America, Dalmatian Club of America, and English Setter Association of America. Samples supplied by anonymous breeders are greatly appreciated. The authors thank Eddie Dziuk from the Orthopedic Foundation for Animals for providing samples.	Adachi N, 2013, J PHYSIOL-LONDON, V591, P4459, DOI 10.1113/jphysiol.2013.258046; [Anonymous], MITF MEL IND TRANSCR; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bismuth K, 2017, REFERENCE MODULE NEU, P143; Blatter M, 2013, SCHWEIZ ARCH TIERH, V155, P229, DOI 10.1024/0036-7281/a000451; Brenig B, 2003, ANIM GENET, V34, P47, DOI 10.1046/j.1365-2052.2003.00931.x; Cargill EJ, 2004, THESIS; Chen L, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0273-2; Chen W, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0426-z; Hayward JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10460; Hickox AE, 2017, J NEUROSCI, V37, P1320, DOI 10.1523/JNEUROSCI.2267-16.2016; Hirobe T, 2011, PIGM CELL MELANOMA R, V24, P462, DOI 10.1111/j.1755-148X.2011.00845.x; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kluth S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080642; Little C., 1957, INHERITANCE COAT COL; Markakis MN, 2014, J GENET, V93, P477, DOI 10.1007/s12041-014-0370-3; Metallinos D., 2000, Genome Biology, V1, P0004, DOI 10.1186/gb-2000-1-2-research0004; Mieskes K, 2007, ANIM GENET, V38, P533, DOI 10.1111/j.1365-2052.2007.01625.x; Mieskes K, 2006, ANIM GENET, V37, P519, DOI 10.1111/j.1365-2052.2006.01497.x; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Philipp U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028857; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price ER, 2001, NEURON, V30, P15, DOI 10.1016/S0896-6273(01)00259-8; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2018, R LANG ENV STAT COMP; Rak SG, 2005, VET J, V169, P188, DOI 10.1016/j.tvjl.2004.01.015; Rak SG, 2003, CYTOGENET GENOME RES, V101, P130, DOI 10.1159/000074168; Rak SG, 2002, CHROMOSOME RES, V10, P407, DOI 10.1023/A:1016805803686; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Ryugo DK, 2012, VET CLIN N AM-SMALL, V42, P1179, DOI 10.1016/j.cvsm.2012.08.008; Schmutz SM, 2009, J HERED, V100, pS66, DOI 10.1093/jhered/esp029; Shim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120758; Sommerlad S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013364; STEEL KP, 1989, DEVELOPMENT, V107, P453; Strain GM, 2011, VET J, V188, P247, DOI 10.1016/j.tvjl.2010.08.015; Strain GM, 2007, VET J, V173, P471, DOI 10.1016/j.tvjl.2006.01.015; Strain GM, 2017, J FELINE MED SURG, V19, P276, DOI 10.1177/1098612X17695062; Strain GM, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00029; Strain GM, 2012, VET CLIN N AM-SMALL, V42, P1209, DOI 10.1016/j.cvsm.2012.08.010; Strain GM, 2011, DEAFNESS IN DOGS AND CATS, P83, DOI 10.1079/9781845937645.0083; Strain GM, 2004, VET J, V167, P23, DOI 10.1016/S1090-0233(03)00104-7; STRAIN GM, 1992, J VET INTERN MED, V6, P175, DOI 10.1111/j.1939-1676.1992.tb00333.x; Stritzel S, 2009, J ANIM BREED GENET, V126, P59, DOI 10.1111/j.1439-0388.2008.00761.x; Stritzel S, 2007, ANIM GENET, V38, P662, DOI 10.1111/j.1365-2052.2007.01660.x; Tachibana M, 2003, PIGM CELL RES, V16, P448, DOI 10.1034/j.1600-0749.2003.00066.x; Tsuchida S, 2009, VET J, V182, P283, DOI 10.1016/j.tvjl.2008.06.004; Uetsuka S, 2015, EUR J NEUROSCI, V42, P1984, DOI 10.1111/ejn.12973; Van Camp G, WELCOME HEREDITARY H; Xia WJ, 2019, CLIN GENET, V96, P300, DOI 10.1111/cge.13590; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	52	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232900	10.1371/journal.pone.0232900	http://dx.doi.org/10.1371/journal.pone.0232900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413090	Green Published, gold			2022-12-26	WOS:000537496000027
J	Liu, B; Arguello, OAD; Chen, D; Chen, SW; Saber, A; Haisma, HJ				Liu, Bin; Arguello, Olivia Adaly Diaz; Chen, Deng; Chen, Siwei; Saber, Ali; Haisma, Hidde J.			CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation	PLOS ONE			English	Article							INHIBITION; RESISTANCE; TRAIL; MECHANISMS; GEFITINIB; SURVIVAL; THERAPY; CANCER; VEGFR	Receptor tyrosine kinases, such as VEGFR, PDGFR and EGFR, play important roles in renal cancer. In this study, we investigated EGFR knockout as a therapeutic approach in renal cell carcinoma (RCC). We showed that a renal cell carcinoma cell line (RC21) has higher expression of EGFR as compared to other frequently used cell lines such as HEK293, A549, Hela and DLD1. Ablation of EGFR by CRISPR/Cas9 significantly restrained tumor cell growth and activated the MAPK (pERK1/2) pathway. The VEGFR and PDGFR inhibitor, sunitinib, attenuated the expression of MAPK (pERK1/2) and pAKT induced by EGFR loss and further inhibited EGFR(-/-) cell proliferation. We showed that loss of EGFR eventually leads to resistance to SAHA and cisplatin. Furthermore, EGFR loss induced G2/M phase arrest and resulted in an increased resistance to TNF-related apoptosis-inducing ligand (TRAIL) in renal cell carcinoma. Thus, ablation of overexpressed EGFR by CRISPR/Cas9 alone or in combination with sunitinib may be a new treatment option for renal cell carcinoma.	[Liu, Bin; Arguello, Olivia Adaly Diaz; Chen, Deng; Chen, Siwei; Saber, Ali; Haisma, Hidde J.] Univ Groningen, Groningen Res Inst Pharm, Dept Chem & Pharmaceut Biol, Groningen, Netherlands; [Liu, Bin] Univ Massachusetts, Med Sch, RNA Therapeut Inst, Worcester, MA 01605 USA	University of Groningen; University of Massachusetts System; University of Massachusetts Worcester	Haisma, HJ (corresponding author), Univ Groningen, Groningen Res Inst Pharm, Dept Chem & Pharmaceut Biol, Groningen, Netherlands.	h.j.haisma@rug.nl	Liu, Bin/AAX-4853-2020; Haisma, Hidde/E-8964-2014	Liu, Bin/0000-0002-3168-8456; CHEN, DENG/0000-0002-6078-6995; Haisma, Hidde/0000-0003-3997-9052; Saber, Ali/0000-0002-7110-6860; Chen, Siwei/0000-0003-1244-834X	program of China Scholarship Council (CSC)	program of China Scholarship Council (CSC)(China Scholarship Council)	Bin Liu and Siwei Chen received financial support from the program of China Scholarship Council (CSC)."	Arabpour M, 2017, J DRUG TARGET, V25, P360, DOI 10.1080/1061186X.2016.1262867; Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Bremer E, 2008, MOL THER, V16, P1919, DOI 10.1038/mt.2008.203; Buonerba C, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.01.31; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Ercan D, 2012, CANCER DISCOV, V2, P934, DOI 10.1158/2159-8290.CD-12-0103; Grill J, 2001, CLIN CANCER RES, V7, P641; Hirsch FR, 2009, ONCOGENE, V28, pS32, DOI 10.1038/onc.2009.199; Krail EB, 2017, ELIFE, V6, DOI [10.7554/eLife.18970, 10.7554/eLife.33173]; Kuwai T, 2008, CLIN EXP METASTAS, V25, P477, DOI 10.1007/s10585-008-9153-7; Leus NGJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45047; Leus NGJ, 2016, CURR OPIN CHEM BIOL, V33, P160, DOI 10.1016/j.cbpa.2016.06.019; Li PX, 2016, CANCER MED-US, V5, P169, DOI 10.1002/cam4.574; Liu B, 2020, NUCLEIC ACIDS RES, V48, P517, DOI 10.1093/nar/gkz1136; Liu B, 2019, CANCERS, V11, DOI 10.3390/cancers11040455; Liu B, 2019, DRUG DISCOV TODAY, V24, P955, DOI 10.1016/j.drudis.2019.02.011; Liu B, 2015, GENET TEST MOL BIOMA, V19, P316, DOI 10.1089/gtmb.2014.0329; Liu B, 2015, J NANOSCI NANOTECHNO, V15, P1946, DOI 10.1166/jnn.2015.9832; Lopez-Fernandez E, 2018, CANCERS, V10, DOI 10.3390/cancers10120485; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Motzer RJ, 2010, AM J CLIN ONCOL-CANC, V33, P614, DOI 10.1097/COC.0b013e3181c4454d; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Runkle KB, 2016, MOL CELL, V62, P385, DOI 10.1016/j.molcel.2016.04.003; Saber A., 2015, CANC TREATMENT COMMU, V143, P23, DOI [DOI 10.1016/j.ctrc.2015.03.005, 10.1016/j.ctrc.2015.03.005]; Saber A, 2020, DARU, V28, P295, DOI 10.1007/s40199-019-00240-z; Sigismund S, 2018, MOL ONCOL, V12, P3, DOI 10.1002/1878-0261.12155; Srigley JR, 2013, AM J SURG PATHOL, V37, P1469, DOI 10.1097/PAS.0b013e318299f2d1; van Cruijsen H, 2010, EUR J CANCER, V46, P901, DOI 10.1016/j.ejca.2009.12.023; van der Sloot AM, 2004, PROTEIN ENG DES SEL, V17, P673, DOI 10.1093/protein/gzh079; van der Wekken AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182885; van der Wekken AJ, 2016, CRIT REV ONCOL HEMAT, V100, P107, DOI 10.1016/j.critrevonc.2016.01.024; Yokoi K, 2005, CANCER RES, V65, P10371, DOI 10.1158/0008-5472.CAN-05-1698	33	8	9	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232985	10.1371/journal.pone.0232985	http://dx.doi.org/10.1371/journal.pone.0232985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413049	Green Published, gold			2022-12-26	WOS:000537496000033
J	Rohani, A; Fakhriy, HA; Suzilah, I; Zurainee, MN; Najdah, WMAW; Ariffin, MM; Shakirudin, NM; Afiq, MSM; Jenarun, J; Tanrang, Y; Lee, HL				Rohani, A.; Fakhriy, H. Ahmad; Suzilah, I.; Zurainee, M. N.; Najdah, W. M. A. Wan; Ariffin, M. Mohd; Shakirudin, N. Mohamad; Afiq, M. S. Mohd; Jenarun, J.; Tanrang, Y.; Lee, H. L.			Indoor and outdoor residual spraying of a novel formulation of deltamethrin K-Othrine (R) (Polyzone) for the control of simian malaria in Sabah, Malaysia	PLOS ONE			English	Article							DIPTERA; INFECTIONS; CULICIDAE; WP	Since 2000, human malaria cases in Malaysia were rapidly reduced with the use of insecticides in Indoor Residual Spray (IRS) and Long-Lasting Insecticide Net (LLIN). Unfortunately, monkey malaria in humans has shown an increase especially in Sabah and Sarawak. The insecticide currently used in IRS is deltamethrin K-Othrine (R) WG 250 wettable granule, targeting mosquitoes that rest and feed indoor. In Sabah, the primary vector for knowlesi malaria is An. balabacensis a species known to bite outdoor. This study evaluates an alternative method, the Outdoor Residual Spray (ORS) using a novel formulation of deltamethrin K-Othrine (R) (PolyZone) to examine it suitability to control knowlesi malaria vector in Sabah, compared to the current method. The study was performed at seven villages in Sabah having similar type of houses (wood, bamboo and concrete). Houses were sprayed with deltamethrin K-Othrine (R) (PolyZone) at two different dosages, 25 mg/m(2) and 30 mg/m(2) and deltamethrin K-Othrine (R) WG 250 wettable granule at 25 mg/m(2), sprayed indoor and outdoor. Residual activity on different walls was assessed using standard cone bioassay techniques. For larval surveillances, potential breeding sites were surveyed. Larvae were collected and identified, pre and post spraying. Adult survey was done using Human Landing Catch (HLC) performed outdoor and indoor. Detection of malaria parasite in adults was conducted via microscopy and molecular methods. Deltamethrin K-Othrine (R) (PolyZone) showed higher efficacy when sprayed outdoor. The efficacy was found varied when sprayed on different types of wall surfaces. Deltamethrin K-Othrine (R) (PolyZone) at 25 mg/m(2) was the most effective with regards to ability to high mortality and effective knock down (KD). The vector population was reduced significantly post-spraying and reduction in breeding sites as well. The number of simian malaria infected vector, human and simian malaria transmission were also greatly reduced.	[Rohani, A.; Fakhriy, H. Ahmad; Najdah, W. M. A. Wan; Ariffin, M. Mohd; Shakirudin, N. Mohamad; Afiq, M. S. Mohd; Lee, H. L.] Inst Med Res, Med Entomol Unit, Kuala Lumpur, Malaysia; [Rohani, A.; Fakhriy, H. Ahmad; Najdah, W. M. A. Wan; Ariffin, M. Mohd; Shakirudin, N. Mohamad; Afiq, M. S. Mohd; Lee, H. L.] Inst Med Res, WHO Collaborating Ctr Vectors, Kuala Lumpur, Malaysia; [Fakhriy, H. Ahmad; Zurainee, M. N.] Univ Malaya, Fac Med, Parasitol Dept, Kuala Lumpur, Malaysia; [Suzilah, I.] Univ Utara Malaysia, Sch Quantitat Sci, Sintok, Kedah, Malaysia; [Jenarun, J.; Tanrang, Y.] Kementerian Kesihatan Malaysia, Sabah Dept Hlth, Kota Kinabalu, Sabah, Malaysia	Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Universiti Malaya; Universiti Utara Malaysia; Kementerian Kesihatan Malaysia	Rohani, A; Fakhriy, HA (corresponding author), Inst Med Res, Med Entomol Unit, Kuala Lumpur, Malaysia.; Rohani, A; Fakhriy, HA (corresponding author), Inst Med Res, WHO Collaborating Ctr Vectors, Kuala Lumpur, Malaysia.; Fakhriy, HA; Zurainee, MN (corresponding author), Univ Malaya, Fac Med, Parasitol Dept, Kuala Lumpur, Malaysia.; Suzilah, I (corresponding author), Univ Utara Malaysia, Sch Quantitat Sci, Sintok, Kedah, Malaysia.	rohania@imr.gov.my; fakhriyhassan@yahoo.com; halizus@uum.edu.my; zuraineemn@um.edu.my	Wan Mohamad Ali, Wan Najdah/GBG-1170-2022; NOR, ZURAINEE MOHAMED/C-1162-2010	Mohamed Nor, Zurainee/0000-0002-9421-2092	National Institute of Health-Ministry of Health Malaysia [16-004, NMRR-16-31829507]	National Institute of Health-Ministry of Health Malaysia(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by National Institute of Health-Ministry of Health Malaysia (Grant No. JPP-IMR: 16-004). All the funding or sources of support received during this study is specific for this research project (NMRR-16-31829507). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2018, SE ASIAN J TROP MED, V49, P566; [Anonymous], 2006, PESTICIDES THEIR APP; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Barber BE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-401; Brooke B, 2014, COMMUNICABLE DIS SUR, V12, P108; CAMILLERI P, 1984, J AGR FOOD CHEM, V32, P1122, DOI 10.1021/jf00125a048; DEMOUTE JP, 1989, PESTIC SCI, V27, P375, DOI 10.1002/ps.2780270406; Dunford JC, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2239-z; Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329; Fuehrer HP, 2011, J CLIN MICROBIOL, V49, P1628, DOI 10.1128/JCM.01792-10; Govella NJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00199; Govere J, 2001, AFR ENTOMOL, V9, P163; Jeffree SM, 2018, AM J TROP MED HYG, V98, P45, DOI 10.4269/ajtmh.17-0081; Jiram AI, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-213; Kijlstra J., 2014, Proceedings of the 8th International Conference on Urban Pests, 20-23 July 2014, Zurich, Switzerland, P383; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Komalamisra N, 2009, SE ASIAN J TROP MED, V40, P1221; Lau YL, 2011, EMERG INFECT DIS, V17, P1314, DOI 10.3201/eid1707.101295; Moiroux N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104967; Mulambalah C. S., 2010, Research Journal of Biological Sciences, V5, P258; Raghavendra K, 2011, J VECTOR DIS, V48, P18; Rajahram GS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-284; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Reid JA, 1968, ANOPHELINE MOSQUITOE; Rohani A, 2007, TROP BIOMED, V24, P77; Rohani A, 2017, ADV ENTOMOLOGY, V2, P151, DOI [10.4236/ae.2014.23023, DOI 10.4236/AE.2014.23023]; Rohani A, 1999, TROPICAL BIOMEDICINE, V16, P1; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Russell TL, 2013, MALARIA J, V12, P1; Sallum MAM, 2005, REV BRAS ENTOMOL, V49, P1, DOI 10.1590/S0085-56262005000500001; Santos Roseli La Corte dos, 2007, Rev Saude Publica, V41, P276, DOI 10.1590/S0034-89102007000200015; Siegert PY, 2009, J ECON ENTOMOL, V102, P2061, DOI 10.1603/029.102.0607; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Vythilingam I, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-436; Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26; Wong ML, 2015, PLOS NEGLECT TROP D, V9, P1; World Health Organization, 2013, 16 WHOPES WORK GROUP; World Health Organization, 2014, CONTR RES MAL PAR TR; World Health Organization, 2018, **NON-TRADITIONAL**; World Health Organization, 2014, WHOHTMGMPMPAC20142; Yewhalaw D, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2122-3; 2013, WORLD MAL REP 2013, P1	45	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0230860	10.1371/journal.pone.0230860	http://dx.doi.org/10.1371/journal.pone.0230860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413033	gold, Green Published			2022-12-26	WOS:000537496000010
J	de Bastos, DR; Nagai, MA				de Bastos, Daniel Rodrigues; Nagai, Maria A.			In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors	PLOS ONE			English	Article							EXPRESSING DIFFERENT LEVELS; GENE-EXPRESSION; OPEN PLATFORM; CANCER CELLS; HOTAIR; SPARC; OVEREXPRESSION; BIOMARKER; PREDICTS; SURVIVAL	Background Long non-coding RNAs (lncRNAs) are characterized as having 200 nucleotides or more and not coding any protein, and several been identified as differentially expressed in several human malignancies, including breast cancer. Methods Here, we evaluated lncRNAs differentially expressed in triple-negative breast cancer (TNBC) from a cDNA microarray data set obtained in a previous study from our group. Using in silico analyses in combination with a review of the current literature, we identify three lncRNAs as potential prognostic factors for TNBC patients. Results We found that the expression of WDFY3-AS2, BDNF-AS, and AFAP1-AS1 was associated with poor survival in patients with TNBCs. WDFY3-AS2 and BDNF-AS are lncRNAs known to play an important role in tumor suppression of different types of cancer, while AFAP1-AS1 exerts oncogenic activity. Conclusion Our findings provided evidence that WDFY3-AS2, BDNF-AS, and AFAP1-AS1 may be potential prognostic factors in TNBC development.	[de Bastos, Daniel Rodrigues; Nagai, Maria A.] Univ Sao Paulo, Dept Radiol & Oncol, Discipline Oncol, Fac Med, Sao Paulo, Brazil; [de Bastos, Daniel Rodrigues; Nagai, Maria A.] Canc Inst Sao Paulo, Ctr Translat Res Oncol, Lab Mol Genet, Sao Paulo, Brazil	Universidade de Sao Paulo	Nagai, MA (corresponding author), Univ Sao Paulo, Dept Radiol & Oncol, Discipline Oncol, Fac Med, Sao Paulo, Brazil.; Nagai, MA (corresponding author), Canc Inst Sao Paulo, Ctr Translat Res Oncol, Lab Mol Genet, Sao Paulo, Brazil.	nagai@usp.br	de Bastos, Daniel Rodrigues/AAP-2825-2021; Nagai, Maria Aparecida/C-6162-2012	de Bastos, Daniel Rodrigues/0000-0001-7091-1959; Nagai, Maria Aparecida/0000-0002-0728-4937	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [309524/2017-2]; CAPES (Coordinacao de Aprimoramento de Pessoal de Nivel Superior)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordinacao de Aprimoramento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) provided support for this study in the form of Research Grant Number 309524/2017-2, awarded to MAN. CAPES (Coordinacao de Aprimoramento de Pessoal de Nivel Superior) provided support for this study in the form of a PhD fellowship for DRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Balas Maggie M, 2018, Noncoding RNA Res, V3, P108, DOI 10.1016/j.ncrna.2018.03.001; Bawazeer S, 2018, MOL BIOL REP, V45, P2313, DOI 10.1007/s11033-018-4394-2; Berse B, 2015, SEMIN ONCOL NURS, V31, P108, DOI 10.1016/j.soncn.2015.02.008; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chen W, 2017, ONCOTARGET, V8, P22783, DOI 10.18632/oncotarget.15199; Collignon J, 2016, BREAST CANCER-TARGET, V8, P93, DOI 10.2147/BCTT.S69488; de Alcantara PR, 2018, BREAST CANCER MANAG, V7, DOI 10.2217/bmt-2017-0019; Deva Magendhra Rao AK, 2019, MOL ONCOL, V13; Dianatpour A, 2018, CANCER BIOMARK, V22, P49, DOI 10.3233/CBM-170831; Dos Santos ML, 2009, INT J MOL MED, V23, P733, DOI 10.3892/ijmm_00000187; Dos Santos ML, 2006, INT J ONCOL, V28, P1441; Gao HL, 2018, ONCOTARGETS THER, V11, P8001, DOI 10.2147/OTT.S172379; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gyorffy B, 2010, BREAST CANC RES TREA; Han L, 2018, CANCER BIOTHER RADI, V33; Huang Q, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181498; Huerta-Cepas, 2019, NUCL ACIDS RES; Lebert JM, 2018, CURR ONCOL, V25, pS142, DOI 10.3747/co.25.3954; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Li J, 2015, CANCER RES, V75, P3728, DOI 10.1158/0008-5472.CAN-15-0273; Li JT, 2019, CELL CYCLE, V18, P1965, DOI 10.1080/15384101.2019.1635870; Li L, 2019, ADV DIFFER EQU-NY, DOI 10.1186/s13662-018-1928-9; Li WJ, 2020, J CELL PHYSIOL, V235, P1141, DOI 10.1002/jcp.29028; Li WS, 2018, BIOMED PHARMACOTHER, V102, P1105, DOI 10.1016/j.biopha.2018.03.118; Liang HG, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819882949; Liu H, 2019, PATHOL ONCOL RES, V2019, P1; Lu RZ, 2018, CANCER BIOMARK, V22, P249, DOI 10.3233/CBM-170874; Ma JJ, 2017, ONCOL LETT, V14, P5876, DOI 10.3892/ol.2017.6925; Maxwell C, 2010, CLIN J ONCOL NURS, V14, P771, DOI 10.1188/10.CJON.771-783; Miao ZM, 2016, MINERVA MED, V107, P392; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Nagai MA, 2011, BREAST CANCER RES TR, V126, P1, DOI 10.1007/s10549-010-0867-2; Neophytou C, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00031; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ransohoff JD, 2018, NAT REV MOL CELL BIO, V19, P143, DOI 10.1038/nrm.2017.104; Richard John Lalith Charles, 2018, Oncotarget, V9, P20179, DOI 10.18632/oncotarget.24591; Santonja A, 2018, ONCOTARGET, V9; Shang M, 2018, J CANCER, V9, P4627, DOI 10.7150/jca.28458; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tian T, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0598-8; Tomar D., 2019, BIOCH BIOPHYS ACTA G; Vikas P, 2018, CANC MANAG RES, V10, P10; Wang J, 2019, J CELL BIOCHEM, V120, P19784, DOI 10.1002/jcb.29284; Wu F, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0603-2; Xu ST, 2017, BIOMED PHARMACOTHER, V96, P14, DOI 10.1016/j.biopha.2017.09.107; Yang R, 2018, CELL PHYSIOL BIOCHEM, V50, P473, DOI 10.1159/000494162; Youness RA, 2019, NON-CODING RNA RES, V4, P36, DOI 10.1016/j.ncrna.2019.01.003; Yu FS, 2019, ONCOL LETT, V18, P3817, DOI 10.3892/ol.2019.10683; Zhang F, 2019, CIV ENG J-STAVEB OBZ, V28, P1, DOI 10.14311/CEJ.2019.01.0001; Zhang HM, 2018, ARCH BIOCHEM BIOPHYS, V646, P113, DOI 10.1016/j.abb.2018.03.023; Zhang T, 2019, LONG NONCODING RNA B, V18; Zhang ZL, 2018, BIOCHEM BIOPH RES CO, V503, P1530, DOI 10.1016/j.bbrc.2018.07.075; Zheng P, 2019, HISTOCHEM CELL BIOL; Zhi H, 2019, CELL BIOCHEM FUNCT	60	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232284	10.1371/journal.pone.0232284	http://dx.doi.org/10.1371/journal.pone.0232284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401758	gold, Green Published			2022-12-26	WOS:000537481000014
J	Jan, SD; Wasickanin, M; Katz, TA; Wickersham, EL; Steed, DOE; Simper, N				Jan Sunde; Wasickanin, Morgan; Katz, Tiffany A.; Wickersham, Emily L.; Steed, D. O. Emilie; Simper, Novae			Prevalence of endosalpingiosis and other benign gynecologic lesions	PLOS ONE			English	Article							TUBAL INTRAEPITHELIAL CARCINOMA; OVARIAN BRENNER TUMORS; SEROUS CARCINOMA; ORIGIN; CANCER; CELL; NEOPLASMS; CYSTS; ENDOMETRIOSIS; PATHOGENESIS	Endosalpingiosis, traditionally regarded as an incidental pathological finding, was recently reported to have an association with gynecologic malignancies. To determine the prevalence of endosalpingiosis, we evaluated all benign appearing adnexal lesions using the Sectioning and Extensively Examining-Fimbria (SEE-Fim) protocol, and queried the pathology database for the presence of endosalpingiosis, gynecologic malignancy, endometriosis, Walthard nests, and paratubal cysts. Using the SEE-Fim protocol, the prevalence of endosalpingiosis, endometriosis, Walthard nests, and paratubal cysts were 22%, 45%, 33%, and 42% respectively, substantially higher than previously reported. All lesions were observed to increase with age except endometriosis which increased until menopause then decreased dramatically. Among specimens including ovarian tissue, the prevalence of implantation of at least one lesion type was ubiquitous in patients age 51 and older (93%). The clinical significance of endosalpingiosis should be a continued area of research with larger trials assessing prevalence, factors affecting incidence, and association with malignancy. Our findings contribute to elucidating the origin of ectopic lesions and gynecologic disease risk.	[Jan Sunde; Wasickanin, Morgan] Madigan Army Med Ctr, Dept Obstet & Gynecol, Tacoma, WA 98431 USA; [Jan Sunde; Katz, Tiffany A.] Baylor Coll Med, Div Gynecol Oncol, Houston, TX 77030 USA; [Wickersham, Emily L.; Simper, Novae] Madigan Army Med Ctr, Dept Pathol, Tacoma, WA 98431 USA; [Steed, D. O. Emilie] Texas Tech Univ, Hlth Sci Ctr, Dept Med, Lubbock, TX 79430 USA	Madigan Army Medical Center; Baylor College of Medicine; Madigan Army Medical Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Jan, SD (corresponding author), Madigan Army Med Ctr, Dept Obstet & Gynecol, Tacoma, WA 98431 USA.; Jan, SD (corresponding author), Baylor Coll Med, Div Gynecol Oncol, Houston, TX 77030 USA.	jan@sunde.cx		Sunde, Jan/0000-0001-9855-2484; Wasickanin, Morgan/0000-0001-8083-0626				Bartlett JMS, 2002, MOL BIOTECHNOL, V21, P149, DOI 10.1385/MB:21:2:149; Bristol-Gould SK, 2005, ENDOCRINOLOGY, V146, P5228, DOI 10.1210/en.2005-0697; Chui MH, 2020, J PATHOL, V250, P148, DOI 10.1002/path.5353; Chui MH, 2019, AM J SURG PATHOL, V43, P1462, DOI 10.1097/PAS.0000000000001325; Dietrich JE, 2017, J PEDIATR ADOL GYNEC, V30, P571, DOI 10.1016/j.jpag.2017.04.002; Dubeau L, 1999, GYNECOL ONCOL, V72, P437, DOI 10.1006/gyno.1998.5275; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Esselen KM, 2016, GYNECOL ONCOL, V142, P255, DOI 10.1016/j.ygyno.2016.05.036; Esselen KM, 2014, GYNECOL ONCOL, V132, P316, DOI 10.1016/j.ygyno.2013.12.007; FERNANDEZMOLINA JC, 2020, ANN DIAGN PATHOL, V46, DOI DOI 10.1016/J.ANNDIAGPATH.2020.151475; Fuldeore MJ, 2017, GYNECOL OBSTET INVES, V82, P453, DOI 10.1159/000452660; GENADRY R, 1977, AM J OBSTET GYNECOL, V129, P873, DOI 10.1016/0002-9378(77)90520-8; Gendronneau G, 2012, ENDOCRINOLOGY, V153, P1484, DOI 10.1210/en.2011-1766; Guo SW, 2006, FERTIL STERIL, V86, P1584, DOI 10.1016/j.fertnstert.2006.04.040; Hao DP, 2017, CLIN CANCER RES, V23, P7400, DOI 10.1158/1078-0432.CCR-17-0638; Hermens M, 2020, CANCER EPIDEMIOL, V65, DOI 10.1016/j.canep.2020.101700; Hesseling MH, 2000, J AM ASSOC GYN LAP, V7, P215, DOI 10.1016/S1074-3804(00)80043-2; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Koc N, 2018, J PATHOL TRANSL MED, V52, P21, DOI 10.4132/jptm.2016.06.17; Kuhn E, 2012, J PATHOL, V226, P421, DOI 10.1002/path.3023; Kurman RJ, 2011, AM J SURG PATHOL, V35, P1605, DOI 10.1097/PAS.0b013e318229449f; Lee Y, 2006, ADV ANAT PATHOL, V13, P1, DOI 10.1097/01.pap.0000201826.46978.e5; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; McMullen ML, 2001, ENDOCRINOLOGY, V142, P5005, DOI 10.1210/en.142.11.5005; Messini I, 2019, INT J GYNECOL CANCER, V29, P572, DOI 10.1136/ijgc-2018-000086; Munksgaard PS, 2012, GYNECOL ONCOL, V124, P164, DOI 10.1016/j.ygyno.2011.10.001; Muolokwu E, 2011, J PEDIATR SURG, V46, P2161, DOI 10.1016/j.jpedsurg.2011.04.054; Paner GP, 2002, GYNECOL ONCOL, V86, P379, DOI 10.1006/gyno.2002.6777; Piek JMJ, 2004, AM J OBSTET GYNECOL, V191, P718, DOI 10.1016/j.ajog.2004.02.067; Piek JMJ, 2003, GYNECOL ONCOL, V90, P491, DOI 10.1016/S0090-8258(03)00365-2; Piek JMJ, 2001, LANCET, V358, P844, DOI 10.1016/S0140-6736(01)05992-X; Prentice L, 2012, FERTIL STERIL, V98, P942, DOI 10.1016/j.fertnstert.2012.06.039; Przybycin CG, 2010, AM J SURG PATHOL, V34, P1407, DOI 10.1097/PAS.0b013e3181ef7b16; Roma AA, 2014, HUM PATHOL, V45, P2417, DOI 10.1016/j.humpath.2014.08.003; Schallert EK, 2019, RADIOLOGY, V292, P172, DOI 10.1148/radiol.2019182563; Seidman JD, 2008, ARCH PATHOL LAB MED, V132, P1753, DOI 10.1043/1543-2165-132.11.1753; Seidman JD, 2011, INT J GYNECOL PATHOL, V30, P4, DOI 10.1097/PGP.0b013e3181f29d2a; Silva EG, 1998, INT J GYNECOL PATHOL, V17, P1, DOI 10.1097/00004347-199801000-00001; Smorgick N, 2009, JSLS-J SOC LAPAROEND, V13, P22; Tafe LJ, 2016, AM J PATHOL, V186, P671, DOI 10.1016/j.ajpath.2015.11.008; Tan OL, 2005, J PATHOL, V205, P483, DOI 10.1002/path.1719; Vang R, 2013, HISTOPATHOLOGY, V62, P44, DOI 10.1111/his.12046; Wang C., 2016, INT J ENV RES PUBLIC, V13; Wang YS, 2019, J PATHOL, V249, P206, DOI 10.1002/path.5308; Zhang S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13116-2	45	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232487	10.1371/journal.pone.0232487	http://dx.doi.org/10.1371/journal.pone.0232487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401810	Green Published, gold			2022-12-26	WOS:000537481000018
J	Tsai, CN; Yu, SC; Lee, CW; Pang, JHS; Wu, CH; Lin, SE; Chung, YH; Tsai, CL; Hsieh, SY; Yu, MC				Tsai, Chi-Neu; Yu, Shu-Chuan; Lee, Chao-Wei; Pang, Jong-Hwei Su; Wu, Chun-Hsin; Lin, Sey-En; Chung, Yi-Hsiu; Tsai, Chia-Lung; Hsieh, Sen-Yung; Yu, Ming-Chin			SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EXPRESSION; HCC; CXCR4; LIVER; GENE; METASTASIS; MANAGEMENT; CHEMOKINES; SORAFENIB	The overexpression of SOX4 in various kinds of cancer cells was associated with poor prognosis for patients. The role of SOX4 in angiogenesis and tumor microenvironment modulation was recently documented in breast cancer but remains unclear in hepatocellular carcinoma (HCC). In our study, the clinical relevance of SOX4 overexpression in HCC and its role in the tumor microenvironment were investigated. The overexpression of SOX4 (SOX4(high)) in tumor lesions was associated with higher microvessel density (P = 0.012), tumor thrombosis formation (P = 0.012), distant metastasis (P < 0.001), and an independent prognostic factor for disease-free survival in HCC patients (P = 0.048). Endogenous SOX4 knockout in Hep3B cells by the CRISPR/cas9 system reduced the expression of CXCL12, which, in turn, attenuated chemotaxis in human umbilical vein endothelial cells, tube formation in vitro, reduced tumor growth, reticular fiber production, and angiogenesis in vivo in a xenograft mouse model. Treatment with an antagonist targeting CXCR4 (AMD3100), a receptor of CXCL12, inhibited chemotaxis and tube formation in endothelial cells in vitro. The CXCL12 promoter was activated by ectopic expression of a Flag-tagged SOX4 plasmid, endogenous SOX4 knockdown abolished promoter activity of CXCL12 as shown by luciferase assays, and an association with the CXCL12 promoter was identified via chromatin immunoprecipitation in HCC cells. In conclusion, SOX4 modulates the CXCL12 promoter in HCC cells. The secretory CXCL12, in turn, modulates CXCR4 in endothelial cells, reticular fibers to regulate the tumor microenvironment and modulate neovascularization, which might contribute to the distant metastasis of tumors.	[Tsai, Chi-Neu; Lee, Chao-Wei; Pang, Jong-Hwei Su] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan 33302, Taiwan; [Tsai, Chi-Neu; Yu, Shu-Chuan; Lee, Chao-Wei; Wu, Chun-Hsin; Yu, Ming-Chin] Chang Gung Mem Hosp, Dept Surg, Linkou Branch, Taoyuan 33305, Taiwan; [Lin, Sey-En] Wan Fang Hosp, Dept Pathol, Taipei 11696, Taiwan; [Lin, Sey-En] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei 11031, Taiwan; [Chung, Yi-Hsiu] Chang Gung Mem Hosp, Ctr Adv Mol Imaging & Translat CAMIT, Taoyuan 33305, Taiwan; [Tsai, Chia-Lung] Chang Gung Mem Hosp, Linkou Branch, Genom Med Core Lab, Taoyuan 33305, Taiwan; [Hsieh, Sen-Yung] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Linkou Branch, Taoyuan 33305, Taiwan; [Yu, Ming-Chin] Xiamen Chang Gung Hosp, Dept Surg, Xiamen 361028, Peoples R China	Chang Gung University; Chang Gung Memorial Hospital; Taipei Municipal WanFang Hospital; Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yu, MC (corresponding author), Chang Gung Mem Hosp, Dept Surg, Linkou Branch, Taoyuan 33305, Taiwan.; Yu, MC (corresponding author), Xiamen Chang Gung Hosp, Dept Surg, Xiamen 361028, Peoples R China.	mingchin2000@gmail.com	Tsai, Chi-Neu/AAZ-2558-2020; Tsai, Chi neu/C-3373-2011; Yu, Ming-Chin/D-4464-2018	Tsai, Chi-Neu/0000-0002-5940-0696; Tsai, Chi neu/0000-0002-5940-0696; Lin, Sey-En/0000-0002-8994-9452; Yu, Ming-Chin/0000-0002-6980-7123	Chang Gung Medical Foundation in Taiwan [CMRPD1G0611, CMRPD1H0661, CORPG1G0021, CMRPG1J0061]; Ministry of Science and Technology [MOST 103-2314-B-182A-082-MY1-3, MOST 106-2314-B-182A-113]	Chang Gung Medical Foundation in Taiwan; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	Financial support by Chang Gung Medical Foundation in Taiwan: CMRPD1G0611 and CMRPD1H0661 for Dr CN Tsai, CORPG1G0021 and CMRPG1J0061 for Dr MC Yu and Ministry of Science and Technology: MOST 103-2314-B-182A-082-MY1-3 and MOST 106-2314-B-182A-113 for Dr MC Yu.	Boogerd CJJ, 2011, CELL MOL LIFE SCI, V68, P3949, DOI 10.1007/s00018-011-0693-7; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cheung M, 2000, MOL BRAIN RES, V79, P180, DOI 10.1016/S0169-328X(00)00109-1; Choi C, 2014, LIVER CANCER, V3, P405, DOI 10.1159/000343861; Chun YS, 2018, ANN SURG ONCOL, V25, P845, DOI 10.1245/s10434-017-6025-x; Chung YH, 2017, MOLECULES, V22, DOI 10.3390/molecules22111946; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dong YY, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0795-5; Fang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052804; Fang JH, 2019, HEPATOLOGY, V70, P824, DOI 10.1002/hep.30366; Fong ZV, 2014, CANCER-AM CANCER SOC, V120, P2824, DOI 10.1002/cncr.28730; Foronda M, 2014, CELL REP, V8, P486, DOI 10.1016/j.celrep.2014.06.031; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ghanem I, 2014, AM J TRANSL RES, V6, P340; Gores GJ, 2014, NAT REV GASTRO HEPAT, V11, P645, DOI 10.1038/nrgastro.2014.157; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Guo F, 2016, ONCOGENE, V35, P816, DOI 10.1038/onc.2015.139; Hanley KL, 2015, HEPATOLOGY, V62, P343, DOI 10.1002/hep.27860; Hasegawa S, 2016, INT J ONCOL, V48, P145, DOI 10.3892/ijo.2015.3258; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue H, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2090-y; Janssens R, 2018, CELL MOL IMMUNOL, V15, P299, DOI 10.1038/cmi.2017.107; Jin PP, 2018, JPN J CLIN ONCOL, V48, P1058, DOI 10.1093/jjco/hyy138; Kasagi Y, 2016, CANCER RES, V76, P347, DOI 10.1158/0008-5472.CAN-15-1563; Keating GM, 2017, TARGET ONCOL, V12, P243, DOI 10.1007/s11523-017-0484-7; Kee BL, 2014, BLOOD, V123, P4009, DOI 10.1182/blood-2014-05-574178; Koumangoye RB, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0284-y; Kow AWC, 2012, ANN SURG ONCOL, V19, P2246, DOI 10.1245/s10434-012-2260-3; Lai YH, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-50; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Liu H, 2008, CELL MOL IMMUNOL, V5, P373, DOI 10.1038/cmi.2008.46; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Pan X, 2006, BIOCHEM BIOPH RES CO, V344, P727, DOI 10.1016/j.bbrc.2006.03.194; Parvani JG, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3466; Polimeno MN, 2015, CELL MOL IMMUNOL, V12, P474, DOI 10.1038/cmi.2014.102; Sartorius K, 2015, CANCER EPIDEMIOL, V39, P284, DOI 10.1016/j.canep.2015.04.006; Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108; Semaan A, 2017, VIRCHOWS ARCH, V470, P185, DOI 10.1007/s00428-016-2051-5; Sethi A, 2011, INVEST OPHTH VIS SCI, V52, P5240, DOI 10.1167/iovs.11-7287; Shah AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142337; Shibuta K, 2002, JPN J CANCER RES, V93, P789, DOI 10.1111/j.1349-7006.2002.tb01321.x; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tadeo I, 2016, BRIT J CANCER, V115, P480, DOI 10.1038/bjc.2016.210; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vervoort SJ, 2018, ELIFE, V7, DOI 10.7554/eLife.27706; Wang BC, 2016, TUMOR BIOL, V37, P9131, DOI 10.1007/s13277-015-4756-5; Wang L, 2014, PROSTATE, V74, P647, DOI 10.1002/pros.22783; Xu J, 2017, CLIN CANCER RES, V23, P4482, DOI 10.1158/1078-0432.CCR-16-2131; You Y, 2016, ONCOTARGET, V7, P32221, DOI 10.18632/oncotarget.8515; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045	55	17	17	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	24					4695	4710		10.1038/s41388-020-1319-z	http://dx.doi.org/10.1038/s41388-020-1319-z		MAY 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LY0HO	32404985				2022-12-26	WOS:000532808000001
J	Hargreaves, SM; Araujo, WMC; Nakano, EY; Zandonadi, RP				Hargreaves, Shila Minari; Coelho Araujo, Wilma Maria; Nakano, Eduardo Yoshio; Zandonadi, Renata Puppin			Brazilian vegetarians diet quality markers and comparison with the general population: A nationwide cross-sectional study	PLOS ONE			English	Article							MEAT-EATERS; EPIC-OXFORD; HEALTH; CONSUMPTION; NUTRITION; NUTRIENT; VEGAN; FOOD	Background Vegetarianism is an increasingly common practice worldwide. Despite good evidence from other countries regarding vegetarians' diet quality, data from the Brazilian population is still scarce. Objective To characterize the vegetarian Brazilian population and evaluate their diet quality compared to the general Brazilian population. Methods We performed a nationwide cross-sectional study using an online self-administered questionnaire, previously validated for the Brazilian population, to evaluate diet quality markers of vegetarians. The invitation to participate in the survey was spread nationwide, aimed at vegetarian communities. Individuals who considered themselves vegetarians and were at least 18 years old were eligible to participate. The results on regular intake and intake adequacy were compared among vegetarians and between genders using the Pearson's chi-square test. The body mass index (BMI) were analyzed by the Analysis of Variance (ANOVA) followed by Tukey post-hoc test. The Kolmogorov-Smirnov test verified normality. All analyses considered bilateral hypotheses and a significance level of 5% (p < 0.05). Results Brazilian vegetarians presented better diet quality markers, such as higher regular weekly intake and adequate daily intake of fruits and vegetables, and lower regular intake of soft drinks when compared to the general Brazilian population. Vegetarians also presented a proportionally higher consumption of natural foods and lower consumption of processed foods. Among vegetarians, a higher proportion of vegans showed positive results regarding diet markers analysis, when compared to vegetarians, pesco-vegetarians, and semi-vegetarians. Conclusions Vegetarians showed better results of diet adequacy when compared to the general population in Brazil, and vegans fared better when compared with other vegetarians. Despite the good results found, a large proportion of the participants still did not achieve the fruits and vegetables daily intake, according to the World Health Organization recommendations.	[Hargreaves, Shila Minari; Coelho Araujo, Wilma Maria; Zandonadi, Renata Puppin] Univ Brasilia UnB, Fac Hlth Sci, Dept Nutr, Brasilia, DF, Brazil; [Nakano, Eduardo Yoshio] Univ Brasilia, Dept Stat, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia	Hargreaves, SM (corresponding author), Univ Brasilia UnB, Fac Hlth Sci, Dept Nutr, Brasilia, DF, Brazil.	shilaminari@gmail.com	Zandonadi, Renata Puppin/O-7908-2017; Nakano, Eduardo Y/G-1660-2011	Zandonadi, Renata Puppin/0000-0003-0370-3089; Nakano, Eduardo Y/0000-0002-9071-8512	Universidade de Brasilia DPI/DPG [02/2020]	Universidade de Brasilia DPI/DPG	This study was supported by Universidade de Brasi ' lia DPI/DPG grant number Edital 02/2020. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkerwi A, 2014, NUTRITION, V30, P613, DOI 10.1016/j.nut.2013.10.001; [Anonymous], PESQ NAC AM DOM CONT; [Anonymous], WHO MEAN BOD MASS IN; Arvaniti F, 2008, CRIT REV FOOD SCI, V48, P317, DOI 10.1080/10408390701326268; Bedford JL, 2005, INT J BEHAV NUTR PHY, V2, P1; Beezhold B, 2015, NUTR NEUROSCI, V18, P289, DOI 10.1179/1476830514Y.0000000164; Beezhold BL, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-26; Brasil Ministerio da Saude, 2014, GUIA ALIMENTAR POPUL; Clarys P, 2014, NUTRIENTS, V6, P1318, DOI 10.3390/nu6031318; Coqueiro R da S, 2009, MEDIDAS AUTOREFERIDA, V11, P113, DOI [10.5007/1980-0037.2009v11n1p112, DOI 10.5007/1980-0037.2009V11N1P112]; Coulston AM, 2001, AM J CLIN NUTR, V74, P417; Craig WJ, 2009, J AM DIET ASSOC, V109, P1266, DOI 10.1016/j.jada.2009.05.027; Craig WJ, 2010, NUTR CLIN PRACT, V25, P613, DOI 10.1177/0884533610385707; Crozier SR, 2010, EUR J CLIN NUTR, V64, P99, DOI 10.1038/ejcn.2009.114; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; Davidson DJ, 1996, ENVIRON BEHAV, V28, P302, DOI 10.1177/0013916596283003; Davis C, 2015, NUTRIENTS, V7, P9139, DOI 10.3390/nu7115459; De Souza E.C.G., 2017, ALIMENTACAO VEGETARI, V1st ed.; Dinu M, 2017, CRIT REV FOOD SCI, V57, P3640, DOI 10.1080/10408398.2016.1138447; Dyett PA, 2013, APPETITE, V67, P119, DOI 10.1016/j.appet.2013.03.015; Evans JR, 2005, INTERNET RES, V15, P195, DOI 10.1108/10662240510590360; Fraser GE, 2009, AM J CLIN NUTR, V89, pS1607, DOI 10.3945/ajcn.2009.26736K; Gomes AA, 2015, CADERNOS SAUDE COLET, V23, P368, DOI [10.1590/1414-462X201500040055, DOI 10.1590/1414-462X201500040055]; Gossard M.H., 2003, HUM ECOL REV, V10, P1, DOI DOI 10.2307/24707082; Group TVR, 2016, MAN AD US VEG VEG MA; Hair J.F., 2009, AN LISE MULTIVARIADA, V6th ed.; Holanda L. B., 2006, REV PAUL PEDIATR, V24, P62; Huang T, 2012, ANN NUTR METAB, V60, P233, DOI 10.1159/000337301; Instituto Brasileiro de Geografia e Estatistica, 2018, PNAD CONT TIC 2017 I; Kahleova H, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030615; Kahleova H, 2015, J AM COLL NUTR, V34, P448, DOI 10.1080/07315724.2014.976890; Kant AK, 2004, DIETARY PATTERNS HLT, DOI [10.1016/j.jada.2004.01.010, DOI 10.1016/J.JADA.2004.01.010]; Kim MS, 2013, ENV MICROBIOL REP, V5, P765, DOI 10.1111/1758-2229.12079; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lea E, 2001, APPETITE, V36, P127, DOI 10.1006/appe.2000.0386; Lea EJ, 2006, EUR J CLIN NUTR, V60, P828, DOI 10.1038/sj.ejcn.1602387; Leitzmann C, 2014, AM J CLIN NUTR, V100, p496S, DOI 10.3945/ajcn.113.071365; Lyon MR, 2012, CURR OBES REP, V1, P59, DOI 10.1007/s13679-012-0016-9; Marsh K, 2012, AM J LIFESTYLE MED, V6, P250, DOI 10.1177/1559827611425762; McEvoy CT, 2015, WORLD REV NUTR DIET, V113, P134, DOI 10.1159/000367873; McEvoy CT, 2012, PUBLIC HEALTH NUTR, V15, P2287, DOI 10.1017/S1368980012000936; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Melina V, 2016, J ACAD NUTR DIET, V116, P1970, DOI 10.1016/j.jand.2016.09.025; Ministerio da Saude, 2018, VIGITEL BRASIL 2017; Ministerio da Saude, 2016, VIG BRAS 2016 HAB BR; Ministerio da Saude, 2019, VIG BRAS 2018 VIG FA, DOI [10.3390/nu11030615, DOI 10.3390/NU11030615]; Miranda D., 2013, DEMETRA ALIMENTACAO, V8, P163, DOI [10.12957/demetra.2013.4773, DOI 10.12957/DEMETRA.2013.4773]; Monteiro CA, 2005, REV SAUDE PUBL, V39, P47, DOI 10.1590/S0034-89102005000100007; Monteiro CA, 2008, REV SAUDE PUBL, V42, P582, DOI 10.1590/S0034-89102008000400002; ORLICH MJ, 2014, AM J CLIN NUTR, V100, P2, DOI DOI 10.3945/AJCN.113.071233.AM; Papier K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040824; Parker HW, 2019, NUTR REV, V77, P144, DOI 10.1093/nutrit/nuy067; Patterson RE, 1989, J AM DIET ASSOC, V94, P57; Pratesi CB, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091167; RIOSCOVIAN D, 2016, FRONT MICROBIOL, V7, DOI DOI 10.3389/FMICB.2016.00001; Rizzo NS, 2013, J ACAD NUTR DIET, V113, P1610, DOI 10.1016/j.jand.2013.06.349; Rosenfeld DL, 2017, APPETITE, V116, P456, DOI 10.1016/j.appet.2017.05.039; Ruby MB, 2012, APPETITE, V58, P141, DOI 10.1016/j.appet.2011.09.019; Slywitch E., GUIA ALIMENTAR DIETA; Souza Amanda de Moura, 2011, Rev Bras Epidemiol, V14 Suppl 1, P44, DOI 10.1590/S1415-790X2011000500005; Spencer EA, 2003, INT J OBESITY, V27, P728, DOI 10.1038/sj.ijo.0802300; Teixeira Rita de Cássia Moreira de Almeida, 2006, Rev. bras. epidemiol., V9, P131, DOI 10.1590/S1415-790X2006000100016; Tharrey M, 2018, INT J EPIDEMIOL, V47, P1603, DOI 10.1093/ije/dyy030; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Wang FL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002408; Weder S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040832; WHO, 2003, WHO TECHN REP SER, V797, P149; Widmer RJ, 2015, AM J MED, V128, P229, DOI 10.1016/j.amjmed.2014.10.014; Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4; Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141	70	12	12	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232954	10.1371/journal.pone.0232954	http://dx.doi.org/10.1371/journal.pone.0232954			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0SY	32396556	Green Published, gold			2022-12-26	WOS:000537475000028
J	Wolf, T; Sebanz, N; Knoblich, G				Wolf, Thomas; Sebanz, Natalie; Knoblich, Gunther			Adaptation to unstable coordination patterns in individual and joint actions	PLOS ONE			English	Article							PHASE-TRANSITIONS; MUSIC; MOVEMENTS; DYNAMICS; RHYTHM; DELAY	Previous research on interlimb coordination has shown that some coordination patterns are more stable than others, and function as attractors in the space of possible phase relations between different rhythmic movements. The canonical coordination patterns, i.e. the two most stable phase relations, are in-phase (0 degree) and anti-phase (180 degrees). Yet, musicians are able to perform other coordination patterns in intrapersonal as well as in interpersonal coordination with remarkable precision. This raises the question of how music experts manage to produce these unstable patterns of movement coordination. In the current study, we invited participants with at least five years of training on a musical instrument. We used an adaptation paradigm to address two factors that may facilitate producing unstable coordination patterns. First, we investigated adaptation in different coordination settings, to test the hypothesis that the lower coupling strength between individuals during joint performance makes it easier to achieve stability outside of the canonical patterns than the stronger coupling during individual bimanual performance. Second, we investigated whether adding to the structure of action effects may support achieving unstable coordination patterns, both intra- and inter-individually. The structure of action effects was strengthened by adding a melodic contour to the action effects, a measure that has been shown to improve the acquisition of bimanual coordination skills. Adaptation performance was measured both in terms of asynchrony and variability thereof. As predicted, we found that producing unstable patterns benefitted from the weaker coupling during joint performance. Surprisingly, the structure of action effects did not help with achieving unstable coordination patterns.	[Wolf, Thomas; Sebanz, Natalie; Knoblich, Gunther] Cent European Univ, Dept Cognit Sci, Budapest, Hungary	Central European University	Wolf, T (corresponding author), Cent European Univ, Dept Cognit Sci, Budapest, Hungary.	wolft@ceu.edu		Sebanz, Natalie/0000-0003-1280-8974; Knoblich, Gunther/0000-0003-4463-5318	European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant [609819]; ERC [616072]	European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant; ERC(European Research Council (ERC)European Commission)	This research was supported by the European Research Council (https://erc.europa.eu) under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no 609819, SOMICS, awarded to G.K, and by ERC grant agreement no 616072, JAXPERTISE, awarded to N.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arom S., 1991, AFRICAN POLYPHONY PO; Aucouturier JJ, 2017, COGNITION; Copland Aaron, 2004, AARON COPLAND READER; DEUTSCH D, 1983, PERCEPT PSYCHOPHYS, V34, P331, DOI 10.3758/BF03203045; Dyer JF, 2017, EXPT BRAIN RES; Dyer JF, 2017, PSYCHOL RES; Eronen A, 2000, INT CONF ACOUST SPEE, P753; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Field A, 2012, DISCOVERING STAT USI, P957; Folio C., 1945, CONCERT MUSIC ROCK J, P103; Fuchs A., 2018, COMPLEXITY SYNERGETI, P301, DOI [DOI 10.1007/978-3-319-64334-2_23, 10.1007/978-3-319-64334-2_23]; GOULD RG, 1970, IEEE SPECTRUM, V7, P47, DOI 10.1109/MSPEC.1970.5213327; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Herrera-Boyer P, 2003, J NEW MUSIC RES; HOLM S, 1979, SCAND J STAT, V6, P65; KAY BA, 1987, J EXP PSYCHOL HUMAN, V13, P178, DOI 10.1037/0096-1523.13.2.178; Keller PE, 2008, EMERG COMMUN-STUD NE, V10, P205; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; KLAPP ST, 1979, MEM COGNITION, V7, P375, DOI 10.3758/BF03196942; Knoblich G, 2003, J EXP PSYCHOL LEARN, V29, P1006, DOI 10.1037/0278-7393.29.5.1006; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; Kubik G., 1964, J ROYAL ANTHR I GREA, V94, P138, DOI DOI 10.2307/2844378; Kubik G., 1960, AFRICAN MUSIC, V2, P6; Large E. W., 1994, Connection Science, V6, P177, DOI 10.1080/09540099408915723; Locke D, 1982, ETHNOMUSICOLOGY; Loehr JD, 2013, J COGNITIVE NEUROSCI, V25, P1049, DOI 10.1162/jocn_a_00388; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Miton H, 2015, TRENDS COGN SCI, V19, P633, DOI 10.1016/j.tics.2015.08.007; Miton H, 2015, EVOL HUM BEHAV, V36, P303, DOI 10.1016/j.evolhumbehav.2015.01.003; Muraoka T., 2016, J PHYS FITNESS SPORT, V5, P349, DOI [10.7600/jpfsm.5.349, DOI 10.7600/JPFSM.5.349]; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Pieslak J, 2007, MUSIC THEOR SPECTRUM, V29, P219, DOI 10.1525/mts.2007.29.2.219; POLLARD HF, 1968, ACUSTICA, V20, P189; Poudrier E, 2013, MUSIC PERCEPTION INT; Pressing J, 2002, MUSIC PERCEPT, V19, P285, DOI 10.1525/mp.2002.19.3.285; Ravignani A, 2016, NATURE HUMAN BEHAV; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2012, MUSIC PERCEPT, V30, P205, DOI 10.1525/MP.2012.30.2.205; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Sabu S, DOES PARTNERS UNPUB; Savage PE, 2017, MUSIC PERCEPT, V34, P327, DOI 10.1525/MP.2017.34.3.327; Schmidt RC, 1998, J EXP PSYCHOL HUMAN, V24, P884, DOI 10.1037/0096-1523.24.3.884; SCHMIDT RC, 1994, BIOL CYBERN, V70, P369, DOI 10.1007/BF00200334; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Schoonderwaldt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106615; Scott-Phillips T, 2018, EVOL ANTHROPOL, V27, P162, DOI 10.1002/evan.21716; Summers JJ, 2002, HUMAN MOVEMENT SCI; Taylor SA, 2003, WORLD MUSIC, V45, P83; Vesper C, 2010, NEURAL NETWORKS; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616	51	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232667	10.1371/journal.pone.0232667	http://dx.doi.org/10.1371/journal.pone.0232667			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0RD	32392210	Green Published, gold			2022-12-26	WOS:000537470300016
J	Chen, S; Zhu, YQ; Wayland, R; Yang, YK				Chen, Si; Zhu, Yiqing; Wayland, Ratree; Yang, Yike			How musical experience affects tone perception efficiency by musicians of tonal and non-tonal speakers?	PLOS ONE			English	Article							CATEGORICAL PERCEPTION; SPEECH-PERCEPTION; LANGUAGE EXPERIENCE; LEXICAL TONES; STEADY-STATE; PITCH; DISCRIMINATION; MANDARIN; IDENTIFICATION; ENGLISH	Purpose To investigate if, regardless of language background (tonal or non-tonal), musicians may show stronger CP than non-musicians; To examine if native speakers of English (English or non-tonal musicians henceforth) or Mandarin Chinese (Mandarin or tonal musicians henceforth) can better accommodate multiple functions of the same acoustic cue and if musicians' sensitivity to pitch of lexical tones comes at the cost of slower processing. Method English and Mandarin Musicians and non-musicians performed a categorical identification and a discrimination task on rising and falling continua of fundamental frequency on two vowels with 9 duration values. Results Non-tonal musicians exhibited significantly stronger categorical perception of pitch contour than non-tonal non-musicians. However, tonal musicians did not consistently perceive the two types of pitch directions more categorically than tonal non-musicians. Both tonal and non-tonal musicians also benefited more from increasing stimulus duration in processing pitch changes than non-musicians and they generally require less time for pitch processing. Musicians were also more sensitive to intrinsic F0 in pitch perception and differences of pitch types. Conclusion The effect of musical training strengthens categorical perception more consistently in non-tonal speakers than tonal speakers. Overall, musicians benefit more from increased stimulus duration, due perhaps to their greater sensitivity to temporal information, thus allowing them to be better at forming a more robust auditory representation and matching sounds to internalized memory templates. Musicians also attended more to acoustic details such as intrinsic F0 and pitch types in pitch processing, and yet, overall, their categorization of pitch was not compromised by traces of these acoustic details from their auditory short-term working memory. These findings may lead to a better understanding of pitch perception deficits in special populations, particularly among individuals diagnosed with autism spectrum disorder (ASD).	[Chen, Si; Yang, Yike] Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Kowloon, Hong Kong, Peoples R China; [Chen, Si] Peking Univ, Hong Kong Polytech Univ, Res Ctr Chinese Linguist, Hong Kong, Peoples R China; [Zhu, Yiqing; Wayland, Ratree] Univ Florida, Dept Linguist, Gainesville, FL USA	Hong Kong Polytechnic University; Hong Kong Polytechnic University; Peking University; State University System of Florida; University of Florida	Chen, S (corresponding author), Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Kowloon, Hong Kong, Peoples R China.; Chen, S (corresponding author), Peking Univ, Hong Kong Polytech Univ, Res Ctr Chinese Linguist, Hong Kong, Peoples R China.	sarah.chen@polyu.edu.hk	Yang, Yike/AGZ-5497-2022; Chen, Si/B-8601-2015	Yang, Yike/0000-0002-2297-6878; Chen, Si/0000-0003-3581-9561	Research Grants Council of the Hong Kong Special Administrative Region; Hong Kong Polytechnic University [1-ZVHJ, 1-ZZJP, G-YBGK];  [25602816]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Hong Kong Polytechnic University(Hong Kong Polytechnic University); 	This work was supported by the Research Grants Council of the Hong Kong Special Administrative Region; Funding scheme: Early Career Scheme (grant number: 25602816) (http://www.ugc.edu.hk/eng/rgc/about/term/rgc.htm), Fund for ECS Project Rated 3.5 CRG (grant number: G-YBGK) Grant of the Hong Kong Polytechnic University (grant number: 1-ZVHJ; 1-ZZJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON AS, 1978, LANG SPEECH, V21, P319, DOI 10.1177/002383097802100406; ADES AE, 1977, PSYCHOL REV, V84, P524, DOI 10.1037/0033-295X.84.6.524; Alexander J.A., 2005, 9 EUR C SPEECH COMM 9 EUR C SPEECH COMM, VNinth; Altmann CF, 2014, NEUROPSYCHOLOGIA, V64, P13, DOI 10.1016/j.neuropsychologia.2014.09.006; Apfelbaum KS, 2014, LANG COGN NEUROSCI, V29, P1070, DOI 10.1080/01690965.2013.824995; Bates D, 2015, J STAT SOFTWARE; Behne D, 2006, J ACOUST SOC AM, V120, P3168; Belotel-Grenie A, 1995, P 13 INT C PHON SCI, P400; Belotel-Grenie A., 1994, 3 INT C SPOK LANG PR 3 INT C SPOK LANG PR; Bidelman GM, 2017, NEUROSCIENCE, V348, P107, DOI 10.1016/j.neuroscience.2017.02.015; Bidelman GM, 2011, BRAIN COGNITION, V77, P1, DOI 10.1016/j.bandc.2011.07.006; BLICHER DL, 1990, J PHONETICS, V18, P37, DOI 10.1016/S0095-4470(19)30357-2; Brownell MD, 2002, J MUSIC THER, V39, P117, DOI 10.1093/jmt/39.2.117; Burnham D, 2007, LANGUAGE EXPERIENCE; Burnham D, 2002, P 9 INT C SPEECH SCI, P2; Burnham D, 2015, PSYCHOL MUSIC, V43, P881, DOI 10.1177/0305735614546359; Casserly ED, 2010, WIRES COGN SCI, V1, P629, DOI 10.1002/wcs.63; Chen S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180656; Cui A, 2019, J ACOUST SOC AM, V146, P4086, DOI 10.1121/1.5134442; EIMAS PD, 1963, LANG SPEECH, V6, P206, DOI 10.1177/002383096300600403; Francis AL, 2003, PERCEPT PSYCHOPHYS, V65, P1029, DOI 10.3758/BF03194832; Fujisaki H., 1970, Annual Report of the Engineering Research Institute, Faculty of Engineering, University of Tokyo, V29, P207; George EM, 2011, NEUROPSYCHOLOGIA, V49, P1083, DOI 10.1016/j.neuropsychologia.2011.02.001; Gottfried T. L., 2000, J ACOUST SOC AM, V108, P2604, DOI DOI 10.1121/1.4743698; Halle PA, 2004, J PHONETICS, V32, P395, DOI 10.1016/S0095-4470(03)00016-0; HEALY AF, 1982, J EXP PSYCHOL HUMAN, V8, P68, DOI 10.1037/0096-1523.8.1.68; Janse E, 2003, PRODUCTION PERCEPTIO; Jiang J, 2015, J AUTISM DEV DISORD, V45, P2067, DOI 10.1007/s10803-015-2370-4; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krishnan A, 2004, HEARING RES, V189, P1, DOI 10.1016/S0378-5955(03)00402-7; Lee CY, 2008, J ACOUST SOC AM, V124, P3235, DOI 10.1121/1.2990713; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; LIBERMAN AM, 1996, SPEECH SPECIAL CODE; Liu SY, 2004, LANG SPEECH, V47, P109, DOI 10.1177/00238309040470020101; LOCKE S, 1973, Cortex, V9, P355; McMurray B, 2002, COGNITION, V86, pB33, DOI 10.1016/S0010-0277(02)00157-9; Medina D, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01315; Mirman D, 2004, J ACOUST SOC AM, V116, P1198, DOI 10.1121/1.1766020; MOULINES E, 1995, SPEECH COMMUN, V16, P175, DOI 10.1016/0167-6393(94)00054-E; Nan Y, 2018, P NATL ACAD SCI USA; Ohman S., 1979, FRONTIERS SPEECH COM, P127; Ortega-Llebaria M, 2017, BILING-LANG COGN, V20, P367, DOI 10.1017/S1366728915000723; Patel AD, 2007, TRENDS COGN SCI, V11, P369, DOI 10.1016/j.tics.2007.08.003; Peng G, 2010, J PHONETICS, V38, P616, DOI 10.1016/j.wocn.2010.09.003; PISONI DB, 1973, PERCEPT PSYCHOPHYS, V13, P253, DOI 10.3758/BF03214136; PISONI DB, 1975, MEM COGNITION, V3, P7, DOI 10.3758/BF03198202; PISONI DB, 1976, J ACOUST SOC AM, V59, pS39, DOI 10.1121/1.2002669; Pisoni DB, 1971, NATURE CATEGORICAL P; POLLACK I, 1971, PSYCHON SCI, V24, P299; Prom-on S, 2009, J ACOUST SOC AM, V125, P405, DOI 10.1121/1.3037222; RAZ I, 1977, J ACOUST SOC AM, V62, pS60, DOI 10.1121/1.2016288; Repp B., 1984, SPEECH LANGUAGE ADV, V10, P243, DOI [10.1016/B978-0-12-608610-2.50012-1, DOI 10.1016/B978-0-12-608610-2.50012-1]; REPP BH, 1979, J EXP PSYCHOL HUMAN, V5, P129, DOI 10.1037/0096-1523.5.1.129; Sares AG, 2018, J SPEECH LANG HEAR R, V61, P496, DOI 10.1044/2017_JSLHR-S-17-0207; Shen GN, 2016, J ACOUST SOC AM, V140, P4396, DOI 10.1121/1.4971765; SIEGEL JA, 1977, PERCEPT PSYCHOPHYS, V21, P399, DOI 10.3758/BF03199493; STOLL G, 1984, SPEECH COMMUN, V3, P137, DOI 10.1016/0167-6393(84)90035-9; Tseng C. Y., 1981, THESIS; Verde MF, 2006, PERCEPT PSYCHOPHYS, V68, P643, DOI 10.3758/BF03208765; WANG WSY, 1976, ANN NY ACAD SCI, V280, P61, DOI 10.1111/j.1749-6632.1976.tb25472.x; Wang XY, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43254; Wang YN, 2011, STAT BIOPHARM RES, V3, P1, DOI 10.1198/sbr.2011.09051; Wang YP, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aan8072; Wayland R, 2010, J PHONETICS, V38, P654, DOI 10.1016/j.wocn.2010.10.001; WHALEN DH, 1992, PHONETICA, V49, P25, DOI 10.1159/000261901; WHALEN DH, 1995, J PHONETICS, V23, P349, DOI 10.1016/S0095-4470(95)80165-0; Wong PCM, 2007, APPL PSYCHOLINGUIST, V28, P565, DOI 10.1017/S0142716407070312; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; WOOD CC, 1976, J ACOUST SOC AM, V60, P1381, DOI 10.1121/1.381231; Wu H, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00436; Xu L, 2002, J ACOUST SOC AM, V112, P247, DOI 10.1121/1.1487843; Xu Y, 2002, J ACOUST SOC AM, V111, P1399, DOI 10.1121/1.1445789; Xu YS, 2006, J ACOUST SOC AM, V120, P1063, DOI 10.1121/1.2213572; Yu AC, 2014, 4 INT S TON ASP LANG; Zhang J, 2005, PSYCHOMETRIKA, V70, P203, DOI 10.1007/s11336-003-1119-8; Zhao TC, 2015, J ACOUST SOC AM, V138, pEL133, DOI 10.1121/1.4927632; Zhao TC, 2015, J ACOUST SOC AM, V137, P1452, DOI 10.1121/1.4913457	77	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232514	10.1371/journal.pone.0232514	http://dx.doi.org/10.1371/journal.pone.0232514			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0QJ	32384088	Green Published, gold			2022-12-26	WOS:000537468300015
J	Bajcar, EA; Adamczyk, WM; Wiercioch-Kuzianik, K; Babel, P				Bajcar, Elzbieta A.; Adamczyk, Waclaw M.; Wiercioch-Kuzianik, Karolina; Babel, Przemyslaw			Nocebo hyperalgesia can be induced by classical conditioning without involvement of expectancy	PLOS ONE			English	Article							PLACEBO ANALGESIA; NONCONSCIOUS ACTIVATION; SPINAL-CORD; PAIN; FEAR; RESPONSES; SEX; MECHANISMS; INDUCTION; ANXIETY	Influential theoretical accounts take the position that classical conditioning can induce placebo effects through conscious expectancies. In the current study two different conditioning procedures (hidden and open) were used to separate expectancy from conditioning in order to reveal the role of expectancy in the formation of nocebo hyperalgesia. Eighty-seven healthy females were randomly assigned to three groups (hidden conditioning, open conditioning, and control). Participants were selected according to the Fear of Pain Questionnaire scores and assigned to two subgroups: high and low level of fear of pain (trait). They received electrocutaneous pain stimuli preceded by either an orange or blue color. During the conditioning phase, one color was paired with pain stimuli of moderate intensity (control stimuli) and the other color was paired with pain stimuli of high intensity (nocebo stimuli) in both hidden and open conditioning groups. Only participants in the open conditioning group were informed about this association, however just before the testing phase the expectancy of hyperalgesia induced in this way was withdrawn. In the control group, both colors were followed by control pain stimuli. During the testing phase all participants received a series of stimuli of the same intensity, regardless of the preceding color. Participants rated pain intensity, expectancy of pain intensity and fear (state). We found that nocebo hyperalgesia was induced by hidden rather than open conditioning. The hidden conditioning procedure did not produce conscious expectancies related to pain. Nocebo hyperalgesia was induced in participants with low and high fear of pain and there was no difference in the magnitude of the nocebo effect between both groups. Nocebo hyperalgesia was not predicted by the fear of upcoming painful stimuli.	[Bajcar, Elzbieta A.; Adamczyk, Waclaw M.; Wiercioch-Kuzianik, Karolina; Babel, Przemyslaw] Jagiellonian Univ, Inst Psychol, Pain Res Grp, Krakow, Poland; [Adamczyk, Waclaw M.] Jerzy Kukuczka Acad Phys Educ, Dept Kinesiotherapy & Special Methods Physiothera, Katowice, Poland	Jagiellonian University; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach	Babel, P (corresponding author), Jagiellonian Univ, Inst Psychol, Pain Res Grp, Krakow, Poland.	przemyslaw.babel@uj.edu.pl	Adamczyk, Waclaw M./X-5590-2018	Adamczyk, Waclaw M./0000-0001-8941-8355; Wiercioch-Kuzianik, Karolina/0000-0003-1480-6569	National Science Centre in Poland [2014/14/E/HS6/00415]	National Science Centre in Poland(National Science Centre, Poland)	The study was funded by the National Science Centre in Poland (https://www.ncn.gov.pl/?language=en) under the grant no. 2014/14/E/HS6/00415 awarded to PB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlas LY, 2012, NEUROSCI LETT, V520, P140, DOI 10.1016/j.neulet.2012.03.039; Babel P, 2008, STUD PSYCHOL, V46, P13; Babel P, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00449; Babel P, 2018, PAIN MED, V19, P1156, DOI 10.1093/pm/pnx177; Babel P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181856; Bajcar EA, 2020, PAIN MED, V21, P548, DOI 10.1093/pm/pnz123; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 2006, J NEUROSCI, V26, P12014, DOI 10.1523/JNEUROSCI.2947-06.2006; Benedetti F, 2018, EXPERT OPIN DRUG SAF, V17, P541, DOI 10.1080/14740338.2018.1474199; Benedetti F, 2003, CURR OPIN ANESTHESIO, V16, P515, DOI 10.1097/00001503-200310000-00012; Blasini M, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000585; Boakes RA., 1989, AVERSION AVOIDANCE A, P381; Brascher AK, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02163; Brewer William P., 1974, COGNITION SYMBOLIC P, P1; Colagiuri B, 2015, J PAIN, V16, P995, DOI 10.1016/j.jpain.2015.06.012; Colloca L, 2008, PAIN, V136, P211, DOI 10.1016/j.pain.2008.02.006; Colloca L, 2004, LANCET NEUROL, V3, P679, DOI 10.1016/S1474-4422(04)00908-1; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Colloca L, 2020, NEW ENGL J MED, V382, P554, DOI 10.1056/NEJMra1907805; Colloca L, 2017, SCIENCE, V358, P44, DOI 10.1126/science.aap8488; Colloca L, 2011, PHILOS T R SOC B, V366, P1859, DOI 10.1098/rstb.2010.0398; Colloca L, 2010, PAIN, V151, P430, DOI 10.1016/j.pain.2010.08.007; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Corsi N, 2017, FRONT PSYCHOL, V8, P1, DOI 10.3389/fpsyg.2017.00308; deJong PJ, 1996, INT J BEHAV MED, V3, P14, DOI 10.1207/s15327558ijbm0301_2; EDENS JL, 1995, BEHAV THER, V26, P197, DOI 10.1016/S0005-7894(05)80102-9; Egorova N, 2017, EUR J PAIN, V21, P1243, DOI 10.1002/ejp.1024; Egorova N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16809; Evers AWM, 2018, PSYCHOTHER PSYCHOSOM, V87, P204, DOI 10.1159/000490354; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Freeman S, 2015, NEUROIMAGE, V112, P197, DOI 10.1016/j.neuroimage.2015.03.015; Geuter S, 2013, J NEUROSCI, V33, P13784, DOI 10.1523/JNEUROSCI.2191-13.2013; Hauser W, 2012, CLIN EXP RHEUMATOL, V30, pS78; Hauser W, 2012, DTSCH ARZTEBL INT, V109, P459, DOI 10.3238/arztebl.2012.0459; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Howick J, 2018, TRIALS, V19, DOI 10.1186/s13063-018-3042-4; Hunter T, 2014, EUR J PAIN, V18, P914, DOI 10.1002/j.1532-2149.2013.00436.x; Jensen K, 2015, P NATL ACAD SCI USA, V112, P7863, DOI 10.1073/pnas.1504567112; Jensen KB, 2015, CEREB CORTEX, V25, P3903, DOI 10.1093/cercor/bhu275; Jensen KB, 2012, P NATL ACAD SCI USA, V109, P15959, DOI 10.1073/pnas.1202056109; KENNEDY W P, 1961, Med World, V95, P203; Keogh E, 2001, PAIN, V91, P91, DOI 10.1016/S0304-3959(00)00422-X; Kirsch I, 1997, APPL PREV PSYCHOL, V6, P69, DOI 10.1016/S0962-1849(05)80012-5; KISSEL P, 1964, PLACEBOS EFFECT PLAC; Klinger R, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000586; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; Lovibond PF, 2002, J EXP PSYCHOL-ANIM B, V28, P3, DOI 10.1037//0097-7403.28.1.3; Lyby PS, 2012, PAIN, V153, P1114, DOI 10.1016/j.pain.2012.02.042; Lyby PS, 2011, PAIN, V152, P2405, DOI 10.1016/j.pain.2011.07.010; Lyby PS, 2010, J PSYCHOSOM RES, V68, P369, DOI 10.1016/j.jpsychores.2009.10.009; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Moseley GL, 2012, PAIN MANAG, V2, P1, DOI [10.2217/PMT.11.73, 10.2217/pmt.11.73]; Palermo S, 2015, HUM BRAIN MAPP, V36, P1648, DOI 10.1002/hbm.22727; Power A, 2018, PALG EUR FILM MED ST, P3, DOI 10.1007/978-3-319-89827-8_1; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Roelofs J, 2004, J PAIN, V5, P250, DOI 10.1016/j.jpain.2004.04.001; Rothwell PM, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010009; Schedlowski M, 2015, PHARMACOL REV, V67, P697, DOI 10.1124/pr.114.009423; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Swider K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158363; Swider K, 2013, PAIN, V154, P1312, DOI 10.1016/j.pain.2013.04.001; Tinnermann A, 2017, SCIENCE, V358, P105, DOI 10.1126/science.aan1221; Tu YH, 2019, NEUROIMAGE, V184, P954, DOI 10.1016/j.neuroimage.2018.10.020; van Laarhoven AIM, 2011, PAIN, V152, P1486, DOI 10.1016/j.pain.2011.01.043; Vogtle E, 2016, J PAIN RES, V9, P241, DOI 10.2147/JPR.S96228; Vogtle E, 2013, PAIN, V154, P1427, DOI 10.1016/j.pain.2013.04.041; Wager TD, 2015, NAT REV NEUROSCI, V16, P403, DOI 10.1038/nrn3976; Watson A, 2007, NEUROREPORT, V18, P771, DOI 10.1097/WNR.0b013e3280c1e2a8; Wiercioch-Kuzianik K, 2019, PAIN MED, V20, P1955, DOI 10.1093/pm/pny285; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	75	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232108	10.1371/journal.pone.0232108	http://dx.doi.org/10.1371/journal.pone.0232108			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZX	32379766	Green Published, gold			2022-12-26	WOS:000537285700022
J	Bondesson, D; Schneider, MJ; Silbernagel, E; Behr, J; Reichenberger, F; Dinkel, J				Bondesson, David; Schneider, Moritz J.; Silbernagel, Edith; Behr, Juergen; Reichenberger, Frank; Dinkel, Julien			Automated evaluation of probe-based confocal laser endomicroscopy in the lung	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; FLUORESCENCE MICROSCOPY; DIAGNOSIS; STATEMENT; CRITERIA; DISEASES	Rationale Probe-based confocal endomicroscopy provides real time videos of autoflourescent elastin structures within the alveoli. With it, multiple changes in the elastin structure due to different diffuse parenchymal lung diseases have previously been described. However, these evaluations have mainly relied on qualitative evaluation by the examiner and manually selected parts post-examination. Objectives To develop a fully automatic method for quantifying structural properties of the imaged alveoli elastin and to perform a preliminary assessment of their diagnostic potential. Methods 46 patients underwent probe-based confocal endomicroscopy, of which 38 were divided into 4 groups categorizing different diffuse parenchymal lung diseases. 8 patients were imaged in representative healthy lung areas and used as control group. Alveolar elastin structures were automatically segmented with a trained machine learning algorithm and subsequently evaluated with two methods developed for quantifying the local thickness and structural connectivity. Measurements and main results The automatic segmentation algorithm performed generally well and all 4 patient groups showed statistically significant differences with median elastin thickness, standard deviation of thickness and connectivity compared to the control group. Conclusion Alveoli elastin structures can be quantified based on their structural connectivity and thickness statistics with a fully-automated algorithm and initial results highlight its potential for distinguishing parenchymal lung diseases from normal alveoli.	[Bondesson, David; Schneider, Moritz J.; Dinkel, Julien] Ludwig Maximilians Univ Munchen, Dept Radiol, Univ Hosp, Munich, Germany; [Bondesson, David; Schneider, Moritz J.; Dinkel, Julien] Ludwig Maximilians Univ Munchen, Comprehens Pneumol Ctr CPC M, Univ Hosp, Helmholtz Zentrum Munchen, Munich, Germany; [Bondesson, David; Schneider, Moritz J.; Silbernagel, Edith; Behr, Juergen; Reichenberger, Frank; Dinkel, Julien] German Ctr Lung Res DZL, Munich, Germany; [Silbernagel, Edith; Behr, Juergen; Reichenberger, Frank] Asklepios Fachklinikun Munich Gauting, Dept Pneumol, Munich, Germany; [Behr, Juergen] Univ Munich LMU, Dept Internal Med 5, Munich, Germany; [Dinkel, Julien] Asklepios Lung Ctr Munich Gauting, Dept Radiol, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich	Bondesson, D (corresponding author), Ludwig Maximilians Univ Munchen, Dept Radiol, Univ Hosp, Munich, Germany.; Bondesson, D (corresponding author), Ludwig Maximilians Univ Munchen, Comprehens Pneumol Ctr CPC M, Univ Hosp, Helmholtz Zentrum Munchen, Munich, Germany.; Bondesson, D (corresponding author), German Ctr Lung Res DZL, Munich, Germany.	david.bondesson@med.uni-muenchen.de		Bondesson, David/0000-0003-3112-886X				Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Chawla NV, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P875, DOI 10.1007/978-0-387-09823-4_45; Doyle TJ, 2012, AM J RESP CRIT CARE, V185, P1147, DOI 10.1164/rccm.201108-1420PP; Filner JJ, 2011, J BRONCHOL INTERN PU, V18, P23, DOI 10.1097/LBR.0b013e318203da1c; Flaherty KR, 2004, AM J RESP CRIT CARE, V170, P904, DOI 10.1164/rccm.200402-147OC; Friedman J. H., 1977, ACM Transactions on Mathematical Software, V3, P209, DOI 10.1145/355744.355745; Hariharan B, 2014, LECT NOTES COMPUT SC, V8695, P297, DOI 10.1007/978-3-319-10584-0_20; Hetzel J, 2018, RESPIRATION, V95, P188, DOI 10.1159/000484055; Hodnett PA, 2013, AM J RESP CRIT CARE, V188, P141, DOI 10.1164/rccm.201208-1544CI; Ikeda N, 2007, LUNG CANCER, V56, P295, DOI 10.1016/j.lungcan.2007.01.009; Le Goualher G, 2004, LECT NOTES COMPUT SC, V3217, P761; Lee P, 2007, LUNG CANCER, V58, P44, DOI 10.1016/j.lungcan.2007.04.009; Lynch DA, 2018, LANCET RESP MED, V6, P138, DOI 10.1016/S2213-2600(17)30433-2; Martinez FJ, 2017, LANCET RESP MED, V5, P61, DOI 10.1016/S2213-2600(16)30325-3; Meng P, 2016, J THORAC DIS, V8, P3505, DOI 10.21037/jtd.2016.12.60; Newton RC, 2012, RESP MED, V106, P127, DOI 10.1016/j.rmed.2011.09.009; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng M, 2016, J PULM RESP MED, V6; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pratt WK, 2007, DIGITAL IMAGE PROCES, Vxix; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Salaun M, 2012, EUR RESP J S56, V40, pP3603; Salaun M, 2019, RESPIROLOGY, V24, P783, DOI 10.1111/resp.13507; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Silbernagel E, 2018, AM J RESP CRIT CARE, V197, P947, DOI 10.1164/rccm.201708-1683IM; Thiberville L, 2007, AM J RESP CRIT CARE, V175, P22, DOI 10.1164/rccm.200605-684OC; Thiberville L, 2010, RESPIRATION, V79, P441, DOI 10.1159/000313495; Wijmans L, 2019, RESPIRATION, V97, P259, DOI 10.1159/000493271; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yick CY, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-85; Yserbyt J, 2013, RESP MED, V107, P1234, DOI 10.1016/j.rmed.2013.04.018; Yserbyt J, 2014, J HEART LUNG TRANSPL, V33, P492, DOI 10.1016/j.healun.2014.01.857; Zadrozny B., 2001, ICML, V1, P609	34	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232847	10.1371/journal.pone.0232847	http://dx.doi.org/10.1371/journal.pone.0232847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374768	gold, Green Published			2022-12-26	WOS:000537283500062
J	Stutz, C; Blein, S				Stutz, Cian; Blein, Stanislas			A single mutation increases heavy-chain heterodimer assembly of bispecific antibodies by inducing structural disorder in one homodimer species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; bispecific engagement by antibodies based on the T-cell receptor (BEAT); CH3; heterodimer; knobs-into-holes (KiH); protein engineering; protein folding; protein stability; protein structure; structural disorder	STAPHYLOCOCCAL PROTEIN-A; CRYSTAL-STRUCTURE; DOMAIN INTERFACE; IGG; COMPLEX; INFORMATION; SECRETION; FRAGMENT; ANGSTROM; KNOB	We previously reported efficient heavy-chain assembly of heterodimeric bispecific antibodies by exchanging the interdomain protein interface of the human IgG1 CH3 dimer with the protein interface of the constant ? and ? domains of the human T-cell receptor, a technology known as bispecific engagement by antibodies based on the T-cell receptor (BEAT). Efficient heterodimerization in mammalian cell transient transfections was observed, but levels were influenced by the nature of the binding arms, particularly in the Fab-scFv-Fc format. In this study, we report a single amino acid change that significantly and consistently improved the heterodimerization rate of this format (?95%) by inducing partial disorder in one homodimer species without affecting the heterodimer. Correct folding and assembly of the heterodimer were confirmed by the high-resolution (1.88?1.98 ?) crystal structure presented here. Thermal stability and 1-anilinonaphthalene-8-sulfonic acid?binding experiments, comparing original BEAT, mutated BEAT, and ?knobs-into-holes? interfaces, suggested a cooperative assembly process of heavy chains in heterodimers. The observed gain in stability of the interfaces could be classified in the following rank order: mutated BEAT > original BEAT > knobs-into-holes. We therefore propose that the superior cooperativity found in BEAT interfaces is the key driver of their greater performance. Furthermore, we show how the mutated BEAT interface can be exploited for the routine preparation of drug candidates, with minimal risk of homodimer contamination using a single Protein A chromatography step.	[Stutz, Cian; Blein, Stanislas] Ichnos Sci SA, Dept Antibody Engn, Epalinges, Switzerland		Blein, S (corresponding author), Ichnos Sci SA, Dept Antibody Engn, Epalinges, Switzerland.	stanislas.blein@ichnossciences.com						Abdiche YN, 2015, MABS-AUSTIN, V7, P331, DOI 10.1080/19420862.2015.1008353; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Brinkmann U, 2017, MABS-AUSTIN, V9, P182, DOI 10.1080/19420862.2016.1268307; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DERRICK JP, 1992, NATURE, V359, P752, DOI 10.1038/359752a0; Elliott JM, 2014, J MOL BIOL, V426, P1947, DOI 10.1016/j.jmb.2014.02.015; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fischer N., 2015, U. S. Patent, Patent No. [2015/0094451, 20150094451]; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; Jackman J, 2010, J BIOL CHEM, V285, P20850, DOI 10.1074/jbc.M110.113910; Kirkitadze MD, 1998, J VIROL, V72, P10066, DOI 10.1128/JVI.72.12.10066-10072.1998; Kiyoshi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7866; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Macchi FD, 2015, ANAL CHEM, V87, P10475, DOI 10.1021/acs.analchem.5b02627; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Oilier R, 2019, MABS-AUSTIN, V11, P1464, DOI 10.1080/19420862.2019.1660564; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; SASSO EH, 1991, J IMMUNOL, V147, P1877; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Skegro D, 2017, J BIOL CHEM, V292, P9745, DOI 10.1074/jbc.M117.782433; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strohl WR, 2018, PROTEIN CELL, V9, P86, DOI 10.1007/s13238-017-0457-8; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; VANLOGHEM E, 1982, SCAND J IMMUNOL, V15, P275; Zhang HM, 2017, ANAL CHEM, V89, P13494, DOI 10.1021/acs.analchem.7b03830	33	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9392	9408		10.1074/jbc.RA119.012335	http://dx.doi.org/10.1074/jbc.RA119.012335			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32404368	Green Published, hybrid			2022-12-26	WOS:000552758600011
J	Monarrez-Gonzalez, JC; Gonzalez-Elizondo, MS; Marquez-Linares, MA; Gutierrez-Yurrita, PJ; Perez-Verdin, G				Carlos Monarrez-Gonzalez, Jose; Socorro Gonzalez-Elizondo, M.; Antonio Marquez-Linares, Marco; Joaquin Gutierrez-Yurrita, Pedro; Perez-Verdin, Gustavo			Effect of forest management on tree diversity in temperate ecosystem forests in northern Mexico	PLOS ONE			English	Article							UNDERSTORY VEGETATION; PLANT DIVERSITY; SERVICES; BIODIVERSITY; METAANALYSIS; PROVISION	An important challenge for silvicultural practices is the conservation of tree diversity while fulfilling the traditional objectives of forest management, most notably timber harvesting. The purpose of this study was to compare the tree diversity before and after the application of silvicultural treatments in a temperate forest in northern Mexico. Fifteen experimental plots, each measuring 2500 m(2), were established to evaluate the immediate effect of four silvicultural treatments. These treatments were identified by their levels of management: intensive (clearcut, removal 100%), semi-intensive (removal of 59-61% of basal area), conservative (removal of 29-31% of basal area), and a control group. New forest guidelines, in contrast to conventional approaches, were applied to the semi-intensive and conservative treatments based on health and diversity conditions. Basal area, canopy cover, tree and total volume were measured in each plot. The Importance Value Index, alpha diversity, and evenness were estimated before and after treatments. Eighteen species belonging to five genera and five families were found in the study area. The species with the highest ecological values were Pinus durangensis, P. teocote, Quercus sideroxyla, and Quercus convallata with IVI numbers between 13.6 and 24.5%. Alpha diversity was intermediate (Margalef: 2.9 to 3.8), while dominance and evenness were above average compared to other studies (Simpson: 0.69 to 0.77; Shannon-Wiener: 1.44 to 1.6; Pielou: 0.76 to 0.85). The species evenness index in the conservative treatment was high (Sorensen, Jaccard, quantitative Sorensen and Morisita-Horn; 88 to 99%), although abundance decreased. Overall, there were no significant differences in IVI values and diversity indicators before and after treatments, with the exception of the clearcut treatment. When associating the diversity indices with stand variables, only the Pielou's evenness index showed a significant relationship between them. We concluded that both the conservative and semi-intensive treatments did not generate significant changes in tree diversity, but the former had slightly higher alpha diversity indices. These results can provide a better insight on silvicultural practices and their effects on species composition.	[Carlos Monarrez-Gonzalez, Jose] Inst Nacl Invest Agr & Forestales, Campo Expt Valle Guadiana, Durango, Mexico; [Carlos Monarrez-Gonzalez, Jose; Socorro Gonzalez-Elizondo, M.; Antonio Marquez-Linares, Marco; Perez-Verdin, Gustavo] Inst Politecn Nacl, CIIDIR DGO, Durango, Mexico; [Joaquin Gutierrez-Yurrita, Pedro] Inst Politecn Nacl, CIIEMAD, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Perez-Verdin, G (corresponding author), Inst Politecn Nacl, CIIDIR DGO, Durango, Mexico.	guperezv@ipn.mx	PEREZ-VERDIN, GUSTAVO/A-4248-2011; Gutierrez-Yurrita, Pedro Joaquin/L-3615-2017	PEREZ-VERDIN, GUSTAVO/0000-0001-6788-2763; Marquez-Linares, Marco Antonio/0000-0002-4778-0185; Gutierrez-Yurrita, Pedro Joaquin/0000-0003-3287-9008; Monarrez-Gonzalez, Jose Carlos/0000-0003-4566-1286	IPN (INSTITUTO POLITECNICO NACIONAL) [SIP 2019-5278]; COCYTED; CONACYT; INIFAP	IPN (INSTITUTO POLITECNICO NACIONAL); COCYTED; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); INIFAP	This work was supported by a IPN (INSTITUTO POLITECNICO NACIONAL) grant number: SIP 2019-5278, COCYTED, CONACYT and INIFAP.	Aguirre-Calderon OA, 2015, MADERA BOSQUES, V21, P17; Ammer C, 2019, NEW PHYTOL, V221, P50, DOI 10.1111/nph.15263; Lopez-Hernandez JA, 2017, MADERA BOSQUES, V23, P39, DOI 10.21829/myb.2017.2311518; Armenteras D, 2016, ECOSISTEMAS, V25, P83, DOI 10.7818/ECOS.2016.25-1.12; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Brockerhoff EG, 2017, BIODIVERS CONSERV, V26, P3005, DOI 10.1007/s10531-017-1453-2; Burke DA, 2008, FOREST ECOL MANAG, V255, P2204, DOI 10.1016/j.foreco.2007.12.032; Chaudhary A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23954; Cook PA, 2000, USING STAT UNDERSTAN; Cordonnier T, 2018, ANN FOREST SCI, V75, DOI 10.1007/s13595-018-0750-6; Corral-Rivas JJ, ANALISIS EFECTO APRO; Delgado Zamora David Alfredo, 2016, Rev. mex. de cienc. forestales, V7, P94; DeRose RJ, 2014, FOREST SCI, V60, P1205, DOI 10.5849/forsci.13-507; Dieler J, 2017, EUR J FOREST RES, V136, P739, DOI 10.1007/s10342-017-1056-1; Duguid MC, 2013, FOREST ECOL MANAG, V303, P81, DOI 10.1016/j.foreco.2013.04.009; Ehbrecht M, 2017, AGR FOREST METEOROL, V242, P1, DOI 10.1016/j.agrformet.2017.04.012; Galicia Leopoldo, 2014, International Journal of Biodiversity Science Ecosystem Services & Management, V10, P275, DOI 10.1080/21513732.2014.973907; Gernandt DS, 2014, REV MEX BIODIVERS, V85, pS126, DOI 10.7550/rmb.32195; Graciano-Avila G, 2017, MADERA BOSQUES, V23, P137, DOI 10.21829/myb.2017.2331480; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; Hernandez-Salas J, REV CHAPINGO SERIE C; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Bautista LJ, 2014, FOREST ECOL MANAG, V329, P10, DOI 10.1016/j.foreco.2014.05.053; Leyva-Lopez JC, REV CHAPINGO SERIE C; Luna-Bautista L, 2015, REV CHAPINGO SER CIE, V21, P109, DOI 10.5154/r.rchscfa.2014.08.037; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Torres-Rojo JM, 2016, CURR FOR REP, V2, P93, DOI 10.1007/s40725-016-0033-0; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Montes C, 2008, ECOSISTEMAS, V16, P137, DOI [10.7818/re.2014.16-3.00, DOI 10.7818/RE.2014.16-3.00]; Mora-Donjuán Carlos Alberto, 2014, Polibotánica, P53; Moreno EC, 2001, METODOS MEDIR BIODIV; Mostacedo B, 2000, MANUAL METODOS BASIC; Návar-Cháidez José de Jesús, 2009, Polibotánica, P71; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Perez-Verdin G., 2015, FOREST PLANS N AM, P97, DOI [DOI 10.1016/B978-0-12-799936-4.00013-8, 10.1016/B978-0-12-799936-4.00013-8]; Perez-Verdin G, 2018, FORESTS, V9, DOI 10.3390/f9040178; Perez-Verdin G, 2016, ECOSYST SERV, V21, P6, DOI 10.1016/j.ecoser.2016.07.003; Quijas S, 2010, BASIC APPL ECOL, V11, P582, DOI 10.1016/j.baae.2010.06.009; Ranius T, 2018, J ENVIRON MANAGE, V209, P409, DOI 10.1016/j.jenvman.2017.12.048; Rzedowski J, 1991, ACTA BOT MEX, V14, P3, DOI [DOI 10.21829/ABM14.1991.611, 10.21829/abm14.1991.611]; Schuler LJ, 2017, LANDSCAPE ECOL, V32, P1499, DOI 10.1007/s10980-016-0422-6; Sing L, 2015, RES NOTE, P1; Solís Moreno Raúl, 2006, Madera bosques, V12, P49, DOI 10.21829/myb.2006.1221242; Thom D, 2016, BIOL REV, V91, P760, DOI 10.1111/brv.12193; Torres-Rojo J.M., 2015, DESARROLLO FORESTAL, P15; Trivino M, 2017, J APPL ECOL, V54, P61, DOI 10.1111/1365-2664.12790; Valdes M, 2003, WEST J APPL FOR, V18, P101, DOI 10.1093/wjaf/18.2.101; Valencia S., 2004, B SOC BOT MEX, V75, P33, DOI DOI 10.17129/BOTSCI.1692; Wood A., 2000, ROOT CAUSES BIODIVER, DOI [10.4324/9781315071688, DOI 10.4324/9781315071688]; Zeller L, 2018, FOR ECOSYST, V5, DOI 10.1186/s40663-017-0127-6; Zhao XiuHai, 2014, Forest Ecosystems, V1, P8, DOI 10.1186/2197-5620-1-8	54	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233292	10.1371/journal.pone.0233292	http://dx.doi.org/10.1371/journal.pone.0233292			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421694	gold, Green Published			2022-12-26	WOS:000537499600040
J	Kim, JW; Im, I; Kim, H; Jeon, JS; Kang, EH; Jo, S; Chun, HS; Yoon, S; Kim, JH; Kim, SK; Park, HJ				Kim, Ji-Woo; Im, Ilkyun; Kim, Hyemin; Jeon, Jang Su; Kang, Eun-Hye; Jo, Seongyea; Chun, Hang-Suk; Yoon, Seokjoo; Kim, Jong-Hoon; Kim, Sang Kyum; Park, Han-Jin			Live-cell screening platform using human-induced pluripotent stem cells expressing fluorescence-tagged cytochrome P450 1A1	FASEB JOURNAL			English	Article						AHR; CRISPR-Cas9; high-content screening; toxicology	ARYL-HYDROCARBON RECEPTOR; KNOCKOUT MOUSE LINES; AH RECEPTOR; GENE; CANCER; CYP1A1; POLYMORPHISMS; INDUCTION; PROTEINS; LIGAND	Human-induced pluripotent stem cells (hiPSCs) are invaluable sources for drug screening and toxicity tests because of their differentiation potential and proliferative capacity. Recently, the CRISPR-Cas9-mediated homologous recombination system has enabled reporter knock-ins at desired loci in hiPSCs, and here, we generated a hiPSC reporter line expressing mCherry-tagged cytochrome P450 1A1 (CYP1A1), which can be utilized to screen for the modulators of aryl hydrocarbon receptor (AHR) in live cells. CYP1A1-mCherry hiPSCs exhibited typical characteristics of pluripotent stem cells such as marker expression, differentiation potential, and normal karyotype. After differentiation into hepatocyte-like cells (HLCs), CYP1A1-mCherry fusion protein was expressed and localized at the endoplasmic reticulum, and induced by AHR agonists. We obtained 23 hits modulating CYP1A1 expression from high-content screening with 241 hepatotoxicity chemicals and nuclear receptor ligands, and identified three upregulating chemicals and two downregulating compounds. Responses of hiPSC-HLCs against an AHR agonist were more similar to human primary hepatocytes than of HepG2 hepatocellular carcinoma cells. This platform has the advantages of live-cell screening without sacrificing cells (unlike previously available CYP1A1 reporter cell lines), as well as an indefinite supply of cells, and can be utilized in a wide range of screening related to AHR- and CYP1A1-associated diseases in desired cell types.	[Kim, Ji-Woo; Im, Ilkyun; Kim, Hyemin; Kang, Eun-Hye; Jo, Seongyea; Chun, Hang-Suk; Yoon, Seokjoo; Park, Han-Jin] Korea Inst Toxicol, Dept Predict Toxicol, Daejeon 34114, South Korea; [Jeon, Jang Su; Kim, Sang Kyum] Chungnam Natl Univ, Coll Pharm, Daejeon, South Korea; [Kang, Eun-Hye; Yoon, Seokjoo] Univ Sci & Technol, Sch Engn, Human & Environm Toxicol, Daejeon, South Korea; [Jo, Seongyea; Kim, Jong-Hoon] Korea Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea	Korea Institute of Toxicology; Chungnam National University; University of Science & Technology (UST); Korea University	Park, HJ (corresponding author), Korea Inst Toxicol, Dept Predict Toxicol, Daejeon 34114, South Korea.	hjpark@kitox.re.kr	Kim, Jong-Hoon/F-2504-2013	Kim, Jong-Hoon/0000-0003-3419-0538	National Research Foundation of Korea (NRF) [NRF-2017R1C1B2010444, NRF-2018M3A9H1021384]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2017R1C1B2010444 and NRF-2018M3A9H1021384	Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Bersten DC, 2013, NAT REV CANCER, V13, P827, DOI 10.1038/nrc3621; Brignac-Huber LM, 2016, DRUG METAB DISPOS, V44, P1859, DOI 10.1124/dmd.115.068981; Byrne SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1246; Cauchi S, 2001, CARCINOGENESIS, V22, P1819, DOI 10.1093/carcin/22.11.1819; Chang JC, 2007, CLIN CANCER RES, V13, P1, DOI 10.1158/1078-0432.CCR-06-2405; Chen I, 1996, BIOCHEM PHARMACOL, V51, P1069, DOI 10.1016/0006-2952(96)00060-3; Ciolino HP, 2008, INT J CANCER, V122, P990, DOI 10.1002/ijc.23218; Corbett JL, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00265; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Frotschl R, 1998, CHEM RES TOXICOL, V11, P1447, DOI 10.1021/tx980164h; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gargaro M, 2016, AM J TRANSPLANT, V16, P2270, DOI 10.1111/ajt.13716; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Go RE, 2015, J STEROID BIOCHEM, V147, P24, DOI 10.1016/j.jsbmb.2014.11.003; Goldring C, 2017, HEPATOLOGY, V65, P710, DOI 10.1002/hep.28886; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; HANKINSON O, 1991, BIOCHIMIE, V73, P61, DOI 10.1016/0300-9084(91)90075-C; Hao N, 2013, BIOCHEM PHARMACOL, V86, P561, DOI 10.1016/j.bcp.2013.07.004; He GC, 2011, TOXICOL SCI, V123, P511, DOI 10.1093/toxsci/kfr189; Hosaka T, 2010, CANCER SCI, V101, P652, DOI 10.1111/j.1349-7006.2009.01454.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08022; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Jackson MP, 2016, ESSAYS BIOCHEM, V60, P173, DOI 10.1042/EBC20160005; Kakarougkas A, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130685; Kim HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21684; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kolluri SK, 2017, ARCH TOXICOL, V91, P2497, DOI 10.1007/s00204-017-1981-2; Li Y, 2011, TOXICOL SCI, V124, P388, DOI 10.1093/toxsci/kfr235; Liu C, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156166; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Nagy SR, 2002, TOXICOL SCI, V65, P200, DOI 10.1093/toxsci/65.2.200; Navas JM, 2004, LIFE SCI, V76, P699, DOI 10.1016/j.lfs.2004.09.015; Nebert D W, 1994, Prog Liver Dis, V12, P63; Nebert DW, 2013, MOL PHARMACOL, V84, P304, DOI 10.1124/mol.113.086637; NEBERT DW, 1991, PHARMACOGENETICS, V1, P68, DOI 10.1097/00008571-199111000-00003; Nebert DW, 1996, DNA CELL BIOL, V15, P273, DOI 10.1089/dna.1996.15.273; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nie YZ, 2018, EBIOMEDICINE, V35, P114, DOI 10.1016/j.ebiom.2018.08.014; O'Donnell EF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013128; Oesch-Bartlomowicz B, 2009, BIOCHEM PHARMACOL, V77, P627, DOI 10.1016/j.bcp.2008.10.017; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Oyama T, 2007, FRONT BIOSCI, V12, P4497, DOI 10.2741/2404; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ramadoss P, 2004, MOL PHARMACOL, V66, P129, DOI 10.1124/mol.66.1.129; Ramme AP, 2019, FUTUR SCI OA, V5, DOI 10.2144/fsoa-2019-0065; Safe S, 2013, TOXICOL SCI, V135, P1, DOI 10.1093/toxsci/kft128; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sirenko O, 2016, ASSAY DRUG DEV TECHN, V14, P381, DOI 10.1089/adt.2016.729; Smith BW, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2574152; Sogawa K, 1997, J BIOCHEM, V122, P1075; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uno S, 2006, MOL PHARMACOL, V69, P1103, DOI 10.1124/mol.105.021501; Uno S, 2008, FREE RADICAL BIO MED, V44, P570, DOI 10.1016/j.freeradbiomed.2007.10.044; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wong JMY, 2001, BIOCHEM BIOPH RES CO, V288, P990, DOI 10.1006/bbrc.2001.5861; Wourms MJ, 2015, CELL IMMUNOL, V295, P60, DOI 10.1016/j.cellimm.2015.02.012; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Xue P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00286; Zhao B, 2010, SCI CHINA CHEM, V53, P1010, DOI 10.1007/s11426-010-0142-8; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	74	1	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9141	9155		10.1096/fj.201903110R	http://dx.doi.org/10.1096/fj.201903110R		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32421247				2022-12-26	WOS:000533521800001
J	Entchev, E; Jantzen, I; Masson, P; Bocart, S; Bournique, B; Luccarini, JM; Bouchot, A; Lacombe, O; Junien, JL; Broqua, P; Tallandier, M				Entchev, Eugeni; Jantzen, Ingrid; Masson, Philippe; Bocart, Stephanie; Bournique, Bruno; Luccarini, Jean-Michel; Bouchot, Andre; Lacombe, Olivier; Junien, Jean-Louis; Broqua, Pierre; Tallandier, Mireille			Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; CHONDROITIN SULFATE PROTEOGLYCAN; BETA-D-XYLOSIDES; HEPARAN-SULFATE; FELINE MODEL; DISEASE; DIAGNOSIS; STORAGE; CELLS; MICE	Mucopolysaccharidoses are a class of lysosomal storage diseases, characterized by enzymatic deficiency in the degradation of specific glycosaminoglycans (GAG). Pathological accumulation of excess GAG leads to multiple clinical symptoms with systemic character, most severely affecting bones, muscles and connective tissues. Current therapies include periodic intravenous infusion of supplementary recombinant enzyme (Enzyme Replacement Therapy-ERT) or bone marrow transplantation. However, ERT has limited efficacy due to poor penetration in some organs and tissues. Here, we investigated the potential of the beta-D-xyloside derivative odiparcil as an oral GAG clearance therapy for Maroteaux-Lamy syndrome (Mucopolysaccharidosis type VI, MPS VI). In vitro, in bovine aortic endothelial cells, odiparcil stimulated the secretion of sulphated GAG into culture media, mainly of chondroitin sulphate (CS)/dermatan sulphate (DS) type. Efficacy of odiparcil in reducing intracellular GAG content was investigated in skin fibroblasts from MPS VI patients where odiparcil was shown to reduce efficiently the accumulation of intracellular CS with an EC50 in the range of 1 mu M. In vivo, in wild type rats, after oral administrations, odiparcil was well distributed, achieving mu M concentrations in MPS VI disease-relevant tissues and organs (bone, cartilage, heart and cornea). In MPS VI Arylsulphatase B deficient mice (Arsb(-)), after chronic oral administration, odiparcil consistently stimulated the urinary excretion of sulphated GAG throughout the treatment period and significantly reduced tissue GAG accumulation in liver and kidney. Furthermore, odiparcil diminished the pathological cartilage thickening observed in trachea and femoral growth plates of MPS VI mice. The therapeutic efficacy of odiparcil was similar in models of early (treatment starting in juvenile, 4 weeks old mice) or established disease (treatment starting in adult, 3 months old mice). Our data demonstrate that odiparcil effectively diverts the synthesis of cellular glycosaminoglycans into secreted soluble species and this effect can be used for reducing cellular and tissue GAG accumulation in MPS VI models. Therefore, our data reveal the potential of odiparcil as an oral GAG clearance therapy for MPS VI patients.	[Entchev, Eugeni; Jantzen, Ingrid; Masson, Philippe; Bocart, Stephanie; Bournique, Bruno; Luccarini, Jean-Michel; Lacombe, Olivier; Junien, Jean-Louis; Broqua, Pierre; Tallandier, Mireille] Invent Pharm, Bourgogne Franche Comte, Daix, France; [Bouchot, Andre] Univ Bourgogne, INSERM, UMR1231, DImaCell Core Facil, CellImaP Site, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Entchev, E; Tallandier, M (corresponding author), Invent Pharm, Bourgogne Franche Comte, Daix, France.	eugeni.entchev@inventivapharma.com; mireille.tallandier@inventivapharma.com		Entchev, Eugeni/0000-0003-0744-5929	Inventiva SA ("Inventiva")	Inventiva SA ("Inventiva")	This study is funded by Inventiva SA ("Inventiva"). Inventiva provided support in the form of salaries and other remuneration for authors (EE, IJ, PM, SB, BB, JML, OL, JLJ, PB and MT; see declared competing interests), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alliston T, 2010, J PEDIATR REHAB MED, V3, P129, DOI 10.3233/PRM-2010-0117; ALROY J, 1989, VET PATHOL, V26, P294, DOI 10.1177/030098588902600402; Alroy Joseph, 2014, J. inborn errors metab. screen., V2, pe130001, DOI 10.1177/2326409813517663; Anderson G, 2005, J CLIN PATHOL, V58, P1305, DOI 10.1136/jcp.2005.027045; Ashworth JL, 2006, EYE, V20, P553, DOI 10.1038/sj.eye.6701921; AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; Baldo Guilherme, 2015, J. inborn errors metab. screen., V3, pe140010, DOI 10.1177/2326409814567741; Baldo G, 2017, CARDIOVASC PATHOL, V27, P45, DOI 10.1016/j.carpath.2017.01.001; Braunlin EA, 2011, J INHERIT METAB DIS, V34, P1183, DOI 10.1007/s10545-011-9359-8; Brooks DA, 1997, BBA-MOL BASIS DIS, V1361, P203, DOI 10.1016/S0925-4439(97)00036-7; Brunelli MJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009806.pub2; CANTOR LB, 1989, AM J OPHTHALMOL, V108, P426, DOI 10.1016/S0002-9394(14)73311-2; Chua JS, 2017, ACCOUNTS CHEM RES, V50, P2693, DOI 10.1021/acs.accounts.7b00289; Chua JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182301; Chuang CK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0135-3; Clarke LA, 2015, BEST PRACT RES CL EN, V29, P219, DOI 10.1016/j.beem.2014.08.010; Clarke LA, 2011, RHEUMATOLOGY, V50, pV13, DOI 10.1093/rheumatology/ker395; Coulson-Thomas V., 2016, BIO-PROTOCOL, V4, DOI [10.21769/bioprotoc.1236, DOI 10.21769/BIOPROTOC.1236, 10.21769/BioProtoc.1236]; Crawley AC, 1996, J CLIN INVEST, V97, P1864, DOI 10.1172/JCI118617; Curtain MM, 2009, MUTATION ARSB UNPUB; Debiec H, 2014, J AM SOC NEPHROL, V25, P675, DOI 10.1681/ASN.2013030290; Eliyahu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022447; Evers M, 1996, P NATL ACAD SCI USA, V93, P8214, DOI 10.1073/pnas.93.16.8214; Fenzl CR, 2015, CLIN OPHTHALMOL, V9, P1633, DOI 10.2147/OPTH.S78368; FLUHARTY AL, 1974, BIOCHEM BIOPH RES CO, V59, P455, DOI 10.1016/S0006-291X(74)80001-X; FONG LV, 1987, CLIN CARDIOL, V10, P362, DOI 10.1002/clc.4960100612; GALLIGANI L, 1975, J BIOL CHEM, V250, P5400; Garud DR, 2008, J BIOL CHEM, V283, P28881, DOI 10.1074/jbc.M805939200; GEETHAHABIB M, 1984, J BIOL CHEM, V259, P7300; Giugliani R, 2016, EXPERT OPIN EMERG DR, V21, P9, DOI 10.1517/14728214.2016.1123690; Golda A, 2012, INT J CARDIOL, V158, P6, DOI 10.1016/j.ijcard.2011.06.097; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Harmatz PR, 2017, FRONT BIOSCI-LANDMRK, V22, P385, DOI 10.2741/4490; Hendrickx G, 2020, HUM MOL GENET, V29, P803, DOI 10.1093/hmg/ddaa006; Kakkis ED, 2001, MOL GENET METAB, V72, P199, DOI 10.1006/mgme.2000.3140; Kishnani PS, 2016, MOL GENET METAB, V117, P66, DOI 10.1016/j.ymgme.2015.11.001; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Mani K, 2004, GLYCOBIOLOGY, V14, P387, DOI 10.1093/glycob/cwh035; Masson P, 1999, THROMB HAEMOSTASIS, V81, P945; MASSON PJ, 1995, J BIOL CHEM, V270, P2662, DOI 10.1074/jbc.270.6.2662; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Muto J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025480; Myers AL, 2008, J CLIN PHARMACOL, V48, P1158, DOI 10.1177/0091270008323751; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nuttall JD, 1999, CALCIFIED TISSUE INT, V65, P47, DOI 10.1007/s002239900656; OBRIEN JF, 1974, BIOCHEM BIOPH RES CO, V60, P1170, DOI 10.1016/0006-291X(74)90435-5; Persson A, 2018, GLYCOBIOLOGY, V28, P499, DOI 10.1093/glycob/cwy049; Persson A, 2018, J BIOL CHEM, V293, P10202, DOI 10.1074/jbc.RA118.002971; Persson A, 2016, J BIOL CHEM, V291, P14871, DOI 10.1074/jbc.M116.716829; Pohl S, 2018, J BONE MINER RES, V33, P2186, DOI 10.1002/jbmr.3563; Prydz K, 2000, J CELL SCI, V113, P193; Randall DR, 2008, MOL GENET METAB, V94, P456, DOI 10.1016/j.ymgme.2008.05.001; Sawamoto K, 2019, DRUGS, V79, P1103, DOI 10.1007/s40265-019-01147-4; SCHWARTZ NB, 1977, J BIOL CHEM, V252, P6316; SCHWARTZ NB, 1974, BIOCHEM BIOPH RES CO, V56, P717, DOI 10.1016/0006-291X(74)90664-0; Shaukat I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146499; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2005, PEDIATR RES, V57, P701, DOI 10.1203/01.PDR.0000156510.96253.5A; SMITHTHOMAS LC, 1995, J CELL SCI, V108, P1307; Stanley P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005199; Strauch OF, 2003, PEDIATR RES, V54, P701, DOI 10.1203/01.PDR.0000084085.65972.3F; Toomey JR, 2006, J THROMB HAEMOST, V4, P1989, DOI 10.1111/j.1538-7836.2006.02064.x; Valayannopoulos V, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-5; Vassal-Stermann E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047933; Weinstein T, 2012, CONNECT TISSUE RES, V53, P169, DOI 10.3109/03008207.2011.620190; Wilson S, 2009, AM J PATHOL, V175, P2053, DOI 10.2353/ajpath.2009.090211; Zhang HY, 2015, MOL GENET METAB, V114, P123, DOI 10.1016/j.ymgme.2014.09.009	67	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233032	10.1371/journal.pone.0233032	http://dx.doi.org/10.1371/journal.pone.0233032			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413051	Green Published, gold			2022-12-26	WOS:000537496000040
J	Moody, EC; Colicino, E; Wright, RO; Mupere, E; Jaramillo, EG; Amarasiriwardena, C; Cusick, SE				Moody, Emily C.; Colicino, Elena; Wright, Robert O.; Mupere, Ezekiel; Jaramillo, Ericka G.; Amarasiriwardena, Chitra; Cusick, Sarah E.			Environmental exposure to metal mixtures and linear growth in healthy Ugandan children	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; SCHOOL-AGE-CHILDREN; BLOOD LEAD LEVELS; ZINC-DEFICIENCY; CHILDHOOD; ASSOCIATION; MANGANESE; SELENIUM; RISK; NEURODEVELOPMENT	Background Stunting is an indicator of poor linear growth in children and is an important public health problem in many countries. Both nutritional deficits and toxic exposures can contribute to lower height-for-age Z-score (HAZ) and stunting (HAZ < -2). Objectives In a community-based cross-sectional sample of 97 healthy children ages 6-59 months in Kampala, Uganda, we examined whether exposure to Pb, As, Cd, Se, or Zn were associated with HAZ individually or as a mixture. Methods Blood samples were analyzed for a mixture of metals, which represent both toxins and essential nutrients. The association between HAZ and metal exposure was tested using multivariable linear regression and Weighted Quantile Sum (WQS) regression, which uses mixtures of correlated exposures as a predictor. Results There were 22 stunted children in the sample, mean HAZ was -0.74 (SD = 1.84). Linear regression showed that Pb (beta = -0.80, p = 0.021) and Se (beta = 1.92, p = 0.005) were significantly associated with HAZ. The WQS models separated toxic elements with a presumed negative effect on HAZ (Pb, As, Cd) from essential nutrients with presumed positive effect on HAZ (Se and Zn). The toxic mixture was significantly associated with lower HAZ (beta = -0.47, p = 0.03), with 62% of the effect from Pb. The nutrient WQS index did not reach statistical significance (beta = -0.47, p = 0.16). Discussion Higher blood lead and lower blood selenium level were both associated with lower HAZ. The significant associations by linear regression were reinforced by the WQS models, although not all associations reached statistical significance. These findings suggest that healthy children in this neighborhood of Kampala, Uganda, who have a high burden of toxic exposures, may experience detrimental health effects associated with these exposures in an environment where exposure sources are not well characterized.	[Moody, Emily C.; Colicino, Elena; Wright, Robert O.; Amarasiriwardena, Chitra] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Mupere, Ezekiel] Mulago Hosp, Dept Paediat & Child Hlth, Kampala, Uganda; [Jaramillo, Ericka G.] Icahn Sch Med Mt Sinai, Dept Med Educ, New York, NY 10029 USA; [Cusick, Sarah E.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA	Icahn School of Medicine at Mount Sinai; Mulago National Referral Hospital; Icahn School of Medicine at Mount Sinai; University of Minnesota System; University of Minnesota Twin Cities	Moody, EC (corresponding author), Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA.	emily.moody@mssm.edu	Colicino, Elena/Q-4973-2016	Colicino, Elena/0000-0002-1875-8448; Mupere, Ezekiel/0000-0002-8746-9009	NIEHS [T32HD049311, P30ES023515]; University of Minnesota School of Medicine Innovation Award; Doris Duke International Clinical Research Fellowship scholarship	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of Minnesota School of Medicine Innovation Award; Doris Duke International Clinical Research Fellowship scholarship	This work was made possible through NIEHS grants T32HD049311 (ECM) and P30ES023515 (ROW), a University of Minnesota School of Medicine Innovation Award (SEC and ECM) and a Doris Duke International Clinical Research Fellowship scholarship (EGJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuShady MM, 2017, J PEDIAT-BRAZIL, V93, P619, DOI 10.1016/j.jped.2016.12.006; Andrade V M, 2017, Adv Neurobiol, V18, P227, DOI 10.1007/978-3-319-60189-2_12; [Anonymous], [No title captured]; Bellinger DC, 2008, CURR OPIN PEDIATR, V20, P172, DOI 10.1097/MOP.0b013e3282f4f97b; Bitarakwate Edward, 2003, Afr Health Sci, V3, P54; Cantoral A, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0086-8; Center for Disease Control, 2010, US WORLD HLTH ORG CH; Crookston BT, 2011, MATERN CHILD NUTR, V7, P397, DOI 10.1111/j.1740-8709.2010.00255.x; Cusick SE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5589-0; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; Ericson B, 2016, ANN GLOB HEALTH, V82, P686, DOI 10.1016/j.aogh.2016.10.015; Ferguson E, 2015, MATERN CHILD NUTR, V11, P6, DOI 10.1111/mcn.12243; Fuglestad AJ, 2016, ACTA PAEDIATR, V105, pE67, DOI 10.1111/apa.13234; Galetti V, 2016, J NUTR, V146, P114, DOI 10.3945/jn.115.216606; Gardner RM, 2013, AM J EPIDEMIOL, V177, P1356, DOI 10.1093/aje/kws437; Gashu D, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0155-z; Gleason KM, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0190-4; Graber LK, 2010, ENVIRON HEALTH PERSP, V118, P884, DOI 10.1289/ehp.0901768; Henn BC, 2014, CURR OPIN PEDIATR, V26, P223, DOI 10.1097/MOP.0000000000000067; Kashala-Abotnes E, 2016, EUR CHILD ADOLES PSY, V25, P1361, DOI 10.1007/s00787-016-0860-3; Kupsco A, 2019, ENVIRON INT, V126, P484, DOI 10.1016/j.envint.2019.02.029; Lalor GC, 2006, W INDIAN MED J, V55, P394; Mallard SR, 2016, J NUTR, V146, P2093, DOI 10.3945/jn.116.233890; Metwally AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158086; Miller AC, 2016, PUBLIC HEALTH NUTR, V19, P1339, DOI 10.1017/S136898001500227X; Mohamed FE, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/545674; Moreno-Reyes R, 2001, J BONE MINER RES, V16, P1556, DOI 10.1359/jbmr.2001.16.8.1556; Mullin AM, 2019, ENVIRON RES, V177, DOI 10.1016/j.envres.2019.108603; Ndeezi G, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-68; Perkins JM, 2017, SOC SCI MED, V193, P101, DOI 10.1016/j.socscimed.2017.09.039; Raihan MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197856; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Renzetti S, 2017, ENVIRON RES, V152, P226, DOI 10.1016/j.envres.2016.10.014; Reuben A, 2017, JAMA-J AM MED ASSOC, V317, P1244, DOI 10.1001/jama.2017.1712; Rolfe ED, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192196; Rukgauer M, 1997, J TRACE ELEM MED BIO, V11, P92; Salgueiro MJ, 2002, NUTRITION, V18, P510, DOI 10.1016/S0899-9007(01)00812-7; Stammers AL, 2015, EUR J CLIN NUTR, V69, P147, DOI 10.1038/ejcn.2014.204; Sudfeld CR, 2015, J NUTR, V145, P2705, DOI 10.3945/jn.115.215996; Sudfeld CR, 2015, PEDIATRICS, V135, pE1266, DOI 10.1542/peds.2014-3111; Ortiz MTY, 2017, ENVIRON INT, V98, P191, DOI 10.1016/j.envint.2016.11.005; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; Tuakuila J, 2014, J TRACE ELEM MED BIO, V28, P45, DOI 10.1016/j.jtemb.2013.09.004; U.S. Department of Health & Human Services, EPI INF CTR SURV EP; Valeri L, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/ehp614, 10.1289/EHP614]; WALKER BE, 1978, J NUTR, V108, P1702, DOI 10.1093/jn/108.10.1702; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Wright RO, 2006, NEUROTOXICOLOGY, V27, P210, DOI 10.1016/j.neuro.2005.10.001; Yakoob MY, 2017, J DEV BEHAV PEDIATR, V38, P665, DOI 10.1097/DBP.0000000000000482	50	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233108	10.1371/journal.pone.0233108	http://dx.doi.org/10.1371/journal.pone.0233108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413070	gold, Green Published			2022-12-26	WOS:000537496000049
J	Ng, SM; Leng, LL; Xie, QW; Chan, JSM; Chan, CHY; So, KF; Li, A; Po, KKT; Yuen, LP; Ku, KS; Choi, AWM; Chouliara, Z; Cheung, ACY; Chan, CLW; Emery, C				Ng, Siu-Man; Leng, Ling-Li; Xie, Qian Wen; Chan, Jessie S. M.; Chan, Celia H. Y.; So, Kwok Fai; Li, Ang; Po, Kevin K. T.; Yuen, L. P.; Ku, Kam-Shing; Choi, Anna W. M.; Chouliara, Zoe; Cheung, Amos C. Y.; Chan, Cecilia L. W.; Emery, Clifton			Trust as a mediator in the relationship between childhood sexual abuse and IL-6 level in adulthood	PLOS ONE			English	Article							PHYSICAL HEALTH; MARITAL QUALITY; INFLAMMATION; DEPRESSION; MALTREATMENT; TRAUMA; ADOLESCENTS; ADVERSITY; SURVIVORS; THERAPY	Childhood sexual abuse (CSA) has been shown to predict the coupling of depression and inflammation in adulthood. Trust within intimate relationships, a core element in marital relations, has been shown to predict positive physical and mental health outcomes, but the mediating role of trust in partners in the association between CSA and inflammation in adulthood requires further study. The present study aimed to examine the impact of CSA on inflammatory biomarkers (IL-6 and IL-1 beta) in adults with depression and the mediating role of trust. A cross-sectional survey data set of adults presenting with mood and sleep disturbance was used in the analysis. CSA demonstrated a significant negative correlation with IL-6 level (r = -0.28, p< 0. 01) in adults with clinically significant depression, while trust showed a significant positive correlation with IL-6 level (r = 0.36, p <.01). Sobel test and bootstrapping revealed a significant mediating role for trust between CSA and IL-6 level. CSA and trust in partners were revealed to have significant associations with IL-6 level in adulthood. Counterintuitively, the directions of association were not those expected. Trust played a mediating role between CSA and adulthood levels of IL-6. Plausible explanations for these counterintuitive findings are discussed.	[Ng, Siu-Man; Leng, Ling-Li; Xie, Qian Wen; Chan, Celia H. Y.; Cheung, Amos C. Y.; Chan, Cecilia L. W.; Emery, Clifton] Univ Hong Kong, Dept Social Work & Social Adm, Sai Wan, Hong Kong, Peoples R China; [Chan, Jessie S. M.] Univ Hong Kong, Lab Neuropsychol, Sai Wan, Hong Kong, Peoples R China; [Chan, Jessie S. M.] Univ Hong Kong, Lab Cognit Affect Neurosci, Sai Wan, Hong Kong, Peoples R China; [So, Kwok Fai; Li, Ang] Jinan Univ, Guangdong Med Key Lab Brain Funct & Dis, Guangdong Hong Kong Macau Inst CNS Regenerat, Joint Int Res Lab CNS Regenerat,Minist Educ, Guangzhou, Guangdong, Peoples R China; [So, Kwok Fai; Po, Kevin K. T.] Univ Hong Kong, LKS Fac Med, Dept Ophthalmol, Sai Wan, Hong Kong, Peoples R China; [So, Kwok Fai] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Sai Wan, Hong Kong, Peoples R China; [Yuen, L. P.] Int Assoc Hlth & Yangsheng, Sai Wan, Hong Kong, Peoples R China; [Ku, Kam-Shing] Haven Hope Haven Hope Christian Serv, Dist Elderly Community Serv, Sai Wan, Hong Kong, Peoples R China; [Choi, Anna W. M.] City Univ Hong Kong, Dept Social & Behav Sci, Sai Wan, Hong Kong, Peoples R China; [Chouliara, Zoe] Abertay Univ, Div Mental Hlth & Counselling, Dundee, Scotland	University of Hong Kong; University of Hong Kong; University of Hong Kong; Jinan University; University of Hong Kong; University of Hong Kong; City University of Hong Kong; University of Abertay Dundee	Ng, SM; Emery, C (corresponding author), Univ Hong Kong, Dept Social Work & Social Adm, Sai Wan, Hong Kong, Peoples R China.	ngsiuman@hku.hk; cemery@hku.hk	Choi, Wai Man/F-9776-2012; Chan, Celia Hoi Yan/A-2502-2010	Choi, Wai Man/0000-0002-9341-8515; Emery, Clifton/0000-0001-7662-2509; So, Kwok-Fai/0000-0003-4039-4246; Chan, Celia Hoi Yan/0000-0002-4800-716X	Innovative Research Fund from the Department of Social Work and Social Administration of The University of Hong Kong	Innovative Research Fund from the Department of Social Work and Social Administration of The University of Hong Kong	This research was funded by the Innovative Research Fund from the Department of Social Work and Social Administration of The University of Hong Kong.; We would like to thank the participants, the volunteers who helped in the data collection, the volunteers from the International Association for Health and Yangsheng in Hong Kong, and the staff of the Centre on Behavioral Health at The University of Hong Kong, who made this project possible.	Baldwin JR, 2018, BRAIN BEHAV IMMUN, V67, P211, DOI 10.1016/j.bbi.2017.08.025; Baumeister D, 2016, MOL PSYCHIATR, V21, P642, DOI 10.1038/mp.2015.67; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Bertone-Johnson ER, 2012, AM J PREV MED, V43, P611, DOI 10.1016/j.amepre.2012.08.014; Bookwala J, 2005, J AGING HEALTH, V17, P85, DOI 10.1177/0898264304272794; Bulloch AGM, 2017, J AFFECT DISORDERS, V223, P65, DOI 10.1016/j.jad.2017.06.007; Carpenter LL, 2010, NEUROPSYCHOPHARMACOL, V35, P2617, DOI 10.1038/npp.2010.159; Chouliara Z, 2014, J PSYCHIATR MENT HLT, V21, P69, DOI 10.1111/jpm.12048; Chouliara Z, 2017, CHILD YOUTH SERV REV, V79, P527, DOI 10.1016/j.childyouth.2017.06.072; Chouliara Z, 2012, COUNS PSYCHOTHER RES, V12, P146, DOI 10.1080/14733145.2012.656136; Chouliara Z, 2011, J CHILD SEX ABUS, V20, P128, DOI 10.1080/10538712.2011.554340; Coelho R, 2014, ACTA PSYCHIAT SCAND, V129, P180, DOI 10.1111/acps.12217; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen-Woods S, 2018, BRAIN BEHAV IMMUN, V67, P203, DOI 10.1016/j.bbi.2017.08.023; Copeland WE, 2014, P NATL ACAD SCI USA; Crosswell AD, 2014, PSYCHOSOM MED, V76, P208, DOI 10.1097/PSY.0000000000000041; Danese A, 2011, MOL PSYCHIATR, V16, P244, DOI 10.1038/mp.2010.5; Danese A, 2008, ARCH GEN PSYCHIAT, V65, P409, DOI 10.1001/archpsyc.65.4.409; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Danese A, 2017, ANNU REV PSYCHOL, V68, P517, DOI 10.1146/annurev-psych-010416-044208; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; do Prado CH, 2017, NEUROPSYCHOPHARMACOL, V42, P2272, DOI 10.1038/npp.2017.137; Donoho CJ, 2012, MARITAL QUALITY GEND; Fergusson DM, 2013, CHILD ABUSE NEGLECT, V37, P664, DOI 10.1016/j.chiabu.2013.03.013; Gouin JP, 2012, ANN BEHAV MED, V44, P287, DOI 10.1007/s12160-012-9386-1; Grosse L, 2016, PSYCHONEUROENDOCRINO, V73, P24, DOI 10.1016/j.psyneuen.2016.07.205; Hostinar CE, 2017, PSYCHONEUROENDOCRINO, V75, P152, DOI 10.1016/j.psyneuen.2016.10.026; Ji XW, 2018, J SLEEP RES, V27, P56, DOI 10.1111/jsr.12583; John NA, 2017, CULT HEALTH SEX, V19, P267, DOI 10.1080/13691058.2016.1215526; Kiecolt-Glaser JK, 2010, NEUROSCI BIOBEHAV R, V35, P33, DOI 10.1016/j.neubiorev.2009.09.003; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kroenke K, 1994, Arch Fam Med, V3, P774; Lam CL, FAMILY PRACTICE, V12, P149; Leung DYP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-513; Liang B, 2006, J INTERPERS VIOLENCE, V21, P42, DOI 10.1177/0886260505281603; MacIntosh HB, 2008, J MARITAL FAM THER, V34, P298, DOI 10.1111/j.1752-0606.2008.00074.x; Maniglio R, 2010, DEPRESS ANXIETY, V27, P631, DOI 10.1002/da.20687; McFarland MJ, 2013, J MARRIAGE FAM, V75, P363, DOI 10.1111/jomf.12015; Miller GE, 2012, BIOL PSYCHIAT, V72, P34, DOI 10.1016/j.biopsych.2012.02.034; Nemeroff CB, 2016, NEURON, V89, P892, DOI 10.1016/j.neuron.2016.01.019; Ng Siu-Man, 2013, BMC Psychol, V1, P9, DOI 10.1186/2050-7283-1-9; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Nowakowski ACH, 2015, SOCIOL SPECTRUM, V35, P161, DOI 10.1080/02732173.2014.1000554; Petrov ME, 2016, J BEHAV MED, V39, P716, DOI 10.1007/s10865-016-9742-x; Reed RG, 2015, INTERPERSONAL IMMUNE; REMPEL JK, 1985, J PERS SOC PSYCHOL, V49, P95, DOI 10.1037/0022-3514.49.1.95; Rich-Edwards JW, 2010, AM J PREV MED, V39, P529, DOI 10.1016/j.amepre.2010.09.007; Roberson PNE, 2018, SOC SCI MED, V201, P18, DOI 10.1016/j.socscimed.2018.01.037; Robles TF, 2014, PSYCHOL BULL, V140, P140, DOI 10.1037/a0031859; Rooks C, 2012, PSYCHOSOM MED, V74, P146, DOI 10.1097/PSY.0b013e318240a7d8; Rusbult CE, 2014, HDB CLOSENESS INTIMA, P137; Savla JT, 2013, CHILD ABUSE NEGLECT, V37, P388, DOI 10.1016/j.chiabu.2012.12.009; Sbarra DA, 2009, PSYCHOSOM MED, V71, P828, DOI 10.1097/PSY.0b013e3181b4c4f2; Schneider IK, 2011, PERS RELATIONSHIP, V18, P668, DOI 10.1111/j.1475-6811.2010.01338.x; Slavic TR, 2017, J MARITAL FAM THER, V43, P422, DOI 10.1111/jmft.12212; Slopen N, 2013, PSYCHONEUROENDOCRINO, V38, P188, DOI 10.1016/j.psyneuen.2012.05.013; South SC, 2013, PSYCHOL SCI, V24, P373, DOI 10.1177/0956797612453116; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Uchino BN, 2013, HEALTH PSYCHOL, V32, P1067, DOI 10.1037/a0033515; Vaccarino AL, 2008, J AFFECT DISORDERS, V110, P270, DOI 10.1016/j.jad.2008.01.009; Walker EC, 2011, J MARITAL FAM THER, V37, P37, DOI 10.1111/j.1752-0606.2009.00153.x; Walsh K, 2016, PSYCHOSOM MED, V78, P920, DOI 10.1097/PSY.0000000000000344; Wells MA, 2016, J COUPLE RELATSH THE, V15, P177, DOI 10.1080/15332691.2014.962210; Whisman MA, 2003, TREATING DIFFICULT COUPLES: HELPING CLIENTS WITH COEXISTING MENTAL AND RELATIONSHIP DISORDERS, P3; Wu XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182961; Zhao X., 2005, CHIN J CLIN REHABIL, V9, P209, DOI [DOI 10.3321/J.ISSN:1673-8225.2005.20.052, 10.3321/j.issn:1673-8225.2005.16.037, DOI 10.3321/J.ISSN:1673-8225.2005.16.037]; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	67	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232932	10.1371/journal.pone.0232932	http://dx.doi.org/10.1371/journal.pone.0232932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1BA	32413063	gold, Green Published			2022-12-26	WOS:000537496000028
J	Shieh, LT; Guo, HR; Ho, CH; Lin, LC; Chang, CH; Ho, SY				Shieh, Li-Tsun; Guo, How-Ran; Ho, Chung-Han; Lin, Li-Ching; Chang, Chin-Hong; Ho, Sheng-Yow			Survival of glioblastoma treated with a moderately escalated radiation dose-Results of a retrospective analysis	PLOS ONE			English	Article							CONFORMAL RADIOTHERAPY; ADJUVANT TEMOZOLOMIDE; MULTIVARIATE-ANALYSIS; MALIGNANT GLIOMA; THERAPY; MULTIFORME; RESECTION; PATTERNS; FAILURE; CONCOMITANT	Glioblastoma (GBM) has the highest fatality rate among primary malignant brain tumors and typically tends to recur locally just adjacent to the original tumor site following surgical resection and adjuvant radiotherapy. We conducted a study to evaluate the survival outcomes between a standard dose (<= 60 Gy) and moderate radiation dose escalation (>60 Gy), and to identify prognostic factors for GBM. We retrospectively reviewed the medical records of primary GBM patients diagnosed between 2005 and 2016 in two referral hospitals in Taiwan. They were identified from the cancer registry database and followed up from the date of diagnosis to October 2018. The progression-free survival (PFS) and overall survival (OS) were compared between the two dose groups, and independent factors for survival were analyzed through Cox proportional hazard model. We also affirmed the results using Cox regression with least absolute shrinkage and selection operator (LASSO) approach. From our cancer registry database, 142 GBM patients were identified, and 84 of them fit the inclusion criteria. Of the 84 patients, 52 (62%) were males. The radiation dose ranged from 50.0 Gy to 66.6 Gy, but their treatment volumes were similar to the others. Fifteen (18%) patients received an escalated dose boost > 60.0 Gy. The escalated group had a longer median PFS (15.4 vs. 7.9 months, p = 0.01 for log-rank test), and a longer median OS was also longer in the escalation group (33.8 vs. 12.5 months, p < 0.001) than the reference group. Following a multivariate analysis, the escalated dose was identified as a significant predictor for good prognosis (PFS: hazard ratio [HR] = 0.48, 95% confidence interval [95%CI]: 0.23-0.98; OS: HR = 0.40, 95%CI: 0.21-0.78). Using the LASSO approach, we found age > 70 (HR = 1.55), diagnosis after 2010 (HR = 1.42), and a larger radiation volume (>= 250ml; HR = 0.81) were predictors of PFS. The escalated dose (HR = 0.47) and a larger radiation volume (HR = 0.76) were identified as predictors for better OS. Following detailed statistical analysis, a moderate radiation dose escalation (> 60 Gy) was found as an independent factor affecting OS in GBM patients. In conclusion, a moderate radiation dose escalation (> 60 Gy) was an independent predictor for longer OS in GBM patients. However, prospective studies including more patients with more information, such as molecular markers and completeness of resection, are needed to confirm our findings.	[Shieh, Li-Tsun; Ho, Sheng-Yow] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ, Dept Environm & Occupat Hlth, Coll Med, Tainan, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan, Taiwan; [Ho, Chung-Han] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Lin, Li-Ching; Ho, Sheng-Yow] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Chang, Chin-Hong] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Ho, Sheng-Yow] Chang Jung Christian Univ, Grad Inst Med Sci, Tainan, Taiwan	Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital; Chang Jung Christian University	Ho, SY (corresponding author), Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan.; Ho, SY (corresponding author), Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan.; Ho, SY (corresponding author), Chang Jung Christian Univ, Grad Inst Med Sci, Tainan, Taiwan.	shengho@seed.net.tw	Guo, How-Ran/AAK-9063-2020	Guo, How-Ran/0000-0003-3343-3446; Ho, Chung-Han/0000-0001-5925-8477; Shieh, Li-tsun/0000-0003-0710-9335	Chi Mei Medical Center, Liouying [CLFH10840]	Chi Mei Medical Center, Liouying	SYH. This study was supported by the grant of Chi Mei Medical Center, Liouying (No. CLFH10840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad A, 2017, J NEURO-ONCOL, V135, P161, DOI 10.1007/s11060-017-2562-1; Chan JL, 2002, J CLIN ONCOL, V20, P1635, DOI 10.1200/JCO.20.6.1635; Graf R, 2005, ONKOLOGIE, V28, P325, DOI 10.1159/000085574; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Kim MM, 2019, J NEURO-ONCOL, V143, P313, DOI 10.1007/s11060-019-03166-3; Kreth FW, 2013, ANN ONCOL, V24, P3117, DOI 10.1093/annonc/mdt388; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Li YM, 2016, J NEUROSURG, V124, P977, DOI 10.3171/2015.5.JNS142087; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lutterbach J, 2003, STRAHLENTHER ONKOL, V179, P8, DOI 10.1007/s00066-003-1004-5; MAHALEY MS, 1989, J NEUROSURG, V71, P826, DOI 10.3171/jns.1989.71.6.0826; Milano MT, 2010, INT J RADIAT ONCOL, V78, P1147, DOI 10.1016/j.ijrobp.2009.09.018; Nakagawa K, 1998, INT J RADIAT ONCOL, V40, P1141, DOI 10.1016/S0360-3016(97)00911-5; Roa W, 2004, J CLIN ONCOL, V22, P1583, DOI 10.1200/JCO.2004.06.082; Shaw E, 2002, J CLIN ONCOL, V20, P2267, DOI 10.1200/JCO.2002.09.126; Shieh LT, 2019, J FORMOSAN MED ASS; Souhami L, 2004, INT J RADIAT ONCOL, V60, P853, DOI 10.1016/j.ijrobp.2004.04.011; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Trifiletti DM, 2017, WORLD NEUROSURG, V103, P330, DOI 10.1016/j.wneu.2017.04.035; Tsien C, 2009, INT J RADIAT ONCOL, V73, P699, DOI 10.1016/j.ijrobp.2008.05.034; Tsien CI, 2012, CLIN CANCER RES, V18, P273, DOI 10.1158/1078-0432.CCR-11-2073; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; WALLNER KE, 1989, INT J RADIAT ONCOL, V16, P1405, DOI 10.1016/0360-3016(89)90941-3; Wegner RE, 2019, RADIAT ONCOL J, V37, P13, DOI 10.3857/roj.2019.00017; Zhong LZ, 2019, RADIAT ONCOL, V14, DOI 10.1186/s13014-019-1305-1; Zschaeck S, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1194-8	29	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233188	10.1371/journal.pone.0233188	http://dx.doi.org/10.1371/journal.pone.0233188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413077	gold, Green Published			2022-12-26	WOS:000537496000058
J	Wilden, JJ; van Kruchten, A; Gieselmann, L; Hrincius, ER; Deinhardt-Emmer, S; Haupt, KF; Preugschas, HF; Niemann, S; Ludwig, S; Ehrhardt, C				Wilden, Janine J.; van Kruechten, Andre; Gieselmann, Lutz; Hrincius, Eike R.; Deinhardt-Emmer, Stefanie; Haupt, Karoline F.; Preugschas, Hannah F.; Niemann, Silke; Ludwig, Stephan; Ehrhardt, Christina			The influenza replication blocking inhibitor LASAG does not sensitize human epithelial cells for bacterial infections	PLOS ONE			English	Article							NF-KAPPA-B; ACETYLSALICYLIC-ACID; VIRULENCE DETERMINANT; VIRUS PROPAGATION; EXPRESSION; COINFECTION; SALICYLATE; PNEUMONIA; DEATH	Severe influenza virus (IV) infections still represent a major challenge to public health. To combat IV infections, vaccines and antiviral compounds are available. However, vaccine efficacies vary with very limited to no protection against newly emerging zoonotic IV introductions. In addition, the development of resistant virus variants against currently available antivirals can be rapidly detected, in consequence demanding the design of novel antiviral strategies. Virus supportive cellular signaling cascades, such as the NF-kappa B pathway, have been identified to be promising antiviral targets against IV in in vitro and in vivo studies and clinical trials. While administration of NF-kappa B pathway inhibiting agents, such as LASAG results in decreased IV replication, it remained unclear whether blocking of NF-kappa B might sensitize cells to secondary bacterial infections, which often come along with viral infections. Thus, we examined IV and Staphylococcus aureus growth during LASAG treatment. Interestingly, our data reveal that the presence of LASAG during superinfection still leads to reduced IV titers. Furthermore, the inhibition of the NF-kappa B pathway resulted in decreased intracellular Staphylococcus aureus loads within epithelial cells, indicating a dependency on the pathway for bacterial uptake. Unfortunately, so far it is not entirely clear if this phenomenon might be a drawback in bacterial clearance during infection.	[Wilden, Janine J.; van Kruechten, Andre; Gieselmann, Lutz; Hrincius, Eike R.; Preugschas, Hannah F.; Ludwig, Stephan; Ehrhardt, Christina] Westfaelische Wilhelms Univ WWU Muenster, Inst Virol Muenster IVM, Munster, Germany; [Deinhardt-Emmer, Stefanie; Haupt, Karoline F.; Ehrhardt, Christina] Jena Univ Hosp, Inst Med Microbiol, Sect Expt Virol, Jena, Germany; [Niemann, Silke] Westfaelische Wilhelms Univ WWU Muenster, Inst Med Microbiol, Munster, Germany; [Ludwig, Stephan] WWUMuenster, Cluster Excellence EXC 1003 Cells Mot, Munster, Germany	Friedrich Schiller University of Jena	Ehrhardt, C (corresponding author), Westfaelische Wilhelms Univ WWU Muenster, Inst Virol Muenster IVM, Munster, Germany.; Ehrhardt, C (corresponding author), Jena Univ Hosp, Inst Med Microbiol, Sect Expt Virol, Jena, Germany.	Christina.Ehrhardt@med.uni-jena.de	Deinhardt-Emmer, Stefanie/AAX-9265-2020	Deinhardt-Emmer, Stefanie/0000-0003-4495-4052; Wilden, Janine J./0000-0003-4925-3933; Ludwig, Stephan/0000-0003-4490-3052	Deutsche Forschungsgemeinschaft [SFB 1009, Lu477/23-1]; Juergen Manchot Stiftung; MedK Muenster; Open Access Publication Fund of the University of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Juergen Manchot Stiftung; MedK Muenster; Open Access Publication Fund of the University of Muenster	This work was supported by the Deutsche Forschungsgemeinschaft [grants SFB 1009, project B01 (S.N) and B02 (J.J.W.)(C.E.), Lu477/23-1(S.L.)], the Juergen Manchot Stiftung (A.vK.)(C.E.) and the MedK Muenster (L.G.). We gratefully acknowledge the support by Open Access Publication Fund of the University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089; Bakaletz LO, 2017, CURR OPIN MICROBIOL, V35, P30, DOI 10.1016/j.mib.2016.11.003; Cai DT, 2011, MOL MEMBR BIOL, V28, P90, DOI 10.3109/09687688.2010.525756; Carestia A, 2020, BLOOD, V135, P1281, DOI 10.1182/blood.2019002783; Chertow DS, 2013, JAMA-J AM MED ASSOC, V309, P275, DOI 10.1001/jama.2012.194139; Droebner K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02130; Duwe S, 2017, GMS INFECT DIS, V5, P1; Ehrhardt C, 2013, CELL MICROBIOL, V15, P1198, DOI 10.1111/cmi.12108; Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Jochems SP, 2018, NAT IMMUNOL, V19, P1299, DOI 10.1038/s41590-018-0231-y; Kobayashi SD, 2018, J INNATE IMMUN, V10, P432, DOI 10.1159/000487756; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Krachler AM, 2011, J CELL BIOL, V195, P1083, DOI 10.1083/jcb.201107132; Kramer A, 2008, P NATL ACAD SCI USA, V105, P11236, DOI 10.1073/pnas.0801967105; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Li N, 2015, P NATL ACAD SCI USA, V112, P238, DOI 10.1073/pnas.1414422112; Liedmann S, 2014, J INFECT DIS, V209, P532, DOI 10.1093/infdis/jit463; Liu YT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10720-4; LOURIA DB, 1959, J CLIN INVEST, V38, P213, DOI 10.1172/JCI103789; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Muhlbauer D, 2015, J VIROL, V89, P6009, DOI 10.1128/JVI.03531-14; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Ouyang W, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12721; Oviedo-Boyso J, 2008, SCAND J IMMUNOL, V67, P169, DOI 10.1111/j.1365-3083.2007.02056.x; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Planz O, 2013, ANTIVIR RES, V98, P457, DOI 10.1016/j.antiviral.2013.04.008; RODRIGUEZ AB, 1989, GEN PHARMACOL, V20, P151, DOI 10.1016/0306-3623(89)90007-4; Rowe HM, 2019, NAT MICROBIOL, V4, P1328, DOI 10.1038/s41564-019-0447-0; Scheuch G, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0023-3; van Kruchten A, 2018, FASEB J, V32, P2779, DOI 10.1096/fj.201701006R; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Warnking K, 2015, CELL MICROBIOL, V17, P303, DOI 10.1111/cmi.12375; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zhu F, 2014, EXP CELL RES, V327, P256, DOI 10.1016/j.yexcr.2014.04.018	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233052	10.1371/journal.pone.0233052	http://dx.doi.org/10.1371/journal.pone.0233052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413095	Green Published, gold			2022-12-26	WOS:000537496000044
J	Chantzi, E; Neidlin, M; Macheras, GA; Alexopoulos, LG; Gustafsson, MG				Chantzi, Efthymia; Neidlin, Michael; Macheras, George A.; Alexopoulos, Leonidas G.; Gustafsson, Mats G.			COMBSecretomics: A pragmatic methodological framework for higher-order drug combination analysis using secretomics	PLOS ONE			English	Article								Multi drug treatments are increasingly used in the clinic to combat complex and co-occurring diseases. However, most drug combination discovery efforts today are mainly focused on anticancer therapy and rarely examine the potential of using more than two drugs simultaneously. Moreover, there is currently no reported methodology for performing second- and higher-order drug combination analysis of secretomic patterns, meaning protein concentration profiles released by the cells. Here, we introduce COMBSecretomics (https://github.com/EffieChantzi/COMBSecretomics.git), the first pragmatic methodological framework designed to search exhaustively for second- and higher-order mixtures of candidate treatments that can modify, or even reverse malfunctioning secretomic patterns of human cells. This framework comes with two novel model-free combination analysis methods; a tailor-made generalization of the highest single agent principle and a data mining approach based on top-down hierarchical clustering. Quality control procedures to eliminate outliers and non-parametric statistics to quantify uncertainty in the results obtained are also included. COMBSecretomics is based on a standardized reproducible format and could be employed with any experimental platform that provides the required protein release data. Its practical use and functionality are demonstrated by means of a proof-of-principle pharmacological study related to cartilage degradation. COMBSecretomics is the first methodological framework reported to enable secretomerelated second- and higher-order drug combination analysis. It could be used in drug discovery and development projects, clinical practice, as well as basic biological understanding of the largely unexplored changes in cell-cell communication that occurs due to disease and/or associated pharmacological treatment conditions.	[Chantzi, Efthymia; Gustafsson, Mats G.] Uppsala Univ, Dept Med Sci, Canc Pharmacol & Computat Med, Uppsala, Sweden; [Chantzi, Efthymia; Gustafsson, Mats G.] Uppsala Univ, Dept Elect Engn, Signals & Syst, Uppsala, Sweden; [Neidlin, Michael; Alexopoulos, Leonidas G.] Natl Tech Univ Athens, Dept Mech Engn, Biomed Syst Lab, Athens, Greece; [Macheras, George A.] Gen Hosp KAT, Orthoped Dept 4, Athens, Greece	Uppsala University; Uppsala University; National Technical University of Athens	Chantzi, E; Gustafsson, MG (corresponding author), Uppsala Univ, Dept Med Sci, Canc Pharmacol & Computat Med, Uppsala, Sweden.; Chantzi, E; Gustafsson, MG (corresponding author), Uppsala Univ, Dept Elect Engn, Signals & Syst, Uppsala, Sweden.	efthymia.chantzi@medsci.uu.se; mats.gustafsson@medsci.uu.se	Alexopoulos, Leonidas/AAN-1148-2021; Macheras, George/ABI-8249-2020	Alexopoulos, Leonidas G/0000-0003-0425-166X; Neidlin, Michael/0000-0002-5582-6905	Swedish Research Council (Vetenskapsradet) [2017-04655]; German Research Foundation (Deutsche Forschungsgemeinschaft) [387071423]; European Commission [T1EDK-00120]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research work was supported by: the Swedish Research Council (Vetenskapsradet, www.vr.se/, grant no. 2017-04655), received by MGG. -the German Research Foundation (Deutsche Forschungsgemeinschaft, www.dfg.de, grant no. 387071423), received by MN. -the European Commission (https://ec.europa.eu/info/index_en, grant no. T1EDK-00120), received by LGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos LG, 1926, N-S ARCH PHARMACOL, V114, P313, DOI [10.1007/BF01952257, DOI 10.1007/BF01952257]; Bavisotto CC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020434; Beppler C, 2016, J R SOC INTERFACE, V13, P125, DOI DOI 10.1098/RSIF.2016.0800; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Berg Ellen L., 2006, Journal of Pharmacological and Toxicological Methods, V53, P67, DOI 10.1016/j.vascn.2005.06.003; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Brown KJ, 2013, BBA-PROTEINS PROTEOM, V1834, P2454, DOI 10.1016/j.bbapap.2013.04.007; Brown KJ, 2012, EXPERT REV PROTEOMIC, V9, P337, DOI [10.1586/epr.12.21, 10.1586/EPR.12.21]; Caccia D, 2013, BBA-PROTEINS PROTEOM, V1834, P2442, DOI 10.1016/j.bbapap.2013.01.039; Chantzi E, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2908-0; Cheng FX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09186-x; Geary N, 2013, AM J PHYSIOL-ENDOC M, V304, pE237, DOI 10.1152/ajpendo.00308.2012; Meyer CT, 2020, TRENDS PHARMACOL SCI, V41, P266, DOI 10.1016/j.tips.2020.01.011; Neidlin M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224231; O'Mahony A, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1532-5; Palmer AC, 2017, CELL, V171, P1678, DOI 10.1016/j.cell.2017.11.009; Pemovska T, 2018, CURR OPIN PHARMACOL, V42, P102, DOI 10.1016/j.coph.2018.07.008; Poubelle PE, 2019, CLIN TRANSL MED, V8, DOI 10.1186/s40169-019-0236-7; Poulet B, 2017, INT J EXP PATHOL, V98, P120, DOI 10.1111/iep.12230; Regan-Fendt KE, 2019, NPJ SYST BIOL APPL, V5, DOI 10.1038/s41540-019-0085-4; Savage VM, 2017, CURRENT OPINION SYST, V4, P16, DOI [10.1016/j.coisb.2017.05.015, DOI 10.1016/J.COISB.2017.05.015]; Song P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163893; Tan X, 2012, NAT BIOTECHNOL, V30, P1125, DOI 10.1038/nbt.2391; Tekin E, 2016, J R SOC INTERFACE, V13, P119; Tekin E, 2018, NPJ SYST BIOL APPL, V4, DOI 10.1038/s41540-018-0069-9; Vivek-Ananth RP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25016-4; Vlot AHC, 2019, DRUG DISCOV TODAY, V24, P2286, DOI 10.1016/j.drudis.2019.09.002; Wetmore BA, 2019, TOXICOL IN VITRO, V54, P41, DOI 10.1016/j.tiv.2018.09.006; Zullo J, 2015, PROSTAG OTH LIPID M, V120, P17, DOI 10.1016/j.prostaglandins.2015.03.012	29	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232989	10.1371/journal.pone.0232989	http://dx.doi.org/10.1371/journal.pone.0232989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407402	Green Published, gold			2022-12-26	WOS:000537490700055
J	Satapathy, SK; Gonzalez, HC; Vanatta, J; Dyer, A; Angel, W; Nouer, SS; Kocak, M; Kedia, SK; Jiang, Y; Clark, I; Yadak, N; Nezakagtoo, N; Helmick, R; Horton, P; Campos, L; Agbim, U; Maliakkal, B; Maluf, D; Nair, S; Halford, HH; Eason, JD				Satapathy, Sanjaya K.; Gonzalez, Humberto C.; Vanatta, Jason; Dyer, Andrew; Angel, Wesley; Nouer, Simonne S.; Kocak, Mehmet; Kedia, Satish K.; Jiang, Yu; Clark, Ian; Yadak, Nour; Nezakagtoo, Nosratollah; Helmick, Ryan; Horton, Peter; Campos, Luis; Agbim, Uchenna; Maliakkal, Benedict; Maluf, Daniel; Nair, Satheesh; Halford, Hollis H.; Eason, James D.			A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction	PLOS ONE			English	Article							EARLY ALLOGRAFT DYSFUNCTION; DENSITY FAT FRACTION; HEPATIC STEATOSIS; QUANTITATIVE ASSESSMENT; VALIDATION; GRADES	Background The utility of ex vivo Magnetic resonance imaging proton density fat fraction (MRI-PDFF) in donor liver fat quantification is unknown. Purpose To evaluate the diagnostic accuracy and utility in predicting early allograft dysfunction (EAD) of ex vivo MRI-PDFF measurement of fat in deceased donor livers using histology as the gold standard. Methods We performed Ex vivo, 1.5 Tesla MRI-PDFF on 33 human deceased donor livers before implantation, enroute to the operating room. After the exclusion of 4 images (technical errors), 29 MRI images were evaluable. Histology was evaluable in 27 of 29 patients. EAD was defined as a peak value of aminotransferase >2000 IU/mL during the first week or an INR of >= 1.6 or bilirubin >= 10 mg/dL at day 7. Results MRI-PDFF values showed a strong positive correlation (Pearson's correlation coefficient) when histology (macro-steatosis) was included (r = 0.78, 95% confidence interval 0.57-0.89, p<0.0001). The correlation appeared much stronger when macro plus micro-steatosis were included (r = 0.87, 95% confidence interval 0.72-0.94, p< 0.0001). EAD was noted in 7 (25%) subjects. AUC (Area Under the Curve) for macro steatosis (histology) predicted EAD in 73% (95% CI: 48-99), micro plus macro steatosis in 76% (95% CI: 49-100). AUC for PDFF values predicted EAD in 67(35-98). Comparison of the ROC curves in a multivariate model revealed, adding MRI PDFF values to macro steatosis increased the ability of the model in predicting EAD (AUC: 79%, 95% CI: 59-99), and addition of macro plus micro steatosis based on histology predicted EAD even better (AUC: 90%: 79-100, P = 0.054). Conclusion In this pilot study, MRI-PDFF imaging showed potential utility in quantifying hepatic steatosis ex-vivo donor liver evaluation and the ability to predict EAD related to severe allograft steatosis in the recipient.	[Satapathy, Sanjaya K.; Gonzalez, Humberto C.; Vanatta, Jason; Nezakagtoo, Nosratollah; Helmick, Ryan; Horton, Peter; Campos, Luis; Agbim, Uchenna; Maliakkal, Benedict; Maluf, Daniel; Nair, Satheesh; Eason, James D.] Methodist Univ Hosp, Transplant Inst, Div Transplant Surg, Memphis, TN 38104 USA; [Satapathy, Sanjaya K.; Gonzalez, Humberto C.; Vanatta, Jason; Nezakagtoo, Nosratollah; Helmick, Ryan; Horton, Peter; Campos, Luis; Agbim, Uchenna; Maliakkal, Benedict; Maluf, Daniel; Nair, Satheesh; Halford, Hollis H.; Eason, James D.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38163 USA; [Satapathy, Sanjaya K.] North Shore Univ Hosp, Northwell Health, Sandra Atlas Bass Ctr Liver Dis, Div Hepatol, Manhasset, NY 11030 USA; [Gonzalez, Humberto C.] Wayne State Univ, Sch Med, Henry Ford Hlth Syst, Detroit, MI USA; [Vanatta, Jason] Cleveland Clin Florida, Ctr Abdominal Transplantat, Weston, FL USA; [Dyer, Andrew; Angel, Wesley] Methodist Univ Hosp, Dept Radiol, Memphis, TN USA; [Nouer, Simonne S.; Kocak, Mehmet] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Knoxville, TN USA; [Kedia, Satish K.; Jiang, Yu] Univ Memphis, Sch Publ Hlth, Memphis, TN 38152 USA; [Clark, Ian; Yadak, Nour] Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Northwell Health; North Shore University Hospital; Henry Ford Health System; Henry Ford Hospital; Wayne State University; Cleveland Clinic Foundation; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Tennessee System; University of Tennessee Health Science Center	Satapathy, SK (corresponding author), Methodist Univ Hosp, Transplant Inst, Div Transplant Surg, Memphis, TN 38104 USA.; Satapathy, SK (corresponding author), North Shore Univ Hosp, Northwell Health, Sandra Atlas Bass Ctr Liver Dis, Div Hepatol, Manhasset, NY 11030 USA.	ssatapat@northwell.edu		Satapathy, Sanjaya/0000-0003-0153-2829; Kedia, Satish/0000-0002-7114-5843; Helmick, Ryan/0000-0002-8819-9522	Methodist Healthcare Foundation	Methodist Healthcare Foundation	This study was supported by the Methodist Healthcare Foundation, which provided staff support for coordination of the research and obtaining MRI scan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received.	Andert A, 2017, HEPATOB PANCREAT DIS, V16, P617, DOI 10.1016/S1499-3872(17)60064-X; Bannas P, 2015, HEPATOLOGY, V62, P1444, DOI 10.1002/hep.28012; Deroose JP, 2011, HPB, V13, P417, DOI 10.1111/j.1477-2574.2011.00310.x; Dulai PS, 2016, J HEPATOL, V65, P1006, DOI 10.1016/j.jhep.2016.06.005; Durand F, 2008, LIVER TRANSPLANT, V14, P1694, DOI 10.1002/lt.21668; Holowko W, 2014, TRANSPL P, V46, P2755, DOI 10.1016/j.transproceed.2014.09.102; Idilman IS, 2016, ACTA RADIOL, V57, P271, DOI 10.1177/0284185115580488; Kuhn JP, 2012, RADIOLOGY, V265, P133, DOI 10.1148/radiol.12112520; Lee DD, 2016, ANN HEPATOL, V15, P53, DOI 10.5604/16652681.1184212; Middleton MS, 2017, GASTROENTEROLOGY, V153, P753, DOI 10.1053/j.gastro.2017.06.005; Noworolski SM, 2012, RADIOLOGY, V264, P88, DOI 10.1148/radiol.12110673; Olthoff KM, 2010, LIVER TRANSPLANT, V16, P943, DOI 10.1002/lt.22091; Permutt Z, 2012, ALIMENT PHARM THER, V36, P22, DOI 10.1111/j.1365-2036.2012.05121.x; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Salvalaggio PR, 2012, TRANSPL P, V44, P2449, DOI 10.1016/j.transproceed.2012.08.002; Satkunasingham J, 2018, LIVER TRANSPLANT, V24, P470, DOI 10.1002/lt.24965; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Spitzer AL, 2010, LIVER TRANSPLANT, V16, P874, DOI 10.1002/lt.22085; Tang A, 2015, RADIOLOGY, V274, P416, DOI 10.1148/radiol.14140754; Wu CJ, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012026	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232006	10.1371/journal.pone.0232006	http://dx.doi.org/10.1371/journal.pone.0232006			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407331	Green Published, gold			2022-12-26	WOS:000537490700010
J	Stoller, N; Wertli, MM; Zaugg, TM; Haynes, AG; Chiolero, A; Rodondi, N; Panczak, R; Aujesky, D				Stoller, Nina; Wertli, Maria M.; Zaugg, Tabea M.; Haynes, Alan G.; Chiolero, Arnaud; Rodondi, Nicolas; Panczak, Radoslaw; Aujesky, Drahomir			Regional variation of hysterectomy for benign uterine diseases in Switzerland	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; SMALL-AREA VARIATIONS; VAGINAL HYSTERECTOMY; LAPAROSCOPIC HYSTERECTOMY; ASSOCIATION; ATTITUDES; TRENDS; FRENCH; INDEX; RATES	Background Hysterectomy is the last treatment option for benign uterine diseases, and vaginal hysterectomy is preferred over more invasive techniques. We assessed the regional variation in hysterectomy rates for benign uterine diseases across Switzerland and explored potential determinants of variation. Methods We conducted a population-based analysis using patient discharge data from all Swiss hospitals between 2013 and 2016. Hospital service areas (HSAs) for hysterectomies were derived by analyzing patient flows. We calculated age-standardized mean procedure rates and measures of regional variation (extremal quotient [EQ], highest divided by lowest rate) and systematic component of variation [SCV]). We estimated the reduction in the variance of crude hysterectomy rates across HSAs in multilevel regression models, with incremental adjustment for procedure year, age, cultural/socioeconomic factors, burden of disease, and density of gynecologists. Results Overall, 40,211 hysterectomies from 54 HSAs were analyzed. The mean age-standardized hysterectomy rate was 298/100,000 women (range 186-456). While the variation in overall procedure rate was moderate (EQ 2.5, SCV 3.7), we found a very high procedure-specific variation (EQ vaginal 5.0, laparoscopic 6.3, abdominal 8.0; SCV vaginal 17.5, laparoscopic 11.2, abdominal 16.9). Adjusted for procedure year, demographic, cultural, and sociodemographic factors, a large share (64%) of the variance remained unexplained (vaginal 63%, laparoscopic 85%, abdominal 70%). The main determinants of variation were socioeconomic/cultural factors. Burden of disease and the density of gynecologists was not associated with procedure rates. Conclusions Switzerland has a very high regional variation in vaginal, laparoscopic, and abdominal hysterectomy for benign uterine disease. After adjustment for potential determinants of variation including demographic factors, socioeconomic and cultural factors, burden of disease, and the density of gynecologists, two thirds of the variation remain unexplained.	[Stoller, Nina; Wertli, Maria M.; Zaugg, Tabea M.; Rodondi, Nicolas; Aujesky, Drahomir] Univ Bern, Bern Univ Hosp, Inselspital, Dept Gen Internal Med, Bern, Switzerland; [Haynes, Alan G.] Univ Bern, CTU Bern, Bern, Switzerland; [Chiolero, Arnaud; Rodondi, Nicolas] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Chiolero, Arnaud] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Panczak, Radoslaw] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Panczak, Radoslaw] Univ Queensland, Sch Earth & Environm Sci, Queensland Ctr Populat Res, Brisbane, Qld, Australia	University of Bern; University Hospital of Bern; University of Bern; University of Bern; McGill University; University of Bern; University of Queensland	Stoller, N (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Gen Internal Med, Bern, Switzerland.	nina.stoller@hopitalvs.ch	Wertli, Maria/Q-3349-2017; Panczak, Radoslaw/E-7384-2018	Wertli, Maria/0000-0001-6347-0198; Panczak, Radoslaw/0000-0001-5141-683X; Rodondi, Nicolas/0000-0001-9083-6896; Haynes, Alan G/0000-0003-1374-081X	National Research Program 74 of the Swiss National Science Foundation (SNSF) [SNSF 407440_167339]; Gottfried and Julia Bangerter-Rhyner-Stiftung; Swiss Society of General Internal Medicine Foundation	National Research Program 74 of the Swiss National Science Foundation (SNSF); Gottfried and Julia Bangerter-Rhyner-Stiftung; Swiss Society of General Internal Medicine Foundation	This research project was supported by the National Research Program 74 of the Swiss National Science Foundation (SNSF), Grant number SNSF 407440_167339: DA, MW, RP, AC, NR Health Services Research funding program of the Gottfried and Julia Bangerter-Rhyner-Stiftung and the Swiss Society of General Internal Medicine Foundation: DA, NR, AC. The sponsors did not have influence on the study design, the collection, analysis and interpretation of the data, the writing of the report, and in the decision to submit the manuscript for publication.	Appleby J, 2011, VARIATIONS HEALTHCAR; Australian Commission on Safety and Quality in Health Care, 2017, ATLAS; Billfeldt NK, 2018, EUR J OBSTET GYN R B, V222, P113, DOI 10.1016/j.ejogrb.2018.01.019; Birkmeyer JD, 2013, LANCET, V382, P1121, DOI 10.1016/S0140-6736(13)61215-5; BRESLOW NE, 1975, J CHRON DIS, V28, P289, DOI 10.1016/0021-9681(75)90010-7; Busato A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-8; Camerini AL, 2016, PATIENT EDUC COUNS, V99, P462, DOI 10.1016/j.pec.2015.10.018; Chrysostomou A, 2018, EUR J OBSTET GYN R B, V231, P262, DOI 10.1016/j.ejogrb.2018.10.058; Clarke-Pearson DL, 2013, OBSTET GYNECOL, V121, P654, DOI 10.1097/AOG.0b013e3182841594; Crivelli L, 2006, HEALTH ECON, V15, P535, DOI 10.1002/hec.1072; De Cure N, 2018, MINIM INVASIVE SURG, V2018, DOI 10.1155/2018/5828071; Deffieux X, 2016, EUR J OBSTET GYN R B, V202, P83, DOI 10.1016/j.ejogrb.2016.04.006; DOMENIGHETTI G, 1988, LANCET, V2, P1470; Egger M, 2014, SWISS NATL COHORT; Einarsson JI, 2010, J MINIM INVAS GYN, V17, P167, DOI 10.1016/j.jmig.2009.12.017; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Gante I, 2017, EUR J OBSTET GYN R B, V208, P97, DOI 10.1016/j.ejogrb.2016.11.021; Hasler S., 2016, BUNDESAMT STAT BFS P; Haynes AG, 2020, HEALTH SERV RES, V55, P469, DOI 10.1111/1475-6773.13275; Ibanez B, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-60; Jacoby VL, 2009, OBSTET GYNECOL, V114, P1041, DOI 10.1097/AOG.0b013e3181b9d222; Klauss G, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-33; Koh WJ, 2018, J NATL COMPR CANC NE, V16, P170, DOI 10.6004/jnccn.2018.0006; Lykke R, 2013, EUR J OBSTET GYN R B, V171, P333, DOI 10.1016/j.ejogrb.2013.09.011; Madhvani K, 2019, BJOG-INT J OBSTET GY, V126, P795, DOI 10.1111/1471-0528.15539; Magos A, 2016, BJOG-INT J OBSTET GY, V123, P633, DOI 10.1111/1471-0528.13904; McCracken G, 2006, Ulster Med J, V75, P54; MCPHERSON K, 1982, NEW ENGL J MED, V307, P1310, DOI 10.1056/NEJM198211183072104; McPherson K, 1996, 23 LOND SCH HYG TROP; Miskry T, 2004, BJOG-INT J OBSTET GY, V111, P877, DOI 10.1111/j.1471-0528.2004.00204.x; Moen M, 2014, OBSTET GYNECOL, V124, P585, DOI 10.1097/AOG.0000000000000398; Morgan DM, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.12.218; Moser A, 2014, J EPIDEMIOL COMMUN H, V68, P1125, DOI 10.1136/jech-2014-204352; Nieboer TE, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003677.pub4, 10.1002/14651858.CD003677.pub5]; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Organisation for Economic Co-operation and Development (OECD), 2018, HLTH CAR UT SURG PRO; Panczak R, 2012, J EPIDEMIOL COMMUN H, V66, P1129, DOI 10.1136/jech-2011-200699; RCore Team, 2020, R LANG ENV STAT COMP; Robinson WS, 2011, INT J EPIDEMIOL, V40, P1134, DOI [10.1093/ije/dyn357, 10.1093/ije/dyr082]; Sandberg EM, 2017, J MINIM INVAS GYN, V24, P206, DOI 10.1016/j.jmig.2016.10.020; Scheuter C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208578; Settnes A, 2020, J MINIM INVAS GYN, V27, P1344, DOI 10.1016/j.jmig.2019.11.005; (SFSO) SFSO, 2014, RAUMGL SCHWEIZ; Shah DK, 2016, J MINIM INVAS GYN, V23, P1113, DOI 10.1016/j.jmig.2016.08.003; Spilsbury K, 2006, BJOG-INT J OBSTET GY, V113, P804, DOI 10.1111/j.1471-0528.2006.00962.x; Swiss Federal Statistical Office (SFSO), 2008, ICD 9 CM, V3; Swiss Federal Statistical Office (SFSO), 2015, MED STAT KRANK 2013; Thurston J, 2019, J OBSTET GYNAECOL CA, V41, P543, DOI 10.1016/j.jogc.2018.12.006; Vatter A., 2003, J PUBLIC POLICY, V23, P301, DOI DOI 10.1017/S0143814X03003143; Waldman I, 2018, WOMEN HEALTH ISS, V28, P456, DOI 10.1016/j.whi.2018.03.006; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; WENNBERG JE, 1987, LANCET, V1, P1185, DOI 10.1016/s0140-6736(87)92152-0; Wennberg JE, 2010, TRACKING MED RES QUE, P344; Wright JD, 2013, OBSTET GYNECOL, V122, P233, DOI 10.1097/AOG.0b013e318299a6cf; Yusuf F, 2016, AUST NZ J OBSTET GYN, V56, P420, DOI 10.1111/ajo.12477	55	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233082	10.1371/journal.pone.0233082	http://dx.doi.org/10.1371/journal.pone.0233082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0YZ	32407404	Green Published, gold			2022-12-26	WOS:000537490700066
J	Coelho, RA; Joffe, LS; Alves, GM; Figueiredo-Carvalho, MHG; Brito-Santos, F; Amaral, ACF; Rodrigues, ML; Almeida-Paes, R				Coelho, Rowena Alves; Joffe, Luna Sobrino; Alves, Gabriela Machado; Galdino Figueiredo-Carvalho, Maria Helena; Brito-Santos, Fabio; Fernandes Amaral, Ana Claudia; Rodrigues, Marcio L.; Almeida-Paes, Rodrigo			A screening of the MMV Pathogen Box (R) reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis	PLOS ONE			English	Article							AURANOFIN; BACTERIAL; FUNGAL	Chromoblastomycosis (CBM) is a chronic subcutaneous mycosis caused by traumatic implantation of many species of black fungi. Due to the refractoriness of some cases and common recurrence of CBM, a more effective and less time-consuming treatment is mandatory. The aim of this study was to identify compounds with in vitro antifungal activity in the Pathogen Box (R) compound collection against different CBM agents. Synergism of these compounds with drugs currently used to treat CBM was also assessed. An initial screening of the drugs present in this collection at 1 mu M was performed with a Fonsecaea pedrosoi clinical strain according to the EUCAST protocol. The compounds with activity against this fungus were also tested against other seven etiologic agents of CBM (Cladophialophora carrionii, Phialophora verrucosa, Exophiala jeanselmei, Exophiala dermatitidis, Fonsecaea monophora, Fonsecaea nubica, and Rhinocladiella similis) at concentrations ranging from 0.039 to 10 mu M. The analysis of potential synergism of these compounds with itraconazole and terbinafine was performed by the checkerboard method. Eight compounds inhibited more than 60% of the F. pedrosoi growth: difenoconazole, bitertanol, iodoquinol, azoxystrobin, MMV688179, MMV021013, trifloxystrobin, and auranofin. Iodoquinol produced the lowest MIC values (1.25-2.5 mu M) and MMV688179 showed MICs that were higher than all compounds tested (5 - >10 mu M). When auranofin and itraconazole were tested in combination, a synergistic interaction (FICI = 0.37) was observed against the C. carrionii isolate. Toxicity analysis revealed that MMV021013 showed high selectivity indices (SI >= 10) against the fungi tested. In summary, auranofin, iodoquinol, and MMV021013 were identified as promising compounds to be tested in CBM models of infection.	[Coelho, Rowena Alves; Alves, Gabriela Machado; Galdino Figueiredo-Carvalho, Maria Helena; Brito-Santos, Fabio; Almeida-Paes, Rodrigo] Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Natl Inst Infect Dis, Mycol Lab, Rio De Janeiro, Brazil; [Joffe, Luna Sobrino] SUNY Stony Brook, Dept Microbiol & Immunol, New York, NY USA; [Fernandes Amaral, Ana Claudia] Fiocruz MS, Lab Nat Prod Chem, Farmanguinhos, Rio De Janeiro, Brazil; [Rodrigues, Marcio L.] Fiocruz MS, Carlos Chagas Inst, Curitiba, Parana, Brazil; [Rodrigues, Marcio L.] Fed Univ Rio de Janeiro UFRJ, Inst Microbiol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Coelho, RA (corresponding author), Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Natl Inst Infect Dis, Mycol Lab, Rio De Janeiro, Brazil.	rowena.alves@ini.fiocruz.br; rodrigo.paes@ini.fiocruz.br	Almeida-Paes, Rodrigo/Q-4933-2019; Rodrigues, Marcio/J-3727-2013	Coelho, Rowena/0000-0002-4255-7486; Rodrigues, Marcio/0000-0002-6081-3439; Almeida-Paes, Rodrigo/0000-0002-6639-6058	Inova Fiocruz/VPPCB [VPPCB-008FIO-18-2-49, VPPCB-007-FIO-18-257, VPPIS-001-FIO-18-66]; Brazilian agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [405520/2018-2, 440015/2018-9, 301304/2017-3]; Inova Fiocruz/VPPIS [VPPCB-007-FIO-18-257, VPPIS-001-FIO-18-66]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; Instituto Nacional de Ciencia e Tecnologia de Inovacao em Doencas de Populacoes Negligenciadas (INCTIDPN)	Inova Fiocruz/VPPCB; Brazilian agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Inova Fiocruz/VPPIS; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia de Inovacao em Doencas de Populacoes Negligenciadas (INCTIDPN)	This work has received major financial support from Inova Fiocruz/VPPCB (VPPCB-008FIO-18-2-49). MLR acknowledges support from the Brazilian agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grants 405520/2018-2, 440015/2018-9, and 301304/2017-3) and Inova Fiocruz/VPPCB and Inova Fiocruz/VPPIS (grants VPPCB-007-FIO-18-257 and VPPIS-001-FIO-18-66). He also acknowledges support from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, finance code 001) and the Instituto Nacional de Ciencia e Tecnologia de Inovacao em Doencas de Populacoes Negligenciadas (INCTIDPN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendrup MC, 2017, J GUINEA SUBCOMMITTE; Austin BA, 2017, ADV EXP MED BIOL, V1031, P233, DOI 10.1007/978-3-319-67144-4_14; BERNHARD GC, 1982, J LAB CLIN MED, V100, P167; Borba-Santos LP, 2015, J MED MICROBIOL, V64, P415, DOI 10.1099/jmm.0.000041; Breckenridge A, 2019, NAT REV DRUG DISCOV, V18, P1, DOI 10.1038/nrd.2018.92; Burnett BP, 2008, CUTIS, V82, P273; Capasso C, 2015, EXPERT OPIN THER TAR, V19, P1689, DOI 10.1517/14728222.2015.1067685; CLSI, 2008, REF METH BROTH DIL A; Coelho RA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006675; Dannaoui E, 2002, ANTIMICROB AGENTS CH, V46, P2708, DOI 10.1128/AAC.46.8.2708-2711.2002; de Azevedo CMPS, 2015, J CLIN MICROBIOL, V53, P2674, DOI 10.1128/JCM.00637-15; de Brito AC, 2018, AN BRAS DERMATOL, V93, P495, DOI 10.1590/abd1806-4841.20187321; de Hoog G S, 2007, Stud Mycol, V58, P219, DOI 10.3114/sim.2007.58.08; Duffy S, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.00379-17, 10.1128/AAC.00379-17]; Fuchs BB, 2016, FUTURE MED CHEM, V8, P117, DOI 10.4155/fmc.15.182; FURST DE, 1983, PHARMACOTHERAPY, V3, P284; Gomes RR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005102; Hafidh Rand R, 2011, Open Microbiol J, V5, P96, DOI 10.2174/1874285801105010096; Hennessey KM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006673; Hikiji W, 2013, J FORENSIC LEG MED, V20, P962, DOI 10.1016/j.jflm.2013.08.012; Jang Y, 2016, J TOXICOL SCI, V41, P731, DOI 10.2131/jts.41.731; Jeong J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195595; Kipandula W, 2018, MOL BIOCHEM PARASIT, V222, P61, DOI 10.1016/j.molbiopara.2018.05.001; Kucerova-Chlupacova M, 2015, MOLECULES, V20, P1104, DOI 10.3390/molecules20011104; Liu CH, 2016, MOLECULES, V21, DOI 10.3390/molecules21070828; Liu HB, 2018, EUR J MED CHEM, V143, P66, DOI 10.1016/j.ejmech.2017.11.027; Lu S, 2013, MYCOPATHOLOGIA, V175, P489, DOI 10.1007/s11046-012-9586-z; Mayer FL, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00120-17, 10.1128/msphere.00120-17]; Najafzadeh MJ, 2010, MED MYCOL, V48, P800, DOI 10.3109/13693780903503081; Najafzadeh MJ, 2009, MED MYCOL, V47, P17, DOI 10.1080/13693780802527178; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; QASRAWI H, 2013, BMJ CLIN EVID, V2013, DOI DOI 10.1155/2013/636034; Queiroz-Telles F, 2017, CLIN MICROBIOL REV, V30, P233, DOI 10.1128/CMR.00032-16; Queiroz-Telles F, 2015, REV INST MED TROP SP, V57, P46, DOI 10.1590/S0036-46652015000700009; Queiroz-Telles F, 2013, MYCOPATHOLOGIA, V175, P477, DOI 10.1007/s11046-013-9648-x; Queiroz-Telles F, 2011, MED MYCOL, V49, P225, DOI 10.3109/13693786.2010.539631; Thangamani S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00004; Torres-Guerrero E, 2012, CLIN DERMATOL, V30, P403, DOI 10.1016/j.clindermatol.2011.09.011; Veale CGL, 2018, MEDCHEMCOMM, V9, P2037, DOI 10.1039/c8md00319j; Vila T, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02006-16; Wall G, 2019, J FUNGI, V5, DOI 10.3390/jof5040092; Wiederhold NP, 2017, VIRULENCE, V8, P138, DOI 10.1080/21505594.2016.1196301; Woods E, 2017, CASE REP INFECT DIS, V2017, DOI 10.1155/2017/5474916; Xi LY, 2009, MED MYCOL, V47, P27, DOI 10.1080/13693780802468209	44	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0229630	10.1371/journal.pone.0229630	http://dx.doi.org/10.1371/journal.pone.0229630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401759	Green Published, gold, Green Submitted			2022-12-26	WOS:000537481000002
J	Greenleaf, AR; Gadiaga, A; Guiella, G; Turke, S; Battle, N; Ahmed, S; Moreau, C				Greenleaf, Abigail R.; Gadiaga, Aliou; Guiella, Georges; Turke, Shani; Battle, Noelle; Ahmed, Saifuddin; Moreau, Caroline			Comparability of modern contraceptive use estimates between a face-to-face survey and a cellphone survey among women in Burkina Faso	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; TELEPHONE SURVEY	Introduction The proliferation of cell phone ownership in Sub-Saharan Africa (SSA) presents the opportunity to collect public health indicators at a lower cost compared to face-to-face (FTF) surveys. This analysis assesses the equivalence of modern contraceptive prevalence estimates between a nationally representative FTF survey and a cell phone survey using random digit dialing (RDD) among women of reproductive age in Burkina Faso. Methods We analyzed data from two surveys conducted in Burkina Faso between December 2017 and May 2018. The FTF survey conducted by Performance Monitoring and Accountability (PMA2020) comprised a nationally representative sample of 3,556 women of reproductive age (15-49 years). The RDD survey was conducted using computer-assisted telephone interviewing and included 2,379 women of reproductive age. Results Compared to FTF respondents, women in the RDD sample were younger, were more likely to have a secondary degree and to speak French. RDD respondents were more likely to report using modern contraceptive use (40%) compared to FTF respondents (26%) and the difference remained unchanged after applying post-stratification weights to the RDD sample (39%). This difference surpassed the equivalence margin of 4%. The RDD sample also produced higher estimates of contraceptive use than the subsample of women who owned a phone in the FTF sample (32%). After adjusting for women's sociodemographic factors, the odds of contraceptive use were 1.9 times higher (95% CI: 1.6-2.2) in the RDD survey compared to the FTF survey and 1.6 times higher (95% CI: 1.3-1.8) compared to FTF phone owners. Conclusions Modern contraceptive prevalence in Burkina Faso is over-estimated when using a cell phone RDD survey, even after adjusting for a number of sociodemographic factors. Further research should explore causes of differential estimates of modern contraceptive use by survey modes.	[Greenleaf, Abigail R.; Turke, Shani; Battle, Noelle; Ahmed, Saifuddin; Moreau, Caroline] Johns Hopkins Univ, Dept Populat Family & Reprod Hlth, Baltimore, MD 21218 USA; [Gadiaga, Aliou; Guiella, Georges] Univ Ouagadougou, Inst Super Sci Populat, Ouagadougou, Burkina Faso; [Moreau, Caroline] Ctr Res Epidemiol & Populat Hlth CESP, Gender Sexual & Reprod Hlth, Villejuif, France	Johns Hopkins University; UDICE-French Research Universities; Universite Paris Saclay	Greenleaf, AR (corresponding author), Johns Hopkins Univ, Dept Populat Family & Reprod Hlth, Baltimore, MD 21218 USA.	agreenleaf@jhu.edu	Moreau, Caroline/A-8989-2019	Moreau, Caroline/0000-0002-8637-6249; Greenleaf, Abigail/0000-0002-8261-7025	Bill & Melinda Gates Foundation [OPP1079004]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation (www.gatesfoundation.org).All authors were funded through award #OPP1079004. The findings and conclusions are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andridge RR, 2010, INT STAT REV, V78, P40, DOI 10.1111/j.1751-5823.2010.00103.x; Areski B., 2014, HANG CAUSE CODE TABL; Ballivian A, 2013, LISTENING LAC USING; Biemer PP, 2010, PUBLIC OPIN QUART, V74, P817, DOI 10.1093/poq/nfq058; Cecatti JG, 2011, CAD SAUDE PUBLICA, V27, P8; Chandy L, 2017, STUFFING DATA GAPS D; Choi Y, 2018, GLOB HEALTH-SCI PRAC, V6, P387, DOI 10.9745/GHSP-D-18-00012; Ferreira Aline Dayrell, 2011, Rev. bras. epidemiol., V14, P16, DOI 10.1590/S1415-790X2011000500003; Francisco Priscila Maria Stolses Bergamo, 2011, Rev. bras. epidemiol., V14, P5, DOI 10.1590/S1415-790X2011000500002; Gibson DG, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7428; Gibson DG, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.7534; Greenleaf A, 2018, INTERACTIVE VOICE RE; Greenleaf AR, 2019, CONTRACEPTION, V99, P170, DOI 10.1016/j.contraception.2018.11.006; Greenleaf AR, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7331; Greenleaf AR, 2019, COMP REMOTE DATA COL; GSMA, 2015, BRIDG GEND GAP MOB A; GSMA (Groupe Speciale Mobile Association), 2018, MOB EC SUB SAH AFR 2; Hyder AA, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7246; Intelligence G, 2014, MEASURING MOBILE PEN; Jiang S., 2018, COMP SURV DES IMPL W; Kempf AM, 2007, ANNU REV PUBL HEALTH, V28, P113, DOI 10.1146/annurev.publhealth.28.021406.144059; L'Engle K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190902; Labrique A, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7329; Larmarange J, 2016, POPULATION, V71, P123, DOI 10.3917/popu.1601.0123; Maiga A, 2015, GLOBAL HEALTH ACTION, V8, P21, DOI 10.3402/gha.v8.29736; Malta DC, 2011, CAD SAUDE PUBLICA, V27, P57, DOI 10.1590/S0102-311X2011000100006; PMA2020, 2018, PMA2020 BURK FAS ROU; Poushter J, 2015, CELL PHONES AFRICA C; Research TAAfPO, 2016, STAND DEF FIN DISP C, V9th; Scoggins S, 2018, FP2020 CATALYZING CO; VotoMobile, 2013, WHAT IS VOT; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Zimmerman L, 2017, PMA2020 WEIGHT CREAT; Zimmerman L, 2017, STUD FAMILY PLANN, V48, P293, DOI 10.1111/sifp.12031	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0231819	10.1371/journal.pone.0231819	http://dx.doi.org/10.1371/journal.pone.0231819			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0VG	32401773	gold, Green Published			2022-12-26	WOS:000537481000006
J	Lindenberg, M; van Beek, A; Retel, V; van Duijnhoven, F; van Harten, W				Lindenberg, Melanie; van Beek, Anne; Retel, Valesca; van Duijnhoven, Frederieke; van Harten, Wim			Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery	PLOS ONE			English	Article							STANDARD WIRE LOCALIZATION; RADIOACTIVE SEED; CONSERVING SURGERY; GUIDED LOCALIZATION; LESIONS; COST; TRIAL; TECHNOLOGY; MULTISITE; BIOPSY	Introduction Current localization techniques used in breast conserving surgery for non-palpable tumors show several disadvantages. Magnetic Seed Localization (MSL) is an innovative localization technique aiming to overcome these disadvantages. This study evaluated the expected budget impact of adopting MSL compared to standard of care. Methods Standard of care with Wire-Guided Localization (WGL) and Radioactive Seed Localization (RSL) use was compared with a future situation gradually adopting MSL next to RSL or WGL from a Dutch national perspective over 5 years (2017-2022). The intervention costs for WGL, RSL and MSL and the implementation costs for RSL and MSL were evaluated using activity-based costing in eight Dutch hospitals. Based on available list prices the price of the magnetic seed was ranged (sic)100-(sic)500. Results The intervention costs for WGL, RSL and MSL were respectively: (sic)2,617, (sic)2,834 and (sic)2,662 per patient and implementation costs were (sic)2,974 and (sic)26,826 for MSL and RSL respectively. For standard of care the budget impact increased from (sic)14.7m to (sic)16.9m. Inclusion of MSL with a seed price of (sic)100 showed a budget impact of (sic)16.7m. Above a price of (sic)178 the budget impact increased for adoption of MSL, rising to (sic)17.6m when priced at (sic)500. Conclusion MSL could be a cost-efficient localization technique in resecting non-palpable tumors in the Netherlands. The online calculation model can inform adoption decisions internationally. When determining retail price of the magnetic seed, cost-effectiveness should be considered.	[Lindenberg, Melanie; van Beek, Anne; Retel, Valesca; van Harten, Wim] Netherlands Canc Inst Antoni van Leeuwenhoek, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Lindenberg, Melanie; Retel, Valesca; van Harten, Wim] Univ Twente, Dept Hlth Technol & Serv Res, Enschede, Netherlands; [van Duijnhoven, Frederieke] Netherlands Canc Inst Antoni van Leeuwenhoek, Div Surg Oncol, Amsterdam, Netherlands	Netherlands Cancer Institute; University of Twente; Netherlands Cancer Institute	van Harten, W (corresponding author), Netherlands Canc Inst Antoni van Leeuwenhoek, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands.; van Harten, W (corresponding author), Univ Twente, Dept Hlth Technol & Serv Res, Enschede, Netherlands.	w.v.harten@nki.nl		Lindenberg, Melanie/0000-0001-7522-1009; Retel, Valesca/0000-0002-5624-3234				Ahmed M, 2013, BREAST, V22, P383, DOI 10.1016/j.breast.2013.04.016; Angarita FA, 2019, CLIN BREAST CANCER, V19, pE364, DOI 10.1016/j.clbc.2019.01.001; [Anonymous], 1965, MANAGEMENT PATIENT C, P88; Arentz C, 2010, ANN SURG ONCOL, V17, pS378, DOI 10.1245/s10434-010-1230-x; Bloomquist EV, 2016, BREAST J, V22, P151, DOI 10.1111/tbj.12564; Chan BKY, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009206.pub2; Cox CE, 2016, ANN SURG ONCOL, V23, P3168, DOI 10.1245/s10434-016-5405-y; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; DICA, 2014, JAARR NBCA 2014; Diego EJ, 2014, ANN SURG ONCOL, V21, P3268, DOI 10.1245/s10434-014-3912-2; Du SM, 2011, BREAST, V20, P246, DOI 10.1016/j.breast.2011.01.007; Dutch Healthcare Authority (NZa), DBC PROD FIND TAR 20; Falcon S, 2018, CLIN IMAG, V52, P280, DOI 10.1016/j.clinimag.2018.07.008; Goudreau SH, 2015, RADIOGRAPHICS, V35, P1319, DOI 10.1148/rg.2015140293; Gray RJ, 2004, AM J SURG, V188, P377, DOI 10.1016/j.amjsurg.2004.06.023; Gray RJ, 2001, ANN SURG ONCOL, V8, P711; Grimm SE, 2018, VALUE HEALTH, V21, P944, DOI 10.1016/j.jval.2018.01.010; Gunn J, 2017, CURR BREAST CANCER R, V9, P165, DOI 10.1007/s12609-017-0244-9; Hakkaart-van Roijen L., 2015, MANUAL COST RES METH; Harvey JR, 2018, BREAST CANCER RES TR, V169, P531, DOI 10.1007/s10549-018-4709-y; Hawkins SC, 2017, EJSO-EUR J SURG ONC, V43, P62, DOI 10.1016/j.ejso.2016.08.018; Hughes JH, 2008, BREAST J, V14, P153, DOI 10.1111/j.1524-4741.2007.00546.x; Jakub JW, 2010, AM J SURG, V199, P522, DOI 10.1016/j.amjsurg.2009.05.019; Lievens Y, 2003, INT J RADIAT ONCOL, V57, P522, DOI 10.1016/S0360-3016(03)00579-0; Loving VA, 2014, AM J ROENTGENOL, V202, P1383, DOI 10.2214/AJR.13.11368; Lovrics PJ, 2011, ANN SURG ONCOL, V18, P3407, DOI 10.1245/s10434-011-1699-y; Merrill AY, 2018, ANN SURG ONCOL, V25, P3076, DOI 10.1245/s10434-018-6596-1; NBCA, 2017, NABON BREAST CANC AU; Nederlandse Vereniging van Ziekenhuizen (NVZ), 2017, SAL; Noblin AM, 2007, HEALTH CARE MANAG, V26, P331, DOI 10.1097/01.HCM.0000299251.06807.a8; Nuclear Regulatory Commission, IOD 125 PALL 103 LOW; Parvez E, 2014, AM J SURG, V208, P711, DOI 10.1016/j.amjsurg.2014.05.030; Postma EL, 2013, ANN SURG ONCOL, V20, P2219, DOI 10.1245/s10434-013-2888-7; Rao R, 2010, ANN SURG ONCOL, V17, P3241, DOI 10.1245/s10434-010-1139-4; Rijksinstituut voor Volksgezondheid en Milieu, 2018, TOEK STIJG AANT NIEU; Rogers EM, 2003, DIFFUSION INNOVATION, V5th, DOI [10.1029/2001WR001015, DOI 10.1029/2001WR001015]; Schermers B, 2017, BREAST, V33, P50, DOI 10.1016/j.breast.2017.03.003; Sharek D, 2015, AM J ROENTGENOL, V204, P872, DOI 10.2214/AJR.14.12743; StatLine, 2020, JAARMUTATIE CONSUMEN; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Zacharioudakis K, 2019, EJSO-EUR J SURG ONC, V45, P2016, DOI 10.1016/j.ejso.2019.06.035; Zhang YM, 2017, ANN SURG ONCOL, V24, P3567, DOI 10.1245/s10434-017-6084-z	43	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232690	10.1371/journal.pone.0232690	http://dx.doi.org/10.1371/journal.pone.0232690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401779	Green Published, gold			2022-12-26	WOS:000537481000030
J	Lu, YF; Xu, XP; Lu, XP; Zhu, Q; Liu, G; Bao, YT; Wen, H; Li, YL; Gu, W; Zhu, WG				Lu, Ya-Fei; Xu, Xiao-Peng; Lu, Xiao-Peng; Zhu, Qian; Liu, Ge; Bao, Yan-Tao; Wen, He; Li, Ying-Lu; Gu, Wei; Zhu, Wei-Guo			SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle	ONCOGENE			English	Article							PROMOTES; ACETYLATION; INHIBITION; STRESS; PHOSPHORYLATION; UBIQUITINATION; METABOLISM; PATHWAY; DIFFERENTIATION; BIOSYNTHESIS	Sirtuin 7 (SIRT7), an NAD(+)-dependent deacetylase, plays vital roles in energy sensing, but the underlying mechanisms of action remain less clear. Here, we report that SIRT7 is required for p53-dependent cell-cycle arrest during glucose deprivation. We show that SIRT7 directly interacts with p300/CBP-associated factor (PCAF) and the affinity for this interaction increases during glucose deprivation. Upon binding, SIRT7 deacetylates PCAF at lysine 720 (K720), which augments PCAF binding to murine double minute (MDM2), the p53 E3 ubiquitin ligase, leading to accelerated MDM2 degradation. This effect results in upregulated expression of the cell-cycle inhibitor, p21(Waf1/Cip1), which further leads to cell-cycle arrest and decreased cell viability. These data highlight the importance of the SIRT7-PCAF interaction in regulating p53 activity and cell-cycle progression during conditions of glucose deprivation. This axis may represent a new avenue to design effective therapeutics based on tumor starvation.	[Lu, Ya-Fei; Xu, Xiao-Peng; Lu, Xiao-Peng; Zhu, Qian; Liu, Ge; Bao, Yan-Tao; Wen, He; Zhu, Wei-Guo] Shenzhen Univ, Dept Biochem & Mol Biol, Guangdong Key Lab Genome Instabil & Human Dis, Int Canc Ctr,Sch Med, Shenzhen 518055, Peoples R China; [Li, Ying-Lu; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Zhu, Wei-Guo] Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Key Lab Carcinogenesis & Translat Res,Minist Educ, Dept Biochem & Mol Biol,Sch Basic Med Sci,Hlth Sc, Beijing 100191, Peoples R China; [Zhu, Wei-Guo] Peking Univ Tsinghua Univ Ctr Life Sci, Beijing 100871, Peoples R China	Shenzhen University; Columbia University; Peking University; Peking University	Zhu, WG (corresponding author), Shenzhen Univ, Dept Biochem & Mol Biol, Guangdong Key Lab Genome Instabil & Human Dis, Int Canc Ctr,Sch Med, Shenzhen 518055, Peoples R China.; Li, YL (corresponding author), Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA.; Zhu, WG (corresponding author), Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Key Lab Carcinogenesis & Translat Res,Minist Educ, Dept Biochem & Mol Biol,Sch Basic Med Sci,Hlth Sc, Beijing 100191, Peoples R China.; Zhu, WG (corresponding author), Peking Univ Tsinghua Univ Ctr Life Sci, Beijing 100871, Peoples R China.	yl4187@cumc.columbia.edu; zhuweiguo@szu.edu.cn	Wen, He/GZL-8825-2022; Bao, Yantao/AAK-6146-2021; Li, Yinglu/GWC-7573-2022	Gu, Wei/0000-0002-1480-2368	National Key R&D Program of China [2017YFA0503900]; NFSC [81720108027, 81530074]; Science and Technology Program of Guangdong Province in China [2017B030301016]; Shenzhen Municipal Commission of Science and Technology Innovation [JCYJ20170818092450901]; Discipline Construction of Shenzhen [(2016)1452]	National Key R&D Program of China; NFSC(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong Province in China; Shenzhen Municipal Commission of Science and Technology Innovation; Discipline Construction of Shenzhen	The authors thank K. F. Chua for providing SIRT7 plasmids. The authors also appreciate Ye Zhang for sharing PCAF plasmids. Finally, the authors are grateful to Dr Jessica Tamanini (Shenzhen University) for proofreading the manuscript. This work was supported by National Key R&D Program of China [2017YFA0503900]; NFSC [81720108027, 81530074]; Science and Technology Program of Guangdong Province in China [2017B030301016]; Shenzhen Municipal Commission of Science and Technology Innovation [JCYJ20170818092450901]; and Discipline Construction Funding of Shenzhen [(2016)1452].	Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Chen SF, 2013, MOL CELL, V52, P303, DOI 10.1016/j.molcel.2013.10.010; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gai X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.76; Gannon HS, 2012, CANCER CELL, V21, P668, DOI 10.1016/j.ccr.2012.04.011; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Han JA, 2002, EMBO J, V21, P5635, DOI 10.1093/emboj/cdf591; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He HQ, 2017, CELL REP, V20, P2010, DOI 10.1016/j.celrep.2017.08.016; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu HG, 2017, HEPATOLOGY, V65, P515, DOI 10.1002/hep.28887; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang L, 2017, J BIOL CHEM, V292, P13296, DOI 10.1074/jbc.M117.780130; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kopeina GS, 2017, BBA-REV CANCER, V1867, P29, DOI 10.1016/j.bbcan.2016.11.002; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12235; Li TT, 2014, J BIOL CHEM, V289, P3775, DOI 10.1074/jbc.M113.531640; Li YL, 2018, NUCLEIC ACIDS RES, V46, P7716, DOI 10.1093/nar/gky568; Lin RT, 2013, MOL CELL, V51, P506, DOI 10.1016/j.molcel.2013.07.002; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Liu L, 1999, MOL CELL BIOL, V19, P1202; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Nihira NT, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8026; Pediconi N, 2009, MOL CELL BIOL, V29, P1989, DOI 10.1128/MCB.00552-08; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Qi H, 2018, J BIOL CHEM, V293, P17769, DOI 10.1074/jbc.RA118.003629; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Sen N, 2011, MOL CELL, V44, P621, DOI 10.1016/j.molcel.2011.08.044; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shin JY, 2013, CELL REP, V5, P654, DOI 10.1016/j.celrep.2013.10.007; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Sun C, 2014, CELL REP, V9, P2250, DOI 10.1016/j.celrep.2014.11.029; Sun LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12497; Sunami Y, 2017, J BIOL CHEM, V292, P2815, DOI 10.1074/jbc.M116.745398; Tang M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav1118; Tang XL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00396-9; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Vazquez BN, 2016, EMBO J, V35, P1488, DOI 10.15252/embj.201593499; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Wu D, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00652; Yan WW, 2018, EMBO REP, V19, DOI 10.15252/embr.201846377; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yoshizawa T, 2014, CELL METAB, V19, P712, DOI 10.1016/j.cmet.2014.03.006; Yu J, 2017, CELL REP, V18, P1229, DOI 10.1016/j.celrep.2017.01.009; Zhang P, 2016, STEM CELLS, V34, P2332, DOI 10.1002/stem.2424; Zheng X, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-96; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	64	17	17	5	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	24					4650	4665		10.1038/s41388-020-1305-5	http://dx.doi.org/10.1038/s41388-020-1305-5		MAY 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LY0HO	32404984	Green Published, hybrid			2022-12-26	WOS:000532808000002
J	Banda, K; Chilengi-Sakala, S; Chunga, CC; Solomon, H; Chalwe, V; Nkaama, JM; Leonard, C; Bobo, M; Aongola, A; Biemba, G				Banda, Kutha; Chilengi-Sakala, Sandra; Chunga, Chipwaila Choolwe; Solomon, Hiwote; Chalwe, Victor; Nkaama, Justine Mweene; Leonard, Colleen; Bobo, Mupeta; Aongola, Agness; Biemba, Godfrey			Towards universal coverage for nutrition services in children under five years-A descriptive analysis of the capacity of level one hospitals to provide nutrition services in five provinces of Zambia	PLOS ONE			English	Article							USE THERAPEUTIC FOOD	Background Malnutrition continues to be a major public health challenge in Zambia. To effectively address this, health systems must be well strengthened to deliver an effective continuum of care. This paper examines health systems issues and services in relation to nutritional support to children under five years, in order to identify gaps and propose interventions towards universal coverage of essential nutrition services. Methods This analysis utilized data from a cross sectional mixed-methods study on factors associated with Severe Acute Malnutrition (SAM) in under-five children to assess health facility nutrition services on offer at select level-one hospitals in five out of ten provinces in Zambia. Stata version 13 was used for analysis. We conducted univariate analysis to assess nutrition services offered, functionality of equipment and tools, availability of human resource and human resource development, and availability of drugs used for assessment and management of nutrition-related health outcomes. Results We found large variations in the level of nutrition services on offer across districts and provinces. Eighty-eight percent of all the hospitals sampled provided group nutrition counseling and 92% of the hospitals in our sample offered individual nutrition counseling to their clients. Overall, the existence of referral and counter-referral systems between the Community Based Volunteers and hospitals were the lowest among all services assessed at 48% and 58% respectively. We also found inadequate numbers of human resource across all cadres with an exception of nutritionists as recommended by the Ministry of Health. Conclusions This study has revealed a number of gaps in the health system and health service delivery that requires to be addressed; most notably, a lack of tools, policies and guidelines, drugs and health specialists to help care for malnourished infants and children. Our findings also reveal inadequate referral systems between the community and health facilities in the management of severe acute malnutrition. Achieving universal coverage for nutrition services in Zambia will require a lot more attention to the health systems issues found in this study.	[Banda, Kutha; Chilengi-Sakala, Sandra; Chunga, Chipwaila Choolwe; Chalwe, Victor; Nkaama, Justine Mweene; Leonard, Colleen; Biemba, Godfrey] Minist Hlth, Natl Hlth Res Author, Lusaka, Zambia; [Solomon, Hiwote] Boston Univ, Sch Publ Hlth, Doctor Publ Hlth Program, Boston, MA USA; [Bobo, Mupeta; Aongola, Agness] Minist Hlth, Dept Publ Hlth, Lusaka, Zambia	Boston University	Banda, K (corresponding author), Minist Hlth, Natl Hlth Res Author, Lusaka, Zambia.	kuthabands@gmail.com		Solomon, Hiwote/0000-0001-9125-5217; Banda, Kutha/0000-0002-8061-1332; Leonard, Colleen/0000-0002-1944-693X	Ministry of Health Zambia	Ministry of Health Zambia	The study was funded by the Ministry of Health Zambia. Some members of the Ministry participated in providing technical information that helped in designing the study and preparation of the manuscript.	Ashworth A, 2006, FOOD NUTR BULL, V27, pS24, DOI 10.1177/15648265060273S303; Berwick DM, 2002, HEALTH AFFAIR, V21, P80, DOI 10.1377/hlthaff.21.3.80; Billah SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178121; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Gawande A., 2009, CHECKLIST MANIFESTO; Grol R, 2000, INT J QUAL HEALTH C, V12, P297, DOI 10.1093/intqhc/12.4.297; Isanaka S, 2009, JAMA-J AM MED ASSOC, V301, P277, DOI 10.1001/jama.2008.1018; Kirkpatrick DH, 2010, OBSTET GYNECOL, V116, P1022, DOI 10.1097/AOG.0b013e3181f97c62; Murray E, 2014, PAEDIAT INT CHILD HL; Nichole Sullivan Cierra, 2015, ASSESSMENT MALNUTRIT; Patient Safety in Obstetrics and Gynecology, 2009, OBSTET GYNECOL, V114, P1424, DOI DOI 10.1097/A0G.0B013E3181C6F90E; Pizzi L, 2001, MAKING HLTH CARE SAF, P505; Ransom SB, 2000, ENHANCING PHYS PERFO; SPRING, 2015, TOOL RAP EV FAC LEV; United Nations Children's Fund (UNICEF) World Health Organization International Bank for Reconstruction and Development/The World Bank, 2021, LEVELS TRENDS CHILD; World Health Organization , 2007, COMM BAS MAN SEV AC; World Health Organization, GLOB NUTR REP 2017 N; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2; 2015, OBSTET GYNECOL, V125, P1268, DOI DOI 10.1097/01.AOG.0000465192.34779.DC	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232663	10.1371/journal.pone.0232663	http://dx.doi.org/10.1371/journal.pone.0232663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396554	gold, Green Published			2022-12-26	WOS:000537475000015
J	Gimunova, M; Zvonar, M; Sebera, M; Turcinek, P; Kolarova, K				Gimunova, Marta; Zvonar, Martin; Sebera, Martin; Turcinek, Pavel; Kolarova, Katerina			Special footwear designed for pregnant women and its effect on kinematic gait parameters during pregnancy and postpartum period	PLOS ONE			English	Article							BODY-MASS; ALIGNMENT; WEIGHT; PHASES	During pregnancy, an array of changes occurs in women body to enable the growth and development of the future baby and the consequent delivery. These changes are reflected in the range of motion of trunk, pelvis, lower limbs and other body segments, affect the locomotion and some of these changes may persist to the postpartum period. The aim of this study was to describe the changes affecting the gait during pregnancy and to determine the effect of tested footwear on kinematic gait characteristics during pregnancy as previous studies indicate that special orthopaedic insoles and footwear might be useful in prevention of the common musculoskeletal pain and discomfort related to pregnancy. Participants from the control group (n = 18), without any intervention, and the experimental group (n = 23), which was wearing the tested shoes, were measured at their 14, 28 and 37 gestational weeks and 28 weeks postpartum to capture the complete pregnancy-related changes in gait. The gait 3D kinematic data were obtained using Simi Motion System. The differences between the control and experimental group at the first data collection session in most of the analysed variables, as well as relatively high standard deviations of analysed variables indicate large individual differences in the gait pattern. The effect of tested footwear on kinematic gait pattern changes may be explained by its preventive effect against the foot arches falling. In the control group, changes associated previously with the foot arches falling and hindfoot hyperpronation were observed during advanced phases of pregnancy and postpartum, e.g. increase in knee flexion or increase in spinal curvature. For the comprehensive evaluation of the tested footwear on pregnancy gait pattern, future studies combining the kinematic and dynamic plantographic methods are needed.	[Gimunova, Marta; Zvonar, Martin; Sebera, Martin; Kolarova, Katerina] Masaryk Univ, Fac Sports Studies, Dept Kinesiol, Brno, Czech Republic; [Turcinek, Pavel] Mendel Univ Brno, Fac Business & Econ, Dept Informat, Brno, Czech Republic	Masaryk University Brno; Mendel University in Brno	Gimunova, M (corresponding author), Masaryk Univ, Fac Sports Studies, Dept Kinesiol, Brno, Czech Republic.	gimunova@fsps.muni.cz	Gimunová, Marta/AGX-8940-2022; Sebera, Martin/M-9818-2018; Turcinek, Pavel/I-6742-2018	Gimunová, Marta/0000-0001-7284-2678; Sebera, Martin/0000-0003-3750-1549; Turcinek, Pavel/0000-0003-4494-3513	Masaryk University [MUNI/A/1360/2016]	Masaryk University	This study was supported by Masaryk University grant MUNI/A/1360/2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Raoof N, 2013, INT J THER REHABIL, V20, P428, DOI 10.12968/ijtr.2013.20.9.428; Aguiar L., 2011, PORTUGUESE J SPORT S, V11, P447; Aguiar L, 2015, GAIT POSTURE, V42, P511, DOI 10.1016/j.gaitpost.2015.07.065; Blaszczyk JW, 2016, GAIT POSTURE, V43, P160, DOI 10.1016/j.gaitpost.2015.09.016; Bohemen EK, 1995, BRAZILIAN J RHEUMATO, V35, P396; Branco M, 2014, BIOMECHANICS GAIT PR, DOI [10.1155/2014/527940, DOI 10.1155/2014/527940]; Branco M, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/718095; Chiou WK, 2015, APPL ERGON, V46, P212, DOI 10.1016/j.apergo.2014.08.004; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dumas G A, 1995, Clin Biomech (Bristol, Avon), V10, P104; Forczek W, 2018, GAIT POSTURE, V62, P7, DOI 10.1016/j.gaitpost.2018.02.024; Forczek W, 2012, ACTA BIOENG BIOMECH, V14, P113, DOI 10.5277/abb120413; Foti T, 2000, J BONE JOINT SURG AM, V82A, P625, DOI 10.2106/00004623-200005000-00003; Gilleard W, 2002, ACTA OBSTET GYN SCAN, V81, P1011, DOI 10.1034/j.1600-0412.2002.811104.x; Gilleard WL, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-71; Gimunova M, 2018, THESIS; Gimunova M, 2018, SPORT TK, V7, P111; Gimunová Marta, 2017, J. vasc. bras., V16, P214, DOI 10.1590/1677-5449.002617; Gimunova M, 2015, KINESIOLOGY, V47, P236; Hagan L., 2010, J WOMENS HLTH PHYS T, V34, P46, DOI DOI 10.1097/JWH.0B013E3181E8FD4D; Hanak J, 2013, PatentWO, Patent No. [2013123922 A1, 20150013189]; Institute of Medicine (IOM), 2009, WEIGHT GAIN PREGN RE; Jang Suck Il, 2010, Obstetrics & Gynecology Science, V53, P988; Jensen RK, 1996, J BIOMECH, V29, P251, DOI 10.1016/0021-9290(95)00042-9; Kerrigan DC, 1998, ARCH PHYS MED REHAB, V79, P317, DOI 10.1016/S0003-9993(98)90013-2; Khamis S, 2007, GAIT POSTURE, V25, P127, DOI 10.1016/j.gaitpost.2006.02.005; Lelas JL, 2003, GAIT POSTURE, V17, P106, DOI 10.1016/S0966-6362(02)00060-7; Marques A. S., 2005, BRAZ J BIOMECHANICS, V6, P9; McCrory JL, 2014, J BIOMECH, V47, P2964, DOI 10.1016/j.jbiomech.2014.07.009; Nyska M, 1997, ISRAEL J MED SCI, V33, P139; Ribeiro AP, 2013, WOMENS HEALTH, V9, P99, DOI [10.2217/WHE.12.59, 10.2217/whe.12.59]; Sawa R, 2015, GAIT POSTURE, V42, P455, DOI 10.1016/j.gaitpost.2015.07.058; Schoenhaus HD, 1992, U.S. Pat. No, Patent No. [5,174,052, 5174052]; Segal NA, 2015, MUSCULOSKELETAL HLTH; Snyder DB, 2001, U.S. Pat. No, Patent No. [6,286,232, 6286232]; Sumithran P, 2018, OBES RES CLIN PRACT, V12, P139, DOI 10.1016/j.orcp.2017.10.007; Vareka I, 2010, KINEZIOLOGIE NOHY; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Wetz HH, 2006, ORTHOPADE, V35, P1124, DOI 10.1007/s00132-006-1011-1; Wu WH, 2004, CLIN BIOMECH, V19, P480, DOI 10.1016/j.clinbiomech.2004.02.003; Zvonar M, 2014, 7TH INTERNATIONAL SCIENTIFIC CONFERENCE ON KINESIOLOGY: FUNDAMENTAL AND APPLIED KINESIOLOGY - STEPS FORWARD, P221	41	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232901	10.1371/journal.pone.0232901	http://dx.doi.org/10.1371/journal.pone.0232901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396578	Green Published, gold			2022-12-26	WOS:000537475000025
J	Horehledova, B; Mihl, C; Boswijk, E; Crombag, GAJC; Nijssen, EC; Nelemans, PJ; Veenstra, LF; Wildberger, JE; Das, M				Horehledova, Barbora; Mihl, Casper; Boswijk, Ellen; Crombag, Genevieve A. J. C.; Nijssen, Estelle C.; Nelemans, Patty J.; Veenstra, Leo F.; Wildberger, Joachim E.; Das, Marco			Retrospectively ECG-gated helical vs. non-ECG-synchronized high-pitch CTA of the aortic root for TAVI planning	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; EXPERT CONSENSUS DOCUMENT; VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CONTRAST MATERIAL; ANNULUS; REPLACEMENT; ANGIOGRAPHY; RISK	Background Multidetector computed tomography (MDCT) plays a key role in patient assessment prior to transcatheter aortic valve implantation (TAVI). However, to date no consensus has been established on what is the optimal pre-procedural imaging protocol. Variability in pre-TAVI acquisition protocols may lead to discrepancies in aortic annulus measurements and may potentially influence prosthesis size selection. Purpose The current study evaluates the magnitude of differences in aortic annulus measurements using max-systolic, end-diastolic, and non-ECG-synchronized imaging, as well as the impact of method on prosthesis size selection. Material and methods Fifty consecutive TAVI-candidates, who underwent retrospectively-ECG-gated CT angiography (CTA) of the aortic root, directly followed by non-ECG-synchronized high-pitch CT of the entire aorta, were retrospectively included. Aortic root dimensions were assessed at each 10% increment of the R-R interval (0-100%) and on the non-ECG-synchronized scan. Dimensional changes within the cardiac cycle were evaluated using a 1-way repeated ANOVA. Agreement in measurements between max-systole, end-diastole and non-ECG-synchronized scans was assessed with Bland-Altman analysis. Results Maximal dimensions of the aortic root structures and minimum annulus-coronary ostia distances were measured during systole. Max-systolic measurements were significantly and substantially larger than end-diastolic (p<0.001) and non-ECG-synchronized measurements (p<0.001). Due to these discrepancies, the three methods resulted in the same prosthesis size selection in only 48-62% of patients. Conclusions The systematic differences between max-systolic, end-diastolic and non-ECG-synchronized measurements for relevant aortic annular dimensions are both statistically significant and clinically relevant. Imaging strategy impacts prosthesis size selection in nearly half the TAVI-candidates. End-diastolic and non-ECG-synchronized imaging does not provide optimal information for prosthesis size selection. Systolic image acquisition is necessary for assessment of maximal annular dimensions and minimum annulus-coronary ostia distances.	[Horehledova, Barbora; Mihl, Casper; Boswijk, Ellen; Crombag, Genevieve A. J. C.; Nijssen, Estelle C.; Wildberger, Joachim E.; Das, Marco] Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, Maastricht, Netherlands; [Horehledova, Barbora; Mihl, Casper; Boswijk, Ellen; Crombag, Genevieve A. J. C.; Wildberger, Joachim E.; Das, Marco] Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Nelemans, Patty J.] Maastricht Univ, Med Ctr, Dept Epidemiol, Maastricht, Netherlands; [Veenstra, Leo F.] Maastricht Univ, Med Ctr, Dept Cardiol, Maastricht, Netherlands; [Das, Marco] Helios Kliniken Duisburg, Dept Diagnost & Intervent Radiol, Duisburg, Germany	Maastricht University; Maastricht University; Maastricht University; Maastricht University	Horehledova, B (corresponding author), Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, Maastricht, Netherlands.; Horehledova, B (corresponding author), Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.	barbora.horehledova@maastrichtuniversity.nl		Wildberger, Joachim/0000-0002-4810-6854; Mihl, Casper/0000-0003-1348-6970				Achenbach S, 2012, J CARDIOVASC COMPUT, V6, P366, DOI 10.1016/j.jcct.2012.11.002; Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Bae KT, 2010, RADIOL CLIN N AM, V48, P9, DOI 10.1016/j.rcl.2009.08.012; Beeres M, 2012, EUR RADIOL, V22, P129, DOI 10.1007/s00330-011-2257-5; Bertaso AG, 2012, INT J CARDIOVAS IMAG, V28, P2091, DOI 10.1007/s10554-012-0018-4; Blanke P, 2019, JACC-CARDIOVASC IMAG, V12, P1, DOI 10.1016/j.jcmg.2018.12.003; Blanke P, 2012, JACC-CARDIOVASC INTE, V5, P984, DOI 10.1016/j.jcin.2012.05.014; Gurvitch R, 2011, JACC-CARDIOVASC INTE, V4, P1235, DOI 10.1016/j.jcin.2011.07.014; Hamdan A, 2012, J AM COLL CARDIOL, V59, P119, DOI 10.1016/j.jacc.2011.09.045; Horehledova B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199732; Jilaihawi H, 2012, J AM COLL CARDIOL, V59, P1275, DOI 10.1016/j.jacc.2011.11.045; Jurencak T, 2015, EUR RADIOL, V25, P1975, DOI 10.1007/s00330-015-3607-5; Karlo C, 2011, EUR RADIOL, V21, P205, DOI 10.1007/s00330-010-1907-3; Kaup M, 2016, ACTA RADIOL OPEN, V5, DOI 10.1177/2058460116684371; Kok M, 2016, EUR RADIOL, V26, P2426, DOI 10.1007/s00330-015-4080-x; Kok M, 2016, J VASC INTERV RADIOL, V27, P531, DOI 10.1016/j.jvir.2016.01.009; Leber AW, 2003, HEART, V89, P633, DOI 10.1136/heart.89.6.633; Leipsic J, 2011, JACC-CARDIOVASC IMAG, V4, P416, DOI 10.1016/j.jcmg.2011.01.014; Marwan M, 2013, INT J CARDIOVAS IMAG, V29, P1191, DOI 10.1007/s10554-013-0197-7; McCollough CH, 2009, RADIOL CLIN N AM, V47, P27, DOI 10.1016/j.rcl.2008.10.006; McDonald JS, 2014, RADIOLOGY, V271, P65, DOI 10.1148/radiol.13130775; Messika-Zeitoun D, 2010, J AM COLL CARDIOL, V55, P186, DOI 10.1016/j.jacc.2009.06.063; Murphy DT, 2016, J CARDIOVASC COMPUT, V10, P37, DOI 10.1016/j.jcct.2015.07.008; Nijssen EC, 2017, LANCET, V389, P1312, DOI 10.1016/S0140-6736(17)30057-0; Plank F, 2012, ANN THORAC SURG, V94, P1961, DOI 10.1016/j.athoracsur.2012.06.044; Ramaraj R, 2008, BMJ-BRIT MED J, V336, P550, DOI 10.1136/bmj.39478.498819.AD; Rixe J, 2012, EUR RADIOL, V22, P2662, DOI 10.1007/s00330-012-2530-2; Schmidkonz C, 2014, EUR J RADIOL, V83, P1672, DOI 10.1016/j.ejrad.2014.06.001; Willson AB, 2012, J CARDIOVASC COMPUT, V6, P406, DOI 10.1016/j.jcct.2012.10.002	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232673	10.1371/journal.pone.0232673	http://dx.doi.org/10.1371/journal.pone.0232673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396570	Green Published, gold			2022-12-26	WOS:000537475000017
J	Lin, TC; Chien, WC; Hu, JM; Tzeng, NS; Chung, CH; Pu, TW; Hsiao, CW; Chen, CY				Lin, Tzu-Chiao; Chien, Wu-Chien; Hu, Je-Ming; Tzeng, Nian-Sheng; Chung, Chi-Hsiang; Pu, Ta-Wei; Hsiao, Cheng-Wen; Chen, Chao-Yang			Risk of colorectal cancer in patients with alcoholism: A nationwide, population-based nested case-control study	PLOS ONE			English	Article							DOSE-RESPONSE METAANALYSIS; CONSUMPTION; DRINKING; SMOKING; COLON	Background Colorectal cancer (CRC) is regarded as a multifactorial disease and shares many risk factors with alcoholism. However, the association between alcoholism and CRC remains controversial. Objectives In this study, we aimed to evaluate the association between alcoholism and risk of CRC. Methods We performed a large-scale, population-based nested case-control study using the Longitudinal Health Insurance Database 2013, derived from Taiwan's National Health Insurance Research Database, and collected data from 2000 to 2013. There were 49,095 diagnosed cases of CRC defined according to the International Classification of Diseases, Ninth Revision, Clinical Modification. Each case was matched with three controls by sex, age, index date of CRC, and annual medical visits; a total of 147,285 controls were identified. Multiple risk factors of CRC in alcoholism cases were investigated using unconditional multiple logistic regression analysis. Results Among 49,095 cases of CRC, alcoholism was associated with a significantly higher risk of CRC (adjusted odds ratio (OR), 1.631; 95% CI, 1.565-1.699) in multivariate logistic regression, after adjusting other CRC risk factors, and in stratified analysis with multivariate logistic regression. In addition, there was a time-dependent relationship between alcoholism duration and CRC risk in > 1 year, > 2 years, > 5 years, and > 11 years groups (adjusted ORs, 1.875, 2.050, 2.662 and 2.670; 95% CI, 1.788-1.967, 1.948-2.158, 2.498-2.835, and 2.511-2.989 respectively). Conclusion An association between alcoholism and risk of CRC was found in this study. Furthermore, patients with longer alcoholism history showed higher likelihood of developing CRC, which indicates a time-dependent relationship between alcoholism exposure and CRC. Further research on colorectal tumorigenesis is needed.	[Lin, Tzu-Chiao; Hu, Je-Ming; Pu, Ta-Wei; Hsiao, Cheng-Wen; Chen, Chao-Yang] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Lin, Tzu-Chiao; Hu, Je-Ming; Tzeng, Nian-Sheng; Pu, Ta-Wei; Hsiao, Cheng-Wen; Chen, Chao-Yang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hu, Je-Ming] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Tzeng, Nian-Sheng] Natl Def Med Ctr, Sch Med, Tri Serv Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Tzeng, Nian-Sheng] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Chen, CY (corresponding author), Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan.; Chen, CY (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.	cartilage77@yahoo.com.tw	Chung, Chi-Hsiang/AAY-3386-2021; Tzeng, Nian-Sheng/AAU-4945-2021		Tri-Service Hospital Research Foundation [TSGHB-109010]	Tri-Service Hospital Research Foundation	This study was supported by grants from Tri-Service Hospital Research Foundation (TSGHB-109010). No additional external funding was received for this study. All of the authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune Dagfinn, 2011, BMJ, V343, pd6617, DOI 10.1136/bmj.d6617; Bagnardi V, 2015, BRIT J CANCER, V112, P580, DOI 10.1038/bjc.2014.579; Bailie L, 2017, GASTROENTEROLOGY, V152, P92, DOI 10.1053/j.gastro.2016.09.003; Bishehsari F, 2017, ALCOHOL RES-CURR REV, V38, P163; Bishehsari F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122017; Burton R, 2018, LANCET, V392, P987, DOI 10.1016/S0140-6736(18)31571-X; Cai SW, 2014, ECOTOXICOLOGY, V23, P76, DOI 10.1007/s10646-013-1153-y; Chiang CP, 2012, ALCOHOL, V46, P37, DOI 10.1016/j.alcohol.2011.08.004; Cho EY, 2004, ANN INTERN MED, V140, P603, DOI 10.7326/0003-4819-140-8-200404200-00007; de Menezes RF, 2013, ASIAN PAC J CANCER P, V14, P4965, DOI 10.7314/APJCP.2013.14.9.4965; Fagunwa IO, 2017, BEST PRACT RES CL GA, V31, P561, DOI 10.1016/j.bpg.2017.09.012; Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653; Feng YL, 2017, EUR J CANCER PREV, V26, P201, DOI 10.1097/CEJ.0000000000000245; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/s0140-6736(18)31310-2, 10.1136/bmj.l94, 10.1016/S0140-6736(18)31310-2]; Health Promotion Administration Ministry of Health and WelfareTaiwan, 2018, HLTH PROM ADM ANN RE; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Hu JM, 2018, INT J COLORECTAL DIS, V33, P349, DOI 10.1007/s00384-018-2965-2; Kunzmann AT, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002585; Lee HC, 2017, J AFFECT DISORDERS, V207, P353, DOI 10.1016/j.jad.2016.09.057; Liang PS, 2009, INT J CANCER, V124, P2406, DOI 10.1002/ijc.24191; Marley AR, 2016, INT J MOL EPIDEMIOL, V7, P105; McNabb S, 2020, INT J CANCER, V146, P861, DOI 10.1002/ijc.32377; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Moskal A, 2007, INT J CANCER, V120, P664, DOI 10.1002/ijc.22299; Mundade Rasika, 2014, Oncoscience, V1, P400; Pan CS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203410; Park JY, 2009, CANCER EPIDEMIOL, V33, P347, DOI 10.1016/j.canep.2009.10.015; Park S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-420; Pedersen A, 2003, GUT, V52, P861, DOI 10.1136/gut.52.6.861; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Rossi M, 2018, CANCERS, V10, DOI 10.3390/cancers10020038; Schwarzinger M, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4587-y; Shieh Y, 2016, NAT REV CLIN ONCOL, V13, P550, DOI 10.1038/nrclinonc.2016.50; Tsuruya A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27923; Varela-Rey M, 2013, ALCOHOL RES-CURR REV, V35, P25	35	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232740	10.1371/journal.pone.0232740	http://dx.doi.org/10.1371/journal.pone.0232740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396577	Green Published, gold			2022-12-26	WOS:000537475000018
J	Nafo, W; Al-Mayah, A				Nafo, Wanis; Al-Mayah, Adil			Mechanical characterization of PVA hydrogels' rate-dependent response using multi-axial loading	PLOS ONE			English	Article							GENERATING LINE SPECTRA; VISCOELASTIC PROPERTIES; RELAXATION; POLYMERS; SHEAR	The time-dependent properties of rubber-like synthesized and biological materials are crucial for their applications. Currently, this behavior is mainly measured using axial tensile test, compression test, or indentation. Limited studies performed on using multi-axial loading measurements of time-dependent material behavior exist in the literature. Therefore, the aim of this study is to investigate the viscoelastic response of rubber-like materials under multi-axial loading using cavity expansion and relaxation tests. The tests were performed on PVA hydrogel specimens. Three hyperelasitc models and one term Prony series were used to characterize the viscoelastic response of the hydrogels. Finite element (FE) simulations were performed to verify the validity of the calibrated material coefficients by reproducing the experimental results. The excellent agreement between the experimental, analytical and numerical data proves the capability of the cavity expansion technique to measure the time-dependent behavior of viscoelastic materials.	[Nafo, Wanis; Al-Mayah, Adil] Univ Waterloo, Civil & Environm Engn Dept, Waterloo, ON, Canada; [Al-Mayah, Adil] Univ Waterloo, Mech & Mech Engn Dept, Waterloo, ON, Canada; [Al-Mayah, Adil] Univ Waterloo, Ctr Bioengn & Biotechnol, Waterloo, ON, Canada	University of Waterloo; University of Waterloo; University of Waterloo	Al-Mayah, A (corresponding author), Univ Waterloo, Civil & Environm Engn Dept, Waterloo, ON, Canada.; Al-Mayah, A (corresponding author), Univ Waterloo, Mech & Mech Engn Dept, Waterloo, ON, Canada.; Al-Mayah, A (corresponding author), Univ Waterloo, Ctr Bioengn & Biotechnol, Waterloo, ON, Canada.	aalmayah@uwaterloo.ca	Nafo, Wanis/AAP-1082-2020	Nafo, Wanis/0000-0001-8320-2422				Ahsanizadeh S, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0023-7; ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6; Bergstrom J., 2015, MECH SOLID POLYM THE, P309; BROWN N, 1988, POLYMER, V29, P463, DOI 10.1016/0032-3861(88)90363-1; Chatelin S, 2011, BIORHEOLOGY, V48, P75, DOI 10.3233/BIR-2011-0584; Chen FF, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/5/055602; Christensen R, 2012, THEORY VISCOELASTICI; Dalrymple T, 2007, ELASTOMER RATE DEPEN; deBotton G, 2013, INT J SOLIDS STRUCT, V50, P403, DOI 10.1016/j.ijsolstr.2012.10.004; DeCarlo PF, 2004, AEROSOL SCI TECH, V38, P1185, DOI 10.1080/027868290903907; Deffieux T, 2015, J HEPATOL, V62, P317, DOI 10.1016/j.jhep.2014.09.020; Dong YF, 2017, COMPOS SCI TECHNOL, V151, P291, DOI 10.1016/j.compscitech.2017.08.025; EMRI I, 1993, RHEOL ACTA, V32, P311, DOI 10.1007/BF00434195; Findley W.N., 1976, CREEP RELAXATION NON; Fung YC., 1993, BIOMECHANICS MECH PR, V2, DOI [10.1007/978-1-4757-2257-4, DOI 10.1007/978-1-4757-2257-4]; Glozman T, 2010, J ULTRAS MED, V29, P387, DOI 10.7863/jum.2010.29.3.387; Hernandez R, 2004, POLYMER, V45, P5543, DOI 10.1016/j.polymer.2004.05.061; Karimi A, 2014, TISSUE CELL, V46, P97, DOI 10.1016/j.tice.2013.12.004; Kendall MJ., 2015, J DYNAM BEHAV MAT, V1, P114, DOI [10.1007/s40870-015-0018-2, DOI 10.1007/S40870-015-0018-2]; Kennedy P, 2018, RADIOLOGY, V286, P738, DOI 10.1148/radiol.2018170601; Kiss MZ, 2009, J BIOMECH, V42, P959, DOI 10.1016/j.jbiomech.2009.03.002; Lakes R, 2009, VISCOELASTIC MATERIALS, P1, DOI 10.1017/CBO9780511626722; Lee CT, 2005, CARBOHYD POLYM, V61, P348, DOI 10.1016/j.carbpol.2005.06.018; Lee SY, 2009, ACTA BIOMATER, V5, P1919, DOI 10.1016/j.actbio.2009.02.014; Leng DX, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11060988; Li XF, 2018, RSC ADV, V8, P16674, DOI 10.1039/c8ra01302k; Liu LF, 2012, WATER RES, V46, P1969, DOI 10.1016/j.watres.2012.01.017; Lu YC, 2010, EXP MECH, V50, P71, DOI 10.1007/s11340-008-9215-4; Maccabi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191919; Mainardi F., 2010, FRACTIONAL CALCULUS, DOI [10.1142/p614, DOI 10.1142/P614]; Nafo W, 2019, EXP MECH, V59, P1047, DOI 10.1007/s11340-019-00504-4; Nafo W, 2018, BIOMECHANICS SOFT TI, P27, DOI DOI 10.1201/9781351135825-2; Nafo W., 2016, EXPT ANAL INVESTIGAT; Park SW, 2001, J MATER CIVIL ENG, V13, P26, DOI 10.1061/(ASCE)0899-1561(2001)13:1(26); Ramkumar DHS, 1997, J APPL POLYM SCI, V64, P2177; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Salameh N, 2009, RADIOLOGY, V253, P90, DOI 10.1148/radiol.2523081817; Shahzad M, 2015, MATER RES-IBERO-AM J, V18, P918, DOI 10.1590/1516-1439.320414; Shi Y, 2013, WEAR, V305, P280, DOI 10.1016/j.wear.2012.12.020; Siviour CR, 2017, HIGH STRAIN RATE CHA, DOI 10.1063/1.4971585; Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8; Steinmann P, 2012, ARCH APPL MECH, V82, P1183, DOI 10.1007/s00419-012-0610-z; TSCHOEGL NW, 1993, RHEOL ACTA, V32, P322, DOI 10.1007/BF00434196; Tzikang C., 2000, DETERMINING PRONY SE; Wan WK, 2002, J BIOMED MATER RES, V63, P854, DOI 10.1002/jbm.10333; Ward I.M., 1990, MECH PROPERTIES SOLI; Wells RG, 2013, BBA-MOL BASIS DIS, V1832, P884, DOI 10.1016/j.bbadis.2013.02.007; YANNAS IV, 1974, MACROMOL REV, V9, P163, DOI 10.1002/pol.1974.230090104; Zhai MY, 2014, J POLYM SCI POL PHYS, V52, P633, DOI 10.1002/polb.23470; Zhang DK, 2012, J BIONIC ENG, V9, P234, DOI 10.1016/S1672-6529(11)60116-9; Zhao JX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170073	51	5	5	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0233021	10.1371/journal.pone.0233021	http://dx.doi.org/10.1371/journal.pone.0233021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396571	gold, Green Published			2022-12-26	WOS:000537475000035
J	Chalich, Y; Mallick, A; Gupta, B; Deen, MJ				Chalich, Yamn; Mallick, Avijit; Gupta, Bhagwati; Deen, M. Jamal			Development of a low-cost, user-customizable, high-speed camera	PLOS ONE			English	Article							MUTANTS	High-speed imaging equipment can be an expensive investment, especially when certain applications require custom solutions. In this paper, we present a low-cost high-speed prototype camera built on a low-end Zynq-7000 System-on-Chip (SoC) platform and off-the-shelf components with the aim of removing the entry barrier into various high-speed imaging applications. The camera is standalone (does not require a host computer) and can achieve 211 frames per second (fps) at its maximum resolution of 1280x1024, and up to 2329 fps at a 256x256 resolution. With a current cost of only several hundred dollars and resource utilization of similar to 5%, the open-source design's modularity and customizability allows users with sufficient hardware or programming experience to modify the camera to suit their needs, potentially driving the cost lower. This can be done by utilizing the large remaining programmable logic for custom image processing algorithms, creating user interface software on the CPU, attaching extensions through the peripheral Module connections, or creating custom carrier or daughter boards. The development and design of the camera is described and a figure-of-merit is presented to provide a value assessment of some available commercial high-speed cameras against which our camera is competitive. Finally, the camera was tested to record low frequency spatial vibration and was found to be useful in investigating phenotypes associated with aging in a leading animal model, the nematode (worm) Caenorhabditis elegans.	[Chalich, Yamn; Deen, M. Jamal] McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON, Canada; [Mallick, Avijit; Gupta, Bhagwati] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Deen, M. Jamal] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Deen, MJ (corresponding author), McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON, Canada.; Deen, MJ (corresponding author), McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.	jamal@mail.ece.mcmaster.ca	Gupta, Bhagwati P/A-2818-2008	Gupta, Bhagwati P/0000-0001-8572-7054; Mallick, Avijit/0000-0002-9423-7134; Deen, Jamal/0000-0002-6390-0933	Natural Sciences and Engineering Research Council (NSERC) of Canada; Canada Research Chair Program	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program(Canada Research Chairs)	This research was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada and the Canada Research Chair Program to MJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi-Kesbi R, 2017, HEALTHC TECHNOL LETT, V4, P73, DOI 10.1049/htl.2016.0106; Alhaddad AY, 2019, LOW COST TEST RIG IM; [Anonymous], 2018, CHOOSE RIGHT CAMERA; [Anonymous], 2018, THIS CHEAP HIGH SPEE; [Anonymous], 2019, SENSOR REV MONO CAME; [Anonymous], 2017, SEMICONDUCTOR PYTHON; [Anonymous], 2016, ARXIV; Apfeld J, 2018, METHODS MOL BIOL, V1706, P53, DOI 10.1007/978-1-4939-7471-9_4; Bacon David, 2013, ACM QUEUE, V11, DOI DOI 10.1145/2436696.2443836; Bigas M, 2006, MICROELECTRON J, V37, P433, DOI 10.1016/j.mejo.2005.07.002; Blackfly S, USB3 MODEL BFS U3 13; Bravo I, 2011, SENSORS-BASEL, V11, P2282, DOI 10.3390/s110302282; BRENNER S, 1974, GENETICS, V77, P71; Brodtkorb AR, 2010, SCI PROGRAMMING-NETH, V18, P1, DOI 10.3233/SPR-2009-0296; Cox GC, 2007, OPTICAL IMAGING TECH, DOI [10.1186/1471-2121-8-S1-S10, DOI 10.1186/1471-2121-8-S1-S10]; Davis A., 2014, ACM T GRAPHIC, V33, P1; Duke DJ, 2019, MEAS SCI TECHNOL, V30, DOI 10.1088/1361-6501/ab1832; Finch C.E., 1994, LONGEVITY SENESCENCE; Fu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026306; Granqvist S, 2003, J VOICE, V17, P319, DOI 10.1067/S0892-1997(03)00070-5; Gu QY, 2013, IEEE T CIRC SYST VID, V23, P30, DOI 10.1109/TCSVT.2012.2202195; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Ingersoll R, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat2980; Ishii I, 2010, IEEE INT CONF ROBOT, P1536, DOI 10.1109/ROBOT.2010.5509731; JAGGI B, 1989, OPT ENG, V28, P675, DOI 10.1117/12.7977019; Jaggi B., 1989, U.S. Patent, Patent No. 4845552; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kishimoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129828; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Linne M, 2010, EXP FLUIDS, V49, P911, DOI 10.1007/s00348-010-0883-3; Long X, 2019, SENSORS, V19; Majumder S., 2011, THESIS; Markaki M, 2010, BIOTECHNOL J, V5, P1261, DOI 10.1002/biot.201000183; Moynihan T., 2014, SLO MO CAMERA INSANE; Nunez I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187163; Pearce JM, 2016, SCI PUBL POLICY, V43, P192, DOI 10.1093/scipol/scv034; Pueo B, 2016, J HUM SPORT EXERC, V11, P53, DOI 10.14198/jhse.2016.111.05; Qasaimeh M, 2015, IEEE T COMPUT IMAG, V1, P56, DOI 10.1109/TCI.2015.2424077; Ranawade A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206540; Schlegel P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215168; Sirowy S, 2008, MICROSOFT RES; Switz NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095330; Tempelman E, 2012, EXP MECH, V52, P1385, DOI 10.1007/s11340-011-9584-y; Uno M, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.10; Versluis M, 2013, EXP FLUIDS, V54, DOI 10.1007/s00348-013-1458-x; Wang X, 2010, SENSORS CAMERAS SYST, P193; Warrick DR, 2005, NATURE, V435, P1094, DOI 10.1038/nature03647	47	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232788	10.1371/journal.pone.0232788	http://dx.doi.org/10.1371/journal.pone.0232788			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384109	Green Published, gold			2022-12-26	WOS:000537468300047
J	Kim, SH; Rhee, Y; Kim, YM; Won, YJ; Noh, J; Moon, H; Lee, J; Kim, SG				Kim, Se Hwa; Rhee, Yumie; Kim, Yoo Mee; Won, Young Jun; Noh, Junghyun; Moon, Hyemi; Lee, Juneyoung; Kim, Sin Gon			Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study	PLOS ONE			English	Article							HYPOCALCEMIC CARDIOMYOPATHY; PARATHYROID-HORMONE; HEART-FAILURE; CALCIUM; EPIDEMIOLOGY; DEFICIENCY; PATIENT; ADULT	Objective The risk of complications of nonsurgical hypoparathyroidism in Asia is unclear. We estimated the prevalence and risk of complications in patients with nonsurgical hypoparathyroidism. Methods We performed a retrospective cohort study using a nationwide claims database from 2005 to 2016. Among the entire Korean population, we identified 897 patients diagnosed with nonsurgical hypoparathyroidism during 2005-2015. We selected 210 patients with nonsurgical hypoparathyroidism during 2005-2008 who had no complications at baseline and followed them to 2016. Control subjects (n = 2075) were matched using propensity scores based on age, sex, and comorbid disease with a 1:10 ratio and monitored until 2016. Results The age-standardized prevalence of nonsurgical hypoparathyroidism was 0.2 cases per 100,000 persons in 2005. During a mean follow-up period of 9.5 years, patients with nonsurgical hypoparathyroidism had a higher risk of cardiovascular disease, especially arrhythmia (hazard ratio [HR], 2.03; 95% confidence interval [CI], 1.11-3.70) and heart failure (HR, 2.43; 95% CI, 1.22-4.83). The risk of vertebral fracture was higher in patients than in controls (HR, 2.27; 95% CI, 1.09-4.72). Patients had a significantly increased risk of renal disease (HR, 2.57; 95% CI, 1.56-4.21), seizure (HR, 5.74; 95% CI, 3.34-9.86), depression and bipolar disease (HR, 1.82; 95% CI, 1.30-2.56), and cataract (HR, 1.90; 95% CI, 1.30-2.79) compared with controls. Conclusions The prevalence of nonsurgical hypoparathyroidism was very low in Korea but was associated with a higher risk of incident cardiovascular disease and vertebral fracture as well as known complications including renal disease, seizure, and cataract.	[Kim, Se Hwa; Kim, Yoo Mee; Won, Young Jun] Catholic Kwandong Univ, Coll Med, Int St Marys Hosp, Dept Internal Med, Incheon, South Korea; [Rhee, Yumie] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Noh, Junghyun] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Goyang, South Korea; [Moon, Hyemi; Lee, Juneyoung] Korea Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Kim, Sin Gon] Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Catholic Kwandong University; Yonsei University; Yonsei University Health System; Inje University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, SG (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	k50367@korea.ac.kr	Noh, Junghyun/AAU-8113-2020; Rhee, Yumie/L-8020-2019	Rhee, Yumie/0000-0003-4227-5638; Lee, Juneyoung/0000-0001-8073-9304; Kim, Sin Gon/0000-0002-7430-3675	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea [HI17C1926]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KNIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI17C1926) to SGK.	Abate EG, 2017, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00172; Agarwal M, 2011, J CARDIOVASC PHARM T, V16, P354, DOI 10.1177/1074248410390214; Arlt W, 2002, EUR J ENDOCRINOL, V146, P215, DOI 10.1530/eje.0.1460215; Bansal B, 2014, J CLIN ENDOCR METAB, V99, P2627, DOI 10.1210/jc.2013-3352; Bilezikian JP, 2011, J BONE MINER RES, V26, P2317, DOI 10.1002/jbmr.483; Bohrer T, 2007, WORLD J BIOL PSYCHIA, V8, P56, DOI 10.1080/15622970600995146; Chavan CB, 2007, ANN INTERN MED, V146, P541, DOI 10.7326/0003-4819-146-7-200704030-00020; Chawla H, 2017, J CLIN ENDOCR METAB, V102, P251, DOI 10.1210/jc.2016-3292; Chen QX, 2003, J CLIN ENDOCR METAB, V88, P4655, DOI 10.1210/jc.2003-030470; Clarke BL, 2011, J BONE MINER RES, V26, pS182; FUJIYAMA K, 1995, J CLIN ENDOCR METAB, V80, P2135, DOI 10.1210/jc.80.7.2135; LAWLOR BA, 1988, J CLIN PSYCHIAT, V49, P317; Lee JH, 2016, KOREAN CIRC J, V46, P658, DOI 10.4070/kcj.2016.46.5.658; Mendonca ML, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-1; Mitchell DM, 2012, J CLIN ENDOCR METAB, V97, P4507, DOI 10.1210/jc.2012-1808; Nakamura Y, 2000, J Epidemiol, V10, P29; Newman D, 2014, HEART FAIL REV, V19, P199, DOI 10.1007/s10741-013-9371-1; RAMPE D, 1991, AM J PHYSIOL, V261, pH1945, DOI 10.1152/ajpheart.1991.261.6.H1945; Rubin MR, 2008, J BONE MINER RES, V23, P2018, DOI 10.1359/JBMR.080803; Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253; SZENTGYORGYI AG, 1975, BIOPHYS J, V15, P707, DOI 10.1016/S0006-3495(75)85849-8; Tziomalos K, 2006, CLIN ENDOCRINOL, V64, P717, DOI 10.1111/j.1365-2265.2006.02538.x; Underbjerg L, 2015, J BONE MINER RES, V30, P1738, DOI 10.1002/jbmr.2501; Velayuthan S, 2014, PEDIATR INT, V56, pE23, DOI 10.1111/ped.12378; Yi SW, 2015, INT J EPIDEMIOL, V44, P1696, DOI 10.1093/ije/dyv138	26	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232842	10.1371/journal.pone.0232842	http://dx.doi.org/10.1371/journal.pone.0232842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384131	Green Published			2022-12-26	WOS:000537468300035
J	Zheng, CL; Xu, R				Zheng, Chunlei; Xu, Rong			Predicting cancer origins with a DNA methylation-based deep neural network model	PLOS ONE			English	Article							UNKNOWN PRIMARY; TUMOR-TISSUE; CARCINOMA; IDENTIFICATION; VALIDATION; PROFILE; MICRORNA; MARKERS; ADENOCARCINOMA; MULTICENTER	Cancer origin determination combined with site-specific treatment of metastatic cancer patients is critical to improve patient outcomes. Existing pathology and gene expression-based techniques often have limited performance. In this study, we developed a deep neural network (DNN)-based classifier for cancer origin prediction using DNA methylation data of 7,339 patients of 18 different cancer origins from The Cancer Genome Atlas (TCGA). This DNN model was evaluated using four strategies: (1) when evaluated by 10-fold cross-validation, it achieved an overall specificity of 99.72% (95% CI 99.69%-99.75%) and sensitivity of 92.59% (95% CI 91.87%-93.30%); (2) when tested on hold-out testing data of 1,468 patients, the model had an overall specificity of 99.83% and sensitivity of 95.95%; (3) when tested on 143 metastasized cancer patients (12 cancer origins), the model achieved an overall specificity of 99.47% and sensitivity of 95.95%; and (4) when tested on an independent dataset of 581 samples (10 cancer origins), the model achieved overall specificity of 99.91% and sensitivity of 93.43%. Compared to existing pathology and gene expression-based techniques, the DNA methylation-based DNN classifier showed higher performance and had the unique advantage of easy implementation in clinical settings. In summary, our study shows that DNA methylation-based DNN models has potential in both diagnosis of cancer of unknown primary and identification of cancer cell types of circulating tumor cells.	[Zheng, Chunlei; Xu, Rong] Case Western Reserve Univ, Sch Med, Ctr Artificial Intelligence Drug Discovery, Cleveland, OH USA	Case Western Reserve University	Xu, R (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Artificial Intelligence Drug Discovery, Cleveland, OH USA.	rxx@case.edu		Zheng, Chunlei/0000-0002-9737-461X	NIH Director's New Innovator Award under the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [DP2HD084068]; NIH National Institute of Aging [R01 AG057557-01, R01 AG061388-01, R56 AG062272-01]; American Cancer Society Research Scholar Grant [RSG-16-049-01MPC]	NIH Director's New Innovator Award under the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; NIH National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Cancer Society Research Scholar Grant(American Cancer Society)	RX and CLZ are funded by the NIH Director's New Innovator Award under the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (DP2HD084068, Xu), NIH National Institute of Aging (R01 AG057557-01, R01 AG061388-01, R56 AG062272-01, Xu) and American Cancer Society Research Scholar Grant (RSG-16-049-01MPC, Xu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; [Anonymous], 2017, BRIEF BIOINFORM, DOI DOI 10.1093/bib/bbw068; Artemov A. V., 2016, BIORXIV, DOI [10.1101/095653, DOI 10.1101/095653]; Arvaniti E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14825; Brendan Mcmahan H., 2014, ADV NEURAL INFORM PR, P1, DOI [10.1056/NEJMRA1303917, DOI 10.1056/NEJMRA1303917]; Brown RW, 1997, AM J CLIN PATHOL, V107, P12; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Dennis JL, 2005, CLIN CANCER RES, V11, P3766, DOI 10.1158/1078-0432.CCR-04-2236; DeYoung BR, 2000, SEMIN DIAGN PATHOL, V17, P184; Chinen LTD, 2017, ADV EXP MED BIOL, V994, P1, DOI 10.1007/978-3-319-55947-6_1; Du T, 2016, METHODS, V110, P97, DOI 10.1016/j.ymeth.2016.06.001; Ettinger DS, 2011, J NATL COMPR CANC NE, V9, P1358, DOI 10.6004/jnccn.2011.0117; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Glorot X., 2010, P 13 INT C ARTIFICIA, V9, P249, DOI DOI 10.1.1/207.2059; Greco FA, 2013, JNCI-J NATL CANCER I, V105, P782, DOI 10.1093/jnci/djt099; Hainsworth JD, 2013, J CLIN ONCOL, V31, P217, DOI 10.1200/JCO.2012.43.3755; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Kingma D.P., 2014, P INT C LEARN REPR; Kramer A, 2008, BREAST CARE, V3, P164, DOI 10.1159/000136001; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Ma XJ, 2006, ARCH PATHOL LAB MED, V130, P465; McDonald J.H., 2014, HDB BIOL STAT; Meiri E, 2012, ONCOLOGIST, V17, P801, DOI 10.1634/theoncologist.2011-0466; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Moran S, 2016, LANCET ONCOL, V17, P1386, DOI 10.1016/S1470-2045(16)30297-2; Ohgane J, 2008, PLACENTA, V29, pS29, DOI 10.1016/j.placenta.2007.09.011; Paoletti C, 2016, ADV EXP MED BIOL, V882, P235, DOI 10.1007/978-3-319-22909-6_10; Park SY, 2007, ARCH PATHOL LAB MED, V131, P1561; Pentheroudakis G, 2007, EUR J CANCER, V43, P2026, DOI 10.1016/j.ejca.2007.06.023; Pentheroudakis G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-57; Pillai R, 2011, J MOL DIAGN, V13, P48, DOI 10.1016/j.jmoldx.2010.11.001; Poplin R, 2018, NAT BIOTECHNOL, V36, P983, DOI 10.1038/nbt.4235; Potdar P., 2015, J CANC METASTASIS TR, V1, DOI [10.4103/2394-4722.158803, DOI 10.4103/2394-4722.158803]; Qian N, 1999, NEURAL NETWORKS, V12, P145, DOI 10.1016/S0893-6080(98)00116-6; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Rosenwald S, 2010, MODERN PATHOL, V23, P814, DOI 10.1038/modpathol.2010.57; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Sindeeva OA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101195; Tothill RW, 2015, PATHOLOGY, V47, P7, DOI 10.1097/PAT.0000000000000194; Varadhachary GR, 2014, INT J CLIN ONCOL, V19, P479, DOI 10.1007/s10147-013-0583-0; Varadhachary GR, 2014, NEW ENGL J MED, V371, P757, DOI 10.1056/NEJMra1303917; Varadhachary GR, 2011, CLIN CANCER RES, V17, P4063, DOI 10.1158/1078-0432.CCR-10-2599; Varadhachary GR, 2008, LANCET ONCOL, V9, P596, DOI 10.1016/S1470-2045(08)70151-7; Zou JF, 2017, GENOM PROTEOM BIOINF, V15, P130, DOI 10.1016/j.gpb.2017.01.004	47	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0226461	10.1371/journal.pone.0226461	http://dx.doi.org/10.1371/journal.pone.0226461			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384093	Green Submitted, gold, Green Published			2022-12-26	WOS:000537468300001
J	Taylor, RM; Mendoza, KM; Abrahante, JE; Reed, KM; Sunde, RA				Taylor, Rachel M.; Mendoza, Kristelle M.; Abrahante, Juan E.; Reed, Kent M.; Sunde, Roger A.			The hepatic transcriptome of the turkey poult (Meleagris gallopavo) is minimally altered by high inorganic dietary selenium	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; SET ENRICHMENT ANALYSIS; SELENOPROTEIN GENES; LIVER; EXPRESSION; SUPPLEMENTATION; DEFICIENCY; RATS; SELENOMETHIONINE; REQUIREMENTS	There is interest in supplementing animals and humans with selenium (Se) above Se-adequate levels, but the only good biomarker for toxicity is tissue Se. We targeted liver because turkeys fed 5 mu g Se/g have hepatic Se concentrations 6-fold above Se-adequate (0.4 mu g Se/g) levels without effects on growth or health. Our objectives were (i) to identify transcript biomarkers for high Se status, which in turn would (ii) suggest proteins and pathways used by animals to adapt to high Se. Turkey poults were fed 0, 0.025, 0.4, 0.75 and 1.0 mu g Se/g diet in experiment 1, and fed 0.4, 2.0 and 5.0 mu g Se/g in experiment 2, as selenite, and the full liver transcriptome determined by RNA-Seq. The major effect of Se-deficiency was to downregulate expression of a subset of selenoprotein transcripts, with little significant effect on general transcript expression. In response to high Se intake (2 and 5 mu g Se/g) relative to Seadequate turkeys, there were only a limited number of significant differentially expressed transcripts, all with only relatively small fold-changes. No transcript showed a consistent pattern of altered expression in response to high Se intakes across the 1, 2 and 5 mu g Se/g treatments, and there were no associated metabolic pathways and biological functions that were significant and consistently found with high Se supplementation. Gene set enrichment analysis also found no gene sets that were consistently altered by high-Se and supernutritionalSe. A comparison of differentially expressed transcript sets with high Se transcript sets identified in mice provided high Se (similar to 3 mu g Se/g) also failed to identify common differentially expressed transcript sets between these two species. Collectively, this study indicates that turkeys do not alter gene expression in the liver as a homeostatic mechanism to adapt to high Se.	[Taylor, Rachel M.; Sunde, Roger A.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [Mendoza, Kristelle M.; Reed, Kent M.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Abrahante, Juan E.] Univ Minnesota, Informat Inst, Minneapolis, MN USA	University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sunde, RA (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	sunde@nutrisci.wisc.edu		Abrahante, Juan/0000-0002-9074-4307	National Institute of Food and Agriculture, United States Department of Agriculture, Hatch project [1016808, 1004389]; Wisconsin Alumni Foundation [12046295]; USDA National Institute of Food and Agriculture Animal Genome Program [2013-01043]	National Institute of Food and Agriculture, United States Department of Agriculture, Hatch project; Wisconsin Alumni Foundation; USDA National Institute of Food and Agriculture Animal Genome Program	This Research was supported by the National Institute of Food and Agriculture, United States Department of Agriculture (accession number 1016808, at: https://portal.nifa.usda.gov/web/crisprojectpages/1016808-advancedtechnologies-for-the-genetic-improvement-of-poultry.html), Hatch project 1004389 to RAS, by the Wisconsin Alumni Foundation (http://www.uwalumni.com) Selenium Nutrition Research Fund No. 12046295 to RAS, and by the USDA National Institute of Food and Agriculture Animal Genome Program project 2013-01043 to KMR.	Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Barnett MPG, 2015, NUTRIENTS, V7, P3370, DOI 10.3390/nu7053370; Bierla K, 2020, METALLOMICS, V12, P758, DOI [10.1039/D0MT00040J, 10.1039/d0mt00040j]; Bierla K, 2012, TRAC-TREND ANAL CHEM, V41, P122, DOI 10.1016/j.trac.2012.08.006; Boehler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101408; Bosse AC, 2010, BIOSCIENCE REP, V30, P293, DOI 10.1042/BSR20090089; Brennan KM, 2011, ANIM REPROD SCI, V125, P180, DOI 10.1016/j.anireprosci.2011.02.027; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; CHEN XS, 1980, BIOL TRACE ELEM RES, V2, P91, DOI 10.1007/BF02798589; ELBEGEARMI MM, 1982, POULTRY SCI, V61, P770, DOI 10.3382/ps.0610770; Elgendy R, 2016, J ANIM SCI, V94, P3169, DOI 10.2527/jas.2016-0363; Feng YJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24826-w; Gladyshev VN, 2016, J BIOL CHEM, V291, P24036, DOI 10.1074/jbc.M116.756155; HARR JR, 1967, SELENIUM BIOMEDICINE, P153; Hu X, 2018, J NUTR, V148, P675, DOI 10.1093/jn/nxy036; Huang JQ, 2011, J NUTR, V141, P1605, DOI 10.3945/jn.111.145722; Huang XF, 2016, RSC ADV, V6, P84990, DOI 10.1039/c6ra14932d; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Knight R, 2016, AQUAT TOXICOL, V180, P103, DOI 10.1016/j.aquatox.2016.09.014; Kobayashi Y, 2002, P NATL ACAD SCI USA, V99, P15932, DOI 10.1073/pnas.252610699; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Li JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152392; Liu CP, 2014, BIOL TRACE ELEM RES, V159, P192, DOI 10.1007/s12011-014-0005-9; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mallonee DH, 2011, BIOL TRACE ELEM RES, V143, P992, DOI 10.1007/s12011-010-8894-8; Maret W, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112285; Matthews JC, 2014, BIOL TRACE ELEM RES, V160, P321, DOI 10.1007/s12011-014-0050-4; MCADAM PA, 1987, NUTR RES, V7, P601, DOI 10.1016/S0271-5317(87)80053-2; Monson MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100930; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; National Research Council, 1994, NUTR REQ POULTR; Nelson AA, 1943, CANCER RES, V3, P230; NESHEIM MC, 1958, J NUTR, V65, P601, DOI 10.1093/jn/65.4.601; Okamura SM, 2006, J BIOL CHEM, V281, P36132, DOI 10.1074/jbc.M605093200; ORT JF, 1978, J NUTR, V108, P1114, DOI 10.1093/jn/108.7.1114; Pacitti D, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2418-7; Pilon-Smits EAH, 2010, PLANT CELL MONOGR, V17, P225, DOI [10.1007/978-3-642-10613-2_10, 10.1016/j.bbagen.2018.05.006]; Raines AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-26; Reed KM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3740-4; Rosenfeld I, 1964, SELENIUM GEOBOTANY B, P142; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; SALBE AD, 1990, J NUTR, V120, P200, DOI 10.1093/jn/120.2.200; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SCHWARZ K, 1957, J AM CHEM SOC, V79, P3292, DOI 10.1021/ja01569a087; SCOTT ML, 1957, POULTRY SCI, V36, P1155; SCOTT ML, 1967, J NUTR, V91, P573, DOI 10.1093/jn/91.4.573; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sunde RA, 2012, MODERN NUTR HLTH DIS, P225; Sunde RA, 2010, DIETARY SUPPLEMENTS, P715; Sunde RA, 2016, ADV NUTR, V7, P1129, DOI 10.3945/an.116.012872; Sunde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129801; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Takahashi K, 2020, METALLOMICS, V12, P241, DOI 10.1039/c9mt00274j; Takahashi K, 2018, J TRACE ELEM MED BIO, V49, P113, DOI 10.1016/j.jtemb.2018.05.007; Taylor RM, 2019, POULTRY SCI, V98, P855, DOI 10.3382/ps/pey413; Taylor RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189001; Taylor RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151665; Tinsley IJ, 1967, SELENIUM BIOMEDICINE, P141; Tsuji PA, 2015, NUTRIENTS, V7, P6529, DOI 10.3390/nu7085297; WALTER ED, 1963, J NUTR, V80, P327, DOI 10.1093/jn/80.3.327; WHANGER PD, 1988, J NUTR, V118, P846; Xu JX, 2016, BIOL TRACE ELEM RES, V170, P438, DOI 10.1007/s12011-015-0470-9; Xu JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182079; Yin YL, 2015, HUM IMMUNOL, V76, P775, DOI 10.1016/j.humimm.2015.09.037; Zeng R, 2019, ENVIRON SCI POLLUT R, V26, P17834, DOI 10.1007/s11356-019-05226-7; Zhao X, 2014, BIOL TRACE ELEM RES, V161, P341, DOI 10.1007/s12011-014-0139-9	71	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232160	10.1371/journal.pone.0232160	http://dx.doi.org/10.1371/journal.pone.0232160			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379770	Green Published, gold			2022-12-26	WOS:000537285700024
J	Guo, AX; Hu, Y; Shi, MF; Wang, H; Wu, YX; Wang, YX				Guo, Aixia; Hu, Ya; Shi, Mingfu; Wang, Hai; Wu, Yuxia; Wang, Yanxiu			Effects of iron deficiency and exogenous sucrose on the intermediates of chlorophyll biosynthesis in Malus halliana	PLOS ONE			English	Article							PROTOPORPHYRINOGEN OXIDASE; SOLUBLE SUGARS; METABOLISM; PLANTS; ACCUMULATION; TETRAPYRROLE; TOLERANCE; RESPONSES; NUTRIENT; STRESS	Malus halliana is an iron (Fe)-efficient apple rootstock growing in calcareous soil that shows obvious 'greenness' traits during Fe deficiency. Recent studies have shown that exogenous sugars can be involved in abiotic stress. To identify the key regulatory steps of chlorophyll (Chl) biosynthesis in M. halliana under Fe deficiency and to verify whether exogenous sucrose (Suc) is involved in Fe deficiency stress, we determined the contents of the Chl precursor and the expression of several Chl biosynthetic genes in M. halliana. The results showed that Fe deficiency caused a significant increase in the contents of protoporphyrin IX (Proto IX), Mg-protoporphyrin IX (Mg-Proto IX) and protochlorophyllide (Pchlide) in M. halliana compared to the Fe-sensitive rootstock Malus hupehensis. Quantitative real-time PCR (RT-qPCR) also showed that the expression of protoporphyrinogen oxidase (PPOX), which synthesizes Proto IX, was upregulated in M. halliana and downregulated in M. hupehensis under Fe deficiency. Exogenous Suc application prominently enhanced the contents of porphobilinogen (PBG) and the subsequent precursor, whereas it decreased the level of delta-aminolaevulinic acid (ALA), suggesting that the transformation from ALA to PBG was catalyzed in M. halliana. Additionally, the transcript level of delta-aminolevulinate acid dehydratase (ALAD) was noticeably upregulated after exogenous Suc treatment. This result, combined with the precursor contents, indicated that Suc accelerated the steps of Chl biosynthesis by modulating the ALAD gene. Therefore, we conclude that PPOX is the key regulatory gene of M. halliana in response to Fe deficiency. Exogenous Suc enhances M. halliana tolerance to Fe deficiency stress by regulating Chl biosynthesis.	[Guo, Aixia; Hu, Ya; Shi, Mingfu; Wang, Hai; Wu, Yuxia; Wang, Yanxiu] Gansu Agr Univ, Coll Hort, Lanzhou, Gansu, Peoples R China; [Guo, Aixia; Hu, Ya] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University; Chinese Academy of Sciences	Wang, YX (corresponding author), Gansu Agr Univ, Coll Hort, Lanzhou, Gansu, Peoples R China.	wangxy@gsau.edu.cn			Gansu Agricultural University Youth Postgraduate Tutor Support Fund Project [GAU-2NDS201710]	Gansu Agricultural University Youth Postgraduate Tutor Support Fund Project	This work was supported by Gansu Agricultural University Youth Postgraduate Tutor Support Fund Project (project No. GAU-2NDS201710).	Apaliya MT, 2017, POSTHARVEST BIOL TEC, V132, P162, DOI 10.1016/j.postharvbio.2017.06.008; BOGORAD L, 1962, METHOD ENZYMOL, V5, P885, DOI 10.1016/S0076-6879(62)05334-3; Breinig S, 2003, NAT STRUCT BIOL, V10, P757, DOI 10.1038/nsb963; Buoso S, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6062-x; Chen H, 2013, PLANT CELL REP, V32, P1855, DOI 10.1007/s00299-013-1498-y; Chen HM, 2019, TREE PHYSIOL, V39, P1235, DOI 10.1093/treephys/tpz055; Chen Xin-bin, 2012, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V32, P1781; Cheng YD, 2015, LWT-FOOD SCI TECHNOL, V60, P1243, DOI 10.1016/j.lwt.2014.09.005; DUKE SO, 1991, WEED SCI, V39, P465, DOI 10.1017/S0043174500073239; Fan XX, 2013, ACTA PHYSIOL PLANT, V35, P2721, DOI 10.1007/s11738-013-1304-z; Feng G, 2002, MYCORRHIZA, V12, P185, DOI 10.1007/s00572-002-0170-0; Hammond JP, 2008, J EXP BOT, V59, P93, DOI 10.1093/jxb/erm221; HAN ZH, 1994, J PLANT NUTR, V17, P1257, DOI 10.1080/01904169409364803; Hao GF, 2009, J PHYS CHEM B, V113, P4865, DOI 10.1021/jp807442n; He Ning, 2019, Acta Agronomica Sinica, V45, P460, DOI 10.3724/SP.J.1006.2019.84002; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; HODGINS RR, 1986, J PLANT PHYSIOL, V125, P311, DOI 10.1016/S0176-1617(86)80153-5; Hu Y, 2018, MOL GENET GENOMICS, V293, P1523, DOI 10.1007/s00438-018-1479-5; ISRAELSTAM GF, 1968, NATURE, V218, P390, DOI 10.1038/218390a0; JAFFE EK, 1995, BIOCHEMISTRY-US, V34, P244, DOI 10.1021/bi00001a029; Jia HF, 2013, NEW PHYTOL, V198, P453, DOI 10.1111/nph.12176; Jin XQ, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1660-y; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Li JM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0699-7; Li ZY, 2019, PLANT CELL PHYSIOL, V60, P2307, DOI 10.1093/pcp/pcz129; Lilley JLS, 2012, PLANT PHYSIOL, V160, P2261, DOI 10.1104/pp.112.205575; Lin XY, 2016, PLANT PHYSIOL, V170, P907, DOI 10.1104/pp.15.01598; MARSH HV, 1963, PLANT PHYSIOL, V38, P632, DOI 10.1104/pp.38.6.632; Meinecke L, 2010, PLANT MOL BIOL, V72, P643, DOI 10.1007/s11103-010-9604-9; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Morton RA, 1975, BIOCH SPECTROSCOPY; Mueller AH, 2012, PLANT CELL PHYSIOL, V53, P1232, DOI 10.1093/pcp/pcs062; Ohto M, 2001, PLANT PHYSIOL, V127, P252, DOI 10.1104/pp.127.1.252; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rombola AD, 2006, IRON NUTRITION IN PLANTS AND RHIZOSPHERIC MICROORGANISMS, P61, DOI 10.1007/1-4020-4743-6_3; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Siebeneichler TJ, 2020, FOOD CHEM, V317, DOI 10.1016/j.foodchem.2020.126407; SPILLER SC, 1982, PLANT PHYSIOL, V69, P107, DOI 10.1104/pp.69.1.107; [王勋陵 Wang Xunling], 2002, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V22, P670; Wang YX, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4846-z; Wasli H, 2018, IND CROP PROD, V126, P466, DOI 10.1016/j.indcrop.2018.10.007; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Xiong JL, 2018, PLANT PHYSIOL BIOCH, V124, P88, DOI 10.1016/j.plaphy.2018.01.001; Yadavalli V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035084; Yuan S, 2007, Z NATURFORSCH C, V62, P403; Zargar SM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00592; Zhang K, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-016-2321-5; Zhang XY, 2019, SCI HORTIC-AMSTERDAM, V258, DOI 10.1016/j.scienta.2019.108792; Zhou M, 2011, BIOL TRACE ELEM RES, V143, P468, DOI 10.1007/s12011-010-8830-y; Zhou YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065906	51	24	24	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232694	10.1371/journal.pone.0232694	http://dx.doi.org/10.1371/journal.pone.0232694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32375166	gold, Green Published			2022-12-26	WOS:000537283500050
J	Natelson, DM; Lai, A; Krishnamoorthy, D; Hoy, RC; Iatridis, JC; Illien-Junger, S				Natelson, Devorah M.; Lai, Alon; Krishnamoorthy, Divya; Hoy, Robert C.; Iatridis, James C.; Illien-Junger, Svenja			Leptin signaling and the intervertebral disc: Sex dependent effects of leptin receptor deficiency and Western diet on the spine in a type 2 diabetes mouse model	PLOS ONE			English	Article							LOW-BACK-PAIN; BONE-MINERAL DENSITY; FRACTURE RISK; LUMBAR SPINE; OBESITY; DEGENERATION; OVERWEIGHT; FAT; HEALTH; CELLS	Type 2 diabetes and obesity are associated with back pain in juveniles and adults and are implicated in intervertebral disc (IVD) degeneration. Hypercaloric Western diets are associated with both obesity and type 2 diabetes. The objective of this study was to determine if obesity and type 2 diabetes result in spinal pathology in a sex-specific manner using in vivo diabetic and dietary mouse models. Leptin is an appetite-regulating hormone, and its deficiency leads to polyphagia, resulting in obesity and diabetes. Leptin is also associated with IVD degeneration, and increased expression of its receptor was identified in degenerated IVDs. We used young, leptin receptor deficient (Db/Db) mice to mimic the effect of diet and diabetes on adolescents. Db/Db and Control mice were fed either Western or Control diets, and were sacrificed at 3 months of age. Db/Db mice were obese, while only female mice developed diabetes. Female Db/Db mice displayed altered IVD morphology, with increased intradiscal notochordal band area, suggesting delayed IVD cell proliferation and differentiation, rather than IVD degeneration. Motion segments from Db/Db mice exhibited increased failure risk with decreased torsional failure strength. Db/Db mice also had inferior bone quality, which was most prominent in females. We conclude that obesity and diabetes due to impaired leptin signaling contribute to pathological changes in vertebrae, as well as an immature IVD phenotype, particularly of females, suggesting a sex-dependent role of leptin in the spine.	[Natelson, Devorah M.; Lai, Alon; Krishnamoorthy, Divya; Hoy, Robert C.; Iatridis, James C.; Illien-Junger, Svenja] Icahn Sch Med Mt Sinai, Dept Orthopaed, New York, NY 10029 USA; [Illien-Junger, Svenja] Emory Univ, Sch Med, Dept Orthopaed, Atlanta, GA 30322 USA	Icahn School of Medicine at Mount Sinai; Emory University	Illien-Junger, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Orthopaed, New York, NY 10029 USA.; Illien-Junger, S (corresponding author), Emory Univ, Sch Med, Dept Orthopaed, Atlanta, GA 30322 USA.	svenja.illien-junger@emory.edu	Hoy, Robert/AGD-8353-2022; Illien-Junger, Svenja/AAV-1853-2020	Illien-Junger, Svenja/0000-0001-9895-0693; Hoy, Robert/0000-0001-9000-5793; Iatridis, James/0000-0002-2186-0590	NIH/NIAMS [R01 AR069315]	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was Funded by NIH/NIAMS R01 AR069315 (JCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdella NA, 2017, DIABETES RES CLIN PR, V133, P159, DOI 10.1016/j.diabres.2017.08.024; Acevedo C, 2018, J BONE MINER RES, V33, P1066, DOI 10.1002/jbmr.3393; Afghani A, 2005, DIABETES CARE, V28, P372, DOI 10.2337/diacare.28.2.372; Allen Terri J, 2004, Curr Diab Rep, V4, P435, DOI 10.1007/s11892-004-0053-1; Alpantaki K, 2019, EUR SPINE J, V28, P2129, DOI 10.1007/s00586-019-06029-7; Best Matthew J, 2015, Iowa Orthop J, V35, P147; Bolesta Michael J, 2011, J Bone Joint Surg Am, V93, pe34, DOI 10.2106/JBJS.J.01854; Cannata F, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3224; Cheng L, 2020, BONE, V131, DOI 10.1016/j.bone.2019.115162; Crujeiras AB, 2015, LIFE SCI, V140, P57, DOI 10.1016/j.lfs.2015.05.003; Dario AB, 2016, EUR SPINE J, V25, P1188, DOI 10.1007/s00586-015-4055-2; Dimitri P, 2018, ANN PEDIATR ENDOCRIN, V23, P62, DOI 10.6065/apem.2018.23.2.62; Dimitri P, 2010, J BONE MINER RES, V25, P527, DOI 10.1359/jbmr.090823; Ding W, 2013, ANAT REC, V296, P1806, DOI 10.1002/ar.22806; Eriksson MA, 2008, BLOOD COAGUL FIBRIN, V19, P625, DOI 10.1097/MBC.0b013e3283099046; Faienza MF, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00269; Fields AJ, 2015, J ORTHOP RES, V33, P738, DOI 10.1002/jor.22807; Gruber HE, 2007, SPINE J, V7, P437, DOI 10.1016/j.spinee.2006.08.001; Hamrick MW, 2004, BONE, V34, P376, DOI 10.1016/j.bone.2003.11.020; Hannema SE, 2016, HORM RES PAEDIAT, V85, P412, DOI 10.1159/000444055; Hassett G, 2003, ARTHRITIS RHEUM, V48, P3112, DOI 10.1002/art.11321; Ho-Pham LT, 2018, OSTEOPOROSIS INT, V29, P2059, DOI 10.1007/s00198-018-4579-5; Hui W, 2012, ANN RHEUM DIS, V71, P455, DOI 10.1136/annrheumdis-2011-200372; Illien-Junger S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116625; Illien-Junger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064302; Iwaniec UT, 2016, J ENDOCRINOL, V230, pR115, DOI 10.1530/JOE-16-0089; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Kim HY, 2017, J KOREAN MED SCI, V32, P1633, DOI 10.3346/jkms.2017.32.10.1633; King A, 2016, BIOCHEM PHARMACOL, V99, P1, DOI 10.1016/j.bcp.2015.08.108; Krishnamoorthy D, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036012; Lekkala S, 2019, CURR OSTEOPOROS REP, V17, P455, DOI 10.1007/s11914-019-00538-6; Leung VYL, 2009, J HISTOCHEM CYTOCHEM, V57, P249, DOI 10.1369/jhc.2008.952184; Li Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053176; Liu XM, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0755-8; Liuke M, 2005, INT J OBESITY, V29, P903, DOI 10.1038/sj.ijo.0802974; Lutz Thomas A, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0561s58; MacLean JJ, 2007, J BIOMECH, V40, P55, DOI 10.1016/j.jbiomech.2005.11.013; Masuda K, 2006, SPINE, V31, P742, DOI 10.1097/01.brs.0000206358.66412.7b; McCabe IC, 2019, J CELL BIOCHEM, V120, P4398, DOI 10.1002/jcb.27726; Mosley GE, 2019, SPINE, V44, P1257, DOI 10.1097/BRS.0000000000003055; O'Connell GD, 2011, J MECH BEHAV BIOMED, V4, P933, DOI 10.1016/j.jmbbm.2011.02.002; Oei L, 2013, DIABETES CARE, V36, P1619, DOI 10.2337/dc12-1188; Ott SM, 2018, AM J NEPHROL, V47, P373, DOI 10.1159/000489672; Palimeri S, 2015, DIABETES METAB SYNDR, V8, P415, DOI 10.2147/DMSO.S63089; Sakellaridis N, 2006, SURG NEUROL, V66, P152, DOI 10.1016/j.surneu.2006.01.019; Samartzis D, 2012, ARTHRITIS RHEUM-US, V64, P1488, DOI 10.1002/art.33462; Samartzis D, 2011, J BONE JOINT SURG AM, V93A, P662, DOI 10.2106/JBJS.I.01568; Samelson EJ, 2018, J BONE MINER RES, V33, P54, DOI 10.1002/jbmr.3240; Schwartz Ann V, 2013, Front Endocrinol (Lausanne), V4, P62, DOI 10.3389/fendo.2013.00062; Segar AH, 2019, EUR SPINE J, V28, P214, DOI 10.1007/s00586-018-5778-7; Selthofer-Relatic K, 2018, DIABETES VASC DIS RE, V15, P260, DOI 10.1177/1479164117752491; Sharma Anirudh, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6020034; Starup-Linde J, 2017, BONE, V95, P136, DOI 10.1016/j.bone.2016.11.026; Tam V, 2018, J ORTHOP RES, V36, P233, DOI 10.1002/jor.23637; The Jackson Lab, PHEN INF B6 DB 00697; Torre OM, 2018, FASEB J, V32, P4753, DOI 10.1096/fj.201701492R; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Videman T, 2010, SPINE J, V10, P26, DOI 10.1016/j.spinee.2009.10.005; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Walsh JS, 2017, CALCIFIED TISSUE INT, V100, P528, DOI 10.1007/s00223-016-0229-0; Walter BA, 2015, J ANAT, V227, P707, DOI 10.1111/joa.12258; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Williams GA, 2011, J BONE MINER RES, V26, P1698, DOI 10.1002/jbmr.367; Yoshimoto T, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-019-0249-3; Zhang TT, 2018, CLIN SPINE SURG, V31, P22, DOI 10.1097/BSD.0000000000000468; Zhao CQ, 2008, SPINE, V33, pE858, DOI 10.1097/BRS.0b013e31818338e5; Zhu ZN, 2014, BONE, V68, P115, DOI 10.1016/j.bone.2014.08.010	67	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0227527	10.1371/journal.pone.0227527	http://dx.doi.org/10.1371/journal.pone.0227527			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374776	Green Submitted, Green Published, gold			2022-12-26	WOS:000537283500004
J	Sun, MM; Jing, Y; Zhao, X; Teng, WL; Qiu, LJ; Zheng, HK; Li, WB; Han, YP				Sun, Mingming; Jing, Yan; Zhao, Xue; Teng, Weili; Qiu, Lijuan; Zheng, Hongkun; Li, Wenbin; Han, Yingpeng			Genome-wide association study of partial resistance to sclerotinia stem rot of cultivated soybean based on the detached leaf method	PLOS ONE			English	Article							GLYCINE-MAX L.; GENE; IDENTIFICATION; RESPONSES; PROTEIN	Sclerotinia stem rot (SSR) is a devastating fungal disease that causes severe yield losses of soybean worldwide. In the present study, a representative population of 185 soybean accessions was selected and utilized to identify the quantitative trait nucleotide (QTN) of partial resistance to soybean SSR via a genome-wide association study (GWAS). A total of 22,048 single-nucleotide polymorphisms (SNPs) with minor allele frequencies (MAF) > 5% and missing data < 3% were used to assess linkage disequilibrium (LD) levels. Association signals associated with SSR partial resistance were identified by two models, including compressed mixed linear model (CMLM) and multi-locus random-SNP-effect mixed linear model (mrMLM). Finally, seven QTNs with major effects (a known locus and six novel loci) via CMLM and nine novel QTNs with minor effects via mrMLM were detected in relation to partial resistance to SSR, respectively. One of all the novel loci (Gm05:14834789 on Chr.05), which was co-located by these two methods, might be a stable one that showed high significance in SSR partial resistance. Additionally, a total of 71 major and 85 minor candidate genes located in the 200-kb genomic region of each peak SNP detected by CMLM and mrMLM were found, respectively. By using a gene-based association, a total of six SNPs from three major effects genes and eight SNPs from four minor effects genes were identified. Of them, Glyma.18G012200 has been characterized as a significant element in controlling fungal disease in plants.	[Sun, Mingming; Jing, Yan; Zhao, Xue; Teng, Weili; Li, Wenbin; Han, Yingpeng] Northeast Agr Univ, Genet Chinese Agr Minist, Key Lab Soybean Biol & Breeding, Key Lab Soybean Biol,Chinese Minist Educ, Harbin, Peoples R China; [Sun, Mingming] Heilongjiang Acad Agr Sci, Heilongjiang Journal Press Agr Sci & Technol, Harbin, Peoples R China; [Qiu, Lijuan] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing, Peoples R China; [Zheng, Hongkun] Biomarker Technol Corp, Bioinformat Div, Beijing, Peoples R China	Northeast Agricultural University - China; Heilongjiang Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Li, WB; Han, YP (corresponding author), Northeast Agr Univ, Genet Chinese Agr Minist, Key Lab Soybean Biol & Breeding, Key Lab Soybean Biol,Chinese Minist Educ, Harbin, Peoples R China.	wenbinli@neau.edu.cn; hyp234286@aliyun.com						Aubert Y, 2015, J EXP BOT, V66, P3879, DOI 10.1093/jxb/erv190; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; Bastien M, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.10.0030; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cheng YB, 2017, THEOR APPL GENET, V130, P1041, DOI 10.1007/s00122-017-2869-5; Cnossen-Fassoni A, 2013, J MICROBIOL, V51, P461, DOI 10.1007/s12275-013-3078-9; Colburn-Clifford J, 2010, MOL PLANT MICROBE IN, V23, P1042, DOI 10.1094/MPMI-23-8-1042; Contreras-Soto RI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171105; Davidson AL, 2016, PLANT PATHOL, V65, P878, DOI 10.1111/ppa.12514; GRAU CR, 1982, PLANT DIS, V66, P506, DOI 10.1094/PD-66-506; Gunupuru LR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204992; Guyon K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-336; Huynh TT, 2010, CROP SCI, V50, P969, DOI 10.2135/cropsci2009.06.0311; Kim HS, 2000, CROP SCI, V40, P55, DOI 10.2135/cropsci2000.40155x; Kull LS, 2003, PLANT DIS, V87, P1471, DOI 10.1094/PDIS.2003.87.12.1471; Kurle JE, 2001, AGRON J, V93, P973, DOI 10.2134/agronj2001.935973x; Li YH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2049-4; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lyu XL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005435; Moellers TC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03695-9; Mueller DS, 2002, PLANT DIS, V86, P26, DOI 10.1094/PDIS.2002.86.1.26; Pan YM, 2018, PLANT SCI, V270, P37, DOI 10.1016/j.plantsci.2018.02.001; Rousseau G, 2004, CAN J PLANT SCI, V84, P615, DOI 10.4141/P03-003; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Wang JY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1249-2; Wang SB, 2016, SCI REP-UK, V6, DOI 10.1038/srep19444; Wei W, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4160-1; Wei W, 2016, AEBMR ADV ECON, V24, P117; Wen YJ, 2018, BRIEF BIOINFORM, V19, P700, DOI 10.1093/bib/bbw145; Westrick NM, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5517-4; Yan L, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3922-0; Zhao X, 2015, PLANT J, V82, P245, DOI 10.1111/tpj.12810; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096	33	6	6	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233366	10.1371/journal.pone.0233366	http://dx.doi.org/10.1371/journal.pone.0233366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421759	Green Published, gold			2022-12-26	WOS:000537499600046
J	Belay, T; Martin, E; Brown, G; Crenshaw, R; Street, J; Freeman, A; Musick, S; Kinder, TJ				Belay, Tesfaye; Martin, Elisha; Brown, Gezelle; Crenshaw, Raenel; Street, Julia; Freeman, Ashleigh; Musick, Shane; Kinder, Tyler J.			Modulation of T helper 1 and T helper 2 immune balance in a murine stress model during Chlamydia muridarum genital infection	PLOS ONE			English	Article							CD8(+) T-CELLS; TRACT INFECTION; IFN-GAMMA; BETA-2-ADRENERGIC RECEPTOR; BETA2-ADRENERGIC RECEPTOR; TRACHOMATIS INFECTION; ANIMAL-MODELS; CROSS-TALK; MICE; CYTOKINE	A murine model to study the effect of cold-induced stress (CIS) on Chlamydia muridarum genital infection and immune response has been developed in our laboratory. Previous results in the lab show that CIS increases the intensity of chlamydia genital infection, but little is known about the effects and mechanisms of CIS on the differentiation and activities of CD4+ T cell subpopulations and bone marrow-derived dendritic cells (BMDCs). The factors that regulate the production of T helper 1 (Th1) or T helper 2 (Th2) cytokines are not well defined. In this study, we examined whether CIS modulates the expressions of beta-adrenergic receptor (beta-AR), transcription factors, hallmark cytokines of Th1 and Th2, and differentiation of BMDCs during C. muridarum genital infection in the murine model. Our results show that the mRNA level of the beta2-adrenergic receptor (beta 2-AR) compared to beta 1-AR and beta 3-AR was high in the mixed populations of CD4+ T cells and BMDCs. Furthermore, we observed decreased expression of T-bet, low level of Interferon-gamma (IFN-gamma) production, increased expression of GATA-3, and Interleukin-4 (IL-4) production in CD4+ T cells of stressed mice. Exposure of BMDCs to Fenoterol, beta 2-AR agonist, or ICI118,551, beta 2-AR antagonist, revealed significant beta 2-AR stimulation or inhibition, respectively, in stressed mice. Moreover, co-culturing of mature BMDCs and naive CD4+ T cells increased the production of IL-4, IL-10, L-17, and IL-23 cytokines, suggesting that stimulation of beta 2-AR leads to the increased production of Th2 cytokines. Overall, our results show for the first time that CIS promotes the switching from a Th1 to Th2 cytokine environment. This was evidenced in the murine stress model by the overexpression of GATA-3 concurrent with elevated IL-4 production, reduced T-bet expression, and IFN-gamma secretion.	[Belay, Tesfaye; Martin, Elisha; Brown, Gezelle; Crenshaw, Raenel; Street, Julia; Freeman, Ashleigh; Musick, Shane; Kinder, Tyler J.] Bluefield State Coll, Bluefield, WV 24701 USA; [Street, Julia] Appalachian Reg Healthcare, Hinton, WV USA; [Freeman, Ashleigh] Princeton High Sch, Princeton, WV USA; [Musick, Shane] Marshall Univ, Med Sch, Huntington, WV USA; [Kinder, Tyler J.] Univ KY, Dept Mol & Cellular Biochem, Lexington, KY USA	Bluefield State College; Marshall University; University of Kentucky	Belay, T (corresponding author), Bluefield State Coll, Bluefield, WV 24701 USA.	tbelay@bluefieldstate.edu		Belay, Tesfaye/0000-0001-9055-3749	WV-INBRE of NIH [P20GM103434, 1R15AI12415601]; National Institute of Allergy and Infectious Diseases (NIAID)	WV-INBRE of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Tesfaye Belay is the only author who received the ward by the WV-INBRE of NIH Grant P20GM103434 http://www.wv-inbre.net, https://www.nigms.nih.gov/NIH grant #1R15AI12415601, https://www.nih.gov/: National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; Aviles H, 2001, NEUROIMMUNOMODULAT, V9, P6, DOI 10.1159/000049002; Avitsur R, 2015, STRESS, V18, P289, DOI 10.3109/10253890.2015.1017464; BARRON AL, 1981, J INFECT DIS, V143, P63, DOI 10.1093/infdis/143.1.63; Belay T, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx045; Belay T, 2013, J MICROBIOL IMMUNOL, V46, P330, DOI 10.1016/j.jmii.2012.06.002; Billerbeck E, 2014, IMMUNOLOGY, V143, P202, DOI 10.1111/imm.12304; Bonneau RH, 1996, BRAIN BEHAV IMMUN, V10, P139, DOI 10.1006/brbi.1996.0014; BYLUND DB, 1994, PHARMACOL REV, V46, P121; CAIN TK, 1995, INFECT IMMUN, V63, P1784, DOI 10.1128/IAI.63.5.1784-1789.1995; Center for Disease Control, 2008, NAT SURV DAT CHLAM G; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Cohen CR, 1999, SEX TRANSM INFECT, V75, P21, DOI 10.1136/sti.75.1.21; Cotter TW, 1997, INFECT IMMUN, V65, P2145, DOI 10.1128/IAI.65.6.2145-2152.1997; Darville T, 2001, INFECT IMMUN, V69, P7419, DOI 10.1128/IAI.69.12.7419-7424.2001; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; Das A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185932; De Clercq E, 2013, INFECT IMMUN, V81, P3060, DOI 10.1128/IAI.00357-13; Elenkov IJ, 1996, P ASSOC AM PHYSICIAN, V108, P374; ELLEN JM, 1995, AM J PUBLIC HEALTH, V85, P1546, DOI 10.2105/AJPH.85.11.1546; Goyarts E, 2008, EXP DERMATOL, V17, P188, DOI 10.1111/j.1600-0625.2007.00677.x; Guereschi MG, 2013, EUR J IMMUNOL, V43, P1001, DOI 10.1002/eji.201243005; Gupta R, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-84; Holland MJ, 1996, CLIN EXP IMMUNOL, V105, P429, DOI 10.1046/j.1365-2249.1996.d01-792.x; Igietseme JU, 2009, J INFECT DIS, V200, P926, DOI 10.1086/605411; JIANG CG, 1990, BRAIN BEHAV IMMUN, V4, P278, DOI 10.1016/0889-1591(90)90032-L; Johansson M, 1997, INFECT IMMUN, V65, P1032, DOI 10.1128/IAI.65.3.1032-1044.1997; Kelly KA, 2000, INFECT IMMUN, V68, P1519, DOI 10.1128/IAI.68.3.1519-1528.2000; Kim BJ, 2010, BRAIN BEHAV IMMUN, V24, P1126, DOI 10.1016/j.bbi.2010.05.003; Lafuse WP, 2017, J IMMUNOL, V198, P2383, DOI 10.4049/jimmunol.1601269; Lorton D, 2015, INT J MOL SCI, V16, P5635, DOI 10.3390/ijms16035635; Loza MJ, 2006, BLOOD, V107, P2052, DOI 10.1182/blood-2005-08-3265; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pharmtox.35.1.417; Marks E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001179; Miguel RDV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162445; Miguel RDV, 2012, MED HYPOTHESES, V79, P713, DOI 10.1016/j.mehy.2012.07.032; Mikhalkevich N, 2006, J IMMUNOL, V176, P1553, DOI 10.4049/jimmunol.176.3.1553; Moniz RJ, 2009, FEMS IMMUNOL MED MIC, V55, P226, DOI 10.1111/j.1574-695X.2008.00523.x; Mormede C, 2002, NEUROIMMUNOMODULAT, V10, P359, DOI 10.1159/000071477; Murthy AK, 2011, INFECT IMMUN, V79, P2928, DOI 10.1128/IAI.05022-11; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; Owusu-Edusei K, 2013, AM J PUBLIC HEALTH, V103, P910, DOI 10.2105/AJPH.2012.301015; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; PATTON DL, 1989, J REPROD FERTIL, V85, P647; Peine M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001633; Perry LL, 1997, J IMMUNOL, V158, P3344; Ramer-Quinn DS, 1997, J IMMUNOL, V159, P4857; Ramsey KH, 1999, INFECT IMMUN, V67, P3019, DOI 10.1128/IAI.67.6.3019-3025.1999; RAMSTEDT K, 1991, ACTA DERM-VENEREOL, P1; RANK RG, 1994, METHOD ENZYMOL, V235, P83; Reber SO, 2006, ENDOCRINOLOGY, V147, P4968, DOI 10.1210/en.2006-0347; Sanders VM, 2012, BRAIN BEHAV IMMUN, V26, P195, DOI 10.1016/j.bbi.2011.08.001; Sanders WM, 2003, BRAIN BEHAV IMMUN, V17, P55, DOI 10.1016/S0889-1591(02)00056-9; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Shao RJ, 2012, FERTIL STERIL, V98, P1175, DOI 10.1016/j.fertnstert.2012.07.1113; SHERIDAN JF, 1994, CLIN MICROBIOL REV, V7, P200, DOI 10.1128/CMR.7.2.200-212.1994; Shimizu N, 1996, AM J PHYSIOL-REG I, V271, pR537, DOI 10.1152/ajpregu.1996.271.3.R537; Simhan HN, 2003, AM J OBSTET GYNECOL, V189, P560, DOI 10.1067/S0002-9378(03)00518-0; Slota C, 2015, BRAIN BEHAV IMMUN, V46, P168, DOI 10.1016/j.bbi.2015.01.015; SOLOMON GF, 1987, J NEUROSCI RES, V18, P1, DOI 10.1002/jnr.490180103; Stamm WE, 1991, SEXUALLY TRANSMITTED, P407; SU H, 1995, INFECT IMMUN, V63, P3302, DOI 10.1128/IAI.63.9.3302-3308.1995; Swanson MA, 2001, J IMMUNOL, V166, P232, DOI 10.4049/jimmunol.166.1.232; Takenaka MC, 2016, J IMMUNOL, V196, P637, DOI 10.4049/jimmunol.1501206; TUFFREY M, 1990, J EXP PATHOL, V71, P403; Wang AY, 2013, CELL MICROBIOL, V15, P779, DOI 10.1111/cmi.12071; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; Ziemssen T, 2007, J NEUROL, V254, P8, DOI 10.1007/s00415-007-2003-8; Zieziulewicz TJ, 2013, CELL STRESS CHAPERON, V18, P279, DOI 10.1007/s12192-012-0380-0	70	5	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0226539	10.1371/journal.pone.0226539	http://dx.doi.org/10.1371/journal.pone.0226539			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1BA	32413046	Green Submitted, Green Published, gold			2022-12-26	WOS:000537496000002
J	Crichton, G; Baker, S; Guo, YF; Korhonen, A				Crichton, Gamal; Baker, Simon; Guo, Yufan; Korhonen, Anna			Neural networks for open and closed Literature-based Discovery	PLOS ONE			English	Article							POTENTIAL TREATMENTS; FISH-OIL; LRD; RAYNAUDS; TOOL	Literature-based Discovery (LBD) aims to discover new knowledge automatically from large collections of literature. Scientific literature is growing at an exponential rate, making it difficult for researchers to stay current in their discipline and easy to miss knowledge necessary to advance their research. LBD can facilitate hypothesis testing and generation and thus accelerate scientific progress. Neural networks have demonstrated improved performance on LBD-related tasks but are yet to be applied to it. We propose four graph-based, neural network methods to perform open and closed LBD. We compared our methods with those used by the state-of-the-art LION LBD system on the same evaluations to replicate recently published findings in cancer biology. We also applied them to a time-sliced dataset of human-curated peer-reviewed biological interactions. These evaluations and the metrics they employ represent performance on real-world knowledge advances and are thus robust indicators of approach efficacy. In the first experiments, our best methods performed 2-4 times better than the baselines in closed discovery and 2-3 times better in open discovery. In the second, our best methods performed almost 2 times better than the baselines in open discovery. These results are strong indications that neural LBD is potentially a very effective approach for generating new scientific discoveries from existing literature. The code for our models and other information can be found at: https://github.com/cambridgeltl/nn_for_LBD.	[Crichton, Gamal; Baker, Simon; Guo, Yufan; Korhonen, Anna] Univ Cambridge, TAL, Language Technol Lab, Cambridge, England	University of Cambridge	Crichton, G (corresponding author), Univ Cambridge, TAL, Language Technol Lab, Cambridge, England.	gkoc2@cam.ac.uk	Crichton, Gamal/AFF-8400-2022	Crichton, Gamal/0000-0002-3036-0811; Baker, Simon/0000-0002-0998-438X	Medical Research Council UK [MR/M013049/1]; Cambridge Commonwealth, European and International Trust; St.Edmund's College, University of Cambridge; MRC [MR/M013049/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Commonwealth, European and International Trust; St.Edmund's College, University of Cambridge; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by: 1. Medical Research Council UK (https://mrc.ukri.org/).Grant number MR/M013049/1]. SB and AK. 2. The Cambridge Commonwealth, European and International Trust (https://www.cambridgetrust.org/).GC.3.St.Edmund's College, University of Cambridge (https://www.st-edmunds.cam.ac.uk/).GC.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers Caroline B, 2007, AMIA Annu Symp Proc, P6; Baker S, 2016, P 5 WORKSH BUILD EV, P1; Baker S, 2017, BIOINFORMATICS, V33, P3973, DOI 10.1093/bioinformatics/btx454; Banerjee P, 2014, 2014 INTERNATIONAL CONFERENCE ON COMPUTING, MANAGEMENT AND TELECOMMUNICATIONS (COMMANTEL), P176, DOI 10.1109/ComManTel.2014.6825600; BUSCHMANN T, 2014, CANC INFORM, V15, DOI DOI 10.1186/1471-2105-15-264; Cameron D, 2015, J BIOMED INFORM, V54, P141, DOI 10.1016/j.jbi.2015.01.014; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Chen JX, 2016, ADV NEUR IN, V29; Chen W., 2009, ADV NEURAL INFORM PR, P315; Cohen T, 2010, J BIOMED INFORM, V43, P240, DOI 10.1016/j.jbi.2009.09.003; Crichton G, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2163-9; Crichton G, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1776-8; DIGIACOMO RA, 1989, AM J MED, V86, P158, DOI 10.1016/0002-9343(89)90261-1; Eronen Lauri, 2012, Bisociative Knowledge Discovery. An Introduction to Concept, Algorithms, Tools and Applications: LNCS 7250, P364, DOI 10.1007/978-3-642-31830-6_26; Gordon MD, 2008, INFORM SCI KNOWL MAN, V15, P23; Gordon MD, 1996, J AM SOC INFORM SCI, V47, P116, DOI 10.1002/(SICI)1097-4571(199602)47:2<116::AID-ASI3>3.0.CO;2-1; Goyal P, 2018, KNOWL-BASED SYST, V151, P78, DOI 10.1016/j.knosys.2018.03.022; Habibi M, 2017, BIOINFORMATICS, V33, pI37, DOI 10.1093/bioinformatics/btx228; Henry S, 2017, J BIOMED INFORM, V74, P20, DOI 10.1016/j.jbi.2017.08.011; Hristovski D, 2015, PROCEEDINGS OF THE 2015 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2015), P805, DOI 10.1145/2808797.2809300; Hristovski Dimitar, 2013, Cardiovascular & Hematological Agents in Medicinal Chemistry, V11, P14; Hristovski D, 2010, LECT N BIOINFORMAT, V6004, P53, DOI 10.1007/978-3-642-13131-8_7; Hristovski D, 2000, LECT NOTES COMPUT<D>, V1910, P446; Hunter L, 2006, MOL CELL, V21, P589, DOI 10.1016/j.molcel.2006.02.012; Kingma DP., 2014, ADAM METHOD STOCHAST; Kostoff RN, 2008, TECHNOL FORECAST SOC, V75, P226, DOI 10.1016/j.techfore.2007.11.007; Kostoff RN, 2008, TECHNOL FORECAST SOC, V75, P239, DOI 10.1016/j.techfore.2007.11.002; Kostoff RN, 2008, TECHNOL FORECAST SOC, V75, P256, DOI 10.1016/j.techfore.2007.11.009; McDonald D., 2012, JISC DIGITAL INFRAST; Murdock SH, 2008, APPLIED DEMOGRAPHY IN THE 21ST CENTURY, P3, DOI 10.1007/978-1-4020-8329-7_1; Nair V., 2010, P 27 INT C INT C MAC, P807; Oktay O., 2017, IEEE T MED IMAGING, V37, P384, DOI DOI 10.1109/TMI.2017.2743464; Preiss J, 2015, J AM MED INFORM ASSN, V22, P987, DOI 10.1093/jamia/ocv002; Pyysalo S, 2019, BIOINFORMATICS, V35, P1553, DOI 10.1093/bioinformatics/bty845; Sang ST, 2018, IEEE INT C BIOINFORM, P751, DOI 10.1109/BIBM.2018.8621423; Sebastian Y, 2017, KNOWL ENG REV, V32, P1, DOI 10.1017/S0269888917000042; Shahid N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212356; Shang N, 2014, J BIOMED INFORM, V52, P293, DOI 10.1016/j.jbi.2014.07.011; Smalheiser NR, 1996, NEUROLOGY, V47, P809, DOI 10.1212/WNL.47.3.809; Smalheiser NR, 1998, COMPUT METH PROG BIO, V57, P149, DOI 10.1016/S0169-2607(98)00033-9; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stegmann J, 2003, SCIENTOMETRICS, V56, P111, DOI 10.1023/A:1021954808804; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; SWANSON DR, 1986, LIBR QUART, V56, P103, DOI 10.1086/601720; SWANSON DR, 1990, PERSPECT BIOL MED, V33, P157; Swanson DR, 1997, ARTIF INTELL, V91, P183, DOI 10.1016/S0004-3702(97)00008-8; SWANSON DR, 1990, B MED LIBR ASSOC, V78, P29; SWANSON DR, 1988, PERSPECT BIOL MED, V31, P526; Tang J, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P1067, DOI 10.1145/2736277.2741093; Weeber M, 2000, J AM MED INFORM ASSN, P903; Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Yetisgen-Yildiz M, 2008, INFORM SCI KNOWL MAN, V15, P101; Yetisgen-Yildiz M, 2009, J BIOMED INFORM, V42, P633, DOI 10.1016/j.jbi.2008.12.001; Zeng T, 2015, IEEE DATA MINING, P579, DOI 10.1109/ICDM.2015.92; Zhang WL, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1475, DOI 10.1145/2783258.2783304	57	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232891	10.1371/journal.pone.0232891	http://dx.doi.org/10.1371/journal.pone.0232891			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1BA	32413059	Green Published, Green Submitted, gold			2022-12-26	WOS:000537496000026
J	Fischer, SC; Corujo-Simon, E; Lilao-Garzon, J; Stelzer, EHK; Munoz-Descalzo, S				Fischer, Sabine C.; Corujo-Simon, Elena; Lilao-Garzon, Joaquin; Stelzer, Ernst H. K.; Munoz-Descalzo, Silvia			The transition from local to global patterns governs the differentiation of mouse blastocysts	PLOS ONE			English	Article							INNER CELL MASS; PRIMITIVE ENDODERM FORMATION; FATE DECISIONS; TROPHECTODERM LINEAGE; SIGNALING PATHWAY; GENE-EXPRESSION; NANOG; SPECIFICATION; PLURIPOTENCY; EMBRYO	During mammalian blastocyst development, inner cell mass (ICM) cells differentiate into epiblast (Epi) or primitive endoderm (PrE). These two fates are characterized by the expression of the transcription factors NANOG and GATA6, respectively. Here, we investigate the spatio-temporal distribution of NANOG and GATA6 expressing cells in the ICM of the mouse blastocysts with quantitative three-dimensional single cell-based neighbourhood analyses. We define the cell neighbourhood by local features, which include the expression levels of both fate markers expressed in each cell and its neighbours, and the number of neighbouring cells. We further include the position of a cell relative to the centre of the ICM as a global positional feature. Our analyses reveal a local three-dimensional pattern that is already present in early blastocysts: 1) Cells expressing the highest NANOG levels are surrounded by approximately nine neighbours, while 2) cells expressing GATA6 cluster according to their GATA6 levels. This local pattern evolves into a global pattern in the ICM that starts to emerge in mid blastocysts. We show that FGF/MAPK signalling is involved in the three-dimensional distribution of the cells and, using a mutant background, we further show that the GATA6 neighbourhood is regulated by NANOG. Our quantitative study suggests that the three-dimensional cell neighbourhood plays a role in Epi and PrE precursor specification. Our results highlight the importance of analysing the three-dimensional cell neighbourhood while investigating cell fate decisions during early mouse embryonic development.	[Fischer, Sabine C.; Stelzer, Ernst H. K.] Goethe Univ Frankfurt Main, Buchmann Inst Mol Life Sci, Phys Biol, Frankfurt, Germany; [Corujo-Simon, Elena; Lilao-Garzon, Joaquin; Munoz-Descalzo, Silvia] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Lilao-Garzon, Joaquin; Munoz-Descalzo, Silvia] Univ Las Palmas Gran Canaria, Inst Univ Invest Biomed & Sanitarias, Las Palmas Gran Canaria, Spain; [Fischer, Sabine C.] Univ Wurzburg, Dept Biol, Ctr Computat & Theoret Biol, Wurzburg, Germany; [Corujo-Simon, Elena] Univ Cambridge, Jeffrey Cheah Biomed Ctr, Wellcome MRC Cambridge Stem Cell Inst, Cambridge Biomed Campus, Cambridge, England	Goethe University Frankfurt; University of Bath; Universidad de Las Palmas de Gran Canaria; University of Wurzburg; University of Cambridge	Stelzer, EHK (corresponding author), Goethe Univ Frankfurt Main, Buchmann Inst Mol Life Sci, Phys Biol, Frankfurt, Germany.; Munoz-Descalzo, S (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.; Munoz-Descalzo, S (corresponding author), Univ Las Palmas Gran Canaria, Inst Univ Invest Biomed & Sanitarias, Las Palmas Gran Canaria, Spain.	ernst.stelzer@physikalischebiologie.de; silvia.munoz@ulpgc.es	Munoz-Descalzo, Silvia/M-8094-2013; Stelzer, Ernst H K/A-7648-2011	Munoz-Descalzo, Silvia/0000-0003-0939-7721; Stelzer, Ernst H K/0000-0003-1545-0736; Fischer, Sabine C/0000-0001-7237-814X; Lilao-Garzon, Joaquin/0000-0002-9971-2459	Deutsche Forschungsgemeinschaft (DFG, CEF-MC II) [EXC-115]; University of Bath; Wellcome Trust Seed Award [109589/Z/15/Z]; Viera y Clavijo Program from ACIISI; ULPGC; Cabildo de Gran Canaria; Royal Society [IE141022]	Deutsche Forschungsgemeinschaft (DFG, CEF-MC II)(German Research Foundation (DFG)); University of Bath; Wellcome Trust Seed Award(Wellcome Trust); Viera y Clavijo Program from ACIISI; ULPGC; Cabildo de Gran Canaria; Royal Society(Royal Society of London)	Research in the AK Stelzer is supported by the Deutsche Forschungsgemeinschaft (DFG, CEF-MC II, EXC-115). Research in the Munoz-Descalzo lab (in Bath) was supported by the University of Bath and a Wellcome Trust Seed Award (109589/Z/15/Z). Research in the Munoz-Descalzo lab (in Las Palmas) is supported by the Viera y Clavijo Program from the ACIISI and the ULPGC. JL (in Las Palmas) is supported by the Cabildo de Gran Canaria and the ULPGC. SCF and SMD acknowledge the support by an International Exchanges Grant from The Royal Society (IE141022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Bassalert C, 2018, CURR TOP DEV BIOL, V128, P81, DOI 10.1016/bs.ctdb.2017.12.001; Bessonnard S, 2014, DEVELOPMENT, V141, P3637, DOI 10.1242/dev.109678; Blanchard GB, 2018, SEMIN CELL DEV BIOL; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Caiazzo M, 2016, NAT MATER, V15, P344, DOI [10.1038/nmat4536, 10.1038/NMAT4536]; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cormier S, 2006, MOL CELL BIOL, V26, P3541, DOI 10.1128/MCB.26.9.3541-3549.2006; Cormier S, 2004, GENE EXPR PATTERNS, V4, P713, DOI 10.1016/j.modgep.2004.04.003; de Mochel NSR, 2015, DEV BIOL, V397, P45, DOI 10.1016/j.ydbio.2014.10.001; Descalzo S, 2013, METHOD MOL BIOL, V1052, P109, DOI [10.1007/7651_2013_19, DOI 10.1007/7651_2013_19]; Descalzo SM, 2012, SEMIN CELL DEV BIOL, V23, P443, DOI 10.1016/j.semcdb.2012.01.012; Dietrich JE, 2015, EMBO REP, V16, P1005, DOI 10.15252/embr.201540162; Ebisuya M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.164368; Evans JD., 1996, STRAIGHTFORWARD STAT; Fabreges D, CONTROL INNER CELLS, DOI [10.1242/dev.152041, DOI 10.1242/DEV.152041]; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; Freyer L, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0086-5; Frum T, 2019, VISUALIZING HIPPO SI, P335, DOI [10.1007/978-1-4939-8910-2_25, DOI 10.1007/978-1-4939-8910-2_25]; Gerbe F, 2008, DEV BIOL, V313, P594, DOI 10.1016/j.ydbio.2007.10.048; Goodwin LD, 2006, J EXP EDUC, V74, P251, DOI 10.3200/jexe.74.3.249-266; Grabarek JB, 2012, DEVELOPMENT, V139, P129, DOI 10.1242/dev.067702; Graham SJL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6667; Guignard L., 2017, BIORXIV, DOI [10.1101/238741, DOI 10.1101/238741]; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; GURDON JB, 1988, NATURE, V336, P772, DOI 10.1038/336772a0; Hashimoto M, 2019, DEV CELL, V50, P138, DOI 10.1016/j.devcel.2019.05.024; Kang MJ, 2017, DEV CELL, V41, P496, DOI 10.1016/j.devcel.2017.05.003; Kang MJ, 2013, DEVELOPMENT, V140, P267, DOI 10.1242/dev.084996; Kim SH, 2014, STEM CELL RES, V13, P1, DOI 10.1016/j.scr.2014.04.001; Kiyonari H, 2019, GENESIS, V57, DOI 10.1002/dvg.23277; Krupinski P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001128; Lavial F, 2012, GENE DEV, V26, P1445, DOI 10.1101/gad.188193.112; Le Bin GC, 2014, DEVELOPMENT, V141, P1001, DOI 10.1242/dev.096875; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liebisch T, 2019, BIORXIV, DOI [10.1101/698928, DOI 10.1101/698928]; Lorthongpanich C, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127803; Lou XH, 2014, STEM CELL REP, V2, P382, DOI 10.1016/j.stemcr.2014.01.010; Mathew B, 2019, BIOPHYS J, V116, P127, DOI 10.1016/j.bpj.2018.11.011; McDole K, 2018, CELL, V175, P859, DOI 10.1016/j.cell.2018.09.031; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Meilhac SM, 2009, DEV BIOL, V331, P210, DOI 10.1016/j.ydbio.2009.04.036; Meng Y, 2018, DEV BIOL, V436, P55, DOI 10.1016/j.ydbio.2018.02.007; Messerschmidt D, 2016, DEVELOPMENT, V143, P1993, DOI 10.1242/dev.133439; Messerschmidt DM, 2010, DEV BIOL, V344, P129, DOI 10.1016/j.ydbio.2010.04.020; Mihajlovic AI, 2015, SCI REP-UK, V5, DOI 10.1038/srep15034; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Mohammed H, 2017, CELL REP, V20, P1215, DOI 10.1016/j.celrep.2017.07.009; Molotkov A, 2017, DEV CELL, V41, P511, DOI 10.1016/j.devcel.2017.05.004; Morgani SM, 2018, DEV BIOL, V441, P104, DOI 10.1016/j.ydbio.2018.06.017; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Descalzo SM, 2012, STEM CELLS, V30, P2683, DOI 10.1002/stem.1230; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Ohnishi Y, 2014, NAT CELL BIOL, V16, P27, DOI 10.1038/ncb2881; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Posfai E, 2017, ELIFE, V6, DOI 10.7554/eLife.22906; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rayon T, 2014, DEV CELL, V30, P410, DOI 10.1016/j.devcel.2014.06.019; Rivron NC, 2018, NATURE, V557, P106, DOI 10.1038/s41586-018-0051-0; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Saiz N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13463; Saiz N, 2015, SEMIN CELL DEV BIOL, V47-48, P92, DOI 10.1016/j.semcdb.2015.06.004; Saiz N, 2013, DEVELOPMENT, V140, P4311, DOI 10.1242/dev.093922; Schmitz A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43693; Scholpp S, 2004, CURR BIOL, V14, P1834, DOI 10.1016/j.cub.2004.09.084; Schrode N, 2015, NIH, P29, DOI [10.1016/j.devcel.2014.04.011, DOI 10.1016/J.DEVCEL.2014.04.011]; Schroter C, 2015, DEVELOPMENT, V142, P4205, DOI 10.1242/dev.127530; Sharpe J, 2017, DEVELOPMENT, V144, P4214, DOI 10.1242/dev.151274; Shimokawa K, 2011, DEV CELL, V21, P257, DOI 10.1016/j.devcel.2011.06.027; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Simon CS, 2018, BIOL OPEN, V7, DOI 10.1242/bio.036517; Simon CS, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.319; Sozen B, 2015, MECH DEVELOP, V138, P375, DOI 10.1016/j.mod.2015.05.002; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tosenberger A, 2017, NPJ SYST BIOL APPL, V3, DOI 10.1038/s41540-017-0017-0; Wamaitha SE, 2015, GENE DEV, V29, P1239, DOI 10.1101/gad.257071.114; Wigger M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15427-0; Xenopoulos P, 2015, CELL REP, V10, P1508, DOI 10.1016/j.celrep.2015.02.010; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	83	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233030	10.1371/journal.pone.0233030	http://dx.doi.org/10.1371/journal.pone.0233030			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413083	Green Published, gold			2022-12-26	WOS:000537496000039
J	Rognvaldsdottir, V; Brychta, RJ; Hrafnkelsdottir, SM; Chen, KY; Arngrimsson, SA; Johannsson, E; Gudmundsdottir, SL				Rognvaldsdottir, Vaka; Brychta, Robert J.; Hrafnkelsdottir, Soffia M.; Chen, Kong Y.; Arngrimsson, Sigurbjorn A.; Johannsson, Erlingur; Gudmundsdottir, Sigridur L.			Less physical activity and more varied and disrupted sleep is associated with a less favorable metabolic profile in adolescents	PLOS ONE			English	Article							BODY-COMPOSITION; RISK-FACTORS; DURATION; CHILDREN; OBESITY; WRIST; FAT; VARIABILITY; RESISTANCE; YOUTH	Background Sleep and physical activity are modifiable behaviors that play an important role in preventing overweight, obesity, and metabolic health problems. Studies of the association between concurrent objective measures of sleep, physical activity, and metabolic risk factors among adolescents are limited. Objective The aim of the study was to examine the association between metabolic risk factors and objectively measured school day physical activity and sleep duration, quality, onset, and variability in adolescents. Materials and methods We measured one school week of free-living sleep and physical activity with wrist actigraphy in 252 adolescents (146 girls), aged 15.8 +/- 0.3 years. Metabolic risk factors included body mass index, waist circumference, total body and trunk fat percentage, resting blood pressure, and fasting glucose and insulin levels. Multiple linear regression adjusted for sex, parental education, and day length was used to assess associations between metabolic risk factors and sleep and activity parameters. Results On average, participants went to bed at 00:22 +/- 0.88 hours and slept 6.2 +/- 0.7 hours/night, with 0.83 +/- 0.36 hours of awakenings/night. However, night-to-night variability in sleep duration was considerable (mean +/- interquartile range) 0.75 +/- 0.55 hours) and bedtime (0.64 +/- 0.53 hours) respectively. Neither average sleep duration nor mean bedtime was associated with any metabolic risk factors. However, greater night-to-night variability in sleep duration and bedtime was associated with higher total body and trunk fat percentage, and less physical activity was associated with higher trunk fat percentage and insulin levels. Conclusion Greater nightly variation in sleep duration and in bedtime and less physical activity were associated with a less favorable metabolic profile in adolescents. These findings support the idea that, along with an adequate amount of physical activity, a regular sleep schedule is important for the metabolic health of adolescents.	[Rognvaldsdottir, Vaka; Hrafnkelsdottir, Soffia M.; Arngrimsson, Sigurbjorn A.; Johannsson, Erlingur; Gudmundsdottir, Sigridur L.] Univ Iceland, Ctr Sport & Hlth Sci, Reykjavik, Iceland; [Brychta, Robert J.; Chen, Kong Y.] Natl Inst Diabet & Digest & Kidney Dis, Diabet Endocrinol & Obes Branch, Bethesda, MD USA; [Johannsson, Erlingur] Western Norway Univ Appl Sci, Dept Sport & Phys Act, Bergen, Norway	University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Western Norway University of Applied Sciences	Gudmundsdottir, SL (corresponding author), Univ Iceland, Ctr Sport & Hlth Sci, Reykjavik, Iceland.	vakar@hi.is	Rögnvaldsdóttir, Vaka/AAR-2000-2020	Rögnvaldsdóttir, Vaka/0000-0003-4244-3152; Brychta, Robert/0000-0001-9491-7968	Icelandic Centre for Research (RANNIS)	Icelandic Centre for Research (RANNIS)	VR had financial support by The Icelandic Centre for Research (RANNIS) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli A, 2009, RADIOL MED, V114, P286, DOI 10.1007/s11547-009-0369-7; [Anonymous], 2020, BACKGROUND; Arora T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072406; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bin YS, 2012, AUST NZ J PUBL HEAL, V36, P462, DOI 10.1111/j.1753-6405.2012.00845.x; Bonanno L, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017642; Brychta RJ, 2016, J CLIN SLEEP MED, V12, P203, DOI 10.5664/jcsm.5486; Burt J, 2014, SLEEP MED, V15, P71, DOI 10.1016/j.sleep.2013.07.015; Cali AMG, 2009, HORM RES, V71, P2, DOI 10.1159/000178028; Chaput JP, 2016, J SLEEP RES, V25, P541, DOI 10.1111/jsr.12410; COLLEY RC, 2018, HLTH REP, V29, P3; Dezenberg CV, 1999, INT J OBESITY, V23, P253, DOI 10.1038/sj.ijo.0800802; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Fusch C, 1999, PEDIATR RES, V46, P465, DOI 10.1203/00006450-199910000-00018; Garaulet M, 2011, INT J OBESITY, V35, P1308, DOI 10.1038/ijo.2011.149; Garaulet M, 2009, CURR OPIN LIPIDOL, V20, P127, DOI 10.1097/MOL.0b013e3283292399; Golley RK, 2013, INT J OBESITY, V37, P546, DOI 10.1038/ijo.2012.212; He F, 2015, SLEEP MED, V16, P1489, DOI 10.1016/j.sleep.2015.07.028; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P233, DOI 10.1016/j.sleh.2015.10.004; Hrafnkelsdottir SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196286; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Iceland S., 2018, POPULATION INHABITAN; Knutson KL, 2009, J PEDIATR-US, V154, P426, DOI 10.1016/j.jpeds.2008.08.035; Lang C, 2016, SLEEP MED REV, V28, P32, DOI 10.1016/j.smrv.2015.07.004; Lee S, 2013, AM J PHYSIOL-ENDOC M, V305, pE1222, DOI 10.1152/ajpendo.00285.2013; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Magnusson KT, 2012, HEALTH EDUC RES, V27, P484, DOI 10.1093/her/cys049; Martin JL, 2011, CHEST, V139, P1514, DOI 10.1378/chest.10-1872; Matthews KA, 2014, PEDIATRICS, V133, pE1189, DOI 10.1542/peds.2013-2399; Matthews KA, 2012, SLEEP, V35, P1353, DOI 10.5665/sleep.2112; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; Mi SJ, 2019, PEDIATR OBES, V14, DOI 10.1111/ijpo.12507; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Morelli C, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030742; Nedeltcheva AV, 2014, CURR OPIN ENDOCRINOL, V21, P293, DOI 10.1097/MED.0000000000000082; Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x; Pacheco SR, 2017, ARCH ENDOCRIN METAB, V61, P367, DOI 10.1590/2359-3997000000265; Patterson KAE, 2020, PREV MED, V130, DOI 10.1016/j.ypmed.2019.105861; Poitras VJ, 2016, APPL PHYSIOL NUTR ME, V41, pS197, DOI 10.1139/apnm-2015-0663; Powell KE, 2019, J PHYS ACT HEALTH, V16, P1, DOI 10.1123/jpah.2018-0618; Rich C, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-49; Ripka WL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228646; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Rognvaldsdottir V, 2018, LAEKNABLADID, V104, P79, DOI [10.17992/lbl.2018.02.173, 10.17902/lbl.2018.02.173]; Rognvaldsdottir V, 2017, SLEEP MED, V33, P103, DOI 10.1016/j.sleep.2016.12.028; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Seo SH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45951-0; Short MA, 2012, SLEEP MED, V13, P378, DOI 10.1016/j.sleep.2011.11.005; Sivertsen B, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-204; Spruyt K, 2011, PEDIATRICS, V127, pE345, DOI 10.1542/peds.2010-0497; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; World Health Organization, 2018, OB OV; Wu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16686; Zhou M, 2018, OBES SCI PRACT, V4, P535, DOI 10.1002/osp4.303; Zinkhan M, 2014, SLEEP MED, V15, P1107, DOI 10.1016/j.sleep.2014.04.015	57	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0229114	10.1371/journal.pone.0229114	http://dx.doi.org/10.1371/journal.pone.0229114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413039	Green Published, Green Submitted, gold			2022-12-26	WOS:000537496000006
J	Smythe, T; Nogaro, MC; Clifton, LJ; Mudariki, D; Theologis, T; Lavy, C				Smythe, Tracey; Nogaro, Marie-Caroline; Clifton, Laura J.; Mudariki, Debra; Theologis, Tim; Lavy, Chris			Remote monitoring of clubfoot treatment with digital photographs in low resource settings: Is it accurate?	PLOS ONE			English	Article							IDIOPATHIC CLUBFOOT; PONSETI METHOD; MANIPULATION	Background Clinical examination and functional assessment are often the first steps to assess outcome of clubfoot treatment. Clinical photographs may be an adjunct used to assess treatment outcomes in lower resourced settings where physical review by a specialist is limited. We aimed to evaluate the diagnostic performance of photographic images of patients with clubfoot in assessing outcome following treatment. Methods In this single-centre diagnostic accuracy study, we included all children with clubfoot from a cohort treated between 2011 and 2013, in 2017. Two physiotherapists trained in clubfoot management calculated the Assessing Clubfoot Treatment (ACT) score for each child to decide if treatment was successful or if further treatment was required. Photographic images were then taken of 79 feet. Two blinded orthopaedic surgeons assessed three sets of images of each foot (n = 237 in total) at two time points (two months apart). Treatment for each foot was rated as 'success', 'borderline' or 'failure'. Intra- and inter-observer variation for the photographic image was assessed. Sensitivity, specificity, positive and negative predictive values were calculated for the photographic image compared to the ACT score. Results There was perfect correlation between clinical assessment and photographic evaluation of both raters at both time-points in 38 (48%) feet. The raters demonstrated acceptable reliability with re-scoring photographs (rater 1, k = 0.55; rater 2, k = 0.88). Thirty percent (n = 71) of photographs were assessed as poor quality image or sub-optimal patient position. Sensitivity of outcome with photograph compared to ACT score was 83.3%-88.3% and specificity ranged from 57.9%-73.3%. Conclusion Digital photography may help to confirm, but not exclude, success of clubfoot treatment. Future work to establish photographic parameters as an adjunct to assessing treatment outcomes, and guidance on a standardised protocol for photographs, may be beneficial in the follow up of children who have treated clubfoot in isolated communities or lower resourced settings.	[Smythe, Tracey] London Sch Hyg & Trop Med, London, England; [Nogaro, Marie-Caroline; Theologis, Tim] Oxford Univ Hosp NHS Trust, Nuffield Orthopaed Ctr, Paediat Orthopaed Surg, Oxford, England; [Clifton, Laura J.] James Cook Univ Hosp, South Tees Hosp NHS Fdn Trust, Middlesbrough, Cleveland, England; [Mudariki, Debra] Univ Witwatersrand, Fac Hlth Sci, Physiotherapy Dept, Johannesburg, South Africa; [Lavy, Chris] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; Nuffield Orthopaedic Centre; Oxford University Hospitals NHS Foundation Trust; James Cook University Hospital; University of Witwatersrand; University of Oxford	Smythe, T (corresponding author), London Sch Hyg & Trop Med, London, England.	tracey.smythe@lshtm.ac.uk	Smythe, Tracey/N-7699-2017	Smythe, Tracey/0000-0003-3408-7362				ANDERSEN JA, 2020, TELEMED J E-HEALTH, P92459, DOI DOI 10.1089/TMJ.2018.0213; Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799; COOPER DM, 1995, J BONE JOINT SURG AM, V77, P1477, DOI 10.2106/00004623-199510000-00002; Dobbs MB, 2012, J PEDIATR ORTHOP B, V21, P7, DOI 10.1097/BPB.0b013e328349927c; Evans AM, 2016, J FOOT ANKLE RES, V9, DOI 10.1186/s13047-016-0175-0; Han XT, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.4.27; Joy H, 2015, J WOUND CARE, V24, P312, DOI 10.12968/jowc.2015.24.7.312; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Nunn TR, 2018, STRATEG TRAUMA LIMB, V13, P171, DOI 10.1007/s11751-018-0324-z; Ponseti IV, 2006, CLIN ORTHOP RELAT R, P171, DOI 10.1097/01.blo.0000224062.39990.48; Smythe T, 2019, J FOOT ANKLE RES, V12, DOI 10.1186/s13047-019-0323-4; Smythe T, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2365-3; Smythe T, 2017, TROP MED INT HEALTH, V22, P269, DOI 10.1111/tmi.12833; Smythe T, 2016, TROP MED INT HEALTH, V21, P1311, DOI 10.1111/tmi.12750; Solis G, 2000, FOOT ANKLE SURG, V6, P145; Tindall AJ, 2005, J PEDIATR ORTHOPED, V25, P627, DOI 10.1097/01.bpo.0000164876.97949.6b; Zhao L, 2019, J PEDIATR-US, V213, P203, DOI 10.1016/j.jpeds.2019.06.021	17	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232878	10.1371/journal.pone.0232878	http://dx.doi.org/10.1371/journal.pone.0232878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413066	Green Published, Green Accepted, gold			2022-12-26	WOS:000537496000025
J	Karakas, N; Bay, S; Turkel, N; Oztunc, N; Oncul, M; Bilgen, H; Shah, K; Sahin, F; Ozturk, G				Karakas, Nihal; Bay, Sadik; Turkel, Nezaket; Oztunc, Nursah; Oncul, Merve; Bilgen, Hulya; Shah, Khalid; Sahin, Fikrettin; Ozturk, Gurkan			Neurons from human mesenchymal stem cells display both spontaneous and stimuli responsive activity	PLOS ONE			English	Article							MARROW STROMAL CELLS; PROMISING CANDIDATE; NEUROTROPHIC FACTOR; IN-VITRO; DIFFERENTIATION; PLASTICITY	Mesenchymal stem cells have the ability to transdifferentiate into neurons and therefore one of the potential adult stem cell source for neuronal tissue regeneration applications and understanding neurodevelopmental processes. In many studies on human mesenchymal stem cell (hMSC) derived neurons, success in neuronal differentiation was limited to neuronal protein expressions which is not statisfactory in terms of neuronal activity. Established neuronal networks seen in culture have to be investigated in terms of synaptic signal transmission ability to develop a culture model for human neurons and further studying the mechanism of neuronal differentiation and neurological pathologies. Accordingly, in this study, we analysed the functionality of bone marrow hMSCs differentiated into neurons by a single step cytokine-based induction protocol. Neurons from both primary hMSCs and hMSC cell line displayed spontaneous activity (>= 75%) as demonstrated by Ca++ imaging. Furthermore, when electrically stimulated, hMSC derived neurons (hMd-Neurons) matched the response of a typical neuron in the process of maturation. Our results reveal that a combination of neuronal inducers enhance differentiation capacity of bone marrow hMSCs into high yielding functional neurons with spontaneous activity and mature into electrophysiologically active state. Conceptually, we suggest these functional hMd-Neurons to be used as a tool for disease modelling of neuropathologies and neuronal differentiation studies.	[Karakas, Nihal] Istanbul Medipol Univ, Sch Med, Med Biol Dept, Istanbul, Turkey; [Karakas, Nihal; Bay, Sadik; Oztunc, Nursah; Oncul, Merve; Ozturk, Gurkan] Istanbul Medipol Univ, Res Inst Hlth Sci & Technol SABITA, Regenerat & Restorat Med Res Ctr REMER, Istanbul, Turkey; [Turkel, Nezaket; Sahin, Fikrettin] Yeditepe Univ, Genet & Bioengn Dept, Fac Engn, Istanbul, Turkey; [Oztunc, Nursah] Istanbul Medipol Univ, Grad Sch Hlth Sci, Med Biol & Genet Program, Istanbul, Turkey; [Bilgen, Hulya] Istanbul Medipol Univ Hosp, Ctr Bone Marrow Transplantat, Istanbul, Turkey; [Shah, Khalid] Harvard Med Sch, Brigham & Womans Hosp, Ctr Stem Cell Therapeut & Imaging, Boston, MA 02115 USA; [Ozturk, Gurkan] Istanbul Medipol Univ, Int Sch Med, Physiol Dept, Istanbul, Turkey	Istanbul Medipol University; Istanbul Medipol University; Yeditepe University; Istanbul Medipol University; Istanbul Medipol University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Istanbul Medipol University	Karakas, N (corresponding author), Istanbul Medipol Univ, Sch Med, Med Biol Dept, Istanbul, Turkey.; Karakas, N (corresponding author), Istanbul Medipol Univ, Res Inst Hlth Sci & Technol SABITA, Regenerat & Restorat Med Res Ctr REMER, Istanbul, Turkey.	nkarakas@medipol.edu.tr	Ozturk, Gurkan/AAE-1401-2019; Bay, Sadık/ABB-7452-2020	Bay, Sadık/0000-0001-8089-1330; Oncul, Merve/0000-0002-7679-3479; Turkel, Nezaket/0000-0002-4480-7282	Istanbul Medipol University Scientific Research Projects Committee [2019-14]; Yeditepe University, Genetics and Bioengineering Department	Istanbul Medipol University Scientific Research Projects Committee; Yeditepe University, Genetics and Bioengineering Department(Yeditepe University)	This study was supported by Istanbul Medipol University Scientific Research Projects Committee with project number 2019-14 (N.K.) and Yeditepe University, Genetics and Bioengineering Department (N.T.).	Abouelfetouh A, 2004, BRAIN RES, V1029, P114, DOI 10.1016/j.brainres.2004.07.092; Belinsky GS, 2014, STEM CELL RES, V12, P101, DOI 10.1016/j.scr.2013.09.014; Boulanger-Weill J, 2017, CURR BIOL, V27, P1707, DOI 10.1016/j.cub.2017.05.029; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Cano E, 2017, CELL STEM CELL, V20, P296, DOI 10.1016/j.stem.2017.02.005; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen Y, 2008, INT J BIOCHEM CELL B, V40, P815, DOI 10.1016/j.biocel.2008.01.007; Cortes-Medina LV, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/7627148; Davila HM, 1999, ANN NY ACAD SCI, V868, P102, DOI 10.1111/j.1749-6632.1999.tb11281.x; DiMarino AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00201; Fakhry Maya, 2013, World J Stem Cells, V5, P136, DOI 10.4252/wjsc.v5.i4.136; Lambert APF, 2009, DIFFERENTIATION, V77, P221, DOI 10.1016/j.diff.2008.10.016; George S, 2019, STEM CELL REV REP, V15, P814, DOI 10.1007/s12015-019-09917-z; Goparaju SK, 2017, SCI REP-UK, V7, DOI 10.1038/srep42367; Gordon David, 2009, V549, P103, DOI 10.1007/978-1-60327-931-4_8; Grade S, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0033-0; Gustafsson E, 2003, EUR J NEUROSCI, V17, P2667, DOI 10.1046/j.1460-9568.2003.02713.x; Han Y, 2019, CELLS, V8; Hayashi T, 2013, J CLIN INVEST, V123, P272, DOI 10.1172/JCI62516; Hermann A, 2006, J NEUROSCI RES, V83, P1502, DOI 10.1002/jnr.20840; Hernandez R, 2020, BIOMOL THER, V28, P34, DOI 10.4062/biomolther.2019.065; Hess DC, 2008, CELL PROLIFERAT, V41, P94, DOI 10.1111/j.1365-2184.2008.00486.x; Imaizumi K, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00027; Irion S, 2017, MOL THER-METH CLIN D, V4, P72, DOI 10.1016/j.omtm.2016.11.005; Irwin RP, 2013, JOVE-J VIS EXP, DOI 10.3791/50794; Johansson PA, 2010, CURR OPIN NEUROBIOL, V20, P400, DOI 10.1016/j.conb.2010.04.003; Khoo MLM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019025; Lee YJ, 2018, J BIOMED MATER RES A, V106, P43, DOI 10.1002/jbm.a.36215; Lindsay SL, 2017, NEUROCHEM INT, V106, P101, DOI 10.1016/j.neuint.2016.08.001; Long XX, 2005, STEM CELLS DEV, V14, P65, DOI 10.1089/scd.2005.14.65; Luhmann HJ, 2016, FRONT NEURAL CIRCUIT, V10, DOI [10.3389/fneir.2016.00040, 10.3389/fncir.2016.00040]; Montzka K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-16; Neirinckx V, 2013, TRENDS CELL SIGNALIN, P327; Ouyang KF, 2005, P NATL ACAD SCI USA, V102, P12259, DOI 10.1073/pnas.0408494102; Paavilainen T, 2018, STEM CELL RES, V27, P151, DOI 10.1016/j.scr.2018.01.018; Park J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04632-6; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raedt R, 2007, EXP NEUROL, V203, P542, DOI 10.1016/j.expneurol.2006.09.016; Scuteri A, 2011, CURR STEM CELL RES T, V6, P82, DOI 10.2174/157488811795495486; Shall G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030720; Singh M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11028-z; Song CG, 2018, NEURAL REGEN RES, V13, P1294, DOI 10.4103/1673-5374.235085; Takeda YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135111; Taran R, 2014, J BIOSCIENCES, V39, P157, DOI 10.1007/s12038-013-9409-5; Tio M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009398; Ullah I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150025; VANOOYEN A, 1994, PROG BRAIN RES, V102, P245; Wei ZJ, 2019, NEURAL REGEN RES, V14, P1462, DOI 10.4103/1673-5374.253532; Winnubst J, 2015, NEURON, V87, P399, DOI 10.1016/j.neuron.2015.06.029; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yu JH, 2014, ANIM CELLS SYST, V18, P17, DOI 10.1080/19768354.2013.877076; Zhang J, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0240-9	54	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0228510	10.1371/journal.pone.0228510	http://dx.doi.org/10.1371/journal.pone.0228510			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407317	Green Submitted, Green Published, gold			2022-12-26	WOS:000537490700004
J	Horvath, G; Pereszlenyi, A; Egri, A; Toth, T; Janosi, IM				Horvath, Gabor; Pereszlenyi, Adam; Egri, Adam; Toth, Timea; Janosi, Imre Miklos			Why do biting horseflies prefer warmer hosts? tabanids can escape easier from warmer targets	PLOS ONE			English	Article							BOX TRAPS; DIPTERA; FLIES; POLARIZATION; ATTRACTIVENESS; EFFICIENCY; ADVANTAGE; SURFACES; CO2	Blood-sucking horseflies (tabanids) prefer warmer (sunlit, darker) host animals and generally attack them in sunshine, the reason for which was unknown until now. Recently, it was hypothesized that blood-seeking female tabanids prefer elevated temperatures, because their wing muscles are quicker and their nervous system functions better at a warmer body temperature brought about by warmer microclimate, and thus they can more successfully avoid the host's parasite-repelling reactions by prompt takeoffs. To test this hypothesis, we studied in field experiments the success rate of escape reactions of tabanids that landed on black targets as a function of the target temperature, and measured the surface temperature of differently coloured horses with thermography. We found that the escape success of tabanids decreased with decreasing target temperature, that is escape success is driven by temperature. Our results explain the behaviour of biting horseflies that they prefer warmer hosts against colder ones. Since in sunshine the darker the host the warmer its body surface, our results also explain why horseflies prefer sunlit dark (brown, black) hosts against bright (beige, white) ones, and why these parasites attack their hosts usually in sunshine, rather than under shaded conditions.	[Horvath, Gabor; Pereszlenyi, Adam; Toth, Timea] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Pereszlenyi, Adam] Hungarian Nat Hist Museum, Dept Zool, Budapest, Hungary; [Egri, Adam] Danube Res Inst, MTA Ctr Ecol Res, Budapest, Hungary; [Egri, Adam] MTA Ctr Ecol Res, Evolutionary Syst Res Grp, Tihany, Hungary; [Janosi, Imre Miklos] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Eotvos Lorand University	Horvath, G (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary.	gh@arago.elte.hu		Horvath, Gabor/0000-0002-9008-2411	Hungarian National Research, Development and Innovation Office [NKFIH K-123930]; Economic Development and Innovation Operational Programme [GINOP-2.3.2-15-2016-00057]; Hungarian Academy of Sciences; NKFIH [PD-131738]	Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Economic Development and Innovation Operational Programme; Hungarian Academy of Sciences(Hungarian Academy of Sciences); NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary)	This work was supported by the grant NKFIH K-123930 (Experimental Study of the Functions of Zebra Stripes: A New Thermophysiological Explanation) received by Ga ' bor Horva ' th from the Hungarian National Research, Development and Innovation Office. A ' da ' m Egri was supported by the Economic Development and Innovation Operational Programme (GINOP-2.3.2-15-2016-00057), the grant NKFIH PD-131738 and the Ja ' nos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benesch Annette R., 2003, Zoologische Garten, V73, P74; Benesch Annette Rabea, 2006, Natur und Museum (Frankfurt am Main), V136, P49; Blaho M, 2013, PHYSIOL BEHAV, V119, P168, DOI 10.1016/j.physbeh.2013.06.013; Blaho M, 2012, VET PARASITOL, V189, P353, DOI 10.1016/j.vetpar.2012.04.016; Blaho M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041138; Caro Tim, 2016, ZEBRA STRIPES; CATTS EP, 1970, MOSQ NEWS, V30, P472; CENA K., 1966, Acta Agraria et Silvestria, Ser. Zootechnica, V6, P93; CENA K, 1973, J MAMMAL, V54, P1005; Cobb A, 2019, J NAT HIST, V53, P863, DOI 10.1080/00222933.2019.1607600; Egri A, 2013, B ENTOMOL RES, V103, P665, DOI 10.1017/S0007485313000357; Egri A, 2013, INT J PARASITOL, V43, P555, DOI 10.1016/j.ijpara.2013.02.002; Egri A, 2012, NATURWISSENSCHAFTEN, V99, P407, DOI 10.1007/s00114-012-0916-2; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; Elzinga R. J., 2003, FUNDAMENTALS ENTOMOL; Heinrich B., 1993, The hot-blooded insects: strategies and mechanisms of thermoregulation.; Herczeg T, 2015, PARASITOL RES, V114, P1087, DOI 10.1007/s00436-014-4280-3; Herczeg T, 2014, PARASITOL RES, V113, P4251, DOI 10.1007/s00436-014-4103-6; Horvath G., 2014, POLARIZED LIGHT POLA; Horvath G, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.191119; Horvath G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27637-1; Horvath G, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170735; Horvath G, 2010, P ROY SOC B-BIOL SCI, V277, P1643, DOI 10.1098/rspb.2009.2202; Krcmar S, 2014, PARASITE, V21, DOI 10.1051/parasite/2014068; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Lendzele SS, 2019, J ASIA-PAC ENTOMOL, V22, P1019, DOI 10.1016/j.aspen.2019.08.012; Mcgavin George C., 2001, ESSENTIAL ENTOMOLOGY; Meglic A, 2019, P NATL ACAD SCI USA, V116, P21843, DOI 10.1073/pnas.1910807116; Otartics Mate Zsolt, 2019, Natura Croatica, V28, P51, DOI 10.30302/NC.2019.28.5; R Core Team, 2021, R LANGUAGE ENV STAT; ROBERTS RH, 1977, MOSQ NEWS, V37, P169; TASHIRO H, 1953, J ECON ENTOMOL, V46, P813, DOI 10.1093/jee/46.5.813; THORSTEINSON AJ, 1966, CAN J ZOOLOG, V44, P275, DOI 10.1139/z66-026; WALL WJ, 1980, ENVIRON ENTOMOL, V9, P371, DOI 10.1093/ee/9.4.371	34	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0233038	10.1371/journal.pone.0233038	http://dx.doi.org/10.1371/journal.pone.0233038			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401816	gold, Green Accepted, Green Published			2022-12-26	WOS:000537481000050
J	Verma, V; Vishwakarma, RK; Verma, A; Nath, DC; Khan, HTA				Verma, Vivek; Vishwakarma, Ramesh K.; Verma, Anita; Nath, Dilip C.; Khan, Hafiz T. A.			Time-to-Death approach in revealing Chronicity and Severity of COVID-19 across the World	PLOS ONE			English	Article								Background The outbreak of coronavirus disease, 2019 (COVID-19), which started from Wuhan, China, in late 2019, have spread worldwide. A total of 5,91,971 cases and 2,70,90 deaths were registered till 28th March, 2020. We aimed to predict the impact of duration of exposure to COVID-19 on the mortality rates increment. Methods In the present study, data on COVID-19 infected top seven countries viz., Germany, China, France, United Kingdom, Iran, Italy and Spain, and World as a whole, were used for modeling. The analytical procedure of generalized linear model followed by Gompertz link function was used to predict the impact lethal duration of exposure on the mortality rates. Findings Of the selected countries and World as whole, the projection based on 21st March, 2020 cases, suggest that a total (95% Cl) of 76 (65-151) days of exposure in Germany, mortality rate will increase by 5 times to 1%. In countries like France and United Kingdom, our projection suggests that additional exposure of 48 days and 7 days, respectively, will raise the mortality rates to10%. Regarding Iran, Italy and Spain, mortality rate will rise to 10% with an additional 3-10 days of exposure. World's mortality rates will continue increase by 1% in every three weeks. The predicted interval of lethal duration corresponding to each country has found to be consistent with the mortality rates observed on 28th March, 2020. Conclusion The prediction of lethal duration was found to have apparently effective in predicting mortality, and shows concordance with prevailing rates. In absence of any vaccine against COVID-19 infection, the present study adds information about the quantum of the severity and time elapsed to death will help the Government to take necessary and appropriate steps to control this pandemic.	[Verma, Vivek; Verma, Anita] All India Inst Med Sci AIIMS, Dept Neurol, New Delhi, India; [Vishwakarma, Ramesh K.] King Saud bin Abdulaziz Univ Hlth Sci MNGHA, King Abdullah Int Med Res Ctr, Dept Biostat & Bioinformat, Riyadh, Saudi Arabia; [Nath, Dilip C.] Assam Univ, Silchar, Assam, India; [Khan, Hafiz T. A.] Univ West London, Grad Sch, London, England	All India Institute of Medical Sciences (AIIMS) New Delhi; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Assam University	Verma, V (corresponding author), All India Inst Med Sci AIIMS, Dept Neurol, New Delhi, India.	viv_verma456@yahoo.com		Vishwakarma, Ramesh/0000-0003-2458-2802; VERMA, VIVEK/0000-0003-2537-4431				Annelies Wilder-Smith, 2020, J TRAVEL MED, V27; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Liu Y, 2020, J TRAVEL MED; Notomi T, 1999, CHEMOTHERAPY, V45, P242, DOI 10.1159/000007192; Padmanaban V, 2020, CUREUS, V12, DOI 10.7759/cureus.7398; Peeri Noah C., 2020, INT J EPIDEMIOLOGY; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Wang HP, 2020, LANCET ONCOL, V21, pE181, DOI 10.1016/S1470-2045(20)30149-2; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1	13	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0233074	10.1371/journal.pone.0233074	http://dx.doi.org/10.1371/journal.pone.0233074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396542	Green Accepted, Green Published, gold			2022-12-26	WOS:000537475000041
J	Akilimali, PZ; Hernandez, J; Anglewicz, P; Kayembe, KP; Bertrand, J				Akilimali, P. Z.; Hernandez, J.; Anglewicz, P.; Kayembe, K. P.; Bertrand, J.			Incidence and determinants of Implanon discontinuation: Findings from a prospective cohort study in three health zones in Kinshasa, DRC	PLOS ONE			English	Article							VAGINAL BLEEDING PATTERNS; QUALITY-OF-CARE; CONTRACEPTIVE METHODS; RATES; WOMEN	Background Kinshasa is Africa's third largest city and one of the continent's most rapidly growing urban areas. PMA2020 data showed that Kinshasa has a modern contraceptive prevalence of 26.5% among married women in 2018. In Kinshasa's method mix, the contraceptive implant recently became the dominant method among contraceptive users married and in union. This study provides insight into patterns of implant use in a high-fertility setting by evaluating the 24-month continuation rate for Implanon NXT and identifying the characteristics associated with discontinuation. Methodology This community-based, prospective cohort study followed 531 Implanon users aged 18-49 years at 6, 12 and 24 months. The following information was collected: socio-demographic characteristics, Method Information Index (MII) and contraceptive history. The main outcome variable for this study was implant discontinuation. The incidence rate of discontinuation is presented as events per 1000 person/months (p-m), from the date of enrolment. The Cox proportional hazards modelling was used to measure predictors of discontinuation. Results A total of 9158.13 p-m were available for analysis, with an overall incidence rate of 9.06 (95% CI: 9.04-9.08) removals per 1000 p-m. Of nine possible co-variates tested, the likelihood of discontinuation was higher among women who lived in military camps, had less than three children, never used injectables or implants in the past, had experienced heavy/prolonged bleeding, and whose MII score was less than 3. Conclusion In addition to four client characteristics that predicted discontinuation, we identified one programmatic factor: quality of counseling as measured by the Method Information Index. Community providers in similar contexts should pay more attention to clients having less than three children, new adopters, and to clients living military camps as underserved population, where clients have less access to health facilities. More targeted counselling and follow-up is needed, especially on bleeding patterns.	[Akilimali, P. Z.; Kayembe, K. P.] Univ Kinshasa, Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Hernandez, J.; Bertrand, J.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Anglewicz, P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA	Universite de Kinshasa; Tulane University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Akilimali, PZ (corresponding author), Univ Kinshasa, Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO.	pierretulanefp@gmail.com			NIH Fogarty International Center [D43TW009340]; Bill and Melinda Gates Foundation [OPP1128892]; UNFPA [COD04CSF]	NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UNFPA	APZ: received grant from NIH Fogarty International Center, (grant number #D43TW009340) for his PostDOC program JB received funding to implement the distribution of contraceptive methods at the community level from the Bill and Melinda Gates Foundation (OPP1128892), and UNFPA (Project ID COD04CSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affandi B, 1998, CONTRACEPTION, V58, p99S, DOI 10.1016/S0010-7824(98)00123-1; Akilimali P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022295; [Anonymous], 2015, WORLD POP PROSP 2015; [Anonymous], 2014, ENQ DEM SANT REP DEM; Balogun OR, 2014, J MED BIOMED SCI, V3, P1, DOI 10.4314/jmbs.v3i1.1; Barden-O'Fallon J, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0529-9; BELSEY EM, 1988, CONTRACEPTION, V38, P207, DOI 10.1016/0010-7824(88)90039-X; BELSEY EM, 1986, CONTRACEPTION, V34, P253, DOI 10.1016/0010-7824(86)90006-5; Chakraborty NM, 2019, GLOB HEALTH-SCI PRAC, V7, P87, DOI 10.9745/GHSP-D-18-00407; Chang KT, 2019, STUD FAMILY PLANN, V50, P25, DOI 10.1111/sifp.12081; Chaudhuri SK., 2000, PRACTICE FERTILITY C; Choi Y, 2018, STUD FAMILY PLANN, V49, P23, DOI 10.1111/sifp.12044; Croxatto HB, 1999, HUM REPROD, V14, P976, DOI 10.1093/humrep/14.4.976; DATEY S, 1995, CONTRACEPTION, V51, P155, DOI 10.1016/0010-7824(95)00012-Y; Ezegwui HU, 2010, NIGER J MED, V20, P448; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Halpern V, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004317.pub2; Hardee K, 2014, STUD FAMILY PLANN, V45, P1, DOI 10.1111/j.1728-4465.2014.00373.x; Harvey C, 2009, CONTRACEPTION, V80, P527, DOI 10.1016/j.contraception.2009.05.132; Hubacher D, 1999, CONTRACEPTION, V60, P345, DOI 10.1016/S0010-7824(99)00104-3; Jain Anrudh K, 2013, Int Perspect Sex Reprod Health, V39, P133, DOI 10.1363/3913313; Jain AK, 2012, J BIOSOC SCI, V44, P27, DOI 10.1017/S0021932011000460; Kaplan B, 2005, EUR J OBSTET GYN R B, V123, P72, DOI 10.1016/j.ejogrb.2005.06.033; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2015, KEN DEM HLTH SURV KE; Koenig MA, 1997, STUD FAMILY PLANN, V28, P278, DOI 10.2307/2137859; Kulier R, 2007, COCHRANE DB SYST REV; Lei ZW, 1996, CONTRACEPTION, V53, P357, DOI 10.1016/0010-7824(96)00085-6; Maina SW, 2016, AFR J PHARM THER, V5, P28; Mansour D, 2008, EUR J CONTRACEP REPR, V13, P13, DOI 10.1080/13625180801959931; Melese S, 2015, IMPLANON DISCONTINUA; Ministere du Plan Macro International., 2008, ENQ DEM SANT REP DEM; PARIANI S, 1991, STUD FAMILY PLANN, V22, P384, DOI 10.2307/1966452; Performance Monitoring and Accountability 2020 (PMA2020), 2016, PERF MONT ACC 2020 P; RamaRao S, 2003, STUD FAMILY PLANN, V34, P227, DOI 10.1111/j.1728-4465.2003.00227.x; Smith A, 2002, J FAM PLAN REPROD H, V28, P193, DOI 10.1783/147118902101196540; Tolesa Bekele, 2015, Epidemiology: Open Access, V5, P179; Tolley E, 2005, INT FAM PLAN PERSPEC, V31, P15, DOI 10.1363/3101505; Uganda Bureau of Statistics, 2012, UG DEM HLTH SURV 201; United Nations Human Settlements Programme (UN -Habitat), 2003, CHALL SLUMS GLOB REP; World Health Organization, 1993, CONTR METH MIX GUID; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232582	10.1371/journal.pone.0232582	http://dx.doi.org/10.1371/journal.pone.0232582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0RD	32392216	gold, Green Published			2022-12-26	WOS:000537470300012
J	Lv, H; Yang, HS; Wang, YR				Lv, Hao; Yang, Huashan; Wang, Yuanrui			Effects of miR-103 by negatively regulating SATB2 on proliferation and osteogenic differentiation of human bone marrow mesenchymal stem cells	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; TIME	Background The proliferation and osteogenic differentiation of human bone marrow mesenchymal stem cells (HBMScs) are modulated by a variety of microRNAs (miRNAs). SATB homeobox 2 (SATB2) is a critical transcription factor that contributes to maintain the balance of bone metabolism. However, it remains unclear how the regulatory relationship between miR-103 and SATB2 on HBMScs proliferation and osteogenic differentiation. Methods HBMScs were obtained from Cyagen Biosciences and successful induced osteogenic differentiation. The proliferation abilities of HBMScs after treatment with agomiR-103 and antagomiR-103 were assessed using a cell counting Kit-8 (CCK-8) assay, and osteogenic differentiation was determined using alizarin red S staining and alkaline phosphatase (ALP) activity assay. The expression levels of miR-103, SATB2, and associated osteogenic differentiation biomarkers, including RUNX family transcription factor 2 (RUNX2), bone gamma-carboxyglutamate protein (BGLAP), and secreted phosphoprotein 1 (SPP1), were evaluated using real-time qPCR and Western blot. The regulatory sites of miR-103 on SATB2 were predicted using bioinformatics software and validated using a dual luciferase reporter assay. The underlying mechanism of miR-103 on SATB2-medicated HBMScs proliferation and osteogenic differentiation were confirmed by co-transfection of antagomiR-103 and SATB2 siRNA. Results The expression of miR-103 in HBMScs after induction of osteogenic differentiation was reduced in a time-dependent way. Overexpression of miR-103 by transfection of agomiR-103 suppressed HBMScs proliferation and osteogenic differentiation, while silencing of miR-103 by antagomiR-103 abolished these inhibitory effects. Consistently, RUNX2, BGLAP and SPP1 mRNA and protein expression were decreased in agomiR-103 treated HBMScs compared with those in agomiR-NC group. Meanwhile, antagomiR-103 upregulated the mRNA and protein expression levels of RUNX2, BGLAP and SPP1 in HBMScs. Further studies revealed that SATB2 was a direct target gene of miR-103. BMSCs transfected with agomiR-103 exhibited significantly downregulated protein expression level of SATB2, whereas knockdown of miR-103 promoted it. Additionally, rescue assays confirmed that silencing of SATB2 partially reversed the effects of antagomiR-103 induced HBMScs proliferation and osteogenic differentiation. Conclusions The present results suggested that miR-103 negatively regulates SATB2 to serve an inhibitory role in the proliferation and osteogenic differentiation of HBMScs, which sheds light upon a potential therapeutic target for treating bone-related diseases.	[Lv, Hao; Yang, Huashan; Wang, Yuanrui] Shandong First Med Univ, Jinan Cent Hosp, Dept Trauma Ctr, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences	Wang, YR (corresponding author), Shandong First Med Univ, Jinan Cent Hosp, Dept Trauma Ctr, Jinan, Shandong, Peoples R China.	wangyrjian@sina.com						Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Caplan AI, 2017, STEM CELL TRANSL MED, V6, P1445, DOI 10.1002/sctm.17-0051; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36347; Chung J, 2011, J BIOL CHEM, V286, P40671, DOI 10.1074/jbc.M111.271189; Conner JR, 2013, HISTOPATHOLOGY, V63, P36, DOI 10.1111/his.12138; Croizier S, 2018, ELIFE, V7, DOI 10.7554/eLife.40429; Du J, 2019, INT J IMMUNOPATH PH, V33, DOI 10.1177/2058738419872621; Fan LY, 2018, STEM CELLS DEV, V27, P600, DOI 10.1089/scd.2017.0276; Fang T, 2018, DRUG DEVELOP RES, V79, P324, DOI 10.1002/ddr.21459; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Hao JB, 2016, CELL TISSUE RES, V366, P733, DOI 10.1007/s00441-016-2469-8; Holik AK, 2016, J CELL BIOCHEM, V117, P2413, DOI 10.1002/jcb.25576; La Noce M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030217; Li M, 2019, EUR REV MED PHARMACO, V23, P479, DOI 10.26355/eurrev_201901_16859; Li MH, 2015, BIOL CHEM, V396, P235, DOI 10.1515/hsz-2014-0241; Li XY, 2017, BIOCHEM BIOPH RES CO, V493, P928, DOI 10.1016/j.bbrc.2017.09.119; Li Y, 2019, J CELL MOL MED, V23, P6140, DOI 10.1111/jcmm.14490; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Moncini S, 2017, MOL NEUROBIOL, V54, P4329, DOI 10.1007/s12035-016-0002-4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen HZ, 2019, ACTA BIOCH BIOPH SIN, V51, P588, DOI 10.1093/abbs/gmz037; Tang JF, 2018, BONE, V114, P137, DOI 10.1016/j.bone.2018.06.010; Tella SH, 2014, J STEROID BIOCHEM, V142, P155, DOI 10.1016/j.jsbmb.2013.09.008; Valassi E, 2019, ENDOCR CONNECT, V8, P39, DOI 10.1530/EC-18-0482; Wang J, 2018, GENE, V644, P13, DOI 10.1016/j.gene.2017.11.066; Wang TS, 2017, EXP THER MED, V13, P669, DOI 10.3892/etm.2016.3991; Winning L, 2019, STEM CELLS DEV, V28, P1050, DOI 10.1089/scd.2019.0023; Wu G, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2863902; Xiao Y, 2019, MOL MED REP, V20, P4558, DOI 10.3892/mmr.2019.10700; Xu HY, 2017, EUR REV MED PHARMACO, V21, P4516; Xu M, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1063-6; Xu Q, 2015, WORLD J GASTROENTERO, V21, P511, DOI 10.3748/wjg.v21.i2.511; Yang D, 2018, ONCOL RES, V26, P519, DOI 10.3727/096504017X15000757094686; Yi JY, 2019, CELL TISSUE RES, V376, P113, DOI 10.1007/s00441-018-2963-2; Yoo JK, 2014, EXP GERONTOL, V58, P139, DOI 10.1016/j.exger.2014.07.020; Yu W, 2016, ONCOTARGET, V7, P57783, DOI 10.18632/oncotarget.10860; Yuan Y, 2017, J CELL PHYSIOL, V232, P1239, DOI 10.1002/jcp.25688; Zhang Y, 2020, BIOCHEM BIOPH RES CO, V521, P9, DOI 10.1016/j.bbrc.2019.09.122; Zhao XY, 2014, CYTOKINE GROWTH F R, V25, P35, DOI 10.1016/j.cytogfr.2013.12.010; Zhen L, 2017, AM J TRANSL RES, V9, P2384	42	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232695	10.1371/journal.pone.0232695	http://dx.doi.org/10.1371/journal.pone.0232695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379794	Green Published, gold			2022-12-26	WOS:000537285700055
J	Wu, QH; Jia, MM; Chen, HM; Zhang, SK; Liu, Y; Prem, K; Qian, MC; Yu, HJ				Wu, Qianhui; Jia, Manman; Chen, Hongmin; Zhang, Shaokai; Liu, Yang; Prem, Kiesha; Qian, Mengcen; Yu, Hongjie			The economic burden of cervical cancer from diagnosis to one year after final discharge in Henan Province, China: A retrospective case series study	PLOS ONE			English	Article							CARE	Background In China, the disease burden of cervical cancer remains substantial. Human papillomavirus (HPV) vaccines are expensive and not yet centrally funded. To inform immunization policy, understanding the economic burden of the disease is necessary. This study adopted a societal perspective and investigated costs and quality of life changes associated with cervical cancer from diagnosis to one year after final discharge in Henan province, China. Methods Inpatient records of cervical cancer patients admitted to the largest cancer hospital in Henan province between Jan. 2017 and Dec. 2018 were extracted. A telephone interview with four modules was conducted in Jun.-Jul. 2019 with a 40% random draw of patients to obtain direct non-medical costs and indirect costs associated with inpatients, costs associated with outpatient visits, and changes in quality of life status using the EQ-5D-5L instrument. Direct medical expenditures were converted to opportunity costs of care using cost-to-charge ratios obtained from hospital financial reports. For each clinical stage (IA-IV), total costs per case from diagnosis to one year after final discharge were extrapolated based on inpatient records, responses to the telephone interview, and recommendation on outpatient followups by Chinese cervical cancer treatment guidelines. Loss in quality-adjusted life years was obtained using the 'under the curve' method and regression predictions. Results A total of 3,506 inpatient records from 1,323 patients were obtained. Among 541 randomly selected patients, 309 completed at least one module of the telephone interview. The average total costs per case associated with cervical cancer from diagnosis to one year after final discharge ranged from $8,066-$22,888 (in 2018 US Dollar) and the quality-adjusted life years loss varied from 0.05-0.26 for IA-IV patients. Conclusions The economic burden associated with cervical cancer is substantial in Henan province. Our study provided important baseline information for cost-effectiveness analysis of HPV immunization program in China.	[Wu, Qianhui; Qian, Mengcen; Yu, Hongjie] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China; [Jia, Manman; Chen, Hongmin; Zhang, Shaokai] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China; [Liu, Yang; Prem, Kiesha] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Qian, Mengcen] Fudan Univ, Minist Hlth, Key Lab Hlth Technol Assessment, Shanghai, Peoples R China; [Yu, Hongjie] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China	Fudan University; Zhengzhou University; University of London; London School of Hygiene & Tropical Medicine; Fudan University; Fudan University	Qian, MC; Yu, HJ (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.; Qian, MC (corresponding author), Fudan Univ, Minist Hlth, Key Lab Hlth Technol Assessment, Shanghai, Peoples R China.; Yu, HJ (corresponding author), Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China.	qianmengcen@fudan.edu.cn; yhj@fudan.edu.cn	Yu, Hongjie/GZK-5351-2022	Prem, Kiesha/0000-0003-0528-798X; Yu, Hongjie/0000-0002-6335-5648; Liu, Yang/0000-0002-9368-0425	National Science Fund for Distinguished Young Scholars [81525023]; National Institute for Health Research (NIHR) from the UK Government [16/137/109]; Key Laboratory of Public Health Safety (Fudan University), Ministry of Education [GW2019-6]; Sanofi Pasteur; GlaxoSmithKline; Yichang HEC Changjiang Pharmaceutical Company; Shanghai Roche Pharmaceutical Company	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Institute for Health Research (NIHR) from the UK Government; Key Laboratory of Public Health Safety (Fudan University), Ministry of Education; Sanofi Pasteur; GlaxoSmithKline(GlaxoSmithKline); Yichang HEC Changjiang Pharmaceutical Company; Shanghai Roche Pharmaceutical Company	This research was supported by National Science Fund for Distinguished Young Scholars (No. 81525023), National Institute for Health Research (NIHR) (grant no. 16/137/109) using UK aid from the UK Government to support global health research and the Key Laboratory of Public Health Safety (Fudan University), Ministry of Education (grant number: GW2019-6). The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. In addition, HY received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, and Shanghai Roche Pharmaceutical Company. These funds were not related to this research.	[Anonymous], 2017, Wkly Epidemiol Rec, V92, P241; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cai Y, 2017, CHINESE J CANCER RES, V29, P253, DOI 10.21147/j.issn.1000-9604.2017.03.11; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; De Araujo Lima Santos CA, 2019, OPEN J OBSTET GYNECO, V9, P117, DOI DOI 10.4236/OJOG.2019.92012; Gong X, 2012, MED PHILOS, V33, P55; Guo L, 2014, ANAL HOSPITALIZATION, V26, P193; He W, 2013, MODERN PREVENTIVE ME, V40, P3980; Lang HC, 2010, SUPPORT CARE CANCER, V18, P1279, DOI 10.1007/s00520-009-0745-9; Li L, 2017, INT J HEALTH PLAN M, V32, P240, DOI 10.1002/hpm.2424; Li XT, 2017, CHINESE J CANCER RES, V29, P477, DOI 10.21147/j.issn.1000-9604.2017.06.02; Liu JH, 2018, CHINESE J PRACTICAL, V34, P613; Liu L, 2016, PREVENTIVE MED TRIBU, V22, P241; Liu YJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222760; Luo N, 2017, VALUE HEALTH, V20, P662, DOI 10.1016/j.jval.2016.11.016; National Bureau of Statistics, 2018, NAT EC SOC DEV STAT; Niu YZ, 2017, MODERN PREVENTIVE ME, V44, P4447; Shi J F, 2016, Zhonghua Zhong Liu Za Zhi, V38, P929, DOI 10.3760/cma.j.issn.0253-3766.2016.12.010; Shi JF, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-123; Tao S Y, 2018, Zhonghua Yu Fang Yi Xue Za Zhi, V52, P1281, DOI 10.3760/cma.j.issn.0253-9624.2018.12.017; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wolfe S, 2015, EPIDEMIOLOGY PREVENT; Xie Y, 2013, CHIN J CANCER, V32, P275, DOI 10.5732/cjc.012.10047; Yang J, 2015, COGN AFFECT BEHAV NE, V15, P381, DOI 10.3758/s13415-014-0329-0; Zhao ZM, 2014, CHIN J CANCER, V33, P339, DOI 10.5732/cjc.013.10139; Zhu Jian-Jun, 2017, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V33, P58, DOI 10.13865/j.cnki.cjbmb.2017.01.09	26	4	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232129	10.1371/journal.pone.0232129	http://dx.doi.org/10.1371/journal.pone.0232129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379783	Green Published, Green Accepted, gold			2022-12-26	WOS:000537285700023
J	Inoue, M; Tsuji, Y; Yoshimine, C; Enomoto, S; Morita, Y; Osaki, N; Kunishige, M; Miki, M; Amano, S; Yamashita, K; Kamada, H; Tsutsumi, Y; Tsunoda, S				Inoue, Masaki; Tsuji, Yuta; Yoshimine, Chinatsu; Enomoto, Shota; Morita, Yuki; Osaki, Natsuki; Kunishige, Masahiro; Miki, Midori; Amano, Shota; Yamashita, Kanako; Kamada, Haruhiko; Tsutsumi, Yasuo; Tsunoda, Shin-ichi			Structural optimization of a TNFR1-selective antagonistic TNF alpha mutant to create new-modality TNF-regulating biologics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); cytokine; autoimmune disease; arthritis; inflammation; inhibition mechanism; protein engineering; drug design; drug delivery; forkhead box P3 (FOXP3); antagonist; single-chain	TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; T-CELLS; RECEPTOR; INFLIXIMAB; ANTIBODY; METHOTREXATE; ETANERCEPT; EXPRESSION; ADALIMUMAB	Excessive activation of the proinflammatory cytokine tumor necrosis factor-alpha (TNF alpha) is a major cause of autoimmune diseases, including rheumatoid arthritis. TNF alpha induces immune responses via TNF receptor 1 (TNFR1) and TNFR2. Signaling via TNFR1 induces proinflammatory responses, whereas TNFR2 signaling is suggested to suppress the pathophysiology of inflammatory diseases. Therefore, selective inhibition of TNFR1 signaling and preservation of TNFR2 signaling activities may be beneficial for managing autoimmune diseases. To this end, we developed a TNFR1-selective, antagonistic TNF alpha mutant (R1antTNF). Here, we developed an R1antTNF derivative, scR1antTNF-Fc, which represents a single-chain form of trimeric R1antTNF with a human IgG-Fc domain. scR1antTNF-Fc had properties similar to those of R1antTNF, including TNFR1-selective binding avidity, TNFR1 antagonistic activity, and thermal stability, and had a significantly extended plasma t(1/2) in vivo. In a murine rheumatoid arthritis model, scR1antTNF-Fc and 40-kDa PEG-scR1antTNF (a previously reported PEGylated form) delayed the onset of collagen-induced arthritis, suppressed arthritis progression in mice, and required a reduced frequency of administration. Interestingly, with these biologic treatments, we observed an increased ratio of regulatory T cells to conventional T cells in lymph nodes compared with etanercept, a commonly used TNF inhibitor. Therefore, scR1antTNF-Fc and 40-kDa PEG-scR1antTNF indirectly induced immunosuppression. These results suggest that selective TNFR1 inhibition benefits the management of autoimmune diseases and that R1antTNF derivatives hold promise as new-modality TNF-regulating biologics.	[Inoue, Masaki; Tsuji, Yuta; Yoshimine, Chinatsu; Enomoto, Shota; Morita, Yuki; Osaki, Natsuki; Kunishige, Masahiro; Miki, Midori; Amano, Shota; Yamashita, Kanako; Tsunoda, Shin-ichi] Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Cellular & Mol Physiol, Chuo Ku, Kobe, Hyogo, Japan; [Inoue, Masaki; Kamada, Haruhiko; Tsunoda, Shin-ichi] Natl Inst Biomed Innovat Hlth & Nutr, Lab Biopharmaceut Res, Ibaraki, Osaka, Japan; [Inoue, Masaki; Kamada, Haruhiko; Tsunoda, Shin-ichi] Natl Inst Biomed Innovat Hlth & Nutr, Ctr Drug Design Res, Ibaraki, Osaka, Japan; [Kamada, Haruhiko; Tsutsumi, Yasuo; Tsunoda, Shin-ichi] Osaka Univ, Global Ctr Med Engn & Informat, Suita, Osaka, Japan; [Tsutsumi, Yasuo] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Toxicol & Safety Sci, Suita, Osaka, Japan	Kobe Gakuin University; Osaka University; Osaka University	Tsunoda, S (corresponding author), Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Cellular & Mol Physiol, Chuo Ku, Kobe, Hyogo, Japan.; Tsunoda, S (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Biopharmaceut Res, Ibaraki, Osaka, Japan.; Tsunoda, S (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Ctr Drug Design Res, Ibaraki, Osaka, Japan.; Tsunoda, S (corresponding author), Osaka Univ, Global Ctr Med Engn & Informat, Suita, Osaka, Japan.	tsunoda@pharm.kobegakuin.ac.jp			JSPS KAKENHI [JP18K14877, JP18H02699, JP18K19567]; Takeda Science Foundation; Mochida Memorial Foundation forMedical and Pharmaceutical Research	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation forMedical and Pharmaceutical Research	This work was supported by JSPS KAKENHI Grants JP18K14877, JP18H02699, and JP18K19567, and the Takeda Science Foundation and Mochida Memorial Foundation forMedical and Pharmaceutical Research.	Abe Y, 2008, J IMMUNOL METHODS, V335, P71, DOI 10.1016/j.jim.2008.02.019; Biton J, 2011, J IMMUNOL, V186, P3899, DOI 10.4049/jimmunol.1003372; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chen X, 2010, CURR DIR AUTOIMMUN, V11, P119, DOI 10.1159/000289201; Dalton AC, 2014, PROTEIN SCI, V23, P517, DOI 10.1002/pro.2439; Dong Y, 2016, P NATL ACAD SCI USA, V113, P12304, DOI 10.1073/pnas.1605195113; Fischer R, 2015, ANTIBODIES, V4, P48, DOI 10.3390/antib4010048; Goel N, 2010, MABS-AUSTIN, V2, P137, DOI 10.4161/mabs.2.2.11271; Gottenberg JE, 2016, JAMA-J AM MED ASSOC, V316, P1172, DOI 10.1001/jama.2016.13512; Inoue M, 2017, J BIOL CHEM, V292, P6438, DOI 10.1074/jbc.M117.779686; Kafrouni MI, 2003, J LEUKOCYTE BIOL, V74, P564, DOI 10.1189/jlb.0103035; Kasagi S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008895; Keystone EC, 2009, ANN RHEUM DIS, V68, P789, DOI 10.1136/ard.2008.099010; Kodama S, 2005, CELL MOL LIFE SCI, V62, P1850, DOI 10.1007/s00018-005-5022-6; La Paglia GMC, 2017, CLIN EXP RHEUMATOL, V35, P551; Laas K, 2008, CLIN RHEUMATOL, V27, P927, DOI 10.1007/s10067-008-0880-6; Larsson E, 2004, RHEUMATOLOGY, V43, P428, DOI 10.1093/rheumatology/keh073; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nomura T, 2011, J CONTROL RELEASE, V149, P8, DOI 10.1016/j.jconrel.2009.12.015; Orti-Casan N, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00049; Pegoretti V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00925; Petrovic-Rackov L, 2006, CLIN RHEUMATOL, V25, P448, DOI 10.1007/s10067-005-0106-0; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200; Shibata H, 2009, BIOMATERIALS, V30, P6638, DOI 10.1016/j.biomaterials.2009.08.041; Smolen JS, 2016, LANCET, V388, P1984; Smolen JS, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.1; Tarcha EJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180762; van der Bijl AE, 2008, CLIN RHEUMATOL, V27, P1021, DOI 10.1007/s10067-008-0866-4; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Wang HL, 2008, J CLIN INVEST, V118, P2629, DOI 10.1172/JCI34916; Wiens A, 2010, RHEUMATOL INT, V30, P1063, DOI 10.1007/s00296-009-1111-4; Williams SK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31957-7; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812; Yi H, 2014, MOL MED REP, V9, P2301, DOI 10.3892/mmr.2014.2127	44	2	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9379	9391		10.1074/jbc.RA120.012723	http://dx.doi.org/10.1074/jbc.RA120.012723			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32398258	Green Published, hybrid			2022-12-26	WOS:000552758600010
J	Menceloglu, M; Grabowecky, M; Suzuki, S				Menceloglu, Melisa; Grabowecky, Marcia; Suzuki, Satoru			Spectral-power associations reflect amplitude modulation and within-frequency interactions on the sub-second timescale and cross-frequency interactions on the seconds timescale	PLOS ONE			English	Article							NEURONAL OSCILLATIONS; BAND OSCILLATIONS; ALPHA; ATTENTION; DYNAMICS; BETA	We investigated the global structure of intrinsic cross-frequency dynamics by systematically examining power-based temporal associations among a broad range of oscillation frequencies both within and across EEG-based current sources (sites). We focused on power-based associations that could reveal unique timescale dependence independently of interacting frequencies. Large spectral-power fluctuations across all sites occurred at two characteristic timescales, sub-second and seconds, yielding distinct patterns of cross-frequency associations. On the fast sub-second timescale, within-site (local) associations were consistently between pairs of beta-gamma frequencies differing by a constant Delta f (particularly Delta f similar to 10 Hz at posterior sites and Delta f similar to 16 Hz at lateral sites) suggesting that higher-frequency oscillations are organized into Delta f amplitude-modulated packets, whereas cross-site (long-distance) associations were all within-frequency (particularly in the > 30 Hz and 6-12 Hz ranges, suggestive of feedforward and feedback interactions). On the slower seconds timescale, within-site (local) associations were characterized by a broad range of frequencies selectively associated with similar to 10 Hz at posterior sites and associations among higher (> 20 Hz) frequencies at lateral sites, whereas cross-site (long-distance) associations were characterized by a broad range of frequencies at posterior sites selectively associated with similar to 10 Hz at other sites, associations among higher (>20 Hz) frequencies among lateral and anterior sites, and prevalent associations at similar to 10 Hz. Regardless of timescale, within-site (local) cross-frequency associations were weak at anterior sites indicative of frequency-specific operations. Overall, these results suggest that the fast sub-second-timescale coordination of spectral power is limited to local amplitude modulation and insulated within-frequency long-distance interactions (likely feedforward and feedback interactions), while characteristic patterns of cross-frequency interactions emerge on the slower seconds timescale. The results also suggest that the occipital a oscillations play a role in organizing higher-frequency oscillations into similar to 10 Hz amplitude-modulated packets to communicate with other regions. Functional implications of these timescale-dependent cross-frequency associations await future investigations.	[Menceloglu, Melisa; Grabowecky, Marcia; Suzuki, Satoru] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Grabowecky, Marcia; Suzuki, Satoru] Northwestern Univ, Interdept Neurosci, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Suzuki, S (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.; Suzuki, S (corresponding author), Northwestern Univ, Interdept Neurosci, Evanston, IL 60208 USA.	satoru@northwestern.edu		Suzuki, Satoru/0000-0003-2543-7244	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Yes. NIH T32 grant to MM.	Adebimpe A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00143; Antonakakis M, 2016, INT J PSYCHOPHYSIOL, V102, P1, DOI 10.1016/j.ijpsycho.2016.02.002; BAITCH LW, 1989, VISION RES, V29, P27, DOI 10.1016/0042-6989(89)90171-5; BAITCH LW, 1988, VISION RES, V28, P1139, DOI 10.1016/0042-6989(88)90140-X; Bonnefond M, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128667; Busch NA, 2010, P NATL ACAD SCI USA, V107, P16048, DOI 10.1073/pnas.1004801107; Buzsaki G., 2006, RHYTHMS BRAIN; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; COLLYER CE, 1994, PERCEPT PSYCHOPHYS, V55, P443, DOI 10.3758/BF03205301; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Duzel E, 2010, CURR OPIN NEUROBIOL, V20, P143, DOI 10.1016/j.conb.2010.01.004; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gonzalez GF, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00341; He BYJ, 2014, TRENDS COGN SCI, V18, P480, DOI 10.1016/j.tics.2014.04.003; HESS RF, 1992, VISION RES, V32, P47, DOI 10.1016/0042-6989(92)90112-V; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Hjorth B., 1980, AM J EEG TECHNOL, P121, DOI 10.1080/00029238.1980.11080015; Hulsemann MJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00573; Jensen O, 2014, TRENDS NEUROSCI, V37, P357, DOI 10.1016/j.tins.2014.04.001; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Kiya H., 2010, SIGNAL PROCESS, P97; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Koch Christof, 1999, P1; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; LICKLIDER JCR, 1950, J ACOUST SOC AM, V22, P468, DOI 10.1121/1.1906629; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Lozano-Soldevilla D, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00087; Lui LL, 2007, EUR J NEUROSCI, V25, P1780, DOI 10.1111/j.1460-9568.2007.05453.x; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Velarde OM, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116031; Mazzoni A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000239; Michalareas G, 2016, NEURON, V89, P384, DOI 10.1016/j.neuron.2015.12.018; Muller V, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00108; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Pachi A, 2005, STRUCTURAL ENG, V83, P36, DOI DOI 10.1016/S0141-0296(00)00020-1; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Pelz Jeff B., 2007, P661, DOI 10.1016/B978-008044980-7/50033-1; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; PERRIN F, 1990, ELECTROEN CLIN NEURO, V76, P565; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Pratt H, 2009, CLIN NEUROPHYSIOL, V120, P1514, DOI 10.1016/j.clinph.2009.06.014; Scally B, 2018, NEUROBIOL AGING, V71, P149, DOI 10.1016/j.neurobiolaging.2018.07.004; Schaworonkow N, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007055; Spaak E, 2012, CURR BIOL, V22, P2313, DOI 10.1016/j.cub.2012.10.020; Tenke CE, 2012, CLIN NEUROPHYSIOL, V123, P2328, DOI 10.1016/j.clinph.2012.06.005; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; VanRullen R, 2005, P NATL ACAD SCI USA, V102, P5291, DOI 10.1073/pnas.0409172102; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191	55	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0228365	10.1371/journal.pone.0228365	http://dx.doi.org/10.1371/journal.pone.0228365			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1CK	32421714	Green Published, Green Submitted, gold			2022-12-26	WOS:000537499600002
J	Van Deun, A; Decroo, T; Maug, AKJ; Hossain, MA; Gumusboga, M; Mulders, W; Ortuno-Gutierrez, N; Lynen, L; de Jong, BC; Rieder, HL				Van Deun, Armand; Decroo, Tom; Maug, Aung Kya Jai; Hossain, Mohamed Anwar; Gumusboga, Murid; Mulders, Wim; Ortuno-Gutierrez, Nimer; Lynen, Lutgarde; de Jong, Bouke C.; Rieder, Hans L.			The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance	PLOS ONE			English	Article							SHORT-COURSE CHEMOTHERAPY; ANTITUBERCULOSIS-DRUG-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; MULTIDRUG-RESISTANCE; BANGLADESH; MUTATIONS; SUSCEPTIBILITY; SURVEILLANCE; MICROSCOPY	Background Meta-analyses on impact of isoniazid-resistant tuberculosis informed the World Health Organization recommendation of a levofloxacin-strengthened rifampicin-based regimen. We estimated the effect of initial rifampicin resistance (Rr) and/or isoniazid resistance (Hr) on treatment failure or relapse. We also determined the frequency of missed initial and acquired Rr to estimate the impact of true Hr. Methods Retrospective analysis of 7291 treatment episodes with known initial isoniazid and rifampicin status obtained from individual patient databases maintained by the Damien Foundation Bangladesh over 20 years. Drug susceptibility test results were confirmed by the programme's designated supra-national tuberculosis laboratory. To detect missed Rr among isolates routinely classified as Hr, rpoB gene sequencing was done randomly and on a sample selected for suspected missed Rr. Results Initial Hr caused a large recurrence excess after the 8-month regimen for new cases (rifampicin for two months), but had little impact on rifampicin-throughout regimens: (6 months, new cases; 3.8%; OR 0.8, 95%CI:0.3,2.8; 8 months, retreatment cases: 7.3%, OR 1.8; 95% CI:1.3,2.6). Rr was missed in 7.6% of randomly selected "Hr" strains. Acquired Rr was frequent among recurrences on rifampicin-throughout regimens, particularly after the retreatment regimen (31.9%). It was higher in mono-Hr (29.3%; aOR 3.5, 95%CI:1.5,8.5) and poly-Hr (53.3%; aOR 10.2, 95%CI 4.4,23.7) than in susceptible tuberculosis, but virtually absent after the 8-month new case regimen. Comparing Bangladesh (low Rr prevalence) with a high Rr prevalence setting,true Hr corrected for missed Rr caused only 2-3 treatment failures per 1000 TB cases (of whom 27% were retreatments) in both. Conclusions Our analysis reveals a non-negligible extent of misclassifying as isoniazid resistance of what is actually missed multidrug-resistant tuberculosis. Recommending for such cases a "strengthened" regimen containing a fluoroquinolone provokes a direct route to extensive resistance while offering little benefit against the minor role of true Hr tuberculosis in rifampicin-throughout first-line regimen.	[Van Deun, Armand; Gumusboga, Murid; Mulders, Wim; de Jong, Bouke C.] Inst Trop Med, Mycobacteriol Unit, Biomed Dept, Antwerp, Belgium; [Decroo, Tom; Lynen, Lutgarde] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Decroo, Tom] Res Fdn Flanders, Brussels, Belgium; [Maug, Aung Kya Jai; Hossain, Mohamed Anwar] Damien Fdn Bangladesh, Dhaka, Bangladesh; [Ortuno-Gutierrez, Nimer] Damien Fdn Brussels, Brussels, Belgium; [Rieder, Hans L.] TB Consultant Serv, Kirchlindach, Switzerland	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Van Deun, A (corresponding author), Inst Trop Med, Mycobacteriol Unit, Biomed Dept, Antwerp, Belgium.	avdeun@itg.be	Lynen, Lutgarde/AAT-9180-2020; Decroo, Tom/AAV-7208-2020; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Decroo, Tom/0000-0002-1205-1484; Lynen, Lutgarde/0000-0001-7183-4895; Gumusboga, Mourad/0000-0003-1322-6490				ANGEL JH, 1984, BRIT J DIS CHEST, V78, P330; [Anonymous], 1974, World Health Organ Tech Rep Ser, P1; Aung KJM, 2020, INT J TUBERC LUNG DI, V24; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Boeree MJ, 2017, LANCET INFECT DIS, V17, P39, DOI 10.1016/S1473-3099(16)30274-2; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Chakravorty S, 2017, MBIO, V8, DOI [10.1128/mBio.00812-17, 10.1128/mbio.00812-17]; Chang KC, 2006, AM J RESP CRIT CARE, V174, P1153, DOI 10.1164/rccm.200605-637OC; Chang KC, 2011, THORAX, V66, P997, DOI 10.1136/thx.2010.148585; Deepa D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076189; East African Medical Research Council British Medical Research Council, 1980, TUBERCLE, V61, P59; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Folkvardsen DB, 2013, J CLIN MICROBIOL, V51, P4220, DOI 10.1128/JCM.01602-13; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Fregonese F, 2018, LANCET RESP MED, V6, P265, DOI 10.1016/S2213-2600(18)30078-X; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gegia M, 2012, INT J TUBERC LUNG D, V16, P812, DOI 10.5588/ijtld.11.0637; Gegia M, 2017, LANCET INFECT DIS, V17, P223, DOI 10.1016/S1473-3099(16)30407-8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong Kong Tuberculosis Treatment Services, 1975, TUBERCLE, V56, P179, DOI [DOI 10.1016/0041-3879(75)90050-1, 10.1016/0041-3879(75)90050-1]; Huang WL, 2009, J CLIN MICROBIOL, V47, P2520, DOI 10.1128/JCM.02499-08; Huyen MNT, 2013, ANTIMICROB AGENTS CH, V57, P3620, DOI 10.1128/AAC.00077-13; Jeong DH, 2018, INTERNAL MED, V57, P3281, DOI 10.2169/internalmedicine.9571-17; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Kamal SMM, 2015, INT J TUBERC LUNG D, V19, P151, DOI 10.5588/ijtld.14.0200; Kumar P, 2014, TUBERCULOSIS, V94, P73, DOI 10.1016/j.tube.2013.10.001; Makhado NA, 2018, LANCET INFECT DIS, V18, P1350, DOI 10.1016/S1473-3099(18)30496-1; Mathew R, 1997, INT J TUBERC LUNG D, V1, P509; MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423; Ng KCS, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00717-19; Nolan CM, 2002, INT J TUBERC LUNG D, V6, P952; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Rigouts L, 2007, J CLIN MICROBIOL, V45, P252, DOI 10.1128/JCM.01489-06; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Santha T, 2004, TROP MED INT HEALTH, V9, P551, DOI 10.1111/j.1365-3156.2004.01229.x; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; Singhal R, 2014, INDIAN J MED RES, V140, P501; Van Deun A, 2018, INT J TUBERC LUNG D, V22, P1450, DOI 10.5588/ijtld.18.0158; Van Deun A, 2018, INT J TUBERC LUNG D, V22, P239, DOI 10.5588/ijtld.17.0660; Van Deun A, 2015, INT J TUBERC LUNG D, V19, P185, DOI 10.5588/ijtld.14.0651; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P23; Van Deun A, 1998, INT J TUBERC LUNG D, V2, P756; Van Deun A, 1999, INT J TUBERC LUNG D, V3, P143; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; Van Deun A, 2012, INT J TUBERC LUNG D, V16, P1558, DOI 10.5588/ijtld.12.0407-2; Variava E, 2018, LANCET INFECT DIS, V18, P1293, DOI 10.1016/S1473-3099(18)30550-4; WHO, 2017, WHO TECH REP SER, V1004, P1; *WHO, 2003, TREATM TUB GUID NAT, P1; World Health Organization, 1964, 8 REP TECH REP SER, V290, P1; Yoshiyama T, 2004, INT J TUBERC LUNG D, V8, P31	51	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233500	10.1371/journal.pone.0233500	http://dx.doi.org/10.1371/journal.pone.0233500			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421749	Green Published, gold			2022-12-26	WOS:000537499600053
J	Fan, YX; Wang, WR; Zhu, QQ				Fan, Yongxian; Wang, Wanru; Zhu, Qingqi			iterb-PPse: Identification of transcriptional terminators in bacterial by incorporating nucleotide properties into PseKNC	PLOS ONE			English	Article							WEB SERVER; PREDICTION; PROMOTERS; SEQUENCE; SKEW; RNA; DNA	Terminator is a DNA sequence that gives the RNA polymerase the transcriptional termination signal. Identifying terminators correctly can optimize the genome annotation, more importantly, it has considerable application value in disease diagnosis and therapies. However, accurate prediction methods are deficient and in urgent need. Therefore, we proposed a prediction method "iterb-PPse" for terminators by incorporating 47 nucleotide properties into PseKNC-I and PseKNC-II and utilizing Extreme Gradient Boosting to predict terminators based on Escherichia coli and Bacillus subtilis. Combing with the preceding methods, we employed three new feature extraction methods K-pwm, Base-content, Nucleotidepro to formulate raw samples. The two-step method was applied to select features. When identifying terminators based on optimized features, we compared five single models as well as 16 ensemble models. As a result, the accuracy of our method on benchmark dataset achieved 99.88%, higher than the existing state-of-the-art predictor iTerm-PseKNC in 100 times five-fold cross-validation test. Its prediction accuracy for two independent datasets reached 94.24% and 99.45% respectively. For the convenience of users, we developed a software on the basis of "iterb-PPse" with the same name. The open software and source code of "iterb-PPse" are available at https://github.com/Sarahyouzi/iterb-PPse.	[Fan, Yongxian; Wang, Wanru; Zhu, Qingqi] Guilin Univ Elect Technol, Sch Comp Sci & Informat Secur, Guilin, Peoples R China	Guilin University of Electronic Technology	Fan, YX (corresponding author), Guilin Univ Elect Technol, Sch Comp Sci & Informat Secur, Guilin, Peoples R China.	yongxian.fan@gmail.com		Wang, Wanru/0000-0001-6511-6643	National Natural Science Foundation of China [61762026, 61462018]; Guangxi Natural Science Foundation [2017GXNSFAA198278, 2016GXNSFAA380043]; Innovation Project of GUET Graduate Education [2018YJCX47, 2019YCXS056]; Guangxi Colleges and Universities Key Laboratory of Intelligent Processing of Computer Images and Graphics [GIIP201502]; Guangxi Key Laboratory of Trusted Software [kx201403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Innovation Project of GUET Graduate Education; Guangxi Colleges and Universities Key Laboratory of Intelligent Processing of Computer Images and Graphics; Guangxi Key Laboratory of Trusted Software	This work was supported by the National Natural Science Foundation of China (Grant NO. 61762026, 61462018) to YXF, the Guangxi Natural Science Foundation (Grant NO. 2017GXNSFAA198278, 2016GXNSFAA380043) to YXF, the Innovation Project of GUET Graduate Education (Grant NO. 2018YJCX47, 2019YCXS056) to YXF, the Guangxi Colleges and Universities Key Laboratory of Intelligent Processing of Computer Images and Graphics (Grant NO. GIIP201502) to YXF and Guangxi Key Laboratory of Trusted Software (Grant NO. kx201403) to YXF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Basu S, 2017, J COMPUT AID MOL DES, V31, P453, DOI 10.1007/s10822-017-0020-y; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Brown GW, 1982, AM J DIS CHILDREN, V136; Charneski CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002283; Chen W, 2015, MOL BIOSYST, V11, P2620, DOI 10.1039/c5mb00155b; Chen W, 2014, ANAL BIOCHEM, V456, P53, DOI 10.1016/j.ab.2014.04.001; Chou KC, 1999, BIOCHEM BIOPH RES CO, V264, P216, DOI 10.1006/bbrc.1999.1325; Chou KC, 2015, MED CHEM, V11, P218, DOI 10.2174/1573406411666141229162834; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Dar D, 2018, NUCLEIC ACIDS RES, V46, P6797, DOI 10.1093/nar/gky274; de Hoon MJL, 2005, PLOS COMPUT BIOL, V1, P212, DOI 10.1371/journal.pcbi.0010025; Di Salvo M, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2704-x; FARNHAM PJ, 1981, NUCLEIC ACIDS RES, V9, P563, DOI 10.1093/nar/9.3.563; Feng CQ, 2019, BIOINFORMATICS, V35, P1469, DOI 10.1093/bioinformatics/bty827; Feng Peng-Mian, 2013, Comput Math Methods Med, V2013, P567529, DOI 10.1155/2013/567529; Feng PM, 2013, ANAL BIOCHEM, V442, P118, DOI 10.1016/j.ab.2013.05.024; Feng PM, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/530696; Fukue Y, 2005, NUCLEIC ACIDS RES, V33, P3821, DOI 10.1093/nar/gki700; Ghandi M, 2014, J MATH BIOL, V69, P469, DOI 10.1007/s00285-013-0705-3; Golam Bari A.T.M., 2013, LECT NOTES COMPUTER, V7827, DOI [10.1007/978-3-642-40270-8_4, DOI 10.1007/978-3-642-40270-8_4]; Granholm V, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S3; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Henkin TM, 1996, ANNU REV GENET, V30, P35, DOI 10.1146/annurev.genet.30.1.35; Ishii T, 2001, NUCLEIC ACIDS RES, V29, P278, DOI 10.1093/nar/29.1.278; Ju XW, 2019, NAT MICROBIOL, V4, P1907, DOI 10.1038/s41564-019-0500-z; Lai HY, 2017, ONCOTARGET, V8, P28169, DOI 10.18632/oncotarget.15963; Li FY, 2018, BIOINFORMATICS, V34, P4223, DOI 10.1093/bioinformatics/bty522; Li FY, 2015, BIOINFORMATICS, V31, P1411, DOI 10.1093/bioinformatics/btu852; Li QZ, 2006, J THEOR BIOL, V242, P135, DOI 10.1016/j.jtbi.2006.02.007; Lin H, 2014, NUCLEIC ACIDS RES, V42, P12961, DOI 10.1093/nar/gku1019; Liu B., 2017, NAT SCI, V09, P67, DOI [10.4236/ns.2017.94007, DOI 10.4236/NS.2017.94007]; Liu B, 2018, BIOINFORMATICS, V34, P33, DOI 10.1093/bioinformatics/btx579; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; PAN X, 2018, GENES, V9, P11, DOI DOI 10.3390/GENES9110536; Pan XY, 2019, BIOINFORMATICS, V35, P1494, DOI 10.1093/bioinformatics/bty859; Panwar B, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-326; Sahyoun AH, 2014, MITOCHONDRION, V17, P56, DOI 10.1016/j.mito.2014.05.009; Santos-Zavaleta A, 2019, NUCLEIC ACIDS RES, V47, pD212, DOI 10.1093/nar/gky1077; Sinha S, 2006, BIOINFORMATICS, V22, pE454, DOI 10.1093/bioinformatics/btl227; Song JN, 2019, BRIEF BIOINFORM, V20, P638, DOI 10.1093/bib/bby028; Song JN, 2018, BIOINFORMATICS, V34, P684, DOI 10.1093/bioinformatics/btx670; Su ZD, 2018, BIOINFORMATICS, V34, P4196, DOI 10.1093/bioinformatics/bty508; Wu Q, 2009, INT J DATA MING BIOI, V5, P22; Xia XH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/917540; Yang H, 2018, INT J BIOL SCI, V14, P883, DOI 10.7150/ijbs.24616	47	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0228479	10.1371/journal.pone.0228479	http://dx.doi.org/10.1371/journal.pone.0228479			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413030	Green Published, gold, Green Submitted			2022-12-26	WOS:000537496000004
J	Stephens, ME; Gage, DJ				Stephens, Michael E.; Gage, Daniel J.			Single-cell amplicon sequencing reveals community structures and transmission trends of protist-associated bacteria in a termite host	PLOS ONE			English	Article							TRICHONYMPHA-AGILIS; PHYLOGENETIC IDENTIFICATION; RETICULITERMES ISOPTERA; N. SP; GUT; FLAGELLATE; GENOME; DIGESTION; LIGNOCELLULOSE; ECTOSYMBIONTS	The hindgut protists of wood-feeding termites are usually colonized by prokaryotic symbionts. Many of the hurdles that have prevented a better understanding of these symbionts arise from variation among protist and termite host species and the inability to maintain prominent community members in culture. These issues have made it difficult to study the fidelity, acquisition, and differences in colonization of protists by bacterial symbionts. In this study, we use high throughput amplicon sequencing of the V4 region of 16S rRNA genes to determine the composition of bacterial communities associated with single protist cells of six protist species, from the genera Pyrsonympha, Dinenympha, and Trichonympha that are present in the hindgut of the termite Reticulitermes flavipes. By analyzing amplicon sequence variants (ASVs), the diversity and distribution of protist-associated bacteria was compared within and across these six different protist species. ASV analysis showed that, in general, each protist genus associated with a distinct community of bacterial symbionts which were conserved across different termite colonies. However, some ASVs corresponding to ectosymbionts (Spirochaetes) were shared between different Dinenympha species and to a lesser extent with Pyrsonympha and Trichonympha hosts. This suggested that certain bacterial symbionts may be cosmopolitan to some degree and perhaps acquired by horizontal transmission. Using a fluorescence-based cell assay, we could observe the horizontal acquisition of surface-bound bacteria. This acquisition was shown to be timedependent, involve active processes, and was non-random with respect to binding locations on some protists.	[Stephens, Michael E.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Stephens, Michael E.; Gage, Daniel J.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	Cornell University; University of Connecticut	Gage, DJ (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	Daniel.gage@uconn.edu		Gage, Daniel/0000-0002-3207-7163	National Science Foundation (NSF) division of Emerging Frontiers in Research and Innovation in Multicellular and Inter-kingdom Signaling [1137249]	National Science Foundation (NSF) division of Emerging Frontiers in Research and Innovation in Multicellular and Inter-kingdom Signaling(National Science Foundation (NSF))	This research was funded by the National Science Foundation (NSF, www.nsf.gov) division of Emerging Frontiers in Research and Innovation in Multicellular and Inter-kingdom Signaling. Award number 1137249 (DJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamino J., 2016, RETICULITERMES FLAVI, V7, P171, DOI DOI 10.3389/FMICB.2016.00171; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Bourguignon T, 2018, CURR BIOL, V28, P649, DOI 10.1016/j.cub.2018.01.035; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Corno G, 2006, APPL ENVIRON MICROB, V72, P78, DOI 10.1128/AEM.72.1.78-86.2006; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; de Goffau MC, 2018, NAT MICROBIOL, V3, P851, DOI 10.1038/s41564-018-0202-y; de Pedro MA, 2004, J BACTERIOL, V186, P2594, DOI 10.1128/JB.186.9.2594-2602.2004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Graber JR, 2004, APPL ENVIRON MICROB, V70, P1307, DOI 10.1128/AEM.70.3.1307-1314.2004; Hongoh Y, 2008, SCIENCE, V322, P1108, DOI 10.1126/science.1165578; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Hongoh Y, 2007, ENVIRON MICROBIOL, V9, P2631, DOI 10.1111/j.1462-2920.2007.01365.x; Iida T, 2000, FEMS MICROBIOL ECOL, V34, P17, DOI 10.1111/j.1574-6941.2000.tb00750.x; Ikeda-Ohtsubo W, 2009, MOL ECOL, V18, P332, DOI 10.1111/j.1365-294X.2008.04029.x; James ER, 2013, INT J SYST EVOL MICR, V63, P3873, DOI 10.1099/ijs.0.054874-0; Jasso-Selles DE, 2017, EUR J PROTISTOL, V61, P48, DOI 10.1016/j.ejop.2017.09.001; Kodama Y, 2008, PROTIST, V159, P483, DOI 10.1016/j.protis.2008.02.005; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lewis JL, 2006, ANN ENTOMOL SOC AM, V99, P1028, DOI 10.1603/0013-8746(2006)99[1028:ANKTPS]2.0.CO;2; Lewis JL, 2004, ANN ENTOMOL SOC AM, V97, P1242, DOI 10.1603/0013-8746(2004)097[1242:PCFFCA]2.0.CO;2; Maekawa K, 1999, MOL PHYLOGENET EVOL, V13, P360, DOI 10.1006/mpev.1999.0647; McFall-Ngai MJ, 2014, ANN REV MICROBIOL; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Noda S, 2003, APPL ENVIRON MICROB, V69, P625, DOI 10.1128/AEM.69.1.625-633.2003; ODELSON DA, 1985, APPL ENVIRON MICROB, V49, P614, DOI 10.1128/AEM.49.3.614-621.1985; Ohkuma M, 1998, J EUKARYOT MICROBIOL, V45, P439, DOI 10.1111/j.1550-7408.1998.tb05096.x; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Ohkuma M, 2007, FEMS MICROBIOL ECOL, V60, P467, DOI 10.1111/j.1574-6941.2007.00311.x; Oksanen AJ, 2008, VEGAN PACKAGE COMMUN; Peterson BE, 2015, INSECT BIOCHEM MOLEC, V59, P80, DOI 10.1016/j.ibmb.2015.02.009; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Radek R, 1999, PROTOPLASMA, V207, P43, DOI 10.1007/BF01294712; Sato T, 2014, ISME J, V8, P1008, DOI 10.1038/ismej.2013.222; Sato T, 2009, ENVIRON MICROBIOL, V11, P1007, DOI 10.1111/j.1462-2920.2008.01827.x; Stephens ME, 2018, BIORXIV; Stingl U, 2005, APPL ENVIRON MICROB, V71, P1473, DOI 10.1128/AEM.71.3.1473-1479.2005; Strassert JFH, 2016, ENV MICROBIOL REP, V8, P865, DOI 10.1111/1758-2229.12451; Tai V, 2016, APPL ENVIRON MICROB, V82, P4682, DOI 10.1128/AEM.00611-16; Tikhonenkov DV, 2016, J EUKARYOT MICROBIOL, V63, P220, DOI 10.1111/jeu.12271; Trager W, 1934, BIOL BULL-US, V66, P182, DOI 10.2307/1537331; Treitli SC, 2019, P NATL ACAD SCI USA, V116, P19675, DOI 10.1073/pnas.1910793116; Utami YD, 2019, ISME J, V13, P455, DOI 10.1038/s41396-018-0297-4; WAIDELE L, 2017, FRONT MICROBIOL, V8, P13159, DOI DOI 10.3389/FMICB.2017.00001; Wickham H, 2011, WIRES COMPUT STAT, V3, P180, DOI 10.1002/wics.147; YAMIN MA, 1979, J GEN MICROBIOL, V113, P417, DOI 10.1099/00221287-113-2-417; Ye WM, 2004, MOL PHYLOGENET EVOL, V30, P815, DOI 10.1016/S1055-7903(03)00230-6; Yuki M, 2015, ENVIRON MICROBIOL, V17, P4942, DOI 10.1111/1462-2920.12945; Zheng H, 2015, MICROBES ENVIRON, V30, P92, DOI 10.1264/jsme2.ME14169	53	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233065	10.1371/journal.pone.0233065	http://dx.doi.org/10.1371/journal.pone.0233065			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413056	Green Published, gold			2022-12-26	WOS:000537496000047
J	Voth, S; Gwin, M; Francis, CM; Balczon, R; Frank, DW; Pittet, JF; Wagener, BM; Moser, SA; Alexeyev, M; Housley, N; Audia, JP; Piechocki, S; Madera, K; Simmons, A; Crawford, I; Stevens, T				Voth, Sarah; Gwin, Meredith; Francis, Christopher Michael; Balczon, Ron; Frank, Dara W.; Pittet, Jean-Francois; Wagener, Brant M.; Moser, Stephen A.; Alexeyev, Mikhail; Housley, Nicole; Audia, Jonathon P.; Piechocki, Scott; Madera, Kayla; Simmons, Autumn; Crawford, Iichacla; Stevens, Troy			Virulent Pseudomonas aeruginosa infection converts antimicrobial amyloids into cytotoxic prions	FASEB JOURNAL			English	Article						amyloid beta (A beta); exoenzyme Y (ExoY); nosocomial pneumonia; prion; tau (tau)	VENTILATOR-ASSOCIATED PNEUMONIA; NUCLEOTIDYL CYCLASE; ALZHEIMERS-DISEASE; A-BETA; ALAMAR BLUE; EXOENZYME Y; TAU; OLIGOMERS; PEPTIDE; EXOY	Pseudomonas aeruginosa infection elicits the production of cytotoxic amyloids from lung endothelium, yet molecular mechanisms of host-pathogen interaction that underlie the amyloid production are not well understood. We examined the importance of type III secretion system (T3SS) effectors in the production of cytotoxic amyloids. P aeruginosa possessing a functional T3SS and effectors induced the production and release of cytotoxic amyloids from lung endothelium, including beta amyloid, and tau. T3SS effector intoxication was sufficient to generate cytotoxic amyloid release, yet intoxication with exoenzyme Y (ExoY) alone or together with exoenzymes S and T (ExoS/T/Y) generated the most virulent amyloids. Infection with lab and clinical strains engendered cytotoxic amyloids that were capable of being propagated in endothelial cell culture and passed to naive cells, indicative of a prion strain. Conversely, T3SS-incompetent P aeruginosa infection produced non-cytotoxic amyloids with antimicrobial properties. These findings provide evidence that (1) endothelial intoxication with ExoY is sufficient to elicit self-propagating amyloid cytotoxins during infection, (2) pulmonary endothelium contributes to innate immunity by generating antimicrobial amyloids in response to bacterial infection, and (3) ExoY contributes to the virulence arsenal of P aeruginosa through the subversion of endothelial amyloid host-defense to promote a lung endothelial-derived cytotoxic proteinopathy.	[Voth, Sarah; Gwin, Meredith; Francis, Christopher Michael; Alexeyev, Mikhail; Piechocki, Scott; Madera, Kayla; Simmons, Autumn; Crawford, Iichacla; Stevens, Troy] Univ S Alabama, Coll Med, Dept Physiol & Cell Biol, Mobile, AL 36688 USA; [Voth, Sarah; Gwin, Meredith; Francis, Christopher Michael; Balczon, Ron; Alexeyev, Mikhail; Audia, Jonathon P.; Stevens, Troy] Univ S Alabama, Coll Med, Ctr Lung Biol, Mobile, AL 36688 USA; [Balczon, Ron] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Frank, Dara W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Pittet, Jean-Francois; Wagener, Brant M.] Univ Alabama Birmingham, Birmingham Sch Med, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA; [Moser, Stephen A.] Univ Alabama Birmingham, Birmingham Sch Med, Dept Pathol, Birmingham, AL USA; [Housley, Nicole; Audia, Jonathon P.] Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA; [Stevens, Troy] Univ S Alabama, Coll Med, Dept Internal Med, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of South Alabama; University of South Alabama	Stevens, T (corresponding author), Univ S Alabama, Coll Med, Dept Physiol & Cell Biol, Mobile, AL 36688 USA.	tstevens@southalabama.edu	Voth, Sarah B./AGJ-8666-2022	Voth, Sarah B./0000-0003-3796-7154	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL140182, HL66299, HL135003, HL60024, HL118334, HL136869, F31HL147512-01]; American Heart Association (AHA) [19PRE34380166]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); American Heart Association (AHA)(American Heart Association)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL140182, HL66299, HL135003, HL60024, HL118334, HL136869 and F31HL147512-01; American Heart Association (AHA), Grant/Award Number: 19PRE34380166	Aoyagi A, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat8462; Azimi S, 2016, GMS HYG INFECT CONTR, V11, DOI 10.3205/dgkh000264; Balczon R, 2018, JOVE-J VIS EXP, DOI 10.3791/57447; Balczon R, 2017, FASEB J, V31, P2785, DOI 10.1096/fj.201601042RR; Beckert U, 2014, BIOCHEM BIOPH RES CO, V451, P497, DOI 10.1016/j.bbrc.2014.07.134; Beckert U, 2014, BIOCHEM BIOPH RES CO, V450, P870, DOI 10.1016/j.bbrc.2014.06.088; Benson MA, 2010, CLIN CHIM ACTA, V411, P190, DOI 10.1016/j.cca.2009.10.025; Castillo-Carranza DL, 2017, AGING DIS, V8, P257, DOI 10.14336/AD.2017.0112; Chan WW, 2016, CLIN MICROBIOLOGY PR, DOI [10.1128/9781555818814, DOI 10.1128/9781555818814]; Chen GF, 2017, ACTA PHARMACOL SIN, V38, P1205, DOI 10.1038/aps.2017.28; Cowan CM, 2012, BIOCHEM SOC T, V40, P693, DOI 10.1042/BST20120135; Danin PE, 2015, RESP CARE, V60, P21, DOI 10.4187/respcare.02722; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Dick A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-432; Dueholm MS, 2013, MICROBIOLOGYOPEN, V2, P365, DOI 10.1002/mbo3.81; Eimer WA, 2018, NEURON, V99, P56, DOI 10.1016/j.neuron.2018.06.030; Ercan E, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0229-1; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Forloni G, 2018, J ALZHEIMERS DIS, V62, P1261, DOI 10.3233/JAD-170819; Frank DW, 2002, J INFECT DIS, V186, P64, DOI 10.1086/341069; Gil-Perotin S, 2012, CRIT CARE, V16, DOI 10.1186/cc11357; Giles K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023499; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Gosztyla ML, 2018, J ALZHEIMERS DIS, V62, P1495, DOI 10.3233/JAD-171133; Grochowska KM, 2017, EMBO REP, V18, P962, DOI 10.15252/embr.201643519; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; He CX, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00239-17; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Hetz C, 2002, P NATL ACAD SCI USA, V99, P2696, DOI 10.1073/pnas.052709699; Howie AJ, 2008, LAB INVEST, V88, P232, DOI 10.1038/labinvest.3700714; Ibanez J, 2016, J INTENSIVE CARE MED, V31, P34, DOI 10.1177/0885066614523918; Intile PJ, 2014, J BACTERIOL, V196, P357, DOI 10.1128/JB.01199-13; Jenkins CEM, 2019, PERFORMANCE STANDARD; Jeon J, 2017, FEBS J, V284, P3392, DOI 10.1111/febs.14199; Karhu J, 2011, ACTA ANAESTH SCAND, V55, P1254, DOI 10.1111/j.1399-6576.2011.02535.x; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kloth C, 2018, TOXINS, V10, DOI 10.3390/toxins10050185; Kobayashi N, 2008, BIOCONTROL SCI, V13, P49, DOI 10.4265/bio.13.49; Kollef MH, 2014, CRIT CARE MED, V42, P2178, DOI 10.1097/CCM.0000000000000510; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Kumar S, 2011, AGING-US, V3, P803, DOI 10.18632/aging.100362; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lathe R, 2017, J ALZHEIMERS DIS REP, V1, P263, DOI 10.3233/ADR-170037; Lin MT, 2018, AM J RESP CRIT CARE, V198, P1575, DOI 10.1164/rccm.201801-0060LE; Luo JH, 2016, J BIOL CHEM, V291, P16485, DOI 10.1074/jbc.R116.714576; Marden JN, 2013, P NATL ACAD SCI USA, V110, P15055, DOI 10.1073/pnas.1307217110; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Mietelska-Porowska A, 2014, INT J MOL SCI, V15, P4671, DOI 10.3390/ijms15034671; Mikkelsen ME, 2012, AM J RESP CRIT CARE, V185, P1307, DOI 10.1164/rccm.201111-2025OC; Miklossy J, 2016, J ALZHEIMERS DIS, V53, P1459, DOI 10.3233/JAD-160451; Ming L, 2015, INT J CLIN EXP MED, V8, P5806; Moir RD, 2018, ALZHEIMERS DEMENT, V14, P1602, DOI 10.1016/j.jalz.2018.06.3040; Morrow KA, 2015, AM J PHYSIOL-LUNG C, V309, pL1199, DOI 10.1152/ajplung.00165.2015; Morrow KA, 2017, HANDB EXP PHARMACOL, V238, P67, DOI 10.1007/164_2016_5003; Morrow KA, 2016, AM J PHYSIOL-LUNG C, V310, P1337, DOI 10.1152/ajplung.00103.2015; Mroczko B, 2018, J NEURAL TRANSM, V125, P177, DOI 10.1007/s00702-017-1820-x; Naini SMA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/151979; Nguyen K, 2016, J PHYS CHEM B, V120, P2187, DOI 10.1021/acs.jpcb.5b12235; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; Ow SY, 2014, PROTEIN SCI, V23, P1315, DOI 10.1002/pro.2524; Park SC, 2016, BIOCHEM BIOPH RES CO, V478, P924, DOI 10.1016/j.bbrc.2016.08.052; Pascoal TA, 2017, ALZHEIMERS DEMENT, V13, P644, DOI 10.1016/j.jalz.2016.11.005; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Portelius E, 2006, J PROTEOME RES, V5, P1010, DOI 10.1021/pr050475v; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Ramirez-Estrada S, 2016, INFECT DRUG RESIST, V9, P7, DOI 10.2147/IDR.S50669; Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Realegeno S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005705; Reichhardt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140388; Rodrigues ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170433; Romero D, 2014, INT MICROBIOL, V17, P65, DOI 10.2436/20.1501.01.208; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Seifert R, 2017, HANDB EXP PHARMACOL, V238, P3, DOI 10.1007/164_2016_5005; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Shima K, 2010, MED MICROBIOL IMMUN, V199, P283, DOI 10.1007/s00430-010-0162-1; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Spitzer P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32228; Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013; Tsay TB, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0417-5; Tumbarello M, 2013, INTENS CARE MED, V39, P682, DOI 10.1007/s00134-013-2828-9; Vallis AJ, 1999, INFECT IMMUN, V67, P2040; Xue C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160696; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Zhou Yizhou, 2013, Methods Mol Biol, V966, P53, DOI 10.1007/978-1-62703-245-2_4	92	15	15	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9156	9179		10.1096/fj.202000051RRR	http://dx.doi.org/10.1096/fj.202000051RRR		MAY 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32413239	Green Published, Green Accepted			2022-12-26	WOS:000533181500001
J	Adedokun, ST				Adedokun, Sulaimon T.			Correlates of childhood morbidity in Nigeria: Evidence from ordinal analysis of cross-sectional data	PLOS ONE			English	Article							CHILDREN; DIARRHEA; COMMUNITY; AGE	Background Child mortality records show that 1 in every 13 children dies before age five in sub-Saharan Africa with diseases such as pneumonia, diarrhoea and malaria considered to be the leading causes of such deaths. In Nigeria where 50% of all under-five deaths are attributed to morbidity, much attention has been directed to single health conditions. This study aims at examining the factors that are associated with single health conditions and comorbidity among children in Nigeria. Materials and methods This study was based on data from 2013 Nigeria Demographic and Health Survey (DHS) which involved 27,571 under-five children who suffered from acute respiratory infection, diarrhoea or fever within two weeks of data collection exercise. Descriptive statistics and generalized ordinal logistic regression model were used for the analysis. Results About 14% of children suffered from a single health condition and 9% suffered from comorbidity. The likelihood of suffering from a single health condition and comorbidity is higher for children who are of third order birth or more (OR = 1.24, 95% CI = 1.11-1.39 & OR = 1.31, 95% CI = 1.12-1.55) compared to those who are of first order birth. The likelihood also increased for children whose mothers live in Northeast (OR = 3.19, 95% CI = 2.86-3.55 & OR = 3.88, 95% CI = 3.30-4.57) compared to children whose mothers live in North Central. The odds of suffering from a single health condition and comorbidity reduced for children who are from richest households, aged 3 years and above and were of average size at birth. Children of women who obtained water from improved source are less likely to experience any morbidity (OR = 0.93, 95% CI = 0.87-0.99) compared to children whose mothers obtained water from non-improved source. Conclusions The study has demonstrated that children in Nigeria are not only exposed to the risk of single health conditions but they are also exposed to the risk of comorbidity. Efforts should be made to design appropriate health care models that would facilitate a considerable reduction in childhood morbidity in the country.	[Adedokun, Sulaimon T.] Obafemi Awolowo Univ, Dept Demog & Social Stat, Ife, Nigeria	Obafemi Awolowo University	Adedokun, ST (corresponding author), Obafemi Awolowo Univ, Dept Demog & Social Stat, Ife, Nigeria.	adedokunsulait@gmail.com						Adedokun ST, 2017, BMC PUBLIC HEALTH, V17, P1; Adeyimika TD, 2017, AFR J REPROD HEALTH, V21, P27, DOI 10.29063/ajrh2017/v21i3.2; Azage M, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0052-2; Bano T, 2018, INT J COMMUNITY MED, V5, P3532; Beyene H, 2018, ETHIOP J HEALTH DEV, V32, P18; Bilkisu G. I., 2014, Annals of Nigerian Medicine, V8, P15; Bouba Djourdebbe F, 2015, J BIOSOC SCI, V47, P536, DOI 10.1017/S0021932014000479; Dairo MD, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.109.8152; Darvesh N, 2017, BMC PUBLIC HEALTH, V17, P1; Degebasa MZ, 2018, PEDIATR HEALTH MED T, V9, P109, DOI 10.2147/PHMT.S159366; Dunn G, 2018, SPAT SPATIO-TEMPORAL, V26, P127, DOI 10.1016/j.sste.2018.06.005; Ezeonwu BU, 2014, ANN MED HEALTH SCI R, V4, P239, DOI 10.4103/2141-9248.141966; Gaston R. T., 2018, African Population Studies, V32, P3893; Habte Dereje, 2013, Afr J Reprod Health, V17, P110; IHME, 2017, WHAT CAUS MOST DEATH; Jain A, 2018, FRONT ENV SCI ENG, V12, DOI 10.1007/s11783-018-1052-9; Johansson EW, 2017, J GLOB HEALTH, V7, P1; Kamal MM, 2016, BMJ OPEN, V5, P1; Kinyoki DK, 2017, INT STAT REV, V85, P164, DOI 10.1111/insr.12206; Knee J, 2018, PLOS NEGLECTED TROPI, V12, P1; Kumi-Kyereme A, 2016, J EPIDEMIOL GLOB HEA, V6, P131, DOI 10.1016/j.jegh.2015.05.001; Liu X., 2016, APPL ORDINAL LOGISTI; Mansour M, 2017, EGYPT J ARCHAEOL RES, V7, P1; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Novignon Jacob, 2012, BMC Res Notes, V5, P380, DOI 10.1186/1756-0500-5-380; Nyirakanani C., 2018, TANZANIA J HLTH RES, V20, P1; Peace OU, 2018, J HLTH ENV RES, V4, P97; Policy Project Nigeria, 2002, CHILD SURV NIG SIT R; Roberts D, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1290-x; Saba Syed, 2015, International Journal of Medical Science and Public Health, V4, P1277; Sebastian SR, 2018, INT J COMMUNITY MED, V5, P3459; Solomon OO., 2018, GLOB J MED PUBLIC HL, V7, P1; UNICEF, 2018, UND 5 MORT UNICEF DA; UNICEF, 2018, DIARRH DIS UNICEF DA; WHO, 2015, WHO COMM ROLL BACK M; WHO, 1996, CHILDH DIS AFR; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2018, CAUS CHILD MORT COUN; Woldu W, 2016, TROPICAL MED HLTH, V44, P1; Wolf J, 2018, TROP MED INT HEALTH, V23, P508, DOI 10.1111/tmi.13051	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233259	10.1371/journal.pone.0233259	http://dx.doi.org/10.1371/journal.pone.0233259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407377	gold, Green Published			2022-12-26	WOS:000537490700088
J	Garcia, MD; Dutto, MS; Chazarreta, CJ; Berasategui, AA; Schloss, IR; Hoffmeyer, MS				Garcia, Maximiliano D.; Sofia Dutto, M.; Chazarreta, Carlo J.; Berasategui, Anabela A.; Schloss, Irene R.; Hoffmeyer, Monica S.			Micro- and mesozooplankton successions in an Antarctic coastal environment during a warm year	PLOS ONE			English	Article							KING GEORGE ISLAND; SEA-ICE; CLIMATE-CHANGE; COMMUNITY COMPOSITION; EUPHAUSIA-SUPERBA; AMUNDSEN SEA; POTTER COVE; POLAR FRONT; PACK-ICE; PHYTOPLANKTON	The rapid increase in atmospheric temperature detected in the last decades in the Western Antarctic Peninsula was accompanied by a strong glacier retreat and an increase in production of melting water, as well as changes in the sea-ice dynamic. The objective of this study was to analyze the succession of micro- and mesozooplankton during a warm annual cycle (December 2010-December 2011) in an Antarctic coastal environment (Potter Cove). The biomass of zooplankton body size classes was used to predict predator-prey size relationships (i.e., to test bottom-up/top-down control effects) using a Multiple Linear Regression Analysis. The micro- and mesozooplanktonic successions were graphically analyzed to detect the influence of environmental periods (defined by the degree of glacial melting, seaice freezing and sea-ice melting) on coupling/uncoupling planktonic biomass curves associated to possible predator-prey size relationship scenarios. At the beginning of the glacial melting, medium and large mesozooplankton (calanoid copepods, Euphausia superba, and Salpa thompsoni) exert a top-down control on Chl-a and microzooplankton. Stratification of the water column benefitted the availability of adequate food-size (Chl-a <20) for large microzooplankton (tintinnids) development observed during fall. High abundance of omnivores mesozooplankton (Oithona similis and furcilia of E. superba) during sea-ice freezing periods would be due to the presence of available heterotrophic food under or within the sea ice. Finally, the increase in microzooplankton abundance in the middle of spring, when seaice melting starts, corresponded to small and medium dinoflagellates and ciliates species, which were possibly part of the biota of sea ice. If glacier retreat continues and the duration and thickness of the sea ice layer fluctuates as predicted by climate models, our results predict a future scenario regarding the zooplankton succession in Antarctic coastal environments.	[Garcia, Maximiliano D.; Sofia Dutto, M.; Chazarreta, Carlo J.; Berasategui, Anabela A.; Hoffmeyer, Monica S.] Univ Nacl Sur UNS, Inst Argentino Oceanog IADO CONICET, Bahia Blanca, Buenos Aires, Argentina; [Schloss, Irene R.] Inst Antartico Argentino IAA, Buenos Aires, San Martin, Argentina; [Schloss, Irene R.] Ctr Austral Invest Cientificas CADIC CONICET, Ushuaia, Argentina; [Schloss, Irene R.] Univ Nacl Tierra Fuego, Antartida & Islas Atlantico UNTdF, Ushuaia, Argentina; [Hoffmeyer, Monica S.] Univ Tecnol Nacl UTN, Fac Reg Bahia Blanca, Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Garcia, MD (corresponding author), Univ Nacl Sur UNS, Inst Argentino Oceanog IADO CONICET, Bahia Blanca, Buenos Aires, Argentina.	maxidg6@yahoo.com.ar	Garcia, Maximiliano D./AAB-2490-2022	Garcia, Maximiliano D./0000-0001-6089-7612	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Direccion Nacional del Antartico/Instituto Antartico Argentino (DNA/IAA) [PICTO 355622005, PICT 2011-1320]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Direccion Nacional del Antartico/Instituto Antartico Argentino (DNA/IAA)	Funding was provided by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT; http://www.agencia.mincyt.gob.ar/index.php) and Direccion Nacional del Antartico/Instituto Antartico Argentino (DNA/IAA; https://cancilleria.gob.ar/es/iniciativas/dna/) to IRS (PICTO 355622005 and PICT 2011-1320) during the development of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre G., 2009, 7 JORN NAC CIENC MAR, P182; Almeda R, 2011, HARMFUL ALGAE, V10, P194, DOI 10.1016/j.hal.2010.09.007; ATKINSON A, 1995, ICES J MAR SCI, V52, P385, DOI 10.1016/1054-3139(95)80054-9; BANSE K, 1963, DEEP-SEA RES, V10, P639, DOI 10.1016/0011-7471(63)90005-6; Beers J. R, 1970, Bull. Scripps Instn Oceanogr. tech. Ser., V17, P67; Bers AV, 2013, CLIMATIC CHANGE, V116, P789, DOI 10.1007/s10584-012-0523-4; Mendes CRB, 2013, POLAR BIOL, V36, P537, DOI 10.1007/s00300-012-1282-4; BOYD CM, 1984, J CRUSTACEAN BIOL, V4, P123, DOI 10.1163/1937240X84X00543; BOYSENENNEN E, 1988, POLAR BIOL, V9, P17, DOI 10.1007/BF00441761; Ciliates Petz W., 2005, MARCHANTEDITORS ANTA, P347; Comiso JC, 2017, J CLIMATE, V30, P2251, DOI [10.1175/JCLI-D-16-0408.1, 10.1175/jcli-d-16-0408.1]; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Daly KL, 2004, DEEP-SEA RES PT II, V51, P2139, DOI 10.1016/j.dsr2.2004.07.010; Deregibus D, 2016, POLAR BIOL, V39, P153, DOI 10.1007/s00300-015-1679-y; Ding QH, 2013, J CLIMATE, V26, P7570, DOI 10.1175/JCLI-D-12-00729.1; Dolan J.R., 2012, BIOL ECOLOGY TINTINN, DOI [10.1002/9781118358092.ch5, DOI 10.1002/9781118358092.CH5]; Dubischar CD, 2002, DEEP-SEA RES PT II, V49, P3871, DOI 10.1016/S0967-0645(02)00115-7; Ferreyra G. A., 1987, THESIS; Fuentes V., 2006, THESIS; Fuentes V., 2008, ANTARCTIC ECOSYSTEM, V571, P75; Fuentes V, 2016, SCI REP-UK, V6, DOI 10.1038/srep27234; Garcia MD, 2016, POLAR BIOL, V39, P123, DOI 10.1007/s00300-015-1678-z; Garcia MD, 2019, REGIONAL STUDIES MAR; Garrison D.L., 1993, P123; Garzio LM, 2013, DEEP-SEA RES PT I, V77, P36, DOI 10.1016/j.dsr.2013.03.001; Hansen PJ, 1999, J EUKARYOT MICROBIOL, V46, P382, DOI 10.1111/j.1550-7408.1999.tb04617.x; HASLE GR, 1978, MONOGRAPHS OCEANOGRA; HEINBOKEL JF, 1988, J PLANKTON RES, V10, P659, DOI 10.1093/plankt/10.4.659; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; IKEDA T, 1989, MAR BIOL, V100, P301, DOI 10.1007/BF00391143; Jiang Y, 2014, PROG OCEANOGR, V128, P49, DOI 10.1016/j.pocean.2014.08.006; Kaufmann RS, 2003, DEEP-SEA RES PT II, V50, P1765, DOI 10.1016/S0967-0645(03)00092-4; Kejna M, 2013, POL POLAR RES, V34, P213, DOI 10.2478/popore-2013-0004; KIORBOE T, 1995, MAR ECOL PROG SER, V120, P285, DOI 10.3354/meps120285; KIVI K, 1995, MAR ECOL PROG SER, V119, P125, DOI 10.3354/meps119125; Klaas C, 2001, DEEP-SEA RES PT I, V48, P1627, DOI 10.1016/S0967-0637(00)00088-1; KLOSER H, 1994, ESTUAR COAST SHELF S, V38, P523, DOI 10.1006/ecss.1994.1036; KOFOID CHARLES A., 1929, UNIV CALIF PUBL ZOOL, V34, P1; Kogan M, 2005, THESIS; Landry MR, 2002, DEEP-SEA RES PT II, V49, P1843, DOI 10.1016/S0967-0645(02)00015-2; Latasa M, 2014, MAR ECOL PROG SER, V513, P39, DOI 10.3354/meps10937; Leps J, 2003, MULTIVARIATE ANAL EC; Loeb V, 2003, AMRL 2001 2002 FIELD, P186; Lukac D., 2005, THESIS; Mayzaud P, 2002, DEEP-SEA RES PT II, V49, P3169, DOI 10.1016/S0967-0645(02)00077-2; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Meredith MP, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2017.0163; Meyer B, 2017, NAT ECOL EVOL, V1, P1853, DOI 10.1038/s41559-017-0368-3; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Omori M., 1984, METHODS ZOOPLANKTON; Pond DW, 2011, J PLANKTON RES, V33, P105, DOI 10.1093/plankt/fbq089; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; Ramirez F.C., 1981, P443; Rose JM, 2009, BIOGEOSCIENCES, V6, P3131, DOI 10.5194/bg-6-3131-2009; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; Ruckamp M, 2011, GLOBAL PLANET CHANGE, V79, P99, DOI 10.1016/j.gloplacha.2011.06.009; Safi KA, 2007, DEEP-SEA RES PT I, V54, P1025, DOI 10.1016/j.dsr.2007.05.003; Sangra P, 2014, MAR ECOL PROG SER, V499, P35, DOI 10.3354/meps10668; Schloss I.R., 1997, THESIS; Schloss IR, 2002, J MARINE SYST, V36, P129, DOI 10.1016/S0924-7963(02)00183-5; Schloss IR, 2012, J MARINE SYST, V92, P53, DOI 10.1016/j.jmarsys.2011.10.006; Schmoker C, 2013, J PLANKTON RES, V35, P691, DOI 10.1093/plankt/fbt023; Schnack S.B., 1985, European Marine Biology Symposium, V18, P65; Sherr EB, 2007, MAR ECOL PROG SER, V352, P187, DOI 10.3354/meps07161; SIEGEL V, 1986, ARCH FISCHEREIWISS, V37, P51; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Strickland J., 1972, J FISH RES BOARD CAN; Tanimura A, 1986, MEM NATL I POLAR RES, V40, P212; Thomson RE, 2003, J ATMOS OCEAN TECH, V20, P319, DOI 10.1175/1520-0426(2003)020<0319:EMLDFO>2.0.CO;2; Torstensson A, 2015, ENVIRON MICROBIOL, V17, P3869, DOI 10.1111/1462-2920.12865; Tremblay G, 2009, AQUAT MICROB ECOL, V54, P55, DOI 10.3354/ame01257; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Turner J, 2017, GEOPHYS RES LETT, V44, P6868, DOI 10.1002/2017GL073656; Turner J, 2017, NATURE, V547, P275, DOI 10.1038/547275a; Turner J, 2016, NATURE, V535, P411, DOI 10.1038/nature18645; Turner J, 2016, CLIM DYNAM, V46, P2391, DOI 10.1007/s00382-015-2708-9; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Venables HJ, 2013, LIMNOL OCEANOGR, V58, P1035, DOI 10.4319/lo.2013.58.3.1035; Voronina NM, 1998, J MARINE SYST, V17, P375, DOI 10.1016/S0924-7963(98)00050-5; Watts J, 2012, DEEP-SEA RES PT II, V59, P117, DOI 10.1016/j.dsr2.2011.05.001; Wirtz KW, 2012, MAR ECOL PROG SER, V445, P1, DOI 10.3354/meps09502; Yang EJ, 2016, DEEP-SEA RES PT II, V123, P58, DOI 10.1016/j.dsr2.2015.06.001; [No title captured]	83	7	8	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232614	10.1371/journal.pone.0232614	http://dx.doi.org/10.1371/journal.pone.0232614			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407403	Green Published, gold			2022-12-26	WOS:000537490700026
J	Murphy, H; McCarthy, G; Dobrovolny, HM				Murphy, Hope; McCarthy, Gabriel; Dobrovolny, Hana M.			Understanding the effect of measurement time on drug characterization	PLOS ONE			English	Article							TUMOR-GROWTH; CANCER-TREATMENT; MODEL; CHEMOTHERAPY; DYNAMICS; RATES; MECHANISM; ONCOLOGY; THERAPY; METRICS	In order to determine correct dosage of chemotherapy drugs, the effect of the drug must be properly quantified. There are two important values that characterize the effect of the drug: epsilon(max) is the maximum possible effect of a drug, and IC50 is the drug concentration where the effect diminishes by half. There is currently a problem with the way these values are measured because they are time-dependent measurements. We use mathematical models to determine how the epsilon(max) and IC50 values depend on measurement time and model choice. Seven ordinary differential equation models (ODE) are used for the mathematical analysis; the exponential, Mendelsohn, logistic, linear, surface, Bertalanffy, and Gompertz models. We use the models to simulate tumor growth in the presence and absence of treatment with a known IC50 and epsilon(max). Using traditional methods, we then calculate the IC50 and epsilon(max) values over fifty days to show the time-dependence of these values for all seven mathematical models. The general trend found is that the measured IC50 value decreases and the measured epsilon(max) increases with increasing measurement day for most mathematical models. Unfortunately, the measured values of IC50 and epsilon(max)rarely matched the values used to generate the data. Our results show that there is no optimal measurement time since models predict that IC50 estimates become more accurate at later measurement times while epsilon(max) is more accurate at early measurement times.	[Murphy, Hope; McCarthy, Gabriel; Dobrovolny, Hana M.] Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA	Texas Christian University	Dobrovolny, HM (corresponding author), Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA.	h.dobrovolny@tcu.edu	Dobrovolny, Hana M./A-2447-2013	Dobrovolny, Hana M./0000-0003-3592-6770				Abdulrashid I, 2020, COMMUN PUR APPL ANAL, V19, P1875, DOI 10.3934/cpaa.2020082; Awasthee N, 2019, SEMIN CANCER BIOL, V56, P12, DOI 10.1016/j.semcancer.2018.02.007; Babaei N, 2019, EUR J CONTROL, V50, P117, DOI 10.1016/j.ejcon.2019.03.001; Babak MV, 2015, CHEM-EUR J, V21, P5110, DOI 10.1002/chem.201403974; Barbolosi D, 2016, NAT REV CLIN ONCOL, V13, P242, DOI 10.1038/nrclinonc.2015.204; Bodnar M, 2019, DISCRETE CONT DYN-B, V24, P2149, DOI 10.3934/dcdsb.2019088; Bodnar M, 2019, COMMUN NONLINEAR SCI, V72, P552, DOI 10.1016/j.cnsns.2019.01.015; Borges GA, 2020, CLIN EXP PHARMACOL P, V47, P857, DOI 10.1111/1440-1681.13256; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bregenzer ME, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216564; Bushweller JH, 2019, NATURE REV CANC; Calhelha RC, 2017, ANALYST, V142, P4124, DOI 10.1039/c7an00782e; Cassidy T, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007495; COLLINS VP, 1956, AMER J ROENTGENOL RA, V76, P988; Demment MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134618; DETHLEFSEN LA, 1968, JNCI-J NATL CANCER I, V40, P389, DOI 10.1093/jnci/40.2.389; Eichler M, 2015, BIOSENS BIOELECTRON, V67, P582, DOI 10.1016/j.bios.2014.09.049; Elazab A, 2018, IEEE ACCESS, V6, P30663, DOI 10.1109/ACCESS.2018.2839681; Eldahshan OA, 2013, BRIT J PHARM RES, V3, P46, DOI 10.9734/BJPR/2013/1864; Fallahi-Sichani M, 2013, NAT CHEM BIOL, V9, P708, DOI [10.1038/nchembio.1337, 10.1038/NCHEMBIO.1337]; Gerlee P, 2013, CANCER RES, V73, P2407, DOI 10.1158/0008-5472.CAN-12-4355; Germani M, 2003, CANCER CHEMOTH PHARM, V52, P507, DOI 10.1007/s00280-003-0688-7; Ghahremanloo A, 2019, CELL ONCOL, V42, P609, DOI 10.1007/s13402-019-00456-w; Gompertz B, 1825, PHILOS T ROY SOC LON, V115, P513, DOI DOI 10.1098/RSTL.1825.0026; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Grassberger C, 2019, CANCER RES, V79, P3776, DOI 10.1158/0008-5472.CAN-18-3652; Gurney H, 2002, BRIT J CANCER, V86, P1297, DOI 10.1038/sj.bjc.6600139; Hafner M, 2016, NAT METHODS, V13, P521, DOI [10.1038/NMETH.3853, 10.1038/nmeth.3853]; Hamilton G, 2019, EXPERT OPIN DRUG MET, V15, P15, DOI 10.1080/17425255.2019.1554055; Han LF, 2019, MATH BIOSCI ENG, V16, P5307, DOI 10.3934/mbe.2019265; Harris LA, 2016, NAT METHODS, V13, P497, DOI [10.1038/NMETH.3852, 10.1038/nmeth.3852]; Hazekawa M, 2019, EXP THER MED, V18, P3197, DOI 10.3892/etm.2019.7876; Heesterman BL, 2019, J NEUROL SURG PART B, V80, P72, DOI 10.1055/s-0038-1667148; Houy N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199076; Jarrett AM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49073-5; Karolak A, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0703; Lai XR, 2019, CANCER RES, V79, P4293, DOI 10.1158/0008-5472.CAN-18-1804; LAIRD AK, 1965, BRIT J CANCER, V19, P278, DOI 10.1038/bjc.1965.32; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; Li HS, 2017, J PHARMACOKINET PHAR, V44, P403, DOI 10.1007/s10928-017-9528-y; Lorenzo G, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0195; McGrail DJ, 2015, AIMS BIOENG, V2, P310, DOI 10.3934/bioeng.2015.4.310; McKenna MT, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00616; McKenna MT, 2018, TRANSL ONCOL, V11, P732, DOI 10.1016/j.tranon.2018.03.009; Mendelsohn ML, 1963, CELL PROLIFERAT, P190; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mishra S, 2008, J BIOSCIENCES, V33, P381, DOI 10.1007/s12038-008-0058-z; Mulder WJM, 2019, NAT REV DRUG DISCOV, V18, P553, DOI 10.1038/s41573-019-0025-4; Murphy H, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2164-x; Nath K, 2016, BBA-REV CANCER, V1866, P151, DOI 10.1016/j.bbcan.2016.08.001; Niepel M, 2019, CELL SYST, V9, P35, DOI 10.1016/j.cels.2019.06.005; Perez-Garcia VM, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006778; Doan P, 2018, EUR J PHARMACOL, V820, P229, DOI 10.1016/j.ejphar.2017.12.049; Roscilli G, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0816-x; Roskoski R, 2019, PHARMACOL RES, V144, P19, DOI 10.1016/j.phrs.2019.03.006; Saccomani MP, 2018, COMPLEXITY, DOI 10.1155/2018/2380650; Sarmento-Ribeiro AB, 2019, DRUG RESIST UPDATE, V47, DOI 10.1016/j.drup.2019.100646; Senapati D, 2019, GENE, V719, DOI 10.1016/j.gene.2019.144071; Shariatpanahi SP, 2018, J THEOR BIOL, V442, P1, DOI 10.1016/j.jtbi.2018.01.006; Shen JY, 2020, CANCERS, V12, DOI 10.3390/cancers12020436; Shiekhzadeh A, 2020, APPL BIOCHEM BIOTECH, V190, P506, DOI 10.1007/s12010-019-03078-y; Sigal D, 2019, MATH BIOSCI, V318, DOI 10.1016/j.mbs.2019.108269; SUMMERS WC, 1966, GROWTH, V30, P333; Talkington A, 2015, B MATH BIOL, V77, P1934, DOI 10.1007/s11538-015-0110-8; Tsur N, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2081-2; Vardhan H, 2014, PLOS ONE, V9; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; VONBERTALANFFY L, 1949, NATURE, V163, P156, DOI 10.1038/163156a0; Wang S, 2019, DISCRETE CONT DYN-B, V24, P2383, DOI 10.3934/dcdsb.2019100; Witzel F, 2015, BIOINFORMATICS, V31, P2705, DOI 10.1093/bioinformatics/btv216; Worschech A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-301; Wu ZM, 2019, MATH BIOSCI ENG, V16, P3512, DOI 10.3934/mbe.2019176; Yankeelov TE, 2016, ANN BIOMED ENG, V44, P2626, DOI 10.1007/s10439-016-1691-6; Ye SF, 2017, ACTA PHARMACOL SIN, V38, P223, DOI 10.1038/aps.2016.114; Yu JL, 2019, APPL MATH COMPUT, V362, DOI 10.1016/j.amc.2019.06.037; Zimmer A, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002518	76	1	2	7	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233031	10.1371/journal.pone.0233031	http://dx.doi.org/10.1371/journal.pone.0233031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407356	Green Published, gold			2022-12-26	WOS:000537490700061
J	Tovbis, D; Agur, A; Mogk, JPM; Zariffa, J				Tovbis, Daniel; Agur, Anne; Mogk, Jeremy P. M.; Zariffa, Jose			Automatic three-dimensional reconstruction of fascicles in peripheral nerves from histological images	PLOS ONE			English	Article								Computational studies can be used to support the development of peripheral nerve interfaces, but currently use simplified models of nerve anatomy, which may impact the applicability of simulation results. To better quantify and model neural anatomy across the population, we have developed an algorithm to automatically reconstruct accurate peripheral nerve models from histological cross-sections. We acquired serial median nerve cross-sections from human cadaveric samples, staining one set with hematoxylin and eosin (H&E) and the other using immunohistochemistry (IHC) with anti-neurofilament antibody. We developed a four-step processing pipeline involving registration, fascicle detection, segmentation, and reconstruction. We compared the output of each step to manual ground truths, and additionally compared the final models to commonly used extrusions, via intersection-over-union (IOU). Fascicle detection and segmentation required the use of a neural network and active contours in H&E-stained images, but only simple image processing methods for IHC-stained images. Reconstruction achieved an IOU of 0.42 +/- 0.07 for H&E and 0.37 +/- 0.16 for IHC images, with errors partially attributable to global misalignment at the registration step, rather than poor reconstruction. This work provides a quantitative baseline for fully automatic construction of peripheral nerve models. Our models provided fascicular shape and branching information that would be lost via extrusion.	[Tovbis, Daniel; Zariffa, Jose] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Tovbis, Daniel; Zariffa, Jose] Univ Hlth Network, Toronto Rehab, KITE, Toronto, ON, Canada; [Agur, Anne; Mogk, Jeremy P. M.] Univ Toronto, Dept Surg, Div Anat, Toronto, ON, Canada; [Agur, Anne; Zariffa, Jose] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Zariffa, Jose] Univ Toronto, Edward S Rogers Sr Dept Elect & Comp Engn, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Toronto; University of Toronto	Zariffa, J (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.; Zariffa, J (corresponding author), Univ Hlth Network, Toronto Rehab, KITE, Toronto, ON, Canada.; Zariffa, J (corresponding author), Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada.; Zariffa, J (corresponding author), Univ Toronto, Edward S Rogers Sr Dept Elect & Comp Engn, Toronto, ON, Canada.	jose.zariffa@utoronto.ca	; Zariffa, Jose/A-6954-2016	Tovbis, Daniel/0000-0001-5230-6923; Zariffa, Jose/0000-0002-8842-745X; Agur, Anne/0000-0002-2303-3628	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-05498]; Institute of Biomaterials and Biomedical Engineering, University of Toronto	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Institute of Biomaterials and Biomedical Engineering, University of Toronto	JZ -Natural Sciences and Engineering Research Council of Canada (RGPIN-2014-05498) https://www.nserc-crsng.gc.ca/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JZ and JPM -Institute of Biomaterials and Biomedical Engineering, University of Toronto https://ibbme.utoronto.ca/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton TJ, 1999, IMAGE VISION COMPUT, V17, P795, DOI 10.1016/S0262-8856(98)00160-7; Behkami S, 2018, BIOMED TECH; Casiraghi E, 2017, EUR J HISTOCHEM; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; D'Anna E, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aau8892; Delgado-Martinez I, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00286; Garai P, 2017, IEEE T NEUR SYS REH, V25, P1653, DOI 10.1109/TNSRE.2016.2633005; Gonzalez HFJ, 2019, NEUROSURGERY CLIN N; Holcombe S., 2014, INTERPMASK INTERPOLA; Jaqua K, 2017, CURRENT UROLOGY REPO; Kent AR, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036010; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pavlov VA, 2017, NATURE NEUROSCIENCE; Pelot NA, 2018, FRONT COMPUT NEUROSC, V12, DOI 10.3389/fncom.2018.00040; Perona Pietro, 1990, IEEE T PATTERN ANAL; Prats-Galino A, 2018, CLIN ANAT, V31, P424, DOI 10.1002/ca.23028; Raspopovic S, 2017, P IEEE; Redmon J., 2018, TECH REP; Rijnbeek EH, 2018, FRONTIERS NEUROSCIEN; Schiefer MA, 2012, J COMPUT NEUROSCI; Sevcencu C, 2018, NEUROMODULATION; Silveira C, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aabca0; Sivagnanam S, 2013, CEUR WORKSHOP P; Sun K, 2009, MICROSURG, V29, P573, DOI 10.1002/micr.20646; Wodlinger B, 2009, IEEE T NEUR SYS REH, V17, P461, DOI 10.1109/TNSRE.2009.2034072; Wolf DN, 2018, IEEE T NEURAL SYST R; Yan LW, 2017, J NEUROSCI METH, V287, P58, DOI 10.1016/j.jneumeth.2017.06.009; Zhang Y, 2009, J BIOACT COMPAT POL, V24, P100, DOI 10.1177/0883911509103944; Zhong YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17168	29	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233028	10.1371/journal.pone.0233028	http://dx.doi.org/10.1371/journal.pone.0233028			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407341	Green Published, Green Submitted, gold			2022-12-26	WOS:000537490700060
J	Tsiplakou, E; Mavrommatis, A; Skliros, D; Righi, F; Flemetakis, E				Tsiplakou, Eleni; Mavrommatis, Alexandros; Skliros, Dimitrios; Righi, Federico; Flemetakis, Emmanouil			The impact of rumen-protected amino acids on the expression of key- genes involved in the innate immunity of dairy sheep	PLOS ONE			English	Article							KAPPA-B ACTIVATION; OXIDATIVE STRESS; DIETARY SUPPLEMENTATION; INFLAMMATION; METHIONINE; MACROPHAGES; MECHANISM; CHOLINE; PROTEIN; SYSTEM	Rumen protected amino acids inclusion in ewes' diets has been proposed to enhance their innate immunity. The objective of this work was to determine the impact of dietary supplementation with rumen-protected methionine or lysine, as well as with a combination of these amino acids in two different ratios, on the expression of selected key-genes (NLRs, MyD88, TRIF, MAPK-1, IRF-3, JunD, TRAF-3, IRF-5, IL-1 alpha, IL-10, IKK-alpha, STAT-3 and HO-1). Thus, sixty Chios dairy ewes (Ovis aries) were assigned to one of the following five dietary treatments (12 animals/ treatment): A: basal diet consist of concentrates, wheat straw and alfalfa hay (control group); B: basal diet +6.0 g/head rumen-protected methionine; C: basal diet + 5.0 g/head rumen-protected lysine; D: basal diet +6.0 g/head rumen-protected methionine + 5.0 g/head rumen-protected lysine and E: basal diet +12.0 g/head rumen-protected methionine + 5.0 g/head rumen-protected lysine. The results revealed a significant downregulation of relative transcript level of the IL-1 alpha gene in the neutrophils of C and in monocytes of D ewes compared with the control. Significantly lower mRNA transcript accumulation was also observed for the MyD88 gene in the neutrophils of ewes fed with lysine only (C). The mRNA relative expression levels of JunD gene were highly induced in the monocytes, while those of IL-10 and HO-1 genes were declined in the neutrophils of ewes fed with the C and D diets compared with the control. Lower transcript levels of STAT-3 gene were observed in the neutrophils of ewes fed with either C or with E diets in comparison with the control. In conclusion, our results suggest that the dietary supplementation of ewes with rumen-protected amino acids, down regulate the expression of some genes involved in the pro-inflammatory signalling.	[Tsiplakou, Eleni; Mavrommatis, Alexandros] Agr Univ Athens, Sch Anim Biosci, Dept Anim Sci, Lab Nutr Physiol & Feeding, Athens, Greece; [Skliros, Dimitrios; Flemetakis, Emmanouil] Agr Univ Athens, Dept Biotechnol, Lab Mol Biol, Sch Food Biotechnol & Dev, Athens, Greece; [Righi, Federico] Univ Parma, Dept Vet Sci, Parma, Italy	Agricultural University of Athens; Agricultural University of Athens; University of Parma	Tsiplakou, E (corresponding author), Agr Univ Athens, Sch Anim Biosci, Dept Anim Sci, Lab Nutr Physiol & Feeding, Athens, Greece.	eltsiplakou@aua.gr	Skliros, Dimitrios/ABH-5254-2020; Mavrommatis, Alexandros/ABH-2104-2020	Mavrommatis, Alexandros/0000-0002-0497-2750; Tsiplakou, Eleni/0000-0002-2544-8966; Righi, Federico/0000-0001-9274-4143; Flemetakis, Emmanouil/0000-0003-2530-9592				Abdelmegeid MK, 2017, J DAIRY SCI, V100, P3155, DOI 10.3168/jds.2016-12025; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Balla J, 2007, ANTIOXID REDOX SIGN, V9, P2119, DOI 10.1089/ars.2007.1787; Bertoni G, 2015, ANIM PROD SCI, V55, P943, DOI 10.1071/AN14863; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bulgari O, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0162-8; CALDER PC, 1995, P NUTR SOC, V54, P65, DOI 10.1079/PNS19950038; Cannas A, 2004, J ANIM SCI, V82, P149; Cao DY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23132; Carasi P, 2017, FRON IMMUNOL, V8; Celi P., 2013, Proceedings of the 4th International Conference on Sustainable Animal Agriculture for Developing Countries (SAADC2013), Lanzhou, China, 27-31 July 2013, P95; Cook RJ, 2010, BIOCHEM BIOPH RES CO, V398, P56, DOI 10.1016/j.bbrc.2010.06.032; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gilbert FB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-40; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Hull RP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-92; Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jacometo CB, 2018, J DAIRY SCI, V101, P8146, DOI 10.3168/jds.2018-14428; Jin J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6930; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lalani AI, 2015, J IMMUNOL, V194, P334, DOI 10.4049/jimmunol.1401548; Laurent G, 2008, CELL METAB, V7, P113, DOI 10.1016/j.cmet.2007.12.010; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Lim MX, 2014, INFECT IMMUN, V82, P4789, DOI 10.1128/IAI.02279-14; McCarthy CG, 2013, APPL PHYSIOL NUTR ME, V38, P33, DOI 10.1139/apnm-2012-0222; Osorio JS, 2014, J DAIRY SCI, V97, P7451, DOI 10.3168/jds.2014-8680; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Qian C, 2012, ANN NY ACAD SCI, V1283, P67; Raghunath A, 2018, TOXICOL APPL PHARM, V360, P236, DOI 10.1016/j.taap.2018.09.013; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rashidi N., 2005, J REPROD INFERTIL, V16, P72; Ricchetti GA, 2004, J LEUKOCYTE BIOL, V76, P719, DOI 10.1189/jlb.0104046; Scalia D, 2006, J DAIRY SCI, V89, P147, DOI 10.3168/jds.S0022-0302(06)72078-1; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sordillo LM, 2016, J DAIRY SCI, V99, P4967, DOI 10.3168/jds.2015-10354; Staples KJ, 2007, J IMMUNOL, V178, P4779, DOI 10.4049/jimmunol.178.8.4779; Swanepoel N, 2010, ANIM FEED SCI TECH, V161, P103, DOI 10.1016/j.anifeedsci.2010.08.005; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Toullec A, 2010, EMBO MOL MED, V2, P211, DOI 10.1002/emmm.201000073; Tsiplakou E, 2017, J ANIM PHYSIOL AN N, V101, P1004, DOI 10.1111/jpn.12537; Tsiplakou E, 2018, J ANIM PHYSIOL AN N, V102, P1437, DOI 10.1111/jpn.12968; Tynan GA, 2014, DIABETES, V63, P2037, DOI 10.2337/db13-1476; Van Amburgh ME, 2015, J DAIRY SCI, V98, P6361, DOI 10.3168/jds.2015-9378; VASQUEZ JA, 2011, J DAIRY SCI S1, V94, P690; Vorachek WR, 2013, INT J MOL SCI, V14, P11484, DOI 10.3390/ijms140611484; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm2; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Wu ZW, 2015, ANTIMICROB AGENTS CH, V59, P7597, DOI 10.1128/AAC.01692-15; Yang S, 2017, J BIOL CHEM, V292, P3379, DOI 10.1074/jbc.M116.756536; Yang XD, 2015, IMMUNOL REV, V266, P56, DOI 10.1111/imr.12311; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhou Z, 2016, J DAIRY SCI, V99, P8716, DOI 10.3168/jds.2015-10525	62	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233192	10.1371/journal.pone.0233192	http://dx.doi.org/10.1371/journal.pone.0233192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407360	Green Published, gold			2022-12-26	WOS:000537490700083
J	Wang, XY; Wang, MM; Chen, C; Wang, XQ				Wang, Xing-Ya; Wang, Ming-Ming; Chen, Chen; Wang, Xiao-Qi			Genetic variation and phylogeographic structure of Spodoptera exigua in western China based on mitochondrial DNA and microsatellite markers	PLOS ONE			English	Article							BEET ARMYWORM; GEOGRAPHIC-DISTRIBUTION; POPULATION-STRUCTURE; COMPUTER-PROGRAM; NULL ALLELES; MIGRATION; LEPIDOPTERA; NOCTUIDAE; SOFTWARE; DIFFERENTIATION	u The beet armyworm, Spodoptera exigua, is a significant agricultural pest of numerous crops and has caused serious economic losses in China. To effectively control this pest, we analyzed its genetic variation, population genetic structure and demographic history. We used mitochondrial DNA (mtDNA) fragments of the cytochrome oxidase subunit I (COI) and eight nuclear microsatellite loci to investigate genetic diversity and population genetic structure of S. exigua populations at 14 sampling sites in western China. Both mtDNA and microsatellite data indicated low levels of genetic diversity among all populations. A moderate genetic differentiation among some S. exigua populations was detected. Neighbor-joining dendrograms, STRUCTURE, and principal coordinate analysis (PCoA) revealed two genetically distinct groups: the KEL group and the remaining population group. Isolation by distance (IBD) results showed a weak significant correlation between geographic distance and genetic differentiation. Haplotype networks, neutrality testing, and mismatch distribution analysis indicated that the beet armyworm experienced a recent rapid expansion without a recent genetic bottleneck in western China. Thus, the results of this population genetic study can help with the development of strategies for managing this highly migratory pest.	[Wang, Xing-Ya; Wang, Ming-Ming; Chen, Chen; Wang, Xiao-Qi] Shenyang Agr Univ, Coll Plant Protect, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Wang, XQ (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Shenyang, Liaoning, Peoples R China.	wangxiaoqi1120@163.com			National Natural Science Foundation of China [31871950]; National Key Research and Development Program of China [2018YFD0200200]; science and technology plan of Liaoning Province [2019JH2/10200012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; science and technology plan of Liaoning Province	This work was supported by the National Natural Science Foundation of China (Grant No. 31871950); The National Key Research and Development Program of China (2018YFD0200200); The science and technology plan of Liaoning Province (2019JH2/10200012).	Adamczyk Jr JJ, 2009, FLORIDA ENTOMOLOGIST, V86, P229; Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; CHAUFAUX J, 1986, AGRONOMIE, V6, P99, DOI 10.1051/agro:19860109; Cornuet JM, 1996, GENETICS, V144, P2001; Cozzolino S, 2003, MOL ECOL, V12, P2783, DOI 10.1046/j.1365-294X.2003.01958.x; Dallimer M, 2003, MOL ECOL, V12, P345, DOI 10.1046/j.1365-294X.2003.01733.x; Endersby NM, 2006, MOL ECOL, V15, P107, DOI 10.1111/j.1365-294X.2005.02789.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fairley TL, 2000, J MED ENTOMOL, V37, P754, DOI 10.1603/0022-2585-37.5.754; Favret C, 2004, MOL PHYLOGENET EVOL, V32, P139, DOI 10.1016/j.ympev.2003.12.005; Feng HQ, 2003, B ENTOMOL RES, V93, P115, DOI 10.1079/BER2002221; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Fu XW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183582; Fu YX, 1997, GENETICS, V147, P915; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Guillot G, 2012, SYST BIOL, V61, P897, DOI 10.1093/sysbio/sys038; Guillot G, 2009, MOL ECOL RESOUR, V9, P1112, DOI 10.1111/j.1755-0998.2008.02496.x; Guo JY, 2010, J PEST SCI, V83, P453, DOI 10.1007/s10340-010-0315-4; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kim M, 2012, APPL ENTOMOL ZOOL, V47, P149, DOI 10.1007/s13355-012-0094-x; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; Luo LZ, 2000, PLANT PROTECTION, V26, P37; Lyons JI, 2012, MOL ECOL, V21, P3433, DOI 10.1111/j.1365-294X.2012.05613.x; MEINKE LJ, 1978, J ECON ENTOMOL, V71, P645, DOI 10.1093/jee/71.4.645; Nater A, 2013, J HERED, V104, P2, DOI 10.1093/jhered/ess065; Niu Cheng-Wei, 2006, Acta Entomologica Sinica, V49, P867; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Scott KD, 2005, J ECON ENTOMOL, V98, P2210, DOI 10.1603/0022-0493-98.6.2210; Song Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088425; TAJIMA F, 1989, GENETICS, V123, P585; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang XY, 2014, J APPL ENTOMOL, V138, P612, DOI 10.1111/jen.12102; Wang Xingya, 2016, Acta Ecologica Sinica, V36, P2337; Wang Yong-Mo, 2007, Acta Entomologica Sinica, V50, P621; Wei J, 2010, J CHANGJIANG VEG, P124; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654; Yuan JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034955; Zheng XL, 2011, J ENTOMOL RES SOC, V13, P39; Zheng XL., 2009, J CHANGJIANG VEG, V18, P4; Zhou LH, 2017, J APPL ENTOMOL, V141, P527, DOI 10.1111/jen.12371; Zhu GR, 2010, J CHANGJIANG VEGETAB, V18, P96	59	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233133	10.1371/journal.pone.0233133	http://dx.doi.org/10.1371/journal.pone.0233133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407374	gold, Green Published			2022-12-26	WOS:000537490700074
J	Raigani, S; Carroll, C; Griffith, S; Pendexter, C; Rosales, I; Deirawan, H; Beydoun, R; Yarmush, M; Uygun, K; Yeh, H				Raigani, Siavash; Carroll, Cailah; Griffith, Stephanie; Pendexter, Casie; Rosales, Ivy; Deirawan, Hany; Beydoun, Rafic; Yarmush, Martin; Uygun, Korkut; Yeh, Heidi			Improvement of steatotic rat liver function with a defatting cocktail during ex situ normothermic machine perfusion is not directly related to liver fat content	PLOS ONE			English	Article							HEPATIC STEATOSIS; NONALCOHOLIC STEATOHEPATITIS; TRANSPLANTATION; SENSITIVITY; METABOLISM; FIBROSIS; DELTA	There is a significant organ shortage in the field of liver transplantation, partly due to a high discard rate of steatotic livers from donors. These organs are known to function poorly if transplanted but make up a significant portion of the available pool of donated livers. This study demonstrates the ability to improve the function of steatotic rat livers using a combination of ex situ machine perfusion and a "defatting" drug cocktail. After 6 hours of perfusion, defatted livers demonstrated lower perfusate lactate levels and improved bile quality as demonstrated by higher bile bicarbonate and lower bile lactate. Furthermore, defatting was associated with decreased gene expression of pro-inflammatory cytokines and increased expression of enzymes involved in mitochondrial fatty acid oxidation. Rehabilitation of marginal or discarded steatotic livers using machine perfusion and tailored drug therapy can significantly increase the supply of donor livers for transplantation.	[Raigani, Siavash; Uygun, Korkut; Yeh, Heidi] Harvard Med Sch, Massachusetts Gen Hosp, Div Transplant Surg, Boston, MA 02115 USA; [Raigani, Siavash; Carroll, Cailah; Griffith, Stephanie; Pendexter, Casie; Yarmush, Martin; Uygun, Korkut; Yeh, Heidi] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02115 USA; [Raigani, Siavash; Carroll, Cailah; Griffith, Stephanie; Pendexter, Casie; Yarmush, Martin; Uygun, Korkut] Shriners Hosp Children, Boston, MA USA; [Rosales, Ivy] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Deirawan, Hany; Beydoun, Rafic] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Yarmush, Martin] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Wayne State University; Rutgers State University New Brunswick	Yeh, H (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Div Transplant Surg, Boston, MA 02115 USA.; Yeh, H (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02115 USA.	hyeh@partners.org		Yarmush, Martin/0000-0003-4986-8444; Raigani, Siavash/0000-0003-2762-7287	US National Institutes of Health [R01DK096075, R01DK107875, R21EB020819, R01DK084053, R01DK114506]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MY, KU, and HY received funding from the US National Institutes of Health (grants R01DK096075, R01DK107875, R21EB020819, R01DK084053 and R01DK114506). The funders had no role in study design, data collection, analysis, or manuscript preparation.	Atmaca M, 2011, J PHYSIOL BIOCHEM, V67, P569, DOI 10.1007/s13105-011-0103-5; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bojic LA, 2013, CURR OPIN LIPIDOL, V24, P171, DOI 10.1097/MOL.0b013e32835cc949; Boteon YL, 2019, LIVER TRANSPLANT, V25, P1007, DOI 10.1002/lt.25439; Boteon YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201419; Boteon YL, 2018, AM J TRANSPLANT, V18, P2384, DOI 10.1111/ajt.14992; Bruinsma BG, 2017, TRANSPLANTATION, V101, P1637, DOI 10.1097/TP.0000000000001699; Chu MJJ, 2015, J GASTROINTEST SURG, V19, P1713, DOI 10.1007/s11605-015-2832-1; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; El-Agroudy NN, 2016, BRIT J PHARMACOL, V173, P3248, DOI 10.1111/bph.13611; Farrell GC, 2008, ANAT REC, V291, P684, DOI 10.1002/ar.20715; Franko A, 2017, MOL METAB, V6, P256, DOI 10.1016/j.molmet.2016.12.007; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Hall AR, 2014, LIVER INT, V34, P1414, DOI 10.1111/liv.12614; Hasegawa T, 2007, AM J PHYSIOL-GASTR L, V292, pG1385, DOI 10.1152/ajpgi.00246.2006; Jamieson RW, 2011, TRANSPLANTATION, V92, P289, DOI 10.1097/TP.0b013e318223d817; Johannsen K, 2019, HORM METAB RES; Khan-Malek R, 2017, METHODS MOL BIOL, V1641, P281, DOI 10.1007/978-1-4939-7172-5_15; Liu Q, 2018, LIVER TRANSPLANT, V24, P233, DOI 10.1002/lt.24972; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Moosburner Simon, 2018, HPB Surg, V2018, P6094936, DOI 10.1155/2018/6094936; Moschen AR, 2010, CURR PHARM DESIGN, V16, P1913, DOI 10.2174/138161210791208947; Nagrath D, 2009, METAB ENG, V11, P274, DOI 10.1016/j.ymben.2009.05.005; Nair S, 2003, AM J GASTROENTEROL, V98, P466, DOI 10.1016/S0002-9270(02)05889-6; Nakamuta M, 2005, TRANSPLANTATION, V80, P608, DOI 10.1097/01.tp.0000166009.77444.f3; Nasralla D, 2018, NATURE, V557, P50, DOI 10.1038/s41586-018-0047-9; Nativ NI, 2014, LIVER TRANSPLANT, V20, P1000, DOI 10.1002/lt.23905; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Nostedt Jordan J, 2018, HPB Surg, V2018, P6867986, DOI 10.1155/2018/6867986; Raigani S, 2019, LIVER TRANSPLANT, V25, P991, DOI 10.1002/lt.25490; Ratziu V, 2016, GASTROENTEROLOGY, V150, P1147, DOI 10.1053/j.gastro.2016.01.038; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Selzner M, 2001, SEMIN LIVER DIS, V21, P105, DOI 10.1055/s-2001-12933; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Staels B, 2013, HEPATOLOGY, V58, P1941, DOI 10.1002/hep.26461; Sumida Y, 2018, J GASTROENTEROL, V53, P362, DOI 10.1007/s00535-017-1415-1; Tanaka N, 2017, PHARMACOL THERAPEUT, V179, P142, DOI 10.1016/j.pharmthera.2017.05.011; Vetelainen R, 2007, BRIT J SURG, V94, P1002, DOI 10.1002/bjs.5672; Wu GM, 2017, METHODS MOL BIOL, V1558, P235, DOI 10.1007/978-1-4939-6783-4_11; Yeh H, 2019, HEPATOLOGY, V70, P431, DOI 10.1002/hep.30523	40	11	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232886	10.1371/journal.pone.0232886	http://dx.doi.org/10.1371/journal.pone.0232886			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396553	Green Published, gold			2022-12-26	WOS:000537475000023
J	Yim, TW; Perling, D; Polcz, M; Komalavilas, P; Brophy, C; Cheung-Flynn, J				Yim, Tsz Wing; Perling, Daniel; Polcz, Monica; Komalavilas, Padmini; Brophy, Colleen; Cheung-Flynn, Joyce			A cell permeant phosphopeptide mimetic of Niban inhibits p38 MAPK and restores endothelial function after injury	FASEB JOURNAL			English	Article						endothelial dysfunction; kinase inhibitor; Niban; p38 MAPK; vascular	ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; SUBFAILURE OVERSTRETCH INJURY; P2X7 RECEPTOR; SIGNALING PATHWAYS; VASCULAR-RESPONSE; EXTRACELLULAR ATP; BLOOD-VESSELS; ORGAN DAMAGE; IN-VITRO	Vascular injury leads to membrane disruption, ATP release, and endothelial dysfunction. Increases in the phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK) and decreases in the phosphorylation of Niban, a protein implicated in ER stress and apoptosis, are associated with vascular injury. A cell permeant phosphopeptide mimetic of Niban (NiPp) was generated. The effects of NiPp in restoring endothelial function were determined ex vivo using intact rat aortic tissue (RA) after pharmacological activation of p38 MAPK and also in multiple clinically relevant injury models. Anisomycin (Aniso) increased p38 MAPK phosphorylation and reduced endothelial-dependent relaxation in RA. Treatment with NiPp prevented Ansio-induced reduction in endothelial function and increases in p38 MAPK phosphorylation. NiPp treatment also restored endothelial function after stretch injury (subfailure stretch), treatment with acidic Normal Saline (NS), and P2X7R activation with 2 '(3 ')-O-(4-Benzoylbenzoyl)adenosine 5 '-triphosphate (BzATP). Aged, diseased, human saphenous vein (HSV) remnants obtained from patients undergoing coronary bypass surgical procedures have impaired endothelial function. Treatment of these HSV segments with NiPp improved endothelial-dependent relaxation. Kinome screening experiments indicated that NiPp inhibits p38 MAPK. These data demonstrate that p38 MAPK and Niban signaling have a role in endothelial function, particularly in response to injury. Niban may represent an endogenous regulator of p38 MAPK activation. The NiPp peptide may serve as an experimental tool to further elucidate p38 MAPK regulation and as a potential therapeutic for endothelial dysfunction.	[Yim, Tsz Wing; Perling, Daniel; Polcz, Monica; Komalavilas, Padmini; Brophy, Colleen; Cheung-Flynn, Joyce] Vanderbilt Univ, Dept Surg, 1211 Med Ctr Dr, Nashville, TN 37232 USA; [Komalavilas, Padmini; Brophy, Colleen] VA Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Cheung-Flynn, J (corresponding author), Vanderbilt Univ, Dept Surg, 1211 Med Ctr Dr, Nashville, TN 37232 USA.	joyce.cheung-flynn@vumc.org			National Institutes of Health [R01HL70715-09, R01HL105731-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: R01HL70715-09 and R01HL105731-01	Abebe W, 2010, EPMA J, V1, P32, DOI 10.1007/s13167-010-0012-7; Behr TM, 2001, CIRCULATION, V104, P1292, DOI 10.1161/hc3601.094275; Brown KA, 2007, ARTERIOSCL THROM VAS, V27, P1941, DOI 10.1161/ATVBAHA.107.146852; BURD JF, 1973, CLIN CHIM ACTA, V46, P223, DOI 10.1016/0009-8981(73)90174-5; Chao CC, 2012, J CELL BIOCHEM, V113, P1377, DOI 10.1002/jcb.24010; Cheriyan J, 2011, CIRCULATION, V123, P515, DOI 10.1161/CIRCULATIONAHA.110.971986; Cheung-Flynn J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220893; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Crimi E, 2012, J CRIT CARE, V27, P108, DOI 10.1016/j.jcrc.2011.06.001; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Dong L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020278; Donnelly-Roberts DL, 2004, J PHARMACOL EXP THER, V308, P1053, DOI 10.1124/jpet.103.059600; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Dubyak GR, 2002, AM J PHYSIOL-CELL PH, V282, pC242, DOI 10.1152/ajpcell.00522.2001; Eagle S, 2011, AM SURGEON, V77, P922; Evstafieva AG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191107; Feng X, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0167-5; Fischer-Colbrie R, 2005, CURR PROTEIN PEPT SC, V6, P373, DOI 10.2174/1389203054546334; Franceschini A, 2015, FASEB J, V29, P2450, DOI 10.1096/fj.14-268714; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Galan M, 2014, BBA-MOL CELL RES, V1843, P1063, DOI 10.1016/j.bbamcr.2014.02.009; Gustin JA, 2004, AM J PHYSIOL-CELL PH, V286, pC547, DOI 10.1152/ajpcell.00332.2002; Guth CM, 2017, J SURG RES, V216, P80, DOI 10.1016/j.jss.2017.03.025; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Harskamp RE, 2014, JAMA SURG, V149, P798, DOI 10.1001/jamasurg.2014.87; Ho A, 2001, CANCER RES, V61, P474; Hocking KM, 2011, J VASC SURG, V53, P454, DOI 10.1016/j.jvs.2010.09.010; Icli B, 2019, FASEB J, V33, P5599, DOI 10.1096/fj.201802063RR; Ji HT, 2012, EMBO REP, V13, P554, DOI 10.1038/embor.2012.53; Jia LX, 2015, J PATHOL, V236, P373, DOI 10.1002/path.4534; Ju HS, 2002, J PHARMACOL EXP THER, V301, P15, DOI 10.1124/jpet.301.1.15; Ju HS, 2003, J PHARMACOL EXP THER, V307, P932, DOI 10.1124/jpet.103.057422; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; KOGA T, 1989, HYPERTENSION, V14, P542, DOI 10.1161/01.HYP.14.5.542; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Komalavilas P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188069; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Li FD, 2014, JAMA SURG, V149, P655, DOI 10.1001/jamasurg.2013.5067; Lum H, 1999, AM J PHYSIOL-CELL PH, V277, pC580, DOI 10.1152/ajpcell.1999.277.3.C580; Luo WF, 2017, PURINERG SIGNAL, V13, P579, DOI 10.1007/s11302-017-9585-0; Luo WF, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00075; Majima S, 2000, JPN J CANCER RES, V91, P869, DOI 10.1111/j.1349-7006.2000.tb01027.x; Malek AM, 1998, STROKE, V29, P2631, DOI 10.1161/01.STR.29.12.2631; Mayr M, 2000, FASEB J, V14, P261, DOI 10.1096/fasebj.14.2.261; McGeachie MJ, 2018, J ALLERGY CLIN IMMUN, V142, P1479, DOI 10.1016/j.jaci.2017.11.059; Niaudet C, 2017, CELL SIGNAL, V33, P10, DOI 10.1016/j.cellsig.2017.02.001; Nozima BH, 2019, ENDOCR-RELAT CANCER, V26, P227, DOI 10.1530/ERC-17-0530; Ohashi N, 2000, ARTERIOSCL THROM VAS, V20, P2521, DOI 10.1161/01.ATV.20.12.2521; Osgood MJ, 2014, J VASC SURG, V60, P202, DOI 10.1016/j.jvs.2013.06.004; Ottesen AH, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.118.007045; Pallmann N, 2019, ONCOGENE, V38, P6301, DOI 10.1038/s41388-019-0879-2; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Stone JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00409; Sun GD, 2007, BIOCHEM BIOPH RES CO, V360, P181, DOI 10.1016/j.bbrc.2007.06.021; TESFAMARIAM B, 1991, J CLIN INVEST, V87, P1643, DOI 10.1172/JCI115179; Ungvari Z, 2018, CIRC RES, V123, P849, DOI 10.1161/CIRCRESAHA.118.311378; Varghese GP, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003031; Ward B, 2009, J PEPT SCI, V15, P668, DOI 10.1002/psc.1168; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695; Wise ES, 2015, SURGERY, V158, P537, DOI 10.1016/j.surg.2015.03.036; Yuki R, 2015, J CELL BIOCHEM, V116, P954, DOI 10.1002/jcb.25046; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0	67	3	3	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9180	9191		10.1096/fj.201902745R	http://dx.doi.org/10.1096/fj.201902745R		MAY 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32396246	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000532318400001
J	Sobhy, NM; Yousef, SGA; Aboubakr, HA; Nisar, M; Nagaraja, KV; Mor, SK; Valeris-Chacin, RJ; Goyal, SM				Sobhy, Nader M.; Yousef, Sarah G. A.; Aboubakr, Hamada A.; Nisar, Muhammad; Nagaraja, Kakambi V.; Mor, Sunil K.; Valeris-Chacin, Robert J.; Goyal, Sagar M.			Virulence factors and antibiograms of Escherichia coli isolated from diarrheic calves of Egyptian cattle and water buffaloes	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; HEALTHY CALVES; DAIRY CALVES; RISK-FACTORS; STRAINS; GENE; PREVALENCE; MORTALITY; PROFILES; STEC	Diarrhea caused by Escherichia coli in calves is an important problem in terms of survivability, productivity and treatment costs. In this study, 88 of 150 diarrheic animals tested positive for E. coli. Of these, 54 samples had mixed infection with other bacterial and/or parasitic agents. There are several diarrheagenic E. coli pathotypes including enteropathogenic E. coli (EPEC), Shiga-toxin producing E. coli (STEC), enterotoxigenic E. coli (ETEC) and necrotoxigenic E. coli (NTEC). Molecular detection of virulence factors Stx2, Cdt3, Eae, CNF2, F5, Hly, Stx1, and ST revealed their presence at 39.7, 27.2, 19.3, 15.9, 13.6, 9.0, 3.4, and 3.4 percent, respectively. As many as 13.6% of the isolates lacked virulence genes and none of the isolate had LT or CNF1 toxin gene. The odds of isolating ETEC from male calves was 3.6 times (95% CI: 1.1, 12.4; P value = 0.042) that of female calves, whereas the odds of isolating NTEC from male calves was 72.9% lower (95% CI: 91.3% lower, 15.7% lower; P value = 0.024) than that in females. The odds of isolating STEC in winter was 3.3 times (95% CI: 1.1, 10.3; P value = 0.037) that of spring. Antibiograms showed 48 (54.5%) of the isolates to be multi-drug resistant. The percent resistance to tetracycline, streptomycin, ampicillin, and trimethoprim-sulfamethoxazole was 79.5, 67.0, 54.5, and 43.0, respectively. Ceftazidime (14.8%), amoxicillin-clavulanic acid (13.6%) and aztreonam (11.3%) showed the lowest resistance, and none of the isolates was resistant to imipenem. The results of this study can help improve our understanding of the epidemiological aspects of E. coli infection and to devise strategies for protection against it. The prevalence of E. coli pathotypes can help potential buyers of calves to avoid infected premises. The antibiograms in this study emphasizes the risks associated with the random use of antibiotics.	[Sobhy, Nader M.; Yousef, Sarah G. A.] Zagazig Univ, Fac Vet Med, Dept Anim Med, Zagazig, Sharkia, Egypt; [Sobhy, Nader M.; Aboubakr, Hamada A.; Mor, Sunil K.; Goyal, Sagar M.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Aboubakr, Hamada A.] Alexandria Univ, Food Sci & Technol Dept, Fac Agr, Alexandria, Egypt; [Nisar, Muhammad; Nagaraja, Kakambi V.; Valeris-Chacin, Robert J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Valeris-Chacin, Robert J.] Univ Zulia, Dept Anim Hlth & Publ Hlth, Fac Vet Sci, Maracaibo, Venezuela	Egyptian Knowledge Bank (EKB); Zagazig University; University of Minnesota System; University of Minnesota Twin Cities; Egyptian Knowledge Bank (EKB); Alexandria University; University of Minnesota System; University of Minnesota Twin Cities	Goyal, SM (corresponding author), Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.	goyal001@umn.edu	Sobhy, Nader/AAA-2339-2021; Nisar, Muhammad/HCG-8320-2022; Aboubakr, Hamada/I-7604-2016; Mor, Sunil Kumar/M-6325-2018	Aboubakr, Hamada/0000-0002-8233-2353; Mor, Sunil Kumar/0000-0002-1112-088X; Sobhy, Nader/0000-0002-9834-9627; Nisar, Muhammad/0000-0002-6987-2224				Aly S. M., 2014, Journal of Aquaculture Research and Development, V5, P247; Arenas-Hernandez Margarita M P, 2012, Curr Gastroenterol Rep, V14, P386, DOI 10.1007/s11894-012-0277-1; Bartels CJM, 2010, PREV VET MED, V93, P162, DOI 10.1016/j.prevetmed.2009.09.020; Berge ACB, 2005, PREV VET MED, V69, P25, DOI 10.1016/j.prevetmed.2005.01.013; Bertin Y, 2001, J CLIN MICROBIOL, V39, P3060, DOI 10.1128/JCM.39.9.3060-3065.2001; Borghese A., 2005, BUFFALO POPULATION R; Borriello G, 2012, RES VET SCI, V93, P18, DOI 10.1016/j.rvsc.2011.05.009; Bova TL, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-58; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Cavalieri S, 2005, MANUAL ANTIMICROBIAL; Chandran A, 2013, APPL ENVIRON MICROB, V79, P7371, DOI 10.1128/AEM.02653-13; Cho YI, 2013, VET MICROBIOL, V166, P375, DOI 10.1016/j.vetmic.2013.07.001; Cray WC, 1998, APPL ENVIRON MICROB, V64, P1975; Duse A, 2015, J DAIRY SCI, V98, P500, DOI 10.3168/jds.2014-8432; El-Seedy F R, 2016, Beni Suef Univ J Basic Appl Sci, V5, P45, DOI 10.1016/j.bjbas.2015.11.010; FDA, 2020, APPR AN DRUG PROD; Foster DM, 2009, VET CLIN N AM-FOOD A, V25, P13, DOI 10.1016/j.cvfa.2008.10.013; Franck SM, 1998, J CLIN MICROBIOL, V36, P1795, DOI 10.1128/JCM.36.6.1795-1797.1998; Gulliksen SM, 2009, J DAIRY SCI, V92, P2782, DOI 10.3168/jds.2008-1807; Herrera-Luna C, 2009, VET MED-CZECH, V54, P1, DOI 10.17221/3080-VETMED; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hoffman MA, 2006, CLIN VACCINE IMMUNOL, V13, P1322, DOI 10.1128/CVI.00205-06; Ishii S, 2007, APPL ENVIRON MICROB, V73, P5703, DOI 10.1128/AEM.00275-07; Jensen MB, 2000, APPL ANIM BEHAV SCI, V67, P35, DOI 10.1016/S0168-1591(99)00113-6; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P103, DOI 10.1016/0882-4010(88)90052-6; Kadhum HJ, 2008, EPIDEMIOL INFECT, V136, P752, DOI 10.1017/S0950268807009247; Korzeniewska E, 2013, ECOTOX ENVIRON SAFE, V91, P96, DOI 10.1016/j.ecoenv.2013.01.014; Landraud L, 2000, LETT APPL MICROBIOL, V30, P213, DOI 10.1046/j.1472-765x.2000.00698.x; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lundborg GK, 2005, PREV VET MED, V68, P123, DOI 10.1016/j.prevetmed.2004.11.014; MAHON CR, 2015, TXB DIAGNOSTIC MICRO; Mainil J, 2000, ANN MED VET, V144, P121; Melton-Celsa AR, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0013-2013; MOON HW, 1993, VACCINE, V11, P213, DOI 10.1016/0264-410X(93)90020-X; Nisa S, 2013, ESCHERICHIA COLI: PATHOTYPES AND PRINCIPLES OF PATHOGENESIS, 2ND EDITION, P75, DOI 10.1016/B978-0-12-397048-0.00004-8; Osek J, 2001, J VET MED B, V48, P641, DOI 10.1046/j.1439-0450.2001.00481.x; Rojas-Lopez M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00440; Sandhu KS, 1996, EPIDEMIOL INFECT, V116, P1, DOI 10.1017/S095026880005888X; Sandhu KS, 2002, CAN J VET RES, V66, P65; Scaria J, 2010, MOL CELL PROBE, V24, P325, DOI 10.1016/j.mcp.2010.07.004; Scuron MD, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2015.00168; Shahrani M, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-28; Soto SM, 2006, ANTIMICROB AGENTS CH, V50, P649, DOI 10.1128/AAC.50.2.649-653.2006; Nguyen TD, 2011, J VET SCI, V12, P159, DOI 10.4142/jvs.2011.12.2.159; Wani SA, 2003, LETT APPL MICROBIOL, V37, P121, DOI 10.1046/j.1472-765X.2003.01364.x; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Windeyer MC, 2014, PREV VET MED, V113, P231, DOI 10.1016/j.prevetmed.2013.10.019; WRAY C, 1993, RES VET SCI, V54, P290, DOI 10.1016/0034-5288(93)90125-Y; Younis EE, 2009, RES VET SCI, V87, P373, DOI 10.1016/j.rvsc.2009.04.006; Zajac A., 2012, PENSION FUND PERFORM, V8th edn, DOI DOI 10.1002/9781119208945.CH8; Zinnah M. A., 2007, Bangladesh Journal of Veterinary Medicine, V5, P25	51	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232890	10.1371/journal.pone.0232890	http://dx.doi.org/10.1371/journal.pone.0232890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392237	Green Published, gold			2022-12-26	WOS:000537470300029
J	Srivastava, V; Ahmad, A				Srivastava, Vartika; Ahmad, Aijaz			Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol	PLOS ONE			English	Article							BIOFILM FORMATION; SOUTH-AFRICA; ALBICANS; EFFLUX; GROWTH; DUBLINIENSIS; EMERGENCE; YEAST	Candida auris, a decade old Candida species, has been identified globally as a significant nosocomial multidrug resistant (MDR) pathogen responsible for causing invasive outbreaks. Biofilms and overexpression of efflux pumps such as Major Facilitator Superfamily and ATP Binding Cassette are known to cause multidrug resistance in Candida species, including C. auris. Therefore, targeting these factors may prove an effective approach to combat MDR in C. auris. In this study, 25 clinical isolates of C. auris from different hospitals of South Africa were used. All the isolates were found capable enough to form biofilms on 96-well flat bottom microtiter plate that was further confirmed by MTT reduction assay. In addition, these strains have active drug efflux mechanism which was supported by rhodamine-6- G extracellular efflux and intracellular accumulation assays. Antifungal susceptibility profile of all the isolates against commonly used drugs was determined following CLSI recommended guidelines. We further studied the role of farnesol, an endogenous quorum sensing molecule, in modulating development of biofilms and drug efflux in C. auris. The MIC for planktonic cells ranged from 62.5-125 mM, and for sessile cells was 125 mM (4h biofilm) and 500 mM (12h and 24h biofilm). Furthermore, farnesol (125 mM) also suppresses adherence and biofilm formation by C. auris. Farnesol inhibited biofilm formation, blocked efflux pumps and down-regulated biofilm- and efflux pump- associated genes. Modulation of C. auris biofilm formation and efflux pump activity by farnesol represent a promising approach for controlling life threatening infections caused by this pathogen.	[Srivastava, Vartika; Ahmad, Aijaz] Univ Witwatersrand, Sch Pathol, Clin Microbiol & Infect Dis, Fac Hlth Sci, Johannesburg, South Africa; [Ahmad, Aijaz] Charlotte Maxeke Johannesburg Acad Hosp, Natl Hlth Lab Serv, Infect Control, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	Ahmad, A (corresponding author), Univ Witwatersrand, Sch Pathol, Clin Microbiol & Infect Dis, Fac Hlth Sci, Johannesburg, South Africa.; Ahmad, A (corresponding author), Charlotte Maxeke Johannesburg Acad Hosp, Natl Hlth Lab Serv, Infect Control, Johannesburg, South Africa.	Aijaz.Ahmad@wits.ac.za		Srivastava, Vartika/0000-0002-8636-3413	National Research Foundation Research Development Grant for Y-Rated Researchers [RDYR180418322304, 116339]; Health Sciences Faculty Research Committee, University of the Witwatersrand [0012548464101 512110500000000000000005254]	National Research Foundation Research Development Grant for Y-Rated Researchers; Health Sciences Faculty Research Committee, University of the Witwatersrand	AA acknowledges financial support from National Research Foundation Research Development Grant for Y-Rated Researchers (RDYR180418322304; Grant No: 116339). VS is thankful to Health Sciences Faculty Research Committee, University of the Witwatersrand for the financial support (FRC, Grant no: 0012548464101 512110500000000000000005254).	Ahmad A, 2013, EUR J PHARM SCI, V48, P80, DOI 10.1016/j.ejps.2012.09.016; Ben-Ami R, 2017, EMERG INFECT DIS, V23, P195, DOI 10.3201/eid2302.161486; Bojsen R, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0305-4; Calvo B, 2016, J INFECTION, V73, P369, DOI 10.1016/j.jinf.2016.07.008; Ceresa C, 2018, AIMS BIOENG, V5, DOI 10.3934/bioeng.2018.3.192; Cernakova L, 2019, MICROB DRUG RESIST, V25, P805, DOI 10.1089/mdr.2017.0332; Chakrabarti A, 2015, INTENS CARE MED, V41, P285, DOI 10.1007/s00134-014-3603-2; Chandra J, 2008, NAT PROTOC, V3, P1909, DOI 10.1038/nprot.2008.192; Chavez-Andrade GM, 2017, ARCH ORAL BIOL, V84, P89, DOI 10.1016/j.archoralbio.2017.09.028; Chen SY, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1344-z; Chowdhary A, 2013, EMERG INFECT DIS, V19, P1670, DOI 10.3201/eid1910.130393; Cortegiani A, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0342-4; Deveau A, 2010, EUKARYOT CELL, V9, P569, DOI 10.1128/EC.00321-09; Egbe NE, 2017, MICROB CELL, V4, P294, DOI 10.15698/mic2017.09.589; Eggimann P, 2008, M27AM CLSI; Govender NP, 2018, EMERG INFECT DIS, V24, P2036, DOI 10.3201/eid2411.180368; Han TL, 2012, FEMS YEAST RES, V12, P879, DOI 10.1111/j.1567-1364.2012.00837.x; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Jabra-Rizk MA, 2006, FEMS YEAST RES, V6, P1063, DOI 10.1111/j.1567-1364.2006.00121.x; Kathuria S, 2015, J CLIN MICROBIOL, V53, P1823, DOI 10.1128/JCM.00367-15; Kean R, 2018, INT J ANTIMICROB AG, V52, P673, DOI 10.1016/j.ijantimicag.2018.05.007; Langford ML, 2010, ANTIMICROB AGENTS CH, V54, P940, DOI 10.1128/AAC.01214-09; Langford ML, 2009, FUTURE MICROBIOL, V4, P1353, DOI [10.2217/fmb.09.98, 10.2217/FMB.09.98]; Larkin E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.02396-16, 10.1128/AAC.02396-16]; Lee WG, 2011, J CLIN MICROBIOL, V49, P3139, DOI 10.1128/JCM.00319-11; Liu SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150859; Lockhart SR, 2017, CLIN INFECT DIS, V64, P134, DOI 10.1093/cid/ciw691; Lone SA, 2019, MYCOSES, V62, P620, DOI 10.1111/myc.12904; Maesaki S, 1999, J ANTIMICROB CHEMOTH, V44, P27, DOI 10.1093/jac/44.1.27; Martins M, 2007, EUKARYOT CELL, V6, P2429, DOI 10.1128/EC.00252-07; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; Ostrowsky B, 2020, MMWR-MORBID MORTAL W, V69, P6, DOI 10.15585/mmwr.mm6901a2; Polke M, 2018, CRIT REV MICROBIOL, V44, P230, DOI [10.1080/1040841x.2017.1337711, 10.1080/1040841X.2017.1337711]; Prasad R., 2006, Infectious Disorders - Drug Targets, V6, P69, DOI 10.2174/187152606784112164; Prasad R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00202; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Rybak JM, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00057-19; Sarma S, 2017, INFECT DRUG RESIST, V10, P155, DOI 10.2147/IDR.S116229; Satoh K, 2009, MICROBIOL IMMUNOL, V53, P41, DOI 10.1111/j.1348-0421.2008.00083.x; Sebaa S, 2019, MOL MED REP, V19, P3201, DOI 10.3892/mmr.2019.9981; Sharma M, 2011, ANTIMICROB AGENTS CH, V55, P4834, DOI 10.1128/AAC.00344-11; Sherry L, 2017, EMERG INFECT DIS, V23, P328, DOI 10.3201/eid2302.161320; Shirtliff ME, 2009, ANTIMICROB AGENTS CH, V53, P2392, DOI 10.1128/AAC.01551-08; Singh S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203079; Srivastava V, 2016, J BIOSCI BIOENG, V122, P434, DOI 10.1016/j.jbiosc.2016.03.013; Tsay S, 2018, CLIN INFECT DIS, V66, P306, DOI 10.1093/cid/cix744; Tsay S, 2017, MMWR-MORBID MORTAL W, V66, P514, DOI 10.15585/mmwr.mm6619a7; van Schalkwyk E, 2019, EMERG INFECT DIS, V25, P1698, DOI 10.3201/eid2509.190040; Wiederhold NP, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01120-19; Yu LH, 2012, ANTIMICROB AGENTS CH, V56, P770, DOI 10.1128/AAC.05290-11	50	17	17	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0233102	10.1371/journal.pone.0233102	http://dx.doi.org/10.1371/journal.pone.0233102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392266	Green Published, gold, Green Submitted			2022-12-26	WOS:000537470300038
J	Lin, S; Song, SZ; Sun, R; Zhang, MB; Du, YT; Zhang, DD; Xu, WH; Wang, HB				Lin, Sen; Song, Suzhen; Sun, Rong; Zhang, Mingbao; Du, Yating; Zhang, Dongdong; Xu, Weihua; Wang, Hongbo			Oncogenic circular RNA Hsa-circ-000684 interacts with microRNA-186 to upregulate ZEB1 in gastric cancer	FASEB JOURNAL			English	Article						angiogenesis; circular RNA hsa-circ-000684; gastric cancer; microRNA-186; ZEB1	MESENCHYMAL TRANSITION; DOWN-REGULATION; CELL; PROLIFERATION; EXPRESSION; PROMOTES; METASTASIS; MIR-15A; PROFILE	Circular RNAs (circRNAs) function as modulators of microRNAs (miRNAs) and are often involved in cancer progression. This study aims to investigate the underlying mechanism by which circRNA hsa-circ-000684 promotes the progression of gastric cancer (GC). Expression of hsa-circ-000684 and that of ZEB1 mRNA were elevated while microRNA-186 (miR-186) expression was downregulated in GC cell lines and clinical tissues. In addition, the effects of hsa-circ-000684 on the proliferation, migration, invasion, and tube formation of GC cells were examined through gain-and loss-of-function experiments. Furthermore, we introduced tumor xenografts into nude mice to better understand these effects in vivo. Either knockdown of hsa-circ-000684 or upregulation of miR-186 inhibited GC cell proliferation, migration, invasion, and tube formation in vitro, and reduced the xenograft tumor growth in nude mice. Moreover, we found that hsa-circ-000684 and ZEB1 directly bound to miR-186. Hsa-circ-000684 increased the expression of ZEB1 by binding to miR-186. The tumor suppressive effects of hsa-circ-000684 knockdown were reversed by inhibition of miR-186. Collectively, our data show that hsa-circ-000684 reduces the miR-186 expression which leads to an increase in the ZEB1 expression and, consequently, promotion of GC progression.	[Lin, Sen; Zhang, Mingbao; Du, Yating; Zhang, Dongdong; Xu, Weihua; Wang, Hongbo] Shandong Univ, Dept Digest Dis, Hosp 2, 247 Beiyuan St, Jinan 250033, Shandong, Peoples R China; [Song, Suzhen] Shandong Univ Tradit Chinese Med, Dept Internal Med, Jinan, Peoples R China; [Sun, Rong] Shandong Univ, Hosp 2, Cent Lab, Jinan, Peoples R China	Shandong University; Shandong University of Traditional Chinese Medicine; Shandong University	Wang, HB (corresponding author), Shandong Univ, Dept Digest Dis, Hosp 2, 247 Beiyuan St, Jinan 250033, Shandong, Peoples R China.	wanghongbo_d@163.com			Major Program of National Nature Significant Drug Discovery National Key Technologies Program of China during the 11th Five-Year Plan Period [2009ZX09502-015]; National Major Fundamental Research Program of China [2009CB522802]; Traditional Chinese Medicine Pharmacology and Toxicology Expert from Taishan Scholar Project of Shandong Province [ts201511107]	Major Program of National Nature Significant Drug Discovery National Key Technologies Program of China during the 11th Five-Year Plan Period; National Major Fundamental Research Program of China; Traditional Chinese Medicine Pharmacology and Toxicology Expert from Taishan Scholar Project of Shandong Province	the Major Program of National Nature Significant Drug Discovery National Key Technologies Program of China during the 11th Five-Year Plan Period, Grant/Award Number: 2009ZX09502-015; the National Major Fundamental Research Program of China, Grant/Award Number: 2009CB522802; Traditional Chinese Medicine Pharmacology and Toxicology Expert from Taishan Scholar Project of Shandong Province, Grant/Award Number: ts201511107	Bian YZ, 2019, CANCER BIOL THER, V20, P886, DOI 10.1080/15384047.2019.1579959; Cai JC, 2013, CANCER RES, V73, P756, DOI 10.1158/0008-5472.CAN-12-2651; Cao G, 2018, ONCOTARGETS THER, V11, P6153, DOI 10.2147/OTT.S175428; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Dang RY, 2017, BIOCHEM BIOPH RES CO, V490, P104, DOI 10.1016/j.bbrc.2017.05.164; Dang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09076-6; Ebbesen KK, 2016, BBA-GENE REGUL MECH, V1859, P163, DOI 10.1016/j.bbagrm.2015.07.007; Guo XB, 2017, AM J CANCER RES, V7, P2234; Guo YM, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109255; Huang TH, 2018, CANCER BIOMARK, V21, P221, DOI 10.3233/CBM-170670; Jia BQ, 2012, MOL CELL BIOCHEM, V366, P223, DOI 10.1007/s11010-012-1299-6; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Li JL, 2018, ARCH BIOCHEM BIOPHYS, V640, P53, DOI 10.1016/j.abb.2018.01.002; Li Y, 2017, CANCER LETT, V411, P64, DOI 10.1016/j.canlet.2017.09.006; Liu L, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.35; Liu LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148774; Nienhuser H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010043; Okugawa Y, 2012, J SURG ONCOL, V106, P280, DOI 10.1002/jso.22142; Ouyang YM, 2019, J CELL PHYSIOL, V234, P10458, DOI 10.1002/jcp.27714; Shan F, 2016, CANCER LETT, V380, P598, DOI 10.1016/j.canlet.2015.12.023; Shao YF, 2017, CANCER MED-US, V6, P1173, DOI 10.1002/cam4.1055; Shi YQ, 2010, J SURG ONCOL, V101, P687, DOI 10.1002/jso.21455; Sun HD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27837-9; Sun WJ, 2019, J CELL BIOCHEM, V120, P10001, DOI 10.1002/jcb.28283; Terzuoli E, 2016, ONCOTARGET, V7, P44350, DOI 10.18632/oncotarget.10051; Wang MQ, 2019, GENE, V700, P110, DOI 10.1016/j.gene.2019.03.043; Wang Y, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0766-4; Wu S, 2019, J CELL PHYSIOL, V234, P19059, DOI 10.1002/jcp.28545; Xie HJ, 2016, ONCOTARGET, V7, P26680, DOI 10.18632/oncotarget.8589; Xue YJ, 2019, MED SCI MONITOR, V25, P1663, DOI 10.12659/MSM.912338; Zare Ali, 2019, Iranian Biomedical Journal, V23, P338, DOI 10.29252/.23.5.338; Zhong ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30919; Zhu X, 2016, ONCOGENE, V35, P323, DOI 10.1038/onc.2015.84; Zou QY, 2018, J CELL BIOCHEM, V119, P2189, DOI 10.1002/jcb.26380	34	17	17	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8187	8203		10.1096/fj.201903246R	http://dx.doi.org/10.1096/fj.201903246R		MAY 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32388910				2022-12-26	WOS:000532112400001
J	de Carvalho, AA; Amorim, FF; Santana, LA; de Almeida, KJQ; Santana, ANC; Neves, FDR				de Carvalho, Anderson Albuquerque; Amorim, Fabio Ferreira; Santana, Levy Aniceto; Quadros de Almeida, Karlo Jozefo; Cruz Santana, Alfredo Nicodemos; Rocha Neves, Francisco de Assis			STOP-Bang questionnaire should be used in all adults with Down Syndrome to screen for moderate to severe obstructive sleep apnea	PLOS ONE			English	Article							OROPHARYNGEAL EXERCISES; BERLIN QUESTIONNAIRE; PORTUGUESE-LANGUAGE; CHILDREN; PREVALENCE; VALIDATION; GUIDELINES; POLYSOMNOGRAPHY; TRANSLATION; MANAGEMENT	Study objectives To determine the prevalence of obstructive sleep apnea (OSA) in adults with Down syndrome (DS), to investigate factors related to OSA severity and to identify which sleep questionnaire is the most appropriate for the screening of OSA in this population. Methods Cross-sectional study that consecutively included 60 adults with DS. All patients underwent type III polysomnography and clinical and laboratory data were collected; sleep assessment questionnaires were applied. Multiple linear regression models evaluated the associations between OSA severity (measured by the respiratory event index-REI) and clinical and laboratory data and sleep questionnaires (Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, BERLIN and STOP-Bang questionnaires). Results Results show that 60 (100%) adults with DS had OSA, with moderate-severe OSA identified in 49 (81.6%). At the multivariate linear regression, REI significantly correlated with hematocrit levels, BMI and STOP-Bang questionnaire (SBQ) results (P < 0.001). The positive STOP-Bang >= 3 points) showed 100% of sensitivity (95%CI: 92.75-100%), 45.45% of specificity (95%CI: 16.75-76.62), positive predictive value of 89.09% (95%CI: 82.64-93.34%), negative predictive value of 100%, accuracy of 90% (95%CI: 79.49-96.24%) and OR of 24.29. Conclusions Adults with DS have a very high prevalence of OSA. Hematocrit levels, BMI and SBQ showed a strong correlation with OSA severity. The SBQ performed well in identifying moderate to severe OSA in this population. Considered together, these results point to the need to perform OSA screening in all adults with DS, and STOP-Bang may play a role in this screening.	[de Carvalho, Anderson Albuquerque; Rocha Neves, Francisco de Assis] Univ Brasilia, Fac Ciencias Saude, Dept Postgrad Hlth Sci, Brasilia, DF, Brazil; [de Carvalho, Anderson Albuquerque; Cruz Santana, Alfredo Nicodemos] Hosp Reg Asa Norte, Resp Dept, Multidisciplinary Sleep Unit, Brasilia, DF, Brazil; [Amorim, Fabio Ferreira; Santana, Levy Aniceto; Cruz Santana, Alfredo Nicodemos] Escola Super Ciencias Saude, Dept Postgrad Hlth Sci, Fac Med & Enfermagem, Brasilia, DF, Brazil; [Quadros de Almeida, Karlo Jozefo] Hosp Reg Asa Norte, Reg Board Secondary Care Dept, Syndrome Reference Ctr, Brasilia, DF, Brazil	Universidade de Brasilia	de Carvalho, AA (corresponding author), Univ Brasilia, Fac Ciencias Saude, Dept Postgrad Hlth Sci, Brasilia, DF, Brazil.; de Carvalho, AA (corresponding author), Hosp Reg Asa Norte, Resp Dept, Multidisciplinary Sleep Unit, Brasilia, DF, Brazil.	carvalhofisio2003@gmail.com	Santana, Alfredo N. C./L-3862-2014; Amorim, Fábio Ferreira/J-4251-2012; de Carvalho, Anderson Albuquerque/Y-2680-2019; Neves, Francisco/O-6244-2014	Santana, Alfredo N. C./0000-0002-4511-9123; Amorim, Fábio Ferreira/0000-0003-0929-5733; de Carvalho, Anderson Albuquerque/0000-0002-1256-7675; Neves, Francisco/0000-0001-8584-3127; Quadros, Karlo/0000-0001-7468-9451; Santana, Levy Aniceto/0000-0001-7743-4892	Fundacao de Ensino e Pesquisa em Ciencias da Saude (FEPECS) [064.000.560/2015, 40, 213]; Fundacao de Ensino e Pesquisa em Ciencias da Saude (FEPECS)	Fundacao de Ensino e Pesquisa em Ciencias da Saude (FEPECS); Fundacao de Ensino e Pesquisa em Ciencias da Saude (FEPECS)	This study was supported by grants from the Fundacao de Ensino e Pesquisa em Ciencias da Sau ' de (FEPECS), process number 064.000.560/2015, of Public Notice number 40 of 10/29/2015, published in DODF n. 213, of 11/06/2015, regarding the Homologation of the Final Selection Result of Research Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Fundacao de Ensino e Pesquisa em Ciencias da Saude (FEPECS): URL: http://www.fepecs.edu.br/Homologation of the Final Selection Result of Research Projects: URL: http://www.dodf.df.gov.br/index/visualizar-arquivo/?pasta= 2015/11_Novembro/DODF%20213%2006-11-2015&arquivo=DODF%20213%2006-11-2015% 20SECAO3.pdf.	Andreou G, 2002, BRAIN COGNITION, V50, P145, DOI 10.1016/S0278-2626(02)00019-2; [Anonymous], 2019, RESEARCH, V8, P1117; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bertolazi AN, 2011, SLEEP MED, V12, P70, DOI 10.1016/j.sleep.2010.04.020; Bertolazi AN, 2009, J BRAS PNEUMOL, V35, P877, DOI 10.1590/S1806-37132009000900009; Brockmann PE, 2016, INT J PEDIATR OTORHI, V83, P47, DOI 10.1016/j.ijporl.2016.01.030; Brockmann PE, 2013, INT J PEDIATR OTORHI, V77, P1960, DOI 10.1016/j.ijporl.2013.09.011; Bull MJ, 2011, PEDIATRICS, V128, P393, DOI 10.1542/peds.2011-1605; Choi JB, 2006, SLEEP BREATH, V10, P155, DOI 10.1007/s11325-006-0064-z; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; CLARK RW, 1980, ARCH INTERN MED, V140, P45, DOI 10.1001/archinte.140.1.45; Cohen W. I., 1999, DOWN SYNDROME Q, V4, P1, DOI DOI 10.1002/0471227579.CH17; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Corral J, 2017, AM J RESP CRIT CARE, V196, P1181, DOI 10.1164/rccm.201612-2497OC; Danzi-Soares ND, 2012, CORONARY ARTERY DIS, V23, P31, DOI 10.1097/MCA.0b013e32834df5d0; de Graaf G, 2017, GENET MED, V19, P439, DOI 10.1038/gim.2016.127; de Miguel-Diaz J, 2003, SLEEP, V26, P1006, DOI 10.1093/sleep/26.8.1006; Fonseca LBD, 2016, J BRAS PNEUMOL, V42, P266, DOI 10.1590/S1806-37562015000000243; Dudoignon B, 2017, AM J MED GENET A, V173, P2074, DOI 10.1002/ajmg.a.38283; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Dyken ME, 2003, ARCH PEDIAT ADOL MED, V157, P655, DOI 10.1001/archpedi.157.7.655; Erman MK, 2007, J CLIN SLEEP MED, V3, P387; Gimenez S, 2018, J CLIN SLEEP MED, V14, P1725, DOI 10.5664/jcsm.7382; Guimaraes KC, 2009, AM J RESP CRIT CARE, V179, P962, DOI 10.1164/rccm.200806-981OC; Hill CM, 2016, SLEEP MED, V27-28, P99, DOI 10.1016/j.sleep.2016.10.001; Hill EA, 2012, J SLEEP RES, V21, P291; Horton Nicholas J., 2011, K KLEINMAN USING R D, P93; Ieto V, 2015, CHEST, V148, P683, DOI 10.1378/chest.14-2953; Ivan DL, 2014, J PEDIATR HEALTH CAR, V28, P280, DOI 10.1016/j.pedhc.2013.05.003; JOHNS MW, 1993, CHEST, V103, P30, DOI 10.1378/chest.103.1.30; Korbmacher Heike, 2004, J Orofac Orthop, V65, P60; Kuczynski W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43199-2; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Lal C, 2015, CHEST, V147, P570, DOI 10.1378/chest.14-0266; Lee CF, 2018, J CLIN SLEEP MED, V14, P867, DOI 10.5664/jcsm.7126; Lin HY, 2020, SLEEP BREATH, V24, P1279, DOI 10.1007/s11325-019-01971-8; Alonso-Alvarez ML, 2015, CHEST, V147, P1020, DOI 10.1378/chest.14-1959; McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599; Mergen H, 2019, CUREUS, V11, DOI 10.7759/cureus.6498; Mohamed AS, 2017, EGYPT J CHEST DIS TU, V66, P121, DOI 10.1016/j.ejcdt.2016.08.014; Montgomery D.C., 2012, INTRO LINEAR REGRESS, Vfifith; Nagappa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143697; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Ponde K, 2019, INT J SCI RES, V8, P1117; Resta Onofrio, 2003, Downs Syndr Res Pract, V8, P115, DOI 10.3104/reports.138; Saccomanno S, 2018, EUR J PAEDIATR DENT, V19, P243, DOI 10.23804/ejpd.2018.19.03.14; Smith DS, 2001, AM FAM PHYSICIAN, V64, P1031; Stancliffe RJ, 2011, AJIDD-AM J INTELLECT, V116, P401, DOI 10.1352/1944-7558-116.6.401; TELAKIVI T, 1987, J MENT DEFIC RES, V31, P31; Trois MS, 2009, J CLIN SLEEP MED, V5, P317; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Urschitz MS, 2010, EUR RESPIR J, V36, P556, DOI 10.1183/09031936.00078409; Van Allen MI, 1999, AM J MED GENET, V89, P100, DOI 10.1002/(SICI)1096-8628(19990625)89:2<100::AID-AJMG8>3.3.CO;2-E; Vaz AP, 2011, REV PORT PNEUMOL, V17, P59; Veasey SC, 2019, NEW ENGL J MED, V380, P1442, DOI 10.1056/NEJMcp1816152; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wu MD, 2018, J THORAC DIS, V10, P6509, DOI 10.21037/jtd.2018.10.105; Zar JH., 2010, BIOSTAT ANAL, V5th	58	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232596	10.1371/journal.pone.0232596	http://dx.doi.org/10.1371/journal.pone.0232596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384092	Green Published, gold, Green Submitted			2022-12-26	WOS:000537468300021
J	Horii, Y; Nakaya, M; Ohara, H; Nishihara, H; Watari, K; Nagasaka, A; Nakaya, T; Sugiura, Y; Okuno, T; Koga, T; Tanaka, A; Yokomizo, T; Kurose, H				Horii, Yuma; Nakaya, Michio; Ohara, Hiroki; Nishihara, Hiroaki; Watari, Kenji; Nagasaka, Akiomi; Nakaya, Takeo; Sugiura, Yuki; Okuno, Toshiaki; Koga, Tomoaki; Tanaka, Akira; Yokomizo, Takehiko; Kurose, Hitoshi			Leukotriene B-4 receptor 1 exacerbates inflammation following myocardial infarction	FASEB JOURNAL			English	Article						inflammation; leukotriene b4 receptor 1; myocardial infarction	CHRONIC HEART-FAILURE; ISCHEMIA-REPERFUSION; MECHANISMS; BLT1; ATHEROSCLEROSIS; RECRUITMENT; ANTAGONIST; THERAPY; RUPTURE; INJURY	Leukotriene B-4 receptor 1 (BLT1), a high-affinity G-protein-coupled receptor for leukotriene B4 (LTB4), is expressed on various inflammatory cells and plays critical roles in several inflammatory diseases. In myocardial infarction (MI), various inflammatory cells are known to be recruited to the infarcted area, but the function of BLT1 in MI is poorly understood. Here, we investigated the role of BLT1 in MI and the therapeutic effect of a BLT1 antagonist, ONO-4057, on MI. Mice with infarcted hearts showed increased BLT1 expression and LTB4 levels. BLT1-knockout mice with infarcted hearts exhibited attenuated leukocyte infiltration, proinflammatory cytokine production, and cell death, which led to reduced mortality and improved cardiac function after MI. Bone-marrow transplantation studies showed that BLT1 expressed on bone marrow-derived cells was responsible for the exacerbation of inflammation in infarcted hearts. Furthermore, ONO-4057 administration attenuated the inflammatory responses in hearts surgically treated for MI, which resulted in reduced mortality and improved cardiac function after MI. Our study demonstrated that BLT1 contributes to excessive inflammation after MI and could represent a new therapeutic target for MI.	[Horii, Yuma; Nakaya, Michio; Ohara, Hiroki; Nishihara, Hiroaki; Watari, Kenji; Nagasaka, Akiomi; Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka, Japan; [Nakaya, Michio] Japan Agcy Med Res & Dev, AHED PRIME, Tokyo, Japan; [Nakaya, Takeo; Tanaka, Akira] Jichi Med Univ, Dept Pathol, Shimotsuke, Tochigi, Japan; [Sugiura, Yuki] Keio Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Okuno, Toshiaki; Koga, Tomoaki; Yokomizo, Takehiko] Juntendo Univ, Grad Sch Med, Dept Biochem, Tokyo, Japan	Kyushu University; Jichi Medical University; Keio University; Juntendo University	Nakaya, M; Kurose, H (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakaya@phar.kyushu-u.ac.jp; hikurose@phar.kyushu-u.ac.jp			Japan Agency for Medical Research and Development (AMED) [JP20gm5810030, JP19fk0210029, JP19am0101091]; MEXT | Japan Society for the Promotion of Science (JSPS) [19J20083]; Ono Medical Research Foundation; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; SENSHIN Medical Research Foundation; Shimabara Science Promotion Foundation; Senri Life Science Foundation; KAKENHI [17H03984, 17H05510, 17H01525];  [25116716]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ono Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Shimabara Science Promotion Foundation; Senri Life Science Foundation; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP20gm5810030; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19fk0210029; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 19J20083; Grants-in-Aid for Scientific Research on Innovative Areas, Grant/Award Number: 25116716; Ono Medical Research Foundation; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; SENSHIN Medical Research Foundation; Shimabara Science Promotion Foundation; Senri Life Science Foundation; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19am0101091; Grants-in-Aid for Scientific Research (KAKENHI), Grant/Award Number: 17H03984, 17H05510 and 17H01525	Abbate A, 2013, AM J CARDIOL, V111, P1394, DOI 10.1016/j.amjcard.2013.01.287; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Blomer N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0367-8; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; de Hoog VC, 2015, CARDIOVASC RES, V108, P367, DOI 10.1093/cvr/cvv224; Dick SA, 2016, CIRC RES, V119, P159, DOI 10.1161/CIRCRESAHA.116.308030; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; FUSTER V, 1990, CIRCULATION, V82, P47; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Gupta K, 2018, J MOL CELL CARDIOL, V118, P26, DOI 10.1016/j.yjmcc.2018.03.003; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; HAHN RA, 1990, J PHARMACOL EXP THER, V253, P58; Haribabu B, 2000, J EXP MED, V192, P433, DOI 10.1084/jem.192.3.433; Hikiji H, 2009, P NATL ACAD SCI USA, V106, P21294, DOI 10.1073/pnas.0905209106; Huang SB, 2018, BRIT J PHARMACOL, V175, P1377, DOI 10.1111/bph.14155; IVERSEN L, 1994, ARCH DERMATOL RES, V286, P261, DOI 10.1007/BF00387598; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; KISHIKAWA K, 1992, PROSTAGLANDINS, V44, P261, DOI 10.1016/0090-6980(92)90002-B; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu JQ, 2016, CLIN MED INSIGHTS-CA, V10, P79, DOI 10.4137/CMC.S33164; Luedde M, 2014, CARDIOVASC RES, V103, P206, DOI 10.1093/cvr/cvu146; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Marchetti C, 2014, J CARDIOVASC PHARM, V63, P316, DOI 10.1097/FJC.0000000000000053; Matsunobu T, 2013, J LIPID RES, V54, P2979, DOI 10.1194/jlr.M037754; MCGEE JE, 1986, P NATL ACAD SCI USA, V83, P1349, DOI 10.1073/pnas.83.5.1349; Miyahara N, 2005, J IMMUNOL, V174, P4979, DOI 10.4049/jimmunol.174.8.4979; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Noiri E, 2000, P NATL ACAD SCI USA, V97, P823, DOI 10.1073/pnas.97.2.823; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Riccioni G, 2008, J LEUKOCYTE BIOL, V84, P1374, DOI 10.1189/jlb.0808476; Rinaldo-Matthis A, 2010, BIOCHIMIE, V92, P676, DOI 10.1016/j.biochi.2010.01.010; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sasaki F, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96902; Sasaki F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185133; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Sun M, 2004, CIRCULATION, V110, P3221, DOI 10.1161/01.CIR.0000147233.10318.23; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Toldo S, 2013, EXP PHYSIOL, V98, P734, DOI 10.1113/expphysiol.2012.069831; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Yokomizo T, 2018, J CLIN INVEST, V128, P2691, DOI 10.1172/JCI97946	50	9	9	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8749	8763		10.1096/fj.202000041R	http://dx.doi.org/10.1096/fj.202000041R		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32385915	hybrid			2022-12-26	WOS:000532120900001
J	Thiel, B; Godfried, MB; van Huizen, EC; Mooijer, BC; de Boer, BA; van Mierlo, RAAM; van Os, J; Geerts, BF; Kalkman, CJ				Thiel, Bram; Godfried, Marc B.; van Huizen, Elise C.; Mooijer, Bart C.; de Boer, Bouke A.; van Mierlo, Rover A. A. M.; van Os, Johan; Geerts, Bart F.; Kalkman, Cor J.			Patient reported postoperative pain with a smartphone application: A proof of concept	PLOS ONE			English	Article							QUALITY; MANAGEMENT; SATURATION; INTERVIEWS; TOOL	Postoperative pain management and pain assessment are still lacking the perspective of the patient. We have developed and studied a prototype smartphone application for patients to self-record postoperative pain. The main objective was to collect patient and stakeholder critique of improvements on the usability in order to develop a definitive version. The secondary objective was to investigate if patient self-recording compared to nurse-led assessment is a suitable method for postoperative pain management. Fifty patients and a stakeholder group consisting of ten healthcare- and ICT professionals and two members of the patient council participated in this study. Main outcome Thirty patients (60%) found it satisfying or very satisfying to communicate their pain with the app. Pain experienced after surgery was scored by patients as 'no': 3 (6%), 'little': 5 (10%), 'bearable': 25 (50%), 'considerable': 13 (26%) and 'severe': 1 (2%). Forty-five patients (90%) were positive about the ease of recording. Forty-five patients (90%) could correctly record their pain with the app. Thirty-eight patients (76%) agreed that in-app notifications to record pain were useful. Two patients (4%) were too ill to use the application. Based on usability feedback, we will redesign the pain intensity wheel and the in-app pain chart to improve clarity for patients to understand the course of their pain. Secondary outcomes The median patient recorded pain app score 4.0 (range 0 to 10) and nurse recorded numerical rating scale (NRS) for pain NRS 4.0 (range 0 to 9) were not statistically different (p = 0.06). Forty-two percent from a total of 307 patient pain app scores were. 5 (on a scale from 0 no pain at all to 10 worst imaginable pain). Of these, 83% were recorded as 'bearable' while only in 18% of the recordings patients asked for additional analgesia. The results suggest that self-recording the severity of postoperative pain by patients with a smartphone application could be useful for postoperative pain management. The application was perceived as user-friendly and had high satisfaction rates from both patients and stakeholders. Further research is needed to validate the 11-point numeric and faces pain scale with the current gold standards visual analogue scale (VAS) and NRS for pain.	[Thiel, Bram; Godfried, Marc B.] OLVG Hosp, Dept Anesthesiol, Amsterdam, Netherlands; [Thiel, Bram] Univ Med Ctr Utrecht, Utrecht, Netherlands; [van Huizen, Elise C.; Mooijer, Bart C.] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [de Boer, Bouke A.] OLVG Hosp, Dept Informat Technol, Amsterdam, Netherlands; [van Mierlo, Rover A. A. M.] Logicapps Inc, Amsterdam, Netherlands; [van Os, Johan] OLVG Hosp, Dept Business Intelligence, Amsterdam, Netherlands; [Geerts, Bart F.] Univ Amsterdam, Med Ctr, Dept Anesthesiol, Amsterdam, Netherlands; [Kalkman, Cor J.] Univ Med Ctr Utrecht, Dept Anesthesiol, Utrecht, Netherlands; [Kalkman, Cor J.] Univ Med Ctr Utrecht, Dept Intens Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; University of Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Thiel, B (corresponding author), OLVG Hosp, Dept Anesthesiol, Amsterdam, Netherlands.; Thiel, B (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.	b.thiel@olvg.nl		van Os, Jim/0000-0002-7245-1586	SIDN fund	SIDN fund	SIDN fund, public benefit organization for Dutch internet domain registration (Url: www.SIDNfonds.nl), partially funded the development of the smartphone application. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Bech RD, 2015, PAIN RES TREAT, V2015, DOI 10.1155/2015/676212; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Carr DB, 1999, LANCET, V353, P2051, DOI 10.1016/S0140-6736(99)03313-9; Ekker A., 2013, MEDISCHE APPS IS CER; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hennink MM, 2017, QUAL HEALTH RES, V27, P591, DOI 10.1177/1049732316665344; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Kim EB, 2012, J PALLIAT MED, V15, P1222, DOI 10.1089/jpm.2012.0183; Krejcie RV, 1970, EDUC PSYCHOL MEAS, V30, P3; Lalloo C, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.8230; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Manias E, 2002, J CLIN NURS, V11, P724, DOI 10.1046/j.1365-2702.2002.00691.x; Meissner W, 2006, EUR J ANAESTH, V23, P142, DOI 10.1017/S026502150500205X; Giang NV, 2015, PAIN MANAG NURS, V16, P678, DOI 10.1016/j.pmn.2015.02.002; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Pellino TA, 1998, J PAIN SYMPTOM MANAG, V15, P110, DOI 10.1016/S0885-3924(97)00255-8; Portelli P, 2016, BRIT J PAIN, V10, P135, DOI 10.1177/2049463716638700; Reynoldson C, 2014, PAIN MED, V15, P898, DOI 10.1111/pme.12327; Santo K, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.6742; Shipton EA, 2018, PAIN THER, V7, P23, DOI 10.1007/s40122-018-0096-7; Stinson JN, 2013, J MED INTERNET RES, V15, P137, DOI 10.2196/jmir.2350; Stone AA, 2007, PAIN MED, V8, P85, DOI 10.1111/j.1526-4637.2007.00372.x; van Andel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121446; van Boekel Rianne L M, 2014, Ned Tijdschr Geneeskd, V158, pA7723; van Dijk JFM, 2016, INT J NURS STUD, V53, P260, DOI 10.1016/j.ijnurstu.2015.08.007; van Dijk JFM, 2012, INT J NURS STUD, V49, P65, DOI 10.1016/j.ijnurstu.2011.07.009; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013	29	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232082	10.1371/journal.pone.0232082	http://dx.doi.org/10.1371/journal.pone.0232082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0QJ	32384103	gold, Green Published			2022-12-26	WOS:000537468300008
J	Zhang, XC; Cash, RE; Bower, JK; Focht, BC; Paskett, ED				Zhang, Xiaochen; Cash, Rebecca E.; Bower, Julie K.; Focht, Brian C.; Paskett, Electra D.			Physical activity and risk of cardiovascular disease by weight status among U.S adults	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; LIFE-STYLE; HEALTH; ASSOCIATION; PREVENTION; EXERCISE; OBESITY; OVERWEIGHT; FITNESS; MORTALITY	Purpose We sought to determine whether the association between physical activity and 10-year cardiovascular disease (CVD) risk varies among normal weight, overweight, and obese adults in a nationally-representative sample of the United States. Methods Data were from the National Health and Nutrition Examination Survey 2007-2016. A subset of 22,476 participants aged 30-64 years was included with no CVD history. Physical activity level was self-reported and stratified into sedentary (0 min/week), inactive (1-149 mins/week), or active (>= 150 mins/week) of moderate or vigorous activities. Framingham risk scores were classified as low/intermediate (< 20%) or high 10-year CVD risk (>= 20%). Results The average age of the population was 45.9 years, 52.3% were female, 33.6% were overweight (BMI 25.0-29.9kg/m(2)), and 35.7% were obese (BMI >= 30kg/m(2)). Individuals who were overweight and obese had a higher 10-year CVD risk compared to those with normal weight (9.5 vs. 10.1 vs. 6.3%, P< 0.001). The association of physical activity and high 10-year CVD risk differed by weight status. Among overweight and obese adults, individuals engaged in any physical activity had lower odds of high 10-year CVD risk compared to sedentary individuals (overweight: OR active = 0.48, 95% CI: 0.36-0.64; OR inactive = 0.53, 95% CI: 0.45-0.86; obese: OR active = 0.50, 95% CI: 0.37-0.68; OR inactive = 0.66, 95% CI: 0.49-0.89). Among normal weight adults, individuals who were physically active had lower odds of high 10-year CVD risk (OR = 0.59, 95% CI: 0.28-0.87). When compared the joint effects of physical activity level and weight status, physical activity was associated with a larger magnitude of reduced odds of 10-year CVD risk than weight status. Conclusion Participation in any level of physical activity is associated with a lower 10-year CVD risk for overweight and obese adults. Future studies are needed to identify effective modes and doses of exercise that offer optimal CVD benefits for populations with different weight statuses.	[Zhang, Xiaochen; Paskett, Electra D.] Ohio State Univ, Ctr Comprehens Canc, Div Populat Sci, Columbus, OH 43210 USA; [Zhang, Xiaochen; Bower, Julie K.; Paskett, Electra D.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Cash, Rebecca E.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Focht, Brian C.] Ohio State Univ, Dept Human Sci, Div Kinesiol, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Massachusetts General Hospital; University System of Ohio; Ohio State University	Paskett, ED (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Div Populat Sci, Columbus, OH 43210 USA.; Paskett, ED (corresponding author), Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA.	electra.paskett@osumc.edu	Cash, Rebecca/GPF-5196-2022	Zhang, Xiaochen/0000-0003-3086-1285; Cash, Rebecca/0000-0002-0355-1014	Susan G. Komen Foundation [GTDR15334082]	Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by Susan G. Komen Foundation (GTDR15334082 to XZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillot A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119017; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Carlsson AC, 2016, EUR J PREV CARDIOL, V23, P359, DOI 10.1177/2047487314568034; Cooper AR, 2000, EUR J CLIN NUTR, V54, P887, DOI 10.1038/sj.ejcn.1601116; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Fernandes V, 2011, J APPL PHYS, V110, DOI 10.1063/1.3664764; Fletcher GF, 2018, J AM COLL CARDIOL, V72, P1622, DOI 10.1016/j.jacc.2018.08.2141; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Grabovac I, 2018, AM J MED; Greenland S, 1983, Stat Med, V2, P243, DOI 10.1002/sim.4780020219; Gregg EW, 2016, LANCET DIABETES ENDO, V4, P913, DOI 10.1016/S2213-8587(16)30162-0; Hales Craig M, 2017, NCHS Data Brief, P1; Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C; Hamer M, 2007, PREV MED, V44, P3, DOI 10.1016/j.ypmed.2006.09.005; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Hirsch KR, 2016, PHYSICIAN SPORTSMED, V44, P362, DOI 10.1080/00913847.2016.1248222; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Jensen, 2014, CIRCULATION, V129, pS139, DOI 10.1161/CIR.0000000000000070; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; Koolhaas CM, 2017, EUR J PREV CARDIOL, V24, P934, DOI 10.1177/2047487317693952; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI [DOI 10.1056/NEJMoa020194, DOI 10.1056/NEJMOA020194, 10.1056/NEJMoa020194]; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Lavie CJ, 2019, CIRC RES, V124, P799, DOI 10.1161/CIRCRESAHA.118.312669; Lavie CJ, 2018, J AM COLL CARDIOL, V72, P1506, DOI 10.1016/j.jacc.2018.08.1037; MALUFMEIKEN LCV, 2012, HYPERTENSION, DOI DOI 10.1155/2012/581780; Moholdt T, 2018, J AM COLL CARDIOL, V71, P1094, DOI 10.1016/j.jacc.2018.01.011; Moholdt T, 2017, AM J MED, V130, P949, DOI 10.1016/j.amjmed.2017.01.043; Myers J, 2015, PROG CARDIOVASC DIS, V57, P306, DOI 10.1016/j.pcad.2014.09.011; NHANES, 2016, PUBL DAT GEN REL FIL; NHANES, 2014, PUBL DAT GEN REL FIL; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; Panagiotakos DB, 2005, PREV MED, V40, P432, DOI 10.1016/j.ypmed.2004.07.010; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Poirier Paul, 2004, Expert Rev Cardiovasc Ther, V2, P193, DOI 10.1586/14779072.2.2.193; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rohm Young D, 2009, PATTERNS PHYS ACTIVI; Romeo S, 2012, DIABETES CARE, V35, P2613, DOI 10.2337/dc12-0193; Rose SA, 2013, INT J OBESITY, V37, P118, DOI 10.1038/ijo.2012.24; Schuler G, 2013, EUR HEART J, V34, P1790, DOI 10.1093/eurheartj/eht111; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Sturm R, 2001, PUBLIC HEALTH, V115, P229, DOI 10.1016/S0033-3506(01)00449-8; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vu THT, 2010, CIRCULATION, V122; Williamson DF, 1998, EXP CLIN ENDOCR DIAB, V106, P14, DOI 10.1055/s-0029-1212031; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	53	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232893	10.1371/journal.pone.0232893	http://dx.doi.org/10.1371/journal.pone.0232893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384119	gold, Green Published			2022-12-26	WOS:000537468300039
J	Briquet, S; Lawson-Hogban, N; Peronet, R; Mecheri, S; Vaquero, C				Briquet, Sylvie; Lawson-Hogban, Nadou; Peronet, Roger; Mecheri, Salaheddine; Vaquero, Catherine			A genetically hmgb2 attenuated blood stage P. berghei induces crossed-long live protection	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MALARIA; IMMUNITY; PARASITES; SPOROZOITES; PROTEINS	Due to the lack of efficiency to control malaria elicited by sub-unit vaccine preparations, vaccination with live-attenuated Plasmodium parasite as reported 70 years ago with irradiated sporozoites regained recently a significant interest. The complex life cycle of the parasite and the different stages of development between mammal host and anopheles do not help to propose an easy vaccine strategy. In order to achieve a complete long-lasting protection against Plasmodium infection and disease, we considered a genetically attenuated blood stage parasite in the hmgb2 gene coding for the high-mobility-group-box 2 (HMGB2). This Plasmodium protein belongs to the HMGB family and hold as the mammal proteins, a double life since it acts first as a nuclear factor involved in chromatin remodelling and transcription regulation and second, when secreted as an active pro-inflammatory alarmin protein. Even though the number of reports on whole living attenuated blood stage parasites is limited when compared to attenuated sporozoites, the results reported with Plasmodium KO parasites are very encouraging. In this report, we present a novel strategy based on preimmunization with Delta hmgb2PbNK65 parasitized red blood cells that confer long-lasting protection in a murine experimental cerebral malaria model against two highly pathogenic homologous and heterologous parasites.	[Briquet, Sylvie; Lawson-Hogban, Nadou; Vaquero, Catherine] Sorbonne Univ, Ctr Immunol & Malad Infect CIMI Paris, Paris, France; [Briquet, Sylvie; Lawson-Hogban, Nadou; Vaquero, Catherine] CIMI Paris, U1135, INSERM, Paris, France; [Briquet, Sylvie; Lawson-Hogban, Nadou; Vaquero, Catherine] CIMI Paris, ERL 8255, CNRS, Paris, France; [Peronet, Roger; Mecheri, Salaheddine] Inst Pasteur, Unite Biol & Genet Paludisme, Paris, France; [Peronet, Roger; Mecheri, Salaheddine] Ctr Natl Rech Sci CNRS, Unite Rech Associee 2581, Paris, France; [Lawson-Hogban, Nadou] ADNUCLEIS SAS 3 Route Pierres Blanches, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Vaquero, C (corresponding author), Sorbonne Univ, Ctr Immunol & Malad Infect CIMI Paris, Paris, France.; Vaquero, C (corresponding author), CIMI Paris, U1135, INSERM, Paris, France.; Vaquero, C (corresponding author), CIMI Paris, ERL 8255, CNRS, Paris, France.	catherine.vaquero@sorbonne-universite.fr		Vaquero, Catherine/0000-0001-9224-822X	INSERM (Institut National de la Sante et de la Recherche MePRIME)	INSERM (Institut National de la Sante et de la Recherche MePRIME)	CV funding from INSERM (Institut National de la Sante et de la Recherche Me ' dicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.)	Aly ASI, 2010, CELL MICROBIOL, V12, P930, DOI 10.1111/j.1462-5822.2010.01441.x; Briquet S, 2006, EUKARYOT CELL, V5, P672, DOI 10.1128/EC.5.4.672-682.2006; Briquet S, 2015, INFECT IMMUN, V83, P2771, DOI 10.1128/IAI.03129-14; Butler NS, 2012, TRENDS IMMUNOL; Demarta-Gatsi C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09684-2; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Good MF, 2013, J CLIN INVEST, V123, P3353, DOI 10.1172/JCI66634; Janse C, NAT PROTOC, V1, P346; Kumar H, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007943; Kumar H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26824; Kumar K, 2008, PARASITOL INT, V57, P150, DOI 10.1016/j.parint.2007.11.005; Lawson-Hogban N., 2010, ETUDE LIMPLICATION F; Low LM, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00587-18; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Raja AI, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00062-17, 10.1128/iai.00062-17]; Raja AI, 2016, INFECT IMMUN, V84, P2274, DOI 10.1128/IAI.00157-16; Sakamoto H, 2018, PARASITOL INT, V67, P203, DOI 10.1016/j.parint.2017.12.002; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Spaccapelo R, 2010, AM J PATHOL, V176, P205, DOI 10.2353/ajpath.2010.090504; Stanisic D. I., 2017, INFECT IMMUN, V86, P1, DOI DOI 10.1128/IAI.00479-17; Stanisic DI, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1173-9; Ting LM, 2008, NAT MED, V14, P954, DOI 10.1038/nm.1867; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Vaquero CM, 2011, Patent No. [WO2013/011247, 2013011247]	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232183	10.1371/journal.pone.0232183	http://dx.doi.org/10.1371/journal.pone.0232183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379764	Green Published, gold			2022-12-26	WOS:000537285700026
J	Li, M; Yue, CL; Zuo, XX; Jin, GQ; Wang, GY; Guo, HL; Wu, F; Huang, SK; Zhao, XH				Li, Miao; Yue, Chenli; Zuo, Xiaoxiao; Jin, Guoquan; Wang, Guanying; Guo, Hulin; Wu, Fang; Huang, Shangke; Zhao, Xinhan			The effect of interleukin 10 polymorphisms on breast cancer susceptibility in Han women in Shaanxi Province	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BEHCETS-DISEASE; IL-10; GENES; RISK; IL10; STATISTICS; VARIANTS; LOCI; EXPRESSION	Background Previous studies have reported on several genetic variants related to breast cancer, but a substantial proportion of mutation loci have not yet been identified. In the current study, we aimed to evaluate the association between single nucleotide polymorphisms (SNPs) of interleukin-10 (IL-10) and susceptibility to breast cancer in Shaanxi Han women in China. Methods Six SNPs were genotyped in 530 breast cancer patients and 628 healthy women from the First Affiliated Hospital of Xi'an Jiaotong University Hospital. Odds ratios and 95% confidence intervals were calculated by unconditional logistic regression analysis to assess the association between breast cancer risk and polymorphisms of six loci. Results Two SNPs, rs3024490 and rs1800871, were found to be significantly different between breast cancer patients and healthy women. These SNPs also increased the risk of breast cancer in co-dominant and dominant models. Moreover, another SNP, rs1554286, was significantly associated with an increased risk of breast cancer in the co-dominant model. Functional assessments indicated that these three variants may influence the expression and transcription factor binding of IL-10. Conclusions Our findings suggest that variants of IL-10 may be likelihood risk factors for the development and progression of breast cancer. Future studies should replicate this study and evaluate functional assessments in Chinese Han women and women from other regions.	[Li, Miao; Zhao, Xinhan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian, Shaanxi, Peoples R China; [Li, Miao; Guo, Hulin] Fifth Peoples Hosp Qinghai Prov, Dept Internal Med Oncol, Xining, Qinghai, Peoples R China; [Yue, Chenli] Shaanxi Prov Crops Hosp Chinese Peoples Armed Pol, Dept Resp Med, Xian, Shaanxi, Peoples R China; [Zuo, Xiaoxiao] Zhengzhou Univ, Dept Radiat Oncol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Jin, Guoquan] Qinghai Prov, Dept Gen Surg, Peoples Hosp 5, Xining, Qinghai, Peoples R China; [Wang, Guanying] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Med Oncol, Xian, Shaanxi, Peoples R China; [Wu, Fang] Xi An Jiao Tong Univ, Dept Neonatol, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Huang, Shangke] Southwest Med Univ, Dept Oncol, Affiliated Hosp, Luzhou, Sichuan, Peoples R China	Xi'an Jiaotong University; Zhengzhou University; Xi'an Jiaotong University; Xi'an Jiaotong University; Southwest Medical University	Zhao, XH (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian, Shaanxi, Peoples R China.	zhaohanxin21@163.com						Ahmad N, 2018, CANCER IMMUNOL IMMUN, V67, P537, DOI 10.1007/s00262-017-2106-8; Alotaibi Moureq R, 2018, Asian Pac J Cancer Prev, V19, P777; Barrett JA, 2004, AGE AGEING, V33, P502, DOI 10.1093/ageing/afh139; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Dai ZJ, 2014, GENET TEST MOL BIOMA, V18, P439, DOI 10.1089/gtmb.2014.0012; Dennis KL, 2013, CURR OPIN ONCOL, V25, P637, DOI DOI 10.1097/CC0.0000000000000006; Eskdale J, 1997, IMMUNOGENETICS, V46, P120, DOI 10.1007/s002510050250; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gerger A, 2010, BREAST CANCER RES TR, V119, P701, DOI 10.1007/s10549-009-0417-y; Gray J, 2012, NATURE, V486, P328, DOI 10.1038/486328a; Heckel MC, 2011, CELL IMMUNOL, V266, P143, DOI 10.1016/j.cellimm.2010.09.010; Leung G, 2014, LYMPHAT RES BIOL, V12, P10, DOI 10.1089/lrb.2013.0024; Liu C, 2018, CANCER MANAG RES, V10, P1749, DOI 10.2147/CMAR.S160452; Llanes-Fernandez L, 2009, J CANCER RES CLIN, V135, P255, DOI 10.1007/s00432-008-0446-7; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Oseguera CAV, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0399-5; Ostapchuk YO, 2015, CELL IMMUNOL, V298, P37, DOI 10.1016/j.cellimm.2015.09.002; Pooja S, 2012, CYTOKINE, V60, P122, DOI 10.1016/j.cyto.2012.06.241; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sato T, 2011, IMMUNOL RES, V51, P170, DOI 10.1007/s12026-011-8262-6; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Slattery ML, 2014, CARCINOGENESIS, V35, P1750, DOI 10.1093/carcin/bgu078; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Ting WC, 2013, J KOREAN MED SCI, V28, P1302, DOI 10.3346/jkms.2013.28.9.1302; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Wu ZY, 2014, HUM IMMUNOL, V75, P271, DOI 10.1016/j.humimm.2013.11.009; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yu KD, 2012, BREAST CANCER RES TR, V131, P27, DOI 10.1007/s10549-010-1133-3; Zheng W, 2013, HUM MOL GENET, V22, P2539, DOI 10.1093/hmg/ddt089	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232174	10.1371/journal.pone.0232174	http://dx.doi.org/10.1371/journal.pone.0232174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32380517	Green Published, gold			2022-12-26	WOS:000537285700025
J	Ryyti, R; Hamalainen, M; Peltola, R; Moilanen, E				Ryyti, Riitta; Hamalainen, Mari; Peltola, Rainer; Moilanen, Eeva			Beneficial effects of lingonberry (Vaccinium vitis-idaea L.) supplementation on metabolic and inflammatory adverse effects induced by high-fat diet in a mouse model of obesity	PLOS ONE			English	Article							BERRY FRUITS; ANTIINFLAMMATORY ACTIVITY; BIOACTIVE COMPONENTS; ANTIOXIDANT ACTIVITY; INSULIN-RESISTANCE; PHENOLIC-COMPOUNDS; OXIDATIVE STRESS; WEIGHT-GAIN; MICE; RESVERATROL	Obesity is a constantly increasing health problem worldwide. It is associated with a systemic low-grade inflammation, which contributes to the development of metabolic disorders and comorbidities such as type 2 diabetes. Diet has an important role in the prevention of obesity and its adverse health effects; as a part of healthy diet, polyphenolrich berries, such as lingonberry (Vaccinium vitis-idaea L.) have been proposed to have health-promoting effects. In the present study, we investigated the effects of lingonberry supplementation on high-fat diet induced metabolic and inflammatory changes in a mouse model of obesity. Thirty male C57BL/6N mice were divided into three groups (n = 10/group) to receive low-fat (LF), high-fat (HF) and lingonberry-supplemented high-fat (HF +LGB) diet for six weeks. Low-fat and high-fat diet contained 10% and 46% of energy from fat, respectively. Lingonberry supplementation prevented the high-fat diet induced adverse changes in blood cholesterol and glucose levels and had a moderate effect on the weight and visceral fat gain, which were 26% and 25% lower, respectively, in the lingonberry group than in the high-fat diet control group. Interestingly, lingonberry supplementation also restrained the high-fat diet induced increases in the circulating levels of the proinflammatory adipocytokine leptin (by 36%) and the inflammatory acute phase reactant serum amyloid A (SAA; by 85%). Similar beneficial effects were discovered in the hepatic expression of the inflammatory factors CXCL-14, S100A10 and SAA by lingonberry supplementation. In conclusion, the present results indicate that lingonberry supplementation significantly prevents high-fat diet induced metabolic and inflammatory changes in a murine model of obesity. The results encourage evaluation of lingonberries as a part of healthy diet against obesity and its comorbidities.	[Ryyti, Riitta; Hamalainen, Mari; Moilanen, Eeva] Tampere Univ, Fac Med & Hlth Technol, Immunopharmacol Res Grp, Tampere, Finland; [Ryyti, Riitta; Hamalainen, Mari; Moilanen, Eeva] Tampere Univ Hosp, Tampere, Finland; [Peltola, Rainer] Nat Resources Inst Finland, Bioecon & Environm, Rovaniemi, Finland	Tampere University; Tampere University; Tampere University Hospital; Natural Resources Institute Finland (Luke)	Moilanen, E (corresponding author), Tampere Univ, Fac Med & Hlth Technol, Immunopharmacol Res Grp, Tampere, Finland.; Moilanen, E (corresponding author), Tampere Univ Hosp, Tampere, Finland.	eeva.moilanen@tuni.fi		Hamalainen, Mari/0000-0002-6409-3758; Ryyti, Riitta/0000-0003-2428-6608; Moilanen, Eeva/0000-0002-8577-0316	European Regional Development Fund (ERDF)	European Regional Development Fund (ERDF)(European Commission)	The study was financially supported by a grant from the European Regional Development Fund (ERDF). Kiantama Ltd, Suomussalmi, Finland provided the lingonberry powder. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	AbuMweis SS, 2008, CURR ATHEROSCLER REP, V10, P467, DOI 10.1007/s11883-008-0073-4; Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; Anhe FF, 2018, DIABETOLOGIA, V61, P919, DOI 10.1007/s00125-017-4520-z; Asghar A, 2017, CELL IMMUNOL, V315, P18, DOI 10.1016/j.cellimm.2017.03.001; Bakowska-Barczak AM, 2007, CAN J PHYSIOL PHARM, V85, P1139, DOI 10.1139/Y07-102; Basu A, 2010, NUTR REV, V68, P168, DOI 10.1111/j.1753-4887.2010.00273.x; Bere E, 2007, EUR J CLIN NUTR, V61, P431, DOI 10.1038/sj.ejcn.1602512; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Bhullar KS, 2015, FOOD CHEM, V168, P595, DOI 10.1016/j.foodchem.2014.07.103; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Blaak EE, 2012, OBES REV, V13, P923, DOI 10.1111/j.1467-789X.2012.01011.x; Blade C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Bujor OC, 2018, FOOD CHEM, V252, P356, DOI 10.1016/j.foodchem.2018.01.052; Chang CC, 2016, ENDOCR J, V63, P169, DOI 10.1507/endocrj.EJ15-0545; Debnath SC, 2009, INT J FRUIT SCI, V9, P185, DOI 10.1080/15538360903005061; Dembinska-Kiec A, 2008, BRIT J NUTR, V99, pES109, DOI 10.1017/S000711450896579X; Desai T, 2019, J FUNCT FOODS, V57, P286, DOI 10.1016/j.jff.2019.04.005; Drozdz P, 2018, MOLECULES, V23, DOI 10.3390/molecules23010053; Ehala S, 2005, J AGR FOOD CHEM, V53, P6484, DOI 10.1021/jf050397w; Eid HM, 2014, EVID-BASED COMPL ALT, V2014, DOI [10.1155/2014/646812, DOI 10.1155/2014/646812]; Ek S, 2006, J AGR FOOD CHEM, V54, P9834, DOI 10.1021/jf0623687; Erasalo H, 2018, J NAT PROD, V81, P1131, DOI 10.1021/acs.jnatprod.7b00384; Garbacki N, 2005, J Inflamm (Lond), V2, P9, DOI 10.1186/1476-9255-2-9; Grace MH, 2014, J AGR FOOD CHEM, V62, P4007, DOI 10.1021/jf403810y; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Hajazimi E, 2016, LWT-FOOD SCI TECHNOL, V74, P128, DOI 10.1016/j.lwt.2016.07.034; Hakkinen SH, 1999, J AGR FOOD CHEM, V47, P2274, DOI 10.1021/jf9811065; Hamalainen M, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/45673; Harbilas D, 2009, CAN J PHYSIOL PHARM, V87, P479, DOI [10.1139/Y09-029, 10.1139/y09-029]; Heinonen M, 2007, MOL NUTR FOOD RES, V51, P684, DOI 10.1002/mnfr.200700006; Heyman L, 2014, J NUTR METAB, V2014, DOI 10.1155/2014/403041; Heyman-Linden L, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.29993; Ji GY, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0139-6; Joseph SV, 2014, J AGR FOOD CHEM, V62, P3886, DOI 10.1021/jf4044056; Jung CH, 2013, PHYTOTHER RES, V27, P139, DOI 10.1002/ptr.4687; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kahkonen MP, 2001, J AGR FOOD CHEM, V49, P4076, DOI 10.1021/jf010152t; Kivimaki AS, 2014, J FUNCT FOODS, V7, P238, DOI 10.1016/j.jff.2014.02.005; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Kolehmainen M, 2012, MOL NUTR FOOD RES, V56, P1501, DOI 10.1002/mnfr.201200195; Kowalska K, 2016, CURR OPIN CLIN NUTR, V19, P446, DOI 10.1097/MCO.0000000000000322; Laavola M, 2015, J AGR FOOD CHEM, V63, P3445, DOI 10.1021/jf504606m; Lee H, 2013, PEDIATR GASTROENTERO, V16, P143, DOI 10.5223/pghn.2013.16.3.143; Mane C, 2011, J AGR FOOD CHEM, V59, P3330, DOI 10.1021/jf103965b; Marungruang N, 2020, NUTR NEUROSCI, V23, P600, DOI 10.1080/1028415X.2018.1536423; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Mursu J, 2014, AM J CLIN NUTR, V99, P328, DOI 10.3945/ajcn.113.069641; Mykkanen OT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114790; Nardi GM, 2016, PHARMACOGN RES, V8, P42, DOI 10.4103/0974-8490.178642; Nile SH, 2014, NUTRITION, V30, P134, DOI 10.1016/j.nut.2013.04.007; Ohara K, 2015, BIOCHEM BIOPH RES CO, V468, P877, DOI 10.1016/j.bbrc.2015.11.047; Pan HT, 2014, PHYSIOL BEHAV, V130, P157, DOI 10.1016/j.physbeh.2014.04.003; Pan MH, 2010, FOOD FUNCT, V1, P15, DOI 10.1039/c0fo00103a; Paz G, 2012, ARQ BRAS ENDOCRINOL, V56, P597, DOI 10.1590/S0004-27302012000900001; Piironen V., 2000, Journal of Food Composition and Analysis, V13, P619, DOI 10.1006/jfca.2000.0898; Podrini C, 2013, MAMM GENOME, V24, P240, DOI 10.1007/s00335-013-9456-0; Prior RL, 2010, J AGR FOOD CHEM, V58, P3970, DOI 10.1021/jf902852d; Prior RL, 2009, MOL NUTR FOOD RES, V53, P1406, DOI 10.1002/mnfr.200900026; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Razavi SM, 2013, J MED FOOD, V16, P255, DOI 10.1089/jmf.2012.2408; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Sack GH, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0047-0; Scotece M, 2014, DRUG DISCOV TODAY, V19, P241, DOI 10.1016/j.drudis.2013.07.012; Shibata R, 2017, J CARDIOL, V70, P329, DOI 10.1016/j.jjcc.2017.02.006; Smith BW, 2011, NAT REV ENDOCRINOL, V7, P456, DOI 10.1038/nrendo.2011.72; Sun L, 2016, GENE, V583, P48, DOI 10.1016/j.gene.2016.02.044; Szajdek A, 2008, PLANT FOOD HUM NUTR, V63, P147, DOI 10.1007/s11130-008-0097-5; Szakiel A, 2012, J AGR FOOD CHEM, V60, P4994, DOI 10.1021/jf300375b; Tonstad S, 2011, EXPERT REV CARDIOVAS, V9, P1069, DOI [10.1586/erc.11.83, 10.1586/ERC.11.83]; Turtiainen M, 2011, SILVA FENN, V45, P237, DOI 10.14214/sf.115; Wahab A, 2017, MOLECULES, V22, DOI 10.3390/molecules22081329; Wang DL, 2012, MOL NUTR FOOD RES, V56, P610, DOI 10.1002/mnfr.201100659; Williamson G, 2017, NUTR BULL, V42, P226, DOI 10.1111/nbu.12278; World Health Organization, 2018, OB OV; Wu T, 2016, MOL NUTR FOOD RES, V60, P687, DOI 10.1002/mnfr.201500734; Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046; Yoon JS, 2012, BRIT J OPHTHALMOL, V96, P1117, DOI 10.1136/bjophthalmol-2012-301537; Zhang Z, 2018, INT J FOOD SCI TECHN; Zheng SJ, 2018, J FUNCT FOODS, V49, P362, DOI 10.1016/j.jff.2018.09.007; Zheng W, 2003, J AGR FOOD CHEM, V51, P502, DOI 10.1021/jf020728u; Zhou YJ, 2013, FRONT MED-PRC, V7, P207, DOI 10.1007/s11684-013-0263-5	82	16	16	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232605	10.1371/journal.pone.0232605	http://dx.doi.org/10.1371/journal.pone.0232605			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379797	Green Published, gold			2022-12-26	WOS:000537285700046
J	Ismail, MB; Al Kassaa, I; El Safadi, D; Al Omari, S; Mallat, H; Dabboussi, F; Hamze, M				Ismail, Mohamad Bachar; Al Kassaa, Imad; El Safadi, Dima; Al Omari, Sarah; Mallat, Hassan; Dabboussi, Fouad; Hamze, Monzer			Prevalence of anti-hepatitis E virus IgG antibodies in sera from hemodialysis patients in Tripoli, Lebanon	PLOS ONE			English	Article							DIAGNOSTIC PERFORMANCE; HEV INFECTION; BLOOD-DONORS; SEROPREVALENCE; TRANSFUSION; RISK; TRANSMISSION; RECIPIENTS; OUTBREAK; PROVINCE	Hepatitis E virus (HEV) is an important global public health concern. Several studies reported a higher HEV prevalence in patients undergoing regular hemodialysis (HD). In Lebanon, the epidemiology of HEV among HD patients has never been investigated previously. In this study, we examine the seroprevalence of HEV infection among 171 HD patients recruited from three hospital dialysis units in Tripoli, North Lebanon. Prevalence of anti-HEV IgG antibodies was evaluated in participant's sera using a commercial enzyme-linked immunosorbent assay (ELISA). The association of socio-demographic and clinical parameters with HEV infection in patients was also evaluated. Overall, 96 women and 75 men were enrolled in this study. Anti-HEV IgG antibodies were found positive in 37/171 HD patients showing a positivity rate of 21.63%. Among all examined variables, only the age of patients was significantly associated with seropositivity (P = 0.001). This first epidemiological study reveals a high seroprevalence of HEV infection among Lebanese HD patients. However, further evaluations that enroll larger samples and include control groups are required to identify exact causative factors of the important seropositivity rate in this population.	[Ismail, Mohamad Bachar; Al Kassaa, Imad; El Safadi, Dima; Mallat, Hassan; Dabboussi, Fouad; Hamze, Monzer] Lebanese Univ, Doctoral Sch Sci & Technol, Fac Publ Hlth, Lab Microbiol Sante & Environm LMSE, Tripoli, Lebanon; [Ismail, Mohamad Bachar] Lebanese Univ, Fac Sci, Tripoli, Lebanon; [Al Omari, Sarah] Lebanese Univ, Fac Publ Hlth, Tripoli, Lebanon	Lebanese University; Lebanese University; Lebanese University	Hamze, M (corresponding author), Lebanese Univ, Doctoral Sch Sci & Technol, Fac Publ Hlth, Lab Microbiol Sante & Environm LMSE, Tripoli, Lebanon.	mhamze@monzerhamze.com	Kassaa, Imad/J-6076-2019; Safadi, Dima El/C-1022-2014	Kassaa, Imad/0000-0002-2951-2427; Safadi, Dima El/0000-0001-6852-3682; Ismail, Mohamad Bachar/0000-0003-4347-1913	Lebanese University	Lebanese University	We would like to thank Dr. Nabil Afyouni, Dr. Nabil Kabbara, Dr. Rachad Alameddine, Dr. Marcel Achkar, Dr. Ahmad Kamaleddine and Dr. Ahmad Raad for facilitating our collection of patient samples. We also acknowledge the technical assistance of Mr. Majdeddine El Mouzawak and Mr. Taha Abdou. This work was supported by the Lebanese University.	Abou Rached Antoine, 2016, World J Nephrol, V5, P101, DOI 10.5527/wjn.v5.i1.101; Aggarwal R, 2011, VIRUS RES, V161, P15, DOI 10.1016/j.virusres.2011.03.017; Ahmed A, 2015, INT J HEPATOL, V2015, DOI 10.1155/2015/872431; Alavian SM, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.23633; Pisano MB, 2017, ARCH VIROL, V162, P787, DOI 10.1007/s00705-016-3171-6; Ben-Ayed Y, 2015, J MED VIROL, V87, P441, DOI 10.1002/jmv.24082; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; BUTI M, 1995, J VIROL METHODS, V55, P49, DOI 10.1016/0166-0934(95)00044-U; Cengiz K, 1996, NEPHRON, V74, P730, DOI 10.1159/000189490; Colson P, 2007, EMERG INFECT DIS, V13, P648, DOI 10.3201/eid1304.061387; COURTNEY MG, 1994, LANCET, V344, P1166, DOI 10.1016/S0140-6736(94)90678-5; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dalekos GN, 1998, TRANSFUSION, V38, P589, DOI 10.1046/j.1537-2995.1998.38698326339.x; Eini P, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.15(5)2015.26260; Fabrizi F, 1997, NEPHROL DIAL TRANSPL, V12, P133, DOI 10.1093/ndt/12.1.133; Gessoni G, 1996, J VIRAL HEPATITIS, V3, P197, DOI 10.1111/j.1365-2893.1996.tb00095.x; HALFON P, 1994, LANCET, V344, P746, DOI 10.1016/S0140-6736(94)92232-2; Harrison A, 2013, J MED VIROL, V85, P266, DOI 10.1002/jmv.23463; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Irani Hakime N, 1998, J Med Liban, V46, P60; Ismail MB, 2019, E MEDITERR HEALTH J, V26, P542; Kamar N, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.86; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Khuroo MS, 2004, J GASTROEN HEPATOL, V19, P778, DOI 10.1111/j.1440-1746.2004.03437.x; Kikuchi K, 2006, THER APHER DIAL, V10, P193, DOI 10.1111/j.1744-9987.2006.00363.x; Mansuy JM, 2009, CLIN INFECT DIS, V48, P373, DOI 10.1086/595893; Marano G, 2015, BLOOD TRANSFUS-ITALY, V13, P6, DOI 10.2450/2014.0063-14; Mateos ML, 1998, VOX SANG, V75, P267; Matsubayashi K, 2004, TRANSFUSION, V44, P934, DOI 10.1111/j.1537-2995.2004.03300.x; Meng XJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005695; Mitsui T, 2004, J MED VIROL, V74, P563, DOI 10.1002/jmv.20215; Mobaien AR, 2013, E MEDITERR HEALTH J, V19, P608; Nimgaonkar I, 2018, NAT REV GASTRO HEPAT, V15, P96, DOI 10.1038/nrgastro.2017.150; Norder H, 2016, J CLIN MICROBIOL, V54, P549, DOI 10.1128/JCM.02343-15; Pas SD, 2013, J CLIN VIROL, V58, P629, DOI 10.1016/j.jcv.2013.10.010; Psichogiou M, 1996, SCAND J INFECT DIS, V28, P443, DOI 10.3109/00365549609037936; Psichogiou M, 1996, NEPHROL DIAL TRANSPL, V11, P1093, DOI 10.1093/oxfordjournals.ndt.a027461; Purdy MA, 2011, VIRUS RES, V161, P31, DOI 10.1016/j.virusres.2011.04.030; Ricco G, 2016, DIGEST LIVER DIS, V48, P536, DOI 10.1016/j.dld.2016.01.007; ROBSON SC, 1992, LANCET, V339, P1424, DOI 10.1016/0140-6736(92)91250-C; Scotto G, 2014, EPIDEMIOL INFECT, V142, P287, DOI 10.1017/S0950268813001167; Scotto G, 2015, WORLD J GASTROENTERO, V21, P3266, DOI 10.3748/wjg.v21.i11.3266; Siddiqui AR, 2005, CLIN INFECT DIS, V40, P908, DOI 10.1086/428357; Stefanidis I, 2004, INT J ARTIF ORGANS, V27, P842, DOI 10.1177/039139880402701005; Sylvan SPE, 1998, J MED VIROL, V54, P38, DOI 10.1002/(SICI)1096-9071(199801)54:1&lt;38::AID-JMV6&gt;3.0.CO;2-Q; Tamura A, 2007, HEPATOL RES, V37, P113, DOI 10.1111/j.1872-034X.2007.00024.x; Ucar E, 2009, MIKROBIYOL BUL, V43, P299; World Health Organization (WHO), 2018, HEP E KEY FACTS; Zaki MES, 2015, IJHSR, V5, P65; Zekavat Omid R, 2013, Asian J Transfus Sci, V7, P21, DOI 10.4103/0973-6247.106724	50	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233256	10.1371/journal.pone.0233256	http://dx.doi.org/10.1371/journal.pone.0233256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421697	Green Published, gold			2022-12-26	WOS:000537499600036
J	Latif, QS; Saab, VA; Dudley, JG; Markus, A; Mellen-McLean, K				Latif, Quresh S.; Saab, Victoria A.; Dudley, Jonathan G.; Markus, Amy; Mellen-McLean, Kim			Development and evaluation of habitat suitability models for nesting white-headed woodpecker (Dryobates albolarvatus) in burned forest	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; SELECTION; BIRDS; DISTRIBUTIONS; CONSERVATION; CLIMATE; FIRE; TRANSFERABILITY; RESTORATION; PREDICTION	Salvage logging in burned forests can negatively affect habitat for white-headed woodpeckers (Dryobates albolarvatus), a species of conservation concern, but also meets socioeconomic demands for timber and human safety. Habitat suitability index (HSI) models can inform forest management activities to help meet habitat conservation objectives. Informing post-fire forest management, however, involves model application at new locations as wildfires occur, requiring evaluation of predictive performance across locations. We developed HSI models for white-headed woodpeckers using nest sites from two burned-forest locations in Oregon, the Toolbox (2002) and Canyon Creek (2015) fires. We measured predictive performance by developing one model at each of the two locations and quantifying discrimination of nest from reference sites at two other wildfire locations where the model had not been developed (either Toolbox or Canyon Creek, and the Barry Point Fire [2011]). We developed and evaluated Maxent models based on remotely sensed environmental metrics to support habitat mapping, and weighted logistic regression (WLR) models that combined remotely sensed and field-collected metrics to inform management prescriptions. Both Maxent and WLR models developed either at Canyon Creek or Toolbox performed adequately to inform management when applied at the alternate Toolbox or Canyon Creek location, respectively (area under the receiver-operating-characteristic curve [AUC] range = 0.61-0.72) but poorly when applied at Barry Point (AUC = 0.53-0.57). The final HSI models fitted to Toolbox and Canyon Creek data quantified suitable nesting habitat as severely burned or open sites adjacent to lower severity and closed canopy sites, where foraging presumably occurs. We suggest these models are applicable at locations similar to development locations but not at locations resembling Barry Point, which were characterized by more (pre-fire) canopy openings, larger diameter trees, less ponderosa pine (Pinus ponderosa), and more juniper (Juniperus occidentalis). Considering our results, we recommend caution when applying HSI models developed at individual wildfire locations to inform postfire management at new locations without first evaluating predictive performance.	[Latif, Quresh S.; Saab, Victoria A.] US Forest Serv, Rocky Mt Res Stn, Bozeman, MT 59715 USA; [Dudley, Jonathan G.] US Forest Serv, Rocky Mt Res Stn, Boise, ID USA; [Markus, Amy] US Forest Serv, Fremont Winema Natl Forest, Lakeview, OR USA; [Mellen-McLean, Kim] US Forest Serv, Pacific Northwest Region Reg 6, Oregon City, OR USA; [Latif, Quresh S.] Bird Conservancy Rockies, Ft Collins, CO 80521 USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Latif, QS; Saab, VA (corresponding author), US Forest Serv, Rocky Mt Res Stn, Bozeman, MT 59715 USA.; Latif, QS (corresponding author), Bird Conservancy Rockies, Ft Collins, CO 80521 USA.	quresh.latif@birdconservancy.org; vsaab@usda.gov			United States Forest Service: Fremont-Winema National Forest; United States Forest Service: Malheur National Forest; United States Forest Service: Rocky Mountain Research Station's National Fire Plan [02.RMS.C2]; United States Forest Service: Pacific Northwest Region; Bird Conservancy of the Rockies	United States Forest Service: Fremont-Winema National Forest; United States Forest Service: Malheur National Forest; United States Forest Service: Rocky Mountain Research Station's National Fire Plan; United States Forest Service: Pacific Northwest Region; Bird Conservancy of the Rockies	Funding was provided primarily by the United States Forest Service: Fremont-Winema National Forest (https://www.fs.usda.gov/fremontwinema/), Malheur National Forest (https://www.fs.usda.gov/malheur/), Rocky Mountain Research Station's (https://www.fs.usda.gov/rmrs/) National Fire Plan (02.RMS.C2), and the Pacific Northwest Region (https://www.fs.usda.gov/r6).Co-authors include current or former employees of funding agencies who also contributed to sampling design at one or more locations. Bird Conservancy of the Rockies supported QSL during manuscript preparation, submission, and peer review. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2013, J ANIM ECOL, V82, P1135, DOI 10.1111/1365-2656.12061; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Barrows CW, 2008, BIOL CONSERV, V141, P1885, DOI 10.1016/j.biocon.2008.05.006; Bull E.L., 1997, PNWGTR391 USDA FOR S; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Donovan TM, 2001, ECOL APPL, V11, P871; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Forristal CD, 2009, THESIS; Franklin J, 2009, MAPPING SPECIES DIST; Gaines W, 2010, FOREST SCI, V56, P88; Gaines WL, 2007, RESTOR ECOL, V15, P670, DOI 10.1111/j.1526-100X.2007.00279.x; Garrett KL, 1996, WHITE HEADED WOODPEC; Gilroy JJ, 2007, TRENDS ECOL EVOL, V22, P351, DOI 10.1016/j.tree.2007.03.014; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hannon Susan J., 2005, Studies in Avian Biology, V30, P97; Heikkinen RK, 2012, ECOGRAPHY, V35, P276, DOI 10.1111/j.1600-0587.2011.06999.x; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; Hollenbeck JP, 2011, J WILDLIFE MANAGE, V75, P1061, DOI 10.1002/jwmg.146; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; Hutto RL, 2006, CONDOR, V108, P817, DOI 10.1650/0010-5422(2006)108[817:TEOPSL]2.0.CO;2; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Key C.H., 2006, FIRE ECOL, V2, P34, DOI [10.4996/fireecology.0202034, DOI 10.4996/FIREECOLOGY.0202034]; Latif QS, RMRSGTR391 USDA FOR, V74, P2018; Latif QS, 2016, CONDOR, V118, P766, DOI 10.1650/CONDOR-16-86.1; Latif QS, 2015, J WILDLIFE MANAGE, V79, P263, DOI 10.1002/jwmg.842; Latif QS, 2013, ECOL EVOL, V3, P4348, DOI 10.1002/ece3.790; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; LEMMA. Landscape Ecology Modeling Mapping and Analysis, 2018, DAT USDA; Lindenmayer D., 2008, SALVAGE LOGGING ITS; Lindenmayer DB, 2014, DIVERS DISTRIB, V20, P467, DOI 10.1111/ddi.12172; Lorenz TJ, 2016, FOREST ECOL MANAG, V363, P110, DOI 10.1016/j.foreco.2015.12.021; Lorenz TJ, 2015, J WILDLIFE MANAGE, V79, P1286, DOI 10.1002/jwmg.957; McDonald TL, 2013, J ANIM ECOL, V82, P1174, DOI 10.1111/1365-2656.12132; Merow C, 2014, METHODS ECOL EVOL, V5, P215, DOI 10.1111/2041-210X.12152; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Morrison ML, 2012, J WILDLIFE MANAGE, V76, P438, DOI 10.1002/jwmg.333; Neter J., 1996, APPL LINEAR STAT MOD; Peterson D. L., 2009, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Phillips S., 2006, BRIEF TUTORIAL MAXEN, P107; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Core Team, 2021, R LANGUAGE ENV STAT; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rotenberry JT, 2006, ECOLOGY, V87, P1458, DOI 10.1890/0012-9658(2006)87[1458:GNMFMS]2.0.CO;2; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Russell RE, 2007, J WILDLIFE MANAGE, V71, P2600, DOI 10.2193/2007-034; Russell RE, 2009, WILSON J ORNITHOL, V121, P82, DOI 10.1676/08-026.1; Ryan KC, 2013, FOREST ECOL MANAG, V294, P208, DOI 10.1016/j.foreco.2012.11.003; Saab V., 2003, RMRSRP44 US DEP AGR; Saab VA, 2004, CONDOR, V106, P20, DOI 10.1650/7485; Saab VA, 2007, CONDOR, V109, P97, DOI 10.1650/0010-5422(2007)109[97:NDOCBI]2.0.CO;2; Saab Victoria A., 2005, Studies in Avian Biology, V30, P76; Saab VA, 2009, FOREST ECOL MANAG, V257, P151, DOI 10.1016/j.foreco.2008.08.028; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Thorn S, 2018, J APPL ECOL, V55, P279, DOI 10.1111/1365-2664.12945; Tingley MW, 2016, METHODS ECOL EVOL, V7, P508, DOI 10.1111/2041-210X.12500; Toupin R, 2008, R6NRFPPR0108 PAC NW; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; USGS, 2018, NAT LAND COV DAT; Vierling KT, 2018, INT J BIOMETEOROL, V62, P553, DOI 10.1007/s00484-017-1464-4; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Whitlock C, 2003, FOREST ECOL MANAG, V178, P5, DOI 10.1016/S0378-1127(03)00051-3; Wiens TS, 2008, ECOL MODEL, V212, P244, DOI 10.1016/j.ecolmodel.2007.10.005; Wightman CS, 2010, J WILDLIFE MANAGE, V74, P1098, DOI 10.2193/2009-174; Willson MF, 2003, CAN J ZOOL, V81, P1202, DOI [10.1139/z03-096, 10.1139/Z03-096]	74	7	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233043	10.1371/journal.pone.0233043	http://dx.doi.org/10.1371/journal.pone.0233043			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413068	Green Published, gold			2022-12-26	WOS:000537496000043
J	Tramer, L; Becker, C; Schumacher, C; Beck, K; Tschan, F; Semmer, NK; Hochstrasser, S; Marsch, S; Hunziker, S				Tramer, Lucas; Becker, Christoph; Schumacher, Cleo; Beck, Katharina; Tschan, Franziska; Semmer, Norbert K.; Hochstrasser, Seraina; Marsch, Stephan; Hunziker, Sabina			Association of self-esteem, personality, stress and gender with performance of a resuscitation team: A simulation-based study	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; HEART-RATE; TRAITS; LEADERSHIP; QUALITY	Background Gender composition, stress and leadership of a resuscitation team influence CPR performance. Whether psychological variables such as self-esteem, motivation and personality traits are associated with resuscitation performance, stress levels and gender of rescuers during a cardiac arrest scenario remains uncertain. Methods We included 108 medical students in this prospective, observational simulator study. We videotaped the resuscitation performance and assessed self-esteem, perceived stress-overload and personality traits using validated questionnaires. In addition, we analysed leadership utterances and ECG data of all participants during the simulation. The primary endpoint was cardiopulmonary resuscitation performance, defined as hands-on time within the first 180 sec. Secondary outcomes included first meaningful measure of resuscitation, leadership statements of group leaders and physiological stress parameters of rescuers. Results Adjusted for group size and leadership designation, mean self-esteem of students was significantly associated with hands-on time (adjusted regression coefficient 7.94 (95%CI 2.61 to 13.27), p< 0.01). The personality trait conscientiousness was positively associated with hands-on time (adjusted regression coefficient 38.4, [95%CI 7.41 to 69.38, p = 0.02]). However, after additional adjustment for self-esteem, this association was no longer significant. Further, agreeableness of team leaders was significantly associated with longer hands-on time (adjusted regression coefficient 20.87 [95%CI 3.81 to 37.94], p = 0.02). Openness to experience was negatively associated with heart rate reactivity (-5.92 (95%CI -10 to -1.85), p<0.01). Male students showed significantly higher (mean, [+/- SD]) self-esteem levels (24.6 [+/- 3.8] vs. 22.0 [+/- 4.4], p< 0.01), expressed significantly more leadership statements (7.9 [+/- 7.8] vs. 4.6 [+/- 3.8], p<0.01) and initiated first resuscitation measures more often (n, [%]) compared to female students (16, [23] vs. 7, [12], p = 0.01). Conclusion This simulator study found that self-esteem of resuscitation teams and agreeableness of team leaders of inexperienced students was associated with cardiopulmonary resuscitation performance. Whether enhancing these factors during resuscitation trainings serve for better performance remains to be studied.	[Tramer, Lucas; Schumacher, Cleo; Marsch, Stephan; Hunziker, Sabina] Univ Basel, Univ Hosp Basel, Med Intens Care Unit, Basel, Switzerland; [Tramer, Lucas; Becker, Christoph; Schumacher, Cleo; Beck, Katharina; Hochstrasser, Seraina; Hunziker, Sabina] Univ Basel, Univ Hosp Basel, Med Commun & Psychosomat Med, Basel, Switzerland; [Becker, Christoph] Univ Basel, Univ Hosp Basel, Dept Emergency Med, Basel, Switzerland; [Tschan, Franziska] Univ Neuchatel, Dept Psychol, Neuchatel, Switzerland; [Semmer, Norbert K.] Univ Bern, Dept Psychol, Bern, Switzerland	University of Basel; University of Basel; University of Basel; University of Neuchatel; University of Bern	Hunziker, S (corresponding author), Univ Basel, Univ Hosp Basel, Med Intens Care Unit, Basel, Switzerland.; Hunziker, S (corresponding author), Univ Basel, Univ Hosp Basel, Med Commun & Psychosomat Med, Basel, Switzerland.	Sabina.Hunziker@usb.ch		Beck, Katharina/0000-0002-6909-6210				Afrisham R, 2016, PSYCHIAT INVEST, V13, P637, DOI 10.4306/pi.2016.13.6.637; Afshar H, 2015, J RES MED SCI, V20, P353; Amacher SA, 2017, CRIT CARE MED, V45, P1184, DOI 10.1097/CCM.0000000000002375; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Bibbey A, 2013, INT J PSYCHOPHYSIOL, V90, P28, DOI 10.1016/j.ijpsycho.2012.10.018; Bleidorn W, 2016, J PERS SOC PSYCHOL, V111, P396, DOI 10.1037/pspp0000078; Butler G., 1993, OCCAS PAP R COLL GEN, V61, P1; Camm AJ, 1996, CIRCULATION, V93, P1043; Cooper S, 1999, RESUSCITATION, V42, P27, DOI 10.1016/S0300-9572(99)00080-5; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Crandal R, 1973, MEASURES SOCIAL PSYC, P80; De Maria S, 2010, MED EDUC, V44, P1006, DOI 10.1111/j.1365-2923.2010.03775.x; Ebstrup JF, 2011, ANXIETY STRESS COPIN, V24, P407, DOI 10.1080/10615806.2010.540012; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Ferring D, 1996, DIAGNOSTICA, V42, P284; Furedy JJ, 1996, INT J PSYCHOPHYSIOL, V22, P173, DOI 10.1016/0167-8760(96)00025-6; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; GrayLittle B, 1997, PERS SOC PSYCHOL B, V23, P443, DOI 10.1177/0146167297235001; Halpin AW, 1955, J APPL PSYCHOL, V39, P82, DOI 10.1037/h0047338; Hengartner MP, 2017, STRESS HEALTH, V33, P35, DOI 10.1002/smi.2671; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Hughes, 2003, PSICOLOGICA, V24, P79; Hughes BM, 2007, ANXIETY STRESS COPIN, V20, P239, DOI 10.1080/10615800701330218; Hunziker S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-8; Hunziker S, 2012, RESUSCITATION, V83, P572, DOI 10.1016/j.resuscitation.2011.11.013; Hunziker S, 2011, INTENS CARE MED, V37, P1473, DOI 10.1007/s00134-011-2277-2; Hunziker S, 2010, CRIT CARE MED, V38, P1086, DOI 10.1097/CCM.0b013e3181cf7383; Hunziker S, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-3; Hyde JS, 2014, ANNU REV PSYCHOL, V65, P373, DOI 10.1146/annurev-psych-010213-115057; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; John O.P., 1991, BIG 5 INVENTORY VERS; Judge TA, 2002, J APPL PSYCHOL, V87, P765, DOI 10.1037/0021-9010.87.4.765; Kleinman ME, 2015, CIRCULATION, V132, pS414, DOI 10.1161/CIR.0000000000000259; Kling KC, 1999, PSYCHOL BULL, V125, P470, DOI 10.1037/0033-2909.125.4.470; Lazarus R S, 1985, Issues Ment Health Nurs, V7, P399, DOI 10.3109/01612848509009463; Lee-Baggley D, 2005, J PERS, V73, P1141, DOI 10.1111/j.1467-6494.2005.00345.x; Li XS, 2015, INT J PSYCHOL, V50, P223, DOI 10.1002/ijop.12094; Marsch SCU, 2005, CRIT CARE MED, V33, P963, DOI 10.1097/01.CCM.0000157750.43459.07; Marsch SCU, 2004, RESUSCITATION, V60, P51, DOI 10.1016/j.resuscitation.2003.08.004; Martin-Albo J, 2009, SPAN J PSYCHOL, V12, P799, DOI 10.1017/S113874160000216X; Michael S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00301; Mount MK, 1998, PERS PSYCHOL, V51, P849, DOI 10.1111/j.1744-6570.1998.tb00743.x; Mount MK, 1998, HUM PERFORM, V11, P145, DOI 10.1207/s15327043hup1102&3_3; O'Donnell K, 2008, BRAIN BEHAV IMMUN, V22, P1241, DOI 10.1016/j.bbi.2008.06.012; PARKES KR, 1986, J PERS SOC PSYCHOL, V51, P1277, DOI 10.1037/0022-3514.51.6.1277; Rosenberg M., 1965, SOC ADOLESCENT SELF; Schallberger U, 1999, U ZURICH BERICHTE AB, P1; Streiff S, 2011, SIMUL HEALTHC, V6, P78, DOI 10.1097/SIH.0b013e318209382b; Taelman J, 2009, IFMBE PROC, V22, P1366; Tramer L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198661; Weisberg YJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00178	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233155	10.1371/journal.pone.0233155	http://dx.doi.org/10.1371/journal.pone.0233155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0YZ	32407382	gold, Green Published			2022-12-26	WOS:000537490700076
J	Lee, LW; Hsieh, CJ; Wu, YH; Liao, YS				Lee, Li-Wen; Hsieh, Chu-Jung; Wu, Yun-Hsuan; Liao, Yu-San			Added values of DXA-derived visceral adipose tissue to discriminate cardiometabolic risks in pre-pubertal children	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; BODY-FAT DISTRIBUTION; METABOLIC SYNDROME; SEXUAL-DIMORPHISM; BLOOD-PRESSURE; ASSOCIATION; OBESITY; LUNAR	Background The new generation of dual energy X-ray absorptiometry (DXA) scanners provide visceral adipose tissue (VAT) estimates by applying different algorithms to the conventional DXA-derived fat parameters such as total fat, trunk fat and android fat for the same image data. Objective This cross-sectional study aimed to investigate whether VAT estimates from Hologic scanners are better predictors of VAT than conventional DXA parameters in pre-pubertal children, and to explore the discrimination ability of these VAT methods for cardiometabolic risks. Methods Healthy pre-pubertal children aged 7-10 years were recruited for basic anthropometric, DXA and magnetic resonance imaging (MRI) measurements. Laboratory tests included lipid profile, glycaemic tests and blood pressure. Results All VAT methods had acceptable to excellent performance for the diagnosis of dyslipidaemia (area under the curve [AUC] = 0.753-0.837) and hypertensive risk (AUC = 0.710-0.821) in boys, but suboptimal performance for these risks in girls, except for VAT by MRI in the diagnosis of dyslipidaemia. In both sexes, all VAT methods had no or poor discrimination ability for diabetes risk. Conclusions DXA-derived VAT estimates are very highly correlated with standard methods but has equivalent discrimination abilities compared to the existing DXA-derived fat estimates.	[Lee, Li-Wen; Hsieh, Chu-Jung; Wu, Yun-Hsuan; Liao, Yu-San] Chang Gung Mem Hosp, Dept Diagnost Radiol, Puzi, Chiayi, Taiwan; [Lee, Li-Wen; Liao, Yu-San] Chang Gung Univ Sci & Technol, Dept Nursing, Puzi, Chiayi, Taiwan; [Liao, Yu-San] Chang Gung Mem Hosp, Dept Diagnost Radiol, Mailiao Township, Yunlin, Taiwan	Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital	Liao, YS (corresponding author), Chang Gung Mem Hosp, Dept Diagnost Radiol, Puzi, Chiayi, Taiwan.; Liao, YS (corresponding author), Chang Gung Univ Sci & Technol, Dept Nursing, Puzi, Chiayi, Taiwan.; Liao, YS (corresponding author), Chang Gung Mem Hosp, Dept Diagnost Radiol, Mailiao Township, Yunlin, Taiwan.	mm601200@gmail.com	Lee, Li-Wen/AAY-3542-2021		Chang Gung Medical Foundation [CMRPG6C0052, CMRPG6G0531]	Chang Gung Medical Foundation	The first author (LWL) received funding from the Chang Gung Medical Foundation (grant no. CMRPG6C0052 and CMRPG6G0531). UPL of the funder website: https://www.cgmh.org.tw/.The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidulescu A, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-9; Blitman NM, 2011, AM J ROENTGENOL, V197, P482, DOI 10.2214/AJR.10.5514; Bosch TA, 2015, PEDIATR OBES, V10, P172, DOI 10.1111/ijpo.249; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cheng X, 2018, EUR J CLIN NUTR, V72, P1567, DOI 10.1038/s41430-018-0122-1; D'Adamo E, 2010, METABOLISM, V59, P671, DOI 10.1016/j.metabol.2009.09.012; Daniels SR, 1999, CIRCULATION, V99, P541, DOI 10.1161/01.CIR.99.4.541; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Demerath EW, 2007, AM J CLIN NUTR, V85, P362, DOI 10.1093/ajcn/85.2.362; Despres J.-P., 2012, AN UPDATE, V126, P1301, DOI [10.1161/circulationaha.111.067264, DOI 10.1161/CIRCULATIONAHA.111.067264, DOI 10.1161/CIRCULATI0NAHA.111.067264]; Diessel E, 2000, J APPL PHYSIOL, V89, P599, DOI 10.1152/jappl.2000.89.2.599; FARRELL TJ, 1989, CLIN PHYS PHYSIOL M, V10, P57, DOI 10.1088/0143-0815/10/1/006; Flynn JT, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-3035; Gower BA, 1999, DIABETES, V48, P1515, DOI 10.2337/diabetes.48.8.1515; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; He Q, 2002, CIRCULATION, V105, P1093, DOI 10.1161/hc0902.104706; He Q, 2002, J CLIN ENDOCR METAB, V87, P2164, DOI 10.1210/jc.87.5.2164; Irlbeck T, 2010, INT J OBESITY, V34, P781, DOI 10.1038/ijo.2009.279; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Korner A, 2013, INT J OBESITY, V37, P931, DOI 10.1038/ijo.2012.163; KOHRT WM, 1995, MED SCI SPORT EXER, V27, P1349; Lee S, 2011, PEDIATR DIABETES, V12, P250, DOI 10.1111/j.1399-5448.2010.00705.x; Lee V, 2018, OBES SCI PRACT, V4, P437, DOI 10.1002/osp4.297; Lindsay RS, 2001, J CLIN ENDOCR METAB, V86, P4061, DOI 10.1210/jc.86.9.4061; Lorente RRM, 2012, FUNDAMENTOS METODOLO, V54, P410, DOI [DOI 10.1016/J.RX.2011.09.023, DOI 10.1016/j.rx.2011.09.023]; LUKASKI HC, 1993, J NUTR, V123, P438, DOI 10.1093/jn/123.suppl_2.438; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; Micklesfield LK, 2012, OBESITY, V20, P1109, DOI 10.1038/oby.2011.367; Neeland IJ, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.28; NIER A, 2019, NUTRIENTS, V11, DOI DOI 10.2471/BLT.07.043497; O'Connor M, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140711; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schousboe JT, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009172; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; Shepherd JA, 2012, J BONE MINER RES, V27, P2208, DOI 10.1002/jbmr.1654; Smith U, 2015, J CLIN INVEST, V125, P1790, DOI 10.1172/JCI81507; Syme C, 2009, ARCH PEDIAT ADOL MED, V163, P818, DOI 10.1001/archpediatrics.2009.92; Taylor RW, 2010, OBESITY, V18, P1410, DOI 10.1038/oby.2009.399; Thomas EL, 2012, NUTR RES REV, V25, P150, DOI 10.1017/S0954422412000054; Toomey CM, 2015, TOP CLIN NUTR, V30, P16, DOI 10.1097/TIN.0000000000000017; TOTHILL P, 1993, BASIC LIFE SCI, P385; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Zhao YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16819-y	45	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0233053	10.1371/journal.pone.0233053	http://dx.doi.org/10.1371/journal.pone.0233053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401808	Green Published, gold			2022-12-26	WOS:000537481000052
J	Yan, JH; Li, HS; Bu, HS; Jiao, KL; Zhang, AX; Le, T; Cao, H; Li, YG; Ding, YH; Xu, XL				Yan, Jianhua; Li, Hongsong; Bu, Haisong; Jiao, Kunli; Zhang, Alex X.; Le, Tai; Cao, Hung; Li, Yigang; Ding, Yonghe; Xu, Xiaolei			Aging-associated sinus arrest and sick sinus syndrome in adult zebrafish	PLOS ONE			English	Article							PACEMAKER ACTIVITY; SINOATRIAL NODE; QT SYNDROME; MODEL; CHANNEL; HEART; ELECTROCARDIOGRAM; MUTATIONS	Because of its powerful genetics, the adult zebrafish has been increasingly used for studying cardiovascular diseases. Considering its heart rate of similar to 100 beats per minute at ambient temperature, which is very close to human, we assessed the use of this vertebrate animal for modeling heart rhythm disorders such as sinus arrest (SA) and sick sinus syndrome (SSS). We firstly optimized a protocol to measure electrocardiogram in adult zebrafish. We determined the location of the probes, implemented an open-chest microsurgery procedure, measured the effects of temperature, and determined appropriate anesthesia dose and time. We then proposed an PP interval of more than 1.5 seconds as an arbitrary criterion to define an SA episode in an adult fish at ambient temperature, based on comparison between the current definition of an SA episode in humans and our studies of candidate SA episodes in aged wild-type fish and Tg(SCN5A-D1275N) fish (a fish model for inherited SSS). With this criterion, a subpopulation of about 5% wild-type fish can be considered to have SA episodes, and this percentage significantly increases to about 25% in 3-year-old fish. In response to atropine, this subpopulation has both common SSS phenotypic traits that are shared with the Tg(SCN5A-D1275N) model, such as bradycardia; and unique SSS phenotypic traits, such as increased QRS/P ratio and chronotropic incompetence. In summary, this study defined baseline SA and SSS in adult zebrafish and underscored use of the zebrafish as an alternative model to study aging-associated SSS.	[Yan, Jianhua; Li, Hongsong; Bu, Haisong; Zhang, Alex X.; Ding, Yonghe; Xu, Xiaolei] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Yan, Jianhua; Li, Hongsong; Bu, Haisong; Zhang, Alex X.; Ding, Yonghe; Xu, Xiaolei] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA; [Jiao, Kunli; Li, Yigang] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Div Cardiol, Shanghai, Peoples R China; [Le, Tai; Cao, Hung] UC Irvine, Dept Elect Engn & Comp Sci, Irvine, CA USA; [Cao, Hung] UC Irvine, Dept Biomed Engn, Irvine, CA USA	Mayo Clinic; Mayo Clinic; Shanghai Jiao Tong University; University of California System; University of California Irvine; University of California System; University of California Irvine	Ding, YH; Xu, XL (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.; Ding, YH; Xu, XL (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA.	ding.yonghe@mayo.edu; xu.xiaolei@mayo.edu	Le, Tai/AAQ-4105-2020	Le, Tai/0000-0002-1845-0064; Xu, Xiaolei/0000-0002-4928-3422	National Institutes of Health (NIH) [R01-HL107304, R01-HL081753, R01-GM63904]; Mayo Foundation [FP00093430]; Ted and Loretta Rogers Cardiovascular Career Development Award Honoring Hugh C. Smith from Mayo Clinic [FP00093430]; National Science Foundation (NSF) [1652818]; NIH [R41-OD024874]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Ted and Loretta Rogers Cardiovascular Career Development Award Honoring Hugh C. Smith from Mayo Clinic; National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (NIH) (https://www.nih.gov/) R01-HL107304, R01-HL081753, R01-GM63904 and the Mayo Foundation FP00093430 (https://www.mayoclinic.org/) to XX, the Ted and Loretta Rogers Cardiovascular Career Development Award Honoring Hugh C. Smith from Mayo Clinic (FP00093430) to YD, and the National Science Foundation (NSF) (https://www.nsf.gov/funding/) #1652818 and NIH R41-OD024874 to HC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from National Institutes of Health (NIH) R01-HL107304, R01-HL081753, R01-GM63904 and the Mayo Foundation to XX; the Ted and Loretta Rogers Cardiovascular Career Development Award Honoring Hugh C. Smith from Mayo Clinic (FP00093430) to YD, and National Science Foundation (NSF) #1652818 and NIH R41OD024874 to HC. We thank Beninio Gores and Kashia B. Stragey for managing the zebrafish facility; Dr. Diane Fatkin, Victor Chang Cardiac Research Institute, Australia, for sharing the Tg(SCN5A-D1275N) fish.	Ardell JL, 2016, COMPR PHYSIOL, V6, P1635, DOI 10.1002/cphy.c150046; Arnaout R, 2007, P NATL ACAD SCI USA, V104, P11316, DOI 10.1073/pnas.0702724104; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Brembilla-Perrot B, 2010, MINERVA CARDIOANGIOL, V58, P505; BRODSKY M, 1977, AM J CARDIOL, V39, P390, DOI 10.1016/S0002-9149(77)80094-5; Cao H, 2014, INTEGR BIOL-UK, V6, P789, DOI 10.1039/c4ib00052h; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Crowcombe J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165655; De Ponti Roberto, 2018, Card Electrophysiol Clin, V10, P183, DOI 10.1016/j.ccep.2018.02.002; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; Epstein AE, 2013, J AM COLL CARDIOL, V61, pE6, DOI 10.1016/j.jacc.2012.11.007; Gut P, 2017, PHYSIOL REV, V97, P889, DOI 10.1152/physrev.00038.2016; Hassel D, 2008, CIRCULATION, V117, P866, DOI 10.1161/CIRCULATIONAHA.107.752220; Hedrick MS, 2003, AM J PHYSIOL-REG I, V284, pR405, DOI 10.1152/ajpregu.00418.2002; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; Huttner IG, 2013, J MOL CELL CARDIOL, V61, P123, DOI 10.1016/j.yjmcc.2013.06.005; Jensen PN, 2014, J AM COLL CARDIOL, V64, P531, DOI 10.1016/j.jacc.2014.03.056; Jones SA, 2007, CIRCULATION, V115, P1183, DOI 10.1161/CIRCULATIONAHA.106.663070; Joung B, 2011, CIRC-ARRHYTHMIA ELEC, V4, P799, DOI 10.1161/CIRCEP.111.965897; Kistler PM, 2004, J AM COLL CARDIOL, V44, P109, DOI 10.1016/j.jacc.2004.03.044; KRAMER K, 1993, J PHARMACOL TOXICOL, V30, P209, DOI 10.1016/1056-8719(93)90019-B; Kusumoto FM, 2019, CIRCULATION, V140, pE333, DOI 10.1161/CIR.0000000000000627; Lee L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145163; Lei M, 2005, J PHYSIOL-LONDON, V567, P387, DOI 10.1113/jphysiol.2005.083188; Lenning M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18010061; Leong IUS, 2010, ACTA PHYSIOL, V199, P257, DOI 10.1111/j.1748-1716.2010.02111.x; Lin E, 2014, AM J PHYSIOL-REG I, V306, pR823, DOI 10.1152/ajpregu.00002.2014; Liu CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25073; Milan DJ, 2006, AM J PHYSIOL-HEART C, V291, pH269, DOI 10.1152/ajpheart.00960.2005; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Orr N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11303; Sandblom E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1490; Semelka M, 2013, AM FAM PHYSICIAN, V87, P691; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Stoyek MR, 2016, AM J PHYSIOL-HEART C, V311, pH676, DOI 10.1152/ajpheart.00330.2016; Tessadori F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047644; Verkerk AO, 2015, INT J MOL SCI, V16, P3071, DOI 10.3390/ijms16023071; Verkerk AO, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00255; WAHLS SA, 1985, AM FAM PHYSICIAN, V31, P117; Wang LW, 2017, DIS MODEL MECH, V10, P63, DOI 10.1242/dmm.026989; Zhao Y, 2015, BIOMEDICAL MICRODEVI, V17, P1; Zhao YL, 2019, JOVE-J VIS EXP, DOI 10.3791/60011	43	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232457	10.1371/journal.pone.0232457	http://dx.doi.org/10.1371/journal.pone.0232457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401822	Green Published, gold			2022-12-26	WOS:000537481000016
J	Smirnov, D; Pikunov, A; Syunyaev, R; Deviatiiarov, R; Gusev, O; Aras, K; Gams, A; Koppel, A; Efimov, IR				Smirnov, Dmitrii; Pikunov, Andrey; Syunyaev, Roman; Deviatiiarov, Ruslan; Gusev, Oleg; Aras, Kedar; Gams, Anna; Koppel, Aaron; Efimov, Igor R.			Genetic algorithm-based personalized models of human cardiac action potential	PLOS ONE			English	Article							REPOLARIZATION; MECHANISM	We present a novel modification of genetic algorithm (GA) which determines personalized parameters of cardiomyocyte electrophysiology model based on set of experimental human action potential (AP) recorded at different heart rates. In order to find the steady state solution, the optimized algorithm performs simultaneous search in the parametric and slow variables spaces. We demonstrate that several GA modifications are required for effective convergence. Firstly, we used Cauchy mutation along a random direction in the parametric space. Secondly, relatively large number of elite organisms (6-10% of the population passed on to new generation) was required for effective convergence. Test runs with synthetic AP as input data indicate that algorithm error is low for high amplitude ionic currents (1.6 +/- 1.6% for IKr, 3.2 +/- 3.5% for IK1, 3.9 +/- 3.5% for INa, 8.2 +/- 6.3% for ICaL). Experimental signal-to-noise ratio above 28 dB was required for high quality GA performance. GA was validated against optical mapping recordings of human ventricular AP and mRNA expression profile of donor hearts. In particular, GA output parameters were rescaled proportionally to mRNA levels ratio between patients. We have demonstrated that mRNA-based models predict the AP waveform dependence on heart rate with high precision. The latter also provides a novel technique of model personalization that makes it possible to map gene expression profile to cardiac function.	[Smirnov, Dmitrii; Pikunov, Andrey; Efimov, Igor R.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Syunyaev, Roman; Aras, Kedar; Gams, Anna; Koppel, Aaron; Efimov, Igor R.] George Washington Univ, Washington, DC 20052 USA; [Syunyaev, Roman] Sechenov Univ, Moscow, Russia; [Deviatiiarov, Ruslan; Gusev, Oleg] Kazan Fed Univ, Kazan, Russia	Moscow Institute of Physics & Technology; George Washington University; Sechenov First Moscow State Medical University; Kazan Federal University	Syunyaev, R (corresponding author), Moscow Inst Phys & Technol, Dolgoprudnyi, Russia.; Syunyaev, R (corresponding author), George Washington Univ, Washington, DC 20052 USA.; Syunyaev, R (corresponding author), Sechenov Univ, Moscow, Russia.	siuniaev.ra@mipt.ru; efimov@gwu.edu	Gams, Anna/AAV-3024-2020; Smirnov, Dmitrii/ABB-1523-2020; Pikunov, Andrey/AAI-2605-2021; Gusev, Oleg/D-9383-2011; Deviatiiarov, Ruslan/D-3438-2014; Syunyaev, Roman/M-1971-2013; Efimov, Igor R./AAJ-3234-2021; Syunyaev, Roman/AFV-5838-2022; Efimov, Igor/B-8040-2010	Gams, Anna/0000-0002-3052-8469; Pikunov, Andrey/0000-0002-5980-8499; Gusev, Oleg/0000-0002-6203-9758; Deviatiiarov, Ruslan/0000-0003-0019-2076; Koppel, Aaron/0000-0003-4887-2695; Efimov, Igor/0000-0002-1483-5039; Aras, Kedar/0000-0002-9898-1462	Russian Foundation for Basic Research [18-07-01480, 19-29-04111, 18-00-01524]; Leducq Foundation; Russian Scientific Foundation [18-71-10058]; Russian Science Foundation [18-71-10058] Funding Source: Russian Science Foundation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Leducq Foundation(Leducq Foundation); Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	The research was supported by Russian Foundation for Basic Research (https://www.rfbr.ru/rffi/eng) grants 18-07-01480 (to RS and DS), 19-29-04111 (to RS), 18-00-01524 (to RS) and Leducq Foundation (https://www.fondationleducq.org/) project RHYTHM (to IE and KA). RNA-based model development study was supported by Russian Scientific Foundation (https://rscf.ru/en/) grant 18-71-10058 (to AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S, FASTQC QUALITY CONTR; Aras KK, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.118.006692; Bishop MJ, 2006, BIOPHYS J, V90, P2938, DOI 10.1529/biophysj.105.076505; Bot CT, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00421; Boukens BJ, 2015, CARDIOVASC RES, V108, P188, DOI 10.1093/cvr/cvv202; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Cathey B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36809-y; Crepinsek M, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2480741.2480752; Deb Kalyanmoy, 2014, International Journal of Artificial Intelligence and Soft Computing, V4, P1, DOI 10.1504/IJAISC.2014.059280; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 1995, Complex Systems, V9, P115; Dutta S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00616; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gloschat C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21333-w; Groenendaal W, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004242; Hansen N, 2001, EVOL COMPUT, V9, P159, DOI 10.1162/106365601750190398; Hasegawa A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-144; Jiang M, 2000, CARDIOVASC RES, V48, P34, DOI 10.1016/S0008-6363(00)00159-0; Jiang M, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005084; Kanaporis G, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.096007; Krogh-Madsen T, 2016, J PHYSIOL-LONDON, V594, P2525, DOI 10.1113/JP270618; Livshitz L, 2009, BIOPHYS J, V97, P1265, DOI 10.1016/j.bpj.2009.05.062; Lopatin AN., 2014, CARDIAC ELECTROPHYSI, V7th, P38; Lou Q, 2012, AM J PHYSIOL-HEART C, V302, pH262, DOI 10.1152/ajpheart.00711.2011; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meadows LS, 2005, CARDIOVASC RES, V67, P448, DOI 10.1016/j.cardiores.2005.04.003; Murata M, 2014, METHODS MOL BIOL, V1164, P67, DOI 10.1007/978-1-4939-0805-9_7; Niederer SA, 2009, EXP PHYSIOL, V94, P486, DOI 10.1113/expphysiol.2008.044610; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Pruvot EJ, 2004, CIRC RES, V94, P1083, DOI 10.1161/01.RES.0000125629.72053.95; Roney CH, 2012, CARDIOVASC RES, V93, pS63; RUSH S, 1978, IEEE T BIO-MED ENG, V25, P389, DOI 10.1109/TBME.1978.326270; Sarkar AX, 2012, J PHYSIOL-LONDON, V590, P2555, DOI 10.1113/jphysiol.2011.223313; Sastry K., 2007, 2007016 ILLIGAL; Severin J, 2014, NAT BIOTECHNOL, V32, P217, DOI 10.1038/nbt.2840; Soneson C., 2015, F1000RESEARCH, V4; Syed Z, 2005, MED BIOL ENG COMPUT, V43, P561, DOI 10.1007/BF02351029; Trayanova NA, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.004743; Walker ML, 2003, CIRCULATION, V108, P2704, DOI 10.1161/01.CIR.0000093276.10885.5B; Weiss JN, 2012, CIRC RES, V111, P493, DOI 10.1161/CIRCRESAHA.112.269084; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Wright SJ, 2015, MATH PROGRAM, V151, P3, DOI 10.1007/s10107-015-0892-3; Yang XS, 2014, NEURAL COMPUT APPL, V24, P169, DOI 10.1007/s00521-013-1367-1; Yao X, 1999, IEEE T EVOLUT COMPUT, V3, P82, DOI 10.1109/4235.771163	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0231695	10.1371/journal.pone.0231695	http://dx.doi.org/10.1371/journal.pone.0231695			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392258	Green Published, gold, Green Submitted			2022-12-26	WOS:000537470300003
J	Heidary, Z; Ghaisari, J; Moein, S; Javanmard, SH				Heidary, Zarifeh; Ghaisari, Jafar; Moein, Shiva; Javanmard, Shaghayegh Haghjooy			The double-edged sword role of fibroblasts in the interaction with cancer cells; an agent-based modeling approach	PLOS ONE			English	Article							TGF-BETA; METASTASIS; PHENOTYPES; CROSSTALK; SYSTEMS	Fibroblasts as key components of tumor microenvironment show different features in the interaction with cancer cells. Although, Normal fibroblasts demonstrate anti-tumor effects, cancer associated fibroblasts are principal participant in tumor growth and invasion. The ambiguity of fibroblasts function can be regarded as two heads of its behavioral spectrum and can be subjected for mathematical modeling to identify their switching behavior. In this research, an agent-based model of mutual interactions between fibroblast and cancer cell was created. The proposed model is based on nonlinear differential equations which describes biochemical reactions of the main factors involved in fibroblasts and cancer cells communication. Also, most of the model parameters are estimated using hybrid unscented Kalman filter. The interactions between two cell types are illustrated by the dynamic modeling of TGF beta and LIF pathways as well as their crosstalk. Using analytical and computational approaches, reciprocal effects of cancer cells and fibroblasts are constructed and the role of signaling molecules in tumor progression or prevention are determined. Finally, the model is validated using a set of experimental data. The proposed dynamic modeling might be useful for designing more efficient therapies in cancer metastasis treatment and prevention.	[Heidary, Zarifeh; Ghaisari, Jafar] Isfahan Univ Technol, Dept Elect & Comp Engn, Esfahan, Iran; [Moein, Shiva] Isfahan Univ Med Sci, Regenerat Med Res Ctr, Esfahan, Iran; [Javanmard, Shaghayegh Haghjooy] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Dept Physiol, Appl Physiol Res Ctr, Esfahan, Iran	Isfahan University of Technology; Isfahan University Medical Science; Isfahan University Medical Science	Javanmard, SH (corresponding author), Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Dept Physiol, Appl Physiol Res Ctr, Esfahan, Iran.	sh_haghjoo@med.mui.ac.ir	Haghjooy Javanmard, Shaghayegh/W-5060-2017; Moein, Shiva/ABD-3110-2021	Haghjooy Javanmard, Shaghayegh/0000-0002-3853-5006; Moein, Shiva/0000-0002-6019-9504				Albrengues J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10204; Albrengues J, 2014, CELL REP, V7, P1664, DOI 10.1016/j.celrep.2014.04.036; An G, 2004, CRIT CARE MED, V32, P2050, DOI 10.1097/01.CCM.0000139707.13729.7D; [Anonymous], 2009, MATLAB; Arina A, 2016, P NATL ACAD SCI USA, V113, P7551, DOI 10.1073/pnas.1600363113; Augsten M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00062; Baker SM, 2011, EURASIP J BIOINFORM, DOI [10.1186/1687-4153-2011-7, 10.1186/1687-4153-2011]; Bellomo C, 2016, BRIT J CANCER, V115, P761, DOI 10.1038/bjc.2016.255; Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Colosimo A, 2018, METHODS MOL BIOL, V1702, P307, DOI 10.1007/978-1-4939-7456-6_15; Deisboeck TS, 2010, MULTISCALE CANC MODE, DOI [10.1146/annurev-bioeng-071910-124729, DOI 10.1146/ANNUREV-BIOENG-071910-124729]; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Fengos G, BMC SYSTEMS BIOL, V5, P184, DOI [10.1186/1752-0509-5-184, DOI 10.1186/1752-0509-5-184]; Fey D., 2008, IFAC, V41, P313, DOI [10.3182/20080706-5-KR-1001.3521, DOI 10.3182/20080706-5-KR-1001.00053]; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Gong C, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0320; Gonzalez-Zubeldia I, 2015, CELL TISSUE RES, V359, P829, DOI 10.1007/s00441-014-2075-6; Hartikainen J., 2011, OPTIMAL FILTERING KA; Heidary Z, 2016, IEEE T NANOBIOSCI, V15, P19, DOI 10.1109/TNB.2015.2509475; Ingalls B. P, 2014, J CHEM INF MODEL, V53, P1; Itoh Y, 2018, ACTA BIOCH BIOPH SIN, V50, P82, DOI 10.1093/abbs/gmx118; Julier SJ, 2004, P IEEE, V92, P401, DOI 10.1109/JPROC.2003.823141; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Kharaishvili G, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-41; Khatibi S, 2017, GROWTH FACTORS, V35, P100, DOI 10.1080/08977194.2017.1363746; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; LaFranzo N, 2019, J IMMUNOTHER CANCER, V7; Lee SW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20886-0; Liao ZH, 2019, CELL IMMUNOL, V343, DOI 10.1016/j.cellimm.2017.12.003; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Liu TY, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00060; Macklin P, 2012, J THEOR BIOL, V301, P122, DOI 10.1016/j.jtbi.2012.02.002; Maishi N, 2017, CANCER SCI, V108, P1921, DOI 10.1111/cas.13336; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Meng WF, 2018, GENE, V641, P105, DOI 10.1016/j.gene.2017.10.015; Meskin N, 2013, IEEE ACM T COMPUT BI, V10, P537, DOI 10.1109/TCBB.2013.19; Metzcar J, 2019, JCO CLIN CANCER INFO, V3, DOI 10.1200/CCI.18.00069; Nickaeen N, 2019, SCI REPORTS, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Norton KA, 2019, PROCESSES, V7, DOI 10.3390/pr7010037; Norton KA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0640; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Picco N, 2017, CANCER RES, V77, P5409, DOI 10.1158/0008-5472.CAN-17-0835; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Sabzpoushan SH, 2018, PHYSICA A, V508, P771, DOI 10.1016/j.physa.2018.05.131; Sadlonova A, 2009, CANCER MICROENVIRON, V2, P9, DOI 10.1007/s12307-008-0017-0; Sakaki-Yumoto M, 2013, BBA-GEN SUBJECTS, V1830, P2280, DOI 10.1016/j.bbagen.2012.08.008; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Simon D, 2006, OPTIMAL STATE ESTIMA, DOI DOI 10.1002/0470045345.CH11; Sitz A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016210; Tao LL, 2017, ONCOL LETT, V14, P2611, DOI 10.3892/ol.2017.6497; Uppal A, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-17; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Wadlow RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006888; Wang MN, 2017, J CANCER, V8, P761, DOI 10.7150/jca.17648; Wang ZH, 2015, SEMIN CANCER BIOL, V30, P70, DOI [10.1016/j.semcancer.2014.04.001, 10.1007/978-3-662-43514-4]; Yamada S, 2003, FEBS LETT, V534, P190, DOI 10.1016/S0014-5793(02)03842-5; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yao YY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060635; Zhang L, 2009, MATH COMPUT MODEL, V49, P307, DOI 10.1016/j.mcm.2008.05.011; Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034	65	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232965	10.1371/journal.pone.0232965	http://dx.doi.org/10.1371/journal.pone.0232965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384110	gold, Green Published			2022-12-26	WOS:000537468300040
J	Hallingstrom, M; Zednikova, P; Tambor, V; Barman, M; Vajrychova, M; Lenco, J; Viklund, F; Tancred, L; Rabe, H; Jonsson, D; Kachikis, A; Nilsson, S; Kacerovsky, M; Waldorf, KMA; Jacobsson, B				Hallingstrom, Maria; Zednikova, Petra; Tambor, Vojtech; Barman, Malin; Vajrychova, Marie; Lenco, Juraj; Viklund, Felicia; Tancred, Linda; Rabe, Hardis; Jonsson, Daniel; Kachikis, Alisa; Nilsson, Staffan; Kacerovsky, Marian; Waldorf, Kristina M. Adams; Jacobsson, Bo			Mid-trimester amniotic fluid proteome's association with spontaneous preterm delivery and gestational duration	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; BIOMARKER DISCOVERY; MICROBIAL INVASION; PREMATURE RUPTURE; MULTIPLE PROTEINS; LABOR; INFLAMMATION; PREDICTION; INFECTION; WOMEN	Background Amniotic fluid is clinically accessible via amniocentesis and its protein composition may correspond to birth timing. Early changes in the amniotic fluid proteome could therefore be associated with the subsequent development of spontaneous preterm delivery. Objective The main objective of this study was to perform unbiased proteomics analysis of the association between mid-trimester amniotic fluid proteome and spontaneous preterm delivery and gestational duration, respectively. A secondary objective was to validate and replicate the findings by enzyme-linked immunosorbent assay using a second independent cohort. Methods Women undergoing a mid-trimester genetic amniocentesis at Sahlgrenska University Hospital/Ostra between September 2008 and September 2011 were enrolled in this study, designed in three analytical stages; 1) an unbiased proteomic discovery phase using LC-MS analysis of 22 women with subsequent spontaneous preterm delivery (cases) and 37 women who delivered at term (controls), 2) a validation phase of proteins of interest identified in stage 1, and 3) a replication phase of the proteins that passed validation using a second independent cohort consisting of 20 cases and 40 matched controls. Results Nine proteins were nominally significantly associated with both spontaneous preterm delivery and gestational duration, after adjustment for gestational age at sampling, but none of the proteins were significant after correction for multiple testing. Several of these proteins have previously been described as being associated with spontaneous PTD etiology and six of them were thus validated using enzyme linked immunosorbent assay. Two of the proteins passed validation; Neutrophil gelatinase-associated lipocalin and plasminogen activator inhibitor 1, but the results could not be replicated in a second cohort. Conclusions Neutrophil gelatinase-associated lipocalin and Plasminogen activator inhibitor 1 are potential biomarkers of spontaneous preterm delivery and gestational duration but the findings could not be replicated. The negative findings are supported by the fact that none of the nine proteins from the exploratory phase were significant after correction for multiple testing.	[Hallingstrom, Maria; Tancred, Linda; Jonsson, Daniel; Waldorf, Kristina M. Adams; Jacobsson, Bo] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Hallingstrom, Maria; Viklund, Felicia; Jonsson, Daniel; Jacobsson, Bo] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Zednikova, Petra; Tambor, Vojtech; Vajrychova, Marie; Lenco, Juraj; Kacerovsky, Marian] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Zednikova, Petra] Univ Pardubice, Fac Chem Technol, Dept Biol & Biochem Sci, Pardubice, Czech Republic; [Barman, Malin] Chalmers Univ Technol, Dept Biol & Biol Engn Food & Nutr Sci, Gothenburg, Sweden; [Vajrychova, Marie] Univ Def, Fac Mil Hlth Sci, Dept Mol Pathol & Biol, Hradec Kralove, Czech Republic; [Lenco, Juraj] Charles Univ Prague, Fac Pharm, Dept Analyt Chem, Hradec Kralove, Czech Republic; [Viklund, Felicia] Stockholm South Gen Hosp, Stockholm, Sweden; [Tancred, Linda] Sahlgrens Univ Hosp, Biobank Vast, Gothenburg, Sweden; [Rabe, Hardis] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Kachikis, Alisa; Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Nilsson, Staffan] Chalmers Univ Technol, Dept Math Sci, Gothenburg, Sweden; [Nilsson, Staffan] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol & Genet, Gothenburg, Sweden; [Kacerovsky, Marian] Charles Univ Prague, Fac Med Hradec Kralove, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic; [Jacobsson, Bo] Inst Publ Hlth, Dept Genet & Bioinformat, Area Hlth Data & Digitalisat, Oslo, Norway	University of Gothenburg; Sahlgrenska University Hospital; University Hospital Hradec Kralove; University of Pardubice; Chalmers University of Technology; University of Defence - Czech Republic; Charles University Prague; Sahlgrenska University Hospital; University of Gothenburg; University of Washington; University of Washington Seattle; Chalmers University of Technology; University of Gothenburg; Charles University Prague; University Hospital Hradec Kralove	Jacobsson, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden.; Jacobsson, B (corresponding author), Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden.; Jacobsson, B (corresponding author), Inst Publ Hlth, Dept Genet & Bioinformat, Area Hlth Data & Digitalisat, Oslo, Norway.	bo.jacobsson@obgyn.gu.se	barman, malin/AAF-7933-2019; Jacobsson, Bo/O-8007-2014; Jacobsson, Bo/ABF-3231-2020; Kacerovsky, Marian/ABE-3437-2020	barman, malin/0000-0002-5317-2768; Jacobsson, Bo/0000-0001-5079-2374; Jacobsson, Bo/0000-0001-5079-2374; Nilsson, Staffan/0000-0003-4748-0446; Rabe, Hardis/0000-0003-1184-6135; Kachikis, Alisa B/0000-0003-0358-5107; Viklund, Felicia/0000-0001-9510-5865	Agreement concerning research and education of doctors, Sweden [ALFGBG-11522, ALFGBG-136431, ALFGBG426411, ALFGBG-507701, ALFGBG-671611, ALFGBG-717501]; Health & Medical Care Committee of the Regional Executive Board, Region Vastra Gotaland, Sweden [VGFOUREG-231311, VGFOUREG308151, VGFOUREG-368351]; Sahlgrenska University Hospital Foundations, Sweden; Swedish foundations "Linne'a och Josef Carlssons Stiftelse" [21, 15, 12]; Alice Swenzons Stiftelse for Vetenskaplig Forskning; Kungl och Hvitfeldtska Stiftelsen; Stiftelsen Wilhelm och Martina Lundgrens vetenskapsfond; National Institutes of Health [AI133976, AI45890]; Faculty Hospital in Hradec Kralove	Agreement concerning research and education of doctors, Sweden; Health & Medical Care Committee of the Regional Executive Board, Region Vastra Gotaland, Sweden; Sahlgrenska University Hospital Foundations, Sweden; Swedish foundations "Linne'a och Josef Carlssons Stiftelse"; Alice Swenzons Stiftelse for Vetenskaplig Forskning; Kungl och Hvitfeldtska Stiftelsen; Stiftelsen Wilhelm och Martina Lundgrens vetenskapsfond; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty Hospital in Hradec Kralove	This study has been funded by grants from the Agreement concerning research and education of doctors, Sweden (grant numbers: ALFGBG-11522, ALFGBG-136431, ALFGBG426411, ALFGBG-507701, ALFGBG-671611 and ALFGBG-717501; grant receiver: BJ; URL: https://www.researchweb.org/is/alfgbg), the Health & Medical Care Committee of the Regional Executive Board, Region Vastra Gotaland, Sweden (grant numbers: VGFOUREG-231311, VGFOUREG308151 and VGFOUREG-368351; grant receiver: BJ; URL: https://www.researchweb.org/is/vgregion), Sahlgrenska University Hospital Foundations, Sweden (grant receiver: MH; URL: https://www.researchweb.org/is/su), the Swedish foundations "Linne ' a och Josef Carlssons Stiftelse" (grant numbers: 2011:1 nr:21, 2012 nr:15 and 2014 nr:12; grant receiver: BJ; URL: http://www.carlssonsstiftelse.se), "Alice Swenzons Stiftelse for Vetenskaplig Forskning" (grant receiver: MH; URL: https://www.stiftelsemedel.se/alice-swenzonsstiftelse-fr-vetenskaplig-forskning), "Kungl och Hvitfeldtska Stiftelsen" (grant receiver: MH; URL: http://www.hvitfeldtskastiftelsen.se/main.htm) and "Stiftelsen Wilhelm och Martina Lundgrens vetenskapsfond" (grant receiver: MH; URL: http://www.wmlundgren.se)", and the National Institutes of Health (grant numbers: AI133976 and AI45890; grant receiver: KAW; URL: https://www.nih.gov).The study was also supported by the Faculty Hospital in Hradec Kralove through a long-term organization development plan. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Faculty Hospital in Hradec Kralove or other funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacelis J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022929; Bacelis J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160335; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Buhimschi IA, 2005, BJOG-INT J OBSTET GY, V112, P173, DOI 10.1111/j.1471-0528.2004.00340.x; Buhimschi IA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002049; Cederqvist K, 2006, PEDIATRICS, V117, P1226, DOI 10.1542/peds.2005-0870; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; Dasilva N, 2012, SENSORS-BASEL, V12, P2284, DOI 10.3390/s120202284; Fotopoulou C, 2012, J MATERN-FETAL NEO M, V25, P2488, DOI 10.3109/14767058.2012.712565; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hallingstrom M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155164; Heikkinen J, 2001, SCAND J IMMUNOL, V53, P310, DOI 10.1046/j.1365-3083.2001.00872.x; Holst RM, 2011, BJOG-INT J OBSTET GY, V118, P240, DOI 10.1111/j.1471-0528.2010.02765.x; Jacobsson B, 2019, LAKARTIDNINGEN, P116, DOI [10.1002/pmic.200300455, DOI 10.1002/PMIC.200300455]; Januzzi JL, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.118.005133; Khatibi T, 2019, ARCH GYNECOL OBSTET, V300, P1565, DOI 10.1007/s00404-019-05325-3; Kinney MV, 2012, EXECUTIVE SUMMARY BO; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Morken NH, 2005, ACTA OBSTET GYN SCAN, V84, P558, DOI 10.1111/j.0001-6349.2005.00765.x; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; Parrow NL, 2013, INFECT IMMUN, V81, P3503, DOI 10.1128/IAI.00602-13; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Polettini J, 2015, PLACENTA, V36, P969, DOI 10.1016/j.placenta.2015.05.003; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Ruetschi U, 2005, J PROTEOME RES, V4, P2236, DOI 10.1021/pr050139e; Sanada F, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00053; Tadesse S, 2011, REPROD SCI, V18, P713, DOI 10.1177/1933719110396722; Tambor V, 2013, PLACENTA, V34, P155, DOI 10.1016/j.placenta.2012.11.028; Tambor V, 2010, PHYSIOL RES, V59, P471, DOI 10.33549/physiolres.931758; Tsiartas P, 2012, BJOG-INT J OBSTET GY, V119, P866, DOI 10.1111/j.1471-0528.2012.03328.x; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Vajrychova M, 2016, J MATERN-FETAL NEO M, V29, P12, DOI 10.3109/14767058.2014.991305; Vuadens F, 2003, PROTEOMICS, V3, P1521, DOI 10.1002/pmic.200300455; Waldorf KMA, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.028; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1162, DOI 10.1067/mob.2001.117678; Zhang G, 2018, BEST PRACT RES CL OB, V52, P33, DOI 10.1016/j.bpobgyn.2018.05.003	44	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232553	10.1371/journal.pone.0232553	http://dx.doi.org/10.1371/journal.pone.0232553			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379834	Green Published, gold			2022-12-26	WOS:000537285700040
J	Riedel, CS; Georg, B; Fahrenkrug, J; Hannibal, J				Riedel, Casper Schwartz; Georg, Birgitte; Fahrenkrug, Jan; Hannibal, Jens			Altered light induced EGR1 expression in the SCN of PACAP deficient mice	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; CYCLASE-ACTIVATING PEPTIDE; RETINAL GANGLION-CELLS; INDUCED PHASE-SHIFT; GENE-EXPRESSION; NGFI-A; CIRCADIAN-RHYTHM; LACKING; RECEPTOR; CLOCK	The brain's biological clock is located in the suprachiasmatic nucleus (SCN) of the hypothalamus and generates circadian rhythms in physiology and behavior. The circadian clock needs daily adjustment by light to stay synchronized (entrained) with the astronomical 24 h light/dark cycle. Light entrainment occurs via melanopsin expressing retinal ganglion cells (mRGCs) and two neurotransmitters of the retinohypothalamic tract (RHT), PACAP and glutamate, which transmit light information to the SCN neurons. In SCN neurons, light signaling involves the immediate-early genes Fos, Egr1 and the clock genes Per1 and Per2. In this study, we used PACAP deficient mice to evaluate PACAP's role in light induced gene expression of EGR1 in SCN neurons during early (ZT17) and late (ZT23) subjective night at high (300 lux) and low (10 lux) white light exposure. We found significantly lower levels of both EGR1 mRNA and protein in the SCN in PACAP deficient mice compared to wild type mice at early subjective night (ZT17) exposed to low but not high light intensity. No difference was found between the two genotypes at late night (ZT23) at neither light intensities. In conclusion, light mediated EGR1 induction in SCN neurons at early night at low light intensities is dependent of PACAP signaling. A role of PACAP in shaping synaptic plasticity during light stimulation at night is discussed.	[Riedel, Casper Schwartz; Georg, Birgitte; Fahrenkrug, Jan; Hannibal, Jens] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, Copenhagen NV, Denmark	University of Copenhagen; Bispebjerg Hospital	Hannibal, J (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, Copenhagen NV, Denmark.	j.hannibal@dadlnet.dk	Riedel, Casper Schwartz/ABB-3158-2021	Riedel, Casper Schwartz/0000-0002-9393-0092; Hannibal, Jens/0000-0001-9416-0125	Danish Biotechnology Center for Cellular Communication	Danish Biotechnology Center for Cellular Communication	The study was supported by the Danish Biotechnology Center for Cellular Communication.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; Colwell CS, 2004, AM J PHYSIOL-REG I, V287, pR1194, DOI 10.1152/ajpregu.00268.2004; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Dziema H, 2002, J NEUROPHYSIOL, V88, P1374, DOI 10.1152/jn.2002.88.3.1374; Ebling FJP, 1996, PROG NEUROBIOL, V50, P109, DOI 10.1016/S0301-0082(96)00032-9; Engelund A, 2010, CELL TISSUE RES, V340, P243, DOI 10.1007/s00441-010-0950-3; Fahrenkrug J, 2018, EXP EYE RES, V169, P134, DOI 10.1016/j.exer.2018.02.004; Georg B, 2016, NEUROPEPTIDES, V60, P83, DOI 10.1016/j.npep.2016.09.004; Gompf HS, 2015, J BIOL RHYTHM, V30, P35, DOI 10.1177/0748730414561545; Guido ME, 1999, J BIOL RHYTHM, V14, P275, DOI 10.1177/074873099129000687; Hannibal J, 2014, J COMP NEUROL, V522, P2231, DOI [10.1002/cne.23588, 10.1002/cne.23555]; Hannibal J, 2000, J COMP NEUROL, V418, P147; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; Hannibal J., 2016, CURRENT TOPICS NEURO, P227; Hannibal J, 2006, INT REV CYTOL, V251, P1, DOI 10.1016/S0074-7696(06)51001-0; Hannibal J, 2019, EUR J NEUROSCI, V50, P3115, DOI 10.1111/ejn.14482; Hannibal J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188166; Hannibal J, 2008, AM J PHYSIOL-REG I, V295, pR2050, DOI 10.1152/ajpregu.90563.2008; Hughes S, 2016, EYE, V30, P247, DOI 10.1038/eye.2015.264; Kawaguchi C, 2003, BIOCHEM BIOPH RES CO, V310, P169, DOI 10.1016/j.bbrc.2003.09.004; Kawaguchi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009286; Kilduff TS, 1998, J BIOL RHYTHM, V13, P347, DOI 10.1177/074873098129000174; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Mizoro Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010951; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Nielsen HS, 2001, NEUROSCIENCE, V103, P433, DOI 10.1016/S0306-4522(00)00563-7; Purrier N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111449; Qin XK, 2015, J BIOL CHEM, V290, P29603, DOI 10.1074/jbc.M115.668889; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Riedel CS, 2018, J MOL NEUROSCI, V64, P9, DOI 10.1007/s12031-017-0996-8; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Shapiro-Reznik M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037894; Sondereker KB, 2020, J COMP NEUROL, V528, P2044, DOI 10.1002/cne.24873; Tanaka M, 1997, BRAIN RES, V756, P305, DOI 10.1016/S0006-8993(97)00302-8; Thiel G, 2010, CELL CALCIUM, V47, P397, DOI 10.1016/j.ceca.2010.02.005; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232748	10.1371/journal.pone.0232748	http://dx.doi.org/10.1371/journal.pone.0232748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379800	Green Published, gold			2022-12-26	WOS:000537285700062
J	Jiang, ZL; Zhou, L; Wang, BF; Wang, DM; Wu, FC; Yin, JQ; Song, XY				Jiang, Zhilei; Zhou, Lin; Wang, Baifeng; Wang, Daming; Wu, Fengci; Yin, Junqi; Song, Xinyuan			Toxicological and biochemical analyses demonstrate no toxic effect of Bt maize on the Folsomia candida	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; COLLEMBOLA ISOTOMIDAE; SOIL; RICE	The potential effects of Bt (Bacillus thuringiensis) maize on non-target organisms must be conducted before the Bt maize is commercially planted. Folsomia candida is one of the nontarget organisms of Bt maize, also as an important indicator of soil quality and environmental pollution. In this study, a 90-day F. candida feeding test were conducted to evaluate the potential effects of two Bt maize lines IE09S034 and BT799 and their non-Bt conventional isolines Zong 31 and Zheng 58. The results show that Bt maize lines had no significant effects on the survival rate, reproduction, adult body length, larval body length, and the activities of acetyl cholinesterase, catalase and superoxide dismutase on the F. candida. Namely, Bt maize had no toxic effects on the F. candida.	[Jiang, Zhilei; Wang, Baifeng; Wang, Daming; Wu, Fengci; Yin, Junqi; Song, Xinyuan] Jilin Acad Agr Sci, Agrobiotechnol Res Inst, Jilin Prov Key Lab Agr Biotechnol, Changchun, Peoples R China; [Zhou, Lin] Northeast Normal Univ, Jilin Prov Key Lab Anim Resource Conservat & Util, Changchun, Peoples R China	Jilin Academy of Agricultural Sciences; Northeast Normal University - China	Song, XY (corresponding author), Jilin Acad Agr Sci, Agrobiotechnol Res Inst, Jilin Prov Key Lab Agr Biotechnol, Changchun, Peoples R China.	songxinyuan1980@163.com			National GMO New Variety Breeding Program of PRC [2016ZX08011-003]	National GMO New Variety Breeding Program of PRC	This study was supported by the National GMO New Variety Breeding Program of PRC (Grant No.2016ZX08011-003 awarded to Xinyuan Song). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YY, 2011, J ECON ENTOMOL, V104, P1892, DOI 10.1603/EC11095; Clark BW, 2006, ENVIRON ENTOMOL, V35, P1121, DOI 10.1603/0046-225X-35.4.1121; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; Fountain MT, 2005, ANNU REV ENTOMOL, V50, P201, DOI 10.1146/annurev.ento.50.071803.130331; Heckmann LH, 2006, ENVIRON POLLUT, V142, P212, DOI 10.1016/j.envpol.2005.10.008; Icoz I, 2008, SOIL BIOL BIOCHEM, V40, P559, DOI 10.1016/j.soilbio.2007.11.002; ISO, 1999, SOIL QUAL INH REPR C; MORRA MJ, 1994, MOL ECOL, V3, P53, DOI 10.1111/j.1365-294X.1994.tb00044.x; O'Callaghan M, 2005, ANNU REV ENTOMOL, V50, P271, DOI 10.1146/annurev.ento.50.071803.130352; PALM CJ, 1994, MOL ECOL, V3, P145, DOI 10.1111/j.1365-294X.1994.tb00115.x; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rusek J, 1998, BIODIVERS CONSERV, V7, P1207, DOI 10.1023/A:1008887817883; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Simonsen V, 2001, PEDOBIOLOGIA, V45, P161, DOI 10.1078/0031-4056-00077; Sims SR, 1997, PEDOBIOLOGIA, V41, P412; Tully T, 2006, PEDOBIOLOGIA, V50, P95, DOI 10.1016/j.pedobi.2005.11.003; Xiao Nengwen, 2005, Yingyong Shengtai Xuebao, V16, P1523; Yang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15619; YANG YJ, 2018, FRONT PLANT SCI, V9, DOI DOI 10.3389/FPLS.2018; Yu L, 1997, J ECON ENTOMOL, V90, P113, DOI 10.1093/jee/90.1.113; Yuan YY, 2014, ENVIRON POLLUT, V184, P170, DOI 10.1016/j.envpol.2013.08.014; Yuan YY, 2011, ENVIRON POLLUT, V159, P3714, DOI 10.1016/j.envpol.2011.07.015; Zhou X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0142714	23	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232747	10.1371/journal.pone.0232747	http://dx.doi.org/10.1371/journal.pone.0232747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374765	Green Published, gold			2022-12-26	WOS:000537283500057
J	Cinar, B; Al-Mathkour, MM; Khan, SA; Moreno, CS				Cinar, Bekir; Al-Mathkour, Marwah M.; Khan, Shafiq A.; Moreno, Carlos S.			Androgen attenuates the inactivating phospho?Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; androgens; androgen receptor; YAP1; Hippo; MST1; STK4; protein phosphatase PP2A; protein?protein interaction; post-translational modification; phosphorylation; nuclear translocation; gene transcription; androgen; cell signaling; Hippo pathway; yes-associated protein (YAP); protein phosphorylation; protein serine; threonine phosphatase (PSP); gene transcription; androgen; AR signaling; YAP1 nuclear localization	HIPPO PATHWAY; CELL-GROWTH; PHOSPHORYLATION; DOMAIN; MST2; LOCALIZATION; REGULATORS; TEAD; NLK	The transcriptional coactivator YAP1 (yes-associated protein 1) regulates cell proliferation, cell?cell interactions, organ size, and tumorigenesis. Post-transcriptional modifications and nuclear translocation of YAP1 are crucial for its nuclear activity. The objective of this study was to elucidate the mechanism by which the steroid hormone androgen regulates YAP1 nuclear entry and functions in several human prostate cancer cell lines. We demonstrate that androgen exposure suppresses the inactivating post-translational modification phospho?Ser-127 in YAP1, coinciding with increased YAP1 nuclear accumulation and activity. Pharmacological and genetic experiments revealed that intact androgen receptor signaling is necessary for androgen's inactivating effect on phospho?Ser-127 levels and increased YAP1 nuclear entry. We also found that androgen exposure antagonizes Ser/Thr kinase 4 (STK4/MST1) signaling, stimulates the activity of protein phosphatase 2A, and thereby attenuates the phospho?Ser-127 modification and promotes YAP1 nuclear localization. Results from quantitative RT-PCR and CRISPR/Cas9?aided gene knockout experiments indicated that androgen differentially regulates YAP1-dependent gene expression. Furthermore, an unbiased computational analysis of the prostate cancer data from The Cancer Genome Atlas revealed that YAP1 and androgen receptor transcript levels correlate with each other in prostate cancer tissues. These findings indicate that androgen regulates YAP1 nuclear localization and its transcriptional activity through the androgen receptor?STK4/MST1?protein phosphatase 2A axis, which may have important implications for human diseases such as prostate cancer.	[Cinar, Bekir; Al-Mathkour, Marwah M.; Khan, Shafiq A.] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Dept Biol Sci, Atlanta, GA 30314 USA; [Cinar, Bekir; Khan, Shafiq A.; Moreno, Carlos S.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Moreno, Carlos S.] Emory Univ, Dept Pathol & Lab Med & Biomed Informat, Atlanta, GA 30322 USA	Clark Atlanta University; Emory University; Emory University	Cinar, B (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Dept Biol Sci, Atlanta, GA 30314 USA.; Cinar, B (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.	bcinar@cau.edu	CİNAR, BEKIR MURAT/AAL-4474-2021; Moreno, Carlos S/B-3863-2009	CİNAR, BEKIR MURAT/0000-0002-7906-5039; Moreno, Carlos S/0000-0002-5582-0028	National Science Foundation-Division of Molecular and Cellular Biosciences Grant [1832022]; NIMHD, National Institutes of Health [2U54MD007590-32]	National Science Foundation-Division of Molecular and Cellular Biosciences Grant(National Science Foundation (NSF)); NIMHD, National Institutes of Health	This work was supported in part by National Science Foundation-Division of Molecular and Cellular Biosciences Grant 1832022 (to B. C.) and by NIMHD, National Institutes of Health Grant 2U54MD007590-32 (to the Center for Cancer Research and Therapeutic Program, Clark Atlanta University). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Chen YA, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00060; Cinar B, 2011, CANCER RES, V71, P4303, DOI 10.1158/0008-5472.CAN-10-4532; Cochrane DR, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3599; Collak FK, 2012, J BIOL CHEM, V287, P23698, DOI 10.1074/jbc.M112.358713; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Ege N, 2018, CELL SYST, V6, P692, DOI 10.1016/j.cels.2018.05.006; Elbediwy A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221788; Elosegui-Artola A, 2017, CELL, V171, P1397, DOI 10.1016/j.cell.2017.10.008; Elosegui-Artola A, 2016, NAT CELL BIOL, V18, P540, DOI 10.1038/ncb3336; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hata Y, 2013, MAR DRUGS, V11, P896, DOI 10.3390/md11030896; He MJ, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0013-6; Hein AL, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0172-9; Hong AW, 2017, EMBO REP, V18, P72, DOI 10.15252/embr.201642681; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kofler M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07450-0; Kuser-Abali G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9126; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lin KC, 2017, NAT CELL BIOL, V19, P996, DOI 10.1038/ncb3581; Liu AM, 2012, BBA-REV CANCER, V1826, P357, DOI 10.1016/j.bbcan.2012.05.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma SH, 2019, ANNU REV BIOCHEM, V88, P577, DOI 10.1146/annurev-biochem-013118-111829; Macedo LF, 2006, CANCER RES, V66, P7775, DOI 10.1158/0008-5472.CAN-05-3984; Manning SA, 2018, CURR BIOL, V28, P1651, DOI 10.1016/j.cub.2018.04.018; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Moon S, 2017, EMBO REP, V18, P61, DOI 10.15252/embr.201642683; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; SUDOL M, 1994, ONCOGENE, V9, P2145; THALMANN GN, 1994, CANCER RES, V54, P2577; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang KC, 2016, P NATL ACAD SCI USA, V113, P11525, DOI 10.1073/pnas.1613121113; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024288; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	47	4	4	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8550	8559		10.1074/jbc.RA120.013794	http://dx.doi.org/10.1074/jbc.RA120.013794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32376689	Green Published, hybrid			2022-12-26	WOS:000546986500019
J	Singh, V; Gowda, CP; Singh, V; Ganapathy, AS; Karamchandani, DM; Eshelman, MA; Yochum, GS; Nighot, P; Spiegelman, VS				Singh, Vikash; Gowda, Chethana P.; Singh, Vishal; Ganapathy, Ashwinkumar S.; Karamchandani, Dipti M.; Eshelman, Melanie A.; Yochum, Gregory S.; Nighot, Prashant; Spiegelman, Vladimir S.			The mRNA-binding protein IGF2BP1 maintains intestinal barrier function by up-regulating occludin expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1); occludin; intestinal epithelium; permeability; mRNA decay; RNA-binding proteins; inflammatory bowel disease (IBD); colitis; epithelial barrier; intestinal mucosa; RNA-binding protein; intestinal mucosa	TIGHT JUNCTION BARRIER; C-MYC; CRD-BP; CODING REGION; CELL-ADHESION; IMP1 PROMOTES; STEM-CELLS; HOMEOSTASIS; PHENOTYPE; FAMILY	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an mRNA-binding protein that has an oncofetal pattern of expression. It is also expressed in intestinal tissue, suggesting that it has a possible role in intestinal homeostasis. To investigate this possibility, here we generated Villin CreERT2:Igf2bp1flox/flox mice, which enabled induction of an IGF2BP1 knockout specifically in intestinal epithelial cells (IECs) of adult mice. Using gut barrier and epithelial permeability assays and several biochemical approaches, we found that IGF2BP1 ablation in the adult intestinal epithelium causes mild active colitis and mild-to-moderate active enteritis. Moreover, the IGF2BP1 deletion aggravated dextran sodium sulfate?induced colitis. We also found that IGF2BP1 removal compromises barrier function of the intestinal epithelium, resulting from altered protein expression at tight junctions. Mechanistically, IGF2BP1 interacted with the mRNA of the tight-junction protein occludin (Ocln), stabilizing Ocln mRNA and inducing expression of occludin in IECs. Furthermore, ectopic occludin expression in IGF2BP1-knockdown cells restored barrier function. We conclude that IGF2BP1-dependent regulation of occludin expression is an important mechanism in intestinal barrier function maintenance and in the prevention of colitis.	[Singh, Vikash; Gowda, Chethana P.; Spiegelman, Vladimir S.] Penn State Coll Med, Div Hematol & Oncol, Pediat Dept, Hershey, PA 17033 USA; [Ganapathy, Ashwinkumar S.; Nighot, Prashant] Penn State Coll Med, Dept Med, Hershey, PA USA; [Karamchandani, Dipti M.] Penn State Coll Med, Dept Pathol, Hershey, PA USA; [Eshelman, Melanie A.; Yochum, Gregory S.] Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA; [Yochum, Gregory S.] Penn State Coll Med, Dept Surg, Hershey, PA USA; [Singh, Vishal] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Spiegelman, VS (corresponding author), Penn State Coll Med, Div Hematol & Oncol, Pediat Dept, Hershey, PA 17033 USA.	vspiegelman@pennstatehealth.psu.edu	Ganapathy, Ashwinkumar Subramenium/AAA-8198-2022; Singh, Vikash/HCI-9902-2022	Singh, Vikash/0000-0002-5325-1386; Spiegelman, Vladimir S/0000-0003-4847-155X; Ganapathy, Ashwinkumar Subramenium/0000-0001-5254-9431	NCI, National Institutes of Health [CA191550, CA243167]; NIDDK, National Institutes of Health [DK114024]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by NCI, National Institutes of Health, Grants CA191550 and CA243167 (to V. S. S.). This work was also supported in part by NIDDK, National Institutes of Health, Grant DK114024 (to P. N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Buschmann MM, 2013, MOL BIOL CELL, V24, P3056, DOI 10.1091/mbc.E12-09-0688; Catalioto RM, 2011, CURR MED CHEM, V18, P398, DOI 10.2174/092986711794839179; Chatterji P, 2019, EMBO REP, V20, DOI 10.15252/embr.201847074; Chen Y, 2015, J BIOL CHEM, V290, P20580, DOI 10.1074/jbc.M115.653584; Conway AE, 2016, CELL REP, V15, P666, DOI 10.1016/j.celrep.2016.03.052; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Degrauwe N, 2016, GENE DEV, V30, P2459, DOI 10.1101/gad.287540.116; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Franklin CL, 2017, LAB ANIMAL, V46, P114, DOI 10.1038/laban.1222; Gehart H, 2019, NAT REV GASTRO HEPAT, V16, P19, DOI 10.1038/s41575-018-0081-y; Goswami S, 2015, J BIOL CHEM, V290, P384, DOI 10.1074/jbc.M114.590158; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hamilton KE, 2015, MOL CANCER RES, V13, P1478, DOI 10.1158/1541-7786.MCR-15-0224; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Harlow E, 1988, ANTIBODIES LABORATOR, P471; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Kanarek N, 2014, P NATL ACAD SCI USA, V111, pE702, DOI 10.1073/pnas.1322691111; Kim DH, 2017, IMMUNE NETW, V17, P25, DOI 10.4110/in.2017.17.1.25; Knuckles P, 2012, NAT NEUROSCI, V15, P962, DOI 10.1038/nn.3139; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Manieri NA, 2012, GASTROENTEROLOGY, V143, P110, DOI 10.1053/j.gastro.2012.03.037; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Martinez C, 2017, GUT, V66, P1597, DOI 10.1136/gutjnl-2016-311477; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Muller S, 2019, NUCLEIC ACIDS RES, V47, P375, DOI 10.1093/nar/gky1012; Muller S, 2018, NUCLEIC ACIDS RES, V46, P6285, DOI 10.1093/nar/gky229; Nighot PK, 2015, J BIOL CHEM, V290, P7234, DOI 10.1074/jbc.M114.597492; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Rath E, 2012, GUT, V61, P1269, DOI 10.1136/gutjnl-2011-300767; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Tambuwala MM, 2010, GASTROENTEROLOGY, V139, P2093, DOI 10.1053/j.gastro.2010.06.068; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2010, J CELL SCI, V123, P2844, DOI 10.1242/jcs.065581; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Vogt M., 2013, BIO-PROTOCOL, V3, pe398, DOI DOI 10.21769/BioProtoc.398; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xiao L, 2014, CURR OPIN PHARMACOL, V19, P46, DOI 10.1016/j.coph.2014.07.006; Yisraeli JK, 2005, BIOL CELL, V97, P87; Yu T, 2016, CELL TISSUE RES, V366, P341, DOI 10.1007/s00441-016-2435-5; Yu TX, 2013, MOL BIOL CELL, V24, P85, DOI 10.1091/mbc.E12-07-0531; Ziegler TR, 2008, AM J PHYSIOL-REG I, V294, pR402, DOI 10.1152/ajpregu.00650.2007	59	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8602	8612		10.1074/jbc.AC120.013646	http://dx.doi.org/10.1074/jbc.AC120.013646			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32385106	hybrid, Green Published			2022-12-26	WOS:000546986500024
J	Kumar, JRH; Seelamantula, CS; Mohan, A; Shetty, R; Berendschot, TJM; Webers, CAB				Kumar, J. R. Harish; Seelamantula, Chandra Sekhar; Mohan, Ashwin; Shetty, Rohit; Berendschot, T. J. M.; Webers, Carroll A. B.			Automatic analysis of normative retinal oximetry images	PLOS ONE			English	Article							VESSEL OXYGEN-SATURATION; BLOOD-FLOW; RETINOPATHY	Retinal oximetry is an important screening tool for early detection of retinal pathologies due to changes in the vasculature and also serves as a useful indicator of human-body-wide vascular abnormalities. We present an automatic technique for the measurement of oxygen saturation in retinal arterioles and venules using dual-wavelength retinal oximetry images. The technique is based on segmenting an optic-disc-centered ring-shaped region of interest and subsequent analysis of the oxygen saturation levels. We show that the two dominant peaks in the histogram of the oxygen saturation levels correspond to arteriolar and venular oxygen saturations from which the arterio-venous saturation difference (AVSD) can be calculated. For evaluation, we use a normative database of Asian Indian eyes containing 44 dual-wavelength retinal oximetry images. Validations against expert manual annotations of arterioles and venules show that the proposed technique results in an average arteriolar oxygen saturation (SatO(2)) of 87.48%, venular SatO(2) of 57.41%, and AVSD of 30.07% in comparison with the expert ground-truth average arteriolar SatO(2) of 89.41%, venular SatO(2) of 56.32%, and AVSD of 33.09%, respectively. The results exhibit high consistency across the dataset indicating that the automated technique is an accurate alternative to the manual procedure.	[Kumar, J. R. Harish; Seelamantula, Chandra Sekhar] Indian Inst Sci, Dept Elect Engn, Bangalore, Karnataka, India; [Kumar, J. R. Harish] MAHE, Manipal Inst Technol, Dept Elect & Elect Engn, Manipal, Karnataka, India; [Mohan, Ashwin; Shetty, Rohit] Narayana Nethralaya, Postgrad Inst Ophthalmol, Bangalore, Karnataka, India; [Berendschot, T. J. M.; Webers, Carroll A. B.] Univ Eye Clin Maastricht, Maastricht, Netherlands	Indian Institute of Science (IISC) - Bangalore; Manipal Academy of Higher Education (MAHE); Maastricht University; Maastricht University Medical Centre (MUMC)	Kumar, JRH; Seelamantula, CS (corresponding author), Indian Inst Sci, Dept Elect Engn, Bangalore, Karnataka, India.; Kumar, JRH (corresponding author), MAHE, Manipal Inst Technol, Dept Elect & Elect Engn, Manipal, Karnataka, India.; Mohan, A (corresponding author), Narayana Nethralaya, Postgrad Inst Ophthalmol, Bangalore, Karnataka, India.	harishj@iisc.ac.in; css@iisc.ac.in; drashwinm@gmail.com	Berendschot, Tos TJM/M-8509-2016	Berendschot, Tos TJM/0000-0002-8101-939X; JR, HARISH KUMAR/0000-0002-7669-0429; Mohan, Ashwin/0000-0003-4054-1402				Beach JM, 1999, J APPL PHYSIOL, V86, P748, DOI 10.1152/jappl.1999.86.2.748; Chong E.K.P., 2001, INTRO OPTIMIZATION; Crittin M, 2002, KLIN MONATSBL AUGENH, V219, P289, DOI 10.1055/s-2002-30648; DELORI FC, 1988, APPL OPTICS, V27, P1113, DOI 10.1364/AO.27.001113; Denninghoff KR, 1997, J TRAUMA, V43, P29, DOI 10.1097/00005373-199707000-00009; Denninghoff KR, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3638134; Geirsdottir A, 2014, ACTA OPHTHALMOL, V92, P27, DOI 10.1111/aos.12294; Geirsdottir A, 2012, INVEST OPHTH VIS SCI, V53, P5433, DOI 10.1167/iovs.12-9912; Hammer M, 2012, INVEST OPHTH VIS SCI, V53, P4063, DOI 10.1167/iovs.12-9659; Hammer M, 2009, GRAEF ARCH CLIN EXP, V247, P1025, DOI 10.1007/s00417-009-1078-6; Hammer M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976032; Hardarson SH, 2006, INVEST OPHTH VIS SCI, V47, P5011, DOI 10.1167/iovs.06-0039; Hardarson SH, 2012, ACTA OPHTHALMOL, V90, P466, DOI 10.1111/j.1755-3768.2011.02109.x; Hardarson SH, 2012, BRIT J OPHTHALMOL, V96, P560, DOI 10.1136/bjophthalmol-2011-300640; Hardarson SH, 2010, AM J OPHTHALMOL, V150, P871, DOI 10.1016/j.ajo.2010.06.020; Harris A, 2003, OPHTHAL SURG LAS IM, V34, P152, DOI 10.3928/1542-8877-20030301-16; HICKAM J B, 1959, Trans Am Clin Climatol Assoc, V71, P34; HICKAM JB, 1963, CIRCULATION, V27, P375, DOI 10.1161/01.CIR.27.3.375; Jani PD, 2014, RETINA-J RET VIT DIS, V34, P394, DOI 10.1097/IAE.0b013e3182979e7b; Johnson WR, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2434950; Kagemann L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2772655; Kumar JRH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43385-2; Kumar JRH, 2015, 2015 IEEE GLOBAL CONFERENCE ON SIGNAL AND INFORMATION PROCESSING (GLOBALSIP), P225, DOI 10.1109/GlobalSIP.2015.7418190; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; Li H, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3655354; Mairbaurl H, 2012, COMPR PHYSIOL, V2, P1463, DOI 10.1002/cphy.c080113; Michelson G, 2006, ACTA OPHTHALMOL SCAN, V84, P289, DOI 10.1111/j.1600-0420.2005.00631.x; Mohan A, 2015, J VISION SCI, V1, P38; Moharir A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074299; Mordant DJ, 2011, EYE, V25, P309, DOI 10.1038/eye.2010.222; Mordant DJ, 2011, INVEST OPHTH VIS SCI, V52, P2851, DOI 10.1167/iovs.10-6217; Olafsdottir OB, 2011, INVEST OPHTH VIS SCI, V52, P6409, DOI 10.1167/iovs.10-6985; Pediredla AK, 2012, INT CONF ACOUST SPEE, P681, DOI 10.1109/ICASSP.2012.6287975; Pittman R.N., 2011, REGULATION TISSUE OX; Ramella-Roman JC, 2008, OPT EXPRESS, V16, P6170, DOI 10.1364/OE.16.006170; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schweitzer D, 2007, KLIN MONATSBL AUGENH, V224, P402, DOI 10.1055/s-2007-963156; Schweitzer D, 1999, IEEE T BIO-MED ENG, V46, P1454, DOI 10.1109/10.804573; SEBAG J, 1989, ARCH OPHTHALMOL-CHIC, V107, P222, DOI 10.1001/archopht.1989.01070010228027; Simmons G.F., 1996, CALCULUS ANAL GEOMET; Thevenaz P, 2008, IEEE T IMAGE PROCESS, V17, P585, DOI 10.1109/TIP.2007.914742; Tiedeman JS, 1998, OPHTHALMOLOGY, V105, P31, DOI 10.1016/S0161-6420(98)71029-1; Traustason S, 2011, INVEST OPHTH VIS SCI, V52, P5064, DOI 10.1167/iovs.11-7275; Vandewalle E, 2014, ACTA OPHTHALMOL, V92, P105, DOI 10.1111/aos.12011	44	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0231677	10.1371/journal.pone.0231677	http://dx.doi.org/10.1371/journal.pone.0231677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421691	Green Published, gold, Green Accepted			2022-12-26	WOS:000537499600006
J	Starlinger, J; Lorenz, G; Fochtmann-Frana, A; Sarahrudi, K				Starlinger, Julia; Lorenz, Greta; Fochtmann-Frana, Alexandra; Sarahrudi, Kambiz			Bisegmental posterior stabilisation of thoracolumbar fractures with polyaxial pedicle screws: Does additional balloon kyphoplasty retain vertebral height?	PLOS ONE			English	Article							PULL-OUT STRENGTH; BURST FRACTURES; CALCIUM-PHOSPHATE; INSTRUMENTATION; SPINE; AUGMENTATION; MANAGEMENT; COMPLICATIONS; FIXATION; DESIGNS	We retrospectively evaluated single-level compression fractures (T12-L3) scheduled for a short-segment POS (posterior-only stabilization) using polyaxial screws. Patients averaged 55.7 years (range, 19-65). Patients received either POS or, concomitantly, BK (balloon kyphoplasty) of the fractured vertebrae as well. Primary endpoint was the radiological outcome at the last radiographic follow-up prior to implant removal. POS together with BK of the fractured vertebrae resulted in a significant improvement of the local kyphosis angle and vertebral body compression rates immediately post-OP. During the further course of FU, a considerable loss of correction was observed post-OP in both groups. (Local KA: pre-OP/post-OP/FU: 12.6 +/- 4.8/3.35 +/- 4.8/11.6 +/- 6.0; anterior vertebral body compression%: pre-OP/post-OP/FU: 71.94 +/- 12.3/94.78 +/- 19.95/78.17 +/- 14.74). VAS was significantly improved from 7.2 +/- 1.3 pre-OP to 2.7 +/- 1.3 (P<0.001) at FU. We found a significant restoration of the vertebral body height by BK. Nevertheless, follow-up revealed a noticeable loss of reduction. Given the fact that BK used together with polyaxial screws did not maintain intra-operative reduction, our data do not support this additional maneuver when used together with bi-segmental polyaxial pedicle screw fixation.	[Starlinger, Julia] Mayo Clin, Dept Orthoped, Rochester, MN 55905 USA; [Starlinger, Julia] Med Univ Vienna, Dept Orthoped & Trauma Surg, Vienna, Austria; [Lorenz, Greta] Trauma Ctr Meidling, Vienna, Austria; [Fochtmann-Frana, Alexandra] Med Univ Vienna, Dept Plast Surg, Vienna, Austria; [Sarahrudi, Kambiz] Landesklinikum Wiener Neustadt, Dept Trauma Surg, Wiener Neustadt, Austria	Mayo Clinic; Medical University of Vienna; Medical University of Vienna	Starlinger, J (corresponding author), Mayo Clin, Dept Orthoped, Rochester, MN 55905 USA.; Starlinger, J (corresponding author), Med Univ Vienna, Dept Orthoped & Trauma Surg, Vienna, Austria.	starlinger.julia@mayo.edu		Starlinger, Julia/0000-0001-7462-5730				Acosta Frank L Jr, 2005, Neurosurg Focus, V18, pe9; Andress HJ, 2002, INJURY, V33, P357, DOI 10.1016/S0020-1383(02)00030-X; Becker S, 2008, EUR SPINE J, V17, P1462, DOI 10.1007/s00586-008-0769-8; Blattert TR, 2018, GLOB SPINE J, V8, p50S, DOI 10.1177/2192568217745823; Blondel B, 2011, ORTHOP TRAUMATOL-SUR, V97, P527, DOI 10.1016/j.otsr.2011.03.020; Choe DH, 2004, AM J ROENTGENOL, V183, P1097, DOI 10.2214/ajr.183.4.1831097; Cosar M, 2009, J NEUROSURG-SPINE, V11, P607, DOI 10.3171/2009.4.SPINE08466; Fuentes S, 2010, EUR SPINE J, V19, P1281, DOI 10.1007/s00586-010-1444-4; Hartmann F, 2012, INJURY, V43, P409, DOI 10.1016/j.injury.2010.03.025; Joaquim AF, 2020, J SPINAL CORD MED, V43, P3, DOI 10.1080/10790268.2018.1474692; Kao FC, 2017, INJURY, V48, P1806, DOI 10.1016/j.injury.2017.06.015; Keynan O, 2006, SPINE, V31, pE156, DOI 10.1097/01.brs.0000201261.94907.0d; Korovessis P, 2008, SPINE, V33, P658, DOI 10.1097/BRS.0b013e318166e0bb; Korovessis P, 2008, SPINE, V33, pE100, DOI 10.1097/BRS.0b013e3181646b07; Kubosch D, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0983-1; Lorenz A, 2017, ORTHOP SURG, V9, P229, DOI 10.1111/os.12322; Mehraj Misbah, 2018, Ortop Traumatol Rehabil, V20, P211, DOI 10.5604/01.3001.0012.2129; Piazzolla A, 2018, EUR SPINE J, V27, P182, DOI 10.1007/s00586-018-5602-4; Reinhold M, 2010, EUR SPINE J, V19, P1657, DOI 10.1007/s00586-010-1451-5; Sadiqi S, 2017, EUR SPINE J, V26, P1483, DOI 10.1007/s00586-016-4716-9; Schnake KJ, 2017, J ORTHOP TRAUMA, V31, pS14, DOI 10.1097/BOT.0000000000000947; Schroerlucke SR, 2014, CLIN ORTHOP RELAT R, V472, P2826, DOI 10.1007/s11999-014-3711-x; Stanford RE, 2004, SPINE, V29, P367, DOI 10.1097/01.BRS.0000092369.50397.85; Ulmar B, 2010, EUR SPINE J, V19, P558, DOI 10.1007/s00586-009-1231-2; Varghese V, 2016, COMPUT METH PROG BIO, V137, P11, DOI 10.1016/j.cmpb.2016.08.023; Verlaan JJ, 2004, SPINE, V29, P803, DOI 10.1097/01.BRS.0000116990.31984.A9; Verlaan JJ, 2015, SPINE J, V15, P1172, DOI 10.1016/j.spinee.2013.11.044; Walchli B, 2001, UNFALLCHIRURG, V104, P742, DOI 10.1007/s001130170076; Wegmann K, 2013, ARCH ORTHOP TRAUM SU, V133, P1493, DOI 10.1007/s00402-013-1842-2; Yang HL, 2011, EUR SPINE J, V20, P380, DOI 10.1007/s00586-010-1542-3; Zairi F, 2012, ORTHOP TRAUMATOL-SUR, V98, pS105, DOI 10.1016/j.otsr.2012.06.004; Zhang L, 2013, ACTA ORTHOP BELG, V79, P718	32	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233240	10.1371/journal.pone.0233240	http://dx.doi.org/10.1371/journal.pone.0233240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421734	Green Published, gold			2022-12-26	WOS:000537499600035
J	Cao, ML; Hu, X				Cao, MengLi; Hu, Xiong			Robust pollution source parameter identification based on the artificial bee colony algorithm using a wireless sensor network	PLOS ONE			English	Article							ATMOSPHERIC DISPERSION; LOCALIZATION; MODEL	Pollution source parameter identification (PSPI) is significant for pollution control, since it can provide important information and save a lot of time for subsequent pollution elimination works. For solving the PSPI problem, a large number of pollution sensor nodes can be rapidly deployed to cover a large area and form a wireless sensor network (WSN). Based on the measurements of WSN, least-squares estimation methods can solve the PSPI problem by searching for the solution that minimize the sum of squared measurement noises. They are independent of the measurement noise distribution, i.e., robust to the noise distribution. To search for the least-squares solution, population-based parallel search techniques usually can overcome the premature convergence problem, which can stagnate the single-point search algorithm. In this paper, we adapt the relatively newly presented artificial bee colony (ABC) algorithm to solve the WSN-based PSPI problem and verifies its feasibility and robustness. Extensive simulation results show that the ABC and the particle swarm optimization (PSO) algorithm obtained similar identification results in the same simulation scenario. Moreover, the ABC and the PSO achieved much better performance than a traditionally used single-point search algorithm, i.e., the trust-region reflective algorithm.	[Cao, MengLi; Hu, Xiong] Shanghai Maritime Univ, Logist Engn Coll, Shanghai, Peoples R China	Shanghai Maritime University	Cao, ML (corresponding author), Shanghai Maritime Univ, Logist Engn Coll, Shanghai, Peoples R China.	mlcao@shmtu.edu.cn			National Natural Science Foundation of China [61801287]; Shanghai Universities' Young teachers' training support program of Shanghai Municipal Education Commission	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Universities' Young teachers' training support program of Shanghai Municipal Education Commission	This research was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under No. 61801287. This research was also funded by Shanghai Universities' Young teachers' training support program of Shanghai Municipal Education Commission (http://edu.sh.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao ML, 2016, IEEE T INSTRUM MEAS, V65, P1484, DOI 10.1109/TIM.2016.2518358; Cao ML, 2015, SENSORS-BASEL, V15, P7512, DOI 10.3390/s150407512; Chen H-M, 2008, GREEDY ALGORITHMS, P305; Conn A.R., 2000, MPS SIAM SERIES OPTI, V53, P119; Farrell JA, 2002, ENVIRON FLUID MECH, V2, P143, DOI 10.1023/A:1016283702837; Fukazawa Y, 2009, IEEE SENS C 2009 25; Gelb A., 1974, APPL OPTIMAL ESTIMAT, P180; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Karaboga D, 2014, ARTIF INTELL REV, V42, P21, DOI 10.1007/s10462-012-9328-0; Karaboga D, 2009, APPL MATH COMPUT, V214, P108, DOI 10.1016/j.amc.2009.03.090; Li JG, 2011, AUTON ROBOT, V30, P281, DOI 10.1007/s10514-011-9219-2; Liu CF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162089; Liu Y, 2010, 2010 8 WORLD C INT C; Liu Y, 2012, IEEE T SIGNAL PROCES, V60, P4350, DOI 10.1109/TSP.2012.2199314; Mann PS, 2019, ARTIF INTELL REV, V51, P329, DOI 10.1007/s10462-017-9564-4; Michaelides MP, 2005, IEEE INT S MED C CON; NEHORAI A, 1995, IEEE T SIGNAL PROCES, V43, P243, DOI 10.1109/78.365304; Nofsinger GT, 2004, DEFENSE AND SECURITY; Roberts OFT, 1923, P R SOC LOND A-CONTA, V104, P640, DOI 10.1098/rspa.1923.0132; Sharan M, 1996, ATMOS ENVIRON, V30, P1137, DOI 10.1016/1352-2310(95)00368-1; Sharan M, 1998, ATMOS ENVIRON, V32, P3481, DOI 10.1016/S1352-2310(98)00048-X; STEIHAUG T, 1983, SIAM J NUMER ANAL, V20, P626, DOI 10.1137/0720042; Wang H-C, 2010, 2010 INT C SYST SCI; Xing Xu, 2015, International Journal of Wireless and Mobile Computing, V9, P199; Yamashita N., 2001, TOPICS NUMERICAL ANA, P239; [杨维 Yang Wei], 2004, [中国工程科学, Engineering science], V6, P87; Zhao T, 2007, IEEE T SIGNAL PROCES, V55, P1511, DOI 10.1109/TSP.2006.889975	28	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232843	10.1371/journal.pone.0232843	http://dx.doi.org/10.1371/journal.pone.0232843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413067	gold, Green Published			2022-12-26	WOS:000537496000024
J	da Cunha, GR; Pellizzaro, M; Martins, CM; Rocha, SM; Yamakawa, AC; da Silva, EC; dos Santos, AP; Morikawa, VM; Langoni, H; Biondo, AW				da Cunha, Graziela Ribeiro; Pellizzaro, Maysa; Martins, Camila Marinelli; Rocha, Suzana Maria; Yamakawa, Ana Carolina; da Silva, Evelyn Cristine; dos Santos, Andrea Pires; Morikawa, Vivien Midori; Langoni, Helio; Biondo, Alexander Welker			Spatial serosurvey of anti-Toxoplasma gondii antibodies in individuals with animal hoarding disorder and their dogs in Southern Brazil	PLOS ONE			English	Article							RIVERSIDE COMMUNITIES; NEOSPORA-CANINUM; LEISHMANIA SPP.; RISK-FACTORS; SEROPREVALENCE; INFECTION; STATE; PREVALENCE; PARANA; CATS	Despite vulnerability and unsanitary conditions of animal hoarding may predispose environmental contamination and spread of vectors and pathogens, no study to date has focused on their impact on public health and zoonotic diseases. Accordingly, this study aimed to assess the seroprevalence of anti-Toxoplasma gondii antibodies and associated factors in individuals with animal hoarding disorder (AHD) and their dogs in Curitiba, Southern Brazil. Blood samples were obtained from 264 dogs (21 households) and 19 individuals with AHD (11 households). Their blood was tested by indirect fluorescent antibody test (IFAT). Overall, anti-Toxoplasma gondii seropositivity was found in 21/264 dogs (7.95%; 95% CI: 4.69-11.22) with titers ranging from 16 to 4096, and in 7/19 individuals with AHD (36.84%; CI: 15.15-58.53) with titers ranging from 16 to 64. Serological analysis for anti-T. gondii antibodies were considered positive in at least one individual or dog in 9/11 (81.82%; 95% CI: 59.03-100.00) cases that were thoroughly assessed. Surprisingly, the seropositivity of individuals with AHD and their dogs was among the lowest reportedly observed in human and dog populations of Brazil. There was no significant association between positive owners and positive dogs or the presence of cats in the household. Regard epidemiological variables, a significant association was found between dog's seropositivity and the type of dog food. To the authors' knowledge, the present study represents the first investigation of T. gondii seroprevalence in individuals with hoarding disorder and their dogs. In conclusion, despite low sanitary conditions, anti-Toxoplasma gondii antibodies frequency in individuals with AHD and their dogs are lower than the general population likely due to low protozoan load in such isolated households.	[da Cunha, Graziela Ribeiro; Rocha, Suzana Maria; Biondo, Alexander Welker] Univ Fed Parana, Dept Vet Med, Curitiba, Parana, Brazil; [Pellizzaro, Maysa] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil; [Martins, Camila Marinelli] Univ Estadual Ponta Grossa, Dept Nursing & Publ Hlth, Ponta Grossa, Parana, Brazil; [Martins, Camila Marinelli] AAC&T Res Consulting, Curitiba, Parana, Brazil; [Yamakawa, Ana Carolina; da Silva, Evelyn Cristine; Langoni, Helio] Sao Paulo State Univ, Sch Vet Med & Anim Sci, Dept Vet Hyg & Publ Hlth, Botucatu, SP, Brazil; [dos Santos, Andrea Pires] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Morikawa, Vivien Midori] Univ Fed Parana, Dept Collect Hlth, Curitiba, Parana, Brazil; [Morikawa, Vivien Midori] Secretary Environm, Curitiba City Hall, Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal da Bahia; Universidade Estadual de Ponta Grossa; Universidade Estadual Paulista; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universidade Federal do Parana	Biondo, AW (corresponding author), Univ Fed Parana, Dept Vet Med, Curitiba, Parana, Brazil.	abiondo@ufpr.br	Langoni, Helio/D-2376-2010; BIONDO, ALEXANDER WELKER/AAU-8955-2021; Pellizzaro, Maysa/P-2881-2015	BIONDO, ALEXANDER WELKER/0000-0002-4182-5821; , Evelyn Cristine da Silva/0000-0003-0722-7710; Yamakawa, Ana Carolina/0000-0002-4557-2083				Aloise Debora de Almeida, 2017, Revista de Patologia Tropical, V46, P307, DOI 10.5216/rpt.v46i4.51013; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Araujo AC, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860028, 10.1590/s1678-9946201860028]; Arluke A, 2002, HEALTH SOC WORK, V27, P125; Arluke A., 2017, PALGRAVE INT HDB ANI, P107, DOI DOI 10.1057/978-1-137-43183-7_6; Baddeley A, 2016, CHAP HALL CRC INTERD, P1; Benitez AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180906; Berry C., 2005, ANIMAL LAW, V11, P167; Brooks JW, 2013, VET MICROBIOL, V167, P704, DOI 10.1016/j.vetmic.2013.08.015; Caldart ET, 2015, SEMIN-CIENC AGRAR, V36, P253, DOI 10.5433/1679-0359.2015v36n1p253; Camargo M.E., 1974, REV BRASIL PATOL 150, V10, P143, DOI DOI 10.1136/JNNP.2005.075242; Constantino C, 2016, REV BRAS PARASITOL V, V25, P504, DOI [10.1590/s1984-29612016062, 10.1590/S1984-29612016062]; Passos ADC, 2018, REV SOC BRAS MED TRO, V51, P781, DOI 10.1590/0037-8682-0214-2017; Cruz MD, 2011, REV BRAS PARASITOL V, V20, P256; da Cunha GR, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00001316, 10.1590/0102-311x00001316]; da Silva RC, 2010, PESQUI VET BRASIL, V30, P161, DOI 10.1590/S0100-736X2010000200011; Dabritz HA, 2010, ZOONOSES PUBLIC HLTH, V57, P34, DOI 10.1111/j.1863-2378.2009.01273.x; Day MR, 2016, ANN NURS PRACT, V3, P1054; De Paula D. M. K, 2013, J VENOM ANIM TOXINS, V19, P23, DOI DOI 10.1186/1678-9199-19-23; de Seabra NM, 2015, REV BRAS PARASITOL V, V24, P454, DOI 10.1590/S1984-29612015046; de Souza IB, 2019, REV SOC BRAS MED TRO, V52, DOI 10.1590/0037-8682-0440-2018; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; ESRI, 2011, ARCGIS DESKT REL 10; Dias RCF, 2011, REV INST MED TROP SP, V53, P185, DOI 10.1590/S0036-46652011000400002; Ferreira MU, 2009, AM J TROP MED HYG, V81, P171, DOI 10.4269/ajtmh.2009.81.171; Francisco Fabio de Moraes, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P167; Frost RO, 2000, HEALTH SOC CARE COMM, V8, P229, DOI 10.1046/j.1365-2524.2000.00245.x; Frost RO, 2015, PSYCHIAT TIMES, V32; IBGE, 2019, CID PAN GER; IBGE, 2010, SIN CENS DEM 2010, V2010, P1; IBGE, 2019, BAS CART MALH DIG; Jacobson LS, 2019, J FELINE MED SURG, P1; Maia Lydiane Parreira, 2012, Revista de Patologia Tropical, V41, P457, DOI 10.5216/rpt.v41i4.21707; Mareze M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212375; Meireles LR, 2004, TROP MED INT HEALTH, V9, P876, DOI 10.1111/j.1365-3156.2004.01280.x; Minervino AHH, 2012, J PARASITOL, V98, P1276, DOI 10.1645/GE-3151.1; Nathanson JN, 2009, J ELDER ABUSE NEGL, V21, P307, DOI 10.1080/08946560903004839; Ockenden EM, 2014, ANTHROZOOS, V27, P33, DOI 10.2752/175303714X13837396326332; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Patronek G, 2008, INTERNATIONAL HANDBOOK OF ANIMAL ABUSE AND CRUELTY: THEORY, RESEARCH, AND APPLICATION, P221; Patronek GJ, 1999, PUBLIC HEALTH REP, V114, P81, DOI 10.1093/phr/114.1.81; Patronek GJ, 2006, ANIMAL HOARDING STRU, P50; Pinto-Ferreira F, 2019, REV BRAS PARASITOL V, V28, P383, DOI [10.1590/S1984-29612019043, 10.1590/s1984-29612019043]; Polak KC, 2014, VET J, V201, P189, DOI 10.1016/j.tvjl.2014.05.020; R Core Team, 2021, R LANGUAGE ENV STAT; Raimundo JM, 2015, REV BRAS PARASITOL V, V24, P475, DOI 10.1590/S1984-29612015068; Reinisch AI, 2009, CAN VET J, V50, P1069; Rodrigues JY, 2016, REV BRAS PARASITOL V, V25, P531, DOI [10.1590/S1984-29612016067, 10.1590/s1984-29612016067]; Santos TR, 2009, VET PARASITOL, V161, P324, DOI 10.1016/j.vetpar.2009.01.017; Svanberg I, 2016, SOC ANIM, V24, P63, DOI 10.1163/15685306-12341388; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tuon FF, 2019, J INFECT PUBLIC HEAL, V12, P289, DOI 10.1016/j.jiph.2018.07.001; Vaillant V, 2005, FOODBORNE PATHOG DIS, V2, P221, DOI 10.1089/fpd.2005.2.221; VanWormer E, 2013, COMP IMMUNOL MICROB, V36, P217, DOI 10.1016/j.cimid.2012.10.006; Vitaliano SN, 2015, REV SOC BRAS MED TRO, V48, P301, DOI 10.1590/0037-8682-0040-2015; Worth D, 1981, Trans Stud Coll Physicians Phila, V3, P280	56	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233305	10.1371/journal.pone.0233305	http://dx.doi.org/10.1371/journal.pone.0233305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1BA	32413075	gold, Green Published			2022-12-26	WOS:000537496000062
J	Ericson, J; Palmer, L				Ericson, Jenny; Palmer, Lina			Cessation of breastfeeding in mothers of preterm infants-A mixed method study	PLOS ONE			English	Article							MILK EXPRESSION; REASONS; KEY	Introduction Many women cease breastfeeding earlier than desired. This study examined the cessation of breastfeeding among mothers of preterm infants. Thus, the aim was to describe the cessation of breastfeeding in mothers of preterm infants up to 12 months after birth. Method This mixed methods study used a convergent design with both qualitative data, consisting of written comments, and quantitative data, on breastfeeding status and breastfeeding satisfaction. The data were collected from questionnaires sent to the mothers at three points during the first year after birth. In total, 270 mothers of preterm infants who breastfed at the time of discharge from the neonatal unit provided data for the study. The quantitative and qualitative data were analysed separately with statistical tests and hermeneutical analysis, respectively and then together according to the convergent mixed methods design. Results Four themes of the meanings of the cessation of breastfeeding were identified in the qualitative analysis: "Desire to regain the mother's and the infant's well-being", "The mothers interpretation that the infants actively ceased breastfeeding", "The mother's body and/or the infants' signals showing the way" and "The mother's own will and perceived external obstacles". Mothers who did not breastfeed as long as they wanted were more likely to report less satisfaction with breastfeeding, a shorter breastfeeding period, and less activity when ceasing breastfeeding. In comparison, mothers who breastfed as long as they wanted were more satisfied with breastfeeding, breastfed for a longer period of time and were more active in decision making in breastfeeding cessation. Conclusion Maternal passivity or activity influenced the cessation of breastfeeding in mothers of preterm infants who breastfed at the time of discharge from the neonatal unit. Passive behaviour related to breastfeeding may result in early cessation of breastfeeding, and low breastfeeding satisfaction while active behaviour may increase breastfeeding length and satisfaction.	[Ericson, Jenny] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [Ericson, Jenny] Uppsala Univ, Ctr Clin Res Dalarna, Falun, Sweden; [Ericson, Jenny] Falun Cent Hosp, Dept Paediat, Falun, Sweden; [Palmer, Lina] Univ Boras, Fac Caring Sci Work Life & Social Welf, Boras, Sweden	Dalarna University; Uppsala University; Falun Hospital; University of Boras	Ericson, J (corresponding author), Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden.; Ericson, J (corresponding author), Uppsala Univ, Ctr Clin Res Dalarna, Falun, Sweden.; Ericson, J (corresponding author), Falun Cent Hosp, Dept Paediat, Falun, Sweden.	jenny.ericson@regiondalarna.se			Centre for Clinical Research Dalarna, Dalarna county, Dalarna University; University of Boras	Centre for Clinical Research Dalarna, Dalarna county, Dalarna University; University of Boras	This study was supported by the Centre for Clinical Research Dalarna, Dalarna county, Dalarna University and University of Boras. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery A, 2009, BIRTH-ISS PERINAT C, V36, P141, DOI 10.1111/j.1523-536X.2009.00312.x; Briere CE, 2014, JOGNN-J OBST GYN NEO, V43, P272, DOI 10.1111/1552-6909.12297; Brown CRL, 2014, CAN J PUBLIC HEALTH, V105, pE179, DOI 10.17269/cjph.105.4244; Colin W Binns, 2002, Breastfeed Rev, V10, P13; Creswell JW., 2017, DESIGNING CONDUCTING; Dahlberg K., 2008, REFLECTIVE LIFEWORLD, V2nd ed.; Dettwyler, 1995, BREASTFEEDING BIOCUL; Dosani A, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0114-0; Dykes F., 2006, BREASTFEEDING HOSP M; Ericson J, 2018, BIRTH; Ericson J, 2018, ACTA PAEDIAT; Ericson J, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12618; Ericson J, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0142-9; Ericson J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012900; Feenstra MM, 2018, SEX REPROD HEALTHC, V16, P167, DOI 10.1016/j.srhc.2018.04.003; Flacking R, 2006, SOC SCI MED, V62, P70, DOI 10.1016/j.socscimed.2005.05.026; Gadamer H-G, 2013, 1 PAPERBACKTRANSLATI; Galvin KT, 2009, J HOLIST NURS, V27, P141, DOI 10.1177/0898010108323303; Gerhardsson E, 2018, ACTA PAEDIATR, V107, P799, DOI 10.1111/apa.14229; Gianni ML, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1260-2; Gianni ML, 2019, NUTRIENTS, V11; Ikonen R, 2015, ADV NEONAT CARE, V15, P394, DOI 10.1097/ANC.0000000000000232; Leff E W, 1994, J Hum Lact, V10, P105, DOI 10.1177/089033449401000217; Martin Emily., 2001, WOMAN BODY CULTURAL; McFadden A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub5; Odom EC, 2013, PEDIATRICS, V131, pE726, DOI 10.1542/peds.2012-1295; Palmer L, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0229-6; Palmer L, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0042-9; Palmer L, 2012, INT J QUAL STUD HEAL, V7, DOI 10.3402/qhw.v7i0.10846; Papile LA, 2012, PEDIATRICS, V130, P587, DOI 10.1542/peds.2012-1999; Parker LA, 2015, BREASTFEED MED, V10, P84, DOI 10.1089/bfm.2014.0089; Sellen DW, 2001, J NUTR, V131, P2707, DOI 10.1093/jn/131.10.2707; The National Board of Health and Welfare in Sweden, 2020, BREASTF STAT; The Swedish Neonatal Quality Register (SNQ), 2020, ANN REPORT; Todres L., 2005, INT J QUAL METHODS, V4, P20, DOI [10.1177/160940690500400202, DOI 10.1177/160940690500400202]; World Health Organization (WHO), 2001, GLOB STRAT INF YOUNG	36	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233181	10.1371/journal.pone.0233181	http://dx.doi.org/10.1371/journal.pone.0233181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1BA	32413062	Green Published, gold			2022-12-26	WOS:000537496000054
J	Naluyange, R; Mboowa, G; Komakech, K; Semugenze, D; Kateete, DP; Ssengooba, W				Naluyange, Resty; Mboowa, Gerald; Komakech, Kevin; Semugenze, Derrick; Kateete, David Patrick; Ssengooba, Willy			High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda	PLOS ONE			English	Article							SPECTRUM	Introduction Susceptibility testing for pyrazinamide (PZA), a cornerstone anti-TB drug is not commonly done in Uganda because it is expensive and characterized with technical difficulties thus resistance to this drug is less studied. Resistance is commonly associated with mutations in the pncA gene and its promoter region. However, these mutations vary geographically and those conferring phenotypic resistance are unknown in Uganda. This study determined the prevalence of PZA resistance and its association with pncA mutations. Materials and methods Using a cross-sectional design, archived isolates collected during the Uganda national drug resistance survey between 2008-2011 were sub-cultured. PZA resistance was tested by BACTEC Mycobacterial Growth Indicator Tube (MGIT) 960 system. Sequence reads were downloaded from the NCBI Library and bioinformatics pipelines were used to screen for PZA resistance-conferring mutations. Results The prevalence of phenotypic PZA resistance was found to be 21%. The sensitivity and specificity of pncA sequencing were 24% (95% CI, 9.36-45.13%) and 100% (73.54% 100.0%) respectively. We identified four mutations associated with PZA phenotypic resistance in Uganda; K96R, T142R, R154G and V180F. Conclusion There is a high prevalence of phenotypic PZA resistance among TB patients in Uganda. The low sensitivity of pncA gene sequencing confirms the already documented discordances suggesting other mechanisms of PZA resistance in Mycobacterium tuberculosis.	[Naluyange, Resty; Komakech, Kevin; Semugenze, Derrick; Ssengooba, Willy] Makerere Univ, Dept Med Microbiol, Mycobacteriol BSL3 Lab, Kampala, Uganda; [Mboowa, Gerald; Kateete, David Patrick] Makerere Univ, Dept Immunol & Mol Biol, Kampala, Uganda; [Mboowa, Gerald] Makerere Univ, McKinnell Knowledge Ctr, Infect Dis Inst, African Ctr Excellence Bioinformat & Data Intens, Kampala, Uganda; [Ssengooba, Willy] Makerere Univ, Coll Hlth Sci, Lung Inst, Kampala, Uganda	Makerere University; Makerere University; Makerere University; Makerere University	Ssengooba, W (corresponding author), Makerere Univ, Dept Med Microbiol, Mycobacteriol BSL3 Lab, Kampala, Uganda.; Ssengooba, W (corresponding author), Makerere Univ, Coll Hlth Sci, Lung Inst, Kampala, Uganda.	willyssengooba@gmail.com	Ssengooba, Willy/ABE-2168-2020; Ssengooba, Willy/AAG-1202-2020; Kateete, David Patrick/HCH-5603-2022; Mboowa, Gerald/K-9976-2018	Ssengooba, Willy/0000-0002-1643-110X; Ssengooba, Willy/0000-0002-1643-110X; Mboowa, Gerald/0000-0001-8445-9414	NIH [D43TW010132]; EDCTP grant [TMA2018CDF-2351]; Africa Centre of Excellence in Materials, Product Development and Nanotechnology (MAPRONANO ACE) grant [MAP/MAS/028]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EDCTP grant; Africa Centre of Excellence in Materials, Product Development and Nanotechnology (MAPRONANO ACE) grant	WS; is a NURTURE fellow under NIH grant D43TW010132 and was supported by EDCTP grant TMA2018CDF-2351. RN: was supported by Africa Centre of Excellence in Materials, Product Development and Nanotechnology (MAPRONANO ACE) grant MAP/MAS/028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdella K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1955-3; Ali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117771; [Anonymous], 2017, MYCOBACTERIUM TUBERC; Arora J, 2015, J GLOB INFECT DIS, V7, P66, DOI 10.4103/0974-777X.154443; Bhuju S, 2013, INFECT GENET EVOL, V19, P1, DOI 10.1016/j.meegid.2013.06.008; Bouzouita I, 2018, INT J TUBERC LUNG D, V22, P661, DOI 10.5588/ijtld.17.0715; Bwalya P, 2018, TUBERCULOSIS, V109, P117, DOI 10.1016/j.tube.2017.12.007; Calderon RI, 2017, INT J TUBERC LUNG D, V21, P894, DOI 10.5588/ijtld.16.0850; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Caulfield Adam J, 2016, J Clin Tuberc Other Mycobact Dis, V4, P33, DOI 10.1016/j.jctube.2016.05.005; Cuevas-Cordoba B, 2013, INFECT GENET EVOL, V19, P330, DOI 10.1016/j.meegid.2012.12.013; Daum LT, 2012, J CLIN MICROBIOL, V50, P3831, DOI 10.1128/JCM.01893-12; Dominguez J, 2016, CLIN IMPLICATIONS MO, DOI [10.5588/ijtld.15.0221, DOI 10.5588/IJTLD.15.0221]; Garrison E, 2012, ARXIV12073907QBIO; Jonmalung J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-223; Khan MT, 2018, J BIOL REG HOMEOS AG, V32, P705; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Ndung'u PW, 2012, J INFECT DEV COUNTR, V6, P33, DOI 10.3855/jidc.2281; Ramirez-Busby SM, 2015, ANTIMICROB AGENTS CH, V59, P5267, DOI 10.1128/AAC.00204-15; Rosales-Klintz S, 2012, INT J MYCOBACT, V1, P124, DOI 10.1016/j.ijmyco.2012.08.001; Rueda D, 2018, INT J MYCOBACT, V7, P16, DOI 10.4103/ijmy.ijmy_187_17; Seemann T., 2019, TSEEMANN SNIPPY; Ssengooba W, 2016, INFECT GENET EVOL, V40, P8, DOI 10.1016/j.meegid.2016.02.019; Stoffels K, 2012, ANTIMICROB AGENTS CH, V56, P5186, DOI 10.1128/AAC.05385-11; Tracevska T, 2004, ANTIMICROB AGENTS CH, V48, P3209, DOI 10.1128/AAC.48.8.3209-3210.2004; Vats C, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S2-S14; Whitfield MG, 2016, TUBERCULOSIS, V99, P128, DOI 10.1016/j.tube.2016.05.003; Whitfield MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133869; Xia Q, 2015, ANTIMICROB AGENTS CH, V59, P1695, DOI 10.1128/AAC.04541-14	30	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232543	10.1371/journal.pone.0232543	http://dx.doi.org/10.1371/journal.pone.0232543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413052	Green Published, gold			2022-12-26	WOS:000537496000017
J	Loomis, G; Dari, B; Rogers, CW; Sihi, D				Loomis, Grant; Dari, Biswanath; Rogers, Christopher W.; Sihi, Debjani			Evaluation of residue management practices on barley residue decomposition	PLOS ONE			English	Article							ORGANIC-MATTER; CORN RESIDUE; WHEAT-STRAW; NITROGEN; SOIL; TILLAGE; PLACEMENT; CARBON; TURNOVER; MOISTURE	Optimizing barley (hordeum vulgare L.) production in Idaho and other parts of the Pacific Northwest (PNW) should focus on farm resource management. The effect of post-harvest residue management on barley residue decomposition has not been adequately studied. Thus, the objective of this study was to determine the effect of residue placement (surface vs. incorporated), residue size (chopped vs. ground-sieved) and soil type (sand and sandy loam) on barley residue decomposition. A 50-day(d) laboratory incubation experiment was conducted at a temperature of 25 degrees C at the Aberdeen Research and Extension Center, Aberdeen, Idaho, USA. Following the study, a Markov-Chain Monte Carlo (MCMC) modeling approach was applied to investigate the first-order decay kinetics of barley residue. An accelerated initial flush of residue carbon(C)-mineralization was measured for the sieved (Day 1) compared to chopped (Day 3 to 5) residues for both surface incorporated applications. The highest evolution of carbon dioxide (CO2)-C of 8.3 g kg(-1) dry residue was observed on Day 1 from the incorporated-sieved application for both soils. The highest and lowest amount of cumulative CO2-C released and percentage residue decomposed over 50-d was observed for surface-chopped (107 g kg(-1) dry residue and 27%, respectively) and incorporated-sieved (69 g kg(-1) dry residue and 18%, respectively) residues, respectively. There were no significant differences in C-mineralization from barley residue based on soil type or its interactions with residue placement and size (p > 0.05). The largest decay constant k of 0.0083 d(-1) was calculated for surface-chopped residue where the predicted half-life was 80 d, which did not differ from surface sieved or incorporated chopped. In contrast, incorporated-sieved treatments only resulted in a k of 0.0054 d(-1) and would need an additional 48 d to decompose 50% of the residue. Future residue decomposition studies under field conditions are warranted to verify the residue C-mineralization and its impact on residue management.	[Loomis, Grant] Univ Idaho Extens, Hailey, ID USA; [Dari, Biswanath] Oregon State Univ, Klamath Basin Res & Extens Ctr, Dept Crop & Soil Sci, Klamath Falls, OR 97603 USA; [Rogers, Christopher W.] USDA ARS, Northwest Irrigat & Soils Lab, Kimberly, ID USA; [Sihi, Debjani] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN USA; [Sihi, Debjani] Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA	Idaho; University of Idaho; Oregon State University; United States Department of Agriculture (USDA); United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Dari, B (corresponding author), Oregon State Univ, Klamath Basin Res & Extens Ctr, Dept Crop & Soil Sci, Klamath Falls, OR 97603 USA.	b.dari@oregonstate.edu	Sihi, Debjani/Q-3874-2017	Sihi, Debjani/0000-0002-5513-8862; Dari, Biswanath/0000-0001-9585-7661	study name, "Assessing Residue Source and Management Practices for Improving Fertilizer Recommendations in Cereal-based Cropping Systems"Idaho Barley Commission	study name, "Assessing Residue Source and Management Practices for Improving Fertilizer Recommendations in Cereal-based Cropping Systems"Idaho Barley Commission	CWR and BD No grant number -funded by study name, "Assessing Residue Source and Management Practices for Improving Fertilizer Recommendations in Cereal-based Cropping Systems"Idaho Barley Commission Website URL of funder: https://barley.idaho.gov/NO.	Al-Kaisi MM, 2017, AGRON J, V109, P2415, DOI 10.2134/agronj2016.11.0633; Al-Kaisi MM, 2013, SOIL TILL RES, V129, P32, DOI 10.1016/j.still.2013.01.004; Angers DA, 1997, PLANT SOIL, V189, P197, DOI 10.1023/A:1004207219678; Angers DA, 1997, SOIL TILL RES, V41, P191, DOI 10.1016/S0167-1987(96)01100-2; AOAC, OFFICIAL METHODS ANA, P17; BEARE MH, 1993, SOIL SCI SOC AM J, V57, P392, DOI 10.2136/sssaj1993.03615995005700020018x; BREMER E, 1991, BIOL FERT SOILS, V11, P221, DOI 10.1007/BF00335771; Buyer JS, 2012, APPL SOIL ECOL, V61, P127, DOI 10.1016/j.apsoil.2012.06.005; CHRISTENSEN BT, 1986, SOIL BIOL BIOCHEM, V18, P523, DOI 10.1016/0038-0717(86)90010-6; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; DALENBERG JW, 1989, SOIL BIOL BIOCHEM, V21, P443, DOI 10.1016/0038-0717(89)90157-0; de Kok-Mercado O, 2015, THESIS; DOUGLAS CL, 1980, SOIL SCI SOC AM J, V44, P833, DOI 10.2136/sssaj1980.03615995004400040035x; Ertl D., 2013, SUSTAINABLE CORN STO, P2; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gilmour JT, 1998, SOIL SCI SOC AM J, V62, P750, DOI 10.2136/sssaj1998.03615995006200030030x; Goering H.R., 1970, AGR HDB ARS USDA, V379; Hossain MB, 2013, SCI WORLD J, DOI 10.1155/2013/638582; Idaho Barley Commission, MARK PRIC ID BARL CO; Malhi SS, 2006, SOIL TILL RES, V90, P171, DOI 10.1016/j.still.2005.09.001; McKenzie RH, 2005, CAN J PLANT SCI, V85, P603, DOI 10.4141/P04-152; Miller J, 2013, LIT TEXT POP MARKETP, P125; MURWIRA HK, 1990, PLANT SOIL, V122, P197, DOI 10.1007/BF02851975; National Agricultural Statistical Services, 2018, BARL PROF NAT INF RE; Rasmussen PE, 1998, SOIL TILL RES, V47, P197, DOI 10.1016/S0167-1987(98)00106-8; Robertson LD, 2003, B U IDAHO, V742; Rogers CW, 2019, AGR ENV LETT, V4, DOI 10.2134/ael2019.10.0044; Rogers CW, 2018, SOIL SCI SOC AM J, V82, P1279, DOI 10.2136/sssaj2018.01.0054; Rogers CW, 2019, J PLANT NUTR SOIL SC, V182, P367, DOI 10.1002/jpln.201800336; Rogers CW, 2017, COMMUN SOIL SCI PLAN, V48, P326, DOI 10.1080/00103624.2016.1269801; SIMS JL, 1970, SOIL SCI, V109, P355, DOI 10.1097/00010694-197006000-00005; STORER DA, 1984, COMMUN SOIL SCI PLAN, V15, P759, DOI 10.1080/00103628409367515; Stotzky G., 1965, METHODS SOIL ANAL 2, V9, P1550; Thomsen IK, 1999, GEODERMA, V89, P199, DOI 10.1016/S0016-7061(98)00084-6; United States Department of Agriculture, 2019, WORLD BARL PROD; United States Department of Agriculture National Resource Conservation Service (USDA-NRCS), 2006, USDA HDB, V296; United States Grain Council, 2018, BARLEY NEWS; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; VANVEEN JA, 1985, SOIL BIOL BIOCHEM, V17, P747, DOI 10.1016/0038-0717(85)90128-2; Ye C., 2017, SCI REPORTS, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]	40	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232896	10.1371/journal.pone.0232896	http://dx.doi.org/10.1371/journal.pone.0232896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401785	Green Published, gold, Green Submitted			2022-12-26	WOS:000537481000038
J	Ruan, QT; Yazdani, N; Reed, ER; Beierle, JA; Peterson, LP; Luttik, KP; Szumlinski, KK; Johnson, WE; Ash, PEA; Wolozin, B; Bryant, CD				Ruan, Qiu T.; Yazdani, Necma; Reed, Eric R.; Beierle, Jacob A.; Peterson, Lucy P.; Luttik, Kimberly P.; Szumlinski, Karen K.; Johnson, William E.; Ash, Peter E. A.; Wolozin, Benjamin; Bryant, Camron D.			5 ' UTR variants in the quantitative trait gene Hnrnph1 support reduced 5 ' UTR usage and hnRNP H protein as a molecular mechanism underlying reduced methamphetamine sensitivity	FASEB JOURNAL			English	Article						alternative splicing; functional variants; positional cloning; psychostimulant; RNA binding protein; untranslated regions	RECEPTOR 1 REGULATION; REGULATE ANXIETY; EXPRESSION; METHYLGLYOXAL; 5'-UTR	We previously identified a 210 kb region on chromosome 11 (50.37-50.58 Mb, mm10) containing two protein-coding genes (Hnrnph1, Rufy1) that was necessary for reduced methamphetamine-induced locomotor activity in C57BL/6J congenic mice harboring DBA/2J polymorphisms. Gene editing of a small deletion in the first coding exon supported Hnrnph1 as a quantitative trait gene. We have since shown that Hnrnph1 mutants also exhibit reduced methamphetamine-induced reward, reinforcement, and dopamine release. However, the quantitative trait variants (QTVs) that modulate Hnrnph1 function at the molecular level are not known. Nine single nucleotide polymorphisms and seven indels distinguish C57BL/6J from DBA/2J within Hnrnph1, including four variants within the 5 ' untranslated region (UTR). Here, we show that a 114 kb introgressed region containing Hnrnph1 and Rufy1 was sufficient to cause a decrease in MA-induced locomotor activity. Gene-level transcriptome analysis of striatal tissue from 114 kb congenics vs Hnrnph1 mutants identified a nearly perfect correlation of fold-change in expression for those differentially expressed genes that were common to both mouse lines, indicating functionally similar effects on the transcriptome and behavior. Exon-level analysis (including noncoding exons) revealed decreased 5 ' UTR usage of Hnrnph1 and immunoblot analysis identified a corresponding decrease in hnRNP H protein in 114 kb congenic mice. Molecular cloning of the Hnrnph1 5 ' UTR containing all four variants (but none of them individually) upstream of a reporter induced a decrease in reporter signal in both HEK293 and N2a cells, thus, identifying a set of QTVs underlying molecular regulation of Hnrnph1.	[Ruan, Qiu T.; Yazdani, Necma; Beierle, Jacob A.; Luttik, Kimberly P.; Bryant, Camron D.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut & Psychiat, Lab Addict Genet, Boston, MA 02118 USA; [Ruan, Qiu T.; Yazdani, Necma; Beierle, Jacob A.; Peterson, Lucy P.; Bryant, Camron D.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Biomol Pharmacol Training Program, Boston, MA 02118 USA; [Ruan, Qiu T.; Yazdani, Necma; Beierle, Jacob A.; Bryant, Camron D.] Boston Univ, Sch Med, Transformat Training Program Addict Sci, Boston, MA 02118 USA; [Reed, Eric R.] Boston Univ, PhD Program Bioinformat, Boston, MA USA; [Szumlinski, Karen K.] Univ Calif Santa Barbara, Neurosci Res Inst, Dept Psychol & Brain Sci Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Johnson, William E.] Boston Univ, Sch Med, Dept Med Computat Biomed, Boston, MA 02118 USA; [Ash, Peter E. A.; Wolozin, Benjamin] Boston Univ, Sch Med, Lab Neurodegenerat, Dept Pharmacol & Expt Therapeut & Neurol, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; University of California System; University of California Santa Barbara; Boston University; Boston University	Bryant, CD (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, 72 E Concord St L-616, Boston, MA 02118 USA.; Bryant, CD (corresponding author), Boston Univ, Sch Med, Dept Psychiat, 72 E Concord St L-616, Boston, MA 02118 USA.	camron@bu.edu	Szumlinski, Karen K./J-9617-2015; Bryant, Camron D/J-2408-2015	Szumlinski, Karen K./0000-0003-1078-1077; Bryant, Camron D/0000-0003-4505-5809; Beierle, Jacob/0000-0001-6517-7614; Ruan, Qiu/0000-0002-7136-1079	National Institute on Drug Abuse (NIDA) [R01DA039168, F31DA40324]; National Institute of General Medical Sciences (NIGMS) [T32GM008541]; Burroughs Wellcome Fund (BWF) [1011479]; National Institute on Aging (NIA) [5R01AG050471-05, 1RF1AG056318-01A1]	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Burroughs Wellcome Fund (BWF)(Burroughs Wellcome Fund); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Drug Abuse (NIDA), Grant/Award Number: R01DA039168 and F31DA40324; National Institute of General Medical Sciences (NIGMS), Grant/Award Number: T32GM008541; Burroughs Wellcome Fund (BWF), Grant/Award Number: 1011479; National Institute on Aging (NIA), Grant/Award Number: 5R01AG050471-05 and 1RF1AG056318-01A1	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Bryant CD, 2018, MOLECULAR-GENETIC AND STATISTICAL TECHNIQUES FOR BEHAVIORAL AND NEURAL RESEARCH, P165, DOI 10.1016/B978-0-12-804078-2.00008-8; Bryant CD, 2012, NEUROPSYCHOPHARMACOL, V37, P1026, DOI 10.1038/npp.2011.287; Bryant CD, 2011, ANN NY ACAD SCI, V1245, P31, DOI 10.1111/j.1749-6632.2011.06325.x; Bryant CD, 2009, PSYCHOPHARMACOLOGY, V203, P703, DOI 10.1007/s00213-008-1417-z; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chen E. Y., 2013, BIOINFORMATICS, V14, P5; Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Dassi E, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00067; de Guglielmo G, 2018, PHARMACOL BIOCHEM BE, V167, P36, DOI 10.1016/j.pbb.2018.03.001; DEMINIERE JM, 1989, NEUROSCI BIOBEHAV R, V13, P141, DOI 10.1016/S0149-7634(89)80023-5; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dickson PE, 2016, PSYCHOPHARMACOLOGY, V233, P701, DOI 10.1007/s00213-015-4147-z; Distler MG, 2013, EPILEPSIA, V54, P649, DOI 10.1111/epi.12121; Distler MG, 2012, J CLIN INVEST, V122, P2306, DOI 10.1172/JCI61319; Dvir S, 2013, P NATL ACAD SCI USA, V110, pE2792, DOI 10.1073/pnas.1222534110; Fisette JF, 2010, RNA, V16, P228, DOI 10.1261/rna.1890310; Fogger SA, 2019, J ADDICT NURS, V30, P219, DOI 10.1097/JAN.0000000000000298; Gelernter J, 2014, MOL PSYCHIATR, V19, P717, DOI 10.1038/mp.2013.99; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Goldberg LR, 2017, GENES BRAIN BEHAV, V16, P725, DOI 10.1111/gbb.12397; Harkness JH, 2015, NEUROPSYCHOPHARMACOL, V40, P2175, DOI 10.1038/npp.2015.61; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jensen Kevin P, 2016, Mol Neuropsychiatry, V2, P37, DOI 10.1159/000444755; Kim Y, 2014, NUCLEIC ACIDS RES, V42, P485, DOI 10.1093/nar/gkt864; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kumar V, 2013, SCIENCE, V342, P1508, DOI 10.1126/science.1245503; Loftis JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220270; McMurray KMJ, 2018, MOL PSYCHIATR, V23, P384, DOI 10.1038/mp.2017.14; McMurray KMJ, 2016, BEHAV BRAIN RES, V301, P119, DOI 10.1016/j.bbr.2015.12.026; McMurray KMJ, 2017, ADDICT BIOL, V22, P381, DOI 10.1111/adb.12333; Miner NB, 2017, NEUROTOXICOLOGY, V63, P57, DOI 10.1016/j.neuro.2017.09.006; Mulligan MK, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00188; Nelson EC, 2016, MOL PSYCHIATR, V21, P608, DOI 10.1038/mp.2015.102; Parker CC, 2012, GENES BRAIN BEHAV, V11, P52, DOI 10.1111/j.1601-183X.2011.00747.x; Pierce RC, 2018, NEUROPSYCHOPHARMACOL, V43, P1471, DOI 10.1038/s41386-018-0008-x; Reed C, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00993; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ruan QT, 2020, J NEUROSCI, V40, P107, DOI 10.1523/JNEUROSCI.1808-19.2019; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152581; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stafford AM, 2019, ELIFE, V8, DOI 10.7554/eLife.46472; Steri M, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1474; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Williams R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004649; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Xu J, 2014, J NEUROSCI, V34, P11048, DOI 10.1523/JNEUROSCI.3986-13.2014; Yalcin B, 2012, MAMM GENOME, V23, P719, DOI 10.1007/s00335-012-9409-z; Yazdani N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005713; Zhou ZF, 2013, P NATL ACAD SCI USA, V110, P16963, DOI 10.1073/pnas.1309839110	61	7	8	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9223	9244		10.1096/fj.202000092R	http://dx.doi.org/10.1096/fj.202000092R		MAY 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32401417	Green Submitted, Green Accepted			2022-12-26	WOS:000532216500001
J	Rudko, SP; Reimink, RL; Peter, B; White, J; Hanington, PC				Rudko, Sydney P.; Reimink, Ronald L.; Peter, Bradley; White, Jay; Hanington, Patrick C.			Democratizing water monitoring: Implementation of a community-based qPCR monitoring program for recreational water hazards	PLOS ONE			English	Article							CITIZEN SCIENCE; PCR; REPRODUCIBILITY; REPEATABILITY; RELIABILITY; DIAGNOSTICS; QUALITY; ZEBRA; GENE	Recreational water monitoring can be challenging due to the highly variable nature of pathogens and indicator concentrations, the myriad of potential biological hazards to measure for, and numerous access points, both official and unofficial, that are used for recreation. The aim of this study was to develop, deploy, and assess the effectiveness of a quantitative polymerase chain reaction (qPCR) community-based monitoring (CBM) program for the assessment of bacterial and parasitic hazards in recreational water. This study developed methodologies for performing qPCR 'in the field,' then engaged with water management and monitoring groups and tested the method in a real-world implementation study to evaluate the accuracy of CBM using qPCR both quantitatively and qualitatively. This study found high reproducibility between qPCR results performed by non-expert field users and expert laboratory results, suggesting that qPCR as a methodology could be amenable to a CBM program.	[Rudko, Sydney P.; Hanington, Patrick C.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Reimink, Ronald L.] Hope Coll, Off Campus Ministries, Holland, MI 49423 USA; [Reimink, Ronald L.] Freshwater Solut LLC, Traverse City, MI USA; [Peter, Bradley] Alberta Lake Management Soc, Edmonton, AB, Canada; [White, Jay] Aqual Environm Consulting Ltd, Edmonton, AB, Canada	University of Alberta; Hope College	Hanington, PC (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	pch1@ualberta.ca		Rudko, Sydney P./0000-0002-3789-7267; Hanington, Patrick/0000-0002-3964-5012; Reimink, Ronald/0000-0001-6882-4653	Alberta Innovates [2078, 3360E085]; Natural Sciences and Engineering Research Council of Canada [2018-05209, 2018-522661]	Alberta Innovates; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this work was provided by grants from Alberta Innovates (#2078 and 3360E085) and the Natural Sciences and Engineering Research Council of Canada (2018-05209 and 2018-522661) to PCH. Freshwater Solutions, LLC provided support for this study in the form of a salary for RLR. Aquality Environmental Consulting Ltd provided support for this study in the form of a salary for JW. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Tayoun AN, 2014, AM J CLIN PATHOL, V141, P17, DOI 10.1309/AJCPA1L4KPXBJNPG; Alberta Environment, 2017, DEC PROT WAT EQ QUIC; [Anonymous], 2007, ECOLOGY SOC, DOI DOI 10.5751/ES-02274-1202R02; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Barzyk TM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15050960; Baum F, 2006, J EPIDEMIOL COMMUN H, V60, P854, DOI 10.1136/jech.2004.028662; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blankespoor H.D., 1991, Michigan Academician, V24, P7; Boehm AB, 2015, ENVIRON SCI TECH LET, V2, P270, DOI 10.1021/acs.estlett.5b00219; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao YP, 2018, WATER RES, V128, P148, DOI 10.1016/j.watres.2017.10.071; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Conrad CT, 2008, ENVIRON MANAGE, V41, P358, DOI 10.1007/s00267-007-9042-x; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; De Ventura L, 2017, MANAG BIOL INVASION, V8, P101, DOI 10.3391/mbi.2017.8.1.10; Ebentier DL, 2013, WATER RES, V47, P6839, DOI 10.1016/j.watres.2013.01.060; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Frischer ME, 2002, HYDROBIOLOGIA, V487, P33, DOI 10.1023/A:1022971918673; Gerba CP, 2015, APPL ENVIRON MICROB, V81, P464, DOI 10.1128/AEM.02633-14; Hunter J, 2013, CONCURR COMP-PRACT E, V25, P454, DOI 10.1002/cpe.2923; Ibelings BW, 2014, HARMFUL ALGAE, V40, P63, DOI 10.1016/j.hal.2014.10.002; Li X, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216827; Obama Administration, 2015, ACC CIT SCI CROWDS A; Qiu Y, 2013, J MOL BIOMARK DIAGN, DOI [10.4172/2155-9929.S5-006, DOI 10.4172/2155-9929.S5-006]; Ratnieks FLW, 2016, METHODS ECOL EVOL, V7, P1226, DOI 10.1111/2041-210X.12581; Rudko SP, 2018, ECOHEALTH, V15, P827, DOI 10.1007/s10393-018-1362-1; Rudko SP, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00547-17; Serrano F, 2014, WHITE PAPER CITIZEN; Shanks OC, 2012, ENVIRON SCI TECHNOL, V46, P945, DOI 10.1021/es2031455; Sipari H, 2010, APPL ENVIRON MICROB, V76, P3797, DOI 10.1128/AEM.00452-10; Trumbull DJ, 2000, SCI ED, DOI [10.1002/(SICI)1098-237X(200003)84:2%3C265::AID-SCE7%3E3.0.CO;2-5, DOI 10.1002/(SICI)1098-237X(200003)84:2%3C265::AID-SCE7%3E3.0.CO;2-5]; Verhougstraete MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121214; Wade TJ, 2006, ENVIRON HEALTH PERSP, V114, P24, DOI 10.1289/ehp.8273; Whitelaw G, 2003, ENVIRON MONIT ASSESS, V88, P409, DOI 10.1023/A:1025545813057; Wilrich C, 2009, J AOAC INT, V92, P1763; Wood CS, 2019, NATURE, V566, P467, DOI 10.1038/s41586-019-0956-2; Wymer LJ, 2005, ENV PROT	38	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0229701	10.1371/journal.pone.0229701	http://dx.doi.org/10.1371/journal.pone.0229701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401786	gold, Green Submitted, Green Published			2022-12-26	WOS:000537481000003
J	Sattar, A; Sher, A; Ijaz, M; Ul-Allah, S; Rizwan, MS; Hussain, M; Jabran, K; Cheema, MA				Sattar, Abdul; Sher, Ahmad; Ijaz, Muhammad; Ul-Allah, Sami; Rizwan, Muhammad Shahid; Hussain, Mubshar; Jabran, Khawar; Cheema, Mumtaz A.			Terminal drought and heat stress alter physiological and biochemical attributes in flag leaf of bread wheat	PLOS ONE			English	Article							TOLERANCE; PROLINE; PLANTS; CHLOROPHYLL; COMBINATION; REVEALS; PROTEIN; STARCH; GROWTH; MAIZE	Heat stress along with low water availability at reproductive stage (terminal growth phase of wheat crop) is major contributing factor towards less wheat production in tropics and subtropics. Flag leaf plays a pivotal role in assimilate partitioning and stress tolerance of wheat during terminal growth phase. However, limited is known about biochemical response of flag leaf to combined and individual heat and drought stress during terminal growth phase. Therefore, current study investigated combined and individual effect of terminal drought and heat stress on water relations, photosynthetic pigments, osmolytes accumulation and antioxidants defense mechanism in flag leaf of bread wheat. Experimental treatments comprised of control, terminal drought stress alone (50% field capacity during reproductive phase), terminal heat stress alone (wheat grown inside plastic tunnel during reproductive phase) and terminal drought stress + terminal heat stress. Individual and combined imposition of drought and heat stresses significantly (p<0.05) altered water relations, osmolyte contents, soluble proteins and sugars along with activated antioxidant defensive system in terms of superoxide dismutase (SOD), peroxidase (POD) and ascorbate peroxidase (APX). Turgor potential, POD and APX activities were lowest under individual heat stress; however, these were improved when drought stress was combined with heat stress. It is concluded that combined effect of drought and heat stress was more detrimental than individual stresses. The interactive effect of both stresses was hypo-additive in nature, but for some traits (like turgor potential and APX) effect of one stress neutralized the other. To best of our knowledge, this is the first report on physiological and biochemical response of flag leaf of wheat to combine heat and drought stress. These results will help future studies dealing with improved stress tolerance in wheat. However, detailed studies are needed to fully understand the genetic mechanisms behind these physiological and biochemical changes in flag leaf in response to combined heat and drought stress.	[Sattar, Abdul; Sher, Ahmad; Ijaz, Muhammad; Ul-Allah, Sami] Bahauddin Zakariya Univ, Coll Agr, Bahadur Sub Campus Layyah, Layyah, Pakistan; [Rizwan, Muhammad Shahid] Islamia Univ Bahawalpur, CIDS, Bahawalpur, Pakistan; [Hussain, Mubshar] Bahauddin Zakariya Univ, Dept Agron, Multan, Pakistan; [Jabran, Khawar] Nigde Omer Halisdemir Univ, Fac Agr Sci & Technol, Dept Plant Prod & Technol, Nigde, Turkey; [Cheema, Mumtaz A.] Grenfell Campus Mem Univ Newfoundland, Sch Sci & Environm, Corner Brook, NF, Canada	Islamia University of Bahawalpur; Bahauddin Zakariya University; Nigde Omer Halisdemir University	Ul-Allah, S (corresponding author), Bahauddin Zakariya Univ, Coll Agr, Bahadur Sub Campus Layyah, Layyah, Pakistan.; Rizwan, MS (corresponding author), Islamia Univ Bahawalpur, CIDS, Bahawalpur, Pakistan.	samipbg@bzu.edu.pk; shahid.hzau@yahoo.com	Jabran, Khawar/B-4679-2012; Sher, Ahmad/H-7489-2018; Ul-Allah, Sami/B-3782-2018; Hussain, Mubshar/O-7848-2017; Cheema, Mumtaz/AAD-3897-2021; ijaz, Muhammad/GXF-2451-2022; Rizwan, Muhammad Shahid/AAC-3816-2021	Jabran, Khawar/0000-0001-8512-3330; Ul-Allah, Sami/0000-0003-1619-9432; Cheema, Mumtaz/0000-0003-1078-3179; 	Higher Education Commission, Pakistan under Start-Up Research Grant Program (SRGP) [21-116/SRGP/RD/HEC/2014]	Higher Education Commission, Pakistan under Start-Up Research Grant Program (SRGP)	AS received funding Higher Education Commission, Pakistan for completion of research project No. 21-116/SRGP/R&D/HEC/2014 under Start-Up Research Grant Program (SRGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], 1997, BIOMETRICAL APPROACH; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asthir B, 2014, J FOOD SCI TECH MYS, V51, P118, DOI 10.1007/s13197-011-0458-1; Awasthi R, 2014, FUNCT PLANT BIOL, V41, P1148, DOI 10.1071/FP13340; Bahuguna RN, 2015, ENVIRON EXP BOT, V111, P83, DOI 10.1016/j.envexpbot.2014.10.007; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Both AJ, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0083-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caverzan A, 2016, GENET MOL BIOL, V39, P1, DOI 10.1590/1678-4685-GMB-2015-0109; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chen J, 2012, J SOIL WATER CONSERV, V67, P354, DOI 10.2489/jswc.67.5.354; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Dias MC, 2010, PHOTOSYNTHETICA, V48, P96, DOI 10.1007/s11099-010-0013-8; Farooq M, 2019, AGR WATER MANAGE, V219, P95, DOI 10.1016/j.agwat.2019.04.010; Farooq S, 2015, J AGRON CROP SCI, V201, P173, DOI 10.1111/jac.12093; Farooq S, 2017, ENVIRON SCI POLLUT R, V24, P13638, DOI 10.1007/s11356-017-8957-x; Giannakoula A, 2008, J PLANT PHYSIOL, V165, P385, DOI 10.1016/j.jplph.2007.01.014; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Guo YP, 2006, SCI HORTIC-AMSTERDAM, V108, P260, DOI 10.1016/j.scienta.2006.01.029; Hussain M, 2016, EXP AGR, V52, P477, DOI 10.1017/S0014479716000053; Hussain M, 2018, AGR WATER MANAGE, V201, P152, DOI 10.1016/j.agwat.2018.01.028; Iqbal M, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1916-2; Jin R, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01123; KAR M, 1976, PLANT PHYSIOL, V57, P315, DOI 10.1104/pp.57.2.315; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Kumari A, 2018, PLANT SCI TODAY, V5, P72, DOI 10.14719/pst.2018.5.2.388; Lamaoui Mouna, 2018, Front Chem, V6, P26, DOI 10.3389/fchem.2018.00026; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Liu P, 2011, J AGR SCI-CAMBRIDGE, V149, P159, DOI 10.1017/S0021859610001024; Lobell DB, 2015, GLOBAL CHANGE BIOL, V21, P4115, DOI 10.1111/gcb.13022; Lou LL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194625; Loutfy N, 2012, J PLANT RES, V125, P173, DOI 10.1007/s10265-011-0419-9; Ma DY, 2016, J PLANT GROWTH REGUL, V35, P1, DOI 10.1007/s00344-015-9500-2; Marutani Y, 2012, PLANTA, V236, P753, DOI 10.1007/s00425-012-1647-5; Nachabe MH, 1998, J IRRIG DRAIN ENG, V124, P230, DOI 10.1061/(ASCE)0733-9437(1998)124:4(230); Ozturk L, 2002, PLANT GROWTH REGUL, V38, P259, DOI 10.1023/A:1021579713832; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; Ristic Z, 2007, CROP SCI, V47, P2067, DOI 10.2135/cropsci2006.10.0674; Rivero RM, 2014, PLANT CELL ENVIRON, V37, P1059, DOI 10.1111/pce.12199; Saeedipour S., 2011, Journal of Plant Breeding and Crop Science, V3, P106; Shahid M, 2017, PHILIPP AGRIC SCI, V100, P278; Sharma DK, 2015, PHYSIOL PLANTARUM, V153, P284, DOI 10.1111/ppl.12245; Simaei M, 2011, RUSS J PLANT PHYSL+, V58, P783, DOI 10.1134/S1021443711050220; Sumesh KV, 2008, BIOL PLANTARUM, V52, P749, DOI 10.1007/s10535-008-0145-x; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Thalmann M, 2017, NEW PHYTOL, V214, P943, DOI 10.1111/nph.14491; Ul-Allah S, 2018, ARCH AGRON SOIL SCI, V64, P1678, DOI 10.1080/03650340.2018.1450974; Zampieri M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa723b; Zandalinas SI, 2018, PHYSIOL PLANTARUM, V162, P2, DOI 10.1111/ppl.12540; Zandalinas SI, 2016, J EXP BOT, V67, P5381, DOI 10.1093/jxb/erw299; Zhang HW, 2010, TRANSGENIC RES, V19, P809, DOI 10.1007/s11248-009-9357-x; Zhang XX, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800262; Zhou R, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0974-x	55	62	62	11	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232974	10.1371/journal.pone.0232974	http://dx.doi.org/10.1371/journal.pone.0232974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401803	Green Published, gold			2022-12-26	WOS:000537481000045
J	de Oliveira, HFM; Camargo, NF; Hemprich-Bennett, DR; Rodriguez-Herrera, B; Rossiter, SJ; Clare, EL				de Oliveira, Hernani Fernandes Magalhaes; Camargo, Nicholas Ferreira; Hemprich-Bennett, David R.; Rodriguez-Herrera, Bernal; Rossiter, Stephen J.; Clare, Elizabeth L.			Wing morphology predicts individual niche specialization in Pteronotus mesoamericanus (Mammalia: Chiroptera)	PLOS ONE			English	Article							RESOURCE USE; DIET VARIATION; INTRASPECIFIC VARIATION; INSECTIVOROUS BAT; INSECT ABUNDANCE; SEASONAL-CHANGES; POPULATION; PREY; FOOD; SELECTION	Morphological variation between individuals can increase niche segregation and decrease intraspecific competition when heterogeneous individuals explore their environment in different ways. Among bat species, wing shape correlates with flight maneuverability and habitat use, with species that possess broader wings typically foraging in more cluttered habitats. However, few studies have investigated the role of morphological variation in bats for niche partitioning at the individual level. To determine the relationship between wing shape and diet, we studied a population of the insectivorous bat species Pteronotus mesoamericanus in the dry forest of Costa Rica. Individual diet was resolved using DNA metabarcoding, and bat wing shape was assessed using geometric morphometric analysis. Interindividual variation in wing shape showed a significant relationship with both dietary dissimilarity based on Bray-Curtis estimates, and nestedness derived from an ecological network. Individual bats with broader and more rounded wings were found to feed on a greater diversity of arthropods (less nested) in comparison to individuals with triangular and pointed wings (more nested). We conclude that individual variation in bat wing morphology can impact foraging efficiency leading to the observed overall patterns of diet specialization and differentiation within the population.	[de Oliveira, Hernani Fernandes Magalhaes] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [de Oliveira, Hernani Fernandes Magalhaes; Hemprich-Bennett, David R.; Rossiter, Stephen J.; Clare, Elizabeth L.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Camargo, Nicholas Ferreira] Univ Brasilia, Lab Ecol Vertebrados, Brasilia, DF, Brazil; [Hemprich-Bennett, David R.] Univ Oxford, Dept Zool, Oxford, England; [Rodriguez-Herrera, Bernal] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica	Iowa State University; University of London; Queen Mary University London; Universidade de Brasilia; University of Oxford; Universidad Costa Rica	de Oliveira, HFM (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.; de Oliveira, HFM (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	oliveiradebioh@gmail.com	Hemprich-Bennett, David/ABD-7318-2021; Camargo, Nícholas F/B-3389-2019	Hemprich-Bennett, David/0000-0002-3555-4295; Camargo, Nícholas F/0000-0001-6859-8780; Oliveira, Hernani/0000-0001-7040-8317; Clare, Elizabeth/0000-0002-6563-3365	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -CAPES (Coordination for the Improvement of Higher Education Personnel) [BEX 8927/13-8, PNPD 23106.023136/2016-81]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -CAPES (Coordination for the Improvement of Higher Education Personnel) for the scholarship provided to Hernani Oliveira to conduct this research (BEX 8927/13-8) and Ni ' cholas Camargo (PNPD 23106.023136/2016-81).	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Alberdi A, 2018, METHODS ECOL EVOL, V9, P134, DOI 10.1111/2041-210X.12849; [Anonymous], BIORXIV357376; Araujo MS, 2007, COPEIA, P855, DOI 10.1643/0045-8511(2007)7[855:IDVIFF]2.0.CO;2; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Araujo MS, 2010, OIKOS, V119, P81, DOI 10.1111/j.1600-0706.2009.17624.x; Asis JD, 2011, BEHAVIOUR, V148, P191, DOI 10.1163/000579510X551651; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bolnick DI, 2010, P ROY SOC B-BIOL SCI, V277, P1789, DOI 10.1098/rspb.2010.0018; Bolnick DI, 2009, EVOL ECOL RES, V11, P1217; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Cantor M, 2013, OIKOS, V122, P1085, DOI 10.1111/j.1600-0706.2012.00070.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAI P, 1990, AM NAT, V135, P398; CHAPMAN CA, 1989, BIOTROPICA, V21, P148, DOI 10.2307/2388705; Clare EL, 2019, MOL ECOL, V28, P503, DOI 10.1111/mec.14941; Clare EL, 2016, GENOME, V59, P981, DOI 10.1139/gen-2015-0184; Clare EL, 2014, MOL ECOL, V23, P3633, DOI 10.1111/mec.12519; Clare EL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-26; COELHO F, 2011, PREDATION HYMENOPTER, P23; Costa-Pereira R, 2017, BIOTROPICA, V49, P531, DOI 10.1111/btp.12434; da Cunha AF, 2018, J FRESHWATER ECOL, V33, P273, DOI 10.1080/02705060.2018.1442371; de Camargo NF, 2019, ECOL EVOL, V9, P3946, DOI 10.1002/ece3.5024; De Camargo NF, 2014, BIOL J LINN SOC, V111, P737, DOI 10.1111/bij.12258; de Camargo NF, 2014, ACTA THERIOL, V59, P183, DOI 10.1007/s13364-013-0152-y; de Camargo NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049734; de Oliveira LQ, 2015, J MAMMAL, V96, P1036, DOI 10.1093/jmammal/gyv108; DENLINGER DL, 1980, BIOTROPICA, V12, P100, DOI 10.2307/2387725; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dupont YL, 2011, OIKOS, V120, P170, DOI 10.1111/j.1600-0706.2010.18699.x; Evans DM, 2016, FUNCT ECOL, V30, P1904, DOI 10.1111/1365-2435.12659; Fawcett K, 2015, BIOL OPEN, V4, P693, DOI 10.1242/bio.201511908; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hedenstrom A, 2001, BEHAV ECOL, V12, P150, DOI 10.1093/beheco/12.2.150; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jacobs DS, 1999, ACTA CHIROPTEROL, V1, P93; Janzen D, 2001, HDB ECOLOGICAL RESTO, P559; Janzen D.H., 1988, P130; Janzen DH, 2019, BIOL CONSERV, V233, P102, DOI 10.1016/j.biocon.2019.02.030; Jones G, 1997, ADV STUD BEHAV, V26, P317, DOI 10.1016/S0065-3454(08)60383-6; KALCOUNIS MC, 1995, CAN J ZOOL, V73, P89, DOI 10.1139/z95-011; Marinello MM, 2014, CAN J ZOOL, V92, P141, DOI 10.1139/cjz-2013-0127; Martins EG, 2008, BIOTROPICA, V40, P132, DOI 10.1111/j.1744-7429.2007.00319.x; Muller J, 2012, OECOLOGIA, V169, P673, DOI 10.1007/s00442-011-2247-y; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; NAKANO S, 1995, J ANIM ECOL, V64, P75, DOI 10.2307/5828; Neves FD, 2010, NAT CONSERVACAO, V8, P160, DOI 10.4322/natcon.00802009; Norberg U., 1990, VERTEBRATE FLIGHT ME; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Norberg Ulla M., 1994, P205; Oksanen J., 2007, COMMUNITY ECOLOGY PA, V10, P719; Pagani-Nunez E, 2015, OECOLOGIA, V179, P629, DOI 10.1007/s00442-015-3334-2; Patterson BD, 2003, BAT ECOLOGY, P536; Pinheiro F, 2002, AUSTRAL ECOL, V27, P132, DOI 10.1046/j.1442-9993.2002.01165.x; PRICE T, 1987, ECOLOGY, V68, P1015, DOI 10.2307/1938373; R Core Team, 2018, R VERS 3 5 1 R FDN S; REICH PB, 1984, J ECOL, V72, P61, DOI 10.2307/2260006; Reid F. A., 2009, FIELD GUIDE MAMMALS; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ, 2016, TPSRELW VER 1 62 DEP; Rohlf FJ, 2004, TPSDIG VERSION 1 4 2; Roslin T, 2016, GENOME, V59, P603, DOI 10.1139/gen-2015-0229; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Svanback R, 2005, EVOL ECOL RES, V7, P993; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Vesterinen EJ, 2016, MOL ECOL, V25, P1581, DOI 10.1111/mec.13564; WEBB PI, 1993, J ZOOL, V230, P619, DOI 10.1111/j.1469-7998.1993.tb02710.x; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	78	8	10	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232601	10.1371/journal.pone.0232601	http://dx.doi.org/10.1371/journal.pone.0232601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392221	Green Published, gold			2022-12-26	WOS:000537470300014
J	Cho, D; Milbury, K; McNeill, LH				Cho, Dalnim; Milbury, Kathrin; McNeill, Lorna H.			Stress and cancer-related lifestyle factors among African American heterosexual couples	PLOS ONE			English	Article							HEALTH BEHAVIOR-CHANGE; DISCRIMINATION; INTERVENTIONS; CONCORDANCE; DISPARITIES; SPILLOVER; MARRIAGE; SMOKING; OBESITY; GENDER	Intimate partners can have a profound influence on individuals' health behaviors. In this exploratory research, we investigated the concordance of cancer-related lifestyle factors including smoking, body mass index, physical activity, fruit and vegetable intake, red meat intake, and alcohol use within African American heterosexual couples. We also examined whether females' stress is associated with their own (actor effect) and males' cancer-related lifestyle factors (partner effect), and vice versa. We analyzed a total of 216 heterosexual couples (i.e., N = 432 individuals) recruited from black churches. Intraclass correlation coefficients (ICCs) were calculated and multilevel modeling in which individuals are nested within couples was conducted. Results showed that there was high concordance of body mass index (ICC = 1.68, p < .001), fruit and vegetable intake (ICC = 1.62, p < .001), red meat intake (ICC = 1.50, p = .001), and alcohol use (ICC = 1.74, p < .001) between spouses. A multilevel analysis showed that there were actor and partner effects of stress on females' BMI; females' stress was positively associated with their own BMI (actor effect; beta = .42, p = .006) and males' stress was positively associated with females' BMI (partner effect; beta = .39, p = .026). Also, females' stress was positively associated with their own red meat intake (actor effect; beta = .20, p = .019). In conclusion, high concordance of cancer-related lifestyle factors (BMI, fruit and vegetable intake, red meat intake and alcohol use) exists between African American spouses. Given the identified actor and partner effects of stress on females' BMI, a couple-based lifestyle or weight management intervention that targets both male and female spouses' stress and coping will be promising, particularly to enhance African American women's health behaviors. Future studies need to investigate mechanisms underlying concordance and discordance of cancer-related lifestyle factors in African American couples. Also, factors that explain African American male spouses' health behaviors need to be uncovered.	[Cho, Dalnim; McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX 77030 USA; [Milbury, Kathrin] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Cho, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX 77030 USA.	dcho1@mdanderson.org			University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment; National Cancer Institute [P20CA221696-02]; Department of Defense [W81XWH1910460]; Brander Beacons Cancer Research	University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Brander Beacons Cancer Research	This work was supported by a faculty fellowship from the University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment (to DC), the National Cancer Institute (P20CA221696-02 to LHM and DC), the Department of Defense (W81XWH1910460 to DC), and Brander Beacons Cancer Research (to DC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ML, 2016, PREV MED, V84, P41, DOI 10.1016/j.ypmed.2015.12.005; American Lung Association, 2015, TOB US RAC ETHN POP; Arden-Close E, 2017, BRIT J HEALTH PSYCH, V22, P215, DOI 10.1111/bjhp.12227; Arias E., 2016, NCHS DATA BRIEF; Ask H, 2012, BEHAV GENET, V42, P354, DOI 10.1007/s10519-011-9509-7; Barton AW, 2018, J FAM PSYCHOL, V32, P186, DOI 10.1037/fam0000376; Borsboom D, 2003, PSYCHOL REV, V110, P203, DOI 10.1037/0033-295X.110.2.203; Buck AA, 2012, J FAM PSYCHOL, V26, P698, DOI 10.1037/a0029260; BUSS DM, 1984, BEHAV GENET, V14, P111, DOI 10.1007/BF01076408; Charles N., 1988, WOMEN FOOD FAMILIES; Clarke T., 2017, EARLY RELEASE SELECT, P1; Cobb LK, 2016, AM J EPIDEMIOL, V183, P435, DOI 10.1093/aje/kwv112; Cobb LK, 2016, AM J EPIDEMIOL, V183, P444, DOI 10.1093/aje/kwv104; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Colditz GA, 2012, ANNU REV PUBL HEALTH, V33, P137, DOI 10.1146/annurev-publhealth-031811-124627; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cronin KA, 2018, CANCER-AM CANCER SOC, V124, P2785, DOI [10.1002/cncr.31551, 10.1002/cncr.32802]; Di Castelnuovo A, 2009, AM J EPIDEMIOL, V169, P1, DOI 10.1093/aje/kwn234; Dougall A.L., 2011, HDB HLTH PSYCHOL, P51; Edvardsson K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-923; Gudonis-Miller LC, 2012, J ADOLESCENCE, V35, P638, DOI 10.1016/j.adolescence.2011.08.011; Hales Craig M, 2020, NCHS Data Brief, P1; Isasi CR, 2015, ANN EPIDEMIOL, V25, P84, DOI 10.1016/j.annepidem.2014.11.002; Jackson SE, 2015, JAMA INTERN MED, V175, P385, DOI 10.1001/jamainternmed.2014.7554; Jurj AL, 2006, ANN EPIDEMIOL, V16, P285, DOI 10.1016/j.annepidem.2005.07.060; Kashy D.A., 2000, HDB RES METHODS SOCI, P451, DOI DOI 10.1017/CBO9780511996481; Kassel JD, 2003, PSYCHOL BULL, V129, P270, DOI 10.1037/0033-2909.129.2.270; Kenny D. A., 2006, DYADIC DATA ANAL; Lazarus R. S., 1984, STRESS APPRAISAL COP; Lewis MA, 2006, SOC SCI MED, V62, P1369, DOI 10.1016/j.socscimed.2005.08.006; McNeill LH, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00191; Meyler D, 2007, SOC SCI MED, V64, P2297, DOI 10.1016/j.socscimed.2007.02.007; Mouchacca J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-828; Murphy K.R., 1998, STAT POWER ANAL SIMP; NCHS in Health United States, 2015, SPEC FEAT RAC ETHN H; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; O'Neal CW, 2015, J HEALTH PSYCHOL, V20, P625, DOI 10.1177/1359105315579797; Park CL, 2004, J STUD ALCOHOL, V65, P126, DOI 10.15288/jsa.2004.65.126; Pieterse AL, 2010, J COUNS PSYCHOL, V57, P255, DOI 10.1037/a0020040; Rehm CD, 2016, JAMA-J AM MED ASSOC, V315, P2542, DOI 10.1001/jama.2016.7491; Rendall MS, 2011, DEMOGRAPHY, V48, P481, DOI 10.1007/s13524-011-0032-5; Richards EA, 2018, INT J HEALTH PROMOT, V56, P51, DOI 10.1080/14635240.2017.1415160; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sliwinski MJ, 2009, PSYCHOL AGING, V24, P828, DOI 10.1037/a0017925; Smith A.W., 2013, J CLIN ONCOLOGY OFFI, V31; StataCorp, 2015, STAT STAT SOFTW REL; THOMPSON FE, 1994, J NUTR, V124, pS2245, DOI 10.1093/jn/124.suppl_11.2245s; Trinidad DR, 2011, AM J PUBLIC HEALTH, V101, P699, DOI 10.2105/AJPH.2010.191668; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Warttig SL, 2013, J HEALTH PSYCHOL, V18, P1617, DOI 10.1177/1359105313508346; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Zapolski TCB, 2014, PSYCHOL BULL, V140, P188, DOI 10.1037/a0032113	52	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232577	10.1371/journal.pone.0232577	http://dx.doi.org/10.1371/journal.pone.0232577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0QJ	32384125	Green Published, gold			2022-12-26	WOS:000537468300020
J	Nwezeobi, J; Onyegbule, O; Nkere, C; Onyeka, J; van Brunschot, S; Seal, S; Colvin, J				Nwezeobi, Joachim; Onyegbule, Onyeyirichi; Nkere, Chukwuemeka; Onyeka, Joseph; van Brunschot, Sharon; Seal, Susan; Colvin, John			Cassava whitefly species in eastern Nigeria and the threat of vector-borne pandemics from East and Central Africa	PLOS ONE			English	Article							BEMISIA-TABACI HEMIPTERA; BROWN STREAK DISEASE; MOSAIC DISEASE; HOMOPTERA ALEYRODIDAE; VIRUS; POPULATIONS; WEST; EVOLUTION; SPREAD; EPIDEMIOLOGY	Bemisia tabaci (sensu latu) is a group of > 40 highly cryptic whitefly species that are of global agricultural importance, both as crop pests and plant-virus vectors. Two devastating cassava diseases in East and Central Africa are spread by abundant populations of one of these species termed Sub-Saharan Africa 1 (SSA1). There is a substantive risk that these whitefly-borne pandemics will continue to spread westwards and disrupt cassava production for millions of smallholder farmers in West Africa. We report here, therefore, the first comprehensive survey of cassava B. tabaci in eastern Nigeria, a West African region likely to be the first affected by the arrival of these whitefly-borne pandemics. We found one haplotype comprising 32 individuals with 100% identical mtCO1 sequence to the East African SSA1 populations (previously termed SSA1-SG1) and 19 mtCO1 haplotypes of Sub-Saharan Africa 3 (SSA3), the latter being the most prevalent and widely distributed B. tabaci species in eastern Nigeria. A more divergent SSA1 mtCO1 sequence (previously termed SSA1SG5) was also identified in the region, as were mtCO1 sequences identifying the presence of the MED ASL B. tabaci species and Bemisia afer. Although B. tabaci SSA1 was found in eastern Nigeria, they were not present in the high abundances associated with the cassava mosaic (CMD) and cassava brown streak disease (CBSD) pandemics of East and Central Africa. Also, no severe CMD or any CBSD symptoms were found in the region.	[Nwezeobi, Joachim; van Brunschot, Sharon; Seal, Susan; Colvin, John] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England; [Onyegbule, Onyeyirichi; Nkere, Chukwuemeka; Onyeka, Joseph] Natl Root Crops Res Inst, Umudike, Abia, Nigeria; [van Brunschot, Sharon] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Nwezeobi, Joachim] Natl Inst Agr Bot, Cambridge, England	University of Greenwich; University of Queensland	Nwezeobi, J; Colvin, J (corresponding author), Univ Greenwich, Nat Resources Inst, Chatham, Kent, England.; Nwezeobi, J (corresponding author), Natl Inst Agr Bot, Cambridge, England.	Joachim.nwezeobi@niab.com; j.colvin@greenwich.ac.uk		Nkere, Chukwuemeka/0000-0002-1212-0785; van Brunschot, Sharon/0000-0002-9634-9463	University of Greenwich through a grant from the Bill & Melinda Gates Foundation entitled African Cassava Whitefly Project; Bill & Melinda Gates Foundation through the project: African Cassava Whitefly Project; Bill & Melinda Gates Foundation through the project: West African Virus Epidemiology Project	University of Greenwich through a grant from the Bill & Melinda Gates Foundation entitled African Cassava Whitefly Project; Bill & Melinda Gates Foundation through the project: African Cassava Whitefly Project; Bill & Melinda Gates Foundation through the project: West African Virus Epidemiology Project	Joachim Nwezeobi was the recipient of a PhD studentship at the University of Greenwich through a grant from the Bill & Melinda Gates Foundation entitled African Cassava Whitefly Project. This work was funded by the Bill & Melinda Gates Foundation through the projects: African Cassava Whitefly Project and the West African Virus Epidemiology Project, https://www.gatesfoundation.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbade S.A., 2010, NEW DIS REP, V21, P22; Alegbejo Matthew D., 2005, Journal of Plant Protection Research, V45, P93; Alicai T, 2007, PLANT DIS, V91, P24, DOI 10.1094/PD-91-0024; Barkley TM, 1986, GREAT PLAINS FLORA A; Bigirimana S, 2004, PLANT PATHOL, V53, P231, DOI 10.1111/j.0032-0862.2004.00971.x; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BURBAN C, 1992, J APPL ENTOMOL, V113, P416, DOI 10.1111/j.1439-0418.1992.tb00682.x; Burns Anna, 2010, Sustainability, V2, P3572, DOI 10.3390/su2113572; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Chen WB, 2019, INSECT BIOCHEM MOLEC, V110, P112, DOI 10.1016/j.ibmb.2019.05.003; Cudjoe A, 2005, WHITEFLIES WHITEFLY, P24; De la Rua P, 2006, J ZOOL SYST EVOL RES, V44, P25, DOI 10.1111/j.1439-0469.2005.00336.x; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Echendu NC, 2005, WHITEFLY WHITEFLY BO, P35; Eni AO, 2018, DATA BRIEF, V19, P370, DOI 10.1016/j.dib.2018.05.016; FARGETTE D, 1985, ANN APPL BIOL, V106, P285, DOI 10.1111/j.1744-7348.1985.tb03118.x; FARGETTE D, 1990, J PHYTOPATHOL, V130, P289, DOI 10.1111/j.1439-0434.1990.tb01179.x; FISHPOOL LDC, 1995, B ENTOMOL RES, V85, P197, DOI 10.1017/S0007485300034271; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Gbaguidi B, 2005, WHITEFLIES WHITEFLY, P30; Ghosh S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0425-5; Gnankine O, 2013, ACTA TROP, V128, P7, DOI 10.1016/j.actatropica.2013.06.004; Gnankine O, 2013, INT J TROP INSECT SC, V33, P99, DOI 10.1017/S1742758413000040; Gnankine O, 2013, INSECT CONSERV DIVER, V6, P411, DOI 10.1111/j.1752-4598.2012.00206.x; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; HarvestChoice, 2010, AGR ZON SUBS AFR; Hillocks RJ, 2003, INT J PEST MANAGE, V49, P225, DOI 10.1080/0967087031000101061; Kalyebi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204862; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Legg JP, 2006, ADV VIRUS RES, V67, P355, DOI 10.1016/S0065-3527(06)67010-3; Legg JP, 2015, ADV VIRUS RES, V91, P85, DOI 10.1016/bs.aivir.2014.10.001; Legg JP, 2014, PEST MANAG SCI, V70, P1446, DOI 10.1002/ps.3793; Legg JP, 2014, VIRUS RES, V186, P61, DOI 10.1016/j.virusres.2013.11.018; Leotard G, 2009, MOL PHYLOGENET EVOL, V53, P329, DOI 10.1016/j.ympev.2009.05.003; Leuschner K., 1977, P CASS PROT WORKSH C, P51; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Maruthi MN, 2005, J PHYTOPATHOL, V153, P307, DOI 10.1111/j.1439-0434.2005.00974.x; Maruthi MN, 2004, SYST ENTOMOL, V29, P560, DOI 10.1111/j.0307-6970.2004.00272.x; Montagnac JA, 2009, COMPR REV FOOD SCI F, V8, P181, DOI 10.1111/j.1541-4337.2009.00077.x; Mugerwa H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20956-3; Mulimbi W., 2012, New Disease Reports, V26, P11, DOI 10.5197/j.2044-0588.2012.026.011; Nigerian metrological agency, 2015, 2015 SEAS RAINF PRED; Omondi AB, 2005, ENTOMOL EXP APPL, V115, P393, DOI 10.1111/j.1570-7458.2005.00296.x; Otim-Nape G.W., 1998, EPIDEMIOLOGY PLANT D, P423; Oyelade O. J., 2015, African Crop Science Journal, V23, P135; Patil BL, 2009, MOL PLANT PATHOL, V10, P685, DOI [10.1111/j.1364-3703.2009.00559.x, 10.1111/J.1364-3703.2009.00559.X]; Polston JE, 2014, PEST MANAG SCI, V70, P1547, DOI 10.1002/ps.3738; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rambaut A, 2016, FIGTREE 1 4 3; Ramos RS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198925; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sartor C, 2008, B INSECTOL, V61, P161; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sseruwagi P, 2004, VIRUS RES, V100, P129, DOI 10.1016/j.virusres.2003.12.021; Storey HH, 1938, ANN APPL BIOL, V25, P790, DOI 10.1111/j.1744-7348.1938.tb02354.x; Szyniszewska A, 2019, CASSAVA BROWN STREAK; Tajebe LS, 2015, J APPL ENTOMOL, V139, P627, DOI 10.1111/jen.12197; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tocko-Marabena BK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182749; van Brunschot SL, 2013, PLANT PATHOL, V62, P1132, DOI 10.1111/ppa.12033; Vyskocilova S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29305-w; Wosula EN, 2017, GENOME BIOL EVOL, V9, P2958, DOI 10.1093/gbe/evx219	63	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232616	10.1371/journal.pone.0232616	http://dx.doi.org/10.1371/journal.pone.0232616			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379806	Green Accepted, Green Published, gold			2022-12-26	WOS:000537285700048
J	Baskaran, L; Al'Aref, SJ; Maliakal, G; Lee, BC; Xu, ZR; Choi, JW; Lee, SE; Sung, JM; Lin, FY; Dunham, S; Mosadegh, B; Kim, YJ; Gottlieb, I; Lee, BK; Chun, EJ; Cademartiri, F; Maffei, E; Marques, H; Shin, SH; Choi, JH; Chinnaiyan, K; Hadamitzky, M; Conte, E; Andreini, D; Pontone, G; Budoff, MJ; Leipsic, JA; Raff, GL; Virmani, R; Samady, H; Stone, PH; Berman, DS; Narula, J; Bax, JJ; Chang, HJ; Min, JK; Shaw, LJ				Baskaran, Lohendran; Al'Aref, Subhi J.; Maliakal, Gabriel; Lee, Benjamin C.; Xu, Zhuoran; Choi, Jeong W.; Lee, Sang-Eun; Sung, Ji Min; Lin, Fay Y.; Dunham, Simon; Mosadegh, Bobak; Kim, Yong-Jin; Gottlieb, Ilan; Lee, Byoung Kwon; Chun, Eun Ju; Cademartiri, Filippo; Maffei, Erica; Marques, Hugo; Shin, Sanghoon; Choi, Jung Hyun; Chinnaiyan, Kavitha; Hadamitzky, Martin; Conte, Edoardo; Andreini, Daniele; Pontone, Gianluca; Budoff, Matthew J.; Leipsic, Jonathon A.; Raff, Gilbert L.; Virmani, Renu; Samady, Habib; Stone, Peter H.; Berman, Daniel S.; Narula, Jagat; Bax, Jeroen J.; Chang, Hyuk-Jae; Min, James K.; Shaw, Leslee J.			Automatic segmentation of multiple cardiovascular structures from cardiac computed tomography angiography images using deep learning	PLOS ONE			English	Article							HEART	Background Segmentation of cardiovascular images is resource-intensive. We design an automated deep learning method for the segmentation of multiple structures from Coronary Computed Tomography Angiography (CCTA) images. Methods Images from a multicenter registry of patients that underwent clinically-indicated CCTA were used. The proximal ascending and descending aorta (PAA, DA), superior and inferior vena cavae (SVC, IVC), pulmonary artery (PA), coronary sinus (CS), right ventricular wall (RVW) and left atrial wall (LAW) were annotated as ground truth. The U-net-derived deep learning model was trained, validated and tested in a 70:20:10 split. Results The dataset comprised 206 patients, with 5.130 billion pixels. Mean age was 59.9 +/- 9.4 yrs., and was 42.7% female. An overall median Dice score of 0.820 (0.782, 0.843) was achieved. Median Dice scores for PAA, DA, SVC, IVC, PA, CS, RVW and LAW were 0.969 (0.979, 0.988), 0.953 (0.955, 0.983), 0.937 (0.934, 0.965), 0.903 (0.897, 0.948), 0.775 (0.724, 0.925), 0.720 (0.642, 0.809), 0.685 (0.631, 0.761) and 0.625 (0.596, 0.749) respectively. Apart from the CS, there were no significant differences in performance between sexes or age groups. Conclusions An automated deep learning model demonstrated segmentation of multiple cardiovascular structures from CCTA images with reasonable overall accuracy when evaluated on a pixel level.	[Baskaran, Lohendran; Al'Aref, Subhi J.; Lee, Benjamin C.; Xu, Zhuoran; Choi, Jeong W.; Lin, Fay Y.; Dunham, Simon; Mosadegh, Bobak; Min, James K.; Shaw, Leslee J.] Weill Cornell Med, Dalio Inst Cardiovasc Imaging, New York, NY 10065 USA; [Baskaran, Lohendran; Al'Aref, Subhi J.; Lin, Fay Y.; Min, James K.; Shaw, Leslee J.] New York Presbyterian Hosp, Dept Radiol, New York, NY 10038 USA; [Baskaran, Lohendran; Al'Aref, Subhi J.; Lin, Fay Y.; Min, James K.; Shaw, Leslee J.] Weill Cornell Med, New York, NY 10065 USA; [Baskaran, Lohendran] Natl Heart Ctr, Dept Cardiovasc Med, Singapore, Singapore; [Maliakal, Gabriel] Cleerly Inc, New York, NY USA; [Lee, Sang-Eun; Sung, Ji Min; Chang, Hyuk-Jae] Yonsei Univ, Integrat Cardiovasc Imaging Ctr, Severance Cardiovasc Hosp, Div Cardiol,Coll Med, Seoul, South Korea; [Lee, Sang-Eun; Shin, Sanghoon] Ewha Womans Univ, Dept Internal Med, Div Cardiol, Seoul Hosp, Seoul, South Korea; [Kim, Yong-Jin] Seoul Natl Univ, Seoul Natl Univ Hosp, Cardiovasc Ctr, Dept Internal Med,Coll Med, Seoul, South Korea; [Gottlieb, Ilan] Casa Saude Sao Jose, Dept Radiol, Rio De Janeiro, Brazil; [Lee, Byoung Kwon] Yonsei Univ, Gangnam Severance Hosp, Div Cardiol, Coll Med, Seoul, South Korea; [Chun, Eun Ju] Seoul Natl Univ, Dept Radiol, Bundang Hosp, Sungnam, South Korea; [Cademartiri, Filippo] SDN IRCCS, Cardiovasc Imaging Ctr, Naples, Italy; [Maffei, Erica] ASUR Marche, Dept Radiol, Area Vasta 1, Urbino, Italy; [Marques, Hugo] Hosp Luz, Unit Cardiovasc Imaging, UNICA, Lisbon, Portugal; [Choi, Jung Hyun] Pusan Univ Hosp, Busan, South Korea; [Chinnaiyan, Kavitha; Raff, Gilbert L.; Virmani, Renu] William Beaumont Hosp, Dept Cardiol, Royal Oak, MI 48072 USA; [Hadamitzky, Martin] German Heart Ctr Munich, Dept Radiol & Nucl Med, Munich, Germany; [Conte, Edoardo; Andreini, Daniele; Pontone, Gianluca] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Budoff, Matthew J.] Los Angeles Biomed Res Inst, Dept Med, Torrance, CA USA; [Leipsic, Jonathon A.] Univ British Columbia, Dept Med & Radiol, Vancouver, BC, Canada; [Virmani, Renu] CVPath Inst, Dept Pathol, Gaithersburg, MD USA; [Samady, Habib] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; [Stone, Peter H.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA 02115 USA; [Berman, Daniel S.] Cedars Sinai Med Ctr, Dept Imaging & Med, Los Angeles, CA 90048 USA; [Narula, Jagat] Icahn Sch Med Mt Sinai, Mt Sinai Heart Zena & Michael Wiener Cardiovasc I, New York, NY 10029 USA; [Narula, Jagat] Icahn Sch Med Mt Sinai, Henry R Kravis Ctr Cardiovasc Hlth, New York, NY 10029 USA; [Bax, Jeroen J.] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands	Cornell University; NewYork-Presbyterian Hospital; Cornell University; National Heart Centre Singapore; Yonsei University; Yonsei University Health System; Ewha Womans University; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Seoul National University (SNU); IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Beaumont Health; German Heart Centre Munich; IRCCS Centro Cardiologico Monzino; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of British Columbia; CVPath Institute; Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cedars Sinai Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Baskaran, L (corresponding author), Weill Cornell Med, Dalio Inst Cardiovasc Imaging, New York, NY 10065 USA.; Baskaran, L (corresponding author), New York Presbyterian Hosp, Dept Radiol, New York, NY 10038 USA.; Baskaran, L (corresponding author), Weill Cornell Med, New York, NY 10065 USA.; Baskaran, L (corresponding author), Natl Heart Ctr, Dept Cardiovasc Med, Singapore, Singapore.	lob2008@med.cornell.edu	Budoff, Matthew/ABD-5175-2021; Leipsic, Jonathon/ABE-6194-2020; Maffei, Erica/J-2370-2016; Lin, Fay/AAJ-9453-2021; Andreini, Daniele/ABG-9647-2020; Conte, Edoardo/AAC-3469-2019; Baskaran, Lohendran/AAE-8338-2019; Lee, Sang-Eun/AAS-3253-2021; GOTTLIEB, ILAN/ABD-2216-2021; Cademartiri, Filippo/H-7336-2015	Budoff, Matthew/0000-0002-9616-1946; Maffei, Erica/0000-0002-0388-4433; Conte, Edoardo/0000-0003-1443-5788; Baskaran, Lohendran/0000-0003-0565-7151; Cademartiri, Filippo/0000-0002-0579-3279; Lee, Byoung Kwon/0000-0001-9259-2776; Chang, Hyuk-Jae/0000-0002-6139-7545; Mosadegh, Bobak/0000-0003-0607-2825; Marques, Hugo/0000-0001-8210-2075; Dunham, Simon/0000-0001-7399-5676	Dalio Institute of Cardiovascular Imaging (New York, NY, USA); Dalio Foundation; National Institutes of Health; GE Healthcare	Dalio Institute of Cardiovascular Imaging (New York, NY, USA); Dalio Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GE Healthcare(General ElectricGE Healthcare)	The research reported in this manuscript was supported by the Dalio Institute of Cardiovascular Imaging (New York, NY, USA). James K. Min received funding from the Dalio Foundation, National Institutes of Health, and GE Healthcare. Dr. Min serves on the scientific advisory board of Arineta and GE Healthcare, and became founder and an employee of Cleerly, Inc after this research was conducted. Dr. Jonathon Leipsic is a consultant and has reported stock options with Circle CVI and HeartFlow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abbara S, 2016, J CARDIOVASC COMPUT, V10, P435, DOI 10.1016/j.jcct.2016.10.002; [Anonymous], 2019, PYTHON PACKAGE READI; Baskaran L, 2019, JACC CARDIOVASCULAR; Do, 2015, ARXIV151106348CS; Ecabert O, 2011, MED IMAGE ANAL, V15, P863, DOI 10.1016/j.media.2011.06.004; Fuchs A, 2016, EUR HEART J-CARD IMG, V17, P1009, DOI 10.1093/ehjci/jev337; Gamechi ZS, 2019, EUR RADIOL, V29, P4613, DOI 10.1007/s00330-018-5931-z; Hinton G, 2018, JAMA-J AM MED ASSOC, V320, P1101, DOI 10.1001/jama.2018.11100; Javaid U, 2018, LECT NOTES COMPUT SC, V11182, P188, DOI 10.1007/978-3-030-01449-0_16; Kivinen JJ, VISUAL BOUNDARY PRED, V10; Kurugol S, 2012, IEEE ENG MED BIO, P2343, DOI 10.1109/EMBC.2012.6346433; Lee SE, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.117.007562; Lee SE, 2016, AM HEART J, V182, P72, DOI 10.1016/j.ahj.2016.09.003; Lin FY, 2009, ACAD RADIOL, V16, P981, DOI 10.1016/j.acra.2009.02.013; Noothout JMH, 2018, ARXIV181005727CS; Peeters LHC, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0515-y; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Roth HR, 2018, COMPUT MED IMAG GRAP, V66, P90, DOI 10.1016/j.compmedimag.2018.03.001; Shah SS, 2012, RADIOGRAPHICS, V32, P991, DOI 10.1148/rg.324105220; Sivanesan K, 2018, CURR ATHEROSCLER REP, V20, DOI 10.1007/s11883-018-0714-1; Sonavane SK, 2015, RADIOGRAPHICS, V35, P1874, DOI 10.1148/rg.2015150056; Sudre CH, 2017, LECT NOTES COMPUT SC, V10553, P240, DOI 10.1007/978-3-319-67558-9_28; Waite S, 2017, AM J ROENTGENOL, V208, P739, DOI 10.2214/AJR.16.16963; Xie YT, 2014, INT J COMPUT ASS RAD, V9, P211, DOI 10.1007/s11548-013-0924-5; Yan ZX, 2017, INT J COMPUT ASS RAD, V12, P1481, DOI 10.1007/s11548-017-1582-9; Zhuang XH, 2015, MED PHYS, V42, P3822, DOI 10.1118/1.4921366	26	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232573	10.1371/journal.pone.0232573	http://dx.doi.org/10.1371/journal.pone.0232573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374784	gold, Green Published			2022-12-26	WOS:000537283500043
J	Lopez-Sanchez, U; Tury, S; Nicolas, G; Wilson, MS; Jurici, S; Ayrignac, X; Courgnaud, V; Saiardi, A; Sitbon, M; Battini, JL				Lopez-Sanchez, Uriel; Tury, Sandrine; Nicolas, Gael; Wilson, Miranda S.; Jurici, Snejana; Ayrignac, Xavier; Courgnaud, Valerie; Saiardi, Adolfo; Sitbon, Marc; Battini, Jean-Luc			Interplay between primary familial brain calcification-associated SLC20A2 and XPR1 phosphate transporters requires inositol polyphosphates for control of cellular phosphate homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						xenotropic and polytropic retrovirus receptor 1 (XPR1); phosphate transporter; primary familial brain calcification (PFBC); phosphate homeostasis; ATP; inositol pyrophosphate; metabolic regulation; SPX domain; efflux transporter; cell metabolism; energy metabolism; anion transport; inositol phosphate	BASAL GANGLIA CALCIFICATION; APE LEUKEMIA-VIRUS; INORGANIC-PHOSPHATE; CEREBROSPINAL-FLUID; MURINE RETROVIRUS; SURFACE RECEPTOR; GENE; MUTATIONS; PYROPHOSPHATES; CLONING	Solute carrier family 20 member 2 (SLC20A2) and xenotropic and polytropic retrovirus receptor 1 (XPR1) are transporters with phosphate uptake and efflux functions, respectively. Both are associated with primary familial brain calcification (PFBC), a genetic disease characterized by cerebral calcium-phosphate deposition and associated with neuropsychiatric symptoms. The association of the two transporters with the same disease suggests that they jointly regulate phosphate fluxes and cellular homeostasis, but direct evidence is missing. Here, we found that cross-talk between SLC20A2 and XPR1 regulates phosphate homeostasis, and we identified XPR1 as a key inositol polyphosphate (IP)-dependent regulator of this process. We found that overexpression of WT SLC20A2 increased phosphate uptake, as expected, but also unexpectedly increased phosphate efflux, whereas PFBC-associated SLC20A2 variants did not. Conversely, SLC20A2 depletion decreased phosphate uptake only slightly, most likely compensated for by the related SLC20A1 transporter, but strongly decreased XPR1-mediated phosphate efflux. The SLC20A2-XPR1 axis maintained constant intracellular phosphate and ATP levels, which both increased in XPR1 KO cells. Elevated ATP levels are a hallmark of altered inositol pyrophosphate (PP-IP) synthesis, and basal ATP levels were restored after phosphate efflux rescue with WT XPR1 but not with XPR1 harboring a mutated PP-IP?binding pocket. Accordingly, inositol hexakisphosphate kinase 1-2 (IP6K1-2) gene inactivation or IP6K inhibitor treatment abolished XPR1-mediated phosphate efflux regulation and homeostasis. Our findings unveil an SLC20A2-XPR1 interplay that depends on IPs such as PP-IPs and controls cellular phosphate homeostasis via the efflux route, and alteration of this interplay likely contributes to PFBC.	[Lopez-Sanchez, Uriel; Tury, Sandrine; Battini, Jean-Luc] Univ Montpellier, Inst Rech Infectiol Montpellier IRIM, CNRS, Montpellier, France; [Lopez-Sanchez, Uriel; Courgnaud, Valerie; Sitbon, Marc; Battini, Jean-Luc] Univ Montpellier, Inst Genet Mol Montpellier IGMM, CNRS, Montpellier, France; [Nicolas, Gael] Normandie Univ, UNIROUEN, Inserm U1245, Rouen, France; [Nicolas, Gael] Normandie Univ, Rouen Univ Hosp, Dept Genet, Rouen, France; [Nicolas, Gael] Normandie Univ, CNR MAJ, Normandy Ctr Genom & Personalized Med, Rouen, France; [Wilson, Miranda S.; Saiardi, Adolfo] UCL, MRC Lab Mol Cell Biol, London, England; [Jurici, Snejana] Perpignan Hosp, Dept Neurol, Perpignan, France; [Ayrignac, Xavier] Montpellier Univ Hosp, Dept Neurol, Montpellier, France; [Lopez-Sanchez, Uriel] Univ Grenoble Alpes, Inst Biol Struct, CEA, CNRS,UMR 5075, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; MRC Laboratory Molecular Biology; University of London; University College London; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Battini, JL (corresponding author), Univ Montpellier, Inst Rech Infectiol Montpellier IRIM, CNRS, Montpellier, France.; Sitbon, M; Battini, JL (corresponding author), Univ Montpellier, Inst Genet Mol Montpellier IGMM, CNRS, Montpellier, France.	marc.sitbon@igmm.cnrs.fr; jean-luc.battini@irim.cnrs.fr	Sitbon, Marc/A-6771-2010	Sitbon, Marc/0000-0003-3616-2338; ayrignac, xavier/0000-0003-3834-2981; Courgnaud, Valerie/0000-0003-1000-0322; Saiardi, Adolfo/0000-0002-4351-0081; TURY, Sandrine/0000-0001-9291-734X; Lopez-Sanchez, Uriel/0000-0003-4937-7055; Nicolas, Gael/0000-0001-9391-7800; Battini, Jean-Luc/0000-0002-5884-9934	Labex EpiGenMed [ANR-10-LABX-12-01]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [243449/440597]; Fondation pour la Recherche Medicale (FRM) [FDT20170436884]; ANR [ANR-17-CE14-0008, ANR-17-CE14-0008-01]; FRM [DBI201312285579]; NIH [DK32094]; Labex GR-Ex [ANR-11-LABX-0051]; European Union; Region Normandie through the Recherche Innovation Normandie (RIN 2018); Inserm; MRC [MR/T028904/1] Funding Source: UKRI	Labex EpiGenMed; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Labex GR-Ex; European Union(European Commission); Region Normandie through the Recherche Innovation Normandie (RIN 2018); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	U. L.-S. was supported successively by the Labex EpiGenMed (Grant ANR-10-LABX-12-01), Consejo Nacional de Ciencia y Tecnologia (CONACYT Grant 243449/440597), the Fondation pour la Recherche Medicale (FRM) (Grant FDT20170436884), and ANR (CALCIPHOS Grant ANR-17-CE14-0008-01); S. T. was supported by ANR (CALCIPHOS Grant ANR-17-CE14-0008-01). This work was supported by grants from FRM grant DBI201312285579 (to M. S.) and NIH grant DK32094 (to M. S.), from ANR (CALCIPHOS Grant ANR-17-CE14-0008 to J.-L. B., G. N., and M. S.), and from Labex GR-Ex (Grant ANR-11-LABX-0051). This study was co-supported by the European Union and Region Normandie, more specifically through the Recherche Innovation Normandie (RIN 2018). Europe gets involved in Normandie with the European Regional Development Fund (ERDF). G. N., M. S., and J.-L. B. are supported by Inserm. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anheim M, 2016, J NEUROL, V263, P1559, DOI 10.1007/s00415-016-8166-4; Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Azevedo C, 2017, TRENDS BIOCHEM SCI, V42, P219, DOI 10.1016/j.tibs.2016.10.008; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Beck-Cormier S, 2019, J BONE MINER RES, V34, P1101, DOI 10.1002/jbmr.3691; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Bon N, 2018, J BIOL CHEM, V293, P2102, DOI 10.1074/jbc.M117.807339; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Cen ZD, 2020, BRAIN, V143, P491, DOI 10.1093/brain/awz392; Collins JF, 2004, PFLUG ARCH EUR J PHY, V447, P647, DOI 10.1007/s00424-003-1088-x; Crouthamel MH, 2013, ARTERIOSCL THROM VAS, V33, P2625, DOI 10.1161/ATVBAHA.113.302249; David S, 2016, EUR J HUM GENET, V24, P1630, DOI 10.1038/ejhg.2016.50; Dong JS, 2019, MOL PLANT, V12, P1463, DOI 10.1016/j.molp.2019.08.002; Durham AL, 2018, CARDIOVASC RES, V114, P590, DOI 10.1093/cvr/cvy010; Giovannini D, 2013, CELL REP, V3, P1866, DOI 10.1016/j.celrep.2013.05.035; Grangeon L, 2019, BRAIN, V142, P1573, DOI 10.1093/brain/awz095; Gu CF, 2017, P NATL ACAD SCI USA, V114, P11968, DOI 10.1073/pnas.1702370114; Gu CF, 2017, J BIOL CHEM, V292, P4544, DOI 10.1074/jbc.M116.765743; Guerreiro PM, 2014, AM J PHYSIOL-RENAL, V306, pF1275, DOI 10.1152/ajprenal.00458.2013; Hilfiker H, 1998, P NATL ACAD SCI USA, V95, P14564, DOI 10.1073/pnas.95.24.14564; Hozumi I, 2018, J NEUROL SCI, V388, P150, DOI 10.1016/j.jns.2018.03.014; Jensen N, 2016, NEUROGENETICS, V17, P125, DOI 10.1007/s10048-015-0469-6; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jung JY, 2018, CURR OPIN BIOTECH, V49, P156, DOI 10.1016/j.copbio.2017.08.012; Kavanaugh MP, 1996, KIDNEY INT, V49, P959, DOI 10.1038/ki.1996.135; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; Khoshniat S, 2011, CELL MOL LIFE SCI, V68, P205, DOI 10.1007/s00018-010-0527-z; Larsen FT, 2017, J MOL NEUROSCI, V61, P215, DOI 10.1007/s12031-016-0868-7; Lassaux A, 2005, J VIROL, V79, P6560, DOI 10.1128/JVI.79.10.6560-6564.2005; Legati A, 2015, NAT GENET, V47, P579, DOI 10.1038/ng.3289; Li XY, 2020, P NATL ACAD SCI USA, V117, P3568, DOI 10.1073/pnas.1908830117; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Lopez-Sanchez U, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43255-x; Mamede JI, 2017, SCI REP-UK, V7, DOI 10.1038/srep45214; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Miklossy J, 2005, ACTA NEUROPATHOL, V109, P643, DOI 10.1007/s00401-005-1007-7; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; Nicolas G, 2015, AM J MED GENET B, V168, P586, DOI 10.1002/ajmg.b.32336; Nicolas G, 2013, BRAIN, V136, P3395, DOI 10.1093/brain/awt255; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Paucar M, 2017, J NEUROL SCI, V375, P245, DOI 10.1016/j.jns.2017.02.007; Prie D, 2010, NEW ENGL J MED, V362, P2399, DOI 10.1056/NEJMra0904186; Ramos E.M., 1993, GENEREVIEWS R; Ramos EM, 2018, EUR J HUM GENET, V26, P1462, DOI 10.1038/s41431-018-0185-4; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Suzuki A, 2010, J BONE MINER METAB, V28, P139, DOI 10.1007/s00774-009-0121-3; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; Vaughan AE, 2012, J VIROL, V86, P1661, DOI 10.1128/JVI.06073-11; Villa-Bellosta R, 2009, PFLUG ARCH EUR J PHY, V458, P1151, DOI 10.1007/s00424-009-0688-5; Wallingford MC, 2017, BRAIN PATHOL, V27, P64, DOI 10.1111/bpa.12362; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; Wege S, 2014, FEBS LETT, V588, P482, DOI 10.1016/j.febslet.2013.12.013; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; Wilson MS, 2019, J BIOL CHEM, V294, P11597, DOI 10.1074/jbc.RA119.007848; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Xu H, 1999, GENOMICS, V62, P281, DOI 10.1006/geno.1999.6009; Yang YL, 1999, NAT GENET, V21, P216, DOI 10.1038/6005; Yao XP, 2018, NEURON, V98, P1116, DOI 10.1016/j.neuron.2018.05.037	63	16	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9366	9378		10.1074/jbc.RA119.011376	http://dx.doi.org/10.1074/jbc.RA119.011376			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32393577	Green Published, hybrid			2022-12-26	WOS:000552758600009
J	Yu, T; Kuang, HY; Chen, JH; Lin, X; Wu, Y; Chen, KY; Zhang, MJ; Zhang, WQ; Wen, ZL				Yu, Tao; Kuang, Haoyue; Chen, Jiahao; Lin, Xi; Wu, Yi; Chen, Keyu; Zhang, Mingjie; Zhang, Wenqing; Wen, Zilong			Tripartite-motif family protein 35-28 regulates microglia development by preventing necrotic death of microglial precursors in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Trim; zebrafish; microglia; development; cell death; macrophage; immune system; central nervous system (CNS; ); genetic screen; neuronal inflammation	PROGRAMMED CELL-DEATH; MYELOID CELLS; ADULT MICROGLIA; B-BOX; ORIGINS; BRAIN; MACROPHAGES; MUTATIONS; ABLATION; REVEALS	Microglia are tissue-resident macrophages in the central nervous system (CNS) that play essential roles in the regulation of CNS development and homeostasis. Yet, the genetic networks governing microglia development remain incompletely defined. Here, we report the identification and characterization of a microglia-defective zebrafish mutantwulong(hkz12)(wul(hkz12)) isolated from an ethylnitrosourea (ENU)-based genetic screen. We show thatwul(hkz12)mutants harbors a missense point mutation in the gene region encoding the PRY/SPRY domain of the tripartite-motif family protein 35-28 (trim35-28) gene. Time-lapse imaging revealed that the loss of Trim35-28 function causes lytic necrosis of microglial precursors/peripheral macrophages, as indicated by cytoplasmic swelling and membrane rupture of these precursors and accompanied by neutrophil infiltration and systemic inflammation. Intriguingly, the lytic necrosis of microglial precursors intrim35-28?deficient mutants appeared to depend neither on the canonical pyroptotic nor necroptotic pathways, as inhibition of the key component in each pathway could not rescue the microglia phenotype intrim35-28?deficient mutants. Finally, results from tissue-specific rescue experiments suggested that Trim35-28 acts cell-autonomously in the survival of microglial precursors. Taken together, the findings of our study reveal Trim35-28 as a regulatory protein essential for microglia development.	[Yu, Tao; Kuang, Haoyue; Wu, Yi; Zhang, Mingjie; Wen, Zilong] Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Biomed Res Inst, Shenzhen Key Lab Neuronal Struct Biol, Shenzhen, Peoples R China; [Chen, Jiahao; Zhang, Wenqing] South China Univ Technol, Sch Med, Dept Cell Dev & Integrat Biol, Guangzhou, Guangdong, Peoples R China; [Lin, Xi; Chen, Keyu; Zhang, Mingjie; Wen, Zilong] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, State Key Lab Mol Neurosci, Div Life Sci,Kowloon, Clear Water Bay, Hong Kong, Peoples R China; [Chen, Keyu; Zhang, Mingjie; Wen, Zilong] Shenzhen Bay Lab, Greater Bay Biomed Innoctr, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; South China University of Technology; Hong Kong University of Science & Technology; Shenzhen Bay Laboratory	Wen, ZL (corresponding author), Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Biomed Res Inst, Shenzhen Key Lab Neuronal Struct Biol, Shenzhen, Peoples R China.; Zhang, WQ (corresponding author), South China Univ Technol, Sch Med, Dept Cell Dev & Integrat Biol, Guangzhou, Guangdong, Peoples R China.; Wen, ZL (corresponding author), Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, State Key Lab Mol Neurosci, Div Life Sci,Kowloon, Clear Water Bay, Hong Kong, Peoples R China.; Wen, ZL (corresponding author), Shenzhen Bay Lab, Greater Bay Biomed Innoctr, Shenzhen, Peoples R China.	mczhangwq@scut.edu.cn; zilong@ust.hk	YU, TAO/HGU-2328-2022; zhang, wenqing/GYA-0786-2022	YU, TAO/0000-0001-6017-4852; Lin, Xi/0000-0003-2526-5163; CHEN, Jiahao/0000-0002-9754-5626	Natural Science Foundation of Guangdong Province [2018A030313149]; Shenzhen Science and Technology Innovation Committee [JCYJ20180223181227269]; China Postdoctoral Science Foundation [2017M620379]; National Natural Science Foundation of China [31801211]; Research Grants Council of the Hong Kong Special Administrative Region [16131916, 16103718, N_HKUST621/17, C6002-17GF, AoE/M-09/12, T13-605/18-W]; Innovation and Technology Commission of the Hong Kong Special Administrative Region [ITCPD/17-9]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Innovation Committee; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Innovation and Technology Commission of the Hong Kong Special Administrative Region	This work was supported by Natural Science Foundation of Guangdong Province Grant 2018A030313149 (to T. Y.), Shenzhen Science and Technology Innovation Committee Grant JCYJ20180223181227269 (to T. Y.), China Postdoctoral Science Foundation Grant 2017M620379 (to T. Y.), National Natural Science Foundation of China Grant 31801211 (to T. Y.), Research Grants Council of the Hong Kong Special Administrative Region Grants 16131916, 16103718, N_HKUST621/17 (to Z. W.), C6002-17GF (to Z. W.), AoE/M-09/12, and T13-605/18-W, and Innovation and Technology Commission of the Hong Kong Special Administrative Region (ITCPD/17-9).	Ah-Young C., 2013, MOL CELLS, V36, P82, DOI [10.1007/s10059-013-0087-9, DOI 10.1007/S10059-013-0087-9]; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Felmer RN, 2004, BIOL RES, V37, P449, DOI 10.4067/S0716-97602004000300009; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gomez-Nicola D, 2015, NEUROSCIENTIST, V21, P169, DOI 10.1177/1073858414530512; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; He SC, 2018, ELIFE, V7, DOI 10.7554/eLife.36131; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hristovska I, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00073; Jin H, 2012, BLOOD, V119, P5239, DOI 10.1182/blood-2011-12-398362; Khan R, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2028; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kimura F, 2003, J BIOL CHEM, V278, P25046, DOI 10.1074/jbc.M303438200; Kitaguchi T, 2009, MECH DEVELOP, V126, P314, DOI 10.1016/j.mod.2009.02.007; Kristiansen M, 2014, CELL DEATH DIFFER, V21, P1025, DOI 10.1038/cdd.2014.47; Lalonde JP, 2004, J BIOL CHEM, V279, P8181, DOI 10.1074/jbc.M306751200; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Li DR, 2017, ELIFE, V6, DOI 10.7554/eLife.27692.001; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Li XL, 2012, DEVELOPMENT, V139, P4321, DOI 10.1242/dev.081869; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Ma ZP, 2019, NATURE, V568, P259, DOI 10.1038/s41586-019-1057-y; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Perez-Garijo A, 2015, DEVELOPMENT, V142, P3253, DOI 10.1242/dev.127878; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shiau CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117513; Shiau CE, 2013, CELL REP, V5, P1342, DOI 10.1016/j.celrep.2013.11.004; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun YH, 2020, GENOME RES, V30, P118, DOI 10.1101/gr.248559.119; van der Vaart M, 2013, DIS MODEL MECH, V6, P841, DOI 10.1242/dmm.010843; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wang TN, 2019, J GENET GENOMICS, V46, P291, DOI 10.1016/j.jgg.2019.06.002; Wang YM, 2015, FEBS LETT, V589, P1322, DOI 10.1016/j.febslet.2015.04.019; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Wu ST, 2018, DEV CELL, V46, P552, DOI 10.1016/j.devcel.2018.08.005; Xu J, 2016, DEV CELL, V38, P214, DOI 10.1016/j.devcel.2016.06.018; Xu J, 2015, DEV CELL, V34, P632, DOI 10.1016/j.devcel.2015.08.018; Yu T, 2017, BLOOD, V129, P509, DOI 10.1182/blood-2016-07-727651; Zhen FH, 2013, DEVELOPMENT, V140, P3977, DOI 10.1242/dev.097071; Zhou Y, 2011, METHOD CELL BIOL, V104, P287, DOI 10.1016/B978-0-12-374814-0.00016-1	61	4	4	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8846	8856		10.1074/jbc.RA119.012043	http://dx.doi.org/10.1074/jbc.RA119.012043			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32398256	hybrid, Green Published			2022-12-26	WOS:000546296800019
J	Alam, SMD; Tsukamoto, Y; Ogawa, M; Senoo, Y; Ikeda, K; Tashima, Y; Takeuchi, H; Okajima, T				Alam, Sayad Md. Didarul; Tsukamoto, Yohei; Ogawa, Mitsutaka; Senoo, Yuya; Ikeda, Kazutaka; Tashima, Yuko; Takeuchi, Hideyuki; Okajima, Tetsuya			N-Glycans on EGF domain-specificO-GlcNAc transferase (EOGT) facilitate EOGT maturation and peripheral endoplasmic reticulum localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAc; EGF domain-specific O-GlcNAc transferase (EOGT); Notch receptor; endoplasmic reticulum; N-linked glycosylation; posttranslational modification; protein folding; oligomannose glycan; protein maturation; glycoprotein; O-linked N-acetylglucosamine (O-GlcNAc); endoplasmic reticulum (ER); EOGT	O-GLCNAC; EXTRACELLULAR DOMAIN; LINKED GLYCOSYLATION; ENZYME-ACTIVITY; NOTCH; GROWTH; ACETYLGLUCOSAMINE; CANCER; GLYCOSYLTRANSFERASE; REPEATS	Epidermal growth factor (EGF) domain-specificO-GlcNAc transferase (EOGT) is an endoplasmic reticulum (ER)-resident protein that modifies EGF repeats of Notch receptors and thereby regulates Delta-like ligand-mediated Notch signaling. SeveralEOGTmutations that may affect putativeN-glycosylation consensus sites are recorded in the cancer database, but the presence and function ofN-glycans in EOGT have not yet been characterized. Here, we identifiedN-glycosylation sites in mouse EOGT and elucidated their molecular functions. Three predictedN-glycosylation consensus sequences on EOGT are highly conserved among mammalian species. Within these sites, we found that Asn-263 and Asn-354, but not Asn-493, are modified withN-glycans. Lectin blotting, endoglycosidase H digestion, and MS analysis revealed that both residues are modified with oligomannoseN-glycans. Loss of an individualN-glycan on EOGT did not affect its endoplasmic reticulum (ER) localization, enzyme activity, and ability toO-GlcNAcylate Notch1 in HEK293T cells. However, simultaneous substitution of bothN-glycosylation sites affected both EOGT maturation and expression levels without an apparent change in enzymatic activity, suggesting thatN-glycosylation at a single site is sufficient for EOGT maturation and expression. Accordingly, a decrease inO-GlcNAc stoichiometry was observed in Notch1 co-expressed with an N263Q/N354Q variant compared with WT EOGT. Moreover, the N263Q/N354Q variant exhibited altered subcellular distribution within the ER in HEK293T cells, indicating thatN-glycosylation of EOGT is required for its ER localization at the cell periphery. These results suggest critical roles ofN-glycans in sustainingO-GlcNAc transferase function both by maintaining EOGT levels and by ensuring its proper subcellular localization in the ER.	[Alam, Sayad Md. Didarul; Tsukamoto, Yohei; Ogawa, Mitsutaka; Senoo, Yuya; Ikeda, Kazutaka; Tashima, Yuko; Takeuchi, Hideyuki; Okajima, Tetsuya] Nagoya Univ, Dept Mol Biochem, Grad Sch Med, Nagoya, Aichi, Japan; [Ikeda, Kazutaka] RIKEN, Ctr Integrat Med Sci, Tsurumi Ku, Suehiro Cho, Yokohama, Kanagawa, Japan	Nagoya University; RIKEN	Okajima, T (corresponding author), Nagoya Univ, Dept Mol Biochem, Grad Sch Med, Nagoya, Aichi, Japan.	tokajima@med.nagoya-u.ac.jp	Takeuchi, Hideyuki/AAZ-9210-2020; Okajima, Tetsuya/I-7332-2014	mitsutaka, ogawa/0000-0001-5808-169X; Alam, Sayad Md. Didarul/0000-0002-2877-2059; Okajima, Tetsuya/0000-0002-3677-648X	JSPS KAKENHI [JP19H03416, JP19H03176, JP19K16073]; Mitsubishi Foundation; Japan Foundation for Applied Enzymology; Takeda Science Foundation; Hori Sciences and Arts foundation; Foundation for Promotion of Cancer Research	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsubishi Foundation; Japan Foundation for Applied Enzymology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Hori Sciences and Arts foundation; Foundation for Promotion of Cancer Research	This work was supported by JSPS KAKENHI Grant JP19H03416 (to T. O.), JP19H03176 (to H. T.), and JP19K16073 (to M. O.), and grants from the Mitsubishi Foundation (to T. O.), the Japan Foundation for Applied Enzymology (to T. O.), Takeda Science Foundation (to M. O. and H. T.), The Hori Sciences and Arts foundation (M. O.), and Foundation for Promotion of Cancer Research (M. O.).	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Allam H, 2017, J BIOL CHEM, V292, P16351, DOI 10.1074/jbc.M117.783936; Cohen I, 2014, EUR J HUM GENET, V22, P374, DOI 10.1038/ejhg.2013.159; Contessa JN, 2010, CLIN CANCER RES, V16, P3205, DOI 10.1158/1078-0432.CCR-09-3331; Ellgaard L, 2016, TRAFFIC, V17, P615, DOI 10.1111/tra.12392; FAST DG, 1993, BIOCHIM BIOPHYS ACTA, V1202, P325, DOI 10.1016/0167-4838(93)90023-K; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gao G, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000355; HARAGUCHI M, 1995, BIOCHEM J, V312, P273, DOI 10.1042/bj3120273; Hebert DN, 2014, NAT CHEM BIOL, V10, P902, DOI 10.1038/nchembio.1651; Holcman D, 2018, NAT CELL BIOL, V20, P1118, DOI 10.1038/s41556-018-0192-2; Hou XH, 2012, J BIOL CHEM, V287, P474, DOI 10.1074/jbc.M111.317578; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Liu G, 2017, MOL CELL PROTEOMICS, V16, P2032, DOI 10.1074/mcp.M117.068239; Liu Y, 2015, ONCOTARGET, V6, P20650, DOI 10.18632/oncotarget.4115; Lopez-Sambrooks C, 2016, NAT CHEM BIOL, V12, P1023, DOI 10.1038/nchembio.2194; Loriol C, 2007, FEBS J, V274, P1202, DOI 10.1111/j.1742-4658.2007.05663.x; Manya H, 2010, J BIOCHEM, V147, P337, DOI 10.1093/jb/mvp170; Martina JA, 1998, J BIOL CHEM, V273, P3725, DOI 10.1074/jbc.273.6.3725; Martina JA, 2000, NEUROCHEM RES, V25, P725, DOI 10.1023/A:1007527523734; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Nagai K, 1997, GLYCOBIOLOGY, V7, P769, DOI 10.1093/glycob/7.6.769; Nixon-Abell J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf3928; Ogawa M, 2020, BIOCHEM BIOPH RES CO, V526, P184, DOI 10.1016/j.bbrc.2020.03.066; Ogawa M, 2018, MOLECULES, V23, DOI 10.3390/molecules23071745; Ogawa M, 2015, J BIOL CHEM, V290, P2137, DOI 10.1074/jbc.M114.598821; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sawaguchi S, 2017, ELIFE, V6, DOI 10.7554/eLife.24419; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Shaheen R, 2013, AM J HUM GENET, V92, P598, DOI 10.1016/j.ajhg.2013.02.012; Shrimal S, 2013, J CELL BIOL, V201, P81, DOI 10.1083/jcb.201301031; St-Pierre P, 2012, J CELL SCI, V125, P1727, DOI 10.1242/jcs.096396; Takeuchi H, 2018, P NATL ACAD SCI USA, V115, pE8395, DOI 10.1073/pnas.1804005115; Takeuchi H, 2018, GLYCOBIOLOGY, V28, P276, DOI 10.1093/glycob/cwy014; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; Tashima Y, 2014, J BIOL CHEM, V289, P11132, DOI 10.1074/jbc.M113.492512; Uemura S, 2006, GLYCOBIOLOGY, V16, P258, DOI 10.1093/glycob/cwj060; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X	43	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8560	8574		10.1074/jbc.RA119.012280	http://dx.doi.org/10.1074/jbc.RA119.012280			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32376684	Green Published, hybrid			2022-12-26	WOS:000546986500020
J	Uchigashima, M; Leung, M; Watanabe, T; Cheung, A; Le, T; Pallat, S; Dinis, ALM; Watanabe, M; Kawasawa, YI; Futai, K				Uchigashima, Motokazu; Leung, Ming; Watanabe, Takuya; Cheung, Amy; Le, Timmy; Pallat, Sabine; Dinis, Alexandre Luis Marques; Watanabe, Masahiko; Kawasawa, Yuka Imamura; Futai, Kensuke			Neuroligin3 splice isoforms shape inhibitory synaptic function in the mouse hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurobiology; neuron; neurotransmitter receptor; synapse; GABA receptor; glutamate receptor; hippocampus; CA1 pyramidal neuron; excitatory and inhibitory balance; neuroligin 3 (NLGN3); splice variants; trans-synaptic cell adhesion; synaptic transmission	SYNAPSES; MUTATIONS; RECEPTOR; CODE	Synapse formation is a dynamic process essential for the development and maturation of the neuronal circuitry in the brain. At the synaptic cleft, trans-synaptic protein?protein interactions are major biological determinants of proper synapse efficacy. The balance of excitatory and inhibitory synaptic transmission (E-I balance) stabilizes synaptic activity, and dysregulation of the E-I balance has been implicated in neurodevelopmental disorders, including autism spectrum disorders. However, the molecular mechanisms underlying the E-I balance remain to be elucidated. Here, using single-cell transcriptomics, immunohistochemistry, and electrophysiology approaches to murine CA1 pyramidal neurons obtained from organotypic hippocampal slice cultures, we investigate neuroligin (Nlgn) genes that encode a family of postsynaptic adhesion molecules known to shape excitatory and inhibitory synaptic function. We demonstrate that the NLGN3 protein differentially regulates inhibitory synaptic transmission in a splice isoform?dependent manner at hippocampal CA1 synapses. We also found that distinct subcellular localizations of the NLGN3 isoforms contribute to the functional differences observed among these isoforms. Finally, results from single-cell RNA-Seq analyses revealed thatNlgn1andNlgn3are the major murineNlgngenes and that the expression levels of theNlgnsplice isoforms are highly diverse in CA1 pyramidal neurons. Our results delineate isoform-specific effects ofNlgngenes on the E-I balance in the murine hippocampus.	[Uchigashima, Motokazu; Watanabe, Takuya; Cheung, Amy; Le, Timmy; Pallat, Sabine; Dinis, Alexandre Luis Marques; Futai, Kensuke] Univ Massachusetts, Sch Med, Dept Neurobiol, Brudnick Neuropsychiat Res Inst, Worcester, MA 01605 USA; [Uchigashima, Motokazu; Watanabe, Masahiko] Hokkaido Univ, Dept Anat, Grad Sch Med, Sapporo, Hokkaido, Japan; [Leung, Ming; Kawasawa, Yuka Imamura] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Leung, Ming; Kawasawa, Yuka Imamura] Penn State Univ, Coll Med, Inst Personalized Med, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Univ Coll Med, Dept Pharmacol, Hershey, PA USA	University of Massachusetts System; University of Massachusetts Worcester; Hokkaido University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Futai, K (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Brudnick Neuropsychiat Res Inst, Worcester, MA 01605 USA.; Kawasawa, YI (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.; Kawasawa, YI (corresponding author), Penn State Univ, Coll Med, Inst Personalized Med, Hershey, PA 17033 USA.; Kawasawa, YI (corresponding author), Penn State Univ Coll Med, Dept Pharmacol, Hershey, PA USA.	yimamura@pennstatehealth.psu.edu; Kensuke.Futai@umassmed.edu	Watanabe, Masahiko/S-3614-2019	Watanabe, Masahiko/0000-0001-5037-7138; Imamura Kawasawa, Yuka/0000-0002-8638-6738; Le, Timmy/0000-0001-9274-3570; Dinis, Alexandre/0000-0002-6813-6380; Uchigashima, Motokazu/0000-0002-0878-2233	National Institutes of Health [R01NS085215, T32 GM107000, 15K06732]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01NS085215 (to K. F.) and T32 GM107000 (to A. C.) and Grant-in-Aid for Scientific Research 15K06732 (to M. U.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Budreck EC, 2013, P NATL ACAD SCI USA, V110, P725, DOI 10.1073/pnas.1214718110; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Futai K, 2013, J NEUROSCI, V33, P3612, DOI 10.1523/JNEUROSCI.1811-12.2013; Hasegawa Y, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0186-17.2017; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jiang M, 2017, MOL PSYCHIATR, V22, P375, DOI 10.1038/mp.2016.80; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Mao WJ, 2018, CELL REP, V23, P3209, DOI 10.1016/j.celrep.2018.05.028; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Nelson SB, 2015, NEURON, V87, P684, DOI 10.1016/j.neuron.2015.07.033; Nguyen QA, 2016, ELIFE, V5, DOI 10.7554/eLife.19236; Shipman SL, 2012, P NATL ACAD SCI USA, V109, P19432, DOI 10.1073/pnas.1217633109; Shipman SL, 2012, NEURON, V76, P309, DOI 10.1016/j.neuron.2012.07.024; Shipman SL, 2011, NAT NEUROSCI, V14, P718, DOI 10.1038/nn.2825; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sudhof TC, 2017, CELL, V171, P745, DOI 10.1016/j.cell.2017.10.024; Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020; Uchigashima M, 2016, P NATL ACAD SCI USA, V113, P4206, DOI 10.1073/pnas.1514074113; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410	30	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8589	8595		10.1074/jbc.AC120.012571	http://dx.doi.org/10.1074/jbc.AC120.012571			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32381505	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000546986500022
J	Bouassa, RSM; Pere, H; Gubavu, C; Prazuck, T; Jenabian, MA; Veyer, D; Meye, JF; Touze, A; Belec, L				Bouassa, Ralph-Sydney Mboumba; Pere, Helene; Gubavu, Camelia; Prazuck, Thierry; Jenabian, Mohammad-Ali; Veyer, David; Meye, Jean-Francois; Touze, Antoine; Belec, Laurent			Serum and cervicovaginal IgG immune responses against alpha 7 and alpha 9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; VIRUS-LIKE PARTICLES; IMMUNOGLOBULIN-A; HIGH PREVALENCE; PRIMARY-CARE; ANTIBODIES; INFECTION; GIRLS; QUADRIVALENT; EFFICACY	Background Cervical cancer associated with high risk-human papillomavirus (HR-HPV) infection is becoming the one of the most common female cancer in many sub-Saharan African countries. First-generation immigrant African women living in Europe are at-risk for cervical cancer, in a context of social vulnerability, with frequent lack of cervical cancer screening and HPV vaccination. Objective Our objective was to address immunologically the issue of catch-up prophylactic HPV vaccination in first-generation African immigrant women living in France. Methods IgG immune responses and cross-reactivities to alpha 7 (HPV-18, -45 and -68) and alpha 9 (HPV-16, -31, -33, -35, -52 and -58) HPV types, including 7 HR-HPV targeted by the Gardasil-9 (R) prophylactic vaccine, were evaluated in paired serum and cervicovaginal secretions (CVS) by HPV L1-virus-like particles-based ELISA. Genital HPV were detected by multiplex real time PCR (Seegene, Seoul, South Korea). Results Fifty-one immigrant women (mean age, 41.7 years; 72.5% HIV-infected) were prospectively included. More than two-third (68.6%) of them carried genital HPV (group I) while 31.4% were negative (group II). The majority (90.2%) exhibited serum IgG to at least one alpha 7/alpha 9 HR-HPV. Serum HPV-specific IgG were more frequently detected in group I than group II (100% versus 68.7%; P = 0.002). The distribution of serum and genital HPV-specific IgG was similar, but mean number of IgG reactivities to alpha 7/alpha 9 HR-HPV was higher in serum than CVS (5.6 IgG per woman in serum versus 3.2 in CVS; P< 0.001). Rates of IgG crossreactivities against HPV different from detected cervicovaginal HPV were higher in serum and CVS in group I than group II. Finally, the majority of groups I and II women (68.6% and 68.7%, respectively) exhibited serum or cervicovaginal IgG to Gardasil-9 (R) HR-HPV, with higher mean rates in group I than group II (6.1 Gardasil-9 (R) HR-HPV per woman versus 1.4; P< 0.01). One-third (31.2%) of group II women did not show any serum and genital HPVspecific IgG. Conclusions Around two-third of first-generation African immigrant women living in France showed frequent ongoing genital HPV infection and high rates of circulating and genital IgG to alpha 7/alpha 9 HPV, generally cross-reacting, avoiding the possibility of catch-up vaccination. Nevertheless, about one-third of women had no evidence of previous HPV infection, or showed only low levels of genital and circulating HR-HPV-specific IgG and could therefore be eligible for catch-up vaccination.	[Bouassa, Ralph-Sydney Mboumba; Pere, Helene; Veyer, David; Belec, Laurent] Hop Europeen Georges Pompidou, AP HP, Lab Virol, Paris, France; [Bouassa, Ralph-Sydney Mboumba; Belec, Laurent] Ecole Doctorale Reg Infectiol Trop, Franceville, Gabon; [Bouassa, Ralph-Sydney Mboumba; Pere, Helene; Belec, Laurent] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Bouassa, Ralph-Sydney Mboumba; Pere, Helene; Belec, Laurent] Hop Europeen Georges Pompidou, AP HP, INSERM UMR S970,Paris Ctr Rech Cardiovasc PARCC, Immunotherapie & Traitement Antiangiogen Cancerol, Paris, France; [Gubavu, Camelia; Prazuck, Thierry] Ctr Hosp Reg Orleans, Serv Malad Infect & Trop, Orleans, France; [Gubavu, Camelia; Prazuck, Thierry] Ctr Gratuit Informat Depistage & Diagnost CEGIDD, Orleans, France; [Jenabian, Mohammad-Ali] Univ Quebec Montreal UQAM, Dept Sci Biol, Montreal, PQ, Canada; [Jenabian, Mohammad-Ali] Univ Quebec Montreal UQAM, Ctr Rech BioMed, Montreal, PQ, Canada; [Meye, Jean-Francois] Ctr Hosp Univ Agondje, Serv Gynecol Obstet, Libreville, Gabon; [Meye, Jean-Francois] Ctr Hosp Univ Agondje, Fac Med Libreville, Libreville, Gabon; [Touze, Antoine] Univ Tours, UMRINRA ISP 1282, Equipe Biol Infect Polyomavirus, Tours, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Regional d'Orleans; University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; INRAE; Universite de Tours	Bouassa, RSM (corresponding author), Hop Europeen Georges Pompidou, AP HP, Lab Virol, Paris, France.; Bouassa, RSM (corresponding author), Ecole Doctorale Reg Infectiol Trop, Franceville, Gabon.; Bouassa, RSM (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Bouassa, RSM (corresponding author), Hop Europeen Georges Pompidou, AP HP, INSERM UMR S970,Paris Ctr Rech Cardiovasc PARCC, Immunotherapie & Traitement Antiangiogen Cancerol, Paris, France.	laurent.belec@aphp.fr			French National Agency for Research on AIDS and Viral Hepatitis; National Public Health Agency [ANRS-2019-1]	French National Agency for Research on AIDS and Viral Hepatitis(ANRS); National Public Health Agency	This study was supported by the French National Agency for Research on AIDS and Viral Hepatitis, and the National Public Health Agency: http://anrs.fr/fr (Grant ANRS-2019-1 awareded by BL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, Wkly Epidemiol Rec, V92, P241; Beachler DC, 2016, J INFECT DIS, V213, P1444, DOI 10.1093/infdis/jiv753; BELEC L, 1995, J INFECT DIS, V172, P691, DOI 10.1093/infdis/172.3.691; BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57; Bierl C, 2005, GYNECOL ONCOL, V99, pS262, DOI 10.1016/j.ygyno.2005.07.100; Bontkes HJ, 1999, J GEN VIROL, V80, P409, DOI 10.1099/0022-1317-80-2-409; Bosch FX, 2018, SALUD PUBLICA MEXICO, V60, P612, DOI 10.21149/10171; Bouassa RSM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217486; Bouassa RSM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197845; Bouassa RSM, 2017, EXPERT REV ANTI-INFE, V15, P613, DOI 10.1080/14787210.2017.1322902; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Bruni L.A.G., 2018, ICO IARC INFORM CTR; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Bruno DM, 2014, VACCINE, V32, P4149, DOI 10.1016/j.vaccine.2014.05.058; Buck CB, 2007, CURRENT PROTOCOLS CE, V26, P1, DOI DOI 10.1002/0471143030.CB2601S37; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Carter JJ, 1997, CLIN DERMATOL, V15, P249; Carter JJ, 2000, J INFECT DIS, V181, P1911, DOI 10.1086/315498; Castellsague X, 2011, BRIT J CANCER, V105, P28, DOI 10.1038/bjc.2011.185; Castellsague X, 2014, J INFECT DIS, V210, P517, DOI 10.1093/infdis/jiu139; Castro FA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-361; Chen W, 2019, VACCINE, V37, P889, DOI 10.1016/j.vaccine.2018.12.030; Chironna M, 2010, J Prev Med Hyg, V51, P139; de Araujo-Souza PS, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0578-0; de Sanjose S, 2018, JNCI CANCER SPECT, V2, DOI 10.1093/jncics/pky045; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; De Vuyst H, 2013, VACCINE, V31, pF32, DOI 10.1016/j.vaccine.2012.07.092; Dillner J, 2007, CLIN EXP IMMUNOL, V148, P199, DOI 10.1111/j.1365-2249.2007.03384.x; Dillner J, 1999, SEMIN CANCER BIOL, V9, P423, DOI 10.1006/scbi.1999.0146; Draper E, 2011, VACCINE, V29, P8585, DOI 10.1016/j.vaccine.2011.09.021; Eklund C, 2012, VACCINE, V30, P294, DOI 10.1016/j.vaccine.2011.10.096; Faust H, 2016, VACCINE, V34, P1559, DOI 10.1016/j.vaccine.2016.02.019; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ginindza TG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170189; Gissmann L, 1996, OBSTET GYN CLIN N AM, V23, P625; Grandahl M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187193; Grillo F., 2012, Bulletin Epidemiologique Hebdomadaire, P45; Grillo F, 2012, PREV MED, V54, P259, DOI 10.1016/j.ypmed.2012.01.013; Hagensee ME, 2000, J INFECT DIS, V181, P1234, DOI 10.1086/315364; Harper DM, 2017, GYNECOL ONCOL, V146, P196, DOI 10.1016/j.ygyno.2017.04.004; Haute Autorite de Sante, 2013, DEP PREV CANC COL UT, P55; Heard I, 2013, BJOG-INT J OBSTET GY, V120, P41, DOI 10.1111/1471-0528.12015; Heard I, 2015, CLIN INFECT DIS, V60, P1559, DOI 10.1093/cid/civ049; Heard I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079372; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Institut National de la Statistique et des Etudes Economiques (INSEE, 2015, POP SEX AG 2012; Kelly H, 2018, J INFECT DIS, V218, P927, DOI 10.1093/infdis/jiy252; Kelly HA, 2017, AIDS, V31, P273, DOI 10.1097/QAD.0000000000001301; Kondo K, 2008, J MED VIROL, V80, P841, DOI 10.1002/jmv.21124; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Kwak K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097232; Lacey CJN, 2019, PAPILLOMAVIRUS RES, V8, DOI 10.1016/j.pvr.2019.100174; Luckett R, 2016, HUM VACC IMMUNOTHER, V12, P1332, DOI 10.1080/21645515.2015.1108500; Malik ZA, 2009, VIRAL IMMUNOL, V22, P445, DOI 10.1089/vim.2009.0055; Marais DJ, 2001, J MED VIROL, V65, P149, DOI 10.1002/jmv.2014; Ruiz-Sternberg AM, 2018, PAPILLOMAVIRUS RES, V5, P63, DOI 10.1016/j.pvr.2017.12.004; Mavundza EJ, 2020, HUM VACC IMMUNOTHER, V16, P426, DOI 10.1080/21645515.2019.1656481; Mbulawa ZZA, 2008, J GEN VIROL, V89, P910, DOI 10.1099/vir.0.83458-0; McCloskey JC, 2017, PAPILLOMAVIRUS RES, V4, P90, DOI 10.1016/j.pvr.2017.10.004; Mestecky J, 2005, AM J REPROD IMMUNOL, V53, P208, DOI 10.1111/j.1600-0897.2005.00267.x; Moller SP, 2018, EUR J CANCER PREV, V27, P42, DOI 10.1097/CEJ.0000000000000274; Ogembo RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122488; Olsson SE, 2009, HUM VACCINES, V5, P696, DOI 10.4161/hv.5.10.9515; Palmroth J, 2010, SCAND J INFECT DIS, V42, P379, DOI 10.3109/00365540903501608; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Passmore JAS, 2007, J MED VIROL, V79, P1375, DOI 10.1002/jmv.20901; Petter A, 2000, J GEN VIROL, V81, P701, DOI 10.1099/0022-1317-81-3-701; Pinto LA, 2018, VACCINE, V36, P4792, DOI 10.1016/j.vaccine.2017.11.089; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2018, NAT REV CANCER, V18, P240, DOI 10.1038/nrc.2018.13; Roteli-Martins CM, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18865; Safaeian M, 2018, J INFECT DIS, V218, P84, DOI 10.1093/infdis/jiy112; Safaeian M, 2010, JNCI-J NATL CANCER I, V102, P1653, DOI 10.1093/jnci/djq384; Sasagawa T, 2003, INT J CANCER, V104, P328, DOI 10.1002/ijc.10939; Sasagawa T, 1998, INT J CANCER, V75, P529, DOI 10.1002/(SICI)1097-0215(19980209)75:4&lt;529::AID-IJC7&gt;3.0.CO;2-V; Scherpenisse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074797; Scherpenisse M, 2013, HUM VACC IMMUNOTHER, V9, P314, DOI 10.4161/hv.22693; Scheurer ME, 2005, INT J GYNECOL CANCER, V15, P727, DOI 10.1111/j.1525-1438.2005.00246.x; Schwarz TF, 2010, HUM VACCINES, V6, P1054, DOI 10.4161/hv.6.12.13399; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stanley MA, 2009, INDIAN J MED RES, V130, P266; Stanley Margaret, 2010, Infect Agent Cancer, V5, P19, DOI 10.1186/1750-9378-5-19; Stern PL, 2019, PAPILLOMAVIRUS RES, V7, P150, DOI 10.1016/j.pvr.2019.04.010; Tjiong MY, 2001, VIRAL IMMUNOL, V14, P415, DOI 10.1089/08828240152716655; Toh ZQ, 2019, INFECT DRUG RESIST, V12, P1951, DOI 10.2147/IDR.S178381; Tornesello ML, 2011, APMIS, V119, P701, DOI 10.1111/j.1600-0463.2011.02784.x; Touze A, 2001, J CLIN MICROBIOL, V39, P4344, DOI 10.1128/JCM.39.12.4344-4348.2001; van der Wal MF, 2005, ARCH DIS CHILD, V90, P36, DOI 10.1136/adc.2003.047126; Wang SS, 2003, BRIT J CANCER, V89, P1248, DOI 10.1038/sj.bjc.6601272; Wang ZH, 1996, J CLIN MICROBIOL, V34, P3056, DOI 10.1128/JCM.34.12.3056-3062.1996; World Health Organization, 2009, REL EP HEBD SECT HYG, V84, P118; World Health Organization, 2013, GLOB ACT PLAN PREV C; World health Organization, 2015, PROJS MORT CAUS DEAT; Bosch FX, 2016, NAT REV CLIN ONCOL, V13, P119, DOI 10.1038/nrclinonc.2015.146	95	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233084	10.1371/journal.pone.0233084	http://dx.doi.org/10.1371/journal.pone.0233084			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421735	Green Published, gold			2022-12-26	WOS:000537499600025
J	Merca, R; Bockstahler, B; Vezzoni, A; Tichy, A; Boano, S; Vidoni, B				Merca, Roxana; Bockstahler, Barbara; Vezzoni, Aldo; Tichy, Alexander; Boano, Simona; Vidoni, Britta			Canine hip dysplasia screening: Comparison of early evaluation to final grading in 231 dogs with Federation Cynologique Internationale A and B	PLOS ONE			English	Article							JUVENILE PUBIC SYMPHYSIODESIS; DEGENERATIVE JOINT DISEASE; LABRADOR-RETRIEVERS; RISK-FACTORS; PROSPECTIVE COHORT; 2 PALPATION; LAXITY; PATHOGENESIS; MODERATE; BREEDS	Objectives This study aimed to verify if a significant difference exists between parameters in the early evaluation of normal and near-normal hip joints, to evaluate the influence of age and breed on the parameters, and to clarify the usefulness of a total score for differentiating between Federation Cynologique Internationale (FCI) grade A and B hips. Methods A total of 231 dogs were classified according to whether they had FCI A or B hips at adulthood, with measurements obtained at 14-28 weeks of age. The total score was calculated by the summation of the following quantitative parameters: angle of subluxation (AS), angle of reduction (AR), laxity index (LI), and dorsal acetabular rim slope (DARS). Logistic regression analysis was performed to establish the probability of the study population to develop an FCI B hip based on the total score. This was repeated for the highest score in combination with the worst-rated hip and once more for breeds. Results No correlation between age and the parameters was found in the cohort, or for FCI A and B. The values of all the parameters were significantly lower in the FCI A group than in the FCI B group (AR: 4.42 degrees +/- 6.0 degrees vs 7.62 degrees +/- 7.2 degrees; AS: 0.45 degrees +/- 1.9 degrees vs 1.55 degrees +/- 3.8 degrees; LI: 0.32 +/- 0.1 vs 0.36 +/- 0.1; DARS: 3.30 degrees +/- 1.8 degrees vs 3.77 degrees +/- 1.9 degrees; TS: 11.47 +/- 8.3 vs 16.65 +/- 10.9). Labrador Retrievers and Golden Retrievers showed significant differences between parameters for both FCI grades. The range, where FCI A and B hips can be predicted on the basis of the total score, was different when assessed for the entire cohort, Labrador Retrievers, and Golden Retrievers. Clinical significance Our results show that even in normal and near-normal hips, the parameters significantly differed in the early evaluation. Moreover, cutoff values should be set for different breeds in the prediction of the FCI grade during early evaluation for a better breeding selection regarding canine hip dysplasia, one of the most common orthopedic diseases among large and giant breed dogs.	[Merca, Roxana; Bockstahler, Barbara; Tichy, Alexander; Vidoni, Britta] Univ Vet Med, Univ Clin Small Anim, Small Anim Surg, Dept Compan Anim & Horses, Vienna, Austria; [Vezzoni, Aldo; Boano, Simona] Clin Vet Vezzoni, Cremona, Italy	University of Veterinary Medicine Vienna	Merca, R (corresponding author), Univ Vet Med, Univ Clin Small Anim, Small Anim Surg, Dept Compan Anim & Horses, Vienna, Austria.	merca.roxana@gmail.com	Vidoni, Britta/AAD-4498-2021					Adams WM, 2000, VET RADIOL ULTRASOUN, V41, P484, DOI 10.1111/j.1740-8261.2000.tb01875.x; Adams WM, 1998, J AM ANIM HOSP ASSOC, V34, P339, DOI 10.5326/15473317-34-4-339; Badertscher RR, 1977, THESIS; Bernarde A, 2010, VET SURG, V39, P158, DOI 10.1111/j.1532-950X.2010.00644.x; Bertal M, 2019, VET COMP ORTHOPAED, V32, P67, DOI 10.1055/s-0038-1676306; Bertal M, 2018, VET COMP ORTHOPAED, V31, P246, DOI 10.1055/s-0038-1656720; Bockstahler BA, 2007, AM J VET RES, V68, P271, DOI 10.2460/ajvr.68.3.271; Broeckx BJG, 2018, VET COMP ORTHOPAED, V31, DOI 10.1055/s-0038-1653959; Broeckx BJG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074811; Coopman F, 2008, VET REC, V163, P654, DOI 10.1136/vr.163.22.654; Dueland RT, 2010, VET COMP ORTHOPAED, V23, P306, DOI 10.3415/VCOT-09-04-0045; Dueland RT, 2010, VET COMP ORTHOPAED, V23, P318, DOI 10.3415/VCOT-09-04-0040; Fels L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096618; Fluckiger M., 2007, EUROPEAN J COMPANION, V17, P135; Fluckinger Mark, 2007, TAKE READ HIP JOINT; FRIES CL, 1995, CAN VET J, V36, P494; Gaisbauer S., 2012, LITERATURUBERSICHT D; Gatineau M, 2012, VET SURG, V41, P42, DOI 10.1111/j.1532-950X.2011.00926.x; Ginja MMD, 2010, VET J, V184, P269, DOI 10.1016/j.tvjl.2009.04.009; Ginja MMD, 2009, VET J, V182, P275, DOI 10.1016/j.tvjl.2008.06.014; Ginja MMD, 2008, J SMALL ANIM PRACT, V49, P641, DOI 10.1111/j.1748-5827.2008.00629.x; Greene LM, 2013, JAVMA-J AM VET MED A, V242, P1528, DOI 10.2460/javma.242.11.1528; Johnston SA, 1997, VET CLIN N AM-SMALL, V27, P699, DOI 10.1016/S0195-5616(97)50076-3; Krontveit RI, 2012, AM J VET RES, V73, P838, DOI 10.2460/ajvr.73.6.838; Krontveit RI, 2012, PREV VET MED, V103, P219, DOI 10.1016/j.prevetmed.2011.09.018; Li TY, 2010, CHINESE MED J-PEKING, V123, P3061, DOI 10.3760/cma.j.issn.0366-6999.2010.21.020; LUST G, 1993, AM J VET RES, V54, P1990; Lust G, 1997, J AM VET MED ASSOC, V210, P1443; LUST G, 1985, J AM VET MED ASSOC, V187, P638; Madsen JS, 1997, J AM VET MED ASSOC, V210, P1463; MARTIN SW, 1980, CAN VET J, V21, P293; Oberbauer AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172918; Ohlerth S, 2003, J SMALL ANIM PRACT, V44, P524, DOI 10.1111/j.1748-5827.2003.tb00114.x; Sanchez-Molano E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00097; Sanchez-Molano E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-833; SLOCUM B, 1990, J AM ANIM HOSP ASSOC, V26, P289; Smith GK, 2012, VET SURG, V41, P20, DOI 10.1111/j.1532-950X.2011.00935.x; Smith GK, 1998, J AM VET MED ASSOC, V212, P1560; SMITH GK, 1993, AM J VET RES, V54, P1021; SMITH GK, 1990, J AM VET MED ASSOC, V196, P59; Smith GK, 2001, J AM VET MED ASSOC, V219, P1719, DOI 10.2460/javma.2001.219.1719; SMITH GK, 1995, J AM VET MED ASSOC, V206, P642; Taroni M, 2018, VET COMP ORTHOPAED, V31, P445, DOI 10.1055/s-0038-1668087; Taroni M, 2018, VET COMP ORTHOPAED, V31, P321, DOI 10.1055/s-0038-1661402; Verhoeven G, 2012, VET SURG, V41, P10, DOI 10.1111/j.1532-950X.2011.00929.x; Vezzoni A, 2008, VET COMP ORTHOPAED, V21, P267; Vezzoni A., 2004, 12th ESVOT Congress Proceedings, Munich, Germany, 10-12 September, 2004, P145; Vezzoni A., 2002, 1st World Orthopaedic Veterinary Congress Proceedings, Munich, Germany, 5-8 September 2002, P204; Vezzoni A., 2005, European Journal of Companion Animal Practice, V15, P173; Vezzoni A, 2010, VET COMP ORTHOPAED, V23, P444, DOI 10.3415/VCOT-10-03-0034	50	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233257	10.1371/journal.pone.0233257	http://dx.doi.org/10.1371/journal.pone.0233257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421701	gold, Green Published			2022-12-26	WOS:000537499600037
J	Ang, BH; Oxley, JA; Chen, WS; Yap, MKK; Song, KP; Lee, SWH				Ang, Boon Hong; Oxley, Jennifer Anne; Chen, Won Sun; Yap, Michelle Khai Khun; Song, Keang Peng; Lee, Shaun Wen Huey			The influence of spouses and their driving roles in self-regulation: A qualitative exploration of driving reduction and cessation practices amongst married older adults	PLOS ONE			English	Article							DRIVERS; PERSPECTIVES	Introduction There is growing evidence to suggest the importance of self-regulatory practices amongst older adults to sustain mobility. However, the decision to self-regulate driving is a complex interplay between an individual's preference and the influence of their social networks including spouse. To our best knowledge, the influence of an older adult's spouse on their decisions during driving transition has not been explored. Materials and methods This qualitative descriptive study was conducted amongst married older adults aged 60 years and above. All interview responses were transcribed verbatim and examined using thematic approach and interpretative description method. Results A total of 11 married couples were interviewed. Three major themes emerged: [1] Our roles in driving; [2] Challenges to continue driving; and, [3] Our driving strategies to ensure continued driving. Older couples adopted driving strategies and regulated their driving patterns to ensure they continued to drive safely. Male partners often took the active driving role as the principal drivers, while the females adopted a more passive role, including being the passenger to accompany the principal drivers or becoming the co-driver to help in navigation. Other coping strategies include sharing the driving duties as well as using public transportation or mixed mode transportation. Discussion Our findings suggest spouse play a significant role in their partners' decision to self-regulate driving. This underscores a need to recognise the importance of interdependency amongst couples and its impact on their driving decisions and outcomes.	[Ang, Boon Hong; Yap, Michelle Khai Khun; Song, Keang Peng] Monash Univ Malaysia, Sch Sci, Subang Jaya, Malaysia; [Oxley, Jennifer Anne] Monash Univ, Accid Res Ctr, Clayton, Vic, Australia; [Chen, Won Sun] Swinburne Univ Technol, Sch Hlth Sci, Melbourne, Vic, Australia; [Lee, Shaun Wen Huey] Monash Univ Malaysia, Sch Pharm, Subang Jaya, Malaysia; [Lee, Shaun Wen Huey] Monash Univ Malaysia, Global Asia 21st Century GA21 Platform, Gerontol Lab, Subang Jaya, Malaysia; [Lee, Shaun Wen Huey] Taylors Univ, Sch Pharm, Subang Jaya, Malaysia	Monash University; Monash University Sunway; Monash University; Swinburne University of Technology; Monash University; Monash University Sunway; Monash University; Monash University Sunway; Taylor's University	Chen, WS (corresponding author), Swinburne Univ Technol, Sch Hlth Sci, Melbourne, Vic, Australia.; Lee, SWH (corresponding author), Monash Univ Malaysia, Sch Pharm, Subang Jaya, Malaysia.; Lee, SWH (corresponding author), Monash Univ Malaysia, Global Asia 21st Century GA21 Platform, Gerontol Lab, Subang Jaya, Malaysia.; Lee, SWH (corresponding author), Taylors Univ, Sch Pharm, Subang Jaya, Malaysia.	wchen@swin.edu.au; shaun.lee@monash.edu	Yap, Michelle/G-8283-2014	Yap, Michelle/0000-0002-9646-3944	School of Science in Monash University Malaysia	School of Science in Monash University Malaysia	The authors would like to thank late Dr Ngin Cin Khai for his contributions to this study. They would also like to thank School of Science in Monash University Malaysia for sponsoring tokens of appreciation for respondents.	Adler G, 2006, J AGING STUD, V20, P227, DOI 10.1016/j.jaging.2005.09.003; Ang BH, 2018, PUBLIC HEALTH, V155, P8, DOI 10.1016/j.puhe.2017.11.003; Ang BH, 2019, J SAFETY RES, V69, P101, DOI 10.1016/j.jsr.2019.03.007; Ang BH, 2019, TRANSPORT RES F-TRAF, V62, P782, DOI 10.1016/j.trf.2019.03.014; Ang BH, 2017, ARCH GERONTOL GERIAT, V72, P32, DOI 10.1016/j.archger.2017.05.004; Bergen G, 2017, J SAFETY RES, V61, P205, DOI 10.1016/j.jsr.2017.01.002; Curl AL, 2015, RES AGING, V37, P171, DOI 10.1177/0164027514527624; Department of Statistics Malaysia, 2017, GDP STAT 2010 2016; Freund B, 2002, GERONTOLOGIST, V42, P621, DOI 10.1093/geront/42.5.621; Gormley M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01329; Hassan H, 2015, TRANSPORT RES F-TRAF, V28, P25, DOI 10.1016/j.trf.2014.11.003; Jang M, 2018, PSYCHIAT INVEST, V15, P1162, DOI 10.30773/pi.2018.10.10.3; Johnson DA, 2013, AUST FAM PHYSICIAN, V42, P317; Kandasamy D, 2018, OCCUP THER HEALTH CA, V32, P363, DOI 10.1080/07380577.2018.1522681; Kostyniuk L.P., 1998, REDUCTION CESSATION; Kostyniuk LP, 2003, J SAFETY RES, V34, P407, DOI 10.1016/j.jsr.2003.09.001; Levasseur M, 2016, TRANSPORT RES F-TRAF, V43, P56, DOI 10.1016/j.trf.2016.09.014; Liddle J., 2008, BRIT J OCCUPATIONAL, V71, P379, DOI [DOI 10.1177/030802260807100905, 10.1177/030802260807100905]; Lumb P., 2004, AUSTR TRANSP RES FOR; Puvanachandra N, 2008, OPHTHAL PHYSL OPT, V28, P313, DOI 10.1111/j.1475-1313.2008.00574.x; Rosenbloom S, 2009, PUBLIC WORKS MANAG P, V13, P338, DOI 10.1177/1087724X09334496; Rotolo T, 2006, J MARRIAGE FAM, V68, P305, DOI 10.1111/j.1741-3737.2006.00254.x; Rudman DL, 2006, CAN J AGING, V25, P65, DOI 10.1353/cja.2006.0031; Schryer E, 2019, J APPL GERONTOL, V38, P1661, DOI 10.1177/0733464817741683; Tey N.P., 2017, AGEING THAILAND MALA; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; World Health Organization, 2004, FUND	27	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232795	10.1371/journal.pone.0232795	http://dx.doi.org/10.1371/journal.pone.0232795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1BA	32413053	gold, Green Published			2022-12-26	WOS:000537496000021
J	da Costa, FHB; Lewis, MS; Truong, A; Carson, DD; Farach-Carson, MC				da Costa, Fabio Henrique Brasil; Lewis, Michael S.; Truong, Anna; Carson, Daniel D.; Farach-Carson, Mary C.			SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; GENE-EXPRESSION ANALYSIS; HEPARAN-SULFATE; REACTIVE STROMA; CELL; PROTEOGLYCAN; BIOSYNTHESIS; COCULTURE; PARACRINE; INVASION	Bone marrow stroma influences metastatic prostate cancer (PCa) progression, latency, and recurrence. At sites of PCa bone metastasis, cancer-associated fibroblasts and tumor-associated macrophages interact to establish a perlecan-rich desmoplastic stroma. As a heparan sulfate proteoglycan, perlecan (HSPG2) stores and stabilizes growth factors, including heparin-binding Wnt3A, a positive regulator of PCa cell growth. Because PCa cells alone do not induce CAF production of perlecan in the desmoplastic stroma, we sought to discover the sources of perlecan and its growth factor-releasing modifiers SULF1, SULF2, and heparanase in PCa cells and xenografts, bone marrow fibroblasts, and macrophages. SULF1, produced primarily by bone marrow fibroblasts, was the main glycosaminoglycanase present, a finding validated with primary tissue specimens of PCa metastases with desmoplastic bone stroma. Expression of both HSPG2 and SULF1 was concentrated in alpha SMA-rich stroma near PCa tumor nests, where infiltrating pro-tumor TAMs also were present. To decipher SULF1's role in the reactive bone stroma, we created a bone marrow biomimetic hydrogel incorporating perlecan, PCa cells, macrophages, and fibroblastic bone marrow stromal cells. Finding that M2-like macrophages increased levels of SULF1 and HSPG2 produced by fibroblasts, we examined SULF1 function in Wnt3A-mediated PCa tumoroid growth in tricultures. Comparing control or SULF1 knockout fibroblastic cells, we showed that SULF1 reduces Wnt3A-driven growth, cellularity, and cluster number of PCa cells in our 3D model. We conclude that SULF1 can suppress Wnt3A-driven growth signals in the desmoplastic stroma of PCa bone metastases, and SULF1 loss favors PCa progression, even in the presence of pro-tumorigenic TAMs.	[da Costa, Fabio Henrique Brasil; Carson, Daniel D.; Farach-Carson, Mary C.] Rice Univ, Biosci Dept, Houston, TX 77005 USA; [da Costa, Fabio Henrique Brasil; Farach-Carson, Mary C.] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77030 USA; [Lewis, Michael S.] Cedars Sinai Med Ctr, Dept Pathol & Med, West Hollywood, CA USA; [Truong, Anna] Rice Univ, Dept Chem, Houston, TX USA; [Carson, Daniel D.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Farach-Carson, Mary C.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Rice University; University of Texas System; University of Texas Health Science Center Houston; Cedars Sinai Medical Center; Rice University; University of Texas System; UTMD Anderson Cancer Center; Rice University	Farach-Carson, MC (corresponding author), Rice Univ, Biosci Dept, Houston, TX 77005 USA.; Farach-Carson, MC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77030 USA.; Farach-Carson, MC (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	Mary.C.FarachCarson@uth.tmc.edu		Brasil da Costa, Fabio Henrique/0000-0002-2089-4051; Truong, Anna/0000-0003-0819-3268	National Institutes of Health/National Cancer Institute [P01CA098912]; Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES)	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by a grant from the National Institutes of Health/National Cancer Institute, P01CA098912. Mr. Brasil da Costa was supported in part by the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Brasil da Costa FH, 2020, CANC STUD THER, V5, P1; Bret C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-72; Chen ZH, 2017, CANCER RES, V77, P2266, DOI 10.1158/0008-5472.CAN-16-2310; Cronin KA, 2018, CANCER-AM CANCER SOC, V124, P2785, DOI [10.1002/cncr.31551, 10.1002/cncr.32802]; Datta MW, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-9; Dvorak HF, 2015, CANCER IMMUNOL RES, V3, P1, DOI 10.1158/2326-6066.CIR-14-0209; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ecke TH, 2010, ANTICANCER RES, V30, P1579; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Fellgett SW, 2015, J CELL SCI, V128, P1408, DOI 10.1242/jcs.164467; Forsten-Williams K, 2008, ANN BIOMED ENG, V36, P2134, DOI 10.1007/s10439-008-9575-z; Freeman C, 1998, BIOCHEM J, V330, P1341, DOI 10.1042/bj3301341; Graham K, 2016, HISTOCHEM CELL BIOL, V146, P85, DOI 10.1007/s00418-016-1425-8; Hammond E, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00195; Harper J, 2014, SEMIN CANCER BIOL, V25, P69, DOI 10.1016/j.semcancer.2013.12.005; Hayward SW, 1997, BRIT J UROL, V79, P18, DOI 10.1111/j.1464-410X.1997.tb16917.x; He XP, 2014, INT J CANCER, V135, P1783, DOI 10.1002/ijc.28818; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; Jamaspishvili T, 2018, NAT REV UROL, V15, P222, DOI 10.1038/nrurol.2018.9; Jones JD, 2019, NEOPLASIA, V21, P172, DOI 10.1016/j.neo.2018.11.003; Junnila S, 2010, GENE CHROMOSOME CANC, V49, P28, DOI 10.1002/gcc.20715; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Khurana A, 2013, AM J CANCER RES, V3, P34; Knelson EH, 2014, TRENDS BIOCHEM SCI, V39, P277, DOI 10.1016/j.tibs.2014.03.001; Lai Jin-Ping, 2008, J Gastrointest Cancer, V39, P149, DOI 10.1007/s12029-009-9058-y; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lalani EN, 1997, CANCER METAST REV, V16, P29, DOI 10.1023/A:1005792206377; Lee HY, 2017, ONCOTARGET, V8, P47216, DOI 10.18632/oncotarget.17590; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li JP, 2016, INT REV CEL MOL BIO, V325, P215, DOI 10.1016/bs.ircmb.2016.02.009; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Li YM, 2011, UROL ONCOL-SEMIN ORI, V29, P802, DOI 10.1016/j.urolonc.2009.09.016; Li ZG, 2008, J CLIN INVEST, V118, P2697, DOI 10.1172/JCI33093; Ling L, 2010, J BIOL CHEM, V285, P26233, DOI 10.1074/jbc.M110.122069; MANTOVANI A, 1986, BIOCHIM BIOPHYS ACTA, V865, P59, DOI 10.1016/0304-419X(86)90013-2; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Nandana S, 2017, CANCER RES, V77, P1331, DOI 10.1158/0008-5472.CAN-16-0497; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; NOONAN DM, 1993, KIDNEY INT, V43, P53, DOI 10.1038/ki.1993.10; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; O'Connor JC, 2007, MOL CANCER RES, V5, P585, DOI 10.1158/1541-7786.MCR-06-0408; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Ojalvo LS, 2009, AM J PATHOL, V174, P1048, DOI 10.2353/ajpath.2009.080676; Roca H, 2018, J CLIN INVEST, V128, P248, DOI 10.1172/JCI92466; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; SAITOH H, 1984, CANCER-AM CANCER SOC, V54, P3078, DOI 10.1002/1097-0142(19841215)54:12<3078::AID-CNCR2820541245>3.0.CO;2-U; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Sluka P, 2013, NAT REV UROL, V10, P441, DOI 10.1038/nrurol.2013.146; Soki FN, 2015, ONCOTARGET, V6, P35782, DOI 10.18632/oncotarget.6042; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; Tang RH, 2009, J BIOL CHEM, V284, P21505, DOI 10.1074/jbc.M109.028472; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tyekucheva S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00460-4; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Wan XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009332; Warren CR, 2014, J CELL BIOCHEM, V115, P1322, DOI 10.1002/jcb.24788; Yamazaki M, 2004, J ORAL PATHOL MED, V33, P177, DOI 10.1111/j.0904-2512.2004.00087.x; Yang WD, 2005, TISSUE ENG, V11, P76, DOI 10.1089/ten.2005.11.76; You SY, 2016, CANCER RES, V76, P4948, DOI 10.1158/0008-5472.CAN-16-0902	70	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0230354	10.1371/journal.pone.0230354	http://dx.doi.org/10.1371/journal.pone.0230354			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413029	Green Published, gold, Green Submitted			2022-12-26	WOS:000537496000009
J	Scala, V; Pucci, N; Salustri, M; Modesti, V; L'Aurora, A; Scortichini, M; Zaccaria, M; Momeni, B; Reverberi, M; Loreti, S				Scala, Valeria; Pucci, Nicoletta; Salustri, Manuel; Modesti, Vanessa; L'Aurora, Alessia; Scortichini, Marco; Zaccaria, Marco; Momeni, Babak; Reverberi, Massimo; Loreti, Stefania			Xylella fastidiosa subsp. pauca and olive produced lipids moderate the switch adhesive versus non-adhesive state and viceversa	PLOS ONE			English	Article							1ST DETECTION; PLANT; OXYLIPINS; DNA	Global trade and climate change are re-shaping the distribution map of pandemic pathogens. One major emerging concern is Xylella fastidiosa, a tropical bacterium recently introduced into Europe from America. In last decades, X. fastidiosa was detected in several European countries. X. fastidiosa is an insect vector-transmitted bacterial plant pathogen associated with severe diseases in a wide range of hosts. X. fastidiosa through a tight coordination of the adherent biofilm and the planktonic states, invades the host systemically. The planktonic phase is correlated to low cell density and vessel colonization. Increase in cell density triggers a quorum sensing system based on mixture of cis 2-enoic fatty acids-diffusible signalling factors (DSF) that promote stickiness and biofilm. The lipidome profile of Olea europaea L. (cv. Ogliarola salentina) samples, collected in groves located in infected zones and uninfected zones was performed. The untargeted analysis of the lipid profiles of Olive Quick Decline Syndrome (OQDS) positive (+) and negative (-) plants showed a clustering of OQDS+ plants apart from OQDS-. The targeted lipids profile of plants OQDS+ and OQDS- identified a shortlist of 10 lipids that increase their amount in OQDS+ and X. fastidiosa positive olive trees. These lipid entities, provided to X. fastidiosa subsp. pauca pure culture, impact on the dual phase, e.g. planktonic <-> biofilm. This study provides novel insights on OQDS lipid hallmarks and on molecules that might modulate biofilm phase in X. fastidiosa subsp. pauca.	[Scala, Valeria; Pucci, Nicoletta; Modesti, Vanessa; L'Aurora, Alessia; Loreti, Stefania] Council Agr Res & Econ CREA, Res Ctr Plant Protect & Certificat, Rome, Italy; [Salustri, Manuel; Reverberi, Massimo] Sapienza Univ, Dept Environm Biol, Rome, Italy; [Scortichini, Marco] Council Agr Res & Econ CREA, Res Ctr Olive Fruit Trees & Citrus, Rome, Italy; [Zaccaria, Marco; Momeni, Babak] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sapienza University Rome; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Boston College	Scala, V (corresponding author), Council Agr Res & Econ CREA, Res Ctr Plant Protect & Certificat, Rome, Italy.; Reverberi, M (corresponding author), Sapienza Univ, Dept Environm Biol, Rome, Italy.	valeria.scala@crea.gov.it; massimo.reverberi@uniroma1.it	Loreti, Stefania/ABD-7867-2020; pucci, nicoletta/ABD-6087-2020	Loreti, Stefania/0000-0001-7761-6186; reverberi, massimo/0000-0003-3671-6783; Zaccaria, Marco/0000-0003-1054-1903	MIPAAFT [23773, 33437]; Regione Puglia agreement: "Strategie di controllo integrato per il contenimento di Xylella fastidiosa in oliveti pugliesi ed analisi epidemiologiche del complesso del disseccamento rapido dell'olivo (CoDiRO); Boston College; Smith Family Foundation	MIPAAFT; Regione Puglia agreement: "Strategie di controllo integrato per il contenimento di Xylella fastidiosa in oliveti pugliesi ed analisi epidemiologiche del complesso del disseccamento rapido dell'olivo (CoDiRO); Boston College; Smith Family Foundation	The study was funded by MIPAAFT, Project Oli.Di.X.I.It ("OLIvicoltura e Difesa da Xylella fastidiosa e da Insetti vettori in Italia"), D.M. 23773 del 6/09/2017, Project SALVAOLIVI ("Salvaguardia e valorizzazione del patrimonio olivicolo italiano con azioni di ricerca nel settore della difesa fitosanitaria"), D.M. 33437 del 21-12-201 and by Regione Puglia agreement: "Strategie di controllo integrato per il contenimento di Xylella fastidiosa in oliveti pugliesi ed analisi epidemiologiche del complesso del disseccamento rapido dell'olivo (CoDiRO). B.M. and M.Z. were supported by a start-up fund from Boston College and by an Award in Biomedical Excellence from the Smith Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2019, Bulletin OEPP, V49, P175, DOI 10.1111/epp.12575; Battilani P, 2018, MOL PLANT PATHOL, V19, P2162, DOI 10.1111/mpp.12690; Beaulieu ED, 2013, MBIO, V4, DOI 10.1128/mBio.00539-12; Belvisi MG, 2009, BRIT J PHARMACOL, V158, P994, DOI 10.1111/j.1476-5381.2009.00373.x; Cardinale M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00431; Castiblanco LF, 2016, J INTEGR PLANT BIOL, V58, P362, DOI 10.1111/jipb.12428; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Deleu M, 2019, COLLOID SURFACE B, V175, P384, DOI 10.1016/j.colsurfb.2018.12.014; Denance N, 2017, PLANT PATHOL, V66, P1054, DOI 10.1111/ppa.12695; (EFSA) EFSA, 2018, EFSA J, V16; Giampetruzzi A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2833-9; Graner G, 2003, PHYTOCHEMISTRY, V63, P89, DOI 10.1016/S0031-9422(02)00724-0; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harper SJ, 2010, PHYTOPATHOLOGY, V100, P1282, DOI 10.1094/PHYTO-06-10-0168; Howe GA, 2018, NAT CHEM BIOL, V14, P109, DOI 10.1038/nchembio.2553; Ionescu M, 2016, MBIO, V7, DOI 10.1128/mBio.01054-16; Jacques MA, 2016, APPL ENVIRON MICROB, V82, P1556, DOI 10.1128/AEM.03299-15; Jud W, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0378-4; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Marcelletti S, 2016, ARCH MICROBIOL, V198, P803, DOI 10.1007/s00203-016-1245-1; Marchi G, 2018, PHYTOPATHOL MEDITERR, V57, P363, DOI 10.14601/Phytopathol_Mediterr-24454; Martinez E, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0310-0; Martinez E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13823; Maurizio C., 2019, CNR IRCRES WORK PAP, V4, DOI [10.23760/2421-7158.2019.004, DOI 10.23760/2421-7158.2019.004]; McElrone AJ, 2001, PLANT DIS, V85, P1160, DOI 10.1094/PDIS.2001.85.11.1160; Newman KL, 2004, P NATL ACAD SCI USA, V101, P1737, DOI 10.1073/pnas.0308399100; Novelli S, 2019, J PLANT RES, V132, P439, DOI 10.1007/s10265-019-01108-8; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Olmo D, 2017, PLANT DIS, V101, P1820, DOI [10.1094/pdis-04-17-0590-pdn, 10.1094/PDI5-04-17-0590-PDN]; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Rapicavoli JN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02861-5; Redeker KR, 2018, ADV ECOL RES, V59, P93, DOI 10.1016/bs.aecr.2018.07.001; Roper C, 2019, CURR OPIN PLANT BIOL, V50, P140, DOI 10.1016/j.pbi.2019.05.005; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; Saponari M, 2013, J PLANT PATHOL, V95, P668; Scala V, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01839; Siebers M, 2016, BBA-MOL CELL BIOL L, V1861, P1379, DOI 10.1016/j.bbalip.2016.02.021; Stevenson JF, 2004, AM J ENOL VITICULT, V55, P238; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Wang LH, 2004, MOL MICROBIOL, V51, P903, DOI 10.1046/j.1365-2958.2003.03883.x; Wang N, 2007, PHYTOPATHOLOGY AM PH, V3340, pS120; Wasternack C, 2018, ANNU REV PLANT BIOL, V69, P363, DOI 10.1146/annurev-arplant-042817-040440	44	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233013	10.1371/journal.pone.0233013	http://dx.doi.org/10.1371/journal.pone.0233013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413086	gold, Green Published			2022-12-26	WOS:000537496000035
J	Eason, AB; Sin, SH; Shah, M; Yuan, H; Phillips, DJ; Droste, M; Shamshiev, A; Dittmer, DP				Eason, Anthony B.; Sin, Sang-Hoon; Shah, Mohsin; Yuan, Hong; Phillips, Douglas J.; Droste, Miriam; Shamshiev, Abdijapar; Dittmer, Dirk P.			DLX1008 (brolucizumab), a single-chain anti-VEGF-A antibody fragment with low picomolar affinity, leads to tumor involution in an in vivo model of Kaposi Sarcoma	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; VASCULAR-PERMEABILITY; GENE-EXPRESSION; HERPESVIRUS-INFECTION; CELL-LINE; PHARMACOKINETICS; ANGIOGENESIS; TRANSFORMATION; TUMORIGENESIS; PENETRATION	Kaposi Sarcoma (KS) is among the most angiogenic cancers in humans and an AIDS-defining condition. KS-associated herpesvirus (KSHV) is necessary for KS development, as is vascular endothelial growth factor (VEGF-A). DLX1008 is a novel anti-VEGF-A antibody single-chain variable fragment (scFv) with low picomolar affinity for VEGF-A. In vivo imaging techniques were used to establish the efficacy of DLX1008 and to establish the mechanism of action; this included non-invasive imaging by ultrasound and optical fluorescence, verified by post-mortem histochemistry. The results showed that DLX1008 was efficacious in a KS mouse model. The NSG mouse xenografts suffered massive internal necrosis or involution, consistent with a lack of blood supply. We found that imaging by ultrasound was superior to external caliper measurements in the validation of the angiogenesis inhibitor DLX1008. Further development of DLX1008 against VEGF-dependent sarcomas is warranted.	[Eason, Anthony B.; Sin, Sang-Hoon; Shah, Mohsin; Dittmer, Dirk P.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Eason, Anthony B.; Sin, Sang-Hoon; Shah, Mohsin; Dittmer, Dirk P.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Yuan, Hong] Univ N Carolina, Sch Med, Biomed Res Imaging Ctr, Chapel Hill, NC 27515 USA; [Phillips, Douglas J.; Droste, Miriam; Shamshiev, Abdijapar] Cell Medica, Zurich, Switzerland	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Dittmer, DP (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Dittmer, DP (corresponding author), Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	ddittmer@med.unc.edu	, Pathology Services Core/CEZ-2246-2022; Dittmer, Dirk/AAH-3535-2021; Dittmer, Dirk/GPW-7423-2022; , Animal Studies Core/ADK-4234-2022; , Animal Studies Core/AAF-4432-2022	Dittmer, Dirk/0000-0003-4968-5656; Eason, Anthony/0000-0002-6723-7999; Shah, Mohsin/0000-0002-1491-356X	public health service grant [CA019014]; NCI Center Core Support Grant [5P30CA016086-41, CA16086]; NCI Cancer Core Grant [P30-CA016086-40]	public health service grant(United States Department of Health & Human ServicesUnited States Public Health Service); NCI Center Core Support Grant; NCI Cancer Core Grant	This work was supported by public health service grant (CA019014) to DPD. The Animal Studies Core is supported by NCI Center Core Support Grant (CA16086) to UNC LCCC, the Small Animal Imaging Facility is supported in part by NCI Cancer Core Grant (P30-CA016086-40), and the Animal Histopathology & Laboratory Medicine Core is supported in part by an NCI Center Core Support Grant (5P30CA016086-41) to UNC LCCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablanedo-Terrazas Y, 2015, LARYNGOSCOPE, V125, pE132, DOI 10.1002/lary.24988; ALLISON JW, 1994, RADIOGRAPHICS, V14, P1099, DOI 10.1148/radiographics.14.5.7991816; An FQ, 2006, J VIROL, V80, P4833, DOI 10.1128/JVI.80.10.4833-4846.2006; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Beecken WDC, 2001, J NATL CANCER I, V93, P382, DOI 10.1093/jnci/93.5.382; Borras L, 2010, J BIOL CHEM, V285, P9054, DOI 10.1074/jbc.M109.072876; BOVI PD, 1986, CANCER RES, V46, P6333; Carroll PA, 2004, VIROLOGY, V328, P7, DOI 10.1016/j.virol.2004.07.008; Carroll PA, 2006, J VIROL, V80, P10802, DOI 10.1128/JVI.00673-06; Cavallin LE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004154; Cheng F, 2011, CELL HOST MICROBE, V10, P577, DOI 10.1016/j.chom.2011.10.011; Ciufo DM, 2001, J VIROL, V75, P5614, DOI 10.1128/JVI.75.12.5614-5626.2001; Cornali E, 1996, AM J PATHOL, V149, P1851; Davis DA, 2007, CANCER RES, V67, P7003, DOI 10.1158/0008-5472.CAN-07-0939; Dirks NL, 2010, CLIN PHARMACOKINET, V49, P633, DOI 10.2165/11535960-000000000-00000; Dittmer DP, 2016, J CLIN INVEST, V126, P3165, DOI 10.1172/JCI84418; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Garrigues HJ, 2014, VIROLOGY, V464, P118, DOI 10.1016/j.virol.2014.06.035; Giffin L, 2014, J VIROL, V88, P9429, DOI 10.1128/JVI.00511-14; Giffin L, 2014, ADV VIRUS RES, V88, P111, DOI 10.1016/B978-0-12-800098-4.00002-7; Gill PS, 1998, P NATL ACAD SCI USA, V95, P8257, DOI 10.1073/pnas.95.14.8257; Grosskopf AK, 2019, J VIROL, V93, DOI 10.1128/JVI.00064-19; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Guilluy C, 2011, BLOOD, V118, P5344, DOI 10.1182/blood-2011-03-341552; Hansen A, 2010, GENE DEV, V24, P195, DOI 10.1101/gad.553410; Haque M, 2006, J VIROL, V80, P7037, DOI 10.1128/JVI.00553-06; Harris-Love MO, 2016, PEERJ, V4, DOI 10.7717/peerj.1721; Herbst RS, 2002, J CLIN ONCOL, V20, P3804, DOI 10.1200/JCO.2002.05.102; Holz FG, 2016, OPHTHALMOLOGY, V123, P1080, DOI 10.1016/j.ophtha.2015.12.030; Hong YK, 2004, NAT GENET, V36, P683, DOI 10.1038/ng1383; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Jones T, 2012, J CLIN INVEST, V122, P1076, DOI 10.1172/JCI58530; Kassambara A., Survminer: Drawing Survival Curves Using 'ggplot2' R Package Version 0.4.9 2021; Krown SE, 2012, JAIDS-J ACQ IMM DEF, V59, P447, DOI 10.1097/QAI.0b013e31823e7884; Kuna M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24897-9; Lagunoff M, 2002, J VIROL, V76, P2440, DOI 10.1128/JVI.76.5.2440-2448.2002; Lee MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12011; Li YQ, 2018, CANCER RES, V78, P230, DOI [10.1158/0008-5472.can-17-1961, 10.1158/0008-5472.CAN-17-1961]; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; LUNARDIISKANDAR Y, 1995, NATURE, V375, P64, DOI 10.1038/375064a0; Ma T, 2015, ANGIOGENESIS, V18, P477, DOI 10.1007/s10456-015-9475-4; MAJNO G, 1995, AM J PATHOL, V146, P3; Masood R, 1997, P NATL ACAD SCI USA, V94, P979, DOI 10.1073/pnas.94.3.979; Miettinen M, 2012, AM J SURG PATHOL, V36, P629, DOI 10.1097/PAS.0b013e318243555b; Moses AV, 1999, J VIROL, V73, P6892, DOI 10.1128/JVI.73.8.6892-6902.1999; Mutlu AD, 2007, CANCER CELL, V11, P471, DOI 10.1016/j.ccr.2007.04.013; Nakamura S, 1997, J IMMUNOL, V158, P4992; Nimz EL, 2016, ARVO ANN M; O'Hara AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000389; Pasternak M, 2017, ONCOTARGET, V8, P19631, DOI 10.18632/oncotarget.14816; Pasternak Maurice M, 2016, Oncoscience, V3, P275, DOI 10.18632/oncoscience.319; Qian LW, 2008, J VIROL, V82, P11902, DOI 10.1128/JVI.01042-08; R Core Team, 2018, R LANG ENV STAT COMP; Raab-Traub N, 2017, NAT REV MICROBIOL, V15, P559, DOI 10.1038/nrmicro.2017.60; Roy D, 2013, CANCER RES, V73, P2235, DOI 10.1158/0008-5472.CAN-12-1851; Ruan XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031628; Samaniego F, 2002, CELL GROWTH DIFFER, V13, P387; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sivakurnar R, 2008, J VIROL, V82, P1759, DOI 10.1128/JVI.00873-07; Staskus KA, 1997, J VIROL, V71, P715, DOI 10.1128/JVI.71.1.715-719.1997; Sturzl M, 2013, INT J CANCER, V132, P1954, DOI 10.1002/ijc.27849; Szabo Emese, 2018, J Pharmacol Exp Ther, V365, P422, DOI 10.1124/jpet.117.246249; Therneau T, PACKAGE SURVIVAL ANA; Therneau T.M., 2000, MODELING SURVIVAL DA; Uldrick TS, 2017, ONCOLOGIST, V22, P505, DOI 10.1634/theoncologist.2016-0486; Uldrick TS, 2012, J CLIN ONCOL, V30, P1476, DOI 10.1200/JCO.2011.39.6853; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; Viollet C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006143; Wagner MJ, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0013-2; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wang L, 2008, CANCER RES, V68, P4640, DOI 10.1158/0008-5472.CAN-07-5988; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; WEINDEL K, 1992, BIOCHEM BIOPH RES CO, V183, P1167, DOI 10.1016/S0006-291X(05)80313-4; Wickham H, DPLYR GRAMMAR DATA M; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; YOKOTA T, 1992, CANCER RES, V52, P3402	77	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233116	10.1371/journal.pone.0233116	http://dx.doi.org/10.1371/journal.pone.0233116			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407363	Green Published, gold			2022-12-26	WOS:000537490700072
J	Kalloch, B; Bazin, PL; Villringer, A; Sehm, B; Hlawitschka, M				Kalloch, Benjamin; Bazin, Pierre-Louis; Villringer, Arno; Sehm, Bernhard; Hlawitschka, Mario			A flexible workflow for simulating transcranial electric stimulation in healthy and lesioned brains	PLOS ONE			English	Article							FIELD; VISUALIZATION; OPTIMIZATION; REGISTRATION; CORTEX; ROBUST; HEAD; EEG	Simulating transcranial electric stimulation is actively researched as knowledge about the distribution of the electrical field is decisive for understanding the variability in the elicited stimulation effect. Several software pipelines comprehensively solve this task in an automated manner for standard use-cases. However, simulations for non-standard applications such as uncommon electrode shapes or the creation of head models from non-optimized T1-weighted imaging data and the inclusion of irregular structures are more difficult to accomplish. We address these limitations and suggest a comprehensive workflow to simulate transcranial electric stimulation based on open-source tools. The workflow covers the head model creation from MRI data, the electrode modeling, the modeling of anisotropic conductivity behavior of the white matter, the numerical simulation and visualization. Skin, skull, air cavities, cerebrospinal fluid, white matter, and gray matter are segmented semi-automatically from T1-weighted MR images. Electrodes of arbitrary number and shape can be modeled. The meshing of the head model is implemented in a way to preserve the feature edges of the electrodes and is free of topological restrictions of the considered structures of the head model. White matter anisotropy can be computed from diffusion-tensor imaging data. Our solver application was verified analytically and by contrasting the tDCS simulation results with that of other simulation pipelines (SimNIBS 3.0, ROAST 3.0). An agreement in both cases underlines the validity of our workflow. Our suggested solutions facilitate investigations of irregular structures in patients (e.g. lesions, implants) or new electrode types. For a coupled use of the described workflow, we provide documentation and disclose the full source code of the developed tools.	[Kalloch, Benjamin; Bazin, Pierre-Louis; Villringer, Arno; Sehm, Bernhard; Hlawitschka, Mario] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Saxony, Germany; [Kalloch, Benjamin; Hlawitschka, Mario] Leipzig Univ Appl Sci, Fac Comp Sci & Media, Leipzig, Saxony, Germany; [Bazin, Pierre-Louis] Univ Amsterdam, Fac Social & Behav Sci, Amsterdam, North Holland, Netherlands	Max Planck Society; University of Amsterdam	Kalloch, B (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Saxony, Germany.; Kalloch, B (corresponding author), Leipzig Univ Appl Sci, Fac Comp Sci & Media, Leipzig, Saxony, Germany.	kalloch@cbs.mpg.de	Hlawitschka, Mario/AAU-8942-2020	Villringer, Arno/0000-0003-2604-2404; Kalloch, Benjamin/0000-0002-9856-1230; Bazin, Pierre-Louis/0000-0002-0141-5510	FAZITSTIFTUNG; International Max Planck Research School on the Neuroscience of Communication (IMPRS NeuroCom)	FAZITSTIFTUNG; International Max Planck Research School on the Neuroscience of Communication (IMPRS NeuroCom)	Benjamin Kalloch was funded by FAZITSTIFTUNG and the International Max Planck Research School on the Neuroscience of Communication (IMPRS NeuroCom).	Ackermann M, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.077102; Alam M, 2016, PHYS MED BIOL, V61, P4506, DOI 10.1088/0031-9155/61/12/4506; Anderson JW, 2007, CONTEMP MATH, V432, P1; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Antonenko D, 2019, BRAIN STIMULATION; Attene M, 2010, VISUAL COMPUT, V26, P1393, DOI 10.1007/s00371-010-0416-3; Ayachit U., 2007, THE PARAVIEW GUIDE; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Ben Naceur M, 2018, COMPUT METH PROG BIO, V166, P39, DOI 10.1016/j.cmpb.2018.09.007; Bikson M, 2015, PROG BRAIN RES, V222, P1, DOI 10.1016/bs.pbr.2015.08.005; Bogovic JA, 2013, COMPUT VIS IMAGE UND, V117, P145, DOI 10.1016/j.cviu.2012.10.006; Cignoni P., 2008, 6 EUR IT CHAPT C 200, DOI 10.2312/LocalChapterEvents/ItalChap/ItalianChapConf2008/129-136; Dannhauer M, 2017, BRAIN STIMUL, V10, pe12; Datta A, 2011, BRAIN STIMUL, V4, P169, DOI 10.1016/j.brs.2010.11.001; Dhollander T. R., 2016, P ISMRM WORKSH BREAK; Fabri A., 2009, P 17 ACM SIGSPATIAL, P538, DOI DOI 10.1145/1653771.1653865; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Guerrero R, 2018, NEUROIMAGE-CLIN, V17, P918, DOI 10.1016/j.nicl.2017.12.022; Han X, 2004, NEUROIMAGE, V23, P997, DOI 10.1016/j.neuroimage.2004.06.043; Htet AT, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/aafbb9; Huang Y, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab208d; Huang Y, 2017, ELIFE, V6, DOI 10.7554/eLife.18834; Huang Y, 2012, IEEE ENG MED BIO, P5376, DOI 10.1109/EMBC.2012.6347209; Huntenburg JM, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy082; Indahlastari A, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/6/066006; Jasak H., 1996, ERROR ANAL ESTIMATIO; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kalloch B, 2018, MAGNETIC RESONANCE M; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kasinadhuni AK, 2017, BRAIN STIMUL, V10, P764, DOI 10.1016/j.brs.2017.04.125; Kim JH, 2014, NEUROSCI LETT, V564, P6, DOI 10.1016/j.neulet.2014.01.054; Laakso I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37226-x; Lampe L, 2019, J CEREBR BLOOD F MET, V39, P36, DOI 10.1177/0271678X17740501; Lee C, 2017, J NEUROSCI METH, V277, P56, DOI 10.1016/j.jneumeth.2016.12.008; Loeffler M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1983-z; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Lucas BC, 2010, NEUROINFORMATICS, V8, P5, DOI 10.1007/s12021-009-9061-2; McAuliffe MJ, 2001, COMP MED SY, P381; McCann H, 2019, BRAIN TOPOGR, V32, P825, DOI 10.1007/s10548-019-00710-2; Minjoli S, 2017, NEUROIMAGE-CLIN, V15, P106, DOI 10.1016/j.nicl.2017.04.014; Nielsen JD, 2018, NEUROIMAGE, V174, P587, DOI 10.1016/j.neuroimage.2018.03.001; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Opitz A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31236; Quarteroni A., 2010, NUMERICAL MATH, V37; Riedel P, 2015, CORTEX, V68, P86, DOI 10.1016/j.cortex.2014.11.016; Rorden C, 2012, NEUROIMAGE, V61, P957, DOI 10.1016/j.neuroimage.2012.03.020; Ruffini G, 2013, IEEE T NEUR SYS REH, V21, P333, DOI 10.1109/TNSRE.2012.2200046; RUSH S, 1968, ANESTH ANAL CURR RES, V47, P717; RUSH S, 1969, IEEE T BIO-MED ENG, VBM16, P15, DOI 10.1109/TBME.1969.4502598; Sehm B, 2013, J NEUROSCI METH, V212, P234, DOI 10.1016/j.jneumeth.2012.10.006; SHAVADIA JS, 2019, BRAIN STIMUL, V12, DOI DOI 10.1161/CIRCOUTCOMES.118.005103; Shiee N, 2010, NEUROIMAGE, V49, P1524, DOI 10.1016/j.neuroimage.2009.09.005; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Taubin G., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P351, DOI 10.1145/218380.218473; Thielscher A, 2015, IEEE ENG MED BIO, P222, DOI 10.1109/EMBC.2015.7318340; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Veraart J, 2016, MAGN RESON MED, V76, P1582, DOI 10.1002/mrm.26059; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Wagner S, 2016, NEUROIMAGE, V140, P163, DOI 10.1016/j.neuroimage.2016.04.005; Wang H, 2019, NEUROSCI LETT, V694, P46, DOI 10.1016/j.neulet.2018.10.041; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Westin C.F., 1997, GEOMETRICAL DIFFUSIO, P1742; Wolters, 2013, INT C BAS CLIN MULT; Wolters CH, 2006, NEUROIMAGE, V30, P813, DOI 10.1016/j.neuroimage.2005.10.014	66	3	3	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0228119	10.1371/journal.pone.0228119	http://dx.doi.org/10.1371/journal.pone.0228119			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407389	Green Published, gold, Green Submitted			2022-12-26	WOS:000537490700003
J	Masuya, T; Suzuki, M; Tsujimura, J; Kanamori, S; Miyasaka, Y; Ohno, T; Murai, A; Horio, F; Kobayashi, M				Masuya, Tomomi; Suzuki, Miyako; Tsujimura, Junko; Kanamori, Shinsaku; Miyasaka, Yuki; Ohno, Tamio; Murai, Atsushi; Horio, Fumihiko; Kobayashi, Misato			Ablation of Iah1, a candidate gene for diet-induced fatty liver, does not affect liver lipid accumulation in mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; MOUSE; OBESITY; LIPODYSTROPHY; PURIFICATION	Nonalcoholic fatty liver disease (NAFLD) is a pathological condition caused by excess triglyceride deposition in the liver. The SMXA-5 severe fatty liver mouse model has been established from the SM/J and A/J strains. To explore the genetic factors involved in fatty liver development in SMXA-5 mice, we had previously performed quantitative trait locus (QTL) analysis, using (SM/JxSMXA-5)F2 intercross mice, and identified Fl1sa on chromosome 12 (centromere-53.06 Mb) as a significant QTL for fatty liver. Furthermore, isoamyl acetate-hydrolyzing esterase 1 homolog (Iah1) was selected as the most likely candidate gene for Fl1sa. Iah1 gene expression in fatty liver-resistant A/J-12(SM) mice was significantly higher than in fatty liver-susceptible A/J mice. These data indicated that the Iah1 gene might be associated with fatty liver development. However, the function of murine Iah1 remains unknown. Therefore, in this study, we created Iah1 knockout (KO) mice with two different backgrounds [C57BL/6N (B6) and A/J-12(SM) (A12)] to investigate the relationship between Iah1 and liver lipid accumulation. Liver triglyceride accumulation in Iah1-KO mice of B6 or A12 background did not differ from their respective Iah1-wild type mice under a high-fat diet. These results indicated that loss of Iah1 did not contribute to fatty liver. On the other hands, adipose tissue dysfunction causes lipid accumulation in ectopic tissues (liver, skeletal muscle, and pancreas). To investigate the effect of Iah1 deficiency on white adipose tissue, we performed DNA microarray analysis of epididymal fat in Iah1-KO mice of A12 background. This result showed that Iah1 deficiency might decrease adipokines Sfrp4 and Metrnl gene expression in epididymal fat. This study demonstrated that Iah1 deficiency did not cause liver lipid accumulation and that Iah1 was not a suitable candidate gene for Fl1sa.	[Masuya, Tomomi; Suzuki, Miyako; Tsujimura, Junko; Kanamori, Shinsaku; Murai, Atsushi; Horio, Fumihiko; Kobayashi, Misato] Nagoya Univ, Grad Sch Bioagr Sci, Dept Anim Sci, Lab Anim Nutr, Nagoya, Aichi, Japan; [Miyasaka, Yuki; Ohno, Tamio] Nagoya Univ, Grad Sch Med, Ctr Promot Med Res & Educ, Div Expt Anim, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Kobayashi, M (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Anim Sci, Lab Anim Nutr, Nagoya, Aichi, Japan.	misatok@agr.nagya-u.ac.jp		KOBAYASHI, Misato/0000-0002-2752-6358	Japan Society for the Promotion of Sciences [25450166, 18K05532]; Uehara Memorial Foundation; Japan Health Foundation	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Health Foundation(Japan Health Foundation)	This work was supported by a Grant-inAid for Scientific Research (C) (No. 25450166, 18K05532) from the Japan Society for the Promotion of Sciences (https://www.jsps.go.jp/), a grant from the Uehara Memorial Foundation (https://www.ueharazaidan.or.jp/), a grant from the the Japan Health Foundation (http://www.jnhf.or.jp/) (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukuda K, 2000, APPL MICROBIOL BIOT, V53, P596, DOI 10.1007/s002530051662; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Horbelt T, 2019, BBA-MOL BASIS DIS, V1865, P2671, DOI 10.1016/j.bbadis.2019.07.008; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kobayashi M, 2004, BIOSCI BIOTECH BIOCH, V68, P226, DOI 10.1271/bbb.68.226; Kobayashi M, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0385-2; Kumazawa M, 2007, J LIPID RES, V48, P2039, DOI 10.1194/jlr.M700222-JLR200; Li ZY, 2015, DIABETES, V64, P4011, DOI 10.2337/db15-0274; Ma JM, 2011, PROTEINS, V79, P662, DOI 10.1002/prot.22865; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Matsumura H, 2004, BIOCHEM BIOPH RES CO, V321, P275, DOI 10.1016/j.bbrc.2004.06.139; NISHIMURA M, 1995, MAMM GENOME, V6, P850, DOI 10.1007/BF00292434; Ohno T, 2012, MAMM GENOME, V23, P764, DOI 10.1007/s00335-012-9435-x; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Suganami T, 2012, ENDOCR J, V59, P849, DOI 10.1507/endocrj.EJ12-0271; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Suzuki M, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0453-7; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233087	10.1371/journal.pone.0233087	http://dx.doi.org/10.1371/journal.pone.0233087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407372	Green Published, gold			2022-12-26	WOS:000537490700069
J	Pourpre, R; Naudon, L; Meziane, H; Lakisic, G; Jouneau, L; Varet, H; Legendre, R; Wendling, O; Selloum, M; Proux, C; Coppee, JY; Herault, Y; Bierne, H				Pourpre, Renaud; Naudon, Laurent; Meziane, Hamid; Lakisic, Goran; Jouneau, Luc; Varet, Hugo; Legendre, Rachel; Wendling, Olivia; Selloum, Mohammed; Proux, Caroline; Coppee, Jean-Yves; Herault, Yann; Bierne, Helene			BAHD1 haploinsufficiency results in anxiety-like phenotypes in male mice	PLOS ONE			English	Article							METHYL-CPG BINDING-PROTEIN-1; SENSORIMOTOR GATING DEFICITS; HISTONE DEACETYLASES 1; PREPULSE INHIBITION; MEMORY; BEHAVIOR; DOMAIN; RECOGNITION; DYSFUNCTION; EXTINCTION	BAHD1 is a heterochomatinization factor recently described as a component of a multiprotein complex associated with histone deacetylases HDAC1/2. The physiological and patho-physiological functions of BAHD1 are not yet well characterized. Here, we examined the consequences of BAHD1 deficiency in the brains of male mice. While Bahd1 knockout mice had no detectable defects in brain anatomy, RNA sequencing profiling revealed about 2500 deregulated genes in Bahd1(-/)-brains compared to Bahd1(+/+) brains. A majority of these genes were involved in nervous system development and function, behavior, metabolism and immunity. Exploration of the Allen Brain Atlas and Dropviz databases, assessing gene expression in the brain, revealed that expression of the Bahd1 gene was limited to a few territories and cell subtypes, particularly in the hippocampal formation, the isocortex and the olfactory regions. The effect of partial BAHD1 deficiency on behavior was then evaluated on Bahd1 heterozygous male mice, which have no lethal or metabolic phenotypes. Bahd1(+/-) mice showed anxiety-like behavior and reduced prepulse inhibition (PPI) of the startle response. Altogether, these results suggest that BAHD1 plays a role in chromatin-dependent gene regulation in a subset of brain cells and support recent evidence linking genetic alteration of BAHD1 to psychiatric disorders in a human patient.	[Pourpre, Renaud; Naudon, Laurent; Lakisic, Goran; Bierne, Helene] Univ Paris Saclay, Micalis Inst, INRAE, AgroParisTech, Jouy En Josas, France; [Naudon, Laurent] Univ Paris Saclay, CNRS, Micalis Inst, INRAE,AgroParisTech, Jouy En Josas, France; [Meziane, Hamid; Wendling, Olivia; Selloum, Mohammed; Herault, Yann] Univ Strasbourg, CNRS, Inst Clin Souris ICS, INSERM,PHENOMIN, Illkirch Graffenstaden, France; [Jouneau, Luc] Univ Paris Saclay, INRAE, Virol & Immunol Mol, Jouy En Josas, France; [Varet, Hugo; Legendre, Rachel] CNRS, USR IP 3756, Inst Pasteur Bioinformat & Biostat Hub, C3BI, Paris, France; [Varet, Hugo; Legendre, Rachel; Proux, Caroline; Coppee, Jean-Yves] Biom Pole, Inst Pasteur Transcriptome & Epigenome Platform, Paris, France; [Herault, Yann] Univ Strasbourg, CNRS, UMR7104, INSERM,Inst Genet Biol Mol & Cellulaire IGBMC,U12, Illkirch Graffenstaden, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bierne, H (corresponding author), Univ Paris Saclay, Micalis Inst, INRAE, AgroParisTech, Jouy En Josas, France.	helene.bierne@inrae.fr	Herault, Yann/B-5500-2012	Herault, Yann/0000-0001-7049-6900; Pourpre, Renaud/0000-0002-0407-5099; LAKISIC, Goran/0000-0002-0079-5072; SELLOUM, MOHAMMED/0000-0003-4057-3519; Bierne, Helene/0000-0002-0525-0848	Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (MICA grant); iXcore Foundation for Research; Ligue Nationale Contre le Cancer; French state funds through the "Agence Nationale de la Recherche" [ANR-10-IDEX-0002-02, ANR-10LABX-0030-INRT, ANR-10-INBS-07 PHENOMIN]	Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (MICA grant); iXcore Foundation for Research; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); French state funds through the "Agence Nationale de la Recherche"(French National Research Agency (ANR))	H.B. acknowledges support from Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (MICA grant) and the iXcore Foundation for Research. R.P received support from Ligue Nationale Contre le Cancer. Y.P acknowledges support from the French state funds through the "Agence Nationale de la Recherche" under the frame programme Investissements d'Avenir labelled ANR-10-IDEX-0002-02, ANR-10LABX-0030-INRT, ANR-10-INBS-07 PHENOMIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Haq R, 2019, J EXP MED, V216, P41, DOI 10.1084/jem.20180794; Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; Anisman H, 2001, BEHAV NEUROSCI, V115, P443, DOI 10.1037/0735-7044.115.2.443; Bahari-Javan S, 2017, P NATL ACAD SCI USA, V114, pE4686, DOI 10.1073/pnas.1613842114; Bahari-Javan S, 2012, J NEUROSCI, V32, P5062, DOI 10.1523/JNEUROSCI.0079-12.2012; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; Bast T, 2011, CURR OPIN NEUROBIOL, V21, P492, DOI 10.1016/j.conb.2011.01.003; Bienkowski MS, 2018, NAT NEUROSCI, V21, P1628, DOI 10.1038/s41593-018-0241-y; Bierne H, 2017, EPIGENETICS HUM HLTH, P113, DOI 10.1007/978-3-319-55021-3_6; Bierne H, 2009, P NATL ACAD SCI USA, V106, P13826, DOI 10.1073/pnas.0901259106; Christopher MA, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0150-4; Cossu D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02966; Derwish R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169338; Ding ZH, 2004, J BIOL CHEM, V279, P28009, DOI 10.1074/jbc.M403793200; Ennaceur A, 2005, BEHAV BRAIN RES, V159, P247, DOI 10.1016/j.bbr.2004.11.006; Escamilla-Del-Arenal M, 2013, MOL CELL BIOL, V33, P5005, DOI 10.1128/MCB.00866-13; Gillespie Laura L, 2012, Atlas Genet Cytogenet Oncol Haematol, V16, P127; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iacono G, 2018, NUCLEIC ACIDS RES, V46, P4950, DOI 10.1093/nar/gky196; Ioannidou C, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2789; Itoh T, 2015, NUCLEIC ACIDS RES, V43, P2033, DOI 10.1093/nar/gkv068; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jakobsson J, 2008, NEURON, V60, P818, DOI 10.1016/j.neuron.2008.09.036; Jakovcevski M, 2013, BIOL PSYCHIAT, V74, P696, DOI 10.1016/j.biopsych.2013.03.020; Jaworska J, 2015, INT J DEV BIOL, V59, P171, DOI 10.1387/ijdb.150071tz; Jiang Y, 2017, NAT GENET, V49, P1239, DOI 10.1038/ng.3906; Jiang Y, 2010, J NEUROSCI, V30, P7152, DOI 10.1523/JNEUROSCI.1314-10.2010; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P99, DOI 10.1007/978-1-4939-8994-2_9; Krause K, 2018, NAT GENET, V50, P1206, DOI 10.1038/s41588-018-0201-1; Kwon MJ, 2016, MOL CELLS, V39, P783, DOI 10.14348/molcells.2016.0233; Lakisic G, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005898; Lebreton A, 2014, MBIO, V5, DOI 10.1128/mBio.00775-13; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lezak KR, 2017, DIALOGUES CLIN NEURO, V19, P181; Libertin E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00339; Liu YQ, 2019, BIOL PSYCHIAT, V85, P635, DOI 10.1016/j.biopsych.2018.11.025; Ludewig S, 2002, DEPRESS ANXIETY, V15, P55, DOI 10.1002/da.10026; Mahgoub M, 2016, NAT NEUROSCI, V19, P1506, DOI 10.1038/nn.4395; McManus RM, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0241-2; Medvedeva YA, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav067; Montagrin A, 2018, HIPPOCAMPUS, V28, P672, DOI 10.1002/hipo.22797; Morris MJ, 2013, J NEUROSCI, V33, P6401, DOI 10.1523/JNEUROSCI.1001-12.2013; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Nakahara Soichiro, 2018, Neuropsychopharmacology Reports, V38, P156, DOI 10.1002/npr2.12031; Pena CJ, 2018, PROG MOL BIOL TRANSL, V157, P41, DOI 10.1016/bs.pmbts.2017.12.011; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Pienkowski VM, 2019, J MED GENET, V56, P104, DOI 10.1136/jmedgenet-2018-105527; Plaster N, 2007, DEV DYNAM, V236, P1891, DOI 10.1002/dvdy.21196; Powell Susan B, 2012, Curr Top Behav Neurosci, V12, P251, DOI 10.1007/7854_2011_195; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Qin YF, 2018, J BIOCHEM, V163, P105, DOI 10.1093/jb/mvx080; Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Rubin RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00742; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Sillivan Stephanie E, 2015, Neuroepigenetics, V1, P28; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; SWERDLOW NR, 1993, BIOL PSYCHIAT, V33, P298, DOI 10.1016/0006-3223(93)90300-3; Swerdlow NR, 1998, SCHIZOPHRENIA BULL, V24, P285, DOI 10.1093/oxfordjournals.schbul.a033326; Tavitian A, 2019, NEUROSCIENTIST, V25, P528, DOI 10.1177/1073858418824072; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vogel JW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14518-3; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Yang N, 2013, CRIT REV BIOCHEM MOL, V48, P211, DOI 10.3109/10409238.2012.742035; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhao D, 2016, PROTEIN CELL, V7, P222, DOI 10.1007/s13238-016-0243-z; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zhu HT, 2015, SCI REP-UK, V5, DOI 10.1038/srep12227	77	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232789	10.1371/journal.pone.0232789	http://dx.doi.org/10.1371/journal.pone.0232789			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407325	Green Published, gold			2022-12-26	WOS:000537490700036
J	Hatch, MD; Abadi, F; Boeing, WJ; Lois, S; Porter, MD; Cowley, DE				Hatch, Michael D.; Abadi, Fitsum; Boeing, Wiebke J.; Lois, Sabela; Porter, Michael D.; Cowley, David E.			Sustainability management of short-lived freshwater fish in human-altered ecosystems should focus on adult survival	PLOS ONE			English	Article							LIFE-HISTORY STRATEGIES; GRANDE SILVERY MINNOW; MIDDLE RIO-GRANDE; POPULATION-DYNAMICS; NEW-MEXICO; CONSERVATION; ECOLOGY; GROWTH; PROPAGATION; CYPRINIDAE	Fish populations globally are susceptible to endangerment through exploitation and habitat loss. We present theoretical simulations to explore how reduced adult survival (age truncation) might affect short-lived freshwater fish species in human-altered contemporary environments. Our simulations evaluate two hypothetical "average fish" and five example fish species of age 1 or age 2 maturity. From a population equilibrium baseline representing a natural, unaltered environment we impose systematic reductions in adult survival and quantify how age truncation affects the causes of variation in population growth rate. We estimate the relative contributions to population growth rate arising from simulated temporal variation in age-specific vital rates and population structure. At equilibrium and irrespective of example species, population structure (first adult age class) and survival probability of the first two adult age classes are the most important determinants of population growth. As adult survival decreases, the first reproductive age class becomes increasingly important to variation in population growth. All simulated examples show the same general pattern of change with age truncation as known for exploited, longer-lived fish species in marine and freshwater environments. This implies age truncation is a general potential concern for fish biodiversity across life history strategies and ecosystems. Managers of short-lived, freshwater fishes in contemporary environments often focus on supporting reproduction to ensure population persistence. However, a strong focus on water management to support reproduction may reduce adult survival. Sustainability management needs a focus on mitigating adult mortality in human-altered ecosystems. A watershed spatial extent embracing land and water uses may be necessary to identify and mitigate causes of age truncation in freshwater species. Achieving higher adult survival will require paradigm transformations in society and government about water management priorities.	[Hatch, Michael D.; Abadi, Fitsum; Boeing, Wiebke J.; Lois, Sabela; Cowley, David E.] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Hatch, Michael D.; Cowley, David E.] New Mexico State Univ, Water Sci & Management Program, Las Cruces, NM 88003 USA; [Porter, Michael D.] US Army, Corps Engineers, Albuquerque, NM USA	New Mexico State University; New Mexico State University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers	Cowley, DE (corresponding author), New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA.; Cowley, DE (corresponding author), New Mexico State Univ, Water Sci & Management Program, Las Cruces, NM 88003 USA.	dcowley@nmsu.edu		Lois, Sabela/0000-0002-2557-8760; Cowley, David/0000-0002-7452-3088	New Mexico Agricultural Experiment Station [Hatch NMCowley-13H, NM Fitsum-2017H]; U.S. Army Corps of Engineers [W912HZ-15-2-0016]	New Mexico Agricultural Experiment Station; U.S. Army Corps of Engineers(United States Department of DefenseUnited States Army)	DEC, FA - The New Mexico Agricultural Experiment Station (Hatch NMCowley-13H; NM Fitsum-2017H), DEC - The U.S. Army Corps of Engineers (W912HZ-15-2-0016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The New Mexico Agricultural Experiment Station (Hatch NMCowley-13H; NM Fitsum2017H) and the U.S. Army Corps of Engineers (W912HZ-15-2-0016) provided support. We thank G. Roemer and M. Schaub for helpful comments and discussions that improved our work. Two anonymous reviewers helped us further improve the presentation. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the U.S. Army Corps of Engineers.	ANDREWS C, 1990, J FISH BIOL, V37, P53, DOI 10.1111/j.1095-8649.1990.tb05020.x; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bajer PG, 2007, J APPL ICHTHYOL, V23, P457, DOI 10.1111/j.1439-0426.2007.00879.x; Barneche DR, 2018, SCIENCE, V360, P642, DOI 10.1126/science.aao6868; Beamish RJ, 2006, PROG OCEANOGR, V68, P289, DOI 10.1016/j.pocean.2006.02.005; Bennett NJ, 2017, BIOL CONSERV, V205, P93, DOI 10.1016/j.biocon.2016.10.006; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; BRONTE CR, 1991, J GREAT LAKES RES, V17, P304, DOI 10.1016/S0380-1330(91)71367-1; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Caldwell CA, 2019, N AM J AQUACULT, V81, P47, DOI 10.1002/naaq.10068; CAMBRAY JA, 1985, S AFR J ZOOL, V20, P155; Caswell, 2000, MATRIX POPULATION MO; Chilton M, 2020, AM J PUBLIC HEALTH, V110, P459, DOI 10.2105/AJPH.2020.305582; Christiansen JS, 2008, J EXP MAR BIOL ECOL, V360, P47, DOI 10.1016/j.jembe.2008.04.003; COSEWIC, 2008, ASS UPD REP W SILV M; Cowley DE, 2007, ECOL FRESHW FISH, V16, P548, DOI 10.1111/j.1600-0633.2007.00250.x; Cowley DE, 2006, REV FISH SCI, V14, P169, DOI 10.1080/10641260500341619; Cowley DE, 2006, REV FISH SCI, V14, P111, DOI 10.1080/10641260500341494; Day JL, 2017, J FISH WILDL MANAG, V8, P301, DOI 10.3996/022016-JFWM-011; DIANA JS, 1983, T AM FISH SOC, V112, P38, DOI 10.1577/1548-8659(1983)112<38:GMAPON>2.0.CO;2; Dick EJ, 2017, FISH RES, V187, P73, DOI 10.1016/j.fishres.2016.11.009; Durham BW, 2009, T AM FISH SOC, V138, P666, DOI 10.1577/T07-234.1; Fricke R, 2020, ESCHMEYERS CATALOG F; George AL, 2009, FISHERIES, V34, P529, DOI 10.1577/1548-8446-34.11.529; Gleick PH, 2018, P NATL ACAD SCI USA, V115, P8863, DOI 10.1073/pnas.1808893115; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; Hatch MD, 2009, LUNAS HABITAT RESTOR; HILBORN R, 1992; Hitt NP, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.3026; Horswill C, 2019, J APPL ECOL, V56, P855, DOI 10.1111/1365-2664.13327; Horwitz RJ, 2018, T AM FISH SOC, V147, P265, DOI 10.1002/tafs.10012; Ishay M., 2020, AM J PUBLIC HEALTH, P460; Jaric I, 2010, REV FISH BIOL FISHER, V20, P219, DOI 10.1007/s11160-009-9151-0; Kellner K.F., 2016, JAGSUI WRAPPER RJAGS; Kenchington TJ, 2014, FISH FISH, V15, P533, DOI 10.1111/faf.12027; Kimberg PK, 2014, AFR J AQUAT SCI, V39, P451, DOI 10.2989/16085914.2014.976169; Kindler DH, 2015, THESIS; Kominoski JS, 2018, GLOBAL CHANGE BIOL, V24, P1175, DOI 10.1111/gcb.13940; Koons DN, 2017, ECOL APPL, V27, P2102, DOI 10.1002/eap.1594; Koons DN, 2016, ECOL LETT, V19, P1023, DOI 10.1111/ele.12628; LANDE R, 1995, AM NAT, V145, P728, DOI 10.1086/285765; Lois S, 2017, DIVERS DISTRIB, V23, P1235, DOI 10.1111/ddi.12623; Lorenzoni M, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011069; Magalhaes MF, 2003, J FISH BIOL, V63, P300, DOI 10.1046/j.1095-8649.2003.00148.x; Miranda Leandro E., 2007, P229; Moyle P.B., 2004, INTRO ICHTHYOLOGY, V5th; Ogle D. H., 2016, T AM FISH SOC, DOI DOI 10.1577/1548-8659(2001)1302.0.CO;2; Ottersen G, 2006, FISH OCEANOGR, V15, P230, DOI 10.1111/j.1365-2419.2006.00404.x; Peterson EE, 2013, ECOL LETT, V16, P707, DOI 10.1111/ele.12084; Plummer M., 2003, P 3 INT WORKSH DISTR; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Rouyer T, 2011, GLOBAL CHANGE BIOL, V17, P3046, DOI 10.1111/j.1365-2486.2011.02443.x; Seibert KL, 2018, J FISH WILDL MANAG, V9, P431, DOI 10.3996/092017-JFWM-079; Smith NG, 2018, T AM FISH SOC, V147, P665, DOI 10.1002/tafs.10040; Stenseth NC, 2008, NATURE, V452, P825, DOI 10.1038/452825a; Tan M, 2018, ZOOTAXA, V4476, P6, DOI 10.11646/zootaxa.4476.1.4; Tickner D, 2020, BIOSCIENCE, V70, P330, DOI 10.1093/biosci/biaa002; U.S. Fish and Wildlife Service, 2003, FIN BIOL C OP BUR RE; U.S. Fish and Wildlife Service, 2016, FIN BIOL C OP BUR RE; VAUGHAN DS, 1976, T AM FISH SOC, V105, P380, DOI 10.1577/1548-8659(1976)105<380:AMFDMR>2.0.CO;2; Velez-Espino LA, 2006, CAN J FISH AQUAT SCI, V63, P2050, DOI 10.1139/F06-093; Wang T, 2017, REV FISH BIOL FISHER, V27, P255, DOI 10.1007/s11160-016-9464-8; Winemiller KO, 2005, CAN J FISH AQUAT SCI, V62, P872, DOI 10.1139/F05-040; Wolkovich EM, 2014, ECOL LETT, V17, P1365, DOI 10.1111/ele.12353; Worthington TA, 2018, FISH FISH, V19, P271, DOI 10.1111/faf.12254; Young JAM, 2013, 2013084 CENTR ARCT R	68	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232872	10.1371/journal.pone.0232872	http://dx.doi.org/10.1371/journal.pone.0232872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396548	gold, Green Published			2022-12-26	WOS:000537475000022
J	Wang, X; Ding, GH; Liu, BD; Wang, QX				Wang, Xin; Ding, Guohua; Liu, Baodong; Wang, Quanxi			Flavonoids and antioxidant activity of rare and endangered fern: Isoetes sinensis	PLOS ONE			English	Article							FATTY-ACIDS; POLYPHENOLS; CHROMATOGRAPHY; CONSTITUENTS; PRODUCTS; EXTRACTS; COLOR; L.	Isoetes sinensis Palmer is a critically endangered, first-class protected plant in China. Until now, researchers have primarily focused on the ultrastructure, phylogeny, and transcriptomes of the plant. However, flavonoid profiles and bioactivity of I. sinensis have not been extensively investigated. To develop the endangered I. sinensis for edible and medicinal purposes, flavonoid content, chemical constitution, and antioxidant activities were investigated in this study. Results revealed the following. 1) The total flavonoid content was determined as 10.74 +/- 0.25 mg/g., 2) Antioxidant activities were stronger than most ferns, especially ABTS free radical scavenging activities. 3) Four flavones, containing apigenin, apigenin-7-glucuronide, acacetin-7-O-glcopyranoside, and homoplantageninisoetin; four flavonols, namely, isoetin, kaempferol-3-O-glucoside, quercetin-3-O-[6 ''-O-(3-hydroxy-3-methylglutaryl)-beta-D-glucopyranoside], and limocitrin-Neo; one prodelphinidin (procyanidins;) and one nothofagin (dihydrochalcone) were tentatively identified in the mass spectrometry-DAD (254nm) chromatograms. This study was the first to report on flavonoid content and antioxidant activities of I. sinensis. Stronger antioxidant activity and flavonoid content suggests that the endangered I. sinensis is an important and potentially edible and medicinal plant.	[Wang, Xin; Ding, Guohua; Liu, Baodong] Harbin Normal Univ, Coll Life Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Wang, Quanxi] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China; [Wang, Quanxi] Chinese Acad Sci, Shanghai Chenshan Bot Garden, Shanghai Key Lab Plant Funct Genom & Resources, Shanghai, Peoples R China	Harbin Normal University; Shanghai Normal University; Chinese Academy of Sciences	Ding, GH; Liu, BD (corresponding author), Harbin Normal Univ, Coll Life Sci & Technol, Harbin, Heilongjiang, Peoples R China.	guohuading@126.com; 99bd@163.com			Shanghai Engineering Research Center of Plant Germplasm Resources [17DZ2252700]	Shanghai Engineering Research Center of Plant Germplasm Resources	The work was sponsored by Shanghai Engineering Research Center of Plant Germplasm Resources (No. 17DZ2252700). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar RK, 2011, B ENV PHARM LIFE SCI, V1, P57; Abu-Reidah IM, 2014, ELECTROPHORESIS, V35, P1571, DOI 10.1002/elps.201300646; Amaya KR, 2011, J NEUROCHEM, V118, P499, DOI 10.1111/j.1471-4159.2011.07274.x; Andrae-Marobela K, 2013, CURR DRUG METAB, V14, P392, DOI 10.2174/13892002113149990095; Arraez-Roman D, 2010, ELECTROPHORESIS, V31, P2289, DOI 10.1002/elps.200900679; ASAKAWA Y, 1982, PROG CH ORG NAT PROD, V42, P1; de Almeida CL, 2018, CHEM-BIOL INTERACT, V279, P227, DOI 10.1016/j.cbi.2017.11.021; Cao JG, 2015, IND CROP PROD, V75, P135, DOI 10.1016/j.indcrop.2015.04.064; Chen SD, 2017, ONCOTARGET, V8, P10071, DOI 10.18632/oncotarget.14336; Chen YY, 2012, AQUAT BOT, V96, P52, DOI 10.1016/j.aquabot.2011.09.001; Chukwumah Y, 2009, INT J MOL SCI, V10, P4941, DOI 10.3390/ijms10114941; Conrad J, 2009, J NAT PROD, V72, P835, DOI 10.1021/np800769g; Dai LM, 2008, ARCH PHARM RES, V31, P1325, DOI 10.1007/s12272-001-2113-2; Delmas D, 2012, ANTI-CANCER AGENT ME, V12, P835, DOI 10.2174/187152012802650093; Ding GH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139231; Gichira AW, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038497; Huang WP, 2018, J PHARMACEUT BIOMED, V154, P236, DOI 10.1016/j.jpba.2018.02.020; Islam MN, 2013, ACTA CHROMATOGR, V25, P555, DOI 10.1556/AChrom.25.2013.3.11; Iswaldi I, 2011, ANAL BIOANAL CHEM, V400, P3643, DOI 10.1007/s00216-011-4998-z; Jiang RW, 2008, PHYTOCHEMISTRY, V69, P2495, DOI 10.1016/j.phytochem.2008.07.005; Jove M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03346; Kang M, 2005, ANN BOT-LONDON, V96, P1265, DOI 10.1093/aob/mci277; Kraus GA, 2011, GREEN CHEM, V13, P2734, DOI 10.1039/c1gc15650k; Ledesma-Escobar CA, 2015, J MASS SPECTROM, V50, P1196, DOI 10.1002/jms.3637; Li ZZ, 2012, AM J BOT, V99, pE184, DOI 10.3732/ajb.1100319; Lopez-Gutierrez N, 2014, J CHROMATOGR B, V973, P17, DOI 10.1016/j.jchromb.2014.09.038; Lung MY, 2011, INT J MOL SCI, V12, P6367, DOI 10.3390/ijms12106367; Madunic J, 2018, CANCER LETT, V413, P11, DOI 10.1016/j.canlet.2017.10.041; MARKHAM KR, 1988, PHYTOCHEMISTRY, V27, P307, DOI 10.1016/0031-9422(88)80645-9; Mbeunkui F, 2012, J SEP SCI, V35, P1682, DOI 10.1002/jssc.201200198; Otero P, 2017, ANAL BIOANAL CHEM, V409, P4659, DOI 10.1007/s00216-017-0412-9; PIGG KB, 1992, ANN MO BOT GARD, V79, P589, DOI 10.2307/2399754; Rahman MAA, 2007, B KOREAN CHEM SOC, V28, P1261; RICHARDSON PM, 1989, BIOCHEM SYST ECOL, V17, P155, DOI 10.1016/0305-1978(89)90073-2; Simirgiotis MJ, 2017, REV BRAS FARMACOGN, V27, P179, DOI 10.1016/j.bjp.2016.10.002; Skrzypczak-Pietraszek E, 2014, CHEM BIODIVERS, V11, P562, DOI 10.1002/cbdv.201300148; Wang JY, 2005, J NATURAL HIST INT J, V60, P358; Wang X, 2017, IND CROP PROD, V97, P137, DOI 10.1016/j.indcrop.2016.12.013; Wang X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173003; Wang X, 2016, MOLECULES, V21, DOI 10.3390/molecules21030360; Wang Y, 2015, J FOOD DRUG ANAL, V23, P310, DOI 10.1016/j.jfda.2014.10.002; Xiao JB, 2015, CURR MED CHEM, V22, P23; Yang T, 2016, PLANT MOL BIOL REP, V34, P136, DOI 10.1007/s11105-015-0906-6; Yao Y, 2012, INT J MOL SCI, V13, P2707, DOI 10.3390/ijms13032707; [叶其刚 Ye Qigang], 2003, [武汉植物学研究, Journal of Wuhan Botanical Research], V21, P216; Yumkham SD, 2017, GENET RESOUR CROP EV, V64, P467, DOI 10.1007/s10722-016-0372-5; Zeng FF, 2017, INT J FOOD SCI TECH, V52, P897, DOI 10.1111/ijfs.13353; Zhang XZ, 2016, ITAL J FOOD SCI, V28, P139	48	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232185	10.1371/journal.pone.0232185	http://dx.doi.org/10.1371/journal.pone.0232185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396536	gold, Green Published			2022-12-26	WOS:000537475000007
J	Li, T; Yu, Y; Song, YR; Li, XC; Lan, DY; Zhang, P; Xiao, YJ; Xing, YF				Li, Tao; Yu, Ying; Song, Yarong; Li, Xuechao; Lan, Dongyang; Zhang, Peng; Xiao, Yajun; Xing, Yifei			Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance	FASEB JOURNAL			English	Article						anoikis resistance; BDNF; epithelial-mesenchymal transition; prostate cancer; TrkB	NEUROTROPHIC FACTOR ACTIVATION; SELECTIVE INHIBITOR; TRUNCATED TRKB; KINASE; EXPRESSION; RECEPTORS; AKT; EMT; ADENOCARCINOMA; SUPPRESSION	Prostate cancer (PCa) is one of the most common malignant diseases in male worldwide, yet, the molecular mechanisms involved in PCa progression are still poorly understood. This study aimed to investigate the roles of the brain-derived neurotrophic factor/tropomyosin receptor kinase B (BDNF/TrkB) pathway in PCa progression. It was demonstrated by immunohistochemical analysis that both BDNF and TrkB were overexpressed in PCa tissues and elevated TrkB expression was tightly related with lymph node metastasis and advanced stage of PCa. In vitro studies showed that stimulation with rhBDNF or overexpression of TrkB in PCa cells promoted cell migration, invasion, and anoikis resistance. Overexpression of TrkB also resulted in epithelial-mesenchymal transition (EMT)-like transformation in cell morphology, whereas RNA interference-mediated TrkB depletion caused reversion of EMT. Further investigation demonstrated that protein kinase B (AKT) was responsible for BDNF/TrkB signaling-induced pro-migratory and pro-invasive effects, EMT, and anoikis resistance. Finally, in vivo studies confirmed that enhanced TrkB expression facilitated tumor growth, whereas downregulation of TrkB suppressed tumor growth. Our findings illustrate that BDNF/TrkB pathway is crucial for PCa progression, which may provide a novel therapeutic strategy for the treatment of advanced PCa.	[Li, Tao; Yu, Ying; Song, Yarong; Li, Xuechao; Lan, Dongyang; Zhang, Peng; Xiao, Yajun; Xing, Yifei] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China; [Li, Tao] Southeast Univ, Sch Med, Zhongda Hosp, Dept Urol, Nanjing, Peoples R China; [Li, Xuechao] Wuhan Cent Hosp, Dept Urol, Wuhan, Peoples R China; [Lan, Dongyang] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol, Zhengzhou, Henan, Peoples R China; [Zhang, Peng] Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Southeast University - China; Zhengzhou University; Wuhan University	Xing, YF (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.	yifei_xing@163.com		Zhang, Peng/0000-0002-9967-1597	National Natural Science Foundation of China [81272847, 81772751, 81974399]; Program for New Century Excellent Talents in University [NCET-13-0239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	National Natural Science Foundation of China, Grant/Award Number: 81272847, 81772751 and 81974399; Program for New Century Excellent Talents in University, Grant/Award Number: NCET-13-0239	Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; BEHRENS J, 1991, EXP SUPPL, V59, P109; Bronzetti E, 2008, ONCOL REP, V19, P969; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; DAVIS PD, 1992, J MED CHEM, V35, P177, DOI 10.1021/jm00079a024; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eide FF, 1996, J NEUROSCI, V16, P3123; ELLIOTT LH, 1990, BIOCHEM BIOPH RES CO, V171, P148, DOI 10.1016/0006-291X(90)91369-4; Fenner BM, 2012, CYTOKINE GROWTH F R, V23, P15, DOI 10.1016/j.cytogfr.2012.01.002; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fujikawa H, 2012, J GASTROENTEROL, V47, P775, DOI 10.1007/s00535-012-0532-0; Ghosh PM, 2003, CURR DRUG METAB, V4, P487, DOI 10.2174/1389200033489226; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; Jaboin J, 2002, CANCER RES, V62, P6756; Kim MS, 2015, ONCOTARGET, V6, P40158, DOI 10.18632/oncotarget.5522; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; Kuzniewska B, 2013, MOL CELL BIOL, V33, P2149, DOI 10.1128/MCB.00008-13; Lam CT, 2011, CLIN CANCER RES, V17, P3123, DOI 10.1158/1078-0432.CCR-10-2802; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Marchetti A, 2008, HUM MUTAT, V29, P609, DOI 10.1002/humu.20707; MATSUMOTO K, 1995, CANCER RES, V55, P1798; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Miknyoczki SJ, 1999, INT J CANCER, V81, P417, DOI 10.1002/(SICI)1097-0215(19990505)81:3<417::AID-IJC16>3.0.CO;2-6; Montanari M, 2017, ONCOTARGET, V8, P35376, DOI 10.18632/oncotarget.15686; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Okugawa Y, 2013, BRIT J CANCER, V108, P121, DOI 10.1038/bjc.2012.499; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paschalis A, 2019, EUR UROL, V76, P469, DOI 10.1016/j.eururo.2019.06.030; Patani N, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-23; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Prakash YS, 2014, PHARMACOL THERAPEUT, V143, P74, DOI 10.1016/j.pharmthera.2014.02.006; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Ricci A, 2013, CELL CYCLE, V12, P1696, DOI 10.4161/cc.24759; Sakamoto S, 2010, MOL ASPECTS MED, V31, P205, DOI 10.1016/j.mam.2010.02.001; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Stoilov P, 2002, BIOCHEM BIOPH RES CO, V290, P1054, DOI 10.1006/bbrc.2001.6301; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; TAPLEY P, 1992, ONCOGENE, V7, P371; Tejeda GS, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809950; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Wang ZW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173335; Weeraratna AT, 2000, PROSTATE, V45, P140, DOI 10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#; Xu DF, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0930-6; Xu WT, 2015, CELL ADHES MIGR, V9, P317, DOI 10.1080/19336918.2015.1016686; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu XH, 2008, CANCER SCI, V99, P543, DOI 10.1111/j.1349-7006.2007.00722.x; Zhang SY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-43	51	19	19	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9087	9101		10.1096/fj.201802159RRR	http://dx.doi.org/10.1096/fj.201802159RRR		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32390303				2022-12-26	WOS:000532276800001
J	Takehara, S; Takaku, Y; Shimomura, M; Hariyama, T				Takehara, Sayuri; Takaku, Yasuharu; Shimomura, Masatsugu; Hariyama, Takahiko			Imaging dataset of fresh hydrous plants obtained by field-emission scanning electron microscopy conducted using a protective NanoSuit	PLOS ONE			English	Article							THIN POLYMER MEMBRANE; SEM	Although scanning electron microscopy (SEM) can generate high-resolution images of nanosized objects, it requires a high vacuum to do so, which precludes direct observations of living organisms and often produces unwanted structural changes. It has previously been reported that a simple surface modification gives rise to a nanoscale layer, termed the "NanoSuit", which can keep small animals alive under the high vacuum required for field-emission scanning electron microscopy (FE-SEM). We have previously applied this technique to plants, and successfully observed healthy petals in a fully hydrated state using SEM. The flower petals protected with the NanoSuit appeared intact, although we still lack a fundamental understanding of the images of other plants observed using FE-SEM. This report presents and evaluates a rich set of images, acquired using the NanoSuit, for a taxonomically diverse set of plant species. This dataset of images allows the surface features of various plants to be analyzed and thus provides a further complementary morphological profile. Image data can be accessed and viewed through Figshare (https://doi.org/10.6084/m9.figshare.c.4446026.v1).	[Takehara, Sayuri; Takaku, Yasuharu; Hariyama, Takahiko] Hamamatsu Univ, Sch Med, Preeminent Med Photon Educ & Res Ctr, Inst NanoSuit Res,Higashi Ku, Hamamatsu, Shizuoka, Japan; [Shimomura, Masatsugu] Chitose Inst Sci & Technol, Dept Bio & Mat Photon, Chitose, Hokkaido, Japan	Hamamatsu University School of Medicine	Hariyama, T (corresponding author), Hamamatsu Univ, Sch Med, Preeminent Med Photon Educ & Res Ctr, Inst NanoSuit Res,Higashi Ku, Hamamatsu, Shizuoka, Japan.	hariyama@hama-med.ac.jp			Takeda Science Foundation [JP25292198, 17K08150, 15K14558, 15H01598, JP 24120001]	Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-Aid of Scientific Research for Y. T. (JP25292198, 17K08150), Grant-in-Aid of challenging Exploratory Research for Y. T. (15K14558), Grant-in-Aid of Scientific Research on Innovative Areas in "Innovative Materials Engineering Based on Biological Diversity" for Y.T. (15H01598) and for T. H. (JP 24120001), and by grants from the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to express our thanks to Dr. Isao Ohta for his technical assistance. We are also grateful to Mr. Masaki Akino (YAMAHEI Co. Ltd.) for providing a green laver. This work was supported by a Grant-in-Aid of Scientific Research for Y. T. (JP25292198, 17K08150); by a Grant-in-Aid of challenging Exploratory Research for Y. T. (15K14558); by a Grant-in-Aid of Scientific Research on Innovative Areas in "Innovative Materials Engineering Based on Biological Diversity" for Y.T. (15H01598) and for T.H. (JP 24120001); and by grants from the Takeda Science Foundation.	DANILATOS GD, 1991, J MICROSC-OXFORD, V162, P391, DOI 10.1111/j.1365-2818.1991.tb03149.x; Ohta I, 2014, MICROSCOPY-JPN, V63, P295, DOI 10.1093/jmicro/dfu015; Suzuki E, 2002, J MICROSC-OXFORD, V208, P153, DOI 10.1046/j.1365-2818.2002.01082.x; Suzuki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078563; Symondson WOC, 1997, ENTOMOL EXP APPL, V85, P75, DOI 10.1023/A:1003061816038; Takaku Y, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160887; Takaku Y, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2857; Takaku Y, 2013, P NATL ACAD SCI USA, V110, P7631, DOI 10.1073/pnas.1221341110; Takehara S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19968-w	9	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232992	10.1371/journal.pone.0232992	http://dx.doi.org/10.1371/journal.pone.0232992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392263	Green Published, gold			2022-12-26	WOS:000537470300034
J	Hata, A; Suzuki, H; Nakajima, T; Fujiwara, T; Shiina, Y; Kaiho, T; Toyoda, T; Inage, T; Ito, T; Sakairi, Y; Tamura, H; Wada, H; Yamada, Y; Chiyo, M; Matsusaka, K; Fukuyo, M; Shinohara, K; Itoga, S; Motohashi, S; Matsushita, K; Kaneda, A; Yoshino, I				Hata, Atsushi; Suzuki, Hidemi; Nakajima, Takahiro; Fujiwara, Taiki; Shiina, Yuki; Kaiho, Taisuke; Toyoda, Takahide; Inage, Terunaga; Ito, Takamasa; Sakairi, Yuichi; Tamura, Hajime; Wada, Hironobu; Yamada, Yoshito; Chiyo, Masako; Matsusaka, Keisuke; Fukuyo, Masaki; Shinohara, Ken-ichi; Itoga, Sakae; Motohashi, Shinichiro; Matsushita, Kazuyuki; Kaneda, Atsushi; Yoshino, Ichiro			Differential gene analysis during the development of obliterative bronchiolitis in a murine orthotopic lung transplantation model: A comprehensive transcriptome-based analysis	PLOS ONE			English	Article							ANTIBODY-MEDIATED REJECTION; INTERNATIONAL SOCIETY; BRONCHIAL EPITHELIUM; CLASS-I; EXPRESSION; CELLS; HLA; ALLOGRAFTS; DIAGNOSIS; ANTIGENS	Background Obliterative bronchiolitis (OB) is a known issue during minor histocompatibility antigen (mHA) disparity during lung transplantation. This study evaluated gene expression in a murine orthotropic lung transplantation model using microarray analysis. Methods Left lungs from C57BL/10(H-2b) donor mice were transplanted into mHA-mismatched C57BL/6(H-2b) recipient mice. Three groups (OB, non-OB, and sham controls) were confirmed pathologically and analyzed. Gene expression changes in the lung grafts were determined by microarray and immunohistochemical staining, and genes were verified by quantitative PCR in the lungs and mediastinal lymph nodes (LNs). Results A total of 1343 genes were upregulated in the OB lungs compared to the sham group. Significant upregulation was observed for genes related to innate, e.g. Tlr2 and CCL3 and adaptive immunity, e.g. H2-ab1 and Il-21. Positive labeling for MHC class II antigen was observed in the bronchial epithelium of OB accompanied with B cells. We found increased Tlr2, Ccl3, H2-ab1, Il-21, Ighg3, Ifng, and Pdcd1 mRNA expression in the OB lung, and increased Il-21, Ighg3, and Pdcd1 expression in the OB LNs. Conclusions Adaptive and innate immune reactions were involved in OB after lung transplantation, and genetic examination of related genes could be used for detection of OB.	[Hata, Atsushi; Suzuki, Hidemi; Nakajima, Takahiro; Fujiwara, Taiki; Shiina, Yuki; Kaiho, Taisuke; Toyoda, Takahide; Inage, Terunaga; Ito, Takamasa; Sakairi, Yuichi; Tamura, Hajime; Wada, Hironobu; Yamada, Yoshito; Chiyo, Masako; Yoshino, Ichiro] Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chiba, Japan; [Toyoda, Takahide; Motohashi, Shinichiro] Chiba Univ, Grad Sch Med, Dept Med Immunol, Chiba, Japan; [Matsusaka, Keisuke; Fukuyo, Masaki; Shinohara, Ken-ichi; Kaneda, Atsushi] Chiba Univ, Grad Sch Med, Dept Mol Oncol, Chiba, Japan; [Fukuyo, Masaki] Kazusa DNA Res Inst, Dept Genome Res & Dev, Chiba, Japan; [Itoga, Sakae; Matsushita, Kazuyuki] Chiba Univ, Grad Sch Med, Dept Lab Med, Chiba, Japan; [Itoga, Sakae; Matsushita, Kazuyuki] Chiba Univ, Grad Sch Med, Div Clin Genet & Prote, Chiba, Japan	Chiba University; Chiba University; Chiba University; Kazusa DNA Research Institute; Chiba University; Chiba University	Suzuki, H (corresponding author), Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chiba, Japan.	hidemisuzukidesu@yahoo.co.jp	Nakajima, Takahiro/GRX-7909-2022; Fujiwara, Taiki/AAB-4962-2021; Ichiro, Yoshino/HCH-1137-2022	Nakajima, Takahiro/0000-0002-4937-5378; 	JSPS KAKENHI [JP17K16603, JP16K10672]; JSPS Fujita Memorial Fund for Medical Research	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Fujita Memorial Fund for Medical Research	This study was supported by grants from JSPS KAKENHI for AH and TF (https://www.jsps.go.jp/j-grantsinaid/)(Grant Numbers JP17K16603 and JP16K10672) and JSPS Fujita Memorial Fund for Medical Research for HS (https://www.jsps.go.jp/j-donation/fujita.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2012, HUM IMMUNOL, V73, P1226, DOI 10.1016/j.humimm.2012.07.330; Almoguera B, 2014, AM J TRANSPLANT, V14, P764, DOI 10.1111/ajt.12653; Andersson-Sjoland A, 2011, J HEART LUNG TRANSPL, V30, P945, DOI 10.1016/j.healun.2011.04.006; Arslan F, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/704202; Barker AF, 2014, NEW ENGL J MED, V370, P1820, DOI 10.1056/NEJMra1204664; Berastegui C, 2013, TRANSPL P, V45, P3163, DOI 10.1016/j.transproceed.2013.06.013; Brocker V, 2006, AM J RESP CRIT CARE, V173, P1276, DOI 10.1164/rccm.200509-1381OC; CHAMBERLAIN D, 1994, J HEART LUNG TRANSPL, V13, P963; Corris PA, 2015, THORAX, V70, P442, DOI 10.1136/thoraxjnl-2014-205998; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dong M, 2015, INT J CLIN EXP PATHO, V8, P7050; Dupin C, 2017, TRANSPLANTATION, V101, P2192, DOI 10.1097/TP.0000000000001553; Fan L, 2011, AM J TRANSPLANT, V11, P911, DOI 10.1111/j.1600-6143.2011.03482.x; FLYER DC, 1985, J IMMUNOL, V135, P2287; GLANVILLE AR, 1989, AM REV RESPIR DIS, V139, P330, DOI 10.1164/ajrccm/139.2.330; Grossman EJ, 2009, TRANSL RES, V153, P153, DOI 10.1016/j.trsl.2009.01.005; Gupta G, 2014, TRANSPLANTATION, V97, P1240, DOI 10.1097/01.TP.0000442503.85766.91; Hayes D, 2016, J HEART LUNG TRANSPL, V35, P186, DOI 10.1016/j.healun.2015.08.022; Honger G, 2011, TRANSPLANTATION, V92, P41, DOI 10.1097/TP.0b013e31821cdf0d; Jonigk D, 2015, AM J PATHOL, V185, P3178, DOI 10.1016/j.ajpath.2015.08.016; KALB TH, 1991, AM J RESP CELL MOL, V4, P320, DOI 10.1165/ajrcmb/4.4.320; Kawakami T, 2017, AM J TRANSPLANT, V17, P2338, DOI 10.1111/ajt.14257; Kittur DS, 2002, J HEART LUNG TRANSPL, V21, P882, DOI 10.1016/S1053-2498(02)00407-2; Lande JD, 2005, AM J TRANSPLANT, V5, P2170, DOI 10.1111/j.1600-6143.2005.01026.x; Levine DJ, 2016, J HEART LUNG TRANSPL, V35, P397, DOI 10.1016/j.healun.2016.01.1223; Lu BS, 2006, CHEST, V130, P847, DOI 10.1378/chest.130.3.847; McGrath MM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00047; Meyer KC, 2014, EUR RESPIR J, V44, P1479, DOI 10.1183/09031936.00107514; Mimura T, 2015, AM J PATHOL, V185, P1564, DOI 10.1016/j.ajpath.2015.03.002; Miyamoto E, 2017, TRANSPLANTATION, V101, pe156, DOI 10.1097/TP.0000000000001665; Mohamed MSA, 2015, ARCH MED RES, V46, P240, DOI 10.1016/j.arcmed.2015.03.004; Morrell MR, 2014, J HEART LUNG TRANSPL, V33, P1288, DOI 10.1016/j.healun.2014.07.018; Opelz G, 2007, TRANSPLANTATION, V84, P137, DOI 10.1097/01.tp.0000269725.74189.b9; Opelz G, 2010, TRANSPLANTATION, V90, P912, DOI 10.1097/TP.0b013e3181f2c981; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pabon MA, 2011, TRANSPL P, V43, P3319, DOI 10.1016/j.transproceed.2011.09.007; Popli R, 2014, IMMUNOL RES, V58, P249, DOI 10.1007/s12026-014-8514-3; Reilly M, 2013, CLIN PHARMACOL THER, V94, P593, DOI 10.1038/clpt.2013.150; ROMANIUK A, 1987, TRANSPLANTATION, V44, P209, DOI 10.1097/00007890-198708000-00007; Roopenian D, 2002, IMMUNOL REV, V190, P86, DOI 10.1034/j.1600-065X.2002.19007.x; Royer PJ, 2016, TRANSPLANTATION, V100, P1803, DOI 10.1097/TP.0000000000001215; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santana-Rodriguez N, 2012, J HEART LUNG TRANSPL, V31, P213, DOI 10.1016/j.healun.2011.11.011; Serrick C, 1997, ANN THORAC SURG, V63, P202; Shi XY, 2016, TRANSPLANT REV-ORLAN, V30, P27, DOI 10.1016/j.trre.2015.06.003; Shitrit D, 2005, J HEART LUNG TRANSPL, V24, P1440, DOI 10.1016/j.healun.2004.08.006; Suviolahti E, 2015, TRANSPL IMMUNOL, V32, P9, DOI 10.1016/j.trim.2014.11.215; Suzuki H, 2012, JOVE-J VIS EXP, DOI 10.3791/3947; Takahashi T, 2018, AM J TRANSPLANT, V18, P216, DOI 10.1111/ajt.14437; Tinckam KJ, 2006, CLIN J AM SOC NEPHRO, V1, P404, DOI 10.2215/CJN.00270106; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; Verleden SE, 2016, CHEST, V150, P219, DOI 10.1016/j.chest.2016.04.014; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Vitalone MJ, 2010, TRANSPLANTATION, V89, P537, DOI 10.1097/TP.0b013e3181ca7389; Walton DC, 2016, AM J TRANSPLANT, V16, P2695, DOI 10.1111/ajt.13798; Weigt SS, 2017, ANN AM THORAC SOC, V14, pS252, DOI 10.1513/AnnalsATS.201608-618MG; Willicombe M, 2012, TRANSPLANTATION, V94, P172, DOI 10.1097/TP.0b013e3182543950; Youssef AR, 2002, TRANSPL INT, V15, P302, DOI 10.1111/j.1432-2277.2002.tb00169.x; Yusen RD, 2015, J HEART LUNG TRANSPL, V34, P1264, DOI 10.1016/j.healun.2015.08.014	59	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232884	10.1371/journal.pone.0232884	http://dx.doi.org/10.1371/journal.pone.0232884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384121	Green Published, gold			2022-12-26	WOS:000537468300037
J	Galassi, TV; Antman-Passig, M; Yaari, Z; Jessurun, J; Schwartz, RE; Heller, DA				Galassi, Thomas, V; Antman-Passig, Merav; Yaari, Zvi; Jessurun, Jose; Schwartz, Robert E.; Heller, Daniel A.			Long-term in vivo biocompatibility of single-walled carbon nanotubes	PLOS ONE			English	Article							AUTOFLUORESCENCE; TOXICITY; CELL	Over the past two decades, measurements of carbon nanotube toxicity and biodistribution have yielded a wide range of results. Properties such as nanotube type (single-walled vs. multi-walled), purity, length, aggregation state, and functionalization, as well as route of administration, greatly affect both the biocompatibility and biodistribution of carbon nanotubes. These differences suggest that generalizable conclusions may be elusive and that studies must be material- and application-specific. Here, we assess the short- and long-term biodistribution and biocompatibility of a single-chirality DNA-encapsulated single-walled carbon nanotube complex upon intravenous administration that was previously shown to function as an in-vivo reporter of endolysosomal lipid accumulation. Regarding biodistribution and fate, we found bulk specificity to the liver and > 90% signal attenuation by 14 days in mice. Using near-infrared hyperspectral microscopy to measure single nanotubes, we found low-level, long-term persistence in organs such as the heart, liver, lung, kidney, and spleen. Measurements of histology, animal weight, complete blood count; biomarkers of organ function all suggest short- and long-term biocompatibility. This work suggests that carbon nanotubes can be used as preclinical research tools in-vivo without affecting acute or long-term health.	[Galassi, Thomas, V; Antman-Passig, Merav; Yaari, Zvi; Heller, Daniel A.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Galassi, Thomas, V; Schwartz, Robert E.; Heller, Daniel A.] Cornell Univ, Physiol Biophys & Syst Biol Grad Program, Weill Cornell Med Coll, New York, NY 10021 USA; [Jessurun, Jose; Schwartz, Robert E.] Cornell Univ, Div Gastroenterol & Hepatol, Dept Med, Weill Med Coll, New York, NY 10021 USA; [Heller, Daniel A.] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	Heller, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA.; Heller, DA (corresponding author), Cornell Univ, Physiol Biophys & Syst Biol Grad Program, Weill Cornell Med Coll, New York, NY 10021 USA.; Heller, DA (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10021 USA.	hellerd@mskcc.org	Schwartz, Robert/AAE-7153-2021; Heller, Daniel/A-4283-2008	Heller, Daniel/0000-0002-6866-0000; Antman-Passig, Merav/0000-0003-2102-9139	NIH [DP2-HD075698]; NIDDK [R01-DK114321]; CTSC [UL1-TR002384]; NCI [R01-CA215719]; Cancer Center Support Grant [P30-CA008748]; National Science Foundation CAREER Award [1752506]; Ara Parseghian Medical Research Fund; American Cancer Society Research Scholar Grant [GC230452]; Pershing Square Sohn Cancer Research Alliance; Honorable Tina Brozman Foundation for Ovarian Cancer Research; Expect Miracles Foundation -Financial Services Against Cancer; Anna Fuller Fund; Louis V. Gerstner Jr. Young Investigator's Fund; Frank A. Howard Scholars Program; MSK's Cycle for Survival's Equinox Innovation Award in Rare Cancers; Alan and Sandra Gerry Metastasis Research Initiative; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center; Imaging & Radiation Sciences Program; Center for Molecular Imaging and Nanotechnology of Memorial Sloan Kettering Cancer Center; DOD [W81XWH1810237]; Irma Hirschl Trust Research Award Scholar;  [1K08DK101754];  [1R03DK117252];  [R01CA234614]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CTSC; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant; National Science Foundation CAREER Award(National Science Foundation (NSF)); Ara Parseghian Medical Research Fund; American Cancer Society Research Scholar Grant(American Cancer Society); Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); Honorable Tina Brozman Foundation for Ovarian Cancer Research; Expect Miracles Foundation -Financial Services Against Cancer; Anna Fuller Fund; Louis V. Gerstner Jr. Young Investigator's Fund; Frank A. Howard Scholars Program; MSK's Cycle for Survival's Equinox Innovation Award in Rare Cancers; Alan and Sandra Gerry Metastasis Research Initiative; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center; Imaging & Radiation Sciences Program; Center for Molecular Imaging and Nanotechnology of Memorial Sloan Kettering Cancer Center; DOD(United States Department of Defense); Irma Hirschl Trust Research Award Scholar; ; ; 	This work was supported in part by the NIH New Innovator Award (DP2-HD075698), NIDDK (R01-DK114321), CTSC (UL1-TR002384) NCI (R01-CA215719), the Cancer Center Support Grant (P30-CA008748), the National Science Foundation CAREER Award (1752506), the Ara Parseghian Medical Research Fund, the American Cancer Society Research Scholar Grant (GC230452), the Pershing Square Sohn Cancer Research Alliance, the Honorable Tina Brozman Foundation for Ovarian Cancer Research, the Expect Miracles Foundation -Financial Services Against Cancer, the Anna Fuller Fund, the Louis V. Gerstner Jr. Young Investigator's Fund, the Frank A. Howard Scholars Program, MSK's Cycle for Survival's Equinox Innovation Award in Rare Cancers, the Alan and Sandra Gerry Metastasis Research Initiative, Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center, the Imaging & Radiation Sciences Program, and the Center for Molecular Imaging and Nanotechnology of Memorial Sloan Kettering Cancer Center. R.E.S. is supported by 1K08DK101754, 1R03DK117252, R01CA234614, DOD grant W81XWH1810237, and is a Irma Hirschl Trust Research Award Scholar.	Alidori S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac9647; Ao GY, 2016, J AM CHEM SOC, V138, P16677, DOI 10.1021/jacs.6b09135; Ao Geyou, 2015, Curr Protoc Chem Biol, V7, P43, DOI 10.1002/9780470559277.ch140099; Ao GY, 2014, J AM CHEM SOC, V136, P10383, DOI 10.1021/ja504078b; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; DELCASTILLO P, 1986, HISTOCHEMISTRY, V85, P439, DOI 10.1007/BF00982676; Ema M, 2016, REGUL TOXICOL PHARM, V74, P42, DOI 10.1016/j.yrtph.2015.11.015; Galassi TV, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2680; Galassi TV, 2017, ANAL CHEM, V89, P1073, DOI 10.1021/acs.analchem.6b04091; Harvey JD, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0041; Heller DA, 2020, NAT NANOTECHNOL, V15, P164, DOI 10.1038/s41565-020-0656-y; Iverson NM, 2013, NAT NANOTECHNOL, V8, P873, DOI [10.1038/nnano.2013.222, 10.1038/NNANO.2013.222]; Lee HJ, 2011, NAT NANOTECHNOL, V6, P120, DOI 10.1038/nnano.2010.281; Lehman JH, 2011, CARBON, V49, P2581, DOI 10.1016/j.carbon.2011.03.028; Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105; Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Ong LC, 2016, ARCH TOXICOL, V90, P103, DOI 10.1007/s00204-014-1376-6; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Roxbury D, 2015, SCI REP-UK, V5, DOI 10.1038/srep14167; Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68; Viegas MS, 2007, EUR J HISTOCHEM, V51, P59; Wang LR, 2014, SMALL, V10, P2859, DOI 10.1002/smll.201303342; Williams RM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq1090; Xue X, 2016, NAT NANOTECHNOL, V11, P613, DOI [10.1038/nnano.2016.23, 10.1038/NNANO.2016.23]; Xue X, 2014, NANO LETT, V14, P5110, DOI 10.1021/nl501839q; Zhang MF, 2018, CARBON, V127, P93, DOI 10.1016/j.carbon.2017.10.085	28	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0226791	10.1371/journal.pone.0226791	http://dx.doi.org/10.1371/journal.pone.0226791			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374764	Green Submitted, Green Published, gold			2022-12-26	WOS:000537283500002
J	Leak, SA; Mmbaga, LG; Mkwizu, EW; Mapendo, PJ; Henke, O				Leak, Steven Alan; Mmbaga, Lilian Gasper; Mkwizu, Elifuraha Wilson; Mapendo, Priscus John; Henke, Oliver			Hematological malignancies in East Africa-Which cancers to expect and how to provide services	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; RISK-FACTORS; ASSOCIATION; CHALLENGES; DIAGNOSIS; POLLUTION	Background Sub-Saharan Africa (SSA) has an increasing non-communicable disease burden. Tanzania has an incidence of more than 35,000 cancer cases per year with an 80% mortality rate. Hematological malignancies account for 10% of these cases. The numbers will double within the next 10 years due to demographic changes, better diagnostic capabilities and life style changes. Kilimanjaro Christian Medical Centre established a Cancer Care Centre (CCC) in December 2016 for a catchment area of 15 million people in Northern Tanzania. This article aims to display the hematological diagnosis and characteristics of the patients as well as to describe the advancements of hematologic services in a low resource setting. Methods A cross-sectional analysis of all hematological malignancies at CCC from December 2016 to May 2019 was performed and a narrative report provides information about diagnostic means, treatment and the use of synergies. Results A total of 209 cases have been documented, the most common malignancies were NHL and MM with 44% and 20%. 36% of NHL cases, 16% of MM cases and 63% of CML cases were seen in patients under the age of 45. When subcategorized, CLL/SLL cases had a median age was 56.5, 51 years for those with other entities of NHL. Sexes were almost equally balanced in all NHL groups while clear male predominance was found in HL and CML. Discussion Malignancies occur at a younger age and higher stages than in Western countries. It can be assumed that infections play a key role herein. Closing the gap of hematologic services in SSA can be achieved by adapting and reshaping existing infrastructure and partnering with international organizations.	[Leak, Steven Alan; Mmbaga, Lilian Gasper; Mkwizu, Elifuraha Wilson; Mapendo, Priscus John; Henke, Oliver] Kilimanjaro Christian Med Ctr, Canc Care Ctr, Moshi, Tanzania	Kilimanjaro Christian Medical Centre	Henke, O (corresponding author), Kilimanjaro Christian Med Ctr, Canc Care Ctr, Moshi, Tanzania.	Henke.oliver@gmx.de	Henke, Oliver/HGA-7260-2022					American Cancer Society, 2018, KEY STAT HODGK LYMPH; Banavali A, 2018, J GLOBAL ONCOLOGY, DOI 10.1200/JGO.17.00133; Bray F, 2015, INT J CANCER, V137, P2060, DOI 10.1002/ijc.29670; Costello CL, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.5359.5359; Dammeh B, 2018, MED REV, V32, P36; Dickens C., 2014, INT J CANCER, V135, P9; Dongho N, 2018, HAEMATOL INT J, V2, P1; Edgil D, 2014, AFR J LAB MED, V3, DOI 10.4102/ajlm.v3i1.101; Elibariki R, 2017, CHEMOSPHERE, V178, P154, DOI 10.1016/j.chemosphere.2017.03.036; Faye BF, 2016, ANN HEMATOL, V95, P1603, DOI 10.1007/s00277-016-2745-4; Ferlay J, 2013, GLOBOCAN 2012 CANC I; Fish M, 2019, ONCOLOGIST, V24, P1557, DOI 10.1634/theoncologist.2019-0207; Fitzgibbon JE, 2014, JAIDS-J ACQ IMM DEF, V65, pS36, DOI 10.1097/QAI.0000000000000038; Gopal S, 2012, BLOOD, V119, P5078, DOI 10.1182/blood-2012-02-387092; Kantarjian, 2016, CHRONIC MYELOID LEUK; Karakosta M, 2016, ARCH ENVIRON OCCUP H, V71, P317, DOI 10.1080/19338244.2015.1116429; Kennedy-LeJeune E, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-116760; Kishimba MA, 2004, TALANTA, V64, P48, DOI 10.1016/j.talanta.2003.11.047; Mendizabal AM, 2013, CANCER EPIDEMIOL, V37, P247, DOI 10.1016/j.canep.2013.01.002; Nabalamba A, 2011, AGING POPULATION CHA, P1; National Health Insurance Fund Tanzania, 2018, 1 QUART FACT SHEET; Odunukwe NN, 2015, PAN AFRICAN MED, V22, P292, DOI 10.11604/pamj.2015.22.292.7774; Omoti CE, 2007, INT J LAB HEMATOL, V29, P426, DOI 10.1111/j.1751-553X.2007.00888.x; Orah N, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00264; Parikh SA, 2014, HAEMATOLOGICA, V99, P140, DOI 10.3324/haematol.2013.086066; Rick TJ, 2019, J CANCER EDUC, V34, P111, DOI 10.1007/s13187-017-1274-8; Robbins H, 2015, JNCI-J NATL CANCER I, V107, P3; Sadeghian MH, 2011, INDIAN J PATHOL MICR, V54, P720, DOI 10.4103/0377-4929.91504; Sall A, 2016, BMC HEMATOL, V16; Shenoy P, 2011, ADV HEMATOLOGY; Shenoy PJ, 2011, CL LYMPH MYELOM LEUK, V11, P498, DOI 10.1016/j.clml.2011.07.002; Slager Susan L., 2014, Journal of the National Cancer Institute Monographs, P41, DOI 10.1093/jncimonographs/lgu001; Sylla BS, 2012, INT J CANCER, V130, P245, DOI 10.1002/ijc.26333; Tetteh DA, 2016, WOMENS HEALTH, V12, P147, DOI 10.2217/whe.15.76; Weldetsadik Abilo Tadesse, 2013, Ethiop Med J, V51, P25; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Zhang HL, 2016, AM J CLIN PATHOL, V146, P199, DOI [10.1093/AJCP/AQW083, 10.1093/ajcp/aqw083]	37	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232848	10.1371/journal.pone.0232848	http://dx.doi.org/10.1371/journal.pone.0232848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374771	gold, Green Published			2022-12-26	WOS:000537283500063
J	Liu, KH; Jiao, XY; Guo, WH; An, YH; Salahou, MK				Liu, Kaihua; Jiao, Xiyun; Guo, Weihua; An, Yunhao; Salahou, Mohamed Khaled			Improving border irrigation performance with predesigned varied-discharge	PLOS ONE			English	Article							NORTH CHINA PLAIN; WINTER-WHEAT; FURROW IRRIGATION; SURGE-FLOW; MANAGEMENT STRATEGIES; GRAIN-YIELD; WATER; TIME; OPTIMIZATION; PRODUCTIVITY	Insufficient water resources restrict wheat production in the North China Plain, so it is urgent and essential to improve the border irrigation performance and water use efficiency. This study developed a predesigned varied-discharge irrigation scheme in the closed-ended border. Field treatments, including continuous-discharge (CD), increased-discharge (ID) and decreased-discharge (DD) border irrigation tests, were conducted to evaluate the irrigation performance of the proposed varied-discharge scheme. The DD border irrigation treatment had great application efficiency (AE), distribution uniformity (DU) and requirement efficiency (RE), and its comprehensive evaluation indicator (Y) was also significantly higher than other treatments. DD treatment achieved the average AE, DU, RE and Y values of 91.4%, 95.5%, 99.5% and 95.4%, respectively. Furthermore, the hydraulic simulation model WinSRFR was used to optimize the scheme of predesigned varied-discharge border irrigation, and sensitivity analyses of infiltration parameters, roughness coefficient, slope and inflow rate were carried out. The results indicate that the predesigned varied-discharge border irrigation scheme can improve the irrigation performance, and the DD border irrigation scheme has more satisfactory robustness than that of the ID border irrigation scheme.	[Liu, Kaihua; Jiao, Xiyun; An, Yunhao; Salahou, Mohamed Khaled] Hohai Univ, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Peoples R China; [Liu, Kaihua; Jiao, Xiyun; Guo, Weihua; An, Yunhao] Hohai Univ, Coll Agr Engn, Nanjing, Peoples R China; [Jiao, Xiyun] Hohai Univ, Cooperat Innovat Ctr Water Safety & Hydro Sci, Nanjing, Peoples R China	Hohai University; Hohai University; Hohai University	Jiao, XY (corresponding author), Hohai Univ, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Peoples R China.; Jiao, XY (corresponding author), Hohai Univ, Coll Agr Engn, Nanjing, Peoples R China.; Jiao, XY (corresponding author), Hohai Univ, Cooperat Innovat Ctr Water Safety & Hydro Sci, Nanjing, Peoples R China.	15651830673@163.com		SALAHOU, Mohamed Khaled/0000-0001-5604-8589	National Natural Science Foundation of China [51879073, 51609064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by National Natural Science Foundation of China, grant number 51879073 and 51609064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazba AA, 1999, J IRRIG DRAIN ENG, V125, P12, DOI 10.1061/(ASCE)0733-9437(1999)125:1(12); Anwar AA, 2016, IRRIGATION SCI, V34, P379, DOI 10.1007/s00271-016-0509-5; Bai MeiJian, 2016, Transactions of the Chinese Society of Agricultural Engineering, V32, P105; BAUTISTA E, 1993, J IRRIG DRAIN ENG, V119, P1099, DOI 10.1061/(ASCE)0733-9437(1993)119:6(1099); Bautista E, 2009, AGR WATER MANAGE, V96, P1146, DOI 10.1016/j.agwat.2009.03.007; Bautista E, 2009, AGR WATER MANAGE, V96, P1162, DOI 10.1016/j.agwat.2009.03.009; Bautista E, 2002, USCID EWRI C EN CLIM, P475; Chen B, 2013, IRRIGATION SCI, V31, P715, DOI 10.1007/s00271-012-0338-0; Dong QG, 2018, WATER-SUI, V10, DOI 10.3390/w10121770; El-Dine TG, 2000, WATER RESOUR MANAG, V14, P77, DOI 10.1023/A:1008189004992; Horst MG, 2007, AGR WATER MANAGE, V87, P115, DOI 10.1016/j.agwat.2006.06.014; Jeong SJ, 2014, NAT CLIM CHANGE, V4, P615, DOI [10.1038/nclimate2266, 10.1038/NCLIMATE2266]; Kanber R, 2001, AGR WATER MANAGE, V47, P119, DOI 10.1016/S0378-3774(00)00102-5; Khatri KL, 2007, IRRIG DRAIN, V56, P463, DOI 10.1002/ird.319; Kifle M, 2008, IRRIGATION SCI, V26, P325, DOI 10.1007/s00271-007-0096-6; Kifle M, 2017, AGR WATER MANAGE, V187, P69, DOI 10.1016/j.agwat.2017.03.018; Koech RK, 2014, IRRIGATION SCI, V32, P319, DOI 10.1007/s00271-014-0432-6; Lalehzari R, 2017, AGR WATER MANAGE, V186, P120, DOI 10.1016/j.agwat.2017.03.005; Li QQ, 2010, AGR WATER MANAGE, V97, P1676, DOI 10.1016/j.agwat.2010.05.025; Liu QunChang, 2002, Transactions of the Chinese Society of Agricultural Engineering, V18, P35; Long Y, 2019, J NW U NATURAL SCI E, V49, P65; Lv LH, 2013, CHIL J AGR RES, V73, P233, DOI 10.4067/S0718-58392013000300005; Ma Shang-yu, 2012, Yingyong Shengtai Xuebao, V23, P2489; Morris MR, 2015, AGR WATER MANAGE, V155, P76, DOI 10.1016/j.agwat.2015.03.017; Nie WB, 2018, WATER-SUI, V10, DOI 10.3390/w10121825; Nie WB, 2014, SPAN J AGRIC RES, V12, P1180, DOI 10.5424/sjar/2014124-5462; Pereira LS, 2002, AGR WATER MANAGE, V57, P175, DOI 10.1016/S0378-3774(02)00075-6; Salahou MK, 2018, AGR WATER MANAGE, V201, P27, DOI 10.1016/j.agwat.2018.01.014; Santos FL, 1996, AGR SYST, V52, P317, DOI 10.1016/0308-521X(95)00077-I; Shang SH, 2006, AGR WATER MANAGE, V85, P314, DOI 10.1016/j.agwat.2006.05.015; Strelkoff TS, 2009, J IRRIG DRAIN ENG, V135, P525, DOI 10.1061/(ASCE)IR.1943-4774.0000119; Sun HY, 2006, AGR WATER MANAGE, V85, P211, DOI 10.1016/j.agwat.2006.04.008; Valiantzas JD, 2001, AGR WATER MANAGE, V52, P17, DOI 10.1016/S0378-3774(01)00128-7; Valipour M., 2013, Journal of Agricultural and Biological Science, V8, P35; Vazquez-Fernandez E, 2005, J IRRIG DRAIN ENG, V131, P379, DOI 10.1061/(ASCE)0733-9437(2005)131:4(379); Wang W. H., 2009, THESIS; Wang WeiHan, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P37; Wu C. F., 2015, THESIS; Yang YH, 2006, AGR WATER MANAGE, V82, P25, DOI 10.1016/j.agwat.2005.07.020; Yuan ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058685; Zhang DZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192000; Zhang MM, 2018, FIELD CROP RES, V225, P130, DOI 10.1016/j.fcr.2018.06.010	42	3	3	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232751	10.1371/journal.pone.0232751	http://dx.doi.org/10.1371/journal.pone.0232751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374769	Green Published, gold			2022-12-26	WOS:000537283500058
J	Stammers, M; Ivanova, IM; Niewczas, IS; Segonds-Pichon, A; Streeter, M; Spiegel, DA; Clark, J				Stammers, Melanie; Ivanova, Irina M.; Niewczas, Izabella S.; Segonds-Pichon, Anne; Streeter, Matthew; Spiegel, David A.; Clark, Jonathan			Age-related changes in the physical properties, cross-linking, and glycation of collagen from mouse tail tendon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tendon; collagen; cross-links; lysine glycation; aging; physical strain; chemistry; diabetes; mechanical stress; connective tissue; tendon; protein cross-linking		Collagen is a structural protein whose internal cross-linking critically determines the properties and functions of connective tissue. Knowing how the cross-linking of collagen changes with age is key to understanding why the mechanical properties of tissues change over a lifetime. The current scientific consensus is that collagen cross-linking increases with age and that this increase leads to tendon stiffening. Here, we show that this view should be reconsidered. Using MS-based analyses, we demonstrated that during aging of healthy C57BL/6 mice, the overall levels of collagen cross-linking in tail tendon decreased with age. However, the levels of lysine glycation in collagen, which is not considered a cross-link, increased dramatically with age. We found that in 16-week-old diabetic db/db mice, glycation reaches levels similar to those observed in 98-week-old C57BL/6 mice, while the other cross-links typical of tendon collagen either decreased or remained the same as those observed in 20-week-old WT mice. These results, combined with findings from mechanical testing of tendons from these mice, indicate that overall collagen cross-linking in mouse tendon decreases with age. Our findings also reveal that lysine glycation appears to be an important factor that contributes to tendon stiffening with age and in diabetes.	[Stammers, Melanie; Ivanova, Irina M.; Niewczas, Izabella S.; Segonds-Pichon, Anne; Clark, Jonathan] Babraham Inst, Cambridge, England; [Ivanova, Irina M.] John Innes Ctr, Norwich, Norfolk, England; [Streeter, Matthew; Spiegel, David A.] Yale Univ, Dept Chem, New Haven, CT USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Yale University	Clark, J (corresponding author), Babraham Inst, Cambridge, England.	jonathan.clark@babraham.ac.uk			SENS Research Foundation; Babraham Institute's Core Capability Grant from the BBSRC	SENS Research Foundation; Babraham Institute's Core Capability Grant from the BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	M. Stammers was funded by SENS Research Foundation. Imagining, chemistry, mass spectroscopy, and statistical analysis were carried out in Babraham Institute facilities which are funded in part by Babraham Institute's Core Capability Grant from the BBSRC.	BAILEY AJ, 1968, BIOCHEM BIOPH RES CO, V33, P812, DOI 10.1016/0006-291X(68)90233-7; Bawazeer S, 2012, J CHROMATOGR A, V1263, P61, DOI 10.1016/j.chroma.2012.09.005; BERNSTEIN PH, 1980, J BIOL CHEM, V255, P414; DAVISON PF, 1989, CONNECT TISSUE RES, V18, P293, DOI 10.3109/03008208909019078; Davison PF., 1972, CONNECT TISSUE RES, V1, P205, DOI [10.3109/03008207209152076, DOI 10.3109/03008207209152076]; Draghici C, 2015, SCIENCE, V350, P294, DOI 10.1126/science.aac9655; Eyre DR, 2019, J BIOL CHEM, V294, P6578, DOI 10.1074/jbc.RA118.007202; Fratzl P, 2008, COLLAGEN STRUCTURE M; Hudson DM, 2018, J BIOL CHEM, V293, P15620, DOI 10.1074/jbc.RA118.004829; LEITER EH, 1988, FASEB J, V2, P2807, DOI 10.1096/fasebj.2.12.3044905; Li QR, 2013, TETRAHEDRON, V69, P10384, DOI 10.1016/j.tet.2013.09.098; Monnier VM, 2014, CLIN CHEM LAB MED, V52, P21, DOI 10.1515/cclm-2013-0174; Monnier VM, 1999, DIABETES, V48, P870, DOI 10.2337/diabetes.48.4.870; Naffa R, 2016, J CHROMATOGR A, V1478, P60, DOI 10.1016/j.chroma.2016.11.060; Nash Anthony, 2019, Matrix Biol Plus, V4, P100013, DOI 10.1016/j.mbplus.2019.100013; ROBINS SP, 1973, BIOCHEM J, V131, P771, DOI 10.1042/bj1310771; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Sricholpech M, 2012, J BIOL CHEM, V287, P22998, DOI 10.1074/jbc.M112.343954; Stammer M., 2020, J BIOL CHEM, V295; TANZER ML, 1973, J BIOL CHEM, V248, P393; TANZER ML, 1970, BIOCHIM BIOPHYS ACTA, V207, P548; Terajima M, 2016, J BIOL CHEM, V291, P9501, DOI 10.1074/jbc.M115.699470	22	11	11	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10562	10571		10.1074/jbc.RA119.011031	http://dx.doi.org/10.1074/jbc.RA119.011031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32381510	hybrid, Green Published			2022-12-26	WOS:000560405600005
J	Rodriguez-Berdini, L; Ferrero, GO; Plonka, FB; Gizzi, AMC; Prucca, CG; Quiroga, S; Caputto, BL				Rodriguez-Berdini, Lucia; Ferrero, Gabriel Orlando; Bustos Plonka, Florentyna; Cardozo Gizzi, Andres Mauricio; Prucca, Cesar German; Quiroga, Santiago; Caputto, Beatriz Leonor			The moonlighting protein c-Fos activates lipid synthesis in neurons, an activity that is critical for cellular differentiation and cortical development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodifferentiation; neurodevelopment; c-Fos; lipid synthesis; phospholipid metabolism; hippocampus; AP-1; central nervous system; oncogene; neurodifferentiation; neurodevelopment; phospholipid metabolism; lipid synthesis; AP1 transcription factor (AP-1); central nervous system (CNS); oncogene	SMOOTH ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE EXPANSION; SQUID GIANT-AXON; PHOSPHOLIPID-SYNTHESIS; HIPPOCAMPAL-NEURONS; ENDOMEMBRANE SYSTEM; PHOSPHATIDIC-ACID; GENE-EXPRESSION; NERVOUS-SYSTEM; BRAIN	Differentiation of neuronal cells is crucial for the development and function of the nervous system. This process involves high rates of membrane expansion, during which the synthesis of membrane lipids must be tightly regulated. In this work, using a variety of molecular and biochemical assays and approaches, including immunofluorescence microscopy and FRET analyses, we demonstrate that the proto-oncogene c-Fos (c-Fos) activates cytoplasmic lipid synthesis in the central nervous system and thereby supports neuronal differentiation. Specifically, in hippocampal primary cultures, blocking c-Fos expression or its activity impairs neuronal differentiation. When examining its subcellular localization, we found that c-Fos co-localizes with endoplasmic reticulum markers and strongly interacts with lipid-synthesizing enzymes, whose activities were markedly increasedin vitroin the presence of recombinant c-Fos. Of note, the expression of c-Fos dominant-negative variants capable of blocking its lipid synthesis?activating activity impaired neuronal differentiation. Moreover, using anin uteroelectroporation model, we observed that neurons with blocked c-Fos expression or lacking its AP-1?independent activity fail to initiate cortical development. These results highlight the importance of c-Fos?mediated activation of lipid synthesis for proper nervous system development.	[Rodriguez-Berdini, Lucia; Ferrero, Gabriel Orlando; Bustos Plonka, Florentyna; Cardozo Gizzi, Andres Mauricio; Prucca, Cesar German; Quiroga, Santiago; Caputto, Beatriz Leonor] Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Ctr Invest Quim Biol Cordoba, Dept Quim Biol Ranwel Caputto,Fac Ciencias Quim, Cordoba, Argentina; [Ferrero, Gabriel Orlando] Univ Tecnol Nacl, Consejo Nacl Invest Cient & Tecn, Ctr Invest & Tecnol Quim Prof Dr Oscar A Orio, Fac Reg Cordoba, Ciudad Univ, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Caputto, BL (corresponding author), Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Ctr Invest Quim Biol Cordoba, Dept Quim Biol Ranwel Caputto,Fac Ciencias Quim, Cordoba, Argentina.	bcaputto@fcq.unc.edu.ar	Prucca, César Germán/AAC-4630-2021	Prucca, César Germán/0000-0003-4165-4660; Rodriguez-Berdini, Lucia/0000-0003-0542-0461; Cardozo Gizzi, Andres Mauricio/0000-0003-3894-1845	Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba; Fondo para la Investigacion Cientifica y Tecnologica, Ministerio de Ciencia, Tecnologia e Innovacion, Argentina [PICT 2017-2761, PICT 2012-2797, PICT 2013-2996, PICT 2015-3702]; Instituto Nacional del Cancer, Ministerio de Salud, Argentina	Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Fondo para la Investigacion Cientifica y Tecnologica, Ministerio de Ciencia, Tecnologia e Innovacion, Argentina; Instituto Nacional del Cancer, Ministerio de Salud, Argentina	This work was supported by the Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba; the Fondo para la Investigacion Cientifica y Tecnologica, Ministerio de Ciencia, Tecnologia e Innovacion, Argentina (Grants PICT 2017-2761, PICT 2012-2797, PICT 2013-2996, and PICT 2015-3702); and the Instituto Nacional del Cancer, Ministerio de Salud, Argentina. Gabriel Orlando Ferrero, Cesar German Prucca, Santiago Quiroga, and Beatriz Leonor Caputto are members of and Lucia Rodriguez Berdini, Florentyna Bustos Plonka, and Andres Mauricio Cardozo Gizzi are fellows of CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnologicas), Ministerio de Ciencia, Tecnologia e Innovacion, Argentina.	Pecchio ARA, 2011, MOL BIOL CELL, V22, P4716, DOI 10.1091/mbc.E11-03-0259; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Armijo-Weingart L, 2017, MOL CELL NEUROSCI, V84, P36, DOI 10.1016/j.mcn.2017.03.007; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Borioli GA, 2001, BIOCHEM BIOPH RES CO, V280, P9, DOI 10.1006/bbrc.2000.4081; BROADWELL RD, 1983, J HISTOCHEM CYTOCHEM, V31, P1077, DOI 10.1177/31.9.6309951; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bussolino DF, 2001, FASEB J, V15, P556; Bussolino DF, 1998, MOL BRAIN RES, V58, P10, DOI 10.1016/S0169-328X(98)00065-5; Caceres A, 2012, CURR OPIN CELL BIOL, V24, P547, DOI 10.1016/j.ceb.2012.05.011; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Gizzi AMC, 2015, J BIOL CHEM, V290, P29578, DOI 10.1074/jbc.M115.678821; CAUBET JF, 1989, MOL CELL BIOL, V9, P2269, DOI 10.1128/MCB.9.5.2269; Racca AC, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00544; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; DECHAVES EP, 1995, J CELL BIOL, V128, P913, DOI 10.1083/jcb.128.5.913; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DRAGUNOW M, 1987, NEUROSCI LETT, V82, P157, DOI 10.1016/0304-3940(87)90121-2; DRAGUNOW M, 1987, EUR J PHARMACOL, V135, P113, DOI 10.1016/0014-2999(87)90767-9; DROZ B, 1975, BRAIN RES, V93, P1, DOI 10.1016/0006-8993(75)90282-6; Ferrero GO, 2012, ONCOGENE, V31, P3381, DOI 10.1038/onc.2011.510; Ferrero GO, 2014, BIOCHEM J, V461, P521, DOI 10.1042/BJ20131376; GALLIARD T, 1965, BIOCHIM BIOPHYS ACTA, V106, P551, DOI 10.1016/0005-2760(65)90071-8; Gallo FT, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00079; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Gil GA, 2012, NEUROCHEM RES, V37, P1364, DOI 10.1007/s11064-012-0763-8; Gonzalez C, 2014, SEMIN CELL DEV BIOL, V27, P23, DOI 10.1016/j.semcdb.2013.12.004; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; GOULD RM, 1983, J NEUROCHEM, V40, P1293, DOI 10.1111/j.1471-4159.1983.tb13569.x; GOULD RM, 1983, J NEUROCHEM, V40, P1300, DOI 10.1111/j.1471-4159.1983.tb13570.x; Guido ME, 1996, J NEUROSCI RES, V43, P93, DOI 10.1002/jnr.490430112; Hatten ME, 1999, NEURON, V22, P2, DOI 10.1016/S0896-6273(00)80668-6; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HAYASHI K, 1967, J BIOCHEM-TOKYO, V62, P15, DOI 10.1093/oxfordjournals.jbchem.a128630; HUGHES P, 1995, PHARMACOL REV, V47, P133; Valenzuela JI, 2011, MOL CELL NEUROSCI, V48, P269, DOI 10.1016/j.mcn.2011.07.001; KUMARASIRI MH, 1980, BRAIN RES, V186, P315, DOI 10.1016/0006-8993(80)90978-6; Kwan AC, 2012, CURR BIOL, V22, P1459, DOI 10.1016/j.cub.2012.06.007; Ledeen R. W., 1985, TRANSPORT EXCHANGE T, P135; LINDSEY JD, 1985, J NEUROSCI, V5, P3135; Luarte A, 2018, DEV NEUROBIOL, V78, P181, DOI 10.1002/dneu.22560; Lykidis A, 1997, J BIOL CHEM, V272, P33402, DOI 10.1074/jbc.272.52.33402; Merianda T, 2013, NEUROSCI BULL, V29, P493, DOI 10.1007/s12264-013-1360-9; Millet Larry J., 2012, Yale Journal of Biology and Medicine, V85, P501; MORGAN JI, 1988, CELL CALCIUM, V9, P303, DOI 10.1016/0143-4160(88)90011-5; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; PALAY S L, 1958, Exp Cell Res, V14, P275; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Portal MM, 2007, ONCOGENE, V26, P3551, DOI 10.1038/sj.onc.1210137; Quiroga S, 2018, DEV NEUROBIOL, V78, P170, DOI 10.1002/dneu.22553; RAMBOURG A, 1980, J NEUROCHEM, V35, P16, DOI 10.1111/j.1471-4159.1980.tb12484.x; Rao K, 2016, MOL BIOL CELL, V27, P3245, DOI 10.1091/mbc.E16-05-0287; Rodriguez-Berdini L., 2016, BIO-PROTOCOL, V6, DOI [10.21769/BioProtoc.1705, DOI 10.21769/BIOPROTOC.1705]; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Schelski M, 2017, MOL CELL NEUROSCI, V84, P11, DOI 10.1016/j.mcn.2017.03.008; SCHIBECI A, 1977, BIOCHEM PHARMACOL, V26, P1769, DOI 10.1016/0006-2952(77)90344-6; Silvestre DC, 2009, J NEUROSCI RES, V87, P857, DOI 10.1002/jnr.21915; Spillane Mirela, 2014, Small GTPases, V5, pe27974, DOI 10.4161/sgtp.27974; Stipursky J, 2012, DEV NEUROSCI-BASEL, V34, P68, DOI 10.1159/000338108; SUN GY, 1989, LIFE SCI, V44, P689, DOI 10.1016/0024-3205(89)90475-X; Tabata H, 2003, J NEUROSCI, V23, P9996; TANAKA T, 1987, BIOCHIM BIOPHYS ACTA, V922, P85, DOI 10.1016/0005-2760(87)90248-7; TONG W, 1994, LIPIDS, V29, P385, DOI 10.1007/BF02537306; Tracey TJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00010; TSUKITA S, 1976, J ELECTRON MICROSC, V25, P141; VANCE JE, 1994, J NEUROCHEM, V62, P329; VANCE JE, 1991, J CELL BIOL, V115, P1061, DOI 10.1083/jcb.115.4.1061; Vance JE, 2000, BBA-MOL CELL BIOL L, V1486, P84, DOI 10.1016/S1388-1981(00)00050-0; Velazquez FN, 2015, ONCOTARGET, V6, P16883, DOI 10.18632/oncotarget.4527; WEISS P, 1948, J EXP ZOOL, V107, P315, DOI 10.1002/jez.1401070302; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Winkle CC, 2016, INT REV CEL MOL BIO, V322, P247, DOI 10.1016/bs.ircmb.2015.10.003; WISSING JB, 1993, FEBS LETT, V315, P95, DOI 10.1016/0014-5793(93)81141-L; Zerpa GAD, 1999, J NEUROCHEM, V73, P1228, DOI 10.1046/j.1471-4159.1999.0731228.x	77	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8808	8818		10.1074/jbc.RA119.010129	http://dx.doi.org/10.1074/jbc.RA119.010129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32385110	Green Published, hybrid			2022-12-26	WOS:000546296800016
J	Yamashita, K; Shibata, T; Takahashi, T; Kobayashi, Y; Kawabata, S				Yamashita, Keisuke; Shibata, Toshio; Takahashi, Toshiaki; Kobayashi, Yuki; Kawabata, Shun-ichiro			Roles of the clip domains of two protease zymogens in the coagulation cascade in horseshoe crabs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serine protease; coagulation cascade; lipopolysaccharide (LPS); enzyme mutation; recombinant protein expression; endotoxin; enzyme processing; clip domain; prochelicerase B (proB); proclotting enzyme (proCE); coagulation factor	SERINE-PROTEASE; CRYSTAL-STRUCTURE; TACHYPLEUS-TRIDENTATUS; PROCLOTTING ENZYME; STRUCTURAL BASIS; FACTOR-B; FACTOR-C; LIPOPOLYSACCHARIDE; HEMOCYTES; RECOGNITION	The lipopolysaccharide (LPS)-triggered coagulation cascade in horseshoe crabs comprises three protease zymogens: prochelicerase C (proC), prochelicerase B (proB), and the proclotting enzyme (proCE). The presence of LPS results in autocatalytic activation of proC to ?-chelicerase C, which, in turn, activates proB to chelicerase B, converting proCE to the clotting enzyme (CE). ProB and proCE contain an N-terminal clip domain, but the roles of these domains in this coagulation cascade remain unknown. Here, using recombinant proteins and kinetics and binding assays, we found that five basic residues in the clip domain of proB are required to maintain its LPS-binding activity and activation by ?-chelicerase C. Moreover, an amino acid substitution at a potential hydrophobic cavity in proB's clip domain (V55A-proB) reduced both its LPS-binding activity and activation rate. WT proCE exhibited no LPS-binding activity, and the WT chelicerase B-mediated activation of a proCE variant with a substitution at a potential hydrophobic cavity (V53A-proCE) was ?4-fold slower than that of WT proCE. Thek(cat)/K(m)value of the interaction of WT chelicerase B with V53A-proCE was 7-fold lower than that of the WT chelicerase B-WT proCE interaction. The enzymatic activities of V55A-chelicerase B and V53A-CE against specific peptide substrates were indistinguishable from those of the corresponding WT proteases. In conclusion, the clip domain of proB recruits it to a reaction center composed of ?-chelicerase C and LPS, where ?-chelicerase C is ready to activate proB, leading to chelicerase B?mediated activation of proCE via its clip domain.	[Yamashita, Keisuke; Shibata, Toshio; Takahashi, Toshiaki; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Grad Sch Syst Life Sci, Fukuoka, Japan; [Shibata, Toshio; Kawabata, Shun-ichiro] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka, Japan; [Kobayashi, Yuki] Seikagaku Corp, Cent Res Lab, LAL Res, Tokyo, Japan	Kyushu University; Kyushu University; Seikagaku Corporation	Kawabata, S (corresponding author), Kyushu Univ, Fac Sci, Grad Sch Syst Life Sci, Fukuoka, Japan.; Kawabata, S (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Fukuoka, Japan.	sskawascb@kyudai.jp		Yamashita, Keisuke/0000-0002-4748-2516	Seikagaku Corporation	Seikagaku Corporation	This study was supported by the joint research fund of the Seikagaku Corporation.	AKETAGAWA J, 1986, J BIOL CHEM, V261, P7357; Anderson KV, 1998, CELL, V95, P439, DOI 10.1016/S0092-8674(00)81610-4; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Ariki S, 2004, P NATL ACAD SCI USA, V101, P953, DOI 10.1073/pnas.0306904101; Armstrong Peter B., 2003, P288; Ashida M., 1997, MOL MECH IMMUNE RESP, P135; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; CORNISHBOWDEN A, 1978, BIOCHIM BIOPHYS ACTA, V523, P268, DOI 10.1016/0005-2744(78)90030-X; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; HOESS A, 1993, EMBO J, V12, P3351, DOI 10.1002/j.1460-2075.1993.tb06008.x; Huang RD, 2007, BIOCHEMISTRY-US, V46, P11431, DOI 10.1021/bi7010724; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Kawabata S, 2010, ADV EXP MED BIOL, V708, P122; Kawabata S, 2010, J BIOCHEM, V147, P611, DOI 10.1093/jb/mvq026; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; Kellenberger C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182741; Kobayashi Y, 2015, J BIOL CHEM, V290, P19379, DOI 10.1074/jbc.M115.653196; Kobayashi Y, 2014, J BIOL CHEM, V289, P25987, DOI 10.1074/jbc.M114.586933; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; Levin Jack, 2003, P310; MARRA MN, 1990, J IMMUNOL, V144, P662; Mizumura H, 2017, INNATE IMMUN-LONDON, V23, P136, DOI 10.1177/1753425916681074; MUTA T, 1993, METHOD ENZYMOL, V223, P352; MUTA T, 1993, J BIOL CHEM, V268, P21384; MUTA T, 1990, J BIOL CHEM, V265, P22426; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; NAKAMURA T, 1985, J BIOCHEM, V97, P1561, DOI 10.1093/oxfordjournals.jbchem.a135213; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Segel I. H., 1975, ENZYME KINETICS, P41; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shibata T, 2018, J BIOL CHEM, V293, P11589, DOI 10.1074/jbc.RA118.002311; TOH Y, 1991, CELL TISSUE RES, V266, P137, DOI 10.1007/BF00678720; Veillard F, 2016, BIOCHIMIE, V122, P255, DOI 10.1016/j.biochi.2015.10.007; Volz J, 2005, J BIOL CHEM, V280, P40161, DOI 10.1074/jbc.M506191200	42	4	4	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8857	8866		10.1074/jbc.RA119.012452	http://dx.doi.org/10.1074/jbc.RA119.012452			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32409575	hybrid, Green Published			2022-12-26	WOS:000546296800020
J	Driehuis, E; Oosterom, N; Heil, SG; Muller, IB; Lin, M; Kolders, S; Jansen, G; de Jonge, R; Pieters, R; Clevers, H; van den Heuvel-Eibrink, MM				Driehuis, E.; Oosterom, N.; Heil, S. G.; Muller, I. B.; Lin, M.; Kolders, S.; Jansen, G.; de Jonge, R.; Pieters, R.; Clevers, H.; van den Heuvel-Eibrink, M. M.			Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia	PLOS ONE			English	Article							HIGH-DOSE METHOTREXATE; STEM-CELLS; DIHYDROFOLATE-REDUCTASE; FOLYLPOLYGLUTAMATE SYNTHETASE; MEMBRANE-TRANSPORT; PROGENITOR CELLS; FOLINIC ACID; SINGLE LGR5; POLYGLUTAMYLATION; RESISTANCE	We have recently established a protocol to grow wildtype human oral mucosa organoids. These three-dimensional structures can be maintained in culture long-term, do not require immortalization, and recapitulate the multilayered composition of the epithelial lining of the oral mucosa. Here, we validate the use of this model to study the effect of Leucovorin (LV) on Methotrexate (MTX)-induced toxicity. MTX is a chemotherapeutic agent used in the treatment of pediatric acute lymphoblastic leukemia. Although effective, the use of MTX often results in severe side-effects, including oral mucositis, which is characterized by epithelial cell death. Here, we show that organoids are sensitive to MTX, and that the addition of LV reduces MTX toxicity, in both a concentration- and timing-dependent manner. Additionally, we show that a 24 hour 'pretreatment' with LV reduces MTX-induced cell death, suggesting that such a pretreatment could decrease mucositis in patients. Taken together, we provide the first in vitro model to study the effect of MTX on wildtype oral mucosa cells. Our findings underscore the relevance of the clinically applied LV regimen and highlight the potential of this model to further optimize modifications in dosing and timing of Leucovorin on oral mucosa cells.	[Driehuis, E.; Kolders, S.; Clevers, H.] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Oncode Inst, Utrecht, Netherlands; [Driehuis, E.; Kolders, S.; Clevers, H.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Oosterom, N.; Pieters, R.; Clevers, H.; van den Heuvel-Eibrink, M. M.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Heil, S. G.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Clin Chem, Rotterdam, Netherlands; [Muller, I. B.; Lin, M.; de Jonge, R.] Amsterdam UMC, Dept Clin Chem, Amsterdam, Netherlands; [Jansen, G.] Amsterdam UMC, Amsterdam Rheumatol & Immunol Ctr, Dept Rheumatol, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	van den Heuvel-Eibrink, MM (corresponding author), Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.	m.m.vandenheuvel-eibrink@prinsesmaximacentrum.nl		Jansen, Gerrit/0000-0001-8190-8368	Oncode Institute (Dutch Cancer Society); Netherlands Organization for Scientific Research (NWO); Stand Up to Cancer International Translational Cancer Research Grant, a program of the Entertainment Industry Foundation [SU2C-AACR-DT1213]; ZonMw grant [116.006.103]	Oncode Institute (Dutch Cancer Society); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Stand Up to Cancer International Translational Cancer Research Grant, a program of the Entertainment Industry Foundation; ZonMw grant	Funded by the Oncode Institute (partly financed by the Dutch Cancer Society), by the gravitation program CancerGenomiCs.nl from the Netherlands Organization for Scientific Research (NWO) and by a Stand Up to Cancer International Translational Cancer Research Grant, a program of the Entertainment Industry Foundation administered by the AACR (SU2C-AACR-DT1213) and a ZonMw grant (116.006.103).	ACKLAND SP, 1987, J CLIN ONCOL, V5, P2017, DOI 10.1200/JCO.1987.5.12.2017; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Berkers G, 2019, CELL REP, V26, P1701, DOI 10.1016/j.celrep.2019.01.068; BERRY CL, 1972, J EMBRYOL EXP MORPH, V28, P601; BERTINO JR, 1993, J CLIN ONCOL, V11, P5, DOI 10.1200/JCO.1993.11.1.5; Blutt SE, 2018, CELL MOL GASTROENTER, V5, P241, DOI 10.1016/j.jcmgh.2017.12.001; BORSI JD, 1991, EUR J CANCER, V27, P1006, DOI 10.1016/0277-5379(91)90269-J; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; den Boer E, 2013, ANAL BIOANAL CHEM, V405, P1673, DOI 10.1007/s00216-012-6581-7; den Hoed MAH, 2015, PHARMACOGENOMICS J, V15, P248, DOI 10.1038/tpj.2014.63; DeWard AD, 2014, CELL REP, V9, P701, DOI 10.1016/j.celrep.2014.09.027; Driehuis E, 2019, P NATL ACAD SCI US; Driehuis E KS, 2019, CANC DISCOV; FABRE I, 1984, CANCER RES, V44, P3190; FRY DW, 1983, CANCER RES, V43, P1087; Galpin AJ, 1997, MOL PHARMACOL, V52, P155, DOI 10.1124/mol.52.1.155; GOLDIN A, 1953, CANCER RES, V13, P843; GOLDIN A, 1966, NATURE, V212, P1548, DOI 10.1038/2121548a0; GOLDMAN I D, 1987, NCI (National Cancer Institute) Monographs, P17; Gonen N, 2012, DRUG RESIST UPDATE, V15, P183, DOI 10.1016/j.drup.2012.07.002; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Howard SC, 2016, ONCOLOGIST, V21, P1471, DOI 10.1634/theoncologist.2015-0164; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Jansen G, 1998, J BIOL CHEM, V273, P30189, DOI 10.1074/jbc.273.46.30189; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Kamps WA, 2010, LEUKEMIA, V24, P309, DOI 10.1038/leu.2009.258; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Kessler M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9989; KOIZUMI S, 1985, J CLIN INVEST, V75, P1008, DOI 10.1172/JCI111761; Kopper O, 2019, NAT MED, V25, P838, DOI 10.1038/s41591-019-0422-6; Kretzschmar K, 2016, DEV CELL, V38, P590, DOI 10.1016/j.devcel.2016.08.014; Lee SH, 2018, CELL, V173, P515, DOI 10.1016/j.cell.2018.03.017; Linnemann JR, 2015, DEVELOPMENT, V142, P3239, DOI 10.1242/dev.123554; MATHERLY LH, 1986, CANCER RES, V46, P588; MATHERLY LH, 1987, J BIOL CHEM, V262, P710; Muller IB, 2019, THER DRUG MONIT; Nanduri LSY, 2014, STEM CELL REP, V3, P957, DOI 10.1016/j.stemcr.2014.09.015; Noel G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45270; Ooft SN, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aay2574; Pauley JL, 2013, CANCER CHEMOTH PHARM, V72, P369, DOI 10.1007/s00280-013-2206-x; Pieters R, 2016, J CLIN ONCOL, V34, P2591, DOI 10.1200/JCO.2015.64.6364; POSER RG, 1981, CANCER RES, V41, P4441; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Raz S, 2016, DRUG RESIST UPDATE, V28, P43, DOI 10.1016/j.drup.2016.06.004; Ren WW, 2014, P NATL ACAD SCI USA, V111, P16401, DOI 10.1073/pnas.1409064111; ROTHENBERG SP, 1982, J PHARMACOL EXP THER, V223, P631; Rots MG, 1999, BLOOD, V93, P1067, DOI 10.1182/blood.V93.3.1067.403k01_1067_1074; Rots MG, 1999, BLOOD, V93, P1677, DOI 10.1182/blood.V93.5.1677.405a16_1677_1683; Sachs N, 2018, CELL, V172, P373, DOI 10.1016/j.cell.2017.11.010; SANDBERG JS, 1970, CANCER RES, V30, P1276; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schutgens F, 2019, NAT BIOTECHNOL, V37, P303, DOI 10.1038/s41587-019-0048-8; Skarby TVC, 2006, LEUKEMIA, V20, P1955, DOI 10.1038/sj.leu.2404404; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Sonis Stephen T, 2010, Curr Opin Support Palliat Care, V4, P26, DOI 10.1097/SPC.0b013e328335fb76; Sterba J, 2006, CLIN CHEM, V52, P692, DOI 10.1373/clinchem.2005.061150; Tadokoro T, 2014, P NATL ACAD SCI USA, V111, pE3641, DOI 10.1073/pnas.1409781111; Tiriac H, 2018, CANCER DISCOV, V8, P1112, DOI 10.1158/2159-8290.CD-18-0349; Van der Beek JN, 2019, CRIT REV ONCOL HEMAT, V142, P1, DOI 10.1016/j.critrevonc.2019.07.003; VANDERLAAN BFAM, 1992, INT J CANCER, V51, P909, DOI 10.1002/ijc.2910510613; Villa A, 2015, CURR OPIN ONCOL, V27, P159, DOI 10.1097/CCO.0000000000000180; Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; WOLFROM C, 1990, EUR J CLIN PHARMACOL, V39, P377, DOI 10.1007/BF00315414; Yao Y, 2020, CELL STEM CELL, V26, P17, DOI 10.1016/j.stem.2019.10.010; Zhao RB, 2003, ONCOGENE, V22, P7431, DOI 10.1038/sj.onc.1206946; Zhao RB, 2011, ANNU REV NUTR, V31, P177, DOI 10.1146/annurev-nutr-072610-145133	70	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0231588	10.1371/journal.pone.0231588	http://dx.doi.org/10.1371/journal.pone.0231588			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421698	Green Published, gold			2022-12-26	WOS:000537499600005
J	Hai-Ying, C; Tanaka, Y; Hifumi, T; Shoji, K; Kayesh, MEH; Abul Hashem, M; Kitab, B; Sanada, T; Fujiyuki, T; Yoneda, M; Hatai, H; Yabuki, A; Miyoshi, N; Kai, C; Kohara, M; Tsukiyama-Kohara, K				Hai-Ying, Chi; Tanaka, Yuki; Hifumi, Tatsuro; Shoji, Koichiro; Kayesh, Mohammad Enamul Hoque; Abul Hashem, Md; Kitab, Bouchra; Sanada, Takahiro; Fujiyuki, Tomoko; Yoneda, Misako; Hatai, Hitoshi; Yabuki, Akira; Miyoshi, Noriaki; Kai, Chieko; Kohara, Michinori; Tsukiyama-Kohara, Kyoko			Pathological and genetic aspects of spontaneous mammary gland tumor in Tupaia belangeri (tree shrew)	PLOS ONE			English	Article							BREAST-CANCER; IN-SITU; EXPRESSION; CARCINOMA; NECTIN-4; RECEPTOR; MODEL; THERAPY	Mammary gland cancer is the most common cancer occurring in women globally. Incidences of this cancer in Japan are on the increase. Annually, more than 70,000 new cases are recorded in Japan and about 1.7 million in the world. Many cases are still difficult to cure completely, and animal models are required for the characterization of the biology, therapeutic strategy, and preventive measures for spontaneous mammary tumor. The mouse model used currently has some limitations owing to structural differences between mouse and human mammary glands. Tupaia belangeri (tree shrew), which belongs to the Tupaiidae family, shows relatively high genetic homology and structural similarity to human mammary glands. Here, we characterized the spontaneous mammary tumors in 61 female tree shrews of different ages. The incidence rate was 24.6% (15/61), and the rate of simultaneous or metachronous multiplex tumors was 60% (9/15). From the incidence pattern, some cases seemed to be of familial mammary gland tumor, as the offspring of female tree shrews No. 3 and 9 and male tree shrew No. 11 showed a high incidence rate, of 73.3% (11/15). Average incidence age for tumor development was 2 years and 3 months, and the earliest was 10 months. Histochemical analysis indicated that spontaneous mammary gland tumors in the tree shrew show the features of intraductal papillary adenomas (22 cases), except 2 tubulopapillary carcinoma cases (No. 75 and 131). All the cases were positive for the progesterone receptor, whereas 91.3% were positive for the estrogen receptor, and 4.3% were HER-2 positive. We have also confirmed the expression of nectin-4 in some mammary tumor cells. Additionally, we subjected tree shrews to cytodiagnosis or X-ray CT. Thus, the findings of this study highlight the potential of the tree shrew as a valuable new animal model for mammary gland tumor study.	[Hai-Ying, Chi; Kayesh, Mohammad Enamul Hoque; Abul Hashem, Md; Kitab, Bouchra; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima, Japan; [Tanaka, Yuki; Hifumi, Tatsuro; Hatai, Hitoshi; Miyoshi, Noriaki] Kagoshima Univ, Joint Fac Vet Med, Dept Pathol, Kagoshima, Japan; [Shoji, Koichiro; Fujiyuki, Tomoko; Yoneda, Misako; Kai, Chieko] Univ Tokyo, Inst Med Sci, Lab Expt Anim, Tokyo, Japan; [Kayesh, Mohammad Enamul Hoque] Patuakhali Sci & Technol Univ, Fac Anim Sci & Vet Med, Dept Microbiol & Publ Hlth, Barishal, Bangladesh; [Abul Hashem, Md] Chattogram City Corp, Dept Hlth, Chattogram, Bangladesh; [Sanada, Takahiro; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo, Japan; [Yabuki, Akira] Kagoshima Univ, Joint Fac Vet Med, Dept Clin Pathol, Kagoshima, Japan	Kagoshima University; Kagoshima University; University of Tokyo; Tokyo Metropolitan Institute of Medical Science; Kagoshima University	Tsukiyama-Kohara, K (corresponding author), Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima, Japan.; Kohara, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo, Japan.	kohara-mc@igakuken.or.jp; kkohara@vet.kagoshima-u.ac.jp	Hashem, Md Abul/GLS-1628-2022; Kayesh, Mohammad Enamul Hoque/GPK-2297-2022; Fujiyuki, Tomoko Kaito/GYD-6398-2022	Hashem, Md Abul/0000-0001-6224-2986; Fujiyuki, Tomoko Kaito/0000-0001-5533-4129; Kayesh, Mohammad Enamul Hoque/0000-0003-4806-9843; Hatai, Hitoshi/0000-0002-9063-7616; Sanada, Takahiro/0000-0002-6362-7762	Japan Agency for Medical Research and Development; Tokyo Metropolitan Government; Ministry of Health and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Tokyo Metropolitan Government(Tokyo Metropolitan Government); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	the Japan Agency for Medical Research and Development, the Tokyo Metropolitan Government; the Ministry of Health and Welfare of Japan; and the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amako Y, 2010, J VIROL, V84, P303, DOI 10.1128/JVI.01448-09; Athanassiadou AM, 2011, FOLIA HISTOCHEM CYTO, V49, P26, DOI 10.5603/FHC.2011.0005; Brack M, 1998, J COMP PATHOL, V118, P301, DOI 10.1016/S0021-9975(07)80006-5; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Cunningham MP, 2005, INT J ONCOL, V27, P317; DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535; Dunbier AK, 2010, J CLIN ONCOL, V28, P1161, DOI 10.1200/JCO.2009.23.9616; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Focke CM, 2016, BREAST CANCER RES TR, V159, P257, DOI 10.1007/s10549-016-3950-5; Fujiyuki T, 2015, ONCOTARGET, V6, P24895, DOI 10.18632/oncotarget.4366; Ge GZ, 2016, INT J CANCER, V138, P642, DOI 10.1002/ijc.29814; Goldschmidt MH, 2016, TUMORS DOMESTIC ANIM, P723, DOI DOI 10.1002/9781119181200.CH17; Hai-Ying C, 2016, EXP ANIM TOKYO, V65, P285, DOI 10.1538/expanim.15-0123; Kayesh MEH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10329-7; Kayesh MEH, 2017, VIRUS RES, V237, P47, DOI 10.1016/j.virusres.2017.05.013; Ling DC, 2019, INT J RADIAT ONCOL, V104, P869, DOI 10.1016/j.ijrobp.2019.03.012; National Comprehensive Cancer Network, 2018, GEN FAM HIGH RISK AS, DOI [10.1016/j.jjrobp.2019.03.012, DOI 10.1016/J.JJROBP.2019.03.012]; Noyce RS, 2012, TRENDS MICROBIOL, V20, P429, DOI 10.1016/j.tim.2012.05.006; Sanada T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48867-x; Sanada T, 2016, BIOCHEM BIOPH RES CO, V469, P229, DOI 10.1016/j.bbrc.2015.11.121; Shia J, 2005, MODERN PATHOL, V18, P1350, DOI 10.1038/modpathol.3800417; Shoji K, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2015.22; Swiatnicki MR, 2019, J MAMMARY GLAND BIOL, V24, P231, DOI 10.1007/s10911-019-09433-3; Takano A, 2009, CANCER RES, V69, P6694, DOI 10.1158/0008-5472.CAN-09-0016; Tsuchiya Shin-ichi, 2005, Medical Molecular Morphology, V38, P216, DOI 10.1007/s00795-005-0300-9; Tsukiyama-Kohara K, 2014, EXP ANIM TOKYO, V63, P367, DOI 10.1538/expanim.14-0007; Vallbohmer Daniel, 2005, Clin Colorectal Cancer, V5 Suppl 1, pS19, DOI 10.3816/CCC.2005.s.003; Vandeweerd V, 2019, EUR J BREAST HEALTH, V15, P130, DOI 10.5152/ejbh.2019.4362; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Xia HJ, 2014, EUR J CANCER, V50, P3230, DOI 10.1016/j.ejca.2014.10.012; Xia Hou-Jun, 2012, Zoological Research, V33, P55, DOI 10.3724/SP.J.1141.2012.01055	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233232	10.1371/journal.pone.0233232	http://dx.doi.org/10.1371/journal.pone.0233232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421739	Green Published, gold			2022-12-26	WOS:000537499600034
J	Stohr, JJJM; Verweij, JJ; Buiting, AGM; Rossen, JWA; Kluytmans, JAJW				Stohr, Joep J. J. M.; Verweij, Jaco J.; Buiting, Anton G. M.; Rossen, John W. A.; Kluytmans, Jan A. J. W.			Within-patient plasmid dynamics in Klebsiella pneumoniae during an outbreak of a carbapenemase-producing Klebsiella pneumoniae	PLOS ONE			English	Article							KPC; EPIDEMIOLOGY	Introduction Knowledge of within-patient dynamics of resistance plasmids during outbreaks is important for understanding the persistence and transmission of plasmid-mediated antimicrobial resistance. During an outbreak of a Klebsiella pneumoniae carbapenemase-producing (KPC) K. pneumoniae, the plasmid and chromosomal dynamics of K. pneumoniae within-patients were investigated. Methods During the outbreak, all K. pneumoniae isolates of colonized or infected patients were collected, regardless of their susceptibility pattern. A selection of isolates was short-read and long-read sequenced. A hybrid assembly of the short-and long-read sequence data was performed. Plasmid contigs were extracted from the hybrid assembly, annotated, and within patient plasmid comparisons were performed. Results Fifteen K. pneumoniae isolates of six patients were short-read whole-genome sequenced. Whole-genome multi-locus sequence typing revealed a maximum of 4 allele differences between the sequenced isolates. Within patients 1 and 2 the resistance gene- and plasmid replicon-content did differ between the isolates sequenced. Long-read sequencing and hybrid assembly of 4 isolates revealed loss of the entire KPC-gene containing plasmid in the isolates of patient 2 and a recombination event between the plasmids in the isolates of patient 1. This resulted in two different KPC-gene containing plasmids being simultaneously present during the outbreak. Conclusion During a hospital outbreak of a KPC-producing K. pneumoniae isolate, plasmid loss of the KPC-gene carrying plasmid and plasmid recombination was detected within the isolates from two patients. When investigating outbreaks, one should be aware that plasmid transmission can occur and the possibility of within- and between-patient plasmid variation needs to be considered.	[Stohr, Joep J. J. M.; Verweij, Jaco J.; Buiting, Anton G. M.] Elisabeth TweeSteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Stohr, Joep J. J. M.; Kluytmans, Jan A. J. W.] Amphia Hosp, Dept Infect Control, Breda, Netherlands; [Rossen, John W. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol & Infect Prevent, Groningen, Netherlands; [Rossen, John W. A.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Kluytmans, Jan A. J. W.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Kluytmans, Jan A. J. W.] Amphia Hosp, Amphia Acad, Infect Dis Fdn, Breda, Netherlands	Elisabeth-TweeSteden Ziekenhuis (ETZ); Amphia Hospital; University of Groningen; Utah System of Higher Education; University of Utah; Utrecht University; Utrecht University Medical Center; Amphia Hospital	Stohr, JJJM (corresponding author), Elisabeth TweeSteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands.; Stohr, JJJM (corresponding author), Amphia Hosp, Dept Infect Control, Breda, Netherlands.	joep.stohr@gmail.com	; Rossen, John W. A./G-7564-2011	Stohr, Joep/0000-0002-4021-9635; Verweij, Jaco J./0000-0001-8553-931X; Rossen, John W. A./0000-0002-7167-8623				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arredondo-Alonso S, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000128; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Conlan S, 2016, MBIO, V7, DOI 10.1128/mBio.00742-16; Conlan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009845; DATTA N, 1971, NATURE, V234, P222, DOI 10.1038/234222a0; Feldman N, 2013, CLIN MICROBIOL INFEC, V19, pE190, DOI 10.1111/1469-0691.12099; Hardiman CA, 2016, ANTIMICROB AGENTS CH, V60, P4910, DOI 10.1128/AAC.00014-16; Kluytmans-van den Bergh MFQ, 2016, J CLIN MICROBIOL, V54, P2919, DOI 10.1128/JCM.01648-16; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Lohr IH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116516; Martin J, 2017, J ANTIMICROB CHEMOTH, V72, P3025, DOI 10.1093/jac/dkx264; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Neves C, 2019, EUR J PUBLIC HEALTH, V29; Nurk Sergey, 2013, Research in Computational Molecular Biology. 17th Annual International Conference (RECOMB 2013). Proceedings, P158, DOI 10.1007/978-3-642-37195-0_13; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Roer L, 2019, J ANTIMICROB CHEMOTH, V74, P557, DOI 10.1093/jac/dky484; Ruppe E, 2017, CLIN MICROBIOL INFEC, V23, P470, DOI 10.1016/j.cmi.2017.01.015; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; The European Committee on Antimicrobial Susceptibility Testing, 2018, BREAKPOINT TABLES IN; van den Bunt G, 2019, EURO SURVEILL, V24; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Weterings V, 2015, EUR J CLIN MICROBIOL, V34, P1647, DOI 10.1007/s10096-015-2401-2; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Wick Ryan R, 2015, Bioinformatics, V31, P3350, DOI 10.1093/bioinformatics/btv383; Xie MM, 2018, J ANTIMICROB CHEMOTH, V73, P1230, DOI 10.1093/jac/dkx540; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	29	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233313	10.1371/journal.pone.0233313	http://dx.doi.org/10.1371/journal.pone.0233313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421705	gold, Green Published			2022-12-26	WOS:000537499600041
J	van Dijk, RM; Koska, I; Bleich, A; Tolba, R; Seiffert, I; Moller, C; Di Liberto, V; Talbot, SR; Potschka, H				van Dijk, Roelof Maarten; Koska, Ines; Bleich, Andre; Tolba, Rene; Seiffert, Isabel; Moeller, Christina; Di Liberto, Valentina; Talbot, Steven Roger; Potschka, Heidrun			Design of composite measure schemes for comparative severity assessment in animal-based neuroscience research: A case study focussed on rat epilepsy models	PLOS ONE			English	Article							HARM-BENEFIT ANALYSIS; FELASA WORKING GROUP; STATUS EPILEPTICUS; EPILEPTOGENESIS; DISCOVERY; SEIZURES; BEHAVIOR; WELFARE	Comparative severity assessment of animal models and experimental interventions is of utmost relevance for harm-benefit analysis during ethical evaluation, an animal welfare-based model prioritization as well as the validation of refinement measures. Unfortunately, there is a lack of evidence-based approaches to grade an animal's burden in a sensitive, robust, precise, and objective manner. Particular challenges need to be considered in the context of animal-based neuroscientific research because models of neurological disorders can be characterized by relevant changes in the affective state of an animal. Here, we report about an approach for parameter selection and development of a composite measure scheme designed for precise analysis of the distress of animals in a specific model category. Data sets from the analysis of several behavioral and biochemical parameters in three different epilepsy models were subjected to a principal component analysis to select the most informative parameters. The top-ranking parameters included burrowing, open field locomotion, social interaction, and saccharin preference. These were combined to create a composite measure scheme (CMS). CMS data were subjected to cluster analysis enabling the allocation of severity levels to individual animals. The results provided information for a direct comparison between models indicating a comparable severity of the electrical and chemical post-status epilepticus models, and a lower severity of the kindling model. The new CMS can be directly applied for comparison of other rat models with seizure activity or for assessment of novel refinement approaches in the respective research field. The respective online tool for direct application of the CMS or for creating a new CMS based on other parameters from different models is available at https://github.com/mytalbot/cms. However, the robustness and generalizability needs to be further assessed in future studies. More importantly, our concept of parameter selection can serve as a practice example providing the basis for comparable approaches applicable to the development and validation of CMS for all kinds of disease models or interventions.	[van Dijk, Roelof Maarten; Koska, Ines; Seiffert, Isabel; Moeller, Christina; Potschka, Heidrun] Ludwig Maximilians Univ Munchen, Inst Pharmacol Toxicol & Pharm, Munich, Germany; [Bleich, Andre; Tolba, Rene; Talbot, Steven Roger] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; [Bleich, Andre; Tolba, Rene; Talbot, Steven Roger] Hannover Med Sch, Cent Anim Facil, Hannover, Germany; [Di Liberto, Valentina] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Palermo, Italy	University of Munich; Hannover Medical School; Hannover Medical School; University of Palermo	Potschka, H (corresponding author), Ludwig Maximilians Univ Munchen, Inst Pharmacol Toxicol & Pharm, Munich, Germany.	potschka@pharmtox.vetmed.uni-muenchen.de	Di+Liberto, Valentina/ACL-0264-2022	Di Liberto, Valentina/0000-0002-8574-0061	Deutsche Forschungsgemeinschaft [FOR 2591, GZ: PO681/9-1, BL953/11-1, TO542/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The project was supported by grants of Deutsche Forschungsgemeinschaft (FOR 2591, GZ: PO681/9-1, BL953/11-1, TO542/6-1 https://www.dfg.de/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkaya MG, 2018, BEHAV BRAIN RES, V352, P161, DOI 10.1016/j.bbr.2017.07.039; BAUMANS V, 1994, LAB ANIM-UK, V28, P97, DOI 10.1258/002367794780745308; Becker AJ, 2018, NEUROPATH APPL NEURO, V44, P112, DOI 10.1111/nan.12451; Bleich A, 2017, LAB ANIM-UK, V51, P667, DOI 10.1177/0023677217733010; Blond BN, 2016, NEUROL CLIN, V34, P395, DOI 10.1016/j.ncl.2015.11.002; Brandt C, 2016, EPILEPSY BEHAV, V61, P141, DOI 10.1016/j.yebeh.2016.05.020; Bronstad A, 2016, LAB ANIM-UK, V50, P1, DOI 10.1177/0023677216642398; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Deuis JR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00284; Di Liberto V, 2018, NEUROBIOL DIS, V118, P9, DOI 10.1016/j.nbd.2018.06.010; Gross D, 2015, EUR SURG RES, V55, P43, DOI 10.1159/000377721; Hager C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006159; Harkin A, 2002, J PSYCHOPHARMACOL, V16, P115, DOI 10.1177/026988110201600201; Hawkins P, 2011, LAB ANIM-UK, V45, P1, DOI 10.1258/la.2010.010031; Jirkof P, 2014, J NEUROSCI METH, V234, P139, DOI 10.1016/j.jneumeth.2014.02.001; Kanner AM, 2014, NEUROTHERAPEUTICS, V11, P358, DOI 10.1007/s13311-014-0271-4; Kanzler S, 2016, LAB ANIM-UK, V50, P459, DOI 10.1177/0023677216678018; Keubler L, 2019, ARE WE HEADED CHALLE; Koska I, 2019, EPILEPSIA, V60, P2114, DOI 10.1111/epi.16330; Laber K, 2016, LAB ANIM-UK, V50, P21, DOI 10.1177/0023677216642397; Langberg T, 2016, NEUROBIOL DIS, V85, P122, DOI 10.1016/j.nbd.2015.10.008; Langer M, 2011, EPILEPSY RES, V96, P207, DOI 10.1016/j.eplepsyres.2011.06.005; Lidster K, 2016, J NEUROSCI METH, V260, P2, DOI 10.1016/j.jneumeth.2015.09.007; Loscher W, 2016, EPILEPSY RES, V126, P157, DOI 10.1016/j.eplepsyres.2016.05.016; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; Loscher W, 2017, NEUROCHEM RES, V42, P1873, DOI 10.1007/s11064-017-2222-z; MATTHEWS K, 1995, PHYSIOL BEHAV, V57, P241, DOI 10.1016/0031-9384(94)00286-E; Moller C, 2018, EPILEPSIA, V59, P765, DOI 10.1111/epi.14028; Muller K, 2019, GGPLOT2 ELEGANT GRAP; Pinkernell S, 2016, LAB ANIM-UK, V50, P442, DOI 10.1177/0023677216675010; Pound P, 2016, ATLA-ALTERN LAB ANIM, V44, P167, DOI 10.1177/026119291604400210; R Core Team, 2019, R LANG ENV STAT COMP; Russmann V, 2016, EPILEPSIA, V57, P638, DOI 10.1111/epi.13328; Russmann V, 2016, EUR J PHARMACOL, V771, P29, DOI 10.1016/j.ejphar.2015.12.002; Seiffert I, 2019, EPILEPSIA, V60, P1539, DOI 10.1111/epi.16095; Tappe-Theodor A, 2019, NEUROSCI BIOBEHAV R, V100, P335, DOI 10.1016/j.neubiorev.2019.03.009; van Dijk RM, 2018, EPILEPSIA, V59, P2194, DOI 10.1111/epi.14586; Walker A, 2016, BRAIN BEHAV IMMUN, V53, P138, DOI 10.1016/j.bbi.2015.12.007; Wei T, 2019, R PACKAGE CORRPLOT V; Zintzsch A, 2017, LAB ANIM-UK, V51, P573, DOI 10.1177/0023677217718863	41	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0230141	10.1371/journal.pone.0230141	http://dx.doi.org/10.1371/journal.pone.0230141			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413036	Green Published, gold			2022-12-26	WOS:000537496000008
J	Zhu, XD; Hu, Z; Nie, Y; Zhu, TT; Kaminga, AC; Yu, YH; Xu, HL				Zhu, Xidi; Hu, Zhao; Nie, Yu; Zhu, Tingting; Kaminga, Atipatsa Chiwanda; Yu, Yunhan; Xu, Huilan			The prevalence of poor sleep quality and associated risk factors among Chinese elderly adults in nursing homes: A cross-sectional study	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; SOCIAL SUPPORT; CARDIOVASCULAR-DISEASE; ANXIETY DISORDERS; PRIMARY-CARE; DEPRESSION; DISTURBANCES; PEOPLE; HEALTH; POPULATION	Background Sleep problems have become the most common complaints among the elderly. There are a few studies that explored the prevalence of poor sleep quality and its associated factors among the elderly in nursing homes. Therefore, this study aimed to examine the prevalence of poor sleep quality and its associated factors among the Chinese elderly in nursing homes. Methods A total of 817 elderly residents, from 24 nursing homes, were included in this cross-sectional study. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), and poor sleep quality was defined as PSQI >5. Multiple binary logistic regression was used to estimate the strength of the association between risk factors and poor sleep quality in terms of adjusted odds ratios (AORs) and their 95% confidence intervals (CIs), and interactions of risk factors for poor sleep quality were also examined. Results The prevalence of poor sleep quality was 67.3% (95% CI: 64.0, 70.5%) among the Chinese elderly in nursing homes. Multiple binary logistic regression results showed that participants with the following characteristics had an increased risk of poor sleep quality after adjustments for other confounders: being 70-79 years old (AOR: 1.78, 95% CI: 1.08, 2.92) or 80 years old and above (AOR: 2.67, 95% CI: 1.68, 4.24); having one to two kinds of chronic diseases (AOR: 2.05, 95% CI: 1.39, 3.01) or three or more kinds of chronic diseases (AOR: 2.35, 95% CI: 1.39, 4.00); depression symptoms (AOR: 1.08, 95% CI: 1.04, 1.11), anxiety symptoms (AOR: 1.11, 95% CI: 1.05, 1.18), and social support(AOR: 0.97, 95% CI: 0.95, 0.99). Additive interactions were detected between age and anxiety symptoms (AOR: 8.34, 95% CI: 4.43, 15.69); between chronic disease and anxiety symptoms (AOR: 8.61, 95% CI; 4.28, 17.31); and between social support and anxiety symptoms (AOR: 6.43, 95% CI: 3.22, 12.86). Conclusions The prevalence of poor sleep quality among the elderly in nursing homes is relatively high. Besides, anxiety symptoms has additive interactions with age, chronic disease and social support for poor sleep quality. These findings have significant implications for interventions that aim to improve sleep quality among elderly residents in nursing homes.	[Zhu, Xidi; Hu, Zhao; Nie, Yu; Yu, Yunhan; Xu, Huilan] Cent South Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Peoples R China; [Zhu, Tingting] Shanghai Hlth Dev Res Ctr, Dept Sci Res Management, Shanghai, Peoples R China; [Kaminga, Atipatsa Chiwanda] Mzuzu Univ, Dept Math & Stat, Mzuzu, Malawi; [Kaminga, Atipatsa Chiwanda] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China	Central South University; Central South University	Xu, HL (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Peoples R China.	xhl6363@sina.com		xu, huilan/0000-0001-8948-3149; Hu, Zhao/0000-0002-6787-4074				Ahmed D, 2014, J EGYPT PUBLIC HEAL, V89, P127, DOI 10.1097/01.EPX.0000455729.66131.49; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Aunjitsakul Warut, 2018, Journal of the Medical Association of Thailand, V101, P137; Bazargan M, 1996, INT J AGING HUM DEV, V42, P143, DOI 10.2190/GM89-NRTY-DERQ-LC7D; Beekman ATF, 2000, AM J PSYCHIAT, V157, P89, DOI 10.1176/ajp.157.1.89; Bo YC, 2019, J CLIN SLEEP MED, V15, P393, DOI 10.5664/jcsm.7660; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; Chang KJ, 2014, ARCH GERONTOL GERIAT, V59, P468, DOI 10.1016/j.archger.2014.04.007; Cho HJ, 2008, AM J PSYCHIAT, V165, P1543, DOI 10.1176/appi.ajp.2008.07121882; da Costa SV, 2011, REV LAT-AM ENFERM, V19, P920, DOI 10.1590/S0104-11692011000400010; da Silva RM, 2020, AGING MENT HEALTH, V24, P1452, DOI 10.1080/13607863.2019.1619168; de Pooter-Stijnman LMM, 2018, EUR GERIATR MED, V9, P829, DOI 10.1007/s41999-018-0115-6; Dong XL, 2018, SLEEP BREATH, V22, P1213, DOI 10.1007/s11325-018-1685-8; Ersser S, 1999, J CLIN NURS, V8, P360, DOI 10.1046/j.1365-2702.1999.00267.x; Eser I, 2007, J GERONTOL NURS, V33, P42, DOI 10.3928/00989134-20071001-07; Eshkoor SA, 2013, AM J ALZHEIMERS DIS, V28, P253, DOI 10.1177/1533317513481098; Fetveit A, 2002, INT J GERIATR PSYCH, V17, P604, DOI 10.1002/gps.639; Gelaye B, 2016, SLEEP BREATH, V20, P1319, DOI 10.1007/s11325-016-1418-9; Gentili A, 1997, AGING-CLIN EXP RES, V9, P207, DOI 10.1007/BF03340151; Gnadinger M, 2018, INT J PUBLIC HEALTH, V63, P1017, DOI 10.1007/s00038-018-1114-6; Gu DN, 2010, SLEEP, V33, P601, DOI 10.1093/sleep/33.5.601; Hayashino Y, 2010, SLEEP MED, V11, P366, DOI 10.1016/j.sleep.2009.05.021; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Kara B, 2017, J TRANSCULT NURS, V28, P296, DOI 10.1177/1043659615623330; Kirmizioglu Y, 2009, INT J GERIATR PSYCH, V24, P1026, DOI 10.1002/gps.2215; Kishimoto Y, 2016, ENVIRON HEALTH PREV, V21, P295, DOI 10.1007/s12199-016-0529-z; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; [刘杰 Liu Jie], 2013, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V21, P39; LIVINGSTON G, 1993, BRIT J GEN PRACT, V43, P445; Luo J, 2013, PLOS ONE, V8; Maggi S, 1998, J AM GERIATR SOC, V46, P161, DOI 10.1111/j.1532-5415.1998.tb02533.x; Matsuda R, 2017, INT J CARDIOL, V228, P977, DOI 10.1016/j.ijcard.2016.11.091; Mazzotti DR, 2012, SLEEP MED, V13, P697, DOI 10.1016/j.sleep.2012.02.009; National Bureau of Statistics of China, 2011, 6 NAT POP CENS DAT G; National committee on aging, 2007, NATL COMMITTEE AGING; Olivera J, 2008, INT J GERIATR PSYCH, V23, P915, DOI 10.1002/gps.2004; Orhan FO, 2012, SLEEP BREATH, V16, P1059, DOI 10.1007/s11325-011-0601-2; Park JH, 2013, INT J NURS PRACT, V19, P116, DOI 10.1111/ijn.12047; Paudel ML, 2008, J AM GERIATR SOC, V56, P1228, DOI 10.1111/j.1532-5415.2008.01753.x; Paukert AL, 2010, J CLIN PSYCHOL MED S, V17, P387, DOI 10.1007/s10880-010-9211-6; Pedraza Sandra, 2012, Aging Clin Exp Res, V24, P391, DOI 10.3275/8106; Potvin O, 2014, INT J GERIATR PSYCH, V29, P1262, DOI 10.1002/gps.4106; Press Y, 2018, AGING CLIN EXP RES, V30, P755, DOI 10.1007/s40520-017-0837-1; Qiu J, 2016, MODERN PREVENTIVE ME, V43, P1835; Quan SA, 2016, J KOREAN MED SCI, V31, P1689, DOI 10.3346/jkms.2016.31.11.1689; Razali R, 2016, NEUROL ASIA, V21, P265; Roberts RE, 2000, AM J PSYCHIAT, V157, P81, DOI 10.1176/ajp.157.1.81; Roepke SK, 2010, INDIAN J MED RES, V131, P302; Sagayadevan V, 2017, PSYCHOGERIATRICS, V17, P43, DOI 10.1111/psyg.12190; Smalbrugge M, 2008, AGING MENT HEALTH, V12, P244, DOI 10.1080/13607860801987238; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stefan L, 2018, INT J ENV RES PUBLIC, V15; Stranges S, 2012, SLEEP, V35, P1173, DOI 10.5665/sleep.2012; Su TP, 2004, AUST NZ J PSYCHIAT, V38, P706, DOI 10.1111/j.1440-1614.2004.01444.x; Sukegawa T, 2003, PSYCHIAT CLIN NEUROS, V57, P265, DOI 10.1046/j.1440-1819.2003.01115.x; Teesson M, 2011, AUST NZ J PSYCHIAT, V45, P939, DOI 10.3109/00048674.2011.614590; Thichumpa W, 2018, EPIDEMIOL HEALTH, V40, DOI 10.4178/epih.e2018018; Troxel WM, 2010, J PSYCHOSOM RES, V69, P459, DOI 10.1016/j.jpsychores.2010.04.003; Tsai YF, 2008, J CLIN NURS, V17, P1219, DOI 10.1111/j.1365-2702.2007.02020.x; Uchmanowicz I, 2019, CLIN INTERV AGING, V14, P155, DOI 10.2147/CIA.S188499; Wang P, 2019, AGING CLIN EXPT RES; Wang Y, 2019, SLEEP MED, V54, P134, DOI 10.1016/j.sleep.2018.10.031; Wilfling D, 2019, J ALZHEIMERS DIS, V69, P227, DOI 10.3233/JAD-180784; Yang CY, 2012, J NURS RES, V20, P249, DOI 10.1097/jnr.0b013e3182736461; Yu JH, 2016, PSYCHOGERIATRICS, V16, P191, DOI 10.1111/psyg.12138; Zhang HQ, 2019, SLEEP MED, V58, P27, DOI 10.1016/j.sleep.2019.03.001	67	8	8	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232834	10.1371/journal.pone.0232834	http://dx.doi.org/10.1371/journal.pone.0232834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1BA	32413064	Green Published, gold, Green Submitted			2022-12-26	WOS:000537496000023
J	Lopez-Carvallo, JA; Mazon-Suastegui, JM; Hernandez-Onate, MA; Tovar-Ramirez, D; Abasolo-Pacheco, F; Morelos-Castro, RM; Arcos-Ortega, GF				Antonio Lopez-Carvallo, Jesus; Manuel Mazon-Suastegui, Jose; Angel Hernandez-Onate, Miguel; Tovar-Ramirez, Dariel; Abasolo-Pacheco, Fernando; Maria Morelos-Castro, Rosa; Fabiola Arcos-Ortega, Guadalupe			Transcriptome analysis of Catarina scallop (Argopecten ventricosus) juveniles treated with highly-diluted immunomodulatory compounds reveals activation of non-self-recognition system	PLOS ONE			English	Article							HOMEOPATHIC MEDICINES; GENE-EXPRESSION; POTENTIAL ROLE; OYSTER; GROWTH; HEPATOPANCREAS; ANTIBIOTICS; AQUACULTURE; ANNOTATION; GENERATION	Marine bivalve hatchery productivity is continuously challenged by apparition and propagation of new diseases, mainly those related to vibriosis. Disinfectants and antibiotics are frequently overused to prevent pathogen presence, generating a potential negative impact on the environment. Recently, the use of highly diluted compounds with immunostimulant properties in marine organisms has been trailed successfully to activate the self-protection mechanisms of marine bivalves. Despite their potential as immunostimulants, little is known about their way of action. To understand their effect, a comparative transcriptomic analysis was performed with Argopecten ventricosus juveniles. The experimental design consisted of four treatments formulated from pathogenic Vibrio lysates at two dilutions: [(T1) Vibrio parahaemolyticus and Vibrio alginolyticus 1D; (T2) V. parahaemolyticus and V. alginolyticus 7C]; minerals [(T3) PhA+SiT 7C], scorpion venom [(T4) ViT 31C]; and one control (C1) hydro-alcoholic solution (ethanol 1%). The RNA sequencing (RNAseq) analysis showed a higher modulation of differentially expressed genes (DEG) in mantle tissue compared to gill tissue. The scallops that showed a higher number of DEG related to immune response in mantle tissue corresponded to T1 (V. parahaemolyticus and V. alginolyticus lysate) and T3 (Silicea terra (R) - Phosphoric acid (R)). The transcriptome analysis allowed understanding some interactions between A. ventricosus juveniles and highly-diluted treatments.	[Antonio Lopez-Carvallo, Jesus; Manuel Mazon-Suastegui, Jose] Ctr Invest Biol Noroeste, Lab Expt Cult Moluscos, La Paz, Mexico; [Angel Hernandez-Onate, Miguel] Ctr Invest Alimentac & Desarrollo AC, CONACyT, Hermosillo, Sonora, Mexico; [Tovar-Ramirez, Dariel] Ctr Invest Biol Noroeste, Lab Fisiol Comparada & Genom Func, La Paz, Mexico; [Abasolo-Pacheco, Fernando] Univ Tecna Estatal Quevedo, Fac Ciencias Agr, Quevedo, Los Rios, Ecuador; [Maria Morelos-Castro, Rosa; Fabiola Arcos-Ortega, Guadalupe] Ctr Invest Biol Noroeste, Lab Imunogenom Marina, La Paz, Mexico	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA; CIAD - Centro de Investigacion en Alimentacion y Desarrollo; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Hernandez-Onate, MA (corresponding author), Ctr Invest Alimentac & Desarrollo AC, CONACyT, Hermosillo, Sonora, Mexico.; Arcos-Ortega, GF (corresponding author), Ctr Invest Biol Noroeste, Lab Imunogenom Marina, La Paz, Mexico.	miguel.hernandez@ciad.mx; farcos04@cibnor.mx	CARVALLO, JESÚS ANTONIO LÓPEZ/AAF-9759-2021; Mazón-Suástegui, José Manuel/AFM-8881-2022; Tovar-Ramírez, Dariel/AAO-2184-2020; Arcos, Guadalupe Fabiola/H-6023-2018; Hernandez Oñate, Miguel Angel/AAX-9368-2021; Hernandez Onate, Miguel Angel/Q-2461-2018	CARVALLO, JESÚS ANTONIO LÓPEZ/0000-0002-7405-8665; Tovar-Ramírez, Dariel/0000-0003-1204-9576; Arcos, Guadalupe Fabiola/0000-0002-6098-3569; Hernandez Onate, Miguel Angel/0000-0001-5857-2608	Sectoral Fund for Research for Education of Mexico; project Basic Science CONACyT [258282]; project PROINNOVA-CONACyT [24177]; CONACYT [301921]	Sectoral Fund for Research for Education of Mexico; project Basic Science CONACyT; project PROINNOVA-CONACyT; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was funded by the Sectoral Fund for Research for Education of Mexico; projects Basic Science CONACyT 258282 and PROINNOVA-CONACyT 24177 under the academic responsibility of JMMS. JALC is the recipient of a doctorate fellowship (CONACYT-301921), under the academic direction of GFAO and JMMS.; This study was under the academic responsibility of JMMS. JALC is the recipient of a doctoral fellowship (CONACYT-301921), under the academic direction of FAO and JMMS. They conceived and assessed the experimental design and research development and JALC performed zoo-technical work, collected and analysed data, and wrote the first draft of the manuscript. All authors revised and approved the final manuscript. The authors are grateful to the technical staff at CIBNOR: Delfino Barajas, Pablo Ormart, Julian Garzon, Carmen Rodriguez, Patricia Hinojosa, Norma Ochoa, Martin Ramirez, Martha Reyes and Eulalia Meza for their support. Diana Fischer provided editorial services in English. Noroeste Sustentable A.C. donated scallops produced by Acuacultura Robles hatchery.	Allam B, 2015, J INVERTEBR PATHOL, V131, P121, DOI 10.1016/j.jip.2015.05.005; Andrews S., 2018, FASTQC QUALITY CONTR; Anick DJ, 2007, HOMEOPATHY, V96, P189, DOI 10.1016/j.homp.2007.03.005; [Anonymous], 2019, GPLOTS STAT PACKAGE; Lopez-Carvallo JA, 2019, LAT AM J AQUAT RES, V47, P65, DOI 10.3856/vol47-issue1-fulltext-8; Antony SP, 2011, IMMUNOBIOLOGY, V216, P184, DOI 10.1016/j.imbio.2010.05.030; Appel HM, 2014, OECOLOGIA, V175, P1257, DOI 10.1007/s00442-014-2995-6; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Bachere E, 2015, FISH SHELLFISH IMMUN, V46, P50, DOI 10.1016/j.fsi.2015.02.040; Bauer M, 2018, TRENDS IMMUNOL, V39, P438, DOI 10.1016/j.it.2018.04.001; Bell IR, 2013, J NANOMEDICINE NANOT, V4, P179; Bell IR, 2015, HOMEOPATHY, V104, P123, DOI 10.1016/j.homp.2014.11.003; Bellavite P, 2014, HOMEOPATHY, V103, P4, DOI 10.1016/j.homp.2013.08.003; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen Y, 2019, PACKAGE EDGER; Coyne VE, 2011, ISJ-INVERT SURVIV J, V8, P48; Rosero-Garcia AD, 2019, HOMEOPATHY, V108, P201, DOI 10.1055/s-0039-1681062; Dong WQ, 2017, FISH SHELLFISH IMMUN, V70, P560, DOI 10.1016/j.fsi.2017.08.034; Dubert J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00762; Ertl NG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156649; Freedman AH, 2020, BIORXIV, DOI [10.1101/585745, DOI 10.1101/585745]; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Genard B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064534; Genard B, 2012, GENE, V499, P70, DOI 10.1016/j.gene.2012.02.021; Gerdol M, 2015, FISH SHELLFISH IMMUN, V46, P17, DOI 10.1016/j.fsi.2015.02.013; Ghosh R, 2016, SCI REP-UK, V6, DOI 10.1038/srep33370; Giovannini C, 2017, SCI REP-UK, V7, DOI 10.1038/srep44685; Gomez-Chiarri M, 2015, J INVERTEBR PATHOL, V131, P137, DOI 10.1016/j.jip.2015.05.007; Gonzalez R, 2017, FISH SHELLFISH IMMUN, V68, P173, DOI 10.1016/j.fsi.2017.07.010; Gonzalez-Munoz MJ, 2008, FOOD CHEM TOXICOL, V46, P1111, DOI 10.1016/j.fct.2007.11.006; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gunther J, 2018, SEMIN IMMUNOPATHOL, V40, P555, DOI 10.1007/s00281-018-0701-1; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HISATSUNE K, 1982, MICROBIOL IMMUNOL, V26, P649, DOI 10.1111/j.1348-0421.1982.tb00209.x; Hu HJ, 2016, TOXICOL RES-UK, V5, P609, DOI 10.1039/c5tx00383k; Hu YF, 2005, CURR MOL MED, V5, P29, DOI 10.2174/1566524053152915; Huang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27578; Iryani MTM, 2017, J EXP MAR BIOL ECOL, V487, P106, DOI 10.1016/j.jembe.2016.12.004; Jin JL, 2012, J APPL ICHTHYOL, V28, P697, DOI 10.1111/j.1439-0426.2012.02024.x; Kesarcodi-Watson A, 2008, AQUACULTURE, V274, P1, DOI 10.1016/j.aquaculture.2007.11.019; Kim BM, 2017, MOL CELL TOXICOL, V13, P105, DOI 10.1007/s13273-017-0011-z; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lawrence Rubina, 2013, BMC Proc, V7, pS1, DOI 10.1186/1753-6561-7-S3-S1; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liang P, 2018, J HAZARD MATER, V360, P1, DOI 10.1016/j.jhazmat.2018.07.096; Liu X, 2017, ENVIRON POLLUT, V223, P161, DOI 10.1016/j.envpol.2017.01.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luna-Gonzalez A, 2002, DIS AQUAT ORGAN, V49, P221, DOI 10.3354/dao049221; Mazon-Suastegui JM, 2019, HOMEOPATHY, V108, P43, DOI 10.1055/s-0038-1672197; Mazon-Suastegui JM, 2017, HOMEOPATHY, V106, P18, DOI 10.1016/j.homp.2016.12.002; Mazon-Suastequi JM, 2019, REV MVZ CORDOBA, V24, P7328, DOI 10.21897/rmvz.1536; Mat AM, 2018, AQUAT TOXICOL, V199, P127, DOI 10.1016/j.aquatox.2018.03.030; Mazon-Suastegui J, 2018, REV MVZ CORDOBA, V23, P6850, DOI 10.21897/rmvz.1373; MazuEn-SuuYstegui JM., 2016, HOMEOPATHY, V105, P33, DOI DOI 10.1016/J.HOMP.2015.12.057; Mohan K, 2019, FISH SHELLFISH IMMUN, V86, P1177, DOI 10.1016/j.fsi.2018.12.072; Moreira R, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3308-0; Morelos RM, 2015, J EXP ZOOL PART A, V323, P239, DOI 10.1002/jez.1914; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Nie HT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00246-0; Ortiz-Cornejo N.L., 2017, REV MED HOMEOPATIA, V10, P28; Pauletto M, 2014, FISH SHELLFISH IMMUN, V37, P154, DOI 10.1016/j.fsi.2014.01.017; Phromkunthong W., 2015, Aqua Culture Asia Pacific, V11, P43; Prado S, 2010, VET MICROBIOL, V145, P187, DOI 10.1016/j.vetmic.2010.08.021; Prasad A, 2014, J PHOTOCH PHOTOBIO B, V139, P47, DOI 10.1016/j.jphotobiol.2014.03.004; Prego-Faraldo MV, 2017, MAR ENVIRON RES, V129, P304, DOI 10.1016/j.marenvres.2017.06.009; Ren YP, 2017, FISH SHELLFISH IMMUN, V64, P14, DOI 10.1016/j.fsi.2017.03.005; Roberts RJ, 2010, J FISH DIS, V33, P789, DOI 10.1111/j.1365-2761.2010.01183.x; Romero J, 2012, HEALTH AND ENVIRONMENT IN AQUACULTURE, P159; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; SEMENZA JC, 2017, ENVIRON HEALTH PERSP, V125; Shi PJ, 2018, J OCEANOL LIMNOL, V36, P490, DOI 10.1007/s00343-018-6347-y; Smith-Unna R, 2016, GENOME RES, V26, P1134, DOI 10.1101/gr.196469.115; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Tarr JM, 2010, J MOL BIOL, V401, P799, DOI 10.1016/j.jmb.2010.06.064; Tatematsu M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2857; Thusberg J, 2007, PROTEIN ENG DES SEL, V20, P133, DOI 10.1093/protein/gzm004; Travers MA, 2015, J INVERTEBR PATHOL, V131, P11, DOI 10.1016/j.jip.2015.07.010; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Ventoso P, 2019, TOXINS, V11, DOI 10.3390/toxins11020097; Wang W, 2017, AQUAC RES, V48, P1, DOI 10.1111/are.13161; Waterhouse RM, 2018, MOL BIOL EVOL, V35, P543, DOI 10.1093/molbev/msx319; Wendling CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094256; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yue X, 2011, FISH SHELLFISH IMMUN, V30, P791, DOI 10.1016/j.fsi.2010.12.027; Zhao XL, 2017, FISH SHELLFISH IMMUN, V67, P523, DOI 10.1016/j.fsi.2017.06.040; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453	90	7	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233064	10.1371/journal.pone.0233064	http://dx.doi.org/10.1371/journal.pone.0233064			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407349	gold, Green Published			2022-12-26	WOS:000537490700062
J	Hirai, J; Tachibana, A; Tsuda, A				Hirai, Junya; Tachibana, Aiko; Tsuda, Atsushi			Large-scale metabarcoding analysis of epipelagic and mesopelagic copepods in the Pacific	PLOS ONE			English	Article							MARINE BIODIVERSITY; COMMUNITY STRUCTURE; DIVERSITY; ZOOPLANKTON; NORTH; OCEAN; CALANOIDA; PATTERNS; SURFACE; GYRES	A clear insight into the large-scale community structure of planktonic copepods is critical to understanding the mechanisms controlling diversity and biogeography of marine taxa in terms of their high abundance, ubiquity, and sensitivity to environmental changes. Here, we applied a 28S metabarcoding approach to large-scale communities of epipelagic and mesopelagic copepods at 70 stations across the Pacific Ocean and three stations in the Arctic Ocean. Major patterns of community structure and diversity, influenced by water mass structures, agreed with results from previous morphology-based studies. However, a large-scale metabarcoding approach could detect community changes even under stable environmental conditions, including changes in the north/south subtropical gyres and east/west areas within each subtropical gyre. There were strong effects of the epipelagic environment on mesopelagic communities, and community subdivisions were observed in the environmentally stable mesopelagic layer. In each sampling station, higher operational taxonomic unit (OTU) numbers and lower phylogenetic diversity were observed in the mesopelagic layer than in the epipelagic layer, indicating a recent rapid increase in species numbers in the mesopelagic layer. The phylogenetic analysis utilizing representative sequences of OTUs revealed trends of recent emergence of cold-water OTUs, which are mainly distributed at high latitudes with low water temperatures. Conversely, the high diversity of copepods at low latitudes was suggested to have been formed through long evolution under high water temperature conditions. The metabarcoding results suggest that evolutionary processes have strong impacts on current patterns of copepod diversity, and support the "out of the tropics" theory explaining latitudinal diversity gradients of copepods. Diversity patterns in both epipelagic and mesopelagic copepods was highly correlated to sea surface temperature; thus, predicted global warming may have a significant impact on copepod diversity in both layers.	[Hirai, Junya; Tsuda, Atsushi] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan; [Tachibana, Aiko] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Tokyo, Japan	University of Tokyo; Tokyo University of Marine Science & Technology	Hirai, J (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan.	hirai@aori.u-tokyo.ac.jp		Tachibana, Aiko/0000-0002-6855-6297	Japan Society for the Promotion of Science [247024, 24121004]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Japan Society for the Promotion of Science (grant nos. 247024 to J.H. and 24121004 to A.T.).	Anderson MJ, 2008, PERMANOVA PRIMER GUI; Andrews KR, 2014, MOL ECOL, V23, P5462, DOI 10.1111/mec.12950; ANGEL MV, 1993, CONSERV BIOL, V7, P760, DOI 10.1046/j.1523-1739.1993.740760.x; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2015, NAT CLIM CHANGE, V5, P695, DOI [10.1038/NCLIMATE2650, 10.1038/nclimate2650]; Berry TE, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007943; Blanco-Bercial L, 2011, MOL PHYLOGENET EVOL, V59, P103, DOI 10.1016/j.ympev.2011.01.008; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradford-Grieve JM, 2002, HYDROBIOLOGIA, V485, P223, DOI 10.1023/A:1021373412738; Brinton E., 1962, DISTRIBUTION PACIFIC; Bucklin A, 2016, J PLANKTON RES, V38, P393, DOI 10.1093/plankt/fbw023; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P2234, DOI 10.1016/j.dsr2.2010.09.025; Clarke K. R., 2015, PRIMER V7 USER MANUA, P296; de Boyer Monte gut C, 2004, J GEOPHYS RES OCEANS, V109; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ghiglione JF, 2012, P NATL ACAD SCI USA, V109, P17633, DOI 10.1073/pnas.1208160109; Goetze E, 2003, P ROY SOC B-BIOL SCI, V270, P2321, DOI 10.1098/rspb.2003.2505; Hays GC, 2005, TRENDS ECOL EVOL, V20, P337, DOI 10.1016/j.tree.2005.03.004; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hirai J, 2015, MOL ECOL RESOUR, V15, P68, DOI 10.1111/1755-0998.12294; Hirai J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181452; Hirai J, 2015, MAR ECOL PROG SER, V534, P65, DOI 10.3354/meps11404; Ibarbalz FM, 2019, CELL, V179, P1084, DOI 10.1016/j.cell.2019.10.008; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Khodami S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06656-4; Kosobokova K, 2000, DEEP-SEA RES PT I, V47, P2029, DOI 10.1016/S0967-0637(00)00015-7; Kuriyama M, 2006, CRUSTACEANA, V79, P293, DOI 10.1163/156854006776759554; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Matsuura H, 2010, DEEP-SEA RES PT II, V57, P2098, DOI 10.1016/j.dsr2.2010.09.013; Mauchline J, 1998, BIOL CALANOID COPEPO; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Mcgowan J.A., 1971, MICROPALEONTOLOGY OC, P3; MCGOWAN JA, 1979, ECOL MONOGR, V49, P195, DOI 10.2307/1942513; MENARD HW, 1966, J GEOPHYS RES, V71, P4305, DOI 10.1029/JZ071i018p04305; Neall VE, 2008, PHILOS T R SOC B, V363, P3293, DOI 10.1098/rstb.2008.0119; Nonomura T, 2008, PROG OCEANOGR, V77, P45, DOI 10.1016/j.pocean.2008.02.001; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Pflaumann U, 2003, PALEOCEANOGRAPHY, V18; Proud R, 2017, CURR BIOL, V27, P113, DOI 10.1016/j.cub.2016.11.003; R Core Team, 2021, R LANGUAGE ENV STAT; Razouls C., 2020, DIVERSITY GEOGRAPHIC; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Rombouts I, 2010, LIMNOL OCEANOGR, V55, P2219, DOI 10.4319/lo.2010.55.5.2219; Rombouts I, 2009, P ROY SOC B-BIOL SCI, V276, P3053, DOI 10.1098/rspb.2009.0742; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schnack-Schiel SB, 2010, DEEP-SEA RES PT II, V57, P2064, DOI 10.1016/j.dsr2.2010.09.010; Steinberg DK, 2000, DEEP-SEA RES PT I, V47, P137, DOI 10.1016/S0967-0637(99)00052-7; Stickley CE, 2009, NATURE, V460, P376, DOI 10.1038/nature08163; Sun D, 2017, J MARINE SYST, V169, P52, DOI 10.1016/j.jmarsys.2017.01.011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Van der Spoel S., 1983, COMP ATLAS ZOOPLANKT; Villarino E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02535-8; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wei W., 1992, Proceedings of the Ocean Drilling Program Scientific Results, V120, P979, DOI 10.2973/odp.proc.sr.120.199.1992; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wessel Paul, 2013, Eos, Transactions American Geophysical Union, V94, P409, DOI 10.1002/2013EO450001; Westcott SL, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00073-17; Williamson M, 2010, J PLANKTON RES, V32, P273, DOI 10.1093/plankt/fbp119; Woodd-Walker RS, 2002, MAR ECOL PROG SER, V236, P189, DOI 10.3354/meps236189; Yamaguchi A, 2015, ZOOL STUD, V54, DOI 10.1186/s40555-014-0091-6; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	68	11	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233189	10.1371/journal.pone.0233189	http://dx.doi.org/10.1371/journal.pone.0233189			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407365	Green Published, Green Submitted, gold			2022-12-26	WOS:000537490700082
J	Jacques, CN; Hulbert, AK; Westenskow, S; Neff, MM				Jacques, Caitlin N.; Hulbert, Anna K.; Westenskow, Shelby; Neff, Michael M.			Production location of the gelling agent Phytagel has a significant impact on Arabidopsis thaliana seedling phenotypic analysis	PLOS ONE			English	Article							BRASSINOSTEROID INACTIVATION; PHYTOCHROME	Background Recently, it was found that 1% Phytagel plates used to conduct Arabidopsis thaliana seedling phenotypic analysis no longer reproduced previously published results. This Phytagel, which is produced in China (Phytagel C), has replace American-made Phytagel (Phytagel), which is no longer commercially available. In this study, we present the impact of Phytagel produced in the United States vs. China on seedling phenotypic analysis. As a part of this study, an alternative gelling agent has been identified that is capable of reproducing previously published seedling morphometrics. Results Phytagel and Phytagel C were investigated based on their ability to reproduce the subtle phenotype of the sob3-4 esc-8 double mutant. Fluence-rate-response analysis of seedlings grown on 1% Phytagel C plates failed to replicate the sob3-4 esc-8 subtle phenotype seen on 1% Phytagel. Furthermore, root penetrance analysis showed a significant difference between sob3-4 esc-8 seedlings grown on 1% Phytagel and 1% Phytagel C. It was also found that 1% Phytagel C was significantly harder than 1% Phytagel. As a replacement for Phytagel C, Gellan was tested. 1% Gellan was able to reproduce the subtle phenotype of sob3-4 esc-8. Furthermore, there was no significant difference in root penetration of the wild type or sob3-4 esc-8 seedlings between 1% Phytagel and 1% Gellan. This may be due to the significant reduction in hardness in 1% Gellan plates compared to 1% Phytagel plates. Finally, we tested additional concentrations of Gellan and found that seedlings on 0.6% Gellan looked more uniform while also being able to reproduce previously published results. Conclusions Phytagel has been the standard gelling agent for several studies involving the characterization of subtle seedling phenotypes. After production was moved to China, Phytagel C was no longer capable of reproducing these previously published results. An alternative gelling agent, Gellan, was able to reproduce previously published seedling phenotypes at both 1% and 0.6% concentrations. The information provided in this manuscript is beneficial to the scientific community as whole, specifically phenomics labs, as it details key problematic differences between gelling agents that should be performing identically (Phytagel and Phytagel C).	[Jacques, Caitlin N.; Neff, Michael M.] Washington State Univ, Grad Program Mol Plant Sci, Pullman, WA 99164 USA; [Jacques, Caitlin N.; Hulbert, Anna K.; Westenskow, Shelby; Neff, Michael M.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Washington State University; Washington State University	Neff, MM (corresponding author), Washington State Univ, Grad Program Mol Plant Sci, Pullman, WA 99164 USA.; Neff, MM (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	mmneff@wsu.edu			United States National Science Foundation [1656265]; USDA National Institute of Food and Agriculture, Hatch Umbrella Project [1015621]	United States National Science Foundation(National Science Foundation (NSF)); USDA National Institute of Food and Agriculture, Hatch Umbrella Project	This work was supported by the United States National Science Foundation Project #1656265 (to M.M.N.). This work was also supported by the USDA National Institute of Food and Agriculture, Hatch Umbrella Project #1015621 (to M.M.N.).	Favero DS, 2016, PLANT PHYSIOL, V171, P2701, DOI 10.1104/pp.16.00405; Millipore Sigma, 2019, GELL AG PLANT TISS C; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Peng H, 2015, DEVELOPMENT, V142, P4129, DOI 10.1242/dev.124347; PhytoTechnology Laboratories, 2013, PROD INF SHEET; Street IH, 2008, PLANT J, V54, P1, DOI 10.1111/j.1365-313X.2007.03393.x; Turk EM, 2005, PLANT J, V42, P23, DOI 10.1111/j.1365-313X.2005.02358.x; Ward JM, 2006, PLANT CELL, V18, P29, DOI 10.1105/tpc.105.036707; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Zhang J, 2006, PLANT J, V46, P834, DOI 10.1111/j.1365-313X.2006.02745.x; Zhao JF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0266-7	12	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0228515	10.1371/journal.pone.0228515	http://dx.doi.org/10.1371/journal.pone.0228515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407318	Green Published, Green Submitted, gold			2022-12-26	WOS:000537490700005
J	Zulyniak, MA; de Souza, RJ; Shaikh, M; Ramasundarahettige, C; Tam, K; Williams, N; Desai, D; Lefebvre, DL; Gupta, M; Subbarao, P; Becker, AB; Mandhane, PJ; Turvey, SE; Moraes, T; Azad, MB; Teo, KK; Sears, MR; Anand, SS				Zulyniak, Michael A.; de Souza, Russell J.; Shaikh, Mateen; Ramasundarahettige, Chinthanie; Tam, Keith; Williams, Natalie; Desai, Dipika; Lefebvre, Diana L.; Gupta, Milan; Subbarao, Padmaja; Becker, Allan B.; Mandhane, Piushkumar J.; Turvey, Stuart E.; Moraes, Theo; Azad, Meghan B.; Teo, Koon K.; Sears, Malcolm R.; Anand, Sonia S.		NutriGen Alliance Investigators	Ethnic differences in maternal diet in pregnancy and infant eczema	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ALLERGIC DISEASES; PATTERN-ANALYSIS; ATOPIC ECZEMA; RISK; WHEEZE; CHILD; ASSOCIATION; FOOD; ATHEROSCLEROSIS	Background The global prevalence of childhood eczema has increased over the last few decades, with a marked increase in high-income countries. Differences in prevalence of childhood eczema between countries and ethnicities suggest that genetic and early modifiable environmental factors, such as dietary intake, may underlie this observation. To investigate the association between pregnancy diet and infant eczema in a consortium of prospective Canadian birth cohorts predominantly comprised of white Europeans and South Asians. Methods We evaluated the association of maternal dietary patterns reported during pregnancy (assessed at 24-28 weeks gestation using a semi-quantitiative food-frequency questionnaire) with parent-reported physician-diagnosed infant eczema at 1-year from 2,160 mother-infant pairs. Using three dietary patterns ("Western", "plant-based", and "Balanced") previously derived in this cohort using principal component analysis, we used multivariable logistic regression to determine the association of these dietary patterns with infant eczema, adjusted for potential confounders. Results We observed a lower odds of eczema in the full sample combining white Europeans and South Asians with greater adherence to a plant-based (OR = 0.65; 95% CI: 0.55, 0.76; <0.001) and Western dietary pattern (OR = 0.73; 95% CI: 0.60, 0.89; P<0.01), after adjusting for other known predictors of eczema, including ethnicity, which was not significant. No associations were observed for the balanced diet. An interaction between the Western diet and ethnicity was observed (P<0.001). Following stratification by ethnicity, a protective association between the plant-based diet and infant eczema was confirmed in both white Europeans (OR = 0.59; 95% CI: 0.47, 0.74; P<0.001) and South Asians (OR = 0.77; 95% CI: 0.61, 0.97; P = 0.025). In white Europeans only, a Western diet was associated with a lower odds of infant eczema (OR = 0.69; 95% CI: 0.56, 0.87; P = 0.001) while a balanced diet increased the odds of infant eczema (OR = 1.23; 95% CI: 1.02, 1.49; P = 0.03). Beyond a plant-based diet, no significant associations with other dietary patterns were observed in South Asians. Conclusion A plant-based diet during pregnancy is associated with a lowered odds of infant eczema at 1 year in all participants. Future studies of the components of plant-based diet which underlie the lower risk of eczema are needed.	[Zulyniak, Michael A.; Tam, Keith; Williams, Natalie; Lefebvre, Diana L.; Gupta, Milan; Teo, Koon K.; Sears, Malcolm R.; Anand, Sonia S.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Zulyniak, Michael A.] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England; [de Souza, Russell J.; Shaikh, Mateen; Anand, Sonia S.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [de Souza, Russell J.; Ramasundarahettige, Chinthanie; Desai, Dipika; Teo, Koon K.; Anand, Sonia S.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [de Souza, Russell J.; Ramasundarahettige, Chinthanie; Desai, Dipika; Teo, Koon K.; Anand, Sonia S.] McMaster Univ, Hamilton, ON, Canada; [Gupta, Milan] Canadian Collaborat Res Network, Brampton, ON, Canada; [Subbarao, Padmaja; Moraes, Theo] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Subbarao, Padmaja; Moraes, Theo] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Subbarao, Padmaja] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Becker, Allan B.] Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB, Canada; [Mandhane, Piushkumar J.] Univ Alberta, Fac Med & Dent, Dept Paediat, Edmonton, AB, Canada; [Turvey, Stuart E.] BC Childrens Hosp, Fac Med, Dept Paediat, Vancouver, BC, Canada; [Turvey, Stuart E.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC, Canada; [Azad, Meghan B.] Univ Manitoba, Childrens Hosp, Hlth Sci Ctr, Dept Pediat & Child Hlth, Winnipeg, MB, Canada	McMaster University; University of Leeds; McMaster University; McMaster University; Population Health Research Institute; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Manitoba; University of Alberta; BC Childrens Hospital; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of Manitoba; Children's Hospital Research Institute of Manitoba	Anand, SS (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.; Anand, SS (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; Anand, SS (corresponding author), Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.; Anand, SS (corresponding author), McMaster Univ, Hamilton, ON, Canada.	anands@mcmaster.ca	Turvey, Stuart/HGV-1191-2022; Azad, Meghan/H-7226-2019; de Souza, Russell J/ABB-7735-2021; Moraes, Theo/CAJ-3254-2022	Azad, Meghan/0000-0002-5942-4444; de Souza, Russell J/0000-0001-8945-513X; Moraes, Theo/0000-0001-9968-6601; Zulyniak, Michael/0000-0003-4944-5521; Turvey, Stuart/0000-0003-1599-1065	Canadian Institute for Health Research (CIHR) [201301FH6]; CIHR RCT Fellowship grant [MTP201410]; ICMR/CIHR [INC-109205]; HSF Canada [NA7283]; CIHR [AEC85761]; AllerGen NCE Inc.	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR RCT Fellowship grant(Canadian Institutes of Health Research (CIHR)); ICMR/CIHR; HSF Canada; CIHR(Canadian Institutes of Health Research (CIHR)); AllerGen NCE Inc.	This work was supported by funding by a Canadian Institute for Health Research (CIHR) Grant in Food & Health Population Health Research grant [RFA#201301FH6; 2013-2018; S.A.A., A.B.B., J.B., R.J.dS., M.G., M.R.S., P.S., G.W.] and a CIHR RCT Fellowship grant [MTP201410; M.A.Z.]. START data was collected as part of a bilateral ICMR/CIHR funded programme [INC-109205] and HSF Canada Grant in Aid [NA7283]. CIHR provided funds for CHILD [AEC85761; A.B.B, P.M., M.R.S., P.S., S.E.T.), FAMILY [K.K.T.], data collection, with additional funding from AllerGen NCE Inc. [S.S.A]. M.R.S holds the AstraZeneca Chair in Respiratory Epidemiology at McMaster University. S.S.A. holds a Canada Research Chair Tier 1 in Ethnic Diversity and Cardiovascular Disease and a Heart and Stroke Foundation/Michael G. De Groote Chair in Population Health Research. M.B.A. holds a Canada Research Chair in the Developmental Origins of Chronic Disease. All authors declare no conflict of interest and that all funders (including AllerGen NCE Inc and AstraZeneca) had no role in study design, data collection and analysis, decision to publish, or preparation of our manuscript. Therefore, there was no influence on our adherence to PLOS ONE policies on sharing data and materials."	Anand SS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-79; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Beckhaus AA, 2015, ALLERGY, V70, P1588, DOI 10.1111/all.12729; Berkowitz AC, 2015, PEDIAT SKIN COLOR, P267; Calov M, 2019, J ALLERGY CLIN IMMUN; Chatzi L, 2013, BRIT J NUTR, V110, P2058, DOI 10.1017/S0007114513001426; Chu LM, 2014, ANN ALLERG ASTHMA IM, V113, P430, DOI 10.1016/j.anai.2014.07.003; de Souza RJ, 2016, J NUTR, V146, P2343, DOI 10.3945/jn.116.236729; Dell Sharon D, 2010, Can Respir J, V17, pe1; Deng QH, 2016, ENVIRON RES, V150, P119, DOI 10.1016/j.envres.2016.05.050; El-Heis S, 2016, CLIN EXP ALLERGY, V46, P1337, DOI 10.1111/cea.12782; Elbert NJ, 2016, PEDIAT ALLERG IMM-UK, V27, P627, DOI 10.1111/pai.12579; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Gadgil MD, 2014, J ACAD NUTR DIET, V114, P238, DOI 10.1016/j.jand.2013.09.021; Garcia-Larsen V, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002507; Garner Rochelle, 2008, Health Rep, V19, P45; Hart CN, 2010, CHILD CARE HLTH DEV, V36, P396, DOI 10.1111/j.1365-2214.2010.01072.x; Honaker J, 2011, J STAT SOFTW, V45, P1; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Huijbregts P, 1997, BRIT MED J, V315, P13, DOI 10.1136/bmj.315.7099.13; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Kant AK, 1996, J AM DIET ASSOC, V96, P785, DOI 10.1016/S0002-8223(96)00217-9; Kim J, 1978, FACTOR ANAL STAT MET; Kull I, 2002, ARCH DIS CHILD, V87, P478, DOI 10.1136/adc.87.6.478; Lankinen MA, 2015, DIABETOLOGIA, V58, P2533, DOI 10.1007/s00125-015-3730-5; Lesser IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088495; Loo EXL, 2017, INT ARCH ALLERGY IMM, V173, P105, DOI 10.1159/000475497; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Millen BE, 1996, AM J HEALTH PROMOT, V11, P42, DOI 10.4278/0890-1171-11.1.42; Miyake Y, 2010, EUR RESPIR J, V35, P1228, DOI 10.1183/09031936.00100609; Miyake Y., 2009, THORAX; Miyake Y, 2011, PEDIAT ALLERG IMM-UK, V22, P734, DOI 10.1111/j.1399-3038.2011.01176.x; Morrison KM, 2009, AM HEART J, V158, P533, DOI 10.1016/j.ahj.2009.07.005; Nafstad P, 2001, ALLERGY, V56, P307, DOI 10.1034/j.1398-9995.2001.00881.x; Nagao A, 2013, BIOSCI BIOTECH BIOCH, V77, P1055, DOI 10.1271/bbb.130025; Nettleton JA, 2009, AM J CLIN NUTR, V90, P647, DOI 10.3945/ajcn.2009.27597; Northstone K, 2008, EUR J CLIN NUTR, V62, P931, DOI 10.1038/sj.ejcn.1602789; Petherick ES, 2016, RESP MED, V119, P122, DOI 10.1016/j.rmed.2016.08.017; Quatromoni PA, 2002, J EPIDEMIOL COMMUN H, V56, P381, DOI 10.1136/jech.56.5.381; Saito K, 2010, PEDIAT ALLERG IMM-UK, V21, P38, DOI 10.1111/j.1399-3038.2009.00897.x; Sausenthaler S, 2007, AM J CLIN NUTR, V85, P530; Stone KD, 2003, CURR OPIN PEDIATR, V15, P495, DOI 10.1097/00008480-200310000-00009; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Subbarao P, 2015, THORAX, V70, P998, DOI 10.1136/thoraxjnl-2015-207246; Wahi G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-608; Willett W., 2012, NUTR EPIDEMIOLOGY; Wurtz P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001765; Zhao CY, 2017, BRIT J DERMATOL, V176, P985, DOI 10.1111/bjd.15271; Zulyniak MA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017753	51	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232170	10.1371/journal.pone.0232170	http://dx.doi.org/10.1371/journal.pone.0232170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407330	gold, Green Published			2022-12-26	WOS:000537490700014
J	Stea, TH; Nordheim, O; Bere, E; Stornes, P; Eikemo, TA				Stea, Tonje Holte; Nordheim, Oda; Bere, Elling; Stornes, Per; Eikemo, Terje Andreas			Fruit and vegetable consumption in Europe according to gender, educational attainment and regional affiliation-A cross-sectional study in 21 European countries	PLOS ONE			English	Article							SOCIOECONOMIC CIRCUMSTANCES; FOOD-HABITS; DISPARITIES; DETERMINANTS; ASSOCIATION; INCOME; COSTS	Objective The purpose of the present study was to examine fruit and vegetable consumption according to gender, educational attainment and regional affiliation in Europe. Design Cross-sectional study. Setting 21 European countries. Participants 37 672 adults participating in the 7th round of the European Social Survey. Main outcome measures Fruit and vegetable consumption was measured using two single frequency questions. Responses were dichotomized into low (<once a day) and high (>= once a day) consumption. The association between consumption of fruit and vegetables and gender, educational level, regional affiliation was examined using logistic regression analyses. Results Overall, females showed increased odds of consuming fruit (OR 1.71 (95%CI:1.62, 1.79) and vegetable (1.59 (1.51, 1.67)) compared to males and high educated participants showed increased odds of consuming fruit (1.53 (1.43, 1.63)) and vegetables (1.86 (1.74, 2.00)) compared to low educated participants. Our results also showed that participants living in Eastern Europe had the lowest odds of consuming fruit and vegetables, whereas participants from Southern- and Northern Europe had the highest odds of consuming fruit and vegetables, respectively. Results from interaction analyses confirmed the positive association between fruit and vegetable consumption and educational level, although for some European regions, decreased odds of fruit and vegetables was observed among medium educated participants compared to those with low education. Conclusions Overall, the present study showed that being female and having a high education were associated with increased consumption of fruit and vegetables. However, the direction and strength of these relationships depends on regional affiliations.	[Stea, Tonje Holte] Univ Agder, Dept Hlth & Nursing Sci, Kristiansand, Norway; [Nordheim, Oda; Stornes, Per; Eikemo, Terje Andreas] Norwegian Univ Sci & Technol NTNU, Dept Sociol & Polit Sci, Ctr Global Hlth Inequal Res CHAIN, Trondheim, Norway; [Bere, Elling] Norwegian Inst Publ Hlth, Dept Hlth & Inequal, Oslo, Norway; [Bere, Elling] Norwegian Inst Publ Hlth, Ctr Evaluat Publ Hlth Measures, Oslo, Norway; [Bere, Elling] Univ Agder, Dept Sport Sci & Phys Educ, Kristiansand, Norway	University of Agder; Norwegian University of Science & Technology (NTNU); Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); University of Agder	Stea, TH (corresponding author), Univ Agder, Dept Hlth & Nursing Sci, Kristiansand, Norway.	tonje.h.stea@uia.no			NORFACE (New Opportunities for Research Funding Agency Cooperation in Europe) Welfare State Futures programme [462-14-110]; Norwegian Research Council [228990]	NORFACE (New Opportunities for Research Funding Agency Cooperation in Europe) Welfare State Futures programme; Norwegian Research Council(Research Council of NorwayEuropean Commission)	TEA was part of a group receiving fuding for this study. This article is part of the HiNEWS project-Health Inequalities in European Welfare States-funded by NORFACE (New Opportunities for Research Funding Agency Cooperation in Europe) Welfare State Futures programme (grant reference: 462-14-110). For more details on NORFACE, see http://www.norface.net/11. This article is also part of the Norwegian Research Council sponsored project ESS R7 Health Module: Equality in the Access to Health Care (project number 228990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Aggarwal A, 2011, EUR J CLIN NUTR, V65, P1059, DOI 10.1038/ejcn.2011.72; Aune D, 2017, INT J EPIDEMIOL, V46, P1029, DOI 10.1093/ije/dyw319; Boylan S, 2011, PUBLIC HEALTH NUTR, V14, P678, DOI 10.1017/S1368980010002570; Cade J, 1999, PUBLIC HEALTH NUTR, V2, P505, DOI 10.1017/S1368980099000683; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; Eikemo TA, 2017, EUR SOCIOL REV, V33, P137, DOI 10.1093/esr/jcw019; Elmadfa I, 2009, FORUM NUTR, V62, P1, DOI [10.1159/000244607, 10.1159/000242367]; Estaquio C, 2008, J AM DIET ASSOC, V108, P2021, DOI 10.1016/j.jada.2008.09.011; Fagerli RA, 1999, APPETITE, V32, P171, DOI 10.1006/appe.1998.0188; Giskes K, 2010, OBES REV, V11, P413, DOI 10.1111/j.1467-789X.2009.00658.x; Groth MV, 2001, EUR J CLIN NUTR, V55, P959, DOI 10.1038/sj.ejcn.1601251; Konttinen H, 2013, PUBLIC HEALTH NUTR, V16, P873, DOI 10.1017/S1368980012003540; Lallukka T, 2007, EUR J CLIN NUTR, V61, P701, DOI 10.1038/sj.ejcn.1602583; Lallukka T, 2010, EUR J CLIN NUTR, V64, P324, DOI 10.1038/ejcn.2009.155; Macdiarmid J, 1998, NUTR RES REV, V11, P231, DOI 10.1079/NRR19980017; Mackenbach JD, 2015, BRIT J NUTR, V114, P1464, DOI 10.1017/S0007114515003025; Mason-D'Croz D, 2019, LANCET PLANET HEALTH, V3, pE318, DOI [10.17632/d7m5h5zvw7.1, 10.1016/S2542-5196(19)30095-6]; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; Michels KB, 2005, AM J EPIDEMIOL, V161, P987, DOI 10.1093/aje/kwi115; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Prattala R, 2009, PUBLIC HEALTH NUTR, V12, P2174, DOI 10.1017/S136898000900559X; Roos E, 2008, EUR J CLIN NUTR, V62, P823, DOI 10.1038/sj.ejcn.1602798; Roos E, 1998, SOC SCI MED, V46, P1519, DOI 10.1016/S0277-9536(98)00032-X; Roos G, 2001, PUBLIC HEALTH NUTR, V4, P35, DOI 10.1079/PHN200048; Stefler D, 2016, EUR J PUBLIC HEALTH, V26, P628, DOI 10.1093/eurpub/ckv216; Stefler D, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0078-8; Trichopoulou A, 2002, P NUTR SOC, V61, P553, DOI 10.1079/PNS2002188; WHO, 2006, COMP AN NUTR POL WHO; Wu Y, 2015, NUTR METAB CARDIOVAS, V25, P140, DOI 10.1016/j.numecd.2014.10.004	30	24	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232521	10.1371/journal.pone.0232521	http://dx.doi.org/10.1371/journal.pone.0232521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0VG	32401798	Green Published, gold			2022-12-26	WOS:000537481000020
J	Zeng, Y; Zhao, CY; Kundzewicz, ZW; Lv, GH				Zeng, Yong; Zhao, Chengyi; Kundzewicz, Zbigniew W.; Lv, Guanghui			Distribution pattern of Tugai forests species diversity and their relationship to environmental factors in an arid area of China	PLOS ONE			English	Article							DESERT RIPARIAN FOREST; TARIM RIVER; POPULUS-EUPHRATICA; LOWER REACHES; WATER-USE; GROUNDWATER FLUCTUATIONS; TAMARIX-RAMOSISSIMA; XINJIANG UYGUR; INLAND RIVER; VEGETATION	Ecological restoration of degraded riparian Tugai forests is a key driver to combat desertification in arid regions. Previous studies have focused mainly on changes in groundwater as the underlying mechanisms of Tugai forest's decline. We evaluated species composition and diversity of Tugai forest and their relationship to groundwater, soil salinity, and soil nutrient. Using 73 quadrats (100 m x 100 m) from 13 transects located perpendicularly to river in the upper reaches of the Tarim River. Eighteen plant species belonging to sixteen genera and eight families were recorded, and the dominant species included Populus euphratica, Phragmites communis, and Tamarix ramosissima. Three P. euphratica stand ages were detected: young stand, mature stand, and old stand. There were significant differences in species diversity, groundwater depth, groundwater salinity, distance from the quadrat to the river channel, soil moisture content, pH, electrical conductivity, total salt, Cl-, SO42-, Ca2-, Mg2+, Na+, K+, soil organic carbon, and soil organic matter across the stand ages. Seven species were identified as indicators of the three stand ages. Redundancy analysis indicated that the Tugai forest diversity indices were negatively correlated with groundwater depth, groundwater salinity, and distance from the river, and positively associated with electrical conductivity, total salt, pH, Cl-, SO42-, CO32-, soil organic matter, soil organic carbon, and soil moisture content. Plant diversity was the highest at 3-6 m groundwater depth, followed by 0-3 m and then 6-9 m, with the lowest recorded at > 9 m. The appropriate groundwater depth for herbs was about 1-4 m, whereas the depth for trees and shrubs was about 3-6 m. The groundwater depth < 6 m was deemed suitable for the growth of desert riparian forests. This results provide a scientific reference for the ecological restoration and protection for Tugai forests in arid areas.	[Zeng, Yong] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [Zeng, Yong; Lv, Guanghui] Xinjiang Univ, Coll Resources & Environm Sci, Urumqi, Xinjiang, Peoples R China; [Zeng, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhao, Chengyi; Kundzewicz, Zbigniew W.] Nanjing Univ Informat Sci & Technol, Land Sci Res Ctr, Nanjing, Peoples R China; [Kundzewicz, Zbigniew W.] Polish Acad Sci, Inst Agr & Forest Environm, Poznan, Poland	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Xinjiang University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing University of Information Science & Technology; Polish Academy of Sciences	Zhao, CY (corresponding author), Nanjing Univ Informat Sci & Technol, Land Sci Res Ctr, Nanjing, Peoples R China.	zhaocy@nuist.edu.cn		Kundzewicz, Zbigniew/0000-0002-3579-5072	National Natural Science Foundation of China [41671030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (41671030). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agbelade A. D., 2017, International Journal of Forestry Research, V2017, P4549756, DOI 10.1155/2017/4549756; Aishan T, 2016, J FORESTRY RES, V27, P889, DOI 10.1007/s11676-016-0222-5; Bao AM, 2017, ECOL INDIC, V74, P261, DOI 10.1016/j.ecolind.2016.11.007; BRESLER EB, 1972, H-S Z PHYSIOL CHEM, V353, P12; Butnik AA, 2001, HALOPHYTES STRUCTURE; Cao DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039121; Chen Y., 2006, CHINESE SCI BULL, V51, P7; Chen YN, 2008, HYDROGEOL J, V16, P1371, DOI 10.1007/s10040-008-0306-1; Chen YN, 2015, ENVIRON EARTH SCI, V73, P547, DOI 10.1007/s12665-013-3002-y; Coudun C, 2006, ECOL MODEL, V199, P164, DOI 10.1016/j.ecolmodel.2006.05.024; D'Souza LE, 2012, CAN J FOREST RES, V42, P260, DOI [10.1139/X11-171, 10.1139/x11-171]; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; [樊自立 Fan Zili], 2004, [干旱区地理, Arid Land Geography], V27, P8; Gartner P, 2014, INT J APPL EARTH OBS, V31, P110, DOI 10.1016/j.jag.2014.03.004; Giliba RA, 2011, J BIODIVERS, V2, P1, DOI [DOI 10.1080/09766901.2011.11884724, 10.1080/09766901.2011.11884724]; Gonzalez E, 2010, TREES-STRUCT FUNCT, V24, P151, DOI 10.1007/s00468-009-0388-y; Gries D, 2003, PLANT CELL ENVIRON, V26, P725, DOI 10.1046/j.1365-3040.2003.01009.x; Hao XM, 2009, ENVIRON MONIT ASSESS, V152, P167, DOI 10.1007/s10661-008-0305-7; Hao XM, 2010, HYDROL PROCESS, V24, P178, DOI 10.1002/hyp.7432; Imada S, 2008, FUNCT ECOL, V22, P1018, DOI 10.1111/j.1365-2435.2008.01454.x; Keyimu M, 2015, INT J APPL ENV SCI, P2007; Keyimu M, 2018, J FORESTRY RES, V29, P749, DOI 10.1007/s11676-017-0478-4; Keylock CJ, 2005, OIKOS, V109, P203, DOI 10.1111/j.0030-1299.2005.13735.x; Khamzina A, 2008, FOREST ECOL MANAG, V255, P168, DOI 10.1016/j.foreco.2007.09.005; Lamontagne S, 2005, J HYDROL, V310, P280, DOI 10.1016/j.jhydrol.2005.01.009; Lang P, 2016, FOREST ECOL MANAG, V380, P139, DOI 10.1016/j.foreco.2016.08.049; Li J, 2007, J ARID ENVIRON, V71, P350, DOI 10.1016/j.jaridenv.2007.03.015; Li SJ, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2355; Li WH, 2013, ECOHYDROLOGY, V6, P949, DOI 10.1002/eco.1385; Li X, 2017, LANDSC ECOL ENG, V13, P71, DOI 10.1007/s11355-016-0302-x; Ling HB, 2019, J HYDROL, V572, P659, DOI 10.1016/j.jhydrol.2019.03.049; Ling HB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15418; Liu S, ECOL RES, V546, DOI [10.1111/j.1744-7909.2007.00626.x, DOI 10.1111/J.1744-7909.2007.00626.X]; [刘耘华 Liu Yunhua], 2011, [土壤, Soils], V43, P975; Ma QL, 2009, ENVIRON EARTH SCI, V59, P765, DOI 10.1007/s12665-009-0072-y; Maestre FT, 2009, ECOL LETT, V12, P930, DOI 10.1111/j.1461-0248.2009.01352.x; Mata-Gonzalez R, 2012, ECOHYDROLOGY, V5, P54, DOI 10.1002/eco.196; McLean E.O., 1982, METHODS SOIL ANAL 2; Merritt DM, 2010, ECOL APPL, V20, P135, DOI 10.1890/08-2251.1; Naumburg E, 2005, ENVIRON MANAGE, V35, P726, DOI 10.1007/s00267-004-0194-7; Pang ZH, 2010, HYDROL PROCESS, V24, P147, DOI 10.1002/hyp.7438; Pockman WT, 2000, AM J BOT, V87, P1287, DOI 10.2307/2656722; Rajput V. D., 2016, Acta Ecologica Sinica - International Journal, V36, P497, DOI 10.1016/j.chnaes.2016.08.001; Ruger N, 2005, ECOL MODEL, V184, P313, DOI 10.1016/j.ecolmodel.2004.10.010; Soykan CU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028235; Thevs N, 2007, J APPL BOT FOOD QUAL, V81, P62; Thevs N, 2008, FORESTRY, V81, P45, DOI 10.1093/forestry/cpm043; Thomas FM, 2006, BASIC APPL ECOL, V7, P253, DOI 10.1016/j.baae.2005.07.008; Veron SR, 2006, J ARID ENVIRON, V66, P751, DOI 10.1016/j.jaridenv.2006.01.021; [王丹丹 Wang Dandan], 2018, [干旱区地理, Arid Land Geography], V41, P349; Wang DD, 2018, CATENA, V166, P89, DOI 10.1016/j.catena.2018.03.020; Wang P, 2011, J PLANT ECOL, V4, P77, DOI 10.1093/jpe/rtr002; Wang Xi-yi, 2015, Shengtaixue Zazhi, V34, P3057; Wang XY, 2019, POL J ENVIRON STUD, V28, P359, DOI 10.15244/pjoes/83610; Westermann J, 2008, J INTEGR PLANT BIOL, V50, P536, DOI 10.1111/j.1744-7909.2007.00626.x; Wu JunXia, 2010, Arid Land Geography, V33, P923; Xu W., 1988, POPLARS; Yan H, 2014, ENVIRON EARTH SCI, V71, P4091, DOI 10.1007/s12665-013-2797-x; [杨晓东 YANG Xiaodong], 2011, [干旱区研究, Arid Zone Research], V28, P768; Yang YH, 2009, ARID LAND RES MANAG, V23, P283, DOI 10.1080/15324980903231991; Zeng Y, 2016, ECOL RES, V31, P427, DOI 10.1007/s11284-016-1352-0; Zhang ZH, 2018, J CLEAN PROD, V182, P765, DOI 10.1016/j.jclepro.2018.01.233; Zhao FF, 2018, FRONT NEUROROBOTICS, V12, DOI 10.3389/fnbot.2018.00056; Zhao Feng-xia, 2007, Shengtaixue Zazhi, V26, P972; Zhou J., 2010, STUDY GROUNDWATER XI; Zhu YH, 2016, ECOL ENG, V94, P629, DOI 10.1016/j.ecoleng.2016.06.107	66	10	11	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232907	10.1371/journal.pone.0232907	http://dx.doi.org/10.1371/journal.pone.0232907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401818	Green Published, gold			2022-12-26	WOS:000537481000039
J	Pepito, VCF; Newton, S				Pepito, Veincent Christian F.; Newton, Sam			Determinants of HIV testing among Filipino women: Results from the 2013 Philippine National Demographic and Health Survey	PLOS ONE			English	Article							PREVENTION; HIV/AIDS; BARRIERS; POVERTY; RISK	Background The prevalence of having ever tested for HIV in the Philippines is very low and is far from the 90% target of the Philippine Department of Health (DOH) and UNAIDS, thus the need to identify the factors associated with ever testing for HIV among Filipino women. Methods We analysed the 2013 Philippine National Demographic and Health Survey (NDHS). The NDHS is a nationally representative survey which utilized a two-stage stratified design to sample Filipino women aged 15-49. We considered the following exposures in our study: socio-demographic characteristics of respondent and her partner (i.e., age of respondent, age of partner, wealth index, etc.), sexual practices and contraception (i.e., age at first intercourse, condom use, etc.), media access, tobacco use, HIV knowledge, tolerance to domestic violence, and women's empowerment. The outcome variable is HIV testing. We used logistic regression for survey data to study the said associations. Results Out of 16,155 respondents, only 372 (2.4%) have ever tested for HIV. After adjusting for confounders, having tertiary education (adjusted odds ratio (aOR) = 2.15; 95% Confidence Interval (CI): 1.15-4.04), living with partner (aOR = 1.72; 95% CI: 1.19-2.48), tobacco use (aOR = 1.87; 95% CI: 1.13-3.11); belonging to the middle class (aOR = 2.72; 95% CI: 1.30-5.67), richer (aOR = 3.00; 95% CI: 1.37-5.68), and richest (aOR = 4.14; 95% CI: 1.80-5.91) populations, having weekly television access (aOR = 1.75; 95% CI: 1.04-2.94) or internet access (aOR = 2.01; 95% CI: 1.35-3.00), living in a rural area (aOR = 1.87; 95% CI: 1.34-2.61); and being a Muslim (aOR = 2.30; 95% CI: 1.15-4.57) were associated with ever testing for HIV. Conclusions The low percentage of respondents who test for HIV is a call to further strengthen efforts to promote HIV testing among Filipino women. Information on its determinants can be used to guide the crafting and implementation of interventions to promote HIV testing to meet DOH and UNAIDS targets.	[Pepito, Veincent Christian F.; Newton, Sam] Univ London, London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Pepito, Veincent Christian F.] Ateneo Manila Univ, Ctr Res & Innovat, Sch Med & Publ Hlth, Pasig, Philippines; [Newton, Sam] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana	University of London; London School of Hygiene & Tropical Medicine; Ateneo de Manila University; Kwame Nkrumah University Science & Technology	Pepito, VCF (corresponding author), Univ London, London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.; Pepito, VCF (corresponding author), Ateneo Manila Univ, Ctr Res & Innovat, Sch Med & Publ Hlth, Pasig, Philippines.	vcfpepito12345@gmail.com	Pepito, Veincent Christian/AAZ-7140-2020	Pepito, Veincent Christian/0000-0001-5391-3784	Ateneo de Manila University School of Medicine and Public Health; PLOS Publication Fee Assistance Office	Ateneo de Manila University School of Medicine and Public Health; PLOS Publication Fee Assistance Office	The authors have not received specific funding to conduct the analysis; however, they have received financial support from the Ateneo de Manila University School of Medicine and Public Health and the PLOS Publication Fee Assistance Office for the publication fee of the manuscript. These funding agencies did not have a role in the analysis, writing of the manuscript, as well as decision to publish.	[Anonymous], 2013, DHS PROGRAM PHILIPPI; [Anonymous], 2015, STAT 14 0; Barmania S, 2017, BMC INT HEALTH HUM R, P17; Clayton D, 1992, STAT METHODS EPIDEMI; Conserve D, 2014, AIDS CARE, V26, P842, DOI 10.1080/09540121.2013.861575; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Department of Health Epidemiology Bureau, 2019, HIV AIDS ART REG PHI; Department of Health (Philippines), STAT PHIL HIV EP 201; Desai AA, 2002, AIDS EDUC PREV, V14, P45, DOI 10.1521/aeap.14.7.45.23867; Farr AC, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-16; Fettig J, 2014, INFECT DIS CLIN N AM, V28, P323, DOI 10.1016/j.idc.2014.05.001; FLANDERS WD, 1992, AM J EPIDEMIOL, V135, P926, DOI 10.1093/oxfordjournals.aje.a116388; Frank TD, 2019, LANCET HIV, V6, pE831, DOI 10.1016/S2352-3018(19)30196-1; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; Gari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071922; Gohil J, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-019-8063-8; Health Technology Assessment Study Group-Health Policy Development and Planning Bureau, 2018, RAP HIV DIAGN ALG RH; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hurt CB, 2014, SEX TRANSM DIS, V41, P10, DOI 10.1097/OLQ.0000000000000076; Iwelunmor J, 2018, INT J ADOLESC MED HL; Katz MH, 2006, MULTIVARIABLE ANALYSIS: A PRACTICAL GUIDE FOR CLINICIANS, 2ND EDITION, P1, DOI 10.1017/CBO9780511811692; Kirakoya-Samadoulougou F, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4417-2; Latkin CA, 2016, AIDS EDUC PREV, V28, P417, DOI 10.1521/aeap.2016.28.5.417; Leclerc-Madlala S, 2002, SOC DYNAMICS, V28, P20; Lee PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06085; Lucea MB, 2012, HEALTH CARE WOMEN IN, V33, P302, DOI 10.1080/07399332.2011.646369; Manalastas E. J., 2007, PHILIPPINE J PSYCHOL, V40, P101; Mugo PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153612; Mwaba K, 2020, AIDS CARE, V32, pS183, DOI 10.1080/09540121.2020.1739214; Nnko S, 2019, BMC PUBLIC HEALTH; Oswald D., 2014, REV SOC STUD, V1, P53, DOI DOI 10.21586/ROSS0000004; Parkhurst JO, 2010, B WORLD HEALTH ORGAN, V88, P519, DOI 10.2471/BLT.09.070185; Peltzer K, 2013, AFR HEALTH SCI, V13, P1012, DOI 10.4314/ahs.v13i4.22; Peng ZX, 2017, INT J INFECT DIS, V55, P72, DOI 10.1016/j.ijid.2016.12.028; Philippine Statistics Authority [Philippines] ICF International, 2014, PHIL STAT AUTH PHIL; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Salvana EMT, 2010, ACTA MED PHILIPP, V4, P60; Tan JY, 2015, INT J STD AIDS, V26, P48, DOI 10.1177/0956462414529264; UCLA Statistical Consulting Group, APPL SURV DAT AN STA; UNAIDS, 2014, 90 90 90 AMB TREATM; VanderWeele TJ, 2011, BIOMETRICS, V67, P1406, DOI 10.1111/j.1541-0420.2011.01619.x; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; WEERASEKERA DR, 1992, STAT MED, V11, P603, DOI 10.1002/sim.4780110505; WHO, 2002, RED RISKS PROM HLTH; World Health Organization Deutsche Gesellschaft fur Technische Zusammenarbeit Joint United Nations Programme on HIV/AIDS International HIV/AIDS Alliance, 2005, SCAL HIV TEST COUNS; World Health Organization-Western Pacific Region, 2016, POL BRIEF TRANSG HLT; Yaya S, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2540-z	49	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232620	10.1371/journal.pone.0232620	http://dx.doi.org/10.1371/journal.pone.0232620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0SY	32396559	Green Published, gold			2022-12-26	WOS:000537475000013
J	Zhu, ZH; Song, JLE; Guo, YG; Huang, ZY; Chen, XJ; Dang, XN; Huang, YJ; Wang, YH; Ou, WJ; Yang, YL; Yu, W; Liu, CY; Cui, L				Zhu, Zhehui; Song, Jinglue; Guo, Yuegui; Huang, Zhenyu; Chen, Xiaojian; Dang, Xuening; Huang, Yuji; Wang, Yuhan; Ou, Weijun; Yang, Yili; Yu, Wei; Liu, Chen-Ying; Cui, Long			LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer	ONCOGENE			English	Article							LAMININ GAMMA-2; ACTIVATION; CARCINOMAS; EXPRESSION; BRD4; SUPPRESSES; ADHESION; INVASION; FAMILY; TARGET	Aberrant expression of laminin-332 promotes tumour growth and metastasis in multiple cancers. However, the dysregulated expression and mechanism of action of LAMB3, which encodes the beta 3 subunit of laminin-332, and the mechanism underlying dysregulated LAMB3 expression in CRC remain obscure. Here, we show that LAMB3 is overexpressed in CRC and that this overexpression is correlated with tumour metastasis and poor prognosis. Overexpression of LAMB3 promoted cell proliferation and cell migration in vitro and tumour growth and metastasis in vivo, while knockdown of LAMB3 elicited opposing effects. LAMB3 inhibited the tumour suppressive function of FOXO3/4 by activating AKT in CRC. Both the BET inhibitor JQ1 and the MEK inhibitor U0126 decreased the mRNA level of LAMB3 in multiple CRC cells. Mechanistically, ELK4 cooperated with BRD2 to regulate the transcription of LAMB3 in CRC by directly binding to the ETS binding motifs in the LAMB3 promoter. ELK4 was as acetylated at K125, which enhanced the interaction between ELK4 and BRD2. JQ1 disrupted the interaction between ELK4 and BRD2, resulting in decreased binding of BRD2 to the LAMB3 promoter and downregulation of LAMB3 transcription. Both ELK4 and BRD2 expression was associated with LAMB3 expression in CRC. LAMB3 expression was also negatively correlated with FOXO3/4 in CRC. Our study reveals the pro-tumorigenic role of LAMB3 through the AKT-FOXO3/4 axis and the transcriptional mechanism of LAMB3 in CRC, demonstrating that LAMB3 is a potential therapeutic target that can be targeted by BET inhibitors and MEK inhibitors.	[Zhu, Zhehui; Song, Jinglue; Guo, Yuegui; Wang, Yuhan; Ou, Weijun; Liu, Chen-Ying; Cui, Long] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Colorectal & Anal Surg, Shanghai 200092, Peoples R China; [Zhu, Zhehui; Huang, Zhenyu; Chen, Xiaojian; Dang, Xuening; Huang, Yuji; Liu, Chen-Ying; Cui, Long] Shanghai Colorectal Canc Res Ctr, Shanghai 200092, Peoples R China; [Yang, Yili] Chinese Acad Med Sci, Ctr Syst Med Res, Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China; [Yu, Wei] Fudan Univ, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Yu, Wei] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Shanghai 200438, Peoples R China; [Yu, Wei] Fudan Univ, Zhongshan Hosp, Shanghai 200438, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fudan University; Fudan University; Fudan University	Liu, CY; Cui, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Colorectal & Anal Surg, Shanghai 200092, Peoples R China.; Liu, CY; Cui, L (corresponding author), Shanghai Colorectal Canc Res Ctr, Shanghai 200092, Peoples R China.; Yu, W (corresponding author), Fudan Univ, State Key Lab Genet Engn, Shanghai 200438, Peoples R China.; Yu, W (corresponding author), Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Shanghai 200438, Peoples R China.; Yu, W (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai 200438, Peoples R China.	yuw@fudan.edu.cn; liuchenying@xinhuamed.com.cn; cuilong@xinhuamed.com.cn		YU, WEI/0000-0001-9898-4607; Liu, Chen-Ying/0000-0002-8930-6182; Zhu, Zhehui/0000-0002-3676-5254	National Natural Science Foundation of China [81974060, 81874177, 81672517, 31771545, 91749120]; National High Technology Research and Development Program of China (863 Program) [2014AA020801]; National Key R&D Program of China [2019YFC1316002]; Program for Professor of Special Appointment (Young Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai Pujiang Program [18PJ1407400]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant [20171918]; Innovative research team of high-level local universities in Shanghai; Innovation Program for Ph.D. students in Shanghai Jiao Tong University School of Medicine [BXJ201827]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key R&D Program of China; Program for Professor of Special Appointment (Young Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant; Innovative research team of high-level local universities in Shanghai; Innovation Program for Ph.D. students in Shanghai Jiao Tong University School of Medicine	This work was supported by the National Natural Science Foundation of China (81974060, 81874177, 81672517, 31771545, and 91749120), the National High Technology Research and Development Program of China (863 Program) (Grant No. 2014AA020801), the National Key R&D Program of China (2019YFC1316002), The Program for Professor of Special Appointment (Young Eastern Scholar) at Shanghai Institutions of Higher Learning (to C-YL), Shanghai Pujiang Program (18PJ1407400), Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant (20171918), Innovative research team of high-level local universities in Shanghai and the Innovation Program for Ph.D. students in Shanghai Jiao Tong University School of Medicine (BXJ201827).	Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Blee AM, 2016, ONCOTARGET, V7, P38319, DOI 10.18632/oncotarget.9513; Chen JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00405-x; Chen XB, 2016, ONCOTARGET, V7, P86695, DOI 10.18632/oncotarget.13435; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750; Feng MB, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0564-9; Fukushima Y, 1998, INT J CANCER, V76, P63, DOI 10.1002/(SICI)1097-0215(19980330)76:1<63::AID-IJC11>3.0.CO;2-H; Gollavilli PN, 2018, CANCER RES, V78, P4760, DOI 10.1158/0008-5472.CAN-18-0484; Hlubek F, 2001, CANCER RES, V61, P8089; Huang ZM, 2018, NAT CHEM BIOL, V14, P1118, DOI 10.1038/s41589-018-0150-0; Irifune H, 2005, CANCER BIOL THER, V4, P449; Jedlicka P, 2008, HISTOL HISTOPATHOL, V23, P1417, DOI 10.14670/HH-23.1417; Jung SN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21216-0; Kai F, 2019, DEV CELL, V49, P332, DOI 10.1016/j.devcel.2019.03.026; Keum N, 2019, NAT REV GASTRO HEPAT, V16, P713, DOI 10.1038/s41575-019-0189-8; Kwon OH, 2011, BIOCHEM BIOPH RES CO, V406, P539, DOI 10.1016/j.bbrc.2011.02.082; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Le Rolle AF, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0555-4; Li QJ, 2003, EMBO J, V22, P281, DOI 10.1093/emboj/cdg028; Lohi J, 2000, APMIS, V108, P161, DOI 10.1034/j.1600-0463.2000.d01-40.x; Ma YF, 2017, CLIN CANCER RES, V23, P2027, DOI 10.1158/1078-0432.CCR-16-0453; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Manohar A, 2004, J CELL SCI, V117, P4043, DOI 10.1242/jcs.01277; McCleland ML, 2016, J CLIN INVEST, V126, P639, DOI 10.1172/JCI83265; Moriya Y, 2001, CANCER, V91, P1129, DOI 10.1002/1097-0142(20010315)91:6<1129::AID-CNCR1109>3.0.CO;2-C; Nguyen BP, 2000, J BIOL CHEM, V275, P31896, DOI 10.1074/jbc.M006379200; Olsen J, 2003, BIOCHEM J, V371, P211, DOI 10.1042/BJ20021454; Peng C, 2016, ONCOGENE, V35, P1170, DOI 10.1038/onc.2015.175; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; PYKE C, 1994, AM J PATHOL, V145, P782; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Sizemore GM, 2017, NAT REV CANCER, V17, P337, DOI 10.1038/nrc.2017.20; Stathis A, 2018, CANCER DISCOV, V8, P24, DOI 10.1158/2159-8290.CD-17-0605; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tani T, 1997, AM J PATHOL, V151, P1289; Tsuruta D, 2008, CURR MED CHEM, V15, P1968, DOI 10.2174/092986708785132834; Wang XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053938, 10.1371/journal.pone.0050627]; Wu TY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0354-y; Young B, 2017, CANCER LETT, V387, P114, DOI 10.1016/j.canlet.2016.01.048; Zhang F, 2018, ONCOGENE, V37, P363, DOI 10.1038/onc.2017.334; Zhang H, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1320-z; Zhou Y, 2016, CANCER RES, V76, P5777, DOI 10.1158/0008-5472.CAN-15-2936; Zou Z, 2014, ONCOGENE, V33, P2395, DOI 10.1038/onc.2013.179	46	19	19	5	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	24					4666	4680		10.1038/s41388-020-1321-5	http://dx.doi.org/10.1038/s41388-020-1321-5		MAY 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LY0HO	32398865				2022-12-26	WOS:000532103100003
J	Karatepe, A; Akgol, O; Abdulkarim, YI; Dalgac, S; Muhammadsharif, FF; Awl, HN; Deng, LW; Unal, E; Karaaslan, M; Heng, L; Huang, SX				Karatepe, Aysegul; Akgol, Oguzhan; Abdulkarim, Yadgar I.; Dalgac, Sekip; Muhammadsharif, Fahmi F.; Awl, Halgurd N.; Deng, Lianwen; Unal, Eminu; Karaaslan, Muharrem; Heng, Luo; Huang, Shengxiang			Multipurpose chemical liquid sensing applications by microwave approach	PLOS ONE			English	Article							ANTENNA; ETHANOL; SENSOR	In this work, a novel sensor based on printed circuit board (PCB) microstrip rectangular patch antenna is proposed to detect different ratios of ethanol alcohol in wines and isopropyl alcohol in disinfectants. The proposed sensor was designed by finite integration technique (FIT) based high-frequency electromagnetic solver (CST) and was fabricated by Proto Mat E33 machine. To implement the numerical investigations, dielectric properties of the samples were first measured by a dielectric probe kit then uploaded into the simulation program. Results showed a linear shifting in the resonant frequency of the sensor when the dielectric constant of the samples were changed due to different concentrations of ethanol alcohol and isopropyl alcohol. A good agreement was observed between the calculated and measured results, emphasizing the usability of dielectric behavior as an input sensing agent. It was concluded that the proposed sensor is viable for multipurpose chemical sensing applications.	[Karatepe, Aysegul; Akgol, Oguzhan; Dalgac, Sekip; Unal, Eminu; Karaaslan, Muharrem] Iskenderun Tech Univ, Dept Elect & Elect, Antakya, Turkey; [Abdulkarim, Yadgar I.; Deng, Lianwen; Heng, Luo; Huang, Shengxiang] Cent South Univ, Sch Phys & Elect, Changsha, Hunan, Peoples R China; [Abdulkarim, Yadgar I.] Univ Sulaimani, Dept Phys, Coll Sci, Sulaimani, Iraq; [Muhammadsharif, Fahmi F.] Koya Univ, Fac Sci & Hlth, Dept Phys, Koya, Iraq; [Awl, Halgurd N.] Sulaimani Polytech Univ, Engn Coll, Dept Commun, Sulaimani, Iraq	Iskenderun Technical University; Central South University; University of Sulimanyah; Koya University	Huang, SX (corresponding author), Cent South Univ, Sch Phys & Elect, Changsha, Hunan, Peoples R China.	hsx351@csu.edu.cn	karaaslan, muharrem/V-3869-2019; Abdulkarim, Yadgar I./CAH-0275-2022; Ünal, Emin/HGB-2129-2022; awl, halgurd/AFV-9583-2022; Muhammadsharif, Fahmi F./B-3802-2010	karaaslan, muharrem/0000-0003-0923-1959; Abdulkarim, Yadgar I./0000-0002-2808-2867; Ünal, Emin/0000-0002-4088-8353; awl, halgurd/0000-0003-3369-5761; Abdulkarim, Yusuf/0000-0003-2699-5416; Muhammadsharif, Fahmi F./0000-0002-4563-9671	National Key Research and Development Program of China [2017YFA0204600]; National Natural Science Foundation of China [51802352, 2019JG085]; Fundamental Research Funds of the Central South University [2018zzts355]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of the Central South University	This work was supported in part by the National Key Research and Development Program of China (Grant no. 2017YFA0204600), the National Natural Science Foundation of China (Grant no. 51802352), teaching reform for postgraduate students of Central South University (Grant no. 2019JG085) and the Fundamental Research Funds of the Central South University (Grant no. 2018zzts355) to SH.	Akhavan H.G., 1999, IEE NAT C ANT PROP, DOI [10.1049/cp:19990003, DOI 10.1049/CP:19990003]; Alpat S, 2010, SENSORS-BASEL, V10, P748, DOI 10.3390/s100100748; Altintas O, 2019, J ELECTROCHEM SOC, V166, pB482, DOI 10.1149/2.1101906jes; Altintas O, 2017, J ELECTROCHEM SOC, V164, pB567, DOI 10.1149/2.1971712jes; Bakir M, 2018, J ELECTROCHEM SOC, V165, pB475, DOI 10.1149/2.0231811jes; Bakir M, 2017, J ELECTROCHEM SOC, V164, pB488, DOI 10.1149/2.0171712jes; Balta S, 2018, MACROMOL CHEM PHYS, V219, DOI 10.1002/macp.201700433; De M, 2019, PHOTONIC NANOSTRUCT, V36, DOI 10.1016/j.photonics.2019.100722; Ebrahimi A, 2014, IEEE SENS J, V14, P1345, DOI 10.1109/JSEN.2013.2295312; Gregory AP, 2006, IEEE T DIELECT EL IN, V13, P727, DOI 10.1109/TDEI.2006.1667730; Islam MT, 2018, APPL COMPUT ELECTROM, V33, P1402; Kotov VA, 2018, PHOTONIC NANOSTRUCT, V28, P12, DOI 10.1016/j.photonics.2017.11.003; Kouhalvandi L, 2017, TURK J ELECTR ENG CO, V25, P1394, DOI 10.3906/elk-1509-148; Ling K, 2015, OPT EXPRESS, V23, P110, DOI 10.1364/OE.23.000110; Ling L, 2018, MACROMOL CHEM PHYS, V219, DOI 10.1002/macp.201800369; Liu WN, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18051438; Mohammad I, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/1/015102; Pal A, 2011, MICRO NANO LETT, V6, P665, DOI 10.1049/mnl.2011.0320; Samphao A, 2018, J ELECTROANAL CHEM, V816, P179, DOI 10.1016/j.jelechem.2018.03.052; Seo Y, 2016, IEEE T ANTENN PROPAG, V64, P3218, DOI 10.1109/TAP.2016.2559581; Soffiatti A, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18051513; Song LN, 2018, IEEE T ANTENN PROPAG, V66, P2219, DOI 10.1109/TAP.2018.2809469; Suresh VM, 2018, MACROMOL CHEM PHYS, V219, DOI 10.1002/macp.201800207; Yildiran O, 2017, 2017 10TH INTERNATIONAL CONFERENCE ON ELECTRICAL AND ELECTRONICS ENGINEERING (ELECO), P959	24	7	7	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232460	10.1371/journal.pone.0232460	http://dx.doi.org/10.1371/journal.pone.0232460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392253	gold, Green Published			2022-12-26	WOS:000537470300006
J	Choi, H; Bae, SJ; Choi, G; Lee, H; Son, T; Kim, JG; An, S; Lee, HS; Seo, JH; Kwon, HB; Jeon, S; Oh, GT; Surh, YJ; Kim, KW				Choi, Hoon; Bae, Sung-Jin; Choi, Garam; Lee, Hyunseung; Son, Taekwon; Kim, Jeong-Gyun; An, Sunho; Lee, Hye Shin; Seo, Ji Hae; Kwon, Hyouk-Bum; Jeon, Sejin; Oh, Goo Taeg; Surh, Young-Joon; Kim, Kyu-Won			Ninjurin1 deficiency aggravates colitis development by promoting M1 macrophage polarization and inducing microbial imbalance	FASEB JOURNAL			English	Article						dysbiosis; homeostasis; inflammatory bowel disease; inflammation; M2 macrophages	INFLAMMATORY-BOWEL-DISEASE; ADHESION MOLECULE; SYSTEM; RECEPTOR; RECOGNITION; METABOLITES; PLASTICITY; DYSBIOSIS; ANXIETY; CELLS	Disruption of colonic homeostasis caused by aberrant M1/M2 macrophage polarization and dysbiosis contributes to inflammatory bowel disease (IBD) pathogenesis. However, the molecular factors mediating colonic homeostasis are not well characterized. Here, we found that Ninjurin1 (Ninj1) limits colon inflammation by regulating macrophage polarization and microbiota composition under homeostatic conditions and during colitis development. Ninj1 deletion in mice induced hypersusceptibility to colitis, with increased prevalence of colitogenic Prevotellaceae strains and decreased immunoregulatory Lachnospiraceae strains. Upon co-housing (CoH) with WT mice, Ninj1(-/-) mice showed increased Lachnospiraceae and decreased Prevotellaceae abundance, with subsequent improvement of colitis. Under homeostatic conditions, M1 macrophage frequency was higher in the Ninj1(-/-) mouse colons than wild-type (WT) mouse colons, which may contribute to increased basal colonic inflammation and microbial imbalance. Following colitis induction, Ninj1 expression was increased in macrophages; meanwhile Ninj1(-/-) mice showed severe colitis development and impaired recovery, associated with decreased M2 macrophages and escalated microbial imbalance. In vitro, Ninj1 knockdown in mouse and human macrophages activated M1 polarization and restricted M2 polarization. Finally, the transfer of WT macrophages ameliorated severe colitis in Ninj1(-/-) mice. These findings suggest that Ninj1 mediates colonic homeostasis by modulating M1/M2 macrophage balance and preventing extensive dysbiosis, with implications for IBD prevention and therapy.	[Choi, Hoon; Choi, Garam; Lee, Hyunseung; Son, Taekwon; Kim, Jeong-Gyun; An, Sunho; Lee, Hye Shin; Surh, Young-Joon; Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea; [Choi, Hoon; Choi, Garam; Lee, Hyunseung; Son, Taekwon; Kim, Jeong-Gyun; An, Sunho; Lee, Hye Shin; Surh, Young-Joon; Kim, Kyu-Won] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul 08826, South Korea; [Bae, Sung-Jin] Pusan Natl Univ, Korean Med Res Ctr Hlth Aging, Yangsan, South Korea; [Seo, Ji Hae] Keimyung Univ, Sch Med, Dept Biochem, Daegu, South Korea; [Kwon, Hyouk-Bum] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Jeon, Sejin; Oh, Goo Taeg] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Crop Biotechnol Inst, GreenBio Sci & Technol, Pyeongchang, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pusan National University; Keimyung University; University of North Carolina; University of North Carolina Chapel Hill; Ewha Womans University; Seoul National University (SNU)	Kim, KW (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea.; Kim, KW (corresponding author), Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul 08826, South Korea.	qwonkim@snu.ac.kr	Oh, Goo Taeg/AAQ-9995-2021; Bae, Sung-Jin/AAX-9144-2021; Jeon, Sejin/GRJ-6826-2022; Jeon, Sejin/GWU-7864-2022	Bae, Sung-Jin/0000-0001-8975-0876	Global Core Research Center Program [2011-0030001]; Midcareer Researcher Program [2018R1A2B6001590]; Bio & Medical Technology Development Program [2015M3A9E6028949]; Young Researcher Program [2020R1C1C1003703]; National Research Foundation of Korea [NRF]; Ministry of Science, ICT and Future Planning [MSIP]; Ministry of Science and ICT [MSIT]	Global Core Research Center Program; Midcareer Researcher Program; Bio & Medical Technology Development Program; Young Researcher Program; National Research Foundation of Korea [NRF](National Research Foundation of Korea); Ministry of Science, ICT and Future Planning [MSIP]; Ministry of Science and ICT [MSIT]	Global Core Research Center Program, Grant/Award Number: 2011-0030001; Midcareer Researcher Program, Grant/Award Number: 2018R1A2B6001590; Bio & Medical Technology Development Program, Grant/Award Number: 2015M3A9E6028949; Young Researcher Program, Grant/Award Number: 2020R1C1C1003703; National Research Foundation of Korea [NRF]; Ministry of Science, ICT and Future Planning [MSIP] or Ministry of Science and ICT [MSIT]	Ahn BJ, 2014, J BIOL CHEM, V289, P3328, DOI 10.1074/jbc.M113.498212; Araki T, 1997, J BIOL CHEM, V272, P21373, DOI 10.1074/jbc.272.34.21373; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bae SJ, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-018-0201-3; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bernardo D, 2018, MUCOSAL IMMUNOL, V11, P1114, DOI 10.1038/s41385-018-0030-7; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chen L, 2017, NAT IMMUNOL, V18, P541, DOI 10.1038/ni.3690; Cho SJ, 2013, P NATL ACAD SCI USA, V110, P9362, DOI 10.1073/pnas.1221242110; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Ding J, 2018, BIOCHEM BIOPH RES CO, V505, P1180, DOI 10.1016/j.bbrc.2018.09.184; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Handley SA, 2016, CELL HOST MICROBE, V19, P323, DOI 10.1016/j.chom.2016.02.010; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311; Hunter MM, 2010, GASTROENTEROLOGY, V138, P1395, DOI 10.1053/j.gastro.2009.12.041; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Isidro RA, 2016, AM J PHYSIOL-GASTR L, V311, pG59, DOI 10.1152/ajpgi.00123.2016; Jennewein C, 2015, AM J RESP CELL MOL, V53, P656, DOI 10.1165/rcmb.2014-0354OC; Ji J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24838; Kaufmann SHE, 2016, IMMUNITY, V44, P476, DOI 10.1016/j.immuni.2016.02.014; Kim TS, 2019, AUTOPHAGY, V15, P1356, DOI 10.1080/15548627.2019.1582743; Kny M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216987; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Le H, 2017, MOL NEUROBIOL, V54, P7353, DOI 10.1007/s12035-016-0207-6; Lee HJ, 2009, CELL DEATH DIFFER, V16, P1395, DOI 10.1038/cdd.2009.78; Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7; Li G, 2019, AGING-US, V11, P8526, DOI 10.18632/aging.102336; Li L, 2015, CELL DEATH DIFFER, V22, P1081, DOI 10.1038/cdd.2014.212; Lin YL, 2014, CELL MOL IMMUNOL, V11, P355, DOI 10.1038/cmi.2014.15; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419; Na YR, 2019, NAT REV GASTRO HEPAT, V16, P531, DOI 10.1038/s41575-019-0172-4; Nahon S, 2012, INFLAMM BOWEL DIS, V18, P2086, DOI 10.1002/ibd.22888; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Postler TS, 2017, CELL METAB, V26, P110, DOI 10.1016/j.cmet.2017.05.008; RELMAN D, 1990, CELL, V61, P1375, DOI 10.1016/0092-8674(90)90701-F; Robertson SJ, 2018, TRENDS IMMUNOL, V39, P992, DOI 10.1016/j.it.2018.10.004; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Shin MW, 2016, INT J ONCOL, V48, P821, DOI 10.3892/ijo.2015.3296; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tang C, 2018, NAT IMMUNOL, V19, P755, DOI 10.1038/s41590-018-0134-y; Thevaranjan N, 2018, CELL HOST MICROBE, V23, P570, DOI 10.1016/j.chom.2018.03.006; Tye H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06125-0; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Wang JJ, 2017, CELL SIGNAL, V35, P231, DOI 10.1016/j.cellsig.2017.04.011; Woo JK, 2016, ONCOTARGET, V7, P29592, DOI 10.18632/oncotarget.9020; Yang HJ, 2017, P NATL ACAD SCI USA, V114, P11500, DOI 10.1073/pnas.1711814114; Zeng MY, 2017, MUCOSAL IMMUNOL, V10, P18, DOI 10.1038/mi.2016.75; Zhou X, 2019, CELL REP, V27, P1176, DOI 10.1016/j.celrep.2019.03.028	62	9	9	3	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8702	8720		10.1096/fj.201902753R	http://dx.doi.org/10.1096/fj.201902753R		MAY 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32385864				2022-12-26	WOS:000532122000001
J	Kataoka, H; Ohara, M; Suzuki, T; Inoue, T; Akanuma, T; Kawachi, K; Manabe, S; Ushio, Y; Kawasoe, K; Akihisa, T; Sato, M; Iwasa, N; Sawara, Y; Honda, K; Mochizuki, T; Tsuchiya, K; Nitta, K				Kataoka, Hiroshi; Ohara, Mamiko; Suzuki, Tomo; Inoue, Takahiro; Akanuma, Takafumi; Kawachi, Keiko; Manabe, Shun; Ushio, Yusuke; Kawasoe, Kentaro; Akihisa, Taro; Sato, Masayo; Iwasa, Naomi; Sawara, Yukako; Honda, Kazuho; Mochizuki, Toshio; Tsuchiya, Ken; Nitta, Kosaku			Time series changes in pseudo-R-2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROGRESSIVE GLOMERULOSCLEROSIS; RENAL CORPUSCLE; HYPERTROPHY; RATS; CLASSIFICATION; DISEASE; MODEL; VALIDATION; INSULIN	There is no effectual pathological factor to predict the long-term renal prognosis of IgA nephropathy. Glomerular hypertrophy plays a crucial role in kidney disease outcomes in both experimental models and humans. This study aimed to 1) confirm the long-term prognostic significance of a maximal glomerular diameter (Max GD) >= 242.3 mu m, 2) test a renal prognosis prediction model adding Max GD >= 242.3 mu m to the Oxford classification (MEST-C), and 3) examine the time series changes in the long-term renal prognosis of patients with IgA nephropathy. The study included 43 patients diagnosed with IgA nephropathy from 1993 to 1998 at Kameda General Hospital. Renal prognosis with the endpoint of a 50% reduction in estimated glomerular filtration rate (eGFR) or the development of end-stage renal disease requiring dialysis was examined using logistic regression analysis, Cox regression analysis, and the Kaplan-Meier method. Pathological evaluation was performed using MEST-C and Max GD, and the validity of the prediction model was evaluated. Patients with Max GD >= 242.3 mu m had significantly poor renal prognosis with multivariate Cox analysis (P = 0.0293). The results of the Kaplan-Meier analysis showed that kidney survival rates in the high-Max GD group were significantly lower than those in the low-Max GD group (log rank, P = 0.0043), which was confirmed in propensity score-matched models (log rank, P = 0.0426). Adding Max GD >= 242.3 mu m to MEST-C improved diagnostic power of the renal prognosis prediction model by renal pathology tissue examination (R-2 : 3.3 to 14.5%, AICc: 71.8 to 68.0, C statistic: 0.657 to 0.772). We confirm that glomerular hypertrophy is useful as a long-term renal prognostic factor.	[Kataoka, Hiroshi; Kawachi, Keiko; Manabe, Shun; Ushio, Yusuke; Kawasoe, Kentaro; Akihisa, Taro; Sato, Masayo; Iwasa, Naomi; Sawara, Yukako; Mochizuki, Toshio; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Nephrol, Tokyo, Japan; [Kataoka, Hiroshi; Iwasa, Naomi; Mochizuki, Toshio] Tokyo Womens Med Univ, Dept Nephrol, Clin Res Div Polycyst Kidney Dis, Tokyo, Japan; [Ohara, Mamiko; Suzuki, Tomo; Inoue, Takahiro; Akanuma, Takafumi] Kameda Med Ctr, Dept Nephrol, Chiba, Japan; [Honda, Kazuho] Showa Univ, Dept Anat, Tokyo, Japan; [Tsuchiya, Ken] Tokyo Womens Med Univ, Kidney Ctr, Dept Blood Purificat, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Showa University; Tokyo Women's Medical University	Kataoka, H; Mochizuki, T (corresponding author), Tokyo Womens Med Univ, Dept Nephrol, Tokyo, Japan.; Kataoka, H; Mochizuki, T (corresponding author), Tokyo Womens Med Univ, Dept Nephrol, Clin Res Div Polycyst Kidney Dis, Tokyo, Japan.	kataoka@twmu.ac.jp						Barbour S, 2018, CURR OPIN NEPHROL HY, V27, P214, DOI 10.1097/MNH.0000000000000405; Barbour SJ, 2016, KIDNEY INT, V89, P167, DOI 10.1038/ki.2015.322; Bledsoe G, 2006, HUM GENE THER, V17, P545, DOI 10.1089/hum.2006.17.545; Bruggeman LA, 1997, J CLIN INVEST, V100, P84, DOI 10.1172/JCI119525; Cahill MM, 1996, KIDNEY INT, V50, P768, DOI 10.1038/ki.1996.375; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chen TY, 2019, AM J KIDNEY DIS, V74, P300, DOI 10.1053/j.ajkd.2019.02.016; Coppo R, 2020, NEPHROL DIAL TRANSPL, V35, P1002, DOI 10.1093/ndt/gfy302; Coppo R, 2014, KIDNEY INT, V86, P828, DOI 10.1038/ki.2014.63; Cosenzi A, 1999, J HYPERTENS, V17, P1843, DOI 10.1097/00004872-199917121-00010; Cusumano AM, 2002, AM J KIDNEY DIS, V40, P1075, DOI 10.1053/ajkd.2002.36348; DOI T, 1990, AM J PATHOL, V137, P541; Donadio JV, 2002, NEPHROL DIAL TRANSPL, V17, P1197, DOI 10.1093/ndt/17.7.1197; DWORKIN LD, 1984, J CLIN INVEST, V73, P1448, DOI 10.1172/JCI111349; FOGO A, 1990, KIDNEY INT, V38, P115, DOI 10.1038/ki.1990.175; FRIES JWU, 1989, LAB INVEST, V60, P205; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P1242, DOI 10.1093/ndt/gfn610; Gu JW, 2008, J AM SOC HYPERTENS, V2, P275, DOI 10.1016/j.jash.2008.03.001; GUIJARRO C, 1995, AM J KIDNEY DIS, V26, P152, DOI 10.1016/0272-6386(95)90169-8; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hauber AB, 2016, VALUE HEALTH, V19, P300, DOI 10.1016/j.jval.2016.04.004; Herzenberg AM, 2011, KIDNEY INT, V80, P310, DOI 10.1038/ki.2011.126; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; IJpelaar DHT, 2008, AM J PHYSIOL-RENAL, V294, pF758, DOI 10.1152/ajprenal.00457.2007; Kataoka H, 2018, CONTRIB NEPHROL, V195, P20, DOI 10.1159/000486931; Kataoka H, 2011, NEPHROL DIAL TRANSPL, V26, P3937, DOI 10.1093/ndt/gfr139; Kim S, 1997, HYPERTENSION, V30, P1054, DOI 10.1161/01.HYP.30.5.1054; Knoop T, 2017, NEPHROL DIAL TRANSPL, V32, P1841, DOI 10.1093/ndt/gfx242; LANE PH, 1992, KIDNEY INT, V41, P1085, DOI 10.1038/ki.1992.165; Li L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142884; MACKAY K, 1990, KIDNEY INT, V37, P741, DOI 10.1038/ki.1990.41; Michel O, 1997, KIDNEY INT, V52, P1532, DOI 10.1038/ki.1997.483; MILLER PL, 1991, AM J PHYSIOL, V261, pF459, DOI 10.1152/ajprenal.1991.261.3.F459; Moriyama T, 2012, INT UROL NEPHROL, V44, P1177, DOI 10.1007/s11255-011-0109-5; NAGATA M, 1992, KIDNEY INT, V42, P136, DOI 10.1038/ki.1992.271; Nakagawa T, 2003, AM J NEPHROL, V23, P2, DOI 10.1159/000066303; Nenov VD, 2000, CURR OPIN NEPHROL HY, V9, P85, DOI 10.1097/00041552-200003000-00001; OLIVETTI G, 1977, J CELL BIOL, V75, P573, DOI 10.1083/jcb.75.2.573; OSTERBY R, 1980, DIABETOLOGIA, V18, P493; OSTERBY R, 1975, DIABETOLOGIA, V11, P225, DOI 10.1007/BF00422326; Phillips AO, 2001, AM J KIDNEY DIS, V37, P400, DOI 10.1053/ajkd.2001.21322; RAYNER HC, 1991, NEPHRON, V57, P453, DOI 10.1159/000186349; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Rodriguez-Lopez AM, 1998, KIDNEY INT, V54, pS36, DOI 10.1046/j.1523-1755.1998.06810.x; Roncal-Jimenez CA, 2016, AM J PHYSIOL-RENAL, V311, pF722, DOI 10.1152/ajprenal.00306.2016; ROSENMANN E, 1971, DIABETES, V20, P803, DOI 10.2337/diab.20.12.803; Schrijvers BF, 2002, KIDNEY INT, V61, P1600, DOI 10.1046/j.1523-1755.2002.00310.x; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; SHIMAMURA T, 1975, AM J PATHOL, V79, P95; Suzuki H, 2005, NEPHROL DIAL TRANSPL, V20, P1362, DOI 10.1093/ndt/gfh782; Taal MW, 2006, KIDNEY INT, V70, P1694, DOI 10.1038/sj.ki.5001794; Toyota E, 2004, KIDNEY INT, V66, P855, DOI 10.1111/j.1523-1755.2004.00816.x; Trimarchi H, 2017, KIDNEY INT, V91, P1014, DOI 10.1016/j.kint.2017.02.003; UEMASU J, 1992, J PHARMACOL EXP THER, V260, P505; Usui H, 2003, NEPHROL DIAL TRANSPL, V18, P265, DOI 10.1093/ndt/18.2.265; Wei P, 2004, DIABETOLOGIA, V47, P1541, DOI 10.1007/s00125-004-1489-1; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Wolf G, 1998, KIDNEY INT, V53, P869, DOI 10.1046/j.1523-1755.1998.00829.x; Xie JY, 2018, AM J KIDNEY DIS, V72, P371, DOI 10.1053/j.ajkd.2018.01.043; Zerbini G, 2006, DIABETES, V55, P2620, DOI 10.2337/db06-0592	61	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232885	10.1371/journal.pone.0232885	http://dx.doi.org/10.1371/journal.pone.0232885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379841	Green Published, gold			2022-12-26	WOS:000537285700076
J	Lee, JH; Kim, HS; Yoon, YC; Seo, SW; Cha, MJ; Jin, W; Cha, JG				Lee, Ji Hyun; Kim, Hyun Su; Yoon, Young Cheol; Seo, Sung Wook; Cha, Min Jae; Jin, Wook; Cha, Jang Gyu			Characterization of small, deeply located soft-tissue tumors: Conventional magnetic resonance imaging features and apparent diffusion coefficient for differentiation between non-malignancy and malignancy	PLOS ONE			English	Article							WEIGHTED MRI; BENIGN; MASSES; MANAGEMENT; LESIONS; SCHWANNOMAS; DIAGNOSIS; SARCOMAS; SIZE	Objectives To compare magnetic resonance imaging (MRI) parameters of small, deeply located nonmalignant and malignant soft-tissue tumors (STTs). Methods Between May 2011 and December 2017, 95 MRIs in 95 patients with pathologically proven STTs of small size (< 5 cm) and deep location (66 non-malignant and 29 malignant) were identified. For qualitative parameters, consensus reading was performed by three radiologists for presence of necrosis, infiltration, lobulation, and the tail sign. Apparent diffusion coefficient (ADC) was analyzed by two other radiologists independently. Univariable and multivariable analyses were performed to determine the diagnostic performances of MRI parameters in differentiating non-malignancy and malignancy, and for non-myxoid, non-hemosiderin STTs and myxoid STTs as subgroups. Interobserver agreement for ADC measurement was calculated with the intraclass correlation coefficient. Results Interobserver agreement on ADC measurement was almost perfect. On univariable analysis, the malignant group showed a significantly larger size, lower ADC, and higher incidence of all qualitative MRI parameters for all STTs. Size (p = 0.012, odds ratio [OR] 2.57), ADC (p = 0.041, OR 3.85), and the tail sign (p = 0.009, OR 6.47) were independently significant on multivariable analysis. For non-myxoid, non-hemosiderin STTs, age, size, ADC, frequency of infiltration, lobulation, and the tail sign showed significant differences between non-malignancy and malignancy on univariable analysis. Only ADC (p = 0.032, OR 142.86) retained its independence on multivariable analysis. For myxoid STTs, only size and tail sign were significant on univariable analysis without independent significance. Conclusions Size, ADC, and incidence of qualitative MRI parameters were significantly different between small, deeply located non-malignant and malignant STTs. Only ADC was independently significant for both overall analysis and the non-myxoid, non-hemosiderin subgroup.	[Lee, Ji Hyun; Kim, Hyun Su; Yoon, Young Cheol] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiol, Seoul, South Korea; [Seo, Sung Wook] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Orthoped Surg, Seoul, South Korea; [Cha, Min Jae] Chung Ang Univ, Chung Ang Univ Hosp, Coll Med, Dept Radiol, Seoul, South Korea; [Jin, Wook] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Sch Med, Dept Radiol, Seoul, South Korea; [Cha, Jang Gyu] Soonchunhyang Univ, Bucheon Hosp, Dept Radiol, Bucheon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Chung Ang University; Chung Ang University Hospital; Kyung Hee University; Kyung Hee University Hospital; Soonchunhyang University	Kim, HS (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiol, Seoul, South Korea.	calmuri@naver.com	CHA, MIN JAE/ABB-5261-2020	Lee, Ji Hyun/0000-0002-8582-5436; Yoon, Young Cheol/0000-0002-7822-5344; Kim, Hyun Su/0000-0002-0179-9542				Ahlawat S, 2018, SKELETAL RADIOL, V47, P313, DOI 10.1007/s00256-017-2822-3; BERQUIST TH, 1990, AM J ROENTGENOL, V155, P1251, DOI 10.2214/ajr.155.6.2122675; Brisson M, 2013, SKELETAL RADIOL, V42, P635, DOI 10.1007/s00256-012-1517-z; Calleja M, 2012, SKELETAL RADIOL, V41, P1517, DOI 10.1007/s00256-012-1385-6; Casali PG, 2014, ANN ONCOL, V25, P102, DOI 10.1093/annonc/mdu254; Chen CK, 2009, J CHIN MED ASSOC, V72, P194, DOI 10.1016/S1726-4901(09)70053-X; Chhabra A, 2012, AM J ROENTGENOL, V199, P1345, DOI 10.2214/AJR.12.8719; Chung WJ, 2012, BRIT J RADIOL, V85, pE831, DOI 10.1259/bjr/27487871; Costa FM, 2011, MAGN RESON IMAGING C, V19, P159, DOI 10.1016/j.mric.2010.10.007; Crombe A, 2016, EUR J RADIOL, V85, P1875, DOI 10.1016/j.ejrad.2016.08.015; De Schepper AM, 2000, EUR RADIOL, V10, P213, DOI 10.1007/s003300050037; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DESCHEPPER AM, 1992, ROFO FORTSCHR RONTG, V156, P587, DOI 10.1055/s-2008-1032948; Drape JL, 2013, ORTHOP TRAUMATOL-SUR, V99, pS115, DOI 10.1016/j.otsr.2012.12.005; Einarsdottir H, 2004, EUR RADIOL, V14, P959, DOI 10.1007/s00330-004-2237-0; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Gielen JLMA, 2004, EUR RADIOL, V14, P2320, DOI 10.1007/s00330-004-2431-0; Harish S, 2006, EUR RADIOL, V16, P2652, DOI 10.1007/s00330-006-0267-5; Jagannathan JP, 2016, SURG ONCOL CLIN N AM, V25, P645, DOI 10.1016/j.soc.2016.05.002; Jeon JY, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150929; Kasraeian S, 2010, CLIN ORTHOP RELAT R, V468, P2992, DOI 10.1007/s11999-010-1401-x; Khoo MC, 2017, SKELETAL RADIOL, V46, P919, DOI 10.1007/s00256-017-2635-4; Khoo MMY, 2011, SKELETAL RADIOL, V40, P665, DOI 10.1007/s00256-011-1106-6; KRANSDORF MJ, 1989, AM J ROENTGENOL, V153, P541, DOI 10.2214/ajr.153.3.541; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41230-0; Lee SY, 2016, EUR RADIOL, V26, P743, DOI 10.1007/s00330-015-3878-x; Lefkowitz RA, 2013, SKELETAL RADIOL, V42, P809, DOI 10.1007/s00256-012-1563-6; Maeda M, 2007, J MAGN RESON IMAGING, V25, P1199, DOI 10.1002/jmri.20931; MOULTON JS, 1995, AM J ROENTGENOL, V164, P1191, DOI 10.2214/ajr.164.5.7717231; MYHREJENSEN O, 1981, ACTA ORTHOP SCAND, V52, P287, DOI 10.3109/17453678109050105; Nagata S, 2008, RADIAT MED, V26, P287, DOI 10.1007/s11604-008-0229-8; Noebauer-Huhmann IM, 2015, SEMIN MUSCULOSKEL R, V19, P475, DOI 10.1055/s-0035-1569251; Okada K, 2016, J ORTHOP SCI, V21, P705, DOI 10.1016/j.jos.2016.06.012; Rochwerger A, 2018, ORTHOP TRAUMATOL-SUR, V104, pS9, DOI 10.1016/j.otsr.2017.05.031; Rougraff BT, 2009, CLIN ORTHOP RELAT R, V467, P2783, DOI 10.1007/s11999-009-0965-9; RYDHOLM A, 1983, ACTA ORTHOP SCAND, V54, P1, DOI 10.3109/17453678309154171; Shimose S, 2007, ACTA RADIOL, V48, P672, DOI 10.1080/02841850701326925; Song Y, 2017, CLIN RADIOL, V72, P691, DOI 10.1016/j.crad.2017.02.003; Subhawong TK, 2014, RADIOGRAPHICS, V34, P1163, DOI 10.1148/rg.345140190; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; TUNG GA, 1993, CRIT REV DIAGN IMAG, V34, P239; Valentin T, 2016, EUR J CANCER, V56, P77, DOI 10.1016/j.ejca.2015.12.015; van Rijswijk CSP, 2002, J MAGN RESON IMAGING, V15, P302, DOI 10.1002/jmri.10061; Wunder JS, 2000, CANCER, V88, P2721, DOI 10.1002/1097-0142(20000615)88:12<2721::AID-CNCR10>3.0.CO;2-D; Zhang ZH, 2015, EUR J RADIOL, V84, P940, DOI 10.1016/j.ejrad.2015.02.003	46	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232622	10.1371/journal.pone.0232622	http://dx.doi.org/10.1371/journal.pone.0232622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379793	Green Published, gold			2022-12-26	WOS:000537285700050
J	Rippin, HL; Hutchinson, J; Greenwood, DC; Jewell, J; Breda, JJ; Martin, A; Rippin, DM; Schindler, K; Rust, P; Fagt, S; Matthiessen, J; Nurk, E; Nelis, K; Kukk, M; Tapanainen, H; Valsta, L; Heuer, T; Sarkadi-Nagy, E; Bakacs, M; Tazhibayev, S; Sharmanov, T; Spiroski, I; Beukers, M; van Rossum, C; Ocke, M; Lindroos, AK; Lemming, EW; Cade, JE				Rippin, H. L.; Hutchinson, J.; Greenwood, D. C.; Jewell, J.; Breda, J. J.; Martin, A.; Rippin, D. M.; Schindler, K.; Rust, P.; Fagt, S.; Matthiessen, J.; Nurk, E.; Nelis, K.; Kukk, M.; Tapanainen, H.; Valsta, L.; Heuer, T.; Sarkadi-Nagy, E.; Bakacs, M.; Tazhibayev, S.; Sharmanov, T.; Spiroski, I; Beukers, M.; van Rossum, C.; Ocke, M.; Lindroos, A. K.; Lemming, Eva Warensjo; Cade, J. E.			Inequalities in education and national income are associated with poorer diet: Pooled analysis of individual participant data across 12 European countries	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; HEALTH; QUALITY; RECALLS	Background Malnutrition linked to noncommunicable diseases presents major health problems across Europe. The World Health Organisation encourages countries to conduct national dietary surveys to obtain data to inform public health policies designed to prevent noncommunicable diseases. Methods Data on 27334 participants aged 19-64y were harmonised and pooled across national dietary survey datasets from 12 countries across the WHO European Region. Weighted mean nutrient intakes were age-standardised using the Eurostat 2013 European Standard Population. Associations between country-level Gross Domestic Product (GDP) and key nutrients and nutrient densities were investigated using linear regression. The potential mitigating influence of participant-level educational status was explored. Findings Higher GDP was positively associated with total sugar intake (5.0% energy for each 10% increase in GDP, 95% CI 0.6, 9.3). Scandinavian countries had the highest vitamin D intakes. Participants with higher educational status had better nutritional intakes, particularly within lower GDP countries. A 10% higher GDP was associated with lower total fat intakes (-0.2% energy, 95% CI -0.3, -0.1) and higher daily total folate intakes (14 mu g, 95% CI 12, 16) in higher educated individuals. Interpretation Lower income countries and lower education groups had poorer diet, particularly for micronutrients. We demonstrate for the first time that higher educational status appeared to have a mitigating effect on poorer diet in lower income countries. It illustrates the feasibility and value of harmonising national dietary survey data to inform European policy regarding access to healthy diets, particularly in disadvantaged groups. It specifically highlights the need for strong policies supporting nutritional intakes, prioritising lower education groups and lower income countries.	[Rippin, H. L.; Hutchinson, J.; Cade, J. E.] Univ Leeds, Sch Food Sci & Nutr, Nutr Epidemiol Grp NEG, Leeds, W Yorkshire, England; [Greenwood, D. C.] Univ Leeds, Inst Cardiovasc & Metab Med LICAMM, Clin & Populat Sci Dept, Leeds, W Yorkshire, England; [Jewell, J.; Breda, J. J.] WHO Reg Off Europe, Div Noncommunicable Dis & Promoting Hlth Life Cou, UN City, Copenhagen, Denmark; [Martin, A.] Univ Leeds, Acad Unit Hlth Econ, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Rippin, D. M.] Univ York, Dept Environm & Geog, Wentworth Way, York, N Yorkshire, England; [Schindler, K.; Rust, P.] Univ Vienna, Dept Nutr Sci, Vienna, Austria; [Fagt, S.; Matthiessen, J.] Natl Food Inst, Lyngby, Denmark; [Nurk, E.; Nelis, K.; Kukk, M.] Natl Inst Hlth Dev, Dept Nutr Res, Tallinn, Estonia; [Nurk, E.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Tapanainen, H.; Valsta, L.] Finnish Inst Hlth & Welf, Publ Hlth Promot Unit, Helsinki, Finland; [Heuer, T.] Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Nutr Behav, Karlsruhe, Germany; [Sarkadi-Nagy, E.; Bakacs, M.] Natl Inst Pharm & Nutr, Budapest, Hungary; [Tazhibayev, S.; Sharmanov, T.] Kazakh Acad Nutr, Alma Ata, Kazakhstan; [Spiroski, I] Inst Publ Hlth, Skopje, North Macedonia; [Beukers, M.; van Rossum, C.; Ocke, M.] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Lindroos, A. K.; Lemming, Eva Warensjo] Livsmedelsverket Swedish Natl Food Agcy, Uppsala, Sweden	University of Leeds; University of Leeds; World Health Organization; University of Leeds; University of York - UK; University of Vienna; Technical University of Denmark; National Institute for Health Development - Estonia; University of Oslo; Kazakh Academy of Nutrition; Netherlands National Institute for Public Health & the Environment; Swedish National Food Agency	Rippin, HL (corresponding author), Univ Leeds, Sch Food Sci & Nutr, Nutr Epidemiol Grp NEG, Leeds, W Yorkshire, England.	rippinholly@gmail.com	Tazhibayev, Shamil/AFV-2170-2022; Rippin, David Manish/AAW-5063-2021; Martin, Adam/AAD-9321-2021; Breda, Joao/J-9371-2014	Tazhibayev, Shamil/0000-0001-9362-3474; Rippin, David Manish/0000-0001-7757-9880; Martin, Adam/0000-0002-2559-6483; Rust, Petra/0000-0002-6477-8407; Rippin, Holly/0000-0002-8879-3978; Breda, Joao/0000-0002-8177-4926; Matthiessen, Jeppe/0000-0002-0798-5602; Fagt, Sisse/0000-0003-0765-5555	WHO Regional Office for Europe	WHO Regional Office for Europe	This project was funded by the WHO Regional Office for Europe. The co-authors Joao Breda and Jo Jewell were staff members of the World Health Organization Regional Office for Europe at the time of research. The views expressed in this publication are the authors' own and do not necessarily represent the decisions or stated policy of WHO. JB and JJ provided insight on WHO policy matters and access to key contacts. They, like all authors, reviewed and approved the final manuscript.	Aggarwal A, 2011, EUR J CLIN NUTR, V65, P1059, DOI 10.1038/ejcn.2011.72; Allgrove J, 2014, CALCIUM DEFICIENCY R; [Anonymous], 2019, POP AG SEX URB RUR R; [Anonymous], 2013, REV EUR STAND POP RE; Brunner EJ, 2018, CONCEPTS DEFINITIONS, V2nd; Busby A, 2005, BMJ-BRIT MED J, V330, P574, DOI 10.1136/bmj.330.7491.574; Clayton P, 2008, J ROY SOC MED, V101, P282, DOI 10.1258/jrsm.2008.080112; Crispim SP, 2011, EUR J CLIN NUTR, V65, pS38, DOI 10.1038/ejcn.2011.86; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; EFCOSUM, 2001, EUR FOOD CONS SURV M; EFSA EFSA, 2009, GEN PRINC COLL NAT F; EFSA EFSA, 2014, GUID EU MEN METH; Euro--Peristat Project, 2018, EUR PER HLTH REP COR; European Heart Network, 2017, EUROPEAN CARDIOVASCU; Fagt S., 2012, NORDIC DIETARY SURVE; Herd P, 2007, J HEALTH SOC BEHAV, V48, P223, DOI 10.1177/002214650704800302; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Institute for Health Metrics and Evaluation, 2018, FIND GLOB BURD DIS S; Kirsten W, 2008, INT J WORKPLACE HEAL, V1, P136, DOI 10.1108/17538350810893928; Lambert J, 2004, BRIT J NUTR, V92, pS147, DOI 10.1079/BJN20041160; Livingstone KM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101092; Micha R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2272; Michels KB, 2004, AM J EPIDEMIOL, V160, P59, DOI 10.1093/aje/kwh169; OECD, 2019, GROSS DOM PROD GDP I; Poslusna K, 2009, BRIT J NUTR, V101, pS73, DOI 10.1017/S0007114509990602; Rippin HL, 2018, NUTR RES REV, V3, P1, DOI DOI 10.1017/S0954422418000161; Rippin HL, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1362; Rippin HL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121288; StataCorp, 2017, STATA STAT SOFTWARE; Vinnari M., 2005, LIFESTYLES SOCIAL CH, P229; Wanders AJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080840; Wang DD, 2014, JAMA INTERN MED, V174, P1587, DOI 10.1001/jamainternmed.2014.3422; World Health Organisation, 2016, COUNTR PROF KAZ COP; World Health Organization, 2018, REPLACE T FAT ACT PA; World Health Organization, 2014, EUR FOOD NUTR ACT PL; World Health Organization, 2018, OV EUR HLTH INF GAT; World Health Organization, 2017, OB OV	37	19	19	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232447	10.1371/journal.pone.0232447	http://dx.doi.org/10.1371/journal.pone.0232447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379781	Green Published, gold			2022-12-26	WOS:000537285700033
J	Du, QD; Chan, LY; Gilding, EK; Henriques, ST; Condon, ND; Ravipati, AS; Kaas, Q; Huang, YH; Craik, DJ				Du, Qingdan; Chan, Lai Y.; Gilding, Edward K.; Henriques, Sonia Troeira; Condon, Nicholas D.; Ravipati, Anjaneya S.; Kaas, Quentin; Huang, Yen-Hua; Craik, David J.			Discovery and mechanistic studies of cytotoxic cyclotides from the medicinal herbHybanthus enneaspermus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic peptide; peptide chemical synthesis; cyclotide; nuclear magnetic resonance (NMR); cancer cell cytotoxicity; peptide-membrane interaction; anticancer property; surface plasmon resonance (SPR); flow cytometry; microscopy; cancer cell cytoxicity	GC-MS ANALYSIS; KALATA B1; CYCLOVIOLACIN O2; HYBANTHUS-ENNEASPERMUS; PLANT CYCLOTIDES; MEMBRANE-BINDING; KNOTTED PROTEINS; SCANNING MUTAGENESIS; CIRCULAR PROTEINS; VIOLA-ODORATA	Cyclotides are plant-derived peptides characterized by an similar to 30-amino acid-long cyclic backbone and a cystine knot motif. Cyclotides have diverse bioactivities, and their cytotoxicity has attracted significant attention for its potential anticancer applications.Hybanthus enneaspermus(Linn) F. Muell is a medicinal herb widely used in India as a libido enhancer, and a previous study has reported that it may contain cyclotides. In the current study, we isolated 11 novel cyclotides and 1 known cyclotide (cycloviolacin O2) fromH. enneaspermusand used tandem MS to determine their amino acid sequences. We found that among these cyclotides, hyen C comprises a unique sequence in loops 1, 2, 3, 4, and 6 compared with known cyclotides. The most abundant cyclotide in this plant, hyen D, had anticancer activity comparable to that of cycloviolacin O2, one of the most cytotoxic known cyclotides. We also provide mechanistic insights into how these novel cyclotides interact with and permeabilize cell membranes. Results from surface plasmon resonance experiments revealed that hyen D, E, L, and M and cycloviolacin O2 preferentially interact with model lipid membranes that contain phospholipids with phosphatidyl-ethanolamine headgroups. The results of a lactate dehydrogenase assay indicated that exposure to these cyclotides compromises cell membrane integrity. Using live-cell imaging, we show that hyen D induces rapid membrane blebbing and cell necrosis. Cyclotide-membrane interactions correlated with the observed cytotoxicity, suggesting that membrane permeabilization and disintegration underpin cyclotide cytotoxicity. These findings broaden our knowledge on the indigenous Indian herbH. enneaspermusand have uncovered cyclotides with potential anticancer activity.	[Du, Qingdan; Chan, Lai Y.; Gilding, Edward K.; Henriques, Sonia Troeira; Condon, Nicholas D.; Ravipati, Anjaneya S.; Kaas, Quentin; Huang, Yen-Hua; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Henriques, Sonia Troeira] Queensland Univ Technol, Sch Biomed Sci, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Henriques, Sonia Troeira] Queensland Univ Technol, Translat Res Inst, Brisbane, Qld, Australia	University of Queensland; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	d.craik@imb.uq.edu.au	Craik, David/B-1695-2010; CHAN, LAI YUE/C-6489-2014; Huang, Yen-Hua/J-9056-2014; Kaas, Quentin/J-8727-2014; Troeira Henriques, Sonia/J-3500-2016	Craik, David/0000-0003-0007-6796; CHAN, LAI YUE/0000-0002-9346-2487; Huang, Yen-Hua/0000-0001-6937-2660; Kaas, Quentin/0000-0001-9988-6152; Troeira Henriques, Sonia/0000-0001-9564-9651; Gilding, Edward Kalani/0000-0003-1720-1282; Du, Qingdan/0000-0002-1165-3766	Australian government; ARC [LE160100218]; ACRF	Australian government(Australian GovernmentCGIAR); ARC(Australian Research Council); ACRF	The Translational Research Institute is supported by a grant from the Australian government. S. T. H. is an ARC Future Fellow (FT150100398). D. J. C. is an ARC Australian Laureate Fellow (FL150100146). The work was facilitated using infrastructure provided by the Australian Government through the National Collaborative Research Infrastructure strategy (NCRIS). We thank Alun Jones and Institute for Molecular Bioscience Mass Spectrometry Facility (The University of Queensland) for technical support and access to MS equipment. We thank Gregoire J.-B. Philippe for experimental help and suggestions on the biological assays. We also acknowledge Dr. Peta Harvey for help in NMR and the Queensland NMR facility for access to NMR equipment and an ARC grant (LE160100218). Microscopy was performed at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Cancer Biology Imaging Facility, which was established with the support of the ACRF.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annie, 2007, PHARMACOLOGYONLINE, V1, P152; Bhanu H. S., 2011, INT J PHARM PHARM SC, V3, P90; Bobey AF, 2018, PLANTA MED, V84, P947, DOI 10.1055/a-0632-2204; Broussalis AM, 2001, PHYTOCHEMISTRY, V58, P47, DOI 10.1016/S0031-9422(01)00173-X; Burman R, 2011, BBA-BIOMEMBRANES, V1808, P2665, DOI 10.1016/j.bbamem.2011.07.004; Burman R, 2011, ORG BIOMOL CHEM, V9, P4306, DOI 10.1039/c0ob00966k; Chan LY, 2013, CHEMBIOCHEM, V14, P617, DOI 10.1002/cbic.201300034; Cheneval O, 2014, J ORG CHEM, V79, P5538, DOI 10.1021/jo500699m; Chiche L, 2004, CURR PROTEIN PEPT SC, V5, P341, DOI 10.2174/1389203043379477; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Colgrave ML, 2008, CHEMBIOCHEM, V9, P1939, DOI 10.1002/cbic.200800174; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2017, CURR OPIN CHEM BIOL, V38, P8, DOI 10.1016/j.cbpa.2017.01.018; Craik DJ, 2013, CURR OPIN CHEM BIOL, V17, P546, DOI 10.1016/j.cbpa.2013.05.033; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; de Veer SJ, 2019, CHEM REV, V119, P12375, DOI 10.1021/acs.chemrev.9b00402; Gerlach SL, 2010, BIOPOLYMERS, V94, P617, DOI 10.1002/bip.21435; Gerlach SL, 2010, J NAT PROD, V73, P1207, DOI 10.1021/np9007365; Goransson U, 2004, J NAT PROD, V67, P1287, DOI 10.1021/np0499719; Goransson U, 2012, J BIOL CHEM, V287, P27001, DOI 10.1074/jbc.R111.300129; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Grundemann C, 2019, INT J PEPT RES THER, V25, P9, DOI 10.1007/s10989-018-9701-1; Hall K, 2012, BBA-BIOMEMBRANES, V1818, P2354, DOI 10.1016/j.bbamem.2012.04.007; He WJ, 2011, PEPTIDES, V32, P1719, DOI 10.1016/j.peptides.2011.06.016; Heitz A, 2001, BIOCHEMISTRY-US, V40, P7973, DOI 10.1021/bi0106639; Hemalatha S., 2003, INDIAN J TRADIT KNOW, V2, P383; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2017, BIOCHEMISTRY-US, V56, P669, DOI 10.1021/acs.biochem.6b01212; Henriques ST, 2014, CHEMBIOCHEM, V15, P1956, DOI 10.1002/cbic.201402144; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Herrmann A, 2006, CELL MOL LIFE SCI, V63, P235, DOI 10.1007/s00018-005-5486-4; Herrmann A, 2008, PHYTOCHEMISTRY, V69, P939, DOI 10.1016/j.phytochem.2007.10.023; Hu EP, 2015, INT J CLIN EXP MED, V8, P4059; Huang YH, 2019, TOXICON, V172, P33, DOI 10.1016/j.toxicon.2019.10.244; Huang YH, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00017; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886; Ivanova A, 2002, Z NATURFORSCH C, V57, P624; Jackson MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04669-9; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Koehbach J, 2013, P NATL ACAD SCI USA, V110, P21183, DOI 10.1073/pnas.1311183110; Koehbach J, 2013, BIOPOLYMERS, V100, P438, DOI 10.1002/bip.22328; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lindholm P, 2002, MOL CANCER THER, V1, P365; Mulvenna JP, 2006, NUCLEIC ACIDS RES, V34, pD192, DOI 10.1093/nar/gkj005; Oguis GK, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00645; Park S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091430; Patel D. K., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P316, DOI 10.1016/S2221-1691(11)60051-8; Philippe GJB, 2019, ACS CHEM BIOL, V14, P2071, DOI 10.1021/acschembio.9b00593; Pinto MEF, 2018, J NAT PROD, V81, P1203, DOI 10.1021/acs.jnatprod.7b00969; Plan MRR, 2008, J AGR FOOD CHEM, V56, P5237, DOI 10.1021/jf800302f; Pranting M, 2010, J ANTIMICROB CHEMOTH, V65, P1964, DOI 10.1093/jac/dkq220; Quimbar P, 2013, J BIOL CHEM, V288, P13885, DOI 10.1074/jbc.M113.460030; Ravipati AS, 2015, ACS CHEM BIOL, V10, P2491, DOI 10.1021/acschembio.5b00454; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Sampath B., 2016, THESIS; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Setty M, 2007, F MUELL PHARMACOLOGY, V2, P158; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Skjeldal L, 2002, ARCH BIOCHEM BIOPHYS, V399, P142, DOI 10.1006/abbi.2002.2769; Suman TY, 2016, ENVIRON SCI POLLUT R, V23, P2705, DOI 10.1007/s11356-015-5468-5; Svangard E, 2004, J NAT PROD, V67, P144, DOI 10.1021/np030101l; Svangard E, 2007, J NAT PROD, V70, P643, DOI 10.1021/np070007v; Tang J, 2010, HELV CHIM ACTA, V93, P2287, DOI 10.1002/hlca.201000115; Tang J, 2010, PEPTIDES, V31, P1434, DOI 10.1016/j.peptides.2010.05.004; Thell K, 2014, DRUG DISCOV TODAY, V19, P645, DOI 10.1016/j.drudis.2013.12.002; Tripathy S, 2009, AFR J PHARM PHARMACO, V3, P611; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vuda M, 2012, EXP TOXICOL PATHOL, V64, P855, DOI 10.1016/j.etp.2011.03.006; Wang CK, 2009, BIOPHYS J, V97, P1471, DOI 10.1016/j.bpj.2009.06.032; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	82	17	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					10911	10925		10.1074/jbc.RA120.012627	http://dx.doi.org/10.1074/jbc.RA120.012627			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32414842	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000562757100004
J	Gur-Arie, L; Eitan-Wexler, M; Weinberger, N; Rosenshine, I; Livnah, O				Gur-Arie, Lihi; Eitan-Wexler, Maayan; Weinberger, Nina; Rosenshine, Ilan; Livnah, Oded			The bacterial metalloprotease NleD selectively cleaves mitogen-activated protein kinases that have high flexibility in their activation loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitogen-activated protein kinase (MAPK); extracellular signal-regulated kinase (ERK); p38; Jun N-terminal kinase (JNK); NleD; metalloprotease; effector protein; type III secretion system (T3SS); bacterial pathogen; protein structure; crystallography; bacterial pathogenesis; structural biology; proteolysis	P38 MAP KINASE; KAPPA-B; IMMUNE; BINDING; ACETYLATION; MECHANISM; EFFECTOR; INSIGHTS; INSERT; ERK2	Microbial pathogens often target the host mitogen-activated protein kinase (MAPK) network to suppress host immune responses. We previously identified a bacterial type III secretion system effector, termed NleD, a metalloprotease that inactivates MAPKs by specifically cleaving their activation loop. Here, we show that NleDs form a growing family of virulence factors harbored by human and plant pathogens as well as insect symbionts. These NleDs disable specifically Jun N-terminal kinases (JNKs) and p38s that are required for host immune response, whereas extracellular signal-regulated kinase (ERK), which is essential for host cell viability, remains intact. We investigated the mechanism that makes ERK resistant to NleD cleavage. Biochemical and structural analyses revealed that NleD exclusively targets activation loops with high conformational flexibility. Accordingly, NleD cleaved the flexible loops of JNK and p38 but not the rigid loop of ERK. Our findings elucidate a compelling mechanism of native substrate proteolysis that is promoted by entropy-driven specificity. We propose that such entropy-based selectivity is a general attribute of proteolytic enzymes.	[Gur-Arie, Lihi; Rosenshine, Ilan] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, IMRIC, Fac Med, Edmond J Safra Campus, Jerusalem, Israel; [Eitan-Wexler, Maayan; Weinberger, Nina; Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Alexander Silverman Inst Life Sci, Dept Biol Chem, Edmond J Safra Campus, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rosenshine, I (corresponding author), Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, IMRIC, Fac Med, Edmond J Safra Campus, Jerusalem, Israel.; Livnah, O (corresponding author), Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Alexander Silverman Inst Life Sci, Dept Biol Chem, Edmond J Safra Campus, Jerusalem, Israel.	ilanr@ekmd.huji.ac.il; oded.livnah@huji.ac.il			Israel Science Foundation - Israel Academy of Science and Humanities [617/15, 1422/16]; European Research Council [810186]	Israel Science Foundation - Israel Academy of Science and Humanities; European Research Council(European Research Council (ERC)European Commission)	Work in the I. R. and O. L. laboratories was supported by grants from the Israel Science Foundation, funded by the Israel Academy of Science and Humanities, grants 617/15 and 1422/16, respectively, and in the I. R. laboratory also by a grant from the European Research Council (810186).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Creuzburg K, 2011, APPL ENVIRON MICROB, V77, P8705, DOI 10.1128/AEM.06492-11; Diskin R, 2008, J MOL BIOL, V375, P70, DOI 10.1016/j.jmb.2007.09.002; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Guerin ME, 2018, P NATL ACAD SCI USA, V115, P11525, DOI 10.1073/pnas.1803872115; Hutter D, 2000, BIOCHEM J, V352, P155, DOI 10.1042/0264-6021:3520155; Incardona MF, 2009, J SYNCHROTRON RADIAT, V16, P872, DOI 10.1107/S0909049509036681; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kayode O, 2016, J BIOL CHEM, V291, P26304, DOI 10.1074/jbc.M116.758417; Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021; Kumar GS, 2018, P NATL ACAD SCI USA, V115, P4655, DOI 10.1073/pnas.1721441115; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mooney LM, 2004, J BIOL CHEM, V279, P11843, DOI 10.1074/jbc.M311841200; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pearson JS, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0012-2013; Peti W, 2013, PROTEIN SCI, V22, P1698, DOI 10.1002/pro.2374; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Reddick LE, 2014, MOL CELL, V54, P321, DOI 10.1016/j.molcel.2014.03.010; Salomon D, 2013, CURR OPIN MICROBIOL, V16, P213, DOI 10.1016/j.mib.2013.01.013; Shaw D, 2008, J MOL BIOL, V383, P885, DOI 10.1016/j.jmb.2008.08.086; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stofega MR, 1997, CELL GROWTH DIFFER, V8, P113; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tesker M, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160020; Trosky JE, 2007, J BIOL CHEM, V282, P34299, DOI 10.1074/jbc.M706970200; Tzarum N, 2013, J BIOL CHEM, V288, P19537, DOI 10.1074/jbc.M113.464511; Tzarum N, 2012, J MOL BIOL, V424, P339, DOI 10.1016/j.jmb.2012.10.007; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; WILSON IA, 1991, METHOD ENZYMOL, V203, P153; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690; Zhang YY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203786; Zhu YQ, 2007, MOL CELL, V28, P899, DOI 10.1016/j.molcel.2007.11.011	51	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9409	9420		10.1074/jbc.RA120.013590	http://dx.doi.org/10.1074/jbc.RA120.013590			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32404367	Green Published, hybrid			2022-12-26	WOS:000552758600012
J	Ghazi, IM; El Nekidy, WS; Asay, R; Fingmori, P; Knarr, A; Awad, M				Ghazi, Islam M.; El Nekidy, Wasim S.; Asay, Regan; Fingmori, Paul; Knarr, Anthony; Awad, Mina			Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach	PLOS ONE			English	Article							PHYSICAL COMPATIBILITY; DRUGS	Imipenem/cilastatin/relebactam is a beta-lactam/beta-lactamase inhibitor that has been recently FDA approved for complicated intra-abdominal and urinary tract infections under the brand name Recarbrio (R). It has activity against imipenem non-susceptible Pseudomonas species as well as KPC-producing Enterobacteriaceae. Optimization of PK/PD of antimicrobials particularly in critically-ill patients is essential, but unfortunately, is hindered by separate administration that requires significant resources. The objective of the study is to investigate the compatibility of Y-site administration of imipenem/cilastatin/relebactam with a wide range of antimicrobials. After admixture, physical characteristics, pH changes and turbidity were measured for each 2-drug combination at a time. With the exception of amphotericin B deoxycholate, and posaconazole, imipenem/cilastatin/relebactam was compatible with a variety of antimicrobial agents. The compatibility profile described, will facilitate incorporation into hospital protocols, contribute to therapy optimization and guide clinicians to avoid successive administration, consequently resulting in reduction of total infusion time, optimization of PK/PD, economizing nursing time and cost containment.	[Ghazi, Islam M.; Asay, Regan; Fingmori, Paul; Knarr, Anthony; Awad, Mina] Univ Sci, Philadelphia Coll Pharm, Philadelphia, PA USA; [El Nekidy, Wasim S.] Cleveland Clin Abu Dhabi, Abu Dhabi, U Arab Emirates; [El Nekidy, Wasim S.] Cleveland Clin, Lerner Coll Med, Abu Dhabi, U Arab Emirates	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Ghazi, IM (corresponding author), Univ Sci, Philadelphia Coll Pharm, Philadelphia, PA USA.	i.ghazi@usciences.edu	El Nekidy, Wasim S./I-6814-2019; Ghazi, Islam/X-6108-2019	El Nekidy, Wasim S./0000-0003-3109-0590; Ghazi, Islam/0000-0003-1108-7706	Merck Co USA	Merck Co USA(Merck & Company)	The corresponding author, IG received research grant from Merck & Co USA to support this study. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN LV, 1977, AM J HOSP PHARM, V34, P939, DOI 10.1093/ajhp/34.9.939; [Anonymous], 2019, CLIN INFECT DIS; Canver MC, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00672-19; Ghazi I, 2016, AM J HEALTH-SYST PH, V73, P1769, DOI 10.2146/ajhp150721; Kidd JM, 2018, CLIN THER, V40, P261, DOI 10.1016/j.clinthera.2017.12.007; Newton DW, 2009, AM J HEALTH-SYST PH, V66, P348, DOI 10.2146/ajhp080059; TRISSEL LA, 1992, AM J HOSP PHARM, V49, P1716, DOI 10.1093/ajhp/49.7.1716; Trissel LA, 2004, AM J HEALTH-SYST PH, V61, P2289, DOI 10.1093/ajhp/61.21.2289; Veiga RP, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2155-1; Young K, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1522-7	10	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233335	10.1371/journal.pone.0233335	http://dx.doi.org/10.1371/journal.pone.0233335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421696	gold, Green Published			2022-12-26	WOS:000537499600043
J	Sercinoglu, O; Ozbek, P				Sercinoglu, Onur; Ozbek, Pemra			Sequence-structure-function relationships in class I MHC: A local frustration perspective	PLOS ONE			English	Article							CELL-SURFACE EXPRESSION; HLA-C; AMINO-ACID; RECEPTOR RECOGNITION; EVOLUTIONARY TRACE; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; MOLECULES; BINDING; POLYMORPHISM	Class I Major Histocompatibility Complex (MHC) binds short antigenic peptides with the help of Peptide Loading Complex (PLC), and presents them to T-cell Receptors (TCRs) of cytotoxic T-cells and Killer-cell Immunglobulin-like Receptors (KIRs) of Natural Killer (NK) cells. With more than 10000 alleles, human MHC (Human Leukocyte Antigen, HLA) is the most polymorphic protein in humans. This allelic diversity provides a wide coverage of peptide sequence space, yet does not affect the three-dimensional structure of the complex. Moreover, TCRs mostly interact with HLA in a common diagonal binding mode, and KIR-HLA interaction is allele-dependent. With the aim of establishing a framework for understanding the relationships between polymorphism (sequence), structure (conserved fold) and function (protein interactions) of the human MHC, we performed here a local frustration analysis on pMHC homology models covering 1436 HLA I alleles. An analysis of local frustration profiles indicated that (1) variations in MHC fold are unlikely due to minimally-frustrated and relatively conserved residues within the HLA peptide-binding groove, (2) high frustration patches on HLA helices are either involved in or near interaction sites of MHC with the TCR, KIR, or tapasin of the PLC, and (3) peptide ligands mainly stabilize the F-pocket of HLA binding groove.	[Sercinoglu, Onur] Recep Tayyip Erdogan Univ, Fac Engn, Dept Bioengn, Fener, Rize, Turkey; [Ozbek, Pemra] Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey	Recep Tayyip Erdogan University; Marmara University	Ozbek, P (corresponding author), Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey.	pemra.ozbek@marmara.edu.tr	Serçinoğlu, Onur/AAJ-3390-2021; Serçinoğlu, Onur/AAS-1335-2020; Ozbek, Pemra/A-3594-2016	Serçinoğlu, Onur/0000-0003-1361-8160; Ozbek, Pemra/0000-0002-3043-0015	Marmara University [BAP FEN-A-101018-0526]	Marmara University(Marmara University)	Support from Marmara University BAP FEN-A-101018-0526 to PO is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriata LA, 2012, FEBS LETT, V586, P3330, DOI 10.1016/j.febslet.2012.07.010; Abualrous ET, 2015, EUR J IMMUNOL, V45, P1248, DOI 10.1002/eji.201445307; Abualrous ET, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135421; Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Antunes DA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01210; Apps R, 2015, J IMMUNOL, V194, P3594, DOI 10.4049/jimmunol.1403234; Bahar I, 2017, PROTEIN ACTIONS PRIN; Bastolla U, 2017, CURR OPIN STRUC BIOL, V42, P59, DOI 10.1016/j.sbi.2016.10.020; Beringer DX, 2015, NAT IMMUNOL, V16, P1153, DOI 10.1038/ni.3271; Blees A, 2017, NATURE, V551, P525, DOI 10.1038/nature24627; Boyington JC, 2002, MOL IMMUNOL, V38, P1007, DOI 10.1016/S0161-5890(02)00030-5; Charles A, 2001, MAJOR HISTOCOMPATIBI; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Courtney AH, 2018, TRENDS BIOCHEM SCI, V43, P108, DOI 10.1016/j.tibs.2017.11.008; Crux NB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00832; Davtyan A, 2012, J PHYS CHEM B, V116, P8494, DOI 10.1021/jp212541y; Dean AM, 2002, MOL BIOL EVOL, V19, P1846, DOI 10.1093/oxfordjournals.molbev.a004009; Dendrou CA, 2018, NAT REV IMMUNOL, V18, P325, DOI 10.1038/nri.2017.143; Dib L, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006188; Echave J, 2017, ANNU REV BIOPHYS, V46, P85, DOI 10.1146/annurev-biophys-070816-033819; Echave J, 2016, NAT REV GENET, V17, P109, DOI 10.1038/nrg.2015.18; Echave J, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/2/025002; Espada R, 2017, BIOCH MOL BIOL J, V03, DOI [10.21767/2471-8084.100031, DOI 10.21767/2471-8084.100031]; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Fay JC, 2001, GENETICS, V158, P1227; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Ferreiro DU, 2018, CURR OPIN STRUC BIOL, V48, P68, DOI 10.1016/j.sbi.2017.09.006; Ferreiro DU, 2014, Q REV BIOPHYS, V47, P285, DOI 10.1017/S0033583514000092; Fisette O, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00408; Fisette O, 2016, SCI REP-UK, V6, DOI 10.1038/srep19085; Fleischmann G, 2015, J IMMUNOL, V195, P4503, DOI 10.4049/jimmunol.1501515; Freiberger MI, 2019, P NATL ACAD SCI USA, V116, P4037, DOI 10.1073/pnas.1819859116; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Parra RG, 2016, NUCLEIC ACIDS RES, V44, pW356, DOI 10.1093/nar/gkw304; Gras S, 2016, IMMUNITY, V45, P749, DOI 10.1016/j.immuni.2016.09.007; Hafstrand I, 2019, P NATL ACAD SCI USA, V116, P5055, DOI 10.1073/pnas.1807656116; Haliloglu T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000845; Harjanto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086655; Hein Z, 2014, J CELL SCI, V127, P2885, DOI 10.1242/jcs.145334; Hilton HG, 2017, CELL REP, V19, P1394, DOI 10.1016/j.celrep.2017.04.059; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Ilca FT, 2019, CELL REP, V29, P1621, DOI 10.1016/j.celrep.2019.09.074; Jiang JS, 2017, SCIENCE, V358, P1064, DOI 10.1126/science.aao5154; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kurimoto E, 2013, MOL IMMUNOL, V55, P393, DOI 10.1016/j.molimm.2013.03.014; Kyeong HH, 2018, BIOINFORMATICS, V34, P469, DOI 10.1093/bioinformatics/btx589; La Gruta NL, 2018, NAT REV IMMUNOL, V18, P467, DOI 10.1038/s41577-018-0007-5; Li YL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00123; Liberles DA, 2012, PROTEIN SCI, V21, P769, DOI 10.1002/pro.2071; Liu J, 2011, MAJOR HISTOCOMPATIBI, DOI [10.1002/9780470015902.a0000922.pub2, DOI 10.1002/9780470015902.A0000922.PUB2]; Madabushi S, 2002, J MOL BIOL, V316, P139, DOI 10.1006/jmbi.2001.5327; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Martinez-Borra J, 2012, ADV EXP MED BIOL, V738, P277, DOI 10.1007/978-1-4614-1680-7_16; Meyer D, 2018, IMMUNOGENETICS, V70, P5, DOI 10.1007/s00251-017-1017-3; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Mukherjee S, 2011, P NATL ACAD SCI USA, V108, P20550, DOI 10.1073/pnas.1117024108; Mukherjee S, 2015, IMMUNOL CELL BIOL, V93, P522, DOI 10.1038/icb.2015.3; Mumtaz S, 2017, J MOL GRAPH MODEL, V77, P130, DOI 10.1016/j.jmgm.2017.07.033; Natarajan K, 2019, CRIT REV BIOCHEM MOL, V54, P164, DOI 10.1080/10409238.2019.1610352; NEEFJES JJ, 1988, EUR J IMMUNOL, V18, P801, DOI 10.1002/eji.1830180522; Neisig A, 1998, J IMMUNOL, V160, P171; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Omasits U, 2008, MOL SIMULAT, V34, P781, DOI 10.1080/08927020802256298; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; PARHAM P, 1988, AM J MED, V85, P2, DOI 10.1016/0002-9343(88)90369-5; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Parra RG, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004659; Rangarajan S, 2018, STRUCTURAL BIOLOGY IN IMMUNOLOGY: STRUCTURE/FUNCTION OF NOVEL MOLECULES OF IMMUNOLOGIC IMPORTANCE, P101, DOI 10.1016/B978-0-12-803369-2.00004-8; Rigo MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep18413; Robinson J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006862; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Sercinoglu O, 2018, J BIOMOL STRUCT DYN, V36, P724, DOI 10.1080/07391102.2017.1295884; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Shahmoradi A, 2016, PROTEINS, V84, P841, DOI 10.1002/prot.25034; Shahmoradi A, 2014, J MOL EVOL, V79, P130, DOI 10.1007/s00239-014-9644-x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sibilio L, 2008, J BIOL CHEM, V283, P1267, DOI 10.1074/jbc.M708068200; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Sikosek T, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0419; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Theodossis A, 2013, MOL IMMUNOL, V55, P131, DOI 10.1016/j.molimm.2012.10.012; Thomas C, 2017, SCIENCE, V358, P1060, DOI 10.1126/science.aao6001; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Tripathi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14259; Tripathi S, 2015, J MOL RECOGNIT, V28, P74, DOI 10.1002/jmr.2413; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; van Deutekom HWM, 2015, IMMUNOGENETICS, V67, P425, DOI 10.1007/s00251-015-0849-y; Vandiedonck Claire, 2009, Briefings in Functional Genomics & Proteomics, V8, P379, DOI 10.1093/bfgp/elp010; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; WARBURTON RJ, 1994, HUM IMMUNOL, V39, P261, DOI 10.1016/0198-8859(94)90269-0; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wieczorek M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00292; Wilke CO, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002572; Wilkins AD, 2010, PROTEIN SCI, V19, P1296, DOI 10.1002/pro.406; Wilkins A, 2012, METHODS MOL BIOL, V819, P29, DOI 10.1007/978-1-61779-465-0_3; Winter CC, 1997, J IMMUNOL, V158, P4026; Winter CC, 1997, J IMMUNOL, V142, P142, DOI [10.4049/jimmunol.166.12.7260, DOI 10.4049/JIMMUNOL.166.12.7260]; ZEMMOUR J, 1992, J EXP MED, V176, P937, DOI 10.1084/jem.176.4.937; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0	103	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0232849	10.1371/journal.pone.0232849	http://dx.doi.org/10.1371/journal.pone.0232849			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421728	Green Published, gold, Green Submitted			2022-12-26	WOS:000537499600018
J	Vitku, J; Dluhos, P; Davidson, J; Nikl, M; Andersson, S; Paska, P; Sinkora, J; Hlubucek, P; Stransky, M; Hyben, M; Poliak, M; Feyereisl, J; Rosa, M				Vitku, Jaroslav; Dluhos, Petr; Davidson, Joseph; Nikl, Matej; Andersson, Simon; Paska, Premysl; Sinkora, Jan; Hlubucek, Petr; Stransky, Martin; Hyben, Martin; Poliak, Martin; Feyereisl, Jan; Rosa, Marek			ToyArchitecture: Unsupervised learning of interpretable models of the environment	PLOS ONE			English	Article							ACTIVE INFERENCE	Research in Artificial Intelligence (AI) has focused mostly on two extremes: either on small improvements in narrow AI domains, or on universal theoretical frameworks which are often uncomputable, or lack practical implementations. In this paper we attempt to follow a big picture view while also providing a particular theory and its implementation to present a novel, purposely simple, and interpretable hierarchical architecture. This architecture incorporates the unsupervised learning of a model of the environment, learning the influence of one's own actions, model-based reinforcement learning, hierarchical planning, and symbolic/subsymbolic integration in general. The learned model is stored in the form of hierarchical representations which are increasingly more abstract, but can retain details when needed. We demonstrate the universality of the architecture by testing it on a series of diverse environments ranging from audio/visual compression to discrete and continuous action spaces, to learning disentangled representations.	[Vitku, Jaroslav; Dluhos, Petr; Davidson, Joseph; Nikl, Matej; Andersson, Simon; Paska, Premysl; Sinkora, Jan; Hlubucek, Petr; Stransky, Martin; Hyben, Martin; Poliak, Martin; Feyereisl, Jan; Rosa, Marek] GoodAI Res Sro, Prague, Czech Republic		Vitku, J (corresponding author), GoodAI Res Sro, Prague, Czech Republic.	jaroslav.vitku@goodai.com		Vitku, Jaroslav/0000-0002-8928-4104	GoodAI Research s.r.o.	GoodAI Research s.r.o.	At the time of working on this study and the manuscript, all of the authors were employed by a commercial company: GoodAI Research s.r.o., which was the sole funder of this research. The funder provided support in the form of salaries for all authors, provided the hardware for performing experiments and approved the final decision to publish. The funder did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of the authors are articulated in the `Author Contributions' section.	Adams RA, 2013, BRAIN STRUCT FUNCT, V218, P611, DOI 10.1007/s00429-012-0475-5; Bach J., 2003, P ICCM 5 INT C COGN, V1, P15; Bach J., 2005, REPRESENTATIONS COMP; Bacon PL, 2016, SCH COMPUTER SCI; Bastos AM, 2012, CANONICAL MICROCIRCU; BAUM LE, 1966, ANN MATH STAT, V37, P1554, DOI 10.1214/aoms/1177699147; Bengio Yoshua, 2017, CORR; Besold T. R., 2021, ARXIV171103902, P1; Blouw P, 2016, COGNITIVE SCI, V40, P1128, DOI 10.1111/cogs.12265; Blundell D, 2016, NEW CHILDHOODS, P1; Brodu N, 2011, ADV COMPLEX SYST, V14, P761, DOI 10.1142/S0219525911003347; Canziani A., 2017, ARXIV170602735; Carlson A, 2010, AAAI CONF ARTIF INTE, P1306; Choo X, 2013, P 35 ANN C COGN SCI, P322; Christian Szegedy, 2014, Arxiv, DOI arXiv:1312.6199; Costa R, 2017, P IEEE VIRT REAL ANN, P271, DOI 10.1109/VR.2017.7892281; Deisenroth M. P., 2013, FDN TRENDS ROBOTICS, V2, P1, DOI 10.1561/2300000021; Dietterich TG, 1999, ARXIVCS9905014; Dileep G., 1987, THESIS, V30, P541; Eisenreich B, 2016, CONTROL CONTROLLERS; Feldman J, 2013, COGN NEURODYNAMICS, V7, P1, DOI 10.1007/s11571-012-9219-8; FIKES RE, 1971, ARTIF INTELL, V2, P189, DOI 10.1016/0004-3702(71)90010-5; Fine S, 1998, MACH LEARN, V32, P41, DOI 10.1023/A:1007469218079; Franklin S, 2006, INTEGRATED DESIGN PR, P1; Franz A., 2015, ARTIFICIAL GEN INTEL; Franz A, 2017, LECT NOTES ARTIF INT, V10414, P77, DOI 10.1007/978-3-319-63703-7_8; Friston KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006421; Friston KJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000081; Georgievski I, 2014, ARXIV14037426; Ghallab M, 2016, AUTOMATED PLANNING A; GoodAI, 2019, TORCHSIM; GoodAI, 2019, AUD GEN ON EXP CONT; GoodAI, 2017, BRAIN SIM; GoodAI, 2019, AUD GEN HIER 3 EXP; GoodAI, 2019, ILL VID INF; GoodAI, 2019, AUT NAV AG RAC TRACK; GoodAI, 2019, VID GEN EXP; GoodAI, 2019, OR AUD FIL LAB; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Ha D., 2018, CORR; Harpur GF, 1996, NETWORK-COMP NEURAL, V7, P277, DOI 10.1088/0954-898X/7/2/007; Hart DA, 2008, OPENCOG SOFTWARE FRA; Hassabis D, 2017, NEURON, V95, P245, DOI 10.1016/j.neuron.2017.06.011; Hawkins J, 2006, HIERARCHICAL TEMPORA; Hawkins J, 2017, BIORXIV; Hawkins J, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00023; Hay N, 2018, BEHAV IS EVERYTHING; He K., 2016, CVPR, P770; Hengst B., 2000, GENERATING HIERARCHI, P533, DOI [10.1007/3-540-44533-1_54, DOI 10.1007/3-540-44533-1_54]; Higgins I, 2018, ARXIV170708475; Hinton GE, 1986, DISTRIBUTED REPRESEN; Hutter M., 2010, UNIVERSAL ARTIFICIAL; Hwang J, 2017, 2017 JOINT IEEE INT; Indyk P., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P604, DOI 10.1145/276698.276876; Jo J., 2017, ARXIV; Kautz H, 1996, MOR KAUF R, P374; Kotseruba I, 2017, ARXIV161008602; Kulkarni TD, 2016, ARXIV16040605; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lake BM, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X16001837; Laukien E, 2016, ARXIV160903971; Laukien E., 2017, ORIGINAL EXPT CAR; Laukien E, 2017, AAAI 2017 SPRING S S; Lazaro-Gredilla M, 2016, ARXIV161102252, P1; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Lillicrap T. P., 2014, ARXIV14110247; Lin HW, 2017, ARXIV160808225; Lin HW, 2016, ARXIV PREPRINT ARXIV; LIU Y, 2017, SCIENCE, V356, DOI DOI 10.1126/SCIENCE.AAG2612; Machery E, 2009, OXFORD HDB COMPOSITI; Marblestone A. H., 2016, ARXIV160603813; Mikolajick T, 2015, ANISOTROPIC NANOMATE, P1; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Nagabandi A., 2017, ARXIV170802596; Narendra KS, 2003, INT J ADAPT CONTROL, V17, P87, DOI 10.1002/acs.740; Nivel E, 2013, ARXIV13126764; Nivel E., 2007, TECHNICAL REPORT; Oliver N, 2004, COMPUT VIS IMAGE UND, V96, P163, DOI 10.1016/j.cviu.2004.02.004; OReilly R. C., 2017, ARXIV170904654; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Pezzulo G, 2018, TRENDS COGN SCI, V22, P294, DOI 10.1016/j.tics.2018.01.009; Piekniewski F, 2016, ARXIV160706854; Qiu J, 2019, ARXIV190109002; Rasmus Antti, 2015, ADV NEURAL INFORM PR, P3546, DOI DOI 10.1186/1477-5956-9-S1-S5; Richert M, 2016, FUNDAMENTAL PRINCIPL; Richert M, 2016, ARXIV160806277; Rosa M, 2016, FRAMEWORK SEARCHING; Roy A, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P215, DOI 10.1109/IJCNN.2011.6033224; Sabour S, 2017, ADV NEURAL INFORM PR, P3859; Santoro A, 2017, ADV NEUR IN, V30; Santoro A, 2016, PR MACH LEARN RES, V48; Schmidhuber J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00313; Schwartz-Ziv, 2017, ARXIV170300810; Shastri L, 1990, SIMPLE ASS SYSTEMATI; Socolar Joshua E. S., 2006, P115; Spratling MW, 2017, BRAIN COGNITION, V112, P92, DOI 10.1016/j.bandc.2015.11.003; Su J., 2017, ABS171008864 CORR; Sutton R.S., 1998, INTRO REINFORCEMENT, DOI [10.1109/TNN.1998.712192, DOI 10.1109/TNN.1998.712192]; Tan R, 2014, ARXIV14046255; Thomas J, 2017, 2017 9TH INTERNATIONAL WORKSHOP ON ADVANCED GROUND PENETRATING RADAR (IWAGPR); Wang P., 2007, P 2007 C ADV ART GEN, P75; Wayne G., 2018, UNSUPERVISED PREDICT; WHITEHEAD SD, 1995, ARTIF INTELL, V73, P271, DOI 10.1016/0004-3702(94)00012-P; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; Wissner-Gross AD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.168702; Yao K, 2015, JETL SUMM WORKSH AUG, P1; 2016, ADV MATER SCI ENG, V2016, P1, DOI DOI 10.1007/978-3-319-41649-6	108	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0230432	10.1371/journal.pone.0230432	http://dx.doi.org/10.1371/journal.pone.0230432			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421693	Green Published, gold, Green Submitted			2022-12-26	WOS:000537499600003
J	Pamplona, JD; Souza, MD; Sousa, DMM; de Mesquita, HC; Freitas, CDM; Lins, HA; Torres, SB; Silva, DV				Pamplona, Juliana de Paiva; Souza, Matheus de Freitas; Macedo Sousa, Danielle Marie; de Mesquita, Helida Campos; Melo Freitas, Claudia Daianny; Lins, Hamurabi Anizio; Torres, Salvador Barros; Silva, Daniel Valadao			Seed germination of Bidens subalternans DC. exposed to different environmental factors	PLOS ONE			English	Article							SALINITY STRESS; TEMPERATURE; EMERGENCE; WATER; WEED; THERMOINHIBITION; EXPRESSION; TOLERANCE; RESPONSES; PLANTS	Bidens subalternans DC. is a weed found in several tropical countries such as Brazil. Large number of produced seeds and easy dispersion favor the colonization of agricultural fields by this species. To know the factors that affect the germination of B. subalternans can help to understand its ecology, permitting to develop control strategies. Laboratory experiments were carried out to evaluate how the temperature, photoperiod, burial depth, water deficit, and salt stress affect the seed germination of B. subalternans. The means of the treatments of each experiment were shown in scatter plots with the bars indicating the least significant difference (LSD, p <= 0.05). The results showed a germination percentage above 77% for a wide alternating temperature (15/20 C to 30/35 C night/day). The highest germination and uniformity occurred at 25/30 degrees C night/day. Only 11% of the seeds germinated at a temperature of 35/40 degrees C night/day. The deeper burial of seeds reduced their germination. Only 17% of the seeds germinated in darkness conditions. However, in constant light and 12 hours of light/dark conditions the germination percentage was over 96%, confirming the light dependence of the B. subalternans during germination. In constant light and 12 hours of light/dark, the germination was over 96%. B. subalternans seeds showed sensitivity to water and salt stress, and their germination was inhibited under a water potential of -0.4 MPa and 100.09 mM, respectively. The sensitivity of B. subalternans seeds to high temperatures, water stress, and salt stress explains the high frequency of this weed in south-central Brazil. The light and sowing depth showed that burial of seeds by mechanical control is a strategy to reduce the high infestation of B. subalternans.	[Pamplona, Juliana de Paiva; Souza, Matheus de Freitas; Macedo Sousa, Danielle Marie; Melo Freitas, Claudia Daianny; Lins, Hamurabi Anizio; Torres, Salvador Barros; Silva, Daniel Valadao] Univ Fed Rural Semi Arido, Dept Agron & Forest Sci, Mossoro, RN, Brazil; [de Mesquita, Helida Campos] Inst Fed Educ Ciencia & Tecnol Rio Grande do Nort, Dept Agron, Apodi, RN, Brazil	Universidade Federal Rural do Semi-Arido (UFERSA); Instituto Federal do Rio Grande do Norte	Lins, HA (corresponding author), Univ Fed Rural Semi Arido, Dept Agron & Forest Sci, Mossoro, RN, Brazil.	hamurabi_a_@hotmail.com	Lins, Hamurábi Anizio/W-3435-2019; sousa, matheus/GXF-4908-2022; de Freitas Souza, Matheus/GSE-3639-2022	Lins, Hamurábi Anizio/0000-0002-4548-9108; Barros Torres, Salvador/0000-0003-0668-3327; de Freitas Souza, Matheus/0000-0002-5424-6028	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Brazil (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The author Juliana de Paiva Pamplona (JPP) received a scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES) -Finance Code 001. The study was also supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Brazil (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Gawad A.M., 2015, EGYPT J BASIC APPL S, V2, P303, DOI [10.1016/j.ejbas.2015.07.003, DOI 10.1016/J.EJBAS.2015.07.003]; Argyris J, 2008, PLANT PHYSIOL, V148, P926, DOI 10.1104/pp.108.125807; Asgarpour R, 2015, WEED SCI, V63, P502, DOI 10.1614/WS-D-14-00162.1; Batlla D, 2014, WEED BIOL MANAG, V14, P77, DOI 10.1111/wbm.12039; Bhullar MS, 2015, CROP PROT, V67, P68; Bogosavljevic Stefan S., 2015, Phytologia Balcanica, V21, P129; Colbach N, 2014, SOIL TILL RES, V138, P1, DOI 10.1016/j.still.2013.12.002; Correia NM, 2015, LEVANTAMENTO FITOSSO; Deiss L, 2017, PLANTA DANINHA, V35, DOI [10.1590/s0100-83582017350100070, 10.1590/S0100-83582017350100070]; Derakhshan A, 2014, WEED SCI, V62, P250, DOI 10.1614/WS-D-13-00055.1; dos Reis AR, 2011, SOYBEAN APPL TECHNOL; Fahad S, 2015, PLANT GROWTH REGUL, V75, P391, DOI 10.1007/s10725-014-0013-y; Fuentes N, 2013, BIOL INVASIONS, V15, P847, DOI 10.1007/s10530-012-0334-6; Grombone-Guaratini MT, 2005, BIOCHEM SYST ECOL, V33, P479, DOI 10.1016/j.bse.2004.11.005; Grundy AC, 2003, WEED RES, V43, P163, DOI 10.1046/j.1365-3180.2003.00330.x; Hu XW, 2015, AM J BOT, V102, P649, DOI 10.3732/ajb.1400507; Huo H., 2015, ADV PLANT DORMANCY, DOI DOI 10.1007/978-3-319-14451-1_1; Huo HQ, 2013, PLANT CELL, V25, P884, DOI 10.1105/tpc.112.108902; Ibrahim EA, 2016, J PLANT PHYSIOL, V192, P38, DOI 10.1016/j.jplph.2015.12.011; Kissmann CG, 1997, BIDENS PILOSA L BIDE; Lamego FP, 2009, WEED RES, V49, P634, DOI 10.1111/j.1365-3180.2009.00734.x; Legris M, 2017, PLANT J, V90, P683, DOI 10.1111/tpj.13467; Liu SJ, 2015, PHYSIOL PLANTARUM, V154, P142, DOI 10.1111/ppl.12292; Lu P, 2006, WEED SCI, V54, P452, DOI 10.1614/WS-05-174R1.1; Machado HO, 2015, PLANTA DANINHA, V33, P57, DOI 10.1590/S0100-83582015000100007; Mahmood AH, 2016, WEED SCI, V64, P486, DOI 10.1614/WS-D-15-00184.1; Menge EO, 2016, AUST J BOT, V64, P441, DOI 10.1071/BT16044; Miransari M, 2014, ENVIRON EXP BOT, V99, P110, DOI 10.1016/j.envexpbot.2013.11.005; Mohler CL, 2016, WEED SCI, V64, P285, DOI 10.1614/WS-D-15-00130.1; Munns R, 2003, PLANT SOIL, V253, P201, DOI 10.1023/A:1024553303144; da Silva DMN, 2016, BIOSCI J, V32, P11, DOI 10.14393/BJ-v32n1a2016-26241; Nosratti I, 2018, WEED SCI, V66, P71, DOI 10.1017/wsc.2017.35; Parihar P, 2015, ENVIRON SCI POLLUT R, V22, P4056, DOI 10.1007/s11356-014-3739-1; Ramirez AHM, 2012, WEED SCI, V60, P374, DOI 10.1614/WS-D-11-00167.1; Randall R. P., 2007, INTRO FLORA AUSTR IT; Santos A. S. dos, 2015, African Journal of Agricultural Research, V10, P4215; Santos G, 2014, PLANTA DANINHA, V32, P409, DOI 10.1590/S0100-83582014000200019; Santos JB, 2011, PLANTA DANINHA, V29, P1159, DOI 10.1590/S0100-83582011000500024; Santos WF, 2018, ACTA SCI-AGRON, V40, DOI 10.4025/actasciagron.v40i1.33049; Savaris M, 2015, REV BRAS ENTOMOL, V59, P14, DOI 10.1016/j.rbe.2014.11.002; Tanveer A, 2015, CROP PROT, V68, P49, DOI 10.1016/j.cropro.2014.11.005; Wang LF, 2016, WEED TECHNOL, V30, P533, DOI 10.1614/WT-D-15-00043; Xu HL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178638	43	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233228	10.1371/journal.pone.0233228	http://dx.doi.org/10.1371/journal.pone.0233228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407422	Green Published, gold			2022-12-26	WOS:000537490700085
J	Kweon, OJ; Lim, YK; Kim, HR; Kim, TH; Ha, SM; Lee, MK				Kweon, Oh Joo; Lim, Yong Kwan; Kim, Hye Ryoun; Kim, Tae-Hyoung; Ha, Sung-min; Lee, Mi-Kyung			Isolation of a novel species in the genus Cupriavidus from a patient with sepsis using whole genome sequencing	PLOS ONE			English	Article							1ST CASE-REPORT; GILARDII; NOV.; ALGORITHM; PAUCULUS; CHILD	Whole genome sequencing (WGS) has become an accessible tool in clinical microbiology, and it allowed us to identify a novel Cupriavidus species. We isolated Gram-negative bacillus from the blood of an immunocompromised patient, and phenotypical and molecular identifications were performed. Phenotypic identification discrepancies were noted between the Vitek 2 (bioMerieux, Marcy-l'Etoile, France) and Vitek MS systems (bioMerieux). Using 16S rRNA gene sequencing, it was impossible to identify the pathogen to the species levels. WGS was performed using the Illumina MiSeq platform (Illumina, San Diego, CA), and genomic sequence database searching with a TrueBac (TM) ID-Genome system (ChunLab, Inc., Seoul, Republic of Korea) showed no strains with average nucleotide identity values higher than 95.0%, which is the cut-off for species-level identification. Phylogenetic analysis indicated that the bacteria was a new Cupriavidus species that formed a subcluster with Cupriavidus gilardii. WGS holds great promise for accurate molecular identification beyond 16S rRNA gene sequencing in clinical microbiology.	[Kweon, Oh Joo; Lim, Yong Kwan; Kim, Hye Ryoun; Lee, Mi-Kyung] Chung Ang Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Kim, Tae-Hyoung] Chung Ang Univ, Coll Med, Dept Urol, Seoul, South Korea; [Ha, Sung-min] ChunLab Inc, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Lee, MK (corresponding author), Chung Ang Univ, Coll Med, Dept Lab Med, Seoul, South Korea.	cpworld@cau.ac.kr	Lim, Yong Kwan/AAD-9243-2022	Kweon, Oh Joo/0000-0003-4751-7384; Lim, Yong Kwan/0000-0002-4300-8964; Ha, Sung-min/0000-0003-3945-8329				[Anonymous], 2018, CLSI GUIDELINE MM18; [Anonymous], 2016, REC MIC DET COL POL; Chun J, 2018, INT J SYST EVOL MICR, V68, P461, DOI [10.1099/ijsem.0.002532, 10.1099/ijsem.0.002516]; CLSI, 2018, M100 CLSI; Cuadrado V, 2010, INT J SYST EVOL MICR, V60, P2606, DOI 10.1099/ijs.0.018341-0; Duggal S, 2013, INDIAN J MED MICROBI, V31, P405, DOI 10.4103/0255-0857.118871; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ha SM, 2019, ANN LAB MED, V39, P530, DOI 10.3343/alm.2019.39.6.530; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Karafin M, 2010, J CLIN MICROBIOL, V48, P1005, DOI 10.1128/JCM.01482-09; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Kobayashi T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1838-y; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Langevin S, 2011, J CLIN MICROBIOL, V49, P744, DOI 10.1128/JCM.01947-10; Lee I, 2017, INT J SYST EVOL MICR, V67, P2053, DOI 10.1099/ijsem.0.001872; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; Liu B, 2014, REV SOC BRAS MED TRO, V47, P451, DOI 10.1590/0037-8682-0081-2014; LPSN, 2019, LIST PROKARYOTIC NAM; MAKKAR NS, 1987, INT J SYST BACTERIOL, V37, P323, DOI 10.1099/00207713-37-4-323; Neuert S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00592; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Sadouki Z, 2017, J ANTIMICROB CHEMOTH, V72, P2496, DOI 10.1093/jac/dkx170; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sohpal Vipan Kumar, 2010, Int J Bioinform Res Appl, V6, P230, DOI 10.1504/IJBRA.2010.034072; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sun LN, 2016, INT J SYST EVOL MICR, V66, P2335, DOI 10.1099/ijsem.0.001034; Tena D, 2014, DIAGN MICR INFEC DIS, V79, P108, DOI 10.1016/j.diagmicrobio.2014.01.023; Vaneechoutte M, 2004, INT J SYST EVOL MICR, V54, P317, DOI 10.1099/ijs.0.02754-0; Wauters G, 2001, J CLIN MICROBIOL, V39, P4583, DOI 10.1128/JCM.39.12.4583-4584.2001; Wilcox MH, 2009, CLIN INFECT DIS, V48, P203, DOI 10.1086/595686; Yahya R, 2017, J INFECT DEV COUNTR, V11, P196, DOI 10.3855/jidc.8349; Yoon SH, 2017, ANTON LEEUW INT J G, V110, P1281, DOI 10.1007/s10482-017-0844-4; Zhang Z, 2017, IDCases, V10, P127, DOI 10.1016/j.idcr.2017.10.009	36	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232850	10.1371/journal.pone.0232850	http://dx.doi.org/10.1371/journal.pone.0232850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401765	gold, Green Published			2022-12-26	WOS:000537481000034
J	Soo, JY; Wiese, MD; Dyson, RM; Gray, CL; Clarkson, AN; Morrison, JL; Berry, MJ				Soo, Jia Yin; Wiese, Michael D.; Dyson, Rebecca M.; Gray, Clint L.; Clarkson, Andrew N.; Morrison, Janna L.; Berry, Mary J.			Methamphetamine administration increases hepatic CYP1A2 but not CYP3A activity in female guinea pigs	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE 2; PREGNANE X-RECEPTOR; P-GLYCOPROTEIN; CYTOCHROME-P450 ENZYMES; EXPRESSION; PHARMACOKINETICS; SEX; PHARMACOLOGY; METABOLISM; KNOCKDOWN	Methamphetamine use has increased over the past decade and the first use of methamphetamine is most often when women are of reproductive age. Methamphetamine accumulates in the liver; however, little is known about the effect of methamphetamine use on hepatic drug metabolism. Methamphetamine was administered on 3 occassions to female Dunkin Hartley guinea pigs of reproductive age, mimicking recreational drug use. Low doses of test drugs caffeine and midazolam were administered after the third dose of methamphetamine to assess the functional activity of cytochrome P450 1A2 and 3A, respectively. Real-time quantitative polymerase chain reaction was used to quantify the mRNA expression of factors involved in glucocorticoid signalling, inflammation, oxidative stress and drug transporters. This study showed that methamphetamine administration decreased hepatic CYP1A2 mRNA expression, but increased CYP1A2 enzyme activity. Methamphetamine had no effect on CYP3A enzyme activity. In addition, we found that methamphetamine may also result in changes in glucocorticoid bioavailability, as we found a decrease in 11 beta-hydroxysteroid dehydrogenase 1 mRNA expression, which converts inactive cortisone into active cortisol. This study has shown that methamphetamine administration has the potential to alter drug metabolism via the CYP1A2 metabolic pathway in female guinea pigs. This may have clinical implications for drug dosing in female methamphetamine users of reproductive age.	[Soo, Jia Yin; Morrison, Janna L.] Univ South Australia, Early Origins Adult Hlth Res Grp, Adelaide, SA, Australia; [Soo, Jia Yin; Wiese, Michael D.; Morrison, Janna L.] Univ South Australia, Hlth & Biomed Innovat, Adelaide, SA, Australia; [Dyson, Rebecca M.; Gray, Clint L.; Berry, Mary J.] Univ Otago, Brain Hlth Res Ctr, Dept Paediat & Child Hlth, Dunedin, New Zealand; [Dyson, Rebecca M.; Gray, Clint L.; Clarkson, Andrew N.; Berry, Mary J.] Univ Otago, Brain Res New Zealand, Dunedin, New Zealand; [Clarkson, Andrew N.] Univ Otago, Brain Hlth Res Ctr, Dept Anat, Dunedin, New Zealand	University of South Australia; University of South Australia; University of Otago; University of Otago; University of Otago	Morrison, JL (corresponding author), Univ South Australia, Early Origins Adult Hlth Res Grp, Adelaide, SA, Australia.; Morrison, JL (corresponding author), Univ South Australia, Hlth & Biomed Innovat, Adelaide, SA, Australia.; Berry, MJ (corresponding author), Univ Otago, Brain Hlth Res Ctr, Dept Paediat & Child Hlth, Dunedin, New Zealand.; Berry, MJ (corresponding author), Univ Otago, Brain Res New Zealand, Dunedin, New Zealand.	Janna.Morrison@unisa.edu.au; max.berry@otago.ac.nz	Morrison, Janna/B-8308-2009; Wiese, Michael/A-4743-2011	Morrison, Janna/0000-0002-8602-8519; Wiese, Michael/0000-0002-3255-9242	Australian Government Research Training Program (RTP) scholarship; University of Otago Health Sciences Career Development Postdoctoral Fellowship; NHMRC Career Development Fellowship [APP1066916]; ARC Future Fellowship [FT170100431]; Otago Medical School Collaborative Grant	Australian Government Research Training Program (RTP) scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); University of Otago Health Sciences Career Development Postdoctoral Fellowship; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ARC Future Fellowship(Australian Research Council); Otago Medical School Collaborative Grant	JYS was funded by an Australian Government Research Training Program (RTP) scholarship. RMD was funded by a University of Otago Health Sciences Career Development Postdoctoral Fellowship. JLM was funded by a NHMRC Career Development Fellowship (APP1066916) and an ARC Future Fellowship (Level 3; FT170100431). The animal component of the work was funded by an Otago Medical School Collaborative Grant to ANC and MJB.	Acevedo SF, 2008, J NEUROCHEM, V107, P976, DOI 10.1111/j.1471-4159.2008.05673.x; Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; Asanuma M, 1998, MOL BRAIN RES, V60, P305, DOI 10.1016/S0169-328X(98)00188-0; Australian Medicines Handbook Pty Ltd, 2018, AMH AUSTR MED HDB; Bade R, 2018, ANAL BIOANAL CHEM, V410, P529, DOI 10.1007/s00216-017-0747-2; Bosilkovska M, 2014, CLIN PHARMACOL THER, V96, P349, DOI 10.1038/clpt.2014.83; BURCHFIELD DJ, 1991, JAMA-J AM MED ASSOC, V265, P1968, DOI 10.1001/jama.265.15.1968; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Check Hayden E., 2010, SEX BIAS BLIGHTS DRU; Cheney K, 2016, AUST NZ J OBSTET GYN, V56, P426, DOI 10.1111/ajo.12466; Cruickshank CC, 2009, ADDICTION, V104, P1085, DOI 10.1111/j.1360-0443.2009.02564.x; de la Torre R, 2004, THER DRUG MONIT, V26, P137, DOI 10.1097/00007691-200404000-00009; Degenhardt L, 2008, DRUG ALCOHOL REV, V27, P243, DOI 10.1080/09595230801950572; Degenhardt L, 2016, MED J AUSTRALIA, V204, DOI 10.5694/mja15.00671; Dluzen DE, 2003, NEUROENDOCRINOLOGY, V77, P232, DOI 10.1159/000070278; Dostalek M, 2005, EUR J DRUG METAB PH, V30, P195, DOI 10.1007/BF03190620; Dvorak Z, 2010, DRUG METAB REV, V42, P621, DOI 10.3109/03602532.2010.484462; El-Sankary W, 2000, DRUG METAB DISPOS, V28, P493; Garcia-Bournissen F, 2007, ARCH DIS CHILD-FETAL, V92, P351, DOI 10.1136/adc.2006.100156; Grov C, 2009, SUBST USE MISUSE, V44, P848, DOI 10.1080/10826080802484702; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hohmann-Marriott BE, 2018, AUST NZ J OBSTET GYN, V58, P247, DOI 10.1111/ajo.12732; Ieiri I, 2013, J CLIN PHARMACOL, V53, P654, DOI 10.1002/jcph.62; Kabbaj M, 2003, MOL BRAIN RES, V117, P8, DOI 10.1016/S0169-328X(03)00257-2; Kaye S, 2008, ADDICTION, V103, P1353, DOI 10.1111/j.1360-0443.2008.02231.x; Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li R, 2014, CLIN PHARMACOKINET, V53, P659, DOI 10.1007/s40262-014-0156-z; Loftis JM, 2011, NEUROTOX RES, V20, P59, DOI 10.1007/s12640-010-9223-x; McGillick EV, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.130; McIntyre I, 2011, J FORENSIC RES, V2, P2; McKetin R, 2006, DRUG ALCOHOL DEPEN, V85, P198, DOI 10.1016/j.drugalcdep.2006.04.007; Pascussi JM, 2000, MOL PHARMACOL, V58, P361, DOI 10.1124/mol.58.2.361; Robson MJ, 2013, EXP NEUROL, V247, P134, DOI 10.1016/j.expneurol.2013.04.009; Sachar M, 2019, AAPS J, V21, DOI 10.1208/s12248-019-0316-z; Soldin OP, 2011, BIOMED RES INT, V2011; Soo PS, 2012, REPROD TOXICOL, V33, P374, DOI 10.1016/j.reprotox.2012.01.013; Substance Abuse and Mental Health Services Administration, 2013, RES 2012 NAT SURV DR; Terplan M, 2009, OBSTET GYNECOL, V113, P1285, DOI 10.1097/AOG.0b013e3181a5ec6f; Tomita M, 2013, MOL MED REP, V7, P1786, DOI 10.3892/mmr.2013.1408; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Volkow ND, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015269; Vrzal R, 2009, CHEM-BIOL INTERACT, V179, P288, DOI 10.1016/j.cbi.2008.10.035; WAGNER GC, 1979, DRUG ALCOHOL DEPEN, V4, P435, DOI 10.1016/0376-8716(79)90076-0; Watanabe K, 2007, LIFE SCI, V80, P1415, DOI 10.1016/j.lfs.2006.12.032; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1; Wilkins C, 2008, NZ MED J, V121; Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393; Yoshikawa Y, 2009, TOXICOLOGY, V264, P89, DOI 10.1016/j.tox.2009.07.017; Yoshikawa Y, 2009, TOXICOL IN VITRO, V23, P1179, DOI 10.1016/j.tiv.2009.05.024; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007; Zuloaga DG, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00178	56	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0233010	10.1371/journal.pone.0233010	http://dx.doi.org/10.1371/journal.pone.0233010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0SY	32396581	Green Published, Green Accepted, gold			2022-12-26	WOS:000537475000034
J	Ahmed, LA; Hassan, OF; Galal, O; Mansour, DF; El-Khatib, A				Ahmed, Lamiaa A.; Hassan, Omnia F.; Galal, Omneya; Mansour, Dina F.; El-Khatib, Aiman			Beneficial effects of benfotiamine, a NADPH oxidase inhibitor, in isoproterenol-induced myocardial infarction in rats	PLOS ONE			English	Article							HEART-FAILURE; INDUCED CARDIOTOXICITY; OXIDATIVE STRESS; LIPID PEROXIDES; DYSFUNCTION; ANTIOXIDANTS; APOPTOSIS; ANALOG; DAMAGE	Background Acute myocardial infarction (AMI) remains the most common cause of morbidity and mortality worldwide. The present study was directed to investigate the beneficial effects of benfotiamine pre- and post-treatments in isoproterenol (ISO)-induced MI in rats. Methods Myocardial heart damage was induced by subcutaneous injection of ISO (150 mg/kg) once daily for two consecutive days. Benfotiamine (100 mg/kg/day) was given orally for two weeks before or after ISO treatment. Results ISO administration revealed significant changes in electrocardiographic recordings, elevation of levels of cardiac enzymes; creatinine kinase (CK-MB) and troponin-I (cTn-I), and perturbation of markers of oxidative stress; nicotinamide adenine dinucleotide phosphate ( NADPH) oxidase, malondialdehyde (MDA), reduced glutathione (GSH), superoxide dismutase (SOD) and glutathione peroxidase (GPx) and markers of inflammation; protein kinase C (PKC), nuclear factor-kappa B (NF-kappa B) and metalloproteinase-9 (MMP-9). The apoptotic markers (caspase-8 and p53) were also significantly elevated in ISO groups in addition to histological alterations. Groups treated with benfotiamine pre- and post-ISO administration showed significantly decreased cardiac enzymes levels and improved oxidative stress, inflammatory and apoptotic markers compared to the ISO groups. Conclusion The current study highlights the potential role of benfotiamine as a promising agent for prophylactic and therapeutic interventions in myocardial damage in several cardiovascular disorders via NADPH oxidase inhibition.	[Ahmed, Lamiaa A.; El-Khatib, Aiman] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Giza, Egypt; [Hassan, Omnia F.] MSA Univ, Fac Pharm, Dept Pharmacol & Toxicol, 6th Of October City, Egypt; [Galal, Omneya] Ahram Canadian Univ, Fac Pharm, Dept Pharmacol & Toxicol, 6th Of October City, Egypt; [Mansour, Dina F.] Natl Res Ctr, Med Res Div, Dept Pharmacol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Modern Sciences & Arts University (MSA); Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Ahmed, LA (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Giza, Egypt.	lamiaa.ahmed@pharma.cu.edu.eg						Attalla DM, 2018, BIOMED PHARMACOTHER, V104, P542, DOI 10.1016/j.biopha.2018.05.005; Balakumar P, 2010, PHARM RES; Beltramo E, 2009, DIABETES-METAB RES, V25, P647, DOI 10.1002/dmrr.1008; Bozic I, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00351; Ceylan-Isik AF, 2006, J APPL PHYSIOL, V100, P150, DOI 10.1152/japplphysiol.00988.2005; Cheng YS, 2009, ACTA PHARMACOL SIN, V30, P1099, DOI 10.1038/aps.2009.104; Choudhary R, 2006, INDIAN J CLIN BIOCHE, V21, P107, DOI 10.1007/BF02912923; de Ponte MC, 2017, KIDNEY BLOOD PRESS R, V42, P1277, DOI 10.1159/000485931; Di Lisa F, 2011, BRIT J PHARMACOL, V162, P1009, DOI 10.1111/j.1476-5381.2010.01130.x; Du H, 2015, INT J CLIN EXP MED, V8, P8854; El-Sawalhi MM, 2014, CHEM-BIOL INTERACT, V207, P58, DOI 10.1016/j.cbi.2013.11.008; Fan HY, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/508938; Fraser DA, 2012, GENES NUTR, V7, P459, DOI 10.1007/s12263-011-0252-8; GARSON K, 2010, J AFRICAN ASS PHYSL, V2, P5; Gomes AC, 2013, HEART FAIL REV, V18, P219, DOI 10.1007/s10741-012-9305-3; Goyal SN, 2015, INT J MOL SCI, V16, P27457, DOI 10.3390/ijms161126040; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; Harisa GI, 2013, J BIOCHEM MOL TOXIC, V27, P398, DOI 10.1002/jbt.21501; Hassan Md Quamrul, 2016, Ther Adv Cardiovasc Dis, V10, P214, DOI 10.1177/1753944716630653; Hemalatha KL, 2015, J BIOCHEM MOL TOXIC, V29, P63, DOI 10.1002/jbt.21668; Huang HB, 2018, IRAN J BASIC MED SCI, V21, P267, DOI 10.22038/ijbms.2018.26110.6415; Hussain S., 2014, THESIS DEPT PHARM; Kadian Gupta, 2016, EFFECT BENFOTIAMINE; Kadry MO, 2018, CARDIOVASC TOXICOL, V18, P232, DOI 10.1007/s12012-017-9432-0; Karthick M, 2006, J PHARM PHARMACOL, V58, P701, DOI 10.1211/jpp.58.5.0016; Katare RG, 2010, CIRC-HEART FAIL, V3, P294, DOI 10.1161/CIRCHEARTFAILURE.109.903450; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Kloner RA, 2015, J AM COLL CARDIOL, V65, P324, DOI 10.1016/j.jacc.2014.11.006; Kumar G. K., 2017, Indian Veterinary Journal, V94, P41; Li AY, 2019, BIOMED PHARMACOTHER, V110, P733, DOI 10.1016/j.biopha.2018.12.029; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048872; Lobo HG, 2011, REV BRAS CIR CARDIOV, V26, P469, DOI 10.5935/1678-9741.20110024; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mapanga R, 2012, FASEB J, V26, P1136, DOI [10.1096/fasebj.26.1_supplement.1136.14, DOI 10.1096/FASEBJ.26.1_SUPPLEMENT.1136.14]; Matsui H, 2006, HYPERTENSION, V48, P225, DOI 10.1161/01.HYP.0000232617.48372.cb; Meeran MFN, 2016, CHEM-BIOL INTERACT, V251, P17, DOI 10.1016/j.cbi.2016.03.017; Metias EF, 2016, BIOCH PHYSL OPEN ACC, V05; Moradi-Arzeloo M, 2016, VET RES FORUM, V7, P47; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Ong SB, 2018, PHARMACOL THERAPEUT, V186, P73, DOI 10.1016/j.pharmthera.2018.01.001; Othman AI, 2017, EUR J PHARMACOL, V794, P27, DOI 10.1016/j.ejphar.2016.11.014; Prince PSM, 2013, INT J CARDIOL, V168, P3259, DOI 10.1016/j.ijcard.2013.04.138; Raj V, 2018, EUR REV MED PHARMACO, V22, P3261, DOI 10.26355/eurrev_201805_15089; Sah D. K., 2016, INT J PHARM RES, V6, P23; Siddiqui M.A., 2016, INT J PHARMACEUT, V6, P138; Verma S. C., 2010, Indian Fern Journal, V27; Xu Q, 2011, BRIT J PHARMACOL, V162, P1012, DOI 10.1111/j.1476-5381.2010.01043.x; Yadav UCS, 2009, INVEST OPHTH VIS SCI, V50, P2276, DOI 10.1167/iovs.08-2816; Zaafan M. A., 2013, Bulletin of the Faculty of Pharmacy, Cairo University, V51, P35, DOI 10.1016/j.bfopcu.2013.03.001; Zhang H, 2019, JACC-CARDIOVASC INTE, V12, P274, DOI 10.1016/j.jcin.2018.09.021	50	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232413	10.1371/journal.pone.0232413	http://dx.doi.org/10.1371/journal.pone.0232413			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384080	Green Published, gold			2022-12-26	WOS:000537468300013
J	Budge, S; Barnett, M; Hutchings, P; Parker, A; Tyrrel, S; Hassard, F; Garbutt, C; Moges, M; Woldemedhin, F; Jemal, M				Budge, Sophie; Barnett, Megan; Hutchings, Paul; Parker, Alison; Tyrrel, Sean; Hassard, Francis; Garbutt, Camila; Moges, Mathewos; Woldemedhin, Fitsume; Jemal, Mohammedyasin			Risk factors and transmission pathways associated with infant Campylobacter spp. prevalence and malnutrition: A formative study in rural Ethiopia	PLOS ONE			English	Article							ENVIRONMENTAL ENTEROPATHY; FECAL CONTAMINATION; YOUNG-CHILDREN; DIARRHEAL DISEASES; ANIMAL FECES; NUTRITIONAL INTERVENTIONS; SYSTEMATIC ANALYSIS; WATER-QUALITY; GROWTH; INFECTION	Early infection from enteropathogens is recognised as both a cause and effect of infant malnutrition. Specifically, evidence demonstrates associations between growth shortfalls and Campylobacter infection, endemic across low-income settings, with poultry a major source. Whilst improvements in water, sanitation and hygiene (WASH) should reduce pathogen transmission, interventions show inconsistent effects on infant health. This cross-sectional, formative study aimed to understand relationships between infant Campylobacter prevalence, malnutrition and associated risk factors, including domestic animal husbandry practices, in rural Ethiopia. Thirty-five households were visited in Sidama zone, Southern Nations, Nationalities and Peoples' region. Infant and poultry faeces and domestic floor surfaces (total = 102) were analysed for presumptive Campylobacter spp. using selective culture. Infant anthropometry and diarrhoeal prevalence, WASH facilities and animal husbandry data were collected. Of the infants, 14.3% were wasted, 31.4% stunted and 31.4% had recent diarrhoea. Presumptive Campylobacter spp. was isolated from 48.6% of infant, 68.6% of poultry and 65.6% of floor surface samples. Compared to non-wasted infants, wasted infants had an increased odds ratio (OR) of 1.41 for a Campylobacter-positive stool and 1.81 for diarrhoea. Positive infant stools showed a significant relationship with wasting (p = 0.026) but not stunting. Significant risk factors for a positive stool included keeping animals inside (p = 0.027, OR 3.5), owning cattle (p = 0.018, OR 6.5) and positive poultry faeces (p<0.001, OR 1.34). Positive floor samples showed a significant correlation with positive infant (p = 0.023), and positive poultry (p = 0.013, OR 2.68) stools. Ownership of improved WASH facilities was not correlated with lower odds of positive stools. This formative study shows a high prevalence of infants positive for Campylobacter in households with free-range animals. Findings reaffirm contaminated floors as an important pathway to infant pathogen ingestion and suggest that simply upgrading household WASH facilities will not reduce infection without addressing the burden of contamination from animals, alongside adequate separation in the home.	[Budge, Sophie; Hutchings, Paul; Parker, Alison; Tyrrel, Sean; Hassard, Francis] Cranfield Univ, Cranfield, Beds, England; [Barnett, Megan] British Geol Survey, Environm Sci Ctr, Nottingham, England; [Garbutt, Camila] People Need UK, London, England; [Moges, Mathewos] Hawassa Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Hawassa, Ethiopia; [Woldemedhin, Fitsume; Jemal, Mohammedyasin] People Need, Hawassa, Ethiopia	Cranfield University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Hawassa University	Parker, A (corresponding author), Cranfield Univ, Cranfield, Beds, England.	a.parker@cranfield.ac.uk	Barnett, Megan/GYU-0888-2022; Hassard, Francis/GSE-1754-2022	Parker, Alison/0000-0001-7370-6758; Budge, Sophie/0000-0001-9587-2132; Hassard, Francis/0000-0003-4803-6523; Hutchings, Paul/0000-0002-7758-4644	People in Need; Cranfield University; GCRF QR grant; NERC [bgs06001] Funding Source: UKRI	People in Need; Cranfield University; GCRF QR grant; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	SB is funded as a research student by People in Need and Cranfield University. CG, FW and MJ from People in Need advised on the practicalities of study design, helped with data collection and reviewed the manuscript. Project consumables and travel were funded by a GCRF QR grant awarded to Cranfield University.	Ahmed T, 2014, ANN NY ACAD SCI, V1332, P22, DOI 10.1111/nyas.12487; Amour C, 2016, CLIN INFECT DIS, V63, P1171, DOI 10.1093/cid/ciw542; Baker KK, 2018, ENVIRON SCI TECHNOL, V52, P10263, DOI 10.1021/acs.est.8b01528; BAQUI AH, 1991, INT J EPIDEMIOL, V20, P1057, DOI 10.1093/ije/20.4.1057; Bensersa-Nedjar D, 2017, EVALUATION COMP 3 MI; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Budge S, 2019, J WATER HEALTH, V17, P655, DOI 10.2166/wh.2019.224; Budge S, 2019, NUTR REV, V77, P240, DOI 10.1093/nutrit/nuy068; Buss JE, 2019, EUR J CLIN MICROBIOL, V38, P1087, DOI 10.1007/s10096-019-03499-x; CALVA JJ, 1988, LANCET, V1, P503; Cameron L, 2019, J DEV ECON, V138, P1, DOI 10.1016/j.jdeveco.2018.12.001; Central Statistical Agency-CSA/Ethiopia I, 2016, ETH DEM HLTH SURV DH, DOI [10.2147/ahmt.s148434, DOI 10.2147/AHMT.S148434]; Checkley W, 1998, AM J EPIDEMIOL, V148, P497, DOI 10.1093/oxfordjournals.aje.a009675; Chen ML, 2006, INFECT IMMUN, V74, P6581, DOI 10.1128/IAI.00958-06; Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Danaei G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002164; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; De Zutter L, 2017, COMP 4 DIFFERENT SEL; Delahoy MJ, 2018, INT J HYG ENVIR HEAL, V221, P661, DOI 10.1016/j.ijheh.2018.03.005; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Ercumen A, 2017, ENVIRON SCI TECHNOL, V51, P8725, DOI 10.1021/acs.est.7b01710; Exum NG, 2016, ENVIRON SCI TECHNOL, V50, P7373, DOI 10.1021/acs.est.6b01283; FAO, 2014, DEC TOOLS FAM POULTR; Fischer Walker CL, 2012, BMC PUBLIC HEALTH, V12, P220, DOI DOI 10.1186/1471-2458-12-220; Forsberg L, 2017, EVALUATION CHROMAGAR; Gedlu E, 1996, ANN TROP PAEDIATR, V16, P207, DOI 10.1080/02724936.1996.11747828; Gelli A, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12818; George C, 2017, TROP MED INT HEALTH, V12, P3218, DOI [10.1111/tmi.13002, DOI 10.1111/TMI.13002]; George CM, 2015, AM J TROP MED HYG, V93, P269, DOI 10.4269/ajtmh.14-0694; George CM, 2015, AM J TROP MED HYG, V92, P1117, DOI 10.4269/ajtmh.14-0672; Gittelsohn J, 2006, HEALTH EDUC BEHAV, V33, P25, DOI 10.1177/1090198105282412; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Hara-Kudo Y, 2011, EPIDEMIOL INFECT, V139, P1505, DOI 10.1017/S095026881000292X; Headey D, 2017, AM J TROP MED HYG, V96, P961, DOI 10.4269/ajtmh.16-0270; Headey D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160590; Humphrey JH, 2019, LANCET GLOB HEALTH, V7, pE132, DOI 10.1016/S2214-109X(18)30374-7; Husseini M, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1179-3; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Keusch GT, 2014, CLIN INFECT DIS, V59, pS207, DOI 10.1093/cid/ciu485; Kosek MN, 2017, EBIOMEDICINE, V18, P109, DOI 10.1016/j.ebiom.2017.02.024; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lee G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002036; Lengerh A, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-82; Lima AAM, 2018, J PEDIATR GASTR NUTR, V66, P325, DOI [10.1097/MPG.0000000000001717, 10.1097/mpg.0000000000001717]; Lin A, 2013, AM J TROP MED HYG, V89, P130, DOI 10.4269/ajtmh.12-0629; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Luby SP, 2018, LANCET GLOB HEALTH, V6, pE302, DOI 10.1016/S2214-109X(17)30490-4; LUNN PG, 1991, LANCET, V338, P907, DOI 10.1016/0140-6736(91)91772-M; Mann F.C., 1961, MANAGING MAJOR CHANG; MARQUIS GS, 1990, AM J PUBLIC HEALTH, V80, P146, DOI 10.2105/AJPH.80.2.146; Martorell R, 2012, ADV NUTR, V3, P227, DOI 10.3945/an.111.001107; Mason J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059663; Mattioli MCM, 2015, ENVIRON SCI TECHNOL, V49, P1912, DOI 10.1021/es505555f; McQuade ETR, 2020, J INFECT DIS, V221, P1379, DOI 10.1093/infdis/jiz179; Acosta AM, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000370; Mitike G, 2000, E AFR MED J, V77, P654; MOLBAK K, 1988, EPIDEMIOL INFECT, V100, P227, DOI 10.1017/S0950268800067364; Morita T, 2017, TROP MED INT HEALTH, V22, P670, DOI 10.1111/tmi.12869; Mulatu Getamesay, 2014, Ethiop J Health Sci, V24, P101, DOI 10.4314/ejhs.v24i2.1; Ngure F, 2019, AM J TROP MED HYG, V100, P998, DOI 10.4269/ajtmh.18-0333; Ngure FM, 2013, AM J TROP MED HYG, V89, P709, DOI 10.4269/ajtmh.12-0568; Null C, 2018, LANCET GLOB HEALTH, V6, pE316, DOI 10.1016/S2214-109X(18)30005-6; Owino V, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0641; Patil SR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001709; Penakalapati G, 2017, ENVIRON SCI TECHNOL, V51, P11537, DOI 10.1021/acs.est.7b02811; Perin J, 2016, J PEDIATR-US, V178, P34, DOI 10.1016/j.jpeds.2016.06.077; Pickering AJ, 2019, LANCET GLOB HEALTH, V7, pE1139, DOI 10.1016/S2214-109X(19)30268-2; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; Platts-Mills JA, 2017, AM J CLIN NUTR, V105, P1132, DOI 10.3945/ajcn.116.138800; Randremanana RV, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-372; Rao MR, 2001, AM J EPIDEMIOL, V154, P166, DOI 10.1093/aje/154.2.166; Reid B, 2018, AM J TROP MED HYG, V98, P816, DOI 10.4269/ajtmh.17-0124; Rogawski ET, 2018, LANCET GLOB HEALTH, V6, pE1319, DOI [10.1016/s2214-109x(18)30351-6, 10.1016/S2214-109X(18)30351-6]; Samuel S O, 2006, East Afr Med J, V83, P478; Schnee AE, 2018, AM J EPIDEMIOL, V187, P2210, DOI 10.1093/aje/kwy106; Schoenbuchner SM, 2019, AM J CLIN NUTR, V110, P498, DOI 10.1093/ajcn/nqy326; Sebastian K., 2014, ATLAS AFRICAN AGR RE, DOI [10.2499/9780896298460, DOI 10.2499/9780896298460]; Tafa Belay, 2014, Int J Bacteriol, V2014, P560617, DOI 10.1155/2014/560617; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Troeger C, 2018, LANCET GLOB HEALTH, V6, pE255, DOI 10.1016/S2214-109X(18)30045-7; Veras HD, 2016, J MICROBIOL METH, V128, P7, DOI 10.1016/j.mimet.2016.06.026; Wagner E. G., 1958, EXCRETA DISPOSAL RUR, V39; WHO, 2006, WHO CHILD GROWTH STA; YEAGER BAC, 1991, J DIARRHOEAL DIS RES, V9, P186	87	10	10	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232541	10.1371/journal.pone.0232541	http://dx.doi.org/10.1371/journal.pone.0232541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0QJ	32384130	Green Published, gold, Green Accepted			2022-12-26	WOS:000537468300018
J	Shojaee, S; Sharma, A; Gottel, N; Sanchez, T; Gilbert, JA; Rahman, NM				Shojaee, Samira; Sharma, Anukriti; Gottel, Neil; Sanchez, Trinidad; Gilbert, Jack A.; Rahman, Najib M.			Microbiome profile associated with malignant pleural effusion	PLOS ONE			English	Article							DIVERSITY	Introduction There is ongoing research into the development of novel molecular markers that may complement fluid cytology malignant pleural effusion (MPE) diagnosis. In this exploratory pilot study, we hypothesized that there are distinct differences in the pleural fluid microbiome profile of malignant and non-malignant pleural diseases. Method From a prospectively enrolled pleural fluid biorepository, samples of MPE were included. Non-MPE effusion were included as comparators. 16S rRNA gene V4 region amplicon sequencing was performed. Exact Sequence Variants (ESVs) were used for diversity analyses. The Shannon and Richness indices of alpha diversity and UniFrac beta diversity measures were tested for significance using permutational multivariate analysis of variance. Analyses of Composition of Microbiome was used to identify differentially abundant bacterial ESVs between the groups controlled for multiple hypothesis testing. Results 38 patients with MPE and 9 with non-MPE were included. A subgroup of patients with metastatic adenocarcinoma histology were identified among MPE group (adenocarcinoma of lung origin (LA-MPE) = 11, breast origin (BA-MPE) = 11). MPE presented with significantly greater alpha diversity compared to non-MPE group. Within the MPE group, BA-MPE was more diverse compared to LA-MPE group. In multivariable analysis, ESVs belonging to family S24-7 and genera Allobaculum, Stenotrophomonas, and Epulopiscium were significantly enriched in the malignant group compared to the non-malignant group. Conclusion Our results are the first to demonstrate a microbiome signature according to MPE and non-MPE. The role of microbiome in pleural effusion pathogenesis needs further exploration.	[Shojaee, Samira; Sanchez, Trinidad] Virginia Commonwealth Univ, Med Ctr, Div Pulm & Crit Care Med, Richmond, VA 23284 USA; [Sharma, Anukriti; Gottel, Neil; Gilbert, Jack A.] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA 92103 USA; [Gottel, Neil; Gilbert, Jack A.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA USA; [Rahman, Najib M.] Univ Oxford, Oxford Ctr Resp Med, Oxford Resp Trials Unit, Oxford, England; [Rahman, Najib M.] Oxford NIHR Biomed Res Ctr, Oxford, England	Virginia Commonwealth University; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Oxford; University of Oxford	Shojaee, S (corresponding author), Virginia Commonwealth Univ, Med Ctr, Div Pulm & Crit Care Med, Richmond, VA 23284 USA.	sas3867@mail.harvard.edu			Virginia Commonwealth University Center for Clinical and Translational Research, Richmond, Virginia, NIH/NCRR [UL 1TR002649]	Virginia Commonwealth University Center for Clinical and Translational Research, Richmond, Virginia, NIH/NCRR	The use of the REDCap Database was supported by the Virginia Commonwealth University Center for Clinical and Translational Research, Richmond, Virginia, NIH/NCRR Grant Number UL 1TR002649. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or NCRR. The funders of REDCap had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00191-16; Arnold DT, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01254-2018; Brenner DR, 2012, PLOS ONE, V6; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; Deng ZH, 2018, ONCOL LETT, V15, P6352, DOI 10.3892/ol.2018.8167; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; Gilbreath JJ, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-105; Goradel NH, 2019, J CELL PHYSIOL, V234, P2337, DOI 10.1002/jcp.27250; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lombardi G, 2010, AM J CLIN ONCOL-CANC, V33, P420, DOI 10.1097/COC.0b013e3181aacbbf; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mao QX, 2018, CANCER LETT, V415, P40, DOI 10.1016/j.canlet.2017.11.036; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meyer MS, 2008, CANCER CAUSE CONTROL, V19, P895, DOI 10.1007/s10552-008-9163-4; Pompilio A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02591; R Foundation for Statistical Computing RCT, 2016, R LANG ENV STAT COMP; Rodriguez-Panadero Francisco, 2013, Expert Opin Med Diagn, V7, P275, DOI 10.1517/17530059.2013.786038; Ross AA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0135-0; Safdar A, 2007, CLIN INFECT DIS, V45, P1602, DOI 10.1086/522998; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Shang FM, 2018, WORLD J GASTRO ONCOL, V10, P71, DOI 10.4251/wjgo.v10.i3.71; Siddhartha Mandal, MICROBIAL ECOLOGY HL, V26, DOI [10.3402/mehd.v26.27663, DOI 10.3402/MEHD.V26.27663]; Sriram KB, 2011, FUTURE ONCOL, V7, P737, DOI [10.2217/fon.11.45, 10.2217/FON.11.45]; Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Wei H, 2010, FEMS MICROBIOL ECOL, V73, P577, DOI 10.1111/j.1574-6941.2010.00924.x; Zhou ZW, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00371	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232181	10.1371/journal.pone.0232181	http://dx.doi.org/10.1371/journal.pone.0232181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384089	Green Published, gold			2022-12-26	WOS:000537468300009
J	Chitongo, R; Obasa, AE; Mikasi, SG; Jacobs, GB; Cloete, R				Chitongo, Rumbidzai; Obasa, Adetayo Emmanuel; Mikasi, Sello Given; Jacobs, Graeme Brendon; Cloete, Ruben			Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding	PLOS ONE			English	Article							CROSS-RESISTANCE; RALTEGRAVIR; INHIBITOR; ELVITEGRAVIR; MANAGEMENT; MECHANISM; PATTERNS; BARRIER; MUTANT; NAIVE	Resistance associated mutations (RAMs) threaten the long-term success of combination antiretroviral therapy (cART) outcomes for HIV-1 treatment. HIV-1 Integrase (IN) strand transfer inhibitors (INSTIs) have proven to be a viable option for highly specific HIV-1 therapy. The INSTI, Dolutegravir is recommended by the World Health Organization for use as first-line cART. This study aims to understand how RAMs affect the stability of IN, as well as the binding of the drug Dolutegravir to the catalytic pocket of the protein. A homology model of HIV-1 subtype C IN was successfully constructed and validated. The site directed mutator webserver was used to predict destabilizing and/or stabilizing effects of known RAMs while FoldX confirmed any changes in protein energy upon introduction of mutation. Also, interaction analysis was performed between neighbouring residues. Three mutations known to be associated with Raltegravir, Elvitegravir and Dolutegravir resistance were selected; E92Q, G140S and Y143R, for molecular dynamics simulations. The structural quality assessment indicated high reliability of the HIV-1C IN tetrameric structure, with more than 90% confidence in modelled regions. Change in free energy for the three mutants indicated different effects, while simulation analysis showed G140S to have the largest affect on protein stability and flexibility. This was further supported by weaker non-bonded pairwise interaction energy and binding free energy values between the drug DTG and E92Q, Y143R and G140S mutants suggesting reduced binding affinity, as indicated by interaction analysis in comparison to the WT. Our findings suggest the G140S mutant has the strongest effect on the HIV-1C IN protein structure and Dolutegravir binding. To the best of our knowledge, this is the first study that uses the consensus wild type HIV-1C IN sequence to build an accurate 3D model to understand the effect of three known mutations on DTG drug binding in a South Africa context.	[Chitongo, Rumbidzai; Cloete, Ruben] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council Bioinformat Unit, Cape Town, South Africa; [Obasa, Adetayo Emmanuel; Mikasi, Sello Given; Jacobs, Graeme Brendon] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, South Africa	University of the Western Cape; Stellenbosch University; University of Cape Town	Cloete, R (corresponding author), Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council Bioinformat Unit, Cape Town, South Africa.	ruben@sanbi.ac.za	Obasa, Adetayo Emmanuel/AAS-1078-2021	Obasa, Adetayo Emmanuel/0000-0003-0934-9586; Jacobs, Graeme/0000-0002-3259-1496	Poliomyelitis Research Foundation (PRF) of South Africa [19/06]; National Research Foundation (NRF); Higher Education Department, next Generation of Academic Programme (nGAP)	Poliomyelitis Research Foundation (PRF) of South Africa; National Research Foundation (NRF); Higher Education Department, next Generation of Academic Programme (nGAP)	This study was funded by the Poliomyelitis Research Foundation (PRF) of South Africa grant no. 19/06 to R. Cloete and in-part by the National Research Foundation (NRF). The Higher Education Department, next Generation of Academic Programme (nGAP) provided support for this study in the form of full time academic positions and salaries to R. Cloete and GBJ. Additionally, the Centre for High Performance Computing (CHPC), Rondebosch, South Africa provided high performance computing cluster.	Abram ME, 2013, ANTIMICROB AGENTS CH, V57, P2654, DOI 10.1128/AAC.02568-12; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Brado D, 2018, SCI REP, V8, P1; Brenner BG, 2017, VIRUS RES, V239, P1, DOI 10.1016/j.virusres.2016.07.006; Brenner BG, 2016, J ANTIMICROB CHEMOTH, V71, P1948, DOI 10.1093/jac/dkw071; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Chen Q, 2015, INTERDISCIP SCI, V7, P36, DOI 10.1007/s12539-014-0235-8; Chen Q, 2013, J CHEM INF MODEL, V53, P3297, DOI 10.1021/ci400537n; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dewdney TG, 2013, J STRUCT BIOL, V184, P245, DOI 10.1016/j.jsb.2013.07.008; Di Santo R, 2014, J MED CHEM, V57, P539, DOI 10.1021/jm400674a; Doyle T, 2015, J ANTIMICROB CHEMOTH, V70, P3080, DOI 10.1093/jac/dkv243; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Garrido C, 2012, ANTIMICROB AGENTS CH, V56, P2873, DOI 10.1128/AAC.06170-11; Geretti AM, 2009, CLIN INFECT DIS, V48, P1296, DOI 10.1086/598502; Haggblom A, 2016, LANCET HIV, V3, pE166, DOI 10.1016/S2352-3018(16)00023-0; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hu ZX, 2010, JAIDS-J ACQ IMM DEF, V55, P148, DOI 10.1097/QAI.0b013e3181e9a87a; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lenz JCC, 2011, EXPERT OPIN INV DRUG, V20, P537, DOI 10.1517/13543784.2011.562189; Lunin VY, 2002, THEORY TECHNIQUES; Marchand C, 2003, MOL PHARMACOL, V64, P600, DOI 10.1124/mol.64.3.600; Mouscadet JF, 2010, DRUG RESIST UPDATE, V13, P139, DOI 10.1016/j.drup.2010.05.001; Nair Pramod C., 2014, In Silico Pharmacology, V2, P4, DOI 10.1186/s40203-014-0004-8; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Okeke NL, 2011, HIV AIDS-RES PALLIAT, V3, P81, DOI 10.2147/HIV.S13985; Passos DO, 2017, SCIENCE, V355, P89, DOI 10.1126/science.aah5163; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Seki T, 2015, ANTIMICROB AGENTS CH, V59, P2596, DOI 10.1128/AAC.04844-14; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Sutherland KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38153; van der Spoel D., 2011, GROMACS REFERENCE MA; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vermeulen M, 2019, TRANSFUSION, V59, P267, DOI 10.1111/trf.14959; Wang J, J CHEM INFORM COMPUT; Wilkinson AL, 2015, JAIDS-J ACQ IMM DEF, V69, P460, DOI 10.1097/QAI.0000000000000613; Wong-ekkabut J, 2012, J CHEM THEORY COMPUT, V8, P2905, DOI 10.1021/ct3001359; Xue WW, 2013, J CHEM INF MODEL, V53, P210, DOI 10.1021/ci300541c; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	47	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0223464	10.1371/journal.pone.0223464	http://dx.doi.org/10.1371/journal.pone.0223464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379830	Green Submitted, Green Published, gold			2022-12-26	WOS:000537285700002
J	Duan, LF; Du, H; Wang, C; Huang, X; Qu, XF; Shi, B; Liu, Y; Zhang, W; Duan, XZ; Wei, LH; Belinson, JL; Wu, RF				Duan, Lyufang; Du, Hui; Wang, Chun; Huang, Xia; Qu, Xinfeng; Shi, Bin; Liu, Yan; Zhang, Wei; Duan, Xianzhi; Wei, Lihui; Belinson, Jerome L.; Wu, Ruifang			The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples	PLOS ONE			English	Article							PREVENTION	Objective To explore the relationship between the viral load reflected by the Ct value of Cobas 4800 HPV test and cervical lesions, and the effectiveness of the viral load for secondary triage of HPV-positive women. Methods The Chinese Multi-Center Screening Trial (CHIMUST) evaluated both self-collected samples and physician-collected samples from women, aged 30 to 59, who were screened for cervical cancer in 6 regions across China. Using physician collected samples, the relationship between the HPV-Ct values of different subtypes and the cervical lesions was analyzed. Then the combined use of the HPV-Ct values with the HPV subtypes was evaluated as a secondary screening algorithm for the women who were HPV positive. Results The Ct values of HPV16 and 12 other HPV subtypes(12-type pool), tested with Cobas decreased with the progression of cervical lesion (HPV16: r = -0.429, P<0.001; 12 other HR-HPV subtypes: r = -0.099, P<0.01). The HPV18-Ct value was not correlated with cervical lesion(P>0.05). Compared with HPV16/18 and cytology (HPV16/18 positive and 12-type pool plus cytology. ASC-US), the sequential secondary screening using HPV16/18 and the viral load of 12-type pool (cut-point HPV-Ct <= 31) had equal sensitivities for CIN2+ and CIN3+ (83.1%vs.80.3%,100%vs.92.6%,P>0.05), with slightly lower specificities (96.2% vs.94.4%,96.5%vs.93.9%,P<0.001) and higher colposcopy referral rate (4.90%vs.6.59%, P<0.05), but required no cytology. Conclusion Type-specific HPV viral load is closely related to cervical lesions severity. It is feasible and efficient to use HPV16/18 and the viral load of 12 other HPV subtypes (with cut-point HPV-Ct <= 31) as the secondary screening for HPV positive women. This algorithm may be useful in low resource regions.	[Duan, Lyufang; Du, Hui; Wang, Chun; Huang, Xia; Wu, Ruifang] Peking Univ, Dept Gynecol & Obstet, Shenzhen Hosp, Shenzhen, Peoples R China; [Duan, Lyufang; Du, Hui; Wang, Chun; Huang, Xia; Wu, Ruifang] Shenzhen Key Lab Technol Early Diag Major Gynecol, Shenzhen, Peoples R China; [Qu, Xinfeng] Peking Univ, Shenzhen Hosp, Sanming Project Med Shenzhen, Shenzhen, Peoples R China; [Shi, Bin] Hebei Med Univ, Hosp 2, Hebie, Peoples R China; [Liu, Yan] Fudan Univ, Huashan Hosp, Shanghai, Peoples R China; [Zhang, Wei] Wuhan Univ, Zhongnan Hosp, Wuhan, Hubei, Peoples R China; [Duan, Xianzhi] Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China; [Wei, Lihui] Peking Univ, Peoples Hosp, Beijing, Peoples R China; [Belinson, Jerome L.] Prevent Oncol Int, Cleveland Hts, OH 44118 USA; [Belinson, Jerome L.] Cleveland Clin, Womens Hlth Inst, Cleveland, OH 44106 USA	Peking University; Peking University; Hebei Medical University; Fudan University; Wuhan University; Capital Medical University; Peking University; Cleveland Clinic Foundation	Wu, RF (corresponding author), Peking Univ, Dept Gynecol & Obstet, Shenzhen Hosp, Shenzhen, Peoples R China.; Wu, RF (corresponding author), Shenzhen Key Lab Technol Early Diag Major Gynecol, Shenzhen, Peoples R China.; Wei, LH (corresponding author), Peking Univ, Peoples Hosp, Beijing, Peoples R China.; Belinson, JL (corresponding author), Prevent Oncol Int, Cleveland Hts, OH 44118 USA.; Belinson, JL (corresponding author), Cleveland Clin, Womens Hlth Inst, Cleveland, OH 44106 USA.	weilhpku@163.com; jlb@poiinc.org; wurfpush@126.com	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022		Shenzhen Health Family Planning Commission, Shenzhen, PR China [SZLY2017005]; Sanming Project of Medicine in Shenzhen [SZSM201412010]; Shenzhen Key Laboratory of Neuropsychiatric Modulation (CN) Science and Education of Shenzhen Health [[2018]61]; China Association for Science and Technology (CN); China International Exchage and Promotion Association for medical and Healthcare	Shenzhen Health Family Planning Commission, Shenzhen, PR China; Sanming Project of Medicine in Shenzhen; Shenzhen Key Laboratory of Neuropsychiatric Modulation (CN) Science and Education of Shenzhen Health; China Association for Science and Technology (CN); China International Exchage and Promotion Association for medical and Healthcare	This work was supported by the Shenzhen Health Family Planning Commission, Shenzhen, PR China (SZLY2017005), Sanming Project of Medicine in Shenzhen (SZSM201412010), Shenzhen Key Laboratory of Neuropsychiatric Modulation (CN) Science and Education of Shenzhen Health [2018]61, the China Association for Science and Technology (CN), and the China International Exchage and Promotion Association for medical and Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Arbyn M, 2012, INT J CANCER, V131, P1969, DOI 10.1002/ijc.27650; Belinson JL, 2016, J LOW GENIT TRACT DI, V20, pe61, DOI 10.1097/LGT.0000000000000239; Bosgraaf RP, 2014, EXPERT REV ANTICANC, V14, P75, DOI 10.1586/14737140.2014.856273; Cox JT, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.020; Dijkstra MG, 2014, ANN ONCOL, V25, P927, DOI 10.1093/annonc/mdt538; Dong L, 2018, GYNECOL ONCOL, V148, P103, DOI 10.1016/j.ygyno.2017.11.016; Duan L F, 2019, Zhonghua Fu Chan Ke Za Zhi, V54, P458, DOI 10.3760/cma.j.issn.0529-567x.2019.07.005; Alvarez-Arguelles ME, 2015, J VIROL METHODS, V222, P95, DOI 10.1016/j.jviromet.2015.05.016; Hoste G, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/610373; Huh WK, 2015, GYNECOL ONCOL, V136, P178, DOI [10.1016/j.ygyno.2014.12.022, 10.1097/AOG.0000000000000669]; Kang Leni, 2014, Zhonghua Zhong Liu Za Zhi, V36, P316; Li L, 2018, CHINA CANC, V27, P311; Long WB, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1003-x; Luo HX, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220200; Luo HX, 2017, J LOW GENIT TRACT DI, V21, P12, DOI 10.1097/LGT.0000000000000277; Maurer K, 2016, J CLIN VIROL, V76, P14, DOI 10.1016/j.jcv.2015.12.010; Rijkaart DC, 2012, INT J CANCER, V130, P602, DOI 10.1002/ijc.26056; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; [沈媛媛 Shen Yuanyuan], 2017, [中国妇产科临床杂志, Chinese Journal of Clinical Obstetrics and Gynecology], V18, P313; Wang D, 2017, INT J EDUC DEV, V52, P1, DOI 10.1016/j.ijedudev.2016.10.009; Wang SM, 2013, INT J GYNECOL CANCER, V23, P716, DOI 10.1097/IGC.0b013e318286a95d; Wentzensen N, 2013, LANCET ONCOL, V14, P107, DOI 10.1016/S1470-2045(12)70568-5; Yu LL, 2016, ONCOTARGET, V7, P21181, DOI 10.18632/oncotarget.8307	24	5	7	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232107	10.1371/journal.pone.0232107	http://dx.doi.org/10.1371/journal.pone.0232107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379782	Green Published, gold			2022-12-26	WOS:000537285700021
J	Grivea, IN; Syrogiannopoulos, GA; Michoula, AN; Gazeti, G; Malli, E; Tsilipounidaki, K; Fouzas, S; Anthracopoulos, MB; Petinaki, E				Grivea, Ioanna N.; Syrogiannopoulos, George A.; Michoula, Aspasia N.; Gazeti, Georgia; Malli, Ergina; Tsilipounidaki, Katerina; Fouzas, Sotirios; Anthracopoulos, Michael B.; Petinaki, Efthymia			emm Types and clusters and macrolide resistance of pediatric group A streptococcal isolates in Central Greece during 2011-2017	PLOS ONE			English	Article							ERYTHROMYCIN RESISTANCE; TYPING SYSTEM; PYOGENES; TELITHROMYCIN; EPIDEMIOLOGY; PREVALENCE; PNEUMONIAE; SEROTYPES; DYNAMICS; EPITOPES	Background The surveillance of emm types and macrolide susceptibility of group A streptococcus (GAS) in various areas and time periods enhances the understanding of the epidemiology of GAS infections and may guide treatment strategies and the formulation of type-specific vaccines. Greece has emerged as a country with high macrolide use. However, studies suggest a gradual reduction in macrolide consumption after 2007. Methods During a 7-year period (2011-2017), 604 GAS isolates were recovered from consecutive children presenting with pharyngeal or nonpharyngeal infections in Central Greece; 517 viable isolates underwent molecular analysis, including emm typing. Results Isolates belonged to 20 different emm types (in decreasing order of prevalence: 1, 89, 4, 12, 28, 3, 75 and 6, accounting for 88.2% of total isolates). The emm types comprised 10 emm clusters (five most common clusters: E4, A-C3, E1, A-C4 and A-C5). The emm89 isolates were acapsular (`new clade`). Overall macrolide resistance rate was 15.4%, and cMLSB emerged as the predominant resistance phenotype (56.4%). The lowest annual resistance rates occurred in 2014 (13.1%), 2016 (5.5%) and 2017(8.0%) (P for trend = 0.002). Consumption of macrolide/lincosamide/streptogramin B declined by 22.6% during 2011-2017. Macrolide resistance and emm28 and emm77 types were associated (both P< 0.001). The most frequently identified genetic lineages of macrolide-resistant GAS included emm28/ ST52, emm77/ST63, emm12/ST36, emm89/ST101 and emm4/ST39. We estimated that 98.8% of the isolates belonged to emm types incorporated into a novel 30-valent M protein vaccine. Conclusions In Central Greece during 2011-2017, the acapsular emm89 isolates comprised the second most prevalent type. Susceptibility testing and molecular analyses revealed decreasing GAS macrolide resistance rates, which may be attributed to the reduction in the consumption of macrolides and/or the reduced circulation of macrolide-resistant clones in recent years. Such data may provide valuable baseline information in targeting therapeutic intervention and the formulation of type-specific GAS vaccines.	[Grivea, Ioanna N.; Syrogiannopoulos, George A.; Michoula, Aspasia N.; Gazeti, Georgia] Univ Thessaly, Fac Med, Sch Hlth Sci, Dept Pediat, Larisa, Greece; [Malli, Ergina; Tsilipounidaki, Katerina; Petinaki, Efthymia] Univ Thessaly, Fac Med, Sch Hlth Sci, Dept Microbiol, Larisa, Greece; [Fouzas, Sotirios; Anthracopoulos, Michael B.] Univ Patras, Fac Med, Sch Hlth Sci, Dept Pediat, Rion, Greece	University of Thessaly; University of Thessaly; University of Patras	Syrogiannopoulos, GA (corresponding author), Univ Thessaly, Fac Med, Sch Hlth Sci, Dept Pediat, Larisa, Greece.	syrogian@otenet.gr	Fouzas, Sotirios/Q-3043-2016	Fouzas, Sotirios/0000-0001-7617-9076				Abdissa A, 2006, CLIN INFECT DIS, V42, P1362, DOI 10.1086/503422; Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; Baroux N, 2014, CLIN INFECT DIS, V59, pE84, DOI 10.1093/cid/ciu490; BEACHEY EH, 1981, NATURE, V292, P457, DOI 10.1038/292457a0; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Beasley TM, 1995, J EXP EDUC, V64, P79, DOI 10.1080/00220973.1995.9943797; Bingen E, 2004, ANTIMICROB AGENTS CH, V48, P3559, DOI 10.1128/AAC.48.9.3559-3562.2004; Chuan CN, 2016, J CLIN MICROBIOL, V54, P157, DOI 10.1128/JCM.02089-15; Cizman M, 2006, INT J ANTIMICROB AG, V28, P537, DOI 10.1016/j.ijantimicag.2006.07.023; Clancy J, 1996, MOL MICROBIOL, V22, P867, DOI 10.1046/j.1365-2958.1996.01521.x; d'Humieres C, 2012, INT J MED MICROBIOL, V302, P300, DOI 10.1016/j.ijmm.2012.09.001; Dale JB, 2013, VACCINE, V31, P1576, DOI 10.1016/j.vaccine.2013.01.019; Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005; DALE JB, 1986, J EXP MED, V163, P1191, DOI 10.1084/jem.163.5.1191; De Azavedo JCS, 1999, ANTIMICROB AGENTS CH, V43, P2144, DOI 10.1128/AAC.43.9.2144; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Friaes A, 2015, MBIO, V6, DOI 10.1128/mBio.01780-15; JONES KF, 1985, J EXP MED, V161, P623, DOI 10.1084/jem.161.3.623; Koutouzi F, 2015, J CLIN MICROBIOL, V53, P2015, DOI 10.1128/JCM.00301-15; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; Littauer P, 2006, ANTIMICROB AGENTS CH, V50, P1896, DOI 10.1128/AAC.50.5.1896-1899.2006; Malhotra-Kumar S, 2005, EMERG INFECT DIS, V11, P939, DOI 10.3201/eid1106.041247; Malli E, 2010, INT J ANTIMICROB AG, V35, P614, DOI 10.1016/j.ijantimicag.2010.01.025; Mazzariol A, 2007, J CHEMOTHERAPY, V19, P500, DOI 10.1179/joc.2007.19.5.500; McMillan DJ, 2013, CLIN MICROBIOL INFEC, V19, pE222, DOI 10.1111/1469-0691.12134; Michos A, 2016, J ANTIMICROB CHEMOTH, V71, P2113, DOI 10.1093/jac/dkw116; Montes M, 2014, J ANTIMICROB CHEMOTH, V69, P1474, DOI 10.1093/jac/dku039; Olivieri R, 2015, J MED MICROBIOL, V64, P1186, DOI 10.1099/jmm.0.000146; Petinaki E, 2003, INT J ANTIMICROB AG, V21, P67, DOI 10.1016/S0924-8579(02)00253-4; Reinert RR, 2004, ANTIMICROB AGENTS CH, V48, P1369, DOI 10.1128/AAC.48.4.1369-1373.2004; Roberts MC, 1999, ANTIMICROB AGENTS CH, V43, P2823, DOI 10.1128/AAC.43.12.2823; Rubio-Lopez V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-215; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Seppala H, 1998, ANTIMICROB AGENTS CH, V42, P257; Shulman ST, 2014, CLIN INFECT DIS, V59, P1651, DOI 10.1093/cid/ciu649; Silva-Costa C, 2008, CLIN MICROBIOL INFEC, V14, P1152, DOI 10.1111/j.1469-0691.2008.02104.x; Silva-Costa C, 2006, CLIN MICROBIOL INFEC, V12, P513, DOI 10.1111/j.1469-0691.2006.01408.x; Silva-Costa C, 2005, ANTIMICROB AGENTS CH, V49, P2109, DOI 10.1128/AAC.49.5.2109-2111.2005; Silva-Costa C, 2015, J ANTIMICROB CHEMOTH, V70, P2729, DOI 10.1093/jac/dkv182; Stevens DL, 1999, STREPTOCOCCAL INFECTIONS, P19; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; Syrogiannopoulos GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071558; Szczypa K, 2004, J ANTIMICROB CHEMOTH, V54, P828, DOI 10.1093/jac/dkh420; Tamayo E, 2014, J INFECTION, V68, P50, DOI 10.1016/j.jinf.2013.08.013; Turner CE, 2015, MBIO, V6, DOI 10.1128/mBio.00622-15; Van Heirstraeten L, 2012, EMERG INFECT DIS, V18, P1515, DOI 10.3201/eid1809.120049; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577	48	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232777	10.1371/journal.pone.0232777	http://dx.doi.org/10.1371/journal.pone.0232777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379802	Green Published, gold			2022-12-26	WOS:000537285700065
J	Ibrahim, AA; Akindele, MO; Ganiyu, SO; Kaka, B; Abdullahi, BB; Sulaiman, SK; Fatoye, F				Ibrahim, Aminu Alhassan; Akindele, Mukadas Oyeniran; Ganiyu, Sokunbi Oluwaleke; Kaka, Bashir; Abdullahi, Bashir Bello; Sulaiman, Surajo Kamilu; Fatoye, Francis			The Hausa 12-item short-form health survey (SF-12): Translation, cross-cultural adaptation and validation in mixed urban and rural Nigerian populations with chronic low back pain	PLOS ONE			English	Article							QUALITY-OF-LIFE; FIT INDEXES; PSYCHOMETRIC EVALUATION; OUTCOMES MEASUREMENT; RELIABILITY; VALIDITY; EPIDEMIOLOGY; DISABILITY; INVARIANCE; CRITERIA	Introduction Measuring health-related quality of life (HRQOL) in patients with chronic low back pain (LBP) is crucial to monitor and improve the patients' health status through effective rehabilitation. While the 12-item short-form health survey (SF-12) was developed as a shorter alternative to the 36-item short-form health survey for assessing HRQOL in large-scale studies, to date, no cross-culturally adapted and validated Hausa version exists. This study aimed to translate and cross-culturally adapt the SF-12 into Hausa language, and test its psychometric properties in mixed urban and rural Nigerian populations with chronic LBP. Methods The Hausa version of the SF-12 was developed following the guidelines of the International Quality of Life Assessment project. Fifteen patients with chronic LBP recruited from urban and rural communities of Nigeria pre-tested the Hausa SF-12. A consecutive sample of 200 patients with chronic LBP recruited from urban and rural clinics of Nigeria completed the instrument, among which 100 respondents re-tested the instrument after two weeks. Factorial structure and invariance were assessed using confirmatory factor analysis (CFA) and multi-group CFA respectively. Multi-trait scaling analysis (for convergent and divergent validity) and known-groups validity were performed to assess construct validity. Composite reliability (CR), internal consistency (Cronbach's alpha), intraclass correlation coefficients (ICC), and Bland-Altman plots were computed to assess reliability. Results After the CFA of the original conceptual SF-12 model, 2 redundant items were removed and 4 error terms were allowed to covary, thus providing adequate fit to the sample. The refined model demonstrated good fit and evidence of factorial invariance in three demographic groups (age, gender, and habitation). Convergent (11:12; 91% success rate) and divergent (10:12; 83% success rate) validity were satisfactory. Known-groups comparison showed that the instrument discriminated well for those who differed in age (p < 0.05) but in gender and habitation (p > 0.05). The physical component summary and the mental component summary demonstrated acceptable CR (0.69 and 0.79 respectively), internal consistency (alpha = 0.73 and 0.78 respectively), test-rest reliability (ICC = 0.79 and 0.85 respectively), and good agreement between test-retest values. Conclusions The Hausa SF-12 was successfully developed and showed evidence of factorial invariance across age, gender, and habitation. The instrument demonstrated satisfactory construct validity, internal consistency, and test-retest reliability. However, stronger psychometric properties need to be established in general population and other patients groups in future studies. The instrument can be used clinically and for research in Hausa-speaking patients with chronic LBP.	[Ibrahim, Aminu Alhassan; Akindele, Mukadas Oyeniran; Ganiyu, Sokunbi Oluwaleke; Kaka, Bashir] Bayero Univ Kano, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Physiotherapy, Kano, Kano State, Nigeria; [Ibrahim, Aminu Alhassan] Muhammad Abdullahi Wase Teaching Hosp, Hosp Management Board, Dept Physiotherapy, Kano, Kano State, Nigeria; [Abdullahi, Bashir Bello] Sir Muhammadu Sunusi Specialist Hosp, Hosp Management Board, Dept Physiotherapy, Kano, Kano State, Nigeria; [Sulaiman, Surajo Kamilu] Kaduna State Univ, Coll Med, Fac Allied Hlth Sci, Dept Physiotherapy, Kaduna, Nigeria; [Fatoye, Francis] Manchester Metropolitan Univ, Fac Hlth Psychol & Social Care, Dept Hlth Profess, Manchester, Lancs, England	Bayero University; Manchester Metropolitan University	Ibrahim, AA (corresponding author), Bayero Univ Kano, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Physiotherapy, Kano, Kano State, Nigeria.; Ibrahim, AA (corresponding author), Muhammad Abdullahi Wase Teaching Hosp, Hosp Management Board, Dept Physiotherapy, Kano, Kano State, Nigeria.	amenconafs@gamil.com	Sulaiman, Surajo Kamilu/AAV-4596-2021; Ibrahim, Aminu A./AAJ-9996-2020; Kaka, Bashir/D-3342-2018	Sulaiman, Surajo Kamilu/0000-0003-3927-8627; Kaka, Bashir/0000-0001-9138-0675; AKINDELE, MUKADAS/0000-0002-7642-1018; A. Ibrahim, Aminu/0000-0002-5711-1639				Aaronson N K, 1992, Qual Life Res, V1, P349, DOI 10.1007/BF00434949; Adamu AS, 2019, SPINE, V44, pE1092, DOI 10.1097/BRS.0000000000003068; Andrade Thamine Lessa, 2007, J. bras. pneumol., V33, P414, DOI 10.1590/S1806-37132007000400010; Barrera R. B., 2014, REV EUROPEA DIRECCIO, V23, P184, DOI DOI 10.1016/J.REDEE.2014.09.004; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bourion-Bedes S, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0365-7; Bowling A, 2001, MEASURING DISEASE RE; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Choi YS, 2014, ASIAN SPINE J, V8, P346, DOI 10.4184/asj.2014.8.3.346; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Vet HCW, 2003, J CLIN EPIDEMIOL, V56, P1137, DOI 10.1016/j.jclinepi.2003.08.012; Fayers P., 2007, QUALITY LIFE ASSESSM; Fleishman JA, 2003, MED CARE, V41, P75, DOI 10.1097/01.MLR.0000076052.42628.CF; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Galenkamp H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203483; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gandhi SK, 2001, CLIN THER, V23, P1080, DOI 10.1016/S0149-2918(01)80093-X; Globe DR, 2002, OPHTHALMOLOGY, V109, P1793, DOI 10.1016/S0161-6420(02)01124-7; Gonzalez-Calvo J, 1997, ARTHRIT CARE RES, V10, P448, DOI 10.1002/art.1790100613; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Hayes CJ, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5020022; Haywood KL, 2002, RHEUMATOLOGY, V41, P1380, DOI 10.1093/rheumatology/41.12.1380; Hinkle D.E., 1988, APPL STAT BEHAV SCI; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Horng YS, 2005, SPINE, V30, P551, DOI 10.1097/01.brs.0000154623.20778.f0; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Islam N, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0683-z; Johnson JA, 1998, QUAL LIFE RES, V7, P155, DOI 10.1023/A:1008809610703; Johnson JA, 2000, MED CARE, V38, P115, DOI 10.1097/00005650-200001000-00013; Kent Peter M, 2005, Chiropr Osteopat, V13, P13, DOI 10.1186/1746-1340-13-13; Kodraliu G, 2001, J Epidemiol Biostat, V6, P305; Koes BW, 2006, BMJ, V332; Kontodimopoulos N, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-55; Kovacs FM, 2004, SPINE, V29, P206, DOI 10.1097/01.BRS.0000107235.47465.08; Lam CLK, 2005, QUAL LIFE RES, V14, P539, DOI 10.1007/s11136-004-0704-3; Lim LLY, 1999, QUAL LIFE RES, V8, P1, DOI 10.1023/A:1026409226544; Luo XM, 2003, SPINE, V28, P1739, DOI 10.1097/00007632-200308010-00020; Megari K, 2013, HEALTH PSYCHOL RES, V1, P141, DOI [10.4081/hpr.2013.e27, 10.4082/hpr.2013.e27]; Meucci RD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005874; Montazeri A, 2010, HDB DIS BURDENS QUAL; Montazeri A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-341; Nationalencyklopedin, 2007, VARLD 100 STORST SPR; Netemeyer R.G., 2003, SCALING PROCEDURES I; Obtel M., 2013, Southern African Journal of Epidemiology & Infection, V28, P166; Putnick DL, 2016, DEV REV, V41, P71, DOI 10.1016/j.dr.2016.06.004; Resnik L, 2003, J ORTHOP SPORT PHYS, V33, P307, DOI 10.2519/jospt.2003.33.6.307; Resnik L, 2003, J ORTHOP SPORT PHYS, V33, P318; Rudy TE, 2007, PAIN, V131, P293, DOI 10.1016/j.pain.2007.01.012; Salyers MP, 2000, MED CARE, V38, P1141, DOI 10.1097/00005650-200011000-00008; Stefane T, 2013, ACTA PAUL ENFERM, V26, P14, DOI 10.1590/S0103-21002013000100004; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Ware J.E., 1994, SF 36 PHYS MENTAL HL; WARE JE, 1995, INT J TECHNOL ASSESS, V11, P525, DOI 10.1017/S0266462300008710; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 2002, SCORE VERSION 2 SF S; Wee CC, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-11; Weiner SS, 2010, BEST PRACT RES CL RH, V24, P267, DOI 10.1016/j.berh.2009.12.001; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Yoon M, 2018, STRUCT EQU MODELING, V25, P201, DOI 10.1080/10705511.2017.1387859; Younsi M, 2014, QUAL LIFE RES, V23, P2047, DOI 10.1007/s11136-014-0641-8	68	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232223	10.1371/journal.pone.0232223	http://dx.doi.org/10.1371/journal.pone.0232223			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZX	32379769	Green Published, gold			2022-12-26	WOS:000537285700027
J	Selig, EE; Zlatic, CO; Cox, D; Mok, YF; Gooley, PR; Ecroyd, H; Griffin, MDW				Selig, Emily E.; Zlatic, Courtney O.; Cox, Dezerae; Mok, Yee-Foong; Gooley, Paul R.; Ecroyd, Heath; Griffin, Michael D. W.			N- and C-terminal regions of ?B-crystallin and Hsp27 mediate inhibition of amyloid nucleation, fibril binding, and fibril disaggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small heat shock protein (sHsp); chaperone; structure?function; amyloid; protein misfolding; ?B-crystallin; Hsp27; alpha-synuclein (?-synuclein); apolipoprotein C-II; neurodegenerative disease	HEAT-SHOCK-PROTEIN; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; CHAPERONE ACTIVITY; THIOFLAVIN-T; LEWY BODIES; AGGREGATION; DEMENTIA; DOMAIN; PHOSPHORYLATION	Small heat-shock proteins (sHSPs) are ubiquitously expressed molecular chaperones that inhibit amyloid fibril formation; however, their mechanisms of action remain poorly understood. sHSPs comprise a conserved ?-crystallin domain flanked by variable N- and C-terminal regions. To investigate the functional contributions of these three regions, we compared the chaperone activities of various constructs of human ?B-crystallin (HSPB5) and heat-shock 27-kDa protein (Hsp27, HSPB1) during amyloid formation by ?-synuclein and apolipoprotein C-II. Using an array of approaches, including thioflavin T fluorescence assays and sedimentation analysis, we found that the N-terminal region of Hsp27 and the terminal regions of ?B-crystallin are important for delaying amyloid fibril nucleation and for disaggregating mature apolipoprotein C-II fibrils. We further show that the terminal regions are required for stable fibril binding by both sHSPs and for mediating lateral fibril?fibril association, which sequesters preformed fibrils into large aggregates and is believed to have a cytoprotective function. We conclude that although the isolated ?-crystallin domain retains some chaperone activity against amyloid formation, the flanking domains contribute additional and important chaperone activities, both in delaying amyloid formation and in mediating interactions of sHSPs with amyloid aggregates. Both these chaperone activities have significant implications for the pathogenesis and progression of diseases associated with amyloid deposition, such as Parkinson's and Alzheimer's diseases.	[Selig, Emily E.; Zlatic, Courtney O.; Cox, Dezerae; Mok, Yee-Foong; Gooley, Paul R.; Griffin, Michael D. W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic, Australia; [Selig, Emily E.; Zlatic, Courtney O.; Cox, Dezerae; Mok, Yee-Foong; Gooley, Paul R.; Griffin, Michael D. W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia; [Ecroyd, Heath] Univ Wollongong, Mol Horizons, Wollongong, NSW, Australia; [Ecroyd, Heath] Univ Wollongong, Sch Chem & Mol Biosci, Wollongong, NSW, Australia; [Ecroyd, Heath] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia	University of Melbourne; University of Melbourne; University of Wollongong; University of Wollongong; University of Wollongong	Griffin, MDW (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic, Australia.; Griffin, MDW (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia.	mgriffin@unimelb.edu.au	Cox, Dezerae/I-7265-2019	Cox, Dezerae/0000-0002-5345-8360; Gooley, Paul/0000-0002-0323-449X; Selig, Emily/0000-0002-3012-6814; Ecroyd, Heath/0000-0001-7574-0044	Australian Government Research Training Program Scholarship; Australian Research Council [FT140100544]	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council(Australian Research Council)	E. E. S. is the recipient of an Australian Government Research Training Program Scholarship. M. D. W. G. is the recipient of Australian Research Council Future Fellowship FT140100544.	Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Aquilina JA, 2007, BIOCHEM BIOPH RES CO, V353, P1115, DOI 10.1016/j.bbrc.2006.12.176; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Arai H, 1997, CELL STRUCT FUNCT, V22, P539, DOI 10.1247/csf.22.539; Arrigo AP, 2001, IUBMB LIFE, V52, P303, DOI 10.1080/152165401317291156; Baba M, 1998, AM J PATHOL, V152, P879; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Baldwin AJ, 2011, J MOL BIOL, V413, P310, DOI 10.1016/j.jmb.2011.07.017; Baranova EV, 2009, ACTA CRYSTALLOGR F, V65, P1277, DOI 10.1107/S1744309109044571; Baughman HER, 2018, J BIOL CHEM, V293, P2687, DOI 10.1074/jbc.M117.803411; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Binger KJ, 2008, BIOCHEMISTRY-US, V47, P10208, DOI 10.1021/bi8009339; Binger KJ, 2008, J MOL BIOL, V376, P1116, DOI 10.1016/j.jmb.2007.12.055; Binger KJ, 2013, FASEB J, V27, P1214, DOI 10.1096/fj.12-220657; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Burre J, 2015, J PARKINSON DIS, V5, P699, DOI 10.3233/JPD-150642; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Clark AR, 2012, INT J BIOCHEM CELL B, V44, P1687, DOI 10.1016/j.biocel.2012.02.015; Clouser AF, 2017, CELL STRESS CHAPERON, V22, P569, DOI 10.1007/s12192-017-0783-z; Cox D, 2018, J BIOL CHEM, V293, P4486, DOI 10.1074/jbc.M117.813865; Cox D, 2017, CELL STRESS CHAPERON, V22, P589, DOI 10.1007/s12192-017-0785-x; Cox D, 2016, J BIOL CHEM, V291, P22618, DOI 10.1074/jbc.M116.739250; Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Delbecq SP, 2015, BIOCHEMISTRY-US, V54, P4276, DOI 10.1021/acs.biochem.5b00490; Duennwald Martin L, 2012, PLoS Biol, V10, pe1001346, DOI 10.1371/journal.pbio.1001346; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P13847, DOI 10.1021/bi061471m; Harding S. E., 1992, ANAL ULTRACENTRIFUGA; Hatters DM, 2000, BIOCHEMISTRY-US, V39, P8276, DOI 10.1021/bi000002w; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Hino M, 2000, BIOCHEM BIOPH RES CO, V271, P164, DOI 10.1006/bbrc.2000.2553; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Horwitz J, 1998, INT J BIOL MACROMOL, V22, P263, DOI 10.1016/S0141-8130(98)00024-5; Ikeda R, 2006, BIOL PHARM BULL, V29, P1815, DOI 10.1248/bpb.29.1815; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Jovcevski B, 2015, CHEM BIOL, V22, P186, DOI 10.1016/j.chembiol.2015.01.001; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Li BS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05971-2; Lohani S, 2016, CASE REPORTS NEPHROL, V2016, DOI DOI 10.1155/2016/8690642; LOWE J, 1990, LANCET, V336, P515, DOI 10.1016/0140-6736(90)92075-S; MacRaild CA, 2004, BIOCHEMISTRY-US, V43, P8084, DOI 10.1021/bi049817l; MacRaild CA, 2003, BIOPHYS J, V84, P2562, DOI 10.1016/S0006-3495(03)75061-9; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; Malmos KG, 2017, AMYLOID, V24, P1, DOI 10.1080/13506129.2017.1304905; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nasr SH, 2017, J AM SOC NEPHROL, V28, P439, DOI 10.1681/ASN.2015111228; OESTERREICH S, 1993, CANCER RES, V53, P4443; Ori A, 2015, CELL SYST, V1, P224, DOI 10.1016/j.cels.2015.08.012; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Pasta SY, 2002, J BIOL CHEM, V277, P45821, DOI 10.1074/jbc.M206499200; Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P511; Renkawek K, 1999, NEUROREPORT, V10, P2273, DOI 10.1097/00001756-199908020-00009; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Ryan TM, 2008, J BIOL CHEM, V283, P35118, DOI 10.1074/jbc.M804004200; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Wilhelmus MMM, 2006, NEUROPATH APPL NEURO, V32, P119, DOI 10.1111/j.1365-2990.2006.00689.x; Wilson LM, 2007, J MOL BIOL, V366, P1639, DOI 10.1016/j.jmb.2006.12.040; Yerbury JJ, 2013, CELL STRESS CHAPERON, V18, P251, DOI 10.1007/s12192-012-0371-1	76	15	15	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					9838	9854		10.1074/jbc.RA120.012748	http://dx.doi.org/10.1074/jbc.RA120.012748			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32417755	hybrid, Green Published			2022-12-26	WOS:000553333300006
J	Hori, N; Okada, K; Takakura, Y; Takano, H; Yamaguchi, N; Yamaguchi, N				Hori, Naoto; Okada, Kazuyuki; Takakura, Yuki; Takano, Hiroyuki; Yamaguchi, Naoto; Yamaguchi, Noritaka			Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; cell signaling; Hippo pathway; transcription coactivator; Yes-associated protein (YAP); TEA domain?containing transcription factor (TEAD); vestigial-like 3 (VGLL3); transcriptional coactivator with PDZ-binding motif (TAZ); cancer; cell proliferation; cell signaling	YAP; TUMOR; EXPRESSION; INDUCTION; GROWTH; GENE; TAZ	Vestigial-like 3 (VGLL3) is a member of the VGLL family, whose members serve as cofactors for TEA domain?containing transcription factors (TEADs). TEADs promote tissue and tumor development together with the cofactors Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ). Although VGLL3 is involved in tumor cell proliferation, its relationship with TEADs and YAP/TAZ remains largely unknown. To close this research gap, here we established tumor cells stably expressing VGLL3 and found that they exhibit enhanced proliferation. Notably, YAP and TAZ were inactivated in the VGLL3-expressing cells, coinciding with activation of the Hippo pathway, which suppresses YAP/TAZ activities. VGLL3 in combination with TEADs promoted expression of the Hippo pathway components large tumor suppressor kinase (LATS2) and angiomotin-like 2 (AMOTL2). VGLL3 was highly expressed in malignant breast tumor cells and osteosarcoma cells, and VGLL3 knockdown increased nuclear localization of YAP and TAZ. Knockdown of LATS2 or AMOTL2, as well as VGLL3 knockdown, repressed proliferation of breast tumor cells. Together, these results suggest that VGLL3 together with TEADs promotes cell proliferation by activating the Hippo pathway through LATS2 and AMOTL2, leading to YAP/TAZ inactivation.	[Hori, Naoto; Okada, Kazuyuki; Takakura, Yuki; Yamaguchi, Naoto; Yamaguchi, Noritaka] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chiba, Japan; [Takano, Hiroyuki; Yamaguchi, Noritaka] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cardiovasc Pharmacol, Chiba, Japan	Chiba University; Chiba University	Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chiba, Japan.; Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cardiovasc Pharmacol, Chiba, Japan.	yamaguchinoritaka@chiba-u.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [19K22482]; Takeda Science Foundation; Foundation for Promotion of Cancer Research in Japan; Chiba Foundation for Health Promotion and Disease Prevention; Daiichi Sankyo Co., Ltd.	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation for Promotion of Cancer Research in Japan; Chiba Foundation for Health Promotion and Disease Prevention; Daiichi Sankyo Co., Ltd.(Daiichi Sankyo Company Limited)	This work was supported in part by Grant-in-aid for Challenging Research (Exploratory) 19K22482 (to Noritaka Yamaguchi) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; grants from the Takeda Science Foundation (to Noritaka Yamaguchi), the Foundation for Promotion of Cancer Research in Japan (to Noritaka Yamaguchi), and the Chiba Foundation for Health Promotion and Disease Prevention (to Naoto Yamaguchi); and a scholarship donation from the Daiichi Sankyo Co., Ltd. (to Naoto Yamaguchi).	Antonescu CR, 2011, GENE CHROMOSOME CANC, V50, P757, DOI 10.1002/gcc.20897; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; Calses PC, 2019, TRENDS CANCER, V5, P297, DOI 10.1016/j.trecan.2019.04.001; Cody NAL, 2007, ONCOGENE, V26, P618, DOI 10.1038/sj.onc.1209821; Cody NAL, 2009, MOL CARCINOGEN, V48, P1077, DOI 10.1002/mc.20535; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Figeac N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.225946; Gambaro K, 2013, MOL ONCOL, V7, P513, DOI 10.1016/j.molonc.2012.12.006; Hallor KH, 2009, J PATHOL, V217, P716, DOI 10.1002/path.2513; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Helias-Rodzewicz Z, 2010, GENE CHROMOSOME CANC, V49, P1161, DOI 10.1002/gcc.20825; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Li CZ, 2013, BIOCHEM BIOPH RES CO, V438, P607, DOI 10.1016/j.bbrc.2013.08.008; Lin KC, 2017, TRENDS BIOCHEM SCI, V42, P862, DOI 10.1016/j.tibs.2017.09.003; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Pobbati AV, 2015, STRUCTURE, V23, P2076, DOI 10.1016/j.str.2015.09.009; Simon E, 2016, DEV GENES EVOL, V226, P297, DOI 10.1007/s00427-016-0546-3; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Yamaguchi N, 2017, J BIOL CHEM, V292, P8136, DOI 10.1074/jbc.M116.763276; Yuki R, 2019, ONCOGENE, V38, P637, DOI 10.1038/s41388-018-0481-z; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang LH, 2019, WORLD J CLIN CASES, V7, P1954, DOI 10.12998/wjcc.v7.i15.1954; Zhang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05856-2; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zheng YG, 2019, DEV CELL, V50, P264, DOI 10.1016/j.devcel.2019.06.003	28	18	18	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8798	8807		10.1074/jbc.RA120.012781	http://dx.doi.org/10.1074/jbc.RA120.012781			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32385107	hybrid, Green Published			2022-12-26	WOS:000546296800015
J	Sanchez, JN; Hudgens, BR				Sanchez, Jessica N.; Hudgens, Brian R.			Vaccination and monitoring strategies for epidemic prevention and detection in the Channel Island fox (Urocyon littoralis)	PLOS ONE			English	Article							CANINE-DISTEMPER; HERD-IMMUNITY; CONTACT RATES; DOMESTIC DOGS; GRAY FOXES; RABIES; POPULATION; DISEASES; SURVEILLANCE; TRANSMISSION	Disease transmission and epidemic prevention are top conservation concerns for wildlife managers, especially for small, isolated populations. Previous studies have shown that the course of an epidemic within a heterogeneous host population is strongly influenced by whether pathogens are introduced to regions of relatively high or low host densities. This raises the question of how disease monitoring and vaccination programs are influenced by spatial heterogeneity in host distributions. We addressed this question by modeling vaccination and monitoring strategies for the Channel Island fox (Urocyon littoralis), which has a history of substantial population decline due to introduced disease. We simulated various strategies to detect and prevent epidemics of rabies and canine distemper using a spatially explicit model, which was parameterized from field studies. Increasing sentinel monitoring frequency, and to a lesser degree, the number of monitored sentinels from 50 to 150 radio collared animals, reduced the time to epidemic detection and percentage of the fox population infected at the time of detection for both pathogens. Fox density at the location of pathogen introduction had little influence on the time to detection, but a large influence on how many foxes had become infected by the detection day, especially when sentinels were monitored relatively infrequently. The efficacy of different vaccination strategies was heavily influenced by local host density at the site of pathogen entry. Generally, creating a vaccine firewall far away from the site of pathogen entry was the least effective strategy. A firewall close to the site of pathogen entry was generally more effective than a random distribution of vaccinated animals when pathogens entered regions of high host density, but not when pathogens entered regions of low host density. These results highlight the importance of considering host densities at likely locations of pathogen invasion when designing disease management plans.	[Sanchez, Jessica N.; Hudgens, Brian R.] Inst Wildlife Studies, Arcata, CA 95501 USA; [Sanchez, Jessica N.] Univ Calif Davis, Karen C Drayer Wildlife Hlth Ctr, Davis, CA 95616 USA	University of California System; University of California Davis	Sanchez, JN (corresponding author), Inst Wildlife Studies, Arcata, CA 95501 USA.; Sanchez, JN (corresponding author), Univ Calif Davis, Karen C Drayer Wildlife Hlth Ctr, Davis, CA 95616 USA.	jnsanchez@ucdavis.edu		Sanchez, Jessica/0000-0002-7689-0324	Department of Defense Legacy Resource Management Program [W912DY-06-2-0015]; National Institutes of Health [T32 OD 011147]	Department of Defense Legacy Resource Management Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Project funding was awarded to BRH and provided by Department of Defense Legacy Resource Management Program (https://www.denix.osd.mil/legacy/home) under grant number W912DY-06-2-0015. JNS was supported in part by the National Institutes of Health under grant number T32 OD 011147 (https://researchtraining.nih.gov/programs/training-grants/t32).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY HELEN, 1952, HUMAN BIOL, V24, P201; ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P481, DOI 10.7589/0090-3558-30.4.481; ANDERSON RM, 1992, VACCINE, V10, P928, DOI 10.1016/0264-410X(92)90327-G; ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; ANDERSON RM, 1981, NATURE, V289, P765, DOI 10.1038/289765a0; APPEL M. J., 1987, VIRUS INFECT CARNIVO, P133; Blancou J., 1991, P257; Blancou Jean, 2009, P97, DOI 10.1007/978-4-431-77134-0_6; Bohrer G, 2002, ECOL MODEL, V152, P205, DOI 10.1016/S0304-3800(02)00003-0; Breed Andrew C., 2009, P215, DOI 10.1007/978-4-431-77134-0_11; Carter Stephen P., 2009, P121, DOI 10.1007/978-4-431-77134-0_7; Cleaveland S, 2000, VET MICROBIOL, V72, P217, DOI 10.1016/S0378-1135(99)00207-2; Coonan T., 2011, ISL FOX WORK GROUP M, P56; Coonan T, 2013, UROCYON LITTORALIS I, DOI [10.2305/IUCN.UK.2013-2.RLTS.T22781A13985603.en, DOI 10.2305/IUCN.UK.2013-2.RLTS.T22781A13985603.EN]; Coonan T., 2018, ISL FOX WORK GROUP M, P16; Coonan TJ, 2010, DECLINE RECOVERY ISL, P34; Coonan TJ, 2010, DECLINE RECOVERY ISL, P21; Coonan TJ, 2010, DECLINE RECOVERY ISL, P73; Craft ME, 2008, J ANIM ECOL, V77, P1257, DOI 10.1111/j.1365-2656.2008.01410.x; Cunningham AA, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0167; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; DAVIDSON WR, 1992, J WILDLIFE DIS, V28, P28, DOI 10.7589/0090-3558-28.1.28; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; Doak DF, 2013, CONSERV BIOL, V27, P303, DOI 10.1111/cobi.12020; Eisinger D, 2008, J APPL ECOL, V45, P415, DOI 10.1111/j.1365-2664.2007.01439.x; FARRELL R. K., 1955, Veterinary Medicine, V50, P412; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Garcia and Associates, 2010, ISL FOX UR LITT CLEM; GILLESPIE JH, 1962, ANN NY ACAD SCI, V101, P540, DOI 10.1111/j.1749-6632.1962.tb18895.x; Gorham J. R., 1953, P BOOK AVMA, P129; Gorham JR, 1999, ADV VET MED-ACAD PR, V41, P557; Greene C. E., 2012, INFECT DIS DOG CAT, P25; HALBROOKS RD, 1981, J AM VET MED ASSOC, V179, P1170; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; Headley SA, 2000, BRAZ J VET RES ANIM, V37, P10; Heesterbeek J. A. P., 1995, P90, DOI 10.1017/CBO9780511629396.004; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Hudgens BR, 2014, EPIDEMIC RESPONSE PL, P71; Hudgens BR, 2013, EPIDEMIC RESPONSE PL, P69; Joseph MB, 2013, J APPL ECOL, V50, P702, DOI 10.1111/1365-2664.12084; Keeling M, 2005, THEOR POPUL BIOL, V67, P1, DOI 10.1016/j.tpb.2004.08.002; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Kitala P, 1997, EPIDEMIOL SANTE ANIM, P31; Lange M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-37; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; MINTA SC, 1992, ECOL APPL, V2, P178, DOI 10.2307/1941774; Morner T, 2002, REV SCI TECH OIE, V21, P67, DOI 10.20506/rst.21.1.1321; Munson L, 2010, DECLINE RECOVERY ISL, P129; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Perrin P, 1999, VACCINE, V18, P479, DOI 10.1016/S0264-410X(99)00247-9; R Core Team, 2019, R LANG ENV STAT COMP, DOI [10.2307/1941774, DOI 10.2307/1941774]; Ralls K, 2013, J MAMMAL, V94, P1185, DOI 10.1644/13-MAMM-A-057.1; Rees EE, 2013, J APPL ECOL, V50, P881, DOI 10.1111/1365-2664.12101; Resnik JR, 2018, J WILDLIFE MANAGE, V82, P1185, DOI 10.1002/jwmg.21464; Rhodes CJ, 1998, PHILOS T R SOC B, V353, P999, DOI 10.1098/rstb.1998.0263; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Roemer GW, 2001, J ZOOL, V255, P1, DOI 10.1017/S0952836901001066; Rupprecht Charles E., 2001, P3, DOI 10.1002/9780470344880.ch1; Rushmore J, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0349; Russell CA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000027; Sanchez JN, 2019, BIOL CONSERV, V236, P593, DOI 10.1016/j.biocon.2019.05.045; Sanchez JN, 2015, ECOL EVOL, V5, P2466, DOI 10.1002/ece3.1533; Smith GC, 2002, ECOL MODEL, V150, P45, DOI 10.1016/S0304-3800(01)00471-9; Sokolow SH, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0342; Thompson RCA, 2013, INT J PARASITOL, V43, P1079, DOI 10.1016/j.ijpara.2013.06.007; Thulke HH, 2008, DEV BIOLOGICALS, V131, P291; Timm SF, 2009, J WILDLIFE DIS, V45, P333, DOI 10.7589/0090-3558-45.2.333; Treanor JJ, 2010, VACCINE, V28, pF64, DOI 10.1016/j.vaccine.2010.03.055; U.S. Fish and Wildlife Service, 2015, REC PLAN 4 SUBSP ISL, P180; U. S. Fish and Wildlife Service (USFWS), 2016, FED REG, V81, P53315; Vickers TW, 2009, ISLAND FOX WORK GROU, P19; Warrell MJ, 2004, LANCET, V363, P959, DOI 10.1016/S0140-6736(04)15792-9; Williams Elizabeth S., 2001, P50; Wimsatt J, 2003, J ZOO WILDLIFE MED, V34, P25, DOI 10.1638/1042-7260(2003)34[0025:EOOASD]2.0.CO;2; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103; 2005, WHO TECHN REP SER, V931, P1	77	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0232705	10.1371/journal.pone.0232705	http://dx.doi.org/10.1371/journal.pone.0232705			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421723	Green Published, gold			2022-12-26	WOS:000537499600016
J	Bilancia, M; Pasculli, G; Di Bona, D				Bilancia, Massimo; Pasculli, Giuseppe; Di Bona, Danilo			A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapy	PLOS ONE			English	Article							COST-EFFECTIVENESS; SUBLINGUAL IMMUNOTHERAPY; SUBCUTANEOUS IMMUNOTHERAPY; TASK-FORCE; RHINITIS; ASTHMA; EFFICACY; RHINOCONJUNCTIVITIS; GUIDELINE; CHILDREN	Introduction Allergic rhino-conjunctivitis (ARC) is an IgE-mediated disease that occurs after exposure to indoor or outdoor allergens, or to non-specific triggers. Effective treatment options for seasonal ARC are available, but the economic aspects and burden of these therapies are not of secondary importance, also considered that the prevalence of ARC has been estimated at 23% in Europe. For these reasons, we propose a novel flexible cost-effectiveness analysis (CEA) model, intended to provide healthcare professionals and policymakers with useful information aimed at cost-effective interventions for grass-pollen induced allergic rhino-conjunctivitis (ARC). Methods Treatments compared are: 1. no AIT, first-line symptomatic drug-therapy with no allergoid immunotherapy (AIT). 2. SCIT, subcutaneous immunotherapy. 3. SLIT, sublingual immunotherapy. The proposed model is a non-stationary Markovian model, that is flexible enough to reflect those treatment-related problems often encountered in real-life and clinical practice, but that cannot be adequately represented in randomized clinical trials (RCTs). At the same time, we described in detail all the structural elements of the model as well as its input parameters, in order to minimize any issue of transparency and facilitate the reproducibility and circulation of the results among researchers. Results Using the no AIT strategy as a comparator, and the Incremental Cost Effectiveness Ratio (ICER) as a statistic to summarize the cost-effectiveness of a health care intervention, we could conclude that: SCIT systematically outperforms SLIT, except when a full societal perspective is considered. For example, for T = 9 and a pollen season of 60 days, we have ICER = (sic)16,729 for SCIT vs. ICER = (sic)15,116 for SLIT (in the full societal perspective). For longer pollen seasons or longer follow-up duration the ICER decreases, because each patient experiences a greater clinical benefit over a larger time span, and Quality-adjusted Life Year (QALYs) gained per cycle increase accordingly. Assuming that no clinical benefit is achieved after premature discontinuation, and that at least three years of immunotherapy are required to improve clinical manifestations and perceiving a better quality of life, ICERs become far greater than (sic)30,000. If the immunotherapy is effective only at the peak of the pollen season, the relative ICERs rise sharply. For example, in the scenario where no clinical benefit is present after premature discontinuation of immunotherapy, we have ICER = (sic)74,770 for SCIT vs. ICER = (sic)152,110 for SLIT. The distance between SCIT and SLIT strongly depends on under which model the interventions are meta-analyzed. Conclusions Even though there is a considerable evidence that SCIT outperforms SLIT, we could not state that both SCIT and SLIT (or only one of these two) can be considered cost-effective for ARC, as a reliable threshold value for cost-effectiveness set by national regulatory agencies for pharmaceutical products is missing. Moreover, the impact of model input parameters uncertainty on the reliability of our conclusions needs to be investigated further.	[Bilancia, Massimo] Univ Bari Aldo Moro, Ion Dept Legal & Econ Syst Mediterranean DJSGEM, Taranto, Italy; [Pasculli, Giuseppe] Univ Roma La Sapienza, Dept Comp Control & Management Engn Antonio Ruber, Rome, Italy; [Di Bona, Danilo] Univ Bari Aldo Moro, Sch & Chair Allergol & Clin Immunol, Dept Emergency & Organ Transplantat DETO, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Sapienza University Rome; Universita degli Studi di Bari Aldo Moro	Bilancia, M (corresponding author), Univ Bari Aldo Moro, Ion Dept Legal & Econ Syst Mediterranean DJSGEM, Taranto, Italy.	massimo.bilancia@uniba.it		BILANCIA, Massimo/0000-0002-5330-2403; Pasculli, Giuseppe/0000-0002-0499-2292				Accordini S, 2013, INT ARCH ALLERGY IMM, V160, P93, DOI 10.1159/000338998; Adalsteinsson Erpur, 2013, J Mark Access Health Policy, V1, DOI 10.3402/jmahp.v1i0.21240; [Anonymous], 2019, R LANG ENV STAT COMP; Ara R, 2012, VALUE HEALTH, V15, P971, DOI 10.1016/j.jval.2012.05.003; Asaria M, 2018, ALLERGY, V73, P269, DOI 10.1111/all.13254; Bachert C, 2007, CLIN EXP ALLERGY, V37, P772, DOI 10.1111/j.1365-2222.2007.02706.x; Baio G., 2012, BAYESIAN METHODS HLT; Baio G, 2018, ANNU REV STAT APPL, V5, P289, DOI 10.1146/annurev-statistics-031017-100404; Baio G, 2015, STAT METHODS MED RES, V24, P615, DOI 10.1177/0962280211419832; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Bauer CS, 2014, J ALLERGY CLIN IMMUN, V134, P765, DOI 10.1016/j.jaci.2014.07.024; Bernert S, 2009, VALUE HEALTH, V12, P750, DOI 10.1111/j.1524-4733.2009.00509.x; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Briggs A, 2006, DECISION MODELLING H; Bruggenjurgen B, 2008, ANN ALLERG ASTHMA IM, V101, P316, DOI 10.1016/S1081-1206(10)60498-X; Compalati E, 2010, EXPERT REV CLIN IMMU, V6, P413, DOI [10.1586/ECI.10.15, 10.1586/eci.10.15]; Dahl R, 2006, J ALLERGY CLIN IMMUN, V118, P434, DOI 10.1016/j.jaci.2006.05.003; del Campo C, 2019, OPER RES HEALTH CARE, V21, P32, DOI 10.1016/j.orhc.2019.04.001; Devillier P, 2014, ALLERGY, V69, P1689, DOI 10.1111/all.12518; Dhami S, 2017, ALLERGY, V72, P1825, DOI 10.1111/all.13208; Di Bona D, 2015, JAMA INTERN MED, V175, P1301, DOI 10.1001/jamainternmed.2015.2840; Di Bona D, 2012, J ALLERGY CLIN IMMUN, V130, P1097, DOI 10.1016/j.jaci.2012.08.012; Di Lorenzo G, 2017, INT FORUM ALLERGY RH, V7, P660, DOI 10.1002/alr.21946; Durham SR, 2016, J ALLERGY CLIN IMMUN, V137, P339, DOI 10.1016/j.jaci.2015.12.1298; Dykewicz MS, 2017, ANN ALLERG ASTHMA IM, V119, P489, DOI 10.1016/j.anai.2017.08.012; Egert-Schmidt AM, 2014, PATIENT PREFER ADHER, V8, P1475, DOI 10.2147/PPA.S70326; EMA European Medicines Agency, 2008, CHMPEWP 185042006; Ferrando Matteo, 2018, Clin Mol Allergy, V16, P6, DOI 10.1186/s12948-018-0085-8; Fleurence RL, 2007, PHARMACOECONOMICS, V25, P3, DOI 10.2165/00019053-200725010-00002; Frew AJ, 2006, J ALLERGY CLIN IMMUN, V117, P319, DOI 10.1016/j.jaci.2005.11.014; Garrison LP, 2010, VALUE HEALTH, V13, P8, DOI 10.1111/j.1524-4733.2009.00660.x; Gray AM, 2010, APPL METHODS COST EF; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Huovinen E, 1997, THORAX, V52, P49, DOI 10.1136/thx.52.1.49; Incorvaia C, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-015-0586-1; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; Jutel M, 2016, ALLERGY ASTHMA IMMUN, V8, P191, DOI 10.4168/aair.2016.8.3.191; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Khan DA, 2014, ALLERGY ASTHMA PROC, V35, P357, DOI 10.2500/aap.2014.35.3794; Kiel MA, 2013, J ALLERGY CLIN IMMUN, V132, P353, DOI 10.1016/j.jaci.2013.03.013; Lemberg ML, 2017, PATIENT PREFER ADHER, V11, P63, DOI 10.2147/PPA.S122948; Liljas B, 1998, PHARMACOECONOMICS, V13, P1, DOI 10.2165/00019053-199813010-00001; Linneberg A, 2016, Clin Mol Allergy, V14, P12; Malone DC, 1997, J ALLERGY CLIN IMMUN, V99, P22, DOI 10.1016/S0091-6749(97)81040-8; Marcellusi Andrea, 2015, Recenti Progressi in Medicina, V106, P517, DOI 10.1701/2032.22086; MCDONALD JB, 1995, J ECONOMETRICS, V66, P133, DOI 10.1016/0304-4076(94)01612-4; Meadows A, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17270; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; Novembre E, 2004, J ALLERGY CLIN IMMUN, V114, P851, DOI 10.1016/j.jaci.2004.07.012; Parmigiani G, 2002, STAT METHODS MED RES, V11, P513, DOI 10.1191/0962280202sm307ra; Paulden M, 2017, EXPERT REV PHARM OUT, V17, P239, DOI 10.1080/14737167.2017.1330152; Penagos Martin, 2018, Curr Treat Options Allergy, V5, P275, DOI 10.1007/s40521-018-0176-2; Pierucci A, 2017, ARXIV170203252V2STAT; Revicki DA, 1998, QUAL LIFE RES, V7, P693, DOI 10.1023/A:1008860113818; Roberts G, 2018, ALLERGY, V73, P765, DOI 10.1111/all.13317; Scadding GK, 2017, CLIN EXP ALLERGY, V47, P856, DOI 10.1111/cea.12953; Scadding GW, 2017, JAMA-J AM MED ASSOC, V317, P615, DOI 10.1001/jama.2016.21040; Seidman MD, 2015, OTOLARYNG HEAD NECK, V152, P197, DOI 10.1177/0194599814562166; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; Sieber J, 2011, CURR MED RES OPIN, V27, P855, DOI 10.1185/03007995.2011.559538; Spedicato GA, 2017, R J, V9, P84, DOI 10.32614/RJ-2017-036; Spiegelhalter D J, 2000, Health Technol Assess, V4, P1; Spiegelhalter DJ, 2003, STAT MED, V22, P3687, DOI 10.1002/sim.1586; Sur DKC, 2015, AM FAM PHYSICIAN, V92, P985; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Verheggen BG, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0045-z; Wallace DV, 2017, ANN INTERN MED, V167, P876, DOI 10.7326/M17-2203; Wallace DV, 2017, CURR OPIN ALLERGY CL, V17, P286, DOI 10.1097/ACI.0000000000000375; Walley T, 1997, BRIT J CLIN PHARMACO, V43, P343, DOI 10.1046/j.1365-2125.1997.00574.x; Wheatley LM, 2015, NEW ENGL J MED, V372, P456, DOI 10.1056/NEJMcp1412282; Whitehead SJ, 2010, BRIT MED BULL, V96, P5, DOI 10.1093/bmb/ldq033; Zielen S, 2018, ALLERGY, V73, P165, DOI 10.1111/all.13213	72	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232753	10.1371/journal.pone.0232753	http://dx.doi.org/10.1371/journal.pone.0232753			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0YZ	32407326	Green Published, gold			2022-12-26	WOS:000537490700032
J	Chavarria-Perez, LM; Giordani, W; Dias, KOG; Costa, ZP; Ribeiro, CAM; Benedetti, AR; Cauz-Santos, LA; Pereira, GS; Rosa, JRBF; Garcia, AAF; Vieira, MLC				Chavarria-Perez, Lourdes Maria; Giordani, Willian; Gracas Dias, Kaio Olimpio; Costa, Zirlane Portugal; Massena Ribeiro, Carolina Albuquerque; Benedetti, Anderson Roberto; Cauz-Santos, Luiz Augusto; Pereira, Guilherme Silva; Bachega Feijo Rosa, Joao Ricardo; Franco Garcia, Antonio Augusto; Carneiro Vieira, Maria Lucia			Improving yield and fruit quality traits in sweet passion fruit: Evidence for genotype by environment interaction and selection of promising genotypes	PLOS ONE			English	Article							SELF-INCOMPATIBILITY; VARIETY; ABILITY; MODELS	Breeding for yield and fruit quality traits in passion fruits is complex due to the polygenic nature of these traits and the existence of genetic correlations among them. Therefore, studies focused on crop management practices and breeding using modern quantitative genetic approaches are still needed, especially for Passiflora alata, an understudied crop, popularly known as the sweet passion fruit. It is highly appreciated for its typical aroma and flavor characteristics. In this study, we aimed to reevaluate 30 genotypes previously selected for fruit quality from a 100 full-sib sweet passion fruit progeny in three environments, with a view to estimating the heritability and genetic correlations, and investigating the GEI and response to selection for nine fruit traits (weight, diameter and length of the fruit; thickness and weight of skin; weight and yield of fruit pulp; soluble solids, and yield). Pairwise genetic correlations among the fruit traits showed mostly intermediate to high values, especially those associated with fruit size and shape. Different genotype rankings were obtained regarding the predicted genetic values of weight of skin, thickness of skin and weight of pulp in each environment. Finally, we used a multiplicative selection index to select simultaneously for weight of pulp and against fruit skin thickness and weight. The response to selection was positive for all traits except soluble solids, and the 20% superior (six) genotypes were ranked. Based on the assumption that incompatibility mechanisms exist in P. alata, the selected genotypes were intercrossed in a complete diallel mating scheme. It is worth noting that all genotypes produced fruits, which is essential to guarantee yields in commercial orchards.	[Chavarria-Perez, Lourdes Maria; Giordani, Willian; Gracas Dias, Kaio Olimpio; Costa, Zirlane Portugal; Massena Ribeiro, Carolina Albuquerque; Benedetti, Anderson Roberto; Cauz-Santos, Luiz Augusto; Bachega Feijo Rosa, Joao Ricardo; Franco Garcia, Antonio Augusto; Carneiro Vieira, Maria Lucia] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Pereira, Guilherme Silva] North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA	Universidade de Sao Paulo; University of North Carolina; North Carolina State University	Vieira, MLC (corresponding author), Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil.	mlcvieir@usp.br	Giordani, Willian/AAE-3416-2022; Da Silva Pereira, Guilherme/AAC-8273-2019; Garcia, Antonio A F/A-4538-2010; Vieira, Maria Lucia Carneiro/D-1628-2012; Rosa, João R Bachega F/H-3822-2011; Costa, Zirlane/C-3002-2019	Giordani, Willian/0000-0002-1685-1446; Da Silva Pereira, Guilherme/0000-0002-7106-8630; Garcia, Antonio A F/0000-0003-0634-3277; Vieira, Maria Lucia Carneiro/0000-0003-0341-5714; Rosa, João R Bachega F/0000-0002-9584-1691; Cauz dos Santos, Luiz Augusto/0000-0003-1694-2433; Olimpio das Gracas Dias, Kaio/0000-0002-9171-1021; Costa, Zirlane/0000-0002-2374-0656; Benedetti, Anderson Roberto/0000-0001-6523-3196	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/52607-5, 2012/09100-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; FAPESP [2018/09069-7, 16/12977-7, 2017/04216-9, 2010/06702-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the following Brazilian institutions: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant no. 2007/52607-5, and the scholarship awarded to LP, grant no. 2012/09100-5); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, scholarships awarded to ZC, CR, and research grants awarded to MV and AG); and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Finance Code 001, and the scholarship awarded to AB). WG, KD, LC-S and JR were also supported by FAPESP scholarships (2018/09069-7, 16/12977-7, 2017/04216-9 and 2010/06702-9, respectively).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akamine EK, 1959, USDA TECHNICAL B; Bernardo R., 2010, BREEDING QUANTITATIV, V2; Braga MF, 2005, MARACUJA GERMOPLASMA, P601; Bruckner C. H., 1995, Acta Horticulturae, P45; Bruckner CH, 1999, HIBRIDACAO ARTIFICIA, P379; Bruckner CH, 1993, ACTA HORTIC, V370, P45, DOI DOI 10.17660/ACTAIL0RTIC.1995.370.7; Butler D., 2009, ANAL MIXED MODELS S; Cavalcante NR, 2017, ACTA SCI-AGRON, V39, P143, DOI 10.4025/actasciagron.v39i2.31022; Cerqueira-Silva CBM, 2014, EUR J PLANT PATHOL, V139, P255, DOI 10.1007/s10658-014-0391-z; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; Dawson JC, 2013, FIELD CROP RES, V154, P12, DOI 10.1016/j.fcr.2013.07.020; de Leon N, 2016, CROP SCI, V56, P2081, DOI 10.2135/cropsci2016.07.0002in; Silva FHDE, 2017, ACTA SCI-AGRON, V39, P183, DOI 10.4025/actasciagron.v39i2.32554; de Moraes MC, 2005, HORTSCIENCE, V40, P1978, DOI 10.21273/HORTSCI.40.7.1978; de Oliveira EJ, 2011, BRAGANTIA, V70, P255, DOI 10.1590/S0006-87052011000200002; do Rego MM, 1999, THEOR APPL GENET, V98, P564, DOI 10.1007/s001220051105; ELSTON RC, 1963, BIOMETRICS, V19, P85, DOI 10.2307/2527573; Ferreira TGT, 2010, PLANT BREEDING, V129, P727, DOI 10.1111/j.1439-0523.2009.01744.x; Henderson C. R, 1984, APPL LINEAR MODELS A; Holland J. B., 2003, Plant Breeding Reviews, V22, P9, DOI 10.1002/9780470650202.ch2; IBGE, 2017, PROD AGR MUN CULT TE; Jesus Carlos Augusto Santos de, 2018, Rev. Bras. Frutic., V40, pe, DOI 10.1590/0100-29452018968; Jung MS, 2007, PESQUI AGROPECU BRAS, V42, P689, DOI 10.1590/S0100-204X2007000500011; Jung Maricelma Simiano, 2007, Cienc. Rural, V37, P963, DOI 10.1590/S0103-84782007000400007; Kelly AM, 2007, CROP SCI, V47, P1063, DOI 10.2135/cropsci2006.08.0540; Malosetti M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00044; Martins Moisés Rodrigues, 2003, Rev. Bras. Frutic., V25, P111, DOI 10.1590/S0100-29452003000100032; Ocampo J, 2016, EUPHYTICA, V209, P395, DOI 10.1007/s10681-016-1647-9; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Penha HA, 2013, PLANT BREEDING, V132, P731, DOI 10.1111/pbr.12083; Pereira GS, 2013, ANN APPL BIOL, V162, P347, DOI 10.1111/aab.12028; Pereira GD, 2017, TROP PLANT BIOL, V10, P18, DOI 10.1007/s12042-016-9181-4; Piepho HP, 2008, EUPHYTICA, V161, P209, DOI 10.1007/s10681-007-9449-8; Revelle W., 2014, PSYCH PROCEDURES PER; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Searle SR., 2009, VARIANCE COMPONENTS; Smith A, 2001, BIOMETRICS, V57, P1138, DOI 10.1111/j.0006-341X.2001.01138.x; Snedecor GW, 1980, STAT METHODS, V7th; Suassuna TDF, 2003, THEOR APPL GENET, V106, P298, DOI 10.1007/s00122-002-1103-1; Viana AP, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2020-3; Yan WK, 2007, CROP SCI, V47, P643, DOI 10.2135/cropsci2006.06.0374; Yan WK, 2000, CROP SCI, V40, P597, DOI 10.2135/cropsci2000.403597x	43	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232818	10.1371/journal.pone.0232818	http://dx.doi.org/10.1371/journal.pone.0232818			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407352	Green Published, Green Submitted, gold			2022-12-26	WOS:000537490700038
J	Jooste, S; Mabaso, M; Taylor, M; North, A; Tadokera, R; Simbayi, L				Jooste, Sean; Mabaso, Musawenkosi; Taylor, Myra; North, Alicia; Tadokera, Rebecca; Simbayi, Leickness			Trends and determinants of ever having tested for HIV among youth and adults in South Africa from 2005-2017: Results from four repeated cross-sectional nationally representative household-based HIV prevalence, incidence, and behaviour surveys	PLOS ONE			English	Article							MEN	Background HIV testing contributes to the prevention and control of the HIV epidemic in the general population. South Africa has made strides to improve HIV testing towards reaching the first of the UNAIDS 90-90-90 targets by 2020. However, to date no nationally representative analysis has examined temporal trends and factors associated with HIV testing among youth and adults in the country. Aim This study aimed to examine the trends and associations with ever having tested for HIV among youth and adults aged 15 years and older in South Africa using the 2005, 2008, 2012 and 2017 nationally representative population-based household surveys. Methods The analysis of the data collected used multi-stage stratified cluster randomised cross-sectional design. P-trend chi-squared test was used to identify any significant changes over the four study periods. Bivariate and multivariate logistic regression analysis was conducted to determine factors associated with HIV testing in each of the survey periods. Results Ever having tested for HIV increased substantially from 2005 (30.6%, n = 16 112), 2008 (50.4%, n = 13 084), 2012 (65.5%, n = 26 381), to 2017 (75.2%, n = 23 190). Those aged 50 years and older were significantly less likely to ever have tested for HIV than those aged 25-49 years. Those residing in rural areas were significantly less likely to have tested for HIV as compared to people from urban areas. There was a change in HIV testing among race groups with Whites, Coloureds and Indian/Asians testing more in 2005 and 2008 and Black Africans in 2017. Marriage, education and employment were significantly associated with increased likelihood of ever testing for HIV. Those who provided a blood specimen for laboratory HIV testing in the survey rounds and were found to have tested positive were more likely to have ever tested for HIV previously. Conclusion The results show that overall there has been an increase in ever having an HIV test in the South African population over time. The findings also suggest that for South Africa to close the testing gap and reach the first of the UNAIDS 90-90-90 targets by 2020, targeted programmes aimed at increasing access and utilization of HIV testing in young people, males, those not married, the less educated, unemployed and those residing in rural areas of South Africa should be prioritised.	[Jooste, Sean; Mabaso, Musawenkosi; North, Alicia; Tadokera, Rebecca] Human Sci Res Council, Social Aspects Publ Hlth Res Programme, Cape Town, South Africa; [Taylor, Myra] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa; [Tadokera, Rebecca] Stellenbosch Univ, Fac Med & Hlth Sci, South African Med Res Council,Div Mol Biol & Huma, Ctr TB Res,NRF DST Ctr Excellence Biomed TB Res, Cape Town, South Africa; [Simbayi, Leickness] Human Sci Res Council, Res, Cape Town, South Africa; [Simbayi, Leickness] Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa	Human Sciences Research Council-South Africa; University of Kwazulu Natal; South African Medical Research Council; Stellenbosch University; Human Sciences Research Council-South Africa; University of Cape Town	Jooste, S (corresponding author), Human Sci Res Council, Social Aspects Publ Hlth Res Programme, Cape Town, South Africa.	sjooste@hsrc.ac.za	Tadokera, Rebecca/D-2027-2019	Tadokera, Rebecca/0000-0001-5195-2376	President's Emergency Plan for AIDS Relief (PEPFAR) [5U2GGH000570]	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) under the terms of 5U2GGH000570. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo OW, 2017, J ASSOC NURSE AIDS C, V28, P342, DOI 10.1016/j.jana.2016.11.006; Asaolu IO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164052; Comulada WS, 2019, PREV SCI, V20, P126, DOI 10.1007/s11121-018-0950-1; Cremin I, 2012, TROP MED INT HEALTH, V17, pe26, DOI 10.1111/j.1365-3156.2011.02937.x; Denison JA, 2017, AIDS, V31, pS195, DOI 10.1097/QAD.0000000000001509; Detsis M, 2017, CURR PHARM DESIGN, V23, P2568, DOI 10.2174/1381612823666170329125820; Gaede B.M., 2011, S AFRICAN HLTH REV, P99; Geoffroy E, 2017, PUBLIC HEALTH ACTION, V7, P95, DOI 10.5588/pha.16.0121; Hayes R, 2011, CURR HIV RES, V9, P429, DOI 10.2174/157016211798038515; Houle B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100420; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Kabudula CW, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4312-x; Lippman SA, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25295; Matovu JKB, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-618; Maughan-Brown B, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20658; McLaren ZM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0541-1; Miller CL, 2017, BOTSHA BOPHELO ADOLE, V18, DOI [10.4102/sajhivmed.v18i1.731, DOI 10.4102/SAJHIVMED.V18I1.731]; Mokgatle MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169765; NDOH, 2016, NAT HIV TEST SERV PO; NDOH, 2017, HLTH SECT HIV PREV S; SANAC, 2017, LET OUR ACT COUNC S; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SHISANA O, 2005, S AFRICAN NATL HIV P; Shisana O, 2009, S AFRICAN NATL HIV P; Shisana O, 2014, S AFRICAN NATL HIV P; Simbayi L, 2019, S AFRICAN NATL HIV P; StatsSA, 2017, MID POP EST 2017; StatsSA, 2001, CENS BRIEF; StatsSA, 2011, SPAT MET; Treves-Kagan S, 2017, AIDS BEHAV, V21, P2579, DOI 10.1007/s10461-016-1671-8; UNAIDS, 2018, MIL GO GLOB AIDS UPD; UNAIDS, 2014, GAP REP	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232883	10.1371/journal.pone.0232883	http://dx.doi.org/10.1371/journal.pone.0232883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407342	gold, Green Published			2022-12-26	WOS:000537490700043
J	Schomaker, S; Potter, D; Warner, R; Larkindale, J; King, N; Porter, AC; Owens, J; Tomlinson, L; Sauer, JM; Johnson, K; Aubrecht, J				Schomaker, Shelli; Potter, David; Warner, Roscoe; Larkindale, Jane; King, Nicholas; Porter, Amy C.; Owens, Jane; Tomlinson, Lindsay; Sauer, John-Michael; Johnson, Kent; Aubrecht, Jiri			Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments	PLOS ONE			English	Article							ALANINE AMINOTRANSFERASE; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MOLECULAR-BASIS; HEPATIC-INJURY; BIOMARKERS; DIAGNOSIS; TRANSFERASE; MDX	Serum activities of alanine and aspartate aminotransferases (ALT and AST) are used as gold standard biomarkers for the diagnosis of hepatocellular injury. Since ALT and AST lack liver specificity, the diagnosis of the onset of hepatocellular injury in patients with underlying muscle impairments is severely limited. Thus, we evaluated the potential of glutamate dehydrogenase (GLDH) as a liver specific alternative biomarker of hepatocellular injury. In our study, serum GLDH in subjects with Duchene muscular dystrophy (DMD) was equivalent to serum GLDH in age matched healthy subjects, while serum ALT was increased 20-fold in DMD subjects. Furthermore, serum GLDH in 131 subjects with variety of muscle impairments was similar to serum GLDH of healthy subjects while serum ALT corelated with serum creatine kinase, a widely accepted biomarker of muscle impairment. In addition, significant elevations of ALT, AST, and CK were observed in a case of a patient with rhabdomyolysis, while serum GLDH stayed within the normal range until the onset of hypoxia-induced liver injury. In a mouse model of DMD (DMDmdx), serum GLDH but not serum ALT clearly correlated with the degree of acetaminophen-induced liver injury. Taken together, our data support the utility of serum GLDH as a liver-specific biomarker of liver injury that has a potential to improve diagnosis of hepatocellular injury in patients with underlying muscle impairments. In drug development, GLDH may have utility as a biomarker of drug induced liver injury in clinical trials of new therapies to treat muscle diseases such as DMD.	[Schomaker, Shelli; Potter, David; Tomlinson, Lindsay; Aubrecht, Jiri] Pfizer Inc, Drug Safety R&D, Groton, CT 06340 USA; [Warner, Roscoe; Johnson, Kent] Univ Michigan, Ann Arbor, MI 48109 USA; [Larkindale, Jane; King, Nicholas; Porter, Amy C.; Sauer, John-Michael] Crit Path Inst, Tucson, AZ USA; [Owens, Jane] Pfizer Inc, Rare Dis Res Unit, Cambridge, MA USA; [Aubrecht, Jiri] Takeda Pharmaceut, Cambridge, MA 02139 USA	Pfizer; University of Michigan System; University of Michigan; Pfizer	Aubrecht, J (corresponding author), Pfizer Inc, Drug Safety R&D, Groton, CT 06340 USA.; Aubrecht, J (corresponding author), Takeda Pharmaceut, Cambridge, MA 02139 USA.	Jiri.Aubrecht@takeda.com		King, Nicholas/0000-0003-0063-2617	Pfizer Inc.; Critical Path Institute	Pfizer Inc.(Pfizer); Critical Path Institute	The project was funded by Pfizer Inc. in forms of research grants to K.J.J and R.W. (University of Michigan). Critical Path Institute provided salary support to J.L., A.C.P., and J-M.S. Pfizer Inc. provided support in the form of salaries for authors [S.J.S., J.O., T.L., and J.A.]. Critical Path Institute and Pfizer Inc reviewed the final manuscript, but the funding organizations did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aithal GP, 2011, CLIN PHARMACOL THER, V89, P806, DOI 10.1038/clpt.2011.58; Amacher DE, 2013, MOL DIAGN THER, V17, P343, DOI 10.1007/s40291-013-0049-0; Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294; Begum T, 2000, J PAEDIATR CHILD H, V36, P189, DOI 10.1046/j.1440-1754.2000.00456.x; BRAAKMAN I, 1991, HEPATOLOGY, V13, P73, DOI 10.1016/0270-9139(91)90218-K; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Burtis C.A., TIETZ FUNDAMENTALS C; Corsini A, 2012, DRUG SAFETY, V35, P1099, DOI 10.2165/11632970-000000000-00000; Dufour DR, 2000, CLIN CHEM, V46, P2027; Edge K, 2006, RHEUMATOLOGY, V45, P487, DOI 10.1093/rheumatology/kel009; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Giffen PS, 2002, TOXICOL PATHOL, V30, P365, DOI 10.1080/01926230252929945; Gopal DV, 2000, POSTGRAD MED, V107, P100, DOI 10.3810/pgm.2000.02.869; Harrill AH, 2012, CLIN PHARMACOL THER, V92, P214, DOI 10.1038/clpt.2012.40; Jackson ER, 2008, DRUG CHEM TOXICOL, V31, P427, DOI [10.1080/01480540802390247, 10.1080/01480540802390247 ]; Kasarala George, 2016, Clin Liver Dis (Hoboken), V8, P13, DOI 10.1002/cld.562; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; LUMEIJ JT, 1987, VET QUART, V9, P255, DOI 10.1080/01652176.1987.9694110; Luo LN, 2014, TOXICOL SCI, V137, P12, DOI 10.1093/toxsci/kft221; Mastorodemos V, 2005, J NEUROSCI RES, V79, P65, DOI 10.1002/jnr.20353; Mathur T, 2014, JCR-J CLIN RHEUMATOL, V20, P130, DOI 10.1097/RHU.0000000000000038; Mohar I, 2014, REDOX BIOL, V2, P377, DOI 10.1016/j.redox.2014.01.008; Nathwani RA, 2005, HEPATOLOGY, V41, P380, DOI 10.1002/hep.20548; O'Brien PJ, 2000, HUM EXP TOXICOL, V19, P277, DOI 10.1191/096032700678815918; O'Brien PJ, 2002, LAB ANIM-UK, V36, P313, DOI 10.1258/002367702320162414; Rosales XQ, 2008, J CHILD NEUROL, V23, P748, DOI 10.1177/0883073808314365; RUTLEDGE J, 1985, CLIN PEDIATR, V24, P500, DOI 10.1177/000992288502400906; SCHMIDT E, 1967, CLIN CHIM ACTA, V15, P283, DOI 10.1016/0009-8981(67)90067-8; SCHMIDT ES, 1988, CLIN CHIM ACTA, V173, P43, DOI 10.1016/0009-8981(88)90356-7; Schomaker S, 2013, TOXICOL SCI, V132, P276, DOI 10.1093/toxsci/kft009; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Singhal R, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-42; SUTHERLAND RJ, 1989, VET CLIN N AM-SMALL, V19, P899, DOI 10.1016/S0195-5616(89)50104-9	33	13	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0229753	10.1371/journal.pone.0229753	http://dx.doi.org/10.1371/journal.pone.0229753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407333	Green Published, gold			2022-12-26	WOS:000537490700006
J	You, JC; Muralidharan, K; Fu, CH; Park, J; Tosi, U; Zhang, XH; Chin, J				You, Jason C.; Muralidharan, Kavitha; Fu, Chia-Hsuan; Park, Jin; Tosi, Umberto; Zhang, Xiaohong; Chin, Jeannie			Distinct patterns of dentate gyrus cell activation distinguish physiologic from aberrant stimuli	PLOS ONE			English	Article							HIPPOCAMPAL GRANULE CELLS; CRITICAL PERIOD; MOUSE MODEL; MEMORY CONSOLIDATION; SPONTANEOUS SEIZURES; GENE-EXPRESSION; FOS EXPRESSION; NEUROGENESIS; INTERNEURONS; INTEGRATION	Under physiologic conditions, the dentate gyrus (DG) exhibits exceptionally low levels of activity compared to other brain regions. A sparse activation pattern is observed even when the DG is engaged to process new information; for example, only similar to 1-3% of neurons in the DG granule cell layer (GCL) are activated after placing animals in a novel, enriched environment. Moreover, such physiologic stimulation of GCL neurons recruits young granule cells more readily than older cells. This sparse pattern of cell activation has largely been attributed to intrinsic circuit properties of the DG, such as reduced threshold for activation in younger cells, and increased inhibition onto older cells. Given these intrinsic properties, we asked whether such activation of young granule cells was unique to physiologic stimulation, or could be elicited by general pharmacological activation of the hippocampus. We found that administration of kainic acid (KA) at a low dose (5 mg/kg) to wildtype C57BL/6 mice activated a similarly sparse number of cells in the GCL as physiologic DG stimulation by exposure to a novel, enriched environment. However, unlike physiologic stimulation, 5 mg/kg KA activated primarily old granule cells as well as GABAergic interneurons. This finding indicates that intrinsic circuit properties of the DG alone may not be sufficient to support the engagement of young granule cells, and suggest that other factors such as the specificity of the pattern of inputs, may be involved.	[You, Jason C.; Muralidharan, Kavitha; Tosi, Umberto; Zhang, Xiaohong; Chin, Jeannie] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA; [You, Jason C.; Muralidharan, Kavitha; Tosi, Umberto; Zhang, Xiaohong; Chin, Jeannie] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [You, Jason C.; Muralidharan, Kavitha; Fu, Chia-Hsuan; Park, Jin; Chin, Jeannie] Baylor Coll Med, Memory & Brain Res Ctr, Dept Neurosci, Houston, TX 77030 USA	Jefferson University; Jefferson University; Baylor College of Medicine	Chin, J (corresponding author), Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA.; Chin, J (corresponding author), Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA.; Chin, J (corresponding author), Baylor Coll Med, Memory & Brain Res Ctr, Dept Neurosci, Houston, TX 77030 USA.	Jeannie.Chin@bcm.edu	Tosi, Umberto/AAL-9793-2020	Tosi, Umberto/0000-0003-0847-2400; Chin, Jeannie/0000-0001-9902-3744; MURALIDHARAN, KAVITHA/0000-0002-0112-2793	National Institutes of Health [F30-AG048710, NS086965, NS085171]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grants F30-AG048710 (JCY) and NS086965 and NS085171 (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alme CB, 2010, HIPPOCAMPUS, V20, P1109, DOI 10.1002/hipo.20810; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Borota D, 2014, NAT NEUROSCI, V17, P201, DOI 10.1038/nn.3623; Cayco-Gajic NA, 2019, NEURON, V101, P584, DOI 10.1016/j.neuron.2019.01.044; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Corbett BF, 2017, CELL REP, V20, P344, DOI 10.1016/j.celrep.2017.06.040; Danielson NB, 2016, NEURON, V90, P101, DOI 10.1016/j.neuron.2016.02.019; Diamantaki M, 2016, ELIFE, V5, DOI 10.7554/eLife.20252; Dieni CV, 2013, J NEUROSCI, V33, P19131, DOI 10.1523/JNEUROSCI.2289-13.2013; Ewell LA, 2010, J NEUROSCI, V30, P12597, DOI 10.1523/JNEUROSCI.1854-10.2010; Ferraro L, 1997, NEUROREPORT, V8, P2883, DOI 10.1097/00001756-199709080-00016; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gass JT, 2008, BIOCHEM PHARMACOL, V75, P218, DOI 10.1016/j.bcp.2007.06.039; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Harvey BD, 2005, J COMP NEUROL, V488, P442, DOI 10.1002/cne.20594; Houser CR, 2007, PROG BRAIN RES, V163, P217, DOI 10.1016/S0079-6123(07)63013-1; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Jungenitz T, 2014, CEREB CORTEX, V24, P1845, DOI 10.1093/cercor/bht035; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kleen JK, 2013, NEUROLOGY, V81, P18, DOI 10.1212/WNL.0b013e318297ee50; Kleen JK, 2010, ANN NEUROL, V67, P250, DOI 10.1002/ana.21896; Kutlu MG, 2016, LEARN MEMORY, V23, P515, DOI 10.1101/lm.042192.116; Leal SL, 2018, NAT NEUROSCI, V21, P163, DOI 10.1038/s41593-017-0065-1; Marin-Burgin A, 2012, SCIENCE, V335, P1238, DOI 10.1126/science.1214956; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Neunuebel JP, 2012, J NEUROSCI, V32, P3848, DOI 10.1523/JNEUROSCI.6038-11.2012; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Piatti VC, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00050; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; SCHARFMAN HE, 1995, J NEUROPHYSIOL, V74, P179, DOI 10.1152/jn.1995.74.1.179; Schmidt B, 2012, BEHAV BRAIN RES, V226, P56, DOI 10.1016/j.bbr.2011.08.039; Smucny J, 2015, NPJ SCHIZOPHR, V1, DOI 10.1038/npjschz.2015.2; Stone JM, 2011, THER ADV PSYCHOPHARM, V1, P5, DOI 10.1177/2045125311400779; Stone SSD, 2011, HIPPOCAMPUS, V21, P1348, DOI 10.1002/hipo.20845; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Temprana SG, 2015, NEURON, V85, P116, DOI 10.1016/j.neuron.2014.11.023; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Wu MV, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00114	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232241	10.1371/journal.pone.0232241	http://dx.doi.org/10.1371/journal.pone.0232241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407421	Green Published, gold			2022-12-26	WOS:000537490700016
J	Abebe, AS; Alemayehu, K; Johansson, AM; Gizaw, S				Abebe, Abiye Shenkut; Alemayehu, Kefyalew; Johansson, Anna Maria; Gizaw, Solomon			Breeding practices and trait preferences of smallholder farmers for indigenous sheep in the northwest highlands of Ethiopia: Inputs to design a breeding program	PLOS ONE			English	Article							GENETIC-PARAMETERS; BODY MEASUREMENTS; MANAGEMENT; OBJECTIVES; LIVESTOCK; MODEL	The aim of this study was to identify breeding practices and trait preferences for indigenous sheep in three districts (Estie, Farta and Lay Gayient) located in the northwest highlands of Ethiopia. Questionnaire survey and choice experiment methods were used to collect data from 370 smallholder farmers. Respondents were selected randomly among smallholder farmers who own sheep in the aforementioned districts. A generalized multinomial logit model was employed to examine preferences for sheep attributes, while descriptive statistics and index values were computed to describe sheep breeding practices. Having the highest index value of 0.36, income generation was ranked as the primary reason for keeping sheep, followed by meat and manure sources. The average flock size per smallholder farmer was 10.21 sheep. The majority of the smallholder farmers (91%) have the experience of selecting breeding rams and ewes within their own flock using diverse criteria. Given the highest index value of 0.34, body size was ranked as a primary ram and ewe selection criteria, followed by coat color. Furthermore, choice modeling results revealed that tail type, body size, coat color, growth rate, horn and ear size have shown significant influences on smallholder farmers' preference for breeding rams (P<0.01). The part-worth utility coefficients were positive for all ram attributes except ear size. For breeding ewes, mothering ability, coat color, body size, lambing interval, growth rate, tail type and litter size have shown significant effects on choice preferences of smallholder farmers (P<0.05). Moreover, significant scale heterogeneity was observed among respondents for ewe attributes (P<0.001). Overall, the results implied that sheep breeding objectives suitable for the northwest highlands of the country can be derived from traits such as linear body measurement, weight and survival at different ages, and lambing intervals. However, selection decisions at the smallholder level should not only be based on estimated breeding values of traits included in the breeding objective but instead, incorporate ways to address farmers' preference for qualitative traits.	[Abebe, Abiye Shenkut; Alemayehu, Kefyalew] Bahir Dar Univ, Dept Anim Prod & Technol, Bahir Dar, Ethiopia; [Abebe, Abiye Shenkut] Debre Tabor Univ, Dept Anim Sci, Debre Tabor, Ethiopia; [Johansson, Anna Maria] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Gizaw, Solomon] Int Livestock Res Inst ILRI, Addis Ababa, Ethiopia	Bahir Dar University; Swedish University of Agricultural Sciences; CGIAR; International Livestock Research Institute (ILRI)	Abebe, AS (corresponding author), Bahir Dar Univ, Dept Anim Prod & Technol, Bahir Dar, Ethiopia.; Abebe, AS (corresponding author), Debre Tabor Univ, Dept Anim Sci, Debre Tabor, Ethiopia.	abiysh85@gmail.com	Abebe, Abiye/AAZ-9901-2020	Johansson, Anna M/0000-0002-9762-0497; Abebe, Abiye Shenkut/0000-0002-3887-1376	Ethiopian Ministry of Education via College of Agriculture and Environmental Sciences of Bahir Dar University [250/2019]	Ethiopian Ministry of Education via College of Agriculture and Environmental Sciences of Bahir Dar University	ASA received fund for this study from the Ethiopian Ministry of Education via College of Agriculture and Environmental Sciences of Bahir Dar University (Ref.No/250/2019). The website for College of Agriculture and Environmental Sciences of Bahir Dar University is https://bdu.edu.et/caes/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amare B., 2012, Animal Genetic Resources, P117; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2018, STAT B, VII; [Anonymous], [No title captured]; Bett RC, 2009, TROP ANIM HEALTH PRO, V41, P307, DOI 10.1007/s11250-008-9191-9; Bimerow T., 2011, Online Journal of Animal and Feed Research (OJAFR), V1, P299; BOX G.E.P., 2005, STAT EXPT DESIGN INN; CSA, 2013, POPULATION PROJECTIO; Dagnew Y, 2017, OPEN J ANIMAL SCI, V7, P179; Duguma G, 2011, ANIMAL, V5, P1984, DOI 10.1017/S1751731111001029; Duguma G, 2010, LIVESTOCK RES RURAL, V22; EDEA Z, 2012, LIVEST RES RURAL DEV, V24, P7; Fiebig DG, 2010, MARKET SCI, V29, P393, DOI 10.1287/mksc.1090.0508; Gebre KT, 2018, J DRYLANDS, V8, P834; Gebreyowhens W, 2016, J BIOL AGR HEALTHCAR, V6, P96; Getachew T., 2016, African Journal of Agricultural Research, V11, P901; Getachew T, 2010, AFR J AGR RES, V5, P685; Gizaw S, 2011, ANIMAL, V5, P995, DOI 10.1017/S1751731111000024; Gizaw S., 2008, ANIM GENET RESOUR, V43, P25, DOI [10.1017/S1014233900002704, DOI 10.1017/S1014233900002704]; Gizaw S., 2013, REV SHEEP RES DEV PR; Gizaw S, 2010, LIVEST SCI, V128, P67, DOI 10.1016/j.livsci.2009.10.016; Gizaw S, 2009, LIVEST SCI, V124, P82, DOI 10.1016/j.livsci.2009.01.001; Haile A, 2011, ICARDA TOOLS GUIDELI; HAILE A, 2013, LIVESTOCK RES RURAL, V28; Hamadou I, 2019, ARCH ANIM BREED, V62, P537, DOI 10.5194/aab-62-537-2019; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Hensher DA, 2003, TRANSPORTATION, V30, P133, DOI 10.1023/A:1022558715350; Jafari S, 2014, S AFR J ANIM SCI, V44, P140, DOI 10.4314/sajas.v44i2.6; Jaitner J, 2001, SMALL RUMINANT RES, V40, P101, DOI 10.1016/S0921-4488(00)00221-2; Janssens S, 2004, SMALL RUMINANT RES, V54, P13, DOI 10.1016/j.smallrumres.2003.10.008; Johnson R., 2003, SEQUIM SAWTOOTH SOFT; Konig EZ, 2016, TROP ANIM HEALTH PRO, V48, P9, DOI 10.1007/s11250-015-0911-7; Lemma G., 2018, ACAD RES J AGRI SCI, V6, P35; Martin-Collado D, 2015, J DAIRY SCI, V98, P4148, DOI 10.3168/jds.2014-9194; McFadden D., 1979, BEHAV TRAVEL MODELLI; Mekuriaw S., 2013, Scientific Journal of Veterinary Advances, V2, P132; Mekuriaw S, 2012, TRADITIONAL MANAGEME; Mirkena M., 2010, THESIS; Mirkena T, 2012, J ANIM BREED GENET, V129, P244, DOI 10.1111/j.1439-0388.2011.00970.x; Nigussie H, 2015, AM ACAD SCI RES J EN, V11, P136; Orme BK., 2019, GETTING STARTED CONJ, V4th; SAS Institute Inc, 2018, NEW FEAT JMP 14; Siddo S, 2015, ARCH TIERZUCHT, V58, P251, DOI 10.5194/aab-58-251-2015; Solkner J., 1998, P 6 WORLD C GEN APPL, P273; Tindano K, 2017, TROP ANIM HEALTH PRO, V49, P1187, DOI 10.1007/s11250-017-1315-7; Wurzinger M, 2011, SMALL RUMINANT RES, V98, P170, DOI 10.1016/j.smallrumres.2011.03.035; WURZINGER M, 2006, P 8 WORLD C GEN APPL	47	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0233040	10.1371/journal.pone.0233040	http://dx.doi.org/10.1371/journal.pone.0233040			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396551	gold, Green Published			2022-12-26	WOS:000537475000038
J	Le, YH; Nguyen, KC; Coleman, KK; Nguyen, TT; Than, ST; Phan, HH; Nguyen, MD; Ngu, ND; Phan, DT; Hoang, PVM; Trieu, LP; Bailey, ES; Warkentien, TE; Gray, GC				Le, Yen H.; Nguyen, Khanh C.; Coleman, Kristen K.; Nguyen, Tham T.; Than, Son T.; Phan, Hai H.; Nguyen, Manh D.; Ngu, Nghia D.; Phan, Dan T.; Hoang, Phuong V. M.; Trieu, Long P.; Bailey, Emily S.; Warkentien, Tyler E.; Gray, Gregory C.			Virus detections among patients with severe acute respiratory illness, Northern Vietnam	PLOS ONE			English	Article							INFLUENZA-VIRUSES; CORONAVIRUSES; ADULTS; COINFECTIONS; INFECTION; DISEASES	Severe acute respiratory illness (SARI) is a major cause of death and morbidity in low- and middle-income countries, however, the etiologic agents are often undetermined due to the lack of molecular diagnostics in hospitals and clinics. To examine evidence for select viral infections among patients with SARI in northern Vietnam, we studied 348 nasopharyngeal samples from military and civilian patients admitted to 4 hospitals in the greater Hanoi area from 2017-2019. Initial screening for human respiratory viral pathogens was performed in Hanoi, Vietnam at the National Institute of Hygiene and Epidemiology (NIHE) or the Military Institute of Preventative Medicine (MIPM), and an aliquot was shipped to Duke-NUS Medical School in Singapore for validation. Patient demographics were recorded and used to epidemiologically describe the infections. Among military and civilian cases of SARI, 184 (52.9%) tested positive for one or more respiratory viruses. Influenza A virus was the most prevalent virus detected (64.7%), followed by influenza B virus (29.3%), enterovirus (3.8%), adenovirus (1.1%), and coronavirus (1.1%). Risk factor analyses demonstrated an increased risk of influenza A virus detection among military hospital patients (adjusted OR, 2.0; 95% CI, 1.2-3.2), and an increased risk of influenza B virus detection among patients enrolled in year 2017 (adjusted OR, 7.9; 95% CI, 2.7-22.9). As influenza A and B viruses were commonly associated with SARI and are treatable, SARI patients entering these hospitals would benefit if the hospitals were able to adapt onsite molecular diagnostics.	[Le, Yen H.; Nguyen, Manh D.; Phan, Dan T.; Trieu, Long P.] Mil Inst Prevent Med, Hanoi, Vietnam; [Nguyen, Khanh C.; Ngu, Nghia D.; Hoang, Phuong V. M.] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Coleman, Kristen K.; Nguyen, Tham T.; Than, Son T.; Gray, Gregory C.] Duke Natl Univ Singapore, Emerging Infect Dis Programme, Singapore, Singapore; [Phan, Hai H.] Hai Phong Prov Prevent Med Ctr, Hai Phong, Vietnam; [Bailey, Emily S.; Gray, Gregory C.] Duke Univ, Global Hlth Inst, Div Infect Dis, Durham, NC USA; [Warkentien, Tyler E.] Naval Med Res Ctr Asia, Singapore, Singapore; [Gray, Gregory C.] Duke Kunshan Univ, Global Hlth Ctr, Kunshan, Peoples R China	National Institute of Hygiene & Epidemiology (NIHE); National University of Singapore; Duke University; Duke Kunshan University	Gray, GC (corresponding author), Duke Natl Univ Singapore, Emerging Infect Dis Programme, Singapore, Singapore.; Gray, GC (corresponding author), Duke Univ, Global Hlth Inst, Div Infect Dis, Durham, NC USA.; Gray, GC (corresponding author), Duke Kunshan Univ, Global Hlth Ctr, Kunshan, Peoples R China.	Gregory.gray@duke.edu	Gray, Gregory C./ABF-1298-2020	Coleman, Kristen/0000-0003-0024-3400; Nguyen, Cong Khanh/0000-0002-3775-9139	Etiology of Acute Respiratory Infections in Vietnamese Military and Civilian Populations [W911QY-14-C-0043]	Etiology of Acute Respiratory Infections in Vietnamese Military and Civilian Populations	This work was supported by the research grant: W911QY-14-C-0043, Etiology of Acute Respiratory Infections in Vietnamese Military and Civilian Populations (originally Duane Gubler and later inherited by author GG as principal investigator). The funders played an administrative role in data collection.	Alroy KA, 2018, INFLUENZA OTHER RESP, V12, P632, DOI 10.1111/irv.12571; [Anonymous], FLUNET; [Anonymous], 2019, PREP HIGH IMP RESP P; Bailey ES, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00104; Bil-Lula I, 2012, MED SCI MONITOR, V18, pBR221, DOI 10.12659/MSM.882898; Bin Seo Y, 2014, INFECT CHEMOTHER, V46, P67, DOI 10.3947/ic.2014.46.2.67; Coleman CM, 2014, J VIROL, V88, P5209, DOI 10.1128/JVI.03488-13; Coleman KK, 2020, J INFECT DIS, V221, P566, DOI 10.1093/infdis/jiz489; Durey A, 2017, INFECT CHEMOTHER, V49, P140, DOI 10.3947/ic.2017.49.2.140; Fieldhouse JK, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0159-1; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; Guarner J., 2020, AM J CLIN PATHOL; Kajon AE, 2018, EMERG INFECT DIS, V24, P201, DOI 10.3201/eid2402.171407; Kalimuddin S, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx053; Lelli D, 2013, VIRUSES-BASEL, V5, P2679, DOI 10.3390/v5112679; Lim LM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205795; McAllister SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118529; McCarthy T, 2009, J CLIN VIROL, V46, P80, DOI 10.1016/j.jcv.2009.06.008; Metlay JP, 2019, AM J RESP CRIT CARE, V200, pE45, DOI 10.1164/rccm.201908-1581ST; Ng OT, 2015, EMERG INFECT DIS, V21, P1192, DOI 10.3201/eid2107.141443; Thao NTT, 2017, J INFECT DIS, V216, P1371, DOI 10.1093/infdis/jix500; Oberste MS, 2013, J VIROL, V87, P558, DOI 10.1128/JVI.00837-12; Russell KL, 2006, VACCINE, V24, P2835, DOI 10.1016/j.vaccine.2005.12.062; Stefanska I, 2013, ADV EXP MED BIOL, V756, P291, DOI 10.1007/978-94-007-4549-0_36; Takahashi K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-296; Toh TH, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz074; World Health Organization (WHO), US CDC PROT REAL TIM; Yu HJ, 2014, INFLUENZA OTHER RESP, V8, P53, DOI 10.1111/irv.12205	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0233117	10.1371/journal.pone.0233117	http://dx.doi.org/10.1371/journal.pone.0233117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396550	Green Published, gold			2022-12-26	WOS:000537475000043
J	Feng, XJ; Pan, LT; Wang, QJ; Liao, ZQ; Wang, XQ; Zhang, XM; Guo, W; Hu, EL; Li, JW; Xu, J; Wu, FK; Lu, YL				Feng, Xuanjun; Pan, Liteng; Wang, Qingjun; Liao, Zhengqiao; Wang, Xianqiu; Zhang, Xuemei; Guo, Wei; Hu, Erliang; Li, Jingwei; Xu, Jie; Wu, Fengkai; Lu, Yanli			Nutritional and physicochemical characteristics of purple sweet corn juice before and after boiling	PLOS ONE			English	Article							DIFFERENT COOKING METHODS; ANTIOXIDANT ACTIVITY; ACID PROFILE; STABILITY; COMPONENTS; MAIZE	Sweet corn juice is becoming increasingly popular in China. In order to provide valuable health-related information to consumers, the nutritional and physicochemical characteristics of raw and boiled purple sweet corn juices were herein investigated. Sugars, antinutrients, total free phenols, anthocyanins, and antioxidant activity were analyzed by conventional chemical methods. The viscosity and stability of juices were determined by Ubbelohde viscosity meter and centrifugation, respectively. Boiling process could elevate viscosity, stability and sugar content, and reduce antinutrients, total free phenols, anthocyanins, and antioxidant activity in corn juice. In addition, short time boiling efficiently reduced the degradation of anthocyanins during subsequent refrigeration. The content of amino acids, vitamin B1/B2 and E were detected by High Performance Liquid Chromatography. Gas Chromatography Mass Spectrometry was used for the analysis of fatty acids and aroma compounds. Several aroma compounds not previously reported in corn were identified, including 1-heptanol, 2-methyl-2-butenal, (Z)-3-nonen-1-ol, 3-ethyl-2-methyl-1,3-hexadiene, and 2,4-bis (1,1-dimethylethyl)phenol. Interestingly, the boiling process had no apparent effect on the amino acids profile, but it caused a 45.8% loss of fatty acids in the juice by promoting the retention of fatty acids in the corn residue. These results provide detailed information that could be used for increasing consumers' knowledge of sweet corn juice, further development of sweet corn juice by food producers, and maize breeding programs.	[Feng, Xuanjun; Pan, Liteng; Wang, Qingjun; Liao, Zhengqiao; Wang, Xianqiu; Zhang, Xuemei; Guo, Wei; Xu, Jie; Wu, Fengkai; Lu, Yanli] Sichuan Agr Univ, State Key Lab Crop Gene Explorat & Utilizat South, Yaan, Sichuan, Peoples R China; [Feng, Xuanjun; Pan, Liteng; Wang, Qingjun; Liao, Zhengqiao; Wang, Xianqiu; Zhang, Xuemei; Guo, Wei; Hu, Erliang; Li, Jingwei; Xu, Jie; Wu, Fengkai; Lu, Yanli] Sichuan Agr Univ, Maize Res Inst, Yaan, Sichuan, Peoples R China; [Feng, Xuanjun; Pan, Liteng; Wang, Qingjun; Liao, Zhengqiao; Wang, Xianqiu; Zhang, Xuemei; Guo, Wei; Hu, Erliang; Li, Jingwei; Xu, Jie; Wu, Fengkai; Lu, Yanli] Minist Agr, Key Lab Biol & Genet Improvement Maize Southwest, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Ministry of Agriculture & Rural Affairs	Lu, YL (corresponding author), Sichuan Agr Univ, State Key Lab Crop Gene Explorat & Utilizat South, Yaan, Sichuan, Peoples R China.; Lu, YL (corresponding author), Sichuan Agr Univ, Maize Res Inst, Yaan, Sichuan, Peoples R China.; Lu, YL (corresponding author), Minist Agr, Key Lab Biol & Genet Improvement Maize Southwest, Chengdu, Sichuan, Peoples R China.	yanli.lu82@hotmail.com	; Wang, Qingjun/AAB-7599-2020	Feng, Xuanjun/0000-0002-3800-4029; Wang, Qingjun/0000-0001-8976-3124	National Key Research and Development Program of China [2018YFD0100100]; Science and technology support program of Sichuan province, China [2016NYZ0029]	National Key Research and Development Program of China; Science and technology support program of Sichuan province, China	YL received two fundings. The National Key Research and Development Program of China (2018YFD0100100) and Science and technology support program of Sichuan province, China (2016NYZ0029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyeye E. I., 2011, Bangladesh Journal of Scientific and Industrial Research, V46, P89, DOI 10.3329/bjsir.v46i1.8112; Adom KK, 2002, J AGR FOOD CHEM, V50, P6182, DOI 10.1021/jf0205099; BUTTERY RG, 1994, J AGR FOOD CHEM, V42, P791, DOI 10.1021/jf00039a038; Buttery RG, 1997, J AGR FOOD CHEM, V45, P837, DOI 10.1021/jf9604807; BUTTERY RG, 1995, J AGR FOOD CHEM, V43, P1878, DOI 10.1021/jf00055a023; Cevallos-Casals BA, 2004, FOOD CHEM, V86, P69, DOI 10.1016/j.foodchem.2003.08.011; Chauvelon G, 2000, CARBOHYD POLYM, V42, P385, DOI 10.1016/S0144-8617(99)00187-3; Choe E, 2005, J FOOD SCI, V70, pR28, DOI 10.1111/j.1365-2621.2005.tb09055.x; Chukwuma O. E., 2016, J FOOD NUTR SCI, V4, P34, DOI DOI 10.11648/J.JFNS.20160402.12; Dewanto V, 2002, J AGR FOOD CHEM, V50, P4959, DOI 10.1021/jf0255937; Dong F.M., 2000, ENCLYCLOPEDIA AQUACU, P45; Dwivedi M, 2015, FOOD SCI BIOTECHNOL, V24, P2113, DOI 10.1007/s10068-015-0280-z; Ersoy B, 2009, FOOD CHEM, V115, P419, DOI 10.1016/j.foodchem.2008.12.018; Evenepoel P, 1998, J NUTR, V128, P1716, DOI 10.1093/jn/128.10.1716; FAO/WHO/UNU, 1985, WHO TECHN REP SER; Hossain F, 2013, J PLANT BIOCHEM BIOT, DOI [10.1007/s13562-013-0245-3, DOI 10.1007/S13562-013-0245-3]; Kahriman F, 2015, J AM OIL CHEM SOC, V92, P1451, DOI 10.1007/s11746-015-2716-2; Kirca A, 2007, FOOD CHEM, V101, P212, DOI 10.1016/j.foodchem.2006.01.019; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Kumar S, 2006, J FOOD COMPOS ANAL, V19, P311, DOI 10.1016/j.jfca.2005.06.007; Li XC, 2012, J AGR FOOD CHEM, V60, P6418, DOI 10.1021/jf204970r; Liu HS, 2006, CARBOHYD POLYM, V65, P357, DOI 10.1016/j.carbpol.2006.01.026; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Miglio C, 2008, J AGR FOOD CHEM, V56, P139, DOI 10.1021/jf072304b; Mohapatra D, 2019, FOOD CHEM, V271, P129, DOI 10.1016/j.foodchem.2018.07.196; Nuss ET, 2010, COMPR REV FOOD SCI F, V9, P417, DOI 10.1111/j.1541-4337.2010.00117.x; Oluwaniyi OO, 2010, FOOD CHEM, V123, P1000, DOI 10.1016/j.foodchem.2010.05.051; Ozcan MM, 2019, J FOOD PROCESS PRES, V43, DOI 10.1111/jfpp.13986; Pedreschi R, 2007, FOOD CHEM, V100, P956, DOI 10.1016/j.foodchem.2005.11.004; Sanjeev P, 2014, J AM OIL CHEM SOC, V91, P1001, DOI 10.1007/s11746-014-2429-y; Sengul M, 2014, INT J FOOD PROP, V17, P481, DOI 10.1080/10942912.2011.619292; Sharma K, 2015, J FOOD DRUG ANAL, V23, P243, DOI 10.1016/j.jfda.2014.10.005; Sheng SY, 2018, FOOD SCI HUM WELL, V7, P185, DOI [10.1016/j.fshw.2018.09.001, 10.1016/j.fshw.2018.09.003]; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sun YZ, 2011, BARLEY CEREAL SCI, V4, P1, DOI [10.14069/j.cnki.32-1769/s.2011.04.008, DOI 10.14069/J.CNKI.32-1769/S.2011.04.008]; van Boekel MAJS, 2006, BIOTECHNOL ADV, V24, P230, DOI 10.1016/j.biotechadv.2005.11.004; Wei SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182604; Xi P, 2016, MOL NUTR FOOD RES, V60, P1819, DOI 10.1002/mnfr.201500963; Yamini S, 2016, NUTR REV, V74, P601, DOI 10.1093/nutrit/nuw027; Yuan GF, 2009, J ZHEJIANG UNIV-SC B, V10, P580, DOI 10.1631/jzus.B0920051	40	6	8	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0233094	10.1371/journal.pone.0233094	http://dx.doi.org/10.1371/journal.pone.0233094			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392267	gold, Green Published			2022-12-26	WOS:000537470300037
J	Cardenas-de la Garza, JA; Welsh, O; Cuellar-Barboza, A; Suarez-Sanchez, KP; Cruz-Gomez, LG; De la Cruz-Valadez, E; Ocampo-Candiani, J; Vera-Cabrera, L				Alberto Cardenas-de la Garza, Jesus; Welsh, Oliverio; Cuellar-Barboza, Adrian; Paola Suarez-Sanchez, Karina; Gerardo Cruz-Gomez, Luis; De la Cruz-Valadez, Estephania; Ocampo-Candiani, Jorge; Vera-Cabrera, Lucio			Climate, soil type, and geographic distribution of actinomycetoma cases in Northeast Mexico: A cross-sectional study	PLOS ONE			English	Article							MADURA FOOT; MYCETOMA	Background Mycetoma is a chronic, granulomatous infection of subcutaneous tissue, that may involve deep structures and bone. It can be caused by bacteria (actinomycetoma) or fungi (eumycetoma). There is an epidemiological association between mycetoma and the environment, including rainfall, temperature and humidity but there are still many knowledge gaps in the identification of the natural habitat of actinomycetes, their primary reservoir, and their precise geographical distribution. Knowing the potential distribution of this infection and its ecological niche in endemic areas is relevant to determine disease management strategies and etiological agent habitat or reservoirs. Methodology/principal findings This was an ambispective descriptive study of 31 patients with actinomycetoma. We determined the biophysical characteristics including temperature, precipitation, soil type, vegetation, etiological agents, and mapped actinomycetoma cases in Northeast Mexico. We identified two disease cluster areas. One in Nuevo Leon, with a predominantly kastanozems soil type, with a mean annual temperature of 22 degrees, and a mean annual precipitation of 585.2 mm. Herein, mycetoma cases were produced by Actinomadura pelletieri, Actinomadura madurae, Nocardia brasiliensis, and Nocardia spp. The second cluster was in San Luis Potosi, where lithosols soil type predominates, with a mean annual temperature of 23.5 degrees and a mean annual precipitation of 635.4 mm. In this area, all the cases were caused by N. brasiliensis. A. madurae cases were identified in rendzinas, kastanozems, vertisols, and lithosols soils, and A. pelletieri cases in xerosols, kastanozems, and rendzinas soils. Previous thorn trauma with Acacia or Prosopis plants was referred by 35.4% of subjects. In these states, the presence of thorny plants, such as Acacia spp., Prosopis spp., Senegalia greggi, Vachellia farnesiana and Vachellia rigidula, are common. Conclusions/significance Mapping this neglected tropical infection aids in the detection of disease cluster areas, the development of public health strategies for early diagnosis and disease prediction models; this paves the way for more ecological niche etiological agent research.	[Alberto Cardenas-de la Garza, Jesus; Welsh, Oliverio; Cuellar-Barboza, Adrian; Paola Suarez-Sanchez, Karina; Gerardo Cruz-Gomez, Luis; De la Cruz-Valadez, Estephania; Ocampo-Candiani, Jorge; Vera-Cabrera, Lucio] Univ Autonoma Nuevo Leon, Fac Med, Serv Dermatol, Monterrey, Mexico; [Alberto Cardenas-de la Garza, Jesus; Welsh, Oliverio; Cuellar-Barboza, Adrian; Paola Suarez-Sanchez, Karina; Gerardo Cruz-Gomez, Luis; De la Cruz-Valadez, Estephania; Ocampo-Candiani, Jorge; Vera-Cabrera, Lucio] Univ Autonoma Nuevo Leon, Hosp Univ, Monterrey, Mexico	Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon	Vera-Cabrera, L (corresponding author), Univ Autonoma Nuevo Leon, Fac Med, Serv Dermatol, Monterrey, Mexico.	luvera_99@yahoo.com	Cardenas-de la Garza, Jesus Alberto/AAL-9288-2020; Cuellar-Barboza, Adrian/AAY-7494-2020; Ocampo-Candiani, Jorge/B-6853-2015	Cardenas-de la Garza, Jesus Alberto/0000-0002-5099-0079; Cuellar-Barboza, Adrian/0000-0003-2405-5201; Ocampo-Candiani, Jorge/0000-0002-0213-0031; Vera-Cabrera, Lucio/0000-0002-0890-9660; Suarez Sanchez, Karina Paola/0000-0003-4632-162X; Cruz Gomez, Luis Gerardo/0000-0003-2798-8832				ABBOTT P., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P11, DOI 10.1016/0035-9203(56)90004-9; Bitan O, 2017, AM J TROP MED HYG, V96, P1355, DOI 10.4269/ajtmh.16-0710; Cardenas-de la Garza JA, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008123; Centro de Investigacion Cienti fica y de Educacion Superior de Ensenada Baja California, 2019, DAT BAS DAT CLIM NAC; Comision Nacional del Agua, 2018, DAT RES MENS TEMP LL; Darre T, 2018, MYCOPATHOLOGIA, V183, P961, DOI 10.1007/s11046-018-0260-y; Driessen P., 2001, LECT NOTES MAJOR SOI; FAO/ITPS, 1992, STAT WORLDS SOIL RES; Food and Agriculture Organization UN Land and Water Division, 2007, DIG SOIL MAP WORLD G; GBIF.org, GBIF OCC DOWNL PROP, DOI [10.15468/dl.jz44ze, DOI 10.15468/DL.JZ44ZE]; Hay SI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0250; Hind Benhiba, 2015, Pan Afr Med J, V20, P306, DOI 10.11604/pamj.2015.20.306.5766; IUSS Grupo de Trabajo WRB, 2006, 103 IUSS; Messoudi A, 2013, Bull Soc Pathol Exot, V106, P9, DOI 10.1007/s13149-012-0269-2; Nenoff P, 2015, J EUR ACAD DERMATOL, V29, P1873, DOI 10.1111/jdv.13008; Samy AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003250; Sanchez-Mateos JLS, 2007, REV CLIN ESP, V207, P527, DOI 10.1157/13111555; Semarnat, 2008, INF SIT MED AMB MEX; van de Sande W, 2018, MED MYCOL, V56, pS153, DOI 10.1093/mmy/myx061; van de Sande WWJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002550; Vera-Cabrera L, 1999, J CLIN MICROBIOL, V37, P1971, DOI 10.1128/JCM.37.6.1971-1976.1999; Zijlstra EE, 2016, LANCET INFECT DIS, V16, P100, DOI 10.1016/S1473-3099(15)00359-X	22	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232556	10.1371/journal.pone.0232556	http://dx.doi.org/10.1371/journal.pone.0232556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384126	Green Published, gold			2022-12-26	WOS:000537468300019
J	Avouac, J; Cauvet, A; Steelandt, A; Shirai, Y; Elhai, M; Kuwana, M; Distler, O; Allanore, Y				Avouac, Jerome; Cauvet, Anne; Steelandt, Alexia; Shirai, Yuichiro; Elhai, Muriel; Kuwana, Masataka; Distler, Oliver; Allanore, Yannick			Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease	PLOS ONE			English	Article							CLASSIFICATION; CRITERIA; FIBROSIS; KL-6	Objective To determine the performance of 3 circulating markers for the diagnosis and the progression of interstitial lung disease (ILD) associated with rheumatoid arthritis (RA). Methods Serum concentrations of 3 circulating markers, lung epithelial-derived surfactant protein D (SPD), chemokine CCL-18 and Krebs von den Lungen-6 glycoprotein (KL-6), were measured by ELISA in consecutive patients with established RA. These patients were recruited from 3 tertiary centers and they all had been investigated by chest high-resolution computed tomography (HRCT). For a subset of French patients, a follow-up HRCT was available (mean interval between HRCT: 3 +/- 1.5 years). Results Among the 147 included patients (age: 66 +/- 12 years, 69% women, disease duration 11 +/- 10 years), 40 (27%) had RA-ILD on chest HRCT. SPD, CCL18 and KL-6 concentrations were significantly higher in patients with RA-ILD. ROC curve analysis to assess the diagnostic abilities of the three markers for the diagnosis of RA-ILD showed a superiority of KL-6 (Area under the curve, AUC: 0.79 95% CI 0.72-0.86) compared to SPD (AUC: 0.66 95% CI 0.58-0.74) and CCL18 (AUC: 0.62, 95% CI 0.53-0.70). The sensitivity of KL-6 for the diagnosis of RA-ILD was 68% with a specificity of 83%. The combination of KL-6 with SPD and CCL18 improved its diagnostic ability, with increased sensitivity from 68% to 77%, specificity from 83% to 97%. Increased KL-6 levels were independently associated with the presence of RA-ILD after the adjustment on other RA-ILD risk factors. In the French subset with longitudinal data, baseline KL-6 serum levels were predictive of ILD progression and the degree of ILD progression on HRCT was proportional to baseline KL-6 concentrations. Conclusion These results show that KL-6 is a relevant circulating marker for the diagnosis and might be an interesting marker for the progression of RA-ILD.	[Avouac, Jerome; Cauvet, Anne; Steelandt, Alexia; Allanore, Yannick] Paris Univ, INSERM, U1016, Sorbonne Paris Cite,Cochin Inst, Paris, France; [Avouac, Jerome; Cauvet, Anne; Steelandt, Alexia; Allanore, Yannick] Paris Univ, CNRS, UMR8104, Sorbonne Paris Cite,Cochin Inst, Paris, France; [Avouac, Jerome; Steelandt, Alexia; Allanore, Yannick] Paris Univ, Cochin Hosp, Rheumatol Dept, Sorbonne Paris Cite, Paris, France; [Shirai, Yuichiro; Kuwana, Masataka] Nippon Med Sch, Allergy & Rheumatol, Grad Sch Med, Tokyo, Japan; [Elhai, Muriel; Distler, Oliver] Dept Rheumatol, Zurich, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Nippon Medical School	Avouac, J (corresponding author), Paris Univ, INSERM, U1016, Sorbonne Paris Cite,Cochin Inst, Paris, France.; Avouac, J (corresponding author), Paris Univ, CNRS, UMR8104, Sorbonne Paris Cite,Cochin Inst, Paris, France.; Avouac, J (corresponding author), Paris Univ, Cochin Hosp, Rheumatol Dept, Sorbonne Paris Cite, Paris, France.	jerome.avouac@aphp.fr		Avouac, Jerome/0000-0002-2463-218X				Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Avouac J, 2017, SEMIN ARTHRITIS RHEU, V46, P537, DOI 10.1016/j.semarthrit.2016.10.007; Distler O, 2019, NEW ENGL J MED, V380, P2518, DOI 10.1056/NEJMoa1903076; Elhai M, 2020, SEMIN ARTHRITIS RHEU, V50, P480, DOI 10.1016/j.semarthrit.2020.01.006; Elhai M, 2019, ARTHRITIS RHEUMATOL, V71, P972, DOI 10.1002/art.40815; Flaherty KR, 2019, NEW ENGL J MED, V381, P1718, DOI 10.1056/NEJMoa1908681; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Hoffmann-Vold AM, 2016, CHEST, V150, P299, DOI 10.1016/j.chest.2016.03.004; Juge PA, 2018, NEW ENGL J MED, V379, P2209, DOI 10.1056/NEJMoa1801562; Kiely P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028466; Kim HC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229997; Kinoshita F, 2004, RESP MED, V98, P1131, DOI 10.1016/j.rmed.2004.04.003; Lee JS, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1835-9; Oyama T, 1997, LUNG, V175, P379, DOI 10.1007/PL00007584; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Volkmann ER, 2019, ARTHRITIS RHEUMATOL, V71, P2059, DOI 10.1002/art.41020; Wu WL, 2018, ANN RHEUM DIS, V77, P1326, DOI 10.1136/annrheumdis-2018-213201	18	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232978	10.1371/journal.pone.0232978	http://dx.doi.org/10.1371/journal.pone.0232978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384128	Green Published, gold			2022-12-26	WOS:000537468300041
J	Zangana, A; Shabila, N; Heath, T; White, S				Zangana, Aso; Shabila, Nazar; Heath, Tom; White, Sian			The determinants of handwashing behaviour among internally displaced women in two camps in the Kurdistan Region of Iraq	PLOS ONE			English	Article							HYGIENE; PROMOTION; EMERGENCIES; STRATEGIES; SANITATION; HEALTH; IMPACT; HANDS; WATER	Background Diarrhoea is one of the most common causes of mortality and morbidity among populations displaced due to conflict. Handwashing with soap has the potential to halve the burden of diarrhoeal diseases in crisis contexts. This study aimed to identify which determinants drive handwashing behaviour in post-conflict, displacement camps. Methods This study was conducted in two camps for internally displaced people in the Kurdistan Region of Iraq. A Barrier Analysis questionnaire was used for assessing the determinants of hand washing behaviour. Participants were screened and classified as either 'doers' (those who wash their hands with soap at critical times) or 'non-doers' (those who do not wash their hands with soap at critical times). Forty-five doers and non-doers were randomly selected from each camp and asked about behavioural determinants. The Barrier Analysis standard tabulation sheet was used for the analysis. Results No differences were observed between doers and non-doers in relation to self-efficacy, action efficacy, the difficulties and benefits of handwashing, and levels of access to soap and water. In the first of the two camps, non-doers found it harder to remember to wash their hands (P = 0.045), had lower perceived vulnerability to diarrhoea (P = 0.037), lower perceived severity of diarrhoea (P = 0.020) and were aware of 'policies' which supported handwashing with soap (P = 0.037). In the second camp non-doers had lower perceived vulnerability to diarrhoea (P = 0.017). Conclusions In these camp settings handwashing behaviour, and the factors that determine it, was relatively homogenous because of the homogeneity of the settings and the socio-demographics of population. Handwashing programmes should seek to improve the convenience and quality of handwashing facilities, create cues to trigger handwashing behaviour and increase perceived risk. We identify several ways to improve the validity of the Barrier Analysis method such as using it in combination with other more holistic qualitative tools and revising the statistical analysis.	[Zangana, Aso] Kurdistan Board Med Specialties KBMS, Erbil, Kurdistan, Iraq; [Shabila, Nazar] Hawler Med Univ, Dept Community Med, Erbil, Kurdistan, Iraq; [Heath, Tom] Action Faim, Paris, France; [White, Sian] London Sch Hyg & Trop Med, Dept Dis Control, London, England	Hawler Medical University; University of London; London School of Hygiene & Tropical Medicine	White, S (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London, England.	sian.white@lshtm.ac.uk	Shabila, Nazar/I-1314-2019	Shabila, Nazar/0000-0002-8921-195X	United States Agency for International Development (USAID); Office of U.S. Foreign Disaster Assistance [AID-OFDA-G-16-00270]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Office of U.S. Foreign Disaster Assistance	This reserach was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID or the United States Government. A grant from the Office of U.S. Foreign Disaster Assistance was recieved by SW (award number AID-OFDA-G-16-00270). Funder website: https://www.usaid.gov/who-we-are/organization/bureaus/bureau-democracy-conflictand-humanitarian-assistance/office-us.The funders played no role in the study design, data collection, analysis, decision to publish or preperation of the manuscript.	Arthur Mikaila, 2013, WILEY BLACKWELL ENCY; Ashraf S, 2017, AM J TROP MED HYG, V96, P421, DOI 10.4269/ajtmh.16-0304; Aunger R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159551; Aunger R, 2010, SOC SCI MED, V70, P383, DOI 10.1016/j.socscimed.2009.10.038; Behaviour Change Network, 2019, BARR AN BA; Bicchieri C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01418; Biran A, 2005, HEALTH POLICY PLANN, V20, P213, DOI 10.1093/heapol/czi024; Biran A, 2014, LANCET; Biran A, 2012, TROP MED INT HEALTH, V17, P1133, DOI 10.1111/j.1365-3156.2012.03045.x; Biswas D, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4316-6; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Cappon L., 2017, MENTAL TRAUMA IRAQS; Ceri V, 2016, NEUROPSYCHIATRIE, V30, P145, DOI 10.1007/s40211-016-0195-9; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; Contzen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136445; Contzen N, 2015, AM J INFECT CONTROL, V43, P826, DOI 10.1016/j.ajic.2015.04.186; CORE Group Behavioural Change Working Group, 2008, DES BEH CHANG CURR; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Curtis VA, 2009, HEALTH EDUC RES, V24, P655, DOI 10.1093/her/cyp002; Czerniewska A, BMC PUBLIC HLTH; Czerniewska A, 2014, BMC PUBLIC HLTH; Davis T., 2004, BARRIER ANAL FACILIT; Dreibelbis R, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010129; Ejemot-Nwadiaro RI, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004265.pub3; Fielding R, 2014, HONG KONG MED J; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Greenland K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-830; Harrington Linda, 2007, J Healthc Qual, V29, P20; Hess AS, 2017, TRANSFUSION, V57, P877, DOI 10.1111/trf.14057; Hirai M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090868; Hulland KRS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-877; Ibrahim H, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1140-5; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kittle B., 2013, PRACTICAL GUIDE COND; Xuan LTT, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI [10.3402/gha.v6i0.20288, 10.3402/gha.v6i0.18869]; Mosler H.-J., 2012, INT J ENV HLTH RES, V22; Nasiroglu S, 2016, NEUROPSYCH DIS TREAT, V12, P2941, DOI 10.2147/NDT.S119506; Nizame FA, 2016, AM J TROP MED HYG, V95, P288, DOI 10.4269/ajtmh.15-0377; Noether G.E., 1981, TEACH STAT, V3, P41, DOI [10.1111/j.1467-9639.1981.tb00422.x, DOI 10.1111/J.1467-9639.1981.TB00422.X]; O'Keefe AM, 2019, J COMMUN HEALTH, V44, P44, DOI 10.1007/s10900-018-0551-8; Pfattheicher S, 2018, J APPL SOC PSYCHOL, V48, P188, DOI 10.1111/jasp.12501; Phillips RM, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0065-2; Rahman MJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4307-7; Ram P., 2010, PRACTICAL GUIDANCE M; Save the Children, 2018, PICK PIEC REB LIV MO; Schmidt WP, 2019, INT J ENVIRON HEAL R, V29, P71, DOI 10.1080/09603123.2018.1511772; Scott B, 2007, HEALTH POLICY PLANN, V22, P225, DOI 10.1093/heapol/czm016; Sphere Association, 2018, SPHER HDB HUM CHART; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; UNHCR, 2017, IR SIT UNHCR FLASH U; UNICEF, 2019, WAT FIR REP; Vujcic J, 2015, J WATER SANIT HYG DE, V5, P574, DOI 10.2166/washdev.2015.009; White S, 2020, INT J HYG ENVIR HEAL, V227, DOI 10.1016/j.ijheh.2020.113512; Wolf J, 2018, TROP MED INT HEALTH, V23, P508, DOI 10.1111/tmi.13051	55	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0231694	10.1371/journal.pone.0231694	http://dx.doi.org/10.1371/journal.pone.0231694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0QJ	32384095	Green Published, gold			2022-12-26	WOS:000537468300005
J	Lautenschlager, J; Wagner-Valladolid, S; Stephens, AD; Fernandez-Villegas, A; Hockings, C; Mishra, A; Manton, JD; Fantham, MJ; Lu, M; Rees, EJ; Kaminski, CF; Schierle, GSK				Lautenschlager, Janin; Wagner-Valladolid, Sara; Stephens, Amberley D.; Fernandez-Villegas, Ana; Hockings, Colin; Mishra, Ajay; Manton, James D.; Fantham, Marcus J.; Lu, Meng; Rees, Eric J.; Kaminski, Clemens F.; Schierle, Gabriele S. Kaminski			Intramitochondrial proteostasis is directly coupled to ?-synuclein and amyloid?1-42 pathologies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						?-synuclein; amyloid-? (A?; ); mitochondria; neurodegeneration; HtrA2; Omi; HtrA serine peptidase 2; Parkinson disease; protein aggregation; protein homeostasis; Lon protease; Lon peptidase 1 mitochondrial; ?-synuclein (a-synuclein); amyloid-? (AB); mitochondria; neurodegenerative disease; neurodegeneration; HtrA serine peptidase 2; HtrA2; Omi; protein homeostasis	CALCIUM-DEPENDENT PROTEASES; ALPHA-SYNUCLEIN; PRECURSOR PROTEIN; BETA-PEPTIDE; MITOCHONDRIAL DYSFUNCTION; DOPAMINERGIC-NEURONS; ESSENTIAL TREMOR; COMPLEX-I; GENE; PINK1	Mitochondrial dysfunction has long been implicated in the neurodegenerative disorder Parkinson's disease (PD); however, it is unclear how mitochondrial impairment and ?-synuclein pathology are coupled. Using specific mitochondrial inhibitors, EM analysis, and biochemical assays, we report here that intramitochondrial protein homeostasis plays a major role in ?-synuclein aggregation. We found that interference with intramitochondrial proteases, such as HtrA2 and Lon protease, and mitochondrial protein import significantly aggravates ?-synuclein seeding. In contrast, direct inhibition of mitochondrial complex I, an increase in intracellular calcium concentration, or formation of reactive oxygen species, all of which have been associated with mitochondrial stress, did not affect ?-synuclein pathology. We further demonstrate that similar mechanisms are involved in amyloid-? 1-42 (A?42) aggregation. Our results suggest that, in addition to other protein quality control pathways, such as the ubiquitin?proteasome system, mitochondriaper secan influence protein homeostasis of cytosolic aggregation-prone proteins. We propose that approaches that seek to maintain mitochondrial fitness, rather than target downstream mitochondrial dysfunction, may aid in the search for therapeutic strategies to manage PD and related neuropathologies.	[Lautenschlager, Janin; Wagner-Valladolid, Sara; Stephens, Amberley D.; Fernandez-Villegas, Ana; Hockings, Colin; Mishra, Ajay; Lu, Meng; Schierle, Gabriele S. Kaminski] Univ Cambridge, Dept Chem Engn & Biotechnol, Mol Neurosci Grp, West Cambridge Site,Philippa Fawcett Dr, Cambridge, England; [Manton, James D.; Rees, Eric J.] Univ Cambridge, Dept Chem Engn & Biotechnol, Quantitat Imaging Grp, West Cambridge Site,Philippa Fawcett Dr, Cambridge, England; [Fantham, Marcus J.; Kaminski, Clemens F.] Univ Cambridge, Dept Chem Engn & Biotechnol, Laser Analyt Grp, West Cambridge Site,Philippa Fawcett Dr, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Lautenschlager, J; Schierle, GSK (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Mol Neurosci Grp, West Cambridge Site,Philippa Fawcett Dr, Cambridge, England.	janin.lautenschlaeger@gmail.com; gsk20@cam.ac.uk	; Kaminski, Clemens/G-7488-2016	mishra, ajay/0000-0001-8201-4067; Kaminski, Clemens/0000-0002-5194-0962; Manton, James/0000-0001-9260-3156	Deutsche Forschungsgemeinschaft (DFG) [LA 3609/2-1]; Wellcome Trust [065807/Z/01/Z, 203249/Z/16/Z]; UK Medical Research Council (MRC) [MR/K02292X/1]; Alzheimer Research UK (ARUK) [ARUK-PG013-14]; Michael J Fox Foundation [16238]; Infinitus China Ltd.; UK Engineering and Physical Sciences Research Council (EPSRC); MRC [MR/K02292X/1, MC_U105184326, MR/N012453/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer Research UK (ARUK)(Alzheimer's Research UK (ARUK)); Michael J Fox Foundation; Infinitus China Ltd.; UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) research fellowship award LA 3609/2-1 (to J. L.), the Wellcome Trust Grants 065807/Z/01/Z and 203249/Z/16/Z (to G. S. K. S.), UK Medical Research Council (MRC) Grant MR/K02292X/1 (to G. S. K. S.), Alzheimer Research UK (ARUK) Grant ARUK-PG013-14 (to G. S. K. S.), Michael J Fox Foundation (16238 to G. S. K. S.), Infinitus China Ltd. (to G. S. K. S. and C. F. K.), the UK Engineering and Physical Sciences Research Council (EPSRC) (to C. F. K.), and Alzheimer Research UK (ARUK) travel grants (to J. L. and A. D. S.).	Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; [Anonymous], 2019, FRONT NEUROSCI SWITZ; [Anonymous], 2017, BMC BIOL; [Anonymous], 2017, JOVE J VIS EXP JAN; Arai K., 2007, REPORTS FAC SCI ENG, V36, P36; Bajar BT, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091488; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bogaerts V, 2008, HUM MUTAT, V29, P832, DOI 10.1002/humu.20713; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Cenini G, 2016, MOL BIOL CELL, V27, P3257, DOI 10.1091/mbc.E16-05-0313; Chao YX, 2015, NEUROGENETICS, V16, P241, DOI 10.1007/s10048-015-0443-3; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen WY, 2017, NANO LETT, V17, P143, DOI 10.1021/acs.nanolett.6b03686; Chen WY, 2015, BIOPHYS J, V108, P999, DOI 10.1016/j.bpj.2015.01.012; Chung SY, 2016, STEM CELL REP, V7, P664, DOI 10.1016/j.stemcr.2016.08.012; Cilenti L, 2003, J BIOL CHEM, V278, P11489, DOI 10.1074/jbc.M212819200; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; da Cruz LN, 2011, INT J PARASITOL, V41, P363, DOI 10.1016/j.ijpara.2010.10.009; Dabir DV, 2013, DEV CELL, V25, P81, DOI 10.1016/j.devcel.2013.03.006; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dehvari N, 2012, NEUROCHEM INT, V60, P533, DOI 10.1016/j.neuint.2012.02.012; DEMARTINO GN, 1982, J NEUROCHEM, V38, P1642, DOI 10.1111/j.1471-4159.1982.tb06645.x; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Edelstein Arthur D, 2014, J Biol Methods, V1; Falkevall A, 2006, J BIOL CHEM, V281, P29096, DOI 10.1074/jbc.M602532200; Fang D, 2015, HUM MOL GENET, V24, P5198, DOI 10.1093/hmg/ddv241; Follett J, 2013, NEUROTOX RES, V23, P378, DOI 10.1007/s12640-012-9366-z; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gibellini L, 2015, ONCOTARGET, V6, P25466, DOI 10.18632/oncotarget.4510; Gispert S, 2015, HUM MOL GENET, V24, P1061, DOI 10.1093/hmg/ddu520; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Gulsuner HU, 2014, P NATL ACAD SCI USA, V111, P18285, DOI 10.1073/pnas.1419581111; GURTUBAY JIG, 1980, J BIOENERG BIOMEMBR, V12, P47, DOI 10.1007/BF00745012; Guzman JN, 2018, J CLIN INVEST, V128, P2266, DOI 10.1172/JCI95898; Herbert S., 2014, P IWBBIO APR 4 9 GRA; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Kotera I, 2010, ACS CHEM BIOL, V5, P215, DOI 10.1021/cb900263z; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lautenschager J, 2019, PROG NEUROBIOL, V181, DOI 10.1016/j.pneurobio.2019.101660; Lautenschlager J, 2015, MITOCHONDRION, V25, P49, DOI 10.1016/j.mito.2015.10.003; Lautenschlager J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03111-4; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lu M, 2019, J BIOL CHEM, V294, P1478, DOI 10.1074/jbc.RA118.004511; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Marchenko Steven, 2007, J Vis Exp, P267, DOI 10.3791/267; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; MELLGREN RL, 1987, FASEB J, V1, P110, DOI 10.1096/fasebj.1.2.2886390; Mossmann D, 2014, CELL METAB, V20, P662, DOI 10.1016/j.cmet.2014.07.024; Muller M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10980; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Oliveras-Salva M, 2014, NEUROBIOL AGING, V35, P2625, DOI 10.1016/j.neurobiolaging.2014.04.032; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Pinotsi D, 2016, P NATL ACAD SCI USA, V113, P3815, DOI 10.1073/pnas.1516546113; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ray P, 2002, J APPL TOXICOL, V22, P139, DOI 10.1002/jat.829; Ruan LH, 2017, NATURE, V543, P443, DOI 10.1038/nature21695; Rui YF, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0261-z; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schierle GSK, 2011, CHEMPHYSCHEM, V12, P673, DOI 10.1002/cphc.201000996; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitz A, 2004, TRAFFIC, V5, P89, DOI 10.1111/j.1600-0854.2004.00159.x; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Subramaniam SR, 2014, NEUROBIOL DIS, V70, P204, DOI 10.1016/j.nbd.2014.06.017; Sum TH, 2016, MOLECULES, V21, DOI 10.3390/molecules21091230; Thakur P, 2017, P NATL ACAD SCI USA, V114, pE8284, DOI 10.1073/pnas.1710442114; Todd AM, 2012, GENET MOL RES, V11, P1497, DOI 10.4238/2012.May.21.6; Todd AM, 2008, GENOME, V51, P1040, DOI 10.1139/G08-085; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang L, 2001, INVEST OPHTH VIS SCI, V42, P194; Warren SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070687; Westerlund M, 2011, FASEB J, V25, P1345, DOI 10.1096/fj.10-163402; Wu HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109438; Young LJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53988	94	12	12	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10138	10152		10.1074/jbc.RA119.011650	http://dx.doi.org/10.1074/jbc.RA119.011650			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32385113	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000556713400005
J	Collins, MP; Stransky, LA; Forgac, M				Collins, Michael P.; Stransky, Laura A.; Forgac, Michael			AKT Ser/Thr kinase increases V-ATPase?dependent lysosomal acidification in response to amino acid starvation in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase; proton transport; lysosomal acidification; Akt PKB; CRISPR; Cas; amino acid homeostasis; nutrient sensing; kinase signaling; pH regulation; MK2206	ATPASE; GLUCOSE; PH; ACTIVATION; MTORC1; COMPARTMENTS; INHIBITORS; MECHANISM; SUBUNIT; AMPK	The vacuolar H+-ATPase (V-ATPase) is an ATP-dependent proton pump that is essential for cellular homeostasis. V-ATPase activity is controlled by the regulated assembly of the enzyme from its component V(1)and V(0)domains. We previously reported that amino acid starvation rapidly increases V-ATPase assembly and activity in mammalian lysosomes, but the signaling pathways controlling this effect are unknown. In testing inhibitors of pathways important for controlling cellular metabolism, we found here that the cAMP-dependent protein kinase (PKA) inhibitor H89 increases lysosomal V-ATPase activity and blocks any further change upon starvation. The AMP-activated protein kinase (AMPK) inhibitor dorsomorphin decreased lysosomal V-ATPase activity and also blocked any increase upon starvation. However, CRISPR-mediated gene editing revealed that PKA and AMPK are not required for the starvation-dependent increase in lysosomal V-ATPase activity, indicating that H89 and dorsomorphin modify V-ATPase activity through other cellular targets. We next found that the AKT Ser/Thr kinase (AKT) inhibitor MK2206 blocks the starvation-dependent increase in lysosomal V-ATPase activity without altering basal activity. Expression of AKT1 or AKT3, but not AKT2, was required for increased lysosomal V-ATPase activity in response to amino acid starvation in mouse fibroblasts. Finally, HEK293T cells expressing only AKT1 responded normally to starvation, whereas cells expressing only AKT2 displayed a significantly reduced increase in V-ATPase activity and assembly upon starvation. These results show that AKT is required for controlling the rapid response of lysosomal V-ATPase activity to changes in amino acid availability and that this response depends on specific AKT isoforms.	[Collins, Michael P.; Forgac, Michael] Tufts Univ, Grad Sch Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA; [Stransky, Laura A.; Forgac, Michael] Tufts Univ, Grad Sch Biomed Sci, Program Cellular & Mol Physiol, Boston, MA 02111 USA; [Forgac, Michael] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Stransky, Laura A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Tufts University; Tufts University; Tufts University; Harvard University; Dana-Farber Cancer Institute	Forgac, M (corresponding author), Tufts Univ, Grad Sch Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA.; Forgac, M (corresponding author), Tufts Univ, Grad Sch Biomed Sci, Program Cellular & Mol Physiol, Boston, MA 02111 USA.; Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	michael.forgac@tufts.edu		Collins, Michael/0000-0002-1806-6775; Stransky, Laura/0000-0001-8834-936X	Tufts Collaborative Cancer Biology Awards; National Institutes of Health [CA189321, GM34478]	Tufts Collaborative Cancer Biology Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by Tufts Collaborative Cancer Biology Awards to M. P. C. and L. A. S., as well as National Institutes of Health Grants CA189321 to L. A. S. and GM34478 to M. F. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Collins MP, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00902; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Daniel S, 1996, J BIOL CHEM, V271, P1385, DOI 10.1074/jbc.271.3.1385; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; Hallows KR, 2009, AM J PHYSIOL-CELL PH, V296, pC672, DOI 10.1152/ajpcell.00004.2009; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hirata N, 2018, ONCOGENE, V37, P5367, DOI 10.1038/s41388-018-0330-0; HORSTRUP K, 1994, EUR J BIOCHEM, V225, P21, DOI 10.1111/j.1432-1033.1994.00021.x; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Inoue H, 2013, EUR J PHARMACOL, V714, P170, DOI 10.1016/j.ejphar.2013.06.018; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Li DL, 2016, CIRCULATION, V133, P1668, DOI 10.1161/CIRCULATIONAHA.115.017443; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marjuki H, 2011, CELL MICROBIOL, V13, P587, DOI 10.1111/j.1462-5822.2010.01556.x; Matsuda-Lennikov M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079795; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McGuire CM, 2018, J BIOL CHEM, V293, P9113, DOI 10.1074/jbc.RA117.001327; NEZU J, 1992, J BIOCHEM, V112, P212, DOI 10.1093/oxfordjournals.jbchem.a123879; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao VK, 2019, J CELL PHYSIOL, V234, P8683, DOI 10.1002/jcp.27528; Rein J, 2008, AM J PHYSIOL-CELL PH, V294, pC56, DOI 10.1152/ajpcell.00041.2007; Sanidas I, 2014, MOL CELL, V53, P577, DOI 10.1016/j.molcel.2013.12.018; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Soliman M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006820; Stransky LA, 2015, J BIOL CHEM, V290, P27360, DOI 10.1074/jbc.M115.659128; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Turnham RE, 2016, GENE, V577, P101, DOI 10.1016/j.gene.2015.11.052; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	42	8	8	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9433	9444		10.1074/jbc.RA120.013223	http://dx.doi.org/10.1074/jbc.RA120.013223			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409581	Green Published, hybrid			2022-12-26	WOS:000552758600014
J	Oosterheert, W; Gros, P				Oosterheert, Wout; Gros, Piet			Cryo-electron microscopy structure and potential enzymatic function of human six-transmembrane epithelial antigen of the prostate 1 (STEAP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						six-transmembrane epithelial antigen of the prostate 1 (STEAP1); membrane protein; metalloenzyme; cryo-electron microscopy; cancer; cancer therapy; antibody; enzyme structure; protein chimera	MOLECULAR-CLONING; TUMOR-GROWTH; PROTEIN; CANCER; MODEL; FERRIREDUCTASE; IMMUNOTHERAPY; STAMP2; DOMAIN; ASSAY	Six-transmembrane epithelial antigen of the prostate 1 (STEAP1) is an integral membrane protein that is highly up-regulated on the cell surface of several human cancers, making it a promising therapeutic target to manage these diseases. It shares sequence homology with three enzymes (STEAP2?STEAP4) that catalyze the NADPH-dependent reduction of iron(III). However, STEAP1 lacks an intracellular NADPH-binding domain and does not exhibit cellular ferric reductase activity. Thus, both the molecular function of STEAP1 and its role in cancer progression remain elusive. Here, we present a ?3.0-? cryo-EM structure of trimeric human STEAP1 bound to three antigen-binding fragments (Fabs) of the clinically used antibody mAb120.545. The structure revealed that STEAP1 adopts a reductase-like conformation and interacts with the Fabs through its extracellular helices. Enzymatic assays in human cells revealed that STEAP1 promotes iron(III) reduction when fused to the intracellular NADPH-binding domain of its family member STEAP4, suggesting that STEAP1 functions as a ferric reductase in STEAP heterotrimers. Our work provides a foundation for deciphering the molecular mechanisms of STEAP1 and may be useful in the design of new therapeutic strategies to target STEAP1 in cancer.	[Oosterheert, Wout; Gros, Piet] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Chem, Fac Sci,Crystal & Struct Chem, Utrecht, Netherlands	Utrecht University	Oosterheert, W; Gros, P (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Chem, Fac Sci,Crystal & Struct Chem, Utrecht, Netherlands.	w.oosterheert@uu.nl; p.gros@uu.nl		Oosterheert, Wout/0000-0003-1189-6044	Netherlands Organization for Scientific Research (NWO), Fund NCI Technology Area [731.015.201]	Netherlands Organization for Scientific Research (NWO), Fund NCI Technology Area	This work has been supported by the Netherlands Organization for Scientific Research (NWO), Fund NCI Technology Area (Project 731.015.201).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alves PMS, 2006, CANCER IMMUNOL IMMUN, V55, P1515, DOI 10.1007/s00262-006-0165-3; Barroca-Ferreira J, 2018, CURR CANCER DRUG TAR, V18, P222, DOI 10.2174/1568009617666170427103732; Boswell CA, 2011, BIOCONJUGATE CHEM, V22, P1994, DOI 10.1021/bc200212a; Cappuccini F, 2016, CANCER IMMUNOL IMMUN, V65, P701, DOI 10.1007/s00262-016-1831-8; Carrasquillo JA, 2019, J NUCL MED, V60, P1517, DOI 10.2967/jnumed.118.222844; Challita-Eid PM, 2007, CANCER RES, V67, P5798, DOI 10.1158/0008-5472.CAN-06-3849; Chen X, 2019, BIOMED PHARMACOTHER, V111, P1124, DOI 10.1016/j.biopha.2019.01.012; Danila DC, 2019, J CLIN ONCOL, V37, P3518, DOI 10.1200/JCO.19.00646; Doran MG, 2014, J NUCL MED, V55, P2045, DOI 10.2967/jnumed.114.145185; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gauss GH, 2013, J BIOL CHEM, V288, P20668, DOI 10.1074/jbc.M113.479154; Genentech Inc, 2015, U.S. Patent, Patent No. [EP2502938B1, 2502938]; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gomes IM, 2012, MOL CANCER RES, V10, P573, DOI 10.1158/1541-7786.MCR-11-0281; Grunewald TGP, 2012, BIOL CELL, V104, P641, DOI 10.1111/boc.201200027; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Herrmann VL, 2016, PROSTATE, V76, P456, DOI 10.1002/pros.23136; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; Isobe T, 2011, EXP CELL RES, V317, P2582, DOI 10.1016/j.yexcr.2011.07.022; Jin Y, 2015, EMBO MOL MED, V7, P315, DOI 10.15252/emmm.201404181; Kim K, 2016, BIOCHEMISTRY-US, V55, P6673, DOI 10.1021/acs.biochem.6b00610; Kleven MD, 2015, J BIOL CHEM, V290, P22558, DOI 10.1074/jbc.M115.664565; Korkmaz CG, 2005, ONCOGENE, V24, P4934, DOI 10.1038/sj.onc.1208677; Korkmaz KS, 2002, J BIOL CHEM, V277, P36689, DOI 10.1074/jbc.M202414200; Mancusso R, 2011, METHODS, V55, P324, DOI 10.1016/j.ymeth.2011.07.008; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; Moreaux J, 2012, BIOCHEM BIOPH RES CO, V429, P148, DOI 10.1016/j.bbrc.2012.10.123; O'Donoghue JA, 2019, MOL PHARMACEUT, V16, P3083, DOI 10.1021/acs.molpharmaceut.9b00326; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Oosterheert W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06817-7; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rouge L, 2020, SCIENCE, V367, P1224, DOI 10.1126/science.aaz9356; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schirmer D, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1175795; Sendamarai AK, 2008, P NATL ACAD SCI USA, V105, P7410, DOI 10.1073/pnas.0801318105; Sikkeland J, 2016, MOL CELL ENDOCRINOL, V425, P26, DOI 10.1016/j.mce.2016.02.013; Sukumaran S, 2017, AAPS J, V19, P130, DOI 10.1208/s12248-016-9993-z; Whiteland H, 2014, CLIN EXP METASTAS, V31, P909, DOI 10.1007/s10585-014-9679-9; Yamamoto T, 2013, EXP CELL RES, V319, P2617, DOI 10.1016/j.yexcr.2013.07.025; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081	47	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9502	9512		10.1074/jbc.RA120.013690	http://dx.doi.org/10.1074/jbc.RA120.013690			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409586	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000552758600019
J	Safina, I; Bourdo, SE; Algazali, KM; Kannarpady, G; Watanabe, F; Vang, KB; Biris, AS				Safina, Ingrid; Bourdo, Shawn E.; Algazali, Karrer M.; Kannarpady, Ganesh; Watanabe, Fumiya; Vang, Kieng Bao; Biris, Alexandru S.			Graphene-based 2D constructs for enhanced fibroblast support	PLOS ONE			English	Article								Complex skin wounds have always been a significant health and economic problem worldwide due to their elusive and sometimes poor or non-healing conditions. If not well-treated, such wounds may lead to amputation, infections, cancer, or even death. Thus, there is a need to efficiently generate multifunctional skin grafts that address a wide range of skin conditions, including non-healing wounds, and enable the regeneration of new skin tissue. Here, we propose studying pristine graphene and two of its oxygen-functionalized derivatives-high and low-oxygen graphene films-as potential substrates for skin cell proliferation and differentiation. Using BJ cells (human foreskin-derived fibroblasts) to represent basic skin cells, we show that the changes in surface properties of pristine graphene due to oxygen functionalization do not seem to statistically impact the normal proliferation and maturation of skin cells. Our results indicate that the pristine and oxidized graphenes presented relatively low cytotoxicity to BJ fibroblasts and, in fact, support their growth and bioactivity. Therefore, these graphene films could potentially be integrated into more complex skin regenerative systems to support skin regeneration. Because graphene's surface can be relatively easily functionalized with various chemical groups, this finding presents a major opportunity for the development of various composite materials that can act as active components in regenerative applications such as skin regeneration.	[Safina, Ingrid; Bourdo, Shawn E.; Algazali, Karrer M.; Kannarpady, Ganesh; Watanabe, Fumiya; Vang, Kieng Bao; Biris, Alexandru S.] Univ Arkansas, Ctr Integrat Nanotechnol Sci, Little Rock, AR 72204 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Safina, I; Biris, AS (corresponding author), Univ Arkansas, Ctr Integrat Nanotechnol Sci, Little Rock, AR 72204 USA.	ixsafina@ualr.edu; asbiris@ualr.edu	Dings, Kieng Vang/AAW-3189-2021	Safina, Ingrid/0000-0003-1036-1101	Center for Advanced Surface Engineering, under the National Science Foundation [IIA-1457888]; Arkansas EPSCoR Program, ASSET III; Center for Advanced Surface Engineering SEED Fund under the National Science Foundation [IIA-1457888]; NIH [1R15AR070460-01A1]; FDA [HSF223201400079C]	Center for Advanced Surface Engineering, under the National Science Foundation; Arkansas EPSCoR Program, ASSET III; Center for Advanced Surface Engineering SEED Fund under the National Science Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FDA(United States Department of Health & Human Services)	Funding for this research was provided by the Center for Advanced Surface Engineering, under the National Science Foundation Grant No. IIA-1457888 and the Arkansas EPSCoR Program, ASSET III awarded to A.S.B. K.B.V was supported by an award from the Center for Advanced Surface Engineering SEED Funding, under the National Science Foundation Grant No. IIA-1457888. S.E.B and A.S.B acknowledge partial support from NIH (Award #1R15AR070460-01A1) and FDA (contract number HSF223201400079C to the Arkansas Research Alliance). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Faouri R, 2017, J APPL TOXICOL; Allen MJ, 2010, CHEM REV; Blake P, 2008, NANO LETT; Bourdo SE, 2017, J APPL TOXICOL; Chang HY, 2002, P NATL ACAD SCI US; Choi DW, 2010, ELECTROCHEM COMMUN, V12, P378, DOI 10.1016/j.elecom.2009.12.039; Choi W, 2010, CRIT REV SOLID STATE; David-Raoudi M, 2008, WOUND REPAIR REGEN; Duan G, 2015, NANOSCALE; Elkhenany H, 2017, NANOMEDICINE NANOTEC; Eming SA, 2014, SCI TRANSLATIONAL ME; Frykberg RG, 2015, ADV WOUND CARE; Genova T, 2019, J BIOMED MAT RES A; Goodpaster T, 2008, J HISTOCHEM CYTOCHEM; Groth T, 1995, J BIOMATER SCI POLYM; Haynes BF, 1984, J EXP MED; Hu W, 2011, ACS NANO; Huebener P, 2008, J IMMUNOL; 이은지, 2014, [Biomaterials Research, 생체재료학회지], V18, P18; Jasim DA, 2018, FLATCHEM; Kalbacova MH, 2014, CARBON N Y; Karmakar A, 2015, RSC ADV; Kim BS, 2011, PROGR POLYM SCI; Kumar P, 2019, NANOMATERIALS; Lasocka I, 2018, TOXICOL VITR; Lee WC, 2011, ACS NANO; Li J, 2014, SCI REP; Liao KH, 2011, ACS APPL MAT INTERFA; Liao L., 2010, NATURE; Lindholm C, 2016, INT WOUND J; Luo J, 2012, ANAL CHIM ACTA; Lutolf MP, 2005, NATURE BIOTECHNOLOGY; Majeed W, 2017, J APPL TOXICOL; Manjunatha R, 2012, TALANTA; Mariggio MA, 2009, INT J IMMUNOPATHOL P; Mattevi C, 2012, NANOTECHNOLOGY; Matthews JA, 2002, BIOMACROMOLECULES; Naor D, 2002, CRITICAL REV CLIN LA; Nedosekin DA, 2017, J APPL TOXICOL; Nima ZA, 2019, NANOSCALE; Peres NMR, 2009, EUROPHYS NEWS; Petibone DM, 2017, J APPL TOXICOL, V37, P1333, DOI 10.1002/jat.3472; Pham VTH, 2015, ACS NANO; Russier J, 2013, NANOSCALE; Sen C. K., 2009, WOUND REPAIR REGENER; Senbanjo LT, 2017, FRONTIERS CELL DEV B; Sengupta I, 2019, COLLOIDS INTERFACE S; Shin SR, 2016, ADV DRUG DELIVERY RE; Sitte N, 2000, FASEB J; Song Y, 2010, ADV MAT; Sun X, 2008, NANO RES; Taha NA, 2015, J DENT; Tiwari SK, 2016, CRITICAL REV SOLID S; Tracy LE, 2016, ADV WOUND CARE; Wang J, 2018, NANO, V13, DOI 10.1142/S1793292018500418; Xu X, 2017, ADV MAT LETT, DOI [10.5185/amlett.2017.1453, DOI 10.5185/AMLETT.2017.1453]; Yang K, 2010, NANO LETT	57	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0232670	10.1371/journal.pone.0232670	http://dx.doi.org/10.1371/journal.pone.0232670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421748	gold, Green Published			2022-12-26	WOS:000537499600015
J	Welch, RD; Billon, C; Kameric, A; Burris, TP; Flaveny, CA				Welch, Ryan D.; Billon, Cyrielle; Kameric, Amina; Burris, Thomas P.; Flaveny, Colin A.			Rev-erba heterozygosity produces a dose-dependent phenotypic advantage in mice	PLOS ONE			English	Article							CIRCADIAN CLOCK; ALPHA; RECEPTOR; METABOLISM; BMAL1; EXPRESSION; RHYTHMS; OBESITY; LINKS	Numerous mutational studies have demonstrated that circadian clock proteins regulate behavior and metabolism. Nr1d1(Rev-erba) is a key regulator of circadian gene expression and a pleiotropic regulator of skeletal muscle homeostasis and lipid metabolism. Loss of Rev-erba expression induces muscular atrophy, high adiposity, and metabolic syndrome in mice. Here we show that, unlike knockout mice, Nr1d1 heterozygous mice are not susceptible to muscular atrophy and in fact paradoxically possess larger myofiber diameters and improved neuromuscular function, compared to wildtype mice. Heterozygous mice lacked dyslipidemia, a characteristic of Nr1d1 knockout mice and displayed increased whole-body fatty-acid oxidation during periods of inactivity (light cycle). Heterozygous mice also exhibited higher rates of glucose uptake when fasted, and had elevated basal rates of gluconeogenesis compared to wildtype and knockout littermates. Rev-erba ablation suppressed glycolysis and fatty acid-oxidation in white-adipose tissue (WAT), whereas partial Rev-erba loss, curiously stimulated these processes. Our investigations revealed that Rev-erba dose-dependently regulates glucose metabolism and fatty acid oxidation in WAT and muscle.	[Welch, Ryan D.] Salk Inst Biol Sci, La Jolla, CA USA; [Billon, Cyrielle; Burris, Thomas P.] St Louis Coll Pharm, Ctr Clin Pharmacol, St Louis, MO USA; [Kameric, Amina; Flaveny, Colin A.] St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO 63103 USA; [Flaveny, Colin A.] Barnes Jewish, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA; [Flaveny, Colin A.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Flaveny, Colin A.] St Louis Univ, Henry & Amelia Nasrallah Ctr Neurosci, St Louis, MO 63103 USA	Salk Institute; Saint Louis University; Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Saint Louis University	Flaveny, CA (corresponding author), St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO 63103 USA.; Flaveny, CA (corresponding author), Barnes Jewish, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA.; Flaveny, CA (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.; Flaveny, CA (corresponding author), St Louis Univ, Henry & Amelia Nasrallah Ctr Neurosci, St Louis, MO 63103 USA.	colin.flaveny@health.slu.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	NIDDK NIH HHS [T32 DK007494] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amador A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196787; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Burke L, 1996, NUCLEIC ACIDS RES, V24, P3481, DOI 10.1093/nar/24.18.3481; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Cohen JC, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-21; Delezie J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29386; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; DOWNES M, 1995, MOL ENDOCRINOL, V9, P1666, DOI 10.1210/me.9.12.1666; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Garaulet M, 2014, MOL NUTR FOOD RES, V58, P821, DOI 10.1002/mnfr.201300361; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Gordon BS, 2016, AM J PHYSIOL-ENDOC M, V311, pE157, DOI 10.1152/ajpendo.00059.2016; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hernandez-Hernandez M, 2017, SEMIN CELL DEV BIOL, V72, P10, DOI 10.1016/j.semcdb.2017.11.010; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Marcheva Biliana, 2013, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-25950-0_6; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Mayeuf-Louchart A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14596-2; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Ruano EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104065; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Solt LA, 2011, FUTURE MED CHEM, V3, P623, DOI [10.4155/FMC.11.9, 10.4155/fmc.11.9]; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Welch RD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17496-7; Welch RD, 2017, MOL METAB, V6, P703, DOI 10.1016/j.molmet.2017.05.001; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0227720	10.1371/journal.pone.0227720	http://dx.doi.org/10.1371/journal.pone.0227720			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407314	gold, Green Submitted, Green Published			2022-12-26	WOS:000537490700002
J	Gao, S; Alawad, M; Schaefferkoetter, N; Penberthy, L; Wu, XC; Durbin, EB; Coyle, L; Ramanathan, A; Tourassi, G				Gao, Shang; Alawad, Mohammed; Schaefferkoetter, Noah; Penberthy, Lynne; Wu, Xiao-Cheng; Durbin, Eric B.; Coyle, Linda; Ramanathan, Arvind; Tourassi, Georgia			Using case-level context to classify cancer pathology reports	PLOS ONE			English	Article							HEALTH	Individual electronic health records (EHRs) and clinical reports are often part of a larger sequence-for example, a single patient may generate multiple reports over the trajectory of a disease. In applications such as cancer pathology reports, it is necessary not only to extract information from individual reports, but also to capture aggregate information regarding the entire cancer case based off case-level context from all reports in the sequence. In this paper, we introduce a simple modular add-on for capturing case-level context that is designed to be compatible with most existing deep learning architectures for text classification on individual reports. We test our approach on a corpus of 431,433 cancer pathology reports, and we show that incorporating case-level context significantly boosts classification accuracy across six classification tasks-site, subsite, laterality, histology, behavior, and grade. We expect that with minimal modifications, our add-on can be applied towards a wide range of other clinical text-based tasks.	[Gao, Shang; Alawad, Mohammed; Schaefferkoetter, Noah; Tourassi, Georgia] Oak Ridge Natl Lab, Computat Sci & Engn Div, Oak Ridge, TN 37830 USA; [Penberthy, Lynne] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Wu, Xiao-Cheng] Louisiana State Univ, Louisiana Tumor Registry, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA; [Durbin, Eric B.] Univ Kentucky, Kentucky Canc Registry, Lexington, KY USA; [Coyle, Linda] Informat Management Serv Inc, Calverton, MD USA; [Ramanathan, Arvind] Argonne Natl Lab, Data Sci & Learning Div, Lemont, IL USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Kentucky; Information Management Services, Inc.; United States Department of Energy (DOE); Argonne National Laboratory	Gao, S; Tourassi, G (corresponding author), Oak Ridge Natl Lab, Computat Sci & Engn Div, Oak Ridge, TN 37830 USA.	gaos@ornl.gov; tourassig@ornl.gov		Durbin, Eric/0000-0002-5600-7645; Gao, Shang/0000-0003-1803-1457	Department of Energy [2450-Z301-19]; National Cancer Institute [2450-Z301-19]; NCI; Joint Design of Advanced Computing Solutions for Cancer (JDACS4C) program; National Cancer Institute (NCI) of the National Institutes of Health; U.S. Department of Energy by Argonne National Laboratory [DEAC02-06-CH11357]; U.S. Department of Energy by Lawrence Livermore National Laboratory [DEAC52-07NA27344]; U.S. Department of Energy by Los Alamos National Laboratory [DE-AC5206NA25396]; U.S. Department of Energy by Oak Ridge National Laboratory [DE-AC05-00OR22725]; Office of Science of the U.S. Department of Energy [DE-AC05-00OR22725]; Information Management Services Inc as part of the Surveillance, Epidemiology, and End Results program	Department of Energy(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Joint Design of Advanced Computing Solutions for Cancer (JDACS4C) program; National Cancer Institute (NCI) of the National Institutes of Health; U.S. Department of Energy by Argonne National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy by Los Alamos National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy by Oak Ridge National Laboratory(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Information Management Services Inc as part of the Surveillance, Epidemiology, and End Results program	Georgia Tourassi (GT) at the Oak Ridge National Laboratory received funding from the Department of Energy (energy.gov) and the National Cancer Institute (cancer.gov). The grant number is 2450-Z301-19. These funds were used to facilitate this study. The provided funding via this grant was used to support of salaries for SG, MA, NS, AR, and GT. In addition to the grant, the National Cancer Institute (NCI) employs or provides funding for authors from NCI (LP), state registries (XCW, and EBD) and Information Management Services Inc (LC) as part of the Surveillance, Epidemiology, and End Results program and authorized their participation in this study. Their efforts included data collection, cleaning, analysis or final review of this study. This work has been supported in part by the Joint Design of Advanced Computing Solutions for Cancer (JDACS4C) program established by the U.S. Department of Energy (DOE) and the National Cancer Institute (NCI) of the National Institutes of Health. This work was performed under the auspices of the U.S. Department of Energy by Argonne National Laboratory under Contract DEAC02-06-CH11357, Lawrence Livermore National Laboratory under Contract DEAC52-07NA27344, Los Alamos National Laboratory under Contract DE-AC5206NA25396, and Oak Ridge National Laboratory under Contract DE-AC05-00OR22725 This research used resources of the Oak Ridge Leadership Computing Facility at the Oak Ridge National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC05-00OR22725. The funding offices from the DOE and NCI did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the `author contributions' section.	Alsentzer E., 2019, PUBLICLY AVAILABLE C, P72; An, 2017, ARXIV COMPUTATION LA, V2017, P316; [Anonymous], 2017, HLTH IT DASHB QUICK; Baker S, 2016, P 5 WORKSH BUILD EV, P1; Birkhead GS, 2015, ANNU REV PUBL HEALTH, V36, P345, DOI 10.1146/annurev-publhealth-031914-122747; Che Z., 2016, NIPS 2016 WORKSH MAC; Chung J., 2020, ARXIV; Clevert D.-A., 2015, P 4 INT C LEARNING R; Cong L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2050435; Devlin J., 2018, ARXIV181004805; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; dos Santos CN, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING, VOL 1, P626; Efron B, 1994, INTRO BOOTSTRAP; Gao S, 2019, ARTIF INTELL MED, V101, DOI 10.1016/j.artmed.2019.101726; Gehring J., 2017, ARXIV170503122; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; He B, 2019, ARTIF INTELL MED, V93, P43, DOI 10.1016/j.artmed.2018.05.001; Huang Kexin, 2019, ARXIV PREPRINT ARXIV; Huang Zhiheng, 2015, CORR; Jagannatha Abhyuday N, 2016, Proc Conf, V2016, P473; Jensen K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46226; Kim Yoon, 2014, P 2014 C EMPIRICAL M, P1746, DOI [DOI 10.3115/V1/D14-1181, 10.3115/v1/D14-1181]; Kingma DP., 2014, ADAM METHOD STOCHAST; Lee Ji Young, 2016, ARXIV160303827, P515, DOI DOI 10.18653/V1/N16-1062; Lipton Z.C., 2015, ICLR, P1; Lipton Z.C., 2015, COMPUT SCI, DOI DOI 10.1093/eurheartj/ehw128; Menachemi N, 2011, RISK MANAG HEALTHC P, V4, P47, DOI 10.2147/RMHP.S12985; Mullenbach James, 2018, NAACL HLT, V1, P1101; Nguyen P, 2017, IEEE J BIOMED HEALTH, V21, P22, DOI 10.1109/JBHI.2016.2633963; Qiu JX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2511-9; Qiu JX, 2018, IEEE J BIOMED HEALTH, V22, P244, DOI 10.1109/JBHI.2017.2700722; Salehinejad H., 2018, RECENT ADV RECURRENT; Sheikhalishahi S, 2019, JMIR MED INF, V7, P15, DOI 10.2196/12239; Shen Z, 2018, ARXIV COMPUTER VISIO; Shickel B, 2018, IEEE J BIOMED HEALTH, V22, P1589, DOI 10.1109/JBHI.2017.2767063; Singh A, 2015, J BIOMED INFORM, V53, P220, DOI 10.1016/j.jbi.2014.11.005; Solares JRA, 2020, J BIOMED INFORM, V101, DOI 10.1016/j.jbi.2019.103337; Tang G., 2018, PROC C EMPIRICAL MET, P4263, DOI DOI 10.18653/V1/D18-1458; Tsujii, 2018, P 2018 C EMP METH NA, P3100, DOI DOI 10.18653/V1/D18-1349; Vaswani A., 2017, PROC ANN C NEURAL IN, V30, P5998; Wu S, 2020, J AM MED INFORM ASSN, V27, P457, DOI 10.1093/jamia/ocz200; Yu Adams Wei, 2018, ARXIV180409541; Zhang S, 2016, ADV NEURAL INFORM PR, P1830; Zhao J, 2017, J BIOMED INFORM, V65, P105, DOI 10.1016/j.jbi.2016.11.006	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232840	10.1371/journal.pone.0232840	http://dx.doi.org/10.1371/journal.pone.0232840			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396579	Green Submitted, Green Published, gold			2022-12-26	WOS:000537475000020
J	Holinda, D; Burgar, JM; Burton, AC				Holinda, Dacyn; Burgar, Joanna M.; Burton, A. Cole			Effects of scent lure on camera trap detections vary across mammalian predator and prey species	PLOS ONE			English	Article							BLACK; BAIT	Camera traps are a unique survey tool used to monitor a wide variety of mammal species. Camera trap (CT) data can be used to estimate animal distribution, density, and behaviour. Attractants, such as scent lures, are often used in an effort to increase CT detections; however, the degree which the effects of attractants vary across species is not well understood. We investigated the effects of scent lure on mammal detections by comparing detection rates between 404 lured and 440 unlured CT stations sampled in Alberta, Canada over 120 day survey periods between February and August in 2015 and 2016. We used zero-inflated negative binomial generalized linear mixed models to test the effect of lure on detection rates for a) all mammals, b) six functional groups (all predator species, all prey, large carnivores, small carnivores, small mammals, ungulates), and c) four varied species of management interest (fisher, Pekania pennanti; gray wolf, Canis lupus; moose, Alces alces; and Richardson's ground squirrel; Urocitellus richardsonii). Mammals were detected at 800 of the 844 CTs, with nearly equal numbers of total detections at CTs with (7110) and without (7530) lure, and variable effects of lure on groups and individual species. Scent lure significantly increased detections of predators as a group, including large and small carnivore sub-groups and fisher specifically, but not of gray wolf. There was no effect of scent lure on detections of prey species, including the small mammal and ungulate sub-groups and moose and Richardson's ground squirrel specifically. We recommend that researchers explicitly consider the variable effects of scent lure on CT detections across species when designing, interpreting, or comparing multi-species surveys. Additional research is needed to further quantify variation in species responses to scent lures and other attractants, and to elucidate the effect of attractants on community-level inferences from camera trap surveys.	[Holinda, Dacyn; Burgar, Joanna M.; Burton, A. Cole] Univ British Columbia, Wildlife Coexistence Lab, Dept Forest Resources Management, Vancouver, BC, Canada; [Burton, A. Cole] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Burton, AC (corresponding author), Univ British Columbia, Wildlife Coexistence Lab, Dept Forest Resources Management, Vancouver, BC, Canada.; Burton, AC (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC, Canada.	cole.burton@ubc.ca	Burgar, Joanna/AAV-1222-2020; Burton, Cole/AAF-9234-2019	Burgar, Joanna/0000-0003-4724-5286; Burton, Cole/0000-0002-8799-3847	Canada Research Chairs Program	Canada Research Chairs Program(Canada Research Chairs)	This research was supported by the Canada Research Chairs Program.	Alberta Biodiversity Monitoring Institute, 2014, TERR FIELD DAT COLL, P47; Beausoleil RA, 2013, WILDLIFE SOC B, DOI [10.1002/wsb.374, DOI 10.1002/WSB.374]; Brooks M. E., 2017, MODELING ZERO INFLAT, DOI 10.1101/132753; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Clapperton B, DOC RES DEV SERIES, V241; du Preez BD, 2014, BIOL CONSERV, V176, P153, DOI 10.1016/j.biocon.2014.05.021; Fisher JT, 2018, FRONT ECOL ENVIRON, V16, P323, DOI 10.1002/fee.1807; Garrote G, 2012, EUR J WILDLIFE RES, V58, P881, DOI 10.1007/s10344-012-0658-7; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Karanth KU, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P97, DOI 10.1007/978-4-431-99495-4_7; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Khwaja H, 2019, GLOB ECOL CONSERV, V20, DOI 10.1016/j.gecco.2019.e00769; MacKenzie D.I., 2018, OCCUPANCY ESTIMATION, V2nd, DOI DOI 10.1016/B978-0-12-407197-1.00015-6; Maffei L, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P119, DOI 10.1007/978-4-431-99495-4_8; Marucco F, 2009, J APPL ECOL, V46, P1003, DOI 10.1111/j.1365-2664.2009.01696.x; Moen R, 2007, TESTING REMOTE CAMER; Morais AR, 2013, BIOL CONSERV, V166, P98, DOI 10.1016/j.biocon.2013.06.010; Noyce KV, 2001, URSUS-SERIES, V12, P211; R Core Team, 2013, R LANG ENV STAT COMP; Read JL, 2015, WILDLIFE RES, V42, P1, DOI 10.1071/WR14193; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; Schlexer Fredrick V., 2008, P263; Scotson L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185336; Stewart FEC, 2019, J WILDLIFE MANAGE, V83, P985, DOI 10.1002/jwmg.21657; Swann DE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P27, DOI 10.1007/978-4-431-99495-4_3; Tattersall ER, 2020, BIOL CONSERV, V241, DOI 10.1016/j.biocon.2019.108295; Thorn M, 2009, S AFR J WILDL RES, V39, P1, DOI 10.3957/056.039.0101; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Trolle M, 2005, MAMMALIA, V69, P409, DOI 10.1515/mamm.2005.032; Wang DJ, 2006, ENVIRON MANAGE, V38, P942, DOI 10.1007/s00267-005-0302-3; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Woods JG, 1999, WILDLIFE SOC B, V27, P616	35	16	16	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0229055	10.1371/journal.pone.0229055	http://dx.doi.org/10.1371/journal.pone.0229055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396558	Green Submitted, Green Published, gold			2022-12-26	WOS:000537475000004
J	Angely, C; Ladant, D; Planus, E; Louis, B; Filoche, M; Chenal, A; Isabey, D				Angely, Christelle; Ladant, Daniel; Planus, Emmanuelle; Louis, Bruno; Filoche, Marcel; Chenal, Alexandre; Isabey, Daniel			Functional and structural consequences of epithelial cell invasion by Bordetella pertussis adenylate cyclase toxin	PLOS ONE			English	Article							MORPHOLOGICAL-CHANGES; IN-VITRO; CAMP; ADHESION; MIGRATION; INHIBITION; EXPRESSION; MECHANICS; CROSSTALK; TRANSLOCATION	Bordetella pertussis, the causative agent of whopping cough, produces an adenylate cyclase toxin (CyaA) that plays a key role in the host colonization by targeting innate immune cells which express CD11b/CD18, the cellular receptor of CyaA. CyaA is also able to invade non-phagocytic cells, via a unique entry pathway consisting in a direct translocation of its catalytic domain across the cytoplasmic membrane of the cells. Within the cells, CyaA is activated by calmodulin to produce high levels of cyclic adenosine monophosphate (cAMP) and alter cellular physiology. In this study, we explored the effects of CyaA toxin on the cellular and molecular structure remodeling of A549 alveolar epithelial cells. Using classical imaging techniques, biochemical and functional tests, as well as advanced cell mechanics method, we quantify the structural and functional consequences of the massive increase of intracellular cyclic AMP induced by the toxin: cell shape rounding associated to adhesion weakening process, actin structure remodeling for the cortical and dense components, increase in cytoskeleton stiffness, and inhibition of migration and repair. We also show that, at low concentrations (0.5 nM), CyaA could significantly impair the migration and wound healing capacities of the intoxicated alveolar epithelial cells. As such concentrations might be reached locally during B. pertussis infection, our results suggest that the CyaA, beyond its major role in disabling innate immune cells, might also contribute to the local alteration of the epithelial barrier of the respiratory tract, a hallmark of pertussis.	[Angely, Christelle; Louis, Bruno; Filoche, Marcel; Isabey, Daniel] Inserm U955, Biomecan & Appareil Resp, Equipe 13, Creteil, France; [Angely, Christelle; Louis, Bruno; Filoche, Marcel; Isabey, Daniel] Univ Paris Est, UPEC, UMR 955, Creteil, France; [Angely, Christelle; Louis, Bruno; Filoche, Marcel; Isabey, Daniel] CNRS, ERL 7000, Creteil, France; [Ladant, Daniel; Chenal, Alexandre] Inst Pasteur, Dept Biol Struct & Chim, CNRS UMR 3528, Unite Biochim Interact Macromol, Paris, France; [Planus, Emmanuelle] Ctr Rech UGA, Inserm U1209, CNRS UMR 5309, Inst Avancee & Biosci IAB, La Tronche, France; [Filoche, Marcel] CNRS, IP Paris, Ecole Polytech, Lab Phys Matiere Condensee, Palaiseau, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris	Isabey, D (corresponding author), Inserm U955, Biomecan & Appareil Resp, Equipe 13, Creteil, France.; Isabey, D (corresponding author), Univ Paris Est, UPEC, UMR 955, Creteil, France.; Isabey, D (corresponding author), CNRS, ERL 7000, Creteil, France.	daniel.isabey@inserm.fr	Louis, Bruno/AGB-7050-2022; planus, emmanuelle/S-3868-2016	Louis, Bruno/0000-0001-9587-9932; planus, emmanuelle/0000-0002-3981-906X; LADANT, Daniel/0000-0003-1955-548X; Chenal, Alexandre/0000-0002-4959-1003; FILOCHE, Marcel/0000-0001-8637-3016	Fondation pour la Recherche Me'tion pour la Recherche Mecdicale http://www.frm.org The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. [DBS20140930771]	Fondation pour la Recherche Me'tion pour la Recherche Mecdicale http://www.frm.org The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DI: grant number DBS20140930771 Fondation pour la Recherche Mecdicale http://www.frm.org The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alouf J., 2006, COMPREHENSIVE SOURCE; Angely C, 2017, BIOL CELL, V109, P293, DOI 10.1111/boc.201600082; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Arumugham VB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00919; Belete HA, 2010, CELL PHYSIOL BIOCHEM, V25, P71, DOI 10.1159/000272052; Cannella SE, 2017, SCI REP-UK, V7, DOI 10.1038/srep42065; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Cerny O, 2017, J IMMUNOL, V198, P1285, DOI 10.4049/jimmunol.1601309; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen L, 2008, J BIOL CHEM, V283, P13799, DOI 10.1074/jbc.M800555200; Chenal A, 2018, TOXINS, V10, DOI 10.3390/toxins10070302; Dal Molin F, 2006, EMBO J, V25, P5405, DOI 10.1038/sj.emboj.7601408; Eby JC, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv081; Eby JC, 2013, INFECT IMMUN, V81, P1390, DOI 10.1128/IAI.00110-13; Eby JC, 2010, J BIOL CHEM, V285, P10662, DOI 10.1074/jbc.M109.089219; Fereol S, 2008, RESP PHYSIOL NEUROBI, V163, P3, DOI 10.1016/j.resp.2008.04.018; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; FRIEDMAN RL, 1992, INFECT IMMUN, V60, P4578, DOI 10.1128/IAI.60.11.4578-4585.1992; Gravelle S, 2010, INNATE IMMUN-LONDON, V16, P14, DOI 10.1177/1753425909106170; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Guiso N, 2017, TOXINS, V9, DOI 10.3390/toxins9090277; HANSKI E, 1985, J BIOL CHEM, V260, P5526; Hasan S, 2019, TOXINS, V11, DOI 10.3390/toxins11060362; Hasan S, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00445-17; Hoon JL, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020017; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Isabey D, 2016, BIOMECH MODEL MECHAN, V15, P947, DOI 10.1007/s10237-015-0734-5; Kamanova J, 2008, J IMMUNOL, V181, P5587, DOI 10.4049/jimmunol.181.8.5587; Karst JC, 2014, J BIOL CHEM, V289, P30702, DOI 10.1074/jbc.M114.580852; Katoh K, 2011, J R SOC INTERFACE, V8, P305, DOI 10.1098/rsif.2010.0419; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; KHELEF N, 1995, FEMS MICROBIOL LETT, V134, P27, DOI 10.1016/0378-1097(95)00375-F; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1992, J BIOL CHEM, V267, P2244; Lamberti YA, 2010, INFECT IMMUN, V78, P907, DOI 10.1128/IAI.01031-09; Laurent VM, 2003, ANN BIOMED ENG, V31, P1263, DOI 10.1114/1.1616932; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; Lefkimmiatis K, 2014, PHARMACOL THERAPEUT, V143, P295, DOI 10.1016/j.pharmthera.2014.03.008; Lele TP, 2007, METHOD CELL BIOL, V83, P443, DOI 10.1016/S0091-679X(07)83019-6; Li YJ, 2017, ONCOTARGET, V8, P69945, DOI 10.18632/oncotarget.19509; Maddugoda MP, 2011, CELL HOST MICROBE, V10, P464, DOI 10.1016/j.chom.2011.09.014; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Mammoto T, 2013, ANNU REV CELL DEV BI, V29, P27, DOI 10.1146/annurev-cellbio-101512-122340; Martin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13774; Martin C, 2010, J BIOL CHEM, V285, P357, DOI 10.1074/jbc.M109.003491; Massin F, 2004, CYTOM PART B-CLIN CY, V60B, P31, DOI 10.1002/cyto.b.20010; Melvin JA, 2014, NAT REV MICROBIOL, V12, P274, DOI 10.1038/nrmicro3235; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; O'Brien DP, 2019, FASEB J, V33, P10065, DOI 10.1096/fj.201802442RR; Ohnishi H, 2008, FEMS MICROBIOL LETT, V279, P174, DOI 10.1111/j.1574-6968.2007.01028.x; Ostolaza H, 2017, TOXINS, V9, DOI 10.3390/toxins9100295; Paccani SR, 2011, J EXP MED, V208, P1317, DOI 10.1084/jem.20101558; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelletier S, 2005, J CELL PHYSIOL, V204, P412, DOI 10.1002/jcp.20308; Planus E, 1999, J CELL SCI, V112, P243; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; ROGEL A, 1992, J BIOL CHEM, V267, P22599; ROGEL A, 1991, J BIOL CHEM, V266, P3154; Singh NK, 2017, J BIOL CHEM, V292, P14080, DOI 10.1074/jbc.M117.777896; STEEG PS, 1988, CANCER RES, V48, P6550; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tso PH, 2013, CELL SIGNAL, V25, P1064, DOI 10.1016/j.cellsig.2013.02.010; Van Slambrouck S, 2009, INT J ONCOL, V34, P1717, DOI 10.3892/ijo_00000302; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang YC, 2013, CANCER LETT, V339, P33, DOI 10.1016/j.canlet.2013.07.025	72	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0228606	10.1371/journal.pone.0228606	http://dx.doi.org/10.1371/journal.pone.0228606			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392246	Green Published, Green Submitted, gold			2022-12-26	WOS:000537470300001
J	Ataei, S; Taheri, MN; Tamaddon, G; Behzad-Behbahani, A; Taheri, F; Rahimi, A; Zare, F; Amirian, N				Ataei, Saeed; Taheri, Mohammad Naser; Tamaddon, Gholamhossein; Behzad-Behbahani, Abbas; Taheri, Fatemeh; Rahimi, Amir; Zare, Farahnaz; Amirian, Niloofar			High-yield production of recombinant platelet factor 4 by harnessing and honing the gram-negative bacterial secretory apparatus	PLOS ONE			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; ESCHERICHIA-COLI; EXTRACELLULAR PRODUCTION; PLATELET ACTIVATION; SIGNAL PEPTIDE; EXPRESSION; PURIFICATION; SYSTEM; OPTIMIZATION; ANTIBODIES	Platelet factor 4 is a cytokine released into the bloodstream by activated platelets where it plays a pivotal role in etiology and diagnosis of heparin-induced thrombocytopenia. Therefore, a sustainable source of recombinant PF4 with structural and functional similarity to its native form is urgently needed to be used in diagnostic procedures. To this end, a three-in-one primary construct was designed from which three secondary constructs can be derived each capable of employing either type I, type II secretory or cytoplasmic pathways. Protein expression and secretion were performed in Escherichia coli BL21 (DE3) and confirmed by SDS-PAGE and Western blotting. To further enhance protein secretion, the effect of several controllable chemical factors including IPTG, Triton X-100, sucrose, and glycine were individually investigated at the outset. In the next step, according to a fractional factorial approach, the synergistic effects of IPTG, Triton X-100, and glycine on secretion were further investigated. To ascertain the structure and function of the secreted recombinant proteins, dynamic light scattering was utilized to confirm the rPF4 tetramerization and heparin-mediated ultra-large complex formation. Moreover, Raman spectroscopy and Western blotting were exploited to evaluate the secondary and quaternary structures, respectively. The type II secretory pathway was proven to be superior to type I in the case of rPF4 secretion. Supplementation with chemical enhancers improved the protein secretion mediated by the Type II system to approximately more than 500 mu g/mL. Large quantities of native rPF4 up to 20 mg were purified as the culture medium was scaled up to 40 mL. Western blotting confirmed the formation of dimers and tetramers in the secreted rPF4 proteins. Dynamic light scattering revealed the rPF4 oligomerization into of larger complexes of approximately 1001200 nm in size following heparin supplementation, implying proper protein folding and tetramerization. Moreover, the rPF4 secondary structure was found to be 43.5% Random coil, 32.5% beta-sheet, 18.6% alpha-helix and 4.9% Turn, which is in perfect agreement with the native structure. Our results indicate that the gram-negative type II bacterial secretory system holds a great promise as a reliable protein production strategy with industrial applications. However, further efforts are required to realize the full potential of secretory pathways regarding their application to proteins with distinct characteristics.	[Ataei, Saeed; Taheri, Mohammad Naser; Tamaddon, Gholamhossein; Behzad-Behbahani, Abbas; Zare, Farahnaz; Amirian, Niloofar] Shiraz Univ Med Sci, Diagnost Lab Sci & Technol Res Ctr, Sch Paramed Sci, Shiraz, Iran; [Ataei, Saeed; Taheri, Mohammad Naser; Tamaddon, Gholamhossein; Behzad-Behbahani, Abbas; Zare, Farahnaz] Shiraz Univ Med Sci, Sch Paramed Sci, Dept Med Biotechnol, Shiraz, Iran; [Taheri, Mohammad Naser; Rahimi, Amir] Shiraz Univ Med Sci, Bioinformat & Computat Biol Res Ctr, Shiraz, Iran; [Taheri, Fatemeh] McGill Univ, Dept Mech Engn, Montreal, PQ, Canada; [Rahimi, Amir] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Mol Med, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; McGill University; Shiraz University of Medical Science	Taheri, MN; Tamaddon, G (corresponding author), Shiraz Univ Med Sci, Diagnost Lab Sci & Technol Res Ctr, Sch Paramed Sci, Shiraz, Iran.; Taheri, MN; Tamaddon, G (corresponding author), Shiraz Univ Med Sci, Sch Paramed Sci, Dept Med Biotechnol, Shiraz, Iran.; Taheri, MN (corresponding author), Shiraz Univ Med Sci, Bioinformat & Computat Biol Res Ctr, Shiraz, Iran.	taheri_mn@sums.ac.ir; tamadon@sums.ac.ir	tamaddon, gholamhossein/Q-9141-2017; Behzad-Behbahani, Abbas/Q-6128-2017	tamaddon, gholamhossein/0000-0001-8158-6004; Behzad-Behbahani, Abbas/0000-0001-5917-920X	Shiraz University of Medical Sciences, Shiraz, Iran [18112]	Shiraz University of Medical Sciences, Shiraz, Iran	This work is based on the Master of Science thesis in medical biotechnology by Saeed Ataei (Project NO. 18112) supported by Shiraz University of Medical Sciences, Shiraz, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2007, POSTGRAD MED J, V83, DOI 10.1136/pgmj.2007.059188; AMIRAL J, 1995, THROMB HAEMOSTASIS, V73, P21; Cai Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9277; Chen R, 2012, BIOTECHNOL ADV, V30, P1102, DOI 10.1016/j.biotechadv.2011.09.013; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; DEUEL TF, 1977, P NATL ACAD SCI USA, V74, P2256, DOI 10.1073/pnas.74.6.2256; Duan YT, 2012, BIOSCI BIOTECH BIOCH, V76, P1855, DOI 10.1271/bbb.120267; ENGSTAD CS, 1995, J LEUKOCYTE BIOL, V58, P575, DOI 10.1002/jlb.58.5.575; FILES JC, 1981, BLOOD, V58, P607; GOEBEL W, 1982, J BACTERIOL, V151, P1290, DOI 10.1128/JB.151.3.1290-1298.1982; Huang CD, 2016, NATURE, V537, P202, DOI 10.1038/nature18965; Huynh A, 2018, PLATELETS, V29, P249, DOI 10.1080/09537104.2017.1378808; KELTON JG, 1994, BLOOD, V83, P3232; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Lambert MP, 2007, BLOOD, V110, P1153, DOI 10.1182/blood-2007-01-067116; Ma R, 2012, ANAL BIOCHEM, V424, P124, DOI 10.1016/j.ab.2012.02.015; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Mergulhao FJM, 2005, BIOTECHNOL ADV, V23, P177, DOI 10.1016/j.biotechadv.2004.11.003; Nazi I, 2015, J THROMB HAEMOST, V13, P1900, DOI 10.1111/jth.13066; Padmanabhan A, 2016, CHEST, V150, P506, DOI 10.1016/j.chest.2016.02.641; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips R, 2012, PHYS BIOL CELL, DOI [10.1111/boc.201100081, DOI 10.1111/BOC.201100081]; Pournejati R, 2014, PROTEIN EXPRES PURIF, V101, P84, DOI 10.1016/j.pep.2014.05.012; Reilly MP, 2001, BLOOD, V98, P2442, DOI 10.1182/blood.V98.8.2442; Reilly RF, 2003, HEPARIN INDUCED THRO, P54; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlapschy M, 2011, PERIPLASMIC CHAPERON, P211; Snyder L., 2007, MOL GENETICS BACTERI, VThird; Su LQ, 2015, J BIOTECHNOL, V204, P47, DOI 10.1016/j.jbiotec.2015.03.029; Su LQ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-8; Taheri MN, 2016, PROTEIN EXPRES PURIF, V128, P14, DOI 10.1016/j.pep.2016.08.003; Thomas S, 2014, BBA-MOL CELL RES, V1843, P1629, DOI 10.1016/j.bbamcr.2013.09.017; Wurm DJ, 2018, APPL MICROBIOL BIOT, V102, P667, DOI 10.1007/s00253-017-8641-6; Yang L, 2018, EFFICIENT EXTRACELLU; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155; Zou C, 2014, BIORESOURCE TECHNOL, V172, P174, DOI 10.1016/j.biortech.2014.09.035	37	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232661	10.1371/journal.pone.0232661	http://dx.doi.org/10.1371/journal.pone.0232661			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379796	Green Submitted, Green Published, gold			2022-12-26	WOS:000537285700053
J	Lee, DK; Lee, H; Park, K; Joh, E; Kim, CE; Ryu, S				Lee, Dong-Kyun; Lee, Hyeongrae; Park, Kyeongwoo; Joh, Euwon; Kim, Chul-Eung; Ryu, Seunghyong			Common gray and white matter abnormalities in schizophrenia and bipolar disorder	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CAUDATE NUCLEI VOLUMES; INTERMEDIATE PHENOTYPES; SYMPTOM DIMENSIONS; I DISORDER; METAANALYSIS; NETWORK; ANTIPSYCHOTICS; IDENTIFICATION; DEPRESSION	This study aimed to investigate abnormalities in the gray matter and white matter (GM and WM, respectively) that are shared between schizophrenia (SZ) and bipolar disorder (BD). We used 3T-magnetic resonance imaging to examine patients with SZ, BD, or healthy control (HC) subjects (aged 20-50 years, N = 65 in each group). We generated modulated GM maps through voxel-based morphometry (VBM) for T1-weighted images and skeletonized fractional anisotropy, mean diffusion, and radial diffusivity maps through tract-based special statistics (TBSS) methods for diffusion tensor imaging (DTI) data. These data were analyzed using a generalized linear model with pairwise comparisons between groups with a family-wise error corrected P < 0.017. The VBM analysis revealed widespread decreases in GM volume in SZ compared to HC, but patients with BD showed GM volume deficits limited to the right thalamus and left insular lobe. The TBSS analysis showed alterations of DTI parameters in widespread WM tracts both in SZ and BD patients compared to HC. The two disorders had WM alterations in the corpus callosum, superior longitudinal fasciculus, internal capsule, external capsule, posterior thalamic radiation, and fornix. However, we observed no differences in GM volume or WM integrity between SZ and BD. The study results suggest that GM volume deficits in the thalamus and insular lobe along with widespread disruptions of WM integrity might be the common neural mechanisms underlying the pathologies of SZ and BD.	[Lee, Dong-Kyun; Lee, Hyeongrae; Joh, Euwon] Natl Ctr Mental Hlth, Dept Mental Hlth Res, Seoul, South Korea; [Park, Kyeongwoo] Natl Ctr Mental Hlth, Dept Clin Psychol, Seoul, South Korea; [Kim, Chul-Eung] Natl Ctr Mental Hlth, Mental Hlth Res Inst, Seoul, South Korea; [Ryu, Seunghyong] Chonnam Natl Univ, Dept Psychiat, Med Sch, Gwangju, South Korea	Chonnam National University	Ryu, S (corresponding author), Chonnam Natl Univ, Dept Psychiat, Med Sch, Gwangju, South Korea.	ryush@chonnam.ac.kr		Ryu, Seunghyong/0000-0001-6127-760X	intramural research grant from the Republic of Korea's National Center for Mental Health [R2019-09]	intramural research grant from the Republic of Korea's National Center for Mental Health	This research was supported by an intramural research grant from the Republic of Korea's National Center for Mental Health (R2019-09).	Ambrosi E, 2016, J AFFECT DISORDERS, V189, P176, DOI 10.1016/j.jad.2015.09.035; Anderson D, 2013, BIPOLAR DISORD, V15, P680, DOI 10.1111/bdi.12096; Anticevic A, 2012, SCHIZOPHRENIA BULL, V38, P967, DOI 10.1093/schbul/sbq168; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Birur B, 2017, NPJ SCHIZOPHR, V3, DOI 10.1038/s41537-017-0013-9; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; Brown GG, 2011, PSYCHIAT RES-NEUROIM, V194, P149, DOI 10.1016/j.pscychresns.2011.05.005; Cea-Canas B, 2019, PROG NEURO-PSYCHOPH, V92, P369, DOI 10.1016/j.pnpbp.2019.02.006; CHAKOS MH, 1995, LANCET, V345, P456, DOI 10.1016/S0140-6736(95)90441-7; CHAKOS MH, 1994, AM J PSYCHIAT, V151, P1430; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; Clark KA, 2011, J PSYCHIATR RES, V45, P980, DOI 10.1016/j.jpsychires.2011.01.006; Cui LQ, 2011, NEUROSCI LETT, V489, P94, DOI 10.1016/j.neulet.2010.11.073; Dikeos DG, 2006, BRIT J PSYCHIAT, V189, P346, DOI 10.1192/bjp.bp.105.017251; Dong DB, 2017, SCHIZOPHR RES, V185, P41, DOI 10.1016/j.schres.2017.01.005; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Gold LH, 2014, J AM ACAD PSYCHIATRY, V42, P173; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Gupta CN, 2015, SCHIZOPHRENIA BULL, V41, P1133, DOI 10.1093/schbul/sbu177; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Haijma SV, 2013, SCHIZOPHRENIA BULL, V39, P1129, DOI 10.1093/schbul/sbs118; Hibar DP, 2018, MOL PSYCHIATR, V23, P932, DOI 10.1038/mp.2017.73; Hibar DP, 2016, MOL PSYCHIATR, V21, P1710, DOI 10.1038/mp.2015.227; Hill SK, 2013, AM J PSYCHIAT, V170, P1275, DOI 10.1176/appi.ajp.2013.12101298; Horowitz E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092573; Ivleva EI, 2013, AM J PSYCHIAT, V170, P1285, DOI 10.1176/appi.ajp.2013.13010126; Kelly S, 2018, MOL PSYCHIATR, V23, P1261, DOI 10.1038/mp.2017.170; Kesby JP, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-017-0071-9; Kumar J, 2015, PSYCHOL MED, V45, P759, DOI 10.1017/S0033291714001810; Lewandowski KE, 2011, PSYCHOL MED, V41, P225, DOI 10.1017/S0033291710001042; Li J, 2014, PSYCHIAT RES-NEUROIM, V221, P58, DOI 10.1016/j.pscychresns.2013.10.007; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lindstrom L, 2017, J AFFECT DISORDERS, V213, P138, DOI 10.1016/j.jad.2017.02.012; Maggioni E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188000; Maller JJ, 2014, J AFFECT DISORDERS, V169, P118, DOI 10.1016/j.jad.2014.08.016; Meisenzahl EM, 2008, SCHIZOPHR RES, V104, P44, DOI 10.1016/j.schres.2008.06.023; Molina V, 2011, EUR ARCH PSY CLIN N, V261, P313, DOI 10.1007/s00406-010-0183-1; Nenadic I, 2015, SCHIZOPHR RES, V165, P212, DOI 10.1016/j.schres.2015.04.007; Nortje G, 2013, J AFFECT DISORDERS, V150, P192, DOI 10.1016/j.jad.2013.05.034; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pantelis C, 1997, BRAIN, V120, P1823, DOI 10.1093/brain/120.10.1823; Perlini C, 2012, ACTA PSYCHIAT SCAND, V126, P363, DOI 10.1111/j.1600-0447.2012.01864.x; Poletti S, 2016, J AFFECT DISORDERS, V189, P290, DOI 10.1016/j.jad.2015.09.049; Redlich R, 2014, JAMA PSYCHIAT, V71, P1222, DOI 10.1001/jamapsychiatry.2014.1100; Selvaraj S, 2012, BIPOLAR DISORD, V14, P135, DOI 10.1111/j.1399-5618.2012.01000.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sheehan DV, 1998, J CLIN PSYCHIAT S20, V59, P4; Shepherd AM, 2015, J PSYCHIATR NEUROSCI, V40, P58, DOI 10.1503/jpn.130283; Skudlarski P, 2013, AM J PSYCHIAT, V170, P886, DOI 10.1176/appi.ajp.2013.12111448; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Squarcina L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178089; Tae WS, 2018, J CLIN NEUROL, V14, P129, DOI 10.3988/jcn.2018.14.2.129; Toomey R, 1998, J NERV MENT DIS, V186, P470, DOI 10.1097/00005053-199808000-00004; Torres US, 2016, NEUROIMAGE-CLIN, V12, P1, DOI 10.1016/j.nicl.2016.06.002; van Erp TGM, 2016, MOL PSYCHIATR, V21, P585, DOI 10.1038/mp.2015.118; van Erp TGM, 2018, BIOL PSYCHIAT, V84, P644, DOI 10.1016/j.biopsych.2018.04.023; Watson DR, 2012, BEHAV BRAIN RES, V227, P91, DOI 10.1016/j.bbr.2011.10.034; Wise T, 2017, MOL PSYCHIATR, V22, P1455, DOI 10.1038/mp.2016.72; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027; Yu K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00189; Yuksel C, 2012, SCHIZOPHR RES, V138, P177, DOI 10.1016/j.schres.2012.03.003; Zhu JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33857	67	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232826	10.1371/journal.pone.0232826	http://dx.doi.org/10.1371/journal.pone.0232826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZX	32379845	Green Published, gold			2022-12-26	WOS:000537285700071
J	Safgren, SL; Olson, RLO; Vrabel, AM; Almada, LL; Marks, DL; Hernandez-Alvarado, N; Gaspar-Maia, A; Fernandez-Zapico, ME				Safgren, Stephanie L.; Olson, Rachel L. O.; Vrabel, Anne M.; Almada, Luciana L.; Marks, David L.; Hernandez-Alvarado, Nelmary; Gaspar-Maia, Alexandre; Fernandez-Zapico, Martin E.			The transcription factor GLI1 cooperates with the chromatin remodeler SMARCA2 to regulate chromatin accessibility at distal DNA regulatory elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GLI family zinc finger 1 (GLI1); SWI; SNF related; matrix associated; actin dependent regulator of chromatin; subfamily A; member 2 (SMARCA2); enhancer; gene transcription; cancer cells; chromatin; epigenetic regulation; transcriptomics; ATAC-seq; chromatin; cancer; transcription enhancer; chromatin remodeling	SONIC HEDGEHOG; GENE-EXPRESSION; ACTIVATION; ONCOGENE; PROMOTER; PATHWAY; PCAF; BRG1; BRM	The transcription factor GLI1 (GLI family zinc finger 1) plays a key role in the development and progression of multiple malignancies. To date, regulation of transcriptional activity at target gene promoters is the only molecular event known to underlie the oncogenic function of GLI1. Here, we provide evidence that GLI1 controls chromatin accessibility at distal regulatory regions by modulating the recruitment of SMARCA2 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 2) to these elements. We demonstrate that SMARCA2 endogenously interacts with GLI1 and enhances its transcriptional activity. Mapping experiments indicated that the C-terminal transcriptional activation domain of GLI1 and SMARCA2's central domains, including its ATPase motif, are required for this interaction. Interestingly, similar to SMARCA2, GLI1 overexpression increased chromatin accessibility, as indicated by results of the micrococcal nuclease assay. Further, results of assays for transposase-accessible chromatin with sequencing (ATAC-seq) after GLI1 knockdown supported these findings, revealing that GLI1 regulates chromatin accessibility at several regions distal to gene promoters. Integrated RNA-seq and ATAC-seq data analyses identified a subset of differentially expressed genes located incisto these regulated chromatin sites. Finally, using the GLI1-regulated geneHHIP(Hedgehog-interacting protein) as a model, we demonstrate that GLI1 and SMARCA2 co-occupy a distal chromatin peak and that SMARCA2 recruitment to this HHIP putative enhancer requires intact GLI1. These findings provide insights into how GLI1 controls gene expression in cancer cells and may inform approaches targeting this oncogenic transcription factor to manage malignancies.	[Safgren, Stephanie L.; Olson, Rachel L. O.; Vrabel, Anne M.; Almada, Luciana L.; Marks, David L.; Hernandez-Alvarado, Nelmary; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Gaspar-Maia, Alexandre] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Hernandez-Alvarado, Nelmary] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	fernandez-zapico.martin@mayo.edu	Gaspar-Maia, Alexandre/AAY-5416-2020	Gaspar-Maia, Alexandre/0000-0001-8528-5575	NCI, National Institutes of Health [CA136526]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grant CA136526 (to M. E. F.-Z.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Bosco-Clement G, 2014, ONCOGENE, V33, P2087, DOI 10.1038/onc.2013.164; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Carr RM, 2020, J BIOL CHEM, V295, P2698, DOI 10.1074/jbc.RA119.011146; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Diao YM, 2018, MOL ONCOL, V12, P1718, DOI 10.1002/1878-0261.12366; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Fiaschi M, 2009, CANCER RES, V69, P4810, DOI 10.1158/0008-5472.CAN-08-3938; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Jiang H, 2014, INT J CLIN EXP PATHO, V7, P4531; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malatesta M, 2013, CANCER RES, V73, P6323, DOI 10.1158/0008-5472.CAN-12-4660; Marechal R, 2015, CLIN CANCER RES, V21, P1215, DOI 10.1158/1078-0432.CCR-14-0667; Mazza D, 2013, CELL DEATH DIFFER, V20, P1688, DOI 10.1038/cdd.2013.120; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Nye MD, 2014, J BIOL CHEM, V289, P15495, DOI 10.1074/jbc.M113.545194; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Stark R., 2016, DIFFBIND DIFFERENTIA; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Wu M, 2016, J BIOL CHEM, V291, P25749, DOI 10.1074/jbc.M116.753129; Xu LS, 2010, BREAST CANCER RES TR, V123, P59, DOI 10.1007/s10549-009-0617-5; Yoon JW, 2015, DNA REPAIR, V34, P9, DOI 10.1016/j.dnarep.2015.06.006; Yoon JW, 1998, J BIOL CHEM, V273, P3496, DOI 10.1074/jbc.273.6.3496; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108	38	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8725	8735		10.1074/jbc.RA120.013268	http://dx.doi.org/10.1074/jbc.RA120.013268			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32376693	Green Published, hybrid			2022-12-26	WOS:000546296800009
J	Xu, B; Qin, TT; Yu, JC; Giordano, TJ; Sartor, MA; Koenig, RJ				Xu, Bin; Qin, Tingting; Yu, Jingcheng; Giordano, Thomas J.; Sartor, Maureen A.; Koenig, Ronald J.			Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thyroid; cancer; gene expression; histone methylation; long noncoding RNA (lncRNA); microRNA; CCAT1; anaplastic thyroid cancer; ASH1-like histone lysine methyltransferase (ASH1L); epigenetics; miR-200b-3p; microRNA (miRNA)	RNA-SEQ; MUTATIONAL LANDSCAPE; DOWN-REGULATION; CANCER; GENE; PROTEIN; TUMORIGENESIS; CATENIN; CCAT1	Anaplastic thyroid cancer (ATC) is one of the most aggressive human malignancies, with an average life expectancy of ?6 months from the time of diagnosis. The genetic and epigenetic changes that underlie this malignancy are incompletely understood. We found that ASH1-like histone lysine methyltransferase (ASH1L) is overexpressed in ATC relative to the much less aggressive and more common differentiated thyroid cancer. This increased expression was due at least in part to reduced levels of microRNA-200b-3p (miR-200b-3p), which represses ASH1L expression, in ATC. Genetic knockout of ASH1L protein expression in ATC cell lines decreased cell growth both in culture and in mouse xenografts. RNA-Seq analysis of ASH1L knockoutversusWT ATC cell lines revealed that ASH1L is involved in the regulation of numerous cancer-related genes and gene sets. The pro-oncogenic long noncoding RNA colon cancer-associated transcript 1 (CCAT1) was one of the most highly (approximately 68-fold) down-regulated transcripts in ASH1L knockout cells. Therefore, we investigated CCAT1 as a potential mediator of the growth-inducing activity of ASH1L. Supporting this hypothesis, CCAT1 knockdown in ATC cells decreased their growth rate, and ChIP-Seq data indicated that CCAT1 is likely a direct target of ASH1L's histone methyltransferase activity. These results indicate that ASH1L contributes to the aggressiveness of ATC and suggest that ASH1L, along with its upstream regulator miR-200b-3p and its downstream mediator CCAT1, represents a potential therapeutic target in ATC.	[Xu, Bin; Yu, Jingcheng; Koenig, Ronald J.] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Qin, Tingting; Sartor, Maureen A.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA; [Giordano, Thomas J.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, B; Koenig, RJ (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	bxu@umich.edu; rkoenig@umich.edu		Giordano, Thomas/0000-0003-0641-8873	National Cancer Institute of the National Institutes of Health [P30CA046592]; Rogel Cancer Center Tissue and Molecular Pathology Shared Resource	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rogel Cancer Center Tissue and Molecular Pathology Shared Resource	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number P30CA046592 (to T. J. G.) by the use of the Rogel Cancer Center Tissue and Molecular Pathology Shared Resource. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2019, MICROB BIOTECHNOL, DOI DOI 10.1093/jb/mvz107; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonhomme B, 2017, THYROID, V27, P682, DOI 10.1089/thy.2016.0254; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; Cavalcante RG, 2017, BIOINFORMATICS, V33, P2381, DOI 10.1093/bioinformatics/btx183; Chen S, 2019, ONCOTARGETS THER, V12, P9215, DOI 10.2147/OTT.S216718; Chen YH, 2020, NUCLEIC ACIDS RES, V48, pD127, DOI 10.1093/nar/gkz757; Colamaio M, 2015, J CLIN ENDOCR METAB, V100, pE59, DOI 10.1210/jc.2014-2280; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DONGHI R, 1993, J CLIN INVEST, V91, P1753, DOI 10.1172/JCI116385; Enomoto K, 2017, J CLIN ENDOCR METAB, V102, P2268, DOI 10.1210/jc.2016-3771; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Feichtinger J, 2012, ONCOTARGET, V3, P843; Fujimoto A, 2016, NAT GENET, V48, P500, DOI 10.1038/ng.3547; Garcia-Rostan G, 1999, CANCER RES, V59, P1811; Ghafouri-Fard S, 2019, J CELL PHYSIOL, V234, P14581, DOI 10.1002/jcp.28176; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Guo XQ, 2017, J CANCER RES CLIN, V143, P555, DOI 10.1007/s00432-016-2268-3; Hebrant A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103871; Hough Soren H, 2016, Per Med, V13, P517, DOI 10.2217/pme-2016-0068; Hua F, 2019, GASTROENTEROLOGY, V156, P708, DOI 10.1053/j.gastro.2018.10.031; Ivanova AV, 2009, CLIN CANCER RES, V15, P2602, DOI 10.1158/1078-0432.CCR-08-2755; Jih G, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-117367; Jones M, 2015, J CLIN INVEST, V125, P2007, DOI 10.1172/JCI78124; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Kitamura Y, 1999, J CLIN ENDOCR METAB, V84, P4043, DOI 10.1210/jc.84.11.4043; Kumari N, 2016, TUMOR BIOL, V37, P11553, DOI 10.1007/s13277-016-5098-7; Kunstman JW, 2015, HUM MOL GENET, V24, P2318, DOI 10.1093/hmg/ddu749; Lancia I, 2016, J CLIN INVEST, V126, P1052, DOI 10.1172/JCI85271; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee C, 2016, BIOINFORMATICS, V32, P1100, DOI 10.1093/bioinformatics/btv694; Liu LX, 2015, ONCOTARGET, V6, P2466, DOI 10.18632/oncotarget.2967; Lu XM, 2018, NEOPLASMA, V65, P656, DOI 10.4149/neo_2018_171024N680; Mebarki S, 2016, ONCOTARGET, V7, P39026, DOI 10.18632/oncotarget.9346; Molinaro E, 2017, NAT REV ENDOCRINOL, V13, P644, DOI 10.1038/nrendo.2017.76; Nakamura T, 2000, P NATL ACAD SCI USA, V97, P7284, DOI 10.1073/pnas.97.13.7284; NAKAMURA T, 1992, JPN J CANCER RES, V83, P1293, DOI 10.1111/j.1349-7006.1992.tb02761.x; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Pallante P, 2014, NAT REV ENDOCRINOL, V10, P88, DOI 10.1038/nrendo.2013.223; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Sato T, 2000, THYROID, V10, P1113, DOI 10.1089/thy.2000.10.1113; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shen W, 2019, EUR J MED GENET, V62, P55, DOI 10.1016/j.ejmg.2018.05.003; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Skawran B, 2008, MODERN PATHOL, V21, P505, DOI 10.1038/modpathol.3800998; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Tang TT, 2019, THERANOSTICS, V9, P7384, DOI 10.7150/thno.37892; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trissal MC, 2018, CANCER RES, V78, P3510, DOI 10.1158/0008-5472.CAN-17-3592; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Xia SJ, 2017, J CANCER, V8, P2816, DOI 10.7150/jca.18482; Xu B, 2016, J BIOL CHEM, V291, P19274, DOI 10.1074/jbc.M116.740324; Xu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014199; Yang Z, 2019, J CELL BIOCHEM, V120, P4634, DOI 10.1002/jcb.27751; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Zhu L, 2016, CANCER DISCOV, V6, P770, DOI 10.1158/2159-8290.CD-16-0058	67	14	14	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8834	8845		10.1074/jbc.RA120.013530	http://dx.doi.org/10.1074/jbc.RA120.013530			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32398261	Green Published, hybrid			2022-12-26	WOS:000546296800018
J	Verster, AM; Liang, JE; Rostal, MK; Kemp, A; Brand, RF; Anyamba, A; Cordel, C; Schall, R; Zwiegers, H; Paweska, JT; Karesh, WB; van Huyssteen, CW				Verster, Anna M.; Liang, Janice E.; Rostal, Melinda K.; Kemp, Alan; Brand, Robert F.; Anyamba, Assaf; Cordel, Claudia; Schall, Robert; Zwiegers, Herman; Paweska, Janusz T.; Karesh, William B.; van Huyssteen, Cornie W.			Selected wetland soil properties correlate to Rift Valley fever livestock mortalities reported in 2009-10 in central South Africa	PLOS ONE			English	Article							TOTAL MICROBIAL ACTIVITY; DIPTERA; ADSORPTION; OUTBREAKS; SURVIVAL; VIRUS; EGGS	Outbreaks of Rift Valley fever have devastating impacts on ruminants, humans, as well as on regional and national economies. Although numerous studies on the impact and outbreak of Rift Valley fever exist, relatively little is known about the role of environmental factors, especially soil, on the aestivation of the virus. This study thus selected 22 sites for study in central South Africa, known to be the recurrent epicenter of widespread Rift Valley fever outbreaks in Southern Africa. Soils were described, sampled and analyzed in detail at each site. Of all the soil variables analyzed for, only eight (cation exchange capacity, exchangeable Ca2+, exchangeable K+, exchangeable Mg2+, soluble Ca2+, medium sand, As, and Br) were statistically identified to be potential indicators of sites with reported Rift Valley fever mortalities, as reported for the 2009-2010 Rift Valley fever outbreak. Four soil characteristics (exchangeable K+, exchangeable Mg2+, medium sand, and Br) were subsequently included in a discriminant function that could potentially be used to predict sites that had reported Rift Valley fever-associated mortalities in livestock. This study therefore constitutes an initial attempt to predict sites prone to Rift Valley fever livestock mortality from soil properties and thus serves as a basis for broader research on the interaction between soil, mosquitoes and Rift Valley fever virus. Future research should include other environmental components such as vegetation, climate, and water properties as well as correlating soil properties with floodwater Aedes spp. abundance and Rift Valley fever virus prevalence.	[Verster, Anna M.; Brand, Robert F.; Zwiegers, Herman; van Huyssteen, Cornie W.] Univ Free State, Dept Soil Crop & Climate Sci, Bloemfontein, South Africa; [Liang, Janice E.; Rostal, Melinda K.; Karesh, William B.] EcoHlth Alliance, New York, NY USA; [Kemp, Alan; Paweska, Janusz T.] Natl Inst Communicable Dis, Johannesburg, South Africa; [Anyamba, Assaf] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Anyamba, Assaf] Univ Space Res Assoc, Columbia, MD USA; [Cordel, Claudia] ExecuVet Vet Clin & Sci Consulting, Bloemfontein, South Africa; [Schall, Robert] Univ Free State, Dept Math Stat & Actuarial Sci, Bloemfontein, South Africa; [Brand, Robert F.] Cuyahoga Cty Board Hlth, Parma, OH USA	University of the Free State; EcoHealth Alliance; National Institute for Communicable Diseases (NICD); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universities Space Research Association (USRA); University of the Free State	van Huyssteen, CW (corresponding author), Univ Free State, Dept Soil Crop & Climate Sci, Bloemfontein, South Africa.	vanhuyssteencw@ufs.ac.za	Karesh, William/AAU-9084-2020	Karesh, William/0000-0001-6042-2860; Brand, Robert/0000-0002-9790-3120; Anyamba, Assaf/0000-0003-0932-9585	U.S. Department of Defense, Defense Threat Reduction Agency's Biological Threat Reduction Program [HDTRA1-14-1-0029]; U.S. Department of Defense, Defense Threat Reduction Agency	U.S. Department of Defense, Defense Threat Reduction Agency's Biological Threat Reduction Program; U.S. Department of Defense, Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	WBK, MKR and JTP are thankful to the U.S. Department of Defense, Defense Threat Reduction Agency's Biological Threat Reduction Program for funding. Grant number: HDTRA1-14-1-0029. URL: https://www.dtra.mil/Mission/Mission-irectorates/Cooperative-ThreatReduction/#.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The project depicted is sponsored by the U.S. Department of Defense, Defense Threat Reduction Agency. The content of the information does not necessarily reflect the position or the policy of the federal government, and no official endorsement should be inferred. Claudia Cordel is affiliated with ExecuVet Veterinary Clinical and Scientific Consulting a private consulting company hired through the funding received by the listed funders. ExecuVet Veterinary Clinical and Scientific Consulting provided support in the form of salaries for authors CC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the `author contributions' section.	Adam G, 2001, SOIL BIOL BIOCHEM, V33, P943, DOI 10.1016/S0038-0717(00)00244-3; [Anonymous], 2014, XRAY FLUORESCENCE XR; [Anonymous], 1992, BIOL MOSQUITOES DEV; [Anonymous], 2014, XRAY POWDER DIFFRACT; Anyamba Assaf, 2006, Int J Health Geogr, V5, P60, DOI 10.1186/1476-072X-5-60; Anyamba A, 2010, AM J TROP MED HYG, V83, P43, DOI 10.4269/ajtmh.2010.09-0289; Archer BN, 2011, SAMJ S AFR MED J, V101, P263, DOI 10.7196/SAMJ.4544; BITTON G, 1975, WATER RES, V9, P473, DOI 10.1016/0043-1354(75)90071-8; Brady N.C, 2000, NATURE PROPERTIES SO; Brand RF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191585; Campos RE, 2008, MEM I OSWALDO CRUZ, V103, P115, DOI 10.1590/S0074-02762008005000001; Committee TN-ASAW, 1990, HDB STAND SOIL TEST; Culman SW, 2012, PROCEDURE DETERMINAT; Department of Water Affairs and Forestry, 2005, PRACT FIELD PROC ID; GARGAN TP, 1988, MED VET ENTOMOL, V2, P231, DOI 10.1111/j.1365-2915.1988.tb00189.x; Hightower A, 2012, AM J TROP MED HYG, V86, P373, DOI 10.4269/ajtmh.2012.11-0450; IUSS Working Group WRB, 2015, WORLD REF BAS SOIL R; JOUBERT J D S, 1951, S Afr Med J, V25, P890; Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; LINTHICUM KJ, 1985, B ENTOMOL RES, V75, P661, DOI 10.1017/S0007485300015923; LOGAN TM, 1992, J AM MOSQUITO CONTR, V8, P89; McIntosh B M, 1972, J S Afr Vet Med Assoc, V43, P391; Mdlulwa Z., 2017, African Journal of Agricultural Research, V12, P979, DOI 10.5897/ajar2016.11130; Mlingano Agricultural Research Institute, 2006, SOILS TANZ THEIR POT; MOORE RS, 1981, APPL ENVIRON MICROB, V42, P963, DOI 10.1128/AEM.42.6.963-975.1981; Mweya Clement Nyamunura, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.21748; OIE, 2010, 17 OIE; Ortega C, 2009, MAR POLLUT BULL, V58, P1374, DOI 10.1016/j.marpolbul.2009.04.015; Romoser WS, 2011, RES REP TROP MED, V2, P121, DOI 10.2147/RRTM.S13947; SAS Institute, 2013, SAS STAT 13 1 US GUI; SCHNURER J, 1982, APPL ENVIRON MICROB, V43, P1256; Sindato C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005002; Smith KR, 1999, EPIDEMIOLOGY, V10, P573, DOI 10.1097/00001648-199909000-00027; Soil Classification Working Group, 1991, SOIL CLASS TAX SYST, V15; Swanepoel R, 2004, INFECT DIS LIVESTOCK, V3; Turner D., 1991, GWA9161 I SOIL CLIM; Weil R. R., 2003, American Journal of Alternative Agriculture, V18, P3, DOI 10.1079/AJAA2003003; WHO, 2017, RIFT VALL FEV FACT S; Williams R, 2016, EMERG INFECT DIS, V22, P2054, DOI 10.3201/eid2212.151352; Wu XN, 2014, JPN J INFECT DIS, V67, P95, DOI 10.7883/yoken.67.95; Zabaloy MC, 2008, APPL SOIL ECOL, V40, P1, DOI 10.1016/j.apsoil.2008.02.004	42	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0232481	10.1371/journal.pone.0232481	http://dx.doi.org/10.1371/journal.pone.0232481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421747	gold, Green Published			2022-12-26	WOS:000537499600011
J	Franco, LVR; Su, CH; Burnett, J; Teixeira, LS; Tzagoloff, A				Ribeiro Franco, Leticia Veloso; Su, Chen-Hsien; Burnett, Julia; Teixeira, Lorisa Simas; Tzagoloff, Alexander			Atco, a yeast mitochondrial complex of Atp9 and Cox6, is an assembly intermediate of the ATP synthase	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; SACCHAROMYCES-CEREVISIAE; PROTEINS; GENE; STOICHIOMETRY; SUPERCOMPLEX; INSERTION	Mitochondrial oxidative phosphorylation (oxphos) is the process by which the ATP synthase conserves the energy released during the oxidation of different nutrients as ATP. The yeast ATP synthase consists of three assembly modules, one of which is a ring consisting of 10 copies of the Atp9 subunit. We previously reported the existence in yeast mitochondria of high molecular weight complexes composed of mitochondrially encoded Atp9 and of Cox6, an imported structural subunit of cytochrome oxidase (COX). Pulse-chase experiments indicated a correlation between the loss of newly translated Atp9 complexed to Cox6 and an increase of newly formed Atp9 ring, but did not exclude the possibility of an alternate source of Atp9 for ring formation. Here we have extended studies on the functions and structure of this complex, referred to as Atco. We show that Atco is the exclusive source of Atp9 for the ATP synthase assembly. Pulse-chase experiments show that newly translated Atp9, present in Atco, is converted to a ring, which is incorporated into the ATP synthase with kinetics characteristic of a precursor-product relationship. Even though Atco does not contain the ring form of Atp9, cross-linking experiments indicate that it is oligomeric and that the intersubunit interactions are similar to those of the bona fide ring. We propose that, by providing Atp9 for biogenesis of ATP synthase, Atco complexes free Cox6 for assembly of COX. This suggests that Atco complexes may play a role in coordinating assembly and maintaining proper stoichiometry of the two oxphos enzymes	[Ribeiro Franco, Leticia Veloso; Su, Chen-Hsien; Burnett, Julia; Teixeira, Lorisa Simas; Tzagoloff, Alexander] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Ribeiro Franco, Leticia Veloso] Univ Sao Paulo, Dept Microbiol, Sao Paulo, SP, Brazil	Columbia University; Universidade de Sao Paulo	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@columbia.edu			National Institutes of Health [5RO1 GM111864]; FAPESP [2019/02799-2]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by National Institutes of Health Grant 5RO1 GM111864 to (AT) and a FAPESP Post-Doctoral Fellowship 2019/02799-2 to (LVRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Altamura N, 1996, FEBS LETT, V382, P111, DOI 10.1016/0014-5793(96)00165-2; Ballhausen B, 2009, J BACTERIOL, V191, P2400, DOI 10.1128/JB.01390-08; Bietenhader M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002876; Clark-Walker GD, 1996, BIOCHEM BIOPH RES CO, V25, P8; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; Jia LX, 2007, MOL BIOL CELL, V18, P1897, DOI 10.1091/mbc.E06-10-0925; Jones PC, 1998, J BIOL CHEM, V273, P29701, DOI 10.1074/jbc.273.45.29701; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luttik MAH, 1998, J BIOL CHEM, V273, P24529, DOI 10.1074/jbc.273.38.24529; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; MULERO JJ, 1993, MOL BIOL CELL, V4, P1327, DOI 10.1091/mbc.4.12.1327; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rathore S, 2019, NAT STRUCT MOL BIOL, V26, P50, DOI 10.1038/s41594-018-0169-7; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578; Sousa JS, 2016, ELIFE, V5, DOI [10.7554/eLife.21290, 10.7554/e.Life.21290]; Srivastava AP, 2018, SCIENCE, V360, DOI 10.1126/science.aas9699; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Su CH, 2014, J BIOL CHEM, V289, P31605, DOI 10.1074/jbc.M114.602706; Su X, 2019, HUM MOL GENET, V28, P3792, DOI 10.1093/hmg/ddz160; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Tzagoloff A, 2004, J BIOL CHEM, V279, P19775, DOI 10.1074/jbc.M401506200; TZAGOLOFF A, 1973, BIOCHIM BIOPHYS ACTA, V301, P71, DOI 10.1016/0304-4173(73)90013-X; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8236; Wilkens V, 2013, J CELL SCI, V126, P103, DOI 10.1242/jcs.108852; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012	40	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233177	10.1371/journal.pone.0233177	http://dx.doi.org/10.1371/journal.pone.0233177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413073	gold, Green Published			2022-12-26	WOS:000537496000053
J	Boie, S; Lauridsen, HH; Glavind, J; Smed, MK; Uldbjerg, N; Bor, P				Boie, Sidsel; Lauridsen, Henrik Hein; Glavind, Julie; Smed, Mette Kiel; Uldbjerg, Niels; Bor, Pinar			The Childbirth Experience Questionnaire (CEQ)-Validation of its use in a Danish-speaking population of new mothers stimulated with oxytocin during labour	PLOS ONE			English	Article							BIRTH EXPERIENCE; INDUCTION; DELIVERY; IMPACT; TRIAL; WOMEN	Background When determining optimal treatment regimens, patient reported outcomes including satisfaction are increasingly appreciated. It is well established that the birth experience may affect the postnatal attachment to the newborn and the management of subsequent pregnancies and deliveries. As we have no robust validated Danish tool to evaluate the childbirth experience exists, we aimed to perform a transcultural adaptation of the Childbirth Experience Questionnaire (CEQ) to a Danish context. Methods In accordance with the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN), we translated the Swedish-CEQ to Danish. The Danish-CEQ was tested for content validity among 10 new mothers. In a population of women who have had their labour induced, we then assessed the electronic questionnaire for validity and reliability using factor analytical design, hypothesis testing, and internal consistency. Based on these data, we determined criterion and construct responsiveness in addition to floor and ceiling effects. Results The content validation resulted in minor adjustments in two items. This improved the comprehensibility. The electronic questionnaire was completed by 377 of 495 women (76.2%). The original Swedish-CEQ was four-dimensional, however an exploratory factor analysis revealed a three-dimensional structure in our Danish population (Own capacity, Participation, and Professional support). Parous women, women who delivered vaginally, and women with a labour duration < 12 hours had a higher score in each domain. The internal consistency (Cronbach's alpha) ranged between 0.75 and 0.89 and the ICC between 0.68-0.93. We found ceiling effects of 57.6% in the domain Professional support and of 25.5% in the domain Participation. Conclusion This study offers transcultural adaptation of the Swedish-CEQ to a Danish context. The 3dimensional Danish-CEQ demonstrates construct validity and reliability. Our results revealed significant ceiling effect especially in the domain Professional support, which needs to be acknowledged when considering implementing the Danish-CEQ into trials and clinical practice.	[Boie, Sidsel; Bor, Pinar] Reg Hosp Randers, Dept Obstet & Gynaecol, Randers NO, Denmark; [Lauridsen, Henrik Hein] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark; [Glavind, Julie; Uldbjerg, Niels] Aarhus Univ Hosp, Dept Obstet & Gynaecol, Aarhus, Denmark; [Smed, Mette Kiel] Rigshosp, Dept Obstet & Gynaecol, Copenhagen, Denmark	University of Southern Denmark; Aarhus University; Rigshospitalet; University of Copenhagen	Boie, S (corresponding author), Reg Hosp Randers, Dept Obstet & Gynaecol, Randers NO, Denmark.	sidselboie@clin.au.dk	Bor, Pinar/AAE-3652-2020; Boie, Sidsel/I-5773-2019; Bor, Pinar/GQH-4429-2022; Glavind, Julie/AAQ-2408-2020; Uldbjerg, Niels/O-2038-2016	Bor, Pinar/0000-0001-5841-5418; Boie, Sidsel/0000-0002-8725-2117; Glavind, Julie/0000-0002-9856-6621; Uldbjerg, Niels/0000-0002-6449-6426; Lauridsen, Henrik/0000-0001-5198-5215	Regional Hospital Randers; Aarhus University; Health Research Fund of Central Denmark Region; Dagmar Marshall Foundation; Danish Regions Medical Foundation; Aase and Ejnar Danielsens Foundation; A.P. Moeller Foundation for the Advancement of Medical Science; Soren Segels and Johanne Wiibroe Segels Research Fund	Regional Hospital Randers; Aarhus University; Health Research Fund of Central Denmark Region; Dagmar Marshall Foundation; Danish Regions Medical Foundation; Aase and Ejnar Danielsens Foundation; A.P. Moeller Foundation for the Advancement of Medical Science; Soren Segels and Johanne Wiibroe Segels Research Fund	Funding for the trial was obtained from the below mentioned organisations and foundations: Regional Hospital Randers, Aarhus University, Health Research Fund of Central Denmark Region, Dagmar Marshall Foundation, The Danish Regions Medical Foundation, Aase and Ejnar Danielsens Foundation, The A.P. Moeller Foundation for the Advancement of Medical Science, and The Soren Segels and Johanne Wiibroe Segels Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Carquillat P, 2016, MIDWIFERY, V43, P21, DOI 10.1016/j.midw.2016.10.002; de Vet HCW, 2005, QUAL LIFE RES, V14, P1203, DOI 10.1007/s11136-004-5742-3; de Vet HCW., 2011, CAMBRIDGE CORE, DOI [10.1017/CBO9780511996214, DOI 10.1017/CBO9780511996214]; Dencker A, 2009, OBSTET GYNECOL SURV, V64, P434, DOI 10.1097/01.ogx.0000351686.94833.e1; Dencker A, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-81; Fuglenes D, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.043; Gottvall K, 2002, BJOG-INT J OBSTET GY, V109, P254, DOI 10.1111/j.1471-0528.2002.01200.x; Grobman WA, 2018, NEW ENGL J MED, V379, P513, DOI 10.1056/NEJMoa1800566; Gurber S, 2017, EUR J OBSTET GYN R B, V215, P68, DOI 10.1016/j.ejogrb.2017.05.021; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Henriksen L, 2017, MIDWIFERY, V51, P33, DOI 10.1016/j.midw.2017.05.004; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; NILVER H, 2017, BMC PREGNANCY CHILDB, V17, DOI DOI 10.1186/S12884-016-1183-6; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pang Man Wah, 2008, Birth, V35, P121, DOI 10.1111/j.1523-536X.2008.00225.x; Soriano-Vidal FJ, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1100-z; STREINER DL, 1994, CAN J PSYCHIAT, V39, P135, DOI 10.1177/070674379403900303; Terwee CB, 2018, QUAL LIFE RES, V27, P1159, DOI 10.1007/s11136-018-1829-0; Walker KF, 2016, OBSTET GYNECOL SURV, V71, P381, DOI 10.1097/01.ogx.0000488681.91547.73; Walker KF, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0513-4; Westfall PH, 2014, AM STAT, V68, P191, DOI 10.1080/00031305.2014.917055; Zasloff E, 2007, ACTA OBSTET GYN SCAN, V86, P1328, DOI 10.1080/00016340701657209	24	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233122	10.1371/journal.pone.0233122	http://dx.doi.org/10.1371/journal.pone.0233122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0YZ	32407376	Green Published, gold			2022-12-26	WOS:000537490700073
J	Smith, EC; Limbach, KJ; Rangel, N; Oda, K; Bolton, JS; Du, MY; Gowda, K; Wang, JY; Moch, JK; Sonawane, S; Velasco, R; Belmonte, A; Danner, R; Lumsden, JM; Patterson, NB; Sedegah, M; Hollingdale, MR; Richie, TL; Sacci, JB; Villasante, ED; Aguiar, JC				Smith, Emily C.; Limbach, Keith J.; Rangel, Nonenipha; Oda, Kyosuke; Bolton, Jessica S.; Du, Mengyan; Gowda, Kalpana; Wang, Jianyang; Moch, J. Kathleen; Sonawane, Sharvari; Velasco, Rachel; Belmonte, Arnel; Danner, Rebecca; Lumsden, Joanne M.; Patterson, Noelle B.; Sedegah, Martha; Hollingdale, Michael R.; Richie, Thomas L.; Sacci, John B., Jr.; Villasante, Eileen D.; Aguiar, Joao C.			Novel malaria antigen Plasmodium yoelii E140 induces antibody-mediated sterile protection in mice against malaria challenge	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; CIRCUMSPOROZOITE PROTEIN; FALCIPARUM; VACCINE; EFFICACY; IMMUNIZATION; PARASITES; INVASION; IDENTIFICATION; TARGET	Only a small fraction of the antigens expressed by malaria parasites have been evaluated as vaccine candidates. A successful malaria subunit vaccine will likely require multiple antigenic targets to achieve broad protection with high protective efficacy. Here we describe protective efficacy of a novel antigen, Plasmodium yoelii (Py) E140 (PyE140), evaluated against P. yoelii challenge of mice. Vaccines targeting PyE140 reproducibly induced up to 100% sterile protection in both inbred and outbred murine challenge models. Although PyE140 immunization induced high frequency and multifunctional CD8(+) T cell responses, as well as CD4(+) T cell responses, protection was mediated by PyE140 antibodies acting against blood stage parasites. Protection in mice was long-lasting with up to 100% sterile protection at twelve weeks post-immunization and durable high titer anti-PyE140 antibodies. The E140 antigen is expressed in all Plasmodium species, is highly conserved in both P. falciparum lab-adapted strains and endemic circulating parasites, and is thus a promising lead vaccine candidate for future evaluation against human malaria parasite species.	[Smith, Emily C.; Limbach, Keith J.; Rangel, Nonenipha; Oda, Kyosuke; Bolton, Jessica S.; Du, Mengyan; Gowda, Kalpana; Wang, Jianyang; Sonawane, Sharvari; Velasco, Rachel; Belmonte, Arnel; Danner, Rebecca; Lumsden, Joanne M.; Patterson, Noelle B.; Sedegah, Martha; Hollingdale, Michael R.; Richie, Thomas L.; Villasante, Eileen D.; Aguiar, Joao C.] Naval Med Res Ctr, Malaria Dept, Silver Spring, MD USA; [Smith, Emily C.; Limbach, Keith J.; Bolton, Jessica S.; Du, Mengyan; Moch, J. Kathleen; Sonawane, Sharvari; Velasco, Rachel; Belmonte, Arnel; Danner, Rebecca; Lumsden, Joanne M.; Patterson, Noelle B.; Hollingdale, Michael R.] Henry M Jackson Fdn Adv Mil Med Inc HJF, Bethesda, MD USA; [Rangel, Nonenipha; Oda, Kyosuke; Wang, Jianyang; Aguiar, Joao C.] CAMRIS Int, Bethesda, MD 20814 USA; [Moch, J. Kathleen] Walter Reed Army Inst Res, Malaria Biol Branch, Silver Spring, MD USA; [Sacci, John B., Jr.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Du, Mengyan] Meso Scale Diagnost, Rockville, MD USA; [Wang, Jianyang] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Moch, J. Kathleen] Walter Reed Army Inst Res, Malaria Biol Branch, Silver Spring, MD USA; [Moch, J. Kathleen] Gen Dynam Informat Technol Inc, Frederick, MD USA; [Sonawane, Sharvari] Univ Rochester, Sch Med & Dent, Dept Pediat Allergy & Immunol, Rochester, NY USA; [Velasco, Rachel; Belmonte, Arnel] Naval Med Res Ctr, Malaria Dept, Silver Spring, MD USA; [Velasco, Rachel; Belmonte, Arnel] Gen Dynam Informat Technol Inc, Frederick, MD USA; [Danner, Rebecca] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Lumsden, Joanne M.] ERPi Inc, Fairfax, VA USA; [Richie, Thomas L.] Sanaria Inc, Rockville, MD USA	Naval Medical Research Center (NMRC); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University System of Maryland; University of Maryland Baltimore; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of Rochester; Naval Medical Research Center (NMRC); Medical College of Wisconsin; Sanaria Inc.	Aguiar, JC (corresponding author), Naval Med Res Ctr, Malaria Dept, Silver Spring, MD USA.; Aguiar, JC (corresponding author), CAMRIS Int, Bethesda, MD 20814 USA.	joao.c.aguiar.ctr@mail.mil	Wu, Jing/GZK-5063-2022; Wang, Jin/GYA-2019-2022; wang, jing/GVT-8700-2022	Lumsden, Joanne/0000-0002-0730-9946; Richie, Thomas/0000-0002-2946-5456	Military Infectious Diseases Research Program (MIDRP) Proposals [F0339_13_NM, F0482_16_NM, A1217]; MIDRP [F0409_14_WR_CS, F0523_17_WR_CS, A1256]; United States Agency for International Development (USAID) [AID-GH-T-17-00002]; Naval Medical Research Center - Silver Spring, MD [N6264518C4003]	Military Infectious Diseases Research Program (MIDRP) Proposals; MIDRP; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Naval Medical Research Center - Silver Spring, MD	EV received support for this study from Military Infectious Diseases Research Program (MIDRP) Proposals F0339_13_NM and F0482_16_NM, funding work unit number A1217; MS received support for this study from MIDRP Proposals F0409_14_WR_CS and F0523_17_WR_CS, funding work unit number A1256. MIDRP provided support in the form of salaries for authors (EV, MS, and KG) and in the form of contract support for CAMRIS International (NR, KO, JW, and JCA), Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) (ECS, KJL, JSB, MD, SS, RV, AB, RD, JML, NBP, and MRH), and University of Maryland (JBS). The United States Agency for International Development (USAID) provided support to NMRC through an interagency agreement, number AID-GH-T-17-00002, received by EV, for an NMRC contract with HJF (JKM). This material is based upon work supported by the Naval Medical Research Center - Silver Spring, MD, under contract N6264518C4003. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author (s) and do not necessarily reflect the views of the Naval Medical Research Center and the Naval Medical Logistics Command. The funders (MIDRP and USAID) did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of each author are articulated in the 'author contributions' section.	Aguiar JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136109; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Blom KG, 2009, CLIN EXP IMMUNOL, V155, P320, DOI 10.1111/j.1365-2249.2008.03815.x; Bowyer PW, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001636; Brough DE, 1996, J VIROL, V70, P6497, DOI 10.1128/JVI.70.9.6497-6501.1996; Bruder JT, 2017, MOL THER-METH CLIN D, V7, P20, DOI 10.1016/j.omtm.2017.08.003; Bruder JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033920; CHAROENVIT Y, 1987, INFECT IMMUN, V55, P604, DOI 10.1128/IAI.55.3.604-608.1987; Choumet V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050464; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Dups JN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00625; Dutta S, 2005, INFECT IMMUN, V73, P2116, DOI 10.1128/IAI.73.4.2116-2122.2005; Dutta S, 2003, P NATL ACAD SCI USA, V100, P12295, DOI 10.1073/pnas.2032858100; Espinosa DA, 2015, J INFECT DIS, V212, P1111, DOI 10.1093/infdis/jiv154; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Haynes J David, 2002, Methods Mol Med, V72, P489, DOI 10.1385/1-59259-271-6:489; Hickey BW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1435-y; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Limbach K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-65; Lindner SE, 2013, MOL CELL PROTEOMICS, V12, P1127, DOI 10.1074/mcp.M112.024505; Mishra S, 2011, VACCINE, V29, P7335, DOI 10.1016/j.vaccine.2011.07.081; Moorthy VS, 2013, LANCET, V382, P1700, DOI 10.1016/S0140-6736(13)62238-2; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; NILLNI EA, 1981, Z PARASITENKD, V64, P279; Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Otto TD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5754; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sedegah M, 1998, P NATL ACAD SCI USA, V95, P7648, DOI 10.1073/pnas.95.13.7648; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sissoko MS, 2017, LANCET INFECT DIS, V17, P498, DOI [10.1016/S1473-3099(17)30104-4, 10.1016/s1473-3099(17)30104-4]; Teneza-Mora N, 2015, VACCINE, V33, P7551, DOI 10.1016/j.vaccine.2015.10.004; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Tsuji M, 2010, EXP PARASITOL, V126, P421, DOI 10.1016/j.exppara.2009.11.009; Walk J, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0923-4; White MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061065; Wilson KL, 2019, EXPERT REV VACCINES, V18, P133, DOI 10.1080/14760584.2019.1561289; Witney AA, 2001, MOL BIOCHEM PARASIT, V118, P233, DOI 10.1016/S0166-6851(01)00372-3	45	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232234	10.1371/journal.pone.0232234	http://dx.doi.org/10.1371/journal.pone.0232234			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407410	Green Published, gold			2022-12-26	WOS:000537490700015
J	Anderson, O; Reed, IKG				Anderson, Olivia; Reed, Irene K. Guttilla			Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition	PLOS ONE			English	Article							MICRORNA THERAPEUTICS; EMT	Breast cancer is the most commonly diagnosed malignancy in women, and has the second highest mortality rate. Over 90% of all cancer-related deaths are due to metastasis, which is the spread of malignant cells from the primary tumor to a secondary site in the body. It is hypothesized that one cause of metastasis involves epithelial-mesenchymal transition (EMT). When epithelial cells undergo EMT and transition into mesenchymal cells, they display increased levels of cell proliferation and invasion, resulting in a more aggressive phenotype. While many factors regulate EMT, microRNAs have been implicated in driving this process. MicroRNAs are short noncoding RNAs that suppress protein production, therefore loss of microRNAs may promote the overexpression of specific target proteins important for EMT. The goal of this study was to investigate the role of miR-96 and miR-183 in EMT in breast cancer. Both miR-96 and miR-183 were found to be downregulated in post-EMT breast cancer cells. When microRNA mimics were transfected into these cells, there was a significant decrease in cell viability and migration, and a shift from a mesenchymal to an epithelial morphology (mesenchymal-epithelial transition or MET). These MET-related changes may be facilitated in part by the regulation of ZEB1 and vimentin, as both of these proteins were downregulated when miR-96 and miR-183 were overexpressed in post-EMT cells. These findings indicate that the loss of miR-96 and miR-183 may help facilitate EMT and contribute to the maintenance of a mesenchymal phenotype. Understanding the role of microRNAs in regulating EMT is significant in order to not only further elucidate the pathways that facilitate metastasis, but also identify potential therapeutic options for preventing or reversing this process.	[Anderson, Olivia; Reed, Irene K. Guttilla] Univ St Joseph, Dept Biol, Hartford, CT 06117 USA		Reed, IKG (corresponding author), Univ St Joseph, Dept Biol, Hartford, CT 06117 USA.	ireed@usj.edu		Guttilla Reed, Irene/0000-0002-6617-1465	University of Saint Joseph Student Research Grant; Beta Beta Beta Research Foundation Award	University of Saint Joseph Student Research Grant; Beta Beta Beta Research Foundation Award	This study was funded by a University of Saint Joseph Student Research Grant (O.A.) and a Beta Beta Beta Research Foundation Award (O.A.). These are small undergraduate student research grants and therefore do not have RFPs, grant numbers, or URLs. Funds are provided for reagents only. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim M, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00815; Das S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-94; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; Gentilin E, 2016, BEST PRACT RES CL EN, V30, P629, DOI 10.1016/j.beem.2016.10.002; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gurda GT, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0057-2; Guttilla IK, 2012, BREAST CANCER RES TR, V132, P75, DOI 10.1007/s10549-011-1534-y; Hanna J, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00478; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Li XL, 2014, MOL CELL BIOL, V34, P533, DOI 10.1128/MCB.01043-13; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052280; Lowery AJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-502; Ma Y, 2016, ONCOTARGET, V7, P42805, DOI 10.18632/oncotarget.8715; Malhotra GK, 2010, CANCER BIOL THER, V10, P955, DOI 10.4161/cbt.10.10.13879; Mehrgou A, 2017, J RES MED SCI, V22, DOI 10.4103/jrms.JRMS_967_16; Reed IKG, 2015, CELL HEALTH CYTOSKEL, V7, P155, DOI 10.2147/CHC.S73822; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Slocum Elizabeth M., 2015, BIOS, V86, P185; Song CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24502	20	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0233187	10.1371/journal.pone.0233187	http://dx.doi.org/10.1371/journal.pone.0233187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396572	Green Published, gold			2022-12-26	WOS:000537475000046
J	Santos, JL; Rodriguez, I; Olesen, MS; Bentzen, BH; Schmitt, N				Santos, Joana Larupa; Rodriguez, Ismael; Olesen, Morten S.; Bentzen, Bo Hjorth; Schmitt, Nicole			Investigating gene-microRNA networks in atrial fibrillation patients with mitral valve regurgitation	PLOS ONE			English	Article							NATRIURETIC-PEPTIDE; POTENTIAL ROLE; EXPRESSION; FIBROSIS; REPOLARIZATION; CONDUCTION; MYOCYTES; REVEALS; DISEASE; MIRNA	Background Atrial fibrillation (AF) is predicted to affect around 17.9 million individuals in Europe by 2060. The disease is associated with severe electrical and structural remodelling of the heart, and increased the risk of stroke and heart failure. In order to improve treatment and find new drug targets, the field needs to better comprehend the exact molecular mechanisms in these remodelling processes. Objectives This study aims to identify gene and miRNA networks involved in the remodelling of AF hearts in AF patients with mitral valve regurgitation (MVR). Methods Total RNA was extracted from right atrial biopsies from patients undergoing surgery for mitral valve replacement or repair with AF and without history of AF to test for differentially expressed genes and miRNAs using RNA-sequencing and miRNA microarray. In silico predictions were used to construct a mRNA-miRNA network including differentially expressed mRNAs and miRNAs. Gene and chromosome enrichment analysis were used to identify molecular pathways and high-density AF loci. Results We found 644 genes and 43 miRNAs differentially expressed in AF patients compared to controls. From these lists, we identified 905 pairs of putative miRNA-mRNA interactions, including 37 miRNAs and 295 genes. Of particular note, AF-associated miR-130b-3p, miR-338-5p and miR-208a-3p were differentially expressed in our AF tissue samples. These miRNAs are predicted regulators of several differentially expressed genes associated with cardiac conduction and fibrosis. We identified two high-density AF loci in chromosomes 14q11.2 and 6p21.3. Conclusions AF in MVR patients is associated with down-regulation of ion channel genes and up-regulation of extracellular matrix genes. Other AF related genes are dysregulated and several are predicted to be targeted by miRNAs. Our novel miRNA-mRNA regulatory network provides new insights into the mechanisms of AF.	[Santos, Joana Larupa; Rodriguez, Ismael; Olesen, Morten S.; Bentzen, Bo Hjorth; Schmitt, Nicole] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen N, Denmark; [Olesen, Morten S.] Univ Hosp Copenhagen, Rigshosp, Dept Cardiol, Lab Mol Cardiol,Heart Ctr, Copenhagen O, Denmark	University of Copenhagen; Rigshospitalet	Bentzen, BH; Schmitt, N (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen N, Denmark.	bobe@sund.ku.dk; nschmitt@sund.ku.dk	olesen, morten/AAC-5752-2021; Bentzen, Bo Hjorth/B-9325-2012	Larupa Santos, Joana/0000-0002-0690-7741; Bentzen, Bo Hjorth/0000-0002-0253-4992; Rodriguez Palomo, Ismael/0000-0001-5313-9709	Carlsberg Foundation Distinguished Associate Professor Fellowship [CF16-0101]; John and Birthe Meyer Foundation; Novo Nordisk Foundation [NNF17OC0031204]	Carlsberg Foundation Distinguished Associate Professor Fellowship; John and Birthe Meyer Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The study was supported by the The Carlsberg Foundation Distinguished Associate Professor Fellowship (CF16-0101) to BHB. The study was also partly funded by grants from The John and Birthe Meyer Foundation and Novo Nordisk Foundation (NNF17OC0031204) awarded to MSO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Bicakci H, 2017, ANATOL J CARDIOL, V17, P18, DOI 10.14744/AnatolJCardiol.2016.7033; BKAILY G, 1993, J MOL CELL CARDIOL, V25, P1305, DOI 10.1006/jmcc.1993.1143; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Campuzano O, 2016, GENES DIS, V3, P257, DOI 10.1016/j.gendis.2016.09.003; Canon S, 2016, J MOL CELL CARDIOL, V99, P162, DOI 10.1016/j.yjmcc.2016.08.012; Castoldi G, 2012, J CELL PHYSIOL, V227, P850, DOI 10.1002/jcp.22939; Chen Y, 2014, J MOL CELL CARDIOL, V77, P113, DOI 10.1016/j.yjmcc.2014.10.001; Chiang DY, 2015, INT J CARDIOL, V184, P190, DOI 10.1016/j.ijcard.2015.01.075; Christophersen IE, 2016, J HUM GENET, V61, P61, DOI 10.1038/jhg.2015.44; CROZIER I, 1993, PACE, V16, P738, DOI 10.1111/j.1540-8159.1993.tb01653.x; de Vos CB, 2010, J AM COLL CARDIOL, V55, P725, DOI 10.1016/j.jacc.2009.11.040; Denham NC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01380; Deshmukh A, 2015, CIRC-ARRHYTHMIA ELEC, V8, P32, DOI 10.1161/CIRCEP.114.001632; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Gregers E, 2017, HEART RHYTHM, V14, P1531, DOI 10.1016/j.hrthm.2017.05.027; Harada M, 2014, CIRC RES, V114, P689, DOI 10.1161/CIRCRESAHA.114.301798; Heijman J, 2014, CIRC RES, V114, P1483, DOI 10.1161/CIRCRESAHA.114.302226; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XH, 2009, HEPATOL RES, V39, P786, DOI 10.1111/j.1872-034X.2009.00502.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanovska I, 2008, CELL CYCLE, V7, P3137, DOI 10.4161/cc.7.20.6923; Jiang Y-Y, 2017, SCI REP, V7; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Lamirault G, 2006, J MOL CELL CARDIOL, V40, P173, DOI 10.1016/j.yjmcc.2005.09.004; Lane DA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005155; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Li SS, 2017, EXP THER MED, V14, P5355, DOI 10.3892/etm.2017.5225; Li Z, 2017, ONCOTARGET, V8, P53714, DOI 10.18632/oncotarget.16342; Li ZM, 2018, METHODS MOL BIOL, V1720, P141, DOI 10.1007/978-1-4939-7540-2_10; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Ling TY, 2017, BBA CLIN, V7, P78, DOI 10.1016/j.bbacli.2017.02.002; Liu H, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-90; Liu H, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-10; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo XB, 2013, J CLIN INVEST, V123, P1939, DOI 10.1172/JCI62185; Molina CE, 2017, J MOL CELL CARDIOL, V102, P22, DOI 10.1016/j.yjmcc.2016.11.007; Nattel S, 2014, J AM COLL CARDIOL, V63, P2335, DOI 10.1016/j.jacc.2014.02.555; Nielsen J.B., 2018, GENOME WIDE ASS STUD; Nishi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073397; Oh H, 2018, INT SOC DESIGN CONF, P7, DOI 10.1109/ISOCC.2018.8649911; Olesen MS, 2014, EUR J HUM GENET, V22, P297, DOI 10.1038/ejhg.2013.139; Perrin MJ, 2012, HEART RHYTHM, V9, P610, DOI 10.1016/j.hrthm.2011.11.019; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Puertas RD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196666; Ren X, 2010, CLIN CHIM ACTA, V411, P481, DOI 10.1016/j.cca.2009.12.019; Rommel C, 2018, CIRC RES, V123, P550, DOI 10.1161/CIRCRESAHA.118.313036; Roselli C, 2018, NAT GENET, V50, P1225, DOI 10.1038/s41588-018-0133-9; Roura-Ferrer M, 2009, CELL PHYSIOL BIOCHEM, V24, P325, DOI 10.1159/000257425; Schmitt N, 2014, PHYSIOL REV, V94, P609, DOI 10.1152/physrev.00022.2013; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sigurdsson MI, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0270-5; Skibsbye L, 2014, CARDIOVASC RES, V103, P156, DOI 10.1093/cvr/cvu121; Slagsvold KH, 2014, PHYSIOL GENOMICS, V46, P505, DOI 10.1152/physiolgenomics.00042.2014; Sticht C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206239; Swartz MF, 2009, HEART RHYTHM, V6, P1415, DOI 10.1016/j.hrthm.2009.06.018; Tamura N, 2000, P NATL ACAD SCI USA, V97, P4239, DOI 10.1073/pnas.070371497; Tsai FC, 2016, INT J CARDIOL, V222, P104, DOI 10.1016/j.ijcard.2016.07.103; van Iterson M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt525; Wang JG, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0085-2; Wei W, 2018, J CELL PHYSIOL, V233, P4981, DOI 10.1002/jcp.26337; Xiao JJ, 2011, PHYSIOL GENOMICS, V43, P655, DOI 10.1152/physiolgenomics.00139.2010; Xie T, 2003, GENOME RES, V13, P2621, DOI 10.1101/gr.1736803; Xu GJ, 2013, CHINESE MED J-PEKING, V126, P1458, DOI 10.3760/cma.j.issn.0366-6999.20121233; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zhang JF, 2017, AM J TRANSL RES, V9, P1822; Zhu JZ, 2018, CIRC J, V82, P2783, DOI 10.1253/circj.CJ-18-0396; Zhuang Y, 2016, AM J TRANSL RES, V8, P3206	75	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232719	10.1371/journal.pone.0232719	http://dx.doi.org/10.1371/journal.pone.0232719			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392228	Green Published, gold			2022-12-26	WOS:000537470300021
J	Samsa, WE; Mamidi, MK; Bashur, LA; Elliott, R; Miron, A; Chen, YQ; Lees, B; Greenfield, EM; Chan, R; Danielpour, D; Zhou, G				Samsa, William E.; Mamidi, Murali K.; Bashur, Lindsay A.; Elliott, Robin; Miron, Alexander; Chen, Yuqing; Lees, Brendan; Greenfield, Edward M.; Chan, Ricky; Danielpour, David; Zhou, Guang			The crucial p53-dependent oncogenic role of JAB1 in osteosarcoma in vivo	ONCOGENE			English	Article							NEDD8-ACTIVATING ENZYME; COP9 SIGNALOSOME; CELL-LINES; P53; RB; INACTIVATION; ACTIVATION; INHIBITOR; CARCINOMA; TOOLS	Osteosarcoma (OS) is the most common primary bone cancer and ranks amongst the leading causes of cancer mortality in young adults. Jun activation domain-binding protein 1 (JAB1) is overexpressed in many cancers and has recently emerged as a novel target for cancer treatment. However, the role of JAB1 in osteosarcoma was virtually unknown. In this study, we demonstrate that JAB1-knockdown in malignant osteosarcoma cell lines significantly reduced their oncogenic properties, including proliferation, colony formation, and motility. We also performed RNA-sequencing analysis in JAB1-knockdown OS cells and identified 4110 genes that are significantly differentially expressed. This demonstrated for the first time that JAB1 regulates a large and specific transcriptome in cancer. We also found that JAB1 is overexpressed in human OS and correlates with a poor prognosis. Moreover, we generated a novel mouse model that overexpresses Jab1 specifically in osteoblasts upon a TP53 heterozygous sensitizing background. Interestingly, by 13 months of age, a significant proportion of these mice spontaneously developed conventional OS. Finally, we demonstrate that a novel, highly specific small molecule inhibitor of JAB1, CSN5i-3, reduces osteosarcoma cell viability, and has specific effects on the ubiquitin-proteasome system in OS. Thus, we show for the first time that the overexpression of JAB1 in vivo can result in accelerated spontaneous tumor formation in a p53-dependent manner. In summary, JAB1 might be a unique target for the treatment of osteosarcoma and other cancers.	[Samsa, William E.; Mamidi, Murali K.; Bashur, Lindsay A.; Zhou, Guang] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA; [Samsa, William E.; Mamidi, Murali K.; Miron, Alexander; Danielpour, David; Zhou, Guang] Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Elliott, Robin] Dept Pathol, Cleveland, OH USA; [Miron, Alexander; Zhou, Guang] Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Chen, Yuqing; Lees, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Greenfield, Edward M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Chan, Ricky] Case Comprehens Canc Ctr, Inst Computat Biol, Cleveland, OH USA; [Danielpour, David] Div Gen Med Sci, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Baylor College of Medicine; Indiana University System; Indiana University Bloomington; Case Western Reserve University	Zhou, G (corresponding author), Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA.; Zhou, G (corresponding author), Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.; Zhou, G (corresponding author), Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	gxz27@case.edu	Mamidi, Murali/ABD-1676-2021		NCI [R03 CA175874]; NIAMS [R01 AR068361, T32 AR7505-30]; Rally Foundation for Childhood Cancer Research and Open Hands Overflowing Hearts Fellowship [CON221575]; ACS [119999-IRG-91-022-18IRG]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Rally Foundation for Childhood Cancer Research and Open Hands Overflowing Hearts Fellowship; ACS(American Cancer Society)	NCI R03 CA175874 to GZ, ACS #119999-IRG-91-022-18IRG to GZ, NIAMS R01 AR068361 to GZ, NIAMS T32 AR7505-30 to WES and LAB, and the Rally Foundation for Childhood Cancer Research and Open Hands Overflowing Hearts Fellowship CON221575 to WES.	Ballatori SE, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2016.1; Bashur LA, 2014, J CELL PHYSIOL, V229, P1607, DOI 10.1002/jcp.24602; Behjati S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15936; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Chen DX, 2013, J CELL SCI, V126, P234, DOI 10.1242/jcs.113795; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Collier CD, 2018, CLIN ORTHOP RELAT R, V476, P1400, DOI 10.1007/s11999.0000000000000059; Crone SG, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-71; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gianferante DM, 2017, NAT REV ENDOCRINOL, V13, P480, DOI 10.1038/nrendo.2017.16; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johmura Y, 2018, J CLIN INVEST, V128, P5603, DOI 10.1172/JCI121679; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Lauvrak SU, 2013, BRIT J CANCER, V109, P2228, DOI 10.1038/bjc.2013.549; Lee YH, 2011, ONCOGENE, V30, P4175, DOI 10.1038/onc.2011.126; Liang BJ, 2012, CALCIFIED TISSUE INT, V90, P76, DOI 10.1007/s00223-011-9550-9; Lin PP, 2009, CARCINOGENESIS, V30, P1789, DOI 10.1093/carcin/bgp180; Liu GH, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00135; Loukil Abdelhalim, 2015, World J Biol Chem, V6, P346, DOI 10.4331/wjbc.v6.i4.346; Lu RQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12044; Malhab LJB, 2016, SCI REP-UK, V6, DOI 10.1038/srep37775; Manasanch EE, 2017, NAT REV CLIN ONCOL, V14, P417, DOI [10.1007/s12079-011-0121-7, 10.1038/nrclinonc.2016.206]; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Mori M, 2008, J BIOL CHEM, V283, P29011, DOI 10.1074/jbc.M804539200; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Pan Y, 2017, ONCOGENE, V36, P1069, DOI 10.1038/onc.2016.271; Pan Y, 2013, ONCOGENE, V32, P2756, DOI 10.1038/onc.2012.294; Panattoni M, 2008, J EXP MED, V205, P465, DOI 10.1084/jem.20070725; Perry JA, 2014, P NATL ACAD SCI USA, V111, pE5564, DOI 10.1073/pnas.1419260111; Schlierf A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13166; Sitte S, 2012, J IMMUNOL, V188, P2677, DOI 10.4049/jimmunol.1101455; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sun R, 2018, CANCER RES, V78, P5274, DOI 10.1158/0008-5472.CAN-17-3647; Swords RT, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.1; Tao JN, 2014, CANCER CELL, V26, P390, DOI 10.1016/j.ccr.2014.07.023; Tian L, 2010, ONCOGENE, V29, P6125, DOI 10.1038/onc.2010.345; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Zhang F, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0791-6; Zhang YD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32428-9; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103; Zhou LS, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0979-1	48	16	16	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	23					4581	4591		10.1038/s41388-020-1320-6	http://dx.doi.org/10.1038/s41388-020-1320-6		MAY 2020	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LU5ZF	32390003	Green Submitted, Green Accepted			2022-12-26	WOS:000531697700001
J	Coe, AB; Vincent, BM; Iwashyna, TJ				Coe, Antoinette B.; Vincent, Brenda M.; Iwashyna, Theodore J.			Statin discontinuation and new antipsychotic use after an acute hospital stay vary by hospital	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; AFTER-DISCHARGE; ICU SURVIVORS; MEDICATION; CONTINUATION; HEALTH; ADMISSION; THERAPY; PRESCRIPTIONS; MANAGEMENT	Introduction Patients are at risk for medication problems after hospital admissions, particularly those with critical illness. Medication problems include continuation of acute medications and discontinuation of chronic medications after discharge. Little is known across a national integrated health care system about the extent of these two medication problems. Objective To examine the extent of statin medication discontinuation and new antipsychotic medication use after hospital discharge. Design Retrospective cohort study. Setting Veterans Affairs healthcare system. Participants Veterans with an inpatient hospitalization from January 1, 2014-December 31, 2016, survived at least 180 days post-discharge, and received at least one medication through the VA outpatient pharmacy within one year around admission were included. Hospitalizations were grouped into: 1) direct admission to the intensive care unit (ICU) and a diagnosis of sepsis, 2) direct admission to the ICU without sepsis diagnosis, and 3) no ICU stay during the hospitalization. Main outcome measures Statin medication discontinuation and new antipsychotic use at six months post-hospital discharge. Results A total of 520,187 participants were included in the statin medication and 910,629 in the antipsychotic medication cohorts. Statin discontinuation ranged from 10-15% and new antipsychotic prescription fills from 2-4% across the three hospitalization groups, with highest rates in the ICU admission and sepsis diagnosis group. Statin discontinuation and new antipsychotic use after a hospitalization varied by hospital, with worse performing hospitals having 11% higher odds of discontinuing a statin (median odds ratio at hospital-level, adjusted for patient differences, aMOR: 1.11 (95% CI: 1.09, 1.13)) and 29% higher odds of new antipsychotic use (aMOR, 1.29 (95% CI: 1.24, 1.34)). Risk-adjusted hospital rates of these two medication changes were not correlated (p = 0.49). Conclusions Systemic variation in the rates of statin medication continuation and new antipsychotic use were found.	[Coe, Antoinette B.] Univ Michigan, Coll Pharm, Dept Clin Pharm, 428 Church St, Ann Arbor, MI 48109 USA; [Coe, Antoinette B.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Vincent, Brenda M.; Iwashyna, Theodore J.] Vet Affairs Ann Arbor Healthcare Syst, Ctr Clin Management Res, Ann Arbor, MI USA; [Iwashyna, Theodore J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Iwashyna, Theodore J.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Coe, AB (corresponding author), Univ Michigan, Coll Pharm, Dept Clin Pharm, 428 Church St, Ann Arbor, MI 48109 USA.; Coe, AB (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.	tonicoe@med.umich.edu	Coe, Antoinette/AAN-6533-2021; McGrath, Brenda/AAT-9185-2020	Coe, Antoinette/0000-0002-5723-0443; McGrath, Brenda/0000-0003-4208-1059	National Center for Advancing Translational Sciences of the National Institutes of Health [KL2TR002241]; U.S Department of Veterans Affairs, Health Services Research & Development Investigator Initiated Research [VA HSRD IIR 17-045]	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); U.S Department of Veterans Affairs, Health Services Research & Development Investigator Initiated Research(US Department of Veterans Affairs)	Antoinette B. Coe is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health, award number KL2TR002241. Theodore J. Iwashyna is supported by the U.S Department of Veterans Affairs, Health Services Research & Development Investigator Initiated Research, award number VA HSR&D IIR 17-045. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the U.S. Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CM, 2011, JAMA-J AM MED ASSOC, V306, P840, DOI 10.1001/jama.2011.1206; Bradley SM, 2017, AM HEART J, V193, P117, DOI 10.1016/j.ahj.2017.05.018; Cecconi M, 2018, LANCET, V392, P75, DOI 10.1016/S0140-6736(18)30696-2; Coe AB, 2019, HOSP PHARM, P1; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Dessap AM, 2011, CRIT CARE, V15, DOI 10.1186/cc10317; Eijsbroek H, 2013, J CRIT CARE, V28, P46, DOI 10.1016/j.jcrc.2012.06.002; Farrokh Salia, 2017, J Pharm Pract, V30, P342, DOI 10.1177/0897190016645026; Flurie RW, 2015, AM J HEALTH-SYST PH, V72, pS133, DOI 10.2146/ajhp150474; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Jasiak Karalea D, 2013, J Pharm Pract, V26, P253, DOI 10.1177/0897190012465987; Kram BL, 2015, J CRIT CARE, V30, P814, DOI 10.1016/j.jcrc.2015.03.030; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Kutner JS, 2015, JAMA INTERN MED, V175, P691, DOI 10.1001/jamainternmed.2015.0289; Marshall J, 2016, J CRIT CARE, V33, P119, DOI 10.1016/j.jcrc.2015.12.017; McDonald EG, 2015, J HOSP MED, V10, P281, DOI 10.1002/jhm.2330; Morandi A, 2013, J AM GERIATR SOC, V61, P1128, DOI 10.1111/jgs.12329; Morandi A, 2011, ARCH INTERN MED, V171, P1032, DOI 10.1001/archinternmed.2011.233; Murphy CE, 2008, PHARMACOTHERAPY, V28, P968, DOI 10.1592/phco.28.8.968; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pavlov A, 2014, RESP CARE, V59, P1524, DOI 10.4187/respcare.02913; Prescott HC, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2375; Prescott HC, 2014, AM J RESP CRIT CARE, V190, P62, DOI 10.1164/rccm.201403-0471OC; Radomski TR, 2016, J MANAG CARE SPEC PH, V22, P114, DOI 10.18553/jmcp.2016.14251; Render ML, 2008, CRIT CARE MED, V36, P1031, DOI 10.1097/CCM.0b013e318169f290; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Rowe AS, 2015, J CRIT CARE, V30, P1283, DOI 10.1016/j.jcrc.2015.08.009; Scales DC, 2016, J GEN INTERN MED, V31, P196, DOI 10.1007/s11606-015-3501-5; Sevin CM, 2018, J CRIT CARE, V46, P141, DOI 10.1016/j.jcrc.2018.02.011; Stollings JL, 2018, ANN PHARMACOTHER, V52, P713, DOI 10.1177/1060028018759343; Stollings JL, 2015, AM J HEALTH-SYST PH, V72, P1315, DOI 10.2146/ajhp140533; Tomichek JE, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1557-1; Trivedi RB, 2015, AM J PUBLIC HEALTH, V105, P2564, DOI 10.2105/AJPH.2015.302836; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Wang XL, 2019, CELL DEATH DISCOV, V5	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232707	10.1371/journal.pone.0232707	http://dx.doi.org/10.1371/journal.pone.0232707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384108	gold, Green Published			2022-12-26	WOS:000537468300025
J	Ho, DE; Mbonu, O; McDonough, A; Pottash, R				Ho, Daniel E.; Mbonu, Oluchi; McDonough, Anne; Pottash, Rebecca			Menu labeling, calories, and nutrient density: Evidence from chain restaurants	PLOS ONE			English	Article							INFORMATION DISCLOSURE; NUTRITION INFORMATION; HEALTHY FOOD; KING COUNTY; INDEX; VALIDATION; GUIDELINES; QUALITY; ENTREES; IMPACT	The Food and Drug Administration's menu labeling rule requires chain restaurants to prominently display calories, while leaving other nutritional information (e.g., fat, sodium, sugar) to the request of consumers. We use rich micronutrient data from 257 large chain brands and 24,076 menu items to examine whether calories are correlated with widely used "nutrient profile" scores that measure healthfulness based on nutrient density. We show that calories are indeed statistically significant predictors of nutrient density. However, as a substantive matter, the correlation is highly attenuated (partial R-2 <= 0.01). Our findings (a) suggest that the promise of calorie labeling to improve nutrient intake quality at restaurants is limited and (b) clarify the basis for transparency of nutrient composition beyond calories to promote healthy menu choices.	[Ho, Daniel E.] Stanford Univ, Law, Stanford, CA 94305 USA; [Ho, Daniel E.] Stanford Univ, Polit Sci, Stanford, CA 94305 USA; [Ho, Daniel E.] Stanford Univ, Stanford Inst Econ & Policy Res, Stanford, CA 94305 USA; [Mbonu, Oluchi] Harvard Univ, Cambridge, MA 02138 USA; [McDonough, Anne; Pottash, Rebecca] Stanford Law Sch, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Harvard University; Stanford University	Ho, DE (corresponding author), Stanford Univ, Law, Stanford, CA 94305 USA.; Ho, DE (corresponding author), Stanford Univ, Polit Sci, Stanford, CA 94305 USA.; Ho, DE (corresponding author), Stanford Univ, Stanford Inst Econ & Policy Res, Stanford, CA 94305 USA.	dho@law.stanford.edu		Ho, Daniel/0000-0002-2195-5469				American Heart Association, 2008, POL POS STAT MEN LAB; [Anonymous], 2013, FED REGISTER, V78, P28111; [Anonymous], 2008, MENU LABELING REQUIR, P6; [Anonymous], 2014, FED REGISTER, V79, P71155; Batada A, 2012, CHILD OBES, V8, P251, DOI 10.1089/chi.2012.0016; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bleich SN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228891; Bleich SN, 2016, AM J PREV MED, V50, pE1, DOI 10.1016/j.amepre.2015.05.007; Bleich SN, 2015, HEALTH AFFAIR, V34, P1877, DOI 10.1377/hlthaff.2015.0512; Bleich SN, 2015, AM J PREV MED, V48, P70, DOI 10.1016/j.amepre.2014.08.026; Bollinger B, 2011, AM ECON J-ECON POLIC, V3, P91, DOI 10.1257/pol.3.1.91; Brody J. E., 2011, NY TIMES; Bruemmer B, 2012, J ACAD NUTR DIET, V112, P1169, DOI 10.1016/j.jand.2012.04.019; Cantor J, 2015, HEALTH AFFAIR, V34, P1893, DOI 10.1377/hlthaff.2015.0623; Center for Food Safety and Applied Nutrition, 2004, CAL COUNT REP WORK G; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI [10.1079/PHN2005666, 10.1079/PHN2004666]; Drewnowski A., 2017, P NUTR SOC, P1; Drewnowski A, 2008, NUTR REV, V66, P23, DOI 10.1111/j.1753-4887.2007.00003.x; Elbel B, 2013, OBESITY, V21, P2172, DOI 10.1002/oby.20550; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Erickson J, 2015, NUTRIENTS, V7, P2866, DOI 10.3390/nu7042866; Finkelstein EA, 2011, AM J PREV MED, V40, P122, DOI 10.1016/j.amepre.2010.10.019; Food Standards Australia New Zealand, 2017, NUTR PROF SCOR CALC; Frelier JM, 2019, AM J PREV MED, V57, P231, DOI 10.1016/j.amepre.2019.03.023; Fulgoni VL, 2009, J NUTR, V139, P1549, DOI 10.3945/jn.108.101360; Fung A, 2007, FULL DISCLOSURE: THE PERILS AND PROMISE OF TRANSPARENCY, P1, DOI 10.1017/CBO9780511510533; Goldman T., 2015, HLTH AFF, P13; Harnack LJ, 2008, INT J BEHAV NUTR PHY, V5, DOI [10.1186/1479-5868-5-51, 10.1186/1479-5868-5-63]; Harris J.L., 2015, SNACK FACTS 2015 EVA; Harris J.L., 2012, CEREAL FACTS 2012 LT; Heid M., 2015, TIME; Heinizerling L, 2015, FOOD DRUG LAW J, V70, P11; Hess J., 2017, GLOB PEDIAT HLTH, V4, P1; Ho DE, 2012, YALE LAW J, V122, P574; Howlett EA, 2009, J CONSUM RES, V36, P494, DOI 10.1086/598799; Julia C, 2014, J NUTR, V144, P2009, DOI 10.3945/jn.114.199679; Kraak VI., 2006, FOOD MARK CHILDR YOU; Lobstein T, 2009, PUBLIC HEALTH NUTR, V12, P331, DOI 10.1017/S1368980008002541; Loewenstein G, 2011, AM J CLIN NUTR, V93, P679, DOI 10.3945/ajcn.111.012658; Ludwig D., 2016, MEDIUM; Ludwig DS, 2016, JAMA-J AM MED ASSOC, V316, P2087, DOI 10.1001/jama.2016.15473; Ludwig DS, 2009, JAMA-J AM MED ASSOC, V302, P434, DOI 10.1001/jama.2009.1045; Lustig R. H., 2013, FAT CHANCE BEATING O; MATKOVIC V, 1991, AM J CLIN NUTR, V54, pS245, DOI 10.1093/ajcn/54.1.245S; Ministere des Solidarites et de la Sante, 2017, NUTR SCOR DOSS PRESS; Mozaffarian D, 2010, JAMA-J AM MED ASSOC, V304, P681, DOI 10.1001/jama.2010.1116; NAMBA A, 2013, PREV CHRONIC DIS, V10, DOI DOI 10.1016/J.AMEPRE.2014.08.026; Nation's Restaurant News, 2018, NATIONS RESTAURANT N; Nestle M., 2012, WHY CALORIES COUNT S; Nestle M, 2010, NEW ENGL J MED, V362, P2343, DOI 10.1056/NEJMp1003814; NPD Group, 2017, NUMB REST US 2011 20; Pan American Health Organization, 2016, NUTR PROF MOD; Pick ME, 2005, J AM DIET ASSOC, V105, P240, DOI 10.1016/j.jada.2004.11.028; Pollan M., 2007, NY TIMES; Roberto CA, 2010, AM J PUBLIC HEALTH, V100, P312, DOI 10.2105/AJPH.2009.160226; Roberto CA, 2009, AM J PUBLIC HEALTH, V99, P820, DOI 10.2105/AJPH.2008.136457; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P337, DOI 10.1017/S1368980007666671; Scheidt DM, 2004, J NUTR EDUC BEHAV, V36, P35, DOI 10.1016/S1499-4046(06)60126-7; Schoffman DE, 2016, J ACAD NUTR DIET, V116, P1606, DOI 10.1016/j.jand.2016.03.020; Slavin J, 2014, AM J CLIN NUTR, V100, P4, DOI 10.3945/ajcn.114.090423; Swartz JJ, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-135; Tandon PS, 2011, AM J PREV MED, V41, P434, DOI 10.1016/j.amepre.2011.06.033; Taubes G., 2007, GOOD CALORIES BAD CA; Thorndike AN, 2014, AM J PREV MED, V46, P143, DOI 10.1016/j.amepre.2013.10.002; Thorndike AN, 2012, AM J PUBLIC HEALTH, V102, P527, DOI 10.2105/AJPH.2011.300391; United Kingdom Food Standards Agency, 2009, NUTR PROF TECHN GUID; United States Department of Agriculture, 2015, 2015 2020 DIE GUID A; Urban LE, 2011, JAMA-J AM MED ASSOC, V306, P287, DOI 10.1001/jama.2011.993; Wartella E, 2010, FRONT PACKAGE NUTR R; Williams R., 2011, NY TIMES; Wolfson JA, 2018, AM J PREV MED, V54, P28, DOI 10.1016/j.amepre.2017.08.018; World Health Organization, 2010, NUTR PROF REP WHO IA; World Health Organization, 2015, NUTR PROF MOD; Zelman K, 2005, NUTR TODAY, V40, P60	74	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232656	10.1371/journal.pone.0232656	http://dx.doi.org/10.1371/journal.pone.0232656			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZX	32379786	Green Published, gold			2022-12-26	WOS:000537285700052
J	Lassiter, A; Darbari, M				Lassiter, Allison; Darbari, Mayank			Assessing alternative methods for unsupervised segmentation of urban vegetation in very high-resolution multispectral aerial imagery	PLOS ONE			English	Article							LAND-COVER CLASSIFICATION; INDEX; PERFORMANCE; GREENSPACE	To analyze types and patterns of greening trends across a city, this study seeks to identify a method of creating very high-resolution urban vegetation maps that scales over space and time. Vegetation poses unique challenges for image segmentation because it is patchy, has ragged boundaries, and high in-class heterogeneity. Existing and emerging public datasets with the spatial resolution necessary to identify granular urban vegetation lack a depth of affordable and accessible labeled training data, making unsupervised segmentation desirable. This study evaluates three unsupervised methods of segmenting urban vegetation: clustering with k-means using k-means++ seeding; clustering with a Gaussian Mixture Model (GMM); and an unsupervised, backpropagating convolutional neural network (CNN) with simple iterative linear clustering superpixels. When benchmarked against internal validity metrics and hand-coded data, k-means is more accurate than GMM and CNN in segmenting urban vegetation. K-means is not able to differentiate between water and shadows, however, and when this segment is important GMM is best for probabilistically identifying secondary land cover class membership. Though we find the unsupervised CNN shows high degrees of accuracy on built urban landscape features, its accuracy when segmenting vegetation does not justify its complexity. Despite limitations, for segmenting urban vegetation, k-means has the highest performance, is the simplest, and is more efficient than alternatives.	[Lassiter, Allison] Univ Penn, Dept City & Reg Planning, Philadelphia, PA 19104 USA; [Darbari, Mayank] Univ Penn, Dept Comp & Informat Sci, 200 S 33Rd St, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lassiter, A (corresponding author), Univ Penn, Dept City & Reg Planning, Philadelphia, PA 19104 USA.	alass@design.upenn.edu			University of Pennsylvania School of Design	University of Pennsylvania School of Design	This work was supported by start-up funds provided by the University of Pennsylvania School of Design. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alom M.Z., 2018, ARXIV18030116V2; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Basu S, 2015, IEEE T GEOSCI REMOTE, V53, P5690, DOI 10.1109/TGRS.2015.2428197; California Data Collaborative, 2016, IND LANDSC AR CLASS; Dallimer M, 2011, BIOL LETTERS, V7, P763, DOI 10.1098/rsbl.2011.0025; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Gan MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112202; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Johnson TD, 2012, J HYDROL, V414, P86, DOI 10.1016/j.jhydrol.2011.10.016; Kanezaki A, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P1543; Karnieli A, 1997, INT J REMOTE SENS, V18, P1207, DOI 10.1080/014311697218368; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; Khan A, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10040489; Laddha A, 2016, IEEE INT VEH SYM, P118, DOI 10.1109/IVS.2016.7535374; Li WM, 2012, ENVIRON PLANN B, V39, P566, DOI 10.1068/b37135; Li XX, 2014, INT J APPL EARTH OBS, V33, P321, DOI 10.1016/j.jag.2014.04.018; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Martel-Brisson N, 2005, PROC CVPR IEEE, P643; Mathieu R, 2007, LANDSCAPE URBAN PLAN, V81, P179, DOI 10.1016/j.landurbplan.2006.11.009; Maxwell AE, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11121409; Maxwell AE, 2017, PHOTOGRAMM ENG REM S, V83, P737, DOI 10.14358/PERS.83.10.737; Myint SW, 2011, REMOTE SENS ENVIRON, V115, P1145, DOI 10.1016/j.rse.2010.12.017; O'Neil-Dunne J, 2014, REMOTE SENS-BASEL, V6, P12837, DOI 10.3390/rs61212837; Permuter H, 2003, 2003 IEEE INT C AC S, V3; Raileanu LE, 2004, ANN MATH ARTIF INTEL, V41, P77, DOI 10.1023/B:AMAI.0000018580.96245.c6; Robinson C., 2019, PROC CVPR IEEE, P12726, DOI DOI 10.1109/CVPR.2019.01301; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; U.S. Environmental Protection Agency, 2017, KEEP RAW SEW CONT ST; Wetherley EB, 2017, REMOTE SENS ENVIRON, V195, P170, DOI 10.1016/j.rse.2017.04.013; Yang Y., 2010, P 18 SIGSPATIAL INT, P270; Zhang CY, 2012, J APPL REMOTE SENS, V6, DOI 10.1117/1.JRS.6.063515; Zhang H, 2008, COMPUT VIS IMAGE UND, V110, P260, DOI 10.1016/j.cviu.2007.08.003; Zhang QC, 2016, INT GEOSCI REMOTE SE, P661, DOI 10.1109/IGARSS.2016.7729166; Zhou WQ, 2018, SCI TOTAL ENVIRON, V627, P1572, DOI 10.1016/j.scitotenv.2018.01.335; Zhou XL, 2011, LANDSCAPE URBAN PLAN, V100, P268, DOI 10.1016/j.landurbplan.2010.12.013; ZHU Z, 2016, REMOTE SENS ENVIRON, V185, P243, DOI DOI 10.1016/J.RSE.2016.03.036	38	7	7	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0230856	10.1371/journal.pone.0230856	http://dx.doi.org/10.1371/journal.pone.0230856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZX	32379776	gold, Green Published			2022-12-26	WOS:000537285700011
J	Hao, WJ; Wang, J; Zhang, YH; Wang, CX; Xia, L; Zhang, WH; Zafar, M; Kang, JY; Wang, RX; Bohio, AA; Pan, L; Zeng, XL; Wei, M; Boldogh, I; Ba, XQ				Hao, Wenjing; Wang, Jing; Zhang, Yuanhang; Wang, Chenxin; Xia, Lan; Zhang, Wenhe; Zafar, Muhammad; Kang, Ju-Yong; Wang, Ruoxi; Ali Bohio, Ameer; Pan, Lang; Zeng, Xianlu; Wei, Min; Boldogh, Istvan; Ba, Xueqing			Enzymatically inactive OGG1 binds to DNA and steers base excision repair toward gene transcription	FASEB JOURNAL			English	Article						8-oxoG; OGG1; oxidative stress; pro-inflammatory gene expression	HUMAN 8-OXOGUANINE DNA; REDOX REGULATION; GLYCOSYLASE 1; G-QUADRUPLEX; TNF-ALPHA; RECOGNITION; DAMAGE; 8-OXO-7,8-DIHYDROGUANINE; 8-HYDROXYGUANINE; ACCUMULATION	8-Oxoguanine DNA glycosylase1 (OGG1)-initiated base excision repair (BER) is the primary pathway to remove the pre-mutagenic 8-oxo-7,8-dihydroguanine (8-oxoG) from DNA. Recent studies documented 8-oxoG serves as an epigenetic-like mark and OGG1 modulates gene expression in oxidatively stressed cells. For this new role of OGG1, two distinct mechanisms have been proposed: one is coupled to base excision, while the other only requires substrate binding of OGG1--both resulting in conformational adjustment in the adjacent DNA sequences providing access for transcription factors to their cis-elements. The present study aimed to examine if BER activity of OGG1 is required for pro-inflammatory gene expression. To this end, Ogg1/OGG1 knockout/depleted cells were transfected with constructs expressing wild-type (wt) and repair-deficient mutants of OGG1. OGG1's promoter enrichment, oxidative state, and gene expression were examined. Results showed that TNF alpha exposure increased levels of oxidatively modified cysteine(s) of wt OGG1 without impairing its association with promoter and facilitated gene expression. The excision deficient K249Q mutant was even a more potent activator of gene expression; whereas, mutant OGG1 with impaired substrate recognition/binding was not. These data suggested the interaction of OGG1 with its substrate at regulatory regions followed by conformational adjustment in the adjacent DNA is the primary mode to modulate inflammatory gene expression.	[Hao, Wenjing; Zhang, Yuanhang; Wang, Chenxin; Xia, Lan; Zhang, Wenhe; Zafar, Muhammad; Kang, Ju-Yong; Wang, Ruoxi; Ali Bohio, Ameer; Zeng, Xianlu; Wei, Min; Ba, Xueqing] Northeast Normal Univ, Key Lab Mol Epignt, Minist Educ, Changchun, Peoples R China; [Hao, Wenjing; Zhang, Yuanhang; Wang, Chenxin; Xia, Lan; Zhang, Wenhe; Zafar, Muhammad; Wang, Ruoxi; Ali Bohio, Ameer; Pan, Lang; Zeng, Xianlu; Wei, Min; Ba, Xueqing] Northeast Normal Univ, Sch Life Sci, Changchun, Peoples R China; [Wang, Jing] Jilin Univ, Dept Resp Med, China Japan Union Hosp, Changchun, Peoples R China; [Kang, Ju-Yong] Kim Il Sung Univ, Fac Life Sci, Pyongyang, North Korea; [Wang, Ruoxi] Shandong Normal Univ, Coll Life Sci, Inst Biomed Sci, Key Lab Anim Resistance Biol Shandong Prov, Jinan, Peoples R China; [Pan, Lang; Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	Northeast Normal University - China; Northeast Normal University - China; Jilin University; Shandong Normal University; University of Texas System; University of Texas Medical Branch Galveston	Ba, XQ (corresponding author), Northeast Normal Univ, Minist Educ, Key Lab Mol Epigenet, Sch Life Sci, 5268 Renmin St, Changchun 130024, Jilin, Peoples R China.	baxq755@nenu.edu.cn		Pan, Lang/0000-0003-2324-2144	National Natural Science Foundation of China (NSFC) [31571339, 31970686, 31900557]; program for Introducing Talent to Universities [B07017]; National Institute of Environmental Health Sciences (NIEHS) [RO1 ES018948]; National Institute of Allergy and Infectious Diseases (NIAID) [AI062885]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); program for Introducing Talent to Universities; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31571339, 31970686 and 31900557; the program for Introducing Talent to Universities, Grant/Award Number: B07017; National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: RO1 ES018948; National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI062885	Allgayer J, 2016, NUCLEIC ACIDS RES, V44, P7267, DOI 10.1093/nar/gkw473; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Arai T, 2006, TOXICOLOGY, V221, P179, DOI 10.1016/j.tox.2006.01.004; Audebert M, 2000, NUCLEIC ACIDS RES, V28, P2672, DOI 10.1093/nar/28.14.2672; Ba XQ, 2018, REDOX BIOL, V14, P669, DOI 10.1016/j.redox.2017.11.008; Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bjoras M, 2002, J MOL BIOL, V317, P171, DOI 10.1006/jmbi.2002.5400; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Bohio AA, 2019, J IMMUNOL, V203, P1521, DOI 10.4049/jimmunol.1801616; Boiteux S, 2017, FREE RADICAL BIO MED, V107, P179, DOI 10.1016/j.freeradbiomed.2016.11.042; Bravard A, 2006, MOL CELL BIOL, V26, P7430, DOI 10.1128/MCB.00624-06; Bravard A, 2010, MUTAT RES-FUND MOL M, V685, P61, DOI 10.1016/j.mrfmmm.2009.09.013; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Bruner SD, 2000, COLD SPRING HARB SYM, V65, P103, DOI 10.1101/sqb.2000.65.103; Cadet J, 2010, FREE RADICAL BIO MED, V49, P9, DOI 10.1016/j.freeradbiomed.2010.03.025; Cividini F, 2016, J BIOL CHEM, V291, P26515, DOI 10.1074/jbc.M116.754481; D'Onofrio G, 1999, ANN NY ACAD SCI, V870, P81, DOI 10.1111/j.1749-6632.1999.tb08867.x; Dalhus B, 2011, STRUCTURE, V19, P117, DOI 10.1016/j.str.2010.09.023; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; Donley N, 2015, ACS CHEM BIOL, V10, P2334, DOI 10.1021/acschembio.5b00452; Fleming AM, 2019, NUCLEIC ACIDS RES, V47, P5049, DOI 10.1093/nar/gkz207; Fleming AM, 2018, BIOCHEMISTRY-US, V57, P991, DOI 10.1021/acs.biochem.7b01172; Fleming AM, 2017, ACS CHEM BIOL, V12, P2417, DOI 10.1021/acschembio.7b00636; Fleming AM, 2017, P NATL ACAD SCI USA, V114, P2604, DOI 10.1073/pnas.1619809114; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gautier C, 2000, CURR OPIN GENET DEV, V10, P656, DOI 10.1016/S0959-437X(00)00144-1; German P, 2013, DNA REPAIR, V12, P856, DOI 10.1016/j.dnarep.2013.06.006; Giese B, 2002, ANNU REV BIOCHEM, V71, P51, DOI 10.1146/annurev.biochem.71.083101.134037; Hao WJ, 2018, REDOX BIOL, V18, P43, DOI 10.1016/j.redox.2018.06.002; HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Karahalil B, 2012, HUM EXP TOXICOL, V31, P981, DOI 10.1177/0960327112444476; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Ke YS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091047; Ke YS, 2019, CELL MOL LIFE SCI, V76, P3283, DOI 10.1007/s00018-019-03120-6; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Koval VV, 2014, ACTA NATURAE, V6, P52, DOI 10.32607/20758251-2014-6-3-52-65; Kumar P, 2011, NUCLEIC ACIDS RES, V39, P8005, DOI 10.1093/nar/gkr536; Kuznetsova AA, 2014, BBA-GEN SUBJECTS, V1840, P387, DOI 10.1016/j.bbagen.2013.09.035; Li GP, 2012, FREE RADICAL BIO MED, V52, P392, DOI 10.1016/j.freeradbiomed.2011.10.490; Liu LL, 2012, HUM IMMUNOL, V73, P439, DOI 10.1016/j.humimm.2012.02.002; Mabley JG, 2004, FASEB J, V18, P290, DOI 10.1096/fj.04-2278fje; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Morreall J, 2015, DNA REPAIR, V26, P15, DOI 10.1016/j.dnarep.2014.11.007; Nash HM, 1997, CHEM BIOL, V4, P693, DOI 10.1016/S1074-5521(97)90225-8; Neeley WL, 2006, CHEM RES TOXICOL, V19, P491, DOI 10.1021/tx0600043; Noren Hooten N, 2011, J BIOL CHEM, V286, P44679, DOI 10.1074/jbc.M111.255869; Pan L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43297; Pan L, 2016, J BIOL CHEM, V291, P25553, DOI 10.1074/jbc.M116.751453; Pastukh V, 2015, AM J PHYSIOL-LUNG C, V309, pL1367, DOI 10.1152/ajplung.00236.2015; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Radak Z, 2010, FREE RADICAL BIO MED, V49, P587, DOI 10.1016/j.freeradbiomed.2010.05.008; Ruchko MV, 2009, FREE RADICAL BIO MED, V46, P352, DOI 10.1016/j.freeradbiomed.2008.09.038; Saito I, 1995, Nucleic Acids Symp Ser, P191; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Seifermann M, 2017, DNA REPAIR, V58, P13, DOI 10.1016/j.dnarep.2017.08.005; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Silvia TA, 2004, DNA REPAIR, V3, P483, DOI 10.1016/j.dnarep.2004.01.003; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Touati E, 2006, HELICOBACTER, V11, P494, DOI 10.1111/j.1523-5378.2006.00442.x; Tyugashev TE, 2019, J PHYS CHEM B, V123, P4878, DOI 10.1021/acs.jpcb.9b02949; van der Kemp PA, 2004, NUCLEIC ACIDS RES, V32, P570, DOI 10.1093/nar/gkh224; Visnes T, 2018, SCIENCE, V362, P834, DOI 10.1126/science.aar8048; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Wang RX, 2018, CELL MOL LIFE SCI, V75, P3741, DOI 10.1007/s00018-018-2887-8; Yang D, 2007, EXP EYE RES, V85, P462, DOI 10.1016/j.exer.2007.06.013; Zhou PT, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0472-z	70	14	14	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7427	7441		10.1096/fj.201902243R	http://dx.doi.org/10.1096/fj.201902243R		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32378256	Green Published, hybrid			2022-12-26	WOS:000530924600001
J	Rieg, AD; Suleiman, S; Bunting, NA; Verjans, E; Spillner, J; Schnoring, H; Kalverkamp, S; Schroder, T; von Stillfried, S; Braunschweig, T; Schalte, G; Uhlig, S; Martin, C				Rieg, Annette Dorothea; Suleiman, Said; Buenting, Nina Andrea; Verjans, Eva; Spillner, Jan; Schnoering, Heike; Kalverkamp, Sebastian; Schroeder, Thomas; von Stillfried, Saskia; Braunschweig, Till; Schaelte, Gereon; Uhlig, Stefan; Martin, Christian			Levosimendan reduces segmental pulmonary vascular resistance in isolated perfused rat lungs and relaxes human pulmonary vessels	PLOS ONE			English	Article							VENTRICULAR DYSFUNCTION; POTASSIUM CHANNELS; CARDIAC-SURGERY; HEART-FAILURE; HYPERTENSION; INODILATOR; ARTERY; MORTALITY; RESPONSES; RECEPTOR	Introduction Levosimendan is approved for acute heart failure. Within this context, pulmonary hypertension represents a frequent co-morbidity. Hence, the effects of levosimendan on segmental pulmonary vascular resistance (PVR) are relevant. So far, this issue has been not studied. Beyond that the relaxant effects of levosimendan in human pulmonary vessel are unknown. We addressed these topics in rats' isolated perfused lungs (IPL) and human precision-cut lung slices (PCLS). Material and methods In IPL, levosimendan (10 mu M) was perfused in untreated and endothelin-1 pre-contracted lungs. The pulmonary arterial pressure (P-PA) was continuously recorded and the capillary pressure (P-cap) was determined by the double-occlusion method. Thereafter, segmental PVR, expressed as precapillary (R-pre) and postcapillary resistance (R-post) and PVR were calculated. Human PCLS were prepared from patients undergoing lobectomy. Levosimendan-induced relaxation was studied in naive and endothelin-1 pre-contracted PAs and PVs. In endothelin-1 pre-contracted PAs, the role of K+-channels was studied by inhibition of K-ATP-channels (glibenclamide), BKCa2+-channels (iberiotoxin) and K-v-channels (4-amino-pyridine). All changes of the vascular tone were measured by videomicroscopy. In addition, the increase of cAMP/GMP due to levosimendan was measured by ELISA. Results Levosimendan did not relax untreated lungs or naive PAs and PVs. In IPL, levosimendan attenuated the endothelin-1 induced increase of PPA, PVR, Rpre and Rpost. In human PCLS, levosimendan relaxed pre-contracted PAs or PVs to 137% or 127%, respectively. In pre-contracted PAs, the relaxant effect of levosimendan was reduced, if K-ATP- and K-v-channels were inhibited. Further, levosimendan increased cGMP in PAs/PVs, but cAMP only in PVs. Discussion Levosimendan reduces rats' segmental PVR and relaxes human PAs or PVs, if the pulmonary vascular tone is enhanced by endothelin-1. Regarding levosimendan-induced relaxation, the activation of K-ATP- and K-v-channels is of impact, as well as the formation of cAMP and cGMP. In conclusion, our results suggest that levosimendan improves pulmonary haemodynamics, if PVR is increased as it is the case in pulmonary hypertension.	[Rieg, Annette Dorothea; Schaelte, Gereon] Rhenish Westphalian Tech Univ, Med Fac Aachen, Dept Anaesthesiol, Aachen, Germany; [Suleiman, Said; Buenting, Nina Andrea; Uhlig, Stefan; Martin, Christian] Rhenish Westphalian Tech Univ, Med Fac Aachen, Inst Pharmacol & Toxicol, Aachen, Germany; [Verjans, Eva] Rhenish Westphalian Tech Univ, Med Fac Aachen, Dept Paediat, Aachen, Germany; [Spillner, Jan; Schnoering, Heike; Kalverkamp, Sebastian] Rhenish Westphalian Tech Univ, Med Fac Aachen, Dept Cardiac & Thorac Surg, Aachen, Germany; [Schroeder, Thomas] Luisenhosp Aachen, Dept Surg, Aachen, Germany; [von Stillfried, Saskia; Braunschweig, Till] Rhenish Westphalian Tech Univ, Med Fac Aachen, Inst Pathol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Rieg, AD (corresponding author), Rhenish Westphalian Tech Univ, Med Fac Aachen, Dept Anaesthesiol, Aachen, Germany.	arieg@ukaachen.de	Uhlig, Stefan/A-7290-2014	Uhlig, Stefan/0000-0003-2332-1280; von Stillfried, Saskia/0000-0002-5260-8494				ATZORI L, 1992, RESPIRATION, V59, P16; Back M, 2002, ACTA PHYSIOL SCAND, V174, P9, DOI 10.1046/j.1365-201x.2002.00928.x; Bonnet S, 2007, PHARMACOL THERAPEUT, V115, P56, DOI 10.1016/j.pharmthera.2007.03.014; Breitling S, 2015, AM J PHYSIOL-LUNG C, V309, pL924, DOI 10.1152/ajplung.00146.2015; Chaliki HP, 2002, CATHETER CARDIO INTE, V56, P432, DOI 10.1002/ccd.10203; Comin-Colet J, 2018, EUR J HEART FAIL, V20, P1128, DOI 10.1002/ejhf.1145; De Witt BJ, 2002, ANESTH ANALG, V94, P1427; Ebade AA, 2013, J ANESTH, V27, P334, DOI 10.1007/s00540-012-1537-9; Endoh M, 2007, BRIT J PHARMACOL, V150, P826, DOI 10.1038/sj.bjp.0707163; Farmakis D, 2016, INT J CARDIOL, V222, P303, DOI 10.1016/j.ijcard.2016.07.202; Fayyaz AU, 2018, CIRCULATION, V137, P1796, DOI 10.1161/CIRCULATIONAHA.117.031608; FELETOU M, 1995, J CARDIOVASC PHARM, V25, P665, DOI 10.1097/00005344-199504000-00022; Gao YS, 2005, AM J PHYSIOL-LUNG C, V288, pL213, DOI 10.1152/ajplung.00103.2004; Gruhn N, 1998, J CARDIOVASC PHARM, V31, P741, DOI 10.1097/00005344-199805000-00013; Orriach JLG, 2013, REV ESP CARDIOL, V66, P999, DOI 10.1016/j.rec.2013.05.015; Guha A, 2016, PROG CARDIOVASC DIS, V59, P3, DOI 10.1016/j.pcad.2016.07.001; Hansen MS, 2018, PULM CIRC, V8, DOI 10.1177/2045894018790905; Hansen MS, 2017, J CARDIOVASC PHARM, V70, P232, DOI 10.1097/FJC.0000000000000508; Harrison RW, 2013, J CARDIOTHOR VASC AN, V27, P1224, DOI 10.1053/j.jvca.2013.03.027; Jiang R, 2018, CLIN RESPIR J, V12, P1518, DOI 10.1111/crj.12699; Kleber FX, 2009, J CLIN PHARMACOL, V49, P109, DOI 10.1177/0091270008325150; Landoni G, 2012, CRIT CARE MED, V40, P634, DOI 10.1097/CCM.0b013e318232962a; Lim JY, 2015, J CARDIAC SURG, V30, P547, DOI 10.1111/jocs.12562; Guerrero-Orriach JL, 2016, THER CLIN RISK MANAG, V12, P623, DOI 10.2147/TCRM.S102772; Maihofer NA, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0514-0; Martin C, 1996, EUR RESPIR J, V9, P2479, DOI 10.1183/09031936.96.09122479; Montani D, 2009, EUR RESPIR J, V33, P189, DOI 10.1183/09031936.00090608; Nijhawan N, 1999, J CARDIOVASC PHARM, V34, P219, DOI 10.1097/00005344-199908000-00007; Norel X, 2004, BRIT J PHARMACOL, V142, P788, DOI 10.1038/sj.bjp.0705843; Pataricza J, 2003, CARDIOVASC DRUG THER, V17, P115, DOI 10.1023/A:1025331617233; Pataricza J, 2000, J PHARM PHARMACOL, V52, P213, DOI 10.1211/0022357001773715; Poidinger B, 2019, J CARDIOTHOR VASC AN, V33, P328, DOI 10.1053/j.jvca.2018.07.013; RABE KF, 1994, AM J PHYSIOL, V266, pL536, DOI 10.1152/ajplung.1994.266.5.L536; RAJ JU, 1989, AM J PHYSIOL, V256, pH766, DOI 10.1152/ajpheart.1989.256.3.H766; Ressmeyer AR, 2006, EUR RESPIR J, V28, P603, DOI 10.1183/09031936.06.00004206; Revermann M, 2011, INTENS CARE MED, V37, P1368, DOI 10.1007/s00134-011-2254-9; Rieg AD, 2013, PLOS ONE; Rieg AD, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1074-2; Rieg AD, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0829-5; Rieg AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087685; Rieg AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066195; Rieg AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029698; Schleputz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047344; Schmeisser Alexander, 2013, Ther Adv Cardiovasc Dis, V7, P131, DOI 10.1177/1753944713477518; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Shimoda LA, 2002, RESP PHYSIOL NEUROBI, V132, P93, DOI 10.1016/S1569-9048(02)00052-6; Shimoda LA, 2013, J MOL MED, V91, P297, DOI 10.1007/s00109-013-0998-0; Townsley MI, 2012, COMPR PHYSIOL, V2, P675, DOI 10.1002/cphy.c100081; UHLIG S, 1994, J PHARMACOL TOXICOL, V31, P85, DOI 10.1016/1056-8719(94)90047-7; Usta C, 2006, EUR J CARDIO-THORAC, V30, P329, DOI 10.1016/j.ejcts.2006.05.019; Wiklund A, 2012, J CARDIOVASC PHARM, V59, P441, DOI 10.1097/FJC.0b013e31824938f0	52	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233176	10.1371/journal.pone.0233176	http://dx.doi.org/10.1371/journal.pone.0233176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421724	Green Published, gold			2022-12-26	WOS:000537499600033
J	Han, XH; He, H; Shen, HY; Tang, JH; Dong, WY; Shi, YF; Wu, SQ; Zhang, FP; Liang, GH				Han, Xiaohong; He, Huan; Shen, Haiyan; Tang, Jinhan; Dong, Wanying; Shi, Yufei; Wu, Songqing; Zhang, Feiping; Liang, Guanghong			Comparative mitochondrial genome analysis of Dendrolimus houi (Lepidoptera: Lasiocampidae) and phylogenetic relationship among Lasiocampidae species	PLOS ONE			English	Article							PINE CATERPILLAR MOTH; SEQUENCE; DNA; RECONSTRUCTION; LAJONQUIERE; INSECTS; ORIGIN	Dendrolimus houi is one of the most common caterpillars infesting Gymnosperm trees, and widely distributed in several countries in Southeast Asia, and exists soley or coexists with several congeners and some Lasiocampidae species in various forest habitats. However, natural hybrids occasionally occur among some closely related species in the same habitat, and host preference, extreme climate stress, and geographic isolation probably lead to their uncertain taxonomic consensus. The mitochondrial DNA (mtDNA) of D. houi was extracted and sequenced by using high-throughput technology, and the mitogenome composition and characteristics were compared and analyzed of these species, then the phylogenetic relationship was constructed using the maximum likelihood method (ML) and the Bayesian method (BI) based on their 13 protein-coding genes (PCGs) dataset, which were combined and made available to download which were combined and made available to download among global Lasiocampidae species data. Mitogenome of D. houi was 15,373 bp in length, with 37 genes, including 13 PCGs, 22 tRNA genes (tRNAs) and 2 rRNA genes (rRNAs). The positions and sequences of genes were consistent with those of most known Lasiocampidae species. The nucleotide composition was highly A+T biased, accounting for similar to 80% of the whole mitogenome. All start codons of PCGs belonged to typical start codons ATN except for COI which used CGA, and most stop codons ended with standard TAA or TAG, while COI, COII, ND4 ended with incomplete T. Only tRNA(Ser (AGN)) lacked DHU arm, while the remainder formed a typical "clover-shaped" secondary structure. For Lasiocampidae species, their complete mitochondrial genomes ranged from 15,281 to 15,570 bp in length, and all first genes started from trnM in the same direction. And base composition was biased toward A and T. Finally, both two methods (ML and BI) separately revealed that the same phylogenetic relationship of D. spp. as ((((D. punctatus + D. tabulaeformis) + D. spectabilis) + D. superans) + (D. kikuchii of Hunan population + D. houi) as in previous research, but results were different in that D. kikuchii from a Yunnan population was included, indicating that different geographical populations of insects have differentiated. And the phylogenetic relationship among Lasiocampidae species was ((((Dendrolimus) + Kunugia) + Euthrix) + Trabala). This provides a better theoretical basis for Lasiocampidae evolution and classification for future research directions.	[Han, Xiaohong; He, Huan; Shen, Haiyan; Tang, Jinhan; Dong, Wanying; Shi, Yufei; Wu, Songqing; Zhang, Feiping; Liang, Guanghong] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian, Peoples R China; [Wu, Songqing; Zhang, Feiping; Liang, Guanghong] Fujian Agr & Forestry Univ, Fujian Prov Univ, Key Lab Integrated Pest Management Ecol Forests, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fuzhou University	Zhang, FP; Liang, GH (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian, Peoples R China.; Zhang, FP; Liang, GH (corresponding author), Fujian Agr & Forestry Univ, Fujian Prov Univ, Key Lab Integrated Pest Management Ecol Forests, Fuzhou, Fujian, Peoples R China.	fpzhang1@163.com; guanghong.liang@fafu.edu.cn	han, xiao/HDN-9782-2022		National Natural Science Fund of China [31870641]; National Key Research and Development Program of China [2017YED0600105]; Science and Technology Department of Fujian Province-China [2018N5101]; Forest and Grassland Department of Fujian Province-China [2017 - 03]; Excellent Graduate Thesis Fund Project of Fujian Agriculture and Forestry University (2019) [2]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Science and Technology Department of Fujian Province-China; Forest and Grassland Department of Fujian Province-China; Excellent Graduate Thesis Fund Project of Fujian Agriculture and Forestry University (2019)	This research was funded by the National Natural Science Fund of China (No. 31870641), National Key Research and Development Program of China (No. 2017YED0600105), Science and Technology Department of Fujian Province-China (No. 2018N5101), Forest and Grassland Department of Fujian Province-China (No. 2017 - 03), Excellent Graduate Thesis Fund Project of Fujian Agriculture and Forestry University ([2019] No. 2).	Arunkumar KP, 2006, MOL PHYLOGENET EVOL, V40, P419, DOI 10.1016/j.ympev.2006.02.023; Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Bogus MI, 2007, J INSECT PHYSIOL, V53, P909, DOI 10.1016/j.jinsphys.2007.02.016; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Botero-Castro F, 2013, MOL PHYLOGENET EVOL, V69, P728, DOI 10.1016/j.ympev.2013.07.003; Cameron SL, 2012, MOL PHYLOGENET EVOL, V65, P163, DOI 10.1016/j.ympev.2012.05.034; Cao YQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-276; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; Dai LS, 2018, INT J BIOL MACROMOL, V108, P981, DOI 10.1016/j.ijbiomac.2017.11.011; Dai LS, 2018, INT J BIOL MACROMOL, V107, P1142, DOI 10.1016/j.ijbiomac.2017.09.093; Dai QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032544; Doose D, 2017, 2017 FIRST IEEE INTERNATIONAL CONFERENCE ON ROBOTIC COMPUTING (IRC), P208, DOI 10.1109/IRC.2017.47; Du Z, 2005, LECT NOTES COMPUT SC, V3726, P776; Gillett CPDT, 2014, MOL BIOL EVOL, V31, P2223, DOI 10.1093/molbev/msu154; Han XH, 2019, INSECTS, V10, DOI 10.3390/insects10120442; Jost MC, 2006, MOL PHYLOGENET EVOL, V38, P510, DOI 10.1016/j.ympev.2005.10.004; Kikuchi T, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1730-z; Kim KG, 2009, MOL CELLS, V27, P429, DOI 10.1007/s10059-009-0064-5; Kim MJ, 2016, MITOCHONDRIAL DNA B, V1, P180, DOI 10.1080/23802359.2016.1149789; Kim MJ, 2014, GENE, V549, P97, DOI 10.1016/j.gene.2014.07.052; Kim MJ, 2011, MOL PHYLOGENET EVOL, V61, P436, DOI 10.1016/j.ympev.2011.07.013; Kong XB, 2007, J CHEM ECOL, V33, P1316, DOI 10.1007/s10886-007-9313-2; Li J, 2019, ECOL EVOL, V9, P7480, DOI 10.1002/ece3.5278; Li WJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112397; [梁光红 Liang Guanghong], 2018, [植物保护, Plant Protection], V44, P177; Lin Haoyu, 2017, Chinese Journal of Biological Control, V33, P842; Liu JH, 2017, MITOCHONDRIAL DNA B, V2, P611, DOI 10.1080/23802359.2017.1372725; Liu YQ, 2018, J INSECT SCI, V18; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu Cheng, 2002, Journal of Agricultural Biotechnology, V10, P163; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ma C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-156; McComish BJ, 2010, GENOME BIOL EVOL, V2, P410, DOI 10.1093/gbe/evq029; Men QL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179706; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Park JS, 2016, CURR GENET, V62, P809, DOI 10.1007/s00294-016-0585-3; Qin J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1566-5; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Song N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11132-0; Stewart JB, 2006, GENOME, V49, P815, DOI 10.1139/G06-037; Stewart JB, 2005, GENOME, V48, P46, DOI 10.1139/G04-090; Sun Fu-cun, 2017, Forest Research, V30, P993, DOI 10.13275/j.cnki.lykxyj.2017.06.015; Sun Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178773; Wang XiaoLi, 2016, Acta Ecologica Sinica - International Journal, V36, P8, DOI 10.1016/j.chnaes.2015.12.004; Wang Yao, 2019, Forest Research, V32, P11, DOI 10.13275/j.cnki.lykxyj.2019.05.002; Wu L., 2017, THESIS; Wu YH, 2017, MITOCHONDRIAL DNA B, V2, P536, DOI 10.1080/23802359.2017.1365654; Yamauchi MM, 2004, INSECT MOL BIOL, V13, P435, DOI 10.1111/j.0962-1075.2004.00505.x; Yi JQ, 2016, MITOCHONDRIAL DNA A, V27, P109, DOI 10.3109/19401736.2013.873926; Zhang Ai-Binge, 2004, Acta Entomologica Sinica, V47, P236; ZHAO Q-S, 1992, Acta Entomologica Sinica, V35, P28; Zhou ZJ, 2009, MOL BIOL REP, V36, P7, DOI 10.1007/s11033-007-9145-8	55	2	2	7	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232527	10.1371/journal.pone.0232527	http://dx.doi.org/10.1371/journal.pone.0232527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407393	Green Published, gold			2022-12-26	WOS:000537490700023
J	Oehri, J; Burgin, M; Schmid, B; Niklaus, PA				Oehri, Jacqueline; Buergin, Marvin; Schmid, Bernhard; Niklaus, Pascal A.			Local and landscape-level diversity effects on forest functioning	PLOS ONE			English	Article							LEAF-AREA INDEX; SPECIES RICHNESS; BIODIVERSITY LOSS; HETEROGENEITY; PRODUCTIVITY; CONSEQUENCES; PHENOLOGY; SCALE; ECOSYSTEMS; TEMPERATE	Research of the past decades has shown that biodiversity is a fundamental driver of ecosystem functioning. However, most of this biodiversity-ecosystem functioning (BEF) research focused on experimental communities on small areas where environmental context was held constant. Whether the established BEF relationships also apply to natural or managed ecosystems that are embedded in variable landscape contexts remains unclear. In this study, we therefore investigated biodiversity effects on ecosystem functions in 36 forest stands that were located across a vast range of environmental conditions in managed landscapes of Central Europe (Switzerland). Specifically, we approximated forest productivity by leaf area index and forest phenology by growing-season length and tested effects of tree species richness and land-cover richness on these variables. We then examined the correlation and the confounding of these local and landscape-level diversity effects with environmental context variables related to forest stand structure (number of trees), landscape structure (land-cover edge density), climate (annual precipitation) and topography (mean altitude). We found that of all tested variables tree species richness was among the most important determinants of forest leaf area index and growing-season length. The positive effects of tree species richness on these two ecosystem variables were remarkably consistent across the different environmental conditions we investigated and we found little evidence of a context-dependent change in these biodiversity effects. Land-cover richness was not directly related to local forest functions but could nevertheless play a role via a positive effect on tree species richness.	[Oehri, Jacqueline; Buergin, Marvin; Schmid, Bernhard; Niklaus, Pascal A.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmid, Bernhard] Univ Zurich, Dept Geog, Zurich, Switzerland	University of Zurich; University of Zurich	Oehri, J; Niklaus, PA (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland.	jacqueline.oehri@ieu.uzh.ch; pascal.niklaus@ieu.uzh.ch	Schmid, Bernhard/C-8625-2009; Oehri, Jacqueline/AAV-2366-2020; Niklaus, Pascal A/G-5786-2010	Schmid, Bernhard/0000-0002-8430-3214; Oehri, Jacqueline/0000-0002-2981-9402; Niklaus, Pascal A/0000-0002-2360-1357	University of Zurich Research Priority Program Global Change and Biodiversity (URPP GCB)	University of Zurich Research Priority Program Global Change and Biodiversity (URPP GCB)	This study was funded by the University of Zurich Research Priority Program Global Change and Biodiversity (URPP GCB) grant to Pascal A. Niklaus and Gabriela Schaepman-Strub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2015, ECOL LETT, V18, P834, DOI 10.1111/ele.12469; Asner GP, 2003, GLOBAL ECOL BIOGEOGR, V12, P191, DOI 10.1046/j.1466-822X.2003.00026.x; Baillod AB, 2017, J APPL ECOL, V54, P1804, DOI 10.1111/1365-2664.12910; Barrufol M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081246; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brose U, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0267; Butler D, 2009, ASREML ASREML FITS L; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Castro-Izaguirre N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167771; Chapin N, 2002, ENTERPRISE INFORMATION SYSTEMS IV, P1; Chen JM, 2006, AGR FOREST METEOROL, V140, P257, DOI 10.1016/j.agrformet.2006.08.005; CHEN JM, 1995, IEEE T GEOSCI REMOTE, V33, P777, DOI 10.1109/36.387593; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Cleland EE, 2012, ECOLOGY, V93, P1765, DOI 10.1890/11-1912.1; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Craven D, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0277; de Beurs KM, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P177, DOI 10.1007/978-90-481-3335-2_9; Delarze R, LEBENSRA UME SCHWEIZ; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Duflot R, 2014, ACTA OECOL, V56, P19, DOI 10.1016/j.actao.2014.01.004; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Fang HL, 2019, REV GEOPHYS, V57, P739, DOI 10.1029/2018RG000608; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Gamez-Virues S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9568; Gold, 1980, INTRO BIVARIATE MULT, DOI DOI 10.2307/2287559; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Hautier Y, 2015, SCIENCE, V348, P336, DOI 10.1126/science.aaa1788; Heffernan JB, 2014, FRONT ECOL ENVIRON, V12, P5, DOI 10.1890/130017; Hullett CR, 2003, COMMUN MONOGR, V70, P52, DOI 10.1080/715114664; Iannone BV, 2016, LANDSCAPE ECOL, V31, P85, DOI 10.1007/s10980-015-0280-7; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jonckheere I, 2004, AGR FOREST METEOROL, V121, P19, DOI 10.1016/j.agrformet.2003.08.027; Jucker T, 2016, J ECOL, V104, P388, DOI 10.1111/1365-2745.12522; Jucker T, 2015, FUNCT ECOL, V29, P1078, DOI 10.1111/1365-2435.12428; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2017, ECOLOGY, V98, P909, DOI 10.1002/ecy.1697; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liang JJ, 2016, SCIENCE, V354, DOI 10.1126/science.aaf8957; Linderholm HW, 2006, AGR FOREST METEOROL, V137, P1, DOI 10.1016/j.agrformet.2006.03.006; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Hernandez-Stefanoni JL, 2011, LANDSCAPE ECOL, V26, P355, DOI 10.1007/s10980-010-9561-3; McGarigal K., 2015, FRAGSTATS 4 2 HELP; Mori AS, 2018, J ECOL, V106, P113, DOI 10.1111/1365-2745.12851; Morin X, 2011, ECOL LETT, V14, P1211, DOI 10.1111/j.1461-0248.2011.01691.x; Mouquet N, 2006, OIKOS, V113, P481, DOI 10.1111/j.2006.0030-1299.14582.x; Niklaus PA, 2017, ECOLOGY, V98, P1104, DOI 10.1002/ecy.1748; Norman JM, 1989, CANOPY STRUCTURE; Oehri J, 2017, P NATL ACAD SCI USA, V114, P10160, DOI 10.1073/pnas.1703928114; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Peng S, 2017, J PLANT ECOL, V10, P128, DOI 10.1093/jpe/rtw016; Perovic D, 2015, J APPL ECOL, V52, P505, DOI 10.1111/1365-2664.12394; Potter KM, 2014, FOREST ECOL MANAG, V321, P117, DOI 10.1016/j.foreco.2013.06.026; Pretzsch H, 2014, FOREST ECOL MANAG, V327, P251, DOI 10.1016/j.foreco.2014.04.027; Ratcliffe S, 2017, ECOL LETT, V20, P1414, DOI 10.1111/ele.12849; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Schleppi P, 2007, AGR FOREST METEOROL, V144, P236, DOI 10.1016/j.agrformet.2007.02.004; Schmid B, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0104; Stein A, 2014, ECOL LETT, V17, P866, DOI 10.1111/ele.12277; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Turner MG, 2013, LANDSCAPE ECOL, V28, P1081, DOI 10.1007/s10980-012-9741-4; VanDerWal J., 2019, SDMTOOLS SPECIES DIS; Vila M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053530; Walz U, 2015, ECOL MODEL, V295, P88, DOI 10.1016/j.ecolmodel.2014.07.011; Wardle DA, 2016, J VEG SCI, V27, P646, DOI 10.1111/jvs.12399; Weber D, 2004, GLOBAL ECOL BIOGEOGR, V13, P97, DOI 10.1111/j.1466-882X.2004.00078.x; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; Williams LJ, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0063; Wohlgemuth Thomas, 1996, Biodiversity Letters, V3, P180, DOI 10.2307/2999675; Wu X, 2015, ECOGRAPHY, V38, P602, DOI 10.1111/ecog.00940	75	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233104	10.1371/journal.pone.0233104	http://dx.doi.org/10.1371/journal.pone.0233104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407371	Green Published, gold, Green Accepted			2022-12-26	WOS:000537490700071
J	Wang, HY; Xia, Q; Xiong, ZZ; Li, ZX; Xiang, WY; Yuan, YW; Liu, YY; Li, Z				Wang, Huiyao; Xia, Qian; Xiong, Zhenzhen; Li, Zhixiong; Xiang, Weiyi; Yuan, Yiwen; Liu, Yaya; Li, Zhe			The psychological distress and coping styles in the early stages of the 2019 coronavirus disease (COVID-19) epidemic in the general mainland Chinese population: A web-based survey	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS; GLOBAL HEALTH; OUTBREAK; IMPACT; DISORDERS; RESPONSES; SYMPTOMS; CHILDREN	As the epidemic outbreak of 2019 coronavirus disease (COVID-19), general population may experience psychological distress. Evidence has suggested that negative coping styles may be related to subsequent mental illness. Therefore, we investigate the general population's psychological distress and coping styles in the early stages of the COVID-19 outbreak. A cross-sectional battery of surveys was conducted from February 1-4, 2020. The Kessler 6 psychological distress scale, the simplified coping style questionnaire and a general information questionnaire were administered on-line to a convenience sample of 1599 in China. A multiple linear regression analysis was performed to identify the influence factors of psychological distress. General population's psychological distress were significant differences based on age, marriage, epidemic contact characteristics, concern with media reports, and perceived impacts of the epidemic outbreak (all p < 0.001) except gender (p = 0.316). The population with younger age (F = 102.04), unmarried (t = 15.28), with history of visiting Wuhan in the past month (t = -40.86), with history of epidemics occurring in the community (t = -10.25), more concern with media reports (F = 21.84), perceived more impacts of the epidemic outbreak (changes over living situations, F = 331.71; emotional control, F = 1863.07; epidemic-related dreams, F = 1642.78) and negative coping style (t = 37.41) had higher level of psychological distress. Multivariate analysis found that marriage, epidemic contact characteristics, perceived impacts of the epidemic and coping style were the influence factors of psychological distress (all p <0.001). Epidemic of COVID-19 caused high level of psychological distress. The general mainland Chinese population with unmarried, history of visiting Wuhan in the past month, perceived more impacts of the epidemic and negative coping style had higher level of psychological distress in the early stages of COVID-19 epidemic. Psychological interventions should be implemented early, especially for those general population with such characteristics.	[Wang, Huiyao; Xia, Qian; Yuan, Yiwen; Liu, Yaya; Li, Zhe] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu, Sichuan, Peoples R China; [Wang, Huiyao; Xia, Qian; Yuan, Yiwen; Liu, Yaya; Li, Zhe] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu, Sichuan, Peoples R China; [Xiong, Zhenzhen] Chengdu Med Coll, Sch Nursing, Chengdu, Sichuan, Peoples R China; [Li, Zhixiong] Karamay Municipal Peoples Hosp, Dept Clin Psychol 3, Karamay, Xinjiang, Peoples R China; [Xiang, Weiyi] Sichuan Univ, West China Coll Med, Chengdu, Sichuan, Peoples R China; [Liu, Yaya] Zun Yi Psychiat Hosp, Zunyi, Guizhou, Peoples R China	Sichuan University; Sichuan University; Chengdu Medical College; Sichuan University	Li, Z (corresponding author), Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu, Sichuan, Peoples R China.; Li, Z (corresponding author), Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu, Sichuan, Peoples R China.	jay_li@163.com						Chen WQ, 2009, AM J IND MED, V52, P500, DOI 10.1002/ajim.20691; Clarke D, 2009, PERS INDIV DIFFER, V46, P460, DOI 10.1016/j.paid.2008.11.014; Dai Xiaoyang, 2015, SIMPLIFIED COPING ST, P99; First MB, 2013, J NERV MENT DIS, V201, P727, DOI 10.1097/NMD.0b013e3182a2168a; Franz M, 2003, SOC PSYCH PSYCH EPID, V38, P59, DOI 10.1007/s00127-003-0605-8; Fredrickson BL, 2002, PSYCHOL SCI, V13, P172, DOI 10.1111/1467-9280.00431; Hao Xu, 2012, SCIENCEPAPER ONLINE; Hollifield M, 2008, BRIT J PSYCHIAT, V192, P39, DOI 10.1192/bjp.bp.107.038422; Huang JH, 2013, NEURAL REGEN RES, V8, P1898, DOI 10.3969/j.issn.1673-5374.2013.20.009; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; Jia Kang, 2020, CHINADAILY; Kang LJ, 2020, LANCET PSYCHIAT, V7, pE14, DOI 10.1016/S2215-0366(20)30047-X; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Lau JTF, 2010, INFECTION, V38, P275, DOI 10.1007/s15010-010-0034-z; Lee S, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013912; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; Li L, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0341-2; Maunder R, 2003, CAN MED ASSOC J, V168, P1245; Mohammed A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2167-6; Matud MP, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030341; Santarnecchi E, 2018, COGN AFFECT BEHAV NE, V18, P495, DOI 10.3758/s13415-018-0583-7; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Sliter M, 2014, J ORGAN BEHAV, V35, P257, DOI 10.1002/job.1868; Stallard P, 2001, BRIT J CLIN PSYCHOL, V40, P197, DOI 10.1348/014466501163643; Taylor MR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-347; Tsang HWH, 2004, EMERG INFECT DIS, V10, P1326; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang L, 2019, IRAN J PUBLIC HEALTH, V48, P95, DOI 10.18502/ijph.v48i1.787; Westerhuis W, 2011, J NEUROL, V258, P37, DOI 10.1007/s00415-010-5677-2; Wu KK, 2005, EMERG INFECT DIS, V11, P1297, DOI 10.3201/eid1108.041083; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8; Xie Yaning, 1999, CHIN J CLIN PSYCHOL, V6, P114; Zhang Yangfei, 2020, CHINADAILY	33	125	126	16	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233410	10.1371/journal.pone.0233410	http://dx.doi.org/10.1371/journal.pone.0233410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0YZ	32407409	Green Published, gold, Green Submitted			2022-12-26	WOS:000537490700091
J	Zhang, L; Yuan, MY; An, Z; Zhao, XM; Wu, H; Li, HB; Wang, Y; Sun, BB; Li, HJ; Ding, SB; Zeng, X; Chao, L; Li, P; Wu, WD				Zhang, Li; Yuan, Mengya; An, Zhen; Zhao, Xiangmei; Wu, Hui; Li, Haibin; Wang, Ya; Sun, Beibei; Li, Huijun; Ding, Shibin; Zeng, Xiang; Chao, Ling; Li, Pan; Wu, Weidong			Prediction of hypertension, hyperglycemia and dyslipidemia from retinal fundus photographs via deep learning: A cross-sectional study of chronic diseases in central China	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; DIABETIC-RETINOPATHY; NEURAL-NETWORKS; BLOOD-PRESSURE; RISK-FACTORS; CLASSIFICATION; OUTLINE	Retinal fundus photography provides a non-invasive approach for identifying early microcirculatory alterations of chronic diseases prior to the onset of overt clinical complications. Here, we developed neural network models to predict hypertension, hyperglycemia, dyslipidemia, and a range of risk factors from retinal fundus images obtained from a cross-sectional study of chronic diseases in rural areas of Xinxiang County, Henan, in central China. 1222 high-quality retinal images and over 50 measurements of anthropometry and biochemical parameters were generated from 625 subjects. The models in this study achieved an area under the ROC curve (AUC) of 0.880 in predicting hyperglycemia, of 0.766 in predicting hypertension, and of 0.703 in predicting dyslipidemia. In addition, these models can predict with AUC>0.7 several blood test erythrocyte parameters, including hematocrit (HCT), mean corpuscular hemoglobin concentration (MCHC), and a cluster of cardiovascular disease (CVD) risk factors. Taken together, deep learning approaches are feasible for predicting hypertension, dyslipidemia, diabetes, and risks of other chronic diseases.	[Zhang, Li; Yuan, Mengya; An, Zhen; Zhao, Xiangmei; Wu, Hui; Li, Haibin; Wang, Ya; Sun, Beibei; Li, Huijun; Ding, Shibin; Zeng, Xiang; Chao, Ling; Li, Pan; Wu, Weidong] Xinxiang Med Univ, Sch Publ Hlth, Xinxiang, Henan, Peoples R China	Xinxiang Medical University	Li, P; Wu, WD (corresponding author), Xinxiang Med Univ, Sch Publ Hlth, Xinxiang, Henan, Peoples R China.	panli@xxmu.edu.cn; wdwu2013@126.com	Zeng, Xiang/AAT-6531-2021	Zeng, Xiang/0000-0001-8252-3558; Zhang, Li/0000-0002-7862-6690	National Key Program of Research and Development of China [2016YFC0900803, 2017YFD0400301]; National Natural Science Foundation of China [U1604178, U1904158]	National Key Program of Research and Development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Key Program of Research and Development of China (2016YFC0900803; 2017YFD0400301) and National Natural Science Foundation of China (U1604178; U1904158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi Martin, 2016, arXiv; Bays H, 2005, FUTUR CARDIOL, V1, P39, DOI 10.1517/14796678.1.1.39; Bi WL, 2019, CA-CANCER J CLIN, V69, P127, DOI 10.3322/caac.21552; Bloice Marcus D, 2017, ARXIV170804680, DOI DOI 10.21105/J0SS.00432; Bundy JD, 2016, ANN GLOB HEALTH, V82, P227, DOI 10.1016/j.aogh.2016.02.002; Chen WW, 2016, EUR HEART J SUPPL, V18, pF2, DOI 10.1093/eurheartj/suw030; Dai GZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230111; Esteva A, 2019, NAT MED, V25, P24, DOI 10.1038/s41591-018-0316-z; Gargeya R, 2017, OPHTHALMOLOGY, V124, P962, DOI 10.1016/j.ophtha.2017.02.008; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Halpern A, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-55; Han S., 2015, NIPS; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Kaushik S, 2007, INVEST OPHTH VIS SCI, V48, P557, DOI 10.1167/iovs.06-0893; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Kifley A, 2007, AM J EPIDEMIOL, V166, P1288, DOI 10.1093/aje/kwm255; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li H, 2015, IJC HEART VASC, V6, P25, DOI 10.1016/j.ijcha.2014.10.002; Li ZX, 2018, DIABETES CARE, V41, P2509, DOI 10.2337/dc18-0147; Liew G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102230; Lopez V, 2013, INFORM SCIENCES, V250, P113, DOI 10.1016/j.ins.2013.07.007; Maqsood M, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19112645; Mukai N, 2017, 2017 NICOGRAPH INTERNATIONAL (NICOINT), P19, DOI 10.1109/NICOInt.2017.9; Nguyen TT, 2009, CURR DIABETES REP, V9, P277, DOI 10.1007/s11892-009-0043-4; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Samala RK, 2016, MED PHYS, V43, P6654, DOI 10.1118/1.4967345; Schlegl T, 2018, OPHTHALMOLOGY, V125, P549, DOI 10.1016/j.ophtha.2017.10.031; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Schmidt-Erfurth U, 2018, PROG RETIN EYE RES, V67, P1, DOI 10.1016/j.preteyeres.2018.07.004; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Tapp RJ, 2003, DIABETES CARE, V26, P1731, DOI 10.2337/diacare.26.6.1731; Triwijoyo BK, 2017, PROCEDIA COMPUT SCI, V116, P166, DOI 10.1016/j.procs.2017.10.066; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069; Wu S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-989; Yan Y, 2015, 2015 IEEE INT S MULT; Yu KH, 2018, NAT BIOMED ENG, V2, P719, DOI 10.1038/s41551-018-0305-z	40	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233166	10.1371/journal.pone.0233166	http://dx.doi.org/10.1371/journal.pone.0233166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407418	Green Published, gold			2022-12-26	WOS:000537490700078
J	Bagheri, H; Tapak, L; Karami, M; Hosseinkhani, Z; Najari, H; Karimi, S; Cheraghi, Z				Bagheri, Hadi; Tapak, Leili; Karami, Manoochehr; Hosseinkhani, Zahra; Najari, Hamidreza; Karimi, Safdar; Cheraghi, Zahra			Forecasting the monthly incidence rate of brucellosis in west of Iran using time series and data mining from 2010 to 2019	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; LABORATORY FEATURES; EPIDEMIOLOGY; PREDICTION; MODEL	Background The identification of statistical models for the accurate forecast and timely determination of the outbreak of infectious diseases is very important for the healthcare system. Thus, this study was conducted to assess and compare the performance of four machine-learning methods in modeling and forecasting brucellosis time series data based on climatic parameters. Methods In this cohort study, human brucellosis cases and climatic parameters were analyzed on a monthly basis for the Qazvin province-located in northwestern Iran-over a period of 9 years (2010-2018). The data were classified into two subsets of education (80%) and testing (20%). Artificial neural network methods (radial basis function and multilayer perceptron), support vector machine and random forest were fitted to each set. Performance analysis of the models were done using the Root Mean Square Error (RMSE), Mean Absolute Error (MAE), Mean Absolute Root Error (MARE), and R-2 criteria. Results The incidence rate of the brucellosis in Qazvin province was 27.43 per 100,000 during 2010-2019. Based on our results, the values of the RMSE (0.22), MAE (0.175), MARE (0.007) criteria were smaller for the multilayer perceptron neural network than their values in the other three models. Moreover, the R-2 (0.99) value was bigger in this model. Therefore, the multilayer perceptron neural network exhibited better performance in forecasting the studied data. The average wind speed and mean temperature were the most effective climatic parameters in the incidence of this disease. Conclusions The multilayer perceptron neural network can be used as an effective method in detecting the behavioral trend of brucellosis over time. Nevertheless, further studies focusing on the application and comparison of these methods are needed to detect the most appropriate forecast method for this disease.	[Bagheri, Hadi; Karami, Manoochehr; Cheraghi, Zahra] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Hamadan, Iran; [Tapak, Leili] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Biostat, Hamadan, Iran; [Tapak, Leili; Karami, Manoochehr; Cheraghi, Zahra] Hamadan Univ Med Sci, Modeling Noncommunicable Dis Res Ctr, Hamadan, Iran; [Hosseinkhani, Zahra; Najari, Hamidreza] Qazvin Univ Med Sci, Sch Hlth, Dept Hlth Serv Management, Qazvin, Iran; [Karimi, Safdar] Qazvin Univ Med Sci & Hlth Serv, Dept Prevent & Fighting Dis Deputy Hlth, Qazvin, Iran	Qazvin University of Medical Sciences (QUMS); Qazvin University of Medical Sciences (QUMS)	Cheraghi, Z (corresponding author), Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Hamadan, Iran.; Cheraghi, Z (corresponding author), Hamadan Univ Med Sci, Modeling Noncommunicable Dis Res Ctr, Hamadan, Iran.	cheraghiz@ymail.com	Karami, Manoochehr/E-5030-2012; Tapak, L/L-1280-2017; Hamidi, Omid/ABF-4777-2020	Karami, Manoochehr/0000-0002-9026-3757; Tapak, L/0000-0002-4378-3143; bagheri, hadi/0000-0002-4679-4366; ansari, parastoo/0000-0003-1536-1565; hosseinkhani, zahra/0000-0002-2772-6181	Vice-Chancellor of Research and Technology of Hamadan University of Medical Sciences	Vice-Chancellor of Research and Technology of Hamadan University of Medical Sciences	This study was funded by the Vice-Chancellor of Research and Technology of Hamadan University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi SM, 2012, JUNDISHAPUR J MICROB, V5, P384, DOI 10.5812/jjm.3248; [Anonymous], 2007, P 2 NAT IR C BRUC 20, P47; [Anonymous], 2005, IMPORTANCE ZOONOTIC; BABOO S, 2010, INT J ENV SCI, V1, P321, DOI DOI 10.7763/IJESD.2010.V1.63; Bayram S, 2016, J CIV ENG MANAG, V22, P480, DOI 10.3846/13923730.2014.897988; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brossette SE, 2000, METHOD INFORM MED, V39, P303; Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Dastjerdi MZ, 2012, PUBLIC HEALTH, V126, P1058, DOI 10.1016/j.puhe.2012.07.001; Donev D, 2010, Prilozi, V31, P33; Eini P, 2012, J RES HEALTH SCI, V12, P105; Esmail Nasab N BN, 2007, AZAD U, V1, P53; Farahani S, 2012, INVESTIGATION EPIDEM; Farrington C, 2003, MONITORING HLTH PERS; Fosgate GT, 2002, EMERG INFECT DIS, V8, P672, DOI 10.3201/eid0807.010351; Gonzalez-Parra G, 2009, COMMUN NONLINEAR SCI, V14, P3967, DOI 10.1016/j.cnsns.2009.02.023; Guan P, 2004, WORLD J GASTROENTERO, V10, P3579, DOI 10.3748/wjg.v10.i24.3579; Hadi Memarian, 2012, Journal of Water Resource and Protection, V4, P870, DOI 10.4236/jwarp.2012.410102; Hamzavi Y KN, J KERMANSHAH, V18, P114; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hatami H RM, 2004, COMPREHENSIVE PUBLIC; Hong WC, 2006, INT J ADV MANUF TECH, V28, P154, DOI 10.1007/s00170-004-2340-z; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Karami M, 2012, IRAN J PUBLIC HEALTH, V41, P102; Mahmoodabad SSM., 2008, PLOS ONE, V5, P522; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; Minas M, 2007, JPN J INFECT DIS, V60, P362; Mirnejad R, 2017, MICROB PATHOGENESIS, V109, P239, DOI 10.1016/j.micpath.2017.06.005; Mohammad Taheri Sudjani MHL, 2016, J JAHROM U MED SCI, V14, P1; Moosazadeh Mahmood, 2016, Osong Public Health Res Perspect, V7, P157, DOI 10.1016/j.phrp.2016.04.009; Moradi GH KS, 2007, P 2 NAT IR C BRUC, P151; Muller K-R, 1997, INT C ART NEUR NETW; Namiduru M, 2003, INT J CLIN PRACT, V57, P20; Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963; Oliveira A, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0697-4; Pai PF, 2005, INT J ADV MANUF TECH, V27, P205, DOI 10.1007/s00170-004-2139-y; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Perez-Rendon Gonzalez J, 1997, Aten Primaria, V19, P290; Prober C, 2012, PRINCIPLES PRACTICE; Purwar S, 2007, SOUTH MED J, V100, P1074, DOI 10.1097/SMJ.0b013e318157f6c5; RADOLF JD, 1994, AM J MED SCI, V307, P64, DOI 10.1097/00000441-199401000-00012; Refai M, 2002, VET MICROBIOL, V90, P81, DOI 10.1016/S0378-1135(02)00248-1; Samaha H, 2008, EMERG INFECT DIS, V14, P1916, DOI 10.3201/eid1412.071452; Segal M.R., 2004, INT C BIOINF, DOI DOI 10.2307/2404188; Serra Alvarez J, 2000, Rev Esp Salud Publica, V74, P45; Shaikh S GR, 2007, P 2 NAT IR C BRUC 20, P267; Shirmohammadi-Khorram N, 2019, ZOONOSES PUBLIC HLTH, V66, P759, DOI 10.1111/zph.12622; Shoraka H HH, 2010, N KHORASAN MUJ, V2, P67; Sofian M, 2008, INT J INFECT DIS, V12, P157, DOI 10.1016/j.ijid.2007.04.019; Sofian M, 2014, SCAND J INFECT DIS, V46, P573, DOI 10.3109/00365548.2014.918275; Soleymani A AS, 2012, TABRIZ J, V3, P64; Spaeder MC, 2012, EPIDEMIOL INFECT, V140, P602, DOI 10.1017/S0950268811001026; Tapak L., 2018, IRAN J EPIDEMIOL, V14, P153; Tapak L, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4393-y; Tapak L, 2013, HEALTHC INFORM RES, V19, P177, DOI 10.4258/hir.2013.19.3.177; Tay FEH, 2002, NEUROCOMPUTING, V48, P847, DOI 10.1016/S0925-2312(01)00676-2; Tohme A, 2001, PRESSE MED, V30, P1339; Tommola M., 1999, Journal of Forest Engineering, V10, P75; Ture M, 2006, EXPERT SYST APPL, V31, P41, DOI 10.1016/j.eswa.2005.09.002; Wu H, 2017, BIOSCIENCE TRENDS; Yoon H, 2011, J HYDROL, V396, P128, DOI 10.1016/j.jhydrol.2010.11.002; Young E MG, 1995, PRINCIPLES PRACTICE; Young EJ, 2000, PRINCIPLES PRACTICE, P2386; Zeinali M, 2009, NATL GUIDELINE BRUCE, P10; Zemestani A, 2016, DEPICTION HLTH, V7, P34; Zhang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085871; Zhang XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149401	69	8	8	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232910	10.1371/journal.pone.0232910	http://dx.doi.org/10.1371/journal.pone.0232910			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396582	gold, Green Published			2022-12-26	WOS:000537475000026
J	Kaiser, R; Liu, D; Arias-Loza, P; Hu, K; Grotemeyer, K; Nordbeck, P				Kaiser, Ralf; Liu, Dan; Arias-Loza, Paula; Hu, Kai; Grotemeyer, Katharina; Nordbeck, Peter			Right ventricular pressure overload directly affects left ventricular torsion mechanics in patients with precapillary pulmonary hypertension	PLOS ONE			English	Article							ECHOCARDIOGRAPHY; INDEX	This study examined the impact of septal flattening on left ventricular (LV) torsion in patients with precapillary pulmonary hypertension (PH). Fifty-two patients with proven precapillary PH and 13 healthy controls were included. Ventricular function was assessed including 4D-measurements, tissue velocity imaging, and speckle tracking analysis. Increased eccentricity index (1.39 vs. 1.08, p<0.001), systolic pulmonary artery pressure (64 vs. 29mmHg, p<0.001) and right ventricular Tei index (0.55 vs. 0.28, p=0.007), and reduced tricuspid annular plane systolic excursion (19.0 vs. 26.5mm, p<0.001) were detected in PH patients as compared to controls. With increasing eccentricity of left ventricle, LV torsion was both decreased and delayed. Torsion rate paralleled this pattern of change during systole, but not during diastole. In conclusion, right ventricular pressure overload directly affects LV torsion mechanics. The echocardiographic methodology applied provides novel insights in the interrelation of right- and left ventricular function.	[Kaiser, Ralf] Saarland Univ, Med Ctr, Dept Internal Med 5, Homburg, Germany; [Liu, Dan; Arias-Loza, Paula; Hu, Kai; Nordbeck, Peter] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Liu, Dan; Arias-Loza, Paula; Hu, Kai; Nordbeck, Peter] Comprehens Heart Failure Ctr, Wurzburg, Germany; [Grotemeyer, Katharina] Saarland Univ, Med Ctr, Dept Internal Med 2, Homburg, Germany	Universitatsklinikum des Saarlandes; University of Wurzburg; University of Wurzburg; Universitatsklinikum des Saarlandes	Nordbeck, P (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany.; Nordbeck, P (corresponding author), Comprehens Heart Failure Ctr, Wurzburg, Germany.	nordbeck_p@ukw.de	Nordbeck, Peter/D-4771-2018	Nordbeck, Peter/0000-0002-2560-4068; Arias-Loza, Anahi-Paula/0000-0003-4048-4719	German Federal Ministry of Education and Research [BMBF 01EO1504]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF 01EO1504, MO.6).	BELENKIE I, 1988, CIRCULATION, V78, P761, DOI 10.1161/01.CIR.78.3.761; Belenkie I, 2001, ANN MED, V33, P236, DOI 10.3109/07853890108998751; DELLITALIA LJ, 1995, J APPL PHYSIOL, V78, P2320, DOI 10.1152/jappl.1995.78.6.2320; Gan CTJ, 2006, AM J PHYSIOL-HEART C, V290, pH1528, DOI 10.1152/ajpheart.01031.2005; Kim WJ, 2009, CIRC-CARDIOVASC IMAG, V2, P123, DOI 10.1161/CIRCIMAGING.108.794719; KING ME, 1983, CIRCULATION, V68, P68, DOI 10.1161/01.CIR.68.1.68; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Luecke T, 2004, INTENS CARE MED, V30, P119, DOI 10.1007/s00134-003-1993-7; Marcus JT, 2008, J AM COLL CARDIOL, V51, P750, DOI 10.1016/j.jacc.2007.10.041; MOON MR, 1994, CIRCULATION, V89, P142, DOI 10.1161/01.CIR.89.1.142; Puwanant S, 2010, CIRCULATION, V121, P259, DOI 10.1161/CIRCULATIONAHA.108.844340; Russel IK, 2009, JACC-CARDIOVASC IMAG, V2, P648, DOI 10.1016/j.jcmg.2009.03.001; Santamore WP, 1998, PROG CARDIOVASC DIS, V40, P289, DOI 10.1016/S0033-0620(98)80049-2; Speich R, 2011, EUR RESPIR J, V37, P994, DOI 10.1183/09031936.00189810; Teng WH, 2019, J CARDIOVASC ECHOGR, V29, P103, DOI 10.4103/jcecho.jcecho_19_19; Wang J, 2011, J CIRCADIAN RHYTHMS, V9, P11, DOI [DOI 10.1186/1740-3391-9-11), 10.1186/1740-3391-9-11, DOI 10.1186/1740-3391-9-11]; YOUNG AA, 1994, CIRCULATION, V89, P740, DOI 10.1161/01.CIR.89.2.740	17	2	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232544	10.1371/journal.pone.0232544	http://dx.doi.org/10.1371/journal.pone.0232544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396557	Green Published, gold			2022-12-26	WOS:000537475000012
J	Leon-Guereno, P; Tapia-Serrano, MA; Sanchez-Miguel, PA				Leon-Guereno, Patxi; Angel Tapia-Serrano, Miguel; Antonio Sanchez-Miguel, Pedro			The relationship of recreational runners' motivation and resilience levels to the incidence of injury: A mediation model	PLOS ONE			English	Article							COMPETITIVE LEVEL; PHYSICAL-ACTIVITY; MENTAL-HEALTH; SPORT; STRESSORS; SCALE; TEAM; LIFE	Running participation has increased significantly in the last decade. Despite its association with different health-related aspects, athletes may experience adverse outcomes, including injuries. The aim of this study was twofold: to examine the relationship between runners' resilience levels, motivation and incidence of injury, on the one hand; and to analyse the mediation that intrinsic and extrinsic motivation has on the association between the number of injuries and psychological resilience levels among amateur athletes. The sample consisted of a total of 1725 runners (age: 40.40 +/- 9.39 years), 1261 of whom were male (age: 43.16 +/- 9.38), and 465 of whom were female (age: 40.34 +/- 9.14). Athletes completed the Behavioural Regulation in Exercise Questionnaire (BREQ-3), the Resilience scale (CD-RISC 10), and an Injury retrospective survey. Three mediation models were constructed, and the results showed a significant indirect association of athletes' intrinsic motivation and resilience on the number of injuries (beta = 0.022, CI = 0.007, 0.0) in mediation model 1, whereas extrinsic motivation was found to have no significant association on those variables (beta = -0.062, CI = -0.137, 0.009) in mediation model 2. Model 3 showed significant differences with respect to resilience (p < 0.05) and intrinsic motivation (p < 0.05). Therefore, the mediation of intrinsic motivation on athletes' resilience levels and incidence of injury was demonstrated, i.e., it was found that intrinsic motivation was associated with a higher incidence of injury, while no such correlation was found for extrinsic motivation. This study shows that the amateur long distance runners with a high level of intrinsic motivation tend to suffer from a greater number of injuries, and at the same time psychological resilience was associated with a lower number of injuries.	[Leon-Guereno, Patxi] Univ Deusto, Fac Psychol & Educ, Donostia San Sebastian, Spain; [Angel Tapia-Serrano, Miguel; Antonio Sanchez-Miguel, Pedro] Univ Extremadura, Fac Teacher Training, Dept Didact Mus Plast & Body Express, Caceres, Spain	University of Deusto; Universidad de Extremadura	Tapia-Serrano, MA (corresponding author), Univ Extremadura, Fac Teacher Training, Dept Didact Mus Plast & Body Express, Caceres, Spain.	pesanchezm@unex.es	Leon, Patxi/X-7467-2019; Serrano, Miguel Angel Tapia/ABA-5834-2020	Serrano, Miguel Angel Tapia/0000-0003-2954-2375				Cano LA, 2010, REV LAT AM PSICOL, V42, P265; AMERICAN PSYCHOLOGICAL ASSOCIATION (APA), 2020, TRANSL ISS PSYCH SCI, V7th, DOI [DOI 10.1037/TPS0000076, 10.1037/bul0000152, DOI 10.1037/0000165-000]; Boullosa DA, 2013, SPORTS MED, V43, P909, DOI 10.1007/s40279-013-0086-1; Brown CJ, 2020, J APPL SPORT PSYCHOL, V32, P277, DOI 10.1080/10413200.2018.1545709; Bryan C, 2019, INT REV SPORT EXER P, V12, P70, DOI 10.1080/1750984X.2017.1381140; Carlos Jaenes Sanchez J, 2009, PERSONALIDAD RESISTE; Sanchez MC, 2016, RETOS-NUEV TEND EDUC, P162; Codonhato R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210174; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Dallinga J, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2018-000489; de la Vega R, 2011, REV PSICOL DEPORTE, V20, P445; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Decroos S, 2017, SPORT EXERC PERFORM, V6, P158, DOI 10.1037/spy0000089; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Eloranta I, 2006, RELIABILITY VALIDITY; Ferrer D. A, 2015, INT J SPORT STUD, V5, P1162; Fletcher D, 2012, PSYCHOL SPORT EXERC, V13, P669, DOI 10.1016/j.psychsport.2012.04.007; Francis P, 2019, J SPORT SCI MED, V18, P21; Galli N., 2019, PSYCHOSOCIAL HLTH WE, DOI [10.4324/9781351210942, DOI 10.4324/9781351210942]; Galli N, 2015, INT J SPORT EXERC PS, V13, P243, DOI 10.1080/1612197X.2014.946947; García Secades Xabel, 2014, CPD, V14, P83; Garcia Secades X, 2015, PAPEL PERFIL RESILIE, V14; Gucciardi DF, 2011, PSYCHOL SPORT EXERC, V12, P423, DOI 10.1016/j.psychsport.2011.02.005; Hosseini SA, 2010, PROCD SOC BEHV, V5, P633, DOI 10.1016/j.sbspro.2010.07.156; Hulteen RM, 2017, PREV MED, V95, P14, DOI 10.1016/j.ypmed.2016.11.027; Kozlovskaia M, 2019, HEALTH PROMOT J AUST, V30, P172, DOI 10.1002/hpja.30; Linton L, 2018, J SCI MED SPORT, V21, P1221, DOI 10.1016/j.jsams.2018.05.021; Llopis D, 2006, CULT CIENC DEPORTE, V2, P33, DOI DOI 10.12800/CCD.V2I4.168; Markland D, 2004, J SPORT EXERCISE PSY, V26, P191, DOI 10.1123/jsep.26.2.191; Mazyarkin Z, 2019, J PSYCHIATR RES, V113, P10, DOI 10.1016/j.jpsychires.2019.03.002; McGregor AH, 2017, CHIN J TRAUMATOL, V20, P63, DOI 10.1016/j.cjtee.2016.11.005; Morgan PBC, 2015, PSYCHOL SPORT EXERC, V16, P91, DOI 10.1016/j.psychsport.2014.08.007; Morgan PBC, 2013, PSYCHOL SPORT EXERC, V14, P549, DOI 10.1016/j.psychsport.2013.01.004; Pucci GCMF, 2012, REV SAUDE PUBL, V46, P166, DOI 10.1590/S0034-89102012000100021; Alberdi AM, 2018, APUNT EDUC FIS DEPOR, P34, DOI 10.5672/apunts.2014-0983.es.(2018/1).131.03; Notario-Pacheco B, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-63; Nwachukwu BU, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119845313; Oja P, 2017, BRIT J SPORT MED, V51, P812, DOI 10.1136/bjsports-2016-096822; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; Pedro S. D., 2018, Cuadernos de Psicologia del Deporte, V18, P151; Penichet-Tomas A, 2012, J HUM SPORT EXERC, V7, P648, DOI 10.4100/jhse.2012.73.05; Quesada JIP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211197; Ruiz-Juan F, 2014, REV LAT AM PSICOL, V46, P1; Sarkar M, 2014, J SPORT SCI, V32, P1419, DOI 10.1080/02640414.2014.901551; Scheerder J, 2015, RUNNING EUROPE RISE, DOI [10.1057/9781137446374, DOI 10.1057/9781137446374]; Secades G., 2017, CUAD PSICOL DEPORT, V17, P73; Smigelskas K, 2019, ZDRAV VARST, V58, P1, DOI 10.2478/sjph-2019-0001; van der Worp MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114937; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; Wagstaff C, 2018, SPORT PSYCHOL, V32, P178, DOI 10.1123/tsp.2016-0068; Wilson PM, 2006, J APPL BIOBEHAV RES, V11, P79, DOI 10.1111/j.1751-9861.2006.tb00021.x; Zurita Ortega F., 2014, CPD, V14, P81; Zurita-Ortega F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207860; Zurita-Ortega F, 2016, ARCH BUDO, V12, P201	54	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0231628	10.1371/journal.pone.0231628	http://dx.doi.org/10.1371/journal.pone.0231628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0RD	32392229	Green Published, gold			2022-12-26	WOS:000537470300002
J	Yagi, N; Aoyama, K; Ohta, N				Yagi, Naoto; Aoyama, Koki; Ohta, Noboru			Microbeam X-ray diffraction study of lipid structure in stratum corneum of human skin	PLOS ONE			English	Article							EPIDERMAL PERMEABILITY BARRIER; MOLECULAR-MODELS; ORGANIZATION; LAMELLAE; MICROSCOPY	Human skin, not previously frozen, was studied by small-angle X-ray diffraction. The samples were folded so that a 6 mu m X-ray beam passed through the top layer of skin, stratum corneum. Diffraction patterns recorded with this method consisted of peaks at about q = 0.5, 1.0 and 1.4 nm(-1) in the direction perpendicular to the skin surface more clearly than in previous studies. These peaks are interpreted to arise from lipids between corneocytes. A simple unit of a linear electron density profile with three minima was used to account for the observed intensity profiles. Combinations of calculated diffraction from models with one, two and three units accounted for the major part of the observed diffraction pattern, showing the diversity in the structure of the intercellular lipids.	[Yagi, Naoto; Aoyama, Koki; Ohta, Noboru] SPring 8, Japan Synchrotron Radiat Res Inst, Sayo, Hyogo, Japan	Japan Synchrotron Radiation Research Institute	Yagi, N (corresponding author), SPring 8, Japan Synchrotron Radiat Res Inst, Sayo, Hyogo, Japan.	yagi@spring8.or.jp		Yagi, Naoto/0000-0003-1792-2733	JST CREST, Japan [JPMJCR1521]	JST CREST, Japan(Core Research for Evolutional Science and Technology (CREST))	This work was supported by JST CREST Grant Number JPMJCR1521, Japan.	Al-Amoudi A, 2005, J INVEST DERMATOL, V124, P764, DOI 10.1111/j.0022-202X.2005.23630.x; AMEMIYA Y, 1995, REV SCI INSTRUM, V66, P2290, DOI 10.1063/1.1145667; BOUWSTRA JA, 1995, J LIPID RES, V36, P496; Bouwstra JA, 1997, BIOCHEMISTRY-US, V36, P7717, DOI 10.1021/bi9628127; BOUWSTRA JA, 1994, BBA-LIPID LIPID MET, V1212, P183, DOI 10.1016/0005-2760(94)90252-6; BOUWSTRA JA, 1991, J INVEST DERMATOL, V97, P1005, DOI 10.1111/1523-1747.ep12492217; BOUWSTRA JA, 1995, J LIPID RES, V36, P685; Doucet J, 2014, J LIPID RES, V55, P2380, DOI 10.1194/jlr.M053389; Groen D, 2009, BIOPHYS J, V97, P2242, DOI 10.1016/j.bpj.2009.07.040; Hatta I, 2006, BBA-BIOMEMBRANES, V1758, P1830, DOI 10.1016/j.bbamem.2006.08.014; Hill JR, 2003, BBA-BIOMEMBRANES, V1616, P121, DOI 10.1016/S0005-2736(03)00238-4; Inoue K, 2001, NUCL INSTRUM METH A, V467, P674, DOI 10.1016/S0168-9002(01)00443-0; Iwai I, 2012, J INVEST DERMATOL, V132, P2215, DOI 10.1038/jid.2012.43; LANDMANN L, 1986, J INVEST DERMATOL, V87, P202, DOI 10.1111/1523-1747.ep12695343; MADISON KC, 1987, J INVEST DERMATOL, V88, P714, DOI 10.1111/1523-1747.ep12470386; Nakagawa N, 2012, J DERMATOL SCI, V65, P196, DOI 10.1016/j.jdermsci.2011.12.011; Norlen L., 2006, International Journal of Cosmetic Science, V28, P397, DOI 10.1111/j.1467-2494.2006.00345.x; Ohta N, 2005, J APPL CRYSTALLOGR, V38, P274, DOI 10.1107/S002188980403403X; Schreiner V, 2000, J INVEST DERMATOL, V114, P654, DOI 10.1046/j.1523-1747.2000.00941.x; SWARTZENDRUBER DC, 1987, J INVEST DERMATOL, V88, P709, DOI 10.1111/1523-1747.ep12470383; SWARTZENDRUBER DC, 1989, J INVEST DERMATOL, V92, P251, DOI 10.1111/1523-1747.ep12276794; Vicanova J, 1998, J Investig Dermatol Symp Proc, V3, P114	22	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0233131	10.1371/journal.pone.0233131	http://dx.doi.org/10.1371/journal.pone.0233131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392265	Green Published, gold			2022-12-26	WOS:000537470300039
J	Roseman, GP; Wu, B; Wadolkowski, MA; Harris, DA; Millhauser, GL				Roseman, Graham P.; Wu, Bei; Wadolkowski, Mark A.; Harris, David A.; Millhauser, Glenn L.			Intrinsic toxicity of the cellular prion protein is regulated by its conserved central region	FASEB JOURNAL			English	Article						cellular studies; electrophysiology; neurodeneration; nuclear magnetic resonance; prion	ALPHA-CLEAVAGE; OCTAREPEAT DOMAIN; FULL-LENGTH; COPPER; PRP; DISEASE; COORDINATION; EXPRESSION; MECHANISM; RECEPTOR	The conserved central region (CR) of PrP (c) has been hypothesized to serve as a passive linker connecting the protein's toxic N-terminal and globular C-terminal domains. Yet, deletion of the CR causes neonatal fatality in mice, implying the CR possesses a protective function. The CR encompasses the regulatory alpha-cleavage locus, and additionally facilitates a regulatory metal ion-promoted interaction between the PrP (c) N- and C-terminal domains. To elucidate the role of the CR and determine why CR deletion generates toxicity, we designed PrP (c) constructs wherein either the cis-interaction or alpha-cleavage are selectively prevented. These constructs were interrogated using nuclear magnetic resonance, electrophysiology, and cell viability assays. Our results demonstrate the CR is not a passive linker and the native sequence is crucial for its protective role over the toxic N-terminus, irrespective of alpha-cleavage or the cis-interaction. Additionally, we find that the CR facilitates homodimerization of PrP (c), attenuating the toxicity of the N-terminus.	[Roseman, Graham P.; Wadolkowski, Mark A.; Millhauser, Glenn L.] Univ Calif Santa Cruz, Dept Chem & Biochem, 1156 High St,Phys Sci Bldg 265, Santa Cruz, CA 95060 USA; [Wu, Bei; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K,Room K206, Boston, MA 02118 USA	University of California System; University of California Santa Cruz; Boston University	Millhauser, GL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, 1156 High St,Phys Sci Bldg 265, Santa Cruz, CA 95060 USA.; Harris, DA (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K,Room K206, Boston, MA 02118 USA.	daharris@bu.edu; glennm@ucsc.edu		Millhauser, Glenn/0000-0003-2442-7220	NIH [R35 GM131781, S10 OD024980, S10 OD018455, R01 NS065244]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: R35 GM131781, S10 OD024980, S10 OD018455 and R01 NS065244	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aronoff-Spencer E, 2000, BIOCHEMISTRY-US, V39, P13760, DOI 10.1021/bi001472t; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Biasini E, 2013, J NEUROSCI, V33, P2408, DOI 10.1523/JNEUROSCI.3406-12.2013; Biasini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033472; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; Chattopadhyay M, 2005, J AM CHEM SOC, V127, P12647, DOI 10.1021/ja053254z; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Christensen HM, 2010, AM J PATHOL, V176, P2695, DOI 10.2353/ajpath.2010.091007; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Coleman BM, 2014, J VIROL, V88, P2690, DOI 10.1128/JVI.02720-13; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collins S, 2001, J CLIN NEUROSCI, V8, P387, DOI 10.1054/jocn.2001.0919; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Evans EGB, 2017, PROG MOL BIOL TRANSL, V150, P35, DOI 10.1016/bs.pmbts.2017.06.005; Evans EGB, 2016, STRUCTURE, V24, P1057, DOI 10.1016/j.str.2016.04.017; Fioriti L, 2005, MOL CELL NEUROSCI, V28, P165, DOI 10.1016/j.mcn.2004.09.006; Gasperini L, 2015, ANTIOXID REDOX SIGN, V22, P772, DOI 10.1089/ars.2014.6032; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goniotaki D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006733; Herrmann US, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004662; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; KITAMOTO T, 1986, ANN NEUROL, V20, P204, DOI 10.1002/ana.410200205; Kuffer A, 2016, NATURE, V536, P464, DOI 10.1038/nature19312; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Liang JJ, 2012, PRION, V6, DOI 10.4161/pri.22511; Liang JJ, 2012, J BIOL CHEM, V287, P16510, DOI 10.1074/jbc.M112.360891; Markham KA, 2019, BIOPHYS J, V116, P610, DOI 10.1016/j.bpj.2019.01.005; Martinez J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13623; Massignan T, 2011, METHODS, V53, P214, DOI 10.1016/j.ymeth.2010.11.005; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; MASTERS CL, 1981, BRAIN, V104, P559, DOI 10.1093/brain/104.3.559; McDonald AJ, 2019, STRUCTURE, V27, P907, DOI 10.1016/j.str.2019.03.008; McDonald AJ, 2017, PRION, V11, P388, DOI 10.1080/19336896.2017.1384894; McDonald AJ, 2014, PRION, V8, P183, DOI 10.4161/pri.28796; McDonald AJ, 2014, J BIOL CHEM, V289, P803, DOI 10.1074/jbc.M113.502351; Mehrabian M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114594; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Oliveira-Martins JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009107; Peralta OA, 2009, PRION, V3, P161, DOI 10.4161/pri.3.3.9772; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Pushie MJ, 2011, METALLOMICS, V3, P206, DOI 10.1039/c0mt00037j; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Sangeetham SB, 2018, J MOL BIOL, V430, P2784, DOI 10.1016/j.jmb.2018.05.027; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solomon IH, 2012, PRION, V6, P40, DOI 10.4161/pri.6.1.18627; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Spevacek AR, 2013, STRUCTURE, V21, P236, DOI 10.1016/j.str.2012.12.002; Stys PK, 2012, J PHYSIOL-LONDON, V590, P1357, DOI 10.1113/jphysiol.2011.225276; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Turnbaugh JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025675; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Walter ED, 2007, J AM CHEM SOC, V129, P15440, DOI 10.1021/ja077146j; Watt NT, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00041; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011; Wu B, 2017, ELIFE, V6, DOI 10.7554/eLife.23473; Wusten KA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32581-1; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Yusa S, 2012, VIRUSES-BASEL, V4, P3109, DOI 10.3390/v4113109	72	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8734	8748		10.1096/fj.201902749RR	http://dx.doi.org/10.1096/fj.201902749RR		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32385908	Green Accepted			2022-12-26	WOS:000532114000001
J	Wu, PT; Rybin, D; Bielak, LF; Feitosa, MF; Franceschini, N; Li, YZ; Lu, YC; Marten, J; Musani, SK; Noordam, R; Raghavan, S; Rose, LM; Schwander, K; Smith, AV; Tajuddin, SM; Vojinovic, D; Amin, N; Arnett, DK; Bottinger, EP; Demirkan, A; Florez, JC; Ghanbari, M; Harris, TB; Launer, LJ; Liu, JM; Liu, J; Mook-Kanamori, DO; Murray, AD; Nalls, MA; Peyser, PA; Uitterlinden, AG; Voortman, T; Bouchard, C; Chasman, D; Correa, A; de Mutsert, R; Evans, MK; Gudnason, V; Hayward, C; Kao, LD; Kardia, SLR; Kooperberg, C; Loos, RJF; Province, MM; Rankinen, T; Redline, S; Ridker, PM; Rotter, JI; Siscovick, D; Smith, BH; van Duijn, C; Zonderman, AB; Rao, DC; Wilson, JG; Dupuis, J; Meigs, JB; Liu, CT; Vassy, JL				Wu, Peitao; Rybin, Denis; Bielak, Lawrence F.; Feitosa, Mary F.; Franceschini, Nora; Li, Yize; Lu, Yingchang; Marten, Jonathan; Musani, Solomon K.; Noordam, Raymond; Raghavan, Sridharan; Rose, Lynda M.; Schwander, Karen; Smith, Albert, V; Tajuddin, Salman M.; Vojinovic, Dina; Amin, Najaf; Arnett, Donna K.; Bottinger, Erwin P.; Demirkan, Ayse; Florez, Jose C.; Ghanbari, Mohsen; Harris, Tamara B.; Launer, Lenore J.; Liu, Jingmin; Liu, Jun; Mook-Kanamori, Dennis O.; Murray, Alison D.; Nalls, Mike A.; Peyser, Patricia A.; Uitterlinden, Andre G.; Voortman, Trudy; Bouchard, Claude; Chasman, Daniel; Correa, Adolfo; de Mutsert, Renee; Evans, Michele K.; Gudnason, Vilmundur; Hayward, Caroline; Kao, Linda; Kardia, Sharon L. R.; Kooperberg, Charles; Loos, Ruth J. F.; Province, Michael M.; Rankinen, Tuomo; Redline, Susan; Ridker, Paul M.; Rotter, Jerome, I; Siscovick, David; Smith, Blair H.; van Duijn, Cornelia; Zonderman, Alan B.; Rao, D. C.; Wilson, James G.; Dupuis, Josee; Meigs, James B.; Liu, Ching-Ti; Vassy, Jason L.			Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RESISTANCE; GENETIC-VARIANTS; CIGARETTE-SMOKING; COMMON VARIANTS; BODY-FAT; LOCI; NICOTINE; INSIGHTS; DISEASE	Smoking is a potentially causal behavioral risk factor for type 2 diabetes (T2D), but not all smokers develop T2D. It is unknown whether genetic factors partially explain this variation. We performed genome-environment-wide interaction studies to identify loci exhibiting potential interaction with baseline smoking status (ever vs. never) on incident T2D and fasting glucose (FG). Analyses were performed in participants of European (EA) and African ancestry (AA) separately. Discovery analyses were conducted using genotype data from the 50,000-single-nucleotide polymorphism (SNP) ITMAT-Broad-CARe (IBC) array in 5 cohorts from from the Candidate Gene Association Resource Consortium (n = 23,189). Replication was performed in up to 16 studies from the Cohorts for Heart Aging Research in Genomic Epidemiology Consortium (n = 74,584). In meta-analysis of discovery and replication estimates, 5 SNPs met at least one criterion for potential interaction with smoking on incident T2D at p< 1x10(-7) (adjusted for multiple hypothesis-testing with the IBC array). Two SNPs had significant joint effects in the overall model and significant main effects only in one smoking stratum: rs140637 (FBN1) in AA individuals had a significant main effect only among smokers, and rs1444261 (closest gene C2orf63) in EA individuals had a significant main effect only among nonsmokers. Three additional SNPs were identified as having potential interaction by exhibiting a significant main effects only in smokers: rs1801232 (CUBN) in AA individuals, rs12243326 (TCF7L2) in EA individuals, and rs4132670 (TCF7L2) in EA individuals. No SNP met significance for potential interaction with smoking on baseline FG. The identification of these loci provides evidence for genetic interactions with smoking exposure that may explain some of the heterogeneity in the association between smoking and T2D.	[Wu, Peitao; Rybin, Denis; Dupuis, Josee; Liu, Ching-Ti] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Bielak, Lawrence F.; Peyser, Patricia A.; Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Feitosa, Mary F.; Province, Michael M.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA; [Franceschini, Nora] Univ N Carolina, Chapel Hill, NC 27515 USA; [Li, Yize; Schwander, Karen; Rao, D. C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Lu, Yingchang; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Marten, Jonathan; Hayward, Caroline] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Musani, Solomon K.] Univ Mississippi, Med Ctr, Jackson Heart Study, University, MS 38677 USA; [Noordam, Raymond] Leiden Univ, Dept Internal Med, Sect Gerontol & Geriatr, Med Ctr, Leiden, Netherlands; [Raghavan, Sridharan] Vet Affairs Eastern Colorado Healthcare Syst, Sect Hosp Med, Denver, CO USA; [Raghavan, Sridharan] Univ Colorado, Sch Med, Div Gen Internal Med, Aurora, CO USA; [Raghavan, Sridharan] Colorado Cardiovasc Outcomes Res Consortium, Aurora, CO USA; [Rose, Lynda M.; Chasman, Daniel; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Smith, Albert, V; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert, V] Univ Iceland, Fac Med, Reykjavik, Iceland; [Tajuddin, Salman M.; Evans, Michele K.; Zonderman, Alan B.] NIA, Lab Epidemiol & Populat Sci, NIH, Baltimore, MD 21224 USA; [Vojinovic, Dina; Amin, Najaf; Demirkan, Ayse; Ghanbari, Mohsen; Liu, Jun; Voortman, Trudy; van Duijn, Cornelia] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Arnett, Donna K.] Univ Kentucky, Coll Publ Hlth, Deans Off, Lexington, KY USA; [Florez, Jose C.] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Florez, Jose C.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Florez, Jose C.; Meigs, James B.] Broad Inst, Programs Metab & Med & Populat Genet, Cambridge, MA USA; [Florez, Jose C.; Meigs, James B.; Vassy, Jason L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Ghanbari, Mohsen; Chasman, Daniel] Mashhad Univ Med Sci, Sch Med, Dept Genet, Mashhad, Razavi Khorasan, Iran; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Liu, Jingmin; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Mook-Kanamori, Dennis O.; de Mutsert, Renee] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [Mook-Kanamori, Dennis O.] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [Murray, Alison D.] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Inst Med Sci, Aberdeen, Scotland; [Nalls, Mike A.] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Nalls, Mike A.] Data Tecn Int LLC, Glen Echo, MD USA; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Bouchard, Claude; Rankinen, Tuomo] Louisiana State Univ Syst, Human Genom Lab, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Redline, Susan; Ridker, Paul M.] Harvard Med Sch, Boston, MA 02115 USA; [Correa, Adolfo; Wilson, James G.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Kao, Linda] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kao, Linda] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Kao, Linda] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Loos, Ruth J. F.] Ichan Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY USA; [Redline, Susan] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Redline, Susan] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Rotter, Jerome, I] Harbor UCLA Med Ctr, Dept Pediat, Inst Translat Genom & Populat Sci, Lundquist Inst Biomed Innovat, Torrance, CA 90509 USA; [Siscovick, David] New York Acad Med, New York, NY USA; [Smith, Blair H.] Univ Dundee, Div Populat Hlth & Genom, Dundee, Scotland; [Dupuis, Josee] NHLBI, Framingham Heart Study, Framingham, MA USA; [Meigs, James B.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Vassy, Jason L.] VA Boston Healthcare Syst, Boston, MA 02130 USA	Boston University; University of Michigan System; University of Michigan; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; University of Edinburgh; University of Mississippi; University of Mississippi Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Erasmus University Rotterdam; Erasmus MC; University of Kentucky; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Mashhad University Medical Science; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Fred Hutchinson Cancer Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Aberdeen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Erasmus University Rotterdam; Erasmus MC; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Harvard University; Harvard Medical School; University of Mississippi; University of Mississippi Medical Center; University of Iceland; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; New York Academy of Medicine; University of Dundee; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Wu, PT; Liu, CT (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.; Vassy, JL (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Vassy, JL (corresponding author), VA Boston Healthcare Syst, Boston, MA 02130 USA.	peitaowu@bu.edu; ctliu@bu.edu; jvassy@partners.org	Smith, Blair H/G-2834-2012; Li, Yize/ABB-9226-2021; Rotter, Jerome/AAY-6598-2021; Li, Yize/HCI-9317-2022; Loos, Ruth/GON-5877-2022; Smith, Albert Vernon/AHC-3838-2022; Bouchard, Claude/AAE-2035-2019; Bouchard, Claude/A-7637-2009; Ghanbari, Mohsen/AAH-1340-2020; Voortman, Trudy/C-2963-2015; Loos, Ruth/Q-2862-2016; Gudnason, Vilmundur/K-6885-2015	Smith, Blair H/0000-0002-5362-9430; Li, Yize/0000-0003-1074-281X; Smith, Albert Vernon/0000-0003-1942-5845; Bouchard, Claude/0000-0002-0048-491X; Ghanbari, Mohsen/0000-0002-9476-7143; Liu, Jun/0000-0001-5288-3042; Voortman, Trudy/0000-0003-2830-6813; Loos, Ruth/0000-0002-8532-5087; Van Duijn, Cornelia/0000-0002-2374-9204; Tajuddin, Salman M./0000-0002-7919-8528; Gudnason, Vilmundur/0000-0001-5696-0084; Noordam, Raymond/0000-0001-7801-809X; Murray, Alison/0000-0003-4915-4847	National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; WHI [R21 HL123677, R56 DK104806, R01 MD012765]; NHLBI [R01HL118305, R01HL117078, HL54471, HL54472, HL54473, HL54495, HL54496, HL54497, HL54509, HL54515, 2 R01 HL55673-12]; NIDDK [5R01DK07568102, 5R01DK089256, K24 DK080140]; Intramural Research Program of the National Institute on Aging, National Institutes of Health [Z01-AG000513, 09-AGN248]; National Heart, Lung and Blood Institute of the National Institutes of Health [HL119443, HL087660, HL054464, HL054457, HL054481]; Netherlands Organisation of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) Netherlands Consortium for Healthy Aging (NCHA) [050-060-810]; European Commission FP6 STRP grant [018947 (LSHG-CT-2006-01947)]; European Community's Seventh Framework Programme (FP7/2007-2013)/grant by the European Commission under the programme "Quality of Life and Management of the Living Resources" of 5th Framework Programme [HEALTH-F4-2007-201413, QLG2-CT-2002-01254]; ENGAGE consortium; CMSB; Netherlands Organisation for Scientific Research [NWORFBR 047.017.043]; Russian Foundation for Basic Research [NWORFBR 047.017.043]; ZonMw grant [91111025]; National Heart, Lung and Blood Institute [N01-HC25195, N02-HL-6-4278]; National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK078616]; Doris Duke Charitable Foundation Clinical Scientist Development Award; National Heart, Lung, and Blood Institute [HL-45670]; National Heart, Lung, and Blood Instutute [HL043851, HL080467]; National Cancer Institute [CA047988, UM1CA182913]; National Heart, Lung, and Blood Institute under ARRA funding [HL099355]; NIH [N01-AG-1-2100, 271201200022C, R01DK110113, U01HG007417, R01DK101855, R01DK107786]; MRC University Unit Programme Grant [MC_UU_00007/10]; Chief Scientist Office of the Scottish Government Health Directorate [CZD/16/6]; Scottish Funding Council [HR03006]; Wellcome Trust [104036/Z/14/Z]; UK's Medical Research Council; National Heart, Lung, and Blood Institute (NHLBI) [NIDDK K24 DK110550]; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; Andrea and Charles Bronfman Philanthropies; Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Genetic Laboratory of the Department of Internal Medicine, Erasmus MC; NIA Intramural Research Program; Hjartavernd (Icelandic Heart 21 Association); Althingi (Icelandic Parliament);  [75N92020D00001];  [HHSN268201500003I];  [N01-HC-95159];  [75N92020D00005];  [N01-HC-95160];  [75N92020D00002];  [N01-HC-95161];  [75N92020D00003];  [N01-HC-95162];  [75N92020D00006];  [N01-HC-95163];  [75N92020D00004];  [N01-HC-95164];  [75N92020D00007];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC-95169];  [UL1-TR-000040];  [UL1-TR-001079];  [UL1-TR-001420];  [UL1-TR-001881];  [DK063491]; MRC [MC_UU_00007/10] Funding Source: UKRI	National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WHI; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Netherlands Organisation of Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) Netherlands Consortium for Healthy Aging (NCHA)(Netherlands Organization for Scientific Research (NWO)); European Commission FP6 STRP grant; European Community's Seventh Framework Programme (FP7/2007-2013)/grant by the European Commission under the programme "Quality of Life and Management of the Living Resources" of 5th Framework Programme; ENGAGE consortium; CMSB; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); ZonMw grant; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Instutute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute under ARRA funding; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC University Unit Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government Health Directorate; Scottish Funding Council; Wellcome Trust(Wellcome Trust); UK's Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; Andrea and Charles Bronfman Philanthropies; Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Genetic Laboratory of the Department of Internal Medicine, Erasmus MC; NIA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hjartavernd (Icelandic Heart 21 Association); Althingi (Icelandic Parliament); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts HHSN268201100046C, HSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. The grant funding of WHI are R21 HL123677, R56 DK104806 and R01 MD012765 to NF. The FamHS was funded by R01HL118305 and R01HL117078 NHLBI grants, and 5R01DK07568102 and 5R01DK089256 NIDDK grant."and "The Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health (project #Z01-AG000513 and human subjects protocol number 09-AGN248). Support for GENOA was provided by the National Heart, Lung and Blood Institute (HL119443, HL087660, HL054464, HL054457, and HL054481) of the National Institutes of Health. Ruth loos is supported by the NIH (R01DK110113, U01HG007417, R01DK101855, R01DK107786). The Rotterdam Study GWAS datasets are supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), and the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) Netherlands Consortium for Healthy Aging (NCHA), project nr. 050-060-810. The ERF study as a part of EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947) and also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F4-2007-201413 by the European Commission under the programme "Quality of Life and Management of the Living Resources" of 5th Framework Programme (no. QLG2-CT-2002-01254). The ERF study was further supported by ENGAGE consortium and CMSB. Highthroughput analysis of the ERF data was supported by joint grant from Netherlands Organisation for Scientific Research and the Russian Foundation for Basic Research (NWORFBR 047.017.043).ERF was further supported by the ZonMw grant (project 91111025), and this work was partially supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (Contract No. N01-HC25195) and its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278). This study is also supported by National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) R01 DK078616 to Drs. Meigs, Dupuis and Florez, NIDDK K24 DK080140 to Dr. Meigs, and a Doris Duke Charitable Foundation Clinical Scientist Development Award to Dr. Florez. The HERITAGE Family Study was supported by National Heart, Lung, and Blood Institute grant HL-45670. The Women's Genome Health Study is supported by the National Heart, Lung, and Blood Instutute (HL043851 and HL080467) and the National Cancer Institute (CA047988 and UM1CA182913). Additional support for endpoint collection was provided by the National Heart, Lung, and Blood Institute under ARRA funding (HL099355). HyperGEN (Hypertension Genetic Epidemiology Network): The hypertension network is funded by cooperative agreements (U10) with NHLBI: HL54471, HL54472, HL54473, HL54495, HL54496, HL54497, HL54509, HL54515, and 2 R01 HL55673-12. The AGES study has been funded by NIH contracts N01-AG-1-2100 and 271201200022C.; Caroline Hayward is supported by an MRC University Unit Programme Grant MC_UU_00007/10 (QTL in Health and Disease)"and "Generation Scotland received core funding from the Chief Scientist Office of the Scottish Government Health Directorate CZD/16/6, the Scottish Funding Council HR03006 and the Wellcome Trust through a Strategic Award (reference 104036/Z/14/Z) for Stratifying Resilience and Depression Longitudinally (STRADL). Genotyping was funded by the UK's Medical Research Council. Jose C. Florez, NIDDK K24 DK110550 The MESA project is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts 75N92020D00001, HHSN268201500003I, N01-HC-95159, 75N92020D00005, N01-HC-95160, 75N92020D00002, N01-HC-95161, 75N92020D00003, N01-HC-95162, 75N92020D00006, N01-HC-95163, 75N92020D00004, N01-HC-95164, 75N92020D00007, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, UL1-TR-001881, and DK063491. Additionally, one or more authors are affiliated with the following commercial entities: Interleukin Genetics, GlaxoSmithKline, Daiichi-Sankyo, AstraZeneca, Data Tecnica International LLC, Illumina Inc., University of California Healthcare, Janssen Pharmaceuticals, Goldfinch Bio, and Novo Nordisk. Please see the Competing Interests Statement for additional details. The funders provided support in the form of salaries for authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center.; The Mount Sinai IPM Biobank Program is supported by The Andrea and Charles Bronfman Philanthropies.; The Rotterdam Study is supported by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam.The authors are grateful to the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. The generation and management of GWAS genotype data for the Rotterdam Study (RS I, RS II, RS III) was executed by the Human Genotyping Facility of the Genetic 20 Laboratory of the Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands. The GWAS datasets are additionally supported by the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC. We thank Pascal Arp, Mila Jhamai, Marijn Verkerk, Lizbeth Herrera and Marjolein Peters, MSc, and Carolina Medina-Gomez, MSc, for their help in creating the GWAS database, and Karol Estrada, PhD, Yurii Aulchenko, PhD, and Carolina MedinaGomez, MSc, for the creation and analysis of imputed data.; The ERF study as a part of EUROSPAN (European Special Populations Research Network) was additionally supported by ENGAGE consortium and CMSB. We are grateful to all study participants and their relatives, general practitioners and neurologists for their contributions and to P. Veraart for her help in genealogy, J. Vergeer for the supervision of the laboratory work, P. Snijders for his help in data collection and E.M. van Leeuwen for genetic imputation.; The AGES study is additionally supported by the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart 21 Association), and the Althingi (the Icelandic Parliament).	[Anonymous], 2017, WHO REPORT GLOBAL TO; Aseem O, 2014, J AM SOC NEPHROL, V25, P1028, DOI 10.1681/ASN.2013060671; Assali AR, 1999, CLIN CARDIOL, V22, P357, DOI 10.1002/clc.4960220512; ATTVALL S, 1993, J INTERN MED, V233, P327, DOI 10.1111/j.1365-2796.1993.tb00680.x; Axelsson T, 2001, J INTERN MED, V249, P539, DOI 10.1046/j.1365-2796.2001.00840.x; Basson J, 2014, AM J HYPERTENS, V27, P431, DOI [10.1093/ajh/hpu149, 10.1093/ajh/hpt283]; Boger CA, 2011, KIDNEY BLOOD PRESS R, V34, P225, DOI 10.1159/000326901; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bruin JE, 2008, TOXICOL SCI, V103, P362, DOI 10.1093/toxsci/kfn012; Bruin JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003371; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Centers for Disease Control and Prevention (CDC), 2017, NAT DIAB STAT REP 20; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; Cooke JN, 2012, DIABETES CARE, V35, P287, DOI 10.2337/dc11-0957; CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; David SP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.41; Dokken BB, 2008, AM J PHYSIOL-ENDOC M, V294, pE615, DOI 10.1152/ajpendo.00578.2007; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Erzurumluoglu AM, 2020, MOL PSYCHIATR, V25, P2392, DOI 10.1038/s41380-018-0313-0; Fall T, 2015, DIABETES, V64, P2676, DOI 10.2337/db14-1710; Fels J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102379; Flannick J, 2019, NATURE, V570, P71, DOI 10.1038/s41586-019-1231-2; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Florez JC, 2017, DIABETOLOGIA, V60, P800, DOI 10.1007/s00125-017-4227-1; FRIEDMAN AJ, 1987, FERTIL STERIL, V47, P398; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grasbeck R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-17; Haase CL, 2015, DIABETES, V64, P3328, DOI 10.2337/db14-1603; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; HOFSTETTER A, 1986, NEW ENGL J MED, V314, P79, DOI 10.1056/NEJM198601093140204; Justice AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14977; Jyothi KU, 2015, META GENE, V5, P9, DOI 10.1016/j.mgene.2015.05.001; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; KLESGES RC, 1990, AM J CLIN NUTR, V51, P784, DOI 10.1093/ajcn/51.5.784; Ley SH, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-1; Liu CT, 2012, DIABETOLOGIA, V55, P2970, DOI 10.1007/s00125-012-2656-4; Liu CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002264; Liu MZ, 2019, NAT GENET, V51, P237, DOI 10.1038/s41588-018-0307-5; Liu T, 2011, EUR J ENDOCRINOL, V165, P961, DOI 10.1530/EJE-11-0596; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marott SCW, 2016, J CLIN ENDOCR METAB, V101, P3212, DOI 10.1210/jc.2015-3777; McMahon GM, 2014, NEPHROL DIAL TRANSPL, V29, P342, DOI 10.1093/ndt/gft386; Meigs JB, 1998, ANN INTERN MED, V128, P524, DOI 10.7326/0003-4819-128-7-199804010-00002; Moen GH, 2018, AM J CLIN NUTR, V108, P398, DOI 10.1093/ajcn/nqy101; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Nakanishi N, 2000, ANN INTERN MED, V133, P183, DOI 10.7326/0003-4819-133-3-200008010-00009; Nowak D, 1996, EUR RESPIR J, V9, P652, DOI 10.1183/09031936.96.09040652; Onat A, 2011, CLIN BIOCHEM, V44, P391, DOI 10.1016/j.clinbiochem.2010.12.009; Rafalson L, 2009, ANN EPIDEMIOL, V19, P365, DOI 10.1016/j.annepidem.2009.01.013; Rao DC, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001649; Schafer SA, 2007, DIABETOLOGIA, V50, P2443, DOI 10.1007/s00125-007-0753-6; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Serdula MK, 1996, EPIDEMIOLOGY, V7, P161, DOI 10.1097/00001648-199603000-00010; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Tatebe J, 2011, HORM METAB RES, V43, P11, DOI 10.1055/s-0030-1267996; Thompson R. L., 1992, Nutrition Research Reviews, V5, P131, DOI 10.1079/NRR19920011; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; White J, 2016, JAMA CARDIOL, V1, P692, DOI 10.1001/jamacardio.2016.1884; WHO, 2016, GLOB REP PSOR; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Yang JY, 2012, DIABETES, V61, P1888, DOI 10.2337/db11-1393; Yoon D, 2012, HUM GENET, V131, P1009, DOI 10.1007/s00439-011-1102-x; Yoshikawa H, 2005, METABOLISM, V54, P247, DOI 10.1016/j.metabol.2004.08.020; Zheng JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077442	78	6	6	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0230815	10.1371/journal.pone.0230815	http://dx.doi.org/10.1371/journal.pone.0230815			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379818	Green Published, gold			2022-12-26	WOS:000537285700010
J	Masin, J; Osickova, A; Jurnecka, D; Klimova, N; Khaliq, H; Sebo, P; Osicka, R				Masin, Jiri; Osickova, Adriana; Jurnecka, David; Klimova, Nela; Khaliq, Humaira; Sebo, Peter; Osicka, Radim			Retargeting from the CR3 to the LFA-1 receptor uncovers the adenylyl cyclase enzyme-translocating segment of Bordetella adenylate cyclase toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AC domain translocation; acylation; acyltransferase; fatty acyl; integrin; RTX toxin; complement receptor 3 (CR3; ); CyaA; HlyA; AC translocon; protein translocation; protein acylation; fatty acid; bacterial toxin; Bordetella pertussis; Escherichia coli (E; coli)	ESCHERICHIA-COLI HEMOLYSIN; PERTUSSIS CYAA-HEMOLYSIN; ALPHA-HEMOLYSIN; FATTY-ACYLATION; MEMBRANE TRANSLOCATION; COMPLEMENT RECEPTOR-3; BACILLUS-ANTHRACIS; LIPID-BILAYERS; TARGET-CELLS; RTX PROTEINS	TheBordetellaadenylate cyclase toxin-hemolysin (CyaA) and the ?-hemolysin (HlyA) ofEscherichia colibelong to the family of cytolytic pore-forming Repeats in ToXin (RTX) cytotoxins. HlyA preferentially binds the ?(L)?(2)integrin LFA-1 (CD11a/CD18) of leukocytes and can promiscuously bind and also permeabilize many other cells. CyaA bears an N-terminal adenylyl cyclase (AC) domain linked to a pore-forming RTX cytolysin (Hly) moiety, binds the complement receptor 3 (CR3, ?(M)?(2), CD11b/CD18, or Mac-1) of myeloid phagocytes, penetrates their plasma membrane, and delivers the AC enzyme into the cytosol. We constructed a set of CyaA/HlyA chimeras and show that the CyaC-acylated segment and the CR3-binding RTX domain of CyaA can be functionally replaced by the HlyC-acylated segment and the much shorter RTX domain of HlyA. Instead of binding CR3, a CyaA(1-710)/HlyA(411-1024)chimera bound the LFA-1 receptor and effectively delivered AC into Jurkat T cells. At high chimera concentrations (25 nm), the interaction with LFA-1 was not required for CyaA(1-710)/HlyA(411-1024)binding to CHO cells. However, interaction with the LFA-1 receptor strongly enhanced the specific capacity of the bound CyaA(1-710)/HlyA(411-1024)chimera to penetrate cells and deliver the AC enzyme into their cytosol. Hence, interaction of the acylated segment and/or the RTX domain of HlyA with LFA-1 promoted a productive membrane interaction of the chimera. These results help delimit residues 400?710 of CyaA as an ?AC translocon? sufficient for translocation of the AC polypeptide across the plasma membrane of target cells.	[Masin, Jiri; Osickova, Adriana; Jurnecka, David; Klimova, Nela; Khaliq, Humaira; Sebo, Peter; Osicka, Radim] Czech Acad Sci, Inst Microbiol, Prague, Czech Republic; [Osickova, Adriana; Jurnecka, David; Klimova, Nela] Charles Univ Prague, Fac Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Masin, J; Osicka, R (corresponding author), Czech Acad Sci, Inst Microbiol, Prague, Czech Republic.	masin@biomed.cas.cz; osicka@biomed.cas.cz	Masin, Jiri/H-3125-2014; Jurnečka, David/ABA-2334-2021; SEBO, Peter/N-2043-2019; Osicka, Radim/H-6776-2014; Jurnečka, David/L-7246-2017; Osickova, Adriana/H-6841-2014; SEBO, Peter/F-7423-2011	Jurnečka, David/0000-0002-1690-8908; SEBO, Peter/0000-0002-9755-7715; Osicka, Radim/0000-0003-2626-5456; Jurnečka, David/0000-0002-1690-8908; Osickova, Adriana/0000-0002-5739-1183; SEBO, Peter/0000-0002-9755-7715; Masin, Jiri/0000-0001-6258-4599; Klimova, Nela/0000-0002-9425-6386	Grant Agency of the Czech Republic [19-04607S, 18-18079S, 19-12695S, 18-20621S]; Ministry of Education, Youth and Sports of the Czech Republic [LM2018133]; Charles University project GA UK [507116]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University project GA UK	This work was supported by Grants 19-04607S (to J. M.), 18-18079S (to R. O.), 19-12695S (to R. O.), and 18-20621S (to P. S.) from the Grant Agency of the Czech Republic, Project LM2018133 (to R. O.) from the Ministry of Education, Youth and Sports of the Czech Republic, and Charles University project GA UK number 507116 (to N. K.).	Ahmad JN, 2016, CELL MICROBIOL, V18, P384, DOI 10.1111/cmi.12519; Basar T, 1999, J BIOL CHEM, V274, P10777, DOI 10.1074/jbc.274.16.10777; Basar T, 2001, J BIOL CHEM, V276, P348, DOI 10.1074/jbc.M006463200; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Basler M, 2007, J BIOL CHEM, V282, P12419, DOI 10.1074/jbc.M611226200; BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1994, J BIOL CHEM, V269, P27231; Benz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112248; BETSOU F, 1993, INFECT IMMUN, V61, P3583, DOI 10.1128/IAI.61.9.3583-3589.1993; BHAKDI S, 1989, J EXP MED, V169, P737, DOI 10.1084/jem.169.3.737; BHAKDI S, 1990, J CLIN INVEST, V85, P1746, DOI 10.1172/JCI114631; Bumba L, 2018, TOXINS, V10, DOI 10.3390/toxins10060245; Bumba L, 2016, MOL CELL, V62, P47, DOI 10.1016/j.molcel.2016.03.018; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; Cerny O, 2017, J IMMUNOL, V198, P1285, DOI 10.4049/jimmunol.1601309; Cerny O, 2015, J IMMUNOL, V194, P4901, DOI 10.4049/jimmunol.1402941; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; Cortajarena AL, 2003, J BIOL CHEM, V278, P19159, DOI 10.1074/jbc.M208552200; Cortajarena AL, 2001, J BIOL CHEM, V276, P12513, DOI 10.1074/jbc.M006792200; Dobereiner A, 1996, EUR J BIOCHEM, V240, P454, DOI 10.1111/j.1432-1033.1996.0454h.x; EHRMANN IE, 1991, FEBS LETT, V278, P79, DOI 10.1016/0014-5793(91)80088-K; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; GADEBERG OV, 1984, INFECT IMMUN, V45, P255, DOI 10.1128/IAI.45.1.255-260.1984; Gmira S, 2001, RES MICROBIOL, V152, P889, DOI 10.1016/S0923-2508(01)01272-4; Gonzalez-Bullon D, 2017, P NATL ACAD SCI USA, V114, pE6784, DOI 10.1073/pnas.1701783114; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; GORDON VM, 1989, J BIOL CHEM, V264, P14792; Gray M, 1998, J BIOL CHEM, V273, P18260, DOI 10.1074/jbc.273.29.18260; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; HACKETT M, 1995, J BIOL CHEM, V270, P20250, DOI 10.1074/jbc.270.35.20250; HANSKI E, 1989, TRENDS BIOCHEM SCI, V14, P459, DOI 10.1016/0968-0004(89)90106-0; Hasan S, 2015, FEBS LETT, V589, P374, DOI 10.1016/j.febslet.2014.12.023; Holubova J, 2012, INFECT IMMUN, V80, P1181, DOI 10.1128/IAI.05711-11; Hyland C, 2001, J BACTERIOL, V183, P5364, DOI 10.1128/JB.183.18.5364-5370.2001; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Johnsen N, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13017; Juntapremjit S, 2015, TOXICON, V106, P14, DOI 10.1016/j.toxicon.2015.09.006; Kamanova J, 2008, J IMMUNOL, V181, P5587, DOI 10.4049/jimmunol.181.8.5587; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karst JC, 2014, J BIOL CHEM, V289, P30702, DOI 10.1074/jbc.M114.580852; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; KEANE WF, 1987, AM J PATHOL, V126, P350; Khan F, 2006, ANAL CHEM, V78, P3072, DOI 10.1021/ac060184l; LADANT D, 1988, J BIOL CHEM, V263, P2612; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Lim KB, 2000, J BIOL CHEM, V275, P36698, DOI 10.1074/jbc.C000544200; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b; Masin J, 2004, BBA-BIOMEMBRANES, V1660, P144, DOI 10.1016/j.bbamem.2003.11.008; Masin J, 2018, P NATL ACAD SCI USA, V115, pE2489, DOI 10.1073/pnas.1722588115; Masin J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09575-6; Masin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29137; Masin J, 2013, INFECT IMMUN, V81, P4571, DOI 10.1128/IAI.00711-13; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Novak J, 2017, TOXINS, V9, DOI 10.3390/toxins9100300; O'Brien DP, 2019, FASEB J, V33, P10065, DOI 10.1096/fj.201802442RR; Osicka R, 2000, INFECT IMMUN, V68, P247; Osicka R, 2015, ELIFE, V4, DOI 10.7554/eLife.10766; Osickova A, 1999, J BIOL CHEM, V274, P37644; Osickova A, 2010, MOL MICROBIOL, V75, P1550, DOI 10.1111/j.1365-2958.2010.07077.x; PEARSON RD, 1987, J IMMUNOL, V139, P2749; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Powthongchin B, 2009, ARCH MICROBIOL, V191, P1, DOI 10.1007/s00203-008-0421-3; Prangkio P, 2018, PROTEIN PEPTIDE LETT, V25, P236, DOI 10.2174/0929866525666171201120456; Ristow LC, 2019, MBIO, V10, DOI 10.1128/mBio.01459-19; Ristow LC, 2016, BBA-BIOMEMBRANES, V1858, P538, DOI 10.1016/j.bbamem.2015.08.015; Roderova J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42200-2; ROGEL A, 1989, EMBO J, V8, P2755, DOI 10.1002/j.1460-2075.1989.tb08417.x; ROGEL A, 1992, J BIOL CHEM, V267, P22599; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; Schwidder M, 2019, TOXINS, V11, DOI 10.3390/toxins11090502; Sebo P, 2014, EXPERT REV VACCINES, V13, P1215, DOI 10.1586/14760584.2014.944900; Soloaga A, 1999, MOL MICROBIOL, V31, P1013, DOI 10.1046/j.1365-2958.1999.01225.x; Soloaga A, 1996, EUR J BIOCHEM, V238, P418, DOI 10.1111/j.1432-1033.1996.0418z.x; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; STANLEY P, 1994, SCIENCE, V266, P1992, DOI 10.1126/science.7801126; Subrini O, 2013, J BIOL CHEM, V288, P32585, DOI 10.1074/jbc.M113.508838; SUTTORP N, 1990, INFECT IMMUN, V58, P3796, DOI 10.1128/IAI.58.11.3796-3801.1990; SZABO G, 1994, J BIOL CHEM, V269, P22496; Valeva A, 2005, J BIOL CHEM, V280, P36657, DOI 10.1074/jbc.M507690200; Voegele A, 2019, TOXINS, V11, DOI 10.3390/toxins11020111; Voegele A, 2017, TOXINS, V9, DOI 10.3390/toxins9110369; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Wagner C, 2001, EUR J IMMUNOL, V31, P1173, DOI 10.1002/1521-4141(200104)31:4<1173::AID-IMMU1173>3.0.CO;2-9; Wald T, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw008; Wang XZ, 2017, BIOCHEMISTRY-US, V56, P1324, DOI 10.1021/acs.biochem.6b01163; Wang XZ, 2015, J BIOL CHEM, V290, P3576, DOI 10.1074/jbc.M114.585281; Westrop G, 1997, J BACTERIOL, V179, P871, DOI 10.1128/jb.179.3.871-879.1997; Wiles TJ, 2013, FUTURE MICROBIOL, V8, P73, DOI [10.2217/fmb.12.131, 10.2217/FMB.12.131]; WOLFF J, 1980, P NATL ACAD SCI-BIOL, V77, P3841, DOI 10.1073/pnas.77.7.3841	96	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9349	9365		10.1074/jbc.RA120.013630	http://dx.doi.org/10.1074/jbc.RA120.013630			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32393579	hybrid, Green Published			2022-12-26	WOS:000552758600008
J	Wesslowski, J; Kozielewicz, P; Wang, XX; Cui, HJ; Schihada, H; Kranz, D; Karuna, MP; Levkin, P; Gross, JC; Boutros, M; Schulte, G; Davidson, G				Wesslowski, Janine; Kozielewicz, Pawel; Wang, Xianxian; Cui, Haijun; Schihada, Hannes; Kranz, Dominique; Karuna, Pradhipa M.; Levkin, Pavel; Gross, Julia Christina; Boutros, Michael; Schulte, Gunnar; Davidson, Gary			eGFP-tagged Wnt-3a enables functional analysis of Wnt trafficking and signaling and kinetic assessment of Wnt binding to full-length Frizzled	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Wnt signaling; G protein?coupled receptor (GPCR); bioluminescence resonance energy transfer (BRET); fusion protein; membrane protein; trafficking; Frizzled; ligand binding; NanoBRET; NanoBiT	SECRETION; PROTEINS; EXPRESSION; RECOGNITION; ORGANIZER; GRADIENT; PLATFORM; PATHWAY; COMPLEX; FAMILY	The Wingless/Int1 (Wnt) signaling system plays multiple, essential roles in embryonic development, tissue homeostasis, and human diseases. Although many of the underlying signaling mechanisms are becoming clearer, the binding mode, kinetics, and selectivity of 19 mammalian WNTs to their receptors of the class Frizzled (FZD(1?10)) remain obscure. Attempts to investigate Wnt-FZD interactions are hampered by the difficulties in working with Wnt proteins and their recalcitrance to epitope tagging. Here, we used a fluorescently tagged version of mouse Wnt-3a for studying Wnt-FZD interactions. We observed that the enhanced GFP (eGFP)-tagged Wnt-3a maintains properties akin to wild-type (WT) Wnt-3a in several biologically relevant contexts. The eGFP-tagged Wnt-3a was secreted in an evenness interrupted (EVI)/Wntless-dependent manner, activated Wnt/?-catenin signaling in 2D and 3D cell culture experiments, promoted axis duplication inXenopusembryos, stimulated low-density lipoprotein receptor-related protein 6 (LRP6) phosphorylation in cells, and associated with exosomes. Further, we used conditioned medium containing eGFP-Wnt-3a to visualize its binding to FZD and to quantify Wnt-FZD interactions in real time in live cells, utilizing a recently established NanoBRET-based ligand binding assay. In summary, the development of a biologically active, fluorescent Wnt-3a reported here opens up the technical possibilities to unravel the intricate biology of Wnt signaling and Wnt-receptor selectivity.	[Wesslowski, Janine; Wang, Xianxian; Cui, Haijun; Levkin, Pavel; Davidson, Gary] Karlsruhe Inst Technol KIT, Inst Biol & Chem Syst Funct Mol Syst IBCS FMS, Karlsruhe, Germany; [Kozielewicz, Pawel; Schihada, Hannes; Schulte, Gunnar] Karolinska Inst, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, Stockholm, Sweden; [Kranz, Dominique; Boutros, Michael] German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany; [Kranz, Dominique; Boutros, Michael] Heidelberg Univ, Heidelberg, Germany; [Karuna, Pradhipa M.; Gross, Julia Christina] Univ Med Ctr Goettingen, Hematol & Oncol Dev Biochem, Gottingen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Karolinska Institutet; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Gottingen	Davidson, G (corresponding author), Karlsruhe Inst Technol KIT, Inst Biol & Chem Syst Funct Mol Syst IBCS FMS, Karlsruhe, Germany.; Schulte, G (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, Stockholm, Sweden.	gary.davidson@kit.edu; gunnar.schulte@ki.se	Kozielewicz, Pawel/ABE-3624-2020; Davidson, Gary/AAA-7321-2021; Gross, Julia Christina/AAN-5730-2020; Levkin, Pavel A/E-5804-2011; Schihada, Hannes/AAB-6440-2022	Davidson, Gary/0000-0002-2264-5518; Gross, Julia Christina/0000-0002-8939-5664; Levkin, Pavel A/0000-0002-5975-948X; Kranz, Dominique/0000-0003-3604-7647; Schihada, Hannes/0000-0002-1889-1636; Boutros, Michael/0000-0002-9458-817X; Cui, Haijun/0000-0003-2065-9542; Schulte, Gunnar/0000-0002-2700-7013; Kozielewicz, Pawel/0000-0003-1414-3566	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [331351713-SFB 1324]; Karolinska Institutet [2018-01520]; Lars Hierta Memorial Foundation [FO2019-0086]; Alex and Eva Wallstrom Foundation for Scientific Research and Education [2020-00228]; Swedish Society of Medical Research [P19-0055]; China Scholar Council; KIT in the context of the Helmholtz program BioInterfaces in Technology and Medicine (BIFTM); Deutsche Forschungsgemeinschaft (DFG) [427840891]; Swedish Research Council [2017-04676]; Swedish Cancer Society [CAN2017/561]; Novo Nordisk Foundation [NNF17OC0026940]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Karolinska Institutet(Karolinska Institutet); Lars Hierta Memorial Foundation; Alex and Eva Wallstrom Foundation for Scientific Research and Education; Swedish Society of Medical Research; China Scholar Council; KIT in the context of the Helmholtz program BioInterfaces in Technology and Medicine (BIFTM); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), project number 331351713-SFB 1324 (project A06 to G. D., Z03 to M. B., and A03 to J. C. G.). P. K. acknowledges funding from Karolinska Institutet (2018-01520), The Lars Hierta Memorial Foundation (FO2019-0086), The Alex and Eva Wallstrom Foundation for Scientific Research and Education (2020-00228), and The Swedish Society of Medical Research (P19-0055). X. W. acknowledges funding from the China Scholar Council. G. D. and P. L. also acknowledge funding by the KIT in the context of the Helmholtz program BioInterfaces in Technology and Medicine (BIFTM). H. S. acknowledges funding from Deutsche Forschungsgemeinschaft (DFG; project 427840891). G. S. acknowledges funding from Karolinska Institutet, the Swedish Research Council (2017-04676), the Swedish Cancer Society (CAN2017/561), and the Novo Nordisk Foundation (NNF17OC0026940).	Arthofer E, 2016, MOL PHARMACOL, V90, P447, DOI 10.1124/mol.116.104919; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Chu MLH, 2013, STRUCTURE, V21, P1235, DOI 10.1016/j.str.2013.05.006; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Demir K, 2013, CELL REP, V4, P1224, DOI 10.1016/j.celrep.2013.08.008; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Eubelen M, 2018, SCIENCE, V361, P663, DOI 10.1126/science.aat1178; Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Galli LM, 2018, DEV BIOL, V439, P53, DOI 10.1016/j.ydbio.2018.04.025; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Gerlach JP, 2018, P NATL ACAD SCI USA, V115, pE3996, DOI 10.1073/pnas.1721321115; Glaeser K, 2018, EMBO J, V37, DOI 10.15252/embj.201797311; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hirai H, 2019, NAT STRUCT MOL BIOL, V26, P372, DOI 10.1038/s41594-019-0216-z; Holzer T, 2012, FEBS LETT, V586, P1638, DOI 10.1016/j.febslet.2012.04.035; Hoppler Stefan, 2008, V469, P319, DOI 10.1007/978-1-60327-469-2_21; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kozielewicz P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14149-3; Kozielewicz P, 2020, MOL PHARMACOL, V97, P23, DOI 10.1124/mol.119.118158; Kozielewicz P, 2020, MOL PHARMACOL, V97, P62, DOI 10.1124/mol.119.117986; Mattes B, 2018, ELIFE, V7, DOI 10.7554/eLife.36953; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Menck K, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1378056; Mihara E, 2016, ELIFE, V5, DOI 10.7554/eLife.11621; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Pani AM, 2018, ELIFE, V7, DOI 10.7554/eLife.38325; PARR BA, 1993, DEVELOPMENT, V119, P247; Petersen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00253-9; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Rodriguez EA, 2017, TRENDS BIOCHEM SCI, V42, P111, DOI 10.1016/j.tibs.2016.09.010; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schulte G, 2018, TRENDS PHARMACOL SCI, V39, P828, DOI 10.1016/j.tips.2018.07.001; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/NMETH.3398, 10.1038/nmeth.3398]; Takada R, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0172-x; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Voloshanenko O, 2017, FASEB J, V31, P4832, DOI 10.1096/fj.201700144R; Wallkamm V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109428; Wang YS, 2016, CURR TOP DEV BIOL, V117, P113, DOI 10.1016/bs.ctdb.2015.11.028; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wiese KE, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.165902; Winn RA, 2002, ONCOGENE, V21, P7497, DOI 10.1038/sj.onc.1205963; Wright SC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08630-2; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang L, 2014, CURR OPIN GENET DEV, V27, P14, DOI 10.1016/j.gde.2014.03.006	65	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8759	8774		10.1074/jbc.RA120.012892	http://dx.doi.org/10.1074/jbc.RA120.012892			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32381507	Green Published, hybrid			2022-12-26	WOS:000546296800012
J	Zhu, SJ; Shi, WJ; Jie, YC; Zhou, QM; Song, CB				Zhu, Shoujing; Shi, Wenjuan; Jie, Yucheng; Zhou, Qingming; Song, Chenbo			A MYB transcription factor, BnMYB2, cloned from ramie (Boehmeria nivea) is involved in cadmium tolerance and accumulation	PLOS ONE			English	Article							DROUGHT STRESS-RESPONSE; ABSCISIC-ACID; GENOTYPIC VARIATION; EXPRESSION ANALYSIS; DEFENSE SYSTEM; ARABIDOPSIS; GENES; PHYTOREMEDIATION; SINGLE; LOCALIZATION	MYB-related transcription factors play important roles in plant development and response to various environmental stresses. In the present study, a novel MYB gene, designated as BnMYB2 (GenBank accession number: MF741319.1), was isolated from Boehmeria nivea using rapid amplification of cDNA ends (RACE) and RT-PCR on a sequence fragment from a ramie transcriptome. BnMYB2 has a 945 bp open reading frame encoding a 314 amino acid protein that contains a DNA-binding domain and shares high sequence identity with MYB proteins from other plant species. The BnMYB2 promoter contains several putative cis-acting elements involved in stress or phytohormone responses. A translational fusion of BnMYB2 with enhanced green fluorescent protein (eGFP) showed nuclear and cytosolic subcellular localization. Real-time PCR results indicated that BnMYB2 expression was induced by Cadmium (Cd) stress. Overexpression of BnMYB2 in Arabidopsis thaliana resulted in a significant increase of Cd tolerance and accumulation. Thus, BnMYB2 positively regulated Cd tolerance and accumulation in Arabidopsis, and could be used to enhance the efficiency of Cd removal with plants.	[Zhu, Shoujing; Jie, Yucheng; Zhou, Qingming] Hunan Agr Univ, Inst Ramie, Changsha, Hunan, Peoples R China; [Zhu, Shoujing; Shi, Wenjuan; Song, Chenbo] Yichun Univ, Coll Life Sci Resources & Environm, Yichun, Jiangxi, Peoples R China	Hunan Agricultural University; Yichun University	Jie, YC (corresponding author), Hunan Agr Univ, Inst Ramie, Changsha, Hunan, Peoples R China.	ibfcjyc@vip.sina.com	zhu, shoujing/AAT-1819-2020		National Natural Science Foundation of China [31371704, 31872877]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 31371704, No. 31872877). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Adesodun JK, 2010, WATER AIR SOIL POLL, V207, P195, DOI 10.1007/s11270-009-0128-3; Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Anjum SA, 2011, J AGRON CROP SCI, V197, P296, DOI 10.1111/j.1439-037X.2011.00468.x; Baldoni E, 2015, INT J MOL SCI, V16, P15811, DOI 10.3390/ijms160715811; Baldwin PR, 2007, MICROCHEM J, V85, P297, DOI 10.1016/j.microc.2006.07.005; Balestrasse KB, 2001, AUST J PLANT PHYSIOL, V28, P497, DOI 10.1071/PP00158; Corguinha APB, 2015, J FOOD COMPOS ANAL, V37, P143, DOI 10.1016/j.jfca.2014.08.004; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Clemens S, 2013, TRENDS PLANT SCI, V18, P92, DOI 10.1016/j.tplants.2012.08.003; Cojocaru P, 2016, ENVIRON SCI POLLUT R, V23, P10693, DOI 10.1007/s11356-016-6176-5; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Dahmani-Muller H, 2000, ENVIRON POLLUT, V109, P231, DOI 10.1016/S0269-7491(99)00262-6; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; do Nascimento CWA, 2006, SCI AGR, V63, P299, DOI 10.1590/S0103-90162006000300014; Du H, 2013, DNA RES, V20, P437, DOI 10.1093/dnares/dst021; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Duruibe JO, 2007, INT J PHYS SCI, V2, P112; Fagioni M, 2009, J PROTEOME RES, V8, P310, DOI 10.1021/pr800507x; Farinati S, 2010, NEW PHYTOL, V185, P964, DOI 10.1111/j.1469-8137.2009.03132.x; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; [雷梅 Lei Mei], 2005, [生态学报, Acta Ecologica Sinica], V25, P1146; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Li CN, 2015, ENVIRON EXP BOT, V114, P80, DOI 10.1016/j.envexpbot.2014.06.014; Li XY, 2012, PLANT J, V71, P239, DOI 10.1111/j.1365-313X.2012.04986.x; Liao Y, 2008, CELL RES, V18, P1047, DOI 10.1038/cr.2008.280; Lin CY, 2013, PLANT MOL BIOL, V81, P507, DOI 10.1007/s11103-013-0020-9; Lipsick JS, 1996, ONCOGENE, V13, P223; Liu TM, 2015, GENE, V558, P131, DOI 10.1016/j.gene.2014.12.057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maksymiec W, 2007, ACTA PHYSIOL PLANT, V29, P177, DOI 10.1007/s11738-007-0036-3; Maroco JP, 2002, FUNCT PLANT BIOL, V29, P451, DOI 10.1071/PP01040; Metwally A, 2005, J EXP BOT, V56, P167; Nazarli H., 2014, J HERBMED PHARM, V3, P87; Peng XY, 2018, CELLULOSE, V25, P1921, DOI 10.1007/s10570-018-1656-z; Qadir S, 2004, PLANT SCI, V167, P1171, DOI 10.1016/j.plantsci.2004.06.018; Ramalingam A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01117; Raskin Ilya, 1994, Current Opinion in Biotechnology, V5, P285, DOI 10.1016/0958-1669(94)90030-2; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Serna L, 2008, PLANT SIGNAL BEHAV, V3, P1077, DOI 10.4161/psb.3.12.6254; She W., 2011, ACTA ECOL SIN, V31, P874; She W, 2015, B ENVIRON CONTAM TOX, V94, P453, DOI 10.1007/s00128-015-1502-z; She W, 2011, ACTA AGR SCAND B-S P, V61, P641, DOI 10.1080/09064710.2010.537678; Shin D, 2011, PLANT PHYSIOL, V155, P421, DOI 10.1104/pp.110.163634; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Ai TN, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01388; Viehweger K, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-35; Wang FZ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01868; Wang SC, 2007, DEVELOPMENT, V134, P3873, DOI 10.1242/dev.009597; Weber M, 2006, PLANT CELL ENVIRON, V29, P950, DOI 10.1111/j.1365-3040.2005.01479.x; Wester K, 2009, DEVELOPMENT, V136, P1487, DOI 10.1242/dev.021733; Xiong HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092913; Xu PX, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-1938-5; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang B, 2010, ENVIRON POLLUT, V158, P551, DOI 10.1016/j.envpol.2009.08.043; Yizong H., 2009, ACTA ECOL SIN, V29, P320, DOI [10.1016/j.chnaes.2009.09.011, DOI 10.1016/J.CHNAES.2009.09.011]; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zeng FR, 2011, ENVIRON POLLUT, V159, P84, DOI 10.1016/j.envpol.2010.09.019; Zhang P, 2019, PLANT PHYSIOL, V180, P529, DOI 10.1104/pp.18.01380; [张顺仓 Zhang Shuncang], 2017, [中草药, Chinese Traditional and Herbal Drugs], V48, P3597; Zheng X, 2016, OPEN LIFE SCI, V11, P191, DOI 10.1515/biol-2016-0025	64	8	9	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233375	10.1371/journal.pone.0233375	http://dx.doi.org/10.1371/journal.pone.0233375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421756	gold, Green Published			2022-12-26	WOS:000537499600048
J	Castro-Diehl, C; Song, RJ; Mitchell, GF; McManus, D; Cheng, SS; Vasan, RS; Xanthakis, V				Castro-Diehl, Cecilia; Song, Rebecca J.; Mitchell, Gary F.; McManus, David; Cheng, Susan; Vasan, Ramachandran S.; Xanthakis, Vanessa			Association of subclinical atherosclerosis with echocardiographic indices of cardiac remodeling: The Framingham Study	PLOS ONE			English	Article							CORONARY-ARTERY CALCIUM; VENTRICULAR DIASTOLIC DYSFUNCTION; CARDIOVASCULAR-DISEASE; CHAMBER QUANTIFICATION; SYSTOLIC DYSFUNCTION; EUROPEAN-ASSOCIATION; ASYMPTOMATIC ADULTS; COMPUTED-TOMOGRAPHY; MYOCARDIAL STRAIN; AMERICAN-SOCIETY	Background It is well established that coronary artery disease progresses along with myocardial disease. However, data on the association between coronary artery calcium (CAC) and echocardiographic variables are lacking. Methods and results Among 2,650 Framingham Study participants (mean age 51 yrs, 48% women; 40% with CAC>0), we related CT-based CAC score to left ventricular (LV) mass index (LVMi), LV ejection fraction (LVEF), E/e', global longitudinal strain (GLS), left atrial emptying fraction (LAEF), and aortic root diameter (AoR), using multivariable-adjusted generalized linear models. CAC score (independent variable) was used as log-transformed continuous [ln (CAC+1)] and as a categorical (0, 1-100, and >= 101) variable. Adjusting for standard risk factors, higher CAC score was associated with higher LVMi and AoR (beta(LVMI) per 1-SD increase 0.012, beta(AoR) 0.008; P<0.05, for both). Participants with 1 <= CAC <= 100 and those with CAC >= 101 had higher AoR (beta(AoR) 0.013 and 0.020, respectively, P = 0.01) than those with CAC = 0. CAC score was not significantly associated with LVEF, E/e', GLS or LAEF. Age modified the association of CAC score with AoR; higher CAC scores were associated with larger AoR more strongly in older (> 58 years; beta(AoR)0.0042;P<0.007) than in younger (<= 58 years) participants (beta(AoR)0.0027;P< 0.03). Conclusions We observed that subclinical atherosclerosis was associated with ventricular and aortic remodeling. The prognostic significance of these associations warrants evaluation in additional mechanistic studies.	[Castro-Diehl, Cecilia; Vasan, Ramachandran S.; Xanthakis, Vanessa] Boston Univ, Sch Med, Dept Med, Sect Prevent Med & Epidemiol, Boston, MA 02118 USA; [Song, Rebecca J.; Vasan, Ramachandran S.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Mitchell, Gary F.] Cardiovasc Engn Inc, Norwood, MA USA; [McManus, David] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Cheng, Susan] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Vasan, Ramachandran S.; Xanthakis, Vanessa] Boston Univ, Framingham, MA 06510 USA; [Vasan, Ramachandran S.; Xanthakis, Vanessa] Natl Heart Lung & Blood Inst, Framingham Heart Study, Framingham, MA 06510 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Cardiol Sect, Dept Med, Boston, MA 02118 USA; [Xanthakis, Vanessa] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA	Boston University; Boston University; Cardiovascular Engineering; University of Massachusetts System; University of Massachusetts Worcester; Cedars Sinai Medical Center; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University	Xanthakis, V (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Prevent Med & Epidemiol, Boston, MA 02118 USA.; Xanthakis, V (corresponding author), Boston Univ, Framingham, MA 06510 USA.; Xanthakis, V (corresponding author), Natl Heart Lung & Blood Inst, Framingham Heart Study, Framingham, MA 06510 USA.; Xanthakis, V (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	vanessax@bu.edu		Xanthakis, Vanessa/0000-0002-7352-621X; Cheng, Susan/0000-0002-4977-036X	National Heart, Lung and Blood Institute [N01-HC-25195, HHSN268201500001I]; Multidisciplinary Training Program (T32) in Cardiovascular Epidemiology [5T32HL125232]; Cardiovascular Engineering., Inc;  [HL076784];  [G028321];  [HL070100];  [HL060040];  [HL080124];  [HL071039];  [HL077447];  [HL107385];  [HL126136];  [2R01HL092577];  [1R01HL128914];  [1P50HL120163];  [R01HL131532];  [R01HL134168];  [2-K24-HL04334]	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Multidisciplinary Training Program (T32) in Cardiovascular Epidemiology; Cardiovascular Engineering., Inc; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	This work was partially supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (Contracts N01-HC-25195 and HHSN268201500001I) and by grants HL076784, G028321, HL070100, HL060040, HL080124, HL071039, HL077447, HL107385, HL126136, 2R01HL092577, 1R01HL128914, 1P50HL120163, R01HL131532 (SC), R01HL134168 (SC); and 2-K24-HL04334. Cecilia Castro-Diehl was supported by the Multidisciplinary Training Program (T32) in Cardiovascular Epidemiology (5T32HL125232). Gary F. Mitchell was supported by Cardiovascular Engineering., Inc; this funder provided support in the form of salary for Gary F. Mitchell, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the `author contributions' section.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bavishi C, 2016, JACC-CARDIOVASC IMAG, V9, P580, DOI 10.1016/j.jcmg.2015.11.023; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; BURSTEIN M, 1960, CLIN CHIM ACTA, V5, P609, DOI 10.1016/0009-8981(60)90075-9; Carr JJ, 2017, JAMA CARDIOL, V2, P391, DOI 10.1001/jamacardio.2016.5493; Cheng S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002071; Cheng S, 2013, CIRC-CARDIOVASC IMAG, V6, P692, DOI 10.1161/CIRCIMAGING.112.000627; Collier P, 2017, J AM COLL CARDIOL, V69, P1043, DOI 10.1016/j.jacc.2016.12.012; Edvardsen T, 2006, ARTERIOSCL THROM VAS, V26, P206, DOI 10.1161/01.ATV.0000194077.23234.ae; Edvardsen T, 2006, AM HEART J, V151, P109, DOI 10.1016/j.ahj.2005.02.018; Eleid MF, 2011, J AM SOC ECHOCARDIOG, V24, P909, DOI 10.1016/j.echo.2011.03.017; Gardin JM, 2005, AM J CARDIOL, V95, P626, DOI 10.1016/j.amjcard.2004.11.010; Glagov S, 2010, NEW ENGL J MED, V316, P1371; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gupta S, 2013, EUR HEART J, V34, P278, DOI 10.1093/eurheartj/ehs188; Hoffmann U, 2016, J AM HEART ASSOC, V5, P1; Hoffmann U, 2008, AM J CARDIOL, V102, P1136, DOI 10.1016/j.amjcard.2008.06.038; Hu K, 2013, EUR HEART J-CARD IMG, V14, P205, DOI 10.1093/ehjci/jes240; Lam CSP, 2010, CIRCULATION, V122, P884, DOI 10.1161/CIRCULATIONAHA.110.937839; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Madaj PM, 2010, CORONARY ARTERY DIS, V21, P428, DOI 10.1097/MCA.0b013e32833db521; Maragiannis D, 2015, J ATHEROSCLER THROMB, V22, P1278, DOI 10.5551/jat.29454; Miyazaki C, 2008, CIRCULATION, V117, P2617, DOI 10.1161/CIRCULATIONAHA.107.733675; Nafakhi H, 2015, ACAD RADIOL, V22, P357, DOI 10.1016/j.acra.2014.09.017; Nayor M, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008291; Osawa K, 2016, HEART VESSELS, V31, P499, DOI 10.1007/s00380-015-0645-5; Osborne JA, ESTIMATING FALSE DIS, P1; Pan NH, 2009, J CARDIOVASC ELECTR, V20, P153, DOI 10.1111/j.1540-8167.2008.01290.x; Parikh NI, 2007, CIRCULATION, V116, P1473, DOI 10.1161/CIRCULATIONAHA.107.705202; Penicka M, 2014, HEART, V100, P68, DOI 10.1136/heartjnl-2011-301321; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Sardana M, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008435; Sardana M, 2017, J AM SOC ECHOCARDIOG, V30, P904, DOI 10.1016/j.echo.2017.05.013; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Staszewsky L, 2013, EUR HEART J, V34, P255, DOI 10.1093/eurheartj/ehs327; Sundstrom J, 2004, CIRCULATION, V109, P2850, DOI 10.1161/01.CIR.0000129318.79570.84; Triposkiadis F, 1995, J Am Soc Echocardiogr, V8, P801, DOI 10.1016/S0894-7317(05)80004-5; Vasan R S, 1995, J Am Soc Echocardiogr, V8, P793, DOI 10.1016/S0894-7317(05)80003-3; Vasan RS, 2018, JACC-CARDIOVASC IMAG, V11, P1, DOI 10.1016/j.jcmg.2017.08.007; Wang L, 2006, J AM COLL CARDIOL, V48, P1018, DOI 10.1016/j.jacc.2006.04.089; WILSON PWF, 1991, AM HEART J, V121, P586, DOI 10.1016/0002-8703(91)90729-2; Yared GS, 2019, CIRC-CARDIOVASC IMAG, V12, DOI 10.1161/CIRCIMAGING.119.009228; Yeboah J, 2016, J AM COLL CARDIOL, V67, P139, DOI 10.1016/j.jacc.2015.10.058	44	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233321	10.1371/journal.pone.0233321	http://dx.doi.org/10.1371/journal.pone.0233321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413074	Green Published, gold			2022-12-26	WOS:000537496000063
J	Fernandez-Urrusuno, R; Barros, CMM; Cantalejo, RSB; Hevia, E; Martino, CS; Aldasoro, AI; Mora, JL; Navas, AL; de la Pisa, BP				Fernandez-Urrusuno, Rocio; Meseguer Barros, Carmen Marina; Benavente Cantalejo, Regina Sandra; Hevia, Elena; Serrano Martino, Carmen; Irastorza Aldasoro, Aranzazu; Limon Mora, Juan; Lopez Navas, Antonio; Pascual de la Pisa, Beatriz			Successful improvement of antibiotic prescribing at Primary Care in Andalusia following the implementation of an antimicrobial guide through multifaceted interventions: An interrupted time-series analysis	PLOS ONE			English	Article							BEHAVIORAL INTERVENTIONS; QUALITY; PROGRAM; CLUSTER	Background Most effective strategies designed to improve antimicrobial prescribing have multiple approaches. We assessed the impact of the implementation of a rigorous antimicrobial guide and subsequent multifaceted interventions aimed at improving antimicrobial use in Primary Care. Methods A quasi-experimental study was designed. Interventions aimed at achieving a good implementation of the guide consisted of the development of electronic decision support tools, local training meetings, regional workshops, conferences, targets for rates of antibiotic prescribing linked to financial incentives, feedback on antibiotic prescribing, and the implementation of a structured educational antimicrobial stewardship program. Interventions started in 2011, and continued until 2018. Outcomes: rates of antibiotics use, calculated into defined daily doses per 1,000 inhabitants-day (DID). An interrupted time-series analysis was conducted. The study ran from January 2004 until December 2018. Results Overall annual antibiotic prescribing rates showed increasing trends in the pre-intervention period. Interventions were followed by significant changes on trends with a decline over time in antibiotic prescribing. Overall antibiotic rates dropped by 28% in the Aljarafe Area and 22% in Andalusia between 2011 and 2018, at rates of -0.90 DID per year (95%CI:-1.05 to -0.75) in Aljarafe, and -0.78 DID (95%CI:-0.95 to -0.60) in Andalusia. Reductions occurred at the expense of the strong decline of penicillins use (33% in Aljarafe, 25% in Andalusia), and more precisely, amoxicillin clavulanate, whose prescription plummeted by around 50%. Quinolones rates decreased before interventions, and continued to decline following interventions with more pronounced downward trends. Decreasing cephalosporins trends continued to decline, at a lesser extent, following interventions in Andalusia. Trends of macrolides rates went from a downward trend to an upward trend from 2011 to 2018. Conclusions Multifaceted interventions following the delivering of a rigorous antimicrobial guide, maintained in long-term, with strong institutional support, could led to sustained reductions in antibiotic prescribing in Primary Care.	[Fernandez-Urrusuno, Rocio] Andalusian Publ Hlth Care Serv, Clin Unit Primary Care Pharm Sevilla, Aljarafe Sevilla Norte Primary Hlth Care Area, Seville, Spain; [Meseguer Barros, Carmen Marina] Madrid Publ Hlth Serv, Ouest Primary Hlth Care Area, Serv Pharm, Madrid, Spain; [Benavente Cantalejo, Regina Sandra; Hevia, Elena] Andalusian Publ Hlth Care Serv, Promot & Rational Use Drugs Serv, Gen Direct Pharm, Seville, Spain; [Serrano Martino, Carmen] Hosp San Juan Dios Aljarafe, Microbiol Serv, Seville, Spain; [Irastorza Aldasoro, Aranzazu; Limon Mora, Juan] Andalusian Publ Hlth Care Serv, Gen Direct Hlth Care & Hlth Outcomes, Seville, Spain; [Lopez Navas, Antonio] Spanish Med Agcy & Hlth Prod, Coordinat Unit Spanish Natl Act Plan Antimicrobia, Madrid, Spain; [Pascual de la Pisa, Beatriz] Andalusian Publ Hlth Care Serv, Clin Unit Camas, Seville, Spain; [Hevia, Elena] Andalusian Publ Hlth Care Serv, Serv Pharm, Univ Hosp Virgen Macarena, Seville, Spain	Hospital Universitario Virgen Macarena	Fernandez-Urrusuno, R (corresponding author), Andalusian Publ Hlth Care Serv, Clin Unit Primary Care Pharm Sevilla, Aljarafe Sevilla Norte Primary Hlth Care Area, Seville, Spain.	rocio.fernandez.sspa@juntadeandalucia.es		Limon Mora, Juan/0000-0002-6758-5088; Hevia Alvarez, Elena/0000-0002-8021-9840; Fernandez Urrusuno, Rocio/0000-0002-6261-6869	Instituto de Salud Carlos III (FISS), Spanish Ministry of Health [PI/10/01152]; Spanish Ministry of Health; European Development Regional Found (FEDER); Andalusian Regional Ministry of Health [PI-0160-2010]	Instituto de Salud Carlos III (FISS), Spanish Ministry of Health; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European Development Regional Found (FEDER); Andalusian Regional Ministry of Health	This work was supported by a research project from Instituto de Salud Carlos III (FISS), Spanish Ministry of Health (PI/10/01152), cofinanced by the European Development Regional Found (FEDER); a research project from the Andalusian Regional Ministry of Health (PI-0160-2010), and by the Spanish Ministry of Health for the Implementation of Strategies for Patient Safety from the National Health System (Fondos de Cohesio ' n, 2011), through the project "Prevention of bacterial resistances and the appropriate use of antimicrobials in the Andalusian Public Health Care System Centres". RFU received PI/10/01152 and PI-0160-2010. JLM received "Fondos de Cohesio ' n, 2011".	Ament Stephanie M C, 2015, BMJ Open, V5, pe008073, DOI 10.1136/bmjopen-2015-008073; [Anonymous], SPAN NAT PLAN ANT RE; [Anonymous], ANT CONS DAT ESAC NE; Bal AM, 2011, CURR OPIN INFECT DIS, V24, P357, DOI 10.1097/QCO.0b013e3283483262; Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118; Biezen R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028329; Buehrle DJ, 2020, CLIN INFECT DIS, V71, pE316, DOI 10.1093/cid/ciz1180; Butler CC, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/bmj.d8173, 10.1136/bmj.e682]; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Davey P, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub4; Abad MD, 2016, JAMA INTERN MED, V176, P21, DOI 10.1001/jamainternmed.2015.7088; European Centre for Disease Prevention and Control, EUR ANT RES SURV NET; European Commission, 2011, ACT PLAN RIS THREATS; Urrusuno RF, 2014, EUR J CLIN PHARMACOL, V70, P1011, DOI 10.1007/s00228-014-1704-z; Urrusuno RF, 2013, EUR J CLIN PHARMACOL, V69, P1845, DOI 10.1007/s00228-013-1542-4; Fernandez-Urrusuno R, 2018, ALJARAFE ANTIMICROBI; Fernandez-Urrusuno R, 2015, ENFERM INFEC MICR CL, V33, P311, DOI 10.1016/j.eimc.2014.07.011; Furst J, 2015, EXPERT REV ANTI-INFE, V13, P279, DOI 10.1586/14787210.2015.990381; GJELSTAD S, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F4403; Guiasalud, CLIN PRACT GUID NAT; Gulliford M, 2019, BMJ-BRIT MED J, V364, P1236; Hallsworth M, 2016, LANCET, V387, P1743, DOI 10.1016/S0140-6736(16)00215-4; Hurlimann D, 2015, J ANTIMICROB CHEMOTH, V70, P602, DOI 10.1093/jac/dku394; King LM, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k3047; Linden A. MMWS, 2014, STAT SOFTWARE COMPON; Linder JA, 2017, JAMA-J AM MED ASSOC, V318, P1391, DOI 10.1001/jama.2017.11152; Little P, 2013, LANCET, V382, P1175, DOI 10.1016/S0140-6736(13)60994-0; Llor C, 2018, J ANTIMICROB CHEMOTH, V73, P2215, DOI 10.1093/jac/dky137; McDonagh M, 2016, IMPROVING ANTIBIOTIC; Meeker D, 2016, JAMA-J AM MED ASSOC, V315, P562, DOI 10.1001/jama.2016.0275; Molstad S, 2017, B WORLD HEALTH ORGAN, V95, P764, DOI 10.2471/BLT.16.184374; Penalva G, 2020, LANCET INFECT DIS, V20, P199, DOI 10.1016/S1473-3099(19)30573-0; Rawson TM, 2017, CLIN MICROBIOL INFEC, V23, P524, DOI 10.1016/j.cmi.2017.02.028; Resources for professionals of the Andalusian Health Service, WEBS CLIN PRACT GUID; Rojo-Martin MD, 2018, PIRASOA PROGRAMME DE, DOI [10.17504/protocols.io.r3bd8in, DOI 10.17504/PROTOCOLS.IO.R3BD8IN]; Schuts EC, 2016, EUR J CLIN PHARMACOL, V72, P249, DOI 10.1007/s00228-015-1969-x; Spanish Medicines Agency, RES SPAN AG MED HLTH; van der Velden AW, 2016, J ANTIMICROB CHEMOTH, V71, P257, DOI 10.1093/jac/dkv328; van der Velden LBJ, 2012, EUR J CLIN MICROBIOL, V31, P1561, DOI 10.1007/s10096-011-1478-5; WHO, 2014, ROL PHARM ENC PRUD U; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1	41	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233062	10.1371/journal.pone.0233062	http://dx.doi.org/10.1371/journal.pone.0233062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413054	Green Published, gold			2022-12-26	WOS:000537496000046
J	Suarez-Garcia, JG; Hernandez-Lopez, JM; Moreno-Barbosa, E; de Celis-Alonso, B				Gerardo Suarez-Garcia, Jose; Miguel Hernandez-Lopez, Javier; Moreno-Barbosa, Eduardo; de Celis-Alonso, Benito			A simple model for glioma grading based on texture analysis applied to conventional brain MRI	PLOS ONE			English	Article							TUMOR GRADE; PERFUSION; RADIOMICS; FEATURES; DIFFERENTIATION; CLASSIFICATION; PREDICTION; SYSTEM; SPECT; PET	Accuracy of glioma grading is fundamental for the diagnosis, treatment planning and prognosis of patients. The purpose of this work was to develop a low-cost and easy-to-implement classification model which distinguishes low-grade gliomas (LGGs) from high-grade gliomas (HGGs), through texture analysis applied to conventional brain MRI. Different combinations of MRI contrasts (T-1Gd and T-2) and one segmented glioma region (necrotic and non-enhancing tumor core, NCR/NET) were studied. Texture features obtained from the gray level size zone matrix (GLSZM) were calculated. An under-sampling method was proposed to divide the data into different training subsets and subsequently extract complementary information for the creation of distinct classification models. The sensitivity, specificity and accuracy of the models were calculated, and the best model explicitly reported. The best model included only three texture features and reached a sensitivity, specificity and accuracy of 94.12%, 88.24% and 91.18%, respectively. According to the features of the model, when the NCR/NET region was studied, HGGs had a more heterogeneous texture than LGGs in the T-1Gd images, and LGGs had a more heterogeneous texture than HGGs in the T-2 images. These novel results partially contrast with results from the literature. The best model proved to be useful for the classification of gliomas. Complementary results showed that the heterogeneity of gliomas depended on the MRI contrast studied. The chosen model stands out as a simple, low-cost, easy-to-implement, reproducible and highly accurate glioma classifier. Importantly, it should be accessible to populations with reduced economic and scientific resources.	[Gerardo Suarez-Garcia, Jose; Miguel Hernandez-Lopez, Javier; Moreno-Barbosa, Eduardo; de Celis-Alonso, Benito] Benemerita Univ Autonoma Puebla BUAP, Fac Phys & Math, Puebla, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla	de Celis-Alonso, B (corresponding author), Benemerita Univ Autonoma Puebla BUAP, Fac Phys & Math, Puebla, Puebla, Mexico.	bdca_BUAP@yahoo.com.mx	, de Celis Alonso Benito/AAP-4512-2021; Moreno-Barbosa, Eduardo/AAX-6669-2020; , db/GRS-6835-2022; Suárez-García, José Gerardo/AAP-5786-2021	, de Celis Alonso Benito/0000-0003-2124-1084; Moreno-Barbosa, Eduardo/0000-0002-1114-2640; Suarez Garcia, Jose Gerardo/0000-0002-5304-9161	National Council of Science and Technology [461568]	National Council of Science and Technology	The author JGSG was supported by the National Council of Science and Technology (https://www.conacyt.gob.mx/), through a scholarship for postgraduate studies (grant number 461568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou GA, 2014, CLIN NEUROL NEUROSUR, V116, P41, DOI 10.1016/j.clineuro.2013.11.003; Anderson MD, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-014-0399-8; Arisawa A, 2018, NEURORADIOLOGY, V60, P599, DOI 10.1007/s00234-018-2024-2; Bakas S., 2018, MULTIMODAL BRAIN TUM; Bakas S., 2017, CANC IMAGING ARCH, V286; Bakas S., 2017, SEGMENTATION LABELS; Bogdanska MU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179999; Brendle C, 2018, NEURORADIOLOGY, V60, P381, DOI 10.1007/s00234-018-1993-5; Caulo M, 2014, RADIOLOGY, V272, P494, DOI 10.1148/radiol.14132040; Chung C, 2015, SEMIN RADIAT ONCOL, V25, P164, DOI 10.1016/j.semradonc.2015.02.002; Crimi A, 2013, I S BIOMED IMAGING, P1102; Crimi A., 2014, INTENSITY NORMALIZAT; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gupta N, 2019, BIOMED SIGNAL PROCES, V47, P115, DOI 10.1016/j.bspc.2018.06.003; Guzman-De-Villoria JA, 2014, CANCER IMAGING, V14, DOI 10.1186/s40644-014-0035-8; Ho VKY, 2014, EUR J CANCER, V50, P2309, DOI 10.1016/j.ejca.2014.05.019; Jeong J., 2018, MACHINE LEARNING BAS; Johnson H. J., 2018, ITK SOFTWARE GUIDE; Khawaldeh S, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8010027; Kotrotsou A, 2016, MAGN RESON IMAGING C, V24, P719, DOI 10.1016/j.mric.2016.06.006; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kuwako T, 2013, ANN NUCL MED, V27, P493, DOI 10.1007/s12149-013-0711-y; Longadge R., 2013, INT J COMPUT NETW IJ; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lu D, 2007, INT J REMOTE SENS, V28, P823, DOI 10.1080/01431160600746456; Manjon JV, 2007, MED IMAGE ANAL, V11, P336, DOI 10.1016/j.media.2007.03.001; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Miloushev VZ, 2015, AM J NEURORADIOL, V36, P302, DOI 10.3174/ajnr.A4097; Mohan G, 2018, BIOMED SIGNAL PROCES, V39, P139, DOI 10.1016/j.bspc.2017.07.007; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Prati R., 2009, DATA MINING IMBALANC, P359; Qin JB, 2017, MED SCI MONITOR, V23, P2168, DOI 10.12659/MSM.901270; Qu Y, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016012; Rachinger W, 2009, J NEUROL NEUROSUR PS, V80, P1134, DOI 10.1136/jnnp.2009.174250; Raja R, 2016, NEURORADIOLOGY, V58, P1217, DOI 10.1007/s00234-016-1758-y; Saini J, 2018, NEURORADIOLOGY, V60, P43, DOI 10.1007/s00234-017-1942-8; Schramm P, 2010, EUR RADIOL, V20, P2482, DOI 10.1007/s00330-010-1817-4; Shaw TB, 2019, J MED IMAG RADIAT ON, V63, P650, DOI 10.1111/1754-9485.12929; Skogen K, 2016, EUR J RADIOL, V85, P824, DOI 10.1016/j.ejrad.2016.01.013; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Takahashi S, 2019, INT J RADIAT ONCOL, V105, P784, DOI 10.1016/j.ijrobp.2019.07.011; Thibault G, 2013, INT J PATTERN RECOGN, V27, DOI 10.1142/S0218001413570024; Tian Q, 2018, J MAGN RESON IMAGING, V48, P1518, DOI 10.1002/jmri.26010; Upadhyay N, 2011, BRIT J RADIOL, V84, pS107, DOI 10.1259/bjr/65711810; Vallieres M, 2015, PHYS MED BIOL, V60, P5471, DOI 10.1088/0031-9155/60/14/5471; Vamvakas A, 2019, PHYS MEDICA, V60, P188, DOI 10.1016/j.ejmp.2019.03.014; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; Verger A, 2017, EUR J NUCL MED MOL I, V44, P2257, DOI 10.1007/s00259-017-3812-3; Wang Q, 2018, J MAGN RESON IMAGING; Wang S, 2018, ONCOL LETT, V15, P7297, DOI 10.3892/ol.2018.8232; Wehbe K, 2015, ANAL BIOANAL CHEM, V407, P7295, DOI 10.1007/s00216-015-8891-z; Xie T, 2018, J MAGN RESON IMAGING, V47, P1099, DOI 10.1002/jmri.25835; Yang Y, 2017, NAT ENERGY, P1, DOI DOI 10.1080/19648189.2017.1356243; Zwanenburg A, 2016, RADOLOGY, DOI DOI 10.1148/RADIOL.2020191145	54	8	9	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0228972	10.1371/journal.pone.0228972	http://dx.doi.org/10.1371/journal.pone.0228972			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413034	Green Submitted, Green Published, gold			2022-12-26	WOS:000537496000005
J	Barbe, A; Mellouk, N; Rame, C; Grandhaye, J; Anger, K; Chahnamian, M; Ganier, P; Brionne, A; Riva, A; Froment, P; Dupont, J				Barbe, Alix; Mellouk, Namya; Rame, Christelle; Grandhaye, Jeremy; Anger, Karine; Chahnamian, Marine; Ganier, Patrice; Brionne, Aurelien; Riva, Antonella; Froment, Pascal; Dupont, Joelle			A grape seed extract maternal dietary supplementation improves egg quality and reduces ovarian steroidogenesis without affecting fertility parameters in reproductive hens	PLOS ONE			English	Article							BROILER BREEDER HENS; OXIDATIVE STRESS; PROANTHOCYANIDIN EXTRACT; FOOD RESTRICTION; LAYING HENS; BODY-WEIGHT; VITAMIN-E; ANTIOXIDANT; PERFORMANCE; HATCHABILITY	In broiler hens, the genetic selection increased susceptibility to metabolic disorders and reproductive dysfunctions. In human ovarian cells, grape seed extracts (GSE) improved steroid production. Here, we investigated the effects of a GSE dietary supplementation on egg production and quality, fertility parameters, Reactive Oxygen Species (ROS) and steroid content in yolk egg associated to plasma adipokines in broiler hens. For this, we designed two in vivo experiments, the first one included three groups of hens: A (control), B and C (supplemented with GSE at 0.5% and 1% of the total diet composition, respectively, since week 4), and the second one used two groups of hens: A (control) and D (supplemented with GSE at 1% of the total diet composition since hatching). We assessed the egg production from 23th to 40th weeks and quality at 33th week. After artificial inseminations, the fertility parameters were calculated. In egg yolk, Reactive Oxygen Species (ROS) level and steroid production were evaluated by Ros-Glo H202 and ELISA assay, respectively. Expression of steroidogenic enzymes and adipokines and their receptors was determined by RT-qPCR in ovarian cells and plasma adipokines (RARRES2, ADIPOQ and NAMPT) were evaluated by specific ELISA assays. The fertility parameters and egg production were unaffected by GSE supplementation whatever the experiment (exp.). However, the rate of double-yolk eggs decreased for all GSE supplemented groups (exp. 1 P < 0.01, exp.2, P< 0.02). In exp.1, C group eggs were bigger and larger (P< 0.0001) and the shell elasticity was higher for both B and C (P< 0.0003) as compared to control. In the egg yolk, GSE supplementation in both exp. reduced ROS content and steroidogenesis consistent with a decrease in P450 aromatase and StAR mRNA expression and basal in vitro progesterone secretion in granulosa cells (P< 0.001). Interestingly, in both exp. RARRES2 plasma levels were positively correlated while ADIPOQ and NAMPT plasma levels were negatively correlated, with steroids and ROS in yolk (P< 0.0001). Taken together, maternal dietary GSE supplementation did not affect egg production and fertility parameters whereas it reduced ROS content and steroidogenesis in yolk egg. Furthermore, it ameliorated egg quality by decreasing the number of double-yolk eggs and by improving the size of normal eggs and the elasticity of the shell. Taken together, our data suggest the possibility of using dietary maternal GSE to improve egg quality.	[Barbe, Alix; Mellouk, Namya; Rame, Christelle; Grandhaye, Jeremy; Froment, Pascal; Dupont, Joelle] INRAE, UMR85, Physiol Reprod & Comportements, Nouzilly, France; [Barbe, Alix; Mellouk, Namya; Rame, Christelle; Grandhaye, Jeremy; Froment, Pascal; Dupont, Joelle] CNRS, UMR7247, Physiol Reprod & Comportements, Nouzilly, France; [Barbe, Alix; Mellouk, Namya; Rame, Christelle; Grandhaye, Jeremy; Froment, Pascal; Dupont, Joelle] Univ Francois Rabelais Tours, Tours, France; [Barbe, Alix; Mellouk, Namya; Rame, Christelle; Grandhaye, Jeremy; Froment, Pascal; Dupont, Joelle] IFCE Nouzilly, Nouzilly, France; [Anger, Karine; Chahnamian, Marine; Ganier, Patrice] INRAE, UEPEAT, F-1295 Nouzilly, France; [Brionne, Aurelien] INRAE, Biol Oiseaux & Aviculture, UMR0083, Nouzilly, France; [Riva, Antonella] INDENA, Tours, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; INRAE	Dupont, J (corresponding author), INRAE, UMR85, Physiol Reprod & Comportements, Nouzilly, France.; Dupont, J (corresponding author), CNRS, UMR7247, Physiol Reprod & Comportements, Nouzilly, France.; Dupont, J (corresponding author), Univ Francois Rabelais Tours, Tours, France.; Dupont, J (corresponding author), IFCE Nouzilly, Nouzilly, France.	joelle.dupont@inrae.fr	Mellouk, Namya/AAL-7583-2021	Grandhaye, Jeremy/0000-0002-0909-837X	Region Centre Val de Loire [32000820]	Region Centre Val de Loire(Region Centre-Val de Loire)	The funder is Region Centre Val de Loire (project number 32000820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarikwu SO, 2020, ANDROLOGIA, V52, DOI 10.1111/and.13509; Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Bagchi D, 2014, MUTAT RES-FUND MOL M, V768, P69, DOI 10.1016/j.mrfmmm.2014.04.004; Bailey RL, 2014, PEERJ, V2, DOI 10.7717/peerj.273; Barbe A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231131; Barbe A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174215; Barbe A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071526; Caimari A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12597-9; Canepa S., 2008, CAH TECHN INRA, V64, P19; Chen SE, 2006, POULTRY SCI, V85, P70, DOI 10.1093/ps/85.1.70; Choi SK, 2012, NUTR RES PRACT, V6, P3, DOI 10.4162/nrp.2012.6.1.3; Decorde K, 2009, J AGR FOOD CHEM, V57, P6461, DOI 10.1021/jf900504g; Decuypere E, 2010, BRIT POULTRY SCI, V51, P569, DOI 10.1080/00071668.2010.519121; Deeming DC, 2011, BRIT POULTRY SCI, V52, P40, DOI 10.1080/00071668.2010.538372; Downing LE, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600347; Dulundu E, 2007, J GASTROEN HEPATOL, V22, P885, DOI 10.1111/j.1440-1746.2007.04875.x; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; Emamverdi M, 2019, THERIOGENOLOGY, V126, P279, DOI 10.1016/j.theriogenology.2018.12.001; ETCHES RJ, 1990, J EXP ZOOL, P112, DOI 10.1002/jez.1402560419; Fasenko GM, 2000, CAN J ANIM SCI, V80, P489, DOI 10.4141/A99-090; FECHHEIMER NS, 1966, J REPROD FERTIL, V12, P363, DOI 10.1530/jrf.0.0120363; Forni C, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/8748253; Galli GM, 2018, RES VET SCI, V118, P101, DOI 10.1016/j.rvsc.2018.01.022; Gil D, 2008, HORM BEHAV, V54, P238, DOI 10.1016/j.yhbeh.2007.11.013; Gonzalez-Abuin N, 2014, FOOD FUNCT, V5, P2357, DOI [10.1039/C4FO00447G, 10.1039/c4fo00447g]; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hajati H., 2014, Research Opinions in Animal and Veterinary Sciences, V4, P633; Hocking PM, 1996, BRIT POULTRY SCI, V37, P263, DOI 10.1080/00071669608417858; Hou FY, 2016, ANAT REC, V299, P450, DOI 10.1002/ar.23320; JAAP RG, 1968, POULTRY SCI, V47, P417, DOI 10.3382/ps.0470417; Kara K, 2016, J APPL ANIM RES, V44, P303, DOI 10.1080/09712119.2015.1031785; LATSHAW JD, 1977, POULTRY SCI, V56, P1876, DOI 10.3382/ps.0561876; Leeson S, 2000, J APPL POULTRY RES, V9, P297, DOI 10.1093/japr/9.3.297; Li HX, 2015, MOL CELL ENDOCRINOL, V414, P216, DOI 10.1016/j.mce.2015.07.006; Lin Yu-Ting, 2019, Cell Physiol Biochem, V52, P1398, DOI 10.33594/000000098; Liu MJ, 2018, FERTIL STERIL, V109, P900, DOI 10.1016/j.fertnstert.2018.01.020; Liu XT, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9390810; Meeprom A, 2011, BRIT J NUTR, V106, P1173, DOI 10.1017/S0007114511001589; Mellouk N, 2018, REPRODUCTION, V155, P321, DOI 10.1530/REP-17-0678; Oita RC, 2010, PFLUG ARCH EUR J PHY, V459, P619, DOI 10.1007/s00424-009-0752-1; Olaku OO, 2015, NUTR CANCER, V67, P730, DOI 10.1080/01635581.2015.1029639; Pearson A. M., 1983, Food Technology, V37, P121; Rajput Shahid Ali, 2019, Toxins (Basel), V11, DOI 10.3390/toxins11010023; Reis JH, 2019, J THERM BIOL, V80, P141, DOI 10.1016/j.jtherbio.2019.01.003; Ribas-Latre A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10954; Richards MP, 2007, POULTRY SCI, V86, P1478, DOI 10.1093/ps/86.7.1478; Sahin K, 2010, POULTRY SCI, V89, P1190, DOI 10.3382/ps.2010-00635; Salary Jalal, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS616; Sun YL, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101132; Surai PF, 2016, ANIM NUTR, V2, P1, DOI 10.1016/j.aninu.2016.01.001; Urso URA, 2015, POULTRY SCI, V94, P976, DOI 10.3382/ps/pev042; Wang F, 2018, INT J CLIN EXP PATHO, V11, P3338; WARREN D. C, 1935, POULTRY SCI, V14, P195, DOI 10.3382/ps.0140195; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Yao JN, 2019, BIOCHEM BIOPH RES CO, V510, P449, DOI 10.1016/j.bbrc.2019.01.125	56	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0233169	10.1371/journal.pone.0233169	http://dx.doi.org/10.1371/journal.pone.0233169			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407420	Green Published, gold			2022-12-26	WOS:000537490700080
J	Blunk, S; Hoffer, J; Brosda, S; de Heer, MI; Sturrock, CJ; Mooney, SJ				Blunk, Sebastian; Hoffer, Jeroen; Brosda, Sandra; de Heer, Martine I.; Sturrock, Craig J.; Mooney, Sacha J.			Impact of fruit orientation and pelleting material on water uptake and germination performance in artificial substrate for sugar beet	PLOS ONE			English	Article							BETA-VULGARIS-L.; CAPILLARY CONDUCTIVITY; SEEDS; ABSORPTION; EMERGENCE; IMBIBITION; SEEDLINGS; CAPACITY; CONTACT; LETTUCE	Water uptake into seeds is a fundamental prerequisite of germination and commonly influenced by commercial seed enhancement technologies. The effect of fruit orientation and contrasting pelleting materials on germination and biological performance of sugar beet was assessed. The results indicated there was orientation dependent fruit shrinkage of 37% for the operculum side supplied by moisture compared to 4% for the basal pore side. The expansion rate of 5% compared to the original size, which was also observed for non-shrinking seeds, indicated this was a temporary effect. This behaviour has importance for the application pelleting materials to seeds. Pellets composed of materials exhibiting low levels of swelling act as a water distribution layer which increased germination rates. Careful selection of pelleting material is crucial as it has direct implications on germination speed and subsequent establishment rates.	[Blunk, Sebastian; Sturrock, Craig J.; Mooney, Sacha J.] Univ Nottingham, Div Agr & Environm Sci, Nottingham, England; [Hoffer, Jeroen] Syngenta Seeds BV, Enkhuizen, Netherlands; [Brosda, Sandra] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [de Heer, Martine I.] Syngenta Ltd, Bracknell, Berks, England	University of Nottingham; Syngenta; University of Queensland; Syngenta	Blunk, S (corresponding author), Univ Nottingham, Div Agr & Environm Sci, Nottingham, England.	sebastian.blunk@nottingham.ac.ukH	Sturrock, Craig/N-6422-2017	Sturrock, Craig/0000-0002-5333-8502; Brosda, Sandra/0000-0002-0867-6166	Syngenta	Syngenta(Syngenta)	Project funded by Syngenta. The funder provided support in the form of salaries for author SBlunk. The specific roles of these authors are articulated in the `author contributions' section.	ARCHER JR, 1972, J SOIL SCI, V23, P475, DOI 10.1111/j.1365-2389.1972.tb01678.x; Aubertot JN, 2002, PLANT SOIL, V241, P177, DOI 10.1023/A:1016170329919; BLACKLOW WM, 1972, CROP SCI, V12, P643, DOI 10.2135/cropsci1972.0011183X001200050027x; Blunk S, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0220-4; Boiffin J, 1994, SOIL TILL RES ORG P, P1143; Bresson LM, 2004, GEODERMA, V118, P277, DOI 10.1016/S0016-7061(03)00212-X; CHEN ZG, 2017, SCI REP, V7, DOI DOI 10.1038/S41598-016-0028-X; CHUNG D S, 1967, Transactions of the ASAE (American Society of Agricultural Engineers), V10, P549; COLLISGEORGE N, 1975, AUST J SOIL RES, V13, P141, DOI 10.1071/SR9750141; DELVALLE JM, 1992, J FOOD PROCESS PRES, V16, P75; Doneen L. D., 1943, PLANT PHYSIOL, V18, P524, DOI 10.1104/pp.18.3.524; Durr C, 2001, SOIL SCI SOC AM J, V65, P414, DOI 10.2136/sssaj2001.652414x; DURRANT MJ, 1986, SEED SCI TECHNOL, V14, P343; Duval Y, 1994, 13 ISTRO C AALB DENM, P633; EVANS CE, 1990, NEW PHYTOL, V115, P539, DOI 10.1111/j.1469-8137.1990.tb00482.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Govinden-Soulange J, 2008, AFR J AGR RES, V3, P725; GRABLE ALBERT R., 1965, SOIL SCI SOC AMER PROC, V29, P12; HADAS A, 1985, ISRAEL J BOT, V34, P7; HADAS A, 1974, AGRON J, V66, P643, DOI 10.2134/agronj1974.00021962006600050012x; HADAS A, 1974, AGRON J, V66, P647, DOI 10.2134/agronj1974.00021962006600050013x; Hadas A., 1973, PHYS ASPECTS SOIL WA, V4, P97, DOI [10.1007/978-3-642-65523-4_11., DOI 10.1007/978-3-642-65523-4_11]; Hakansson I, 2012, ACTA AGR SCAND B-S P, V62, P166, DOI 10.1080/09064710.2011.597423; Hermann K, 2007, J EXP BOT, V58, P3047, DOI 10.1093/jxb/erm162; Hill H. J., 1999, Journal of New Seeds, V1, P105, DOI 10.1300/J153v01n01_09; Ilarslan H, 2001, ANN BOT-LONDON, V88, P243, DOI 10.1006/anbo.2001.1453; Joosen RVL, 2010, PLANT J, V62, P148, DOI 10.1111/j.1365-313X.2009.04116.x; Kang JS, 2007, KOR J LIFE SCI, V17, P1701; KIGEL J., 1995, SEED DEV GERMINATION; Kikuchi K, 2006, ANN BOT-LONDON, V98, P545, DOI 10.1093/aob/mcl145; LINDSTROM MJ, 1976, AGRON J, V68, P137, DOI 10.2134/agronj1976.00021962006800010038x; MANOHAR MS, 1964, NATURE, V202, P22, DOI 10.1038/202022a0; MCDONALD MB, 1988, CROP SCI, V28, P993, DOI 10.2135/cropsci1988.0011183X002800060026x; McDonald MB, 2001, PRINCIPLES SEED SCI; Meyer CJ, 2007, J EXP BOT, V58, P717, DOI 10.1093/jxb/erl244; Orzeszko-Rywka A, 2003, PLANT SOIL ENVIRON, V49, P249, DOI 10.17221/4121-PSE; Ryu CM, 2006, BIOL CONTROL, V39, P282, DOI 10.1016/j.biocontrol.2006.04.014; SANTOS DSB, 1989, SEED SCI TECHNOL, V17, P601; SHARPLES GC, 1981, HORTSCIENCE, V16, P661; SHAYKEWICH CF, 1973, J EXP BOT, V24, P1056, DOI 10.1093/jxb/24.6.1056; Sikhao P, 2015, SCI HORTIC-AMSTERDAM, V184, P85, DOI 10.1016/j.scienta.2014.12.028; Slatyer R., 1967, PLANT WATER RELATION; van der Weele CM, 2000, J EXP BOT, V51, P1555, DOI 10.1093/jexbot/51.350.1555; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Verslues PE, 1998, PLANT PHYSIOL, V116, P1403, DOI 10.1104/pp.116.4.1403; VERTUCCI CW, 1987, PLANT PHYSIOL, V85, P224, DOI 10.1104/pp.85.1.224; WAGGONER PE, 1976, PLANT PHYSIOL, V57, P153, DOI 10.1104/pp.57.2.153; WILLIAMS J, 1971, J EXP BOT, V22, P586, DOI 10.1093/jxb/22.3.586	48	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232875	10.1371/journal.pone.0232875	http://dx.doi.org/10.1371/journal.pone.0232875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407357	Green Published, gold			2022-12-26	WOS:000537490700042
J	Comins, CA; Rucinski, KB; Baral, S; Abebe, SA; Mulu, A; Schwartz, SR				Comins, Carly A.; Rucinski, Katherine B.; Baral, Stefan; Abebe, Samuele A.; Mulu, Andargachew; Schwartz, Sheree R.			Vulnerability profiles and prevalence of HIV and other sexually transmitted infections among adolescent girls and young women in Ethiopia: A latent class analysis	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RISK BEHAVIORS; ADHERENCE; PREDICTORS; DISEASES; SEX; MEN	Background Adolescent girls and young women (AGYW) aged 15-24 years have among the highest risk for HIV and other sexually transmitted infections (STI) across sub-Saharan Africa. A latent class analysis (LCA) was conducted to identify intersecting social- and structural-level determinants of HIV/STI acquisition among AGYW in Ethiopia. Methods AGYW were recruited from venues using time-location sampling, completing an interviewer-administered behavioral survey and biological testing for HIV, syphilis, and chlamydia. LCA was used to identify distinct groups, defined by social- and structural-level determinants of HIV/STI risk, among AGYW. Prevalence ratios (PR) and 95% confidence intervals (CI) compared differences in HIV/STI prevalence by group. Results A total of 1,501 AGYW were enrolled across Addis Ababa (March-May 2018) and Gambella (June-July 2019). We identified three patterns of vulnerability defined by schooling status, migration history, food insecurity, orphan status, social support, and employment. We labeled these groups as "highly vulnerable" (representing similar to 21% of the population), "stable, out-of-school, migrated" (similar to 42%), and "stable, in-school, never migrated" (similar to 37%). STI prevalence was nearly two-fold higher among AGYW in the "highly vulnerable" group compared to AGYW in the "stable, in-school, never migrated" group (PR 1.93; 95% CI 1.33, 2.80). Conclusions Characterizing patterns of vulnerability among AGYW that reflect higher-level social and structural factors can help facilitate early identification of AGYW at the highest risk of HIV/STI acquisition, thus differentiating groups of AGYW who may most benefit from targeted HIV prevention interventions during adolescence and early adulthood.	[Comins, Carly A.; Rucinski, Katherine B.; Baral, Stefan; Schwartz, Sheree R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Abebe, Samuele A.; Mulu, Andargachew] Armauer Hansen Res Inst AHRI, Addis Ababa, Ethiopia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Comins, CA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	ccomins1@jhu.edu	Mulu, Andargachew/GMW-4823-2022; Baral, Stefan/AAG-4818-2020	Mulu, Andargachew/0000-0003-2862-0175; Baral, Stefan/0000-0002-5482-2419; Rucinski, Katherine/0000-0002-9858-5953	Project SOAR [AID-OAA-140060]; United States President's Emergency Plan for AIDS Relief (PEPFAR); United States Agency for International Development (USAID) [115896]; National Institute of Allergy and Infectious Diseases [T32 AI102623]	Project SOAR; United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Project SOAR (Cooperative agreement AID-OAA-140060), made possible by the generous support of the American people through the United States President's Emergency Plan for AIDS Relief (PEPFAR), United States Agency for International Development (USAID, 115896: Dr. Stefan Baral), and National Institute of Allergy and Infectious Diseases (T32 AI102623: Dr. Katherine B. Rucinski). The contents of this paper are the sole responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID, or the United States Government.	Ankrah DNA, 2016, PATIENT PREFER ADHER, V10, P329, DOI 10.2147/PPA.S96691; [Anonymous], 2005, PLACE PRIOR LOC AIDS; [Anonymous], 2011, MULT CONC SEX PARTN; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Becker ML, 2018, JAIDS-J ACQ IMM DEF, V79, P296, DOI 10.1097/QAI.0000000000001826; Bergman LR, 2006, MERRILL PALMER QUART, V52, P601, DOI 10.1353/mpq.2006.0023; Bermudez LG, 2016, AIDS CARE, V28, P83, DOI 10.1080/09540121.2016.1176681; Bill & Melinda Gates Foundation, 2018, GOALK REP 2018; Browne F., 2015, HIV RISK BEHAV ADOLE; Cluver LD, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000539; Cluver LD, 2015, J INT AIDS SOC, V18, P73, DOI 10.7448/IAS.18.7.20260; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; De Neve JW, 2015, LANCET GLOB HEALTH, V3, pE470, DOI 10.1016/S2214-109X(15)00087-X; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Department of Economic and Social Affairs United Nations., 2015, YOUTH POPULATION TRE; Erulkar A, 2017, JOURNEY OUT OF SCH G; EZRA M, 2001, ECOLOGICAL DEGRADATI; Federal Democratic Republic of Ethiopia, 2016, ETH DEM HLTH SURV 20; Federal Ministry of Health Ethiopia, 2017, NAT GUID COMPR HIV P; Gibbs A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1290427; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Grimsrud Anna, 2017, J Int AIDS Soc, V20, P22024, DOI 10.7448/IAS.20.5.22024; Gross IM, 2016, AIDS PATIENT CARE ST, V30, P324, DOI 10.1089/apc.2015.0351; Haley DF, 2014, J WOMENS HEALTH, V23, P541, DOI 10.1089/jwh.2013.4654; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Harrell PT, 2012, DRUG ALCOHOL DEPEN, V122, P220, DOI 10.1016/j.drugalcdep.2011.10.001; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harrison A, 2015, CURR HIV-AIDS REP, V12, P207, DOI 10.1007/s11904-015-0261-0; ICAP at Columbia University, 2018, ETHIOPIA POPULATION; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Johnson LF, 2008, SEX TRANSM DIS, V35, P946, DOI 10.1097/OLQ.0b013e3181812d15; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Kilburn K, 2018, AIDS, V32, P1669, DOI 10.1097/QAD.0000000000001866; Konda KA, 2011, AIDS BEHAV, V15, P862, DOI 10.1007/s10461-010-9772-2; Kuhns LM, 2016, AIDS PATIENT CARE ST, V30, P185, DOI 10.1089/apc.2015.0328; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Lanza ST, 2011, INFANT BEHAV DEV, V34, P390, DOI 10.1016/j.infbeh.2011.02.002; Lehrer JA, 2006, PEDIATRICS, V118, P189, DOI 10.1542/peds.2005-1320; Lyons C, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3711-2; Mackesy-Amiti M, 2018, J ACQ IMMUN DEF SYND, V79, P1, DOI [10.1097/QAI.0000000000001770, DOI 10.1097/QAI.0000000000001770]; McCarty-Caplan D, 2014, AIDS BEHAV, V18, P1339, DOI 10.1007/s10461-013-0622-x; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nguyen N, 2019, JAIDS-J ACQ IMM DEF, V82, P24, DOI 10.1097/QAI.0000000000002096; Onyango MA, 2015, JAIDS-J ACQ IMM DEF, V68, pS131, DOI 10.1097/QAI.0000000000000455; Operario D, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-25; Price JT, 2018, JAIDS-J ACQ IMM DEF, V77, P53, DOI 10.1097/QAI.0000000000001567; Salam RA, 2016, J ADOLESCENT HEALTH, V59, pS11, DOI 10.1016/j.jadohealth.2016.05.022; Santelli JS, 2013, JAIDS-J ACQ IMM DEF, V63, P393, DOI 10.1097/QAI.0b013e3182926795; Saul J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208167; Schaefer R, 2017, AIDS, V31, P1461, DOI [10.1097/qad.0000000000001506, 10.1097/QAD.0000000000001506]; Schwartz SR, 2019, BMJ QUAL SAF, V28, P257, DOI 10.1136/bmjqs-2018-008339; Sexton J, 2005, SEX TRANSM DIS, V32, P351, DOI 10.1097/01.olq.0000154504.54686.d1; Shacham E, 2017, AIDS CARE, V29, P189, DOI 10.1080/09540121.2016.1204422; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Stoner MCD, 2019, AIDS, V33, P83, DOI 10.1097/QAD.0000000000002037; Tsevat DG, 2017, AM J OBSTET GYNECOL, V216, P1, DOI 10.1016/j.ajog.2016.08.008; UNAIDS, 2018, TRANS SEX HIV RISK A; UNAIDS, 2016, HIV PREV AD GIRLS YO; UNAIDS (Joint United Nations Programme on HIV and AIDS), 2018, DAT 2018; Wamoyi J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20992; Wang Y, 2019, AIDS BEHAV, V23, pS183, DOI 10.1007/s10461-019-02537-1; Weine SM, 2012, AIDS BEHAV, V16, P1605, DOI 10.1007/s10461-012-0183-4; White D, 2017, ARCH SEX BEHAV, V46, P961, DOI 10.1007/s10508-016-0743-1; World Bank, 2015, ETH URB REV URB I MI; Ziraba A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197479	65	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232598	10.1371/journal.pone.0232598	http://dx.doi.org/10.1371/journal.pone.0232598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407394	Green Published, gold			2022-12-26	WOS:000537490700024
J	Hammond, A; Stuijfzand, B; Avison, MB; Hay, AD				Hammond, Ashley; Stuijfzand, Bobby; Avison, Matthew B.; Hay, Alastair D.			Antimicrobial resistance associations with national primary care antibiotic stewardship policy: Primary care-based, multilevel analytic study	PLOS ONE			English	Article							GENERAL-PRACTICE; COMMUNITY	Background Recent UK antibiotic stewardship policies have resulted in significant changes in primary care dispensing, but whether this has impacted antimicrobial resistance is unknown. Aim To evaluate associations between changes in primary care dispensing and antimicrobial resistance in community-acquired urinary Escherichia coli infections. Methods Multilevel logistic regression modelling investigating relationships between primary care practice level antibiotic dispensing for approximately 1.5 million patients in South West England and resistance in 152,704 community-acquired urinary E. coli between 2013 and 2016. Relationships presented for within and subsequent quarter drug-bug pairs, adjusted for patient age, deprivation, and rurality. Results In line with national trends, overall antibiotic dispensing per 1000 registered patients fell 11%. Amoxicillin fell 14%, cefalexin 20%, ciprofloxacin 24%, co-amoxiclav 49% and trimethoprim 8%. Nitrofurantoin increased 7%. Antibiotic reductions were associated with reduced within quarter same-antibiotic resistance to: amoxicillin, ciprofloxacin and trimethoprim. Subsequent quarter reduced resistance was observed for trimethoprim and amoxicillin. Antibiotic dispensing reductions were associated with increased within and subsequent quarter resistance to cefalexin and co-amoxiclav. Increased nitrofurantoin dispensing was associated with reduced within and subsequent quarter trimethoprim resistance without affecting nitrofurantoin resistance. Conclusions This evaluation of a national primary care stewardship policy on antimicrobial resistance in the community suggests both hoped-for benefits and unexpected harms. Some increase in resistance to cefalexin and co-amoxiclav could result from residual confounding. Randomised controlled trials are urgently required to investigate causality.	[Hammond, Ashley; Hay, Alastair D.] Univ Bristol, Bristol Med Sch, Ctr Acad Primary Care, Bristol, Avon, England; [Stuijfzand, Bobby] Univ Bristol, Jean Golding Inst, Royal Ft House, Bristol, Avon, England; [Avison, Matthew B.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol	Hammond, A (corresponding author), Univ Bristol, Bristol Med Sch, Ctr Acad Primary Care, Bristol, Avon, England.	ashley.hammond@bristol.ac.uk		Hay, Alastair/0000-0003-3012-375X; Hammond, Ashley/0000-0002-6657-1514; Stuijfzand, Bobby/0000-0002-2782-3408; Avison, Matthew/0000-0003-1454-8440	 [NE/N01961X/1]; NERC [NE/N01961X/1] Funding Source: UKRI	; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Antimicrobial Resistance Cross Council Initiative supported by the seven research councils (www.mrc.ac.uk/amr).Grant reference is NE/N01961X/1.	Arcilla MS, 2017, LANCET INFECT DIS, V17, P78, DOI 10.1016/S1473-3099(16)30319-X; Balinskaite V, 2019, CLIN INFECT DIS, V69, P233, DOI 10.1093/cid/ciy904; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Bevan ER, 2018, MBIO, V9, DOI 10.1128/mBio.02408-18; Bryce A, 2018, J ANTIMICROB CHEMOTH; Butler CC, 2007, BRIT J GEN PRACT, V57, P785; Costelloe Ceire, 2010, BMJ, V340, pc2096, DOI 10.1136/bmj.c2096; Curtice John, 2019, BRIT SOCIAL ATTITUDE; Department for Communities and Local Government, 2011, ENGLISH INDICES DEPR; Dolk FCK, 2018, J ANTIMICROB CHEMOTH, V73, P2, DOI 10.1093/jac/dkx504; Enne VI, 2010, J ANTIMICROB CHEMOTH, V65, P179, DOI 10.1093/jac/dkp443; Findlay J, 2019, BIORXIV; Gharbi M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l525; Gottesman BS, 2009, CLIN INFECT DIS, V49, P869, DOI 10.1086/605530; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hay AD, 2016, BMJ BRIT MED J, V352, pI939, DOI DOI 10.1136/BMJ.I939; Heinemann JA, 2000, DRUG DISCOV TODAY, V5, P195, DOI 10.1016/S1359-6446(00)01483-5; Hox J.J, 2010, MULTILEVEL ANAL TECH, V2nd ed., DOI [10.4324/9780203852279, DOI 10.4324/9780203852279]; Ironmonger D, 2018, J ANTIMICROB CHEMOTH, V73, P787, DOI 10.1093/jac/dkx465; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kumar M, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02023; Low M, 2019, LANCET INFECT DIS, V19, P419, DOI 10.1016/S1473-3099(18)30676-5; National Institute for Health and Care Excellence (NICE), 2018, UR TRACT INF LOW ANT; NHS Digital, 2019, PAT REG GP PRACT 201; NHS England, 2015, QUAL PREM 2015 16 GU; Pouwels KB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218134; Pouwels KB, 2018, J ANTIMICROB CHEMOTH, V73, P1700, DOI 10.1093/jac/dky031; Priest P, 2001, BMJ-BRIT MED J, V323, P1037, DOI 10.1136/bmj.323.7320.1037; Public Health England, 2018, ENGL SURV PROGR ANT; R Core Team, 2021, R LANGUAGE ENV STAT; Sommet A, 2004, J ANTIMICROB CHEMOTH, V54, P524, DOI 10.1093/jac/dkh342; Tonkin-Crine SKG, 2017, COCHRANE DB SYST REV, P9, DOI DOI 10.1038/S41598-021-87369-7; Wang H, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2012-001801, 10.1136/bmjopen-2013-003320]; Yamamoto S, 1997, J UROLOGY, V157, P1127, DOI 10.1016/S0022-5347(01)65154-1	35	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232903	10.1371/journal.pone.0232903	http://dx.doi.org/10.1371/journal.pone.0232903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407346	Green Published, gold			2022-12-26	WOS:000537490700046
J	Valerio, VC; Walther, OJ; Eilitta, M; Cisse, B; Muneepeerakul, R; Kiker, GA				Valerio, Valerie C.; Walther, Olivier J.; Eilitta, Marjatta; Cisse, Brahima; Muneepeerakul, Rachata; Kiker, Gregory A.			Network analysis of regional livestock trade in West Africa	PLOS ONE			English	Article							RAINFALL	In West Africa, long and complex livestock value chains connect producers mostly in the Sahel with consumption basins in urban areas and the coast. Regional livestock trade is highly informal and, despite recent efforts to understand animal movement patterns in the region, remains largely unrecorded. Using CILSS' database on intraregional livestock trade, we built yearly and overall weighted networks of animal movements between markets. We mapped and characterized the trade networks, identified market communities, key markets and their roles. Additionally, we compared the observed network properties with null-model generated ensembles. Most movements corresponded to cattle, were made by vehicle, and originated in Burkina Faso. We found that live animals in the central and eastern trade basins flow through well-defined, long distance trade corridors where markets tend to trade in a disassortive way with others in their proximity. Modularity- based communities indicated that both national and cross-border trade groups exist. The network's degree and link distributions followed a log-normal or a power-law distribution, and key markets located primarily in urban centers and near borders serve as hubs that give peripheral markets access to the regional network. The null model ensembles could not reproduce the observed higher-level properties, particularly the propinquity and highly negative assortativity, suggesting that other possibly spatial factors shape the structure of regional live animal trade. Our findings support eliminating cross-border impediments and improving the condition of the regional road network, which limit intraregional trade of and contribute to the high prices of food products in West Africa. Although with limitations, our study sheds light on the abstruse structure of regional livestock trade, and the role of trade communities and markets in West Africa.	[Valerio, Valerie C.; Muneepeerakul, Rachata; Kiker, Gregory A.] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Walther, Olivier J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Eilitta, Marjatta] Cultivating New Frontiers Agr CNFA, Washington, DC USA; [Cisse, Brahima] Com Permanent Inter Etats Lutte Secheresse Sahel, Ouagadougou, Burkina Faso	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Valerio, VC (corresponding author), Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA.	valerie.valerio@ufl.edu	; Kiker, Gregory/K-6149-2017	Walther, Olivier/0000-0002-5768-2845; Kiker, Gregory/0000-0001-6215-0686	United States Agency for International Development (USAID) Bureau for Food Security as part of the Feed the Future Innovation Lab for Livestock Systems [AID-OAA-L-15-00003]; USDA-NIFA NNF proposal USDA National Institute of Food and Agriculture [2014-10398]	United States Agency for International Development (USAID) Bureau for Food Security as part of the Feed the Future Innovation Lab for Livestock Systems(United States Agency for International Development (USAID)); USDA-NIFA NNF proposal USDA National Institute of Food and Agriculture	This work was funded in whole or part by the United States Agency for International Development (USAID) Bureau for Food Security under Agreement #AID-OAA-L-15-00003 as part of the Feed the Future Innovation Lab for Livestock Systems. This work was also partly supported by USDA-NIFA NNF proposal #2014-10398 USDA National Institute of Food and Agriculture. Any opinions, findings, conclusions, or recommendations expressed here are those of the authors alone and do not necessarily reflect the view of the United States Agency for International Development (USAID) or the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen T., 2017, W AFRICAN PAPERS; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Apolloni A, 2018, PLOS ONE, V13, P1, DOI DOI 10.1371/J0URNAL.P0NE.0191565; Bossard L., 2009, REGIONAL ATLAS W AFR; CILSS, 2016, W AFRICAN LANDSCAPES; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075570; Dube C, 2009, TRANSBOUND EMERG DIS, V56, P73, DOI 10.1111/j.1865-1682.2008.01064.x; Elbehri A., 2013, REBUILDING W AFRICAS; Fagiolo G, 2013, J EC INTERACT COORD; FEWSNET, 2016, W AFR FOOD SEC AL; FEWSNET, 2015, BURK FAS FOOD SEC OU; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Herrero M., 2014, AFRICAN LIVESTOCK FU; Hollinger F, 2015, AGR GROWTH W AFRICA, P1; Josserand H.P., 2013, ASSESSMENT VOLUME VA; Kemi AO, 2016, IOSR J AGR VET SCI, V9, P77; Motta P, 2017, SCI REP-UK, V7, DOI 10.1038/srep43932; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nicholson SE, 2018, INT J CLIMATOL, V38, P3770, DOI 10.1002/joc.5530; Nicholson SE, 2018, GLOBAL PLANET CHANGE, V165, P114, DOI 10.1016/j.gloplacha.2017.12.014; Nicolas G, 2018, PLOS ONE, V13, P1, DOI DOI 10.1371/; OECD, 2019, AFR DAT URB AFR; OECD/SWAC, 2019, 23 OECDSWAC; Office of the Chief Economist, 2018, OCE20181 WORLD AGR O; Pannhausen C, 2010, REGIONAL AG TRADE W; Pebesma E, 2018, R J, V10, P439; Soule BG, 2008, DEV LOCAL REGIONAL M; SWAC-OECD/ECOWAS, 2008, LIV REG MARK SAH W A; Terpend N., 2006, BILAN CONNAISSANCES; Thebaud B, 2018, TRANSHUMANCE LIVESTO; Van Den Hoek J., 2017, W AFRICAN PAPERS, DOI [10.1787/13ba9f2e-en, DOI 10.1787/13BA9F2E-EN]; Walther OJ, 2019, WOMEN TRADE NETWORKS; Walther OJ, 2015, J DEV STUD, V51, P603, DOI 10.1080/00220388.2015.1010152; Walther OJ, 2014, J MOD AFR STUD, V52, P179, DOI 10.1017/S0022278X14000032; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams T.O., 2006, IMPROVING LIVESTOCK; World Bank, 2007, BURK FAS CHALL EXP D; World Bank, 2015, 97279AFR WORLD BANK; World Bank, 2010, DIAGN TRAD INT STUD; ZANIN M, 2018, J ADV TRANSPORT, V2018, P1, DOI DOI 10.1155/2018/3156137	45	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232681	10.1371/journal.pone.0232681	http://dx.doi.org/10.1371/journal.pone.0232681			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407336	gold, Green Published			2022-12-26	WOS:000537490700030
J	Sprygin, A; Pestova, Y; Bjadovskaya, O; Prutnikov, P; Zinyakov, N; Kononova, S; Ruchnova, O; Lozovoy, D; Chvala, I; Kononov, A				Sprygin, Alexander; Pestova, Yana; Bjadovskaya, Olga; Prutnikov, Pavel; Zinyakov, Nikolay; Kononova, Svetlana; Ruchnova, Olga; Lozovoy, Dmitiy; Chvala, Ilya; Kononov, Aleksandr			Evidence of recombination of vaccine strains of lumpy skin disease virus with field strains, causing disease	PLOS ONE			English	Article							GENETIC-RECOMBINATION; EPIDEMIOLOGY; EVOLUTION; GENOME; GAIN	Vaccination against lumpy skin disease (LSD) is crucial for maintaining the health of animals and the economic sustainability of farming. Either homologous vaccines consisting of live attenuated LSD virus (LSDV) or heterologous vaccines consisting of live attenuated sheeppox or goatpox virus (SPPV/GPPV) can be used for control of LSDV. Although SPPV/GTPV-based vaccines exhibit slightly lower efficacy than live attenuated LSDV vaccines, they do not cause vaccine-induced viremia, fever, and clinical symptoms of the disease following vaccination, caused by the replication capacity of live attenuated LSDVs. Recombination of capripoxviruses in the field was a long-standing hypothesis until a naturally occurring recombinant LSDV vaccine isolate was detected in Russia, where the sheeppox vaccine alone is used. This occurred after the initiation of vaccination campaigns using LSDV vaccines in the neighboring countries in 2017, when the first cases of presumed vaccine-like isolate circulation were documented with concurrent detection of a recombinant vaccine isolate in the field. The follow-up findings presented herein show that during the period from 2015 to 2018, the molecular epidemiology of LSDV in Russia split into two independent waves. The 2015-2016 epidemic was attributable to the field isolate. Whereas the 2017 epidemic and, in particular, the 2018 epidemic represented novel disease importations that were not genetically linked to the 2015-2016 field-type incursions. This demonstrated a new emergence rather than the continuation of the field-type epidemic. Since recombinant vaccine-like LSDV isolates appear to have entrenched across the country's border, the policy of using certain live vaccines requires revision in the context of the biosafety threat it presents.	[Sprygin, Alexander; Pestova, Yana; Bjadovskaya, Olga; Prutnikov, Pavel; Zinyakov, Nikolay; Kononova, Svetlana; Ruchnova, Olga; Lozovoy, Dmitiy; Chvala, Ilya; Kononov, Aleksandr] Fed Ctr Anim Hlth, Vladimir, Russia	Federal Centre for Animal Health	Sprygin, A (corresponding author), Fed Ctr Anim Hlth, Vladimir, Russia.	spriginav@mail.ru	Sprygin, Alexander/L-2752-2019	Sprygin, Alexander/0000-0001-5982-3675; Zinyakov, Nikolay/0000-0002-3015-5594; Chvala, Ilya/0000-0002-1659-3256				Abutarbush S., 2013, TRANSBOUND EMERG DIS, V62, P549; Abutarbush SM, 2016, TRANSBOUND EMERG DIS, V63, pE213, DOI 10.1111/tbed.12257; Adedeji AJ, 2019, TRANSBOUND EMERG DIS, V66, P1631, DOI 10.1111/tbed.13197; Agianniotaki EI, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00550-17, 10.1128/genomea.00550-17]; Agianniotaki EI, 2017, J VIROL METHODS, V249, P48, DOI 10.1016/j.jviromet.2017.08.011; Aleksandr K, 2020, ARCH VIROL, V165, P1343, DOI 10.1007/s00705-020-04607-5; Alexander S, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4412-z; Argyros R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062229; Bull JJ, 2018, TRENDS MICROBIOL, V26, P6, DOI 10.1016/j.tim.2017.09.007; Calistri P, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5638; CARN VM, 1995, EPIDEMIOL INFECT, V114, P219, DOI 10.1017/S0950268800052067; Davies F. G., 1991, World Animal Review, V68, P37; DAVIES FG, 1982, J HYG-CAMBRIDGE, V88, P95, DOI 10.1017/S002217240006993X; Eclercy J, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030296; El-Tholoth M, 2016, TRANSBOUND EMERG DIS, V63, pE288, DOI 10.1111/tbed.12344; Gari G, 2011, PREV VET MED, V102, P274, DOI 10.1016/j.prevetmed.2011.07.003; GERSHON PD, 1989, J GEN VIROL, V70, P485, DOI 10.1099/0022-1317-70-2-485; GERSHON PD, 1988, VIROLOGY, V164, P341, DOI 10.1016/0042-6822(88)90547-8; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hanley Kathryn A, 2011, Evolution (N Y), V4, P635; HENDERSON LM, 1990, AM J VET RES, V51, P1656; Hughes AL, 2005, MOL PHYLOGENET EVOL, V35, P186, DOI 10.1016/j.ympev.2004.12.008; Kara PD, 2018, VACCINE, V36, P4708, DOI 10.1016/j.vaccine.2018.06.017; Kolcov A., 2018, EPIZONE M AUG 27 30; Kononov A, 2019, ARCH VIROL, V164, P1575, DOI 10.1007/s00705-019-04229-6; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lyubvina I.V., 2016, SAMARSKII VESTNIK, V14, P38; Manic M, 2019, TRANSBOUND EMERG DIS, V66, P2087, DOI 10.1111/tbed.13261; McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100; OIE, 2019, TERR AN HLTH COD INF; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Roy P, 2018, TRANSBOUND EMERG DIS, V65, P32, DOI 10.1111/tbed.12763; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sprygin A, 2019, VIRUS RES, V269, DOI 10.1016/j.virusres.2019.05.015; Sprygin A, 2018, TRANSBOUND EMERG DIS, V65, P1137, DOI 10.1111/tbed.12897; Sprygin A, 2018, TRANSBOUND EMERG DIS, V65, P1514, DOI 10.1111/tbed.12889; Sprygin AV, 2014, J VECTOR ECOL, V39, P306, DOI 10.1111/jvec.12105; Sprygin A, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.01733-18; Sprygin A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207480; Staden R, 2000, Methods Mol Biol, V132, P115; Tasioudi KE, 2016, TRANSBOUND EMERG DIS, V63, P260, DOI 10.1111/tbed.12497; Toplak I, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00882-17, 10.1128/genomea.00882-17]; Tulman ER, 2001, J VIROL, V75, P7122, DOI 10.1128/JVI.75.15.7122-7130.2001; Tuppurainen ESM, 2020, PREV VET MED, V181, DOI 10.1016/j.prevetmed.2018.12.006; Tuppurainen ESM, 2017, TRANSBOUND EMERG DIS, V64, P729, DOI 10.1111/tbed.12444; VESELKIN G. A., 1966, ENTOMOL OBOZRENIE, V45, P779; VESELKIN GA, 1981, PARAZITOLOGIYA+, V15, P371; Weiss K. E., 1968, Virology Monographs, V3, P111	48	29	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232584	10.1371/journal.pone.0232584	http://dx.doi.org/10.1371/journal.pone.0232584			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401805	Green Published, gold			2022-12-26	WOS:000537481000023
J	Klein, J; Neilen, M; van Verk, M; Dutilh, BE; van den Ackerveken, G				Klein, Joel; Neilen, Manon; van Verk, Marcel; Dutilh, Bas E.; van den Ackerveken, Guido			Genome reconstruction of the non-culturable spinach downy mildew Peronospora effusa by metagenome filtering	PLOS ONE			English	Article							FILAMENTOUS PLANT-PATHOGENS; HORIZONTAL GENE-TRANSFER; HYALOPERONOSPORA-ARABIDOPSIDIS; EVOLUTION; SEQUENCE; PROTEINS; SUPPRESSION; AVIRULENCE; ANNOTATION; MECHANISMS	Peronospora effusa (previously known as P. farinosa f. sp. spinaciae, and here referred to as Pfs) is an obligate biotrophic oomycete that causes downy mildew on spinach (Spinacia oleracea). To combat this destructive many disease resistant cultivars have been bred and used. However, new Pfs races rapidly break the employed resistance genes. To get insight into the gene repertoire of Pfs and identify infection-related genes, the genome of the first reference race, Pfs1, was sequenced, assembled, and annotated. Due to the obligate biotrophic nature of this pathogen, material for DNA isolation can only be collected from infected spinach leaves that, however, also contain many other microorganisms. The obtained sequences can, therefore, be considered a metagenome. To filter and obtain Pfs sequences we utilized the CAT tool to taxonomically annotate ORFs residing on long sequences of a genome pre-assembly. This study is the first to show that CAT filtering performs well on eukaryotic contigs. Based on the taxonomy, determined on multiple ORFs, contaminating long sequences and corresponding reads were removed from the metagenome. Filtered reads were re-assembled to provide a clean and improved Pfs genome sequence of 32.4 Mbp consisting of 8,635 scaffolds. Transcript sequencing of a range of infection time points aided the prediction of a total of 13,277 gene models, including 99 RxLR(-like) effector, and 14 putative Crinkler genes. Comparative analysis identified common features in the predicted secretomes of different obligate biotrophic oomycetes, regardless of their phylogenetic distance. Their secretomes are generally smaller, compared to hemi-biotrophic and necrotrophic oomycete species. We observe a reduction in proteins involved in cell wall degradation, in Nep1-like proteins (NLPs), proteins with PAN/apple domains, and host translocated effectors. The genome of Pfs1 will be instrumental in studying downy mildew virulence and for understanding the molecular adaptations by which new isolates break spinach resistance.	[Klein, Joel; Neilen, Manon; van Verk, Marcel; van den Ackerveken, Guido] Univ Utrecht, Plant Microbe Interact, Dept Biol, Utrecht, Netherlands; [van Verk, Marcel] KeyGene, Crop Data Sci, Wageningen, Netherlands; [Dutilh, Bas E.] Univ Utrecht, Dept Biol Theoret Biol & Bioinformat, Utrecht, Netherlands	Utrecht University; Utrecht University	van den Ackerveken, G (corresponding author), Univ Utrecht, Plant Microbe Interact, Dept Biol, Utrecht, Netherlands.	g.vandenackerveken@uu.nl	Dutilh, Bas E./B-9719-2011; Klein, Joel/HDN-4496-2022; Van den Ackerveken, Guido/B-8568-2011	Dutilh, Bas E./0000-0003-2329-7890; Van den Ackerveken, Guido/0000-0002-0183-8978; Neilen, Manon/0000-0001-6261-5199; Klein, Joel/0000-0002-0134-5196	Netherlands Organisation for Scientific Research (NWO) Vidi grant [864.14.004]	Netherlands Organisation for Scientific Research (NWO) Vidi grant(Netherlands Organization for Scientific Research (NWO))	This study was part of a TopSector Horticulture and Starting Materials (TKI) project (https://topsectortu.nl/en) in collaboration with four industrial partners; Enza Zaden (https://www.enzazaden.com/), Pop Vriend Seeds (https://www.popvriendseeds.com/), RijkZwaan Breeding B.V. https://www.rijkzwaan.com/) and Syngenta (https://www.syngenta.com/).The grant was commissioned to GVdA. BED was supported by the Netherlands Organisation for Scientific Research (NWO) Vidi grant 864.14.004. Co-author MvV is currently employed by Keygene NV, but was employed by the UU at the time of study. The funders provided financial support for the research, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Adhikari BN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075072, 10.1371/journal.pone.0053810]; [Anonymous], 2019, SMRT ANAL SOFTWARE; Armitage AD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202305; Ascunce MS, 2017, MOL PHYLOGENET EVOL, V114, P199, DOI 10.1016/j.ympev.2017.06.013; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Blackman LM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-785; Bohlin J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3543-7; Bourret TB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192502; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Bushnell B, 2014, LBNL7065E; Cabral A, 2012, MOL PLANT MICROBE IN, V25, P697, DOI 10.1094/MPMI-10-11-0269; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Cook CE, 2016, NUCLEIC ACIDS RES, V44, pD20, DOI 10.1093/nar/gkv1352; Cooper AJ, 2008, MOL PLANT MICROBE IN, V21, P745, DOI 10.1094/MPMI-21-6-0745; Cui CM, 2019, MOL PLANT MICROBE IN, V32, P1559, DOI 10.1094/MPMI-04-19-0103-TA; De Bustos A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36665; Deb D, 2018, MOL PLANT MICROBE IN, V31, P374, DOI 10.1094/MPMI-07-17-0169-FI; Derevnina L, 2015, MOL PLANT MICROBE IN, V28, P1198, DOI 10.1094/MPMI-05-15-0112-R; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dong SM, 2015, CURR OPIN GENET DEV, V35, P57, DOI 10.1016/j.gde.2015.09.001; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Dussert Y, 2019, GENOME BIOL EVOL, V11, P954, DOI 10.1093/gbe/evz048; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ellis JG, 2009, CURR OPIN PLANT BIOL, V12, P399, DOI 10.1016/j.pbi.2009.05.004; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Feng CD, 2018, MOL PLANT MICROBE IN, V31, P1230, DOI 10.1094/MPMI-04-18-0085-A; Fletcher K, 2019, BIORXIV, DOI [10.1101/516526, DOI 10.1101/516526]; Fletcher K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5214-8; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; He ZL, 2016, NUCLEIC ACIDS RES, V44, pW236, DOI 10.1093/nar/gkw370; Hoff KJ, 2016, BIOINFORMATICS, V32, P767, DOI 10.1093/bioinformatics/btv661; Hu G, 2004, J EVOLUTION BIOL, V17, P1204, DOI 10.1111/j.1420-9101.2004.00786.x; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jashni MK, 2015, MOL PLANT MICROBE IN, V28, P996, DOI 10.1094/MPMI-04-15-0074-R; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kamoun, 2009, OOMYCETE GENETICS GE, P47; Kandel SL, 2019, PLANT DIS, V103, P791, DOI 10.1094/PDIS-10-18-1720-FE; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kemen E, 2012, TRENDS PLANT SCI, V17, P448, DOI 10.1016/j.tplants.2012.04.005; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Klein J., 2018, GITHUB REPOSITORY; Koike S. T., 1992, California Agriculture, V46, P29; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larroque M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-605; Latijnhouwers M, 2003, TRENDS MICROBIOL, V11, P462, DOI 10.1016/j.tim.2003.08.002; Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93; Lee SC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003028; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Lyon R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148385; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Masson Florent, MBIO, V9, DOI [10.1128/mBio.00024-18, DOI 10.1128/MBIO.00024-18, DOI 10.1128/MBIO.01216-18]; McCarthy CGP, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00095-17, 10.1128/msphere.00095-17]; McGowan J, 2019, GENOME BIOL EVOL, V11, P189, DOI 10.1093/gbe/evy267; McGowan J, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00408-17; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meisrimler CN, 2019, PLANT J, V99, P1098, DOI 10.1111/tpj.14383; Meneghin J., 2009, GET GC CONTENT PERL; Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; Ooi HS, 2009, NUCLEIC ACIDS RES, V37, pW435, DOI 10.1093/nar/gkp254; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; R Core Team, 2021, R LANGUAGE ENV STAT; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Richards TA, 2011, P NATL ACAD SCI USA, V108, P15258, DOI 10.1073/pnas.1105100108; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Seidl MF, 2019, ANN REV PHYTOPATHOLO, V57; Seidl MF, 2012, GENOME BIOL EVOL, V4, P199, DOI 10.1093/gbe/evs003; Sharma R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1904-7; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smit A.F.A., 2015, REPEATMASKER OPEN 4; Soanes D, 2014, ANNU REV PHYTOPATHOL, V52, P583, DOI 10.1146/annurev-phyto-102313-050127; Sperschneider J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01168; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Team R, 2015, RSTUDIO INT DEV R; THINES M, 2019, BIORXIV, DOI DOI 10.1101/721027; Thines M, 2014, EUR J PLANT PATHOL, V138, P431, DOI 10.1007/s10658-013-0366-5; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; von Meijenfeldt FAB, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1817-x; Vurture GW, 2017, BIOINFORMATICS, V33, P2202, DOI 10.1093/bioinformatics/btx153; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, VVIII; Wilcoxon F, 1970, CRITICAL VALUES PROB, P171; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Zhang H, 2018, NUCLEIC ACIDS RES, V46, pW95, DOI 10.1093/nar/gky418	99	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0225808	10.1371/journal.pone.0225808	http://dx.doi.org/10.1371/journal.pone.0225808			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396560	gold, Green Published, Green Submitted			2022-12-26	WOS:000537475000001
J	Kwon, OS; Lee, H; Kong, HJ; Kwon, EJ; Park, JE; Lee, W; Kang, S; Kim, M; Kim, W; Cha, HJ				Kwon, Ok-Seon; Lee, Haeseung; Kong, Hyeon-Joon; Kwon, Eun-Ji; Park, Ji Eun; Lee, Wooin; Kang, Seungmin; Kim, Mirang; Kim, Wankyu; Cha, Hyuk-Jin			Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer	ONCOGENE			English	Article							TGF-BETA; EXPRESSION; INHIBITORS; GENE; GLYCOSYLATION; CANDIDATES; PROTEASOME; DULANERMIN; GALNAC-T14; MIGRATION	Despite the continual discovery of promising new cancer targets, drug discovery is often hampered by the poor druggability of these targets. As such, repurposing FDA-approved drugs based on cancer signatures is a useful alternative to cancer precision medicine. Here, we adopted an in silico approach based on large-scale gene expression signatures to identify drug candidates for lung cancer metastasis. Our clinicogenomic analysis identified GALNT14 as a putative driver of lung cancer metastasis, leading to poor survival. To overcome the poor druggability of GALNT14 in the control of metastasis, we utilized the Connectivity Map and identified bortezomib (BTZ) as a potent metastatic inhibitor, bypassing the direct inhibition of the enzymatic activity of GALNT14. The antimetastatic effect of BTZ was verified both in vitro and in vivo. Notably, both BTZ treatment and GALNT14 knockdown attenuated TGF beta-mediated gene expression and suppressed TGF beta-dependent metastatic genes. These results demonstrate that our in silico approach is a viable strategy for the use of undruggable targets in cancer therapies and for revealing the underlying mechanisms of these targets.	[Kwon, Ok-Seon; Kwon, Eun-Ji; Park, Ji Eun; Lee, Wooin; Cha, Hyuk-Jin] Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea; [Kwon, Ok-Seon; Cha, Hyuk-Jin] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 08826, South Korea; [Lee, Haeseung; Kim, Wankyu] Ewha Womans Univ, Dept Life Sci, Coll Nat Sci, Seoul 03760, South Korea; [Kong, Hyeon-Joon] Sogang Univ, Dept Life Sci, Coll Nat Sci, Seoul 04107, South Korea; [Kang, Seungmin] Ewha Womans Univ, KaiPharm, Seoul 03760, South Korea; [Kim, Mirang] Korea Res Inst Biosci & Biotechnol KRIBB, Personalized Genom Med Res Ctr, Daejeon 34141, South Korea; [Kwon, Ok-Seon] Korea Res Inst Biosci & Biotechnol KRIBB, Stem Cell Convergence Res Ctr, Daejeon 34141, South Korea; [Lee, Haeseung] Korea Inst Oriental Med, Future Med Div, Intellectual Informat Team, Daejeon 34054, South Korea	Seoul National University (SNU); Seoul National University (SNU); Ewha Womans University; Sogang University; Ewha Womans University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Institute of Oriental Medicine (KIOM)	Cha, HJ (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea.; Cha, HJ (corresponding author), Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 08826, South Korea.; Kim, W (corresponding author), Ewha Womans Univ, Dept Life Sci, Coll Nat Sci, Seoul 03760, South Korea.	wkim@ewha.ac.kr; hjcha93@snu.ac.kr	Lee, Wooin/K-7789-2012	Lee, Wooin/0000-0001-7805-869X; Lee, Haeseung/0000-0002-9947-4032; Cha, Hyuk-Jin/0000-0001-9277-2662	National Research Foundation of Korea [NRF-2017M3C9A5028691, NRF-2019R1C1C1008710, NRF-2017M3A9B3061843]	National Research Foundation of Korea(National Research Foundation of Korea)	We appreciate Jeong-Hwan Kim, Seon-Young Kim and Dong-Uk Kim at Korea Research Institute of Bioscience and Biotechnology (KRIBB) for helpful discussions. This work was supported by a grant from the National Research Foundation of Korea (NRF-2017M3C9A5028691 from HJ.C, NRF-2019R1C1C1008710 from OS.K and NRF-2017M3A9B3061843 from W.K).	Argyriou AA, 2008, BLOOD, V112, P1593, DOI 10.1182/blood-2008-04-149385; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bertolini F, 2015, NAT REV CLIN ONCOL, V12, P732, DOI 10.1038/nrclinonc.2015.169; Chang TP, 2015, J IMMUNOL, V194, P2942, DOI 10.4049/jimmunol.1402610; Chen B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16022; Dang CV, 2017, NAT REV CANCER, V17, P502, DOI 10.1038/nrc.2017.36; De Mariano M, 2015, ONCOTARGET, V6, P26335, DOI 10.18632/oncotarget.4501; Gandolfi S, 2017, CANCER METAST REV, V36, P561, DOI 10.1007/s10555-017-9707-8; Gayvert KM, 2016, CELL REP, V15, P2348, DOI 10.1016/j.celrep.2016.05.037; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Gross BJ, 2008, J AM CHEM SOC, V130, P440, DOI 10.1021/ja078125s; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hang HC, 2004, CHEM BIOL, V11, P337, DOI 10.1016/j.chembiol.2004.02.023; Huang DD, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705849; Iorio F, 2013, DRUG DISCOV TODAY, V18, P350, DOI 10.1016/j.drudis.2012.07.014; Jahchan NS, 2013, CANCER DISCOV, V3, P1364, DOI 10.1158/2159-8290.CD-13-0183; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kwon OS, 2019, ARCH PHARM RES, V42, P879, DOI 10.1007/s12272-019-01176-3; Kwon OS, 2015, ONCOTARGET, V6, P41916, DOI 10.18632/oncotarget.6019; Lazo JS, 2016, ANNU REV PHARMACOL, V56, P23, DOI 10.1146/annurev-pharmtox-010715-103440; Lee H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150460; Lee JS, 2015, NEURO-ONCOLOGY, V17, P95, DOI 10.1093/neuonc/nou145; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li AM, 2013, BIOCHEM BIOPH RES CO, V436, P486, DOI 10.1016/j.bbrc.2013.05.131; Liang KH, 2016, PHARMACOGENOMICS, V17, P353, DOI 10.2217/pgs.15.179; Maggiora G, 2014, J MED CHEM, V57, P3186, DOI 10.1021/jm401411z; Marquart J, 2018, JAMA ONCOL, V4, P1093, DOI 10.1001/jamaoncol.2018.1660; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Moon YW, 2015, CELL DEATH DIFFER, V22, P1341, DOI 10.1038/cdd.2014.228; Nagaraj AB, 2018, ONCOGENE, V37, P403, DOI 10.1038/onc.2017.328; Olsen D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00105; Oprea TI, 2015, ASSAY DRUG DEV TECHN, V13, P299, DOI 10.1089/adt.2015.29011.tiodrrr; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Shan JS, 2018, TRANSL ONCOL, V11, P786, DOI 10.1016/j.tranon.2018.04.003; Sleire L, 2017, PHARMACOL RES, V124, P74, DOI 10.1016/j.phrs.2017.07.013; Song KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13796; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Stern HM, 2010, CLIN CANCER RES, V16, P1587, DOI 10.1158/1078-0432.CCR-09-3108; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Tian HN, 2015, MOL CARCINOGEN, V54, P1159, DOI 10.1002/mc.22186; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; van Noort V, 2014, CANCER RES, V74, P5690, DOI 10.1158/0008-5472.CAN-13-3540; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; Wagle MC, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0051-4; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang ZQ, 2014, ONCOTARGET, V5, P544, DOI 10.18632/oncotarget.1652; Wu C, 2009, J BIOSCIENCES, V34, P389, DOI 10.1007/s12038-009-0045-z; Yeh CT, 2014, INT J CANCER, V134, P1214, DOI 10.1002/ijc.28439; Zeniya M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13486-x; Zhou X, 2017, J THORAC ONCOL, V12, pS1542, DOI 10.1016/j.jtho.2017.06.044	54	17	17	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	23					4567	4580		10.1038/s41388-020-1316-2	http://dx.doi.org/10.1038/s41388-020-1316-2		MAY 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LU5ZF	32388539				2022-12-26	WOS:000531196000001
J	Kang, JK; Heo, S; Kim, HP; Song, SH; Yun, H; Han, SW; Kang, GH; Bang, D; Kim, TY				Kang, Jun-Kyu; Heo, Sunghoon; Kim, Hwang-Phill; Song, Sang-Hyun; Yun, Hongseok; Han, Sae-Won; Kang, Gyeong Hoon; Bang, Duhee; Kim, Tae-You			Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing	PLOS ONE			English	Article							MUTATIONS; DNA; LANDSCAPE	Analyzing cell-free DNA (cfDNA) as a source of circulating tumor DNA is useful for diagnosing or monitoring patients with cancer. However, the concordance between cfDNA within liquid biopsy and genomic DNA (gDNA) within tumor tissue biopsy is still under debate. To evaluate the concordance in a clinical setting, we enrolled 54 patients with metastatic colorectal cancer and analyzed their plasma cfDNA, gDNA from peripheral blood mononuclear cells (PBMC), and gDNA from available matched tumor tissues using ultra-deep sequencing targeting 10 genes (38-kb size) recurrently mutated in colorectal cancer. We first established a highly reliable cut-off value using reference material. The sensitivity of detecting KRAS hotspot mutations in plasma was calculated as 100%, according to digital droplet PCR. We could selectively detect clinically important somatic alterations with a variant allele frequency as low as 0.18%. We next compared somatic mutations of the 10 genes between cfDNA and genomic DNA from tumor tissues and observed an overall 93% concordance rate between the two types of samples. Additionally, the concordance rate of patients with the time interval between liquid biopsy and tumor tissue biopsy within 6 months and no prior exposure to chemotherapy was much higher than those without. The patients with KRAS mutant fragments in plasma had poor prognosis than those without the mutant fragments (33 months vs. 63 months; p<0.05). Consequently, the profiling with our method could achieve highly concordant results and may facilitate the surveillance of the tumor status with liquid biopsy in CRC patients.	[Kang, Jun-Kyu; Kim, Hwang-Phill; Song, Sang-Hyun; Kim, Tae-You] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Kang, Jun-Kyu; Song, Sang-Hyun; Han, Sae-Won; Kang, Gyeong Hoon; Kim, Tae-You] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Heo, Sunghoon; Bang, Duhee] Yonsei Univ, Dept Chem, Seoul, South Korea; [Kim, Hwang-Phill] IMBDx Inc, Seoul, South Korea; [Yun, Hongseok; Han, Sae-Won; Kim, Tae-You] Seoul Natl Univ Hosp, Ctr Precis Med, Seoul, South Korea; [Han, Sae-Won; Kim, Tae-You] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kang, Gyeong Hoon] Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, TY (corresponding author), Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea.; Kim, TY (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.; Kim, TY (corresponding author), Seoul Natl Univ Hosp, Ctr Precis Med, Seoul, South Korea.; Kim, TY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	kimty@snu.ac.kr	Kang, Gyeong Hoon/F-1051-2010	Kang, Gyeong Hoon/0000-0003-2380-6675	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health Welfare [HI182282, HI14C1277]; Ministry of Science, ICT & Future Planning [2016M3A9B6026918, 2017M3A9A7050614]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health Welfare; Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	The authors are grateful to all members of our group for their helpful advice. This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare (HI182282, HI14C1277), and by the Ministry of Science, ICT & Future Planning (2016M3A9B6026918, 2017M3A9A7050614).	Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Chen KZ, 2019, CLIN CANCER RES, V25, P7058, DOI 10.1158/1078-0432.CCR-19-1213; Corcoran RB, 2018, NEW ENGL J MED, V379, P1754, DOI 10.1056/NEJMra1706174; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gale D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194630; Han SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064271; Heitzer E, 2019, NAT REV GENET, V20, P71, DOI 10.1038/s41576-018-0071-5; Husain H, 2017, JAMA-J AM MED ASSOC, V318, P1272, DOI 10.1001/jama.2017.12131; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kusnoor Sheila V, 2016, AMIA Jt Summits Transl Sci Proc, V2016, P112; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Lee DW, 2017, CANCER-AM CANCER SOC, V123, P3513, DOI 10.1002/cncr.30760; Lee DH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32900-6; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Pantel K, 2019, NAT REV CLIN ONCOL, V16, P409, DOI 10.1038/s41571-019-0187-3; Park JH, 2019, CLIN MOL HEPATOL, V25, P12, DOI 10.3350/cmh.2018.0067; Razavi P, 2019, NAT MED, V25, P1928, DOI 10.1038/s41591-019-0652-7; Robinson JT, 2017, CANCER RES, V77, pE31, DOI 10.1158/0008-5472.CAN-17-0337; Russo M, 2016, CANCER DISCOV, V6, P147, DOI 10.1158/2159-8290.CD-15-1283; Sacher AG, 2016, JAMA ONCOL, V2, P1014, DOI 10.1001/jamaoncol.2016.0173; Schwaederle M, 2016, CLIN CANCER RES, V22, P5497, DOI 10.1158/1078-0432.CCR-16-0318; Schwaederle MC, 2017, CLIN CANCER RES, V23, P5101, DOI 10.1158/1078-0432.CCR-16-2497; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Torga G, 2018, JAMA ONCOL, V4, P868, DOI 10.1001/jamaoncol.2017.4027; Wan JCM, 2017, NAT REV CANCER, V17, P223, DOI 10.1038/nrc.2017.7; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yaeger R, 2018, CANCER CELL, V33, P125, DOI 10.1016/j.ccell.2017.12.004	30	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232754	10.1371/journal.pone.0232754	http://dx.doi.org/10.1371/journal.pone.0232754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379795	Green Published, gold			2022-12-26	WOS:000537285700063
J	Ramos, B; Gordon, SV; Cunha, MV				Ramos, Beatriz; Gordon, Stephen, V; Cunha, Monica, V			Revisiting the expression signature of pks15/1 unveils regulatory patterns controlling phenolphtiocerol and phenolglycolipid production in pathogenic mycobacteria	PLOS ONE			English	Article							DIFFERENTIAL GENE; IRON HOMEOSTASIS; TUBERCULOSIS; BIOSYNTHESIS; VIRULENCE; ROLES; IDER	One of the most important and exclusive characteristics of mycobacteria is their cell wall. Amongst its constituent components are two related families of glycosylated lipids, diphthioceranates and phthiocerol dimycocerosate (PDIM) and its variant phenolic glycolipids (PGL). PGL have been associated with cell wall impermeability, phagocytosis, defence against nitrosative and oxidative stress and, intriguingly, biofilm formation. In bacteria from the Mycobacterium tuberculosis complex (MTBC), the biosynthetic pathway of the phenolphthiocerol moiety of PGL depends upon the expression of several genes encoding type I polyketide synthases (PKS), namely ppsA-E and pks15/1 which constitute the PDIM + PGL locus, and that are highly conserved in PDIM/PGL-producing strains. Consensus has not been achieved regarding the genetic organization of pks15/1 locus and knowledge is lacking on its transcriptional signature. Here we explore publicly available datasets of transcriptome data (RNA-seq) from more than 100 MTBC experiments in 40 growth conditions to outline the transcriptional structure and signature of pks15/1, using a differential expression approach to infer the regulatory patterns involving these and related genes. We show that pks1 expression is highly correlated with fadD22, Rv2949c, lppX, fadD29 and, also, pks6 and pks12, with the first three putatively integrating into a polycistronic structure. We evidence dynamic transcriptional heterogeneity within the genes involved in phenolphtiocerol and phenolic glycolipid production, most exhibiting up-regulation upon acidic pH and antibiotic exposure and down-regulation under hypoxia, dormancy, and low/high iron concentration. We finally propose a model based on transcriptome data in which sD positively regulates pks1, pks15 and fadD22, while sB and sE factors exert negative regulation at an upper level.	[Ramos, Beatriz; Cunha, Monica, V] Natl Inst Agr & Vet Res INIAV, IP, Oeiras, Portugal; [Ramos, Beatriz; Cunha, Monica, V] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes cE3c, Lisbon, Portugal; [Gordon, Stephen, V] Univ Coll Dublin, Sch Vet Med, Dublin, Ireland; [Gordon, Stephen, V] Univ Coll Dublin, Conway Inst, Dublin, Ireland; [Cunha, Monica, V] Univ Lisbon, Biosyst & Integrat Sci Inst BioISI, Fac Ciencias, Lisbon, Portugal	Universidade de Lisboa; University College Dublin; University College Dublin; BIOISI; Universidade de Lisboa	Cunha, MV (corresponding author), Natl Inst Agr & Vet Res INIAV, IP, Oeiras, Portugal.; Cunha, MV (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes cE3c, Lisbon, Portugal.; Cunha, MV (corresponding author), Univ Lisbon, Biosyst & Integrat Sci Inst BioISI, Fac Ciencias, Lisbon, Portugal.	monica.cunha@iniav.pt	Cunha, Mónica V./AAH-6246-2019	Cunha, Mónica V./0000-0003-0401-0276; Ramos, Beatriz/0000-0003-1471-9334; Gordon, Stephen/0000-0002-4833-5542	Programa Operacional de Competitividade e Internacionalizacao (POCI) (FEDER component); Programa Operacional Regional de Lisboa; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [POCI-01-0145-FEDER-029783, PTDC/CVT/117794/2010]; BioISI Research Units [UID/BIA/00329/2020, UID/Multi/04046/2020]	Programa Operacional de Competitividade e Internacionalizacao (POCI) (FEDER component); Programa Operacional Regional de Lisboa; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); BioISI Research Units	This work was funded by Programa Operacional de Competitividade e Internacionalizacao (POCI) (FEDER component), Programa Operacional Regional de Lisboa, and Fundacao para a Ciencia e a Tecnologia (FCT) (www.fct.pt), Portugal, in the scope of project "Colossus: Control Of tubercuLOsiS at the wildlife/livestock interface uSing innovative natUre-based Solutions"(ref. POCI-01-0145-FEDER-029783) awarded to MVC, project "MyPATH-Insights into Mycobacterium tuberculosis complex PATHogenesis: assessing the benefit of confinement-induced biofilm strategies by comparative genomics" (ref. PTDC/CVT/117794/2010) awarded to MVC, and strategic funding to cE3c and BioISI Research Units (UID/BIA/00329/2020 and UID/Multi/04046/2020]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Alnimr AM, 2015, BRAZ J MICROBIOL, V46, P641, DOI 10.1590/S1517-838246320140507; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Baker JJ, 2014, MOL MICROBIOL, V94, P56, DOI 10.1111/mmi.12688; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Boot M, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00083-18, 10.1128/aac.00083-18]; Burian J, 2012, J BIOL CHEM, V287, P299, DOI 10.1074/jbc.M111.302588; Calamita H, 2005, CELL MICROBIOL, V7, P233, DOI 10.1111/j.1462-5822.2004.00454.x; Chauhan R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11062; Chavadi SS, 2011, J BIOL CHEM, V286, P24616, DOI 10.1074/jbc.M111.247601; Chiaradia L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12718-4; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Daffe M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0021-2013; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; DU PC, 2016, FRONT MICROBIOL, V7, DOI DOI 10.3389/FRNICB.2016.01346; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Ferreras JA, 2008, CHEM BIOL, V15, P51, DOI 10.1016/j.chembiol.2007.11.010; Flentie K, 2016, J BACTERIOL; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; He WG, 2009, J AM CHEM SOC, V131, P16744, DOI 10.1021/ja904792q; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ignatov DV, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2197-6; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Lee JH, 2008, J BACTERIOL, V190, P699, DOI 10.1128/JB.01273-07; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Liu D, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2026-4; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Matern WM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00610; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mohandas P, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw016; Oberto J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-4; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Pandey R, 2014, MOL MICROBIOL, V91, P98, DOI 10.1111/mmi.12441; Pang JM, 2012, J BACTERIOL, V194, P715, DOI 10.1128/JB.06304-11; Peddireddy V, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00084; Quadri LEN, 2014, CRIT REV BIOCHEM MOL, V49, P179, DOI 10.3109/10409238.2014.896859; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Reiss DJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv300; Ridley CP, 2008, P NATL ACAD SCI USA, V105, P4595, DOI 10.1073/pnas.0710107105; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Rodriguez JG, 2014, MBIO, V5, DOI 10.1128/mBio.01125-14; Rousseau C, 2004, CELL MICROBIOL, V6, P277, DOI 10.1046/j.1462-5822.2004.00368.x; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Sachdeva P, 2010, FEBS J, V277, P605, DOI 10.1111/j.1742-4658.2009.07479.x; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Salim B, 2006, MUTATIONS MYCOBACTER, V62, P1251; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sia JK, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/747543; Simeone R, 2010, FEBS J, V277, P2715, DOI [10.1111/j.1742-4658.2010.07688.x, 10.1111/j.1742-464X.2010.07688.x]; Smith T, 2014, CURR TOP MICROBIOL, V374, P53, DOI 10.1007/82_2012_279; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Song NN, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1492-9; Sritharan M, 2016, J BACTERIOL, V198, P2399, DOI 10.1128/JB.00359-16; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Sundaramurthy V, 2007, MICROBES INFECT, V9, P1671, DOI 10.1016/j.micinf.2007.09.007; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turkarslan S, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.10; Vandal OH, 2009, J BACTERIOL, V191, P4714, DOI 10.1128/JB.00305-09; Vergnolle O, 2015, J BACTERIOL, V197, P1040, DOI 10.1128/JB.02546-14; World Health Organization, 2018, GLOB TUB REP 2018	68	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0229700	10.1371/journal.pone.0229700	http://dx.doi.org/10.1371/journal.pone.0229700			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379829	Green Published, gold, Green Submitted			2022-12-26	WOS:000537285700007
J	Abdelkarim, H; Hitchinson, B; Qu, XY; Banerjee, A; Komarova, YA; Gaponenko, V				Abdelkarim, Hazem; Hitchinson, Ben; Qu, Xinyan; Banerjee, Avik; Komarova, Yulia A.; Gaponenko, Vadim			NMR resonance assignment and structure prediction of the C-terminal domain of the microtubule end-binding protein 3	PLOS ONE			English	Article							I-TASSER; PLUS; EB1; DYNAMICS; COMPLEXES; SYSTEM	End-binding proteins (EBs) associate with the growing microtubule plus ends to regulate microtubule dynamics as well as the interaction with intracellular structures. EB3 contributes to pathological vascular leakage through interacting with the inositol 1,4,5-trisphosphate receptor 3 (IP3R3), a calcium channel located at the endoplasmic reticulum membrane. The C-terminal domain of EB3 (residues 200-281) is functionally important for this interaction because it contains the effector binding sites, a prerequisite for EB3 activity and specificity. Structural data for this domain is limited. Here, we report the backbone chemical shift assignments for the human EB3 C-terminal domain and computationally explore its EB3 conformations. Backbone assignments, along with computational models, will allow future investigation of EB3 structural dynamics, interactions with effectors, and will facilitate the development of novel EB3 inhibitors.	[Abdelkarim, Hazem; Hitchinson, Ben; Gaponenko, Vadim] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Qu, Xinyan; Komarova, Yulia A.] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA; [Qu, Xinyan; Komarova, Yulia A.] Univ Illinois, Ctr Lung Biol, Chicago, IL 60607 USA; [Banerjee, Avik] Univ Illinois, Dept Chem, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gaponenko, V (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.; Komarova, YA (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA.; Komarova, YA (corresponding author), Univ Illinois, Ctr Lung Biol, Chicago, IL 60607 USA.	ykomarov@uic.edu; vadimg@uic.edu			National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268201700007C]; American Cancer Society [132722-PF-18-196-01DMC]; National Institutes of Health (NIH)-National Cancer Institute (NCI) [R01CA188427]; Horizon award under the Congressionally Directed Medical Research Program (CDMPRP), Department of Defense (DoD) [W81XWH-38817-10509]	National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Cancer Society(American Cancer Society); National Institutes of Health (NIH)-National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Horizon award under the Congressionally Directed Medical Research Program (CDMPRP), Department of Defense (DoD)	Y.A.K.; HHSN268201700007C; The National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services. H.A.; 132722-PF-18-196-01DMC, The American Cancer Society V.G.; R01CA188427; The National Institutes of Health (NIH)-National Cancer Institute (NCI) grant A.B.; W81XWH-38817-10509; The Horizon award under the Congressionally Directed Medical Research Program (CDMPRP), Department of Defense (DoD).	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Ban R, 2009, J BIOL CHEM, V284, P28367, DOI 10.1074/jbc.M109.000273; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; BYERS B, 1964, P NATL ACAD SCI USA, V52, P1091, DOI 10.1073/pnas.52.4.1091; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; Collin GB, 1998, GENOMICS, V53, P359, DOI 10.1006/geno.1998.5542; De Groot CO, 2010, J BIOL CHEM, V285, P5802, DOI 10.1074/jbc.M109.068130; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ganguly A, 2012, J BIOL CHEM, V287, P43359, DOI 10.1074/jbc.M112.423905; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Geyer M, 2015, CELL REP, V12, P79, DOI 10.1016/j.celrep.2015.06.001; GIBBINS JR, 1969, J CELL BIOL, V41, P201, DOI 10.1083/jcb.41.1.201; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Kadi A, 1998, BIOCHEM BIOPH RES CO, V246, P690, DOI 10.1006/bbrc.1998.8536; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Komarova YA, 2012, MOL CELL, V48, P914, DOI 10.1016/j.molcel.2012.10.011; Kumar A, 2017, STRUCTURE, V25, P924, DOI 10.1016/j.str.2017.04.010; Li HP, 1997, P NATL ACAD SCI USA, V94, P1086, DOI 10.1073/pnas.94.4.1086; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; RIEHEMANN K, 1993, TRENDS BIOCHEM SCI, V18, P82, DOI 10.1016/0968-0004(93)90159-K; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Sen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074448; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Su LK, 2001, GENOMICS, V71, P142, DOI 10.1006/geno.2000.6428; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; van Haren J, 2014, CURR BIOL, V24, P1778, DOI 10.1016/j.cub.2014.06.037; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036	51	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0232338	10.1371/journal.pone.0232338	http://dx.doi.org/10.1371/journal.pone.0232338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421702	gold, Green Published			2022-12-26	WOS:000537499600009
J	Borey, M; Estelle, J; Caidi, A; Bruneau, N; Coville, JL; Hennequet-Antier, C; Mignon-Grasteau, S; Calenge, F				Borey, Marion; Estelle, Jordi; Caidi, Aziza; Bruneau, Nicolas; Coville, Jean-Luc; Hennequet-Antier, Christelle; Mignon-Grasteau, Sandrine; Calenge, Fanny			Broilers divergently selected for digestibility differ for their digestive microbial ecosystems	PLOS ONE			English	Article							LINES; EFFICIENCY; IDENTIFICATION; DIVERSITY; CHICKENS	Improving the digestive efficiency of broiler chickens (Gallus gallus) could reduce organic waste, increase the use of alternative feed not used for human consumption and reduce the impact of feed in production costs. By selecting chicken lines divergently for their digestive efficiency, we showed previously that digestive efficiency is under genetic control and that the two resulting divergent lines, D+ (high digestive efficiency or "digestibility +") and D- (low digestive efficiency or "digestibility -"), also differ for the abundance of specific bacteria in their caeca. Here we perform a more extensive census of the bacteria present in the digestive microbiota of 60 chickens selected for their low apparent metabolizable energy corrected for nitrogen balance (AMEn-) or high (AMEn+) digestive efficiency in a [D+ x D-] F8 progeny of 200 individuals. We sequenced the 16S rRNA genes of the ileal, jejunal and caecal microbiotas, and compared the compositions and predicted functions of microbiotas from the different intestinal segments for 20 AMEn+ and 19 AMEn- birds. The intestinal segment of origin was the main factor structuring the samples. The caecal microbiota was the most impacted by the differences in digestive efficiency, with 41 bacterial species with abundances differing between highly and poorly efficient birds. Furthermore, we predicted that the caecal microbiota of efficient birds might be enriched in genes contributing to the degradation of short chain fatty acids (SCFA) from non-starch polysaccharides. These results confirm the impact of the genetic selection led on digestibility on the caecal microbiota taxonomic composition. They open the way toward the identification of specific, causal genes of the host controlling variations in the abundances of bacterial taxons.	[Borey, Marion; Estelle, Jordi; Caidi, Aziza; Bruneau, Nicolas; Coville, Jean-Luc; Calenge, Fanny] Univ Paris Saclay, INRAE, AgroParisTech, GABI, Jouy En Josas, France; [Hennequet-Antier, Christelle; Mignon-Grasteau, Sandrine] Univ Tours, INRAE, BOA, Nouzilly, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Tours	Calenge, F (corresponding author), Univ Paris Saclay, INRAE, AgroParisTech, GABI, Jouy En Josas, France.	fanny.calenge@inrae.fr	Estellé, Jordi/A-7976-2008	Estellé, Jordi/0000-0002-6241-1732; CALENGE, Fanny/0000-0003-3529-3387	INRA; Credit Agricole d'Ile de France Mecenat	INRA; Credit Agricole d'Ile de France Mecenat	FC received a grant from her institution, INRA, after submission of her project to the GISA (Gestion Integree de la Sante Animale) metaprogramme (http://metaprogrammes.inra.fr/en).The funders approved the contents of this project. Marion Borey had a postdoctoral fellowship funded by Credit Agricole d'Ile de France Mecenat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkl P, 2018, POULTRY SCI, V97, P3009, DOI 10.3382/ps/pey167; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Borda-Molina D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02033; BOURDILLON A, 1990, BRIT POULTRY SCI, V31, P567, DOI 10.1080/00071669008417288; Calenge F, 2014, AVIAN PATHOL, V43, P78, DOI 10.1080/03079457.2013.873531; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carre B, 2002, BRIT POULTRY SCI, V43, P404, DOI 10.1080/00071660120103684; DARVASI A, 1995, GENETICS, V141, P1199; de Verdal H, 2013, J ANIM SCI, V91, P613, DOI 10.2527/jas.2012-5572; de Verdal H, 2010, POULTRY SCI, V89, P1955, DOI 10.3382/ps.2010-813; Ding J, 2016, GENETICS, V48, P1; Eeckhaut V, 2008, INT J SYST EVOL MICR, V58, P2799, DOI 10.1099/ijs.0.65730-0; Eeckhaut V, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01416; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Goodrich JK, 2016, SCIENCE, V352, P532, DOI 10.1126/science.aad9379; Hou Q, 2016, SCI REP, V6, P1; Juanchich A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5344-z; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lluch J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142334; Meng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089862; Mignon-Grasteau S, 2004, POULTRY SCI, V83, P860, DOI 10.1093/ps/83.6.860; Mignon-Grasteau S, 2010, WORLD C GEN APPL LIV, P9; Mignon-Grasteau S, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0156-y; Mignon-Grasteau S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135488; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; R Core Team, 2018, R LANG ENV STAT COMP; Rideau N, 2014, POULTRY SCI, V93, P1245, DOI 10.3382/ps.2013-03756; Rideout JR, 2014, PEERJ, P1; Rougiere N, 2010, ANIMAL, V4, P1861, DOI 10.1017/S1751731110001266; Schokker D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1646-6; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Siegerstetter SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187766; Stanley D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00187; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Stanley D, 2013, VET MICROBIOL, V164, P85, DOI 10.1016/j.vetmic.2013.01.030; Torok VA, 2011, APPL ENVIRON MICROB, V77, P5868, DOI 10.1128/AEM.00165-11; Tran TS, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-25; Vispo C, 1997, INTERACTION AVIAN GU, P117; Witzig M, 2015, PLOS ONE, V10, P1; Yan W, 2017, SCI REP-UK, V7, DOI 10.1038/srep45308; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0232418	10.1371/journal.pone.0232418	http://dx.doi.org/10.1371/journal.pone.0232418			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421690	Green Published, gold			2022-12-26	WOS:000537499600010
J	Lee, D; Daunizeau, J				Lee, Douglas; Daunizeau, Jean			Choosing what we like vs liking what we choose: How choice-induced preference change might actually be instrumental to decision-making	PLOS ONE			English	Article							COGNITIVE-DISSONANCE REDUCTION; ACTION-BASED MODEL; NEURAL MECHANISMS; ATTITUDE-CHANGE; CORTEX	For more than 60 years, it has been known that people report higher (lower) subjective values for items after having selected (rejected) them during a choice task. This phenomenon is coined "choice-induced preference change" or CIPC, and its established interpretation is that of "cognitive dissonance" theory. In brief, if people feel uneasy about their choice, they later convince themselves, albeit not always consciously, that the chosen (rejected) item was actually better (worse) than they had originally estimated. While this might make sense from an intuitive psychological standpoint, it is challenging from a theoretical evolutionary perspective. This is because such a cognitive mechanism might yield irrational biases, whose adaptive fitness would be unclear. In this work, we consider an alternative possibility, namely that CIPC is -at least partially- due to the refinement of option value representations that occurs while people are pondering about choice options. For example, contemplating competing possibilities during a choice may highlight aspects of the alternative options that were not considered before. In the context of difficult decisions, this would enable people to reassess option values until they reach a satisfactory level of confidence. This makes CIPC the epiphenomenal outcome of a cognitive process that is instrumental to the decision. Critically, our hypothesis implies novel predictions about how observed CIPC should relate to two specific meta-cognitive processes, namely: choice confidence and subjective certainty regarding pre-choice value judgments. We test these predictions in a behavioral experiment where participants rate the subjective value of food items both before and after choosing between equally valued items; we augment this traditional design with both reports of choice confidence and subjective certainty about value judgments. The results confirm our predictions and provide evidence that many quantitative features of CIPC (in particular: its relationship with metacognitive judgments) may be explained without ever invoking post-choice cognitive dissonance reduction explanation. We then discuss the relevance of our work in the context of the existing debate regarding the putative cognitive mechanisms underlying CIPC.	[Lee, Douglas; Daunizeau, Jean] Sorbonne Univ, Paris, France; [Lee, Douglas; Daunizeau, Jean] Inst Cerveau & Moelle Epiniere, Paris, France; [Lee, Douglas; Daunizeau, Jean] INSERM UMRS 1127, Paris, France	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Daunizeau, J (corresponding author), Sorbonne Univ, Paris, France.; Daunizeau, J (corresponding author), Inst Cerveau & Moelle Epiniere, Paris, France.; Daunizeau, J (corresponding author), INSERM UMRS 1127, Paris, France.	jean.daunizeau@gmail.com	Lee, Douglas/ABG-6828-2021	Lee, Douglas/0000-0001-5892-8694	Labex Bio-Psy (Laboratory of excellence of Biology for Psychiatry)	Labex Bio-Psy (Laboratory of excellence of Biology for Psychiatry)	DL received a PhD fellowship from the Labex Bio-Psy (Laboratory of excellence of Biology for Psychiatry). https://biopsy.fr/index.php/en/The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2018, J POLIT, V80, P400, DOI 10.1086/694541; AKERLOF GA, 1982, AM ECON REV, V72, P307; Allahverdyan AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099557; Beasley RK, 2001, POLIT PSYCHOL, V22, P521, DOI 10.1111/0162-895X.00252; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BREHM JW, 1956, J ABNORM SOC PSYCH, V52, P384, DOI 10.1037/h0041006; Chammat M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41320; Chen MK, 2010, J PERS SOC PSYCHOL, V99, P573, DOI 10.1037/a0020217; Colosio M, 2017, J NEUROSCI, V37, P5074, DOI 10.1523/JNEUROSCI.3209-16.2017; Cooper J, 2019, PSYCHOL AGING, V34, P709, DOI 10.1037/pag0000338; Coppin G, 2014, Q J EXP PSYCHOL, V67, P1415, DOI 10.1080/17470218.2013.863953; Coppin G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037857; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Egan LC, 2007, PSYCHOL SCI, V18, P978, DOI 10.1111/j.1467-9280.2007.02012.x; GILAD B, 1987, J ECON BEHAV ORGAN, V8, P61, DOI 10.1016/0167-2681(87)90021-7; Harmon-Jones E, 2007, Z SOZIALPSYCHOL, V38, P7, DOI 10.1024/0044-3514.38.1.7; Harmon-Jones E, 2015, CURR DIR PSYCHOL SCI, V24, P184, DOI 10.1177/0963721414566449; Harmon-Jones E, 2009, ADV EXP SOC PSYCHOL, V41, P119, DOI 10.1016/S0065-2601(08)00403-6; Izuma K, 2015, J NEUROSCI, V35, P3598, DOI 10.1523/JNEUROSCI.4591-14.2015; Izuma K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00041; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Jarcho JM, 2011, SOC COGN AFFECT NEUR, V6, P460, DOI 10.1093/scan/nsq054; Kitayama S, 2013, NEUROIMAGE, V69, P206, DOI 10.1016/j.neuroimage.2012.11.034; Lee D. G., 2019, BIORXIV, DOI [10.1101/661116, DOI 10.1101/661116]; Lichtenstein S, 2006, CONSTRUCTION OF PREFERENCE, P1, DOI 10.2277/ 0521542200; Lieberman MD, 2001, PSYCHOL SCI, V12, P135, DOI 10.1111/1467-9280.00323; Mengarelli F, 2015, CEREB CORTEX, V25, P1219, DOI 10.1093/cercor/bht314; Musslick S., 2015, COMPUTATIONAL MODEL; Navajas J, 2016, CURR OPIN BEHAV SCI, V11, P55, DOI 10.1016/j.cobeha.2016.05.005; Perlovsky L, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00179; Ratcliff R, 2016, TRENDS COGN SCI, V20, P260, DOI 10.1016/j.tics.2016.01.007; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Salti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108579; Sharot T, 2012, PSYCHOL SCI, V23, P1123, DOI 10.1177/0956797612438733; Sharot T, 2010, PSYCHOL SCI, V21, P1231, DOI 10.1177/0956797610379235; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Simon D, 2004, PSYCHOL SCI, V15, P331, DOI 10.1111/j.0956-7976.2004.00678.x; Simon D, 2015, J PERS SOC PSYCHOL, V109, P369, DOI 10.1037/pspa0000029; SLOVIC P, 1977, ANNU REV PSYCHOL, V28, P1, DOI 10.1146/annurev.ps.28.020177.000245; Tajima S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12400; TVERSKY A, 1990, J ECON PERSPECT, V4, P201, DOI 10.1257/jep.4.2.201; van Veen V, 2009, NAT NEUROSCI, V12, P1469, DOI 10.1038/nn.2413; Voigt K, 2019, J NEUROSCI, V39, P718, DOI 10.1523/JNEUROSCI.1681-18.2018; Warren C, 2011, WIRES COGN SCI, V2, P193, DOI 10.1002/wcs.98; West S, 2010, J COMP PSYCHOL, V124, P425, DOI 10.1037/a0019932	47	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0231081	10.1371/journal.pone.0231081	http://dx.doi.org/10.1371/journal.pone.0231081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1CK	32421699	Green Published, gold, Green Submitted			2022-12-26	WOS:000537499600004
J	Menezes, FD; Latorre, MDDD; Conceicao, GMD; Curado, MP; Antunes, JLF; Toporcov, TN				Menezes, Fabricio dos Santos; Dias de Oliveira Latorre, Maria do Rosario; de Souza Conceicao, Gleice Margarete; Curado, Maria Paula; Ferreira Antunes, Jose Leopoldo; Toporcov, Tatiana Natasha			The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil	PLOS ONE			English	Article							PAPILLOMAVIRUS-ASSOCIATED CANCERS; SQUAMOUS-CELL CARCINOMAS; NECK-CANCER; INTERNATIONAL HEAD; INCIDENCE TRENDS; POOLED ANALYSIS; UNITED-STATES; PREVALENCE; POPULATION; EPIDEMIOLOGY	Human papillomavirus (HPV) is responsible for the rise in the incidence of cancer in the oropharynx, tonsils, and base of the tongue (i.e., HPV-related subsites). HPV triggered the changes in the epidemiology of oropharyngeal and oral cavity cancer (OPC/OCC) in Asia, Europe, North America, and Oceania. Hence, the incidence of cancer in HPV-related subsites is augmenting, while that in other HPV-unrelated subsites is decreasing. In South America, although the incidence of HPV-positive tumors has gradually increased, there is an atypically low prevalence of HPV in people with OPC/OCC. To clarify whether this dramatic shift in incidence trends also occurred in this population, we estimated the burden of HPV on the incidence trends of OPCs/OCCs in Sao Paulo city in Brazil. In this population-based study, we categorized OPCs/OCCs by HPV-related and HPV-unrelated subsites. We used Poisson regression to assess the age-standardized incidence rates (ASRs) stratified by sex and age groups, as well as to examine the age-period-cohort effects. There were 15,391 cases of OPCs/OCCs diagnosed in HPV-related (n = 5,898; 38.3%) and HPV-unrelated (n = 9,493; 61.7%) subsites. Overall, the ASRs decreased for most subsites, for both sexes and for all age groups, except for HPV-related OPC/OCC in young males and females, which increased by 3.8% and 8.6% per year, respectively. In the birth-cohort-effect analysis, we identified an increasing risk for HPV-related OPC/OCC in both sexes in recent birth cohorts; however, this risk was sharply decreased in HPV-unrelated subsites. Our data demonstrate an emerging risk for HPV-related OPC/OCC in young people, which supports prophylactic HPV vaccination in this group.	[Menezes, Fabricio dos Santos] Univ Fed Sergipe, Dept Hlth Educ, Lagarto, Sergipe, Brazil; [Menezes, Fabricio dos Santos; Dias de Oliveira Latorre, Maria do Rosario; de Souza Conceicao, Gleice Margarete; Ferreira Antunes, Jose Leopoldo; Toporcov, Tatiana Natasha] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, SP, Brazil; [Curado, Maria Paula] AC Camargo Canc Ctr, Dept Epidemiol, Int Res Ctr, Sao Paulo, SP, Brazil; [Curado, Maria Paula] Int Prevent Res Inst, Ecully, France	Universidade Federal de Sergipe; Universidade de Sao Paulo; A.C.Camargo Cancer Center	Menezes, FD (corresponding author), Univ Fed Sergipe, Dept Hlth Educ, Lagarto, Sergipe, Brazil.; Menezes, FD (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, SP, Brazil.	fabriciomenezes@usp.br	Menezes, Fabrício/AAP-1310-2021; Antunes, Jose Leopoldo Ferreira/F-6969-2010; Curado, Maria Paula/M-6200-2013	Antunes, Jose Leopoldo Ferreira/0000-0003-3972-9723; Curado, Maria Paula/0000-0001-8172-2483; dos Santos Menezes, Fabricio/0000-0001-9230-1879	Federal University of Sergipe	Federal University of Sergipe	The authors are grateful to the Federal University of Sergipe for supporting FSM in his doctoral degree. Also, we thank the Population-based Cancer Registry of Sao Paulo for providing the cancer database, and the SEADE Foundation for demographic information on the city of Sao Paulo.	Ahmad OB, 2001, PAPER SERIES GENEVA, V31, P1; Anantharaman D, 2017, INT J CANCER, V140, P1968, DOI 10.1002/ijc.30608; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; [Anonymous], 2019, VIG BRAS 2018 VIG FA, P132; Associac ao Hospitalar Moinhos de Vento, 2017, EST EP PEL HPV POP B; Auluck A, 2010, CANCER-AM CANCER SOC, V116, P2635, DOI 10.1002/cncr.25087; Bahl A, 2014, HEAD NECK-J SCI SPEC, V36, P505, DOI 10.1002/hed.23317; Blomberg M, 2011, INT J CANCER, V129, P733, DOI 10.1002/ijc.25699; Boscolo-Rizzo P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192621; Carstensen B, 2007, STAT MED, V26, P3018, DOI 10.1002/sim.2764; Chan MH, 2018, ANN OTO RHINOL LARYN, V127, P895, DOI 10.1177/0003489418802287; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Cole L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032657; De Cicco R, 2019, HEAD NECK-J SCI SPEC, P1, DOI [10.1002/hed, DOI 10.1002/HED]; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; de Matos LL, 2015, BRAZ J OTORHINOLAR, V81, P554, DOI 10.1016/j.bjorl.2015.04.001; Oliveira Max Moura de, 2015, Rev. bras. epidemiol., V18, P146, DOI 10.1590/1980-5497201500060013; Draper NR, 1998, APPL REGRESSION ANAL, DOI [10.1002/9781118625590, DOI 10.1002/9781118625590, 10.1002/9781118625590.]; Elwood JM, 2014, CANCER EPIDEMIOL, V38, P16, DOI 10.1016/j.canep.2013.12.004; Forte T, 2012, CANCER CAUSE CONTROL, V23, P1343, DOI 10.1007/s10552-012-0013-z; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Hocking JS, 2011, BRIT J CANCER, V104, P886, DOI 10.1038/sj.bjc.6606091; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Hong A, 2016, HEAD NECK-J SCI SPEC, V38, P743, DOI 10.1002/hed.23942; Jehannin-Ligier K, 2017, INT J CANCER, V140, P2032, DOI 10.1002/ijc.30631; Kuiava VA, 2019, ARCH BIOSCI HLTH, V1, P45, DOI [10.18593/abh.17091, DOI 10.18593/ABH.17091]; Kurdgelashvili G, 2013, CANCER-AM CANCER SOC, V119, P2291, DOI 10.1002/cncr.27989; Lam JO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146185; de Souza DLB, 2012, HEAD NECK-J SCI SPEC, V34, P649, DOI 10.1002/hed.21793; Licitra L, 2008, HEMATOL ONCOL CLIN N, V22, P1143, DOI 10.1016/j.hoc.2008.10.002; Louie KS, 2015, ORAL ONCOL, V51, P341, DOI 10.1016/j.oraloncology.2015.01.002; Mehanna H, 2013, HEAD NECK-J SCI SPEC, V35, P747, DOI 10.1002/hed.22015; Lopez RVM, 2014, CANCER CAUSE CONTROL, V25, P461, DOI 10.1007/s10552-014-0348-8; Mourad M, 2017, J ORAL MAXIL SURG, V75, P2562, DOI 10.1016/j.joms.2017.05.008; Nygard M, 2012, EUR J CANCER, V48, P1341, DOI 10.1016/j.ejca.2012.03.014; Oh Junhie, 2014, R I Med J (2013), V97, P47; Ramqvist T, 2010, EMERG INFECT DIS, V16, P1671, DOI 10.3201/eid1611.100452; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249; Ryerson AB, 2008, CANCER-AM CANCER SOC, V113, P2901, DOI 10.1002/cncr.23745; Shack Lorraine, 2014, CMAJ Open, V2, pE127, DOI 10.9778/cmajo.20140005; Smeets SJ, 2006, ONCOGENE, V25, P2558, DOI 10.1038/sj.onc.1209275; Tam S, 2018, ORAL ONCOL, V82, P91, DOI 10.1016/j.oraloncology.2018.04.005; van Monsjou HS, 2015, ORAL ONCOL, V51, P901, DOI 10.1016/j.oraloncology.2015.06.011; Walter L, 2014, HEAD NECK-J SCI SPEC, V36, P729, DOI 10.1002/hed.23369; Watson M, 2008, CANCER-AM CANCER SOC, V113, P2841, DOI 10.1002/cncr.23758; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Zumsteg ZS, 2016, JAMA ONCOL, V2, P1617, DOI 10.1001/jamaoncol.2016.1804	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232871	10.1371/journal.pone.0232871	http://dx.doi.org/10.1371/journal.pone.0232871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407339	gold, Green Published			2022-12-26	WOS:000537490700041
J	Tartari, E; Saris, K; Kenters, N; Marimuthu, K; Widmer, A; Collignon, P; Cheng, VCC; Wong, SC; Gottlieb, T; Tambyah, PA; Perencevich, E; Allegranzi, B; Dramowski, A; Edmond, MB; Voss, A				Tartari, Ermira; Saris, Katja; Kenters, Nikki; Marimuthu, Kalisvar; Widmer, Andreas; Collignon, Peter; Cheng, Vincent C. C.; Wong, Shuk C.; Gottlieb, Thomas; Tambyah, Paul A.; Perencevich, Eli; Allegranzi, Benedetta; Dramowski, Angela; Edmond, Michael B.; Voss, Andreas		ISAC IPC Working Grp	Not sick enough to worry? "Influenza-like" symptoms and work-related behavior among healthcare workers and other professionals: Results of a global survey	PLOS ONE			English	Article							PRESENTEEISM; ABSENTEEISM; ILLNESS; ILL	Background Healthcare workers (HCWs) and non-HCWs may contribute to the transmission of influenza-like illness (ILI) to colleagues and susceptible patients by working while sick (presenteeism). The present study aimed to explore the views and behavior of HCWs and nonHCWs towards the phenomenon of working while experiencing ILI. Methods The study was a cross-sectional online survey conducted between October 2018 and January 2019 to explore sickness presenteeism and the behaviour of HCWs and non-HCWs when experiencing ILI. The survey questionnaire was distributed to the members and international networks of the International Society of Antimicrobial Chemotherapy (ISAC) Infection Prevention and Control (IPC) Working Group, as well as via social media platforms, including LinkedIn, Twitter and IPC Blog. Results In total, 533 respondents from 49 countries participated (Europe 69.2%, Asia-Pacific 19.1%, the Americas 10.9%, and Africa 0.8%) representing 249 HCWs (46.7%) and 284 nonHCWs (53.2%). Overall, 312 (58.5%; 95% confidence interval [CI], 56.2-64.6) would continue to work when sick with ILI, with no variation between the two categories. Sixty-seven (26.9%) HCWs and forty-six (16.2%) non-HCWs would work with fever alone (p< 0.01) Most HCWs (89.2-99.2%) and non-HCWs (80%-96.5%) would work with "minor" ILI symptoms, such as sore throat, sinus cold, fatigue, sneezing, runny nose, mild cough and reduced appetite. Conclusion A future strategy to successfully prevent the transmission of ILI in healthcare settings should address sick-leave policy management, in addition to encouraging the uptake of influenza vaccine.	[Tartari, Ermira] Geneva Univ Hosp, Infect Control Programme, Geneva, Switzerland; [Tartari, Ermira] Geneva Univ Hosp, WHO Collaborating Ctr Patient Safety, Geneva, Switzerland; [Tartari, Ermira] Univ Geneva, Fac Med, Geneva, Switzerland; [Tartari, Ermira; Allegranzi, Benedetta] Univ Geneva, Inst Global Hlth, Fac Med, Geneva, Switzerland; [Tartari, Ermira] Univ Malta, Fac Hlth Sci, Msida, Malta; [Saris, Katja; Kenters, Nikki; Voss, Andreas] Canisius Wilhelmina Hosp CWZ, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Saris, Katja; Voss, Andreas] Radboudumc, Dept Med Microbiol, Nijmegen, Netherlands; [Saris, Katja; Voss, Andreas] Radboudumc, REshape Ctr Innovat, Nijmegen, Netherlands; [Marimuthu, Kalisvar] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Marimuthu, Kalisvar] Natl Ctr Infect Dis, Singapore, Singapore; [Marimuthu, Kalisvar] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Widmer, Andreas] Univ Basel, Hosp & Clin, Basel, Switzerland; [Collignon, Peter] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Cheng, Vincent C. C.] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Peoples R China; [Cheng, Vincent C. C.; Wong, Shuk C.] Queen Mary Hosp, Infect Control Team, Hong Kong West Cluster, Hosp Author, Hong Kong, Peoples R China; [Gottlieb, Thomas] Concord Repatriat Gen Hosp, Dept Microbiol & Infect Dis, Sydney, NSW, Australia; [Tambyah, Paul A.] Natl Univ Singapore, Dept Med, Singapore, Singapore; [Perencevich, Eli] Univ Iowa, Carver Coll Med, Div Gen Internal Med, Iowa City, IA USA; [Perencevich, Eli] Univ Iowa, Carver Coll Med, Div Infect Dis, Iowa City, IA USA; [Allegranzi, Benedetta] World Hlth Org, Dept Integrated Hlth Serv, Infect Prevent & Control Tech & Clin Hub, Geneva, Switzerland; [Dramowski, Angela] Stellenbosch Univ, Div Paediat Infect Dis, Dept Paediat & Child Hlth, Cape Town, South Africa; [Edmond, Michael B.] Univ Iowa, Hosp & Clin, Iowa City, IA USA	University of Geneva; University of Geneva; World Health Organization; University of Geneva; University of Geneva; University of Malta; Radboud University Nijmegen; Radboud University Nijmegen; Tan Tock Seng Hospital; National Centre for Infectious Diseases Singapore; National University of Singapore; University of Basel; Australian National University; University of Hong Kong; University of Hong Kong; Concord Repatriation General Hospital; National University of Singapore; University of Iowa; University of Iowa; World Health Organization; Stellenbosch University; University of Iowa	Tartari, E (corresponding author), Geneva Univ Hosp, Infect Control Programme, Geneva, Switzerland.; Tartari, E (corresponding author), Geneva Univ Hosp, WHO Collaborating Ctr Patient Safety, Geneva, Switzerland.; Tartari, E (corresponding author), Univ Geneva, Fac Med, Geneva, Switzerland.; Tartari, E (corresponding author), Univ Geneva, Inst Global Hlth, Fac Med, Geneva, Switzerland.; Tartari, E (corresponding author), Univ Malta, Fac Hlth Sci, Msida, Malta.	ermira.tartari@gmail.com	El-Sokkary, Rehab/B-9599-2018; Saris, Katja/M-9661-2018; Saris, Katja/I-4755-2013; Tartari, Ermira/AAC-6804-2021	El-Sokkary, Rehab/0000-0002-8135-7671; Saris, Katja/0000-0001-5661-3197; Saris, Katja/0000-0001-5661-3197; HSUEH, PO-REN/0000-0002-7502-9225; CHENG, Vincent Chi-Chung/0000-0003-1765-7706; WONG, Shuk-Ching/0000-0001-6101-1932; Schweizer, Marin/0000-0002-3604-0093; Perencevich, Eli/0000-0002-3721-3355	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Aronsson G, 2000, J EPIDEMIOL COMMUN H, V54, P502, DOI 10.1136/jech.54.7.502; Asfaw A, 2017, J OCCUP ENVIRON MED, V59, P822, DOI 10.1097/JOM.0000000000001076; Bergstrom G, 2009, J OCCUP ENVIRON MED, V51, P629, DOI [10.1097/JOM.0b913e3181a8281b, 10.1097/JOM.0b013e3181a8281b]; Bracewell LM, NZ MED J, V2010123; Bramley TJ, 2002, J OCCUP ENVIRON MED, V44, P822, DOI 10.1097/00043764-200209000-00004; Brborovic H, 2017, ARH HIG RADA TOKSIKO, V68, P185, DOI 10.1515/aiht-2017-68-2957; Chiu S, 2017, AM J INFECT CONTROL, V45, P1254, DOI 10.1016/j.ajic.2017.04.008; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cowman K, 2019, AM J INFECT CONTROL, V47, P895, DOI 10.1016/j.ajic.2019.02.004; Danzmann L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-98; de Perio MA, 2014, AM J INFECT CONTROL, V42, P450, DOI 10.1016/j.ajic.2013.11.012; Eibach D, 2014, J HOSP INFECT, V86, P188, DOI 10.1016/j.jhin.2013.11.009; Flannery B, 2018, MMWR-MORBID MORTAL W, V67, P180, DOI 10.15585/mmwr.mm6706a2; Huttunen R, 2014, EUR J CLIN MICROBIOL, V33, P1477, DOI 10.1007/s10096-014-2119-6; Imai C, 2019, AM J INFECT CONTROL; Jena AB, 2010, JAMA-J AM MED ASSOC, V304, P1166, DOI 10.1001/jama.2010.1315; Kaldjian LC, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0602-7; Kivimaki M, 2005, AM J PUBLIC HEALTH, V95, P98, DOI 10.2105/AJPH.2003.035873; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; MacIntyre CR, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006577; Miraglia M, 2016, J OCCUP HEALTH PSYCH, V21, P261, DOI 10.1037/ocp0000015; Mossad SB, 2017, INFECT CONT HOSP EP, V38, P966, DOI 10.1017/ice.2017.91; Pollara CP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-127; Ridgway JP, 2015, CLIN INFECT DIS, V60, P1591, DOI 10.1093/cid/civ163; Schultz AB, 2009, PHARMACOECONOMICS, V27, P365, DOI 10.2165/00019053-200927050-00002; Szymczak JE, 2015, JAMA PEDIATR, V169, P815, DOI 10.1001/jamapediatrics.2015.0684; United States Centers for Disease Control and Prevention, 2019, PREV STRAT SEAS INFL; Wilson KE, 2019, AM J INFECT CONTROL, V47, P683, DOI 10.1016/j.ajic.2018.10.024; World Health Organization, 60 WHO; World Health Organization (WHO), INFL VACC COV EFF; Zhu N, 2020, NEW ENGLAND J MED	32	18	18	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232168	10.1371/journal.pone.0232168	http://dx.doi.org/10.1371/journal.pone.0232168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0VG	32401751	gold, Green Published			2022-12-26	WOS:000537481000008
J	Chang, SC; Adami, A; Lin, HC; Lin, YC; Chen, CPC; Fu, TC; Hsu, CC; Huang, SC				Chang, Shih-Chieh; Adami, Alessandra; Lin, Hsin-Chin; Lin, Yin-Chou; Chen, Carl P. C.; Fu, Tieh-Cheng; Hsu, Chih-Chin; Huang, Shu-Chun			Relationship between maximal incremental and high-intensity interval exercise performance in elite athletes	PLOS ONE			English	Article							HEART-RATE RECOVERY; SKELETAL-MUSCLE MASS; AEROBIC FITNESS; POWER OUTPUT; PEAK POWER; METABOLISM; AGE; SPECTROSCOPY; DURATION; ADAPTATIONS	This descriptive study aimed to explore the physiological factors that determine tolerance to exertion during high-intensity interval effort. Forty-seven young women (15-28 years old) were enrolled: 23 athletes from Taiwan national or national reserve teams and 24 moderately active females. Each participant underwent a maximal incremental INC (modified Bruce protocol) cardiopulmonary exercise test on the first day and high-intensity interval testing (HIIT) on the second day, both performed on a treadmill. The HIIT protocol involved alternation between 1-min effort at 120% of the maximal speed, at the same slope reached at the end of the INC, and 1-min rest until volitional exhaustion. Gas exchange, heart rate (HR), and muscle oxygenation at the right vastus lateralis, measured by near-infrared spectroscopy, were continuously recorded. The number of repetitions completed (R-lim) by each participant was considered the HIIT tolerance index. The results showed a large difference in the R-lim (range, 2.6-12.0 repetitions) among the participants. Stepwise linear regression revealed that the variance in the R-lim within the cohort was related to the recovery rates of oxygen consumption ((V) over dot(2)), HR at the second minute after INC, and muscle tissue saturation index at exhaustion (R = 0.644). In addition, age was linearly correlated with R-lim (adjusted R =- 0.518, p < 0.0001). In conclusion, the recovery rates for (V) over dot(2) and HR after the incremental test, and muscle saturation index at exhaustion, were the major physiological factors related to HIIT performance. These findings provide insights into the role of the recovery phase after maximal INC exercise testing. Future research investigating a combination of INC and HIIT testing to determine training-induced performance improvement is warranted.	[Chang, Shih-Chieh; Lin, Hsin-Chin; Lin, Yin-Chou; Chen, Carl P. C.; Huang, Shu-Chun] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Linkou, Taiwan; [Adami, Alessandra] Univ Rhode Isl, Dept Kinesiol, Kingston, RI 02881 USA; [Lin, Yin-Chou; Chen, Carl P. C.] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan Branch, Taoyuan, Taiwan; [Chen, Carl P. C.; Fu, Tieh-Cheng; Hsu, Chih-Chin; Huang, Shu-Chun] Chang Gung Univ, Coll Med, Kwei Shan, Tao Yuan County, Taiwan; [Fu, Tieh-Cheng; Hsu, Chih-Chin] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Keelung, Taiwan; [Huang, Shu-Chun] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Huang, Shu-Chun] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, New Taipei Municipal Tucheng Hosp, New Taipei, Taiwan	Chang Gung Memorial Hospital; University of Rhode Island; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, SC (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Linkou, Taiwan.; Huang, SC (corresponding author), Chang Gung Univ, Coll Med, Kwei Shan, Tao Yuan County, Taiwan.; Huang, SC (corresponding author), Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan.; Huang, SC (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, New Taipei Municipal Tucheng Hosp, New Taipei, Taiwan.	h0711@ms13.hinet.net	Fu, Tieh-Cheng/AAX-8012-2021; Adami, Alessandra/AAS-5805-2020	Fu, Tieh-Cheng/0000-0002-8702-0391; Adami, Alessandra/0000-0002-1917-9296; Lin, Yin-Chou/0000-0002-1058-2329	Ministry of Science and Technology [104-2314-B-182A-045-MY2, 106-2314-B182A-134-MY3]; Chang Gung Memorial Hospital [CMRPG3E1561/2]; Taiwan Ministry of Education's Higher Education Deep Plowing Program [EMRPD1H0351, EMRPD1H0551]; Healthy Aging Research Center, Chang Gung University	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Taiwan Ministry of Education's Higher Education Deep Plowing Program; Healthy Aging Research Center, Chang Gung University	This research was supported by (1) Ministry of Science and Technology (Grant No. 104-2314-B-182A-045-MY2 and 106-2314-B182A-134-MY3, https://www.most.gov.tw/?l=de) (2)Chang Gung Memorial Hospital (grant No. CMRPG3E1561/2, http://www.chang-gung.com/en/) to Shu-Chun Huang and (3) Healthy Aging Research Center, Chang Gung University and the Taiwan Ministry of Education's Higher Education Deep Plowing Program (Grant Numbers EMRPD1H0351 and EMRPD1H0551, http://www.cgu.edu.tw/bin/home.php?Lang=en) to Shu-Chun Huang.	Adami A, 2013, EUR J APPL PHYSIOL, V113, P2647, DOI 10.1007/s00421-013-2705-9; Arena R, 2011, CIRCULATION, V123, P668, DOI 10.1161/CIRCULATIONAHA.109.914788; Armstrong N, 2015, BRIT J SPORT MED, V49, P860, DOI 10.1136/bjsports-2014-094491; ASTRAND I, 1960, Acta Physiol Scand Suppl, V49, P1; Bacon AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073182; Baker AB, 2003, EXP AGING RES, V29, P47, DOI 10.1080/03610730303706; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Beltz Nicholas M, 2016, J Sports Med (Hindawi Publ Corp), V2016, P3968393, DOI 10.1155/2016/3968393; Benelli P, 2007, EUR J APPL PHYSIOL, V99, P685, DOI 10.1007/s00421-006-0334-2; Boisseau N, 2000, SPORTS MED, V30, P405, DOI 10.2165/00007256-200030060-00003; Borsheim E, 2003, SPORTS MED, V33, P1037; Boushel R, 2001, SCAND J MED SCI SPOR, V11, P213, DOI 10.1034/j.1600-0838.2001.110404.x; Buchheit M, 2012, EUR J APPL PHYSIOL, V112, P711, DOI 10.1007/s00421-011-2014-0; Buchheit M, 2009, INT J SPORTS MED, V30, P418, DOI 10.1055/s-0028-1105933; Buchheit M, 2011, EUR J APPL PHYSIOL, V111, P293, DOI 10.1007/s00421-010-1654-9; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Christensen PM, 2011, MED SCI SPORT EXER, V43, P1716, DOI 10.1249/MSS.0b013e318211c01a; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Connes P, 2010, EXERCISE PHYSL CELLU; Crisafulli A, 2004, EXP PHYSIOL, V89, P665, DOI 10.1113/expphysiol.2004.027946; Daanen HAM, 2012, INT J SPORT PHYSIOL, V7, P251, DOI 10.1123/ijspp.7.3.251; Day JR, 2003, J APPL PHYSIOL, V95, P1901, DOI 10.1152/japplphysiol.00024.2003; Dolci F, 2020, J STRENGTH COND RES, V34, P1188, DOI 10.1519/JSC.0000000000003499; Dupont G, 2003, EUR J APPL PHYSIOL, V89, P548, DOI 10.1007/s00421-003-0834-2; ERIKSSON BO, 1973, ACTA PHYSIOL SCAND, V87, P485, DOI 10.1111/j.1748-1716.1973.tb05415.x; Fair RC, 2007, EXP AGING RES, V33, P37, DOI 10.1080/03610730601006305; Fernandez-Fernandez J, 2015, J SPORT SCI MED, V14, P783; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Gibala MJ, 2008, EXERC SPORT SCI REV, V36, P58, DOI 10.1097/JES.0b013e318168ec1f; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; HARRIS RC, 1976, PFLUG ARCH EUR J PHY, V367, P137, DOI 10.1007/BF00585149; Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013; Hill DW, 2002, MED SCI SPORT EXER, V34, P709, DOI 10.1097/00005768-200204000-00023; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Huang SC, 2014, EUR J APPL PHYSIOL, V114, P1853, DOI 10.1007/s00421-014-2913-y; Iannetta D, 2020, MED SCI SPORT EXER, V52, P466, DOI 10.1249/MSS.0000000000002147; Jones AM, 2017, SPORTS MED, V47, pS65, DOI 10.1007/s40279-017-0688-0; Kavaliauskas Mykolas, 2017, Sport Sci Health, V13, P17, DOI 10.1007/s11332-016-0313-x; KUNO SY, 1995, EUR J APPL PHYSIOL O, V70, P301, DOI 10.1007/BF00865026; Lador F, 2013, RESP PHYSIOL NEUROBI, V186, P206, DOI 10.1016/j.resp.2013.01.017; Lazic JS, 2017, CLIN PHYSIOL FUNCT I, V37, P117, DOI 10.1111/cpf.12271; Mattu AT, 2020, SCAND J MED SCI SPOR, V30, P472, DOI 10.1111/sms.13590; Morishita Y, 2014, THER APHER DIAL, V18, P612, DOI 10.1111/1744-9987.12174; Morishita Y, 2014, INT UROL NEPHROL, V46, P633, DOI 10.1007/s11255-014-0662-9; Murakami K, 2015, GERIATR GERONTOL INT, V15, P1185, DOI 10.1111/ggi.12572; Muscat KM, 2015, APPL PHYSIOL NUTR ME, V40, P1199, DOI 10.1139/apnm-2015-0179; Noakes TD, 2008, BRIT J SPORT MED, V42, P551, DOI 10.1136/bjsm.2008.046821; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Paul DJ, 2019, J SPORT MED PHYS FIT, V59, P962, DOI 10.23736/S0022-4707.18.08547-X; Pierpont GL, 2004, AM J CARDIOL, V94, P64, DOI 10.1016/j.amjcard.2004.03.032; Ratel S, 2002, INT J SPORTS MED, V23, P397, DOI 10.1055/s-2002-33737; Reaburn P, 2009, EUR REV AGING PHYS A, V6, P39, DOI 10.1007/s11556-008-0041-6; Sperlich PF, 2015, J SPORT SCI MED, V14, P386; Tabata I, 1997, MED SCI SPORT EXER, V29, P390, DOI 10.1097/00005768-199703000-00015; Taylor DJ, 1997, MOL CELL BIOCHEM, V174, P321, DOI 10.1023/A:1006802602497; TAYLOR HL, 1955, J APPL PHYSIOL, V8, P73, DOI 10.1152/jappl.1955.8.1.73; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Trevizani GA, 2012, ARQ BRAS CARDIOL, V99, P802, DOI 10.1590/S0066-782X2012005000069; Turner AP, 2006, MED SCI SPORT EXER, V38, P492, DOI 10.1249/01.mss.0000188450.82733.f0; van Beekvelt MCP, 2001, CLIN SCI, V101, P21, DOI 10.1042/CS20000247; Vicente-Campos D, 2014, EUR J APPL PHYSIOL, V114, P1123, DOI 10.1007/s00421-014-2847-4; Wahl P, 2014, J SPORT SCI MED, V13, P259; Zafeiridis A, 2005, MED SCI SPORT EXER, V37, P505, DOI 10.1249/01.MSS.0000155394.76722.01; ZANCONATO S, 1993, J APPL PHYSIOL, V74, P2214, DOI 10.1152/jappl.1993.74.5.2214	65	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0226313	10.1371/journal.pone.0226313	http://dx.doi.org/10.1371/journal.pone.0226313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396576	gold, Green Published, Green Submitted			2022-12-26	WOS:000537475000002
J	Fan, JX; Song, Y; Tang, G; Ochi, K; Shentu, XP; Yu, XP				Fan, Jing-Xuan; Song, Yang; Tang, Gu; Ochi, Kozo; Shentu, Xu-Ping; Yu, Xiao-Ping			Substantial improvement of tetraene macrolide production in Streptomyces diastatochromogenes by cumulative drug resistance mutations	PLOS ONE			English	Article							BIOSYNTHETIC GENE CLUSTERS; ANTIBIOTIC PRODUCTION; RPOB MUTATIONS; ACTIVATION; DIFFERENTIATION; COELICOLOR; SUBUNIT; PPGPP; RPSL	Tetraene macrolides remain one of the most reliable fungicidal agents as resistance of fungal pathogens to these antibiotics is relatively rare. The modes of action and biosynthesis of polyene macrolides had been the focus of research over the past few years. However, few studies have been carried out on the overproduction of polyene macrolides. In the present study, cumulative drug-resistance mutation was used to obtain a quintuple mutant G5-59 with huge tetraene macrolide overproduction from the starting strain Streptomyces diastatochromogenes 1628. Through DNA sequence analysis, the mutation points in the genes of rsmG, rpsL and rpoB were identified. Additionally, the growth characteristic and expression level of tetrRI gene (belonging to the large ATP binding regulator of LuxR family) involved in the biosynthesis of tetraene macrolides were analyzed. As examined with 5L fermentor, the quintuple mutant G5-59 grew very well and the maximum productivity of tetramycin A, tetramycin P and tetrin B was as high as 1735, 2811 and 1500 mg/L, which was 8.7-, 16- and 25-fold higher than that of the wild-type strain 1628, respectively. The quintuple mutant G5-59 could be useful for further improvement of tetraene macrolides production at industrial level.	[Fan, Jing-Xuan; Song, Yang; Tang, Gu; Shentu, Xu-Ping; Yu, Xiao-Ping] China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou, Peoples R China; [Ochi, Kozo] Hiroshima Inst Technol, Dept Life Sci, Hiroshima, Japan	China Jiliang University; Hiroshima Institute of Technology	Shentu, XP; Yu, XP (corresponding author), China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou, Peoples R China.	stxp@cjlu.edu.cn; yxp@cjlu.edu.cn		Shentu, Xuping/0000-0003-4524-0334	National Natural Science Foundation of China [31401793, 31640018]; Zhejiang Provincial Programs for Science and Technology Development [2018C02030, 2019C02015, 2017C32006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Programs for Science and Technology Development	This work was supported by National Natural Science Foundation of China (31401793), X.P. Shentu. http://www.nsfc.gov.cn/publish/portal0/default.htm. National Natural Science Foundation of China (31640018), X.P. Shentu. http://www.nsfc.gov.cn/publish/portal0/default.htm. Zhejiang Provincial Programs for Science and Technology Development (2018C02030), X.P. Shentu. http://kjt.zj.gov.cn/. Zhejiang Provincial Programs for Science and Technology Development (2019C02015), X.P. Yu. http://kjt.zj.gov.cn/. Zhejiang Provincial Programs for Science and Technology Development (2017C32006), X.P. Shentu. http://kjt.zj.gov.cn/.	Caffrey P, 2016, APPL MICROBIOL BIOT, V100, P3893, DOI 10.1007/s00253-016-7474-z; Cao B, 2012, CHEMBIOCHEM, V13, P2234, DOI 10.1002/cbic.201200402; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cropp A, 2001, J IND MICROBIOL BIOT, V27, P368, DOI 10.1038/sj.jim.7000206; Fjaervik E, 2005, APPL MICROBIOL BIOT, V67, P436, DOI 10.1007/s00253-004-1802-4; Funane K, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00188-18; Hosoya Y, 1998, ANTIMICROB AGENTS CH, V42, P2041, DOI 10.1128/AAC.42.8.2041; Hu HF, 2002, J BACTERIOL, V184, P3984, DOI 10.1128/JB.184.14.3984-3991.2002; Hu HF, 2001, APPL ENVIRON MICROB, V67, P1885, DOI 10.1128/AEM.67.4.1885-1892.2001; Lai CX, 2002, MICROBIOL-SGM, V148, P3365, DOI 10.1099/00221287-148-11-3365; Lemke A, 2005, APPL MICROBIOL BIOT, V68, P151, DOI 10.1007/s00253-005-1955-9; LEVINSKAS GJ, 1966, TOXICOL APPL PHARM, V8, P97, DOI 10.1016/0041-008X(66)90105-0; [李宁 LI Ning], 2008, [波谱学杂志, Chinese Journal of Magnetic Resonance], V25, P514; Liang JG, 2008, ENZYME MICROB TECH, V42, P145, DOI 10.1016/j.enzmictec.2007.08.012; Liu NN, 2016, ISOLATION PURIFICATI; Ochi K, 2004, ADV APPL MICROBIOL, V56, P155, DOI 10.1016/S0065-2164(04)56005-7; OCHI K, 1987, J BACTERIOL, V169, P3608, DOI 10.1128/jb.169.8.3608-3616.1987; Ochi K, 2007, BIOSCI BIOTECH BIOCH, V71, P1373, DOI 10.1271/bbb.70007; Ochi K, 2017, J ANTIBIOT, V70, P25, DOI 10.1038/ja.2016.82; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shentu XP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203006; Shentu XP, 2016, J ANTIBIOT, V69, P406, DOI 10.1038/ja.2015.123; Shima J, 1996, J BACTERIOL, V178, P7276, DOI 10.1128/jb.178.24.7276-7284.1996; Tanaka Y, 2013, J BACTERIOL, V195, P2959, DOI 10.1128/JB.00147-13; Tanaka Y, 2009, J ANTIBIOT, V62, P669, DOI 10.1038/ja.2009.97; Tanaka Y, 2009, APPL ENVIRON MICROB, V75, P4919, DOI 10.1128/AEM.00681-09; Tojo S, 2015, ANTIMICROB AGENTS CH, V59, P7799, DOI 10.1128/AAC.01932-15; Wang GJ, 2008, APPL ENVIRON MICROB, V74, P2834, DOI 10.1128/AEM.02800-07; Xu J, 2002, MOL GENET GENOMICS, V268, P179, DOI 10.1007/s00438-002-0730-1; Zhang N, 2013, WORLD J MICROB BIOT, V29, P1443, DOI 10.1007/s11274-013-1307-3; Zhu SB, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8030133; Zotchev SB, 2003, CURR MED CHEM, V10, P211, DOI 10.2174/0929867033368448	32	6	7	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232927	10.1371/journal.pone.0232927	http://dx.doi.org/10.1371/journal.pone.0232927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396566	Green Published, gold			2022-12-26	WOS:000537475000027
J	Numbers, K; Crawford, JD; Kochan, NA; Draper, B; Sachdev, PS; Brodaty, H				Numbers, Katya; Crawford, John D.; Kochan, Nicole A.; Draper, Brian; Sachdev, Perminder S.; Brodaty, Henry			Participant and informant memory-specific cognitive complaints predict future decline and incident dementia: Findings from the Sydney Memory and Ageing Study	PLOS ONE			English	Article							OBJECTIVE MEMORY; IMPAIRMENT; DEPRESSION; QUESTIONNAIRE; PREVALENCE; CRITERIA; PEOPLE; ADULTS	Subjective Cognitive Complaints (SCCs) may represent one of the earliest stages of preclinical dementia. The objective of the present study was to extend previous work by our group to examine the relationship between participant-reported and informant-reported memory and non-memory SCCs, cognitive decline and incident dementia, over a six-year period. Participants were 873 community dwelling older adults (M-age = 78.65, SD = 4.79) without dementia and 843 informants (close friends or family) from the Sydney Memory and Ageing Study. Comprehensive neuropsychological testing and diagnostic assessments were carried out at baseline and biennially for six years. Linear mixed models and Cox proportional hazard models were performed to determine the association of SCCs, rate of cognitive decline and risk of incident dementia, controlling demographics and covariates of mood and personality. Participant and informant memory-specific SCCs were associated with rate of global cognitive decline; for individual cognitive domains, participant memory SCCs predicted decline for language, while informant memory SCCs predicted decline for executive function and memory. Odds of incident dementia were associated with baseline participant memory SCCs and informant memory and non-memory SCCs in partially adjusted models. In fully adjusted models, only informant SCCs were associated with increased risk of incident dementia. Self-reported memory-specific cognitive complaints are associated with decline in global cognition over 6-years and may be predictive of incident dementia, particularly if the individual is depressed or anxious and has increased neuroticism or decreased openness. Further, if and where possible, informants should be sought and asked to report on their perceptions of the individual's memory ability and any memory-specific changes that they have noticed as these increase the index of diagnostic suspicion.	[Numbers, Katya; Crawford, John D.; Kochan, Nicole A.; Draper, Brian; Sachdev, Perminder S.; Brodaty, Henry] Univ New South Wales, Sch Psychiat, CHeBA Ctr Hlth Brain Ageing, Kensington, NSW, Australia; [Draper, Brian; Sachdev, Perminder S.; Brodaty, Henry] Univ New South Wales, Dementia Collaborat Res Ctr, Kensington, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Numbers, K (corresponding author), Univ New South Wales, Sch Psychiat, CHeBA Ctr Hlth Brain Ageing, Kensington, NSW, Australia.	k.numbers@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020; Numbers, Katya/AAU-8963-2021	Sachdev, Perminder/0000-0002-9595-3220; Numbers, Katya/0000-0002-7009-2401	National Health & Medical Research Council (NHMRC) of Australia Program Grants [ID350833, ID568969, APP1093083]	National Health & Medical Research Council (NHMRC) of Australia Program Grants(National Health and Medical Research Council (NHMRC) of Australia)	HB and PS received the following grants to support this work: three National Health & Medical Research Council (NHMRC) of Australia Program Grants (ID350833, ID568969, APP1093083). https://www.nhmrc.gov.au/funding.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the participants for their enthusiastic support. The Sydney Memory and Ageing Study Team comprises, in addition to the authors, the following individuals (research assistants, past study coordinators, data French, Cathy Foster, Emma NugentCleary-Fox, Chien Gooi, Evelyn Harvey, Rebecca Helyer, Sharpley Hsieh, Laura Hughes, Sarah Jacassistants): Adam Bentvelzen, Virginia Winter, Josie Bigland, Allison Bowman, Kim Burns, Anthony Broe, Joula Dekker, Louise Dooley, Michele de Permentier, Sarah Fairjones, Janelle Fletcher, Therese ek, Mary Johnston, Kate Maston, Donna McCade, Samantha Meeth, Eveline Milne, Angharad Moir, Ros O'Grady, Kia Pfaeffli, Carine Pose, Simone Reppermund, Laura Reuser, Amanda Rose, Peter Schofield, Zeeshan Shahnawaz, Amanda Sharpley, Melissa Slavin, Adam Theobald, Claire Thompson, Ruby Tsang, Wiebke Queisser, and Sam Wong.	Amariglio RE, 2012, NEUROPSYCHOLOGIA, V50, P2880, DOI 10.1016/j.neuropsychologia.2012.08.011; Association AP, 1994, DIAGN STAT MAN MENT, P143; Brodaty H, 2002, J AM GERIATR SOC, V50, P530, DOI 10.1046/j.1532-5415.2002.50122.x; Buckley RF, 2015, NEUROPSYCHOLOGY, V29, P571, DOI 10.1037/neu0000156; Burmester B, 2016, NEUROPSYCHOL REV, V26, P376, DOI 10.1007/s11065-016-9332-2; Chung JCC, 2009, DEMENT GERIATR COGN, V27, P187, DOI 10.1159/000200467; Costa Jr T., 1992, PSYCHOL ASSESSMENT R; Crook T H 3rd, 1992, Int Psychogeriatr, V4, P165, DOI 10.1017/S1041610292000991; Draper B, 2016, INT J GERIATR PSYCH, V31, P1217, DOI 10.1002/gps.4430; Duchek JM, 2007, J GERONTOL B-PSYCHOL, V62, pP353, DOI 10.1093/geronb/62.6.P353; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Hindmarch I, 1998, DEMENT GERIATR COGN, V9, P20, DOI 10.1159/000051195; Hohman TJ, 2011, NEUROPSYCHOLOGY, V25, P125, DOI 10.1037/a0020859; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Jungwirth S, 2004, J AM GERIATR SOC, V52, P263, DOI 10.1111/j.1532-5415.2004.52066.x; Kochan NA, 2010, AM J GERIAT PSYCHIAT, V18, P711, DOI 10.1097/JGP.0b013e3181d6b6a9; Mitchell AJ, 2014, ACTA PSYCHIAT SCAND, V130, P439, DOI 10.1111/acps.12336; Molinuevo JL, 2017, ALZHEIMERS DEMENT, V13, P296, DOI 10.1016/j.jalz.2016.09.012; Montejo P, 2014, EUR J AGEING, V11, P77, DOI 10.1007/s10433-013-0286-4; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Ponds RWHM, 1996, EDUC GERONTOL, V22, P341, DOI 10.1080/0360127960220404; Purser JL, 2006, J AM GERIATR SOC, V54, P335, DOI 10.1111/j.1532-5415.2005.00589.x; Rabin LA, 2015, J ALZHEIMERS DIS, V48, pS63, DOI 10.3233/JAD-150154; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Sheikh JI, 1986, CLIN GERONTOLOGIST J; Sierra-Rion A, 2016, NEURODEGENER DIS, V16, P69, DOI 10.1159/000439258; Slavin MJ, 2015, AM J GERIAT PSYCHIAT, V23, P906, DOI 10.1016/j.jagp.2014.09.001; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Verbeke G, 2009, SPRINGER SER STAT, P1; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yates JA, 2017, AGING MENT HEALTH, V21, P313, DOI 10.1080/13607863.2015.1081150; Zlatar ZZ, 2014, J GERIATR PSYCH NEUR, V27, P181, DOI 10.1177/0891988714524628	38	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0232961	10.1371/journal.pone.0232961	http://dx.doi.org/10.1371/journal.pone.0232961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0SY	32396544	Green Published, gold			2022-12-26	WOS:000537475000030
J	Sy, JBA; Hsu, TC; Limaye, A; Liu, JR				Sy, Jamie Bernadette A.; Hsu, Tsui-Chun; Limaye, Aniket; Liu, Je-Ruei			Oral administration with a traditional fermented multi-fruit beverage modulates non-specific and antigen-specific immune responses in BALB/c mice	PLOS ONE			English	Article							PAPAYA PREPARATION; CHINESE MEDICINE; GRAPE SEED; CANCER; RISK; IMMUNOMODULATION; PHYTOCHEMICALS; CONSUMPTION; CARCINOMA; LYCOPENE	Fruits have been widely considered as the default "health foods" because they contain numerous vitamins and minerals needed to sustain human health. Fermentation strategies have been utilized to enhance the nutritive and flavor features of healthy and readily consumable fruit products while extending their shelf lives. A traditional fermented multi-fruit beverage was made from five fruits including kiwi, guava, papaya, pineapple, and grape fermented by Saccharomyces cerevisiae along with lactic acid bacteria and acetic acid bacteria. The immunomodulatory properties of the fermented multi-fruit beverage, in vivo nonspecific and ovalbumin (OVA)-specific immune response experiments using female BALB/c mice were performed. Administration of the fermented multi-fruit beverage reduced the calorie intake, thus resulting in a less weight gain in mice compared to the water (placebo)-fed mice. In the nonspecific immune study model, the fermented multi-fruit beverage enhanced phagocytosis and T cell proliferation but did not affect B cell proliferation and immunoglobulin G (IgG) production. Analysis of cytokine secretion profile also revealed that the fermented multi-fruit beverage enhanced proinflammatory cytokines interleukin (IL)-6, tumor necrosis factor (TNF)-alpha, and T helper (Th)1-related cytokine interferon (IFN)-gamma production, thus creating an immunostimulatory effect. Nonetheless, in the specific immune study model, the results showed that the fermented multi-fruit beverage decreased the production of proinflammatory cytokines IL-6 and TNF-alpha production in OVA-immunized mice. Moreover, it also caused a decrease in the production of anti-OVA IgG1, which was accompanied by a decrease in Th2-related cytokines IL-4 and IL-5 production and an increase in Th1-related cytokine IFN-gamma production, indicating that it may have the potential to shift the immune system from the allergen-specific Th2 responses toward Th1-type responses. The results indicate that fermented multi-fruit beverage has the potential to modulate immune responses both in a nonspecific and specific manners.	[Sy, Jamie Bernadette A.; Limaye, Aniket; Liu, Je-Ruei] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Sy, Jamie Bernadette A.] Univ Philippines Manila, Dept Phys Sci & Math, Coll Arts & Sci, Manila, Philippines; [Hsu, Tsui-Chun; Liu, Je-Ruei] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Hsu, Tsui-Chun; Liu, Je-Ruei] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan	National Taiwan University; University of the Philippines System; University of the Philippines Manila; National Taiwan University; Academia Sinica - Taiwan	Liu, JR (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.; Liu, JR (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Liu, JR (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan.	jrliu@ntu.edu.tw		LIU, JE-RUEI/0000-0002-2152-7536	Ministry of Science and Technology [MOST 108-2313-B-002-012, MOST 108-2321-B-002-064]; Council of Agriculture, Executive Yuan [108AS-21.1.7-AD-U1]; Academia Sinica [AS-KPQ-108-ITAR-TD03]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Council of Agriculture, Executive Yuan; Academia Sinica(Academia Sinica - Taiwan)	This research was conducted using funds provided by the Ministry of Science and Technology (MOST 108-2313-B-002-012 and MOST 108-2321-B-002-064 to JRL), the Council of Agriculture, Executive Yuan (108AS-21.1.7-AD-U1 to JRL), and Academia Sinica (AS-KPQ-108-ITAR-TD03 to JRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai WC, 2013, INT J ENV RES PUB HE, V10, P3834, DOI 10.3390/ijerph10093834; Aliyev R, 2010, Georgian Med News, P38; Ambroziak AM, 2016, CENT EUR J IMMUNOL, V41, P195, DOI 10.5114/ceji.2016.60995; Amoutzopoulos B, 2013, J SCI FOOD AGR, V93, P3604, DOI 10.1002/jsfa.6158; Anderson GH, 2003, AM J CLIN NUTR, V78, p843S, DOI 10.1093/ajcn/78.4.843S; Ang A, 2018, BIOCHEM SOC T, V46, P1147, DOI 10.1042/BST20180169; Araujo HM, 2015, EXCLI J, V14, P1020, DOI 10.17179/excli2015-522; Aruoma OI, 2014, MUTAT RES-FUND MOL M, V768, P60, DOI 10.1016/j.mrfmmm.2014.04.007; Bagger M, 1996, BRIT J NUTR, V75, P483, DOI 10.1079/BJN19960149; Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424; Caplice E, 1999, INT J FOOD MICROBIOL, V50, P131, DOI 10.1016/S0168-1605(99)00082-3; Carr AC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111211; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; Chase CR, 2018, MED ACUPUNCT, V30, P167, DOI 10.1089/acu.2018.1288; Chen BA, 2010, INT J NANOMED, V5, P593; Chen CY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092729; Chen JZ, 2014, ANTI-CANCER AGENT ME, V14, P800, DOI 10.2174/1871520614666140521121317; Cheng JT, 2000, J CLIN PHARMACOL, V40, P445, DOI 10.1177/00912700022009198; Denny C, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-235; Dhama K, 2015, INT J PHARMACOL, V11, P253, DOI 10.3923/ijp.2015.253.290; Dopico-Garcia MS, 2008, TALANTA, V75, P1190, DOI 10.1016/j.talanta.2008.01.012; dos Santos RC, 2018, FOOD RES INT, V105, P184, DOI 10.1016/j.foodres.2017.10.045; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Endrizzi I, 2009, J SCI FOOD AGR, V89, P1227, DOI 10.1002/jsfa.3580; Fessard A, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5020023; Gescher A, 2004, J CHEMOTHERAPY, V16, P3, DOI 10.1179/joc.2004.16.Supplement-1.3; Hale LP, 2010, INFLAMM BOWEL DIS, V16, P2012, DOI 10.1002/ibd.21320; Hernandez-Jimenez A, 2009, J AGR FOOD CHEM, V57, P10798, DOI 10.1021/jf903465p; Hussain A, 2018, CUREUS J MED SCIENCE, V10, DOI 10.7759/cureus.3062; Huynh NT, 2014, INT J MOL SCI, V15, P19369, DOI 10.3390/ijms151119369; Imao K, 1998, BIOCHEM MOL BIOL INT, V45, P11; Jeon J, 2015, IMMUNE NETW, V15, P304, DOI 10.4110/in.2015.15.6.304; Kavoussi B, 2007, EVID-BASED COMPL ALT, V4, P293, DOI 10.1093/ecam/nem005; Kim Yejin, 2013, Immune Netw, V13, P70, DOI 10.4110/in.2013.13.2.70; Ko YP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003816; Kumar RK, 2008, CURR DRUG TARGETS, V9, P485, DOI 10.2174/138945008784533561; Latimer G. W, 2019, OFFICIAL METHODS ANA, V21st; Lavin JH, 2002, INT J OBESITY, V26, P384, DOI 10.1038/sj.ijo.0801829; LEMARCHAND L, 1991, AM J EPIDEMIOL, V133, P215; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Lu DP, 2013, ACUPUNCTURE ELECTRO, V38, P77, DOI 10.3727/036012913X13831831849529; Maassen CBM, 2003, VACCINE, V21, P2751, DOI 10.1016/S0264-410X(03)00220-2; Madka V, 2013, CURR CANCER DRUG TAR, V13, P542; Mazza Giuseppe Joe, 2007, Ann Ist Super Sanita, V43, P369; McBride JA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006624; Murakami S, 2018, NUTR NEUROSCI, V21, P176, DOI [10.1080/1028415X.2016.1253171, 10.1080/1028415x.2016.1253171]; Pandey S, 2016, J IMMUNOTOXICOL, V13, P590, DOI 10.3109/1547691X.2016.1149528; RICARDO-DA-SILVA JM, 1991, PHYTOCHEMISTRY, V30, P1259, DOI 10.1016/S0031-9422(00)95213-0; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; ROMAGNANI S, 1995, J CLIN IMMUNOL, V15, P121, DOI 10.1007/BF01543103; Romano B, 2014, MOL NUTR FOOD RES, V58, P457, DOI 10.1002/mnfr.201300345; Saruwatari A, 2008, J MED FOOD, V11, P623, DOI 10.1089/jmf.2007.0050; Scott-Taylor TH, 2018, IMMUN INFLAMM DIS, V6, P13, DOI 10.1002/iid3.192; Slavin JL, 2012, ADV NUTR, V3, P506, DOI 10.3945/an.112.002154; Somanah J, 2016, LIFE SCI, V151, P330, DOI 10.1016/j.lfs.2016.03.026; Stonehouse W, 2013, CAN J PHYSIOL PHARM, V91, P442, DOI 10.1139/cjpp-2012-0303; Stubbs RJ, 2001, J NUTR, V131, p2775S, DOI 10.1093/jn/131.10.2775S; Swain Manas Ranjan, 2014, Biotechnol Res Int, V2014, P250424, DOI 10.1155/2014/250424; Tominaga T, 2010, IMMUNOPHARM IMMUNOT, V32, P593, DOI 10.3109/08923971003604786; Tong HB, 2011, J AGR FOOD CHEM, V59, P11543, DOI 10.1021/jf203170k; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Wada M, 2007, FOOD CHEM, V101, P980, DOI 10.1016/j.foodchem.2006.02.050; Wang S, 2011, J AGR FOOD CHEM, V59, P960, DOI 10.1021/jf1040977; Xu AB, 2013, Chinese patent, Patent No. [CN103609985A, 103609985]; Xutian S, 2012, AM J CHINESE MED, V40, P231, DOI 10.1142/S0192415X12500188; Zhang CX, 2009, INT J CANCER, V125, P181, DOI 10.1002/ijc.24358	66	5	5	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0233047	10.1371/journal.pone.0233047	http://dx.doi.org/10.1371/journal.pone.0233047			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392269	Green Published, gold			2022-12-26	WOS:000537470300036
J	Biavati, M; Kozlitina, J; Alder, AC; Foglia, R; McColl, RW; Peshock, RM; Kelly, RE; Garcia, CK				Biavati, Mikaela; Kozlitina, Julia; Alder, Adam C.; Foglia, Robert; McColl, Roderick W.; Peshock, Ronald M.; Kelly, Robert E., Jr.; Garcia, Christine Kim			Prevalence of pectus excavatum in an adult population-based cohort estimated from radiographic indices of chest wall shape	PLOS ONE			English	Article							HALLER INDEX; CARINATUM; REPAIR; CLASSIFICATION; DEFORMITIES; EXPERIENCE; CHILDREN; THERAPY; SAMPLE	Background Pectus excavatum is the most common chest wall skeletal deformity. Although commonly evaluated in adolescence, its prevalence in adults is unknown. Methods and findings Radiographic indices of chest wall shape were analyzed for participants of the first (n = 2687) and second (n = 1780) phases of the population-based Dallas Heart Study and compared to clinical cases of pectus (n = 297). Thoracic computed tomography imaging studies were examined to calculate the Haller index, a measure of thoracic axial shape, and the Correction index, which quantitates the posterior displacement of the sternum relative to the ribs. At the level of the superior xiphoid, 0.5%, 5% and 0.4% of adult Dallas Heart Study subjects have evidence of pectus excavatum using thresholds of Haller index > 3.25, Correction index > 10%, or both, respectively. Radiographic measures of pectus are more common in females than males and there is a greater prevalence of pectus in women than men. In the general population, the Haller and Correction indices are associated with height and weight, independent of age, gender, and ethnicity. Repeat imaging of a subset of subjects (n = 992) demonstrated decreases in the mean Haller and Correction indices over seven years, suggesting change to a more circular axial thorax, with less sternal depression, over time. Conclusions To our knowledge, this is the first study estimating the prevalence of pectus in an unselected adult population. Despite the higher reported prevalence of pectus cases in adolescent boys, this study demonstrates a higher prevalence of radiographic indices of pectus in adult females.	[Biavati, Mikaela; Kozlitina, Julia; Garcia, Christine Kim] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Alder, Adam C.; Foglia, Robert] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [McColl, Roderick W.; Peshock, Ronald M.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Kelly, Robert E., Jr.] Eastern Virginia Med Ctr, Dept Surg & Pediat, Norfolk, VA USA; [Kelly, Robert E., Jr.] Childrens Hosp Kings Daughters, Norfolk, VA USA; [Garcia, Christine Kim] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garcia, CK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.; Garcia, CK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	ckg2116@cumc.columbia.edu		peshock, ron/0000-0003-3217-1966; Alder, Adam/0000-0002-4877-9012	National Center for Advancing Translational Sciences [UL1TR000451, KL2TR000453]	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was supported by grants UL1TR000451 and KL2TR000453 from the National Center for Advancing Translational Sciences as well as institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertal M, 2013, J PEDIATR SURG, V48, P2011, DOI 10.1016/j.jpedsurg.2013.01.044; Archer JE, 2016, J ANAT, V229, P577, DOI 10.1111/joa.12499; Birkemeier KL, 2011, AM J ROENTGENOL, V197, pW934, DOI 10.2214/AJR.11.6430; Cartoski MJ, 2006, J PEDIATR SURG, V41, P1573, DOI 10.1016/j.jpedsurg.2006.05.055; Chlif M, 2007, INT J OBESITY, V31, P1456, DOI 10.1038/sj.ijo.0803546; Chlif M, 2005, INT J OBESITY, V29, P1478, DOI 10.1038/sj.ijo.0803030; Choi JH, 2016, ANN THORAC SURG, V102, P1886, DOI 10.1016/j.athoracsur.2016.05.079; Chung C S, 1975, Birth Defects Orig Artic Ser, V11, P1; Coskun ZK, 2010, INDIAN J PEDIATR, V77, P1017, DOI 10.1007/s12098-010-0155-5; Daunt SW, 2004, PEDIATR RADIOL, V34, P326, DOI 10.1007/s00247-003-1116-1; Fokin AA, 2009, SEMIN THORAC CARDIOV, V21, P44, DOI 10.1053/j.semtcvs.2009.03.001; Fonkalsrud EW, 2000, ANN SURG, V231, P443, DOI 10.1097/00000658-200003000-00019; HALLER JA, 1987, J PEDIATR SURG, V22, P904, DOI 10.1016/S0022-3468(87)80585-7; Jaroszewski D, 2010, J AM BOARD FAM MED, V23, P230, DOI 10.3122/jabfm.2010.02.090234; Kelly RE, 2013, ARCH BRONCONEUMOL, V49, P196, DOI 10.1016/j.arbres.2012.09.013; Kelly RE, 2010, ANN SURG, V252, P1072, DOI 10.1097/SLA.0b013e3181effdce; Lawson ML, 2011, J PEDIATR-US, V159, P256, DOI 10.1016/j.jpeds.2011.01.065; Lee RT, 2013, J PEDIATR SURG, V48, P184, DOI 10.1016/j.jpedsurg.2012.10.037; Park HJ, 2016, EUR J CARDIO-THORAC, V50, P1102, DOI 10.1093/ejcts/ezw162; Poston PM, 2014, ANN THORAC SURG, V97, P1176, DOI 10.1016/j.athoracsur.2013.12.050; Rajabi-Mashhadi MT, 2010, IRAN J PEDIATR, V20, P221; St Peter SD, 2011, J PEDIATR SURG, V46, P2270, DOI 10.1016/j.jpedsurg.2011.09.009; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Weiner P, 1998, THORAX, V53, P39, DOI 10.1136/thx.53.1.39; Westphal FL, 2009, J BRAS PNEUMOL, V35, P221, DOI 10.1590/S1806-37132009000300005; Williams A M, 2003, Paediatr Respir Rev, V4, P237, DOI 10.1016/S1526-0542(03)00053-8; YUCESAN S, 1993, EUR J EPIDEMIOL, V9, P373, DOI 10.1007/BF00157393	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232575	10.1371/journal.pone.0232575	http://dx.doi.org/10.1371/journal.pone.0232575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379835	Green Published, gold			2022-12-26	WOS:000537285700041
J	Kumar, H; Finer-Moore, J; Smirnova, I; Kasho, V; Pardon, E; Steyaert, J; Kaback, HR; Stroud, RM				Kumar, Hemant; Finer-Moore, Janet; Smirnova, Irina; Kasho, Vladimir; Pardon, Els; Steyaert, Jan; Kaback, H. Ronald; Stroud, Robert M.			Diversity in kinetics correlated with structure in nano body-stabilized LacY	PLOS ONE			English	Article							LACTOSE PERMEASE; ALTERNATING ACCESS; CRYSTAL-STRUCTURE; SUGAR BINDING; CONFORMERS; MECHANISM; COMPLEX; SITE	The structure of lactose permease, stabilized in a periplasmic open conformation by two Gly to Trp replacements (LacYww) and complexed with a nanobody directed against this conformation, provides the highest resolution structure of the symporter. The nanobody binds in a different manner than two other nanobodies made against the same mutant, which also bind to the same general region on the periplasmic side. This region of the protein may represent an immune hotspot. The CDR3 loop of the nanobody is held by hydrogen bonds in a conformation that partially blocks access to the substrate-binding site. As a result, k(on) and k(off) for galactoside binding to either LacY or the double mutant complexed with the nanobody are lower than for the other two LacY/nanobody complexes though the K-d values are similar, reflecting the fact that the nanobodies rigidify structures along the pathway. While the wild-type LacY/nanobody complex clearly stabilizes a similar 'extracellular open' conformation in solution, judged by binding kinetics, the complex with wild-type LacY did not yet crystallize, suggesting the nanobody does not bind strongly enough to shift the equilibrium to stabilize a periplasmic side-open conformation suitable for crystallization. However, the similarity of the galactoside binding kinetics for the nanobody-bound complexes with wild type LacY and with LacY(WW) indicates that they have similar structures, showing that the reported co-structures reliably show nanobody interactions with LacY.	[Kumar, Hemant; Finer-Moore, Janet; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94115 USA; [Smirnova, Irina; Kasho, Vladimir; Kaback, H. Ronald] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA; [Pardon, Els; Steyaert, Jan] VIB, VIB VUB Ctr Struct Biol, Brussels, Belgium; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussels, Struct Biol Brussels, Brussels, Belgium; [Kaback, H. Ronald] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Kaback, H. Ronald] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Kumar, Hemant] Banaras Hindu Univ, Inst Med Sci, Mol Biol Unit, Varanasi, Uttar Pradesh, India	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Banaras Hindu University (BHU)	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94115 USA.	stroud@msg.ucsf.edu	steyaert, jan/GQP-7811-2022; Kumar, Hemant/AAW-6086-2021; Steyaert, Jan/H-4662-2011	Steyaert, Jan/0000-0002-3825-874X; Pardon, Els/0000-0002-2466-0172; Kumar, Hemant/0000-0001-7698-2301	NIH [R01 GM024485, R01 GM120043]; NSF Eager Grant [MCB1747705]; INSTRUCT-ERIC; Research Foundation Flanders; Program for Breakthrough Biomedical Research, Sandler Foundation; University of California Office of the President, Multicampus Research Programs and Initiatives [MR-15-328559]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Eager Grant(National Science Foundation (NSF)); INSTRUCT-ERIC; Research Foundation Flanders(FWO); Program for Breakthrough Biomedical Research, Sandler Foundation; University of California Office of the President, Multicampus Research Programs and Initiatives(University of California System)	NIH R01 GM024485 (RMS) www.NIH.gov, NIH R01 GM120043 (HRK) www.NIH.gov, NSF Eager Grant MCB1747705 (HRK) INSTRUCT-ERIC (JS) instruct-eMRric.eu, Research Foundation Flanders (JS) www.fwo.be, Program for Breakthrough Biomedical Research, Sandler Foundation (RMS) https://pbbr.ucsf.edu/, MR-15-328559 University of California Office of the President, Multicampus Research Programs and Initiatives (RMS) www.ucop.edu. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chaptal V, 2011, P NATL ACAD SCI USA, V108, P9361, DOI 10.1073/pnas.1105687108; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Jiang X, 2016, P NATL ACAD SCI USA, V113, P12420, DOI 10.1073/pnas.1615414113; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Kaback HR, 2019, J GEN PHYSIOL, V151, P878, DOI 10.1085/jgp.201912377; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar H, 2018, P NATL ACAD SCI USA, V115, P8769, DOI 10.1073/pnas.1801774115; Kumar H, 2015, P NATL ACAD SCI USA, V112, P9004, DOI 10.1073/pnas.1509854112; Kumar H, 2014, P NATL ACAD SCI USA, V111, P1784, DOI 10.1073/pnas.1324141111; Majumdar DS, 2007, P NATL ACAD SCI USA, V104, P12640, DOI 10.1073/pnas.0700969104; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Smirnova I, 2015, P NATL ACAD SCI USA, V112, P13839, DOI 10.1073/pnas.1519485112; Smirnova I, 2014, P NATL ACAD SCI USA, V111, P18548, DOI 10.1073/pnas.1422265112; Smirnova I, 2014, P NATL ACAD SCI USA, V111, P8440, DOI 10.1073/pnas.1408374111; Smirnova I, 2013, P NATL ACAD SCI USA, V110, P8876, DOI 10.1073/pnas.1306849110; Smirnova I, 2011, P NATL ACAD SCI USA, V108, P15147, DOI 10.1073/pnas.1112157108; Smirnova I, 2009, P NATL ACAD SCI USA, V106, P21561, DOI 10.1073/pnas.0911434106; Smirnova IN, 2006, BIOCHEMISTRY-US, V45, P15279, DOI 10.1021/bi061632m; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; STROUD RM, 1995, PROTEIN SCI, V4, P2392, DOI 10.1002/pro.5560041118; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	30	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232846	10.1371/journal.pone.0232846	http://dx.doi.org/10.1371/journal.pone.0232846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32380514	Green Published, gold			2022-12-26	WOS:000537285700074
J	Laxhuber, KS; Morrison, MJ; Chure, G; Belliveau, NM; Strandkvist, C; Naughton, KL; Phillips, R				Laxhuber, Kathrin S.; Morrison, Muir J.; Chure, Griffin; Belliveau, Nathan M.; Strandkvist, Charlotte; Naughton, Kyle L.; Phillips, Rob			Theoretical investigation of a genetic switch for metabolic adaptation	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; PURINE NUCLEOSIDE PHOSPHORYLASE; TRANSCRIPTIONAL REGULATION; XANTHOSINE PHOSPHORYLASE; LAC OPERON; GLUCOSE; ORGANIZATION; BISTABILITY; MECHANISMS; EXPRESSION	Membrane transporters carry key metabolites across the cell membrane and, from a resource standpoint, are hypothesized to be produced when necessary. The expression of membrane transporters in metabolic pathways is often upregulated by the transporter substrate. In E. coli, such systems include for example the lacY, araFGH, and xylFGH genes, which encode for lactose, arabinose, and xylose transporters, respectively. As a case study of a minimal system, we build a generalizable physical model of the xapABR genetic circuit, which features a regulatory feedback loop via membrane transport (positive feedback) and enzymatic degradation (negative feedback) of an inducer. Dynamical systems analysis and stochastic simulations show that the membrane transport makes the model system bistable in certain parameter regimes. Thus, it serves as a genetic "on-off" switch, enabling the cell to only produce a set of metabolic enzymes when the corresponding metabolite is present in large amounts. We find that the negative feedback from the degradation enzyme does not significantly disturb the positive feedback from the membrane transporter. We investigate hysteresis in the switching and discuss the role of cooperativity and multiple binding sites in the model circuit. Fundamentally, this work explores how a stable genetic switch for a set of enzymes is obtained from transcriptional auto-activation of a membrane transporter through its substrate.	[Laxhuber, Kathrin S.] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland; [Morrison, Muir J.; Phillips, Rob] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Chure, Griffin; Phillips, Rob] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Belliveau, Nathan M.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Strandkvist, Charlotte] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Naughton, Kyle L.] Univ Southern Calif, Dept Phys & Astron, Los Angeles, CA 90007 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; University of Southern California	Phillips, R (corresponding author), CALTECH, Dept Phys, Pasadena, CA 91125 USA.; Phillips, R (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu		Chure, Griffin/0000-0002-2216-2057; Morrison, Muir/0000-0002-0768-7234; Laxhuber, Kathrin/0000-0002-8104-3525; Belliveau, Nathan/0000-0002-1536-1963	National Institutes of Health [1R35 GM118043-01]; Werner Siemens Foundation through the Swiss Study Foundation; National Science Foundation [DGE-1745301]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Werner Siemens Foundation through the Swiss Study Foundation; National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health (https://www.nih.gov/) through 1R35 GM118043-01 Maximizing Investigators' Research Award (MIRA) (to R.P.), and the Werner Siemens Foundation (https://www.wernersiemens-stiftung.ch/en/) through the Swiss Study Foundation (https://www.studyfoundation.ch/) (K. S.L.). This material is based upon work supported by the National Science Foundation Graduate Research Fellowship (https://www.nsfgrfp.org/) under Grant No. DGE-1745301 (M.J.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2010, SENSORS-BASEL, V10, P5031, DOI 10.3390/s100505031; Belliveau NM, 2018, P NATL ACAD SCI USA, V115, pE4796, DOI 10.1073/pnas.1722055115; BUXTON RS, 1980, MOL GEN GENET, V179, P331, DOI 10.1007/BF00425461; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Chure G, 2019, BIORXIV; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fritz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089532; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; HAMMERJESPERSEN K, 1980, MOL GEN GENET, V179, P341, DOI 10.1007/BF00425462; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jenkins A, 2017, B MATH BIOL, V79, P1778, DOI 10.1007/s11538-017-0306-1; Jones DL, 2014, SCIENCE, V346, P1533, DOI 10.1126/science.1255301; Jorgensen C, 1999, J BACTERIOL, V181, P4397; Kaback HR, 2015, P NATL ACAD SCI USA, V112, P1259, DOI 10.1073/pnas.1419325112; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Maarleveld TR, 2015, STOCHASTIC MODELING; Marzen S, 2013, J MOL BIOL, V425, P1433, DOI 10.1016/j.jmb.2013.03.013; Milo R, 2016, GARLAND SCI, P217; Narang A, 2008, B MATH BIOL, V70, P1032, DOI 10.1007/s11538-007-9289-7; Norholm MHH, 2001, J BACTERIOL, V183, P4900, DOI 10.1128/JB.183.16.4900-4904.2001; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Razo-Mejia M, 2018, CELL SYST, V6, P456, DOI 10.1016/j.cels.2018.02.004; Santillan M, 2008, J R SOC INTERFACE, V5, pS29, DOI 10.1098/rsif.2008.0086.focus; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; SEEGER C, 1995, J BACTERIOL, V177, P5506, DOI 10.1128/jb.177.19.5506-5516.1995; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Song SG, 1997, J BACTERIOL, V179, P7025, DOI 10.1128/jb.179.22.7025-7032.1997; TIEDGE M, 1991, BIOCHEM J, V279, P899, DOI 10.1042/bj2790899; Wolf DM, 1998, J THEOR BIOL, V195, P167, DOI 10.1006/jtbi.1998.0790; Wong P, 1997, BIOTECHNOL PROGR, V13, P132, DOI 10.1021/bp970003o	38	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0226453	10.1371/journal.pone.0226453	http://dx.doi.org/10.1371/journal.pone.0226453			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379825	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000537285700005
J	Narayan, M; Fey, AM				Narayan, Meenakshi; Fey, Ann Majewicz			Developing a novel force forecasting technique for early prediction of critical events in robotics	PLOS ONE			English	Article							NEEDLE INSERTION; TISSUE; MODEL	Safety critical events in robotic applications can often be characterized by forces between the robot end-effector and the environment. One application in which safe interaction between the robot and environment is critical is in the area of medical robots. In this paper, we propose a novel Compact Form Dynamic Linearization Model-Free Prediction (CFDLMFP) technique to predict future values of any time-series sensor data, such as interaction forces. Existing time series forecasting methods have high computational times which motivates the development of a novel technique. Using Autoregressive Integrated Moving Average (ARIMA) forecasting as benchmark, the performance of the proposed model was evaluated in terms of accuracy, computation efficiency, and stability on various force profiles. The proposed algorithm was 11% more accurate than ARIMA and maximum computation time of CFDL-MFP was 4ms, compared to ARIMA (7390ms). Furthermore, we evaluate the model in the special case of predicting needle buckling events, before they occur, by using only axial force and needle-tip position data. The model was evaluated experimentally for robustness with steerable needle insertions into different tissues including gelatin and biological tissue. For a needle insertion velocity of 2.5mm/s, the proposed algorithm was able to predict needle buckling 2.03s sooner than human detections. In biological tissue, no false positive or false negative buckling detections occurred and the rates were low in artificial tissue. The proposed forecasting model can be used to ensure safe robot interactions with delicate environments by predicting adverse force-based events before they occur.	[Narayan, Meenakshi; Fey, Ann Majewicz] Univ Texas Dallas, Dept Mech Engn, Richardson, TX 75083 USA; [Fey, Ann Majewicz] UT Southwestern Med Ctr, Dept Surg, Dallas, TX USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Narayan, M (corresponding author), Univ Texas Dallas, Dept Mech Engn, Richardson, TX 75083 USA.	Meenakshi.Narayan@utdallas.edu		Majewicz Fey, Ann/0000-0002-1802-6730	National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001105]	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award Number UL1TR001105. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abdulali A, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18010237; Abolhassani N, 2007, MED ENG PHYS, V29, P413, DOI 10.1016/j.medengphy.2006.07.003; Adebar TK, 2014, IEEE T BIO-MED ENG, V61, P2899, DOI 10.1109/TBME.2014.2334309; Ahmed NK, 2010, ECONOMET REV, V29, P594, DOI 10.1080/07474938.2010.481556; Alemzadeh H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151470; Assimakopoulos V, 2000, INT J FORECASTING, V16, P521, DOI 10.1016/S0169-2070(00)00066-2; Ben Taieb S, 2014, P 31 INT C MACH LEAR, P109; Billis A., 2014, NETMED ECAI, P31; Bui C, 2018, 6 INT C DEV BIOMED E, P809, DOI [10.1007/978-981-10-4361-1_138, DOI 10.1007/978-981-10-4361-1_138]; Buzurovic I, 2010, J ROBOT, V2010, DOI 10.1155/2010/581840; Carroll AL, 2010, USDA FOR SERV N RES, V75, P1; Chevillon G, 2005, INT J FORECASTING, V21, P201, DOI 10.1016/j.ijforecast.2004.08.004; de Jong TL, 2017, DATA BRIEF, V11, P308, DOI 10.1016/j.dib.2017.01.018; Demiris Yiannis, 2007, Cogn Process, V8, P151, DOI 10.1007/s10339-007-0168-9; Elgezua I, 2014, IEEE INT C INT ROBOT, P4315, DOI 10.1109/IROS.2014.6943172; Elgezua I, 2013, PROC CIRP, V5, P94, DOI 10.1016/j.procir.2013.01.019; Engh JA, 2010, NEUROSURGERY, V67, P1117, DOI 10.1227/NEU.0b013e3181ec1551; Fioruci J.A., 2015, ARXIV150303529; Fukushima Y, 2013, PROC CIRP, V5, P265, DOI 10.1016/j.procir.2013.01.052; Gessert N, 2019, INT J COMPUTER ASSIS, P1; Ghezzi TL, 2016, WORLD J SURG, V40, P2550, DOI 10.1007/s00268-016-3543-9; Grespan L, 2019, MEASURING SAFETY ROB, P37; Gruijthuijsen Caspar, 2018, J Med Robot Res, V3, DOI 10.1142/S2424905X18410015; Hameed HH, 2015, SMOOTHING TECHNIQUES; Hardy J, 2015, INT J ROBOT RES, V34, P1211, DOI 10.1177/0278364915584007; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Hernandez-Hernandez C, 2017, ENERGIES, V10, DOI 10.3390/en10070884; Hou ZS, 2011, IEEE T NEURAL NETWOR, V22, P2173, DOI 10.1109/TNN.2011.2176141; Hyndman R. J., 2018, FORECASTING PRINCIPL; Kronreif G, 2003, ADV ROBOTICS, V17, P541, DOI 10.1163/15685530360675532; Lehmann T, 2013, J SENSORS, V2013, DOI 10.1155/2013/263153; Li MH, 2018, IEEE-ASME T MECH, V23, P286, DOI 10.1109/TMECH.2017.2775663; Lokare N, 2017, INVENTIONS-BASEL, V2, DOI 10.3390/inventions2040032; Mahvash Mohsen, 2009, 2009 IEEE International Conference on Robotics and Automation (ICRA), P3097, DOI 10.1109/ROBOT.2009.5152617; Majewicz A, 2014, IEEE INT CONF ROBOT, P5883, DOI 10.1109/ICRA.2014.6907725; Majewicz A, 2013, 2013 WORLD HAPTICS CONFERENCE (WHC), P395, DOI 10.1109/WHC.2013.6548441; Martens P, 2018, ACTA CARDIOL, V73, P115, DOI 10.1080/00015385.2017.1351239; Minhas DS, 2007, P ANN INT IEEE EMBS, P2756, DOI 10.1109/IEMBS.2007.4352899; Misra S, 2010, INT J ROBOT RES, V29, P1640, DOI 10.1177/0278364910369714; Najmaei N, 2010, IEEE INT CONF ROBOT, P3434, DOI 10.1109/ROBOT.2010.5509179; Narayan M, 2018, 2018 INTERNATIONAL SYMPOSIUM ON MEDICAL ROBOTICS (ISMR); Narazani M., 2018, P 2018 INT ELECT ENG, P1, DOI DOI 10.1109/IEECON.2018.8712218; Oldewurtel F, 2012, ENERG BUILDINGS, V45, P15, DOI 10.1016/j.enbuild.2011.09.022; Paxton C, 2019, IEEE INT CONF ROBOT, P6942, DOI 10.1109/ICRA.2019.8794441; Piccin O, 2009, INT J ROBOT RES, V28, P1154, DOI 10.1177/0278364909101408; Reed KB, 2011, IEEE ROBOT AUTOM MAG, V18, P35, DOI 10.1109/MRA.2011.942997; Rossa C, 2017, MED BIOL ENG COMPUT, V55, P1401, DOI 10.1007/s11517-016-1599-1; Rossa C, 2017, CONTROL ENG PRACT, V62, P55, DOI 10.1016/j.conengprac.2017.03.004; Russell S., 2002, ARTIF INTELL; Sakes A, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/2/021001; Salimbeni H, 2017, ADV NEUR IN, V30; Sangvinatsos A, 2017, QUANT FINANC, V17, P327, DOI 10.1080/14697688.2016.1256598; Sato RC, 2013, EINSTEIN-SAO PAULO, V11, P128, DOI 10.1590/S1679-45082013000100024; Scali M, 2017, P I MECH ENG H, V231, P250, DOI 10.1177/0954411916672149; Shahriari N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210052; Siciliano B., 2016, SPRINGER HDB ROBOTIC, DOI DOI 10.1007/978-3-540-30301-5; Simone C, 2002, MODELING NEEDLE INSE; Sprang T, 2016, LECT NOTES COMPUT SC, V9793, P307, DOI 10.1007/978-3-319-42417-0_28; Storms J, 2017, INT J ROBOT RES, V36, P820, DOI 10.1177/0278364917693690; Taieb SB, 2012, RECURSIVE DIRECT MUL, V19; Tang LB, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-5, P612, DOI 10.1109/ROBIO.2007.4522232; van de Berg NJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40477; van de Berg NJ, 2015, IEEE-ASME T MECH, V20, P2172, DOI 10.1109/TMECH.2014.2365999; van Gerwen DJ, 2014, ANN BIOMED ENG, V42, P685, DOI 10.1007/s10439-013-0924-1; van Gerwen DJ, 2012, MED ENG PHYS, V34, P665, DOI 10.1016/j.medengphy.2012.04.007; Wang YL, 2014, LECT NOTES COMPUT SC, V8866, P69, DOI 10.1007/978-3-319-12436-0_9; Webster RJ, 2006, INT J ROBOT RES, V25, P509, DOI 10.1177/0278364906065388; Yan K, 2009, MED PHYS, V36, P3356, DOI 10.1118/1.3148834; Yang CJ, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020561; Young P. C., 1989, ADV THEORY APPL, V30, P119; Zhang YX, 2019, J NAVIGATION, V72, P375, DOI 10.1017/S0373463318000760; Zhou T, 2019, INT J ROBOT RES, DOI 10.1177/0278364919872252	73	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0230009	10.1371/journal.pone.0230009	http://dx.doi.org/10.1371/journal.pone.0230009			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379827	Green Published, gold			2022-12-26	WOS:000537285700009
J	Pechlivanis, S; Moebus, S; Lehmann, N; Erbel, R; Mahabadi, AA; Hoffmann, P; Jockel, KH; Nothen, MM; Bachmann, HS				Pechlivanis, Sonali; Moebus, Susanne; Lehmann, Nils; Erbel, Raimund; Mahabadi, Amir A.; Hoffmann, Per; Joeckel, Karl-Heinz; Noethen, Markus M.; Bachmann, Hagen S.		Heinz Nixdorf Recall Study Investi	Genetic risk scores for coronary artery disease and its traditional risk factors: Their role in the progression of coronary artery calcification-Results of the Heinz Nixdorf Recall study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MIDDLE-AGED SUBJECTS; BODY-MASS INDEX; BLOOD-PRESSURE; LIPID-LEVELS; SUSCEPTIBILITY LOCI; CARDIOVASCULAR RISK; ATHEROSCLEROSIS; CALCIUM; EVENTS	Background Atherosclerosis is the primary cause of coronary artery disease (CAD). Several observational studies have examined the association of traditional CAD risk factors with the progression of coronary artery calcification (CAC). In our study we investigated the effect of 11 different genetic risk scores associated with CAD and CAD risk factors on the progression of CAC. Methods and results We included 3097 participants from the Heinz Nixdorf Recall study who had available CAC measurements at baseline (CAC(b)) and at the 5-year follow-up (CAC(5y)). A weighted genetic risk score for CAD and each of the CAD-associated risk factors was constructed. Multiple regression analyses were applied to i) the difference between the observed log(CAC(5y)+1) (log(obs)) and expected log(CAC(5y)+1) (log(exp)) at the 5-year follow-up following the individual's log(CAC(b)+1) percentile for the time between scans (log(obs)-log(exp)) and ii) the 5-year CAC progression, defined as 5*(log(CAC(5y)+1)-log(CAC(b)+1))/time between the scans, adjusted for age, sex, and log(CAC(b)+1) as well as for risk factors. The median percent deviation from the expected (CAC(5y)+1) and the 5-year progression of (CAC+1) in our study were 0 (first quartile: Q1; third quartile: Q3: -0.32; 0.48) and 45.4% (0%; 171.0%) respectively. In the age-, sex- and log(CAC(b)+1)-adjusted model, the per-standard deviation (SD) increase in CAD genetic risk score was associated with the percent deviation from the expected (CAC(5y)+1) (9.7% (95% confidence interval: 5.2%; 14.5%), p = 1.6x10(-5)) and the 5-year progression of CAC (7.1% (3.0%; 11.4%), p = 0.0005). The CAD genetic risk score explains an additional 0.6% of the observed phenotypic variance for "log(obs)-log(exp)" and 0.4% for 5-year progression of CAC. Additionally, the per-SD increase in the CAC genetic risk score was associated with the percent deviation from the expected (CAC(5y)+1) (6.2% (1.9%; 10.8%, p = 0.005)) explaining an additional 0.2% of the observed phenotypic variance. However, the per-SD increase in the CAC genetic risk score was not associated with the 5-year progression of CAC (4.4% (0.4%; 8.5%), p = 0.03) after multiple testing. Adjusting for risk factors did not change the results. None of the other genetic risk scores showed an association with the percent deviation from the expected (CAC(5y)+1) or with the 5-year progression of CAC. Conclusions The association of the CAC genetic risk score and the CAD genetic risk score provides evidence that genetic determinants for CAC and CAD influence the progression of CAC.	[Pechlivanis, Sonali; Moebus, Susanne; Lehmann, Nils; Erbel, Raimund; Joeckel, Karl-Heinz] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Moebus, Susanne] Univ Hosp Essen, Ctr Urban Epidemiol, Essen, Germany; [Mahabadi, Amir A.] Univ Hosp Essen, West German Heart & Vasc Ctr, Dept Cardiol & Vasc Med, Essen, Germany; [Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Hoffmann, Per] Univ Basel, Dept Biomed, Div Med Genet, Basel, Switzerland; [Pechlivanis, Sonali; Bachmann, Hagen S.] Witten Herdecke Univ, Ctr Biomed Educ & Res, Inst Pharmacol & Toxicol, Witten, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Bonn; University of Basel	Pechlivanis, S (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany.; Pechlivanis, S (corresponding author), Witten Herdecke Univ, Ctr Biomed Educ & Res, Inst Pharmacol & Toxicol, Witten, Germany.	Sonali.Pechlivanis@uk-essen.de	Hoffmann, Per/A-5149-2010; Mahabadi, Amir/ABE-6057-2020	Hoffmann, Per/0000-0002-6573-983X; Moebus, Susanne/0000-0002-0072-5410; Pechlivanis, Sonali/0000-0002-6181-7044	Heinz Nixdorf Foundation; Deutsche Forschungsgemeinschaft [PE 2309/2-1, ER 155/6-1, ER 155/6-2]; Bundesministerium fur Bildung und Forschung; Ministry of Innovation, Science and Research, Nordrhine-Westfalia; GE Imatron Inc.; South San Francisco, CA; Sarstedt AG & Co. (Numbrecht, Germany)	Heinz Nixdorf Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Ministry of Innovation, Science and Research, Nordrhine-Westfalia; GE Imatron Inc.; South San Francisco, CA; Sarstedt AG & Co. (Numbrecht, Germany)	Financial support for the Heinz Nixdorf Recall Study was received from the Heinz Nixdorf Foundation [Chairman: M. Nixdorf; Past Chairman: G. Schmidto], the "Deutsche Forschungsgemeinschaft" (Project numbers: SP: PE 2309/2-1, RE: ER 155/6-1 and RE: ER 155/6-2) and the "Bundesministerium fur Bildung und Forschung" for the generous support of this study. We thank the Ministry of Innovation, Science and Research, Nordrhine-Westfalia for the generous support for the genotyping of the Heinz Nixdorf Recall study participants. GE Imatron Inc., South San Francisco, CA and Sarstedt AG & Co. (Numbrecht, Germany) provided financial support for EBCT scanners and laboratory equipment. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This funding did not alter our adherence to PLOS ONE policies on sharing data and materials.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Anand DV, 2007, J AM COLL CARDIOL, V50, P2218, DOI 10.1016/j.jacc.2007.08.032; Bos D, 2013, CIRC-CARDIOVASC GENE, V6, P47, DOI 10.1161/CIRCGENETICS.112.963934; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Cassidy AE, 2005, CIRCULATION, V111, P1877, DOI 10.1161/01.CIR.0000161820.40494.5D; Cassidy-Bushrow AE, 2007, CIRCULATION, V116, P25, DOI 10.1161/CIRCULATIONAHA.106.658583; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Diederichsen SZ, 2017, JACC-CARDIOVASC IMAG, V10, P858, DOI 10.1016/j.jcmg.2017.05.010; Dykun I, 2016, J AM COLL CARDIOL, V68, P2123, DOI 10.1016/j.jacc.2016.08.040; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Elias-Smale SE, 2010, J AM COLL CARDIOL, V56, P1407, DOI 10.1016/j.jacc.2010.06.029; Erbel R, 2014, EUR HEART J, V35, P2960, DOI 10.1093/eurheartj/ehu288; Erbel R, 2012, EUR HEART J, V33, P1201, DOI 10.1093/eurheartj/ehs076; Frank M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221252; Gassett AJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001726; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Geisel MH, 2016, ATHEROSCLEROSIS, V249, P83, DOI 10.1016/j.atherosclerosis.2016.03.042; Isaacs A, 2013, ARTERIOSCL THROM VAS, V33, P2233, DOI 10.1161/ATVBAHA.113.301236; Kramer CK, 2009, DIABETES CARE, V32, P141, DOI 10.2337/dc08-1360; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Lehmann N, 2018, CIRCULATION, V137, P665, DOI 10.1161/CIRCULATIONAHA.116.027034; Lehmann N, 2016, J HYPERTENS, V34, P2233, DOI 10.1097/HJH.0000000000001080; Lehmann N, 2014, ATHEROSCLEROSIS, V232, P339, DOI 10.1016/j.atherosclerosis.2013.11.045; Lieb W, 2013, HYPERTENSION, V61, P995, DOI 10.1161/HYPERTENSIONAHA.111.00275; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mahabadi AA, 2015, HERZ, V40, P863, DOI 10.1007/s00059-015-4342-z; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; McClelland RL, 2015, J AM COLL CARDIOL, V66, P1643, DOI 10.1016/j.jacc.2015.08.035; McCullough PA, 2005, J AM SOC NEPHROL, V16, pS115, DOI 10.1681/ASN.2005060664; Mohlenkamp S, 2011, J AM COLL CARDIOL, V57, P1455, DOI 10.1016/j.jacc.2010.10.043; Neefjes LA, 2011, ATHEROSCLEROSIS, V219, P721, DOI 10.1016/j.atherosclerosis.2011.09.052; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Onuma OK, 2017, AM J CARDIOL, V119, P1584, DOI 10.1016/j.amjcard.2017.02.021; Pechlivanis S, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-23; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Shah S, 2013, EUR HEART J, V34, P972, DOI 10.1093/eurheartj/ehs243; Snell-Bergeon JK, 2003, DIABETES CARE, V26, P2923, DOI 10.2337/diacare.26.10.2923; Stang A, 2006, AM J EPIDEMIOL, V164, P85, DOI 10.1093/aje/kwj160; Taylor AJ, 2008, ATHEROSCLEROSIS, V197, P339, DOI 10.1016/j.atherosclerosis.2007.05.027; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van Setten J, 2015, CIRC-CARDIOVASC GENE, V8, P327, DOI 10.1161/CIRCGENETICS.114.000496; van Setten J, 2013, ATHEROSCLEROSIS, V228, P400, DOI 10.1016/j.atherosclerosis.2013.02.039; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Warren HR, 2017, NAT GENET, V49, P403, DOI 10.1038/ng.3768; Webb TR, 2017, J AM COLL CARDIOL, V69, P823, DOI 10.1016/j.jacc.2016.11.056; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Zhao W, 2017, NAT GENET, V49, P1450, DOI 10.1038/ng.3943	54	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232735	10.1371/journal.pone.0232735	http://dx.doi.org/10.1371/journal.pone.0232735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379805	Green Published, gold			2022-12-26	WOS:000537285700061
J	Ullrich, T; Weirich, S; Jeltsch, A				Ullrich, Timo; Weirich, Sara; Jeltsch, Albert			Development of an epigenetic tetracycline sensor system based on DNA methylation	PLOS ONE			English	Article							WHOLE-CELL BIOSENSORS; ESCHERICHIA-COLI; BACTERIAL SENSORS; EXPRESSION; ANTIBIOTICS; ENVIRONMENT	Bacterial live cell sensors are potentially powerful tools for the detection of environmental toxins. In this work, we have established and validated a flow cytometry readout for an existing bacterial arabinose sensor system with DNA methylation based memory function (Maier et al., 2017, Nat. Comm., 8:15336). Flow cytometry readout is convenient and enables a multiparameter analysis providing information about single-cell variability, which is beneficial for further development of sensor systems of this type in the future. We then designed a tetracycline sensor system, because of the importance of antibiotics pollution in the light of multi-resistant pathogens. To this end, a tetracycline trigger plasmid was constructed by replacing the araC repressor gene and the ara operator of the arabinose trigger plasmid with the tetR gene coding for the tetracycline repressor and the tet operon. After combination with the memory plasmid, the tetracycline sensor system was shown to be functional in E. coli allowing to detect and memorize the presence of tetracycline. Due to a positive feedback between the trigger and memory systems, the combined whole-cell biosensor showed a very high sensitivity for tetracycline with a detection threshold at 0.1 ng/ml tetracycline, which may be a general property of sensors of this type. Moreover, acute presence of tetracycline and past exposure can be detected by this sensor using the dual readout of two reporter fluorophores.	[Ullrich, Timo; Weirich, Sara; Jeltsch, Albert] Univ Stuttgart, Inst Biochem & Tech Biochem, Dept Biochem, Stuttgart, Germany	University of Stuttgart	Jeltsch, A (corresponding author), Univ Stuttgart, Inst Biochem & Tech Biochem, Dept Biochem, Stuttgart, Germany.	albert.jeltsch@ibtb.uni-stuttgart.de	Jeltsch, Albert/O-7404-2014	Jeltsch, Albert/0000-0001-6113-9290	Deutsche Forschungsgemeinschaft (DFG) [JE 252/35-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work has been supported by the Deutsche Forschungsgemeinschaft (DFG) grant JE 252/35-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan A, 2017, CRIT REV BIOTECHNOL, V37, P163, DOI 10.3109/07388551.2015.1128876; Bahl MI, 2005, FEMS MICROBIOL LETT, V253, P201, DOI 10.1016/j.femsle.2005.09.034; Belkin S, 2003, CURR OPIN MICROBIOL, V6, P206, DOI 10.1016/S1369-5274(03)00059-6; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; Bound JP, 2004, CHEMOSPHERE, V56, P1143, DOI 10.1016/j.chemosphere.2004.05.010; CHOPRA I, 1992, J ANTIMICROB CHEMOTH, V29, P245, DOI 10.1093/jac/29.3.245; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Daghrir R, 2013, ENVIRON CHEM LETT, V11, P209, DOI 10.1007/s10311-013-0404-8; Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041; Deblonde T, 2011, INT J HYG ENVIR HEAL, V214, P442, DOI 10.1016/j.ijheh.2011.08.002; Eltzov E, 2011, ANAL BIOANAL CHEM, V400, P895, DOI 10.1007/s00216-010-4084-y; Garamella J, 2016, ACS SYNTH BIOL, V5, P344, DOI 10.1021/acssynbio.5b00296; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Griep RA, 1999, PROTEIN EXPRES PURIF, V16, P63, DOI 10.1006/prep.1999.1041; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Grossman TH, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025387; Gu C, 2005, ENVIRON SCI TECHNOL, V39, P2660, DOI 10.1021/es048603o; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen LH, 2001, MICROBIAL ECOL, V42, P483, DOI 10.1007/s00248-001-0025-9; Hansen LH, 2001, APPL ENVIRON MICROB, V67, P239, DOI 10.1128/AEM.67.1.239-244.2001; Hansen LH, 2000, FEMS MICROBIOL LETT, V190, P273, DOI 10.1016/S0378-1097(00)00347-5; Hsiao V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156663; Krapac IG, 2001, REP CSREES PROJ, V35, P102, DOI [10.1111/j.1574-6976.2011.00268.x, DOI 10.1111/J.1574-6976.2011.00268.X]; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Luo Y, 2011, ENVIRON SCI TECHNOL, V45, P1827, DOI 10.1021/es104009s; Maier JAH, 2018, METHODS MOL BIOL, V1867, P29, DOI 10.1007/978-1-4939-8799-3_3; Maier JAH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15336; Mimee M, 2018, SCIENCE, V360, P915, DOI 10.1126/science.aas9315; Miyamoto T, 2013, ACS SYNTH BIOL, V2, P72, DOI 10.1021/sb3001112; MOLLER TSB, 2016, BMC MICROBIOL, V16, P22790, DOI DOI 10.1186/S12866-015-0617-Z; Muller H, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy057; Olivenza DR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47650-2; Park M, 2019, CELL, V176, P227, DOI 10.1016/j.cell.2018.11.002; Roggo C, 2017, CURR OPIN BIOTECH, V45, P24, DOI 10.1016/j.copbio.2016.11.023; Sheth RU, 2017, SCIENCE, V358, P1457, DOI 10.1126/science.aao0958; Stavropoulos TA, 2000, FEMS MICROBIOL LETT, V190, P147, DOI 10.1111/j.1574-6968.2000.tb09277.x; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Wu LN, 2016, SCI CHINA CHEM, V59, P30, DOI 10.1007/s11426-015-5518-3; Xie XJ, 2010, ENVIRON TOXICOL CHEM, V29, P922, DOI 10.1002/etc.79; Yagi K, 2007, APPL MICROBIOL BIOT, V73, P1251, DOI 10.1007/s00253-006-0718-6; Yang L, 2014, NAT METHODS, V11, P1261, DOI [10.1038/nmeth.3147, 10.1038/NMETH.3147]; Zhou Q, 2012, CHINESE CHEM LETT, V23, P745, DOI 10.1016/j.cclet.2012.01.039	44	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232701	10.1371/journal.pone.0232701	http://dx.doi.org/10.1371/journal.pone.0232701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379807	Green Published, gold			2022-12-26	WOS:000537285700056
J	Camalan, S; Niazi, MKK; Moberly, AC; Teknos, T; Essig, G; Elmaraghy, C; Taj-Schaal, N; Gurcan, MN				Camalan, Seda; Niazi, Muhammad Khalid Khan; Moberly, Aaron C.; Teknos, Theodoros; Essig, Garth; Elmaraghy, Charles; Taj-Schaal, Nazhat; Gurcan, Metin N.			OtoMatch: Content-based eardrum image retrieval using deep learning	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; OTITIS-MEDIA	Acute infections of the middle ear are the most commonly treated childhood diseases. Because complications affect children's language learning and cognitive processes, it is essential to diagnose these diseases in a timely and accurate manner. The prevailing literature suggests that it is difficult to accurately diagnose these infections, even for experienced ear, nose, and throat (ENT) physicians. Advanced care practitioners (e.g., nurse practitioners, physician assistants) serve as first-line providers in many primary care settings and may benefit from additional guidance to appropriately determine the diagnosis and treatment of ear diseases. For this purpose, we designed a content-based image retrieval (CBIR) system (called OtoMatch) for normal, middle ear effusion, and tympanostomy tube conditions, operating on eardrum images captured with a digital otoscope. We present a method that enables the conversion of any convolutional neural network (trained for classification) into an image retrieval model. As a proof of concept, we converted a pre-trained deep learning model into an image retrieval system. We accomplished this by changing the fully connected layers into lookup tables. A database of 454 labeled eardrum images (179 normal, 179 effusion, and 96 tube cases) was used to train and test the system. On a 10-fold cross validation, the proposed method resulted in an average accuracy of 80.58% (SD 5.37%), and maximum F1 score of 0.90 while retrieving the most similar image from the database. These are promising results for the first study to demonstrate the feasibility of developing a CBIR system for eardrum images using the newly proposed methodology.	[Camalan, Seda; Niazi, Muhammad Khalid Khan; Gurcan, Metin N.] Wake Forest Sch Med, Ctr Biomed Informat, Winston Salem, NC 27101 USA; [Moberly, Aaron C.; Essig, Garth; Elmaraghy, Charles] Ohio State Univ, Dept Otolaryngol, Columbus, OH 43210 USA; [Teknos, Theodoros] UH Seidman Canc Ctr, Cleveland, OH USA; [Taj-Schaal, Nazhat] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	Wake Forest University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Camalan, S (corresponding author), Wake Forest Sch Med, Ctr Biomed Informat, Winston Salem, NC 27101 USA.	scamalan@wakehealth.edu		Gurcan, Metin/0000-0002-2421-8229	National Institute on Deafness and Other Communication Disorders [R21 DC016972]	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The project described was supported in part by Award R21 DC016972 (PIs: Gurcan, Moberly) from National Institute on Deafness and Other Communication Disorders. Moberly and Gurcan are directors of Otologic, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, P 22 ACM INT C MULT; Antani S, 2004, J VIS COMMUN IMAGE R, V15, P285, DOI 10.1016/j.jvcir.2004.04.005; Binol H, 2020, MED IMAGING 2020 COM; Binol H, ROS NET DEEP CONVOLU; Cheng PM, 2017, J DIGIT IMAGING, V30, P234, DOI 10.1007/s10278-016-9929-2; Chung YA, 2017, LEARNING DEEP REPRES; Faria AV, 2015, NEUROIMAGE-CLIN, V7, P367, DOI 10.1016/j.nicl.2015.01.008; Holt A, 2005, KNOWL ENG REV, V20, P289, DOI 10.1017/S0269888906000622; Hou L, 2016, PROC CVPR IEEE, P2424, DOI 10.1109/CVPR.2016.266; Jain AK, 1996, PATTERN RECOGN, V29, P1233, DOI 10.1016/0031-3203(95)00160-3; Kang SW, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2462561; Kasher MS, 2018, OTITIS MEDIA ANAL AU; Keysers D, 2003, J ELECTRON IMAGING, V12, P59, DOI 10.1117/1.1525790; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kruthika K. R., 2019, Informatics in Medicine Unlocked, V14, P59, DOI 10.1016/j.imu.2018.12.001; Kumar A, 2016, COMPUT MED IMAG GRAP, V49, P37, DOI 10.1016/j.compmedimag.2016.01.001; Kuruvilla A, 2013, J BIOMEDICAL IMAGING, V2013, P27; Lundervold AS, 2019, Z MED PHYS, V29, P102, DOI 10.1016/j.zemedi.2018.11.002; Mironica I, 2011, E-HEALTH BIOENG CONF; Mitro J., 2016, CONTENT BASED IMAGE; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Myburgh HC, 2016, EBIOMEDICINE, V5, P156, DOI 10.1016/j.ebiom.2016.02.017; Niazi MKK, 2018, J UROLOGY; Niazi MKK, 2019, LANCET ONCOL, V20, pE253, DOI 10.1016/S1470-2045(19)30154-8; Niazi MKK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195621; Pisov M, 2018, BRAIN TUMOR IMAGE RE; Qayyum A, 2017, NEUROCOMPUTING, V266, P8, DOI 10.1016/j.neucom.2017.05.025; Rosenfeld RM, 2004, OTOLARYNG HEAD NECK, V130, pS95, DOI 10.1016/j.otohns.2004.02.002; Senaras C., 2018, MED IMAGING 2018 COM; Senaras C., 2017, MED IMAGING 2017 COM, V10134, p101341X; Shah A, 2016, MED IMAGING 2016 IMA; Shie C.-K., 2015, 2015 37 ANN INT C IE; Shie C-K, 2014, 2014 36 ANN INT C IE; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Szegedy C, 2015, P IEEE C COMP VIS PA, V19; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Tsochatzidis L, 2017, PATTERN RECOGN, V71, P106, DOI 10.1016/j.patcog.2017.05.023; Tzelepi M, 2018, NEUROCOMPUTING, V275, P2467, DOI 10.1016/j.neucom.2017.11.022; Xue Z, 2007, AMIA ANN S P	40	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232776	10.1371/journal.pone.0232776	http://dx.doi.org/10.1371/journal.pone.0232776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413096	Green Published, gold			2022-12-26	WOS:000537496000020
J	Le Gall, A; Vallee, F; Pushparajah, K; Hussain, T; Mebazaa, A; Chapelle, D; Gayat, E; Chabiniok, R				Le Gall, Arthur; Vallee, Fabrice; Pushparajah, Kuberan; Hussain, Tarique; Mebazaa, Alexandre; Chapelle, Dominique; Gayat, Etienne; Chabiniok, Radomir			Monitoring of cardiovascular physiology augmented by a patient-specific biomechanical model during general anesthesia. A proof of concept study	PLOS ONE			English	Article							INTRAOPERATIVE HYPOTENSION; HEART; PRESSURE; VOLUME; NOREPINEPHRINE; ASSOCIATION; CONTRACTION; VENTRICLE; INJURY	During general anesthesia (GA), direct analysis of arterial pressure or aortic flow waveforms may be inconclusive in complex situations. Patient-specific biomechanical models, based on data obtained during GA and capable to perform fast simulations of cardiac cycles, have the potential to augment hemodynamic monitoring. Such models allow to simulate Pressure-Volume (PV) loops and estimate functional indicators of cardiovascular (CV) system, e.g. ventricular-arterial coupling (Vva), cardiac efficiency (CE) or myocardial contractility, evolving throughout GA. In this prospective observational study, we created patient-specific biomechanical models of heart and vasculature of a reduced geometric complexity for n = 45 patients undergoing GA, while using transthoracic echocardiography and aortic pressure and flow signals acquired in the beginning of GA (baseline condition). If intraoperative hypotension (IOH) appeared, diluted norepinephrine (NOR) was administered and the model readjusted according to the measured aortic pressure and flow signals. Such patients were a posteriori assigned into a so-called hypotensive group. The accuracy of simulated mean aortic pressure (MAP) and stroke volume (SV) at baseline were in accordance with the guidelines for the validation of new devices or reference measurement methods in all patients. After NOR administration in the hypotensive group, the percentage of concordance with 10% exclusion zone between measurement and simulation was > 95% for both MAP and SV. The modeling results showed a decreased Vva (0.64 +/- 0.37 vs 0.88 +/- 0.43; p = 0.039) and an increased CE (0.8 +/- 0.1 vs 0.73 +/- 0.11; p = 0.042) in hypotensive vs normotensive patients. Furthermore, Vva increased by 92 +/- 101%, CE decreased by 13 +/- 11% (p < 0.001 for both) and contractility increased by 14 +/- 11% (p = 0.002) in the hypotensive group post-NOR administration. In this work we demonstrated the application of fast-running patient-specific biophysical models to estimate PV loops and functional indicators of CV system using clinical data available during GA. The work paves the way for model-augmented hemodynamic monitoring at operating theatres or intensive care units to enhance the information on patient-specific physiology.	[Le Gall, Arthur; Vallee, Fabrice; Chapelle, Dominique; Chabiniok, Radomir] Inria, Paris, France; [Le Gall, Arthur; Vallee, Fabrice; Chapelle, Dominique; Chabiniok, Radomir] Inst Polytech Paris, CNRS, Ecole Polytech, LMS, Paris, France; [Le Gall, Arthur; Vallee, Fabrice; Mebazaa, Alexandre; Gayat, Etienne] Lariboisiere St Louis Fernand Widal Univ Hosp, Anesthesiol & Intens Care Dept, Paris, France; [Le Gall, Arthur; Vallee, Fabrice; Mebazaa, Alexandre; Gayat, Etienne] INSERM, Paris, France; [Pushparajah, Kuberan; Chabiniok, Radomir] Kings Coll London, Sch Biomed Engn & Imaging Sci, St Thomas Hosp, London, England; [Hussain, Tarique] UT SouthWestern Med Ctr, Div Pediat Cardiol, Dept Pediat, Dallas, TX USA; [Chabiniok, Radomir] Czech Tech Univ, Fac Nucl Sci & Phys Engn, Dept Math, Prague, Czech Republic	Inria; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Texas System; University of Texas Southwestern Medical Center Dallas; Czech Technical University Prague	Chabiniok, R (corresponding author), Inria, Paris, France.; Chabiniok, R (corresponding author), Inst Polytech Paris, CNRS, Ecole Polytech, LMS, Paris, France.; Chabiniok, R (corresponding author), Kings Coll London, Sch Biomed Engn & Imaging Sci, St Thomas Hosp, London, England.; Chabiniok, R (corresponding author), Czech Tech Univ, Fac Nucl Sci & Phys Engn, Dept Math, Prague, Czech Republic.	radomir.chabiniok@inria.fr	Gayat, Etienne/ABG-5308-2021; Chabiniok, Radomir/AAO-9829-2020; Pushparajah, Kuberan/ABA-5484-2020	Chabiniok, Radomir/0000-0002-7527-2751; Pushparajah, Kuberan/0000-0003-1541-1155; Hussain, Tarique/0000-0003-4091-992X; Hussain, Tariq/0000-0002-1332-2418	Assistance Publique -Hopitaux de Paris; Inria; Wellcome/EPSRC Centre for Medical Engineering [WT 203148/Z/16/Z]; Inria-UTSW Associated Team TOFMOD; Ministry of Health of the Czech Republic [NV19-08-00071]	Assistance Publique -Hopitaux de Paris; Inria; Wellcome/EPSRC Centre for Medical Engineering(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Inria-UTSW Associated Team TOFMOD; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	A.L.G. and F.V. were employed full-time by a research program "Poste d'accueil APHP" funded 50% by Assistance Publique -Hopitaux de Paris and 50% by Inria. R.C. and K.P. acknowledge the support of Wellcome/EPSRC Centre for Medical Engineering [WT 203148/Z/16/Z]. R.C., D.C. and T. H. acknowledge the support of Inria-UTSW Associated Team TOFMOD. R.C. additionally acknowledges support of the Ministry of Health of the Czech Republic (project No. NV19-08-00071).	Arts T, 2005, AM J PHYSIOL-HEART C, V288, pH1943, DOI 10.1152/ajpheart.00444.2004; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; BURKHOFF D, 1994, J MOL CELL CARDIOL, V26, P959, DOI 10.1006/jmcc.1994.1117; Caremani M, 2016, P NATL ACAD SCI USA, V113, P3675, DOI 10.1073/pnas.1525057113; Caruel M, 2014, BIOMECH MODEL MECHAN, V13, P897, DOI 10.1007/s10237-013-0544-6; Casas B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06339-0; Chabiniok R, 2012, BIOMECH MODEL MECHAN, V11, P609, DOI 10.1007/s10237-011-0337-8; Chabiniok R, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0083; Chapelle D, 2012, INT J MULTISCALE COM, V10, P189, DOI 10.1615/IntJMultCompEng.2011002360; Critchley LA, 2010, ANESTH ANALG, V111, P1180, DOI 10.1213/ANE.0b013e3181f08a5b; CUDKOWICZ L, 1968, THORAX, V23, P63, DOI 10.1136/thx.23.1.63; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Gaddum N, 2017, AM J PHYSIOL-HEART C, V313, pH558, DOI 10.1152/ajpheart.00844.2016; Guarracino F, 2013, CRIT CARE, V17, DOI 10.1186/cc12522; Hadjicharalambous M, 2017, ANN BIOMED ENG, V45, P605, DOI 10.1007/s10439-016-1721-4; Holzapfel GA, 2009, PHILOS T R SOC A, V367, P3445, DOI 10.1098/rsta.2009.0091; HUXLEY AF, 1974, J PHYSIOL-LONDON, V243, P1; Joachim J, 2018, J CLIN MONIT COMPUT, V32, P833, DOI 10.1007/s10877-017-0082-3; Kimmig Francois, 2019, Advanced Modeling and Simulation in Engineering Sciences, V6, DOI 10.1186/s40323-019-0128-9; King JM, 2019, BIOMED ENG ONLINE, V18, DOI 10.1186/s12938-019-0628-3; Klotz S, 2006, AM J PHYSIOL-HEART C, V291, pH403, DOI 10.1152/ajpheart.01240.2005; Le Gall A, 2019, LECT NOTES COMPUT SC, V11504, P266, DOI 10.1007/978-3-030-21949-9_29; Lienhart A, 2006, ANESTHESIOLOGY, V105, P1087, DOI 10.1097/00000542-200612000-00008; Mayr VD, 2006, CRIT CARE, V10, DOI 10.1186/cc5086; Muller LO, 2019, IEEE T BIO-MED ENG, V66, P1269, DOI 10.1109/TBME.2018.2872323; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nash MP, 2000, J ELASTICITY, V61, P113, DOI 10.1023/A:1011084330767; Niederer SA, 2011, CARDIOVASC RES, V89, P336, DOI 10.1093/cvr/cvq318; Nordsletten DA, 2011, PROG BIOPHYS MOL BIO, V104, P77, DOI 10.1016/j.pbiomolbio.2009.11.001; Pfaller MR, 2019, BIOMECH MODEL MECHAN, V18, P503, DOI 10.1007/s10237-018-1098-4; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Popovic ZB, 2005, AM J PHYSIOL-HEART C, V288, pH416, DOI 10.1152/ajpheart.00615.2004; Ruijsink B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229015; Ruijsink B, 2019, LECT NOTES COMPUT SC, V11504, P379, DOI 10.1007/978-3-030-21949-9_41; Sainte-Marie J, 2006, COMPUT STRUCT, V84, P1743, DOI 10.1016/j.compstruc.2006.05.003; Schafer A, 2019, ESC HEART FAIL, V6, P457, DOI 10.1002/ehf2.12417; Seemann F, 2019, CIRC-CARDIOVASC IMAG, V12, DOI 10.1161/CIRCIMAGING.118.008493; Sermesant M, 2012, MED IMAGE ANAL, V16, P201, DOI 10.1016/j.media.2011.07.003; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; Sun LY, 2015, ANESTHESIOLOGY, V123, P515, DOI 10.1097/ALN.0000000000000765; Vallee F, 2017, ACTA ANAESTH SCAND, V61, P590, DOI 10.1111/aas.12905; Vallee F, 2018, J CLIN MONIT COMPUT, V32, P23, DOI 10.1007/s10877-017-9982-5; van Waes JAR, 2016, ANESTHESIOLOGY, V124, P35, DOI 10.1097/ALN.0000000000000922; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Wang VY, 2015, ANNU REV BIOMED ENG, V17, P351, DOI 10.1146/annurev-bioeng-071114-040609; Wang VY, 2009, MED IMAGE ANAL, V13, P773, DOI 10.1016/j.media.2009.07.006; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Westerhof N, 2009, MED BIOL ENG COMPUT, V47, P131, DOI 10.1007/s11517-008-0359-2; WHITE WB, 1993, HYPERTENSION, V21, P504, DOI 10.1161/01.HYP.21.4.504; [No title captured]; [No title captured]	51	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232830	10.1371/journal.pone.0232830	http://dx.doi.org/10.1371/journal.pone.0232830			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407353	gold, Green Published			2022-12-26	WOS:000537490700040
J	Skomina, Z; Verdenik, M; Hren, NI				Skomina, Zala; Verdenik, Miha; Hren, Natasa Ihan			Effect of aging and body characteristics on facial sexual dimorphism in the Caucasian Population	PLOS ONE			English	Article							SYMMETRY; ATTRACTIVENESS; HEALTH; FACES; AVERAGENESS; MORPHOLOGY; AESTHETICS; SELECTION; GENDER; BEAUTY	Aim The aim of this study was to quantify gender-specific facial characteristics in younger and older adults and to determine how aging and body characteristics, such as height and body-mass index (BMI), influence facial sexual dimorphism. Methods The cohort study included 90 younger adults of Caucasian origin (average age of 45 females 23.2 +/- 1.9 and 45 males 23.7 +/- 2.4 years) and 90 older adults (average age of 49 females 78.1 +/- 8.1 and 41 males 74.5 +/- 7.7 years). Three-dimensional facial scans were performed with an Artec MHT 3D scanner. The data were analyzed using the software package Rapid-form (R). The parameters to evaluate facial symmetry, height, width, profile, facial shape, nose, eyes and mouth characteristics were determined based on 39 facial landmarks. Student's t-test was used to calculate the statistical differences between the genders in the younger and older adults and a multiple-linear-regression analysis was used to evaluate the impact of gender, age, body-mass index and body height. Results We found that the female faces were more symmetrical than the male faces, and this was statistically significant in the older adults. The female facial shape was more rounded and their faces were smaller, after normalizing for body size. The males had wider mouths, longer upper lips, larger noses and more prominent lower foreheads. Surprisingly, we found that all the gender-dependent characteristics were even more pronounced in the older adults. Increased facial asymmetry, decreased facial convexity, increased forehead angle, narrower vermilions and longer inter-eye distances occurred in both genders during aging. An increased BMI was associated with wider faces, more concave facial profiles and wider noses, while greater body height correlated with increased facial heights and wider mouths. Conclusion Facial sexual dimorphism was confirmed by multiple parameters in our study, while the differences between the genders were more pronounced in the older adults.	[Skomina, Zala; Hren, Natasa Ihan] Univ Ljubljana, Fac Med Ljubljana, Dept Maxillofacial & Oral Surg, Ljubljana, Slovenia; [Verdenik, Miha; Hren, Natasa Ihan] Univ Med Ctr Ljubljana, Dept Maxillofacial & Oral Surg, Ljubljana, Slovenia	University of Ljubljana; University Medical Centre Ljubljana	Skomina, Z (corresponding author), Univ Ljubljana, Fac Med Ljubljana, Dept Maxillofacial & Oral Surg, Ljubljana, Slovenia.	zala.skomina@kclj.si		Skomina, Zala/0000-0003-3584-3983				Angelopoulou R, 2006, COLLEGIUM ANTROPOL, V30, P653; BISHARA SE, 1994, ANGLE ORTHOD, V64, P89; Bozic M, 2009, ANGLE ORTHOD, V79, P640, DOI 10.2319/081608-432.1; CHIU CSW, 1991, J DENT, V19, P130, DOI 10.1016/0300-5712(91)90111-B; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Dixson BJW, 2016, J EVOLUTION BIOL, V29, P2311, DOI 10.1111/jeb.12958; Djordjevic J, 2014, EUR J ORTHODONT, V36, P125, DOI 10.1093/ejo/cjr091; Pham DD, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/749209; Farkas LG, 2005, J CRANIOFAC SURG, V16, P615, DOI 10.1097/01.scs.0000171847.58031.9e; Foo YZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep39731; Geniole SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132726; Gibelli D, 2015, AESTHET PLAST SURG, V39, P771, DOI 10.1007/s00266-015-0495-7; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; HABAL MB, 1990, AESTHET PLAST SURG, V14, P143, DOI 10.1007/BF01578340; Imaizumi K, 2019, FORENSIC SCI INT, V302, DOI 10.1016/j.forsciint.2019.109878; JOHNSTON VS, 1993, ETHOL SOCIOBIOL, V14, P183, DOI 10.1016/0162-3095(93)90005-3; Kahn DM, 2010, FACIAL PLAST SURG, V26, P350, DOI 10.1055/s-0030-1265024; KEATING CF, 1985, SOC PSYCHOL QUART, V48, P61, DOI 10.2307/3033782; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; Komori M, 2009, VISION RES, V49, P862, DOI 10.1016/j.visres.2009.03.005; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Maal TJJ, 2011, INT J ORAL MAX SURG, V40, P1252, DOI 10.1016/j.ijom.2011.02.033; Mendelson BC., 2013, PLAST SURG-CHIR PLAS, V3, P79; Mendelson B, 2012, AESTHET PLAST SURG, V36, P753, DOI 10.1007/s00266-012-9904-3; Lopez-Mateos MLM, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0898-y; Mogilski JK, 2017, HUM NATURE-INT BIOS, V28, P53, DOI 10.1007/s12110-016-9277-4; Mydlova M, 2015, FORENSIC SCI INT, V257, DOI 10.1016/j.forsciint.2015.09.008; Nkenke E, 2006, CLEFT PALATE-CRAN J, V43, P129, DOI 10.1597/04-138.1; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Pelin C, 2010, J FORENSIC SCI, V55, P1326, DOI 10.1111/j.1556-4029.2010.01429.x; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Raschke GF, 2014, J CRANIO MAXILL SURG, V42, pE312, DOI 10.1016/j.jcms.2013.10.012; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Rongo R, 2014, ANGLE ORTHOD, V84, P788, DOI 10.2319/092313-699.1; Toriumi D M, 1996, Facial Plast Surg, V12, P205, DOI 10.1055/s-0028-1082411; Zacharopoulos GV, 2016, J CRANIOFAC SURG, V27, pE71, DOI 10.1097/SCS.0000000000002231	40	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0231983	10.1371/journal.pone.0231983	http://dx.doi.org/10.1371/journal.pone.0231983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407322	Green Published, gold			2022-12-26	WOS:000537490700009
J	Pelgrom, AJE; Meisrimler, CN; Elberse, J; Koorman, T; Boxem, M; Van den Ackerveken, G				Pelgrom, Alexandra J. E.; Meisrimler, Claudia-Nicole; Elberse, Joyce; Koorman, Thijs; Boxem, Mike; Van den Ackerveken, Guido			Host interactors of effector proteins of the lettuce downy mildew Bremia lactucae obtained by yeast two-hybrid screening	PLOS ONE			English	Article							TAIL-ANCHORED PROTEINS; SUBCELLULAR-LOCALIZATION; UBIQUITIN LIGASE; BTB PROTEINS; ARABIDOPSIS; TRANSCRIPTION; RESISTANCE; IDENTIFICATION; PREDICTION; TARGET	Plant pathogenic bacteria, fungi and oomycetes secrete effector proteins to manipulate host cell processes to establish a successful infection. Over the last decade the genomes and transcriptomes of many agriculturally important plant pathogens have been sequenced and vast candidate effector repertoires were identified using bioinformatic analyses. Elucidating the contribution of individual effectors to pathogenicity is the next major hurdle. To advance our understanding of the molecular mechanisms underlying lettuce susceptibility to the downy mildew Bremia lactucae, we mapped physical interactions between B. lactucae effectors and lettuce candidate target proteins. Using a lettuce cDNA library-based yeast-two-hybrid system, 61 protein-protein interactions were identified, involving 21 B. lactucae effectors and 46 unique lettuce proteins. The top ten interactors based on the number of independent colonies identified in the Y2H and two interactors that belong to gene families involved in plant immunity, were further characterized. We determined the subcellular localization of the fluorescently tagged lettuce proteins and their interacting effectors. Importantly, relocalization of effectors or their interactors to the nucleus was observed for four protein-pairs upon their co-expression, supporting their interaction in planta.	[Pelgrom, Alexandra J. E.; Meisrimler, Claudia-Nicole; Elberse, Joyce; Van den Ackerveken, Guido] Univ Utrecht, Dept Biol, Plant Microbe Interact, Utrecht, Netherlands; [Koorman, Thijs; Boxem, Mike] Univ Utrecht, Dept Biol, Dev Biol, Utrecht, Netherlands; [Pelgrom, Alexandra J. E.] Dummen Orange, De Lier, South Holland, Netherlands; [Meisrimler, Claudia-Nicole] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Koorman, Thijs] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Utrecht University; Utrecht University; University of Canterbury; Utrecht University; Utrecht University Medical Center	Van den Ackerveken, G (corresponding author), Univ Utrecht, Dept Biol, Plant Microbe Interact, Utrecht, Netherlands.	g.vandenackerveken@uu.nl	Van den Ackerveken, Guido/B-8568-2011	Van den Ackerveken, Guido/0000-0002-0183-8978; Meisrimler, Claudia-Nicole/0000-0002-3571-245X	Netherlands Organization for Scientific Research [12683, 864.09.008]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	GVdA was awarded grant #12683 by the Netherlands Organization for Scientific Research (https://www.nwo.nl/).MB was awarded grant 864.09.008 by the Netherlands Organization for Scientific Research (https://www.nwo.nl/).	Kamei CLA, 2008, PLANT PHYSIOL, V147, P1735, DOI 10.1104/pp.108.122226; Anderson RG, 2015, MOL PLANT MICROBE IN, V28, P1063, DOI 10.1094/MPMI-01-15-0022-CR; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bi GZ, 2017, CELL HOST MICROBE, V21, P270, DOI 10.1016/j.chom.2017.02.004; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Boevink PC, 2017, J EXP BOT, V68, P5411, DOI 10.1093/jxb/erx369; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Caillaud MC, 2012, PLANT J, V69, P252, DOI 10.1111/j.1365-313X.2011.04787.x; Choi K, 2011, PLANT CELL, V23, P289, DOI 10.1105/tpc.110.075911; Fletcher K, 2019, BIORXIV, DOI [10.1101/516526, DOI 10.1101/516526]; Fromont-Racine M, 2002, METHOD ENZYMOL, V350, P513, DOI 10.1016/S0076-6879(02)50982-4; Giesbers AKJ, 2017, NEW PHYTOL, V216, P915, DOI 10.1111/nph.14741; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; He Q, 2019, NEW PHYTOL, V222, P438, DOI 10.1111/nph.15635; Hemsley PA, 2015, NEW PHYTOL, V205, P476, DOI 10.1111/nph.13085; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kim DH, 2013, TRAFFIC, V14, P613, DOI 10.1111/tra.12043; King SRF, 2014, PLANT CELL, V26, P1345, DOI 10.1105/tpc.113.120055; Knodler LA, 2011, CELL MICROBIOL, V13, P1497, DOI 10.1111/j.1462-5822.2011.01635.x; Korves TM, 2003, PLANT PHYSIOL, V133, P339, DOI 10.1104/pp.103.027094; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Krek W, 2003, NAT CELL BIOL, V5, P950, DOI 10.1038/ncb1103-950; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lechner E, 2011, DEV CELL, V21, P1116, DOI 10.1016/j.devcel.2011.10.018; Lee JH, 2013, NAT COMMUN, V4, DOI [10.1038/ncomms3186, 10.1038/ncomms3027]; Li HY, 2018, ELIFE, V7, DOI 10.7554/eLife.40039; Li L, 2016, CELL HOST MICROBE, V20, P504, DOI 10.1016/j.chom.2016.09.007; Li Shutian, 2015, Plant Signal Behav, V10, pe1044192, DOI 10.1080/15592324.2015.1044192; Liu YX, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00286; Lozano-Duran R, 2011, PLANT CELL, V23, P1014, DOI 10.1105/tpc.110.080267; Lyons R, 2015, PLOS ONE, V10, P1; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Meisrimler CN, 2019, PLANT J, V99, P1098, DOI 10.1111/tpj.14383; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nordgard O, 2001, BIOCHIMIE, V83, P969, DOI 10.1016/S0300-9084(01)01329-3; Parra L, 2016, EUPHYTICA, V210, P309, DOI 10.1007/s10681-016-1687-1; Pecrix Y, 2019, PLANT J, V97, P730, DOI 10.1111/tpj.14157; Pedrazzini E, 2009, J PLANT BIOL, V52, P88, DOI 10.1007/s12374-009-9014-1; Pelgrom AJE, 2019, MOL PLANT PATHOL, V20, P240, DOI 10.1111/mpp.12751; Petre B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001801; Rajan VBV, 2009, FUNCT INTEGR GENOMIC, V9, P433, DOI 10.1007/s10142-009-0132-0; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Reyes-Chin-Wo S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14953; Robert-Seilaniantz A, 2006, MOL PLANT MICROBE IN, V19, P130, DOI 10.1094/MPMI-19-0130; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Scholthof HB, 2006, NAT REV MICROBIOL, V4, P405, DOI 10.1038/nrmicro1395; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sperschneider J, 2016, NEW PHYTOL, V210, P743, DOI 10.1111/nph.13794; Stassen JHM, 2013, MOL PLANT MICROBE IN, V26, P1259, DOI 10.1094/MPMI-05-13-0142-R; Stassen JHM, 2012, MOL PLANT PATHOL, V13, P719, DOI 10.1111/j.1364-3703.2011.00780.x; Thieme F, 2007, MOL PLANT MICROBE IN, V20, P1250, DOI 10.1094/MPMI-20-10-1250; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tucker CL, 2009, GENETICS, V182, P1377, DOI 10.1534/genetics.109.103069; Waaijers S, 2013, J PROTEOME RES, V12, P3181, DOI 10.1021/pr400047p; Walkenhorst WF, 2009, BBA-BIOMEMBRANES, V1788, P1321, DOI 10.1016/j.bbamem.2009.02.017; Weber H, 2009, FEBS J, V276, P6624, DOI 10.1111/j.1742-4658.2009.07373.x; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Wood K., 2019, BIORXIV PREPRINT, DOI [10.1101/679787, DOI 10.1101/679787]; Xiang TT, 2011, MOL PLANT MICROBE IN, V24, P100, DOI 10.1094/MPMI-04-10-0096; Xie YB, 2016, SCI REP-UK, V6, DOI 10.1038/srep28249; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x	77	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2020	15	5							e0226540	10.1371/journal.pone.0226540	http://dx.doi.org/10.1371/journal.pone.0226540			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0SY	32396563	Green Published, Green Submitted, gold			2022-12-26	WOS:000537475000003
J	Kastl, SP; Katsaros, KM; Krychtiuk, KA; Jagersberger, G; Kaun, C; Huber, K; Wojta, J; Speidl, WS				Kastl, Stefan P.; Katsaros, Katharina M.; Krychtiuk, Konstantin A.; Jaegersberger, Gerlinde; Kaun, Christoph; Huber, Kurt; Wojta, Johann; Speidl, Walter S.			The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; EXPRESSION; ADIPOCYTOKINE; PROLIFERATION; MECHANISM; APOPTOSIS; ADHESION	Background Percutaneous coronary intervention represents the most important treatment modality of coronary artery stenosis. In-stent restenosis (ISR) is still a limitation for the long-term outcome despite the introduction of drug eluting stents. It has been shown that adipokines directly influence vessel wall homeostasis by influencing the function of endothelial cells and arterial smooth muscle cells. Visceral adipose tissue-derived serpin vaspin was recently identified as a member of serine protease inhibitor family and serveral studies could demonstrate a relation to metabolic diseases. The aim of this study was to investigate a role of vaspin in the development of in-stent restenosis in vivo and on migration of smooth muscle cells and endothelial cells in vitro. Methods We studied 85 patients with stable coronary artery disease who underwent elective and successful PCI with implatation of drug eluting stents. Blood samples were taken directly before PCI. Vaspin plasma levels were measured by specific ELISA. ISR was evaluated eight months later by coronary angiography. Human coronary artery smooth muscle cells (HCASMC) and human umbilical vein endothelial cells (HUVEC) migration was analyzed by an in-vitro migration assay with different concentrations (0.004ng/mL up to 40ng/mL) of vaspin as well as by an scratch assay. For proliferation an impedance measurement with specialiced E-Plates was performed. Results During the follow up period, 14 patients developed ISR. Patients with ISR had significantly lower vaspin plasma levels compared to patients without ISR (0.213 ng/ml vs 0.382 ng/ml; p = 0.001). In patients with plasma vaspin levels above 1.35 ng/ml we could not observe any restenosis. There was also a significant correlation of plasma vaspin levels and late lumen loss in the stented coronary segments. Further we could demonstrate that vaspin nearly abolishes serum induced migration of HCASMC (100% vs. 9%; p<0.001) in a biphasic manner but not migration of HUVEC. Proliferation of HCASMC and HUVEC was not modulated by vaspin treatment. Conclusion We were able to show that the adipokine vaspin selectively inhibits human coronary SMC migration in vitro and has no effect on HUVEC migration. Vaspin had no effect on proliferation of HUVEC which is an important process of the healing of the stented vessel. In addition, the occurrence of ISR after PCI with implantation of drug eluting stents was significantly associated with low vaspin plasma levels before intervention. Determination of vaspin plasma levels before PCI might be helpful in the identification of patients with high risk for development of ISR after stent implantation. In addition, the selective effects of vaspin on smooth muscle cell migration could potentially be used to reduce ISR without inhibition of re-endothelialization of the stented segment.	[Kastl, Stefan P.; Katsaros, Katharina M.; Krychtiuk, Konstantin A.; Jaegersberger, Gerlinde; Kaun, Christoph; Wojta, Johann; Speidl, Walter S.] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria; [Kastl, Stefan P.; Katsaros, Katharina M.; Krychtiuk, Konstantin A.; Wojta, Johann] Ludwig Boltzmann Cluster Cardiovasc Res, Vienna, Austria; [Huber, Kurt] Wilhelminenhosp, Dept Med Cardiol & Emergency Med, Vienna, Austria	Medical University of Vienna; Ludwig Boltzmann Institute; Wilhelminenspital	Wojta, J (corresponding author), Med Univ Vienna, Dept Internal Med 2, Vienna, Austria.; Wojta, J (corresponding author), Ludwig Boltzmann Cluster Cardiovasc Res, Vienna, Austria.	johann.wojta@meduniwien.ac.at	Wojta, Johann/AAC-8433-2020; Speidl, Walter S./AAU-8830-2020	Wojta, Johann/0000-0002-1282-9276; Speidl, Walter S./0000-0002-7267-3138	Hans and Blanca Moser Foundation; Ludwig Boltzmann Foundation for Cardiovascular Research; Association for Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology	Hans and Blanca Moser Foundation; Ludwig Boltzmann Foundation for Cardiovascular Research; Association for Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology	This work was supported by the Hans and Blanca Moser Foundation in a grant awarded to WSS, the Ludwig Boltzmann Foundation for Cardiovascular Research in a grant awarded to JW, and the Association for Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology in a grant awarded to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LD, 2000, CIRC RES, V87, P623, DOI 10.1161/01.RES.87.7.623; Auer J, 2010, ATHEROSCLEROSIS, V210, P503, DOI 10.1016/j.atherosclerosis.2009.12.003; Bilancio A, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20171112; CARTER AJ, 1994, J AM COLL CARDIOL, V24, P1398, DOI 10.1016/0735-1097(94)90126-0; Demyanets S, 2011, ARTERIOSCL THROM VAS, V31, P2080, DOI 10.1161/ATVBAHA.111.231431; Esaki E, 2014, ATHEROSCLEROSIS, V233, P248, DOI 10.1016/j.atherosclerosis.2013.12.040; Furman MI, 1998, J AM COLL CARDIOL, V31, P352, DOI 10.1016/S0735-1097(97)00510-X; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Habara M, 2011, CIRC-CARDIOVASC INTE, V4, P232, DOI 10.1161/CIRCINTERVENTIONS.110.959999; Heiker JT, 2013, CELL MOL LIFE SCI, V70, P2569, DOI 10.1007/s00018-013-1258-8; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171; Jung CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052346; Jung CH, 2011, BIOCHEM BIOPH RES CO, V413, P264, DOI 10.1016/j.bbrc.2011.08.083; Lago F, 2007, CYTOKINE GROWTH F R, V18, P313, DOI 10.1016/j.cytogfr.2007.04.007; Li HL, 2013, ATHEROSCLEROSIS, V228, P61, DOI 10.1016/j.atherosclerosis.2013.02.013; Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742; Nakatsuka A, 2013, CIRC RES, V112, P771, DOI 10.1161/CIRCRESAHA.111.300049; Ott I, 1996, CIRCULATION, V94, P1239, DOI 10.1161/01.CIR.94.6.1239; Park SJ, 2012, J AM COLL CARDIOL, V59, P2051, DOI 10.1016/j.jacc.2011.10.909; Phalitakul S, 2012, BIOCHEM BIOPH RES CO, V423, P844, DOI 10.1016/j.bbrc.2012.06.052; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sato K, 2018, INT J MOL SCI, V19; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Smirnova NF, 2014, J EXP MED, V211, P1779, DOI 10.1084/jem.20131276; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Weiner J, 2019, ADV EXP MED BIOL, V1111, P159, DOI 10.1007/5584_2018_241; WOJTA J, 1993, THROMB HAEMOSTASIS, V70, P469	28	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232483	10.1371/journal.pone.0232483	http://dx.doi.org/10.1371/journal.pone.0232483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392256	Green Published, gold			2022-12-26	WOS:000537470300007
J	Santana-Pineros, AM; Cruz-Quintana, Y; May-Tec, AL; Mera-Loor, G; Aguirre-Macedo, ML; Suarez-Morales, E; Gonzalez-Solis, D				Maria Santana-Pineros, Ana; Cruz-Quintana, Yanis; Luisa May-Tec, Ana; Mera-Loor, Geormery; Leopoldina Aguirre-Macedo, Maria; Suarez-Morales, Eduardo; Gonzalez-Solis, David			The 2015-2016 El Nino increased infection parameters of copepods on Eastern Tropical Pacific dolphinfish populations	PLOS ONE			English	Article							CORYPHAENA-HIPPURUS PISCES; PARASITIC COPEPODS; CALIGUS-ROGERCRESSEYI; SOUTHERN-OSCILLATION; MARINE FISHES; ECOLOGY; CLIMATE; DISEASE; CALIGIDAE; ABUNDANCE	The oceanographic conditions of the Pacific Ocean are largely modified by El Nino (EN), affecting several ecological processes. Parasites and other marine organisms respond to environmental variation, but the influence of the EN cycle on the seasonal variation of parasitic copepods has not been yet evaluated. We analysed the relation between infection parameters (prevalence and mean intensity) of the widespread parasitic copepods Caligus bonito and Charopinopsis quaternia in the dolphinfish Coryphaena hippurus and oceanography during the strong 2015-16 EN. Fish were collected from capture fisheries on the Ecuadorian coast (Tropical Eastern Pacific) over a 2-year period. Variations of sea surface temperature (SST), salinity, chlorophyll a (Chl-a), Oceanic Nino Index (ONI), total host length (TL) and monthly infection parameters of both copepod species were analysed using time series and cross-correlations. We used the generalised additive models for determine the relationship between environmental variables and infection parameters. The total body length of the ovigerous females and the length of the eggs of C. bonito were measured in both periods. Infection parameters of both C. bonito and Ch. quaternia showed seasonal and annual patterns associated with the variation of environmental variables examined (SST, salinity, Chl-a and ONI 1+2). Infection parameters of both copepod species were significantly correlated with ONI 1+2, SST, TL and Chl-a throughout the GAMLSS model, and the explained deviance contribution ranged from 16%-36%. Our results suggest than an anomaly higher than +0.5 degrees C triggers a risen in infection parameters of both parasitic copepods. This risen could be related to increases in egg length, female numbers and the total length of the ovigerous females in EN period. This study provides the first evidence showing that tropical parasitic copepods are sensitive to the influence of EN event, especially from SST variations. The observed behaviour of parasitic copepods likely affects the host populations and structure of the marine ecosystem at different scales.	[Maria Santana-Pineros, Ana; Cruz-Quintana, Yanis] Univ Tecn Manabi, Grp Invest Sanidad Acuicola Inocuidad & Salud Amb, Escuela Acuicultura & Pesqueria, Bahia De Caraquez, Manabi, Ecuador; [Maria Santana-Pineros, Ana; Cruz-Quintana, Yanis; Mera-Loor, Geormery] Univ Laica Eloy Alfaro Manabi, Dept Cent Invest, Manta, Manabi, Ecuador; [Maria Santana-Pineros, Ana; Cruz-Quintana, Yanis; Suarez-Morales, Eduardo; Gonzalez-Solis, David] El Colegio Frontera Sur ECOSUR, Unidad Chetumal, Chetmal, Quintana Roo, Mexico; [Luisa May-Tec, Ana; Leopoldina Aguirre-Macedo, Maria] CINVESTAV IPN Unidad Merida, Lab Patol Acuat & Parasitol, Dept Recursos Mar, Merida, Yucatan, Mexico; [Mera-Loor, Geormery] Secretaria Educ Super Ciencia Tecnol & Innovac, Inst Tecnol Super Luis Arboleda Martinez, Carrera Tecnol Super Acuicultura, Jaramijo, Manabi, Ecuador	Universidad Tecnica de Manabi; Universidad Laica Eloy Alfaro De Manabi; El Colegio de la Frontera Sur (ECOSUR); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Santana-Pineros, AM (corresponding author), Univ Tecn Manabi, Grp Invest Sanidad Acuicola Inocuidad & Salud Amb, Escuela Acuicultura & Pesqueria, Bahia De Caraquez, Manabi, Ecuador.; Santana-Pineros, AM (corresponding author), Univ Laica Eloy Alfaro Manabi, Dept Cent Invest, Manta, Manabi, Ecuador.; Santana-Pineros, AM (corresponding author), El Colegio Frontera Sur ECOSUR, Unidad Chetumal, Chetmal, Quintana Roo, Mexico.	anasantana4@gmail.com	Aguirre-Macedo, Ma. Leopoldina/P-7812-2019; Aguirre-Macedo, Ma. L/A-2511-2008	Aguirre-Macedo, Ma. Leopoldina/0000-0002-3910-8305; Aguirre-Macedo, Ma. L/0000-0002-3910-8305; May-Tec, Ana Luisa/0000-0001-7980-6135; Santana-Pineros, Ana Maria/0000-0001-6917-0508	Departamento Central de Investigacion of Universidad Laica Eloy Alfaro de Manabi [CUP 91740000.0000.377806]; Universidad Tecnica de Manabi (Biodiversidad de parasitos metazoarios en peces desembarcados en los cantones Manta y Sucre, provincial de Manabi, Ecuador)	Departamento Central de Investigacion of Universidad Laica Eloy Alfaro de Manabi; Universidad Tecnica de Manabi (Biodiversidad de parasitos metazoarios en peces desembarcados en los cantones Manta y Sucre, provincial de Manabi, Ecuador)	The work was supported by the Departamento Central de Investigacion of Universidad Laica Eloy Alfaro de Manabi (CUP 91740000.0000.377806) and the Universidad Tecnica de Manabi (Biodiversidad de parasitos metazoarios en peces desembarcados en los cantones Manta y Sucre, provincial de Manabi, Ecuador). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Macedo ML, 2011, INT J PARASITOL, V41, P1403, DOI 10.1016/j.ijpara.2011.10.002; Alejo-Plata C, 2011, FISH RES, V110, P207, DOI 10.1016/j.fishres.2011.04.008; Arocha F, 1999, SCI MAR, V63, P401, DOI 10.3989/scimar.1999.63n3-4401; Arriaza BT, 2010, MEM I OSWALDO CRUZ, V105, P66, DOI 10.1590/S0074-02762010000100010; Bessey C, XTRACTO 3D BDAP R CO; Boxshall A, 2004, INTRO COPEPOD DIVERS; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; BURNETTH.J, 1974, T AM FISH SOC, V103, P101, DOI 10.1577/1548-8659(1974)103&lt;101:POTGAB&gt;2.0.CO;2; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Cai WJ, 2018, NATURE, V564, P201, DOI 10.1038/s41586-018-0776-9; CAMPOS JA, 1993, REV BIOL TROP, V41, P783; Castro-Marques L., 2011, CAD UNIFOA, V16, P111, DOI [10.47385/cadunifoa.v6.n16.1070, DOI 10.47385/CADUNIFOA.V6.N16.1070]; Choo JM, 2015, ECOLOGICAL PARASITOL, V4, P1; Cohen RE, 2018, OCEANOGRAPHY, V31, P182, DOI 10.5670/oceanog.2018.201; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; des Clers S, 1994, SAMPLING DETECT INFE; Dojiri M, 2013, CRUSTACEANA MONOGR, V18, P1, DOI 10.1163/9789004204256; Espino M, 1999, REV PERUANA BIOL, P97; Farrell ER, 2014, FISH RES, V151, P177, DOI 10.1016/j.fishres.2013.11.014; Fiedler PC, 2002, MAR ECOL PROG SER, V244, P265, DOI 10.3354/meps244265; Ford SE, 1996, J SHELLFISH RES, V15, P45; Garces-Vargas J, 2005, DEEP-SEA RES PT I, V52, P1789, DOI 10.1016/j.dsr.2005.05.008; GIBBS ROBERT H., 1959, BULL MARINE SCI GULF AND CARIBBEAN, V9, P117; Gonzalez L, 2003, AQUACULTURE, V220, P101, DOI 10.1016/S0044-8486(02)00512-4; Groner ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088465; Hakalahti T, 2003, PARASITOLOGY, V127, P79, DOI 10.1017/S0031182003003196; Harrison DE, 2013, DEEP SEA RES 2, V113, P9; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Ho J.-S., 2000, P13; Ho JS., 2004, SEA LICE TAIWAN COPE; Jimenez R, 1984, REV COM PERM PACIFIC, V15, P269; Johnson PTJ, 2010, J EXP BIOL, V213, P961, DOI 10.1242/jeb.037721; Johnson SC, 2004, ZOOL STUD, V43, P229; Johnson SC, 1996, CAN J FISH AQUAT SCI, V53, P2888, DOI 10.1139/cjfas-53-12-2888; Jones JB, 1998, J MARINE SYST, V15, P207, DOI 10.1016/S0924-7963(97)00056-0; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Koch W, 2014, J MAR BIOL ASSOC UK, V94, P547, DOI 10.1017/S0025315413001677; KOJIMA S., 1961, BULL JAPANESE SOC SCI FISH, V27, P625; Kojima S, 1966, B JAP SOC SCI FISH, V32, P647, DOI DOI 10.2331/SUISAN.32.647; Koprivnikar J, 2010, PARASITOL RES, V106, P1167, DOI 10.1007/s00436-010-1779-0; Koprivnikar J, 2009, PARASITOL RES, V105, P957, DOI 10.1007/s00436-009-1477-y; Kraul S, 1999, SCI MAR, V63, P261, DOI 10.3989/scimar.1999.63n3-4267; Lamb RW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34929-z; Lasso J, 1999, SCI MAR, V63, P387, DOI 10.3989/scimar.1999.63n3-4387; Laverty C, 2017, INT J PARASITOL, V47, P291, DOI [10.1016/j.ijpara.2016.12.004, 10.1016/j.ijpara]; Legendre P., 2012, NUMERICAL ECOLOGY; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Martinez Juan A., 2015, 2015 IEEE Power & Energy Society General Meeting, P1, DOI 10.1109/PESGM.2015.7285787; Martinez-Rincon RO, 2009, FISH RES, V96, P296, DOI 10.1016/j.fishres.2008.12.008; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; MASSUTI E, 1995, SCI MAR, V59, P357; May-Tec AL, 2013, PARASITOLOGY, V140, P385, DOI 10.1017/S0031182012001734; Montero JT, 2016, FISH OCEANOGR, V25, P1, DOI 10.1111/fog.12130; Montory JA, 2018, AQUACULTURE, V486, P68, DOI 10.1016/j.aquaculture.2017.12.017; Morales-Bojorquez E, 2016, REV FISH SCI AQUAC, V24, P98, DOI 10.1080/23308249.2015.1102862; Morley NJ, 2013, PARASITOLOGY, V140, P1211, DOI 10.1017/S0031182012001783; Mouritsen KN, 2002, OIKOS, V97, P462, DOI 10.1034/j.1600-0706.2002.970318.x; Mouritsen KN, 1997, MAR ECOL PROG SER, V151, P123, DOI 10.3354/meps151123; Murtugudde RG, 1999, J GEOPHYS RES-OCEANS, V104, P18351, DOI 10.1029/1999JC900135; National Weather Service, NOAA CTR WEATH CLIM; NEILSON JD, 1987, MAR ECOL PROG SER, V39, P221, DOI 10.3354/meps039221; Morales-Serna FN, 2014, PARASITOL INT, V63, P69, DOI 10.1016/j.parint.2013.09.005; Niquen M, 2014, REUN TECN DOR COM IN; NOAA, GLOB CLIM REP YEAR 2; Norton J.G., 1999, CURRENT SCI MAR, V63, P261; Okteners A, 2009, ACTA ADRIAT, V50, P121; Olden JD, 2001, MAR BIOL, V138, P1063, DOI 10.1007/s002270000517; Oliva ME, 2008, HELGOLAND MAR RES, V62, pS57, DOI 10.1007/s10152-007-0082-7; Oxenford HA, 1999, SCI MAR, V63, P277, DOI 10.3989/scimar.1999.63n3-4303; Palko Bj, 443 NOAA NMFS; Park JY, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007056; Pech D, 2010, INT J PARASITOL, V40, P937, DOI 10.1016/j.ijpara.2010.01.009; PLATT T, 1975, ANNU REV ECOL SYST, V6, P189, DOI 10.1146/annurev.es.06.110175.001201; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Poulin R, 2008, PARASITOL RES, V103, P187, DOI 10.1007/s00436-008-0953-0; Prasetyo Y, 2017, IOP C SER EARTH ENV, V98, DOI 10.1088/1755-1315/98/1/012041; Press W.H., 1996, NUMERICAL RECIPES FO; R Core Team, 2013, R LANG ENV STAT COMP; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Ritchie G, PATHOGENS WILD FARME, P153; Robert RJ, 2012, FISH PATHOL, P144; Rodriguez J, 2003, J FISH DIS, V26, P439, DOI 10.1046/j.1365-2761.2003.00483.x; ROHDE K, 1980, NEW ZEAL J MAR FRESH, V14, P1, DOI 10.1080/00288330.1980.9515837; Rossel F, 2009, HYDROL PROCESS, V23, P3253, DOI 10.1002/hyp.7401; Sagua Hernan, 2001, Boletin Chileno de Parasitologia, V56, P22; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Schwenke KL, 2008, FISH B-NOAA, V106, P82; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Soniat T, 2009, INT J EARTH SCI, V98, P99, DOI 10.1007/s00531-008-0364-6; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478; Strutton PG, 2000, J GEOPHYS RES-OCEANS, V105, P26089, DOI 10.1029/1999JC000056; Studer A, 2013, OECOLOGIA, V172, P1213, DOI 10.1007/s00442-012-2569-4; Suarez-Morales E, 2016, ZOOTAXA, V4174, P424, DOI 10.11646/zootaxa.4174.1.26; Tellez R, 2017, SEASONAL VARIATION D, V1, DOI [10.19080/ofdaj.2017.03.555602, DOI 10.19080/OFDAJ.2017.03.555602]; Thiel M, 2004, INT J BIFURCAT CHAOS, V14, P2107, DOI 10.1142/S0218127404010527; Thomas F, 1998, PARASITOLOGY, V116, P431, DOI 10.1017/S003118209800239X; TULLY O, 1989, J MAR BIOL ASSOC UK, V69, P279, DOI 10.1017/S0025315400029404; Wang GJ, 2017, NAT CLIM CHANGE, V7, P568, DOI [10.1038/nclimate3351, 10.1038/NCLIMATE3351]; Wei WWS., 1990, TIME SERIES ANAL UNI, V2; Williams EH, 2010, REV FISH SCI, V18, P73, DOI 10.1080/10641260903295909; Wilson WH, 2001, AQUAT MICROB ECOL, V25, P99, DOI 10.3354/ame025099; Wu CC, 2001, FISHERIES SCI, V67, P784, DOI 10.1046/j.1444-2906.2001.00324.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; [No title captured]	105	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232737	10.1371/journal.pone.0232737	http://dx.doi.org/10.1371/journal.pone.0232737			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392234	Green Published, gold			2022-12-26	WOS:000537470300022
J	Veiga, P; Ramos-Oliveira, C; Sampaio, L; Rubal, M				Veiga, Puri; Ramos-Oliveira, Catarina; Sampaio, Leandro; Rubal, Marcos			The role of urbanisation in affecting Mytilus galloprovincialis	PLOS ONE			English	Article							FRESH-WATER MUSSELS; METAL CONTAMINATION; NORTHWEST COAST; ROCKY SHORE; MARINE; IMPACTS; BIODIVERSITY; ASSEMBLAGES; PORTUGAL; PATTERNS	Urbanisation is considered as one of the most critical and widespread threats to coastal marine ecosystems. The aim of this study was to compare the density, percentage cover, thickness of clumps, condition index and size-frequency distribution of Mytilus galloprovincialis between urban and non-urban shores, at nested spatial scales, in the Northern Portuguese coast. M. galloprovincialis was selected as model because it is economically and ecologically relevant. Moreover, the relationship between mussel size and the other variables (i.e. density, percentage cover, thickness and condition index) were investigated. Mussels on urban shores showed a smaller density and a greater frequency of larger individuals. A significant negative correlation between mussel length with density and with thickness of clumps was also found. Our results seem to indicate that recruitment has declined on urban shores and, as a result, intraspecific competition is also smaller, leading to more resources being available for a fewer individuals which can reach larger sizes. As mussel beds support a great biodiversity of invertebrates and provide many ecosystem services, urbanisation may have indirect effects on communities associated with mussels. Understanding the vulnerability of mussel beds to urbanisation could inform management.	[Veiga, Puri; Ramos-Oliveira, Catarina; Sampaio, Leandro; Rubal, Marcos] Univ Porto, CIIMAR Interdisciplinary Ctr Marine & Environm Re, Novo Edificio Terminal Cruzeiros Porto Leixoes, Matosinhos, Portugal; [Veiga, Puri; Ramos-Oliveira, Catarina; Sampaio, Leandro; Rubal, Marcos] Univ Porto, Dept Biol, Fac Sci, Porto, Portugal	Universidade do Porto; Universidade do Porto	Veiga, P (corresponding author), Univ Porto, CIIMAR Interdisciplinary Ctr Marine & Environm Re, Novo Edificio Terminal Cruzeiros Porto Leixoes, Matosinhos, Portugal.; Veiga, P (corresponding author), Univ Porto, Dept Biol, Fac Sci, Porto, Portugal.	puri.sanchez@fc.up.pt	Oliveira, Catarina/AAQ-3443-2021	Oliveira, Catarina/0000-0002-3242-8795; Rubal, Marcos/0000-0002-1106-6035; Veiga, Puri/0000-0002-5706-465X	COMPETE 2020, Portugal 2020 [30181]; European Union through the ERDF; FCT	COMPETE 2020, Portugal 2020; European Union through the ERDF; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was developed under the Project No. 30181, co-financed by COMPETE 2020, Portugal 2020 and the European Union through the ERDF, and by FCT through national funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2005, MAR ECOL PROG SER, V299, P55, DOI 10.3354/meps299055; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Airoldi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022985; [Anonymous], 2006, MARINE COASTAL ECOSY; Arribas LP, 2014, MAR BIODIVERS, V44, P203, DOI 10.1007/s12526-014-0201-z; Beaumont NJ, 2007, MAR POLLUT BULL, V54, P253, DOI 10.1016/j.marpolbul.2006.12.003; Beck M. W., 2009, SHELLFISH REEFS RISK; Bertocci I, 2012, MAR ENVIRON RES, V77, P60, DOI 10.1016/j.marenvres.2012.02.003; Beukema JJ, 1996, MAR ECOL-P S Z N I, V17, P279, DOI 10.1111/j.1439-0485.1996.tb00508.x; BROSNAN DM, 1994, J EXP MAR BIOL ECOL, V177, P79, DOI 10.1016/0022-0981(94)90145-7; Bugnot AB, 2019, SCI TOTAL ENVIRON, V648, P711, DOI 10.1016/j.scitotenv.2018.08.134; Bulleri F, 2005, J APPL ECOL, V42, P1063, DOI 10.1111/j.1365-2664.2005.01096.x; Bulleri F, 2005, AUSTRAL ECOL, V30, P655, DOI 10.1111/j.1442-9993.2005.01507.x; Bulleri F, 2006, TRENDS ECOL EVOL, V21, P658, DOI 10.1016/j.tree.2006.09.004; Carranza A, 2009, REV FISH BIOL FISHER, V19, P349, DOI 10.1007/s11160-009-9108-3; Celliers Louis, 2015, W INDIAN OCEAN, P377, DOI [10.18356/cd2f1dd6-en, DOI 10.18356/CD2F1DD6-EN]; Creel L., 2003, RIPPLE EFFECTS POPUL; Dafforn KA, 2015, FRONT ECOL ENVIRON, V13, P82, DOI 10.1890/140050; Dame RF, 1996, ECOLOGY MARINE BIVAL; DETHIER MN, 1993, MAR ECOL PROG SER, V96, P93, DOI 10.3354/meps096093; Duarte CM, 2013, FRONT ECOL ENVIRON, V11, P91, DOI 10.1890/110246; Gestoso I, 2013, MAR ENVIRON RES, V90, P85, DOI 10.1016/j.marenvres.2013.05.015; Gillis PL, 2017, SCI TOTAL ENVIRON, V574, P671, DOI 10.1016/j.scitotenv.2016.09.110; Gillis PL, 2012, SCI TOTAL ENVIRON, V431, P348, DOI 10.1016/j.scitotenv.2012.05.061; Glasby TM, 1999, ESTUAR COAST SHELF S, V48, P281, DOI 10.1006/ecss.1998.0417; Gundersen H., 2016, ECOSYSTEM SERVICES C, DOI [10.6027/TN2016-552, DOI 10.6027/TN2016-552]; Harris M, 2003, AUMLA, P61; Lander TR, 2012, J SHELLFISH RES, V31, P997, DOI 10.2983/035.031.0412; LEVITAN DR, 1991, BIOL BULL-US, V181, P261, DOI 10.2307/1542097; Mainwaring K., 2014, 506 JNCC; Malerba ME, 2019, FRONT ECOL ENVIRON, V17, P400, DOI 10.1002/fee.2074; Barragan JM, 2015, OCEAN COAST MANAGE, V114, P11, DOI 10.1016/j.ocecoaman.2015.06.004; Mayer-Pinto M, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aa98a5; McPhee DP, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9030422; Montes MO, 2012, J HAZARD MATER, V225, P139, DOI 10.1016/j.jhazmat.2012.05.009; Philippart CJM, 2012, ESTUAR COAST SHELF S, V108, P52, DOI 10.1016/j.ecss.2012.05.014; Pineiro-Corbeira C, 2018, ICES J MAR SCI, V75, P2213, DOI 10.1093/icesjms/fsy107; Puccinelli E, 2016, ESTUAR COAST SHELF S, V169, P147, DOI 10.1016/j.ecss.2015.12.017; Reis PA, 2014, ENVIRON MONIT ASSESS, V186, P5447, DOI 10.1007/s10661-014-3794-6; Reis PA, 2013, MAR POLLUT BULL, V70, P155, DOI 10.1016/j.marpolbul.2013.02.027; Reis PA, 2012, ENVIRON MONIT ASSESS, V184, P5421, DOI 10.1007/s10661-011-2350-x; Rius M, 2004, SCI MAR, V68, P545; Rius M, 2006, S AFR J SCI, V102, P130; Robinson TB, 2007, J EXP MAR BIOL ECOL, V345, P1, DOI 10.1016/j.jembe.2006.12.019; Rubal M, 2011, J SEA RES, V66, P187, DOI 10.1016/j.seares.2011.07.003; Rubal M, 2014, ENVIRON POLLUT, V191, P101, DOI 10.1016/j.envpol.2014.04.019; Sara G, 2009, HYDROBIOLOGIA, V636, P129, DOI 10.1007/s10750-009-9942-2; Selig ER, 2019, CONSERV LETT, V12, DOI 10.1111/conl.12617; Smith JR, 2008, ENVIRON MANAGE, V41, P599, DOI 10.1007/s00267-007-9066-2; Smith JR, 2005, MAR BIOL, V147, P699, DOI 10.1007/s00227-005-1619-4; Stafford J, 1918, NATIVE OYSTER BRIT C; Stuart-Smith RD, 2015, MAR POLLUT BULL, V95, P324, DOI 10.1016/j.marpolbul.2015.03.023; Todd PA, 2019, OIKOS, V128, P1215, DOI 10.1111/oik.05946; Torres AC, 2018, FRONT MAR SCI C IMMR, DOI [10.3389/conf.FMARS.2018.06.00014, DOI 10.3389/CONF.FMARS.2018.06.00014]; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, 1993, OCEAN COAST MANAGE, V20, P41, DOI 10.1016/0964-5691(93)90012-N; Veiga P, 2013, HELGOLAND MAR RES, V67, P191, DOI 10.1007/s10152-012-0315-2; Vinagre C, 2015, MAR ENVIRON RES, V110, P53, DOI 10.1016/j.marenvres.2015.07.016; Wijsman J.W.M., 2019, GOODS SERVICES MARIN, P7, DOI DOI 10.1007/978--3-319-96776-9_2; [No title captured]	60	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232797	10.1371/journal.pone.0232797	http://dx.doi.org/10.1371/journal.pone.0232797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384115	Green Published, gold			2022-12-26	WOS:000537468300030
J	Vorkapic, M; Savic, A; Jankovic, M; Useinovic, N; Isakovic, M; Puskas, N; Stanojlovic, O; Hrncic, D				Vorkapic, Marko; Savic, Andrej; Jankovic, Milica; Useinovic, Nemanja; Isakovic, Milica; Puskas, Nela; Stanojlovic, Olivera; Hrncic, Dragan			Alterations of medial prefrontal cortex bioelectrical activity in experimental model of isoprenaline-induced myocardial infarction	PLOS ONE			English	Article							LIMBIC SYSTEM; ALPHA-BAND; BRAIN; ACTIVATION; DEPRESSION; APOPTOSIS; MODULATION; TRYPTOPHAN; INCREASES; COHERENCE	Background Clinical and animal studies have found that anxiety and depression are significantly more common after acute myocardial infarction (AMI). The medial prefrontal cortex (PFC) has a dual role: in higher brain functions and in cardiovascular control, making it a logical candidate for explaining the perceived bidirectional heart-brain connection. We used parallel Electrocardiography (ECG) and Electrocorticography (ECoG) registration to investigate AMI-induced changes in medial PFC bioelectrical activity in a rat model of AMI. Materials and methods Adult male Wistar albino rats were used in the study. Gold-plated recording electrodes were implanted over the frontal cortex for ECoG recording. ECG was recorded via two holter electrodes attached on the skin of the back fixed in place by a jacket. Induction of AMI was performed by isoprenaline (150 mg/kg, i.p.). ECoG and ECG signals were registered at baseline, during 3 hours after isoprenaline administration and at 24 hours after isoprenaline administration. Results Significant increases of theta, alpha, and beta electroencephalographic (EEG) band power were observed in different time intervals after isoprenaline administration. Significant increase of theta band peak frequency was also observed during the first hour after isoprenaline administration. No statistically significant differences in band-power activity were found between the pre-isoprenaline measurements and 24 hours after administration. Conclusion Our results demonstrate significant increases in EEG band power of alpha beta and theta bands during isoprenaline-induced AMI model. These are the first findings to connect heart damage during isoprenaline- induced AMI to disturbances in the cortical bioelectrical activity.	[Vorkapic, Marko; Useinovic, Nemanja; Stanojlovic, Olivera; Hrncic, Dragan] Univ Belgrade, Fac Med, Inst Med Physiol Richard Burian, Belgrade, Serbia; [Savic, Andrej; Jankovic, Milica; Isakovic, Milica] Univ Belgrade, Sch Elect Engn, Belgrade, Serbia; [Isakovic, Milica] TECNALIA, Hlth Div, Donostia San, Sebastian, Spain; [Puskas, Nela] Univ Belgrade, Fac Med, Inst Histol & Embryol Aleksandar Kostic, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Hrncic, D (corresponding author), Univ Belgrade, Fac Med, Inst Med Physiol Richard Burian, Belgrade, Serbia.	drhrncic@yahoo.com	Useinovic, Nemanja/GNP-5750-2022; Jankovic, Milica/AAX-4707-2021; Hrncic, Dragan/AAT-2544-2021	Hrncic, Dragan/0000-0003-0806-444X; Jankovic, Milica/0000-0002-7506-4995; Stanojlovic, Olivera/0000-0001-5317-3827; Isakovic, Dr. Milica/0000-0002-4353-8594	Ministry of Science Education and Technological Development of Serbia [175032, 175016]	Ministry of Science Education and Technological Development of Serbia	The study was supported by Ministry of Science Education and Technological Development of Serbia, Grant No. 175032 and 175016. The TECNALIA provided support in the form of salary for author MI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Armour JA, 2008, EXP PHYSIOL, V93, P165, DOI 10.1113/expphysiol.2007.041178; Bah TM, 2010, SLEEP, V33, P1703, DOI 10.1093/sleep/33.12.1703; Banozic A, 2014, INT HEART J, V55, P169, DOI 10.1536/ihj.13-275; Benedek M, 2014, NEUROPSYCHOLOGIA, V56, P393, DOI 10.1016/j.neuropsychologia.2014.02.010; Benedek M, 2011, NEUROPSYCHOLOGIA, V49, P3505, DOI 10.1016/j.neuropsychologia.2011.09.004; Burke NN, 2015, MOD TR PHARMACOPSYCH, V30, P36, DOI 10.1159/000435931; Cerqueira JJ, 2008, BRAIN BEHAV IMMUN, V22, P630, DOI 10.1016/j.bbi.2008.01.005; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; CONOLLY ME, 1972, BRIT J PHARMACOL, V46, P458, DOI 10.1111/j.1476-5381.1972.tb08143.x; ERIKSSON T, 1982, PSYCHOPHARMACOLOGY, V77, P98, DOI 10.1007/BF00436106; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Festing Michael F W, 2002, ILAR J, V43, P244; Filho LHG, 2011, REV BRAS CIR CARDIOV, V26, P469, DOI DOI 10.5935/1678-9741.20110024; Fink A, 2013, NEUROSCIENCE OF CREATIVITY, P207; Foster PS, 2002, INT J NEUROSCI, V112, P1463, DOI 10.1080/00207450290158359; Frasure-Smith N, 2010, POSTGRAD MED J, V86, P193, DOI 10.1136/hrt.2009.186957; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Hassan SF, 2013, J PHYSIOL-LONDON, V591, P6069, DOI 10.1113/jphysiol.2013.262071; HERTTING G, 1964, BIOCHEM PHARMACOL, V13, P1119, DOI 10.1016/0006-2952(64)90112-1; Hilz MJ, 2006, BRAIN, V129, P3343, DOI 10.1093/brain/awl299; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; HUTSON PH, 1980, BIOCHEM PHARMACOL, V29, P509, DOI 10.1016/0006-2952(80)90370-6; Jefferson AL, 2011, AM J CARDIOL, V108, P1346, DOI 10.1016/j.amjcard.2011.06.056; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Keene DL, 2000, EPILEPTIC DISORD, V2, P57; Khayyam-Nekouei Z, 2013, ARYA ATHEROSCLER, V9, P102; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; LeBlanc BW, 2016, PAIN, V157, P2330, DOI 10.1097/j.pain.0000000000000652; LeBlanc BW, 2014, PAIN, V155, P773, DOI 10.1016/j.pain.2014.01.013; Li H, 2017, J ATTEN DISORD, V21, P754; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048872; Lin WL, 2016, INT J CARDIOL, V225, P65, DOI 10.1016/j.ijcard.2016.09.121; Marrufo MV, 2001, COGNITIVE BRAIN RES, V12, P315; McCraty R, 2011, ACT NERV SUPER REDIV, V53, P85; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; NEAFSEY EJ, 1990, PROG BRAIN RES, V85, P147; Nichtova Z, 2012, GEN PHYSIOL BIOPHYS, V31, P141, DOI 10.4149/gpb_2012_015; OLESEN J, 1978, STROKE, V9, P344, DOI 10.1161/01.STR.9.4.344; OPPENHEIMER SM, 1990, BRAIN RES, V533, P66, DOI 10.1016/0006-8993(90)91796-J; Owens NC, 2001, BRAIN RES, V919, P221, DOI 10.1016/S0006-8993(01)03017-7; Padilla-Coreano N, 2016, NEURON, V89, P857, DOI 10.1016/j.neuron.2016.01.011; Pozuelo L, 2009, CLEV CLIN J MED, V76, P59, DOI 10.3949/ccjm.75a.08011; Pratt LA, 1996, CIRCULATION, V94, P3123, DOI 10.1161/01.CIR.94.12.3123; Resstel LBM, 2006, AUTON NEUROSCI-BASIC, V126, P130, DOI 10.1016/j.autneu.2006.02.022; Ritz K, 2013, NETH HEART J, V21, P55, DOI 10.1007/s12471-012-0348-9; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Sang K, 2018, MOL PAIN, V14, P1; Siddiqui M.A., 2016, INT J PHARMACEUT, V6, P138; Tavares RF, 2009, J NEUROSCI RES, V87, P2601, DOI 10.1002/jnr.22070; Tokgozoglu SL, 1999, STROKE, V30, P1307, DOI 10.1161/01.STR.30.7.1307; van der Wall EE, 2011, NETH HEART J, V19, P447, DOI 10.1007/s12471-011-0205-2; Verberne AJM, 1998, PROG NEUROBIOL, V54, P149, DOI 10.1016/S0301-0082(97)00056-7; Wann BP, 2009, J PSYCHOPHARMACOL, V23, P451, DOI 10.1177/0269881108089820; Wann BP, 2007, J PSYCHIATR NEUROSCI, V32, P11; Wann BP, 2006, BIOL PSYCHIAT, V59, P430, DOI 10.1016/j.biopsych.2005.07.018; Yadav C. H., 2014, INT J PHARM PHARM SC, V6, P654; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	59	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232530	10.1371/journal.pone.0232530	http://dx.doi.org/10.1371/journal.pone.0232530			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0QJ	32384091	Green Published, gold			2022-12-26	WOS:000537468300016
J	Johnson, JK; Cottle, BK; Mondal, A; Hitchcock, R; Kaza, AK; Sachse, FB				Johnson, Jordan K.; Cottle, Brian K.; Mondal, Abhijit; Hitchcock, Robert; Kaza, Aditya K.; Sachse, Frank B.			Localization of the sinoatrial and atrioventricular nodal region in neonatal and juvenile ovine hearts	PLOS ONE			English	Article							CARDIAC CONDUCTION SYSTEM; HUMAN SINUS NODE; HIS-BUNDLE; IMMUNOHISTOCHEMICAL DELINEATION; PURKINJE-FIBERS; PERMANENT; ARRHYTHMIAS; MORPHOLOGY; RECONSTRUCTION; IDENTIFICATION	Localization of the components of the cardiac conduction system (CCS) is essential for many therapeutic procedures in cardiac surgery and interventional cardiology. While histological studies provided fundamental insights into CCS localization, this information is incomplete and difficult to translate to aid in intraprocedural localization. To advance our understanding of CCS localization, we set out to establish a framework for quantifying nodal region morphology. Using this framework, we quantitatively analyzed the sinoatrial node (SAN) and atrioventricular node (AVN) in ovine with postmenstrual age ranging from 4.4 to 58.3 months. In particular, we studied the SAN and AVN in relation to the epicardial and endocardial surfaces, respectively. Using anatomical landmarks, we excised the nodes and adjacent tissues, sectioned those at a thickness of 4 mu m at 100 mu m intervals, and applied Masson's trichrome stain to the sections. These sections were then imaged, segmented to identify nodal tissue, and analyzed to quantify nodal depth and superficial tissue composition. The minimal SAN depth ranged between 20 and 926 mu m. AVN minimal depth ranged between 59 and 1192 mu m in the AVN extension region, 49 and 980 mu m for the compact node, and 148 and 888 mu m for the transition to His Bundle region. Using a logarithmic regression model, we found that minimal depth increased logarithmically with age for the AVN (R-2 = 0.818, P = 0.002). Also, the myocardial overlay of the AVN was heterogeneous within different regions and decreased with increasing age. Age associated alterations of SAN minimal depth were insignificant. Our study presents examples of characteristic tissue patterns superficial to the AVN and within the SAN. We suggest that the presented framework provides quantitative information for CCS localization. Our studies indicate that procedural methods and localization approaches in regions near the AVN should account for the age of patients in cardiac surgery and interventional cardiology.	[Johnson, Jordan K.; Cottle, Brian K.; Hitchcock, Robert; Kaza, Aditya K.; Sachse, Frank B.] Univ Utah, Dept Biomed Engn, Salt Lake City, UT 84112 USA; [Johnson, Jordan K.; Cottle, Brian K.; Sachse, Frank B.] Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; [Mondal, Abhijit; Kaza, Aditya K.] Boston Childrens Hosp, Cardiac Surg, Boston, MA USA; [Mondal, Abhijit; Kaza, Aditya K.] Harvard Med Sch, Boston, MA 02115 USA	Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Sachse, FB (corresponding author), Univ Utah, Dept Biomed Engn, Salt Lake City, UT 84112 USA.; Sachse, FB (corresponding author), Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA.	frank.sachse@utah.edu	Mondal, Abhijit/V-5672-2019	Mondal, Abhijit/0000-0001-9795-9872; Kaza, Aditya/0000-0003-3450-4496; Sachse, Frank/0000-0003-4987-705X	National Heart, Lung and Blood Institute [FBS -R56 HL128813, R01 HL135077]	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	RH, AK, FBS -R56 HL128813 and R01 HL135077, National Heart, Lung and Blood Institute, https://www.nhlbi.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello VD, 2015, WORLD J PEDIATR CONG, V6, P239, DOI 10.1177/2150135115572376; Anderson RH, 2013, WILCOXS SURG ANATOMY, VFourth; BERNHARD WF, 1961, NEW ENGL J MED, V265, P1079, DOI 10.1056/NEJM196111302652202; Bogers AJJC, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-74; Bonatti V, 1998, Pediatr Med Chir, V20, P181; Chandler N, 2011, ANAT REC, V294, P970, DOI 10.1002/ar.21379; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; COL JJ, 1972, AM J CARDIOL, V29, P344, DOI 10.1016/0002-9149(72)90529-2; Coppen SR, 1999, DEV GENET, V24, P82, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<82::AID-DVG9>3.0.CO;2-1; Csepe TA, 2016, PROG BIOPHYS MOL BIO, V120, P164, DOI 10.1016/j.pbiomolbio.2015.12.011; DEFELICE LJ, 1969, CIRC RES, V24, P457, DOI 10.1161/01.RES.24.3.457; DENES P, 1975, AM J CARDIOL, V35, P23, DOI 10.1016/0002-9149(75)90554-8; Deshmukh P, 2000, CIRCULATION, V101, P869, DOI 10.1161/01.CIR.101.8.869; Dobrzynski H, 2013, PHARMACOL THERAPEUT, V139, P260, DOI 10.1016/j.pharmthera.2013.04.010; Duan DY, 2017, J MORPHOL, V278, P975, DOI 10.1002/jmor.20691; FERRER MI, 1968, J AMER MED ASSOC, V206, P645, DOI 10.1001/jama.206.3.645; Fitzpatrick AP, 1996, AM HEART J, V131, P499, DOI 10.1016/S0002-8703(96)90528-1; Graham TP, 2000, J AM COLL CARDIOL, V36, P255, DOI 10.1016/S0735-1097(00)00682-3; Gross GJ, 2006, HEART RHYTHM, V3, P601, DOI 10.1016/j.hrthm.2006.01.023; Hill RW, 2012, ANIMAL PHYSIOLOGY, THIRD EDITION, P99; Ho S.B., 2015, AUST J BASIC APPL SC, V9, P1; Huang C, 2013, CIRC-CARDIOVASC IMAG, V6, P739, DOI 10.1161/CIRCIMAGING.112.000121; Jackson AP, 1987, FEBS LETT, V215; JAMES TN, 1977, AM J CARDIOL, V40, P965, DOI 10.1016/0002-9149(77)90048-0; Kawashima T, 2011, ANN ANAT, V193, P1, DOI 10.1016/j.aanat.2010.11.002; Keith A, 1907, J ANAT PHYSIOL, V41, P172; Kurian T, 2010, PACE, V33, P754, DOI 10.1111/j.1540-8159.2010.02699.x; LINCOLN C, 1979, BRIT HEART J, V42, P339; MARRIOTT HJ, 1970, CHEST, V58, P342, DOI 10.1378/chest.58.4.342; MASSING GK, 1976, CIRCULATION, V53, P609, DOI 10.1161/01.CIR.53.4.609; Meijler F, 1988, PHYSL REV, V68; Merin O, 2009, PACE, V32, P7, DOI 10.1111/j.1540-8159.2009.02170.x; Mondal A, 2019, SEMIN THORAC CARDIOV, V31, P537, DOI 10.1053/j.semtcvs.2019.02.006; Nabipour A, 2012, TURK J VET ANIM SCI, V36, P463, DOI 10.3906/vet-0807-2; OOSTHOEK PW, 1993, CIRC RES, V73, P482, DOI 10.1161/01.RES.73.3.482; OOSTHOEK PW, 1993, CIRC RES, V73, P473, DOI 10.1161/01.RES.73.3.473; ORMEROD OJM, 1984, BRIT HEART J, V51, P618; Park DS, 2017, J CARDIOVASC DEV DIS, V4, DOI 10.3390/jcdd4020007; Park DS, 2011, CIRCULATION, V123, P904, DOI 10.1161/CIRCULATIONAHA.110.942284; Pasic M, 1998, J AM COLL CARDIOL, V32, P1040, DOI 10.1016/S0735-1097(98)00358-1; Patterson E, 2005, J INTERV CARD ELECTR, V13, P95, DOI 10.1007/s10840-005-0273-6; PIRES LA, 1995, AM HEART J, V129, P799, DOI 10.1016/0002-8703(95)90332-1; RABBINO MD, 1961, AM J CARDIOL, V7, P681, DOI 10.1016/0002-9149(61)90453-2; ROKSETH R, 1971, BRIT HEART J, V33, P639; Ruaengsri C, 2018, EUR J CARDIO-THORAC, V53, P19, DOI 10.1093/ejcts/ezx326; Sanchez-Quintana D, 2005, HEART, V91, P189, DOI 10.1136/hrt.2003.031542; Sato Y, 2003, CIRC J, V67, P107, DOI 10.1253/circj.67.107; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shinohara G, 2016, WORLD J PEDIATR CONG, V7, P700, DOI 10.1177/2150135116675844; Silverman ME, 2006, CIRCULATION, V113, P2775, DOI 10.1161/CIRCULATIONAHA.106.616771; Smith A, 2006, CARDIOL YOUNG, V16, P437, DOI 10.1017/S1047951106000382; Stephenson RS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07694-8; Stephenson RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035299; Tawara S., 1906, REIZLEITUNGSSYSTEM S; TITUS JL, 1963, CIRCULATION, V28, P82, DOI 10.1161/01.CIR.28.1.82; Torres AG, 2015, A A CASE REP, V5, P33, DOI 10.1213/XAA.0000000000000170; TRANUMJENSEN J, 1991, CIRC RES, V69, P429, DOI 10.1161/01.RES.69.2.429; TRUEX RAYMOND D., 1965, ANN N Y ACAD SCI, V127, P19, DOI 10.1111/j.1749-6632.1965.tb49390.x; van Weerd JH, 2016, DEVELOPMENT, V143, P197, DOI 10.1242/dev.124883; Venius J, 2013, TOHOKU J EXP MED, V229, P67, DOI 10.1620/tjem.229.67; Vijayaraman P, 2014, HEART RHYTHM, V11, P529, DOI 10.1016/j.hrthm.2013.01.027; WOHL AJ, 1976, ARCH INTERN MED, V136, P406, DOI 10.1001/archinte.136.4.406; Xu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00504-1	63	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232618	10.1371/journal.pone.0232618	http://dx.doi.org/10.1371/journal.pone.0232618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379798	Green Published, gold			2022-12-26	WOS:000537285700049
J	Laharnar, N; Grote, L; Zou, D; Hedner, J; Sommermeyer, D; Strassberger, C; Marciniak, A; Potzka, S; Lederer, K; Glos, M; Zimmermann, S; Fietze, I; Penzel, T				Laharnar, Naima; Grote, Ludger; Zou, Ding; Hedner, Jan; Sommermeyer, Dirk; Strassberger, Christian; Marciniak, Albert; Potzka, Sabrina; Lederer, Katharina; Glos, Martin; Zimmermann, Sandra; Fietze, Ingo; Penzel, Thomas			Overnight pulse wave analysis to assess autonomic changes during sleep in insomnia patients and healthy sleepers	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; CARDIOVASCULAR RISK; PHOTOPLETHYSMOGRAPHIC SIGNAL; ASSOCIATION; STIFFNESS; DISEASE; EVENTS; INDEX; HYPERTENSION; DISTURBANCE	Insomnia has been associated with increased cardiovascular (CV) risk, which may be linked to sympathetic activation. Non-invasive overnight pulse wave analysis may be a useful tool to detect early signs of autonomic changes during sleep in insomniacs. Fifty-two participants (26 men, 37 +/- 13 years, BMI: 24 +/- 5 kg/m(2), 26 insomniacs/26 controls) underwent overnight polysomnography with pulse oximetry and pulse wave analysis including pulse rate, vascular stiffness (pulse propagation time, PPT), and a composite cardiac risk index based on autonomic function and overnight hypoxia. We identified two subgroups of insomniacs, with and without objectively disturbed sleep (sleep efficiency SE <= 80%, n = 14 vs. SE>80%, n = 12), and observed increased pulse rate and vascular stiffness in insomnia cases when diagnosis was based on both, subjective and objective criteria. Both insomnia groups were associated with higher overnight pulse rate than controls (median/IQR: low-SE (low sleep efficiency): 67/58-70bpm; high-SE: 66/63-69bpm; controls: 58/52-63bpm; p = 0.01). Vascular stiffness was higher (reduction of PPT) in low-SE insomniacs compared with high-SE insomniacs and controls (169/147-232ms; 237/215-254ms; 244/180-284ms; p = 0.01). The cardiac risk index was increased in low-SE insomniacs (0.2/0.0-0.7; 0.0/0.0-0.4; 0.0/0.0-0.3; p = 0.05). Our results suggest a hyperarousal state in young and otherwise healthy insomniacs during sleep. The increased pulse rate and vascular stiffness in insomniacs with low SE suggest early signs of rigid vessels and potentially, an elevated CV risk. Overnight pulse wave analysis may be feasible for CV risk assessment in insomniacs and may provide a useful tool for phenotyping insomnia in order to provide individualized therapy.	[Laharnar, Naima; Potzka, Sabrina; Lederer, Katharina; Glos, Martin; Zimmermann, Sandra; Fietze, Ingo; Penzel, Thomas] Charite Univ Med Berlin, Interdisciplinary Ctr Sleep Med, Berlin, Germany; [Grote, Ludger; Zou, Ding; Hedner, Jan; Strassberger, Christian; Marciniak, Albert] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Sleep & Vigilance Disorders, Gothenburg, Sweden; [Sommermeyer, Dirk] Univ Mannheim, Fac Informat Technol, Inst Digital Signal Proc, Mannheim, Germany; [Lederer, Katharina] Adv Sleep Res GmbH, Berlin, Germany; [Penzel, Thomas] Saratov NG Chernyshevskii State Univ, Saratov, Russia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Gothenburg; University of Mannheim; Saratov State University	Laharnar, N (corresponding author), Charite Univ Med Berlin, Interdisciplinary Ctr Sleep Med, Berlin, Germany.	naima.laharnar@charite.de	Penzel, Thomas/M-2344-2014	Penzel, Thomas/0000-0002-4304-0112; Fietze, Ingo/0000-0001-5567-5206; Laharnar, Naima/0000-0001-7484-7747	Qatar National Research Fund -National Priorities Research Program (NPRP) [5-1327-2-568]; Charite-Universitatsmedizin Berlin; Swedish Heart and Lung Foundation [20120811, 20160584]; Russian Federation RF Government [075-15-2019-1885]; Sahlgrenska University Hospital [LUA ALF ALFGBG-534591, 725601]; ASR (Advanced Sleep Research GmbH)	Qatar National Research Fund -National Priorities Research Program (NPRP); Charite-Universitatsmedizin Berlin; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Russian Federation RF Government; Sahlgrenska University Hospital; ASR (Advanced Sleep Research GmbH)	The study was funded by the Qatar National Research Fund -National Priorities Research Program (NPRP #5-1327-2-568), the Charite-Universitatsmedizin Berlin owned funding, the Swedish Heart and Lung Foundation (grant 20120811, 20160584), the Russian Federation RF Government (#075-15-2019-1885), and the agreement concerning research and education of doctors at the Sahlgrenska University Hospital (LUA ALF ALFGBG-534591 and 725601). The funder ASR (Advanced Sleep Research GmbH) provided support in the form of salary for author KL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; American Academy of Sleep Medicine, 2007, SCOR MAN FREQ ASK QU; Benes H, 2009, SLEEP MED, V10, P515, DOI 10.1016/j.sleep.2008.06.006; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bonnet MH, 1998, PSYCHOSOM MED, V60, P610, DOI 10.1097/00006842-199809000-00017; Buysse D J, 1989, Psychiatry Res, V28, P193; Clarenbach CF, 2012, HYPERTENS RES, V35, P228, DOI 10.1038/hr.2011.168; Dodds KL, 2017, SLEEP MED REV, V33, P88, DOI 10.1016/j.smrv.2016.06.004; Elgendi M, 2012, CURR CARDIOL REV, V8, P14, DOI 10.2174/157340312801215782; Elwood P, 2006, J EPIDEMIOL COMMUN H, V60, P69, DOI 10.1136/jech.2005.039057; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Grandner MA, 2010, SLEEP MED REV, V14, P239, DOI 10.1016/j.smrv.2009.08.001; Grote L, 2017, PRINCIPLE PRACTICE S, P1633; Grote L, 2011, CHEST, V139, P253, DOI 10.1378/chest.09-3029; Gunarathne A, 2008, AM J HYPERTENS, V21, P866, DOI 10.1038/ajh.2008.207; Iber C, 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lombardi C, 2019, AUTON NEUROSCI-BASIC, V221, DOI 10.1016/j.autneu.2019.102563; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Millasseau SC, 2002, CLIN SCI, V103, P371, DOI 10.1042/cs1030371; Moraes JL, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18061894; Morin CM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.26; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Nilsson PM, 2001, J INTERN MED, V250, P521, DOI 10.1046/j.1365-2796.2001.00913.x; Nitzan M, 1998, PHYSIOL MEAS, V19, P93, DOI 10.1088/0967-3334/19/1/008; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Parthasarathy S, 2015, AM J MED, V128, P268, DOI 10.1016/j.amjmed.2014.10.015; Phillips B, 2007, J CLIN SLEEP MED, V3, P489; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; R Core Team, 2021, R LANGUAGE ENV STAT; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Roth T, 2007, J CLIN SLEEP MED, V3, pS7, DOI [10.5664/jcsm.26929, DOI 10.5664/JCSM.26929]; Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970; Sommermeyer D, 2016, MED BIOL ENG COMPUT, V54, P1111, DOI 10.1007/s11517-015-1410-8; Sommermeyer D, 2014, J HYPERTENS, V32, P276, DOI 10.1097/HJH.0000000000000039; Svedmyr S, 2016, J HYPERTENS, V34, P2427, DOI 10.1097/HJH.0000000000001111; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Williams B, 2018, BLOOD PRESSURE, V27, P314, DOI [10.1080/08037051.2018.1527177, 10.1097/HJH.0000000000001961]; Wu MN, 2015, J SLEEP RES, V24, P722, DOI 10.1111/jsr.12314	42	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232589	10.1371/journal.pone.0232589	http://dx.doi.org/10.1371/journal.pone.0232589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LT7ZX	32379833	Green Published, gold			2022-12-26	WOS:000537285700043
J	Lee, KM; Kim, M; Oh, S; Kim, SH				Lee, Kyoung Min; Kim, Martha; Oh, Sohee; Kim, Seok Hwan			Hemisphere opposite to vascular trunk deviation is earlier affected by glaucomatous damage in myopic high-tension glaucoma	PLOS ONE			English	Article							OPTIC-NERVE HEAD; LAMINA-CRIBROSA; PATTERN	Purpose To investigate whether the position of the central vascular trunk, as a surrogate of lamina cribrosa (LC) shift, is associated with the initial hemisphere of visual field defect in myopic high-tension glaucoma (HTG) eyes. Methods The deviation of the central vascular trunk was measured from the center of the Bruch's membrane opening (BMO), which was delineated by OCT imaging. The angular deviation was measured with the horizontal nasal midline as 0 degrees and the superior location as a positive value. The initial hemisphere developing visual field defect was defined as three connected abnormal points (having a P value with less than 0.5% probability of being normal) appearing in only one hemisphere in pattern deviation plots. If those points were observed in both hemispheres initially, the eye was classified as bi-hemispheric visual field defect. Results Initially, 36 eyes (44%) had superior visual field defects, 27 (33%) inferior visual field defects, and 18 (22%) bi-hemispheric visual field defects. After a mean follow-up of 5 years, the number of bi-hemispheric visual field defects had increased to 34 (42%). A logistic regression analysis revealed that inferior deviation of vascular trunk was the only factor associated with initial inferior visual field defect (P = 0.001), while initial bi-hemispheric visual field defects were associated with worse mean deviation at initial visits (P<0.001). A conditional inference tree analysis showed that both the angular deviation (P<0.001) and initial mean deviation (P = 0.025) determined the initial hemispheres developing visual field defect. Conclusions Although both hemispheres were involved as glaucoma progression, the axons on the side counter to the vascular trunk deviation were damaged earlier in HTG. This finding implies the LC shift could add additional stress to axons exposed to high intraocular pressure.	[Lee, Kyoung Min; Kim, Seok Hwan] Seoul Natl Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Lee, Kyoung Min; Kim, Seok Hwan] Seoul Natl Univ, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Kim, Martha] Dongguk Univ, Ilsan Hosp, Dept Ophthalmol, Goyang, South Korea; [Oh, Sohee] Seoul Natl Univ, Boramae Med Ctr, Dept Biostat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Dongguk University; NHIS Ilsan Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, SH (corresponding author), Seoul Natl Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea.; Kim, SH (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea.	xcski@hanmail.net		Kim, Seok Hwan/0000-0002-0820-9090	Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center [03-2019-23]	Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center	This work was supported by a clinical research grant-in-aid from the Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center (grant no. 03-2019-23) (KML, SHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; DRANCE SM, 1986, AM J OPHTHALMOL, V102, P612, DOI 10.1016/0002-9394(86)90533-7; DRANCE SM, 1992, EYE, V6, P337, DOI 10.1038/eye.1992.69; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Han JC, 2020, AM J OPHTHALMOL, V209, P77, DOI 10.1016/j.ajo.2019.08.023; Han JC, 2016, AM J OPHTHALMOL, V169, P33, DOI 10.1016/j.ajo.2016.06.005; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Iester M, 1999, ARCH OPHTHALMOL-CHIC, V117, P1010; Jonas JB, 2000, OPHTHALMOLOGY, V107, P704, DOI 10.1016/S0161-6420(99)00172-4; Jonas JB, 2017, LANCET, V390, P2183, DOI 10.1016/S0140-6736(17)31469-1; Kim M, 2019, INVEST OPHTH VIS SCI, V60, P3381, DOI 10.1167/iovs.19-27363; Kim M, 2018, OPHTHALMOLOGY, V125, P1215, DOI 10.1016/j.ophtha.2018.01.026; Konstantakopoulou E, 2008, OPTOMETRY VISION SCI, V85, P538, DOI 10.1097/OPX.0b013e31817dad6a; Lee KM, 2018, OPHTHALMOL GLAUCOMA, V1, P32, DOI 10.1016/j.ogla.2018.05.003; Lee KM, 2018, INVEST OPHTH VIS SCI, V59, P4020, DOI 10.1167/iovs.18-24775; Lee KM, 2018, OPHTHALMOLOGY, V125, P1224, DOI 10.1016/j.ophtha.2018.02.002; MILLER KM, 1987, OPHTHALMIC SURG LAS, V18, P882; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P640, DOI 10.1016/S0161-6420(96)30640-4; Park HYL, 2016, INVEST OPHTH VIS SCI, V57, P4170, DOI 10.1167/iovs.16-19564; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; YAMAZAKI Y, 1991, GRAEF ARCH CLIN EXP, V229, P517, DOI 10.1007/BF00203313	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2020	15	5							e0233270	10.1371/journal.pone.0233270	http://dx.doi.org/10.1371/journal.pone.0233270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1CK	32421695	Green Published, gold			2022-12-26	WOS:000537499600039
J	Lin, EW; Brady, GF; Kwan, R; Nesvizhskii, AI; Omary, MB				Lin, Eric W.; Brady, Graham F.; Kwan, Raymond; Nesvizhskii, Alexey, I; Omary, M. Bishr			Genotype-phenotype analysis of LMNA-related diseases predicts phenotype-selective alterations in lamin phosphorylation	FASEB JOURNAL			English	Article						intermediate filaments; laminopathy; mutation; post-translational modifications	DILATED CARDIOMYOPATHY; NUCLEAR LAMINA; MUTATION; DATABASE; INHIBITION; IDENTIFICATION; LAMINOPATHIES; LOCALIZATION; ACTIVATION; PROTEINS	Laminopathies are rare diseases associated with mutations in LMNA, which encodes nuclear lamin A/C. LMNA variants lead to diverse tissue-specific phenotypes including cardiomyopathy, lipodystrophy, myopathy, neuropathy, progeria, bone/skin disorders, and overlap syndromes. The mechanisms underlying these heterogeneous phenotypes remain poorly understood, although post-translational modifications, including phosphorylation, are postulated as regulators of lamin function. We catalogued all known lamin A/C human mutations and their associated phenotypes, and systematically examined the putative role of phosphorylation in laminopathies. In silico prediction of specific LMNA mutant-driven changes to lamin A phosphorylation and protein structure was performed using machine learning methods. Some of the predictions we generated were validated via assessment of ectopically expressed wild-type and mutant LMNA. Our findings indicate phenotype- and mutant-specific alterations in lamin phosphorylation, and that some changes in phosphorylation may occur independently of predicted changes in lamin protein structure. Therefore, therapeutic targeting of phosphorylation in the context of laminopathies will likely require mutant- and kinase-specific approaches.	[Lin, Eric W.; Brady, Graham F.; Kwan, Raymond; Omary, M. Bishr] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Lin, Eric W.; Brady, Graham F.; Omary, M. Bishr] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kwan, Raymond; Omary, M. Bishr] Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Lane West,Room 206, Piscataway, NJ 08854 USA; [Nesvizhskii, Alexey, I] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Nesvizhskii, Alexey, I] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Omary, MB (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Lane West,Room 206, Piscataway, NJ 08854 USA.	bishr.omary@rutgers.edu			National Institutes of Health (NIH) [R01 DK47918, R01 GM094231, P30 DK034933]; American Liver Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Foundation	National Institutes of Health (NIH), Grant/Award Number: R01 DK47918, R01 GM094231 and P30 DK034933; American Liver Foundation	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11684-x; Ao Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5078; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bera M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27879; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertrand AT, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040844; Boudreau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045918; Brady GF, 2018, GASTROENTEROLOGY, V154, P1602, DOI 10.1053/j.gastro.2018.03.026; Brady GF, 2018, HEPATOLOGY, V67, P1710, DOI 10.1002/hep.29522; Buljan M, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20177974; Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Cenni V, 2005, J MED GENET, V42, P214, DOI 10.1136/jmg.2004.026112; Chamcheu JC, 2016, EXP DERMATOL, V25, P183, DOI 10.1111/exd.12893; Chatzifrangkeskou M, 2018, HUM MOL GENET, V27, P3060, DOI 10.1093/hmg/ddy215; Chen L, 2018, J BIOMED RES, V32, P314, DOI 10.7555/JBR.32.20180003; Choi JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003875; Delvecchio CJ, 2008, J ENDOCRINOL, V197, P121, DOI 10.1677/JOE-07-0525; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; DUBOSE AJ, 2018, P NATL ACAD SCI USA, V115; Elzeneini E, 2017, J CELL BIOL, V216, P2607, DOI 10.1083/jcb.201707090; Fryxell KJ, 2005, MOL BIOL EVOL, V22, P650, DOI 10.1093/molbev/msi043; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466; Herrmann H, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018242; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hu JF, 2014, BIOINFORMATICS, V30, P141, DOI 10.1093/bioinformatics/btt627; Hubner S, 2006, J CELL BIOCHEM, V98, P810, DOI 10.1002/jcb.20791; Ishiyama A, 2018, HUM GENOME VAR, V5, DOI 10.1038/s41439-018-0018-6; Kelley JB, 2011, MOL CELL BIOL, V31, P3378, DOI 10.1128/MCB.05087-11; Kochin V, 2014, J CELL SCI, V127, P2683, DOI 10.1242/jcs.141820; Kwan R, 2017, CELL MOL GASTROENTER, V4, P365, DOI 10.1016/j.jcmgh.2017.06.005; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Martelli AM, 2002, J CELL BIOCHEM, V86, P320, DOI 10.1002/jcb.10227; Mitsuhashi H, 2010, J CELL SCI, V123, P3893, DOI 10.1242/jcs.072157; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2014, BIOCHEM BIOPH RES CO, V452, P958, DOI 10.1016/j.bbrc.2014.09.020; Muchir A, 2012, HUM MOL GENET, V21, P4325, DOI 10.1093/hmg/dds265; Muchir A, 2012, CARDIOVASC RES, V93, P311, DOI 10.1093/cvr/cvr301; Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343; Naetar N, 2017, J CELL SCI, V130, P2087, DOI 10.1242/jcs.203430; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; PEJAVER V, MUTPRED2 INFERRING M; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Raharjo WH, 2001, J CELL SCI, V114, P4447; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Scharner J, 2010, BIOCHEM SOC T, V38, P257, DOI 10.1042/BST0380257; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Simon DN, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7050044; Simon DN, 2013, CHROMOSOMA, V122, P13, DOI 10.1007/s00412-013-0399-8; Simon DN, 2013, MOL BIOL CELL, V24, P342, DOI 10.1091/mbc.E12-07-0527; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Sporrer M, 2019, EBIOMEDICINE, V44, P502, DOI 10.1016/j.ebiom.2019.04.062; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Strnad P, 2011, J CELL SCI, V124, P4221, DOI 10.1242/jcs.089516; Sylvius N, 2008, EXP CELL RES, V314, P2362, DOI 10.1016/j.yexcr.2008.04.017; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Thompson LJ, 1997, J BIOL CHEM, V272, P29693, DOI 10.1074/jbc.272.47.29693; Torvaldson E, 2015, NUCLEUS-PHILA, V6, P166, DOI 10.1080/19491034.2015.1017167; Wadhwa R., 2018, J OPEN SOURCE SOFTW, V3, P1008, DOI DOI 10.21105/JOSS.01008; Wagih O, 2015, NAT METHODS, V12, P531, DOI 10.1038/nmeth.3396; Wang DL, 2017, BIOINFORMATICS, V33, P3909, DOI 10.1093/bioinformatics/btx496; Wu W, 2014, HUM MOL GENET, V23, P1, DOI 10.1093/hmg/ddt387; Wu W, 2011, CIRCULATION, V123, P53, DOI 10.1161/CIRCULATIONAHA.110.970673; Wu W, 2010, BBA-MOL BASIS DIS, V1802, P632, DOI 10.1016/j.bbadis.2010.04.001; Young SG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005229	73	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9051	9073		10.1096/fj.202000500R	http://dx.doi.org/10.1096/fj.202000500R		MAY 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32413188	Green Published, Green Accepted, Bronze			2022-12-26	WOS:000533180700001
J	Serman, F; Favre, J; Deken, V; Guittet, L; Collins, C; Rochoy, M; Messaadi, N; Duhamel, A; Launay, L; Berkhout, C; Raginel, T				Serman, Fanny; Favre, Jonathan; Deken, Valerie; Guittet, Lydia; Collins, Claire; Rochoy, Michael; Messaadi, Nassir; Duhamel, Alain; Launay, Ludivine; Berkhout, Christophe; Raginel, Thibaut			The association between cervical cancer screening participation and the deprivation index of the location of the family doctor's office	PLOS ONE			English	Article							GENERAL-PRACTITIONERS; HEALTH; INEQUALITIES; WOMEN; CARE; MORTALITY; FRANCE; IMPACT; BREAST	Background Cervical cancer screening rates are known to be strongly associated with socioeconomic status. Our objective was to assess whether the rate is also associated with an aggregated deprivation marker, defined by the location of family doctors' offices. Methods To access this association, we 1) collected data from the claim database of the French Health Insurance Fund about the registered family doctors and their enlisted female patients eligible for cervical screening; 2) carried out a telephone survey with all registered doctors to establish if they were carrying out Pap-smears in their practices; 3) geotracked all the doctors' offices in the smallest existing blocks of socioeconomic homogenous populations (IRIS census units) that were assigned a census derived marker of deprivation, the European Deprivation Index (EDI), and a binary variable of urbanization; and 4) we used a multivariable linear mixed model with IRIS as a random effect. Results Of 348 eligible doctors, 343 responded to the telephone survey (98.6%) and were included in the analysis, encompassing 88,152 female enlisted patients aged 25-65 years old. In the multivariable analysis (adjusted by the gender of the family doctor, the practice of Papsmears by the doctor and the urbanization of the office location), the EDI of the doctor's office was strongly associated with the cervical cancer screening participation rate of eligible patients (p< 0.001). Conclusion The EDI linked to the location of the family doctor's office seems to be a robust marker to predict female patients' participation in cervical cancer screening.	[Serman, Fanny; Favre, Jonathan; Rochoy, Michael; Messaadi, Nassir; Berkhout, Christophe] Lille Univ, Sch Med, Dept Gen Med, Lille, France; [Deken, Valerie; Duhamel, Alain] Lille Univ, Univ Hosp Lille, Dept Publ Hlth, Lille, France; [Guittet, Lydia; Launay, Ludivine] Univ Hosp Caen, Dept Epidemiol Res & Evaluat, Caen, France; [Guittet, Lydia; Launay, Ludivine; Raginel, Thibaut] Normandie Univ, Univ Hosp Caen, INSERM, U1086 Anticipe, Caen, France; [Guittet, Lydia; Launay, Ludivine; Raginel, Thibaut] Normandie Univ, Med Sch, Dept Gen Med, Caen, France; [Collins, Claire] Irish Coll Gen Practitioners, Dublin, Ireland	Universite de Franche-Comte; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie	Serman, F (corresponding author), Lille Univ, Sch Med, Dept Gen Med, Lille, France.	docteur.serman@gmail.com	Raginel, Thibaut/AAZ-3882-2020; Launay, Ludivine/ABD-8881-2020; Collins, Claire/AFN-0839-2022; Rochoy, Michaël/AAD-7340-2020; Guittet, Lydia/ABC-5830-2020; GUITTET, Lydia/L-7229-2015	Raginel, Thibaut/0000-0003-1598-9221; Collins, Claire/0000-0001-8967-5159; GUITTET, Lydia/0000-0003-2660-776X; Launay, Ludivine/0000-0002-4006-9585; Berkhout, Christophe/0000-0002-1471-4894; Favre, Jonathan/0000-0002-9354-1505; Serman, Fanny/0000-0002-6507-9667; Rochoy, Michael/0000-0002-8865-3748	French Ministry of Health [PREPS: LIC-14-14-0615]; University Hospital of Lille	French Ministry of Health; University Hospital of Lille	This study was granted by the French Ministry of Health (PREPS: LIC-14-14-0615, 12/19/2014) and sponsored by the University Hospital of Lille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; The authors wish to acknowledge the whole PaCUDAHL-Geresearch group; the CPAM of Flanders and in particular Ghislaine Liekens, Laurent Duplessy, Eliane Vanderghote and Therese Devienne-Rollin, for the extraction of our dataset from the SIAM-ERASME claim database; Elise Gers and Malek Dib, for the management of the PaCUDAHL-Geresearch team; the 16 family medicine residents who carried out the telephone survey: Margot Badelon, Pauline Beauvallet, Ludovic Cerol, Marianne Delsert, Axel Descamps, Lynda Donat, Marie Francke, Anissa Hindi, Perrine Kuczera, Claire Laloy-Degraeve, Maxime Lamirand, Helene Langin, Marine Pelletier, Francois Quersin and Camille Santandreu. We want to thank Colleen O'Neil and Matthew Roberts for their help in the copyediting.	Aklimunnessa K, 2006, JPN J CLIN ONCOL, V36, P511, DOI 10.1093/jjco/hyl060; Ameli, SIT ASS MAL LIGN; Araujo M, 2017, CANCER EPIDEMIOL, V48, P117, DOI 10.1016/j.canep.2017.04.014; Bach PB, 2010, LANCET, V375, P963, DOI 10.1016/S0140-6736(09)62029-8; Barghouti FE, 2008, SAUDI MED J, V29, P1036; Barre S, 2017, B EPIDEMIOLOGIQUE HE, V39; Beck F., PRATIQUES DEPISTAGE; Berkhout C., 2016, PARTICIPATION SCREEN; Binder-Foucard FBA, 2013, ESTIMATION NATL INCI; Clifford GM, 2009, LANCET, V374, P1948, DOI 10.1016/S0140-6736(09)61789-X; CNGOF, 2007, REC PREV CANC COL UT; De pistage et pre vention du cancer du col de l'ute rus, 2013, ACT REF PRAT EX PER; Dugue PA, 2014, INT J CANCER, V134, P2674, DOI 10.1002/ijc.28586; Duport N, 2008, REV EPIDEMIOL SANTE, V56, P303, DOI 10.1016/j.respe.2008.07.086; Favre J, 2018, J WOMENS HEALTH, V27, P933, DOI 10.1089/jwh.2017.6656; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gelly J, 2014, FAM PRACT, V31, P445, DOI 10.1093/fampra/cmu032; Grillo F, 2012, PREV MED, V54, P259, DOI 10.1016/j.ypmed.2012.01.013; HAS, 2010, SYNTH REC; Jones NR, 2013, HEALTH PLACE, V24, P90, DOI 10.1016/j.healthplace.2013.08.010; Kim MH, 2013, KOREAN J FAM MED, V34, P258, DOI 10.4082/kjfm.2013.34.4.258; LEWIS D, 1994, MED J AUSTRALIA, V160, P628, DOI 10.5694/j.1326-5377.1994.tb125870.x; Li GW, 2016, J CLIN EPIDEMIOL, V80, P16, DOI 10.1016/j.jclinepi.2016.08.003; Limmer Karen, 2014, J Adv Pract Oncol, V5, P31; Maj C, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-1004-x; Martin-Lopez R, 2012, EUR J CANCER PREV, V21, P82, DOI 10.1097/CEJ.0b013e32834a7e46; McGuire S, 2016, ADV NUTR, V7, P418, DOI 10.3945/an.116.012211; Menvielle G, 2014, CANCER CAUSE CONTROL, V25, P977, DOI 10.1007/s10552-014-0397-z; Moriceau G, 2016, ONCOTARGET, V7, P1055, DOI 10.18632/oncotarget.6274; Nelson W, 2009, J WOMENS HEALTH, V18, P1759, DOI 10.1089/jwh.2009.1430; Parikh S, 2003, INT J CANCER, V105, P687, DOI 10.1002/ijc.11141; Polman NJ, 2019, PREV MED, V125, P5, DOI 10.1016/j.ypmed.2019.04.025; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Prouvost H. I, 2007, B EPIDEMIOLOGIE HEBD, V2-3, P17; Rochoy Michael, 2017, BMC Res Notes, V10, P723, DOI 10.1186/s13104-017-2999-5; Rustagi AS, 2014, AM J EPIDEMIOL, V179, P1107, DOI 10.1093/aje/kwu035; Seidel D, 2009, J CANCER RES CLIN, V135, P533, DOI 10.1007/s00432-008-0485-0; Stafford M, 2014, J EPIDEMIOL COMMUN H, V68, P979, DOI 10.1136/jech-2014-203902; Wee LE, 2012, PREV MED, V55, P61, DOI 10.1016/j.ypmed.2012.04.011	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0232814	10.1371/journal.pone.0232814	http://dx.doi.org/10.1371/journal.pone.0232814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413044	Green Published, gold			2022-12-26	WOS:000537496000022
J	Settelmeier, S; Schreiber, T; Maki, J; Byts, N; Koivunen, P; Myllyharju, J; Fandrey, J; Winning, S				Settelmeier, Stephan; Schreiber, Timm; Maki, Joni; Byts, Nadiya; Koivunen, Peppi; Myllyharju, Johanna; Fandrey, Joachim; Winning, Sandra			Prolyl hydroxylase domain 2 reduction enhances skeletal muscle tissue regeneration after soft tissue trauma in mice	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SATELLITE CELLS; MYOGENIC DIFFERENTIATION; REGULATORY FACTORS; COX-2 PATHWAY; GROWTH-FACTOR; SELF-RENEWAL; EXPRESSION; INHIBITION; PROTECTS	The transcription factor Hypoxia-inducible factor 1 (HIF-1) plays a pivotal role in tissue regeneration. HIF-1 is negatively controlled by O-2-dependent prolyl hydroxylases with a predominant role of prolyl hydroxylase 2 isoform (Phd2). Transgenic mice, hypomorphic for this isoform, accumulate more HIF-1 under normoxic conditions. Using these mice, we investigated the influence of Phd2 and HIF-1 on the regenerative capability of skeletal muscle tissue after myotrauma. Phd2-hypomorphic and wild type mice (on C57Bl/6 background) were grouped with regeneration times from 6 to 168 hours after closed mechanic muscle trauma to the hind limb. Tissue samples were analysed by immuno-staining and real-time PCR. Bone marrow derived macrophages of wild type and Phd2-hypomorphic mice were isolated and analysed via flow cytometry and quantitative real-time PCR. Phd2 reduction led to a higher regenerative capability due to enhanced activation of myogenic factors accompanied by induction of genes responsible for glucose and lactate metabolism in Phd2-hypomorphic mice. Macrophage infiltration into the trauma areas in hypomorphic mice started earlier and was more pronounced compared to wild type mice. Phd2-hypomorphic mice also showed higher numbers of macrophages in areas with sustained trauma 72 hours after myotrauma application. In conclusion, we postulate that the HIF-1 pathway is activated secondary to a Phd2 reduction which may lead to i) higher activation of myogenic factors, ii) increased number of positive stem cell proliferation markers, and iii) accelerated macrophage recruitment to areas of trauma, resulting in faster muscle tissue regeneration after myotrauma. With the current development of prolyl hydroxylase domain inhibitors, our findings point towards a potential clinical benefit after myotrauma.	[Settelmeier, Stephan; Schreiber, Timm; Fandrey, Joachim; Winning, Sandra] Univ Duisburg Essen, Inst Physiol, Essen, Germany; [Maki, Joni; Byts, Nadiya; Koivunen, Peppi; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Maki, Joni; Byts, Nadiya; Koivunen, Peppi; Myllyharju, Johanna] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland	University of Duisburg Essen; University of Oulu; University of Oulu	Fandrey, J (corresponding author), Univ Duisburg Essen, Inst Physiol, Essen, Germany.	joachim.fandrey@uni-due.de	Fandrey, Joachim/AAA-3524-2021	Byts, Nadiya/0000-0003-4567-2604; Schreiber, Timm/0000-0001-6848-3158; Fandrey, Joachim/0000-0001-9585-0531	JMY group	JMY group	JMY owns equity in FibroGen Inc., which develops PHD inhibitors as potential therapeutics. This company supports research in the JMY group. The funder provided support in the form of salaries/research materials for one author [JMY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the `author contributions' section.	ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211; Backer V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190074; Billin AN, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0179-5; Bondesen BA, 2004, AM J PHYSIOL-CELL PH, V287, pC475, DOI 10.1152/ajpcell.00088.2004; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chu SH, 2009, MOL BIOL REP, V36, P1967, DOI 10.1007/s11033-008-9406-1; Cirillo F, 2017, FASEB J, V31, P2146, DOI 10.1096/fj.201600878R; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Crisco JJ, 1996, J BIOMECH, V29, P1291, DOI 10.1016/0021-9290(96)00047-4; Cummins EP, 2020, PHYSIOL REV, V100, P463, DOI 10.1152/physrev.00003.2019; Dehne N, 2011, SHOCK, V35, P632, DOI 10.1097/SHK.0b013e3182111f3d; Dhillon S, 2019, DRUGS, V79, P563, DOI 10.1007/s40265-019-01077-1; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Dumont NA, 2015, COMPR PHYSIOL, V5, P1027, DOI 10.1002/cphy.c140068; Duscher D, 2015, PLAST RECONSTR SURG, V136, P1004, DOI 10.1097/PRS.0000000000001699; Fandrey J, 2006, CARDIOVASC RES, V71, P642, DOI 10.1016/j.cardiores.2006.05.005; Fluck K, 2016, MUCOSAL IMMUNOL, V9, P379, DOI 10.1038/mi.2015.67; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karsikas S, 2016, J MOL MED, V94, P301, DOI 10.1007/s00109-015-1349-0; Kerkweg U, 2006, EUR SURG RES, V38, P83, DOI 10.1159/000092609; Kharraz Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/491497; Koning M, 2011, TISSUE ENG PT A, V17, P1747, DOI 10.1089/ten.tea.2010.0624; Kook SH, 2008, CELL BIOL INT, V32, P871, DOI 10.1016/j.cellbi.2008.03.017; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Liu XG, 2017, CELL BIOL INT, V41, P228, DOI 10.1002/cbin.10705; Martinez CO, 2010, AM J PHYSIOL-REG I, V299, pR832, DOI 10.1152/ajpregu.00797.2009; Merrick MA, 2002, J ATHL TRAINING, V37, P209; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Motohashi N, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00001; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Myllyharju J, 2013, BIOL CHEM, V394, P435, DOI 10.1515/hsz-2012-0328; Nagahisa H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207040; Nunomiya A, 2017, ACTA PHYSIOL, V220, P99, DOI 10.1111/apha.12751; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Ono Y, 2006, J CELL BIOCHEM, V98, P642, DOI 10.1002/jcb.20804; Pillon NJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE453, DOI 10.1152/ajpendo.00553.2012; Rahtu-Korpela L, 2016, ARTERIOSCL THROM VAS, V36, P608, DOI 10.1161/ATVBAHA.115.307136; Rahtu-Korpela L, 2014, DIABETES, V63, P3324, DOI 10.2337/db14-0472; Richard DE, 1999, BIOCHEM BIOPH RES CO, V266, P718, DOI 10.1006/bbrc.1999.1889; Scheerer N, 2013, J IMMUNOL, V191, P407, DOI 10.4049/jimmunol.1103779; Schreiber T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17324-y; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shen W, 2008, J CELL PHYSIOL, V214, P405, DOI 10.1002/jcp.21212; Sinha KM, 2019, FASEB J, V33, P8321, DOI 10.1096/fj.201801794R; Strowitzki MJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050384; Stuart CA, 2000, AM J PHYSIOL-ENDOC M, V279, pE855, DOI 10.1152/ajpendo.2000.279.4.E855; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tang D, 2018, CELL PHYSIOL BIOCHEM, V46, P2460, DOI 10.1159/000489652; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Urbani L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049860; Wagatsuma A, 2006, PHYSIOL RES, V55, P633, DOI 10.33549/physiolres.930811; Wagatsuma A, 2011, MOL CELL BIOCHEM, V347, P145, DOI 10.1007/s11010-010-0622-3; Warren GL, 2004, FASEB J, V18, P413, DOI 10.1096/fj.04-2421fje; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Winning S, 2010, J IMMUNOL, V185, P1786, DOI 10.4049/jimmunol.0903244; Xie LW, 2018, J CLIN INVEST, V128, P2339, DOI 10.1172/JCI96208	65	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233261	10.1371/journal.pone.0233261	http://dx.doi.org/10.1371/journal.pone.0233261			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413092	Green Published, gold			2022-12-26	WOS:000537496000060
J	Lim, W; Zhang, PF				Lim, Wooyoung; Zhang, Pengfei			Herd immunity and a vaccination game: An experimental study	PLOS ONE			English	Article							PUBLIC GOOD; PARTICIPATION; PROVISION	Would the affected communities voluntarily obtain herd immunity if a cure for COVID-19 was available? This paper experimentally investigates people's vaccination choices in the context of a nonlinear public good game. A "vaccination game" is defined in which costly commitments (vaccination) are required of a fraction of the population to reach the critical level needed for herd immunity, without which defectors are punished by the natural contagion of epidemics. Our experimental implementation of a vaccination game in a controlled laboratory setting reveals that endogenous epidemic punishment is a credible threat, resulting in voluntary vaccination to obtain herd immunity, for which the orthodox principle of positive externalities fails to account. The concave nature of the infection probability plays a key role in facilitating the elimination of an epidemic.	[Lim, Wooyoung] Hong Kong Univ Sci & Technol, Dept Econ, Hong Kong, Peoples R China; [Zhang, Pengfei] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA	Hong Kong University of Science & Technology; Cornell University	Lim, W (corresponding author), Hong Kong Univ Sci & Technol, Dept Econ, Hong Kong, Peoples R China.; Zhang, PF (corresponding author), Cornell Univ, Dept Econ, Ithaca, NY 14853 USA.	wooyoung@ust.hk; pz82@cornell.edu		Zhang, Pengfei/0000-0001-8237-5700	Research Grants Council of Hong Kong [GRF-16502015]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This study is supported by a grant from the Research Grants Council of Hong Kong (Grant No. GRF-16502015). NO.	ANDERSON R M, 1991; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Capraro V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131419; Casari M, 2003, J ECON BEHAV ORGAN, V51, P217, DOI 10.1016/S0167-2681(02)00098-7; Cason TN, 2015, EXP ECON, V18, P66, DOI 10.1007/s10683-014-9393-0; Chen F, 2014, J THEOR BIOL, V363, P105, DOI 10.1016/j.jtbi.2014.08.003; DIEKMANN A, 1985, J CONFLICT RESOLUT, V29, P605, DOI 10.1177/0022002785029004003; Dixit A, 2000, J PUBLIC ECON, V76, P309, DOI 10.1016/S0047-2727(99)00089-4; FARRELL J, 1985, RAND J ECON, V16, P70, DOI 10.2307/2555589; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Galeotti A, 2013, AM ECON J-MICROECON, V5, P1, DOI 10.1257/mic.5.2.1; Geoffard PY, 1997, AM ECON REV, V87, P222; Gersovitz M, 2004, ECON J, V114, P1, DOI 10.1046/j.0013-0133.2003.0174.x; Goeree JK, 2017, GAME ECON BEHAV, V102, P303, DOI 10.1016/j.geb.2017.01.002; Goeree JK, 2000, EXPLANATION AN UNPUB; Heal G, 2005, VACCINATION GAME RIS; Ibuka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087164; Isaac R. M., 1998, EXP ECON, V1, P191, DOI [DOI 10.1023/, 10.1023/A:1009996324622, DOI 10.1023/A:1009996324622]; KATZ ML, 1985, AM ECON REV, V75, P424; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Keser C, 1996, ECON LETT, V50, P359, DOI 10.1016/0165-1765(95)00769-5; Laury SK, 1999, PUBLIC CHOICE, V99, P139, DOI 10.1023/A:1018302432659; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Ostrom E., 1994, RULES GAMES COMMON P; PALFREY TR, 1984, J PUBLIC ECON, V24, P171, DOI 10.1016/0047-2727(84)90023-9; Sefton M, 1996, J PUBLIC ECON, V61, P263, DOI 10.1016/0047-2727(95)01534-5; WHO Ebola Response Team, 2015, NEW ENGL J MED, V372, P584, DOI 10.1056/NEJMc1414992	27	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232652	10.1371/journal.pone.0232652	http://dx.doi.org/10.1371/journal.pone.0232652			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0YZ	32407329	Green Published, gold			2022-12-26	WOS:000537490700029
J	Parisa, A; Roya, G; Mahdi, R; Shabnam, R; Maryam, E; Malihe, T				Parisa, Asadollahi; Roya, Ghanavati; Mahdi, Rohani; Shabnam, Razavi; Maryam, Esghaei; Malihe, Talebi			Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; COLORECTAL-CANCER; RESISTANT STARCH; EGFR; EXPRESSION; INHIBITOR; LAPATINIB; COX-2; CHEMOPREVENTION; PROLIFERATION	Introduction Probiotics are suggested to prevent colorectal cancer (CRC). This study aimed to investigate the anticancer properties of some potential probiotics in vitro and in vivo. Materials and methods Anticancer effects of potential probiotic groups were investigated following of in LS174T cancer cells compared to IEC-18 normal cells. 1. a single strain of Bifidobacterium. breve, 2. a single strain of Lactobacillus. reuteri, 3. a cocktail of 5 strains of Lactobacilli (LC), 4. a cocktail of 5 strains of Bifidobacteria (BC), 5. a cocktail of 10 strains from Lactobacillus and Bifidobacterium (L+B). Apoptosis rate, EGFR, HER-2 and PTGS-2 (COX-2 protein) expression levels were assessed as metrics of evaluating anticancer properties. Effect of BC, as the most effective group in vitro, was further assessed in mice models. Results BC induced similar to 21% and only similar to 3% apoptosis among LS174T and IEC-18 cells respectively. BC decreased the expression of EGFR by 4.4 folds, HER-2 by 6.7 folds, and PTGS-2 by 20 folds among the LS174T cells. In all these cases, BC did not interfere significantly with the expression of the genes in IEC-18 cells. This cocktail has caused only 1.1 folds decrease, 1.8 folds increase and 1.7 folds decrease in EGFR, HER-2 and PTGS-2 expression, respectively. Western blot analysis confirmed these results in the protein level. BC significantly ameliorated the disease activity index, restored colon length, inhibited the increase in incidence and progress of tumors to higher stages and grades. Conclusions BC was the most efficient treatment in this study. It had considerable "protective" anti-cancer properties and concomitantly down regulated EGFR, HER-2 and PTGS-2 (COX-2), while having significant anti-CRC effects on CRC mice models. In general, this potential probiotic could be considered as a suitable nutritional supplement to treat and prevent CRC.	[Parisa, Asadollahi; Roya, Ghanavati; Shabnam, Razavi; Malihe, Talebi] Iran Univ Med Sci, Microbial Biotechnol Res Ctr, Tehran, Iran; [Parisa, Asadollahi; Shabnam, Razavi; Malihe, Talebi] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran; [Roya, Ghanavati] Behbahan Fac Med Sci, Behbahan, Iran; [Mahdi, Rohani] Pasteur Inst Iran, Dept Microbiol, Tehran, Iran; [Maryam, Esghaei] Iran Univ Med Sci, Sch Med, Dept Virol, Tehran, Iran	Iran University of Medical Sciences; Iran University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Iran University of Medical Sciences	Malihe, T (corresponding author), Iran Univ Med Sci, Microbial Biotechnol Res Ctr, Tehran, Iran.; Malihe, T (corresponding author), Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran.	talebi.m@iums.ac.ir	Rohani, Mahdi/ABG-3890-2021; Ghanavati, Roya/AAQ-2269-2020; Asadollahi, Parisa/AAX-9372-2020; Ghanavati, Roya/AAX-3223-2020; esghaei, maryam/M-8177-2018	Rohani, Mahdi/0000-0001-8956-5072; Ghanavati, Roya/0000-0002-3851-0001; Asadollahi, Parisa/0000-0001-8889-6988; esghaei, maryam/0000-0003-2944-2147; razavi, shabnam/0000-0001-8210-9031	Iran University Medical Science, Tehran, Iran [33109]	Iran University Medical Science, Tehran, Iran	This work was supported by Iran University Medical Science, Tehran, Iran (grant number 33109: https://iums.ac.ir/) given to TM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARICAULT L, 1995, CARCINOGENESIS, V16, P245, DOI 10.1093/carcin/16.2.245; Bibalan MH, 2017, J MED MICROBIOL, V66, P1416, DOI 10.1099/jmm.0.000591; Ceccarelli C, 2005, ANN ONCOL, V16, P74, DOI 10.1093/annonc/mdi912; Challa A, 1997, CARCINOGENESIS, V18, P517, DOI 10.1093/carcin/18.3.517; Eshaghi M, 2017, MICROB PATHOGENESIS, V111, P94, DOI 10.1016/j.micpath.2017.08.014; Fogh J, 2013, HUMAN TUMOR CELLS IN; Fotiadis CI, 2008, WORLD J GASTROENTERO, V14, P6453, DOI 10.3748/wjg.14.6453; Gemmete JJ, 2011, AM J NEURORADIOL, V32, P1373, DOI 10.3174/ajnr.A2619; Guo WM, 2010, NUTR CANCER, V62, P1007, DOI 10.1080/01635581.2010.492090; Hervent AS, 2012, INT J MOL SCI, V13, P12268, DOI 10.3390/ijms131012268; Hu Xu YY, 2005, MOL CANC THER, V4; Iyer C, 2008, CELL MICROBIOL, V10, P1442, DOI 10.1111/j.1462-5822.2008.01137.x; Kawaguchi Y, 2007, BRIT J CANCER, V97, P494, DOI 10.1038/sj.bjc.6603885; Koval M, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0125717, DOI 10.1371/JOURNAL.PONE.0125717]; Krasinskas AM, 2011, EGFR SIGNALING COLOR, P1; LaBonte MJ, 2011, CANCER RES, V71, P3635, DOI 10.1158/0008-5472.CAN-10-2430; Le Leu RK, 2010, CARCINOGENESIS, V31, P246, DOI 10.1093/carcin/bgp197; Le Leu RK, 2005, J NUTR, V135, P996, DOI 10.1093/jn/135.5.996; Li SS., 2014, DISCOVERIES REPORTS, V1, pE1, DOI [DOI 10.15190/drep.2014.1, 10.15190/drep.2014.1]; Lin PW, 2008, PEDIATR RES, V64, P511, DOI 10.1203/PDR.0b013e3181827c0f; Ma EL, 2010, INT J CANC; Marmol I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010197; Montemurro F, 2007, EXPERT OPIN BIOL TH, V7, P257, DOI 10.1517/14712598.7.2.257; Nowak A, 2019, CRIT REV FOOD SCI, V59, P3456, DOI 10.1080/10408398.2018.1494539; Otte JM, 2009, NUTR CANCER, V61, P103, DOI 10.1080/01635580802372625; Pied S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Putaala H, 2008, RES MICROBIOL, V159, P692, DOI 10.1016/j.resmic.2008.08.002; Rohani M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144467; Rusnak DW, 2007, CELL PROLIFERAT, V40, P580, DOI 10.1111/j.1365-2184.2007.00455.x; Shin DM, 2013, CLIN CANCER RES, V19, P1244, DOI 10.1158/1078-0432.CCR-12-3149; Tiptiri-Kourpeti A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147960; Uccello M, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-S1-S35; Vadlamudi R, 1999, ONCOGENE, V18, P305, DOI 10.1038/sj.onc.1202307; Wang LH, 2014, J BIOL CHEM, V289, P20234, DOI 10.1074/jbc.M114.553800; Wu QB, 2015, WORLD J GASTROENTERO, V21, P6206, DOI 10.3748/wjg.v21.i20.6206; Xu H, 2005, MOL CANCER THER, V4, P435; Yang Lu CS, 2016, ONCOTARGET, V7; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13	38	32	33	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232930	10.1371/journal.pone.0232930	http://dx.doi.org/10.1371/journal.pone.0232930			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401801	Green Published, gold			2022-12-26	WOS:000537481000041
J	Abadiga, M; Hasen, T; Mosisa, G; Abdisa, E				Abadiga, Muktar; Hasen, Tahir; Mosisa, Getu; Abdisa, Eba			Adherence to antiretroviral therapy and associated factors among Human immunodeficiency virus positive patients accessing treatment at Nekemte referral hospital, west Ethiopia, 2019	PLOS ONE			English	Article							OUTCOMES; ADOLESCENTS	Background Antiretroviral therapy has a remarkable clinical effect in reducing the progress of Acquired Immune Deficiency Syndrome. The clinical outcome of Anti-Retroviral therapy depends on strict adherence. Poor adherence reduces the effectiveness of antiretroviral therapy and increases viral replication. With changes in service delivery over time and differences in socio-demographic status from region to region, it is essential to measure adherence. Therefore, this study aimed to assess adherence to antiretroviral therapy and its associated factors among HIV/AIDS patients accessing treatment at Nekemte referral hospital, West Ethiopia. Methods Institutional based cross-sectional study was conducted on 311 HIV/AIDS patients from March 01 to March 30, 2019. The study participants were selected by a simple random sampling method and interviewed using structured questionnaires. Bivariable logistic regression was conducted to find an association between each independent variable and adherence to antiretroviral medication. Multivariable logistic regression was used to find the independent variables which best predict adherence. The statistical significance was measured using odds ratio at a 95% confidence interval with a p-value of less than 0.05. Results Out of a total of 311 patients sampled, 305 were participated in the study, making a response rate of 98.07%. From these 305 study participants,73.1% (95% CI = 68.2, 78.0) were adherent to their medication. Having knowledge about HIV and its treatment (AOR = 8.24, 95% CI: 3.10, 21.92), having strong family/social support (AOR = 6.21, 95% CI: 1.39, 27.62), absence of adverse drug reaction (AOR = 5.33, 95% CI: 1.95, 14.57), absence of comorbidity of other chronic diseases (AOR = 5.72, 95% CI: 1.91, 17.16) and disclosing HIV status to the family (AOR = 5.08, 95% CI: 2.09, 12.34) were significantly associated with an increased likelihood of adherence to antiretroviral medication. Conclusion The level of adherence to antiretroviral therapy was found low compared to WHO recommendation. The clinician should emphasize reducing adverse drug reaction, detecting and treating co-morbidities early, improving knowledge through health education, and encouraging the patients to disclose their HIV status to their families.	[Abadiga, Muktar; Hasen, Tahir; Mosisa, Getu; Abdisa, Eba] Wollega Univ, Inst Hlth Sci, Sch Nursing & Midwifery, Nekemte, Ethiopia		Abadiga, M (corresponding author), Wollega Univ, Inst Hlth Sci, Sch Nursing & Midwifery, Nekemte, Ethiopia.	muktarabadiga@gmail.com	Kebebew, Getu Mosisa/ABI-5268-2020	Abadiga, Muktar/0000-0002-3006-3155				Adeniyi OV, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3087-8; Ammon N, 2018, PUBLIC HEALTH, V157, P20, DOI 10.1016/j.puhe.2017.12.010; [Anonymous], 2007, ART FAILURE STRATEGI; Aye WL, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4309-5; De Geest S, 2003, EUR J CARDIOVASC NUR, V2, P323, DOI [DOI 10.1016/S1474-5151(03)00091-4, 10.1016/S1474-5151(03)00091-4]; Edward L, 2006, ADHERENCE HIV ANTIRE; Fonsah JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170893; Silva JAG, 2015, CAD SAUDE PUBLICA, V31, P1188, DOI 10.1590/0102-311X00106914; Granich R., 2018, INT J VIROL AIDS, V5, DOI [10.23937/2469-567X/1510043, DOI 10.23937/2469-567X/1510043]; Hill A, 2015, AIDS, V29, P2523, DOI 10.1097/QAD.0000000000000864; Hogan D, 2005, B WHOM, V83, P2; Howard AA, 2002, AIDS, V16, P2175, DOI 10.1097/00002030-200211080-00010; Kahema SE, 2018, INT ARCH MED MICROBI, V1, P002, DOI [10.23937/iamm-2017/1710002, DOI 10.23937/IAMM-2017/1710002]; Kocalevent Ruya-Daniela, 2018, BMC Psychol, V6, P31, DOI 10.1186/s40359-018-0249-9; Koyra H., 2018, INT J VIROL AIDS, V5, P10, DOI [10.23937/2469-567X/1510038, DOI 10.23937/2469-567X/1510038]; Letta S, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0071-x; Li JZ, 2014, AIDS, V28, P181, DOI 10.1097/QAD.0000000000000123; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Molla AA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3176-8; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Neupane S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7051-3; Obirikorang Christian, 2013, ISRN AIDS, V2013, P873939, DOI 10.1155/2013/873939; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Reinius M, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0691-z; Sahay S, 2011, INDIAN J MED RES, V134, P835, DOI 10.4103/0971-5916.92629; Semvua SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189460; Suryana K., 2019, HIV AIDS RES PALLIAT, P11; Tefera G, 2011, J ASSOC NURSE AIDS C, V24, P530; U. Nation, 2016, UN POL DECL END AIDS; UNAIDS, 90 90 90 AMB TREATM; UNAIDS, 2016, GLOB AIDS UPD; World Health Organization, 2008, HIV AIDS MENT HLTH; World Health Organization, 2013, ADH LONG TERM THER E, VXII, P92; World Health Organization, HIV AIDS; Yaya I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1308; Yu Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5731-z	37	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232703	10.1371/journal.pone.0232703	http://dx.doi.org/10.1371/journal.pone.0232703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392244	Green Published, gold			2022-12-26	WOS:000537470300019
J	Kim, AY; Lee, JK; Kim, SH; Choi, J; Song, JJ; Chae, SW				Kim, Angela Yun; Lee, Jung Kyu; Kim, Shin Hye; Choi, June; Song, Jae Jun; Chae, Sung Won			Is postural dysfunction related to sarcopenia? A population-based study	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; ASIAN WORKING GROUP; BALANCE PROBLEMS; PRIMARY-CARE; DIZZINESS; STRENGTH; AGE; FALLS; PREVALENCE; STABILITY	Postural dysfunction is one of the most common community health symptoms and frequent chief complaints in hospitals. Sarcopenia is a syndrome characterized by degenerative loss of skeletal muscle mass, muscle quality, and muscle strength, and is the main contributor to musculoskeletal impairment in the elderly. Previous studies reported that loss of muscle mass is associated with a loss of diverse functional abilities. Meanwhile, there have been limited studies concerning postural dysfunction among older adults with sarcopenia. Although sarcopenia is primarily a disease of the elderly, its development may be associated with conditions that are not exclusively seen in older persons. Also, recent studies recognize that sarcopenia may begin to develop earlier in life. The objective of this paper was to investigate the association between the prevalence of sarcopenia and postural dysfunction in a wide age range of adults using data from a nationally representative cohort study in Korea. Korean National Health & Nutrition Exhibition Survey V (KNHANES V, 2010-2012) data from the fifth cross-sectional survey of the South Korean population performed by the Korean Ministry of Health and Welfare were used. Appendicular skeletal muscle mass (ASM)/height (ht)(2) was used to define sarcopenia, and the Modified Romberg test using a foam pad ("foam balance test") was performed to evaluate postural dysfunction. ASM/ht(2) was lower in women and significantly decreased with age in men. Subjects with sarcopenia were significantly more likely to fail the foam balance test, regardless of sex and age. Regression analysis showed a significant relationship between sarcopenia and postural dysfunction (OR: 2.544, 95% CI: 1.683-3.846, p< 0.001). Multivariate regression analysis revealed that sarcopenia (OR: 1.747, 95% CI: 1.120-2.720, p = 0.014) and age (OR: 1.131, 95% CI: 1.105-1.158, p< 0.001) are independent risk factors for postural instability. In middle age subjects, the adjusted OR for sarcopenia was 3.344 (95% CI: 1.350-8.285) (p = 0.009). The prevalence of postural dysfunction is higher in sarcopenia patients, independent of sex and age.	[Kim, Angela Yun; Lee, Jung Kyu; Choi, June; Song, Jae Jun; Chae, Sung Won] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Shin Hye] Inje Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Busan, South Korea	Korea University; Korea University Medicine (KU Medicine); Inje University	Chae, SW (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	koreachae@gmail.com		Kim, Angela/0000-0001-7200-6151; CHOI, JUNE/0000-0002-6330-279X; CHAE, Sung Won/0000-0001-6401-352X	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2017M3A9G1027929]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant (https://ernd.nrf.re.kr/index.do) funded by the Korea government (MSIT) (No. 2017M3A9G1027929) awarded to Sung Won Chae(SWC) and Jae Jung Song(JJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bird JC, 1998, BRIT J GEN PRACT, V48, P1828; Chen LK, 2020, J AM MED DIR ASSOC, V21, P300, DOI 10.1016/j.jamda.2019.12.012; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cho KH, 2012, ANN REHABIL MED-ARM, V36, P386, DOI 10.5535/arm.2012.36.3.386; Cohen HS, 2019, J NEUROPHYSIOL, V122, P81, DOI 10.1152/jn.00819.2018; Cohen HS, 2019, OTOL NEUROTOL, V40, P658, DOI 10.1097/MAO.0000000000002173; Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Cuevas-Trisan R, 2019, CLIN GERIATR MED, V35, P173, DOI 10.1016/j.cger.2019.01.008; Deutz NEP, 2014, CLIN NUTR, V33, P929, DOI 10.1016/j.clnu.2014.04.007; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Fonteyn EMR, 2013, EUR NEUROL, V69, P53, DOI 10.1159/000342907; Forbes GB, 1999, AM J CLIN NUTR, V70, P1025; Frisoli A, 2011, BONE, V48, P952, DOI 10.1016/j.bone.2010.12.025; Frontera WR, 2000, J APPL PHYSIOL, V88, P1321; Fujimoto C, 2012, OTOL NEUROTOL, V33, P432, DOI 10.1097/MAO.0b013e3182487f48; Gadelha AB, 2018, EXP AGING RES, V44, P258, DOI 10.1080/0361073X.2018.1449591; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Gucluturk MT, 2016, J INT ADV OTOLOGY, V12; Hong SK, 2015, EUR ARCH OTO-RHINO-L, V272, P2741, DOI 10.1007/s00405-014-3273-2; Hunter SK, 1999, J APPL PHYSIOL, V86, P1858, DOI 10.1152/jappl.1999.86.6.1858; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Jahn K, 2015, DTSCH ARZTEBL INT, V112, P387, DOI 10.3238/arztebl.2015.0387; Jahn K, 2010, DTSCH ARZTEBL INT, V107, P306, DOI 10.3238/arztebl.2010.0306; Jonsson R, 2004, J VESTIBUL RES-EQUIL, V14, P47; Jorstad EC, 2005, J AM GERIATR SOC, V53, P501; Kim KM, 2016, KOREAN J INTERN MED, V31, P643, DOI 10.3904/kjim.2016.015; Kirchengast S, 2009, ANTHROPOL ANZ, V67, P139, DOI 10.1127/0003-5548/2009/0018; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Lee J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150281; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Looker AC, 2015, OSTEOPOROSIS INT, V26, P93, DOI 10.1007/s00198-014-2904-1; Ministry of Health and Welfare, 2012, KOR HLTH STAT 2011 K; da Silva VCP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103480, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0095536, 10.1371/journal.pone.0099366, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0095422]; Patel M, 2008, GAIT POSTURE, V28, P649, DOI 10.1016/j.gaitpost.2008.04.018; Phillips SM, 2015, ADV NUTR, V6, P452, DOI 10.3945/an.115.008367; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Post RE, 2010, AM FAM PHYSICIAN, V82, P361; PYYKKO I, 1990, AGE AGEING, V19, P215, DOI 10.1093/ageing/19.3.215; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177; Sayer AA, 2008, J NUTR HEALTH AGING, V12, P427, DOI 10.1007/BF02982703; Sayer AA, 2004, J GERONTOL A-BIOL, V59, P930, DOI 10.1093/gerona/59.9.M930; Shafiee G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0302-x; SLOANE PD, 1989, J FAM PRACTICE, V29, P33; Song QH, 2014, INT J CLIN EXP MED, V7, P1569; Tanimoto Y, 2014, ARCH GERONTOL GERIAT, V59, P295, DOI 10.1016/j.archger.2014.04.016; Venturelli M, 2015, ACTA PHYSIOL, V215, P58, DOI 10.1111/apha.12524; Whitney SL, 1998, AM J OCCUP THER, V52, P666, DOI 10.5014/ajot.52.8.666	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232135	10.1371/journal.pone.0232135	http://dx.doi.org/10.1371/journal.pone.0232135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU0RD	32392270	gold, Green Published			2022-12-26	WOS:000537470300004
J	Kriem, LS; Wright, K; Ccahuana-Vasquez, RA; Rupp, S				Kriem, Lukas Simon; Wright, Kevin; Ccahuana-Vasquez, Renzo Alberto; Rupp, Steffen			Confocal Raman microscopy to identify bacteria in oral subgingival biofilm models	PLOS ONE			English	Article							SPECTROSCOPY; IDENTIFICATION; HEALTH	The study of oral disease progression, in relation to the accumulation of subgingival biofilm in gingivitis and periodontitis is limited, due to either the ability to monitor plaque in vitro. When compared, optical spectroscopic techniques offer advantages over traditional destructive or biofilm staining approaches, making it a suitable alternative for the analysis and continued development of three-dimensional structures. In this work, we have developed a confocal Raman spectroscopy analysis approach towards in vitro subgingival plaque models. The main objective of this study was to develop a method for differentiating multiple oral subgingival bacterial species in planktonic and biofilm conditions, using confocal Raman microscopy. Five common subgingival bacteria (Fusobacterium nucleatum, Streptococcus mutans, Veillonella dispar, Actinomyces naeslundii and Prevotella nigrescens) were used and differentiated using a 2-way orthogonal Partial Least Square with Discriminant Analysis (O2PLS-DA) for the collected spectral data. In addition to planktonic growth, mono-species biofilms cultured using the 'Zurich Model' were also analyzed. The developed method was successfully used to predict planktonic and mono-species biofilm species in a cross validation setup. The results show differences in the presence and absence of chemical bands within the Raman spectra. The O2PLS-DA model was able to successfully predict 100% of all tested planktonic samples and 90% of all mono-species biofilm samples. Using this approach we have shown that Confocal Raman microscopy can analyse and predict the identity of planktonic and mono-species biofilm species, thus enabling its potential as a technique to map oral multi-species biofilm models.	[Kriem, Lukas Simon; Rupp, Steffen] Fraunhofer Inst Interfacial Engn & Biotechnol, Stuttgart, Germany; [Wright, Kevin] Procter & Gamble, Egham, Surrey, England; [Ccahuana-Vasquez, Renzo Alberto] Procter & Gamble, Kronberg, Germany	Fraunhofer Gesellschaft; Procter & Gamble; Procter & Gamble	Rupp, S (corresponding author), Fraunhofer Inst Interfacial Engn & Biotechnol, Stuttgart, Germany.	steffen.rupp@igb.fraunhofer.de		Kriem, Lukas/0000-0001-6077-8314	European Union's Horizon 2020 research innovation programme [722871]; EU	European Union's Horizon 2020 research innovation programme; EU(European Commission)	This work is funded by the European Union's Horizon 2020 research innovation programme under grant agreement No. 722871 in the scope of the Marie Sklodowska-Curie Action ITN BioClean to LSK. P&G and other partners contributed time, industrial supervision, training and technical guidance/expertise, access to equipment, placements in industry and coauthored and reviewed associated papers, including this submission all in line with EU Horizon 2020 funding rules. More details can be found on the Horizon 2020 website (http://www.biocleanh2020.eu/index.php). The funders had no role in study design, data collection and analysis, or decision to publish the manuscript.	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Almarashi JFM, 2012, SPECTROSC-INT J, V27, P361, DOI 10.1155/2012/540490; [Anonymous], 2017, DEFEN LIF SCIEN J, DOI DOI 10.14429/DLSJ.2.12275; Beier BD, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-35; Beier BD, 2011, PROC SPIE, V7888, DOI 10.1117/12.871819; Beier BD, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505010; Berger AJ, 2003, J MOD OPTIC, V50, P2375, DOI 10.1080/0950034032000121055; Cals FLJ, 2018, ANALYST, V143, P4090, DOI 10.1039/c7an02106b; Carey PR, 2017, BIOCHEMISTRY-US, V56, P2247, DOI 10.1021/acs.biochem.7b00116; Cepeda-Perez E, 2016, BIOMED PHYS ENG EXPR, V2, DOI 10.1088/2057-1976/2/6/065006; Chao YQ, 2012, ANAL BIOANAL CHEM, V404, P1465, DOI 10.1007/s00216-012-6225-y; Colnita A, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7090248; De Gelder J, 2007, J RAMAN SPECTROSC, V38, P1133, DOI 10.1002/jrs.1734; El Senousy AS, 2014, PHYTOCHEMISTRY, V108, P67, DOI 10.1016/j.phytochem.2014.09.004; Fanesi A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02999; Feng ZJ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00845; GMUR R, 1983, INFECT IMMUN, V42, P459; Gualerzi A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10448-1; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Guggenheim B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-280; Huang RJ, 2011, VIRULENCE, V2, P435, DOI 10.4161/viru.2.5.16140; Jung GB, 2014, BIOMED OPT EXPRESS, V5, P3238, DOI 10.1364/BOE.5.003238; Kelestemur S, 2020, COLLOID SURFACE B, V188, DOI 10.1016/j.colsurfb.2019.110765; Kelestemur S, 2018, CHEMOSENSORS, V6, DOI 10.3390/chemosensors6010005; Kommerein N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173973; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kumar S, 2016, CHEM SOC REV, V45, P1879, DOI 10.1039/c5cs00540j; Lu XN, 2011, FOOD BIOPROCESS TECH, V4, P919, DOI 10.1007/s11947-011-0516-8; MCCABE RM, 1977, INFECT IMMUN, V18, P726, DOI 10.1128/IAI.18.3.726-734.1977; Pantanella F, ANAL TECHNIQUES STUD; Patzold R, 2006, ANAL BIOANAL CHEM, V386, P286, DOI 10.1007/s00216-006-0663-3; Rebrosova K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13940-w; Rzhevskii A, 2019, BIOSENSORS-BASEL, V9, DOI 10.3390/bios9010025; Shi BC, 2015, MBIO, V6, DOI 10.1128/mBio.01926-14; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stockel S, 2016, J RAMAN SPECTROSC, V47, P89, DOI 10.1002/jrs.4844; Strola SA, 2013, PROC SPIE, V8572, DOI 10.1117/12.2002301; Tanner A, 1996, J PERIODONTAL RES, V31, P195, DOI 10.1111/j.1600-0765.1996.tb00484.x; Tewes T, 2019, ENTWICKLUNG METHODE; Thurnheer T, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01716; Vacca-Smith AM, 1998, ARCH ORAL BIOL, V43, P103, DOI 10.1016/S0003-9969(97)00111-8; Villa JEL, 2019, ANAL BIOANAL CHEM, V411, P705, DOI 10.1007/s00216-018-1485-9; Xiao J, 2017, INT J ORAL SCI, V9, P74, DOI 10.1038/ijos.2017.8; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Zhu QY, 2004, J BIOMED OPT, V9, P1182, DOI 10.1117/1.1803844; Zijnge V, 2012, FRONT ORAL BIOL, V15, P1, DOI 10.1159/000329667	46	11	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232912	10.1371/journal.pone.0232912	http://dx.doi.org/10.1371/journal.pone.0232912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392236	Green Published, gold			2022-12-26	WOS:000537470300031
J	Nous, A; Peeters, I; Nieboer, K; Vanbinst, AM; De Keyser, J; De Raedt, S				Nous, Amber; Peeters, Ilse; Nieboer, Koenraad; Vanbinst, Anne-Marie; De Keyser, Jacques; De Raedt, Sylvie			Post-stroke infections associated with spleen volume reduction: A pilot study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; HEART-RATE-VARIABILITY; SPLENIC RESPONSES; B-CELLS; SIZE	Background Spleen volume reduction followed by re-expansion has been described in acute ischemic stroke in both animal and human studies. Splenic contraction might be partially due to sympathetic hyperactivity and might be accompanied by release of splenocytes in the peripheral circulation, leading to immunodepression. Aims To investigate whether spleen volume changes in the first week after stroke are associated with post-stroke infections, changes in lymphocytes count and autonomic dysfunction. Methods In patients with acute ischemic stroke, spleen sizes were calculated from abdominal CT images on day one and day seven. Spleen size reduction was defined as > 10% spleen size reduction between day one and day seven. Post stroke infections were diagnosed during the first seven days after stroke onset using the modified criteria of the US Center of Disease Control and Prevention. We assessed the time course of leukocyte subsets and analysed pulse rate variability (PRV) indices. Results Post-stroke infections occurred in six out of 11 patients (55%) with spleen size reduction versus in five out of 27 patients (19%) without spleen size reduction (p = 0,047). Spleen size reduction was associated with a drop in lymphocytes and several lymphocyte subsets from admission to day one, and a higher NIHSS at admission and at day three (p = 0,028 and p = 0,006 respectively). No correlations could be found between spleen volume change and PRV parameters. Conclusion Post-stroke infections and a drop in lymphocytes and several lymphocyte subsets are associated with spleen volume reduction in acute ischemic stroke.	[Nous, Amber; Peeters, Ilse; De Keyser, Jacques; De Raedt, Sylvie] Vrije Univ Brussel, Ctr Neurosci, Univ Ziekenhuis Brussel, Dept Neurol, Brussels, Belgium; [Nieboer, Koenraad; Vanbinst, Anne-Marie] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Radiol, Brussels, Belgium	University Hospital Brussels; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University Hospital Brussels	Nous, A (corresponding author), Vrije Univ Brussel, Ctr Neurosci, Univ Ziekenhuis Brussel, Dept Neurol, Brussels, Belgium.	amber.nous@uzbrussel.be	De Keyser, Jacques/D-3725-2013; Nieboer, Koenraad/AAD-1653-2021; De Raedt, Sylvie/AAX-4965-2020; Nieboer, Koenraad/GWQ-9231-2022	De Keyser, Jacques/0000-0002-3394-7757; Nieboer, Koenraad/0000-0001-6530-5014; De Raedt, Sylvie/0000-0001-8042-2024; Nieboer, Koenraad/0000-0001-6530-5014; Vanbinst, Anne-Marie/0000-0003-4867-6133				Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Ajmo CT, 2009, EXP NEUROL, V218, P47, DOI 10.1016/j.expneurol.2009.03.044; Berchtold D, 2019, FRIEND FOE B CELL ST, V25, P173; Bulte CSE, 2011, EUR J ANAESTH, V28, P34, DOI 10.1097/EJA.0b013e32834088c4; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Chiu NL, 2016, J STROKE CEREBROVASC, V25, P2958, DOI 10.1016/j.jstrokecerebrovasdis.2016.08.012; De Raedt S, 2015, J NEUROL SCI, V348, P24, DOI 10.1016/j.jns.2014.12.007; Harms H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002158; Kim HG, 2018, PSYCHIAT INVEST, V15, P235, DOI 10.30773/pi.2017.08.17; Liu ZJ, 2015, CNS NEUROSCI THER, V21, P320, DOI 10.1111/cns.12361; Mcculloch L, 2017, NAT COMMUN, V8, P1; Nakamura K, 2019, J BIOCH; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Ren XF, 2011, J NEUROSCI, V31, P8556, DOI 10.1523/JNEUROSCI.1623-11.2011; Sahota P, 2013, INT J STROKE, V8, P60, DOI 10.1111/ijs.12022; Schlesinger L, 1995, IMMUNE DEPRESSION IN, V57; Seifert HA, 2012, J NEUROIMMUNE PHARM, V7, P1017, DOI 10.1007/s11481-012-9406-8; Shen P, 2015, INT IMMUNOL, V27, P513, DOI 10.1093/intimm/dxv037; Vahidy FS, 2016, J CEREBR BLOOD F MET, V36, P1012, DOI 10.1177/0271678X15607880; Zha A, 2018, TRANSL STROKE RES, V9, P484, DOI 10.1007/s12975-017-0596-5	22	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232497	10.1371/journal.pone.0232497	http://dx.doi.org/10.1371/journal.pone.0232497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392257	Green Published, gold			2022-12-26	WOS:000537470300009
J	Rana, MM; Islam, MR; Karim, MR; Islam, AZ; Haque, MA; Shahiduzzaman, M; Hossain, MG				Rana, Md. Masud; Islam, Md. Rafiqul; Karim, Md. Reazul; Islam, Ahmed Zohirul; Haque, Md. Akramul; Shahiduzzaman, Md.; Hossain, Md. Golam			Knowledge and practices of exclusive breastfeeding among mothers in rural areas of Rajshahi district in Bangladesh: A community clinic based study	PLOS ONE			English	Article							YOUNG MOTHERS; ATTITUDES; DURATION; INFANT	Background World Health Organization (WHO) suggests that exclusive breastfeeding (EBF) is the best nutrition for the neonate. Still, it remains a big challenge to establish EBF not only in Bangladesh but also in any developing countries. Objective The aim of this study was to determine the level of knowledge and practices on EBF and its relationship between different socioeconomic and demographic factors among mothers having at least one child of aged 6-12 months in the rural area of Rajshahi District, Bangladesh. Methodology A community clinic (CC) based study has been conducted by using semi-structured questionnaire. A total of 513 mothers having at least one child aged 6-12 months from 32 different CC in the rural area of Rajshahi District, Bangladesh during September to December 2015. A composite index, chi-square test, and logistic regression model were utilized in this study. Results The prevalence of knowledge and practices on EBF were 34.5% and 27.9% among mothers having at least one child aged 6-12 months. From the analyses, mothers age of >= 21 years were (adjusted odds ratio (AOR) = 13.840, 95% CI: 7.394-25.904; p<0.001) times more likely to have knowledge on EBF and (AOR = 0.084, 95% CI: 0.050-0.143; p<0.05) times less likely to have practices of EBF compared to mother's age <= 20 years. Service holders mothers were (AOR = 9.992, 95% CI: 4.485-22.260, p<0.05) times more likely to have practices than that of house wife. Home delivery mothers was (AOR = 0.208, 95% CI: 0.111-0.389; p<0.05) times less likely to have practices of EBF than that of the hospital delivery mothers. Those mothers monthly family income >= 10,000 Bangladeshi taka (BDT) currency was (AOR = 0.092, 95% CI: 0.050-0.168, p<0.05) times less likely to have practices of EBF compared to their counterparts. Conclusions This study was found poor knowledge and practices on EBF. This study suggested that education and EBF related intervention could play an important role to increase good knowledge and practices on EBF among mothers. Malnutrition will be decreased if EBF was widely established in Bangladesh.	[Rana, Md. Masud; Islam, Md. Rafiqul; Karim, Md. Reazul; Islam, Ahmed Zohirul] Univ Rajshahi, Dept Populat Sci & Human Resource Dev, Rajshahi, Bangladesh; [Haque, Md. Akramul] DASCOH Fdn, Rajshahi, Bangladesh; [Shahiduzzaman, Md.] Northern Univ, Dept Elect & Elect Engn, Dhaka, Bangladesh; [Hossain, Md. Golam] Univ Rajshahi, Dept Stat, Rajshahi, Bangladesh	University of Rajshahi; University of Rajshahi	Islam, MR (corresponding author), Univ Rajshahi, Dept Populat Sci & Human Resource Dev, Rajshahi, Bangladesh.	rafique_pops@yahoo.com	Rana, Masud/AAT-8858-2021; ISLAM, Ahmed Zohirul/AAJ-5095-2021	ISLAM, Ahmed Zohirul/0000-0002-7057-016X; Islam, Md. Rafiqul/0000-0001-6959-4554				AlFaleh KM, 2014, J TAIBAH UNIV MED SC, V9, P139, DOI 10.1016/j.jtumed.2013.11.003; Asfaw MM, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0049-2; BBS, 2013, RAJSH STAT CENS 2011; Bhandari S, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0208-y; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Cai XD, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-12; Centers for Disease Control and Prevention (CDC), 2016, BREASTF REP CARD 201; Chekol DA, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0118-9; Derso T, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0116-y; DGHS, 2015, HLTH B 2015; DGHS, 2007, NAT STRAT INF YOUNG; Dhakal S, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14050455; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; Gelaw BK, 2015, GLOBAL J MED RES; Hackett KM, 2015, MATERN CHILD NUTR, V11, P173, DOI 10.1111/mcn.12007; Haque SE, 2012, WOMEN HEALTH ISS, V22, pE171, DOI 10.1016/j.whi.2011.08.004; Hashim TH, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0102-4; Hossain M, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1076-0; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S25; Joshi PC, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-7; Kasahun AW, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0107-z; Kramer MS, 2004, ADV EXP MED BIOL, V554, P63; Mbada Chidozie E, 2013, BMC Res Notes, V6, P552, DOI 10.1186/1756-0500-6-552; Mekuria G, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-014-0027-0; Nakamura Soraia S., 2003, J. Pediatr. (Rio J.), V79, P181, DOI 10.1590/S0021-75572003000200014; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; NIPORT Mitra and Associates and ICF International, 2000, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ORC Macro, 2005, BANGL DEM HLTH SURV; Nkrumah J, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0100-6; Oche MO, 2011, AFR HEALTH SCI, V11, P518; Ogbo FA, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0214-0; Oh AL, 2011, J INFECT DEV COUNTR, V5, P338; Osman H, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-12; Perera PJ, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-21; Pokhrel HP, 2018, FACTORS ASS EXCLUSIV, V4, P1; Quigley MA, 2016, EUR J CLIN NUTR, V70, P1420, DOI 10.1038/ejcn.2016.135; Rahman M. S., 2016, South Asian Anthropologist, V16, P27; Rana M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2071-0; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Setegn T, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-17; Tewabe T, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0103-3; *UNDP, 2005, HUM DEV REP; UNICEF, 2011, INF YOUNG CHILD FEED, P17; United Nations International Children's Emergency Fund (UNICEF), 2018, AD OPT FEED PRACT FU; Velusamy V, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0127-8; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Vijayalakshmi P, 2015, INT J HEALTH SCI-IJH, V9, P364; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; WHO, 2003, WHO COMPL FEED REP G; WHO, 2009, INF YOUNG CHILD FEED; WHO, 2017, TRACK PROGR BREAST P; WHO, 2003, GLOB STRAT INF YOUNG; World Health Organization, 2013, ESS NUTR ACT IMPR MA; Zenebu BB, 2015, EPIDEMIOL OPEN ACCES, V5, P182, DOI DOI 10.4172/2161-1165.1000182	54	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232027	10.1371/journal.pone.0232027	http://dx.doi.org/10.1371/journal.pone.0232027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384096	gold, Green Published			2022-12-26	WOS:000537468300007
J	Tremmel-Bede, K; Szentmiklossy, M; Tomoskozi, S; Torok, K; Lovegrove, A; Shewry, PR; Lang, L; Bedo, Z; Vida, G; Rakszegi, M				Tremmel-Bede, Karolina; Szentmiklossy, Marietta; Tomoskozi, Sandor; Torok, Kitti; Lovegrove, Alison; Shewry, Peter R.; Lang, Laszlo; Bedo, Zoltan; Vida, Gyula; Rakszegi, Marianna			Stability analysis of wheat lines with increased level of arabinoxylan	PLOS ONE			English	Article							DIETARY FIBER; QUALITY CHARACTERISTICS; ENVIRONMENT INTERACTION; GENETIC DIVERSITY; BIPLOT ANALYSIS; BAKING QUALITY; DROUGHT STRESS; HEAT-STRESS; GRAIN-YIELD; TRIAL DATA	Plant breeders have long sought to develop lines that combine outstanding performance with high and stable quality in different environments. The high-arabinoxylan (AX) Chinese variety Yumai-34 was crossed with three Central European wheat varieties (Lupus, Mv-Mambo, Ukrainka) and 31 selected high-AX lines were compared for physical (hectolitre weight, thousand grain weight, flour yield), compositional (protein content, gluten content, pentosan) and processing quality traits (gluten index, Zeleny sedimentation, Farinograph parameters) in a three-year experiment (2013-2015) in the F-7-F-9 generations. The stability and heritability of different traits, including the relative effects of the genotype (G) and environment (E), were determined focusing on grain composition. The contents of total and water-soluble pentosans were significantly affected by G, E and G x E interactions, but the heritability of total (TOT)-pentosan was significantly lower (0.341) than that of water-extractable (WE)-pentosan (0.825). The main component of the pentosans, the amount and composition (arabinose: xylose ratio) of the arabinoxylan (AX), was primarily determined by the environment and, accordingly, the broader heritability of these parameters were 0.516 and 0.772. However, genotype significantly affected the amount of water-soluble arabinoxylan and its composition and thus the heritability of these traits was also significant (0.840 and 0.721). The genotypes exhibiting higher stability of content of TOT-pentosan also showed more stable contents of WE-pentosan. There was a positive correlation between the stability of contents of WE-pentosan and WE-AX, while the stability of the WE-AX content and AX composition were also strongly correlated. Water absorption was strongly genetically determined with a heritability of 0.829 with the genotype determining 38.67% of the total variance. Many lines were grouped in the GGE biplot, indicating that they did not significantly differ stability.	[Tremmel-Bede, Karolina; Lang, Laszlo; Bedo, Zoltan; Vida, Gyula; Rakszegi, Marianna] Ctr Agr Res, Agr Inst, Martonvasar, Hungary; [Szentmiklossy, Marietta; Tomoskozi, Sandor; Torok, Kitti] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Budapest, Hungary; [Lovegrove, Alison; Shewry, Peter R.] Rothamsted Res, Dept Plant Sci, Harpenden, Herts, England	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Budapest University of Technology & Economics; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Rakszegi, M (corresponding author), Ctr Agr Res, Agr Inst, Martonvasar, Hungary.	rakszegi.mariann@agrar.mta.hu	Rakszegi, Marianna/B-2904-2013	Shewry, Peter/0000-0001-6205-2517; Rakszegi, Marianna/0000-0003-0798-8974	National Research, Development and Innovation Office (NKFIH) of Hungary [K112169, K112179]; Biotechnology and Biological Sciences Research Council (BBSRC) of the UK [BB/P016855/1]; Innovate UK [L005654/1]; COST Action [18101]; BBSRC [BBS/E/C/000I0250, BB/L025108/1] Funding Source: UKRI	National Research, Development and Innovation Office (NKFIH) of Hungary; Biotechnology and Biological Sciences Research Council (BBSRC) of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Innovate UK(UK Research & Innovation (UKRI)Innovate UK); COST Action(European Cooperation in Science and Technology (COST)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MR, KTB, GV, LL, and ZB received support from the National Research, Development and Innovation Office (NKFIH) of Hungary (project No K112169) "Improvement of bioactive composition and its effects." Partners of the same research program ST, MS and KT received support under project No K112179. AL and PRS received grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC) of the UK, with the work reported forming part of the Designing Future Wheat Institute Strategic Programme [BB/P016855/1], with additional support from Innovate UK grant, L005654/1 "High fibre wheat for healthier white bread." Cooperation between all partners is supported by COST Action 18101 (European Cooperation in Science and Technology) SOURDOMICS project with the title: "Sourdough biotechnology network towards novel, healthier and sustainable food and bioprocesses" to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas B, 2019, APPL ECOL ENV RES, V17, P12921, DOI 10.15666/aeer/1706_1292112936; Amiri R, 2018, PHYSIOL MOL BIOL PLA, V24, P147, DOI 10.1007/s12298-017-0481-4; [Anonymous], 2019, 797132019 MSZ EN ISO; [Anonymous], 520 MSZ EN ISO; [Anonymous], 1995, 1052 ICC INT ASS CER; Ashraf M, 2014, CRIT REV FOOD SCI, V54, P1576, DOI 10.1080/10408398.2011.644354; Balla K, 2011, CZECH J FOOD SCI, V29, P117, DOI 10.17221/227/2010-CJFS; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Beres BL, 2008, CAN J PLANT SCI, V88, P859, DOI 10.4141/CJPS07173; Bilgin O, 2016, CROP SCI, V56, P73, DOI 10.2135/cropsci2015.03.0148; BRANLARD G, 1991, Journal of Genetics and Breeding, V45, P263; Branlard G, 2001, EUPHYTICA, V119, P59, DOI 10.1023/A:1017586220359; Coles GD, 1997, J CEREAL SCI, V26, P47, DOI 10.1006/jcrs.1996.0102; Corol DI, 2012, J AGR FOOD CHEM, V60, P5471, DOI 10.1021/jf3008794; Dornez E, 2008, J CEREAL SCI, V47, P180, DOI 10.1016/j.jcs.2007.03.008; DOUGLAS SG, 1981, FOOD CHEM, V7, P139, DOI 10.1016/0308-8146(81)90059-5; EBERHART SA, 1966, CROP SCI, V6, P36, DOI 10.2135/cropsci1966.0011183X000600010011x; Finnie SM, 2006, CEREAL CHEM, V83, P617, DOI 10.1094/CC-83-0617; Flagella Z, 2010, EUR J AGRON, V33, P197, DOI 10.1016/j.eja.2010.05.006; GAN Z, 1992, J CEREAL SCI, V15, P151, DOI 10.1016/S0733-5210(09)80066-0; Gebruers K., 2009, HEALTHGRAIN methods: analysis of bioactive components in small grain cereals, P177; Gebruers K, 2008, J AGR FOOD CHEM, V56, P9740, DOI 10.1021/jf800975w; Gebruers K, 2010, J AGR FOOD CHEM, V58, P9353, DOI 10.1021/jf100447g; George N, 2019, CROP SCI, V59, P1960, DOI 10.2135/cropsci2019.01.0010; Gupta S, 2016, INDIAN J GENET PL BR, V76, P137, DOI 10.5958/0975-6906.2016.00030.4; HOLAS J, 1978, CEREAL CHEM, V55, P637; HONG BH, 1989, CEREAL CHEM, V66, P369; International Association for Cereal Science and Technology, 1995, 155 ICC INT ASS CER; International Association for Cereal Science and Technology, 1995, 1371 ICC INT ASS CER; International Association for Cereal Science and Technology, 1995, 1151 ICC INT ASS CER; Izydorczyk MS, 2008, FOOD CHEM, V108, P561, DOI 10.1016/j.foodchem.2007.11.012; Izydorczyk MS, 2001, J CEREAL SCI, V34, P251, DOI 10.1006/jcrs.2000.0363; Jiang D, 2009, J AGRON CROP SCI, V195, P89, DOI 10.1111/j.1439-037X.2008.00353.x; Karaman M, 2019, APPL ECOL ENV RES, V17, P1431, DOI 10.15666/aeer/1701_14311450; Katina K., 2003, Bread making: improving quality, P487, DOI 10.1533/9781855737129.2.487; KULP K, 1968, Cereal Science Today, V13, P414; Laurentin AM, 2003, NUTR BULL, V28, P69; Lempereur I, 1997, J CEREAL SCI, V25, P103, DOI 10.1006/jcrs.1996.0090; Li SB, 2009, CEREAL CHEM, V86, P88, DOI 10.1094/CCHEM-86-1-0088; Li YF, 2013, J CEREAL SCI, V57, P73, DOI 10.1016/j.jcs.2012.09.014; Martinant JP, 1999, J CEREAL SCI, V30, P45, DOI 10.1006/jcrs.1998.0259; Matlala M, 2019, S AFR J PLANT SOIL, V36, P299, DOI 10.1080/02571862.2019.1566502; Mehraban A, 2019, POL J ENVIRON STUD, V28, P739, DOI 10.15244/pjoes/85350; Primo-Martin C, 2003, J FOOD SCI, V68, P31, DOI 10.1111/j.1365-2621.2003.tb14110.x; Rakszegi M, 2014, CEREAL RES COMMUN, V42, P629, DOI 10.1556/CRC.2014.0007; Rakszegi M, 2014, CARBOHYD POLYM, V102, P557, DOI 10.1016/j.carbpol.2013.12.005; Reynolds M, 2007, J EXP BOT, V58, P177, DOI 10.1093/jxb/erl250; Rosell CM, 2010, EUR FOOD RES TECHNOL, V231, P535, DOI 10.1007/s00217-010-1310-y; Santos E, 2008, CEREAL CHEM, V85, P457, DOI 10.1094/CCHEM-85-4-0455; Shamsi K, 2011, AFR J BIOTECHNOL, V10, P2708; Shewry PR, 2013, WOODH PUB INDIA FOOD, V237, P153, DOI 10.1533/9780857095787.2.153; Shewry PR, 2011, J AGR FOOD CHEM, V59, P10564, DOI 10.1021/jf202762b; Shewry PR, 2010, J AGR FOOD CHEM, V58, P9291, DOI 10.1021/jf100039b; Silva RR, 2014, ACTA SCI-AGRON, V36, P201, DOI 10.4025/actasciagron.v36i2.16180; Singh C, 2019, CROP BREED APPL BIOT, V19, P309, DOI 10.1590/1984-70332019v19n3a43; Skendi A, 2009, J FOOD ENG, V91, P594, DOI 10.1016/j.jfoodeng.2008.10.009; Sudha ML, 2007, FOOD CHEM, V100, P1365, DOI 10.1016/j.foodchem.2005.12.013; Abraha MT, 2019, J CROP IMPROV, V33, P797, DOI 10.1080/15427528.2019.1662531; Thungo Z, 2019, ACTA AGR SCAND B-S P, V69, P725, DOI 10.1080/09064710.2019.1646797; Torok K, 2019, J CEREAL SCI, V86, P117, DOI 10.1016/j.jcs.2019.01.012; Tremmel-Bede K, 2016, CEREAL RES COMMUN, V44, P694, DOI 10.1556/0806.44.2016.027; Tremmel-Bede K, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2066-2; Virk DS, 2009, EXP AGR, V45, P77, DOI 10.1017/S0014479708007047; Yabwalo DN, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2202-7; Yan W, 2006, CAN J PLANT SCI, V86, P623, DOI 10.4141/P05-169; Yildirim M, 2018, FRESEN ENVIRON BULL, V27, P4830	66	5	5	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232892	10.1371/journal.pone.0232892	http://dx.doi.org/10.1371/journal.pone.0232892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384107	Green Published, gold, Green Accepted			2022-12-26	WOS:000537468300038
J	Daemi-Saeidabad, M; Shojaeiyan, A; Vivian-Smith, A; Stenoien, HK; Falahati-Anbaran, M				Daemi-Saeidabad, Mehdi; Shojaeiyan, Abdolali; Vivian-Smith, Adam; Stenoien, Hans K.; Falahati-Anbaran, Mohsen			The taxonomic significance of ddRADseq based microsatellite markers in the closely related species of Heracleum (Apiaceae)	PLOS ONE			English	Article							TORDYLIEAE; PHYLOGENY; SEQUENCES; RADSEQ	Many studies on Heracleum have shown poor correspondence between observed molecular clusters and established taxonomic classification amongst closely related species. This might reflect both unresolved taxonomy but perhaps also a lack of good genetic markers. This lack of appropriate and cost effective species-specific genetic markers hinders a resolved relationship for the species complex, and this in turn causes profound management challenges for a genus that contains both endemic species, with important ecological roles, and species with an invasive potential. Microsatellites are traditionally considered markers of choice for comprehensive, yet inexpensive, analyses of genetic variation, including examination of population structure, species identity, linkage map construction and cryptic speciation. In this study, we have used double digest restriction site associated DNA sequencing (ddRADseq) to develop microsatellite markers in Heracleum rechingeri. Genomic DNA from three individuals were digested with Sbf1 and Nde1 and size selected for library construction. The size-selected fragments were sequenced on an Ion Torrent sequencer and a total of 54 microsatellite sequences were bioinformatically confirmed. Twenty five loci were then tested for amplification, resulting in 19 of these being successfully amplified across eight species, comprising both the so-called thick-stemmed species (H. persicum, H. rechingeri, H. gorganicum and H. lasiopetalum), and thin-stemmed species (H. anisactis, H. pastinasifolium and H. transcaucasicum). Both Bayesian and distance-based clustering, and principal coordinate analyses clearly separated these into two groups. Surprisingly, three H. pastinacifolium populations were not separated from populations of the morphologically similar endemic species, H. anisactis, suggesting lack of genetic differentiation. Likewise, high genetic similarity was found between H. persicum and H. rechingeri populations, questioning taxonomic separation at the species level between these taxa. Further analyses are needed to re-evaluate the taxonomic significance of observed morphological variability currently applied to distinguish these sister taxa. Nevertheless, our results represent progress in the effort to develop cost-efficient molecular tools for species discrimination in this genus.	[Daemi-Saeidabad, Mehdi; Falahati-Anbaran, Mohsen] Univ Tehran, Coll Sci, Sch Biol, Dept Plant Sci, Tehran, Iran; [Shojaeiyan, Abdolali] Tarbiat Modares Univ TMU, Fac Agr, Dept Hort Sci, Tehran, Iran; [Vivian-Smith, Adam] Norwegian Inst Bioecon Res, Dept Forest Genet & Biodivers, As, Norway; [Stenoien, Hans K.] Norwegian Univ Sci & Technol, NTNU Univ Museum, Trondheim, Norway	University of Tehran; Tarbiat Modares University; Norwegian Institute of Bioeconomy Research; Norwegian University of Science & Technology (NTNU)	Falahati-Anbaran, M (corresponding author), Univ Tehran, Coll Sci, Sch Biol, Dept Plant Sci, Tehran, Iran.	falahati@ut.ac.ir		Daemi-Saeedabad, Mehdi/0000-0002-9205-9100; Vivian-Smith, Adam/0000-0002-8074-7950; Shojaeiyan, Abdolali/0000-0002-8065-0454	Iran National Science Foundation [92038838]	Iran National Science Foundation(Iran National Science Foundation (INSF))	This work was partially supported by the Iran National Science Foundation (grant number 92038838). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bahadori MB, 2016, COMPR REV FOOD SCI F, V15, P1018, DOI 10.1111/1541-4337.12222; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eidi M, 2019, J CELL MOL RES; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Falahati-Anbaran M, 2018, CHEM BIODIVERS, V15, DOI 10.1002/cbdv.201800230; Falahati-Anbaran M, 2017, PLANT SPEC BIOL, V32, P179, DOI 10.1111/1442-1984.12142; Falahati-Anbaran M, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200492; Fernandez M, 2017, SYST BIODIVERS, V15, P489, DOI 10.1080/14772000.2016.1273975; Gimode D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159437; Goldstein D, 1999, MICROSATELLITES EVOL; Haasl RJ, 2013, MOL BIOL EVOL, V30, P285, DOI 10.1093/molbev/mss247; Hedge I., 1987, FLORA IRANICA UMBELL; Jahodova S, 2007, DIVERS DISTRIB, V13, P99, DOI 10.1111/j.1366-9516.2006.00305.x; Karam MJ, 2015, MOL ECOL RESOUR, V15, P601, DOI 10.1111/1755-0998.12329; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Logacheva MD, 2008, PLANT SYST EVOL, V270, P139, DOI 10.1007/s00606-007-0619-x; Meglecz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040861; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Merritt BJ, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1500025; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Movahedi R, 2019, PLANT MOL BIOL REP, V37, P14, DOI 10.1007/s11105-018-1126-7; Mozafarian V, 2007, FLORA IRAN, P596; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Ozerova NA, 2018, RUSS J BIOL INVASION, V9, P155, DOI 10.1134/S2075111718020091; Pimenov M. G., 2004, Turkish Journal of Botany, V28, P139; Pintaud Jean-Christophe, 2010, P267; Pritchard JK, 2000, GENETICS, V155, P945; Qin HT, 2017, PLANT DIVERSITY, V39, P294, DOI 10.1016/j.pld.2017.05.008; Radjabian T, 2014, CHEM BIODIVERS, V11, P1945, DOI 10.1002/cbdv.201400085; Rijal DP, 2017, ECOL EVOL, V7, P4936, DOI 10.1002/ece3.3055; Rijal DP, 2015, PLANT MOL BIOL REP, V33, P1381, DOI 10.1007/s11105-014-0841-y; Sundseth K, 2016, INVASIVE ALIEN SPECI, P28; Vivian-Smith A, STREAMLINED DDRAD TA, DOI [10.17504/protocols.io.khuot6w.2017, DOI 10.17504/PROTOCOLS.IO.KHUOT6W.2017]; Vukosavljev M, 2015, MOL ECOL RESOUR, V15, P17, DOI 10.1111/1755-0998.12289; Weising K., 1998, Journal of Crop Production, V1, P113, DOI 10.1300/J144v01n01_06; Yu Y, 2011, PLANT SYST EVOL, V296, P179, DOI 10.1007/s00606-011-0486-3; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394	40	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232471	10.1371/journal.pone.0232471	http://dx.doi.org/10.1371/journal.pone.0232471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379780	gold, Green Published			2022-12-26	WOS:000537285700035
J	Kim, HJ; Lee, H; Lee, Y; Choi, I; Ko, Y; Lee, S; Jang, S				Kim, Hyung Jun; Lee, Hyunjung; Lee, Yunmi; Choi, Inhee; Ko, Yoonae; Lee, Sangchul; Jang, Soojin			The ThiL enzyme is a valid antibacterial target essential for both thiamine biosynthesis and salvage pathways inPseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thiamine; thiamine monophosphate kinase; bacterial metabolism; bacterial pathogenesis; Pseudomonas aeruginosa; infection; antibacterial target; PaThiL; virulence; drug target	RESISTANT PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; MONOPHOSPHATE KINASE; MUTANT; GENES; PYROPHOSPHOKINASE; PLASMID; DISEASE; DESIGN	Thiamine pyrophosphate (TPP) is an essential cofactor for various pivotal cellular processes in all living organisms, including bacteria. Thiamine biosynthesis occurs in bacteria but not in humans; therefore, the enzymes in this pathway are attractive targets for antibiotic development. Among these enzymes, thiamine monophosphate kinase (ThiL) catalyzes the final step of this pathway, phosphorylating thiamine monophosphate to produce TPP. Here, we extensively investigated ThiL inPseudomonas aeruginosa, a major pathogen responsible for hospital-acquired infections. We demonstrate thatthiLdeletion abolishes not only thiamine biosynthesis but also thiamine salvage capability and results in growth defects of the ?thiLstrain even in the presence of thiamine derivatives, except for TPP. Most importantly, the pathogenesis of the ?thiLstrain was markedly attenuated, compared with that of WT cells, with lower inflammatory cytokine induction and 10(3)?10(4)-fold decreased bacterial loads in anin vivoinfection model in which the intracellular TPP level was in the submicromolar range. To validateP. aeruginosaThiL (PaThiL) as a drug target, we further characterized its biochemical properties, determining aV(max)of 4.0 ? 0.2 nmol?min(?1)andK(m)values of 111 ? 8 and 8.0 ? 3.5 ?mfor ATP and thiamine monophosphate, respectively. Anin vitrosmall-molecule screening assay identified PaThiL inhibitors including WAY213613, a noncompetitive inhibitor with aK(i)value of 13.4 ? 2.3 ?mand potential antibacterial activity againstP. aeruginosa. These comprehensive biological and biochemical results indicate that PaThiL represents a potential drug target for the development of an augmented repertoire of antibiotics againstP. aeruginosa.	[Kim, Hyung Jun; Lee, Hyunjung; Lee, Yunmi; Jang, Soojin] Inst Pasteur Korea, Discovery Biol Dept, Antibacterial Resistance Lab, Seongnam Si, Gyeonggi Do, South Korea; [Choi, Inhee; Ko, Yoonae; Lee, Sangchul] Inst Pasteur Korea, Translat Res Dept, Med Chem, Seongnam Si, Gyeonggi Do, South Korea	Institut Pasteur Korea; Institut Pasteur Korea	Jang, S (corresponding author), Inst Pasteur Korea, Discovery Biol Dept, Antibacterial Resistance Lab, Seongnam Si, Gyeonggi Do, South Korea.	soojin.jang@ip-korea.org			National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2017M3A9G6068246]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (Grant NRF-2017M3A9G6068246), as well as Gyeonggi-do.	de Andrade JAA, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-11; Barbier F, 2010, M S-MED SCI, V26, P960, DOI 10.1051/medsci/20102611960; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; Botelho J, 2019, DRUG RESIST UPDATE, V44, P26, DOI 10.1016/j.drup.2019.07.002; Branski LK, 2009, SURG INFECT, V10, P389, DOI 10.1089/sur.2009.024; Bunik VI, 2013, FEBS J, V280, P6412, DOI 10.1111/febs.12512; Chatzinikolaou I, 2000, ARCH INTERN MED, V160, P501, DOI 10.1001/archinte.160.4.501; Cho JH, 2013, BIOCHIMIE, V95, P1411, DOI 10.1016/j.biochi.2013.03.007; Choi J, 2018, INT J CHRONIC OBSTR, V13, P3077, DOI 10.2147/COPD.S173759; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Dhir S, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00207; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Fernandes M, 2016, GRAEF ARCH CLIN EXP, V254, P315, DOI 10.1007/s00417-015-3208-7; Filloux A, 2014, METHODS MOL BIOL, V1149, P1, DOI 10.1007/978-1-4939-0473-0; Frank RAW, 2007, CELL MOL LIFE SCI, V64, P892, DOI 10.1007/s00018-007-6423-5; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Gigliobianco T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-148; Glasser NR, 2017, J BIOL CHEM, V292, P5593, DOI 10.1074/jbc.M116.772848; IMAMURA N, 1982, J BACTERIOL, V151, P708, DOI 10.1128/JB.151.2.708-717.1982; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Karunakaran R, 2006, J BACTERIOL, V188, P6661, DOI 10.1128/JB.00641-06; Khare G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022441; Krucinska J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53301-3; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Leonardi R, 2004, J BIOL CHEM, V279, P17054, DOI 10.1074/jbc.M312714200; Lunse CE, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00053; Lunse CE, 2014, INT J MED MICROBIOL, V304, P79, DOI 10.1016/j.ijmm.2013.09.002; Manfredi R, 2000, EUR J EPIDEMIOL, V16, P111, DOI 10.1023/A:1007626410724; McCulloch KM, 2008, BIOCHEMISTRY-US, V47, P3810, DOI 10.1021/bi800041h; Melnick J, 2004, J BACTERIOL, V186, P3660, DOI 10.1128/JB.186.11.3660-3662.2004; Moradali MF, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00039; NAKAYAMA H, 1972, J BACTERIOL, V112, P1118, DOI 10.1128/JB.112.3.1118-1126.1972; NISHINO H, 1972, J BIOCHEM-TOKYO, V72, P1093, DOI 10.1093/oxfordjournals.jbchem.a129996; NOSAKA K, 1993, J BIOL CHEM, V268, P17440; Odum EP, 2012, NIGER J CLIN PRACT, V15, P442, DOI 10.4103/1119-3077.104522; Parkins MD, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00019-18; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Ruiz-Garbajosa P, 2017, REV ESP QUIM, V30, P8; Schweizer HP, 2001, CURR OPIN BIOTECH, V12, P439, DOI 10.1016/S0958-1669(00)00242-1; Settembre E, 2003, CURR OPIN STRUC BIOL, V13, P739, DOI 10.1016/j.sbi.2003.10.006; Singleton Charles K., 2001, Current Molecular Medicine (Hilversum), V1, P197, DOI 10.2174/1566524013363870; Sullivan AH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40558-x; Suzuki K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180279; Swier LJYM, 2015, CHEMBIOCHEM, V16, P819, DOI 10.1002/cbic.201402673; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Tylicki A, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171148; Wang JR, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-18; Webb E, 1997, J BIOL CHEM, V272, P15702, DOI 10.1074/jbc.272.25.15702; Wilson R, 2016, RESP MED, V117, P179, DOI 10.1016/j.rmed.2016.06.007	54	3	3	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					10081	10091		10.1074/jbc.RA120.013295	http://dx.doi.org/10.1074/jbc.RA120.013295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32404369	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000553333300027
J	Molina, M; Moulis, C; Monties, N; Guieysse, D; Morel, S; Cioci, G; Remaud-Simeon, M				Molina, Manon; Moulis, Claire; Monties, Nelly; Guieysse, David; Morel, Sandrine; Cioci, Gianluca; Remaud-Simeon, Magali			A specific oligosaccharide-binding site in the alternansucrase catalytic domain mediates alternan elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucansucrase; alternan; biosourced; polysaccharide; GH70; polymerase; sugar-binding pockets; surface-binding site; processivity; alternansucrase; enzyme catalysis; enzyme mechanism; carbohydrate structure; biotechnology; dextran; green chemistry	CARBOHYDRATE-ACTIVE ENZYMES; MOLAR-MASS DEXTRAN; BRANCHING SUCRASE; GLUCANSUCRASE; SUCROSE	Microbial ?-glucans produced by GH70 (glycoside hydrolase family 70) glucansucrases are gaining importance because of the mild conditions for their synthesis from sucrose, their biodegradability, and their current and anticipated applications that largely depend on their molar mass. Focusing on the alternansucrase (ASR) fromLeuconostoc citreumNRRL B-1355, a well-known glucansucrase catalyzing the synthesis of both high- and low-molar-mass alternans, we searched for structural traits in ASR that could be involved in the control of alternan elongation. The resolution of five crystal structures of a truncated ASR version (ASR?2) in complex with different gluco-oligosaccharides pinpointed key residues in binding sites located in the A and V domains of ASR. Biochemical characterization of three single mutants and three double mutants targeting the sugar-binding pockets identified in domain V revealed an involvement of this domain in alternan binding and elongation. More strikingly, we found an oligosaccharide-binding site at the surface of domain A, distant from the catalytic site and not previously identified in other glucansucrases. We named this site surface-binding site (SBS) A1. Among the residues lining the SBS-A1 site, two (Gln(700)and Tyr(717)) promoted alternan elongation. Their substitution to alanine decreased high-molar-mass alternan yield by a third, without significantly impacting enzyme stability or specificity. We propose that the SBS-A1 site is unique to alternansucrase and appears to be designed to bind alternating structures, acting as a mediator between the catalytic site and the sugar-binding pockets of domain V and contributing to a processive elongation of alternan chains.	[Molina, Manon; Moulis, Claire; Monties, Nelly; Guieysse, David; Morel, Sandrine; Cioci, Gianluca; Remaud-Simeon, Magali] Univ Toulouse, Toulouse Biotechnol Inst TBI, CNRS, INRAE,INSA, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National des Sciences Appliquees de Toulouse	Cioci, G; Remaud-Simeon, M (corresponding author), Univ Toulouse, Toulouse Biotechnol Inst TBI, CNRS, INRAE,INSA, Toulouse, France.	cioci@insa-toulouse.fr; remaud@insa-toulouse.fr		MOULIS, Claire/0000-0002-1937-9052; GUIEYSSE, David/0000-0002-8802-4968; Molina, Manon/0000-0002-6323-8185				Albenne C, 2006, PROTEIN-STRUCT FUNCT, V66, P118, DOI DOI 10.1002/prot.21083; BIELY P, 1994, EUR J BIOCHEM, V226, P633, DOI 10.1111/j.1432-1033.1994.tb20090.x; Bounaix MS, 2010, INT J FOOD MICROBIOL, V144, P1, DOI 10.1016/j.ijfoodmicro.2010.05.026; Brison Y, 2016, J BIOL CHEM, V291, P7527, DOI 10.1074/jbc.M115.688796; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Charoenwongpaiboon T, 2019, RSC ADV, V9, P4370, DOI 10.1039/c8ra10263e; Claverie M, 2020, J BIOL CHEM, V295, P5602, DOI 10.1074/jbc.RA119.011995; Claverie M, 2019, BIOCHEMISTRY-US, V58, P2853, DOI 10.1021/acs.biochem.9b00373; Claverie M, 2017, ACS CATAL, V7, P7106, DOI 10.1021/acscatal.7b02182; Cockburn D, 2014, BIOLOGIA, V69, P705, DOI 10.2478/s11756-014-0373-9; Cockburn D, 2013, SPR CARB CH, V39, P204, DOI 10.1039/9781849737173-00204; COTE GL, 1982, CARBOHYD RES, V101, P57, DOI 10.1016/S0008-6215(00)80795-8; Cote GL, 2003, ACS SYM SER, V849, P76; COTE GL, 1992, CARBOHYD POLYM, V19, P249, DOI 10.1016/0144-8617(92)90077-4; Cote GL, 2006, CARBOHYD RES, V341, P2066, DOI 10.1016/j.carres.2006.04.044; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dennes T. J., 2015, U.S. Patent, Patent No. [9,957,334, 9957334]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freitas F, 2011, TRENDS BIOTECHNOL, V29, P388, DOI 10.1016/j.tibtech.2011.03.008; Hernandez-Hernandez O, 2011, J AGR FOOD CHEM, V59, P10901, DOI 10.1021/jf202466s; Holt SM, 2005, LETT APPL MICROBIOL, V40, P385, DOI 10.1111/j.1472-765X.2005.01681.x; Hudson KL, 2015, J AM CHEM SOC, V137, P15152, DOI 10.1021/jacs.5b08424; Irague R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077837; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Joucla G, 2006, FEBS LETT, V580, P763, DOI 10.1016/j.febslet.2006.01.001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Leathers TD, 2009, BIOTECHNOL LETT, V31, P289, DOI 10.1007/s10529-008-9866-3; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Meng XF, 2017, FOOD CHEM, V217, P81, DOI 10.1016/j.foodchem.2016.08.087; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Molina M, 2019, ACS CATAL, V9, P2222, DOI 10.1021/acscatal.8b04510; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moscovici M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01012; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Moulis C, 2016, CELL MOL LIFE SCI, V73, P2661, DOI 10.1007/s00018-016-2244-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nivedha AK, 2016, J CHEM THEORY COMPUT, V12, P892, DOI 10.1021/acs.jctc.5b00834; Paullin J. L., 2013, U.S. Patent, Patent No. [9,139,718, 9139718]; Pijning T, 2012, ACTA CRYSTALLOGR F, V68, P1448, DOI 10.1107/S1744309112044168; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sanz ML, 2005, J AGR FOOD CHEM, V53, P5911, DOI 10.1021/jf050344e; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Soetaert W, 1995, PROGR BIOTECHNOL, V10, P351, DOI 10.1016/S0921-0423(06)80116-4; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Wangpaiboon K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26721-w; Wilkens C, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01652; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	54	4	4	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9474	9489		10.1074/jbc.RA120.013028	http://dx.doi.org/10.1074/jbc.RA120.013028			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409580	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000552758600017
J	Nelson, AC; Turbyville, TJ; Dharmaiah, S; Rigby, M; Yang, RD; Wang, TY; Columbus, J; Stephens, R; Taylor, T; Sciacca, D; Onsongo, G; Sarver, A; Subramanian, S; Nissley, DV; Simanshu, DK; Lou, E				Nelson, Andrew C.; Turbyville, Thomas J.; Dharmaiah, Srisathiyanarayanan; Rigby, Megan; Yang, Rendong; Wang, Ting-You; Columbus, John; Stephens, Robert; Taylor, Troy; Sciacca, Drew; Onsongo, Getiria; Sarver, Anne; Subramanian, Subbaya; Nissley, Dwight, V; Simanshu, Dhirendra K.; Lou, Emil			RASinternal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RAS protein; colon cancer; structural biology; protein structure; oncogene; bedside-to-bench analysis; exome sequencing; personalized medicine; switch II domain; tandem duplication	CANCER-RELATED ANALYSIS; MUTATIONS; RAS; VARIANTS; PLATFORM; BREAST; CSMD1; KRAS	The oncogene RAS is one of the most widely studied proteins in cancer biology, and mutant active RAS is a driver in many types of solid tumors and hematological malignancies. Yet the biological effects of differentRASmutations and the tissue-specific clinical implications are complex and nuanced. Here, we identified an internal tandem duplication (ITD) in the switch II domain of NRAS from a patient with extremely aggressive colorectal carcinoma. Results of whole-exome DNA sequencing of primary and metastatic tumors indicated that this mutation was present in all analyzed metastases and excluded the presence of any other clear oncogenic driver mutations. Biochemical analysis revealed increased interaction of the RAS ITD with Raf proto-oncogene Ser/Thr kinase (RAF), leading to increased phosphorylation of downstream MAPK/ERK kinase (MEK)/extracellular signal?regulated kinase (ERK). The ITD prevented interaction with neurofibromin 1 (NF1)?GTPase?activating protein (GAP), providing a mechanism for sustained activity of the RAS ITD protein. We present the first crystal structures of NRAS and KRAS ITD at 1.65?1.75 ? resolution, respectively, providing insight into the physical interactions of this class of RAS variants with its regulatory and effector proteins. Our in-depth bedside-to-bench analysis uncovers the molecular mechanism underlying a case of highly aggressive colorectal cancer and illustrates the importance of robust biochemical and biophysical approaches in the implementation of individualized medicine.	[Nelson, Andrew C.; Sciacca, Drew; Onsongo, Getiria] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Turbyville, Thomas J.; Dharmaiah, Srisathiyanarayanan; Rigby, Megan; Columbus, John; Stephens, Robert; Taylor, Troy; Nissley, Dwight, V; Simanshu, Dhirendra K.] Leidos Biomed Res Inc, NCI RAS Initiat, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Yang, Rendong; Wang, Ting-You] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Sarver, Anne; Subramanian, Subbaya] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Lou, Emil] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Nelson, AC (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.; Simanshu, DK (corresponding author), Leidos Biomed Res Inc, NCI RAS Initiat, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA.; Lou, E (corresponding author), Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA.	nels2055@umn.edu; dhirendra.simanshu@nih.gov; emil-lou@umn.edu	WANG, TINGYOU/ADF-9723-2022; yang, rendong/I-5552-2014	WANG, TINGYOU/0000-0003-4354-3198; yang, rendong/0000-0002-9512-2240; Dharmaiah, Srisathiyanarayanan/0000-0001-7630-3962; Simanshu, Dhirendra/0000-0002-9717-4618; Nelson, Andrew/0000-0002-4741-0010	Department of Laboratory Medicine and Pathology, University of Minnesota; Eastern Star Scholars, University of Minnesota Masonic Cancer Center; American Cancer Society Clinical Scientist Development Grant [CSDG-18-139-01-CSM]; Mezin-Koats Colon Cancer Research Award; Randy Shaver Cancer Research and Community Fund; Litman Family Fund for Cancer Research; Central Society for Clinical and Translational Research Early Career Development Award; American Cancer Society [118198-IRG-58-001-52-IRG94]; Minnesota Masonic Charities; Minnesota Medical Foundation/University of Minnesota Foundation; Masonic Cancer Center, University of Minnesota; Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota; National Institutes of Health Clinical and Translational Science KL2 Scholar Award [8UL1TR000114]; National Cancer Institute, NIH Contract [HHSN261200800001E]	Department of Laboratory Medicine and Pathology, University of Minnesota(University of Minnesota System); Eastern Star Scholars, University of Minnesota Masonic Cancer Center; American Cancer Society Clinical Scientist Development Grant(American Cancer Society); Mezin-Koats Colon Cancer Research Award; Randy Shaver Cancer Research and Community Fund; Litman Family Fund for Cancer Research; Central Society for Clinical and Translational Research Early Career Development Award; American Cancer Society(American Cancer Society); Minnesota Masonic Charities; Minnesota Medical Foundation/University of Minnesota Foundation; Masonic Cancer Center, University of Minnesota(University of Minnesota System); Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota; National Institutes of Health Clinical and Translational Science KL2 Scholar Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH Contract	This research was supported in part by contributions from the patient's parents, and research funding from the Department of Laboratory Medicine and Pathology, University of Minnesota (to A. C. N.); Eastern Star Scholars, University of Minnesota Masonic Cancer Center (to A. C. N.); American Cancer Society Clinical Scientist Development Grant CSDG-18-139-01-CSM (to A. C. N.); the Mezin-Koats Colon Cancer Research Award (to E. L.); The Randy Shaver Cancer Research and Community Fund (to E. L.); the Litman Family Fund for Cancer Research; a Central Society for Clinical and Translational Research Early Career Development Award (to E. L.); Institutional Research Grant 118198-IRG-58-001-52-IRG94 from the American Cancer Society (to E. L.); Minnesota Masonic Charities; Minnesota Medical Foundation/University of Minnesota Foundation (to E. L.); the Masonic Cancer Center and Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota (to E. L.); and the National Institutes of Health Clinical and Translational Science KL2 Scholar Award 8UL1TR000114 (to E. L.). This project was funded in whole or in part with federal funds from the National Cancer Institute, NIH Contract HHSN261200800001E. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, and the mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agamasu C, 2019, BIOPHYS J, V116, P1049, DOI 10.1016/j.bpj.2019.02.004; Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Dharmaiah S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46846-w; Douville C, 2013, BIOINFORMATICS, V29, P647, DOI 10.1093/bioinformatics/btt017; Eijkelenboom A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44584-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escudero-Esparza A, 2016, ONCOTARGET, V7, P76920, DOI 10.18632/oncotarget.12729; Farrell CL, 2008, CANCER BIOL THER, V7, P609, DOI 10.4161/cbt.7.4.5623; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Guedes JG, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-169; Henzler C, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.05.07; Hsu HC, 2016, ONCOTARGET, V7, P22257, DOI 10.18632/oncotarget.8076; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kamal M, 2017, ONCOL REP, V38, P283, DOI 10.3892/or.2017.5656; Kopra K, 2020, ANAL CHEM, V92, P4971, DOI 10.1021/acs.analchem.9b05126; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li MM, 2017, J MOL DIAGN, V19, P4, DOI 10.1016/j.jmoldx.2016.10.002; Ma CQ, 2009, CANCER BIOL THER, V8, P907, DOI 10.4161/cbt.8.10.8132; Machleidt T, 2015, ACS CHEM BIOL, V10, P1797, DOI 10.1021/acschembio.5b00143; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; Masica DL, 2017, CANCER RES, V77, pE35, DOI 10.1158/0008-5472.CAN-17-0338; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Rabara D, 2019, P NATL ACAD SCI USA, V116, P22122, DOI 10.1073/pnas.1908353116; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Riihimaki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29765; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Shull AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058731; Shutes A, 2006, METHOD ENZYMOL, V407, P9, DOI 10.1016/S0076-6879(05)07002-3; Taylor T, 2017, METHODS MOL BIOL, V1586, P65, DOI 10.1007/978-1-4939-6887-9_5; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Wall VE, 2014, METHODS MOL BIOL, V1116, P193, DOI 10.1007/978-1-62703-764-8_14; Weinstock MT, 2016, NAT METHODS, V13, P849, DOI 10.1038/nmeth.3970; White Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10647; Wojcik P, 2008, POL J PATHOL, V59, P93; Xie QG, 2011, METHODS MOL BIOL, V680, P3, DOI 10.1007/978-1-60761-901-7_1; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yang RD, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0251-2	50	3	3	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9335	9348		10.1074/jbc.RA119.011080	http://dx.doi.org/10.1074/jbc.RA119.011080			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32393580	hybrid, Green Published			2022-12-26	WOS:000552758600007
J	Liu, ZL; Deng, YW; Li, T; Zhu, FS; Zhou, XJ; He, Y				Liu Zhonglong; Deng Yiwen; Li Tao; Zhu Fengshuo; Zhou Xiaojun; He Yue			The opposite functions of miR-24 in the osteogenesis and adipogenesis of adipose-derived mesenchymal stem cells are mediated by the HOXB7/beta-catenin complex	FASEB JOURNAL			English	Article						adipogenesis; adipose-derived mesenchymal stem cells (ADMSCs); miR-24; HOXB7; beta-catenin signal pathway; opposite functions; osteogenesis	MESOPOROUS SILICA NANOPARTICLES; MICRORNA EXPRESSION; STROMAL CELLS; DIFFERENTIATION; PROLIFERATION; DELIVERY; HOXB7; RUNX2	Adipose-derived mesenchymal stem cells (ADMSCs) used in combination with nanoparticles or scaffolds represent promising candidates for bone engineering. Compared to bone marrow-derived MSCs (BMMSCs), ADMSCs show a relatively low capacity for osteogenesis. In the current study, miR-24 was identified as an osteogenesis- and adipogenesis-related miRNA that performs opposing roles (inhibition in osteogenesis and promotion in adipogenesis) during these two differentiation processes. Through bioinformatics analysis and luciferase reporter assays, homeobox protein Hox-B7 (HOXB7) was identified as a potential novel downstream target of miR-24 that contains a miR-24 binding site in the 3 '-UTR of its mRNA. Overexpression of HOXB7 could partly halt the inhibitory effect of miR-24 on osteogenesis, and downregulation of HOXB7 could also partly suppress the positive effect of miR-24 on adipogenesis. Furthermore, immunoprecipitation experiments found that HOXB7 and beta-catenin formed a functional complex that acted as an essential modulator during osteogenesis and adipogenesis of ADMSCs. After transfecting ADMSCs with an MSNs-PEI-miR-24 agomir or antagomir and loading the cells onto gelatin-chitosan scaffolds, the compounds were assessed for their abilities to repair the critical-sized calvarial defects in rats. Comprehensive evaluation, including micro-CT, sequential fluorescent labeling, and immunohistochemistry analysis, revealed that silencing miR-24 distinctly promoted in vivo bone remolding, whereas overexpression of miR-24 significantly repressed bone formation. Taken together, our findings demonstrated opposite roles for the miR-24/HOXB7/beta-catenin signaling pathway in the osteogenesis and adipogenesis of ADMSCs, which may provide a novel mechanism for determining the balance between these two biological processes.	[Liu Zhonglong; Zhu Fengshuo; He Yue] Shanghai Jiao Tong Univ, Natl Clin Res Ctr Stomatol, Dept Oral Maxillofacial & Head & Neck Oncol, Shanghai Peoples Hosp 9,Sch Med, Shanghai 200011, Peoples R China; [Deng Yiwen] Shanghai Jiao Tong Univ, Natl Clin Res Ctr Stomatol, Dept Oral Mucosal Dis, Shanghai Peoples Hosp 9,Sch Med, Shanghai, Peoples R China; [Li Tao; Zhou Xiaojun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Orthoped, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	He, Y (corresponding author), Shanghai Jiao Tong Univ, Natl Clin Res Ctr Stomatol, Dept Oral Maxillofacial & Head & Neck Oncol, Shanghai Peoples Hosp 9,Sch Med, Shanghai 200011, Peoples R China.; Zhou, XJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Orthoped, Shanghai 200011, Peoples R China.	xjz362@163.com; eddielew@alumni.sjtu.edu.cn	Zhou, Xiaojun/ABA-5017-2020	Zhou, Xiaojun/0000-0001-5040-8053	National Natural Science Foundation of China [NSFC: 81570949, 81900969]; Shanghai Sailing Program [19YF1426200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program	This work was supported by the National Natural Science Foundation of China (NSFC: 81570949, 81900969), and Shanghai Sailing Program (19YF1426200).	Baglio SR, 2013, GENE, V527, P321, DOI 10.1016/j.gene.2013.06.021; Bellavia D, 2019, BONE, V122, P52, DOI 10.1016/j.bone.2019.02.013; Bertucci A, 2019, ACS APPL MATER INTER, V11, P23926, DOI 10.1021/acsami.9b07980; Bhattarai SR, 2010, PHARM RES-DORDR, V27, P2556, DOI 10.1007/s11095-010-0245-0; Candini O, 2015, STEM CELLS, V33, P939, DOI 10.1002/stem.1897; Castano IM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27941; Chen X, 2015, BIOMATERIALS, V53, P239, DOI 10.1016/j.biomaterials.2015.02.071; Clark EA, 2014, STEM CELLS, V32, P1074, DOI 10.1002/stem.1623; Deng Y, 2013, BIOMATERIALS, V34, P6717, DOI 10.1016/j.biomaterials.2013.05.042; Di Ianni T, 2019, J CONTROL RELEASE, V309, P1, DOI 10.1016/j.jconrel.2019.07.024; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fang SJ, 2015, INT J MOL SCI, V16, P8227, DOI 10.3390/ijms16048227; Gao D, 2018, AM J PHYSIOL-CELL PH, V315, pC675, DOI 10.1152/ajpcell.00291.2017; Gao J, 2011, J CELL BIOCHEM, V112, P1844, DOI 10.1002/jcb.23106; Gao RT, 2015, INT J CLIN EXP MED, V8, P10459; Geng HY, 2017, CHEM-EUR J, V23, P10878, DOI 10.1002/chem.201701806; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hong PY, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1358-y; Hu CX, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1310-1; Huang C, 2017, CELL TISSUE RES, V368, P229, DOI 10.1007/s00441-016-2462-2; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Jiao J, 2016, MAT SCI ENG C-MATER, V67, P26, DOI 10.1016/j.msec.2016.04.091; Jin M, 2016, BIOCHEM BIOPH RES CO, V474, P76, DOI 10.1016/j.bbrc.2016.04.073; Jin T, 2015, J CELL BIOCHEM, V116, P2804, DOI 10.1002/jcb.25225; Kim DY, 2017, HISTOL HISTOPATHOL, V32, P1, DOI 10.14670/HH-11-798; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Li BB, 2018, CURR STEM CELL RES T, V13, P26, DOI 10.2174/1574888X12666170605112727; Liu JJ, 2016, BIOMATERIALS, V83, P51, DOI 10.1016/j.biomaterials.2016.01.008; Liu ZL, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/5845402; Maria ATJ, 2017, CLIN REV ALLERG IMMU, V52, P234, DOI 10.1007/s12016-016-8552-9; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Papaioannou G, 2014, CELL MOL LIFE SCI, V71, P4747, DOI 10.1007/s00018-014-1700-6; Park H, 2015, DIFFERENTIATION, V90, P91, DOI 10.1016/j.diff.2015.10.010; Qi YC, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1362-2; Qureshi AT, 2013, BIOMATERIALS, V34, P7799, DOI 10.1016/j.biomaterials.2013.07.004; Saleh B, 2019, SMALL, V15, DOI 10.1002/smll.201902232; Scioli MG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133296; Seifert A, 2015, WORLD J STEM CELLS, V7, P583, DOI 10.4252/wjsc.v7.i3.583; Sekar D, 2015, CURR PHARM BIOTECHNO, V16, P43, DOI 10.2174/138920101601150105100851; Seo Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153827; Shao M, 2019, COLLOID SURFACE B, V183, DOI 10.1016/j.colsurfb.2019.110427; Su X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.221; Wang ZS, 2016, INT J NANOMED, V11, DOI 10.2147/IJN.S104851; Wu GS, 2016, CARBOHYD POLYM, V138, P49, DOI 10.1016/j.carbpol.2015.11.044; Xie Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep42840; Xie Q, 2016, BIOMATERIALS, V75, P279, DOI 10.1016/j.biomaterials.2015.10.042; Yi X, 2020, J CELL PHYSIOL, V235, P328, DOI 10.1002/jcp.28972; Zhang JF, 2011, MOL BIOL CELL, V22, P3955, DOI 10.1091/mbc.E11-04-0356; Zhao WG, 2015, INT J MOL SCI, V16, P11699, DOI 10.3390/ijms160511699	50	5	5	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9034	9050		10.1096/fj.202000006RR	http://dx.doi.org/10.1096/fj.202000006RR		MAY 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32413244				2022-12-26	WOS:000533180100001
J	Cai, GH; Scofield, SR				Cai, Guohong; Scofield, Steven R.			Mitochondrial genome sequence of Phytophthora sansomeana and comparative analysis of Phytophthora mitochondrial genomes	PLOS ONE			English	Article							IRISH POTATO FAMINE; MULTILOCUS PHYLOGENY; TRANSFER-RNA; EVOLUTION; DNA; IDENTIFICATION; POLYMORPHISMS; INFESTANS; ALIGNMENT; DATABASE	Phytophthora sansomeana infects soybean and causes root rot. It was recently separated from the species complex P. megasperma sensu lato. In this study, we sequenced and annotated its complete mitochondrial genome and compared it to that of nine other Phytophthora species. The genome was assembled into a circular molecule of 39,618 bp with a 22.03% G+C content. Forty-two protein coding genes, 25 tRNA genes and two rRNA genes were annotated in this genome. The protein coding genes include 14 genes in the respiratory complexes, four ATP synthase genes, 16 ribosomal proteins genes, a tatC translocase gene, six conserved ORFs and a unique orf402. The tRNA genes encode tRNAs for 19 amino acids. Comparison among mitochondrial genomes of 10 Phytophthora species revealed three inversions, each covering multiple genes. These genomes were conserved in gene content with few exceptions. A 3' truncated atp9 gene was found in P. nicotianae. All 10 Phytophthora species, as well as other oomycetes and stramenopiles, lacked tRNA genes for threonine in their mitochondria. Phylogenomic analysis using the mitochondrial genomes supported or enhanced previous findings of the phylogeny of Phytophthora spp.	[Cai, Guohong; Scofield, Steven R.] ARS, Crop Prod & Pest Control Res Unit, USDA, W Lafayette, IN 47907 USA; [Cai, Guohong; Scofield, Steven R.] Purdue Univ, Coll Agr, W Lafayette, IN 47907 USA	United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cai, GH (corresponding author), ARS, Crop Prod & Pest Control Res Unit, USDA, W Lafayette, IN 47907 USA.	Guohong.cai@usda.gov		Cai, Guohong/0000-0002-7700-6019	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was supported by the United States Department of Agriculture. The authors, as USDA employees, performed study design, data collection and analysis, and manuscript preparation.	[Anonymous], 2019, MOL MORPH ID PHYT BA; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Avila-Adame C, 2006, CURR GENET, V49, P39, DOI 10.1007/s00294-005-0016-3; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Bienapfl JC, 2011, FUNGAL BIOL-UK, V115, P733, DOI 10.1016/j.funbio.2011.05.007; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Blair JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037003; Bourke A., 1993, VISITATION GOD POTAT; Braiser CM, 2007, P 4 M INT UN FOR RES, P101; CARTER DA, 1990, MYCOL RES, V94, P1123, DOI 10.1016/S0953-7562(09)81344-0; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Erwin D. C., 1996, Phytophthora diseases worldwide.; Fletcher K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5214-8; Grayburn WS, 2004, MYCOLOGIA, V96, P981, DOI 10.2307/3762082; Griffith GW, 1998, APPL ENVIRON MICROB, V64, P4007; Hansen EM, 2009, MYCOLOGIA, V101, P129, DOI 10.3852/07-203; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; KARLOVSKY P, 1992, J MOL EVOL, V34, P254, DOI 10.1007/BF00162974; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lassiter ES, 2015, CURR GENET, V61, P567, DOI 10.1007/s00294-015-0480-3; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Lu WJ, 2016, MITOCHONDRIAL DNA A, V27, P3487, DOI 10.3109/19401736.2015.1066361; Martin FN, 2007, CURR GENET, V51, P285, DOI 10.1007/s00294-007-0121-6; Martin FN, 2014, FUNGAL GENET BIOL, V66, P19, DOI 10.1016/j.fgb.2014.02.006; Martin FN, 2012, PLANT DIS, V96, P1080, DOI 10.1094/PDIS-12-11-1036-FE; Martin MD, 2014, MOL BIOL EVOL, V31, P1414, DOI 10.1093/molbev/msu086; May KJ, 2004, MYCOL RES, V108, P471, DOI [10.1017/S0953756204009876, 10.1017/s0953756204009876]; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; O'Brien MA, 2014, J EUKARYOT MICROBIOL, V61, P146, DOI 10.1111/jeu.12092; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Paquin B, 1997, CURR GENET, V31, P380, DOI 10.1007/s002940050220; Park J, 2008, PLANT DIS, V92, P966, DOI 10.1094/PDIS-92-6-0966; Petru M, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0607-3; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rahman A, 2019, PHYTOPATHOLOGY, V109, P1354, DOI 10.1094/PHYTO-11-18-0431-R; REESER P W, 1991, Phytopathology, V81, P1201; Rojas JA, 2017, PHYTOPATHOLOGY, V107, P280, DOI 10.1094/PHYTO-04-16-0177-R; Secq MPOL, 2011, GENE, V476, P20, DOI 10.1016/j.gene.2011.02.001; Sogin ML, 1998, INT J PARASITOL, V28, P11, DOI 10.1016/S0020-7519(97)00181-1; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tang QH, 2010, PLANT DIS, V94, P378, DOI 10.1094/PDIS-94-3-0378A; Tangphatsornruang S, 2016, GENE, V575, P34, DOI 10.1016/j.gene.2015.08.036; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; Yang X, 2017, IMA FUNGUS, V8, P355, DOI 10.5598/imafungus.2017.08.02.09; Yuan XL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01484	53	6	6	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0231296	10.1371/journal.pone.0231296	http://dx.doi.org/10.1371/journal.pone.0231296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407378	Green Submitted, Green Published, gold			2022-12-26	WOS:000537490700007
J	Yang, CL; Yong, L; Liang, C; Li, Y; Ma, YL; Wei, F; Jiang, L; Zhou, H; He, GP; Pan, XY; Hai, B; Wu, J; Xu, YL; Liu, ZJ; Liu, XG				Yang, Chenlong; Yong, Lei; Liang, Chen; Li, Yan; Ma, Yunlong; Wei, Feng; Jiang, Liang; Zhou, Hua; He, Guanping; Pan, Xiaoyu; Hai, Bao; Wu, Jian; Xu, Yulun; Liu, Zhongjun; Liu, Xiaoguang			Genetic landscape and ligand-dependent activation of sonic hedgehog-Gli1 signaling in chordomas: a novel therapeutic target	ONCOGENE			English	Article							PATHWAY; GROWTH; CANCER; EXPRESSION; CARCINOMA; MUTATIONS; BIOLOGY; BCL-2; PTCH; GLI1	Chordoma, a rare neoplasm derived from intraosseous notochordal remnants, is unresponsive to conventional chemotherapy and radiotherapy. Sonic Hedgehog (Shh) is a crucial fetal notochord-secreted morphogen that directs notochordal development. The aim of this study was to determine the functional roles and therapeutic potential of Shh-Gli1 signaling in chordomas. Tissue samples and clinical profiles were collected from 42 patients with chordoma. The chordoma cell lines U-CH1 and MUG-Chor1 were used for functional experiments. Shh-Gli1 signaling pathway genetic alterations were screened, and the functions of the identified novel variants were analyzed using in silico analyses, real-time quantitative PCR, and minigene assays. Ligand-dependent Shh-Gli1 signaling activation was assessed using single- and dual-label immunostaining, western blot analysis, and a Shh-responsive Gli-luciferase reporter assay. The small-molecule inhibitor vismodegib was used to target Shh-Gli1 signaling in vitro and in vivo. Overall, 44 genetic alterations were identified, including four novel variants (c.67_69dupCTG in SMO, c.-6_-4dupGGC and c.3306 + 83_3306 + 84insG in PTCH1, and c.183-67_183-66delinsA in SUFU). Shh, PTCH1, SMO, SUFU, and Gli1 were extensively expressed in chordomas, and higher Gli1 expression correlated with poorer prognosis. A luciferase reporter assay and dual-label immunostaining indicated the occurrence of juxtacrine ligand-dependent Shh-Gli1 signaling activation. Vismodegib significantly inhibited cell proliferation and induced apoptosis and G1/S cell cycle arrest. In vivo investigation demonstrated that vismodegib effectively inhibited chordoma xenograft growth. This current preclinical evidence elucidates the therapeutic potential of Shh-Gli1 signaling pathway targeting for chordoma treatment. Vismodegib may be a promising targeted agent, and further clinical trials are warranted.	[Yang, Chenlong; Yong, Lei; Liang, Chen; Ma, Yunlong; Wei, Feng; Jiang, Liang; Zhou, Hua; He, Guanping; Pan, Xiaoyu; Hai, Bao; Liu, Zhongjun; Liu, Xiaoguang] Peking Univ, Hosp 3, Dept Orthoped, Beijing, Peoples R China; [Li, Yan] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing, Peoples R China; [Wu, Jian] Capital Med Univ, Sch Clin Med, Beijing, Peoples R China; [Xu, Yulun] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Dept Neurosurg, Beijing, Peoples R China	Peking University; Peking University; Capital Medical University; Capital Medical University	Liu, XG (corresponding author), Peking Univ, Hosp 3, Dept Orthoped, Beijing, Peoples R China.	liuxg.puth@hotmail.com	Zhou, Hua/HGC-9504-2022; Pan, Xiaoyu/ABE-1764-2021	Pan, Xiaoyu/0000-0002-5184-222X; Wu, Jian/0000-0003-3199-0492; Zhou, hua/0000-0002-2718-4108; Yang, Chenlong/0000-0001-8102-8811; Yang, Jun/0000-0002-7460-2800	National Natural Science Foundation of China [81641103, 81901202]; Postdoctoral Science Foundation of China [2018M630047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (81641103 to XL; 81901202 to CY) and the Postdoctoral Science Foundation of China (2018M630047 to CY).	Ahmed AT, 2018, SPINE, V43, pE1157, DOI 10.1097/BRS.0000000000002638; Akhavan-Sigari R, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020248; Amini P, 2017, BMC MOL BIOL, V18, DOI 10.1186/s12867-017-0099-7; Armas-Lopez L, 2017, ONCOTARGET, V8, P60684, DOI 10.18632/oncotarget.19527; Bari R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11098; Begnini A, 2010, BRIT J DERMATOL, V163, P364, DOI 10.1111/j.1365-2133.2010.09776.x; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Cates JMM, 2010, HISTOPATHOLOGY, V56, P978, DOI 10.1111/j.1365-2559.2010.03572.x; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chen H, 2017, CLIN CANCER RES, V23, P5176, DOI 10.1158/1078-0432.CCR-17-0177; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Cortes JE, 2019, CANCER TREAT REV, V76, P41, DOI 10.1016/j.ctrv.2019.04.005; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; GOTZ W, 1995, CELL TISSUE RES, V280, P455; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Incardona JP, 2000, CELL MOL LIFE SCI, V57, P1709, DOI 10.1007/PL00000653; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kitamura Y, 2017, BRAIN TUMOR PATHOL, V34, P78, DOI 10.1007/s10014-017-0283-y; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Lee IJ, 2017, WORLD NEUROSURG, V104, P346, DOI 10.1016/j.wneu.2017.04.118; Magic M, 2019, CLIN ORAL INVEST, V23, P2675, DOI 10.1007/s00784-018-2686-5; Otani R, 2018, J NEUROSURG, V128, P1428, DOI 10.3171/2016.12.JNS161444; Raffel C, 1997, CANCER RES, V57, P842; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Sari IN, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110208; Scheil-Bertram S, 2014, INT J ONCOL, V44, P1041, DOI 10.3892/ijo.2014.2268; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; SINICROPE FA, 1995, CANCER RES, V55, P237; Skoda AM, 2018, BOSNIAN J BASIC MED, V18, P8, DOI 10.17305/bjbms.2018.2756; Sun X, 2015, CURR REV MUSCULOSKE, V8, P344, DOI 10.1007/s12178-015-9311-x; Szkandera J, 2014, CLIN CANCER RES, V20, P1687, DOI 10.1158/1078-0432.CCR-13-1517; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Vinall RL, 2007, CLIN CANCER RES, V13, P6204, DOI 10.1158/1078-0432.CCR-07-0600; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075407; Williams S, 2019, CURR TOP DEV BIOL, V133, P49, DOI 10.1016/bs.ctdb.2018.11.018; Wu FJ, 2017, CELL CHEM BIOL, V24, P252, DOI 10.1016/j.chembiol.2017.02.010; Yakldoui Y, 2014, BBA-REV CANCER, V1846, P655, DOI 10.1016/j.bbcan.2014.07.012; Zhu JJ, 2016, P NATL ACAD SCI USA, V113, P3820, DOI 10.1073/pnas.1601252113	44	6	6	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	24					4711	4727		10.1038/s41388-020-1324-2	http://dx.doi.org/10.1038/s41388-020-1324-2		MAY 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LY0HO	32404987				2022-12-26	WOS:000532807900002
J	Shmulevich, R; Nissim, TBK; Wolf, I; Merenbakh-Lamin, K; Fishman, D; Sekler, I; Rubinek, T				Shmulevich, Riva; Nissim, Tsipi Ben-Kasus; Wolf, Ido; Merenbakh-Lamin, Keren; Fishman, Daniel; Sekler, Israel; Rubinek, Tami			Klotho rewires cellular metabolism of breast cancer cells through alteration of calcium shuttling and mitochondrial activity	ONCOGENE			English	Article							OPERATED CA2+ ENTRY; TUMOR-SUPPRESSOR; PROTEIN-KINASE; TCA CYCLE; GROWTH; AMPK; ACTIVATION; PATHWAY; PROLIFERATION; LIVER	Klotho is a transmembrane protein, which can be shed and act as a circulating hormone and is involved in regulating cellular calcium levels and inhibition of the PI3K/AKT pathway. As a longevity hormone, it protects normal cells from oxidative stress, and as a tumor suppressor it inhibits growth of cancer cells. Mechanisms governing these differential activities have not been addressed. Altered cellular metabolism is a hallmark of cancer and dysregulation of mitochondrial activity is a hallmark of aging. We hypothesized that klotho exerts its differential effects through regulation of these two hallmarks. Treatment with klotho inhibited glycolysis, reduced mitochondrial activity and membrane potential only in cancer cells. Accordingly, global metabolic screen revealed that klotho altered pivotal metabolic pathways, amongst them glycolysis and tricarboxylic acid cycle in breast cancer cells. Alteration of metabolic activity and increased AMP/ATP ratio lead to LKB1-dependent AMPK activation. Indeed, klotho induced AMPK phosphorylation; furthermore, inhibition of LKB1 partially abolished klotho's tumor suppressor activity. By diminishing deltapsi (Delta psi) klotho also inhibited mitochondria Ca2+ shuttling thereby impairing mitochondria communication with SOCE leading to reduced Ca2+ influx by SOCE channels. The reduced SOCE was followed by ER Ca2+ depletion and stress. These data delineate mechanisms mediating the differential effects of klotho toward cancer versus normal cells, and indicate klotho as a potent regulator of metabolic activity.	[Shmulevich, Riva; Wolf, Ido; Merenbakh-Lamin, Keren; Rubinek, Tami] Tel Aviv Sourasky Med Ctr, Inst Oncol, Tel Aviv, Israel; [Shmulevich, Riva; Wolf, Ido; Rubinek, Tami] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Nissim, Tsipi Ben-Kasus; Fishman, Daniel; Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, Beer Sheva, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University	Rubinek, T (corresponding author), Tel Aviv Sourasky Med Ctr, Inst Oncol, Tel Aviv, Israel.; Rubinek, T (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.; Sekler, I (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, Beer Sheva, Israel.	sekler@bgu.ac.il; rubinekt@gmail.com						Abramovitz L, 2011, CLIN CANCER RES, V17, P4254, DOI 10.1158/1078-0432.CCR-10-2749; Brown KA, 2013, MOL CELL ENDOCRINOL, V366, P170, DOI 10.1016/j.mce.2012.06.016; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-99; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Corbet C, 2017, BBA-REV CANCER, V1868, P7, DOI 10.1016/j.bbcan.2017.01.002; Cui CC, 2017, ACTA PHARM SIN B, V7, P3, DOI 10.1016/j.apsb.2016.11.001; Delcroix V, 2018, CANCERS, V10, DOI 10.3390/cancers10110439; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Fedida-Metula S, 2012, CARCINOGENESIS, V33, P740, DOI 10.1093/carcin/bgs021; Fox Melissa M, 2013, Genes Cancer, V4, P3, DOI 10.1177/1947601913486346; Hadad SM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-307; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2014, PHYSIOLOGY, V29, P99, DOI 10.1152/physiol.00050.2013; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Kim Hak-Su, 2014, Genes Cancer, V5, P175; Krishnan S, 2019, FASEB J, V33; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Lee Minjong, 2015, World J Biol Chem, V6, P148, DOI 10.4331/wjbc.v6.i3.148; Lewis RS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003970; Ligumsky H, 2015, MOL CANCER RES, V13, P1398, DOI 10.1158/1541-7786.MCR-15-0141; Lim K, 2015, J CLIN ENDOCR METAB, V100, P1308, DOI DOI 10.1210/jc.2015-1800; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Lojkin I, 2015, CANCER LETT, V362, P149, DOI 10.1016/j.canlet.2015.03.035; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Luengo A, 2017, CELL CHEM BIOL, V24, P1161, DOI 10.1016/j.chembiol.2017.08.028; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Manjarres IM, 2011, CELL CALCIUM, V49, P153, DOI 10.1016/j.ceca.2011.01.007; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Mignen O, 2005, J CELL SCI, V118, P5615, DOI 10.1242/jcs.02663; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nabeshima Y, 2002, AGEING RES REV, V1, P627, DOI 10.1016/S1568-1637(02)00027-2; Palty R, 2012, J BIOL CHEM, V287, P31650, DOI 10.1074/jbc.R112.355867; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pesakhov S, 2016, ONCOTARGET, V7, P31847, DOI 10.18632/oncotarget.7240; Putney JW, 2017, BBA-MOL CELL RES, V1864, P900, DOI 10.1016/j.bbamcr.2016.11.028; Raffaello A, 2016, TRENDS BIOCHEM SCI, V41, P1035, DOI 10.1016/j.tibs.2016.09.001; Rios M, 2013, CANCER RES, V73, P2628, DOI 10.1158/0008-5472.CAN-12-0861; Rubinek T, 2016, VITAM HORM, V101, P197, DOI 10.1016/bs.vh.2016.03.001; Rubinek T, 2012, BREAST CANCER RES TR, V133, P649, DOI 10.1007/s10549-011-1824-4; Rubinstein TA, 2019, ONCOGENE, V38, P794, DOI 10.1038/s41388-018-0489-4; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Spat A, 2017, ADV EXP MED BIOL, V993, P257, DOI 10.1007/978-3-319-57732-6_14; To MS, 2010, ARCH BIOCHEM BIOPHYS, V495, P152, DOI 10.1016/j.abb.2010.01.004; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vashisht A, 2015, AM J PHYSIOL-CELL PH, V309, pC457, DOI 10.1152/ajpcell.00064.2015; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Xie B, 2013, PATHOL ONCOL RES, V19, P611, DOI 10.1007/s12253-013-9663-8; Xie B, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-18; Zinger L, 2019, CLIN CANCER RES, V25, P2900, DOI 10.1158/1078-0432.CCR-18-1505; Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011	61	7	7	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	24					4636	4649		10.1038/s41388-020-1313-5	http://dx.doi.org/10.1038/s41388-020-1313-5		MAY 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LY0HO	32398866				2022-12-26	WOS:000532103100001
J	Mackay, AI; Bailleul, F; Carroll, EL; Andrews-Goff, V; Baker, CS; Bannisters, J; Boren, L; Carlyon, K; Donnelly, DM; Double, M; Goldsworthy, SD; Harcourt, R; Holman, D; Lowther, A; Parra, GJ; Childerhouse, SJ				Mackay, Alice, I; Bailleul, Frederic; Carroll, Emma L.; Andrews-Goff, Virginia; Baker, C. Scott; Bannisters, John; Boren, Laura; Carlyon, Krisa; Donnelly, David M.; Double, Michael; Goldsworthy, Simon D.; Harcourt, Robert; Holman, Dirk; Lowther, Andrew; Parra, Guido J.; Childerhouse, Simon J.			Satellite derived offshore migratory movements of southern right whales (Eubalaena australis) from Australian and New Zealand wintering grounds	PLOS ONE			English	Article							ATLANTIC RIGHT WHALE; FORAGING BEHAVIOR; GENETIC-STRUCTURE; INDIAN-OCEAN; POPULATION; VARIABILITY; FIDELITY; ECOLOGY; NOISE	Southern right whales (Eubalaena australis) migrate between Austral-winter calving and socialising grounds to offshore mid- to high latitude Austral-summer feeding grounds. In Australasia, winter calving grounds used by southern right whales extend from Western Australia across southern Australia to the New Zealand sub-Antarctic Islands. During the Austral-summer these whales are thought to migrate away from coastal waters to feed, but the location of these feeding grounds is only inferred from historical whaling data. We present new information on the satellite derived offshore migratory movements of six southern right whales from Australasian wintering grounds. Two whales were tagged at the Auckland Islands, New Zealand, and the remaining four at Australian wintering grounds, one at Pirates Bay, Tasmania, and three at Head of Bight, South Australia. The six whales were tracked for an average of 78.5 days (range: 29 to 150) with average individual distance of 38 km per day (range: 20 to 61 km). The length of individually derived tracks ranged from 645-6,381 km. Three likely foraging grounds were identified: south-west Western Australia, the Subtropical Front, and Antarctic waters, with the Subtropical Front appearing to be a feeding ground for both New Zealand and Australian southern right whales. In contrast, the individual tagged in Tasmania, from a sub-population that is not showing evidence of post-whaling recovery, displayed a distinct movement pattern to much higher latitude waters, potentially reflecting a different foraging strategy. Variable population growth rates between wintering grounds in Australasia could reflect fidelity to different quality feeding grounds. Unlike some species of baleen whale populations that show movement along migratory corridors, the new satellite tracking data presented here indicate variability in the migratory pathways taken by southern right whales from Australia and New Zealand, as well as differences in potential Austral summer foraging grounds.	[Mackay, Alice, I; Bailleul, Frederic; Goldsworthy, Simon D.] Primary Ind & Reg South Australia, South Australian Res & Dev Inst, Adelaide, SA, Australia; [Bailleul, Frederic; Goldsworthy, Simon D.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Carroll, Emma L.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Carroll, Emma L.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Andrews-Goff, Virginia; Double, Michael] Australian Marine Mammal Ctr, Australian Antarctic Div, Kingston, Tas, Australia; [Baker, C. Scott] Hatfield Marine Sci Ctr, Newport, OR USA; [Bannisters, John] Western Australian Museum, Welshpool Dc, WA, Australia; [Boren, Laura] New Zealand Dept Conservat, Wellington, New Zealand; [Carlyon, Krisa] Marine Conservat Program, Tasmanian Dept Primary Ind Pk Water & Environm, Hobart, Tas, Australia; [Donnelly, David M.] Killer Whales Australia, Box Hill, Vic, Australia; [Harcourt, Robert] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Holman, Dirk] Dept Environm & Water, Port Lincoln, SA, Australia; [Lowther, Andrew] Norwegian Polar Res Inst, Tromso, Norway; [Parra, Guido J.] Flinders Univ S Australia, Cetacean Ecol Behav & Evolut Lab, Adelaide, SA, Australia; [Childerhouse, Simon J.] Blue Planet Marine, Nelson, New Zealand	South Australian Research & Development Institute (SARDI); University of Adelaide; University of Auckland; University of St Andrews; Australian Antarctic Division; Western Australian Museum; Macquarie University; Norwegian Polar Institute; Flinders University South Australia	Mackay, AI (corresponding author), Primary Ind & Reg South Australia, South Australian Res & Dev Inst, Adelaide, SA, Australia.	Alice.I.Mackay@gmail.com	Carroll, Emma/U-9133-2019	Carroll, Emma/0000-0003-3193-7288; Andrews-Goff, Virginia/0000-0002-4609-7317; Goldsworthy, Simon/0000-0003-4988-9085; Harcourt, Robert/0000-0003-4666-2934; Lowther, Andrew/0000-0003-4294-3157	Australian Marine Mammal Center [13/48]	Australian Marine Mammal Center	Australian Marine Mammal Center Grant 13/48 AIM, SDG, DH, AL http://www.marinemammals.gov.au/The Australian Marine Mammal Center was involved in study design and anlaysis through the involvement in the project by AMMC staff, Dr Mike Double and Dr Virgina Andrews-Goff Princess Melikoff Trust Marine Mammal Conservation Program KC New Zealand Department of Conservation SC	Andrews Russel D., 2019, Journal of Cetacean Research and Management, V20, P27; Andrews-Goff V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30748-4; Baker CS, 2013, MAR ECOL PROG SER, V494, P291, DOI 10.3354/meps10508; Bannister J.L., 1986, Reports of the International Whaling Commission Special Issue, P255; Bannister JL, 1999, MAR MAMMAL SCI, V15, P1337, DOI 10.1111/j.1748-7692.1999.tb00895.x; Bannister JL, 1993, INT WHAL COMM UNPUB, P13; Bannister JL, 2016, IWC SCI COMM MAY; Bannister John, 2001, Journal of Cetacean Research and Management Special Issue, V2, P103; Barendse J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081238; Baumgartner MF, 2017, MAR ECOL PROG SER, V581, P165, DOI 10.3354/meps12315; BEST PB, 1993, MAR MAMMAL SCI, V9, P227, DOI 10.1111/j.1748-7692.1993.tb00451.x; Best PB, 2000, AFRICAN J MARINE SCI, P22; Best PB, 2015, MAR MAMMAL SCI, V31, P520, DOI 10.1111/mms.12168; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Burnell Stephen R., 2001, Journal of Cetacean Research and Management Special Issue, V2, P89; Carroll E, 2011, MAR ECOL PROG SER, V432, P257, DOI 10.3354/meps09145; Carroll EL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146590; Carroll EL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16182; Carroll EL, 2013, ECOL APPL, V23, P1677, DOI 10.1890/12-1657.1; Carroll EL, 2014, MAR MAMMAL SCI, V30, P206, DOI 10.1111/mms.12031; Charlton C, 2019, AQUAT CONSERV, V29, P576, DOI 10.1002/aqc.3032; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Clapham PJ, 2008, MAR MAMMAL SCI, V24, P183, DOI 10.1111/j.1748-7692.2007.00175.x; Clarke RH, 2017, AUST MAMMAL, V39, P248, DOI 10.1071/AM16007; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Davison GM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40329; Dawbin W., 1986, REPORT INT WHALING C, V10, P261; Double MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093578; Gales N, 2009, SC61SH17 INT WHAL CO; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Gowan TA, 2019, SCI REPORTS, V9, P1; Harcourt R, 2019, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00530; Haskins Townsend Charles, 1935, THE DISTRIBUTION OF; Hucke-Gaete R, 2018, PEERJ, V6, DOI 10.7717/peerj.4695; Hunt KE, 2016, CONSERV PHYSIOL, V4; Jackson JA, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150669; Lopez MEJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209324; Jonsen I, 2016, SCI REP-UK, V6, DOI 10.1038/srep20625; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kostianoy AG, 2004, J MARINE SYST, V45, P55, DOI 10.1016/j.jmarsys.2003.09.004; Lang AR, 2014, MAR MAMMAL SCI, V30, P1473, DOI 10.1111/mms.12129; Leaper R, 2006, BIOL LETTERS, V2, P289, DOI 10.1098/rsbl.2005.0431; Lysiak NSJ, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00168; Mate B, 2010, FEEDING HABITATS MIG; Mate BR, 2011, MAR MAMMAL SCI, V27, P455, DOI 10.1111/j.1748-7692.2010.00412.x; Mate BR, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0071; MAYO CA, 1990, CAN J ZOOL, V68, P2214, DOI 10.1139/z90-308; Meyer-Gutbrod EL, 2014, OCEANOGRAPHY, V27, P148; Moore JK, 2000, J GEOPHYS RES-OCEANS, V105, P28709, DOI 10.1029/1999JC000043; Moore M, 2013, MAR MAMMAL SCI, V29, pE98, DOI 10.1111/j.1748-7692.2012.00591.x; Morano JL, 2012, CONSERV BIOL, V26, P698, DOI 10.1111/j.1523-1739.2012.01866.x; Parks SE, 2007, J ACOUST SOC AM, V122, P3725, DOI 10.1121/1.2799904; Patenaude NJ, 2007, J HERED, V98, P147, DOI 10.1093/jhered/esm005; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Pettis HM, 2017, ENDANGER SPECIES RES, V32, P237, DOI 10.3354/esr00800; Pirzl R, 2009, MAR MAMMAL SCI, V25, P455, DOI 10.1111/j.1748-7692.2008.00276.x; Robbins J., 2013, REPORT SC65ASH05 PRE; Rolland RM, 2012, P ROY SOC B-BIOL SCI, V279, P2363, DOI 10.1098/rspb.2011.2429; Rowntree Victoria J., 2001, Journal of Cetacean Research and Management Special Issue, V2, P133; Seyboth E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28205; Smith TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034905; Suisted R, 2004, DEP CONSERVATION MAR; Swartz SL, 2006, MAMMAL REV, V36, P66, DOI 10.1111/j.1365-2907.2006.00082.x; Tomczak M, 2004, OCEAN DYNAM, V54, P506, DOI 10.1007/s10236-004-0095-6; Tormosov DD, 1998, BIOL CONSERV, V86, P185, DOI 10.1016/S0006-3207(98)00008-1; Torres LG, 2017, POLAR BIOL, V40, P95, DOI 10.1007/s00300-016-1926-x; Valenzuela LO, 2009, MOL ECOL, V18, P782, DOI 10.1111/j.1365-294X.2008.04069.x; van der Hoop J, 2017, ECOL EVOL, V7, P92, DOI 10.1002/ece3.2615; van der Hoop JM, 2016, MAR MAMMAL SCI, V32, P619, DOI 10.1111/mms.12292; Waite AM, 2007, DEEP-SEA RES PT II, V54, P789, DOI 10.1016/j.dsr2.2006.12.008; Watson M., 2014, 1229 AUSTR MAR MAMM; Weller DW, 2008, REPORT LARGE WHALE T; Zerbini A.N., 2018, IWC SCI COMM SLOV; Zerbini AN, 2016, SC66BBRG26 COMM INT	75	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0231577	10.1371/journal.pone.0231577	http://dx.doi.org/10.1371/journal.pone.0231577			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32380516	gold, Green Published			2022-12-26	WOS:000537285700013
J	Medeiros, CMP; Moreira, EUM; Pires, CV; Torres, LM; Guimaraes, LFF; Alves, JRS; Lima, BAS; Fontes, CJF; Costa, HL; Brito, CFA; Sousa, TN; Ntumngia, FB; Adams, JH; Kano, FS; Carvalho, LH				Medeiros, Camila M. P.; Moreira, Eduardo U. M.; Pires, Camilla, V; Torres, Leticia M.; Guimaraes, Luiz F. F.; Alves, Jessica R. S.; Lima, Barbara A. S.; Fontes, Cor J. F.; Costa, Helena L.; Brito, Cristiana F. A.; Sousa, Tais N.; Ntumngia, Francis B.; Adams, John H.; Kano, Flora S.; Carvalho, Luzia H.			Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-VIVAX; INHIBITORY ANTIBODIES; ACQUIRED-IMMUNITY; PLASMA-CELLS; MALARIA; ANTIGEN; BLOOD; ACQUISITION; EPITOPES	Background A low proportion of P. vivax-exposed individuals acquire protective strain-transcending neutralizing IgG antibodies that are able to block the interaction between the Duffy binding protein II (DBPII) and its erythrocyte-specific invasion receptor. In a recent study, a novel surface-engineered DBPII-based vaccine termed DEKnull-2, whose antibody response target conserved DBPII epitopes, was able to induce broadly binding-inhibitory IgG antibodies (BIAbs) that inhibit P. vivax reticulocyte invasion. Toward the development of DEKnull-2 as an effective P. vivax blood-stage vaccine, we investigate the relationship between naturally acquired DBPII-specific IgM response and the profile of IgG antibodies/BIAbs activity over time. Methodology/principal findings A nine-year follow-up study was carried-out among long-term P. vivax-exposed Amazonian individuals and included six cross-sectional surveys at periods of high and low malaria transmission. DBPII immune responses associated with either strain-specific (Sal1, natural DBPII variant circulating in the study area) or conserved epitopes (DEKnull-2) were monitored by conventional serology (ELISA-detected IgM and IgG antibodies), with IgG BIAbs activity evaluated by functional assays (in vitro inhibition of DBPII-erythrocyte binding). The results showed a tendency of IgM antibodies toward Sal1-specific response; the profile of Sal1 over DEKnull-2 was not associated with acute malaria and sustained throughout the observation period. The low malaria incidence in two consecutive years allowed us to demonstrate that variant-specific IgG (but not IgM) antibodies waned over time, which resulted in IgG skewed to the DEKnull-2 response. A persistent DBPII-specific IgM response was not associated with the presence (or absence) of broadly neutralizing IgG antibody response. Conclusions/significance The current study demonstrates that long-term exposure to low and unstable levels of P. vivax transmission led to a sustained DBPII-specific IgM response against variant-specific epitopes, while sustained IgG responses are skewed to conserved epitopes. Further studies should investigate on the role of a stable and persistent IgM antibody response in the immune response mediated by DBPII.	[Medeiros, Camila M. P.; Moreira, Eduardo U. M.; Pires, Camilla, V; Torres, Leticia M.; Guimaraes, Luiz F. F.; Alves, Jessica R. S.; Lima, Barbara A. S.; Costa, Helena L.; Brito, Cristiana F. A.; Sousa, Tais N.; Kano, Flora S.; Carvalho, Luzia H.] FIOCRUZ Minas, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Medeiros, Camila M. P.; Torres, Leticia M.; Carvalho, Luzia H.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Fontes, Cor J. F.] Univ Fed Mato Grosso, Hosp Julio Muller, Cuiaba, Mato Grosso, Brazil; [Ntumngia, Francis B.; Adams, John H.] Univ S Florida, Coll Publ Hlth, Ctr Global Hlth & Infect Dis Res, Tampa, FL 33620 USA	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal de Mato Grosso; State University System of Florida; University of South Florida	Kano, FS; Carvalho, LH (corresponding author), FIOCRUZ Minas, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.; Carvalho, LH (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	flora.kano@fiocruz.br; luzia.carvalho@fiocruz.br	Kano, Flora S./AAS-3215-2020; de Sousa, Tais Nobrega/AAG-6225-2019; Adams, John H./ABB-8458-2020; Carvalho, Luzia H/AAW-3461-2021	de Sousa, Tais Nobrega/0000-0002-6874-9427; Adams, John H./0000-0003-3707-7979; Ntumngia, Francis/0000-0001-9867-3534; Utsch Madureira Moreira, Eduardo/0000-0002-9513-2342; Guimaraes, Luiz/0000-0002-6346-027X	National Research Council for Scientific and Technological Development-CNPq [422257/2016-8]; Research Foundation of Minas Gerais-FAPEMIG [APQ-02625-15]; Programa Fiocruz de Fomento a Inovacao: Inova Fiocruz [VPPCB-007FIO-18-2-33]; NIH Research Project Grant Program [R01AI064478]; Coordination for the Improvement of Higher Education Personnel-CAPES (BASL); Coordination for the Improvement of Higher Education Personnel-CAPES (JRSA); Coordination for the Improvement of Higher Education Personnel-CAPES (LFFG); Coordination for the Improvement of Higher Education Personnel-CAPES (LMT); CNPq (CMPM); CNPq (HLC); CNPq (CVP); CNPq (EUMM); Program for Institutional Internationalization of the Higher Education Institutions; Research Institutions of Brazil-CAPES-PrInt from FIOCRUZ; UFMG	National Research Council for Scientific and Technological Development-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Foundation of Minas Gerais-FAPEMIG; Programa Fiocruz de Fomento a Inovacao: Inova Fiocruz; NIH Research Project Grant Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordination for the Improvement of Higher Education Personnel-CAPES (BASL); Coordination for the Improvement of Higher Education Personnel-CAPES (JRSA); Coordination for the Improvement of Higher Education Personnel-CAPES (LFFG); Coordination for the Improvement of Higher Education Personnel-CAPES (LMT); CNPq (CMPM)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq (HLC)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq (CVP)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq (EUMM)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Program for Institutional Internationalization of the Higher Education Institutions; Research Institutions of Brazil-CAPES-PrInt from FIOCRUZ; UFMG	This work was supported by The National Research Council for Scientific and Technological Development-CNPq (422257/2016-8 by LHC); The Research Foundation of Minas Gerais-FAPEMIG (APQ-02625-15 by LHC); Programa Fiocruz de Fomento a Inovacao: Inova Fiocruz (VPPCB-007FIO-18-2-33 by FSK); NIH Research Project Grant Program (R01AI064478 by JHA and LHC). LHC, CFAB, TNS and CFJF are research fellows from CNPq. Scholarships were sponsored by the Coordination for the Improvement of Higher Education Personnel-CAPES (BASL, JRSA, LFFG and LMT)) and CNPq (CMPM, HLC, CVP and EUMM). We also thank the financial support from the Program for Institutional Internationalization of the Higher Education Institutions and Research Institutions of Brazil-CAPES-PrInt from FIOCRUZ and UFMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; Adams JH, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a025585; Amaral LC, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2781-3; [Anonymous], 2009, MAN DIAGN LAB MAL; Arama C, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv118; Barber BE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004558; Battle KE, 2019, LANCET, V394, P332, DOI 10.1016/S0140-6736(19)31096-7; Boes M, 1998, J IMMUNOL, V160, P4776; Bohannon C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11826; Boonyaratanakornkit J, 2019, IMMUNOL CELL BIOL, V97, P771, DOI 10.1111/imcb.12292; Boyle MJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax4489; Carias LL, 2019, J IMMUNOL, V202, P2648, DOI 10.4049/jimmunol.1801631; Cassiano GC, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1350-2; Ceravolo IP, 2008, SCAND J IMMUNOL, V67, P270, DOI 10.1111/j.1365-3083.2007.02059.x; Ceravolo IP, 2009, CLIN EXP IMMUNOL, V156, P502, DOI 10.1111/j.1365-2249.2009.03931.x; Chen E, 2016, P NATL ACAD SCI USA, V113, P6277, DOI 10.1073/pnas.1600488113; Cheng Q, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003413; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Cole-Tobian JL, 2002, J INFECT DIS, V186, P531, DOI 10.1086/341776; Couper KN, 2005, PARASITE IMMUNOL, V27, P171, DOI 10.1111/j.1365-3024.2005.00760.x; da Silva HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202522; de Sousa TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022944; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029; FANG XD, 1991, MOL BIOCHEM PARASIT, V44, P125, DOI 10.1016/0166-6851(91)90228-X; George MT, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00194-19; HARTE PG, 1983, NATURE, V302, P256, DOI 10.1038/302256a0; Kano FS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005177; Kano FS, 2012, TROP MED INT HEALTH, V17, P989, DOI 10.1111/j.1365-3156.2012.03016.x; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Krotoski W A, 1989, Prog Clin Parasitol, V1, P1; Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452, DOI 10.4269/ajtmh.2009.80.452; Lopes SCP, 2014, J INFECT DIS, V209, P1403, DOI 10.1093/infdis/jiu018; McKenzie FE, 2002, J PARASITOL, V88, P521, DOI 10.1645/0022-3395(2002)088[0521:PVBSD]2.0.CO;2; MERTENS F, 1993, AM J TROP MED HYG, V49, P383, DOI 10.4269/ajtmh.1993.49.383; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Tomaz FMMB, 2015, CYTOKINE, V74, P273, DOI 10.1016/j.cyto.2015.03.020; Moreira CM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0884-z; Mueller I, 2013, ADV PARASIT, V81, P77, DOI 10.1016/B978-0-12-407826-0.00003-5; Nicolete VC, 2016, J INFECT DIS, V214, P1539, DOI 10.1093/infdis/jiw407; Ntumngia FB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13891-2; Ntumngia FB, 2012, INFECT IMMUN, V80, P1203, DOI 10.1128/IAI.05924-11; Ntumngia FB, 2012, CLIN VACCINE IMMUNOL, V19, P30, DOI 10.1128/CVI.05466-11; Obaldia N, 2018, MBIO, V9, DOI 10.1128/mBio.00625-18; Papillion AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178853; Patgaonkar M, 2018, PARASITE IMMUNOL, V40, DOI 10.1111/pim.12580; Pires CV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207244; Pleass RJ, 2016, TRENDS PARASITOL, V32, P108, DOI 10.1016/j.pt.2015.09.007; Roth A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30713-1; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Soares IS, 1999, AM J TROP MED HYG, V60, P357, DOI 10.4269/ajtmh.1999.60.357; Sousa TN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-334; Souza-Silva FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093782; Stanisic DI, 2015, INFECT IMMUN, V83, P646, DOI 10.1128/IAI.02398-14; Stone SL, 2016, IMMUNITY, V45, P235, DOI 10.1016/j.immuni.2016.08.005; Urusova D, 2019, NAT MICROBIOL, V4, P1486, DOI 10.1038/s41564-019-0461-2; Winter O, 2012, J IMMUNOL, V189, P5105, DOI 10.4049/jimmunol.1202317	59	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232786	10.1371/journal.pone.0232786	http://dx.doi.org/10.1371/journal.pone.0232786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379804	Green Published, gold			2022-12-26	WOS:000537285700067
J	Nikinmaa, S; Alapulli, H; Auvinen, P; Vaara, M; Rantala, J; Kankuri, E; Sorsa, T; Meurman, J; Patila, T				Nikinmaa, Sakari; Alapulli, Heikki; Auvinen, Petri; Vaara, Martti; Rantala, Juha; Kankuri, Esko; Sorsa, Timo; Meurman, Jukka; Patila, Tommi			Dual-light photodynamic therapy administered daily provides a sustained antibacterial effect on biofilm and prevents Streptococcus mutans adaptation	PLOS ONE			English	Article							INDOCYANINE GREEN; RESISTANCE; CARIES	Antibacterial photodynamic therapy (aPDT) and antibacterial blue light (aBL) are emerging treatment methods auxiliary to mechanical debridement for periodontitis. APDT provided with near-infrared (NIR) light in conjunction with an indocyanine green (ICG) photosensitizer has shown efficacy in several dental in-office-treatment protocols. In this study, we tested Streptococcus mutans biofilm sensitivity to either aPDT, aBL or their combination dual-light aPDT (simultaneous aPDT and aBL) exposure. Biofilm was cultured by pipetting diluted Streptococcus mutans suspension with growth medium on the bottom of well plates. Either aPDT (810 nm) or aBL (405 nm) or a dual-light aPDT (simultaneous 810 nm aPDT and 405 nm aBL) was applied with an ICG photosensitizer in cases of aPDT or dual-light, while keeping the total given radiant exposure constant at 100 J/cm(2). Single-dose light exposures were given after one-day or four-day biofilm incubations. Also, a model of daily treatment was provided by repeating the same light dose daily on four-day and fourteen-day biofilm incubations. Finally, the antibacterial action of the dual-light aPDT with different energy ratios of 810 nm and 405 nm of light were examined on the single-day and four-day biofilm protocols. At the end of each experiment the bacterial viability was assessed by colony-forming unit method. Separate samples were prepared for confocal 3D biofilm imaging. On a one-day biofilm, the dual-light aPDT was significantly more efficient than aBL or aPDT, although all modalities were bactericidal. On a four-day biofilm, a single exposure of aPDT or dual-light aPDT was more efficient than aBL, resulting in a four logarithmic scale reduction in bacterial counts. Surprisingly, when the same amount of aPDT was repeated daily on a four-day or a fourteen-day biofilm, bacterial viability improved significantly. A similar improvement in bacterial viability was observed after repetitive aBL application. This viability improvement was eliminated when dual-light aPDT was applied. By changing the 405 nm to 810 nm radiant exposure ratio in dual-light aPDT, the increase in aBL improved the antibacterial action when the biofilm was older. In conclusion, when aPDT is administered repeatedly to S. mutans biofilm, a single wavelength-based aBL or aPDT leads to a significant biofilm adaptation and increased S. mutans viability. The combined use of aBL light in synchrony with aPDT arrests the adaptation and provides significantly improved and sustained antibacterial efficacy.	[Nikinmaa, Sakari; Meurman, Jukka; Patila, Tommi] Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland; [Nikinmaa, Sakari; Rantala, Juha; Patila, Tommi] Koite Hlth Oy, Espoo, Finland; [Alapulli, Heikki; Sorsa, Timo; Meurman, Jukka] Univ Helsinki, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Auvinen, Petri] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Vaara, Martti] Northern Antibiot, Espoo, Finland; [Vaara, Martti] Univ Helsinki, Med Sch, Dept Bacteriol & Immunol, Helsinki, Finland; [Kankuri, Esko] Univ Helsinki, Dept Pharmacol, Helsinki, Finland; [Sorsa, Timo] Karolinska Inst, Dept Oral Dis, Huddinge, Sweden; [Patila, Tommi] Univ Helsinki, New Childrens Hosp, Dept Congenital Heart Surg & Organ Transplantat, Helsinki, Finland	Aalto University; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Karolinska Institutet; University of Helsinki	Patila, T (corresponding author), Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland.; Patila, T (corresponding author), Koite Hlth Oy, Espoo, Finland.; Patila, T (corresponding author), Univ Helsinki, New Childrens Hosp, Dept Congenital Heart Surg & Organ Transplantat, Helsinki, Finland.	tommi.patila@hus.fi	Auvinen, Petri/AAP-8117-2021; Auvinen, Petri/D-5044-2009	Auvinen, Petri/0000-0002-3947-4778; Kankuri, Esko/0000-0002-2193-8773				Chenicheri S, 2017, OPEN DENT J, V11, P312, DOI 10.2174/1874210601711010312; Cieplik F, 2018, CRIT REV MICROBIOL, V44, P571, DOI 10.1080/1040841X.2018.1467876; Claydon NC, CURRENT CONCEPTS TOO; Costa EM, 2013, ANAEROBE, V20, P27, DOI 10.1016/j.anaerobe.2013.02.002; CRUZ CD, 2018, BMC MICROBIOL, V18, P4806, DOI DOI 10.1186/S12866-017-1144-X; de Sousa DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131941; Engel E, 2008, INVEST OPHTH VIS SCI, V49, P1777, DOI 10.1167/iovs.07-0911; Esberg A, 2017, EBIOMEDICINE, V24, P205, DOI 10.1016/j.ebiom.2017.09.027; Fekrazad R, 2013, PHOTODIAGN PHOTODYN, V10, P626, DOI 10.1016/j.pdpdt.2013.07.002; Guffey JS, 2013, PHOTOMED LASER SURG, V31, P179, DOI 10.1089/pho.2012.3450; HOLLINS B, 1987, CLIN CHEM, V33, P765; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Larsen T, 2017, APMIS, V125, P376, DOI 10.1111/apm.12688; Lee YH, 2012, INT J ORAL SCI, V4, P196, DOI 10.1038/ijos.2012.63; Liu CC, 2015, SCI REP-UK, V5, DOI 10.1038/srep12929; Rineh A, 2018, BIOORG MED CHEM LETT, V28, P2736, DOI 10.1016/j.bmcl.2018.02.041; Robinson JM, 2009, HISTOCHEM CELL BIOL, V131, P465, DOI 10.1007/s00418-009-0565-5; Shafirstein G, 2012, INT J CANCER, V130, P1208, DOI 10.1002/ijc.26126; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Song T, 2013, PROCEEDINGS OF THE 2013 SUZHOU-SILICON VALLEY-BEIJING INTERNATIONAL INNOVATION CONFERENCE (SIIC): TECHNOLOGY INNOVATION AND DIASPORAS IN A GLOBAL ERA, P72, DOI 10.1109/SIIC.2013.6624169; Soukos NS, 2005, ANTIMICROB AGENTS CH, V49, P1391, DOI 10.1128/AAC.49.4.1391-1396.2005; Steinberg D, 2008, ANTIMICROB AGENTS CH, V52, P2626, DOI 10.1128/AAC.01666-07; Tam K, 2007, CARIES RES, V41, P474, DOI 10.1159/000108321; Tavares A, 2010, MAR DRUGS, V8, P91, DOI 10.3390/md8010091; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P196, DOI 10.1128/AAC.50.1.196-203.2006; Wang YC, 2017, DRUG RESIST UPDATE, V33-35, P1, DOI 10.1016/j.drup.2017.10.002; Yuan BH, 2004, J BIOMED OPT, V9, P497, DOI 10.1117/1.1695411	27	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232775	10.1371/journal.pone.0232775	http://dx.doi.org/10.1371/journal.pone.0232775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374766	Green Published, Green Submitted, gold			2022-12-26	WOS:000537283500060
J	Junkova, P; Pleskot, R; Prchal, J; Sys, J; Ruml, T				Junkova, Petra; Pleskot, Roman; Prchal, Jan; Sys, Jakub; Ruml, Tomas			Differences and commonalities in plasma membrane recruitment of the two morphogenetically distinct retroviruses HIV-1 and MMTV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1; mouse mammary tumor virus (MMTV); matrix protein; covalent labeling?mass spectrometry; coarse-grained molecular dynamics; Gag polyprotein; particle assembly; viral replication; retrovirus; membrane binding; mass spectrometry (MS); molecular dynamics; retrovirus; lipid?protein interaction; human immunodeficiency virus (HIV)	VIRUS MATRIX PROTEIN; PFIZER MONKEY VIRUS; COARSE-GRAINED SIMULATIONS; AMINO-ACID SUBSTITUTIONS; GAG PROTEIN; BINDING DOMAIN; TUMOR-VIRUSES; BASIC REGION; FORCE-FIELD; ENVELOPE	Retroviral Gag polyproteins are targeted to the inner leaflet of the plasma membrane through their N-terminal matrix (MA) domain. Because retroviruses of different morphogenetic types assemble their immature particles in distinct regions of the host cell, the mechanism of MA-mediated plasma membrane targeting differs among distinct retroviral morphogenetic types. Here, we focused on possible mechanistic differences of the MA-mediated plasma membrane targeting of the B-type mouse mammary tumor virus (MMTV) and C-type HIV-1, which assemble in the cytoplasm and at the plasma membrane, respectively. Molecular dynamics simulations, together with surface mapping, indicated that, similarly to HIV-1, MMTV uses a myristic switch to anchor the MA to the membrane and electrostatically interacts with phosphatidylinositol 4,5-bisphosphate to stabilize MA orientation. We observed that the affinity of MMTV MA to the membrane is lower than that of HIV-1 MA, possibly related to their different topologies and the number of basic residues in the highly basic MA region. The latter probably reflects the requirement of C-type retroviruses for tighter membrane binding, essential for assembly, unlike for D/B-type retroviruses, which assemble in the cytoplasm. A comparison of the membrane topology of the HIV-1 MA, using the surface-mapping method and molecular dynamics simulations, revealed that the residues at the HIV-1 MA C terminus help stabilize protein?protein interactions within the HIV-1 MA lattice at the plasma membrane. In summary, HIV-1 and MMTV share common features such as membrane binding of the MA via hydrophobic interactions and exhibit several differences, including lower membrane affinity of MMTV MA.	[Junkova, Petra; Prchal, Jan; Sys, Jakub; Ruml, Tomas] Univ Chem & Technol, Dept Biochem & Microbiol, Prague, Czech Republic; [Junkova, Petra] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Pleskot, Roman] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Pleskot, Roman] VIB Ctr Plant Syst Biol, Ghent, Belgium	University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Ruml, T (corresponding author), Univ Chem & Technol, Dept Biochem & Microbiol, Prague, Czech Republic.	tomas.ruml@vscht.cz	Prchal, Jan/H-9756-2014; Pleskot, Roman/F-7774-2014	Prchal, Jan/0000-0002-3398-5059; Pleskot, Roman/0000-0003-0436-9748	Czech Science Foundation [GA17-24281S]; European Regional Development Fund Project "ChemBioDrug" Grant [CZ.02.1.01/0.0/0.0/16_ 019/0000729]	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund Project "ChemBioDrug" Grant	This work was supported by Czech Science Foundation Grant GA17-24281S (to T. R.) and by European Regional Development Fund Project "ChemBioDrug" Grant CZ.02.1.01/0.0/0.0/16_ 019/0000729 (to P. J.).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Alfadhli A, 2007, J VIROL, V81, P1472, DOI 10.1128/JVI.02122-06; Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERNHARD W, 1958, CANCER RES, V18, P491; BERNHARD W, 1960, CANCER RES, V20, P712; Brandano L, 2012, J VIROL, V86, P2347, DOI 10.1128/JVI.06047-11; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Burniston MT, 1999, J VIROL, V73, P8527, DOI 10.1128/JVI.73.10.8527-8540.1999; Charlier L, 2014, BIOPHYS J, V106, P577, DOI 10.1016/j.bpj.2013.12.019; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Choi G, 1999, J VIROL, V73, P5431, DOI 10.1128/JVI.73.7.5431-5437.1999; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Dalton AK, 2005, J VIROL, V79, P6227, DOI 10.1128/JVI.79.10.6227-6238.2005; Datta SAK, 2007, J MOL BIOL, V365, P799, DOI 10.1016/j.jmb.2006.10.072; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Dick RA, 2012, P NATL ACAD SCI USA, V109, P18761, DOI 10.1073/pnas.1209408109; Dolezal M, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-015-0235-8; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; ERDIE CR, 1990, J VIROL, V64, P5204, DOI 10.1128/JVI.64.10.5204-5208.1990; Fernandes F, 2011, TRAFFIC, V12, P438, DOI 10.1111/j.1600-0854.2010.01153.x; FINE D, 1978, CANCER RES, V38, P3123; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Gaines CR, 2018, J MOL BIOL, V430, P2113, DOI 10.1016/j.jmb.2018.04.042; GELDERBLOM HR, 1989, ARCH VIROL, V106, P1, DOI 10.1007/BF01311033; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; Hearps AC, 2008, BIOCHEMISTRY-US, V47, P2199, DOI 10.1021/bi701360j; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNTER E, 1990, CURR TOP MICROBIOL, V157, P187; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Inlora J, 2014, MBIO, V5, DOI 10.1128/mBio.02202-14; Inlora J, 2011, J VIROL, V85, P3802, DOI 10.1128/JVI.02383-10; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Junkova P, 2016, PROTEINS, V84, P1717, DOI 10.1002/prot.25156; Kiernan RE, 1998, J VIROL, V72, P4116, DOI 10.1128/JVI.72.5.4116-4126.1998; Kroupa T, 2016, J MOL BIOL, V428, P4708, DOI 10.1016/j.jmb.2016.10.010; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Lindwasser OW, 2002, P NATL ACAD SCI USA, V99, P13037, DOI 10.1073/pnas.212409999; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; Lochrie MA, 1997, NUCLEIC ACIDS RES, V25, P2902, DOI 10.1093/nar/25.14.2902; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Mendoza VL, 2009, MASS SPECTROM REV, V28, P785, DOI 10.1002/mas.20203; Mercredi PY, 2016, J MOL BIOL, V428, P1637, DOI 10.1016/j.jmb.2016.03.005; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Murphy RE, 2019, J BIOL CHEM, V294, P18600, DOI 10.1074/jbc.RA119.010997; Nadaraia-Hoke S, 2013, J VIROL, V87, P3609, DOI 10.1128/JVI.03059-12; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 1997, J VIROL, V71, P4409, DOI 10.1128/JVI.71.6.4409-4418.1997; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Ott DE, 2005, J VIROL, V79, P13839, DOI 10.1128/JVI.79.22.13839-13847.2005; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Prchal J, 2012, J MOL BIOL, V423, P427, DOI 10.1016/j.jmb.2012.07.021; Prchal J, 2011, PROTEIN EXPRES PURIF, V79, P122, DOI 10.1016/j.pep.2011.05.010; Provitera P, 2000, J MOL BIOL, V296, P887, DOI 10.1006/jmbi.1999.3482; Qi YF, 2015, J CHEM THEORY COMPUT, V11, P4486, DOI 10.1021/acs.jctc.5b00513; Ramalingam D, 2011, J VIROL, V85, P305, DOI 10.1128/JVI.02626-09; RHEE SS, 1991, EMBO J, V10, P535, DOI 10.1002/j.1460-2075.1991.tb07980.x; RHEE SS, 1990, CELL, V63, P77, DOI 10.1016/0092-8674(90)90289-Q; RHEE SS, 1987, J VIROL, V61, P1045, DOI 10.1128/JVI.61.4.1045-1053.1987; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Sanford B, 2014, VIROLOGY, V468, P293, DOI 10.1016/j.virol.2014.08.017; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Stansell E, 2007, J VIROL, V81, P8977, DOI 10.1128/JVI.00657-07; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tedbury PR, 2016, P NATL ACAD SCI USA, V113, pE182, DOI 10.1073/pnas.1516618113; Tedbury PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003739; Thornhill D, 2019, J VIROL, V93, DOI 10.1128/JVI.00756-19; Valentine KG, 2010, STRUCTURE, V18, P9, DOI 10.1016/j.str.2009.11.010; Vlach J, 2008, P NATL ACAD SCI USA, V105, P10565, DOI 10.1073/pnas.0801765105; Vlach J, 2018, J BIOL CHEM, V293, P18828, DOI 10.1074/jbc.RA118.003944; Vlach J, 2014, J BIOL CHEM, V289, P8697, DOI 10.1074/jbc.M113.543694; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Vlach J, 2009, J MOL BIOL, V390, P967, DOI 10.1016/j.jmb.2009.05.063; Watanabe SM, 2018, J BIOL CHEM, V293, P18841, DOI 10.1074/jbc.RA118.003947; Yandrapalli N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39332; Yasuda J, 2000, VIROLOGY, V268, P533, DOI 10.1006/viro.1999.0179; Zhang GZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131515; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	86	3	3	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8819	8833		10.1074/jbc.RA119.011991	http://dx.doi.org/10.1074/jbc.RA119.011991			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32385109	Green Published, hybrid			2022-12-26	WOS:000546296800017
J	Miyazaki, T; Park, EY				Miyazaki, Takatsugu; Park, Enoch Y.			Structure?function analysis of silkworm sucrose hydrolase uncovers the mechanism of substrate specificity in GH13 subfamily 17exo-?-glucosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; crystal structure; enzyme kinetics; sucrose; carbohydrate metabolism; phylogenetic; glycoside hydrolase family 13 subfamily 17 (GH13_17); BmSUH; BmSUC1; Bombyx mori; conformational change; enzyme mechanism; inhibitor; substrate specificity; phylogenetics	ALPHA-GLUCOSIDASE-I; CRYSTAL-STRUCTURE; STRUCTURAL-ANALYSIS; TREHALOSE SYNTHASE; MOLECULAR-CLONING; PRODUCT SPECIFICITY; CATALYTIC MECHANISM; BOMBYX-MORI; AMYLASE; ENZYME	The domestic silkwormBombyx moriexpresses two sucrose-hydrolyzing enzymes, BmSUH and BmSUC1, belonging to glycoside hydrolase family 13 subfamily 17 (GH13_17) and GH32, respectively. BmSUH has little activity on maltooligosaccharides, whereas other insect GH13_17 ?-glucosidases are active on sucrose and maltooligosaccharides. Little is currently known about the structural mechanisms and substrate specificity of GH13_17 enzymes. In this study, we examined the crystal structures of BmSUH without ligands; in complexes with substrates, products, and inhibitors; and complexed with its covalent intermediate at 1.60?1.85 ? resolutions. These structures revealed that the conformations of amino acid residues around subsite ?1 are notably different at each step of the hydrolytic reaction. Such changes have not been previously reported among GH13 enzymes, includingexo- andendo-acting hydrolases, such as ?-glucosidases and ?-amylases. Amino acid residues at subsite +1 are not conserved in BmSUH and other GH13_17 ?-glucosidases, but subsite ?1 residues are absolutely conserved. Substitutions in three subsite +1 residues, Gln(191), Tyr(251), and Glu(440), decreased sucrose hydrolysis and increased maltase activity of BmSUH, indicating that these residues are key for determining its substrate specificity. These results provide detailed insights into structure?function relationships in GH13 enzymes and into the molecular evolution of insect GH13_17 ?-glucosidases.	[Miyazaki, Takatsugu; Park, Enoch Y.] Shizuoka Univ, Res Inst Green Sci & Technol, Green Chem Res Div, Shizuoka, Japan	Shizuoka University	Miyazaki, T (corresponding author), Shizuoka Univ, Res Inst Green Sci & Technol, Green Chem Res Div, Shizuoka, Japan.	miyazaki.takatsugu@shizuoka.ac.jp	Miyazaki, Takatsugu/M-1498-2016	Miyazaki, Takatsugu/0000-0003-1809-0641	Japan Society for the Promotion of Science KAKENHI [19K15748]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 19K15748 (to T. M.).	Alonso-Gil S, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00269; Auiewiriyanukul W, 2018, FEBS LETT, V592, P2268, DOI 10.1002/1873-3468.13126; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; Caner S, 2013, GLYCOBIOLOGY, V23, P1075, DOI 10.1093/glycob/cwt044; Caputo AT, 2016, P NATL ACAD SCI USA, V113, pE4630, DOI 10.1073/pnas.1604463113; Champion E, 2009, ACTA CRYSTALLOGR D, V65, P1309, DOI 10.1107/S0907444909040311; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dai X, 2019, INSECT MOL BIOL, V28, P862, DOI 10.1111/imb.12603; Daimon T, 2008, J BIOL CHEM, V283, P15271, DOI 10.1074/jbc.M709350200; do Nascimento NA, 2017, INSECT BIOCHEM MOLEC, V81, P62, DOI 10.1016/j.ibmb.2016.12.009; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gabrisko M, 2013, J MOL EVOL, V76, P129, DOI 10.1007/s00239-013-9545-4; Gabrisko M, 2011, J MOL EVOL, V72, P104, DOI 10.1007/s00239-010-9406-3; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Guerin F, 2012, J BIOL CHEM, V287, P6642, DOI 10.1074/jbc.M111.322917; Hobbs JK, 2013, ACS CHEM BIOL, V8, P2388, DOI 10.1021/cb4005029; Holm L, 2019, BIOINFORMATICS, V35, P5326, DOI 10.1093/bioinformatics/btz536; Hondoh H, 2008, J MOL BIOL, V378, P913, DOI 10.1016/j.jmb.2008.03.016; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; JAMES AA, 1989, GENE, V75, P73, DOI 10.1016/0378-1119(89)90384-3; Jensen MH, 2004, BIOCHEMISTRY-US, V43, P3104, DOI 10.1021/bi0357762; Ji XM, 2005, J MOL EVOL, V60, P615, DOI 10.1007/s00239-004-0242-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kim HS, 2004, J BACTERIOL, V186, P411, DOI 10.1128/JB.186.2.411-418.2004; Kim MJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P277, DOI 10.1006/abbi.1999.1423; Kimura A, 2004, CARBOHYD RES, V339, P1035, DOI 10.1016/j.carres.2003.10.035; Kobayashi M, 2015, FEBS LETT, V589, P484, DOI 10.1016/j.febslet.2015.01.005; Konno K, 2006, P NATL ACAD SCI USA, V103, P1337, DOI 10.1073/pnas.0506944103; Koropatkin NM, 2010, STRUCTURE, V18, P200, DOI 10.1016/j.str.2009.12.010; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lammens W, 2009, J EXP BOT, V60, P727, DOI 10.1093/jxb/ern333; Larsbrink J, 2012, J BIOL CHEM, V287, P43288, DOI 10.1074/jbc.M112.416511; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li CM, 2005, BIOCHEMISTRY-US, V44, P3347, DOI 10.1021/bi048334e; Li XT, 2017, SCI REP-UK, V7, DOI 10.1038/srep45787; Light SH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.202; Lin MG, 2016, ACTA CRYSTALLOGR D, V72, P59, DOI 10.1107/S2059798315020756; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; MATSUURA Y, 1984, J BIOCHEM-TOKYO, V95, P697, DOI 10.1093/oxfordjournals.jbchem.a134659; Mirza O, 2006, J BIOL CHEM, V281, P35576, DOI 10.1074/jbc.M605611200; Miyazaki T, 2019, INSECT BIOCHEM MOLEC, V115, DOI 10.1016/j.ibmb.2019.103254; Miyazaki T, 2016, J STRUCT BIOL, V196, P479, DOI 10.1016/j.jsb.2016.09.015; Moller MS, 2012, J BACTERIOL, V194, P4249, DOI 10.1128/JB.00622-12; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ngiwsara L, 2012, BIOSCI BIOTECH BIOCH, V76, P1967, DOI 10.1271/bbb.120473; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1703, DOI 10.1271/bbb.70125; Ohashi K, 1996, BIOCHEM BIOPH RES CO, V221, P380, DOI 10.1006/bbrc.1996.0604; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palcic MM, 1999, GLYCOCONJUGATE J, V16, P351, DOI 10.1023/A:1007096011392; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ravaud S, 2007, J BIOL CHEM, V282, P28126, DOI 10.1074/jbc.M704515200; Ravaud S, 2009, FEBS LETT, V583, P1964, DOI 10.1016/j.febslet.2009.05.002; Reid SJ, 2005, APPL MICROBIOL BIOT, V67, P312, DOI 10.1007/s00253-004-1885-y; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roy R, 2013, ACS CHEM BIOL, V8, P2245, DOI 10.1021/cb400508k; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sharma M, 2019, INT J BIOL MACROMOL, V140, P1315, DOI 10.1016/j.ijbiomac.2019.08.126; Shen X, 2015, ACTA CRYSTALLOGR D, V71, P1382, DOI 10.1107/S139900471500721X; Shirai T, 2008, PROTEINS, V73, P126, DOI 10.1002/prot.22044; SIERKS MR, 1990, PROTEIN ENG, V3, P193, DOI 10.1093/protein/3.3.193; SILVERSTEIN R, 1967, J BIOL CHEM, V242, P1338; Sim L, 2014, J BIOL CHEM, V289, P22991, DOI 10.1074/jbc.M114.565044; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Skov LK, 2001, J BIOL CHEM, V276, P25273, DOI 10.1074/jbc.M010998200; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Strobl S, 1998, J MOL BIOL, V278, P617, DOI 10.1006/jmbi.1998.1667; Suthangkornkul R, 2015, PROTEIN EXPRES PURIF, V110, P145, DOI 10.1016/j.pep.2015.02.018; Syson K, 2014, BIOCHEMISTRY-US, V53, P2494, DOI 10.1021/bi500183c; Tagami T, 2013, J BIOL CHEM, V288, P19296, DOI 10.1074/jbc.M113.465211; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Wang HB, 2015, INSECT BIOCHEM MOLEC, V61, P46, DOI 10.1016/j.ibmb.2015.04.005; Wang JQ, 2017, J AGR FOOD CHEM, V65, P7726, DOI 10.1021/acs.jafc.7b02732; Wang YL, 2014, ACTA CRYSTALLOGR D, V70, P3144, DOI 10.1107/S1399004714022500; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; Wongchawalit J, 2006, BIOSCI BIOTECH BIOCH, V70, P2889, DOI 10.1271/bbb.60302; Woo EJ, 2008, J BIOL CHEM, V283, P28641, DOI 10.1074/jbc.M802560200; Xie J, 2016, J BIOL CHEM, V291, P25667, DOI 10.1074/jbc.M116.759290; Xu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074788; Yamamoto K, 2010, FEBS J, V277, P4205, DOI 10.1111/j.1742-4658.2010.07810.x; Zhang DH, 2003, J BIOL CHEM, V278, P35428, DOI 10.1074/jbc.M302616200; Zhang R, 2009, BIOCHEMISTRY-US, V48, P10752, DOI 10.1021/bi901400p; Zheng LB, 1995, EXP PARASITOL, V81, P272, DOI 10.1006/expr.1995.1118	89	5	5	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8784	8797		10.1074/jbc.RA120.013595	http://dx.doi.org/10.1074/jbc.RA120.013595			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32381508	Green Published, hybrid			2022-12-26	WOS:000546296800014
J	Misawa, K; Mai, A; Matsui, H; Kanai, A; Misawa, Y; Mochizuki, D; Mima, M; Yamada, S; Kurokawa, T; Nakagawa, T; Mineta, H				Misawa, Kiyoshi; Mai, Atsushi; Matsui, Hirotaka; Kanai, Akinori; Misawa, Yuki; Mochizuki, Daiki; Mima, Masato; Yamada, Satoshi; Kurokawa, Tomoya; Nakagawa, Takuya; Mineta, Hiroyuki			Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA	ONCOGENE			English	Article							CALMODULIN-LIKE PROTEIN; HUMAN-PAPILLOMAVIRUS; CLINICAL-SIGNIFICANCE; DNA METHYLATION; NECK-CANCER; HEAD; SURVIVAL; SERUM; STAGE	Human papilloma virus (HPV)-associated oropharyngeal cancer (OPC) is an independent tumour type with regard to cellular, biological, and clinical features. The use of non-invasive biomarkers such as circulating tumour DNA (ctDNA) may be relevant in early diagnosis and eventually improve the outcomes of patients with head and neck squamous cell carcinoma (HNSCC). Genome-wide discovery using RNA sequencing and reduced representation bisulfite sequencing yielded 21 candidates for methylation-targeted genes. A verification study (252 HNSCC patients) using quantitative methylation-specific PCR (Q-MSP) identified 10 genes (ATP2A1, CALML5, DNAJC5G, GNMT, GPT, LY6D, LYNX1, MAL, MGC16275, and MRGPRF) that showed a significant increase recurrence in methylation groups with OPC. Further study on ctDNA using Q-MSP in HPV-associated OPC showed that three genes (CALML5, DNAJC5G, and LY6D) had a high predictive ability as emerging biomarkers for a validation set, each capable of discriminating between the plasma of the patients from healthy individuals. Among the 42 ctDNA samples, methylated CALML5, DNAJC5G, and LY6D were observed in 31 (73.8%), 19 (45.2%), and 19 (45.2%) samples, respectively. Among pre-treatment ctDNA samples, methylated CALML5, DNAJC5G, and LY6D were observed in 8/8 (100%), 7/8 (87.5%), and 7/8 (87.5%) samples, respectively. Methylated CALML5, DNAJC5G, and LY6D were found in 2/8 (25.0%), 0/8 (0%), and 1/8 (12.5%) of the final samples in the series, respectively. Here, we present the relationship between the methylation status of three specific genes and cancer recurrence for risk classification of HPV-associated OPC cases. In conclusion, ctDNA analysis has the potential to aid in determining patient prognosis and real-time surveillance for disease recurrences and serves as an alternative method of screening for HPV-associated OPC.	[Misawa, Kiyoshi; Mai, Atsushi; Misawa, Yuki; Mochizuki, Daiki; Mima, Masato; Yamada, Satoshi; Mineta, Hiroyuki] Hamamatsu Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Shizuoka, Japan; [Matsui, Hirotaka] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Lab Med, Kumamoto, Japan; [Kanai, Akinori] Hiroshima Univ, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Kurokawa, Tomoya; Nakagawa, Takuya] Chiba Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Chiba, Japan	Hamamatsu University School of Medicine; Kumamoto University; Hiroshima University; Chiba University	Misawa, K (corresponding author), Hamamatsu Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Shizuoka, Japan.	kiyoshim@hama-med.ac.jp	Matsui, Hirotaka/AED-6669-2022; Yamada, Satohi/HHY-9909-2022	Matsui, Hirotaka/0000-0002-6266-3227; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [16K11228, 16K20239, 17K16904, 17K16903, 19K09866, 19K09906, 19K18728]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by a Grant-in-Aid for Scientific Research (No. 16K11228, No. 16K20239, 17K16904, 17K16903, 19K09866, 19K09906 and 19K18728) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Barros-Silva JD, 2018, CELL REP, V25, P3504, DOI 10.1016/j.celrep.2018.11.069; Berman TA, 2017, CANCER-AM CANCER SOC, V123, P2219, DOI 10.1002/cncr.30588; Bose P, 2013, INT J CANCER, V133, P2013, DOI 10.1002/ijc.28112; Chera BS, 2020, J CLIN ONCOL, V38, P1050, DOI 10.1200/JCO.19.02444; Chera BS, 2019, CLIN CANCER RES, V25, P4682, DOI 10.1158/1078-0432.CCR-19-0211; Cree IA, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3693-7; Damerla RR, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00276; Debald M, 2013, J CANCER RES CLIN, V139, P2125, DOI 10.1007/s00432-013-1541-y; Fakhry C, 2019, CANCER-AM CANCER SOC, V125, P2027, DOI 10.1002/cncr.32025; Fici P, 2019, METHODS MOL BIOL, V1909, P47, DOI 10.1007/978-1-4939-8973-7_4; Garnaes E, 2016, INT J CANCER, V139, P2598, DOI 10.1002/ijc.30389; Golusinski P, 2019, ORAL ONCOL, V88, P145, DOI 10.1016/j.oraloncology.2018.11.020; Gonda TA, 2012, GASTROENTEROLOGY, V142, P824, DOI 10.1053/j.gastro.2011.12.058; Granata R, 2012, ANN ONCOL, V23, P1832, DOI 10.1093/annonc/mdr544; IJzerman MJ, 2018, EXPERT REV PHARM OUT, V18, P593, DOI 10.1080/14737167.2018.1505505; Jeannot E, 2016, J PATHOL CLIN RES, V2, P201, DOI 10.1002/cjp2.47; Kong HK, 2012, BMB REP, V45, P595, DOI 10.5483/BMBRep.2012.45.11.210; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kurokawa T, 2020, CANCER SCI, V111, P1407, DOI 10.1111/cas.14338; Ludwig ML, 2018, ORAL ONCOL, V87, P144, DOI 10.1016/j.oraloncology.2018.10.031; Mayama A, 2018, CANCER SCI, V109, P3350, DOI 10.1111/cas.13770; Mazurek AM, 2019, HEAD NECK-J SCI SPEC, V41, P632, DOI 10.1002/hed.25368; Mehul B, 2000, J BIOL CHEM, V275, P12841, DOI 10.1074/jbc.275.17.12841; Misawa K, 2020, SCI REP, V10; Misawa K, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0363-1; Misawa K, 2016, ONCOTARGET, V7, P26087, DOI 10.18632/oncotarget.8317; Moss J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07466-6; Mydlarz WK, 2016, HEAD NECK-J SCI SPEC, V38, P9, DOI 10.1002/hed.23842; Nakagawa T, 2020, INT J CANCER, V146, P2460, DOI 10.1002/ijc.32890; Nieuwenhuis EJC, 2003, LAB INVEST, V83, P1233, DOI 10.1097/01.LAB.0000083532.46536.56; Ossandon MR, 2018, JNCI-J NATL CANCER I, V110, P929, DOI 10.1093/jnci/djy105; Ribeiro IP, 2019, MOL CYTOGENET, V12, DOI 10.1186/s13039-019-0447-z; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Schmidt H, 2018, DIAGNOSTICS, V8, DOI 10.3390/diagnostics8040079; Schrock A, 2017, CLIN CHEM, V63, P1288, DOI 10.1373/clinchem.2016.270207; Seyhan AA, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1864-9; Shen SY, 2018, NATURE, V563, P579, DOI 10.1038/s41586-018-0703-0; Sullivan CS, 2001, VIROLOGY, V287, P1, DOI 10.1006/viro.2001.1038; Sun BK, 2015, GENE DEV, V29, P2225, DOI 10.1101/gad.267708.115; Swiecicki PL, 2019, LARYNGOSCOPE, V129, P1836, DOI 10.1002/lary.27725; Terai H, 2015, INT J ONCOL, V46, P430, DOI 10.3892/ijo.2014.2733; Urano E, 2013, JAIDS-J ACQ IMM DEF, V64, P154, DOI 10.1097/QAI.0b013e31829a2ef8; van Ginkel JH, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3424-0; Volik S, 2016, MOL CANCER RES, V14, P898, DOI 10.1158/1541-7786.MCR-16-0044	46	20	20	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2020	39	24					4741	4755		10.1038/s41388-020-1327-z	http://dx.doi.org/10.1038/s41388-020-1327-z		MAY 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LY0HO	32415241	hybrid, Green Published			2022-12-26	WOS:000533041900001
J	Pavlikova, D; Zemanova, V; Pavlik, M; Dobrev, PI; Hnilicka, F; Motyka, V				Pavlikova, Daniela; Zemanova, Veronika; Pavlik, Milan; Dobrev, Petre I.; Hnilicka, Frantisek; Motyka, Vaclav			Response of cytokinins and nitrogen metabolism in the fronds of Pteris sp. under arsenic stress	PLOS ONE			English	Article							FREE AMINO-ACIDS; MAIZE BETA-GLUCOSIDASE; TRANS-ZEATIN CONTENT; NOCCAEA-CAERULESCENS; CONTAMINATED SITES; MEMBRANE-RECEPTORS; TOBACCO PLANTS; ROOT; NITRATE; LEAF	Given the close relationship between cytokinins (CKs), photosynthesis and nitrogen metabolism, this study assessed the effect of arsenic (As) contamination on these metabolic components in the As-hyperaccumulators Pteris cretica L. var. Albo-lineata (Pc-A) and var. Parkerii (Pc-P) as well as the As-non-hyperaccumulator Pteris straminea Mett. ex Baker (Ps). The ferns were cultivated in a pot experiment for 23 weeks in soil spiked with As at the levels 20 and 100 mg.kg(-1). For the purpose of this study, the CKs were placed into five functionally different groups according to their structure and physiological roles: bioactive forms (bCKs; CK free bases); inactive or weakly active forms (dCKs; CK N-glucosides); transport forms (tCKs; CK ribosides); storage forms (sCKs; O-glucosides); and primary products of CK biosynthesis (ppbCKs; CK nucleotides). An important finding was higher CKs total content, accumulation of sCKs and reduction of dCKs in As-hyperaccumulators in contrast to non-hyperaccumulator ferns. A significant depletion of C resources was confirmed in ferns, especially Ps, which was determined by measuring the photosynthetic rate and chlorophyll fluorescence. A fluorescence decrease signified a reduction in the C/N ratio, inducing an increase of bioactive CKs forms in Pc-P and Ps. The impact of As on N utilization was significant in As-hyperaccumulators. The glutamic acid/glutamine ratio, an indicator of primary N assimilation, diminished in all ferns with increased As level in the soil. In conclusion, the results indicate a large phenotypic diversity of Pteris species to As and suggest that the CKs composition and the glutamic acid/glutamine ratio can be used as a tool to diagnose As stress in plants.	[Pavlikova, Daniela; Zemanova, Veronika; Pavlik, Milan] Czech Univ Life Sci Prague, Dept Agroenvironm Chem & Plant Nutr, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic; [Zemanova, Veronika; Pavlik, Milan] Czech Acad Sci, Isotope Lab, Inst Expt Bot, Prague, Czech Republic; [Dobrev, Petre I.; Motyka, Vaclav] Czech Acad Sci, Lab Hormonal Regulat Plants, Inst Expt Bot, Prague, Czech Republic; [Hnilicka, Frantisek] Czech Univ Life Sci Prague, Dept Bot & Plant Physiol, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Pavlikova, D; Zemanova, V (corresponding author), Czech Univ Life Sci Prague, Dept Agroenvironm Chem & Plant Nutr, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic.; Zemanova, V (corresponding author), Czech Acad Sci, Isotope Lab, Inst Expt Bot, Prague, Czech Republic.	pavlikova@af.czu.cz; zemanovav@af.czu.cz	Pavlíková, Daniela/V-4971-2018; Pavlík, Milan/G-7052-2014; Zemanova, Veronika/I-2171-2018; Centre, NutRisk/AAX-1925-2020; Zemanová, Veronika/ADF-4648-2022; Motyka, Vaclav/F-6115-2014	Pavlíková, Daniela/0000-0003-3341-5053; Pavlík, Milan/0000-0003-4209-9937; Zemanova, Veronika/0000-0001-7115-8348; Motyka, Vaclav/0000-0001-7878-7788	Czech Science Foundation [17-10591S]; Ministry of Education, Youth and Sports; European Regional Development Fund-Project "Centre for Experimental Plant Biology" [CZ.02.1.01/0.0/0.0/16_019/0000738]; European Regional Development Fund-Project "Centre for the investigation of synthesis and transformation of nutritional substances in the food chain in interaction with potentially harmful substances of anthropogenic origin: comprehensive assessment of soi [CZ.02.1.01/0.0/0.0/16_019/0000845]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund-Project "Centre for Experimental Plant Biology"; European Regional Development Fund-Project "Centre for the investigation of synthesis and transformation of nutritional substances in the food chain in interaction with potentially harmful substances of anthropogenic origin: comprehensive assessment of soi	This study was supported by the Czech Science Foundation [grant number 17-10591S] and by the Ministry of Education, Youth and Sports. It was also supported by the European Regional Development Fund-Projects "Centre for Experimental Plant Biology" [grant number CZ.02.1.01/0.0/0.0/16_019/0000738] and "Centre for the investigation of synthesis and transformation of nutritional substances in the food chain in interaction with potentially harmful substances of anthropogenic origin: comprehensive assessment of soil contamination risks for the quality of agricultural production"[grant number CZ.02.1.01/0.0/0.0/16_019/0000845].	Agnihotri A, 2016, PHYSIOL MOL BIOL PLA, V22, P341, DOI 10.1007/s12298-016-0370-2; Ananieva K, 2008, PHYSIOL PLANTARUM, V134, P609, DOI 10.1111/j.1399-3054.2008.01161.x; Bittsanszky A, 2015, PLANT SCI, V231, P184, DOI 10.1016/j.plantsci.2014.12.005; BROUQUISSE R, 1992, PLANTA, V188, P384, DOI 10.1007/BF00192806; BRZOBOHATY B, 1993, SCIENCE, V262, P1051, DOI 10.1126/science.8235622; Campos NV, 2016, PHYSIOL PLANTARUM, V157, P135, DOI 10.1111/ppl.12426; Chakrabarty D, 2009, CHEMOSPHERE, V74, P688, DOI 10.1016/j.chemosphere.2008.09.082; Chernyad'ev II, 2009, APPL BIOCHEM MICRO+, V45, P351, DOI 10.1134/S0003683809040012; Connor EF, 2012, ARTHROPOD-PLANT INTE, V6, P489, DOI 10.1007/s11829-012-9210-7; Cortleven A, 2016, PLANT PHYSIOL, V172, P464, DOI 10.1104/pp.16.00640; Cortleven A, 2015, J EXP BOT, V66, P4999, DOI 10.1093/jxb/erv132; Cortleven A, 2014, PLANT PHYSIOL, V164, P1470, DOI 10.1104/pp.113.224667; Curaba J, 2014, J EXP BOT, V65, P1425, DOI 10.1093/jxb/eru002; Danilova MN, 2017, RUSS J PLANT PHYSL+, V64, P301, DOI [10.1134/S1021443717030062, 10.1134/s1021443717030062]; Danilova MN, 2014, RUSS J PLANT PHYSL+, V61, P434, DOI 10.1134/S1021443714040062; Finnegan PM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00182; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Foyer CH, 2011, J EXP BOT, V62, P1467, DOI 10.1093/jxb/erq453; Gelova Z, 2018, J EXP BOT, V69, P441, DOI 10.1093/jxb/erx426; Gough SP, 2003, J PLANT BIOL, V46, P135, DOI 10.1007/BF03030443; Guiboileau A, 2010, CR BIOL, V333, P382, DOI 10.1016/j.crvi.2010.01.016; Guo JC, 2005, J PLANT GROWTH REGUL, V24, P93, DOI 10.1007/s00344-005-0005-2; Guo QQ, 2017, J EXP BOT, V68, P1569, DOI 10.1093/jxb/erx056; Havlova M, 2008, PLANT CELL ENVIRON, V31, P341, DOI 10.1111/j.1365-3040.2007.01766.x; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Hodges M, 2003, PLANT PHYSIOL BIOCH, V41, P577, DOI 10.1016/S0981-9428(03)00062-7; Honig M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124045; Kiran NS, 2012, PHYTOCHEMISTRY, V79, P67, DOI 10.1016/j.phytochem.2012.03.012; Kiran NS, 2006, J EXP BOT, V57, P985, DOI 10.1093/jxb/erj084; Kopecny D, 2005, BIOCHIMIE, V87, P1011, DOI 10.1016/j.biochi.2005.04.006; Kosova K, 2012, J PLANT PHYSIOL, V169, P567, DOI 10.1016/j.jplph.2011.12.013; Kruse J, 2010, PLANT SOIL, V332, P387, DOI 10.1007/s11104-010-0305-6; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Lea PJ, 2007, ANN APPL BIOL, V150, P1, DOI 10.1111/j.1744-7348.2006.00104.x; Lea PJ, 2003, PLANT PHYSIOL BIOCH, V41, P555, DOI 10.1016/S0981-9428(03)00060-3; Li QC, 2018, PLANT PHYSIOL BIOCH, V132, P652, DOI 10.1016/j.plaphy.2018.10.009; Li QC, 2016, ENVIRON SCI POLLUT R, V23, P23422, DOI 10.1007/s11356-016-7544-x; Liu CJ, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00693; Mackova H, 2013, J EXP BOT, V64, P2805, DOI 10.1093/jxb/ert131; MCGAW BA, 1983, PHYTOCHEMISTRY, V22, P1103, DOI 10.1016/0031-9422(83)80200-3; Mohan TC, 2016, PLANT PHYSIOL, V171, P1418, DOI 10.1104/pp.16.00372; Neuberg M, 2011, PLANT SOIL ENVIRON, V57, P381, DOI 10.17221/152/2011-PSE; Okazaki K, 2008, PLANT CELL PHYSIOL, V49, P170, DOI 10.1093/pcp/pcm173; Pathare V, 2013, ACTA PHYSIOL PLANT, V35, P3377, DOI 10.1007/s11738-013-1370-2; Pavlik M, 2017, J PLANT PHYSIOL, V208, P94, DOI 10.1016/j.jplph.2016.09.014; Pavlik M, 2012, ECOTOX ENVIRON SAFE, V79, P101, DOI 10.1016/j.ecoenv.2011.12.009; Pavlik M, 2010, ECOTOX ENVIRON SAFE, V73, P1309, DOI 10.1016/j.ecoenv.2010.07.008; Pavlikova D, 2017, PLANT SOIL ENVIRON, V63, P455, DOI 10.17221/606/2017-PSE; Pavlikova D, 2014, J PLANT PHYSIOL, V171, P559, DOI 10.1016/j.jplph.2013.11.016; Pavlikova D, 2014, ECOTOX ENVIRON SAFE, V100, P166, DOI 10.1016/j.ecoenv.2013.10.028; Poschenrieder C, 2013, PLANT SCI, V212, P15, DOI 10.1016/j.plantsci.2013.07.012; Rahayu YS, 2005, J EXP BOT, V56, P1143, DOI 10.1093/jxb/eri107; Ripullone F, 2003, TREE PHYSIOL, V23, P137, DOI 10.1093/treephys/23.2.137; Ronzan M, 2019, ENVIRON EXP BOT, V165, P59, DOI 10.1016/j.envexpbot.2019.05.013; Sakakibara H, 2006, TRENDS PLANT SCI, V11, P440, DOI 10.1016/j.tplants.2006.07.004; Sarwat M, 2013, BIOTECHNOL ADV, V31, P1153, DOI 10.1016/j.biotechadv.2013.02.003; Schmidt AC, 2005, APPL ORGANOMET CHEM, V19, P590, DOI 10.1002/aoc.869; Shahid MA, 2019, ECOTOX ENVIRON SAFE, V180, P588, DOI 10.1016/j.ecoenv.2019.05.037; Shoaib M, 2019, PEERJ, V7, DOI 10.7717/peerj.6300; Singh N, 2009, ENVIRON POLLUT, V157, P2300, DOI 10.1016/j.envpol.2009.03.036; Singh VP, 2015, J PLANT PHYSIOL, V181, P20, DOI [10.1016/j.plph.03.015, 10.1016/j.jplph.2015.03.015]; Takei K, 2001, PLANT CELL PHYSIOL, V42, P85, DOI 10.1093/pcp/pce009; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Wang HB, 2006, INT J PHYTOREMEDIAT, V8, P1, DOI 10.1080/16226510500214517; Wang HB, 2012, ENVIRON EXP BOT, V75, P298, DOI 10.1016/j.envexpbot.2011.08.002; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Zemanova V, 2013, PLANT SOIL ENVIRON, V59, P417, DOI 10.17221/403/2013-PSE; Zemanova V, 2019, ENVIRON EXP BOT, V166, DOI 10.1016/j.envexpbot.2019.103822; Zemanova V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177963; Zemanova V, 2016, ARCH ENVIRON CON TOX, V70, P464, DOI 10.1007/s00244-015-0198-8; Zhang XM, 2017, ECOTOX ENVIRON SAFE, V138, P199, DOI 10.1016/j.ecoenv.2016.12.031; Zizkova E, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0415-7; Zwack PJ, 2015, J EXP BOT, V66, P4863, DOI 10.1093/jxb/erv172	77	12	12	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2020	15	5							e0233055	10.1371/journal.pone.0233055	http://dx.doi.org/10.1371/journal.pone.0233055			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1BA	32413087	gold, Green Published			2022-12-26	WOS:000537496000045
J	Morales, KY; Singh, N; Perez, FA; Ignacio, JC; Thapa, R; Arbelaez, JD; Tabien, RE; Famoso, A; Wang, DR; Septiningsih, EM; Shi, YX; Kretzschmar, T; McCouch, SR; Thomson, MJ				Morales, Karina Y.; Singh, Namrata; Perez, Francisco Agosto; Ignacio, John Carlos; Thapa, Ranjita; Arbelaez, Juan D.; Tabien, Rodante E.; Famoso, Adam; Wang, Diane R.; Septiningsih, Endang M.; Shi, Yuxin; Kretzschmar, Tobias; McCouch, Susan R.; Thomson, Michael J.			An improved 7K SNP array, the C7AIR, provides a wealth of validated SNP markers for rice breeding and genetics studies	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GELATINIZATION TEMPERATURE; COMPLEX TRAITS; CORE SUBSET; ASSOCIATION; ENCODES; RESISTANCE; DIVERSITY	Single nucleotide polymorphisms (SNPs) are highly abundant, amendable to high-throughput genotyping, and useful for a number of breeding and genetics applications in crops. SNP frequencies vary depending on the species and populations under study, and therefore target SNPs need to be carefully selected to be informative for each application. While multiple SNP genotyping systems are available for rice (Oryza sativa L. and its relatives), they vary in their informativeness, cost, marker density, speed, flexibility, and data quality. In this study, we report the development and performance of the Cornell-IR LD Rice Array (C7AIR), a second-generation SNP array containing 7,098 markers that improves upon the previously released C6AIR. The C7AIR is designed to detect genome-wide polymorphisms within and between subpopulations of O. sativa, as well as O. glaberrima, O. rufipogon and O. nivara. The C7AIR combines top-performing SNPs from several previous rice arrays, including 4,007 SNPs from the C6AIR, 2,056 SNPs from the High Density Rice Array (HDRA), 910 SNPs from the 384-SNP GoldenGate sets, 189 SNPs from the 44K array selected to add information content for elite U.S. tropical japonica rice varieties, and 8 trait-specific SNPs. To demonstrate its utility, we carried out a genome-wide association analysis for plant height, employing the C7AIR across a diversity panel of 189 rice accessions and identified 20 QTLs contributing to plant height. The C7AIR SNP chip has so far been used for genotyping > 10,000 rice samples. It successfully differentiates the five subpopulations of Oryza sativa, identifies introgressions from wild and exotic relatives, and is useful for quantitative trait loci (QTL) and association mapping in diverse materials. Moreover, data from the C7AIR provides valuable information that can be used to select informative and reliable SNP markers for conversion to lower-cost genotyping platforms for genomic selection and other downstream applications in breeding.	[Morales, Karina Y.; Thapa, Ranjita; Septiningsih, Endang M.; Thomson, Michael J.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Singh, Namrata; Perez, Francisco Agosto; Wang, Diane R.; Shi, Yuxin; McCouch, Susan R.] Cornell Univ, Sch Integrat Plant Sci, Plant Breeding & Genet Sect, Ithaca, NY 14850 USA; [Ignacio, John Carlos; Arbelaez, Juan D.; Kretzschmar, Tobias] Int Rice Res Inst, Rice Breeeding Platform, Los Banos, Philippines; [Tabien, Rodante E.] Texas A&M AgriLife Res Ctr, Beaumont, TX USA; [Famoso, Adam] Louisiana State Univ, Ag Ctr, Rayne, LA USA; [Thapa, Ranjita] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Arbelaez, Juan D.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Wang, Diane R.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Kretzschmar, Tobias] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia	Texas A&M University System; Texas A&M University College Station; Cornell University; CGIAR; International Rice Research Institute (IRRI); Louisiana State University System; Louisiana State University; University of Nebraska System; University of Nebraska Lincoln; University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Southern Cross University	Thomson, MJ (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.; McCouch, SR (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Breeding & Genet Sect, Ithaca, NY 14850 USA.	srm4@cornell.edu; m.thomson@tamu.edu	kretzschmar, tobias/AAH-3739-2021	Arbelaez Velez, Juan David/0000-0002-5803-7872; Morales, Karina/0000-0001-8899-0894; Thomson, Michael/0000-0003-1868-6867; Ignacio, John Carlos/0000-0002-1799-7316	United States National Science Foundation (NSF-PGRP) [1026555, IOS-1444511]; Bill and Melinda Gates Foundation; Bill and Melinda Gates Foundation grant "Transforming Rice Breeding" [OPP1076488]; Texas A&M AgriLife Research; National Institute of Food and Agriculture, U.S. Department of Agriculture [1009299, 1009300]	United States National Science Foundation (NSF-PGRP); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Bill and Melinda Gates Foundation grant "Transforming Rice Breeding"; Texas A&M AgriLife Research; National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	Funding was provided by the United States National Science Foundation (NSF-PGRP awards #1026555 and #IOS-1444511 to SMc), the Bill and Melinda Gates Foundation (via AfricaRice: "Rapid mobilization of alleles for rice cultivar improvement in sub-saharan Africa"), the Bill and Melinda Gates Foundation grant "Transforming Rice Breeding" number OPP1076488 (TK, JDA), Texas A&M AgriLife Research (MJT, EMS, RET), and the National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch projects 1009299 (MJT) and 1009300 (EMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2009, CROP SCI, V49, P1336, DOI 10.2135/cropsci2008.06.0551; Arbelaez JD, 2019, RICE, V12, DOI 10.1186/s12284-019-0311-0; Bai MY, 2007, P NATL ACAD SCI USA, V104, P13839, DOI 10.1073/pnas.0706386104; Bao JS, 2006, THEOR APPL GENET, V113, P1171, DOI 10.1007/s00122-006-0355-6; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Dobo M, 2010, J CEREAL SCI, V52, P450, DOI 10.1016/j.jcs.2010.07.010; Domingo C, 2009, MOL PLANT MICROBE IN, V22, P201, DOI 10.1094/MPMI-22-2-0201; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Gao ZY, 2003, SCI CHINA SER C, V46, P661, DOI 10.1360/03yc0099; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; Iwamoto M, 2011, BIOTECHNOL LETT, V33, P173, DOI 10.1007/s10529-010-0405-7; Jia YL, 2003, PHYTOPATHOLOGY, V93, P1452, DOI 10.1094/PHYTO.2003.93.11.1452; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Miyoshi K, 2004, P NATL ACAD SCI USA, V101, P875, DOI 10.1073/pnas.2636936100; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; SCHULTZ BB, 1985, SYST ZOOL, V34, P449, DOI 10.2307/2413207; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Teng B, 2017, J SCI FOOD AGR, V97, P108, DOI 10.1002/jsfa.7693; Thomson MJ, 2017, RICE, V10, DOI 10.1186/s12284-017-0181-2; Thomson MJ, 2012, MOL BREEDING, V29, P875, DOI 10.1007/s11032-011-9663-x; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Venske E, 2018, J APPL GENET, P1; Yan W, 2007, CROP SCI, V47, P869, DOI 10.2135/cropsci2006.07.0444; Yang GX, 2003, PLANT MOL BIOL, V52, P843, DOI 10.1023/A:1025001304994; Yang WB, 2011, PLANT CELL, V23, P661, DOI 10.1105/tpc.110.081802; Yonemaru J, 2010, RICE, V3, P194, DOI 10.1007/s12284-010-9041-z; Yu HH, 2014, PLANT BIOTECHNOL J, V12, P28, DOI 10.1111/pbi.12113; Zhang CQ, 2011, PLANTA, V234, P541, DOI 10.1007/s00425-011-1423-y; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	35	21	21	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232479	10.1371/journal.pone.0232479	http://dx.doi.org/10.1371/journal.pone.0232479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407369	Green Published, gold			2022-12-26	WOS:000537490700021
J	Shields, MC; Bowers, MR; Kramer, HL; Fulcer, MM; Perinet, LC; Metz, MJ; Reist, NE				Shields, Mallory C.; Bowers, Matthew R.; Kramer, Hannah L.; Fulcer, McKenzie M.; Perinet, Lara C.; Metz, Marissa J.; Reist, Noreen E.			The role of the C(2)A domain of synaptotagmin 1 in asynchronous neurotransmitter release	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; CA2+ BINDING; C-2 DOMAIN; PHOSPHOLIPID-BINDING; CALCIUM-BINDING; GABA RELEASE; C2 DOMAINS; SENSOR; MUTATIONS	Following nerve stimulation, there are two distinct phases of Ca2+- dependent neurotransmitter release: a fast, synchronous release phase, and a prolonged, asynchronous release phase. Each of these phases is tightly regulated and mediated by distinct mechanisms. Synaptotagmin 1 is the major Ca2+ sensor that triggers fast, synchronous neurotransmitter release upon Ca2+ binding by its C(2)A and C2B domains. It has also been implicated in the inhibition of asynchronous neurotransmitter release, as blocking Ca2+ binding by the C(2)A domain of synaptotagmin 1 results in increased asynchronous release. However, the mutation used to block Ca2+ binding in the previous experiments (aspartate to asparagine mutations, syt(D-N)) had the unintended side effect of mimicking Ca2+ binding, raising the possibility that the increase in asynchronous release was directly caused by ostensibly constitutive Ca2+ binding. Thus, rather than modulating an asynchronous sensor, syt(D-N) may be mimicking one. To directly test the C(2)A inhibition hypothesis, we utilized an alternate C(2)A mutation that we designed to block Ca2+ binding without mimicking it (an aspartate to glutamate mutation, syt(D-E)). Analysis of both the original syt(D-N) mutation and our alternate syt(D-E) mutation at the Drosophila neuromuscular junction showed differential effects on asynchronous release, as well as on synchronous release and the frequency of spontaneous release. Importantly, we found that asynchronous release is not increased in the syt(D-E) mutant. Thus, our work provides new mechanistic insight into synaptotagmin 1 function during Ca2+- evoked synaptic transmission and demonstrates that Ca2+ binding by the C(2)A domain of synaptotagmin 1 does not inhibit asynchronous neurotransmitter release in vivo.	[Shields, Mallory C.; Bowers, Matthew R.; Kramer, Hannah L.; Fulcer, McKenzie M.; Perinet, Lara C.; Metz, Marissa J.; Reist, Noreen E.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Shields, Mallory C.; Bowers, Matthew R.; Metz, Marissa J.; Reist, Noreen E.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Reist, NE (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.; Reist, NE (corresponding author), Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA.	reist@colostate.edu		Reist, Noreen/0000-0002-1647-3166	National Science Foundation [1257363]; Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences award (CRC); CSU	National Science Foundation(National Science Foundation (NSF)); Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences award (CRC); CSU	NER is funded by the National Science Foundation (1257363, www.nsf.gov) and a Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences award (CRC, https://vetmedbiosci.colostate.edu/).MCS is funded through the Vice President for Research Fellowship at CSU (https://www.research.colostate.edu/).Funders did not play a role in any aspect of the study.	Aghajanian GK, 1999, BRAIN RES, V825, P161, DOI 10.1016/S0006-8993(99)01224-X; Bacaj T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002267; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bowers MR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228348; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; Evans CS, 2016, MOL BIOL CELL, V27, P979, DOI 10.1091/mbc.E15-07-0503; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2002, J NEUROSCI, V22, P8438; Gaffaney JD, 2014, MOL BIOL CELL, V25, P481, DOI 10.1091/mbc.E13-10-0571; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Han J, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00005; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hjelmstad GO, 2006, J NEUROPHYSIOL, V95, P2020, DOI 10.1152/jn.01149.2005; Iremonger KJ, 2007, J NEUROSCI, V27, P6684, DOI 10.1523/JNEUROSCI.0934-07.2007; Jensen K, 2000, NEUROSCIENCE, V101, P581, DOI 10.1016/S0306-4522(00)00416-4; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kiyosue K, 2002, EUR J NEUROSCI, V16, P1587, DOI 10.1046/j.1460-9568.2002.02217.x; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Paddock BE, 2011, J NEUROSCI, V31, P2248, DOI 10.1523/JNEUROSCI.3153-09.2011; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Regehr WG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005702; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Striegel AR, 2012, J NEUROSCI, V32, P1253, DOI 10.1523/JNEUROSCI.4652-11.2012; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Vermaas JV, 2017, BIOCHEMISTRY-US, V56, P281, DOI 10.1021/acs.biochem.6b00468; Volman V, 2011, NEURAL COMPUT, V23, P927, DOI 10.1162/NECO_a_00098; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; YAO KM, 1994, J NEUROCHEM, V63, P41; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Yoshihara M, 2010, P NATL ACAD SCI USA, V107, P14869, DOI 10.1073/pnas.1000606107; Zhang Bing, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5488	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232991	10.1371/journal.pone.0232991	http://dx.doi.org/10.1371/journal.pone.0232991			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407359	Green Published, gold, Green Submitted			2022-12-26	WOS:000537490700056
J	Wrobel, ER; Bentz, AB; Lorenz, WW; Gardner, ST; Mendonca, MT; Navara, KJ				Wrobel, Elizabeth R.; Bentz, Alexandra B.; Lorenz, W. Walter; Gardner, Stephen T.; Mendonca, Mary T.; Navara, Kristen J.			Corticosterone and testosterone treatment influence expression of gene pathways linked to meiotic segregation in preovulatory follicles of the domestic hen	PLOS ONE			English	Article							PRIMARY SEX-RATIO; OFFSPRING SEX; OOCYTE MATURATION; OXIDATIVE STRESS; HEPARAN-SULFATE; DNA METHYLATION; QUALITY; FEMALE; BIAS; ORGANIZATION	Decades of work indicate that female birds can control their offspring sex ratios in response to environmental and social cues. In laying hens, hormones administered immediately prior to sex chromosome segregation can exert sex ratio skews, indicating that these hormones may act directly on the germinal disc to influence which sex chromosome is retained in the oocyte and which is discarded into an unfertilizable polar body. We aimed to uncover the gene pathways involved in this process by testing whether treatments with testosterone or corticosterone that were previously shown to influence sex ratios elicit changes in the expression of genes and/or gene pathways involved in the process of meiotic segregation. We injected laying hens with testosterone, corticosterone, or control oil 5h prior to ovulation and collected germinal discs from the F1 preovulatory follicle in each hen 1.5h after injection. We used RNA-sequencing (RNA-seq) followed by DESeq2 and gene set enrichment analyses to identify genes and gene pathways that were differentially expressed between germinal discs of control and hormone-treated hens. Corticosterone treatment triggered downregulation of 13 individual genes, as well as enrichment of gene sets related to meiotic spindle organization and chromosome segregation, and additional gene sets that function in ion transport. Testosterone treatment triggered upregulation of one gene, and enrichment of one gene set that functions in nuclear chromosome segregation. This work indicates that corticosterone can be a potent regulator of meiotic processes and provides potential gene targets on which corticosterone and/or testosterone may act to influence offspring sex ratios in birds.	[Wrobel, Elizabeth R.; Navara, Kristen J.] Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA; [Bentz, Alexandra B.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Lorenz, W. Walter] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Lorenz, W. Walter] Univ Georgia, Georgia Genom & Bioinformat Core, Athens, GA 30602 USA; [Gardner, Stephen T.; Mendonca, Mary T.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	University System of Georgia; University of Georgia; Indiana University System; Indiana University Bloomington; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Auburn University System; Auburn University	Navara, KJ (corresponding author), Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA.	knavara@gmail.com		Bentz, Alexandra/0000-0003-2445-4886; Gardner, Steven/0000-0003-3997-2643	National Science Foundation [1456442]	National Science Foundation(National Science Foundation (NSF))	MTM and KJN Award #1456442 (collaborative grant to KJN and MTM) National Science Foundation https://www.nsf.gov/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista IDA, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0017-6; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2016, BIORXIV, DOI [DOI 10.1101/060012, 10.1101/060012]; Aslam MA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123380; Aslam MA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115352; Bell SC, 2014, BEHAV ECOL, V25, P352, DOI 10.1093/beheco/art112; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonier F, 2007, BEHAV ECOL, V18, P1045, DOI 10.1093/beheco/arm075; Booksmythe I, 2017, BIOL REV, V92, P108, DOI 10.1111/brv.12220; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Cordero PJ, 2008, J EVOLUTION BIOL, V14, P829; Mendonca MAC, 2010, J HISTOCHEM CYTOCHEM, V58, P229, DOI 10.1369/jhc.2009.954727; da Costa NN, 2016, THERIOGENOLOGY, V85, P323, DOI 10.1016/j.theriogenology.2015.08.010; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; Di Carlo A, 2000, INT J DEV BIOL, V44, P241; Gagliardi LJ, 2005, J ELECTROSTAT, V63, P309, DOI 10.1016/j.elstat.2004.09.007; Gam AE, 2011, J AVIAN BIOL, V42, P253, DOI 10.1111/j.1600-048X.2010.05251.x; GARD DL, 1995, ZYGOTE, V3, P17, DOI 10.1017/S0967199400002331; Gileva EA, 2006, RUSS J GENET+, V42, P498, DOI 10.1134/S1022795406050061; Goerlich VC, 2009, GEN COMP ENDOCR, V163, P184, DOI 10.1016/j.ygcen.2009.01.004; Gupta S, 2006, GENE, V377, P159, DOI 10.1016/j.gene.2006.04.020; Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913; Jin Jun-Xue, 2017, J Pineal Res, V62, DOI 10.1111/jpi.12388; JOHNSON AL, 1980, BIOL REPROD, V23, P386, DOI 10.1095/biolreprod23.2.386; Johnson AL, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P635; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim KH, 2018, CELL PHYSIOL BIOCHEM, V45, P37, DOI 10.1159/000486221; Komdeur J, 1996, P ROY SOC B-BIOL SCI, V263, P661, DOI 10.1098/rspb.1996.0099; KRAEMER PM, 1972, J CELL BIOL, V55, P713, DOI 10.1083/jcb.55.3.713; Krebs EA, 2002, BEHAV ECOL SOCIOBIOL, V51, P447, DOI 10.1007/s00265-002-0459-1; LEYTON C, 1995, CELL PROLIFERAT, V28, P481, DOI 10.1111/j.1365-2184.1995.tb00087.x; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malik HS, 2006, BIOCHEM SOC T, V34, P569, DOI 10.1042/BST0340569; Merkling T, 2012, BEHAV ECOL, V23, P751, DOI 10.1093/beheco/ars023; MERRY NE, 1995, MOL REPROD DEV, V41, P212, DOI 10.1002/mrd.1080410212; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Navara KJ, 2018, FASCINAT LIFE SCI, P1, DOI 10.1007/978-3-319-71271-0; Navara KJ, 2019, POULTRY SCI, V98, P1903, DOI 10.3382/ps/pey518; Navara KJ, 2013, INTEGR COMP BIOL, V53, P923, DOI 10.1093/icb/ict083; NOVITSKI E, 1967, Annual Review of Genetics, V1, P71, DOI 10.1146/annurev.ge.01.120167.000443; Pike TW, 2005, ANIM BEHAV, V70, P745, DOI 10.1016/j.anbehav.2004.12.020; Pike TW, 2006, P ROY SOC B-BIOL SCI, V273, P1093, DOI 10.1098/rspb.2005.3422; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; Pinson SE, 2015, J COMP PHYSIOL B, V185, P539, DOI 10.1007/s00360-015-0897-5; Pinson SE, 2011, GEN COMP ENDOCR, V174, P195, DOI 10.1016/j.ygcen.2011.08.020; Pinson SE, 2011, PHYSIOL BIOCHEM ZOOL, V84, P292, DOI 10.1086/659373; Pryke SR, 2011, BEHAV ECOL, V22, P717, DOI 10.1093/beheco/arr040; Quirici V, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0133-5; Rathburn MK, 2005, BEHAV ECOL, V16, P41, DOI 10.1093/beheco/arh117; Rodrigue KL, 2005, CHROMOSOME RES, V13, P581, DOI 10.1007/s10577-005-0984-7; Rose NR, 2014, BBA-GENE REGUL MECH, V1839, P1362, DOI 10.1016/j.bbagrm.2014.02.007; Rutkowska J, 2008, PHILOS T R SOC B, V363, P1675, DOI 10.1098/rstb.2007.0006; Rutkowska J, 2006, ANIM BEHAV, V71, P1283, DOI 10.1016/j.anbehav.2005.07.025; Rutstein AN, 2004, P ROY SOC B-BIOL SCI, V271, pS286, DOI 10.1098/rsbl.2003.0154; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stier A, 2015, OECOLOGIA, V179, P999, DOI 10.1007/s00442-015-3429-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teranishi M, 2001, CHROMOSOME RES, V9, P147, DOI 10.1023/A:1009235120741; Thanh QDN, 2014, MOL REPROD DEV, V81, P230, DOI 10.1002/mrd.22289; Tremoleda JL, 2001, MOL REPROD DEV, V60, P260, DOI 10.1002/mrd.1086; Veiga JP, 2004, HORM BEHAV, V46, P47, DOI 10.1016/j.yhbeh.2004.01.007; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Whittingham LA, 2005, P ROY SOC B-BIOL SCI, V272, P1775, DOI 10.1098/rspb.2005.3167; Zhang HQ, 2012, MOL BIOL REP, V39, P5651, DOI 10.1007/s11033-011-1372-3	67	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2020	15	5							e0232120	10.1371/journal.pone.0232120	http://dx.doi.org/10.1371/journal.pone.0232120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0YZ	32407351	gold, Green Published			2022-12-26	WOS:000537490700013
J	Miller, JB; McKinnon, LM; Whiting, MF; Kauwe, JSK; Ridge, PG				Miller, Justin B.; McKinnon, Lauren M.; Whiting, Michael F.; Kauwe, John S. K.; Ridge, Perry G.			Codon Pairs are Phylogenetically Conserved: A comprehensive analysis of codon pairing conservation across the Tree of Life	PLOS ONE			English	Article							FEATURE FREQUENCY PROFILES; COMMON SUBSTRING APPROACH; DATABASE RESOURCES; NATIONAL-CENTER; PHYLOGENY; SEQUENCE; GENE; RECONSTRUCTION; RECOGNITION; EXPRESSION	Identical codon pairing and co-tRNA codon pairing increase translational efficiency within genes when two codons that encode the same amino acid are translated by the same tRNA before it diffuses from the ribosome. We examine the phylogenetic signal in both identical and co-tRNA codon pairing across 23 428 species using alignment-free and parsimony methods. We determined that conserved codon pairing typically has a smaller window size than the length of a ribosome, and codon pairing tracks phylogenies across various taxonomic groups. We report a comprehensive analysis of codon pairing, including the extent to which each codon pairs. Our parsimony method generally recovers phylogenies that are more congruent with the established phylogenies than our alignment-free method. However, four of the ten taxonomic groups did not have sufficient orthologous codon pairings and were therefore analyzed using only the alignment-free methods. Since the recovered phylogenies using only codon pairing largely match phylogenies from the Open Tree of Life and the NCBI taxonomy, and are comparable to trees recovered by other algorithms, we propose that codon pairing biases are phylogenetically conserved and should be considered in conjunction with other phylogenomic techniques.	[Miller, Justin B.; McKinnon, Lauren M.; Whiting, Michael F.; Kauwe, John S. K.; Ridge, Perry G.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Whiting, Michael F.] Brigham Young Univ, ML Bean Museum, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Ridge, PG (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	perry.ridge@byu.edu	Kauwe, John/AAC-6646-2021; Miller, Justin/AAG-8696-2021	Kauwe, John/0000-0001-8641-2468; Miller, Justin/0000-0002-5309-1570; Harmon, Lauren/0000-0002-2248-0602	Brigham Young University	Brigham Young University	We appreciate the support of Brigham Young University and the technical assistance of the Fulton Supercomputing Laboratory staff.	[Anonymous], [No title captured]; Bonham-Carter O, 2014, BRIEF BIOINFORM, V15, P890, DOI 10.1093/bib/bbt052; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chan CX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06504; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; ELLENBERGER T, 1994, CURR OPIN STRUC BIOL, V4, P12, DOI 10.1016/S0959-440X(94)90054-X; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foley KC, 2017, MOL THER-ONCOLYTICS, V5, P105, DOI 10.1016/j.omto.2017.05.004; Giribet G., 2005, SYST BIOL, V54, P176, DOI DOI 10.1080/10635150590905830; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; HASZPRUNAR G, 1992, J EVOLUTION BIOL, V5, P13, DOI 10.1046/j.1420-9101.1992.5010013.x; Haubold B, 2015, BIOINFORMATICS, V31, P1169, DOI 10.1093/bioinformatics/btu815; Haubold B, 2009, J COMPUT BIOL, V16, P1487, DOI 10.1089/cmb.2009.0106; Hinchliff CE, 2015, P NATL ACAD SCI USA, V112, P12764, DOI 10.1073/pnas.1423041112; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lee D, 2013, PHYS CHEM CHEM PHYS, V15, P5844, DOI 10.1039/c3cp00160a; Leimeister CA, 2017, BIOINFORMATICS, V33, P971, DOI 10.1093/bioinformatics/btw776; Leimeister CA, 2014, BIOINFORMATICS, V30, P2000, DOI 10.1093/bioinformatics/btu331; Martens AT, 2015, NUCLEIC ACIDS RES, V43, P3680, DOI 10.1093/nar/gkv200; Miller JB, 2019, PEERJ PREPRINTS, V7, DOI [10.7287/peerj.preprints.27756v1, DOI 10.7287/PEERJ.PREPRINTS.27756V1]; Miller JB, 2020, MOL PHYLOGENET EVOL, V144, DOI 10.1016/j.ympev.2019.106697; Miller JB, 2017, CLADISTICS, V33, P545, DOI 10.1111/cla.12183; Pavey SA, 2010, ANN NY ACAD SCI, V1206, P110, DOI 10.1111/j.1749-6632.2010.05765.x; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; POST LE, 1979, P NATL ACAD SCI USA, V76, P1697, DOI 10.1073/pnas.76.4.1697; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Shao ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033547; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; Shen XX, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0126; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; Soltis DE, 2003, PLANT PHYSIOL, V132, P1790, DOI 10.1104/pp.103.022509; Tan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep26027; Thomas F, 2017, BIOCHEMISTRY-US, V56, P6544, DOI 10.1021/acs.biochem.7b00848; Truebestein L, 2016, BIOESSAYS, V38, P903, DOI 10.1002/bies.201600062; Ulitsky I, 2006, J COMPUT BIOL, V13, P336, DOI 10.1089/cmb.2006.13.336; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wilgenbusch JC, INFERRING EVOLUTIONA, DOI [10.1002/0471250953.bi0604s00, DOI 10.1002/0471250953.BI0604S00]; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Yi HG, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt003; Zhang YM, 2013, GENOMICS, V101, P362, DOI 10.1016/j.ygeno.2013.04.008; Zuo GH, 2015, GENOM PROTEOM BIOINF, V13, P321, DOI 10.1016/j.gpb.2015.08.004	54	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232260	10.1371/journal.pone.0232260	http://dx.doi.org/10.1371/journal.pone.0232260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401752	Green Published, gold			2022-12-26	WOS:000537481000013
J	Picariello, T; Hou, YQ; Kubo, T; McNeill, NA; Yanagisawa, H; Oda, T; Witman, GB				Picariello, Tyler; Hou, Yuqing; Kubo, Tomohiro; McNeill, Nathan A.; Yanagisawa, Haruaki; Oda, Toshiyuki; Witman, George B.			TIM, a targeted insertional mutagenesis method utilizing CRISPR/Cas9 in Chlamydomonas reinhardtii	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT; GUIDE RNA; GENES; IFT; MUTANT; MUTATIONS; PROTEINS; KNOCKOUT; COMPLEX; CILIUM	Generation and subsequent analysis of mutants is critical to understanding the functions of genes and proteins. Here we describe TIM, an efficient, cost-effective, CRISPR-based targeted insertional mutagenesis method for the model organism Chlamydomonas reinhardtii. TIM utilizes delivery into the cell of a Cas9-guide RNA (gRNA) ribonucleoprotein (RNP) together with exogenous double-stranded (donor) DNA. The donor DNA contains gene-specific homology arms and an integral antibiotic-resistance gene that inserts at the double-stranded break generated by Cas9. After optimizing multiple parameters of this method, we were able to generate mutants for six out of six different genes in two different cell-walled strains with mutation efficiencies ranging from 40% to 95%. Furthermore, these high efficiencies allowed simultaneous targeting of two separate genes in a single experiment. TIM is flexible with regard to many parameters and can be carried out using either electroporation or the glass-bead method for delivery of the RNP and donor DNA. TIM achieves a far higher mutation rate than any previously reported for CRISPR-based methods in C. reinhardtii and promises to be effective for many, if not all, non-essential nuclear genes.	[Picariello, Tyler; Hou, Yuqing; McNeill, Nathan A.; Witman, George B.] Univ Massachusetts, Sch Med, Dept Radiol, Div Cell Biol & Imaging, Worcester, MA 01605 USA; [Kubo, Tomohiro; Oda, Toshiyuki] Univ Yamanashi, Interdisciplinary Grad Sch, Dept Anat & Struct Biol, Chuo Ku, Yamanashi, Japan; [Yanagisawa, Haruaki] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Picariello, Tyler] Sanofi Genzyme, Framingham, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Yamanashi; University of Tokyo; Sanofi-Aventis; Genzyme Corporation	Witman, GB (corresponding author), Univ Massachusetts, Sch Med, Dept Radiol, Div Cell Biol & Imaging, Worcester, MA 01605 USA.	george.witman@umassmed.edu	Oda, Toshiyuki/GLR-2321-2022	Oda, Toshiyuki/0000-0001-8090-2159; Yanagisawa, Haruaki/0000-0003-0313-2343; Hou, Yuqing/0000-0002-7038-675X; McNeill, Nathan/0000-0001-9688-5728	National Institutes of Health [R37 GM030626, R35 GM122574]; Robert W. Booth Endowment at the University of Massachusetts Medical School; Japan Society for the Promotion of Science [17H05057, 17K15115, 19K16123]; Takeda Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert W. Booth Endowment at the University of Massachusetts Medical School; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by National Institutes of Health (https://www.nih.gov/) grants R37 GM030626 and R35 GM122574 (to G.B.W.); by the Robert W. Booth Endowment at the University of Massachusetts Medical School (https://www.umassmed.edu/) (to G.B.W.); by the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) KAKENHI grants 17H05057 (to T.O.) and 17K15115 and 19K16123 (to T.K.); and by the Takeda Science Foundation (https://www.takeda-sci.or.jp/index.html) (to T.O. and T.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Brown JM, 2015, CURR BIOL, V25, P1583, DOI 10.1016/j.cub.2015.04.060; Brown JM, 2012, J CELL SCI, V125, P3904, DOI 10.1242/jcs.107151; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Craft JM, 2015, J CELL BIOL, V208, P223, DOI 10.1083/jcb.201409036; Dai J, 2018, MOL BIOL CELL, V29, P2553, DOI 10.1091/mbc.E18-05-0291; Fagerlund RD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0824-9; Ferenczi A, 2017, P NATL ACAD SCI USA, V114, P13567, DOI 10.1073/pnas.1710597114; Ferris PJ, 1996, MOL BIOL CELL, V7, P1235, DOI 10.1091/mbc.7.8.1235; Findinier J, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008047; Fu G, 2019, J CELL BIOL, V218, P4236, DOI 10.1083/jcb.201906006; Galvan A, 2007, ADV EXP MED BIOL, V616, P77; Gonzalez-Ballester D, 2005, ANAL BIOCHEM, V340, P330, DOI 10.1016/j.ab.2005.01.031; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Greiner A, 2017, PLANT CELL, V29, P2498, DOI 10.1105/tpc.17.00659; Guzman-Zapata D, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051247; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Hayashi M, 2002, CELL MOTIL CYTOSKEL, V53, P273, DOI 10.1002/cm.10075; Hou YQ, 2004, MOL BIOL CELL, V15, P4382, DOI 10.1091/mbc.E04-05-0377; Hunter EL, 2018, MOL BIOL CELL, V29, P886, DOI 10.1091/mbc.E17-12-0729; Jeong J, 2018, J EXP BOT, V69, P1147, DOI 10.1093/jxb/erx457; Jiang WZ, 2014, EUKARYOT CELL, V13, P1465, DOI 10.1128/EC.00213-14; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jinkerson RE, 2015, PLANT J, V82, P393, DOI 10.1111/tpj.12801; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kubo T, 2016, J CELL SCI, V129, P2106, DOI 10.1242/jcs.187120; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Li XB, 2019, NAT GENET, V51, P627, DOI 10.1038/s41588-019-0370-6; Lin HW, 2018, PLANT PHYSIOL, V178, P1436, DOI 10.1104/pp.18.00474; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; PAZOUR GJ, 1995, J CELL BIOL, V131, P427, DOI 10.1083/jcb.131.2.427; Pazour GJ, 2000, METHODS, V22, P285, DOI 10.1006/meth.2000.1081; Piasecki BP, 2009, MOL BIOL CELL, V20, P368, DOI 10.1091/mbc.E08-09-0900; Picariello T, 2019, J CELL SCI, V132; Pollock SV, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0170-x; SAGER R, 1953, ANN NY ACAD SCI, V56, P831, DOI 10.1111/j.1749-6632.1953.tb30261.x; Salome PA, 2019, PLANT CELL, V31, P1682, DOI 10.1105/tpc.18.00952; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; Shamoto N, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090124; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Shin YS, 2019, BIORESOURCE TECHNOL, V271, P368, DOI 10.1016/j.biortech.2018.09.121; TAM LW, 1993, GENETICS, V135, P375; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; Wren KN, 2013, CURR BIOL, V23, P2463, DOI 10.1016/j.cub.2013.10.044; Zhao L, 2019, J CELL BIOL, V218, P2051, DOI 10.1083/jcb.201902017	48	16	16	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2020	15	5							e0232594	10.1371/journal.pone.0232594	http://dx.doi.org/10.1371/journal.pone.0232594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0VG	32401787	Green Published, gold			2022-12-26	WOS:000537481000024
J	Rogers, CJ; Lukaszewicz, AI; Yamada-Hanff, J; Micewicz, ED; Ratikan, JA; Starbird, MA; Miller, TA; Nguyen, C; Lee, JT; Olafsen, T; Iwamoto, KS; McBride, WH; Schaue, D; Menon, N				Rogers, Claude J.; Lukaszewicz, Agnes I.; Yamada-Hanff, Jason; Micewicz, Ewa D.; Ratikan, Josephine A.; Starbird, Mark A.; Miller, Thomas A.; Nguyen, Christine; Lee, Jason T.; Olafsen, Tove; Iwamoto, Keisuke S.; McBride, William H.; Schaue, Dorthe; Menon, Naresh			Identification of miRNA signatures associated with radiation-induced late lung injury in mice	PLOS ONE			English	Article							GENE-EXPRESSION; IRRADIATION; MICRORNAS; RESISTANT; FIBROSIS; DAMAGE; MODEL; RNAS	Acute radiation exposure of the thorax can lead to late serious, and even life-threatening, pulmonary and cardiac damage. Sporadic in nature, late complications tend to be difficult to predict, which prompted this investigation into identifying non-invasive, tissue-specific biomarkers for the early detection of late radiation injury. Levels of circulating microRNA (miRNA) were measured in C3H and C57Bl/6 mice after whole thorax irradiation at doses yielding approximately 70% mortality in 120 or 180 days, respectively (LD70/120 or 180). Within the first two weeks after exposure, weight gain slowed compared to sham treated mice along with a temporary drop in white blood cell counts. 52% of C3H (33 of 64) and 72% of C57Bl/6 (46 of 64) irradiated mice died due to late radiation injury. Lung and heart damage, as assessed by computed tomography (CT) and histology at 150 (C3H mice) and 180 (C57Bl/6 mice) days, correlated well with the appearance of a local, miRNA signature in the lung and heart tissue of irradiated animals, consistent with inherent differences in the C3H and C57Bl/6 strains in their propensity for developing radiation-induced pneumonitis or fibrosis, respectively. Radiation-induced changes in the circulating miRNA profile were most prominent within the first 30 days after exposure and included miRNA known to regulate inflammation and fibrosis. Importantly, early changes in plasma miRNA expression predicted survival with reasonable accuracy (88-92%). The miRNA signature that predicted survival in C3H mice, including miR-34a-5p, -100-5p, and -150-5p, were associated with pro-inflammatory NF-kappa B-mediated signaling pathways, whereas the signature identified in C57Bl/6 mice (miR-34b-3p, -96-5p, and -802-5p) was associated with TGF-beta/SMAD signaling. This study supports the hypothesis that plasma miRNA profiles could be used to identify individuals at high risk of organ-specific late radiation damage, with applications for radiation oncology clinical practice or in the context of a radiological incident.	[Rogers, Claude J.; Lukaszewicz, Agnes I.; Yamada-Hanff, Jason; Starbird, Mark A.; Miller, Thomas A.; Menon, Naresh] ChromoLogic LLC, Monrovia, CA USA; [Micewicz, Ewa D.; Ratikan, Josephine A.; Nguyen, Christine; Iwamoto, Keisuke S.; McBride, William H.; Schaue, Dorthe] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA; [Lee, Jason T.; Olafsen, Tove] Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Menon, N (corresponding author), ChromoLogic LLC, Monrovia, CA USA.	nmenon@chromologic.com		Nguyen, Kieu Duyen/0000-0003-1397-769X; Lee, Jason/0000-0003-2590-2011	National Institute of Allergy and Infectious Disease [HHSN272201700012C, 2R44A108019-03]; NIAID	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded by the National Institute of Allergy and Infectious Disease (Contract Number HHSN272201700012C and Grant Number 2R44A108019-03; https://www.niaid.nih.gov).Funding was provided by NIAID to ChromoLogic. ChromoLogic provided support in the form of salaries for authors CJR, AIL, JYH, MAS, TAM, NM. NIAID did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; [Anonymous], 1926, REP PUBLIC HLTH MED; [Anonymous], 2011, GUIDE CARE USE LAB A; Aryankalayil MJ, 2018, BIOMARKERS, V23, P689, DOI 10.1080/1354750X.2018.1479771; Aryankalayil MJ, 2018, RADIAT RES, V189, P251, DOI 10.1667/RR14891.1; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brzoska K, 2015, RADIAT ENVIRON BIOPH, V54, P353, DOI 10.1007/s00411-015-0603-8; Chen RH, 2019, CONTRAST MEDIA MOL I, DOI 10.1155/2019/9463926; Chiang CS, 2005, INT J RADIAT ONCOL, V62, P862, DOI 10.1016/j.ijrobp.2005.02.037; Dinh TKT, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0636-4; Dodge A, 2006, ANALYST, V131, P1122, DOI 10.1039/b606394b; DOWN JD, 1986, RADIOTHER ONCOL, V6, P43, DOI 10.1016/S0167-8140(86)80108-6; Duhachek-Muggy S, 2020, STEM CELL TRANSL MED, V9, P106, DOI 10.1002/sctm.19-0136; Fendler W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2408; Fendler W, 2016, DIABETOLOGIA, V59, P1463, DOI 10.1007/s00125-016-3945-0; Ghandhi SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191402; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Haston CK, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00094; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Jackson IL, 2012, HEALTH PHYS, V103, P463, DOI 10.1097/HP.0b013e31826386ef; Jacob NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057603; JOHNSTON CJ, 1995, RADIAT RES, V142, P197, DOI 10.2307/3579029; Johnston CJ, 1998, EXP LUNG RES, V24, P321, DOI 10.3109/01902149809041538; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31740-8; Li L, 2019, CHEM COMMUN, V55, P10404, DOI 10.1039/c9cc05553c; Li S, 2017, BIOMED ENVIRON SCI, V30, P834, DOI 10.3967/bes2017.112; Liang H, 2007, PHYS MED BIOL, V52, P3881, DOI 10.1088/0031-9155/52/13/015; Liu K, 2019, PROTEOM CLIN APPL, V13, DOI 10.1002/prca.201900035; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Luo JD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33038-1; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Marchetti F, 2006, INT J RADIAT BIOL, V82, P605, DOI 10.1080/09553000600930103; McBride WH, 1997, RADIAT RES, V147, P501, DOI 10.2307/3579509; Menon N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167333; Micewicz ED, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181577; Ostheim P, 2019, RAD RES; Purbey PK, 2017, IMMUNITY, V47, P421, DOI 10.1016/j.immuni.2017.08.017; Romero F, 2015, AM J RESP CELL MOL, V53, P74, DOI 10.1165/rcmb.2014-0343OC; RUBIN P, 1983, INT J RADIAT ONCOL, V9, P1669, DOI 10.1016/0360-3016(83)90420-0; Shimizu Y, 2014, INT J IMMUNOPATH PH, V27, P37, DOI 10.1177/039463201402700106; Steinman J, 2018, RADIAT RES, V189, P68, DOI 10.1667/RR14787.1; Stiles JM, 2013, CANCER GENOM PROTEOM, V10, P251; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang WJ, 2019, DOSE-RESPONSE, V17, DOI 10.1177/1559325819829543; Wei L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20370-9; Xi X, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3648020; Xin ZL, 2018, AGEING RES REV, V41, P42, DOI 10.1016/j.arr.2017.11.002; Yahyapour R, 2018, CURR MOL PHARMACOL, V11, P285, DOI 10.2174/1874467211666180619125653; Yahyapour R, 2018, CURR MOL PHARMACOL, V11, P203, DOI 10.2174/1874467210666171108165641; Zhang XL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46000	54	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2020	15	5							e0232411	10.1371/journal.pone.0232411	http://dx.doi.org/10.1371/journal.pone.0232411			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0RD	32392259	gold, Green Published			2022-12-26	WOS:000537470300005
J	Jervan, M; Szlosek, DA; Friis, H; Coyne, MJ; DeNicola, D; Johnsen, OH				Jervan, Marte; Szlosek, Donald A.; Friis, Hanne; Coyne, Michael J.; DeNicola, Dennis; Johnsen, Ole H.			Characterization of C-reactive protein in dogs undergoing medial patellar luxation surgery	PLOS ONE			English	Article								C-reactive protein (CRP) is a major acute phase protein used to monitor response to treatment during surgical recovery. Depending on the anatomical problem, surgery type and technique, the level of CRP can change drastically. The aim of this study was to describe the changes in CRP and white blood cell (WBC) levels following surgery for medial patellar luxation in otherwise healthy dogs. Twenty-two dogs completed the study. CRP was measured using a commercially available dry chemistry slide on a commercially available in-clinic analyser. Analyses were performed using the Wilcoxon Rank Sum test and a mixed effects Poisson regression model. A significant change in CRP levels was found between the pre-anesthetic and 24 hr post-surgical timepoint with a median difference of 92.0 mg/dL (P < 0.001). Though a median drop in the CRP value of 13.9 mg/dL was observed between the 24 hr and 48 hr post-surgical time period, the result was not statistically significant (P = 0.456). Similarly, there was a significant increase in WBC between the pre-anesthetic and 24-hr post-surgical time point (P < 0.001) followed by a significant decrease in WBC between the 24 hr and 48-hr post-surgical time points (P = 0.015). In this study population, CRP levels were observed to aid in monitoring of the overall health of the dogs following surgery for medial patellar luxation. The results of this study suggest that both CRP and WBC values significantly increase by 24 hr but where CRP levels remain elevated through 48 hr post-surgery, WBC showed a significant drop between 24 and 48 hr. Further investigation into the length of time for both CRP and WBC to reach basal levels in this particular type of surgery would be of value to monitor recovery from surgery.	[Jervan, Marte; Johnsen, Ole H.] Fredrikstad Dyrehosp, Fredrikstad, Norway; [Szlosek, Donald A.; Friis, Hanne; Coyne, Michael J.; DeNicola, Dennis] IDEXX Labs Inc, Westbrook, ME 04092 USA		Friis, H (corresponding author), IDEXX Labs Inc, Westbrook, ME 04092 USA.	hanne-friis@idexx.com		Lund, Hanne Friis/0000-0003-2759-1616; Coyne, Michael/0000-0003-4107-2353	IDEXX Laboratories, Inc. Westbrook, ME, USA	IDEXX Laboratories, Inc. Westbrook, ME, USA	The work presented in this study was partly funded by IDEXX Laboratories, Inc. Westbrook, ME, USA (https://www.idexx.com/en/about-idexx/).IDEXX Laboratories provided support in the form of salaries for authors (HF, DS, MC, DDN) and cost of the CRP tests, but did not have any additional role in the study design, data collection and analysis or decision to publish. The specific roles of these authors are articulated in the author contributions section	[Anonymous], J STAT SOFTW, DOI [10.18637/jss.v067.i01, DOI 10.18637/JSS.V067.I01]; Bilbrough GE, IDEXX CATALYST CRP T; Cameron A. C., 1986, J APPL ECONOMET, V1, P29, DOI DOI 10.1002/JAE.3950010104; Christensen MB, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0164-5; Di Dona F, 2018, VET MED-RES REP, V9, P23, DOI 10.2147/VMRR.S142545; Kanno N, 2019, ACTA VET SCAND, V61, DOI 10.1186/s13028-019-0468-y; Kjelgaard-Hansen M, 2013, VET CLIN PATH, V42, P342, DOI 10.1111/vcp.12063; Lofqvist K, 2018, ACTA VET SCAND, V60, DOI 10.1186/s13028-018-0385-5; NCLSI, 2008, CLIN LAB STAND I MAN; R Core Team, 2020, R LANG ENV STAT COMP; Sibanda S, 2006, VET ANAESTH ANALG, V33, P246, DOI 10.1111/j.1467-2995.2005.00261.x; Zhang SX, 2013, J VET MED SCI, V75, P1161, DOI 10.1292/jvms.12-0538	12	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0231445	10.1371/journal.pone.0231445	http://dx.doi.org/10.1371/journal.pone.0231445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384082	Green Published, gold			2022-12-26	WOS:000537468300003
J	Rowneki, M; Aronson, N; Du, PC; Sachs, P; Blakemore, R; Chakravorty, S; Levy, S; Jones, AL; Trivedi, G; Chebore, S; Addo, D; Byarugaba, DK; Njobvu, PD; Wabwire-Mangen, F; Erima, B; Ramos, ES; Evans, CA; Hale, B; Mancuso, JD; Alland, D				Rowneki, Mazhgan; Aronson, Naomi; Du, Peicheng; Sachs, Paige; Blakemore, Robert; Chakravorty, Soumitesh; Levy, Shawn; Jones, Angela L.; Trivedi, Geetika; Chebore, Sheilla; Addo, Dennis; Byarugaba, Denis K.; Njobvu, Panganani Dalisani; Wabwire-Mangen, Frederick; Erima, Bernard; Ramos, Eric S.; Evans, Carlton A.; Hale, Braden; Mancuso, James D.; Alland, David			Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears	PLOS ONE			English	Article							STAINED SPUTUM SMEARS; RIFAMPIN RESISTANCE; RAPID DETECTION; PCR; STRAINS; COMPLEX	Background Drug susceptibility testing for Mycobacterium tuberculosis (MTB) is difficult to perform in resource-limited settings where Acid Fast Bacilli (AFB) smears are commonly used for disease diagnosis and monitoring. We developed a simple method for extraction of MTB DNA from AFB smears for sequencing-based detection of mutations associated with resistance to all first and several second-line anti-tuberculosis drugs. Methods We isolated MTB DNA by boiling smear content in a Chelex solution, followed by column purification. We sequenced PCR-amplified segments of the rpoB, katG, embB, gyrA, gyrB, rpsL, and rrs genes, the inhA, eis, and pncA promoters and the entire pncA gene. Results We tested our assay on 1,208 clinically obtained AFB smears from Ghana (n = 379), Kenya (n = 517), Uganda (n = 262), and Zambia (n = 50). Coverage depth varied by target and slide smear grade, ranging from 300X to 12000X on average. Coverage of >= 20X was obtained for all targets in 870 (72%) slides overall. Mono-resistance (5.9%), multi-drug resistance (1.8%), and poly-resistance (2.4%) mutation profiles were detected in 10% of slides overall, and in over 32% of retreatment and follow-up cases. Conclusion This rapid AFB smear DNA-based method for determining drug resistance may be useful for the diagnosis and surveillance of drug-resistant tuberculosis.	[Rowneki, Mazhgan; Blakemore, Robert; Chakravorty, Soumitesh; Alland, David] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Aronson, Naomi; Sachs, Paige] Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA; [Du, Peicheng] Rutgers State Univ, Off Adv Res Comp, Newark, NJ USA; [Levy, Shawn; Jones, Angela L.; Trivedi, Geetika] HudsonAlpha Inst Biotechnol, Genom Serv Lab, Huntsville, AL USA; [Chebore, Sheilla] US Army, Med Res Directorate Africa, Kenya Med Res Inst, Kericho, Kenya; [Addo, Dennis] 37 Mil Hosp, Ghana Armed Forces TB Control Program, Accra, Ghana; [Byarugaba, Denis K.; Wabwire-Mangen, Frederick; Erima, Bernard] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Njobvu, Panganani Dalisani] Maina Soko Mil Hosp, Zambia Def Force Med Serv, Lusaka, Zambia; [Ramos, Eric S.; Evans, Carlton A.] Univ Peruana Cayetano Heredia, Lab Res & Dev IFHAD, Innovat Hlth & Dev, Lima, Peru; [Ramos, Eric S.] Asociac Benef Prisma, Innovac Salud & Desarollo IPSYD, Lima, Peru; [Evans, Carlton A.] Wellcome Trust Imperial Coll, Infect Dis & Immun, Ctr Global Hlth Res, London, England; [Hale, Braden] Def Hlth Agcy, Naval Hlth Res Ctr, San Diego, CA USA; [Hale, Braden] Univ Calif San Diego, La Jolla, CA 92093 USA; [Mancuso, James D.] Armed Forces Hlth Surveillance Branch, Silver Spring, MD USA; [Rowneki, Mazhgan] Vet Affairs New Jersey Healthcare Syst, War Related Illness & Injury Study Ctr, E Orange, NJ 07018 USA; [Blakemore, Robert] Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA USA; [Chakravorty, Soumitesh] Cepheid Inc, Res & Dev, Sunnyvale, CA USA; [Mancuso, James D.] Uniformed Serv Univ Hlth Sci, Prevent Med & Biostat Dept, Bethesda, MD 20814 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Uniformed Services University of the Health Sciences - USA; Rutgers State University Newark; Rutgers State University New Brunswick; HudsonAlpha Institute for Biotechnology; Kenya Medical Research Institute; Makerere University; Universidad Peruana Cayetano Heredia; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); University of California System; University of California San Diego; Tufts University; Uniformed Services University of the Health Sciences - USA	Rowneki, M; Alland, D (corresponding author), Rutgers New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA.; Rowneki, M (corresponding author), Vet Affairs New Jersey Healthcare Syst, War Related Illness & Injury Study Ctr, E Orange, NJ 07018 USA.	Mazhgan.Rowneki@VA.gov; allandda@njms.rutgers.edu	; Mancuso, James/M-9339-2016	Ramos Maguina, Eric Steve/0000-0003-1236-5990; Mancuso, James/0000-0002-0717-8202; Byarugaba, Denis K./0000-0002-4175-5659; Evans, Carlton/0000-0002-6873-5447	Department of Defense Armed Forces Health Surveillance Branch; Global Emerging Infections Surveillance Section [P0028_14_HS]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [RC1 AI087062]; Department For International Development (UK-AID) Civil Society Challenge Fund (DFID-CSCF) [419]; Wellcome Trust [078340/Z/05/Z]; MRC [MR/K007467/1] Funding Source: UKRI	Department of Defense Armed Forces Health Surveillance Branch; Global Emerging Infections Surveillance Section; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department For International Development (UK-AID) Civil Society Challenge Fund (DFID-CSCF); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Department of Defense Armed Forces Health Surveillance Branch and the Global Emerging Infections Surveillance Section[grant number: P0028_14_HS; funding years: 2011-17] and from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health [award numberRC1 AI087062] awarded to N.A. E.S.R. and C.A.E. acknowledge funding from Department For International Development (UK-AID) Civil Society Challenge Fund (DFID-CSCF)[award 419] and Wellcome Trust [award number 078340/Z/05/Z]. The funding sources mentioned above did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Addo KK, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2853-3; Bhutia R, 2013, INT J TUBERC LUNG D, V17, P258, DOI 10.5588/ijtld.12.0452; Cauwelaert ND, 2011, J CLIN MICROBIOL, V49, P3600, DOI 10.1128/JCM.00745-11; Colman RE, 2016, J CLIN MICROBIOL, V54, P2058, DOI 10.1128/JCM.00535-16; International Union Against Tuberculosis and Lung Disease (IUATLD), 2000, SPUT EX TUB DIR MICR, P5; Kapata N, 2015, TROP MED INT HEALTH, V20, P1492, DOI 10.1111/tmi.12581; Kigozi E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198091; Lavania S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189149; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Miotto P, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01354-2017; Mokrousov I, 2002, J CLIN MICROBIOL, V40, P2509, DOI 10.1128/JCM.40.7.2509-2512.2002; Mokrousov I, 2003, ANTIMICROB AGENTS CH, V47, P2231, DOI 10.1128/AAC.47.7.2231-2235.2003; Otchere ID, 2016, TUBERCULOSIS, V99, P147, DOI 10.1016/j.tube.2016.05.014; Patnaik M, 2001, J CLIN MICROBIOL, V39, P51, DOI 10.1128/JCM.39.1.51-52.2001; Salamon H, 2015, J INFECT DIS, V211, pS50, DOI 10.1093/infdis/jiu816; Ssengooba W, 2016, INFECT GENET EVOL, V40, P8, DOI 10.1016/j.meegid.2016.02.019; Suresh N, 2007, DIAGN MICR INFEC DIS, V58, P217, DOI 10.1016/j.diagmicrobio.2007.01.007; Van Der Zanden AGM, 2003, J CLIN MICROBIOL, V41, P1101, DOI 10.1128/JCM.41.3.1101-1108.2003; Vincent V, 2012, INT J TUBERC LUNG D, V16, P24, DOI 10.5588/ijtld.11.0223; Whitfield MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133869; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2011, GLOB TUB CONTR WHO R; World Health Organization, 2018, RAP COMM KEY CHANG T; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106	26	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2020	15	5							e0232343	10.1371/journal.pone.0232343	http://dx.doi.org/10.1371/journal.pone.0232343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU0QJ	32384098	Green Published, gold			2022-12-26	WOS:000537468300010
J	Bancha, B; Kinfe, AA; Chanko, KP; Workie, SB; Tadese, T				Bancha, Belete; Kinfe, Aseb Arba; Chanko, Kebreab Paulos; Workie, Shimelash Bitew; Tadese, Takele			Prevalence of hepatitis B viruses and associated factors among pregnant women attending antenatal clinics in public hospitals of Wolaita Zone, South Ethiopia	PLOS ONE			English	Article								Background Hepatitis B virus (HBV) infection is a serious public health problem in sub-Saharan Africa pregnant women. HBV Infection has high tendency of vertical transmission and have adverse effect on both the mother and child. However, there is no evidence on prevalence of hepatitis B virus among pregnant women in Wolaita Zone. Therefore, this study aims to determine prevalence and associated factors of hepatitis B virus infection among pregnant attending Antenatal clinics of public Hospitals of Wolaita Zone. Method An institution based cross sectional study was conducted among pregnant women attending antenatal clinics of Wolaita Zone from October-November, 2018. Systematic random sampling was used to get respondents. A pretested, structured questionnaire was used to collect socio-demographic characteristics and other variables. In addition, 5 ml of venous blood was collected from each study participants and serum was tested for Hepatitis B surface antigen. Data was entered to Epidata 3.1 version and exported Statistical Package for Social Sciences Version 20.0 for descriptive and logistic regression analysis. All variables in bivariate analysis with p<0.25 were taken to multivariable analysis. P-value and Odds ratio with 95% CI was used to measure the presence and strength of the association respectively. Result The prevalence of Hepatitis B surface Antigen among pregnant women was 49(7.3%). History of multiple sexual partners (AOR = 2.675, 95%CI = 1.107-6.463), surgical procedure (AOR = 3.218, 95%CI = 1.446-7.163), genital mutilation (AOR = 2.72, 95% CI = 1.407-5.263), and tooth extraction (AOR = 2.049, 95%CI = 1.061-3.956) were statistically associated with HBV. Conclusion and recommendation Intermediate endemicity of Hepatitis B Virus (7.3%) was observed among mothers attending antenatal clinics of Wolaita Zone. History of tooth extraction, history of surgical procedure, history of genital mutilation and history multiple sexual partners were factors associated with acquisition of Hepatitis B Virus infection. Therefore, we recommend that the health education programs should be done to avoid traditional and non-sterile tooth extraction methods, female genital mutilation and avoiding having multiple sexual partner and its consequences to community and to raise the awareness of mothers attending antenatal clinics. Facilities should strictly follow sterile procedures in every surgical procedure.	[Bancha, Belete] Wolaita Sodo Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Wolaita Sodo, Ethiopia; [Kinfe, Aseb Arba] Wolaita Sodo Univ, Coll Med & Hlth Sci, Sch Nursing, Wolaita Sodo, Ethiopia; [Chanko, Kebreab Paulos] Wolaita Sodo Univ, Coll Med & Hlth Sci, Sch Midwifery, Wolaita Sodo, Ethiopia; [Workie, Shimelash Bitew; Tadese, Takele] Wolaita Sodo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Wolaita Sodo, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar	Kinfe, AA (corresponding author), Wolaita Sodo Univ, Coll Med & Hlth Sci, Sch Nursing, Wolaita Sodo, Ethiopia.	40aseb@gmail.com	Arba, Aseb/AAM-7998-2020	Arba, Aseb/0000-0002-7026-6731; Bitew, Shimelash/0000-0002-6159-6309				Adabara N. U., 2012, Shiraz E Medical Journal, V13, P28; Adugna Gudeta, 2016, INT J RES, V3; Allen N., 2017, INT BLOOD RES REV, V7, P1; Amsalu A, 2018, J PREGNANCY, V2018, DOI 10.1155/2018/8435910; BrunelM A., 2016, INT J SCI REIJSR, V5; Chernet Asrat, 2017, BMC Res Notes, V10, P418, DOI 10.1186/s13104-017-2702-x; Cruz HM, 2017, MEM I OSWALDO CRUZ, V112, P209, DOI 10.1590/0074-02760160394; Delelegn Tsegaye, 2018, EC GYNAECOLOGY, V7, P421; Frambo Andreas A Besong, 2014, BMC Res Notes, V7, P394, DOI 10.1186/1756-0500-7-394; Hassan Dahie, 2017, ARCH BUSINESS RES, P5, DOI [10.14738/abr.511.3876, DOI 10.14738/ABR.511.3876]; Lem EA., 2016, EUROPEAN J RES MED S, V4; Makhlouf NA, 2014, EGYPTIAN LIVER J, V4, P57, DOI DOI 10.1111/liv.13260; Mohammed Abuelgasim, 2015, J US CHINA MED SCI, V12, P10; Mohammed Seid B.G., 2014, ADV LIFE SCI HLTH, V1; Ngaira JAM, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.315.9255; Nongo B. H., 2016, Annals of Nigerian Medicine, V10, P58, DOI 10.4103/0331-3131.206213; Nordin AS, 2015, ADV SOC SCI EDUC HUM, V14, P7; Olokoba AB, 2011, NIGER J CLIN PRACT, V14, P10, DOI 10.4103/1119-3077.79232; Omokayode Emmanuel, 2015, IJEBU ODE, V2; Shazia PS, 2012, J MICROBIOL BIOTECHN, V2, P343; Sibia Preetkanwal, 2016, J Clin Diagn Res, V10, pQC08, DOI 10.7860/JCDR/2016/20614.8299; Sule W. F., 2011, NATURE SCI, V9, P37; Umare A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166936; Utoo Bt, 2013, AFRICAN HLTH SCI, V13; Yeshi Metaferia, 2016, EPIDEMIOLOGY HLTH, V38; Yohanes T., 2016, SEROPREVALENCE PREDI, P7; Yohannes Zenebe, 2014, BMC INFECT DIS, V14	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2020	15	5							e0232653	10.1371/journal.pone.0232653	http://dx.doi.org/10.1371/journal.pone.0232653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZX	32379803	Green Published, gold			2022-12-26	WOS:000537285700051
J	Nguyen, ITN; Brandt, MM; van de Wouw, J; van Drie, RWA; Wesseling, M; Cramer, MJ; de Jager, SCA; Merkus, D; Duncker, DJ; Cheng, C; Joles, JA; Verhaar, MC				Nguyen, Isabel T. N.; Brandt, Maarten M.; van de Wouw, Jens; van Drie, Ruben W. A.; Wesseling, Marian; Cramer, Maarten J.; de Jager, Saskia C. A.; Merkus, Daphne; Duncker, Dirk J.; Cheng, Caroline; Joles, Jaap A.; Verhaar, Marianne C.			Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction	PLOS ONE			English	Article							SEX-DIFFERENCES; DIAGNOSIS; PATHOPHYSIOLOGY; EPIDEMIOLOGY; GUIDELINES; FIBROSIS; MODELS	Heart failure with a preserved ejection fraction (HFpEF) is associated with multiple comorbidities, such as old age, hypertension, type 2 diabetes and obesity and is more prevalent in females. Although the male obese ZSF1 rat has been proposed as a suitable model to study the development of diastolic dysfunction and early HFpEF, studies in female animals have not been performed yet. Therefore, we aimed to characterize the cardiac phenotype in female obese ZSF1 rats and their lean counterparts. Additionally, we aimed to investigate whether differences exist in disease progression in obese male and female ZSF1 rats. Therefore, male and female ZSF1 rats, lean as well as obese (N = 6-9/subgroup), were used. Every two weeks, from 12 to 26 weeks of age, systolic blood pressure and echocardiographic measurements were performed, and venous blood was sampled. Female obese ZSF1 rats, as compared to female lean ZSF1 rats, developed diastolic dysfunction with cardiac hypertrophy and fibrosis in the presence of severe dyslipidemia, increased plasma growth differentiation factor 15 and mild hypertension, and preservation of systolic function. Although obese female ZSF1 rats did not develop hyperglycemia, their diastolic dysfunction was as severe as in the obese males. Taken together, the results from the present study suggest that the female obese ZSF1 rat is a relevant animal model for HFpEF with multiple comorbidities, suitable for investigating novel therapeutic interventions.	[Nguyen, Isabel T. N.; Cheng, Caroline; Joles, Jaap A.; Verhaar, Marianne C.] Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands; [Brandt, Maarten M.; van de Wouw, Jens; van Drie, Ruben W. A.; Merkus, Daphne; Duncker, Dirk J.; Cheng, Caroline] Univ Med Ctr Rotterdam, Dept Cardiol, Div Expt Cardiol, Erasmus MC, Rotterdam, Netherlands; [Wesseling, Marian; de Jager, Saskia C. A.] Univ Utrecht, Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Cramer, Maarten J.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Merkus, Daphne] Walter Brendel Ctr Expt Med WBex, Munich, Germany; [Merkus, Daphne] German Ctr Cardiovasc Res DZHK, Munich Heart Alliance MHA, Partner Site Munich, Munich, Germany	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; German Centre for Cardiovascular Research	Verhaar, MC (corresponding author), Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands.	m.C.Verhaar@umcutrecht.nl	Joles, Jaap/AAX-3249-2020; de+Jager, Saskia/AAE-1132-2022; de+Jager, Saskia/ABC-4264-2020	van Drie, Ruben/0000-0002-5383-4960; van de Wouw, Jens/0000-0001-7133-3046; de Jager, Saskia/0000-0002-5233-0066	Netherlands CardioVascular Research Initiative; Dutch Heart Foundation [CVON2014-11]; German Center for Cardiovascular Research (DZHK) [81Z0600207]	Netherlands CardioVascular Research Initiative; Dutch Heart Foundation(Netherlands Heart Foundation); German Center for Cardiovascular Research (DZHK)	This study was supported by a grant from the Netherlands CardioVascular Research Initiative: an initiative with support of the Dutch Heart Foundation [CVON2014-11 (RECONNECT)] and by the German Center for Cardiovascular Research (DZHK; 81Z0600207).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex L, 2018, AM J PHYSIOL-HEART C, V315, pH934, DOI 10.1152/ajpheart.00238.2018; Altara R, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00160; Beale AL, 2018, CIRCULATION, V138, P198, DOI 10.1161/CIRCULATIONAHA.118.034271; Bergeron R, 2014, HORM METAB RES, V46, P774, DOI 10.1055/s-0034-1381980; Bongartz LG, 2010, AM J PHYSIOL-REG I, V298, pR815, DOI 10.1152/ajpregu.00727.2009; Bongartz LG, 2012, AM J PHYSIOL-RENAL, V303, pF1253, DOI 10.1152/ajprenal.00392.2012; Borlaug BA, 2006, CIRCULATION, V114, P2138, DOI 10.1161/CIRCULATIONAHA.106.632745; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Brandt MM, 2019, J CELL MOL MED, V23, P6666, DOI 10.1111/jcmm.14542; BUNAG RD, 1991, MECH AGEING DEV, V59, P197, DOI 10.1016/0047-6374(91)90085-E; Chan V, 2011, J CARDIOVASC PHARM, V57, P469, DOI 10.1097/FJC.0b013e3182102c3b; Chandramouli C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20703-8; Conceicao G, 2016, NETH HEART J, V24, P275, DOI 10.1007/s12471-016-0815-9; Cook RF, 2017, EXP PHYSIOL, V102, P911, DOI 10.1113/EP086293; Corsetti JP, 2000, ATHEROSCLEROSIS, V148, P231, DOI 10.1016/S0021-9150(99)00265-8; Daniels A, 2012, EUR J HEART FAIL, V14, P193, DOI 10.1093/eurjhf/hfr166; de Lucia C, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004153; de Simone G, 2014, J AM SOC ECHOCARDIOG, V27, P1275, DOI 10.1016/j.echo.2014.10.006; Dinh Wilfried, 2011, Arq. Bras. Cardiol., V97, P65; Dunlay SM, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.65; Eaton CB, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002883; Gades MD, 1998, KIDNEY INT, V53, P130, DOI 10.1046/j.1523-1755.1998.00746.x; Gori M, 2014, EUR J HEART FAIL, V16, P535, DOI 10.1002/ejhf.67; Gouma E, 2012, LAB ANIM-UK, V46, P40, DOI 10.1258/la.2011.011021; Gustavsson C, 2011, J MOL ENDOCRINOL, V47, P129, DOI 10.1530/JME-11-0007; Hamdani N, 2013, CIRC-HEART FAIL, V6, P1239, DOI 10.1161/CIRCHEARTFAILURE.113.000539; Ho PM, 2008, DIABETES CARE, V31, P1531, DOI 10.2337/dc08-0616; Juilliere Y, 2018, ARCH CARDIOVASC DIS, V111, P766, DOI 10.1016/j.acvd.2018.04.007; Lam CSP, 2011, EUR J HEART FAIL, V13, P18, DOI 10.1093/eurjhf/hfq121; Leite S, 2015, AM J PHYSIOL-HEART C, V308, pH1556, DOI 10.1152/ajpheart.00076.2015; Li J, 2018, MED SCI MONITOR, V24, P4992, DOI 10.12659/MSM.910671; Litwin SE, 1999, CARDIOLOGY, V91, P173, DOI 10.1159/000006906; Lok SI, 2012, EUR J HEART FAIL, V14, P1249, DOI 10.1093/eurjhf/hfs120; Lourenco AP, 2018, EUR J HEART FAIL, V20, P216, DOI 10.1002/ejhf.1059; Lum-Naihe K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18003-8; Matyas C, 2017, EUR J HEART FAIL, V19, P326, DOI 10.1002/ejhf.711; Nauta JF, 2018, EUR J HEART FAIL, V20, P1303, DOI 10.1002/ejhf.1220; OHNEDA M, 1995, DIABETOLOGIA, V38, P173, DOI 10.1007/BF00400091; Patten Richard D, 2007, Drug Discov Today Dis Models, V4, P227, DOI 10.1016/j.ddmod.2007.11.002; Phan TT, 2010, CIRC-HEART FAIL, V3, P29, DOI 10.1161/CIRCHEARTFAILURE.109.877720; Pieske B, 2019, EUR HEART J, V40, P3297, DOI 10.1093/eurheartj/ehz641; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rafikova O, 2008, METABOLISM, V57, P1434, DOI 10.1016/j.metabol.2008.05.014; Regitz-Zagrosek V, 2017, PHYSIOL REV, V97, P1, DOI 10.1152/physrev.00021.2015; Rider OJ, 2013, EUR HEART J, V34, P292, DOI 10.1093/eurheartj/ehs341; Siwy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051334; Sorop O, 2018, CARDIOVASC RES, V114, P954, DOI 10.1093/cvr/cvy038; Stahrenberg R, 2010, EUR J HEART FAIL, V12, P1309, DOI 10.1093/eurjhf/hfq151; Su Z, 2016, AM J NEPHROL, V44, P339, DOI 10.1159/000449324; Thaung HPA, 2015, DIABETES, V64, P2944, DOI 10.2337/db14-0955; Tofovic SP, 2003, METH MOLEC MED, V86, P29; van Dijk CGM, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002760; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; Wan SH, 2014, J AM COLL CARDIOL, V63, P407, DOI 10.1016/j.jacc.2013.10.063; Youcef G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096452	55	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2020	15	5							e0232399	10.1371/journal.pone.0232399	http://dx.doi.org/10.1371/journal.pone.0232399			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7ZB	32374790	gold, Green Published			2022-12-26	WOS:000537283500031
